data_6fe6_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6fe6 _Structure_validation_residue.Date_analyzed 2019-01-25 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.7 mp0 . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 120.526 0.203 . . . . 0.0 111.298 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 63.3 t -109.97 126.36 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.072 -1.018 . . . . 0.0 109.922 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -115.29 159.47 20.98 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.638 -0.663 . . . . 0.0 110.074 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 62.7 t -116.63 129.94 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.521 -0.737 . . . . 0.0 110.034 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.5 p -136.99 139.57 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.543 -0.723 . . . . 0.0 110.003 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 72.7 m -125.12 141.2 52.25 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.5 -0.75 . . . . 0.0 110.381 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.68 -177.36 3.34 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.565 -0.709 . . . . 0.0 109.988 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.49 -40.01 77.29 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.594 -0.691 . . . . 0.0 111.238 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 67.2 p -114.42 -19.43 11.21 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.341 -0.849 . . . . 0.0 111.569 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -133.58 160.05 38.63 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.205 -0.935 . . . . 0.0 110.725 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.0 t -138.75 119.87 14.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.592 -0.693 . . . . 0.0 110.12 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -135.19 177.11 8.07 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.617 -0.677 . . . . 0.0 109.843 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 65.6 mt -118.68 160.34 22.01 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.486 -0.759 . . . . 0.0 110.36 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -124.99 153.32 42.97 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.544 -0.722 . . . . 0.0 110.043 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.8 m -125.87 140.09 52.94 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.522 -0.736 . . . . 0.0 110.402 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.9 t -88.84 108.76 19.7 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.504 -0.747 . . . . 0.0 110.094 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.6 t -123.0 129.99 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.648 -0.657 . . . . 0.0 109.921 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 54.47 38.71 30.18 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.568 -0.707 . . . . 0.0 110.899 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.87 17.49 69.5 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 65.6 t -130.22 129.94 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.227 -1.161 . . . . 0.0 109.734 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 69.2 m -79.24 130.15 35.18 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.498 -0.751 . . . . 0.0 109.898 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.452 ' CG ' ' CE ' ' A' ' 175' ' ' MET . 97.0 m95 -120.01 137.16 54.25 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.473 -0.767 . . . . 0.0 110.729 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.7 t -137.35 172.39 13.05 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.465 ' CG1' ' CE1' ' A' ' 57' ' ' HIS . 59.4 t -80.81 142.3 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.367 -0.833 . . . . 0.0 109.691 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.445 ' CE2' ' CG2' ' A' ' 78' ' ' VAL . 33.0 t80 -79.28 -39.89 31.85 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.448 -0.783 . . . . 0.0 111.636 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.465 ' CE1' ' CG1' ' A' ' 55' ' ' VAL . 1.4 p-80 -59.72 -23.27 63.03 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.968 -1.083 . . . . 0.0 110.396 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -74.15 -70.64 1.22 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.831 -1.708 . . . . 0.0 108.831 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.52 -52.9 62.57 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.543 -0.975 . . . . 0.0 109.743 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.432 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.403 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 35.9 m . . . . . 0 N--CA 1.493 1.714 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -60.24 125.1 22.39 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.509 -0.744 . . . . 0.0 110.509 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 91.0 mmm -92.12 -32.55 15.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.716 -0.615 . . . . 0.0 109.91 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -118.95 129.73 55.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.589 -0.694 . . . . 0.0 109.864 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.6 p -141.02 144.95 35.3 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.525 -0.734 . . . . 0.0 110.307 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -168.17 100.93 0.44 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.71 -0.619 . . . . 0.0 109.999 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.445 ' CG2' ' CE2' ' A' ' 56' ' ' TYR . 53.3 t -70.06 -42.84 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.427 -0.796 . . . . 0.0 109.88 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -60.06 -44.2 94.87 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.507 -0.746 . . . . 0.0 110.162 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -90.04 -8.56 51.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.811 -0.556 . . . . 0.0 110.563 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.4 t0 54.16 39.72 30.98 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.998 -1.064 . . . . 0.0 109.684 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.5 tp -119.93 129.98 54.58 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.329 0.585 . . . . 0.0 110.472 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.6 p -153.13 150.29 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.684 -0.635 . . . . 0.0 109.414 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -176.06 -174.31 42.48 Favored Glycine 0 N--CA 1.496 2.65 0 C-N-CA 119.622 -1.275 . . . . 0.0 110.571 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 14.1 m-90 -128.81 160.03 33.86 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.78 -0.836 . . . . 0.0 109.766 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -93.0 131.14 38.26 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.539 -0.726 . . . . 0.0 110.097 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -111.94 159.6 32.96 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.461 -0.774 . . . . 0.0 110.462 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.2 159.16 50.45 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 O-C-N 123.428 1.225 . . . . 0.0 110.608 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.17 160.2 39.85 Favored 'Trans proline' 0 C--N 1.317 -1.101 0 O-C-N 123.506 1.266 . . . . 0.0 110.412 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 115.35 -4.49 21.74 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -109.93 142.4 41.34 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.092 -1.24 . . . . 0.0 110.172 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -60.34 140.06 57.32 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.507 -0.745 . . . . 0.0 110.124 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 52.6 m -133.1 156.87 46.63 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.593 -0.692 . . . . 0.0 110.402 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.9 mt -91.36 162.84 14.43 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.67 -0.644 . . . . 0.0 110.234 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.2 p -120.89 165.07 19.89 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.63 -0.669 . . . . 0.0 110.075 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.34 164.81 32.69 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 O-C-N 123.369 1.194 . . . . 0.0 110.207 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 7.2 t -75.2 128.1 34.7 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.564 -0.71 . . . . 0.0 110.405 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 46.7 p -129.58 45.48 2.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.743 -0.598 . . . . 0.0 109.682 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.3 p -145.07 12.22 1.39 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.642 -0.661 . . . . 0.0 111.474 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.23 50.97 49.89 Favored Glycine 0 N--CA 1.499 2.866 0 O-C-N 121.062 -1.024 . . . . 0.0 110.546 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.1 m -92.7 107.09 18.95 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.42 -1.047 . . . . 0.0 110.4 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.1 p -70.11 -39.95 75.19 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.487 -0.758 . . . . 0.0 109.931 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -75.11 123.09 24.59 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.653 -0.654 . . . . 0.0 109.857 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 73.9 mt -129.99 150.61 51.19 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.607 -0.683 . . . . 0.0 110.2 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -106.84 133.5 51.4 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.49 -0.757 . . . . 0.0 109.874 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.1 tt -98.85 130.3 45.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.536 -0.728 . . . . 0.0 110.467 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.1 t -87.79 123.41 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.691 -0.63 . . . . 0.0 109.707 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.2 m -100.77 166.82 10.67 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.56 -0.713 . . . . 0.0 110.386 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 78.3 ttt-85 -61.89 -27.33 68.73 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.59 -0.694 . . . . 0.0 110.332 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -93.41 25.48 3.4 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.527 -0.733 . . . . 0.0 110.781 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.98 40.03 31.85 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.284 -0.885 . . . . 0.0 110.843 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -93.27 156.24 16.94 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.644 -0.66 . . . . 0.0 109.78 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.9 p -129.93 133.44 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.47 -0.769 . . . . 0.0 110.404 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.4 tp -146.13 134.89 11.04 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.702 -0.624 . . . . 0.0 109.892 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -76.15 139.2 21.16 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 O-C-N 123.155 1.082 . . . . 0.0 110.291 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.3 t -129.92 130.1 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.646 -0.659 . . . . 0.0 109.713 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.62 146.44 34.13 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.567 -0.708 . . . . 0.0 109.853 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -85.71 118.33 25.14 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.567 -0.708 . . . . 0.0 110.202 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.03 21.22 11.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.759 -0.588 . . . . 0.0 110.34 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 162.64 168.15 24.13 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -70.03 -40.02 75.43 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.566 -0.961 . . . . 0.0 110.693 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 89.8 p -114.68 -7.15 12.73 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.496 -0.753 . . . . 0.0 111.474 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -128.55 143.97 51.06 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.09 -1.006 . . . . 0.0 110.484 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -141.49 -174.64 14.5 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 80.1 p -120.53 144.17 48.2 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.558 -0.966 . . . . 0.0 110.165 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 57.8 tp -91.17 131.3 36.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.636 -0.665 . . . . 0.0 109.899 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.7 tp -60.09 -48.66 80.81 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.585 -0.697 . . . . 0.0 110.511 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 45.7 t -106.5 119.54 51.4 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.504 -0.747 . . . . 0.0 110.18 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.87 121.39 7.58 Favored 'Trans proline' 0 N--CA 1.486 1.034 0 O-C-N 123.191 1.101 . . . . 0.0 110.581 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 12.7 mtp85 -132.83 162.81 55.19 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.52 -0.737 . . . . 0.0 110.323 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.6 150.9 63.82 Favored 'Trans proline' 0 N--CA 1.486 1.076 0 O-C-N 123.482 1.254 . . . . 0.0 110.87 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.9 t -56.64 -35.29 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.484 -0.76 . . . . 0.0 110.252 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 34.8 t -58.44 -39.97 81.27 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.47 -0.768 . . . . 0.0 110.745 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -63.28 -39.94 95.98 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.489 -0.757 . . . . 0.0 109.592 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 21.3 tp -94.57 16.2 16.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.781 -0.574 . . . . 0.0 110.593 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 44.7 tttt -89.77 141.06 28.98 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.026 -1.046 . . . . 0.0 110.761 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 87.78 20.51 50.39 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 10.5 p -119.58 15.21 12.81 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.37 -1.077 . . . . 0.0 110.933 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 48.9 m -58.75 144.7 42.94 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.183 -0.948 . . . . 0.0 110.043 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 94.72 -16.67 60.72 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -58.5 111.1 2.94 Favored Glycine 0 N--CA 1.498 2.796 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -73.11 139.63 29.91 Favored 'Trans proline' 0 C--N 1.317 -1.082 0 O-C-N 123.197 1.104 . . . . 0.0 111.099 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.4 mp -93.37 123.71 36.85 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.3 mp -118.38 127.27 53.53 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.184 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 27.2 p -66.61 163.97 36.9 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.7 -0.625 . . . . 0.0 109.384 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.54 -19.86 68.48 Favored 'Trans proline' 0 C--N 1.315 -1.204 0 O-C-N 123.231 1.121 . . . . 0.0 110.952 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.4 m -69.97 -27.33 64.64 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.295 -0.878 . . . . 0.0 110.031 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 121.64 -21.46 8.01 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.466 -1.053 . . . . 0.0 110.466 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -77.56 162.96 26.7 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.253 -1.145 . . . . 0.0 110.632 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -105.09 145.03 31.08 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.65 -0.656 . . . . 0.0 110.353 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 12.5 p -101.51 -29.18 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.552 -0.718 . . . . 0.0 110.809 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 169.26 -161.55 35.12 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 55.9 mt -128.87 155.86 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.566 -0.961 . . . . 0.0 110.255 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -66.61 139.94 57.91 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.621 -0.674 . . . . 0.0 110.076 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -122.59 -67.48 0.95 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.564 -0.71 . . . . 0.0 110.803 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -135.27 150.3 50.01 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.453 -0.779 . . . . 0.0 110.78 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.41 151.74 19.15 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 48.6 t -120.01 119.97 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.507 -0.745 . . . . 0.0 110.432 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.4 p -141.6 157.81 44.63 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.543 -0.723 . . . . 0.0 110.415 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 18.4 p -94.58 -46.07 7.12 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.442 -0.786 . . . . 0.0 109.97 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 55.1 mmm-85 -130.37 35.96 4.01 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.644 -0.66 . . . . 0.0 109.552 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 101.2 -10.11 58.09 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 57.3 t -96.55 123.47 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.184 -1.186 . . . . 0.0 109.473 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.66 117.3 26.38 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.496 -0.753 . . . . 0.0 110.776 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -109.46 -29.96 8.18 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.654 -0.654 . . . . 0.0 109.674 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -126.5 157.22 39.26 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.633 -0.667 . . . . 0.0 109.618 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 31.0 m -129.42 142.89 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.485 -0.759 . . . . 0.0 110.675 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -117.23 132.51 56.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.653 -0.654 . . . . 0.0 110.421 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -141.31 159.57 41.93 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.595 -0.69 . . . . 0.0 110.135 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 12.9 p -93.15 142.85 25.85 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.505 -0.747 . . . . 0.0 110.446 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -77.34 162.43 31.02 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 O-C-N 123.288 1.151 . . . . 0.0 110.559 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 67.1 t -69.91 -32.38 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.627 -0.671 . . . . 0.0 109.881 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -60.03 -40.01 87.87 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.493 -0.755 . . . . 0.0 110.355 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 48.0 t -62.54 -39.95 95.26 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.633 -0.667 . . . . 0.0 109.924 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' MET . . . . . 0.452 ' CE ' ' CG ' ' A' ' 53' ' ' TRP . 95.0 mtp -60.25 -40.0 88.77 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.674 -0.641 . . . . 0.0 110.177 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.7 -40.02 90.65 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.706 -0.621 . . . . 0.0 110.322 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 94.0 m -60.11 -40.11 88.55 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.645 -0.659 . . . . 0.0 110.156 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 88.2 m -68.17 -44.21 76.47 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.583 -0.698 . . . . 0.0 110.047 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 33.9 ttp -60.63 -40.99 93.97 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.556 -0.715 . . . . 0.0 110.387 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -61.15 -40.02 92.28 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.609 -0.682 . . . . 0.0 110.178 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.767 0 O-C-N 121.608 -0.682 . . . . 0.0 110.268 179.982 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 . . . . . 0 N--CA 1.509 2.495 0 CA-C-O 120.966 0.413 . . . . 0.0 110.746 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.9 t -103.1 133.33 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.385 -0.822 . . . . 0.0 109.892 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -102.86 162.31 13.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.625 -0.672 . . . . 0.0 109.85 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.8 m -117.98 136.59 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.506 -0.746 . . . . 0.0 110.196 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.8 m -144.21 149.27 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.493 -0.755 . . . . 0.0 110.35 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.8 m -119.68 137.8 53.68 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.602 -0.687 . . . . 0.0 110.179 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -99.57 -178.43 3.89 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.577 -0.702 . . . . 0.0 110.001 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.0 -45.99 90.93 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.841 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.4 p -118.67 -27.99 5.74 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.403 -0.811 . . . . 0.0 110.995 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -114.27 173.95 6.19 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.324 -0.86 . . . . 0.0 110.526 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 40.3 t -151.87 121.33 6.85 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.55 -0.719 . . . . 0.0 109.975 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 34.7 p90 -132.65 -179.51 5.5 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.625 -0.672 . . . . 0.0 110.064 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 34.7 mt -118.76 178.62 4.41 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.518 -0.739 . . . . 0.0 109.605 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.0 161.37 38.3 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.474 -0.767 . . . . 0.0 110.98 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.8 p -125.34 144.09 50.66 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.721 -0.612 . . . . 0.0 109.689 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 27.0 p -91.9 111.79 23.46 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 121.72 0.772 . . . . 0.0 111.403 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.9 t -130.73 123.44 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.213 -0.929 . . . . 0.0 110.683 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 51.4 34.88 12.79 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.53 -0.731 . . . . 0.0 112.412 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.43 -17.04 41.19 Favored Glycine 0 N--CA 1.499 2.872 0 C-N-CA 120.1 -1.047 . . . . 0.0 111.659 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 62.8 t -105.82 128.63 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.091 -1.241 . . . . 0.0 110.477 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 78.5 m -84.32 107.78 16.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.634 -0.666 . . . . 0.0 109.532 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -91.85 137.48 32.33 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.509 -0.744 . . . . 0.0 110.59 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.402 ' OG1' ' CZ3' ' A' ' 85' ' ' TRP . 77.8 p -136.51 179.74 6.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.773 -0.58 . . . . 0.0 109.611 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.481 ' CG1' ' CE1' ' A' ' 57' ' ' HIS . 94.5 t -80.93 141.93 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.105 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.445 ' CE2' ' CG2' ' A' ' 78' ' ' VAL . 16.7 t80 -84.98 -43.44 13.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.445 -0.784 . . . . 0.0 111.248 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.481 ' CE1' ' CG1' ' A' ' 55' ' ' VAL . 2.2 p-80 -58.76 -25.02 62.63 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.24 -0.912 . . . . 0.0 110.941 -177.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -81.47 -48.67 5.82 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.52 -63.09 1.47 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.6 -0.941 . . . . 0.0 110.167 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.45 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 179.84 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.3 t . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 121.162 0.506 . . . . 0.0 110.433 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.5 tm0? -80.08 128.27 33.29 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.611 -0.681 . . . . 0.0 110.163 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.1 tpp -106.36 -51.13 3.01 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.604 -0.685 . . . . 0.0 110.129 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -120.73 138.63 53.89 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.48 -0.763 . . . . 0.0 110.184 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 98.8 m -152.23 127.86 10.11 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.602 -0.686 . . . . 0.0 110.175 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -168.45 120.23 0.81 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.416 -0.802 . . . . 0.0 110.833 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.445 ' CG2' ' CE2' ' A' ' 56' ' ' TYR . 91.8 t -72.25 -39.54 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.35 -0.844 . . . . 0.0 109.735 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.66 -43.01 75.87 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.363 -0.836 . . . . 0.0 109.803 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -92.02 -14.24 29.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.793 -0.567 . . . . 0.0 109.885 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.417 ' HB3' ' NE ' ' A' ' 155' ' ' ARG . 49.5 t0 54.27 35.38 22.61 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.064 -1.022 . . . . 0.0 110.099 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.5 mt -123.2 149.73 44.29 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.836 0.827 . . . . 0.0 111.934 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.42 HG11 ' CZ2' ' A' ' 85' ' ' TRP . 2.7 t -146.64 150.95 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 178.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -138.35 148.19 19.74 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 118.992 -1.575 . . . . 0.0 111.636 -178.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.42 ' CZ2' HG11 ' A' ' 83' ' ' VAL . 5.1 m-90 -138.25 124.6 20.54 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.18 135.33 57.69 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.34 -0.85 . . . . 0.0 110.721 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.418 ' CB ' ' CD ' ' A' ' 92' ' ' ARG . . . -101.41 175.44 2.33 Favored Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 121.417 -0.802 . . . . 0.0 109.849 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.45 147.96 59.55 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 O-C-N 123.465 1.245 . . . . 0.0 109.548 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.72 134.46 24.01 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 O-C-N 123.369 1.194 . . . . 0.0 110.245 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 131.59 -25.98 3.93 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -150.81 71.64 1.04 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.102 -1.234 . . . . 0.0 111.761 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.418 ' CD ' ' CB ' ' A' ' 87' ' ' ALA . 12.2 mmt180 -154.25 91.78 1.46 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.061 -1.024 . . . . 0.0 110.498 178.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.4 p -177.04 104.98 0.06 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.211 -0.93 . . . . 0.0 111.166 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 25.6 tp -117.34 131.91 56.7 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.583 -0.698 . . . . 0.0 109.406 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.3 t -76.45 137.28 67.66 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.363 -0.836 . . . . 0.0 110.74 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.04 166.21 28.35 Favored 'Trans proline' 0 N--CA 1.484 0.924 0 O-C-N 123.252 1.132 . . . . 0.0 110.204 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 47.4 t -82.41 132.85 35.21 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.505 -0.747 . . . . 0.0 110.24 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.0 t -135.98 48.87 2.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.655 -0.653 . . . . 0.0 109.797 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.4 p -144.92 0.17 0.94 Allowed 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 120.114 -0.634 . . . . 0.0 112.384 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 52.26 89.27 0.01 OUTLIER Glycine 0 N--CA 1.5 2.924 0 O-C-N 120.811 -1.181 . . . . 0.0 110.553 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.0 m -129.67 128.85 43.42 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.418 -1.048 . . . . 0.0 110.251 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.2 m -69.01 -40.02 78.94 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.577 -0.702 . . . . 0.0 110.122 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.69 142.13 58.24 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.557 -0.714 . . . . 0.0 109.965 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 57.2 mt -143.61 158.27 43.79 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.575 -0.703 . . . . 0.0 110.314 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -126.35 109.86 12.72 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.518 -0.739 . . . . 0.0 109.91 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.4 tt -93.42 133.58 36.55 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.528 -0.733 . . . . 0.0 110.462 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.1 t -98.28 130.03 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.668 -0.645 . . . . 0.0 109.762 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 68.1 p -99.04 169.91 9.08 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.527 -0.733 . . . . 0.0 110.456 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -63.34 -18.96 64.2 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.691 -0.631 . . . . 0.0 110.877 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -94.16 25.95 3.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.31 -0.869 . . . . 0.0 110.661 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 53.42 39.93 30.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.346 -0.846 . . . . 0.0 110.887 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -104.68 167.06 9.97 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.531 -0.731 . . . . 0.0 110.078 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.5 p -133.65 131.53 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.589 -0.694 . . . . 0.0 110.435 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 87.0 mt -133.08 127.99 20.34 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.587 -0.696 . . . . 0.0 109.872 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -74.94 125.05 9.1 Favored 'Trans proline' 0 N--CA 1.485 0.982 0 O-C-N 123.096 1.051 . . . . 0.0 110.392 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.9 t -120.25 129.53 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.567 -0.708 . . . . 0.0 109.771 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -87.53 136.8 32.8 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.506 -0.746 . . . . 0.0 110.197 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -74.39 140.11 44.52 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.657 -0.652 . . . . 0.0 110.293 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.35 9.5 3.45 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.589 -0.694 . . . . 0.0 111.0 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -169.34 -172.44 36.01 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -70.28 -39.97 74.6 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.615 -0.932 . . . . 0.0 110.68 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 96.1 p -130.77 9.81 5.02 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.462 -0.774 . . . . 0.0 111.393 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -123.66 148.72 46.23 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.1 -1.0 . . . . 0.0 110.17 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.15 167.82 24.8 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 19.2 p -107.76 158.9 16.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.52 -0.988 . . . . 0.0 110.21 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 40.1 tp -117.59 133.21 56.2 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.577 -0.702 . . . . 0.0 110.272 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.3 mp -69.28 -43.15 74.44 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.588 -0.695 . . . . 0.0 110.401 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 58.4 p -97.42 111.97 59.84 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.474 -0.766 . . . . 0.0 110.168 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -80.91 106.87 1.85 Allowed 'Trans proline' 0 C--N 1.319 -1.006 0 O-C-N 123.197 1.104 . . . . 0.0 110.607 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.72 157.89 38.12 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.554 -0.716 . . . . 0.0 109.851 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.12 150.25 65.75 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.421 1.221 . . . . 0.0 110.867 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 55.3 t -54.13 -30.47 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.422 -0.799 . . . . 0.0 109.723 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 46.0 t -59.91 -41.94 92.79 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.559 -0.713 . . . . 0.0 110.869 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -67.97 -39.97 83.26 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.482 -0.761 . . . . 0.0 109.719 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 33.0 tp -92.18 15.49 13.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.803 -0.56 . . . . 0.0 110.286 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -79.65 114.65 18.74 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 122.537 1.161 . . . . 0.0 112.128 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.93 37.18 3.72 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 61.3 m -119.26 19.13 12.89 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.705 -0.88 . . . . 0.0 110.454 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 66.3 m -70.54 136.28 49.2 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.25 -0.906 . . . . 0.0 109.169 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 109.77 -25.35 17.2 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.181 -1.567 . . . . 0.0 109.181 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.0 112.63 3.69 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.24 148.8 44.5 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 123.25 1.131 . . . . 0.0 111.105 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 67.7 mt -98.22 116.3 30.15 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.6 mp -103.37 127.71 50.66 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.509 -0.744 . . . . 0.0 111.015 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . 0.401 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 27.8 p -67.92 164.85 37.09 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.755 -0.59 . . . . 0.0 109.505 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.401 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 39.4 Cg_endo -65.09 -14.22 44.05 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 O-C-N 123.148 1.078 . . . . 0.0 111.104 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.9 t -69.61 -40.02 76.88 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.147 -0.97 . . . . 0.0 109.768 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 122.17 37.82 0.63 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 28.2 m170 -133.6 -173.28 3.18 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.388 -1.066 . . . . 0.0 110.276 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -104.55 145.39 30.37 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.552 -0.718 . . . . 0.0 110.158 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 50.7 t -115.75 -62.42 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.518 -0.739 . . . . 0.0 110.454 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -157.08 -158.59 8.99 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.2 mt -133.48 146.68 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.565 -0.962 . . . . 0.0 110.003 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -61.97 140.01 58.36 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.369 -0.832 . . . . 0.0 110.479 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.417 ' NE ' ' HB3' ' A' ' 81' ' ' ASP . 0.6 OUTLIER -117.23 -76.13 0.57 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.57 0.7 . . . . 0.0 110.496 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -125.3 147.18 49.22 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 121.377 -0.827 . . . . 0.0 111.234 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.06 124.83 37.31 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.3 t -95.75 119.03 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.585 -0.697 . . . . 0.0 111.026 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.4 p -139.89 146.09 38.84 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.593 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 59.6 m -78.87 -49.92 12.09 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.6 -0.687 . . . . 0.0 109.855 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 5.9 ptt180 -129.11 36.17 4.21 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.614 -0.679 . . . . 0.0 109.915 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 102.7 -11.93 56.39 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 62.9 t -92.33 121.2 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.249 -1.148 . . . . 0.0 109.009 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.17 116.92 25.58 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.5 -0.75 . . . . 0.0 111.218 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -110.98 -29.93 7.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.833 -0.542 . . . . 0.0 109.729 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -120.05 168.27 11.35 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.638 -0.664 . . . . 0.0 109.958 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 35.1 m -146.05 137.2 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.581 -0.699 . . . . 0.0 110.64 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -113.05 143.63 43.99 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.598 -0.689 . . . . 0.0 110.404 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -149.49 162.2 40.61 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.631 -0.668 . . . . 0.0 110.879 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 5.6 m -101.62 143.73 27.19 Favored Pre-proline 0 N--CA 1.505 2.317 0 O-C-N 121.448 -0.783 . . . . 0.0 110.135 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -79.69 168.18 19.8 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 O-C-N 123.339 1.179 . . . . 0.0 110.171 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 64.9 t -66.29 -24.0 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.521 -0.737 . . . . 0.0 110.118 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -54.32 -38.89 66.5 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.429 -0.795 . . . . 0.0 111.449 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 82.2 p -61.66 -24.55 66.81 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.671 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 65.5 mtt -70.11 -28.72 65.62 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.431 -0.793 . . . . 0.0 110.898 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -59.28 -50.85 72.41 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.409 -0.807 . . . . 0.0 110.596 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 22.1 m -72.03 -29.03 63.76 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.49 -0.756 . . . . 0.0 110.334 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 32.5 m -68.0 -32.29 72.58 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.561 -0.712 . . . . 0.0 110.507 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 34.5 mmm -59.45 -52.04 67.31 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.484 -0.76 . . . . 0.0 110.485 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 56.4 mtp85 -63.87 -40.02 95.57 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.528 -0.732 . . . . 0.0 110.115 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.804 0 O-C-N 121.564 -0.71 . . . . 0.0 110.261 -179.891 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 121.142 0.496 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.4 t -109.83 143.96 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.569 -0.707 . . . . 0.0 109.808 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -116.63 148.25 41.15 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.63 -0.669 . . . . 0.0 110.308 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.8 t -78.43 124.62 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.701 -0.624 . . . . 0.0 109.699 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.6 m -134.12 138.65 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.428 -0.795 . . . . 0.0 110.545 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 74.7 m -119.38 154.56 33.44 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.593 -0.692 . . . . 0.0 110.294 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.5 m -110.99 179.6 4.0 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.63 -0.669 . . . . 0.0 110.121 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.43 -40.03 95.25 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.807 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.7 t -119.78 -28.3 5.26 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.401 -0.812 . . . . 0.0 111.204 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -118.2 178.08 4.56 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.405 -0.81 . . . . 0.0 110.213 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 83.0 p -153.71 117.03 4.59 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.541 -0.724 . . . . 0.0 110.565 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 6.7 p90 -130.4 -176.91 4.11 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.635 -0.665 . . . . 0.0 110.007 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.9 mt -117.3 162.93 17.11 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.433 -0.792 . . . . 0.0 110.545 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -129.53 150.23 50.95 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.668 -0.645 . . . . 0.0 110.504 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 78.9 p -125.69 144.17 50.72 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.602 -0.687 . . . . 0.0 110.077 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 25.9 p -100.51 106.71 18.27 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.741 0.781 . . . . 0.0 110.575 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.8 t -130.64 139.58 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.285 -0.884 . . . . 0.0 110.341 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 10.8 m120 55.02 40.48 32.02 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.57 -0.706 . . . . 0.0 111.529 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 63.78 14.46 55.33 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.43 138.55 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.148 -1.207 . . . . 0.0 109.354 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 43.6 t -87.67 126.28 34.87 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.56 -0.713 . . . . 0.0 110.464 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -111.08 136.78 49.6 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.649 -0.657 . . . . 0.0 110.13 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.9 t -137.37 -179.81 5.95 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.658 -0.651 . . . . 0.0 110.005 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.465 ' CG1' ' CE1' ' A' ' 57' ' ' HIS . 63.6 t -84.13 141.47 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.491 -0.756 . . . . 0.0 109.124 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.456 ' CZ ' HG21 ' A' ' 78' ' ' VAL . 14.4 t80 -85.73 -43.7 13.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.514 -0.741 . . . . 0.0 111.405 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.465 ' CE1' ' CG1' ' A' ' 55' ' ' VAL . 2.6 p-80 -60.53 -22.28 63.44 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.219 -0.926 . . . . 0.0 110.821 -178.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -93.57 -32.64 7.56 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.03 -63.43 1.35 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.55 -0.97 . . . . 0.0 110.274 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.472 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.836 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 58.6 m . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -86.04 143.53 28.05 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.49 -0.756 . . . . 0.0 110.783 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.9 tpp -119.13 -48.07 2.45 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.549 -0.719 . . . . 0.0 110.742 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -109.62 128.46 55.24 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.355 -0.84 . . . . 0.0 110.32 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 54.7 m -152.19 123.38 7.64 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.527 -0.733 . . . . 0.0 110.147 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -166.09 124.24 1.49 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.405 -0.81 . . . . 0.0 111.32 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.456 HG21 ' CZ ' ' A' ' 56' ' ' TYR . 94.3 t -72.59 -30.83 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.528 -0.732 . . . . 0.0 109.797 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -57.83 -40.05 79.12 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.47 -0.768 . . . . 0.0 110.433 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -97.63 -7.75 30.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.57 -0.706 . . . . 0.0 111.009 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.8 t0 53.35 39.66 30.17 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.958 -1.088 . . . . 0.0 110.569 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.14 155.54 46.93 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.574 -0.851 . . . . 0.0 111.314 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.1 t -145.55 156.74 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -155.46 172.59 33.63 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 119.292 -1.432 . . . . 0.0 111.064 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 10.6 m-90 -147.0 159.65 43.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.89 -0.77 . . . . 0.0 109.602 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -70.83 115.64 10.21 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.517 -0.739 . . . . 0.0 110.31 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.57 157.93 54.87 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.623 -0.673 . . . . 0.0 110.056 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.43 155.91 59.21 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.422 1.222 . . . . 0.0 110.396 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -75.22 155.12 41.91 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.466 1.245 . . . . 0.0 110.341 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 97.26 -25.93 25.0 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.5 154.31 24.92 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.396 -1.061 . . . . 0.0 110.063 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.94 135.15 44.99 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.599 -0.688 . . . . 0.0 110.025 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 58.4 m -105.39 130.02 53.58 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.526 -0.734 . . . . 0.0 110.098 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.0 tp -83.81 148.94 26.72 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.552 -0.717 . . . . 0.0 110.435 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.407 HG21 ' CE1' ' A' ' 149' ' ' HIS . 6.5 t -113.22 150.98 43.87 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.606 -0.684 . . . . 0.0 110.196 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.72 154.96 63.63 Favored 'Trans proline' 0 N--CA 1.486 1.071 0 O-C-N 123.319 1.168 . . . . 0.0 110.702 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 7.1 t -87.17 144.64 26.75 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.567 -0.708 . . . . 0.0 110.572 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.4 p -136.52 67.97 1.44 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.61 -0.681 . . . . 0.0 110.441 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 28.0 p -145.15 7.16 1.17 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.385 -0.822 . . . . 0.0 111.97 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 52.02 47.84 53.48 Favored Glycine 0 N--CA 1.499 2.881 0 O-C-N 120.863 -1.148 . . . . 0.0 110.384 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.3 t -100.02 120.49 39.9 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.502 -0.999 . . . . 0.0 110.512 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.8 p -69.94 -39.78 75.89 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.629 -0.669 . . . . 0.0 109.918 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -61.58 134.92 57.39 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.561 -0.712 . . . . 0.0 109.881 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 49.9 mt -142.68 160.15 40.86 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.564 -0.71 . . . . 0.0 110.707 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -120.02 134.04 55.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.674 -0.641 . . . . 0.0 109.347 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.6 tt -127.33 112.58 15.21 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.489 -0.757 . . . . 0.0 110.711 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 55.9 t -69.14 147.52 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.49 -0.756 . . . . 0.0 108.993 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.8 p -108.29 -168.25 1.34 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.51 -0.744 . . . . 0.0 110.614 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.73 -22.97 23.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.585 -0.697 . . . . 0.0 110.348 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -102.56 29.23 5.4 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.452 -0.78 . . . . 0.0 110.167 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 56.89 55.65 6.01 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.471 -0.768 . . . . 0.0 111.019 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.95 144.06 49.09 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.476 -0.765 . . . . 0.0 109.297 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.5 t -115.28 128.29 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.364 -0.835 . . . . 0.0 110.461 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.404 HG22 HD11 ' A' ' 114' ' ' ILE . 14.8 tt -137.96 134.91 18.24 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.62 -0.675 . . . . 0.0 109.864 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -74.82 145.52 32.29 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 O-C-N 123.208 1.109 . . . . 0.0 110.569 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.4 t -129.95 129.94 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.576 -0.702 . . . . 0.0 109.684 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -85.26 155.84 21.21 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.587 -0.696 . . . . 0.0 110.171 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 71.6 ttt-85 -99.1 134.55 41.79 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.596 -0.69 . . . . 0.0 110.146 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -118.75 -12.58 9.65 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.598 -0.689 . . . . 0.0 110.936 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -169.05 -160.57 17.48 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -70.04 -37.46 75.58 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.549 -0.971 . . . . 0.0 110.874 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.0 m -134.27 28.02 3.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.356 -0.84 . . . . 0.0 111.07 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 17.4 tpt85 -141.93 139.87 32.64 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.298 -0.876 . . . . 0.0 110.242 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -147.89 161.71 28.61 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 71.4 p -98.78 163.89 12.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.43 -1.041 . . . . 0.0 110.147 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.9 tp -112.63 127.62 56.15 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.649 -0.657 . . . . 0.0 110.151 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.4 mp -64.19 -39.8 94.74 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.587 -0.696 . . . . 0.0 110.408 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.0 t -100.36 106.65 43.71 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.528 -0.732 . . . . 0.0 110.298 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -76.1 113.22 3.66 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 O-C-N 123.275 1.145 . . . . 0.0 110.515 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -119.33 155.19 54.04 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.585 -0.697 . . . . 0.0 109.917 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -70.0 150.42 66.76 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 O-C-N 123.432 1.227 . . . . 0.0 110.013 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 90.8 t -53.39 -34.39 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.252 -0.905 . . . . 0.0 110.002 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 34.5 t -57.87 -49.11 77.83 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.587 -0.695 . . . . 0.0 110.632 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -66.55 -38.37 86.98 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.501 -0.749 . . . . 0.0 109.548 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.405 ' O ' ' HG ' ' A' ' 135' ' ' LEU . 40.7 tp -90.23 16.85 7.86 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.826 -0.547 . . . . 0.0 110.335 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -83.28 121.09 26.66 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.757 -1.214 . . . . 0.0 112.126 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.49 33.26 4.87 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.6 m -106.05 13.02 29.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.653 -0.91 . . . . 0.0 110.525 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 18.1 m -62.36 143.58 56.81 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.272 -0.893 . . . . 0.0 109.849 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 83.0 7.06 87.7 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.82 133.54 51.27 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -80.17 117.15 3.46 Favored 'Trans proline' 0 N--CA 1.485 0.999 0 O-C-N 123.24 1.126 . . . . 0.0 110.934 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.8 mp -98.75 104.04 16.04 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.407 -0.808 . . . . 0.0 109.018 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.8 mp -117.74 147.43 42.97 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.498 -0.751 . . . . 0.0 111.065 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.27 178.68 1.69 Allowed Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.746 -0.596 . . . . 0.0 109.455 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -70.01 -24.96 27.92 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.215 1.113 . . . . 0.0 110.416 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 36.4 t -69.9 -40.1 75.81 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.48 -0.762 . . . . 0.0 110.035 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 124.15 45.86 0.27 Allowed Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.407 ' CE1' HG21 ' A' ' 95' ' ' THR . 62.5 m-70 -135.96 134.79 39.01 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.574 -0.956 . . . . 0.0 110.318 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -77.86 140.87 39.38 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.495 -0.753 . . . . 0.0 110.353 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 34.7 m -117.37 -25.82 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.629 -0.67 . . . . 0.0 110.66 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -174.37 -173.77 40.63 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 64.4 mt -129.33 158.17 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.659 -0.907 . . . . 0.0 109.672 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -69.81 148.01 49.66 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.385 -0.822 . . . . 0.0 110.167 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.41 -80.35 0.5 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.781 -0.575 . . . . 0.0 110.354 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -120.66 143.58 48.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.178 -0.951 . . . . 0.0 111.269 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.85 129.82 40.12 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.3 t -100.32 121.27 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.491 -0.756 . . . . 0.0 111.33 -177.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.8 p -140.66 149.54 42.39 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.535 -0.728 . . . . 0.0 110.517 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 37.7 m -88.79 -49.62 6.72 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.553 -0.717 . . . . 0.0 109.804 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -119.71 32.03 6.26 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.52 0.676 . . . . 0.0 109.229 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 97.65 -11.56 64.7 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.244 -1.543 . . . . 0.0 109.244 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 62.4 t -88.11 122.42 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.279 -1.13 . . . . 0.0 109.061 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.55 113.14 22.97 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.528 -0.733 . . . . 0.0 110.784 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -109.14 -30.21 8.15 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.651 -0.656 . . . . 0.0 109.687 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -116.52 168.32 10.27 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.664 -0.648 . . . . 0.0 109.681 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 35.9 m -148.74 135.82 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.541 -0.724 . . . . 0.0 111.085 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.65 134.46 51.93 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.664 -0.647 . . . . 0.0 109.883 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -131.56 159.94 36.74 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.42 -0.8 . . . . 0.0 110.389 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 60.4 t -92.54 140.53 24.02 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.57 -0.707 . . . . 0.0 110.212 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -75.15 162.51 36.64 Favored 'Trans proline' 0 C--N 1.32 -0.966 0 O-C-N 123.131 1.069 . . . . 0.0 110.337 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 87.6 t -79.75 -30.59 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.554 -0.716 . . . . 0.0 110.257 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -60.02 -39.24 85.19 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.493 -0.754 . . . . 0.0 110.605 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 58.4 p -61.7 -25.7 67.58 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.516 -0.74 . . . . 0.0 110.871 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 53.9 mtm -66.99 -36.98 83.38 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.422 -0.799 . . . . 0.0 110.542 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -60.05 -40.01 87.92 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.472 -0.767 . . . . 0.0 110.404 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 31.3 m -61.05 -31.69 71.34 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.536 -0.727 . . . . 0.0 110.511 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 93.2 m -59.95 -40.04 87.64 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.515 -0.74 . . . . 0.0 110.465 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 1.4 ttp -58.82 -36.29 74.26 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.44 -0.787 . . . . 0.0 110.437 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 5.5 ttp180 -59.91 -39.98 87.26 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.433 -0.792 . . . . 0.0 110.212 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.833 0 O-C-N 121.603 -0.686 . . . . 0.0 110.301 179.944 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 . . . . . 0 N--CA 1.498 1.947 0 CA-C-O 121.302 0.572 . . . . 0.0 110.458 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 63.3 t -114.63 125.5 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.54 -0.725 . . . . 0.0 109.78 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -103.01 138.98 39.17 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.576 -0.702 . . . . 0.0 110.065 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.5 m -88.38 132.14 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.554 -0.716 . . . . 0.0 110.476 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.1 m -130.6 159.97 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.467 -0.77 . . . . 0.0 110.346 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 64.7 m -135.9 153.49 51.44 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.566 -0.709 . . . . 0.0 110.383 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.424 ' OG1' ' CE1' ' A' ' 43' ' ' PHE . 1.6 m -117.8 179.82 3.96 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.618 -0.677 . . . . 0.0 109.982 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.14 -23.73 62.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.671 -0.643 . . . . 0.0 111.288 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.6 p -119.8 -28.29 5.25 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.32 -0.863 . . . . 0.0 111.418 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -142.34 164.72 29.37 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.371 -0.831 . . . . 0.0 110.639 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.4 t -130.94 124.62 31.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.497 -0.752 . . . . 0.0 110.14 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.424 ' CE1' ' OG1' ' A' ' 38' ' ' THR . 4.5 p90 -133.9 178.32 7.04 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.604 -0.685 . . . . 0.0 110.121 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 25.0 mt -121.16 167.55 12.54 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.574 -0.704 . . . . 0.0 110.026 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.79 152.14 46.33 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.592 -0.692 . . . . 0.0 110.06 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.6 m -119.98 135.42 54.92 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.477 -0.765 . . . . 0.0 110.286 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 45.8 t -93.27 103.82 16.04 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.562 -0.711 . . . . 0.0 110.482 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.0 p -130.44 139.64 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.546 -0.721 . . . . 0.0 110.4 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 57.67 36.17 26.39 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.412 -0.805 . . . . 0.0 110.836 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 63.26 15.76 57.1 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.425 HG12 ' CE2' ' A' ' 53' ' ' TRP . 56.5 t -139.47 119.3 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.266 -1.137 . . . . 0.0 109.657 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 28.5 p -79.98 137.95 36.95 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.587 -0.696 . . . . 0.0 110.41 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.425 ' CE2' HG12 ' A' ' 51' ' ' VAL . 87.0 m95 -125.92 137.43 53.71 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.554 -0.716 . . . . 0.0 110.404 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.9 t -137.16 179.6 6.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.705 -0.622 . . . . 0.0 109.804 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.465 ' CG1' ' CE1' ' A' ' 57' ' ' HIS . 0.5 OUTLIER -81.32 142.65 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.175 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.458 ' CE2' ' CG2' ' A' ' 78' ' ' VAL . 27.5 t80 -81.02 -42.54 20.95 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.458 -0.776 . . . . 0.0 111.199 -178.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.465 ' CE1' ' CG1' ' A' ' 55' ' ' VAL . 2.2 p-80 -53.72 -21.2 6.64 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.444 -0.785 . . . . 0.0 111.956 -177.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -119.62 -23.63 3.06 Favored Glycine 0 N--CA 1.496 2.677 0 C-N-CA 119.984 -1.103 . . . . 0.0 111.064 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -113.77 -27.14 7.9 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.235 -1.156 . . . . 0.0 111.083 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.434 ' HA3' ' CD1' ' A' ' 56' ' ' TYR . . . . . . . . 0 N--CA 1.494 2.562 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 40.7 p . . . . . 0 N--CA 1.498 1.947 0 CA-C-O 121.273 0.559 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -87.96 130.95 34.78 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.729 -0.607 . . . . 0.0 109.721 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.7 tpt -119.07 -44.54 2.6 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.464 -0.773 . . . . 0.0 110.976 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -109.81 124.78 51.89 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.271 -0.893 . . . . 0.0 110.083 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 56.9 m -152.17 135.47 15.91 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.609 -0.682 . . . . 0.0 110.355 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -167.28 111.85 0.71 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.504 -0.748 . . . . 0.0 110.813 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.458 ' CG2' ' CE2' ' A' ' 56' ' ' TYR . 75.7 t -72.25 -29.21 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.297 -0.877 . . . . 0.0 109.322 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -60.0 -42.89 95.23 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.47 -0.769 . . . . 0.0 110.012 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -99.81 -6.99 26.0 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.514 -0.741 . . . . 0.0 110.652 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.409 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 30.4 t0 56.39 33.98 23.38 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.065 -1.022 . . . . 0.0 110.635 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.42 HD22 ' CZ3' ' A' ' 53' ' ' TRP . 7.8 tt -119.83 145.27 46.79 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.249 -0.907 . . . . 0.0 111.751 -178.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.452 ' CG1' ' CZ2' ' A' ' 85' ' ' TRP . 3.1 t -143.97 159.25 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -168.96 164.37 38.02 Favored Glycine 0 N--CA 1.496 2.645 0 C-N-CA 119.46 -1.352 . . . . 0.0 110.624 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.452 ' CZ2' ' CG1' ' A' ' 83' ' ' VAL . 20.3 m-90 -146.75 160.02 42.76 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.793 -0.828 . . . . 0.0 109.47 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -62.21 138.0 58.34 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.575 -0.703 . . . . 0.0 110.08 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.97 148.5 57.06 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.478 -0.764 . . . . 0.0 110.284 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.9 160.0 48.94 Favored 'Trans proline' 0 C--N 1.317 -1.105 0 O-C-N 123.484 1.254 . . . . 0.0 110.359 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -73.31 126.83 11.36 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 123.377 1.199 . . . . 0.0 110.447 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 108.81 30.09 3.86 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -117.42 159.49 22.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.513 -0.993 . . . . 0.0 110.089 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.2 mtp180 -96.29 163.87 12.9 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.53 -0.731 . . . . 0.0 110.378 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 80.7 p -130.89 145.17 51.93 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.678 -0.639 . . . . 0.0 109.901 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -105.09 139.92 39.04 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.588 -0.695 . . . . 0.0 110.303 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 60.3 m -78.07 143.8 66.37 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.747 -0.596 . . . . 0.0 109.917 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.64 161.98 43.82 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 O-C-N 123.302 1.159 . . . . 0.0 110.319 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 45.6 t -72.9 128.01 34.24 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.539 -0.725 . . . . 0.0 110.483 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.3 m -135.73 55.79 1.85 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.662 -0.649 . . . . 0.0 109.531 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.4 p -145.01 4.66 1.1 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.58 -0.7 . . . . 0.0 112.175 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 51.25 91.06 0.01 OUTLIER Glycine 0 N--CA 1.502 3.064 0 O-C-N 120.905 -1.122 . . . . 0.0 110.495 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 98.1 p -139.35 148.06 42.38 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.436 -1.038 . . . . 0.0 110.362 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 63.7 m -95.03 -34.54 12.3 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.64 -0.662 . . . . 0.0 110.176 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -66.37 129.67 40.6 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.642 -0.661 . . . . 0.0 109.915 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 97.3 mt -136.28 156.53 48.53 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.625 -0.672 . . . . 0.0 110.546 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -126.34 108.72 11.5 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.667 -0.646 . . . . 0.0 109.519 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.42 HD12 ' CD1' ' A' ' 154' ' ' PHE . 9.7 tt -89.46 129.39 35.96 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.638 -0.663 . . . . 0.0 110.763 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.5 t -84.91 131.07 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.64 -0.663 . . . . 0.0 109.575 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.7 p -97.82 -175.51 3.19 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.48 -0.762 . . . . 0.0 110.509 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.2 ttt-85 -69.95 -27.01 64.4 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.706 -0.621 . . . . 0.0 110.846 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.437 ' CD2' ' HB2' ' A' ' 112' ' ' ASP . 41.0 p-80 -106.22 29.96 6.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.43 -0.794 . . . . 0.0 110.859 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 55.36 56.84 5.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.532 -0.73 . . . . 0.0 111.884 178.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.437 ' HB2' ' CD2' ' A' ' 110' ' ' HIS . 0.4 OUTLIER -110.8 137.34 48.57 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.401 -0.812 . . . . 0.0 109.88 179.118 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.4 p -84.46 128.34 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.65 -0.656 . . . . 0.0 110.275 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 48.6 mm -129.98 105.86 16.67 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.523 -0.735 . . . . 0.0 110.11 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -70.66 119.84 6.64 Favored 'Trans proline' 0 N--CA 1.487 1.088 0 O-C-N 123.241 1.127 . . . . 0.0 110.242 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.5 t -120.36 129.39 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.515 -0.741 . . . . 0.0 110.137 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -83.03 135.86 34.7 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.566 -0.709 . . . . 0.0 109.809 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -82.24 134.23 35.28 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.522 -0.736 . . . . 0.0 110.431 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.7 18.63 3.3 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.587 -0.696 . . . . 0.0 110.581 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -173.33 178.94 45.05 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -69.55 -39.97 77.11 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.572 -0.958 . . . . 0.0 110.331 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.6 m -130.33 25.06 5.17 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.527 -0.733 . . . . 0.0 110.781 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -142.58 141.83 32.06 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.423 -0.798 . . . . 0.0 110.306 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -142.11 157.16 26.37 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 50.6 p -91.57 157.63 16.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.664 -0.904 . . . . 0.0 110.125 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 39.9 tp -105.77 127.17 52.92 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.531 -0.731 . . . . 0.0 110.36 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.3 mp -68.6 -42.26 78.44 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.581 -0.7 . . . . 0.0 110.092 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.6 p -102.2 99.79 13.58 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.694 -0.629 . . . . 0.0 109.701 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.15 106.94 2.01 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.388 1.204 . . . . 0.0 110.945 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -114.47 161.5 28.25 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.713 -0.617 . . . . 0.0 109.748 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.18 150.59 59.86 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 O-C-N 123.391 1.206 . . . . 0.0 110.354 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 64.6 t -51.03 -29.93 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 O-C-N 121.399 -0.813 . . . . 0.0 109.828 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.2 t -61.43 -40.04 92.97 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.728 -0.608 . . . . 0.0 110.956 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -66.87 -39.97 87.71 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.326 -0.859 . . . . 0.0 109.538 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.426 HD23 ' CZ ' ' A' ' 154' ' ' PHE . 17.6 tp -95.4 18.9 11.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.922 -0.486 . . . . 0.0 110.135 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -81.14 116.67 21.16 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 122.541 1.162 . . . . 0.0 112.412 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.72 22.12 11.54 Favored Glycine 0 N--CA 1.492 2.401 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.269 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.3 m -103.44 20.85 17.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.47 -1.018 . . . . 0.0 110.53 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.2 m -69.96 136.12 50.17 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.28 -0.888 . . . . 0.0 109.541 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 100.06 -23.29 36.56 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.79 110.02 1.93 Allowed Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -72.43 138.7 30.35 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 O-C-N 123.18 1.095 . . . . 0.0 111.073 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.1 mp -86.35 146.3 26.53 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.1 mp -126.9 162.23 26.41 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.403 -0.81 . . . . 0.0 111.23 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 27.1 p -119.1 165.12 17.93 Favored Pre-proline 0 N--CA 1.494 1.774 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.42 -12.23 33.98 Favored 'Trans proline' 0 N--CA 1.489 1.218 0 O-C-N 123.082 1.043 . . . . 0.0 111.853 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.7 p -72.01 -32.66 67.39 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.117 -0.989 . . . . 0.0 109.943 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 116.15 20.74 5.1 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -131.34 152.95 50.11 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.325 -1.103 . . . . 0.0 110.377 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.77 152.36 31.5 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.542 -0.724 . . . . 0.0 109.931 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 34.0 m -112.55 -28.81 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.5 -0.75 . . . . 0.0 110.989 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 177.7 -161.01 27.96 Favored Glycine 0 N--CA 1.498 2.776 0 C-N-CA 119.753 -1.213 . . . . 0.0 110.339 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.5 mt -134.42 151.76 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.652 -0.911 . . . . 0.0 110.162 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.426 ' CZ ' HD23 ' A' ' 135' ' ' LEU . 14.5 t80 -70.13 153.49 43.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.685 -0.634 . . . . 0.0 110.14 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 46.6 ttm-85 -135.95 -76.41 0.43 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.659 -0.651 . . . . 0.0 110.327 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -120.53 143.04 48.79 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.38 -0.825 . . . . 0.0 110.616 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.27 127.71 38.97 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.5 t -96.9 117.77 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.602 -0.686 . . . . 0.0 111.535 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 28.9 p -140.06 147.68 40.67 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.414 -0.804 . . . . 0.0 110.565 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 17.9 m -79.49 -50.59 10.53 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.488 -0.758 . . . . 0.0 109.77 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -130.26 36.7 3.96 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.633 -0.667 . . . . 0.0 109.904 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 104.28 -11.76 51.47 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 65.1 t -93.12 121.95 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.259 -1.142 . . . . 0.0 109.158 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.2 121.1 29.2 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.541 -0.725 . . . . 0.0 111.347 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 5.4 mttp -113.29 -30.11 7.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.804 -0.56 . . . . 0.0 109.933 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -123.64 168.4 12.69 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.518 -0.739 . . . . 0.0 109.9 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 35.1 m -140.23 137.34 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.517 -0.74 . . . . 0.0 110.887 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -104.65 126.57 51.85 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.53 -0.731 . . . . 0.0 110.606 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -147.8 162.14 39.83 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.595 -0.691 . . . . 0.0 110.332 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 27.1 m -110.96 149.59 40.65 Favored Pre-proline 0 N--CA 1.502 2.129 0 O-C-N 121.353 -0.842 . . . . 0.0 110.708 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -78.6 161.28 28.03 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.496 1.261 . . . . 0.0 109.378 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 54.0 t -58.9 -25.93 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.385 -0.822 . . . . 0.0 110.051 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -59.92 -35.53 75.08 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.557 -0.715 . . . . 0.0 110.643 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 2.3 t -61.51 -24.35 66.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.468 -0.77 . . . . 0.0 110.568 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 68.0 mtt -69.96 -39.06 76.23 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.431 -0.793 . . . . 0.0 110.507 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -60.11 -39.98 88.08 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.443 -0.786 . . . . 0.0 110.566 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 85.3 m -60.8 -40.04 91.15 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.474 -0.766 . . . . 0.0 110.124 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 61.8 m -67.73 -36.34 80.4 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.559 -0.713 . . . . 0.0 110.321 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 7.9 ttt -60.06 -42.23 94.05 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.553 -0.717 . . . . 0.0 110.539 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -60.07 -39.9 87.66 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.539 -0.726 . . . . 0.0 110.342 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.722 0 O-C-N 121.581 -0.699 . . . . 0.0 110.187 179.956 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.7 mp0 . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 120.988 0.423 . . . . 0.0 110.485 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.1 p -119.31 143.66 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.566 -0.709 . . . . 0.0 110.069 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 54.9 tp60 -110.39 141.65 43.16 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.582 -0.699 . . . . 0.0 110.181 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.0 p -82.74 130.26 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.643 -0.661 . . . . 0.0 110.212 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.7 m -138.14 144.31 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.509 -0.744 . . . . 0.0 110.48 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.4 m -130.05 144.04 51.12 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.54 -0.725 . . . . 0.0 110.632 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.86 -169.98 1.82 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.602 -0.686 . . . . 0.0 109.768 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.83 -40.04 69.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.614 -0.679 . . . . 0.0 111.597 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 77.6 p -114.59 -18.82 11.34 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.226 -0.922 . . . . 0.0 111.608 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -139.75 161.67 36.99 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.244 -0.91 . . . . 0.0 110.134 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 99.1 p -138.4 123.28 18.87 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.458 -0.776 . . . . 0.0 110.857 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 4.4 p90 -128.05 -174.96 3.35 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.632 -0.668 . . . . 0.0 109.503 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 44.0 mt -126.57 166.08 17.96 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.335 -0.853 . . . . 0.0 110.746 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.49 152.48 44.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.711 -0.618 . . . . 0.0 110.261 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 87.8 m -130.03 139.9 50.94 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.511 -0.743 . . . . 0.0 110.291 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 77.8 m -77.63 120.49 22.65 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.562 -0.712 . . . . 0.0 110.431 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.1 t -130.48 120.82 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.467 -0.771 . . . . 0.0 110.628 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 33.4 m120 50.05 34.47 8.3 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.534 -0.729 . . . . 0.0 111.969 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.25 -23.61 23.53 Favored Glycine 0 N--CA 1.497 2.736 0 C-N-CA 120.198 -1.001 . . . . 0.0 110.8 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.0 p -108.89 133.58 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.3 -1.118 . . . . 0.0 109.781 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 77.1 m -91.55 125.03 36.15 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.392 -0.818 . . . . 0.0 110.159 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 71.9 m95 -99.33 137.17 38.21 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.567 -0.708 . . . . 0.0 110.422 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.456 ' CG2' ' CH2' ' A' ' 85' ' ' TRP . 8.4 t -137.06 173.43 11.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.765 -0.584 . . . . 0.0 109.751 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.482 ' CG1' ' CE1' ' A' ' 57' ' ' HIS . 96.9 t -81.78 142.09 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.462 -0.774 . . . . 0.0 109.26 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.448 ' CE2' ' CG2' ' A' ' 78' ' ' VAL . 15.2 t80 -85.0 -43.37 14.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.63 -0.669 . . . . 0.0 110.806 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.482 ' CE1' ' CG1' ' A' ' 55' ' ' VAL . 2.2 p-80 -59.45 -22.55 61.67 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.167 -0.958 . . . . 0.0 110.476 -178.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -82.28 -65.77 1.61 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.409 ' HA ' ' CE1' ' A' ' 43' ' ' PHE . . . -59.0 -63.28 1.36 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.418 -1.048 . . . . 0.0 110.188 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.47 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 179.316 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.497 1.901 0 CA-C-O 121.037 0.446 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -92.36 150.83 20.59 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.551 -0.718 . . . . 0.0 110.565 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 97.8 mmm -116.98 -32.7 4.98 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.65 -0.656 . . . . 0.0 110.35 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -110.11 129.15 55.74 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.374 -0.829 . . . . 0.0 109.436 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 89.3 m -151.44 132.65 14.46 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.399 -0.813 . . . . 0.0 110.456 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -166.73 125.42 1.42 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.372 -0.83 . . . . 0.0 111.141 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.448 ' CG2' ' CE2' ' A' ' 56' ' ' TYR . 78.5 t -72.32 -39.29 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.459 -0.776 . . . . 0.0 109.607 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -55.81 -44.93 78.32 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.354 -0.842 . . . . 0.0 110.268 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.0 tp60 -82.9 -14.0 55.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.754 -0.591 . . . . 0.0 110.279 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 40.2 t0 53.09 39.9 30.31 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.117 -0.989 . . . . 0.0 110.67 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.3 156.98 43.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.406 -0.809 . . . . 0.0 111.065 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.5 t -145.11 145.14 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -130.5 154.69 20.77 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.626 -1.273 . . . . 0.0 110.912 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.456 ' CH2' ' CG2' ' A' ' 54' ' ' THR . 4.4 m-90 -125.07 159.88 30.36 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.904 -0.763 . . . . 0.0 109.431 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -83.15 122.9 28.98 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.474 -0.766 . . . . 0.0 109.877 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -101.28 160.62 26.1 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.457 -0.777 . . . . 0.0 110.538 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.77 160.05 49.06 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 O-C-N 123.484 1.255 . . . . 0.0 110.506 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.52 158.81 47.28 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.448 1.236 . . . . 0.0 110.526 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 74.27 31.12 59.69 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -107.23 151.33 25.58 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.43 -1.041 . . . . 0.0 110.307 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -60.5 152.3 26.22 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.589 -0.694 . . . . 0.0 110.46 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 92.5 p -148.23 155.39 41.3 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.612 -0.68 . . . . 0.0 110.457 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 90.9 mt -111.13 131.92 54.7 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.563 -0.711 . . . . 0.0 110.36 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 72.6 p -76.5 159.91 78.54 Favored Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 121.597 -0.689 . . . . 0.0 110.082 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.0 159.22 50.78 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.38 1.2 . . . . 0.0 110.481 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 47.0 t -86.93 128.15 35.06 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.564 -0.71 . . . . 0.0 110.388 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.5 p -133.69 55.09 1.91 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.603 -0.685 . . . . 0.0 109.989 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.5 p -145.18 7.68 1.18 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.481 -0.762 . . . . 0.0 111.864 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 52.26 41.67 54.72 Favored Glycine 0 N--CA 1.499 2.894 0 O-C-N 121.003 -1.06 . . . . 0.0 110.496 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.8 m -78.92 107.96 12.04 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.519 -0.989 . . . . 0.0 110.386 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.4 m -66.24 -40.01 89.92 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.569 -0.707 . . . . 0.0 110.195 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -67.92 129.12 38.94 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.589 -0.694 . . . . 0.0 109.97 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 90.8 mt -134.99 150.08 50.29 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.609 -0.682 . . . . 0.0 110.356 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -117.5 125.19 50.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.535 -0.728 . . . . 0.0 109.768 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 26.8 tp -102.53 144.22 31.23 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.5 -0.75 . . . . 0.0 110.556 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.6 t -105.92 126.68 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.603 -0.686 . . . . 0.0 109.73 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 69.7 p -93.98 176.49 6.31 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.501 -0.749 . . . . 0.0 110.58 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -60.13 -24.63 64.84 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.598 -0.689 . . . . 0.0 110.722 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -95.32 27.15 3.43 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.474 -0.766 . . . . 0.0 110.555 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 53.21 27.79 6.39 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.296 -0.878 . . . . 0.0 110.916 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -80.68 152.59 28.36 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.546 -0.721 . . . . 0.0 109.913 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 63.2 t -116.05 128.17 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.543 -0.723 . . . . 0.0 109.929 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.415 HD11 HG23 ' A' ' 114' ' ' ILE . 40.1 pt -134.56 139.07 31.5 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.49 -0.756 . . . . 0.0 110.19 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -82.91 146.45 12.98 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 O-C-N 123.177 1.093 . . . . 0.0 110.521 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.1 t -139.36 129.94 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.584 -0.698 . . . . 0.0 109.768 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.7 tpp180 -92.98 130.71 38.47 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.538 -0.726 . . . . 0.0 110.154 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -80.26 121.33 25.5 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.606 -0.684 . . . . 0.0 110.328 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.88 -12.29 9.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.523 -0.736 . . . . 0.0 110.473 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -134.92 -175.55 13.92 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -70.14 -45.09 67.54 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.557 -0.966 . . . . 0.0 110.57 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.6 m -127.67 21.04 6.54 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.45 -0.781 . . . . 0.0 110.819 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.72 142.13 34.86 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.315 -0.866 . . . . 0.0 110.057 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -134.25 166.86 23.99 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 52.9 p -98.72 165.19 11.91 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.541 -0.976 . . . . 0.0 110.222 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 47.7 tp -120.0 124.2 45.33 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.527 -0.733 . . . . 0.0 110.337 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.4 mp -62.13 -41.67 98.49 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.51 -0.744 . . . . 0.0 110.182 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.4 p -102.58 105.9 46.6 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.548 -0.72 . . . . 0.0 109.945 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.36 106.85 2.15 Favored 'Trans proline' 0 C--N 1.319 -0.999 0 O-C-N 123.32 1.169 . . . . 0.0 110.876 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.42 ' HD2' ' CD2' ' A' ' 134' ' ' TYR . 4.4 mtt85 -106.89 153.09 41.05 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.644 -0.66 . . . . 0.0 109.643 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.27 150.38 52.93 Favored 'Trans proline' 0 C--N 1.315 -1.207 0 O-C-N 123.383 1.202 . . . . 0.0 110.884 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 73.6 t -53.6 -31.95 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.473 -0.767 . . . . 0.0 109.565 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 31.2 t -59.85 -39.99 87.07 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.689 -0.632 . . . . 0.0 110.65 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.42 ' CD2' ' HD2' ' A' ' 130' ' ' ARG . 87.3 t80 -70.06 -39.73 75.5 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.444 -0.785 . . . . 0.0 109.604 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 22.1 tp -95.01 13.59 24.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.725 -0.609 . . . . 0.0 110.581 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.71 113.03 13.9 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.601 1.191 . . . . 0.0 111.087 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.53 34.3 4.48 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 31.1 m -115.29 19.15 15.76 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.747 -0.855 . . . . 0.0 110.46 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.5 m -68.12 147.47 52.27 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.3 -0.875 . . . . 0.0 109.508 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 94.56 -19.75 52.02 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -58.29 112.69 4.15 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.49 157.56 52.65 Favored 'Trans proline' 0 C--N 1.319 -1.025 0 O-C-N 123.201 1.106 . . . . 0.0 110.955 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.9 mp -109.4 127.66 54.54 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -110.41 160.26 16.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.535 -0.728 . . . . 0.0 111.078 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . 0.406 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 27.1 p -119.92 165.64 17.26 Favored Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 38.5 Cg_endo -63.97 -15.21 47.84 Favored 'Trans proline' 0 N--CA 1.488 1.18 0 O-C-N 123.079 1.042 . . . . 0.0 111.454 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.5 t -70.24 -39.95 74.75 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.282 -0.886 . . . . 0.0 110.044 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 114.87 31.61 2.06 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -132.15 155.76 47.6 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.492 -1.005 . . . . 0.0 110.404 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.41 146.85 44.78 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.556 -0.715 . . . . 0.0 109.985 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.9 t -112.08 -61.67 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.479 -0.763 . . . . 0.0 110.353 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -163.19 -158.76 10.0 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.8 mt -133.97 155.42 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.594 -0.945 . . . . 0.0 109.882 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -70.04 147.49 49.98 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.45 -0.781 . . . . 0.0 109.861 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 4.6 ttm-85 -128.6 -79.85 0.57 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.602 -0.686 . . . . 0.0 110.829 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -119.5 143.7 47.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.964 . . . . 0.0 111.313 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.56 128.08 39.53 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.4 t -98.86 119.11 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 121.48 -0.762 . . . . 0.0 111.282 -177.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.9 p -139.88 143.59 36.77 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.506 -0.746 . . . . 0.0 110.689 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 87.0 m -76.33 -41.98 46.56 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.596 -0.69 . . . . 0.0 109.872 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -143.24 50.28 1.41 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.646 -0.659 . . . . 0.0 109.897 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 90.77 -11.57 71.41 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 64.3 t -96.07 120.13 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.141 -1.211 . . . . 0.0 108.91 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.63 120.91 29.42 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.529 -0.732 . . . . 0.0 111.243 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -112.81 -32.28 6.46 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.296 0.57 . . . . 0.0 109.678 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -118.6 168.26 10.87 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.669 -0.644 . . . . 0.0 109.685 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 35.6 m -144.02 135.77 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.36 -0.838 . . . . 0.0 110.823 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -110.34 138.37 46.81 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.655 -0.653 . . . . 0.0 110.242 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -141.84 162.07 36.39 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.507 -0.746 . . . . 0.0 110.544 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 51.6 t -101.89 143.39 26.51 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.466 -0.771 . . . . 0.0 110.24 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -75.69 166.38 28.47 Favored 'Trans proline' 0 N--CA 1.485 1.006 0 O-C-N 123.296 1.156 . . . . 0.0 110.389 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 77.3 t -88.46 -25.86 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.536 -0.728 . . . . 0.0 110.536 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -59.33 -32.94 70.54 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.408 -0.808 . . . . 0.0 110.596 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.8 t -69.19 -22.94 63.86 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.469 -0.769 . . . . 0.0 110.49 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 35.1 mmt -63.29 -27.8 69.58 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.334 -0.854 . . . . 0.0 110.411 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -57.37 -49.95 74.53 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.404 -0.81 . . . . 0.0 110.67 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 6.1 t -70.03 -23.33 63.09 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.525 -0.735 . . . . 0.0 110.503 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 87.6 m -72.06 -32.95 67.57 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.427 -0.796 . . . . 0.0 110.243 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 95.7 mtp -60.02 -37.02 78.54 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.568 -0.707 . . . . 0.0 110.419 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -59.92 -39.87 86.94 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.528 -0.732 . . . . 0.0 110.273 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.837 0 O-C-N 121.56 -0.713 . . . . 0.0 110.111 179.954 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 120.908 0.385 . . . . 0.0 110.746 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.8 t -126.5 140.57 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.399 -0.813 . . . . 0.0 110.311 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -106.84 159.73 16.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.572 -0.705 . . . . 0.0 110.05 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 62.2 t -107.57 118.34 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.485 -0.76 . . . . 0.0 110.224 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 68.0 t -120.9 133.85 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.468 -0.77 . . . . 0.0 110.158 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.5 t -130.48 135.74 48.28 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.617 -0.677 . . . . 0.0 109.763 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.24 173.6 6.25 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.525 -0.734 . . . . 0.0 110.245 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.84 -34.88 74.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.746 -0.596 . . . . 0.0 111.203 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 68.9 p -103.49 -28.18 11.93 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.362 -0.836 . . . . 0.0 111.049 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -142.93 178.11 7.9 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.38 -0.825 . . . . 0.0 110.619 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 24.0 m -148.74 120.6 8.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.711 -0.618 . . . . 0.0 110.223 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -127.53 172.38 10.76 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.664 -0.647 . . . . 0.0 109.674 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.8 mt -121.14 153.96 36.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.492 -0.755 . . . . 0.0 109.978 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -125.76 154.66 42.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.594 -0.691 . . . . 0.0 110.379 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.4 t -129.11 144.18 51.11 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.667 -0.646 . . . . 0.0 109.902 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 27.9 p -94.84 118.8 32.36 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.696 0.76 . . . . 0.0 110.679 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.4 t -130.27 127.64 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.44 -0.787 . . . . 0.0 109.827 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 52.16 39.13 26.15 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.418 -0.801 . . . . 0.0 110.991 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.71 24.67 75.41 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.3 t -136.64 115.09 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.382 -1.069 . . . . 0.0 109.836 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 47.9 t -77.42 116.35 17.94 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.546 -0.721 . . . . 0.0 109.958 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.455 ' CZ3' ' CE ' ' A' ' 175' ' ' MET . 56.9 m95 -100.09 137.25 38.8 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.446 -0.783 . . . . 0.0 110.578 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.451 ' CG2' ' CH2' ' A' ' 85' ' ' TRP . 7.5 t -137.11 173.59 11.52 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.646 -0.659 . . . . 0.0 109.47 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.48 ' CG1' ' CE1' ' A' ' 57' ' ' HIS . 71.5 t -82.52 143.66 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.362 -0.836 . . . . 0.0 109.495 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.467 ' CE2' ' CG2' ' A' ' 78' ' ' VAL . 21.2 t80 -84.37 -42.21 15.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.754 -0.591 . . . . 0.0 111.027 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.48 ' CE1' ' CG1' ' A' ' 55' ' ' VAL . 1.4 p-80 -56.86 -20.02 20.67 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.967 -1.083 . . . . 0.0 111.227 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -102.16 -65.82 0.76 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.68 -22.83 49.94 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.473 -1.016 . . . . 0.0 111.027 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.603 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -179.75 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.6 p . . . . . 0 N--CA 1.493 1.718 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.2 mm-40 -96.8 113.94 25.54 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.493 -0.754 . . . . 0.0 111.123 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.418 ' HG3' ' CD2' ' A' ' 75' ' ' TYR . 19.4 ptt? -113.08 -29.73 7.22 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.658 -0.651 . . . . 0.0 109.783 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.418 ' CD2' ' HG3' ' A' ' 74' ' ' MET . 29.9 m-85 -120.22 116.37 25.47 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.572 -0.705 . . . . 0.0 109.596 179.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.1 m -150.31 130.92 13.96 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.481 -0.762 . . . . 0.0 110.316 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -167.74 123.24 1.04 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.363 -0.836 . . . . 0.0 111.327 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.467 ' CG2' ' CE2' ' A' ' 56' ' ' TYR . 70.1 t -72.67 -38.18 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.49 -0.756 . . . . 0.0 109.5 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -55.66 -33.3 63.97 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.484 -0.76 . . . . 0.0 110.641 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -100.61 -15.28 17.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.579 -0.7 . . . . 0.0 110.642 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.3 t0 61.1 39.79 15.73 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.111 -0.993 . . . . 0.0 113.631 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.409 ' C ' ' CD2' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -148.76 160.32 43.31 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.721 -1.237 . . . . 0.0 111.68 176.578 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.2 t -137.6 159.47 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -140.29 137.98 8.73 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.602 -1.285 . . . . 0.0 110.513 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.451 ' CH2' ' CG2' ' A' ' 54' ' ' THR . 5.3 m-90 -111.79 157.92 19.99 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.845 -0.797 . . . . 0.0 109.701 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -68.32 115.08 7.35 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.609 -0.682 . . . . 0.0 109.974 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -99.87 164.84 15.71 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.483 -0.761 . . . . 0.0 110.19 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.42 139.55 31.88 Favored 'Trans proline' 0 C--N 1.317 -1.097 0 O-C-N 123.408 1.215 . . . . 0.0 110.299 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -76.77 160.11 34.49 Favored 'Trans proline' 0 C--N 1.319 -1.003 0 O-C-N 123.26 1.137 . . . . 0.0 110.439 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 70.03 29.82 70.39 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -109.03 168.12 9.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.49 -1.006 . . . . 0.0 110.055 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.8 mtm180 -59.98 138.54 57.82 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.583 -0.698 . . . . 0.0 110.248 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 78.9 p -132.95 152.05 51.97 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.545 -0.722 . . . . 0.0 110.372 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 81.2 mt -97.1 131.58 43.73 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.589 -0.695 . . . . 0.0 110.258 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 44.4 p -85.0 155.54 60.91 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.595 -0.691 . . . . 0.0 110.256 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.67 162.98 39.79 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 O-C-N 123.49 1.258 . . . . 0.0 110.428 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.8 t -82.37 131.23 35.23 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.557 -0.714 . . . . 0.0 110.187 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.2 m -135.77 56.3 1.83 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.596 -0.69 . . . . 0.0 110.088 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.7 p -145.25 6.08 1.12 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.456 -0.778 . . . . 0.0 112.029 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 51.44 51.06 39.03 Favored Glycine 0 N--CA 1.502 3.05 0 O-C-N 120.949 -1.095 . . . . 0.0 110.541 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.2 p -99.06 121.74 41.39 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.441 -1.035 . . . . 0.0 110.525 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 68.2 m -73.42 -40.08 64.52 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.627 -0.671 . . . . 0.0 110.247 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -65.5 131.42 46.36 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.618 -0.676 . . . . 0.0 110.22 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 95.6 mt -135.95 144.95 45.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.543 -0.723 . . . . 0.0 110.379 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -114.11 129.26 56.62 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.502 -0.749 . . . . 0.0 110.203 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 38.1 tp -105.41 140.08 39.06 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.572 -0.705 . . . . 0.0 110.228 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.9 t -91.83 121.89 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.6 -0.688 . . . . 0.0 109.76 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.3 m -85.45 172.69 10.82 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.54 -0.725 . . . . 0.0 110.34 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.9 -26.53 65.99 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.572 -0.705 . . . . 0.0 110.523 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -96.05 26.32 4.25 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.528 -0.732 . . . . 0.0 110.453 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 52.9 39.99 30.1 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.323 -0.861 . . . . 0.0 110.827 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -94.52 162.51 13.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.539 -0.725 . . . . 0.0 110.127 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 63.9 t -110.27 130.34 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.538 -0.726 . . . . 0.0 109.897 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.0 tp -137.88 119.57 10.72 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.606 -0.684 . . . . 0.0 109.994 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -73.07 142.91 35.2 Favored 'Trans proline' 0 N--CA 1.486 1.069 0 O-C-N 123.074 1.039 . . . . 0.0 110.699 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.7 t -139.05 129.06 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.713 -0.617 . . . . 0.0 109.693 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -85.51 129.18 34.88 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.529 -0.732 . . . . 0.0 110.075 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -73.88 135.65 43.36 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.612 -0.68 . . . . 0.0 110.278 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -137.44 26.98 2.84 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.662 -0.649 . . . . 0.0 110.24 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.23 -179.54 43.77 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -70.08 -39.59 75.52 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.592 -0.946 . . . . 0.0 110.562 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 98.4 p -131.44 29.19 4.59 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.431 -0.793 . . . . 0.0 110.875 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.12 160.29 43.05 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.435 -0.791 . . . . 0.0 110.333 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -160.16 -170.14 24.36 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 88.3 p -126.34 164.55 20.82 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.577 -0.955 . . . . 0.0 110.159 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 46.5 tp -119.99 126.37 50.68 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.586 -0.696 . . . . 0.0 110.183 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.0 mp -59.83 -49.84 76.14 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.556 -0.715 . . . . 0.0 110.272 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.1 m -91.28 113.51 58.62 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.549 -0.72 . . . . 0.0 110.063 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.81 107.09 2.33 Favored 'Trans proline' 0 C--N 1.32 -0.939 0 O-C-N 123.153 1.081 . . . . 0.0 110.596 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.411 ' HD3' ' CE2' ' A' ' 134' ' ' TYR . 81.8 mtt-85 -110.98 149.78 40.93 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.599 -0.688 . . . . 0.0 109.929 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.04 150.37 60.31 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.463 1.243 . . . . 0.0 110.89 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 39.3 t -51.92 -30.09 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.461 -0.774 . . . . 0.0 109.79 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.1 t -61.65 -41.03 96.94 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.626 -0.672 . . . . 0.0 111.222 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.411 ' CE2' ' HD3' ' A' ' 130' ' ' ARG . 86.7 t80 -67.69 -39.96 84.41 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.349 -0.844 . . . . 0.0 109.75 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 23.9 tp -93.66 18.94 9.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.838 -0.539 . . . . 0.0 110.253 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -81.34 117.2 21.62 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.542 1.163 . . . . 0.0 112.757 -178.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.2 37.88 3.71 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.0 m -119.55 21.23 12.18 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.715 -0.873 . . . . 0.0 110.44 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.6 m -71.98 129.69 39.17 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.324 -0.86 . . . . 0.0 109.497 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 109.84 -24.4 19.4 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.82 110.69 2.28 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.34 149.11 56.38 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 O-C-N 123.234 1.123 . . . . 0.0 110.857 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.6 mp -99.59 119.33 37.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.708 -0.62 . . . . 0.0 109.535 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.6 tp -105.82 120.91 42.92 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.582 -0.699 . . . . 0.0 110.775 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 26.9 p -64.36 163.34 26.23 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.72 -0.613 . . . . 0.0 109.697 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.09 -15.22 47.74 Favored 'Trans proline' 0 N--CA 1.487 1.118 0 O-C-N 123.245 1.129 . . . . 0.0 111.158 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.2 m -70.0 -27.09 64.41 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.264 -0.898 . . . . 0.0 110.084 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 107.84 43.14 1.35 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -144.7 158.65 43.69 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.497 -1.002 . . . . 0.0 110.267 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.04 148.49 34.29 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.578 -0.701 . . . . 0.0 110.318 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.4 t -119.17 -62.44 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.573 -0.704 . . . . 0.0 110.22 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -156.53 -158.03 8.64 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.6 mt -135.86 145.36 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.597 -0.943 . . . . 0.0 109.675 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -62.55 155.46 25.83 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.438 -0.789 . . . . 0.0 109.605 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 33.2 ttm-85 -140.38 -66.17 0.44 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.945 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -130.57 143.68 50.92 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.935 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.59 127.64 39.36 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.1 119.95 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.617 -0.677 . . . . 0.0 111.305 -177.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.7 p -141.26 158.98 43.16 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.497 -0.752 . . . . 0.0 110.508 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 11.0 m -91.18 -56.86 2.99 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.567 -0.708 . . . . 0.0 109.456 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.5 ptp85 -123.85 36.62 4.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.607 -0.683 . . . . 0.0 109.449 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 103.7 -11.46 53.41 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 63.1 t -92.46 124.23 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.219 -1.165 . . . . 0.0 109.132 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.17 119.84 27.81 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.521 -0.737 . . . . 0.0 110.895 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 12.0 mtpp -110.15 -28.74 8.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.709 -0.619 . . . . 0.0 109.907 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -130.14 168.14 17.26 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.601 -0.687 . . . . 0.0 110.172 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.3 m -139.5 142.48 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.548 -0.72 . . . . 0.0 110.518 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -117.06 137.0 52.55 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.588 -0.695 . . . . 0.0 110.851 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -147.75 159.89 43.31 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.677 -0.64 . . . . 0.0 110.525 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 22.5 t -107.33 143.62 27.55 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 121.481 -0.762 . . . . 0.0 109.441 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -74.35 -179.67 4.99 Favored 'Trans proline' 0 C--N 1.319 -0.985 0 O-C-N 123.336 1.177 . . . . 0.0 110.603 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 57.4 t -94.79 -27.87 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.623 -0.673 . . . . 0.0 110.025 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -59.95 -34.2 72.93 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.581 -0.699 . . . . 0.0 110.552 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 34.7 t -61.7 -31.31 71.45 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.546 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' MET . . . . . 0.455 ' CE ' ' CZ3' ' A' ' 53' ' ' TRP . 69.3 mmm -71.6 -27.37 63.07 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.443 -0.786 . . . . 0.0 110.564 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -56.8 -42.99 80.51 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.361 -0.837 . . . . 0.0 110.496 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 86.3 m -69.59 -40.11 76.88 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.471 -0.768 . . . . 0.0 109.684 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 91.0 m -71.68 -34.47 69.69 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.622 -0.674 . . . . 0.0 110.24 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 4.9 tmm? -60.06 -39.93 87.72 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.511 -0.743 . . . . 0.0 110.278 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -60.08 -39.9 87.71 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.527 -0.733 . . . . 0.0 110.132 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.911 0 O-C-N 121.619 -0.676 . . . . 0.0 110.169 179.841 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 . . . . . 0 N--CA 1.498 1.965 0 CA-C-O 121.062 0.458 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 97.8 t -139.3 140.03 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.569 -0.707 . . . . 0.0 109.808 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -133.62 151.49 51.7 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.535 -0.728 . . . . 0.0 110.201 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.435 ' HA ' HD23 ' A' ' 44' ' ' LEU . 91.0 t -93.79 119.45 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.616 -0.677 . . . . 0.0 110.087 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.1 p -134.07 130.07 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.488 -0.757 . . . . 0.0 109.824 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 66.8 m -116.89 155.15 29.56 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.646 -0.659 . . . . 0.0 110.312 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -116.38 -178.65 3.46 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.709 -0.619 . . . . 0.0 110.121 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.29 -25.47 60.68 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.308 -178.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.3 p -119.11 -28.27 5.51 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.312 -0.868 . . . . 0.0 111.19 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.1 pm0 -140.43 171.9 13.48 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.366 -0.834 . . . . 0.0 110.321 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.0 t -142.99 119.06 10.7 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.503 -0.748 . . . . 0.0 110.658 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 3.4 p90 -128.31 177.69 6.78 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.574 -0.704 . . . . 0.0 109.692 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 35' ' ' VAL . 54.7 mt -115.83 160.48 20.1 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.504 -0.747 . . . . 0.0 110.052 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -129.64 153.96 47.59 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.39 -0.819 . . . . 0.0 110.504 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.5 p -130.98 144.08 51.21 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.636 -0.665 . . . . 0.0 110.099 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 28.4 p -93.99 121.41 35.43 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.509 -0.744 . . . . 0.0 110.564 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.4 t -130.34 136.66 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.388 -0.82 . . . . 0.0 110.412 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 43.59 34.32 0.79 Allowed 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.66 -24.23 15.81 Favored Glycine 0 N--CA 1.497 2.74 0 C-N-CA 120.279 -0.962 . . . . 0.0 111.264 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 62.8 t -107.5 129.56 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.179 -1.189 . . . . 0.0 110.073 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -82.45 131.49 35.22 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.653 -0.654 . . . . 0.0 109.955 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.474 ' CE3' ' CD2' ' A' ' 82' ' ' LEU . 90.5 m95 -117.15 137.83 52.06 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.528 -0.733 . . . . 0.0 110.738 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.423 HG22 ' CH2' ' A' ' 85' ' ' TRP . 10.0 t -136.6 -179.1 5.48 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.722 -0.611 . . . . 0.0 109.752 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.455 HG13 ' CE1' ' A' ' 57' ' ' HIS . 18.0 t -80.32 142.29 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.542 -0.724 . . . . 0.0 109.465 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.467 ' CE2' HG21 ' A' ' 78' ' ' VAL . 7.8 t80 -84.86 -42.61 14.91 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.633 -0.667 . . . . 0.0 110.875 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.455 ' CE1' HG13 ' A' ' 55' ' ' VAL . 1.1 p-80 -55.77 -20.55 15.29 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.256 -0.903 . . . . 0.0 111.161 -177.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -73.65 -63.92 2.61 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 108.354 -1.899 . . . . 0.0 108.354 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.83 -63.51 1.29 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.563 -0.963 . . . . 0.0 109.568 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.548 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 178.919 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.9 m . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 120.948 0.404 . . . . 0.0 109.953 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -96.31 146.21 24.92 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.502 -0.749 . . . . 0.0 110.312 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.406 ' HG3' ' CD2' ' A' ' 75' ' ' TYR . 19.4 ptp -119.22 -38.53 3.02 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.575 -0.703 . . . . 0.0 110.625 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.406 ' CD2' ' HG3' ' A' ' 74' ' ' MET . 31.6 m-85 -112.4 120.46 41.74 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.301 -0.874 . . . . 0.0 109.752 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 85.6 m -148.53 130.13 14.96 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.471 -0.768 . . . . 0.0 110.331 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -167.28 117.99 0.87 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.411 -0.806 . . . . 0.0 111.532 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.467 HG21 ' CE2' ' A' ' 56' ' ' TYR . 73.7 t -72.59 -35.09 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.37 -0.831 . . . . 0.0 109.523 178.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -55.71 -35.48 66.14 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.425 -0.797 . . . . 0.0 110.225 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -106.82 -8.02 16.93 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.624 -0.673 . . . . 0.0 110.659 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.9 t0 53.0 43.28 31.93 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.085 -1.009 . . . . 0.0 110.431 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.474 ' CD2' ' CE3' ' A' ' 53' ' ' TRP . 0.6 OUTLIER -133.15 140.88 47.84 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.928 0.871 . . . . 0.0 111.836 -178.783 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -145.65 154.13 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -162.97 170.6 38.52 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.783 -1.199 . . . . 0.0 110.344 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.423 ' CH2' HG22 ' A' ' 54' ' ' THR . 0.3 OUTLIER -136.58 167.78 20.74 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.884 -0.774 . . . . 0.0 109.062 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -78.53 122.29 25.69 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.618 -0.677 . . . . 0.0 110.27 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.58 173.76 5.84 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.523 -0.735 . . . . 0.0 110.101 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.31 142.6 37.65 Favored 'Trans proline' 0 C--N 1.317 -1.124 0 O-C-N 123.396 1.208 . . . . 0.0 110.362 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -76.12 154.38 37.26 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.378 1.199 . . . . 0.0 110.413 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.42 -28.73 14.08 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.74 143.74 45.98 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.522 -0.987 . . . . 0.0 110.223 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.8 ptt-85 -79.28 159.99 27.01 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.579 -0.701 . . . . 0.0 110.288 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.0 m -125.3 159.21 32.27 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.596 -0.69 . . . . 0.0 110.268 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.99 147.12 39.05 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.518 -0.739 . . . . 0.0 110.152 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 86.0 m -91.4 144.0 29.04 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.626 -0.671 . . . . 0.0 110.103 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.54 166.1 30.45 Favored 'Trans proline' 0 C--N 1.318 -1.056 0 O-C-N 123.259 1.137 . . . . 0.0 110.398 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 46.7 t -65.84 140.02 58.35 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.503 -0.748 . . . . 0.0 110.353 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.8 m -134.38 38.52 3.11 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.654 -0.654 . . . . 0.0 110.029 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.8 p -144.78 -8.31 0.64 Allowed 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 119.981 -0.688 . . . . 0.0 112.368 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 55.65 34.62 60.76 Favored Glycine 0 N--CA 1.5 2.91 0 O-C-N 120.769 -1.207 . . . . 0.0 110.322 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 52.4 p -74.6 159.9 31.54 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.366 -1.079 . . . . 0.0 110.339 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.7 m -95.8 -33.51 12.23 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.635 -0.665 . . . . 0.0 110.302 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -70.29 120.83 16.54 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.503 -0.748 . . . . 0.0 110.112 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 58.5 mt -130.86 149.95 52.25 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.578 -0.702 . . . . 0.0 110.4 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -115.16 131.01 57.07 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.62 -0.675 . . . . 0.0 109.587 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 36.8 tp -111.83 143.48 42.7 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.48 -0.763 . . . . 0.0 110.58 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 63.3 t -104.61 129.07 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.679 -0.638 . . . . 0.0 109.392 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 70.1 p -104.35 169.38 8.51 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.475 -0.766 . . . . 0.0 110.852 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.409 ' NH1' ' CG1' ' A' ' 35' ' ' VAL . 16.2 tpt180 -59.99 -21.96 61.95 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.64 -0.662 . . . . 0.0 110.264 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -90.85 20.03 5.1 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.336 -0.852 . . . . 0.0 111.019 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 52.21 36.58 19.69 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.208 -0.932 . . . . 0.0 110.878 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -101.14 149.63 23.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.63 -0.669 . . . . 0.0 110.055 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 62.0 t -109.96 128.73 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.644 -0.66 . . . . 0.0 110.044 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 35.7 pt -138.55 138.91 23.06 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.634 -0.666 . . . . 0.0 110.139 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -79.61 151.6 22.38 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 O-C-N 123.289 1.152 . . . . 0.0 110.495 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.7 t -137.55 134.9 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.605 -0.684 . . . . 0.0 109.92 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 8.4 tpp180 -92.2 135.41 34.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.576 -0.703 . . . . 0.0 110.068 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 54.3 ttt180 -81.34 128.58 33.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.574 -0.703 . . . . 0.0 110.193 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.53 20.63 6.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.651 -0.656 . . . . 0.0 109.811 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 168.28 170.82 33.47 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -60.27 -50.05 75.19 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.499 -1.0 . . . . 0.0 110.032 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 53.1 m -114.75 -15.16 11.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.563 -0.71 . . . . 0.0 110.71 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -95.61 136.99 35.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.435 -0.791 . . . . 0.0 110.016 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -140.72 178.92 19.68 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 88.6 p -132.26 165.02 25.11 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.586 -0.95 . . . . 0.0 110.198 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 38.5 tp -121.18 138.23 54.31 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.503 -0.748 . . . . 0.0 110.218 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.5 mp -68.77 -54.85 13.57 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.516 -0.74 . . . . 0.0 110.03 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.1 p -92.41 109.32 37.4 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.581 -0.699 . . . . 0.0 109.809 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -75.11 120.57 6.08 Favored 'Trans proline' 0 C--N 1.319 -0.978 0 O-C-N 123.223 1.118 . . . . 0.0 111.168 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.422 ' HD2' ' CD2' ' A' ' 134' ' ' TYR . 94.1 mtm-85 -121.06 154.97 58.36 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.649 -0.657 . . . . 0.0 109.603 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -68.09 150.3 77.27 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 O-C-N 123.282 1.148 . . . . 0.0 111.141 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 40.6 t -53.43 -29.91 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 121.511 -0.743 . . . . 0.0 109.773 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.4 t -59.9 -41.57 91.94 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.659 -0.651 . . . . 0.0 111.23 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.422 ' CD2' ' HD2' ' A' ' 130' ' ' ARG . 83.6 t80 -68.16 -40.0 82.44 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.347 -0.845 . . . . 0.0 109.779 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 31.5 tp -92.71 18.2 9.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.787 -0.571 . . . . 0.0 110.122 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -81.92 115.01 20.9 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 122.567 1.175 . . . . 0.0 112.078 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.78 28.92 6.76 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 58.1 m -110.66 20.04 18.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.57 -0.959 . . . . 0.0 110.546 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.8 m -65.64 145.18 56.36 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.268 -0.895 . . . . 0.0 109.487 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 95.9 -21.66 43.74 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.04 109.76 1.64 Allowed Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -75.69 150.63 35.52 Favored 'Trans proline' 0 C--N 1.32 -0.927 0 O-C-N 123.203 1.107 . . . . 0.0 111.036 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.0 mp -100.72 111.5 23.74 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.2 tp -97.04 140.1 32.07 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.528 -0.732 . . . . 0.0 110.758 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -76.12 174.57 5.4 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.657 -0.652 . . . . 0.0 109.785 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.05 -28.63 28.42 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 O-C-N 123.368 1.193 . . . . 0.0 110.235 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 83.8 p -70.36 -35.35 73.5 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.573 -0.704 . . . . 0.0 110.108 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 118.88 38.95 0.73 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 58.3 m170 -124.53 137.37 54.42 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.541 -0.976 . . . . 0.0 110.403 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.4 140.04 58.6 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.523 -0.736 . . . . 0.0 110.148 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 62.1 t -111.29 -55.99 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.614 -0.679 . . . . 0.0 110.146 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -161.83 -165.25 18.39 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 83.3 mt -131.31 143.71 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.664 -0.903 . . . . 0.0 109.778 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -61.57 147.34 45.91 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.429 -0.795 . . . . 0.0 110.07 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.94 -71.21 0.64 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.597 0.713 . . . . 0.0 110.104 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -126.27 144.57 50.74 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 121.794 0.807 . . . . 0.0 111.269 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.49 128.52 39.63 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.4 t -99.02 120.47 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.531 -0.731 . . . . 0.0 111.671 -177.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 28.2 p -141.29 136.9 32.06 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.507 -0.746 . . . . 0.0 110.622 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 87.1 m -71.28 -42.52 68.64 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.546 -0.721 . . . . 0.0 109.92 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -140.86 49.54 1.68 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.575 -0.703 . . . . 0.0 110.075 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 89.99 -11.64 70.07 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 61.7 t -94.66 120.44 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.245 -1.15 . . . . 0.0 108.925 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.45 117.49 26.28 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.632 -0.668 . . . . 0.0 111.074 -178.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -113.19 -26.23 8.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.751 -0.593 . . . . 0.0 110.008 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -125.98 168.45 13.91 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.485 -0.759 . . . . 0.0 110.394 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 35.3 m -144.73 135.81 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.542 -0.724 . . . . 0.0 110.48 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -112.94 133.87 54.71 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.411 -0.806 . . . . 0.0 110.954 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -147.04 162.32 39.04 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.67 -0.644 . . . . 0.0 110.366 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 4.1 m -104.23 145.21 30.23 Favored Pre-proline 0 N--CA 1.505 2.291 0 O-C-N 121.449 -0.782 . . . . 0.0 110.456 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -75.33 -171.82 1.12 Allowed 'Trans proline' 0 C--N 1.319 -1.019 0 O-C-N 123.436 1.23 . . . . 0.0 109.83 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 57.3 t -87.39 -23.26 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.595 -0.69 . . . . 0.0 110.417 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -61.69 -30.31 70.66 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.412 -0.805 . . . . 0.0 111.28 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 9.5 t -62.67 -24.46 67.64 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.161 -0.962 . . . . 0.0 110.687 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' MET . . . . . 0.42 ' HG2' ' CD2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -80.73 -28.25 36.62 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.487 -0.758 . . . . 0.0 111.15 -179.457 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -59.94 -44.62 94.26 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.433 -0.792 . . . . 0.0 110.551 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 90.0 m -69.9 -39.94 75.93 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.433 -0.792 . . . . 0.0 110.492 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 58.9 m -67.77 -31.85 72.03 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.543 -0.723 . . . . 0.0 110.679 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.8 -38.27 81.45 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.377 -0.827 . . . . 0.0 110.556 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -59.92 -39.96 87.22 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.443 -0.785 . . . . 0.0 110.374 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.803 0 O-C-N 121.499 -0.751 . . . . 0.0 110.148 179.871 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? . . . . . 0 N--CA 1.497 1.921 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.3 p -135.0 128.52 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.089 -1.007 . . . . 0.0 109.895 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -107.52 134.56 50.36 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.671 -0.643 . . . . 0.0 110.413 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.2 m -72.54 147.74 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.615 -0.678 . . . . 0.0 110.096 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.5 t -124.9 145.92 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.562 -0.712 . . . . 0.0 109.74 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.6 t -115.85 126.67 54.27 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.656 -0.652 . . . . 0.0 110.36 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.3 m -113.92 175.57 5.41 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.578 -0.701 . . . . 0.0 110.012 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.01 -13.96 59.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.668 -0.645 . . . . 0.0 111.326 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 77.5 p -121.25 -28.21 4.73 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.173 -0.954 . . . . 0.0 111.424 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -154.42 175.86 13.05 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.278 -0.888 . . . . 0.0 110.95 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.5 t -135.91 122.82 21.3 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.71 -0.619 . . . . 0.0 109.935 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -127.78 -169.61 2.09 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.504 -0.748 . . . . 0.0 110.368 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.41 167.83 10.69 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.574 -0.704 . . . . 0.0 110.491 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.61 140.71 35.12 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.604 -0.685 . . . . 0.0 110.151 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 67.7 p -119.26 138.62 52.88 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.428 -0.795 . . . . 0.0 110.057 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.1 t -101.14 115.09 29.68 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.541 -0.725 . . . . 0.0 110.596 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.0 t -129.98 127.1 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.457 -0.777 . . . . 0.0 110.159 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 64.8 t30 53.16 40.21 30.88 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.455 -0.778 . . . . 0.0 111.045 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.01 21.5 71.67 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 62.9 t -130.21 113.75 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.399 -1.059 . . . . 0.0 109.463 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.2 t -82.98 133.02 35.12 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.593 -0.692 . . . . 0.0 109.906 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.401 ' CH2' ' O ' ' A' ' 175' ' ' MET . 92.9 m95 -119.95 136.39 54.55 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.492 -0.755 . . . . 0.0 111.094 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.5 t -137.71 -179.92 6.04 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.47 ' CG1' ' CE1' ' A' ' 57' ' ' HIS . 47.2 t -92.39 147.56 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.294 -0.879 . . . . 0.0 109.979 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.499 ' CE2' HG21 ' A' ' 78' ' ' VAL . 21.6 t80 -84.15 -43.45 14.98 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.539 -0.726 . . . . 0.0 111.407 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.47 ' CE1' ' CG1' ' A' ' 55' ' ' VAL . 1.5 p-80 -52.38 -25.91 11.08 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.116 -0.99 . . . . 0.0 111.114 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.431 ' N ' ' CD2' ' A' ' 57' ' ' HIS . . . -89.59 -55.99 1.95 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.24 -63.38 1.41 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.527 -0.984 . . . . 0.0 110.334 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.433 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.961 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 64.6 p . . . . . 0 N--CA 1.498 1.938 0 CA-C-O 121.221 0.534 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -82.66 119.95 24.94 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.578 -0.701 . . . . 0.0 110.086 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.2 mtp -83.97 -51.15 7.37 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.526 -0.734 . . . . 0.0 110.473 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.467 ' CD2' ' N ' ' A' ' 75' ' ' TYR . 1.2 p90 -122.54 130.09 52.66 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.672 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.433 ' HA ' HG11 ' A' ' 83' ' ' VAL . 57.0 m -135.28 141.1 45.63 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.659 -0.651 . . . . 0.0 110.501 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -161.34 120.92 2.57 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.234 -0.916 . . . . 0.0 112.133 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.499 HG21 ' CE2' ' A' ' 56' ' ' TYR . 54.2 t -72.88 -39.11 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.295 -0.878 . . . . 0.0 109.34 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -55.54 -43.04 75.45 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.389 -0.82 . . . . 0.0 110.369 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.407 ' HB3' ' CD2' ' A' ' 82' ' ' LEU . 3.3 tp60 -90.92 -9.68 45.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.608 -0.683 . . . . 0.0 110.485 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t0 52.47 42.0 31.09 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.088 -1.007 . . . . 0.0 111.54 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.407 ' CD2' ' HB3' ' A' ' 80' ' ' GLN . 0.3 OUTLIER -148.58 143.1 26.37 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.173 -0.954 . . . . 0.0 111.123 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.433 HG11 ' HA ' ' A' ' 76' ' ' THR . 28.4 m -145.18 144.08 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.448 ' N ' ' CE1' ' A' ' 75' ' ' TYR . . . -142.61 156.83 26.46 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.571 -1.3 . . . . 0.0 110.347 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -113.63 168.11 10.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.901 -0.764 . . . . 0.0 109.331 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -87.29 100.62 12.84 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.494 -0.754 . . . . 0.0 109.299 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.08 158.88 82.6 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.636 -0.665 . . . . 0.0 110.461 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.43 160.13 49.49 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.523 1.275 . . . . 0.0 110.299 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.49 151.01 52.69 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 O-C-N 123.402 1.212 . . . . 0.0 110.283 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.34 -23.72 34.28 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.13 152.76 23.55 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.336 -1.096 . . . . 0.0 110.291 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -70.25 148.01 49.08 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.561 -0.712 . . . . 0.0 110.244 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 80.0 p -126.7 149.71 49.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.58 -0.7 . . . . 0.0 110.093 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.6 mt -109.79 157.4 19.2 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.541 -0.725 . . . . 0.0 110.548 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 89.7 m -98.16 144.4 27.99 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.701 -0.625 . . . . 0.0 109.727 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.48 160.47 49.67 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.256 1.135 . . . . 0.0 110.407 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 45.2 t -60.02 134.64 57.23 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.587 -0.695 . . . . 0.0 110.445 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 21.6 m -136.1 48.29 2.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.673 -0.642 . . . . 0.0 109.977 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.9 p -144.89 -8.31 0.63 Allowed 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 119.949 -0.701 . . . . 0.0 112.383 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.68 72.01 0.61 Allowed Glycine 0 N--CA 1.5 2.928 0 O-C-N 120.766 -1.209 . . . . 0.0 110.288 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.0 m -125.09 129.98 51.31 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.522 -0.987 . . . . 0.0 110.471 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.7 m -67.19 -39.95 86.47 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.492 -0.755 . . . . 0.0 110.138 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -60.17 131.75 51.79 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.589 -0.694 . . . . 0.0 110.356 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 88.3 mt -136.36 160.21 39.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.646 -0.658 . . . . 0.0 110.153 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -122.98 109.45 14.13 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.477 -0.764 . . . . 0.0 110.246 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.413 ' O ' ' CG1' ' A' ' 113' ' ' VAL . 21.1 tp -74.17 148.14 41.96 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.708 -0.62 . . . . 0.0 109.837 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.0 t -126.28 119.99 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.289 -0.882 . . . . 0.0 110.244 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 53.0 p -91.36 -164.93 1.25 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.264 -0.898 . . . . 0.0 110.076 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.26 -18.99 24.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.522 -0.736 . . . . 0.0 111.229 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.428 ' O ' ' CG ' ' A' ' 110' ' ' HIS . 4.5 t60 -109.65 29.4 7.62 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.259 -0.9 . . . . 0.0 110.666 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 57.47 33.62 23.52 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.301 -0.874 . . . . 0.0 112.063 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.423 ' O ' ' CG1' ' A' ' 113' ' ' VAL . 7.0 p-10 -119.39 134.01 55.43 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.285 -0.884 . . . . 0.0 109.727 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -176.37 -173.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.425 0 CA-C-O 121.853 0.835 . . . . 0.0 111.143 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.19 168.8 10.58 Favored Pre-proline 0 N--CA 1.49 1.568 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -70.36 145.12 52.77 Favored 'Trans proline' 0 C--N 1.317 -1.106 0 O-C-N 123.217 1.114 . . . . 0.0 110.066 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.3 t -126.91 130.0 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.569 -0.707 . . . . 0.0 110.116 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.9 mmm180 -83.28 132.39 35.03 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.487 -0.758 . . . . 0.0 110.053 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 49.6 ttm-85 -65.96 133.27 50.49 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.535 -0.728 . . . . 0.0 110.242 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -116.49 -22.44 8.72 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.622 -0.674 . . . . 0.0 110.478 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -155.93 -167.33 17.21 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -70.09 -39.95 75.27 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.598 -0.942 . . . . 0.0 110.565 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 36.9 p -129.9 26.46 5.24 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.396 -0.815 . . . . 0.0 110.801 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.48 152.61 41.7 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.511 -0.743 . . . . 0.0 110.181 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -149.19 -179.98 25.51 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 78.0 p -120.0 151.5 38.88 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.703 -0.881 . . . . 0.0 110.217 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.0 tp -100.0 129.88 46.11 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.653 -0.655 . . . . 0.0 110.195 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.3 mp -61.91 -53.91 49.17 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.581 -0.699 . . . . 0.0 110.404 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.6 t -95.28 129.91 33.87 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.561 -0.712 . . . . 0.0 110.124 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -79.27 106.85 2.1 Favored 'Trans proline' 0 C--N 1.32 -0.97 0 O-C-N 123.175 1.092 . . . . 0.0 110.673 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.415 ' HD2' ' CD2' ' A' ' 134' ' ' TYR . 4.6 mtm180 -114.21 149.91 42.81 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.599 -0.688 . . . . 0.0 109.636 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.36 150.31 70.52 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 123.317 1.167 . . . . 0.0 111.153 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 66.0 t -52.85 -29.26 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.501 -0.749 . . . . 0.0 109.81 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.93 -43.26 95.05 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.605 -0.685 . . . . 0.0 111.279 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.415 ' CD2' ' HD2' ' A' ' 130' ' ' ARG . 88.9 t80 -65.89 -40.01 91.18 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.358 -0.838 . . . . 0.0 109.619 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 21.8 tp -93.26 18.87 8.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.926 -0.484 . . . . 0.0 110.278 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -82.47 116.64 22.01 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 122.523 1.154 . . . . 0.0 112.514 -178.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.97 30.14 6.18 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.0 m -110.57 20.26 17.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.687 -0.89 . . . . 0.0 110.353 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.7 m -76.44 141.81 41.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.311 -0.868 . . . . 0.0 109.557 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 95.91 -26.62 19.74 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.84 128.35 44.83 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 108.911 -1.675 . . . . 0.0 108.911 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.05 172.54 16.16 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 O-C-N 123.201 1.106 . . . . 0.0 111.142 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.3 mp -117.68 115.61 25.41 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.408 ' N ' ' CD2' ' A' ' 144' ' ' LEU . 4.5 mm? -90.09 152.37 21.17 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.701 -0.624 . . . . 0.0 111.017 -178.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.95 179.28 1.28 Allowed Pre-proline 0 N--CA 1.494 1.733 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.63 -26.62 27.99 Favored 'Trans proline' 0 C--N 1.318 -1.069 0 O-C-N 123.202 1.106 . . . . 0.0 110.319 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 66.2 m -79.41 -29.06 41.8 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.519 -0.738 . . . . 0.0 110.043 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 113.43 50.26 0.54 Allowed Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -135.77 148.06 48.63 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.517 -0.99 . . . . 0.0 110.288 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -76.1 136.94 39.86 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.537 -0.727 . . . . 0.0 110.051 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 13.0 p -119.06 -24.45 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.559 -0.713 . . . . 0.0 110.878 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 176.6 -167.74 39.38 Favored Glycine 0 N--CA 1.498 2.784 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.29 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 71.8 mt -130.38 158.88 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.598 -0.942 . . . . 0.0 109.833 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -75.84 151.64 37.42 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.454 -0.779 . . . . 0.0 109.918 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.401 ' CZ ' ' CG2' ' A' ' 170' ' ' VAL . 30.7 ttm180 -131.83 -76.41 0.51 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.572 -0.705 . . . . 0.0 110.797 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -122.46 143.68 49.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.086 -1.009 . . . . 0.0 111.406 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.65 127.87 39.55 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.5 t -97.67 117.98 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 O-C-N 121.506 -0.746 . . . . 0.0 111.673 -177.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 28.9 p -141.07 148.72 40.63 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.371 -0.831 . . . . 0.0 110.672 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 63.7 m -85.56 -50.14 7.47 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.448 -0.782 . . . . 0.0 109.72 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.75 32.79 5.61 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.74 -0.6 . . . . 0.0 109.608 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 101.44 -11.69 58.23 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 63.4 t -89.51 120.92 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.223 -1.163 . . . . 0.0 108.991 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -86.97 113.25 22.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.644 -0.66 . . . . 0.0 110.975 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -108.52 -26.23 10.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.787 -0.571 . . . . 0.0 109.862 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -121.27 164.02 17.65 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.47 -0.769 . . . . 0.0 109.952 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 35.0 m -141.81 131.1 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.534 -0.729 . . . . 0.0 110.659 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -103.83 129.67 51.32 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.477 -0.765 . . . . 0.0 110.709 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -142.65 162.17 36.18 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.568 -0.708 . . . . 0.0 110.188 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.401 ' CG2' ' CZ ' ' A' ' 155' ' ' ARG . 86.1 t -111.93 144.93 31.7 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.427 -0.796 . . . . 0.0 110.089 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.95 175.2 10.09 Favored 'Trans proline' 0 N--CA 1.486 1.061 0 O-C-N 123.319 1.168 . . . . 0.0 110.984 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 59.4 t -79.42 -41.41 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.657 -0.652 . . . . 0.0 110.153 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -54.41 -36.32 63.84 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.835 -0.541 . . . . 0.0 111.045 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 45.2 t -61.84 -33.71 74.66 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.485 -0.76 . . . . 0.0 109.906 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' MET . . . . . 0.401 ' O ' ' CH2' ' A' ' 53' ' ' TRP . 67.2 mtt -70.05 -27.94 65.05 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.595 -0.69 . . . . 0.0 110.446 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -59.5 -50.09 75.28 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.495 -0.753 . . . . 0.0 110.64 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 7.1 t -69.98 -22.54 63.14 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.516 -0.74 . . . . 0.0 110.825 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 68.4 m -68.68 -29.08 67.46 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.439 -0.788 . . . . 0.0 110.53 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 91.1 mtp -59.98 -48.49 81.48 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.476 -0.765 . . . . 0.0 110.257 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -59.91 -40.07 87.55 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.606 -0.684 . . . . 0.0 110.315 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.792 0 O-C-N 121.65 -0.656 . . . . 0.0 110.188 -179.961 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.1 mp0 . . . . . 0 N--CA 1.501 2.124 0 CA-C-O 120.79 0.328 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.4 m -132.77 160.06 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.483 -0.76 . . . . 0.0 109.83 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -143.42 126.53 16.46 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.615 -0.678 . . . . 0.0 110.24 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.0 m -74.39 145.54 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.506 -0.746 . . . . 0.0 109.934 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.427 HG21 ' CE2' ' A' ' 43' ' ' PHE . 33.6 m -136.0 148.07 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.444 -0.785 . . . . 0.0 110.19 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.8 m -116.41 126.09 52.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.613 -0.68 . . . . 0.0 110.412 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.52 -171.01 1.91 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.624 -0.672 . . . . 0.0 109.455 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.08 -51.74 68.32 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.77 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.1 t -128.02 10.78 6.47 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.468 -0.77 . . . . 0.0 111.529 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -148.29 161.24 41.92 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.135 -0.978 . . . . 0.0 110.603 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 81.2 p -143.3 125.71 15.7 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.547 -0.72 . . . . 0.0 110.144 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.427 ' CE2' HG21 ' A' ' 36' ' ' VAL . 27.5 p90 -129.45 -169.69 2.15 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.638 -0.664 . . . . 0.0 110.252 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.1 mt -126.13 164.49 20.79 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.617 -0.677 . . . . 0.0 110.43 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -138.65 140.33 38.83 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.588 -0.695 . . . . 0.0 110.16 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.7 m -115.01 127.86 55.92 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.528 -0.732 . . . . 0.0 110.096 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 26.7 p -75.62 117.02 16.94 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.569 -0.707 . . . . 0.0 110.773 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.7 t -130.29 123.95 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.33 -0.856 . . . . 0.0 110.436 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 50.74 34.06 9.4 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.568 -0.708 . . . . 0.0 111.764 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.76 -24.23 13.49 Favored Glycine 0 N--CA 1.498 2.778 0 C-N-CA 120.365 -0.921 . . . . 0.0 111.216 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.7 t -106.53 113.94 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.155 -1.203 . . . . 0.0 109.781 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 27.5 p -71.12 154.49 41.69 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.438 -0.789 . . . . 0.0 110.259 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.432 ' CZ2' ' HB3' ' A' ' 175' ' ' MET . 79.0 m95 -124.36 137.06 54.51 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.606 -0.684 . . . . 0.0 110.779 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.454 ' CG2' ' CH2' ' A' ' 85' ' ' TRP . 7.5 t -136.99 -179.97 6.02 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.738 -0.601 . . . . 0.0 109.888 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.486 ' CG1' ' CE1' ' A' ' 57' ' ' HIS . 62.4 t -85.41 142.01 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.608 -0.682 . . . . 0.0 109.547 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.475 ' CE2' ' CG2' ' A' ' 78' ' ' VAL . 25.3 t80 -85.2 -44.04 13.27 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.495 -0.753 . . . . 0.0 111.031 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.486 ' CE1' ' CG1' ' A' ' 55' ' ' VAL . 2.3 p-80 -60.68 -20.15 60.25 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.025 -177.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -92.71 -54.49 1.78 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.15 -47.64 19.82 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.49 -1.006 . . . . 0.0 110.58 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.412 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.801 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 t . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 121.154 0.502 . . . . 0.0 110.541 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.434 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -77.44 124.96 28.58 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.588 -0.695 . . . . 0.0 110.502 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 8.2 ttt -82.78 -52.77 6.44 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.368 -0.832 . . . . 0.0 109.795 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.524 ' CZ ' ' HA3' ' A' ' 84' ' ' GLY . 12.1 p90 -147.08 139.91 25.05 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.294 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 81.7 p -130.52 140.41 50.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.724 -0.61 . . . . 0.0 109.711 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -159.67 120.74 3.17 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.253 -0.904 . . . . 0.0 111.033 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.475 ' CG2' ' CE2' ' A' ' 56' ' ' TYR . 99.0 t -72.22 -35.6 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.411 -0.806 . . . . 0.0 109.769 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -55.87 -35.71 66.8 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.46 -0.775 . . . . 0.0 110.275 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 31.9 tp60 -102.55 -13.79 17.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.736 -0.603 . . . . 0.0 110.469 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 44.9 t0 55.25 38.02 29.77 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.167 -0.958 . . . . 0.0 110.621 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.42 HD21 ' CE3' ' A' ' 53' ' ' TRP . 2.2 mp -136.18 148.93 48.38 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.611 -0.681 . . . . 0.0 110.361 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.42 ' CG2' ' HB2' ' A' ' 56' ' ' TYR . 4.8 t -146.52 129.87 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.524 ' HA3' ' CZ ' ' A' ' 75' ' ' TYR . . . -118.68 163.7 13.1 Favored Glycine 0 N--CA 1.502 3.071 0 C-N-CA 118.817 -1.658 . . . . 0.0 111.307 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.454 ' CH2' ' CG2' ' A' ' 54' ' ' THR . 5.7 m-90 -132.51 158.42 42.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.958 -0.731 . . . . 0.0 109.469 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -74.32 103.98 4.91 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.534 -0.729 . . . . 0.0 110.013 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.4 158.51 87.49 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.645 -0.659 . . . . 0.0 110.274 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.45 160.03 47.77 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 O-C-N 123.453 1.238 . . . . 0.0 110.367 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -74.98 160.05 40.68 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 O-C-N 123.404 1.213 . . . . 0.0 110.391 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 87.64 28.18 24.94 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -123.84 139.45 53.96 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.492 -1.005 . . . . 0.0 110.153 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.39 139.02 38.8 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.514 -0.741 . . . . 0.0 110.209 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.9 p -92.39 145.09 24.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.578 -0.701 . . . . 0.0 110.185 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 40.2 mt -79.08 157.35 28.01 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.594 -0.691 . . . . 0.0 110.175 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.2 t -110.99 150.09 41.39 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.623 -0.673 . . . . 0.0 110.209 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.22 161.38 44.69 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 O-C-N 123.388 1.204 . . . . 0.0 110.708 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 37.3 t -70.56 135.55 48.59 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.626 -0.671 . . . . 0.0 110.267 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.2 t -136.19 50.35 2.07 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.61 -0.681 . . . . 0.0 110.337 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.7 p -145.12 4.12 1.07 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.492 -0.755 . . . . 0.0 112.107 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 50.79 70.29 0.89 Allowed Glycine 0 N--CA 1.5 2.928 0 O-C-N 120.897 -1.127 . . . . 0.0 110.693 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 92.7 p -120.89 133.47 55.3 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.467 -1.02 . . . . 0.0 110.474 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 63.8 m -83.01 -28.81 29.4 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.643 -0.66 . . . . 0.0 110.198 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -66.56 133.58 50.62 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.629 -0.669 . . . . 0.0 110.181 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 91.2 mt -134.9 162.19 33.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.586 -0.696 . . . . 0.0 110.143 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -130.26 108.9 10.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.521 -0.737 . . . . 0.0 110.072 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 21.9 tp -74.11 147.19 42.95 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.668 -0.645 . . . . 0.0 109.524 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.5 t -118.62 127.08 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.385 -0.822 . . . . 0.0 110.054 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 37.5 m -103.19 168.12 9.38 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.348 -0.845 . . . . 0.0 110.344 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 -63.22 -27.63 69.49 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.625 -0.672 . . . . 0.0 110.965 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -96.44 26.97 4.03 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.428 -0.795 . . . . 0.0 110.812 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 52.63 24.18 3.01 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.361 -0.837 . . . . 0.0 111.092 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -115.03 139.33 49.95 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.426 -0.796 . . . . 0.0 109.547 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -175.7 -172.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 CA-C-O 121.803 0.811 . . . . 0.0 111.05 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.01 170.35 8.28 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -76.13 138.21 20.15 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 O-C-N 123.288 1.152 . . . . 0.0 110.439 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.4 t -120.27 130.01 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.619 -0.676 . . . . 0.0 109.889 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -85.44 135.41 33.87 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.525 -0.734 . . . . 0.0 109.965 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -66.8 135.29 53.71 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.582 -0.699 . . . . 0.0 110.489 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -140.27 27.38 2.13 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.633 -0.667 . . . . 0.0 110.144 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 163.6 169.35 26.96 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -62.53 -45.16 94.25 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.592 -0.946 . . . . 0.0 110.272 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.8 m -123.51 27.08 7.57 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.615 -0.678 . . . . 0.0 110.394 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.53 155.84 45.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.505 -0.747 . . . . 0.0 110.114 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -151.52 -177.09 24.96 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 78.9 p -119.67 152.3 37.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.638 -0.919 . . . . 0.0 110.211 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.51 145.44 34.74 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.667 -0.645 . . . . 0.0 109.898 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.5 mp -89.98 -73.79 0.51 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.658 -0.651 . . . . 0.0 109.796 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 43.0 t -72.29 112.63 15.46 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.59 -0.694 . . . . 0.0 109.334 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.68 124.19 9.57 Favored 'Trans proline' 0 C--N 1.319 -0.984 0 O-C-N 123.161 1.085 . . . . 0.0 111.266 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -127.63 153.54 77.66 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.61 150.32 56.77 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 O-C-N 123.338 1.178 . . . . 0.0 110.671 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.6 t -52.38 -29.51 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.387 -0.821 . . . . 0.0 109.577 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 46.8 t -61.24 -46.06 91.96 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.745 -0.597 . . . . 0.0 111.382 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -63.87 -39.42 94.15 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.254 -0.904 . . . . 0.0 109.618 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 35.4 tp -92.2 18.62 7.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.855 -0.528 . . . . 0.0 110.025 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 19.6 tttm -83.47 119.23 24.42 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.491 1.139 . . . . 0.0 112.837 -178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 98.79 23.51 11.8 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.5 m -105.09 20.79 18.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.496 -1.002 . . . . 0.0 110.584 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.6 m -73.61 144.41 45.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.316 -0.865 . . . . 0.0 109.243 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 97.31 -25.44 27.09 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -58.5 119.41 17.28 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.65 173.87 13.19 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 O-C-N 123.214 1.112 . . . . 0.0 111.058 -178.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.2 mp -121.18 130.55 53.76 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -115.02 126.15 54.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.597 -0.689 . . . . 0.0 111.093 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . 0.423 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 29.2 p -72.24 165.75 47.79 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.438 -0.789 . . . . 0.0 108.878 178.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.423 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 38.1 Cg_endo -63.54 -14.9 45.3 Favored 'Trans proline' 0 N--CA 1.488 1.188 0 O-C-N 123.022 1.011 . . . . 0.0 111.36 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 8.8 t -75.32 -34.14 61.21 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.227 -0.921 . . . . 0.0 110.02 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 114.31 47.47 0.59 Allowed Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -146.29 147.79 31.75 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.645 -0.915 . . . . 0.0 110.136 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -76.98 137.99 39.36 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.485 -0.759 . . . . 0.0 109.89 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.3 p -119.14 -30.87 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.512 -0.742 . . . . 0.0 111.102 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.52 -169.51 32.04 Favored Glycine 0 N--CA 1.498 2.785 0 C-N-CA 119.678 -1.249 . . . . 0.0 110.602 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.4 tt -139.96 148.89 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.701 -0.882 . . . . 0.0 109.588 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -66.42 154.95 38.83 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.156 -0.965 . . . . 0.0 111.654 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -137.82 -70.62 0.44 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.06 0.457 . . . . 0.0 109.998 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -123.29 145.59 48.57 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.26 -0.9 . . . . 0.0 111.743 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.52 129.65 41.23 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.3 t -100.43 122.02 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 121.404 -0.81 . . . . 0.0 111.476 -177.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 28.2 p -141.28 139.48 33.68 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.411 -0.805 . . . . 0.0 110.647 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 86.9 m -71.28 -44.16 65.74 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.579 -0.7 . . . . 0.0 109.693 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -145.23 52.38 1.2 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.606 -0.684 . . . . 0.0 109.872 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 90.78 -11.59 71.37 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 64.3 t -99.41 129.53 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.19 -1.182 . . . . 0.0 108.779 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.15 123.91 32.7 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.464 -0.772 . . . . 0.0 111.536 -178.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -113.32 -28.84 7.45 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.205 0.526 . . . . 0.0 109.775 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -138.52 168.36 19.94 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.581 -0.7 . . . . 0.0 109.452 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.7 m -138.73 148.83 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.338 -0.851 . . . . 0.0 111.297 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -120.11 137.92 53.86 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.67 -0.644 . . . . 0.0 110.146 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -139.0 161.9 36.24 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.589 -0.694 . . . . 0.0 110.853 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 59.0 t -93.37 137.84 23.31 Favored Pre-proline 0 N--CA 1.497 1.905 0 O-C-N 121.504 -0.748 . . . . 0.0 110.017 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -77.53 156.28 32.14 Favored 'Trans proline' 0 C--N 1.32 -0.971 0 O-C-N 123.18 1.095 . . . . 0.0 110.293 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 96.0 t -79.94 -26.99 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.352 -0.842 . . . . 0.0 110.213 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.402 ' HG3' ' N ' ' A' ' 174' ' ' SER . 2.4 pt-20 -59.95 -28.71 67.87 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.367 -0.833 . . . . 0.0 110.375 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' SER . . . . . 0.402 ' N ' ' HG3' ' A' ' 173' ' ' GLU . 72.2 m -76.51 -28.83 56.54 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.472 -0.767 . . . . 0.0 110.195 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' MET . . . . . 0.432 ' HB3' ' CZ2' ' A' ' 53' ' ' TRP . 64.9 mtt -59.86 -32.82 71.06 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.631 -0.668 . . . . 0.0 110.647 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -59.87 -50.08 75.17 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.433 -0.792 . . . . 0.0 110.168 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 88.1 m -72.05 -39.96 68.69 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.626 -0.671 . . . . 0.0 109.838 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 89.9 m -61.27 -38.06 85.4 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.628 -0.67 . . . . 0.0 110.236 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 5.0 tmm? -59.78 -33.94 72.35 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.509 -0.744 . . . . 0.0 110.372 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 25.9 ttm180 -59.97 -40.07 87.82 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.504 -0.747 . . . . 0.0 110.253 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.734 0 O-C-N 121.579 -0.701 . . . . 0.0 110.229 179.995 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 . . . . . 0 N--CA 1.498 1.926 0 CA-C-O 121.029 0.442 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.3 p -127.14 140.07 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.563 -0.711 . . . . 0.0 110.055 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -102.88 141.61 35.39 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.602 -0.686 . . . . 0.0 110.246 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.7 m -87.05 116.28 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.589 -0.695 . . . . 0.0 110.387 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.2 p -138.57 136.14 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.468 -0.77 . . . . 0.0 109.984 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 75.7 m -131.83 143.26 50.06 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.425 -0.797 . . . . 0.0 110.745 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 70.3 p -96.58 -179.98 4.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.629 -0.669 . . . . 0.0 109.737 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.63 -14.25 61.14 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.302 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 75.2 p -119.27 -25.4 6.13 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.136 -0.977 . . . . 0.0 111.432 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -141.83 168.17 20.4 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.253 -0.905 . . . . 0.0 110.96 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.8 t -138.62 118.94 13.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.582 -0.699 . . . . 0.0 110.342 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -140.26 175.83 9.27 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.532 -0.73 . . . . 0.0 109.995 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 81.5 mt -115.6 152.7 32.6 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.251 -0.906 . . . . 0.0 110.545 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -117.17 141.02 48.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.604 -0.685 . . . . 0.0 110.24 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 86.2 m -117.27 143.06 46.31 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.537 -0.727 . . . . 0.0 110.228 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 93.3 m -94.13 113.75 25.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.576 -0.703 . . . . 0.0 110.654 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.2 t -127.49 129.95 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.599 -0.688 . . . . 0.0 109.905 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 53.84 39.84 30.84 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.522 -0.736 . . . . 0.0 111.175 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.61 17.8 67.27 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 62.3 t -129.95 130.04 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.25 -1.147 . . . . 0.0 109.755 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 97.9 m -82.02 112.72 19.36 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.529 -0.732 . . . . 0.0 110.002 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -101.76 137.48 40.01 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.606 -0.684 . . . . 0.0 110.52 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.416 HG21 ' CZ3' ' A' ' 85' ' ' TRP . 7.4 t -136.55 -179.87 5.94 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.643 -0.661 . . . . 0.0 109.738 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.475 ' CG1' ' CE1' ' A' ' 57' ' ' HIS . 91.0 t -83.23 142.1 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.516 -0.74 . . . . 0.0 109.872 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.432 ' CE2' HG21 ' A' ' 78' ' ' VAL . 43.0 t80 -84.55 -42.52 15.39 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.609 -0.682 . . . . 0.0 111.223 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.475 ' CE1' ' CG1' ' A' ' 55' ' ' VAL . 1.9 p-80 -62.01 -20.83 64.32 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.399 -0.921 . . . . 0.0 110.588 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -83.94 -75.28 1.2 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.77 -48.18 77.99 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.581 -0.952 . . . . 0.0 110.082 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.379 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.923 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.6 t . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 120.996 0.427 . . . . 0.0 110.105 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -98.16 126.57 43.68 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.513 -0.742 . . . . 0.0 110.381 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 49.3 tpp -97.22 -47.26 5.81 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.51 -0.744 . . . . 0.0 110.713 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -119.72 134.95 55.03 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.526 -0.734 . . . . 0.0 110.252 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.4 m -151.55 128.09 10.75 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.512 -0.742 . . . . 0.0 110.348 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -158.88 116.31 2.81 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.372 -0.83 . . . . 0.0 111.242 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.432 HG21 ' CE2' ' A' ' 56' ' ' TYR . 54.5 t -69.98 -40.02 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.523 -0.736 . . . . 0.0 109.531 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -59.96 -44.55 94.37 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.414 -0.804 . . . . 0.0 110.294 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -80.88 -13.45 58.91 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.706 -0.621 . . . . 0.0 110.177 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 39.5 t0 53.44 36.89 24.28 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.269 -0.894 . . . . 0.0 110.866 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 80.5 mt -140.13 156.16 46.67 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.492 -0.755 . . . . 0.0 110.677 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.0 t -138.42 155.73 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -137.0 147.49 19.26 Favored Glycine 0 N--CA 1.494 2.561 0 C-N-CA 119.552 -1.308 . . . . 0.0 111.142 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.416 ' CZ3' HG21 ' A' ' 54' ' ' THR . 3.7 m-90 -127.09 139.35 53.05 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.77 -0.841 . . . . 0.0 109.388 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -60.39 137.37 58.15 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.396 -0.815 . . . . 0.0 110.46 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -108.87 162.63 19.3 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.532 -0.73 . . . . 0.0 110.195 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.91 148.83 52.39 Favored 'Trans proline' 0 C--N 1.317 -1.1 0 O-C-N 123.397 1.209 . . . . 0.0 110.613 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -76.15 160.35 36.43 Favored 'Trans proline' 0 C--N 1.319 -1.01 0 O-C-N 123.354 1.186 . . . . 0.0 110.54 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 93.82 -10.67 72.08 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.38 -176.82 5.48 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.108 -1.231 . . . . 0.0 110.328 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.88 157.98 43.72 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.656 -0.653 . . . . 0.0 109.977 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.9 m -137.61 175.19 9.82 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.469 -0.769 . . . . 0.0 110.834 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.6 mt -84.43 170.21 13.77 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.741 -0.599 . . . . 0.0 110.271 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 60.5 p -115.97 158.93 41.15 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.596 -0.69 . . . . 0.0 110.112 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.37 123.41 8.68 Favored 'Trans proline' 0 C--N 1.317 -1.095 0 O-C-N 123.466 1.245 . . . . 0.0 110.675 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 10.7 t -70.86 142.13 51.23 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.546 -0.722 . . . . 0.0 110.043 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.4 t -135.39 72.21 1.44 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.506 -0.746 . . . . 0.0 110.464 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 27.3 p -144.86 -0.46 0.91 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.515 -0.741 . . . . 0.0 112.285 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 55.29 39.94 73.91 Favored Glycine 0 N--CA 1.498 2.784 0 O-C-N 120.825 -1.172 . . . . 0.0 110.283 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.3 t -69.97 122.75 19.95 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.434 -1.039 . . . . 0.0 110.246 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 58.4 m -70.34 -39.96 74.39 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.561 -0.712 . . . . 0.0 110.283 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -81.62 119.59 24.0 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.566 -0.709 . . . . 0.0 110.183 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 91.0 mt -129.88 150.73 51.05 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.59 -0.694 . . . . 0.0 110.472 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -115.31 133.31 56.15 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.596 -0.69 . . . . 0.0 109.728 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.6 tt -113.49 138.28 50.35 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.435 -0.791 . . . . 0.0 110.351 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.3 t -97.85 129.15 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.602 -0.686 . . . . 0.0 109.839 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 75.0 p -100.9 169.97 8.62 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.623 -0.673 . . . . 0.0 110.391 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 78.8 ttt-85 -62.5 -23.49 66.97 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.635 -0.666 . . . . 0.0 110.342 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.406 ' O ' ' CG ' ' A' ' 110' ' ' HIS . 81.1 t60 -92.86 25.7 3.06 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.409 -0.807 . . . . 0.0 110.75 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.82 44.8 27.86 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.128 -0.983 . . . . 0.0 110.83 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -113.86 155.5 25.61 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.554 -0.716 . . . . 0.0 109.975 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.2 137.2 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.561 -0.712 . . . . 0.0 110.437 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.407 HD12 HG23 ' A' ' 114' ' ' ILE . 42.2 pt -136.46 141.72 36.77 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.613 -0.679 . . . . 0.0 109.957 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -76.67 139.45 20.13 Favored 'Trans proline' 0 C--N 1.319 -1.021 0 O-C-N 123.25 1.131 . . . . 0.0 110.447 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.5 t -126.66 130.06 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.608 -0.682 . . . . 0.0 109.86 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -89.7 137.33 32.42 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.495 -0.753 . . . . 0.0 110.078 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 79.1 ttt-85 -82.08 124.33 29.73 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.514 -0.741 . . . . 0.0 110.216 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -128.85 25.19 5.64 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.612 -0.68 . . . . 0.0 110.302 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 168.88 179.56 41.07 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -61.23 -41.33 96.68 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.565 -0.962 . . . . 0.0 110.172 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.3 p -137.15 24.17 3.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.518 -0.739 . . . . 0.0 110.572 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -131.0 139.91 50.06 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.409 -0.807 . . . . 0.0 110.479 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -146.56 179.74 23.3 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 46.9 t -129.63 144.98 51.52 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.506 -0.997 . . . . 0.0 110.26 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.2 tp -99.86 136.8 39.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.605 -0.684 . . . . 0.0 110.145 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.4 mp -69.67 -39.99 76.67 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.531 -0.731 . . . . 0.0 110.452 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.6 t -98.63 109.48 53.28 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.424 -0.798 . . . . 0.0 110.099 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -76.82 135.3 15.71 Favored 'Trans proline' 0 C--N 1.32 -0.956 0 O-C-N 123.213 1.112 . . . . 0.0 110.751 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -135.96 162.37 57.17 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.62 -0.675 . . . . 0.0 109.769 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.5 150.29 57.4 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 O-C-N 123.385 1.202 . . . . 0.0 110.263 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 83.9 t -59.09 -34.29 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.431 -0.793 . . . . 0.0 109.796 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 46.7 t -59.91 -40.04 87.47 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.578 -0.701 . . . . 0.0 110.323 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -61.05 -41.47 96.66 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.491 -0.755 . . . . 0.0 109.68 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 43.9 tp -89.97 -10.1 46.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.784 -0.573 . . . . 0.0 111.332 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -62.53 138.31 58.45 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.158 -0.964 . . . . 0.0 110.657 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 87.0 20.71 52.63 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 21.8 m -120.59 13.58 11.71 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.317 -1.107 . . . . 0.0 111.052 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.8 m -59.79 151.99 24.07 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.155 -0.966 . . . . 0.0 110.287 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 92.52 -17.68 56.9 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -58.08 110.62 2.54 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -76.19 143.4 25.38 Favored 'Trans proline' 0 C--N 1.32 -0.943 0 O-C-N 123.134 1.071 . . . . 0.0 110.963 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.5 mp -95.78 131.82 41.66 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.8 mp -110.04 156.36 20.62 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.631 -0.668 . . . . 0.0 110.973 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.0 176.16 1.85 Allowed Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.718 -0.614 . . . . 0.0 109.642 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.59 -26.96 19.24 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 O-C-N 123.324 1.17 . . . . 0.0 110.252 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.53 -30.77 69.65 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.508 -0.745 . . . . 0.0 110.06 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 114.91 27.58 3.18 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -127.73 147.44 50.4 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.38 -1.071 . . . . 0.0 110.218 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -83.38 134.3 34.9 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.465 -0.772 . . . . 0.0 110.276 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 34.4 m -90.98 -22.89 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.594 -0.691 . . . . 0.0 110.868 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 167.74 -163.58 37.25 Favored Glycine 0 N--CA 1.498 2.769 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.43 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 77.0 mt -130.05 156.16 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.641 -0.917 . . . . 0.0 109.97 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -68.23 134.78 50.97 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.496 -0.753 . . . . 0.0 109.914 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -114.26 -64.86 1.25 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.569 -0.707 . . . . 0.0 111.02 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -136.09 149.81 48.87 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.431 -0.793 . . . . 0.0 110.991 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -95.99 126.46 41.25 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.662 -0.648 . . . . 0.0 109.855 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 45.1 t -95.75 118.15 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.595 -0.69 . . . . 0.0 110.453 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 26.7 p -140.05 144.87 37.08 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.464 -0.772 . . . . 0.0 110.632 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 91.8 m -73.95 -49.98 22.1 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.566 -0.709 . . . . 0.0 110.051 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -139.35 50.1 1.8 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.602 -0.686 . . . . 0.0 110.117 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 96.46 -11.25 66.97 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 62.0 t -102.04 121.78 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.237 -1.155 . . . . 0.0 109.151 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.36 118.78 27.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.55 -0.719 . . . . 0.0 111.078 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -103.37 -25.83 13.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.704 -0.622 . . . . 0.0 109.641 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -135.45 167.62 20.72 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.596 -0.69 . . . . 0.0 109.802 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.8 m -133.58 140.0 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.497 -0.752 . . . . 0.0 110.721 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -110.83 131.01 55.41 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.625 -0.672 . . . . 0.0 109.853 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -139.84 158.07 44.68 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.532 -0.73 . . . . 0.0 110.613 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 62.8 t -95.27 134.94 23.74 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.576 -0.703 . . . . 0.0 109.715 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.02 154.05 57.71 Favored 'Trans proline' 0 C--N 1.318 -1.045 0 O-C-N 123.175 1.092 . . . . 0.0 110.77 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 61.8 t -60.03 -38.82 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.645 -0.659 . . . . 0.0 110.062 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -57.22 -34.07 68.18 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.687 -0.633 . . . . 0.0 110.749 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 47.4 t -61.52 -40.05 93.24 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.504 -0.748 . . . . 0.0 109.964 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 61.3 mtt -59.95 -38.64 83.03 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.637 -0.665 . . . . 0.0 110.333 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -59.97 -33.14 71.53 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.667 -0.646 . . . . 0.0 110.578 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 93.9 m -59.88 -40.06 87.41 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.455 -0.778 . . . . 0.0 110.377 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 92.9 m -62.92 -49.78 73.42 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.495 -0.753 . . . . 0.0 110.094 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 76.6 mtm -65.04 -35.84 82.47 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.528 -0.732 . . . . 0.0 110.244 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -60.0 -40.01 87.74 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.524 -0.735 . . . . 0.0 110.148 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.837 0 O-C-N 121.617 -0.677 . . . . 0.0 110.148 179.87 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 . . . . . 0 N--CA 1.498 1.941 0 CA-C-O 121.304 0.573 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.4 p -142.39 139.98 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.8 -0.563 . . . . 0.0 109.901 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -103.08 139.98 37.9 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.564 -0.71 . . . . 0.0 110.101 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.0 p -83.48 134.5 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.513 -0.742 . . . . 0.0 110.223 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.8 t -127.93 129.99 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.572 -0.705 . . . . 0.0 110.029 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.9 m -121.96 134.28 54.83 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.608 -0.683 . . . . 0.0 110.026 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.74 -175.11 2.66 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.464 -0.773 . . . . 0.0 110.123 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.04 -38.46 75.85 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.646 -0.659 . . . . 0.0 111.333 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.6 t -118.56 -20.02 8.54 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.305 -0.872 . . . . 0.0 111.738 -178.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -132.38 154.32 49.9 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.21 -0.931 . . . . 0.0 110.743 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 73.6 m -132.34 124.07 28.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.539 -0.726 . . . . 0.0 109.923 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -136.11 170.37 16.12 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.587 -0.696 . . . . 0.0 110.532 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.6 mt -115.63 149.6 38.04 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.693 -0.629 . . . . 0.0 109.836 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -115.91 148.32 40.15 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.496 -0.752 . . . . 0.0 110.189 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 87.3 m -119.9 136.55 54.46 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.557 -0.715 . . . . 0.0 109.873 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 28.3 p -94.57 121.07 35.75 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.337 -0.852 . . . . 0.0 111.073 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.6 t -130.08 129.99 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.512 -0.743 . . . . 0.0 109.751 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 53.44 39.95 30.66 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.46 -0.775 . . . . 0.0 111.099 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.94 16.19 70.19 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 62.5 t -126.07 123.39 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.181 -1.188 . . . . 0.0 109.722 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 36.2 t -79.67 115.87 19.53 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.535 -0.728 . . . . 0.0 110.166 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 71.6 m95 -104.65 137.57 42.28 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.648 -0.658 . . . . 0.0 110.139 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 34.9 p -136.38 179.32 6.43 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.58 -0.7 . . . . 0.0 109.733 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.447 HG12 ' CE1' ' A' ' 57' ' ' HIS . 59.4 t -85.63 142.28 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.525 -0.734 . . . . 0.0 109.528 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.441 ' CE2' HG23 ' A' ' 78' ' ' VAL . 39.4 t80 -79.82 -42.9 23.39 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.424 -0.798 . . . . 0.0 111.598 -178.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.447 ' CE1' HG12 ' A' ' 55' ' ' VAL . 2.2 p-80 -67.02 -20.0 65.79 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.111 -0.993 . . . . 0.0 110.722 -178.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.74 -50.5 1.51 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -102.56 -38.34 7.57 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.498 -1.001 . . . . 0.0 110.399 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.583 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.853 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 56.3 m . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 121.012 0.434 . . . . 0.0 109.951 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -58.86 124.0 18.38 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.517 -0.739 . . . . 0.0 110.38 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.4 tpt -70.0 -40.03 75.53 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.578 -0.701 . . . . 0.0 110.294 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -126.01 129.99 50.28 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.497 -0.752 . . . . 0.0 110.338 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 60.4 m -137.97 118.8 14.16 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.711 -0.618 . . . . 0.0 110.309 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -157.02 113.01 2.93 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.358 -0.838 . . . . 0.0 111.136 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.441 HG23 ' CE2' ' A' ' 56' ' ' TYR . 56.1 t -70.02 -39.99 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.445 -0.785 . . . . 0.0 109.441 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -58.35 -46.03 87.05 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.442 -0.787 . . . . 0.0 110.033 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.9 -14.25 48.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.681 -0.637 . . . . 0.0 110.076 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 43.8 t0 53.88 39.99 31.04 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.245 -0.909 . . . . 0.0 110.575 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 68.6 mt -137.63 147.83 45.28 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.565 -0.71 . . . . 0.0 111.325 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.8 m -149.96 178.85 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -179.76 171.99 43.63 Favored Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.607 -1.283 . . . . 0.0 110.774 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 7.7 m-90 -130.06 159.53 36.46 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.828 -0.807 . . . . 0.0 109.627 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -81.62 124.14 29.29 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.456 -0.777 . . . . 0.0 110.194 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -97.19 163.85 19.03 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.575 -0.703 . . . . 0.0 110.256 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -70.65 151.52 64.04 Favored 'Trans proline' 0 C--N 1.318 -1.078 0 O-C-N 123.391 1.206 . . . . 0.0 110.476 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.28 157.2 54.05 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.379 1.199 . . . . 0.0 110.404 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.04 30.58 12.44 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -123.66 154.36 39.48 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.529 -0.983 . . . . 0.0 110.244 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -70.52 150.05 46.53 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.572 -0.705 . . . . 0.0 110.161 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 94.8 p -134.07 158.96 42.25 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.596 -0.69 . . . . 0.0 110.202 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 59.8 mt -104.16 141.14 36.78 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.52 -0.738 . . . . 0.0 110.381 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 31.5 p -105.77 160.99 24.2 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.647 -0.658 . . . . 0.0 110.229 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.72 152.48 58.86 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.345 1.182 . . . . 0.0 110.328 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 5.5 t -85.69 139.31 31.48 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.476 -0.765 . . . . 0.0 110.271 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.6 m -125.94 72.63 1.3 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.672 -0.643 . . . . 0.0 110.179 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 27.1 p -144.48 -8.29 0.67 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.455 -0.778 . . . . 0.0 112.426 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 55.4 33.2 58.33 Favored Glycine 0 N--CA 1.499 2.841 0 O-C-N 120.773 -1.204 . . . . 0.0 110.318 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.7 t -80.67 118.58 22.35 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.558 -0.966 . . . . 0.0 110.478 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 57.9 m -60.02 -39.97 87.68 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.516 -0.74 . . . . 0.0 110.088 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -64.23 125.59 25.03 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.579 -0.701 . . . . 0.0 109.84 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.6 mt -130.14 155.38 46.3 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.636 -0.665 . . . . 0.0 110.305 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -117.85 135.78 53.87 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.678 -0.639 . . . . 0.0 109.684 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.9 tt -114.31 132.0 56.33 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.581 -0.7 . . . . 0.0 110.488 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.0 t -92.32 119.88 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.615 -0.678 . . . . 0.0 109.643 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.0 m -99.21 161.47 13.6 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.558 -0.714 . . . . 0.0 110.391 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.7 ttp180 -60.47 -24.64 65.42 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.567 -0.708 . . . . 0.0 110.359 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 18.3 m80 -92.59 26.84 2.5 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.314 -0.866 . . . . 0.0 110.942 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.61 31.9 16.04 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.151 -0.968 . . . . 0.0 110.545 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -104.89 129.41 53.26 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.66 -0.65 . . . . 0.0 109.847 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 61.9 t -109.9 125.29 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.592 -0.692 . . . . 0.0 110.238 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 38.3 mt -119.73 135.51 24.23 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.678 -0.639 . . . . 0.0 109.648 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -75.72 135.5 17.87 Favored 'Trans proline' 0 C--N 1.319 -1.026 0 O-C-N 123.213 1.112 . . . . 0.0 110.594 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.1 t -129.82 129.98 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.557 -0.714 . . . . 0.0 109.572 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -80.16 156.04 27.15 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.515 -0.741 . . . . 0.0 110.151 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -99.28 121.45 41.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.63 -0.669 . . . . 0.0 110.249 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 31.0 mtp85 -119.63 24.24 10.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.576 -0.703 . . . . 0.0 110.621 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -177.1 -176.9 45.6 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -64.78 -39.97 94.49 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.544 -0.974 . . . . 0.0 110.435 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 46.6 m -136.54 24.48 3.16 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.516 -0.74 . . . . 0.0 110.522 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -125.21 150.56 46.87 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.436 -0.79 . . . . 0.0 110.4 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -144.02 168.92 26.38 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 82.9 p -112.02 152.43 28.17 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.555 -0.968 . . . . 0.0 110.23 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 35.2 tp -100.13 120.34 39.71 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.553 -0.717 . . . . 0.0 110.179 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.8 mt -59.95 -47.1 87.19 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.49 -0.756 . . . . 0.0 110.683 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 36.2 t -97.93 111.68 59.79 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.632 -0.667 . . . . 0.0 110.168 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.64 113.21 3.72 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 O-C-N 123.173 1.091 . . . . 0.0 110.479 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.424 ' HD3' ' CD2' ' A' ' 134' ' ' TYR . 37.6 mtt180 -120.25 162.78 32.05 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.577 -0.702 . . . . 0.0 110.126 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.04 150.49 66.56 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 123.384 1.202 . . . . 0.0 110.429 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 86.4 t -55.92 -33.25 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.479 -0.763 . . . . 0.0 110.114 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.3 m -58.66 -46.59 86.82 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.62 -0.675 . . . . 0.0 110.763 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.424 ' CD2' ' HD3' ' A' ' 130' ' ' ARG . 64.0 t80 -59.99 -41.61 92.43 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.549 -0.719 . . . . 0.0 110.201 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 58.8 tp -84.87 -9.8 57.76 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.773 -0.579 . . . . 0.0 111.461 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -68.83 143.97 54.41 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.098 -1.002 . . . . 0.0 110.748 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.17 -2.52 65.83 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 89.2 p -102.39 10.49 39.03 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.136 -1.214 . . . . 0.0 110.807 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.97 140.69 56.57 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.252 -0.905 . . . . 0.0 110.188 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 90.51 -10.56 74.15 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.52 129.29 33.62 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -76.86 148.92 28.8 Favored 'Trans proline' 0 C--N 1.318 -1.037 0 O-C-N 123.217 1.114 . . . . 0.0 110.886 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 21.1 mt -99.14 118.16 35.25 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.3 mp -92.0 163.14 14.1 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.586 -0.697 . . . . 0.0 111.157 -179.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.2 177.4 1.36 Allowed Pre-proline 0 N--CA 1.493 1.7 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.06 -26.7 21.25 Favored 'Trans proline' 0 C--N 1.317 -1.106 0 O-C-N 123.264 1.139 . . . . 0.0 110.434 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 90.6 p -69.97 -33.04 71.57 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.544 -0.722 . . . . 0.0 110.236 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 106.21 45.22 1.28 Allowed Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -137.17 160.19 39.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.535 -0.979 . . . . 0.0 110.293 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.48 125.3 29.17 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.588 -0.695 . . . . 0.0 110.34 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 63.3 t -91.55 -53.43 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.565 -0.71 . . . . 0.0 110.133 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -171.08 -161.9 22.51 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.411 HD12 HG22 ' A' ' 153' ' ' ILE . 96.7 mt -130.22 140.06 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.593 -0.945 . . . . 0.0 110.153 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -61.83 128.64 37.19 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.593 -0.692 . . . . 0.0 109.814 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -103.59 -69.6 0.79 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.595 -0.691 . . . . 0.0 110.851 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -133.88 152.41 51.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.528 -0.733 . . . . 0.0 110.692 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.01 149.81 20.9 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 57.9 t -117.79 119.32 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.542 -0.724 . . . . 0.0 110.517 -179.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.2 p -141.5 142.23 33.59 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.565 -0.709 . . . . 0.0 110.55 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 44.4 m -75.38 -40.84 57.58 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.523 -0.735 . . . . 0.0 110.03 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -145.49 51.58 1.19 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.586 -0.697 . . . . 0.0 110.402 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 91.35 -10.36 75.04 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.381 -1.087 . . . . 0.0 110.381 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 96.9 t -101.77 122.31 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.165 -1.197 . . . . 0.0 109.132 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.33 118.49 26.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.586 -0.696 . . . . 0.0 110.899 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -106.21 -27.75 10.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.777 -0.577 . . . . 0.0 109.645 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -132.62 162.41 31.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.534 -0.728 . . . . 0.0 110.017 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.9 m -129.99 139.59 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.583 -0.698 . . . . 0.0 110.232 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -117.76 123.41 45.92 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.534 -0.729 . . . . 0.0 110.485 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -132.49 159.97 37.85 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.575 -0.703 . . . . 0.0 109.796 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 27.1 m -97.54 142.45 24.58 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.516 -0.74 . . . . 0.0 110.414 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -77.65 171.08 18.06 Favored 'Trans proline' 0 C--N 1.318 -1.045 0 O-C-N 123.265 1.139 . . . . 0.0 110.255 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 61.4 t -59.98 -36.14 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.532 -0.73 . . . . 0.0 110.167 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -59.65 -33.22 71.26 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.729 -0.607 . . . . 0.0 110.996 -178.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 64.8 p -61.5 -33.32 73.59 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.387 -0.821 . . . . 0.0 109.984 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 44.8 mtt -69.08 -40.07 78.68 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.643 -0.661 . . . . 0.0 110.134 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -60.0 -38.89 83.94 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.651 -0.656 . . . . 0.0 110.468 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 94.2 m -60.07 -39.97 87.88 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.6 -0.688 . . . . 0.0 110.144 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 87.2 m -60.63 -40.48 92.11 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.469 -0.77 . . . . 0.0 109.985 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 40.8 ttp -61.06 -42.03 97.72 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.658 -0.652 . . . . 0.0 110.218 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -62.25 -40.07 94.95 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.495 -0.753 . . . . 0.0 110.292 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.829 0 O-C-N 121.594 -0.691 . . . . 0.0 110.182 179.942 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 . . . . . 0 N--CA 1.496 1.854 0 CA-C-O 121.074 0.464 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.2 t -99.05 126.37 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.638 -0.664 . . . . 0.0 110.068 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -108.2 142.24 38.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.622 -0.674 . . . . 0.0 110.123 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 65.4 t -87.18 114.16 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.55 -0.719 . . . . 0.0 109.589 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 62.0 t -118.45 131.33 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.448 -0.782 . . . . 0.0 109.98 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.8 m -123.12 135.37 54.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.642 -0.661 . . . . 0.0 110.086 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.22 -179.39 4.02 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.658 -0.651 . . . . 0.0 110.284 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.91 -40.07 83.48 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.898 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 76.6 p -113.79 -28.22 7.51 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.381 -0.824 . . . . 0.0 110.92 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 -126.26 -179.03 4.54 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.473 -0.767 . . . . 0.0 110.452 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 81.2 p -153.47 125.9 8.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.621 -0.674 . . . . 0.0 110.317 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -131.89 -175.98 3.91 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.644 -0.66 . . . . 0.0 109.803 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.4 mt -126.74 150.44 49.07 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.437 -0.789 . . . . 0.0 110.475 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -112.71 162.03 16.2 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.595 -0.69 . . . . 0.0 110.295 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.5 p -131.25 129.03 41.06 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.495 -0.753 . . . . 0.0 110.349 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 98.8 m -78.42 109.5 12.64 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.514 -0.741 . . . . 0.0 110.379 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.6 t -130.07 133.52 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.553 -0.717 . . . . 0.0 110.278 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 12.3 p30 43.91 34.26 0.88 Allowed 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.69 -19.11 38.9 Favored Glycine 0 N--CA 1.498 2.818 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.479 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 63.2 t -109.45 128.75 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.115 -1.227 . . . . 0.0 110.283 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 92.7 m -76.57 149.42 36.63 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.595 -0.691 . . . . 0.0 109.735 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -134.21 136.76 43.9 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.494 -0.754 . . . . 0.0 111.048 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.6 t -137.58 178.29 7.22 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.48 ' CG1' ' CE1' ' A' ' 57' ' ' HIS . 75.9 t -80.54 141.69 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.314 -0.866 . . . . 0.0 108.993 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.446 ' CZ ' HG23 ' A' ' 78' ' ' VAL . 6.5 t80 -85.0 -43.28 14.11 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.506 -0.746 . . . . 0.0 111.327 -179.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.48 ' CE1' ' CG1' ' A' ' 55' ' ' VAL . 1.8 p-80 -58.8 -21.38 56.11 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.291 -0.88 . . . . 0.0 111.366 -177.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -87.87 -53.64 2.66 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.87 -63.08 1.49 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.526 -0.985 . . . . 0.0 110.46 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.448 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.907 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 64.7 m . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 121.062 0.458 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -68.16 128.73 37.61 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.535 -0.728 . . . . 0.0 110.568 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 40.6 mtm -119.2 -49.71 2.38 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.537 -0.727 . . . . 0.0 110.128 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -110.33 127.98 55.32 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.48 -0.763 . . . . 0.0 110.149 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 90.4 m -151.21 122.58 7.84 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.572 -0.705 . . . . 0.0 110.008 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -162.9 125.13 2.64 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.368 -0.833 . . . . 0.0 111.257 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.446 HG23 ' CZ ' ' A' ' 56' ' ' TYR . 74.3 t -72.36 -38.8 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.548 -0.72 . . . . 0.0 109.647 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -55.69 -39.53 71.11 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.477 -0.764 . . . . 0.0 110.488 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.1 tp60 -91.18 -14.03 31.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.704 -0.622 . . . . 0.0 110.342 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 46.8 t0 53.18 39.94 30.46 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.104 -0.997 . . . . 0.0 110.324 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.3 mt -142.16 160.69 39.74 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.855 0.836 . . . . 0.0 111.391 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.0 t -144.56 160.97 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -155.39 160.42 29.84 Favored Glycine 0 N--CA 1.497 2.731 0 C-N-CA 119.04 -1.553 . . . . 0.0 111.612 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 17.6 m-90 -144.79 168.0 21.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.931 -0.746 . . . . 0.0 109.458 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -69.93 143.74 52.61 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.518 -0.739 . . . . 0.0 109.931 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.54 162.58 29.18 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.445 -0.784 . . . . 0.0 110.524 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.87 149.79 48.24 Favored 'Trans proline' 0 C--N 1.317 -1.093 0 O-C-N 123.581 1.306 . . . . 0.0 110.267 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -76.15 160.07 36.66 Favored 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 123.35 1.184 . . . . 0.0 110.428 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.14 29.03 52.31 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -151.68 137.02 17.6 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.516 -0.99 . . . . 0.0 110.248 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.8 mtm180 -110.81 131.89 54.66 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.553 -0.717 . . . . 0.0 110.219 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.7 m -91.79 175.54 6.85 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.546 -0.721 . . . . 0.0 110.311 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.8 mp -87.02 170.46 11.54 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.53 -0.731 . . . . 0.0 110.222 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.64 172.19 3.73 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.709 -0.62 . . . . 0.0 110.057 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.66 156.85 62.51 Favored 'Trans proline' 0 C--N 1.318 -1.039 0 O-C-N 123.314 1.165 . . . . 0.0 110.173 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.5 t -81.41 154.96 26.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.499 -0.751 . . . . 0.0 110.493 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.5 t -136.05 56.35 1.82 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.695 -0.628 . . . . 0.0 110.312 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 27.3 p -144.81 -8.41 0.63 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.413 -0.804 . . . . 0.0 112.447 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.42 29.2 38.11 Favored Glycine 0 N--CA 1.499 2.869 0 O-C-N 120.753 -1.217 . . . . 0.0 110.532 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.5 p -70.53 150.38 46.19 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.554 -0.968 . . . . 0.0 110.33 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 58.0 m -86.39 -26.63 24.69 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.639 -0.663 . . . . 0.0 110.474 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -71.74 120.46 17.36 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.544 -0.723 . . . . 0.0 110.122 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 94.9 mt -137.06 149.68 47.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.553 -0.717 . . . . 0.0 110.347 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -120.53 129.2 53.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.564 -0.71 . . . . 0.0 109.833 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 47.1 tp -108.09 146.15 33.03 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.554 -0.716 . . . . 0.0 110.276 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.1 t -107.36 122.39 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.655 -0.653 . . . . 0.0 109.812 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.8 p -91.67 178.53 5.89 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.58 -0.7 . . . . 0.0 110.404 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.5 ptt85 -70.2 -15.75 62.97 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.62 -0.675 . . . . 0.0 111.112 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -94.28 26.04 3.54 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.142 -0.974 . . . . 0.0 110.816 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 53.22 25.54 4.43 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.298 -0.876 . . . . 0.0 110.884 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -96.19 155.37 16.79 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.546 -0.721 . . . . 0.0 110.046 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 61.4 t -117.88 125.81 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.511 -0.743 . . . . 0.0 110.053 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 42.9 pt -126.51 142.14 42.18 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.605 -0.685 . . . . 0.0 110.093 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -76.32 153.15 35.47 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 O-C-N 123.289 1.152 . . . . 0.0 110.623 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 63.0 t -140.02 139.64 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.649 -0.657 . . . . 0.0 109.743 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 -105.1 135.04 47.2 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.591 -0.693 . . . . 0.0 110.153 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 14.6 ttt-85 -73.28 139.27 46.01 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.577 -0.702 . . . . 0.0 110.26 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.59 22.05 2.92 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.572 -0.705 . . . . 0.0 110.404 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 166.54 -170.77 41.25 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -71.03 -39.69 72.18 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.591 -0.946 . . . . 0.0 110.284 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 10.6 p -134.43 24.87 3.79 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.527 -0.733 . . . . 0.0 110.703 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -141.62 140.45 33.31 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.507 -0.746 . . . . 0.0 110.317 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -143.7 178.03 22.07 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 81.7 p -111.07 164.18 13.1 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.597 -0.943 . . . . 0.0 110.178 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 30.4 tp -109.42 131.01 55.47 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.5 -0.75 . . . . 0.0 110.366 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.12 -51.74 68.31 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.552 -0.717 . . . . 0.0 110.447 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 67.9 m -100.14 107.86 49.38 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.532 -0.73 . . . . 0.0 109.954 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.78 108.41 2.56 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 O-C-N 123.197 1.104 . . . . 0.0 110.9 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.42 ' HD3' ' CD2' ' A' ' 134' ' ' TYR . 31.9 mtt180 -115.24 161.31 30.3 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.669 -0.644 . . . . 0.0 109.849 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.21 150.39 71.5 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 O-C-N 123.405 1.213 . . . . 0.0 110.996 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 66.2 t -51.84 -30.04 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 121.507 -0.746 . . . . 0.0 109.731 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 36.9 t -60.71 -41.79 95.93 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.682 -0.636 . . . . 0.0 111.056 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.42 ' CD2' ' HD3' ' A' ' 130' ' ' ARG . 88.5 t80 -66.85 -39.97 87.76 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.355 -0.84 . . . . 0.0 109.41 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 23.0 tp -93.61 18.65 9.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.912 -0.493 . . . . 0.0 110.078 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -82.09 117.71 22.48 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.446 1.117 . . . . 0.0 112.066 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.65 26.87 7.83 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 36.7 m -112.7 21.61 15.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.579 -0.954 . . . . 0.0 110.405 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.33 129.89 41.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.312 -0.867 . . . . 0.0 108.851 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 106.37 -13.35 43.67 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -55.04 112.12 2.68 Favored Glycine 0 N--CA 1.499 2.839 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.13 153.22 51.63 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 O-C-N 123.142 1.075 . . . . 0.0 111.128 -178.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 44.9 mt -108.52 123.42 48.87 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.702 -0.624 . . . . 0.0 109.515 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.41 139.5 53.37 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.432 -0.792 . . . . 0.0 110.849 -179.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 68.4 m -74.08 163.63 66.94 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.638 -0.664 . . . . 0.0 109.484 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.62 -43.12 5.95 Favored 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.411 1.216 . . . . 0.0 109.561 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.7 m -119.42 27.54 8.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.705 -0.622 . . . . 0.0 109.899 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -139.0 -173.55 13.05 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -96.82 -168.11 1.66 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.65 -0.912 . . . . 0.0 110.472 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.56 148.28 51.1 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.573 -0.705 . . . . 0.0 110.892 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 34.4 m -119.13 -29.67 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.701 -0.624 . . . . 0.0 110.722 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.41 -163.42 22.34 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.3 tt -142.51 158.69 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.602 -0.94 . . . . 0.0 109.82 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -71.1 159.31 34.93 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.178 -0.951 . . . . 0.0 111.029 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -145.75 -75.66 0.21 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.757 -0.59 . . . . 0.0 109.95 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -121.68 142.62 49.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.035 -1.04 . . . . 0.0 111.313 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.79 128.89 40.26 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.2 t -100.02 122.94 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.483 -0.76 . . . . 0.0 111.472 -177.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 28.1 p -141.15 142.57 34.04 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.482 -0.761 . . . . 0.0 110.541 178.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 88.7 m -75.93 -41.76 50.77 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.527 -0.733 . . . . 0.0 109.837 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -142.75 50.1 1.46 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.665 -0.647 . . . . 0.0 109.721 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 90.18 -11.68 70.21 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 62.6 t -94.14 120.29 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.142 -1.211 . . . . 0.0 108.997 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.24 113.74 23.23 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.534 -0.729 . . . . 0.0 111.022 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -110.08 -29.68 8.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.747 -0.596 . . . . 0.0 109.661 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -116.6 168.29 10.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.701 -0.624 . . . . 0.0 109.815 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.9 m -145.11 132.9 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.532 -0.73 . . . . 0.0 110.824 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -107.45 132.14 53.52 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.576 -0.703 . . . . 0.0 110.264 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -130.17 161.1 31.88 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.712 -0.618 . . . . 0.0 110.432 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.9 t -96.3 142.05 24.0 Favored Pre-proline 0 N--CA 1.498 1.973 0 O-C-N 121.514 -0.741 . . . . 0.0 109.96 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -74.96 159.99 40.81 Favored 'Trans proline' 0 N--CA 1.486 1.047 0 O-C-N 123.253 1.133 . . . . 0.0 110.186 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 67.7 t -87.55 -28.2 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.453 -0.779 . . . . 0.0 110.748 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -58.8 -28.64 66.17 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.354 -0.841 . . . . 0.0 110.615 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 58.0 m -68.15 -28.49 67.34 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.487 -0.758 . . . . 0.0 110.319 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 57.8 mtt -60.37 -29.46 68.94 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.51 -0.743 . . . . 0.0 110.504 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -60.07 -41.09 91.67 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.459 -0.776 . . . . 0.0 110.196 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 88.1 m -70.1 -41.19 74.35 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.551 -0.718 . . . . 0.0 110.05 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 88.0 m -70.1 -39.87 75.27 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.618 -0.676 . . . . 0.0 110.102 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 5.5 tmm? -59.97 -39.88 87.17 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.582 -0.699 . . . . 0.0 110.195 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.03 -39.84 87.26 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.618 -0.676 . . . . 0.0 110.245 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.845 0 O-C-N 121.651 -0.656 . . . . 0.0 110.227 -179.902 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 121.191 0.519 . . . . 0.0 110.294 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.1 p -135.2 146.7 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.489 -0.757 . . . . 0.0 110.064 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -104.24 165.53 10.99 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.561 -0.712 . . . . 0.0 110.256 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.8 p -121.69 129.96 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.578 -0.701 . . . . 0.0 110.074 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.8 m -141.11 147.48 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.532 -0.73 . . . . 0.0 110.512 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 54.2 m -120.07 154.72 34.23 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.581 -0.7 . . . . 0.0 110.201 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.78 -178.09 3.84 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.6 -0.687 . . . . 0.0 110.085 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.9 -49.84 76.11 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.553 -0.717 . . . . 0.0 110.744 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.4 p -125.8 8.06 7.49 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.479 -0.763 . . . . 0.0 111.541 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -143.41 159.32 42.6 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.06 -1.025 . . . . 0.0 110.83 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 41.0 m -142.82 121.15 12.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.67 -0.644 . . . . 0.0 109.55 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -135.39 174.81 10.19 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.575 -0.703 . . . . 0.0 110.485 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.8 mt -122.74 163.47 20.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.64 -0.662 . . . . 0.0 110.619 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -132.0 144.98 51.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.648 -0.657 . . . . 0.0 110.125 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.9 m -121.73 140.7 51.99 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.494 -0.754 . . . . 0.0 110.233 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.5 t -83.3 106.88 15.43 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.535 -0.728 . . . . 0.0 110.114 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.1 t -122.32 128.38 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.501 -0.749 . . . . 0.0 110.14 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 53.46 39.95 30.68 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.498 -0.751 . . . . 0.0 111.009 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 64.09 21.56 66.05 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.7 t -130.2 129.62 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.392 -1.064 . . . . 0.0 109.667 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 35.1 t -81.7 104.51 12.15 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.577 -0.702 . . . . 0.0 109.297 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -95.8 136.91 35.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.599 -0.688 . . . . 0.0 110.779 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.5 t -136.97 177.73 7.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.74 -0.6 . . . . 0.0 109.736 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.448 ' CG1' ' CE1' ' A' ' 57' ' ' HIS . 95.2 t -81.47 141.88 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.477 -0.764 . . . . 0.0 109.277 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.446 ' CE2' HG21 ' A' ' 78' ' ' VAL . 43.6 t80 -84.29 -42.28 15.99 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.333 -0.855 . . . . 0.0 111.18 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.448 ' CE1' ' CG1' ' A' ' 55' ' ' VAL . 2.2 p-80 -65.72 -17.13 64.39 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.338 -0.851 . . . . 0.0 111.014 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -99.57 -57.32 0.94 Allowed Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.93 -36.52 27.95 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.468 -1.019 . . . . 0.0 110.586 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.531 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -179.703 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 72.4 m . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 121.165 0.507 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -68.8 130.29 42.37 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.593 -0.692 . . . . 0.0 110.722 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.6 ttt -72.94 -40.01 65.77 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.621 -0.674 . . . . 0.0 110.632 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -113.18 140.01 48.28 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.451 -0.781 . . . . 0.0 110.414 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.7 m -145.07 127.31 15.75 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.535 -0.728 . . . . 0.0 110.346 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 -155.36 105.81 2.51 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.38 -0.825 . . . . 0.0 111.184 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.446 HG21 ' CE2' ' A' ' 56' ' ' TYR . 54.4 t -69.94 -40.03 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.466 -0.771 . . . . 0.0 109.21 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -57.8 -45.76 85.61 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.464 -0.772 . . . . 0.0 109.958 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -81.69 -12.47 58.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.795 -0.566 . . . . 0.0 110.114 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 39.6 t0 54.39 39.91 31.35 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.163 -0.961 . . . . 0.0 110.756 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 76.5 mt -140.23 151.57 45.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.588 -0.695 . . . . 0.0 110.698 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.8 t -131.94 152.57 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -131.19 156.11 21.63 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.544 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -136.08 159.79 40.63 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.785 -0.833 . . . . 0.0 109.755 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -83.4 123.34 29.58 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.394 -0.816 . . . . 0.0 109.954 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -97.1 149.5 35.77 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.558 -0.714 . . . . 0.0 110.33 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.33 154.95 56.27 Favored 'Trans proline' 0 C--N 1.316 -1.158 0 O-C-N 123.507 1.267 . . . . 0.0 110.272 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.39 160.14 49.55 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 O-C-N 123.377 1.199 . . . . 0.0 110.345 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.21 30.18 13.08 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -129.85 159.14 37.48 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.469 -1.019 . . . . 0.0 110.103 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -87.77 148.44 24.71 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.557 -0.715 . . . . 0.0 110.213 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 71.3 p -120.26 140.22 51.52 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.595 -0.69 . . . . 0.0 110.204 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 70.4 mt -80.01 160.01 26.02 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.601 -0.687 . . . . 0.0 110.17 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 63.8 p -117.26 155.82 49.42 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.655 -0.653 . . . . 0.0 110.131 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.68 164.45 35.39 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 O-C-N 123.374 1.197 . . . . 0.0 110.295 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 7.8 t -68.03 128.45 36.58 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.504 -0.748 . . . . 0.0 110.333 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.0 p -131.93 48.75 2.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.637 -0.664 . . . . 0.0 109.745 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.8 p -144.42 -8.32 0.67 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.63 -0.669 . . . . 0.0 112.428 -179.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.76 32.32 74.06 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.1 t -80.55 113.69 18.92 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.443 -1.034 . . . . 0.0 110.281 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 66.5 m -60.01 -39.96 87.61 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.549 -0.719 . . . . 0.0 110.467 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -68.44 136.21 52.9 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.554 -0.716 . . . . 0.0 110.067 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 48.9 mt -137.44 159.55 41.62 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.563 -0.711 . . . . 0.0 110.61 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -119.98 139.75 52.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.661 -0.649 . . . . 0.0 109.378 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 51.7 tp -115.15 126.74 54.98 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.515 -0.74 . . . . 0.0 110.223 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 89.5 t -90.61 111.73 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.677 -0.639 . . . . 0.0 109.58 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.5 m -90.02 154.29 19.92 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.607 -0.683 . . . . 0.0 110.321 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 72.6 ttt-85 -60.01 -19.27 51.67 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.652 -0.655 . . . . 0.0 110.619 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -94.82 26.97 3.29 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.341 -0.849 . . . . 0.0 110.544 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 55.69 45.79 23.88 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.262 -0.899 . . . . 0.0 110.648 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -119.72 146.05 45.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.62 -0.675 . . . . 0.0 109.975 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.9 p -124.21 129.98 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.44 -0.788 . . . . 0.0 110.743 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 61.5 mt -127.77 137.9 31.74 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.63 -0.669 . . . . 0.0 109.727 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -75.97 140.32 22.78 Favored 'Trans proline' 0 N--CA 1.485 1.018 0 O-C-N 123.197 1.104 . . . . 0.0 110.819 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.5 t -129.94 130.86 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.535 -0.728 . . . . 0.0 110.049 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.8 mmm180 -90.51 135.86 33.43 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.53 -0.732 . . . . 0.0 110.229 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 45.5 ttt85 -67.6 122.57 18.31 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.513 -0.742 . . . . 0.0 110.095 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -127.19 22.17 6.64 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.531 -0.731 . . . . 0.0 110.526 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 167.88 -175.92 42.62 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -70.58 -41.29 72.57 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.588 -0.949 . . . . 0.0 110.672 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.7 p -131.18 13.07 5.14 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.525 -0.734 . . . . 0.0 111.275 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 -130.27 138.58 50.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.187 -0.945 . . . . 0.0 110.269 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -137.29 156.15 23.28 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.3 p -86.3 159.48 19.41 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.509 -0.995 . . . . 0.0 110.16 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 49.4 tp -108.05 128.54 54.76 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.652 -0.655 . . . . 0.0 110.012 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.94 -40.05 91.79 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.618 -0.676 . . . . 0.0 110.338 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 62.3 m -116.15 102.61 53.7 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.447 -0.783 . . . . 0.0 110.35 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.3 123.3 8.13 Favored 'Trans proline' 0 C--N 1.319 -1.003 0 O-C-N 123.319 1.168 . . . . 0.0 110.508 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.465 ' CB ' ' CD1' ' A' ' 134' ' ' TYR . 12.7 mtt-85 -131.91 170.94 10.04 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.588 -0.695 . . . . 0.0 110.161 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -65.86 150.22 85.99 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 O-C-N 123.385 1.203 . . . . 0.0 111.322 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 79.2 t -54.26 -28.44 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.216 -0.927 . . . . 0.0 110.075 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 29.3 t -63.48 -31.04 72.09 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.619 -0.676 . . . . 0.0 109.637 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.465 ' CD1' ' CB ' ' A' ' 130' ' ' ARG . 0.0 OUTLIER -64.76 -40.74 95.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.675 -0.64 . . . . 0.0 109.52 179.784 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.416 ' HB2' ' CE1' ' A' ' 134' ' ' TYR . 13.9 tp -101.93 17.84 22.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.805 -0.559 . . . . 0.0 110.974 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -84.86 136.02 33.83 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.428 -0.795 . . . . 0.0 110.555 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.71 23.89 57.04 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 19.8 m -120.07 11.15 11.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.444 -1.033 . . . . 0.0 110.967 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 12.6 m -59.18 156.49 12.13 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.184 -0.947 . . . . 0.0 110.352 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 89.97 -13.05 65.66 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.574 -1.011 . . . . 0.0 110.574 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -64.62 120.26 18.39 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -78.09 145.03 21.65 Favored 'Trans proline' 0 C--N 1.32 -0.949 0 O-C-N 123.039 1.02 . . . . 0.0 111.12 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.01 121.02 40.72 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.5 mp -118.53 154.48 32.49 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.535 -0.728 . . . . 0.0 111.267 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -96.22 175.3 2.78 Favored Pre-proline 0 N--CA 1.491 1.603 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.97 -24.93 38.91 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.233 1.122 . . . . 0.0 110.415 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 28.8 m -65.59 -39.94 92.14 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.442 -0.786 . . . . 0.0 110.172 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 117.03 39.17 0.83 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -127.54 144.56 51.05 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.532 -0.981 . . . . 0.0 110.334 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -74.66 145.2 43.4 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.574 -0.704 . . . . 0.0 110.492 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 66.4 t -113.47 -51.47 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.612 -0.68 . . . . 0.0 109.93 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -174.64 -164.27 29.22 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 95.2 mt -131.72 144.04 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.522 -0.987 . . . . 0.0 109.981 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -59.95 126.56 28.02 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.55 -0.719 . . . . 0.0 109.825 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 44.5 ttt180 -105.8 -69.2 0.83 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.664 -0.647 . . . . 0.0 110.71 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -132.39 151.07 52.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.525 -0.734 . . . . 0.0 110.749 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -95.15 133.93 38.44 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.726 -0.609 . . . . 0.0 110.162 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 51.8 t -100.7 114.88 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.602 -0.686 . . . . 0.0 110.351 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.3 p -140.26 140.55 35.77 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.491 -0.755 . . . . 0.0 110.709 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 36.0 m -81.23 -47.9 12.77 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.611 -0.681 . . . . 0.0 110.045 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -127.31 42.58 3.29 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.674 -0.641 . . . . 0.0 110.031 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 91.38 -11.33 72.44 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 77.4 t -97.52 122.43 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.141 -1.211 . . . . 0.0 109.198 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -88.84 115.8 26.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.59 -0.694 . . . . 0.0 110.594 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -104.03 -30.1 10.48 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -124.43 155.76 38.3 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.54 139.99 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.539 -0.726 . . . . 0.0 110.384 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -115.3 131.33 56.96 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.657 -0.652 . . . . 0.0 110.408 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -137.14 158.79 43.66 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.652 -0.655 . . . . 0.0 110.015 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 60.2 t -96.52 130.35 30.85 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.555 -0.716 . . . . 0.0 110.361 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.26 167.27 27.76 Favored 'Trans proline' 0 N--CA 1.485 0.989 0 O-C-N 123.157 1.083 . . . . 0.0 110.314 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 67.8 t -70.17 -30.5 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.532 -0.73 . . . . 0.0 110.237 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -59.94 -40.06 87.68 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.546 -0.721 . . . . 0.0 110.586 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 19.8 t -61.74 -38.77 89.19 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.57 -0.706 . . . . 0.0 110.37 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 68.6 mtt -59.93 -29.1 68.16 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.573 -0.704 . . . . 0.0 110.499 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -59.98 -38.11 81.61 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.603 -0.686 . . . . 0.0 110.665 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 91.4 m -60.02 -40.02 87.87 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.409 -0.807 . . . . 0.0 110.615 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 88.0 m -60.01 -36.4 77.14 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.442 -0.786 . . . . 0.0 110.48 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.8 mtt -60.0 -38.96 84.15 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.454 -0.779 . . . . 0.0 110.722 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 53.3 mtt180 -60.05 -39.96 87.79 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.39 -0.819 . . . . 0.0 110.364 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.791 0 O-C-N 121.608 -0.683 . . . . 0.0 110.205 179.894 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 . . . . . 0 N--CA 1.497 1.888 0 CA-C-O 121.106 0.479 . . . . 0.0 110.368 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 71.7 t -118.08 130.01 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.549 -0.719 . . . . 0.0 110.034 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -104.58 140.5 37.91 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.682 -0.636 . . . . 0.0 110.304 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.1 p -89.62 119.7 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.504 -0.747 . . . . 0.0 110.269 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 62.7 t -124.23 129.9 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.399 -0.813 . . . . 0.0 110.103 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.5 m -119.42 135.67 54.64 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.509 -0.744 . . . . 0.0 110.345 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.43 178.31 4.59 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.469 -0.769 . . . . 0.0 109.892 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.0 -50.18 74.77 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.678 -0.639 . . . . 0.0 110.602 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 74.3 p -117.77 -20.03 9.04 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.575 -0.703 . . . . 0.0 111.041 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -114.81 171.08 7.86 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.313 -0.867 . . . . 0.0 110.394 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 72.1 p -149.84 121.46 8.02 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.642 -0.661 . . . . 0.0 110.034 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.408 ' CE2' ' HB3' ' A' ' 59' ' ' ALA . 41.1 p90 -134.49 171.01 14.91 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.557 -0.715 . . . . 0.0 110.028 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 91.3 mt -119.26 158.37 26.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.568 -0.707 . . . . 0.0 110.529 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -125.64 151.99 45.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.634 -0.666 . . . . 0.0 110.212 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.1 p -125.78 144.12 50.77 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.623 -0.673 . . . . 0.0 110.007 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 35.4 t -94.61 110.08 21.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.448 -0.783 . . . . 0.0 110.434 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.3 t -123.05 126.98 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.589 -0.695 . . . . 0.0 110.144 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.9 m120 53.09 39.02 28.88 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.461 -0.774 . . . . 0.0 111.227 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.44 19.59 72.8 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 63.2 t -130.18 129.87 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.296 -1.12 . . . . 0.0 109.623 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 92.4 m -84.47 133.54 34.47 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.522 -0.736 . . . . 0.0 109.684 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -119.91 136.61 54.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.519 -0.738 . . . . 0.0 110.546 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.8 t -137.96 175.02 9.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.708 -0.62 . . . . 0.0 109.72 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.46 ' CG1' ' CE1' ' A' ' 57' ' ' HIS . 85.8 t -80.98 142.45 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.448 -0.783 . . . . 0.0 109.993 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.435 ' CE2' HG22 ' A' ' 78' ' ' VAL . 31.4 t80 -76.54 -42.75 41.92 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.644 -0.66 . . . . 0.0 111.71 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.46 ' CE1' ' CG1' ' A' ' 55' ' ' VAL . 2.5 p-80 -69.94 -15.22 63.02 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.313 -0.867 . . . . 0.0 111.102 -178.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -104.84 -77.95 1.19 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.408 ' HB3' ' CE2' ' A' ' 43' ' ' PHE . . . -71.16 -39.99 71.58 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.513 -0.993 . . . . 0.0 110.697 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.505 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -179.657 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.3 m . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 121.064 0.459 . . . . 0.0 110.366 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -64.13 131.0 46.17 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.595 -0.691 . . . . 0.0 110.009 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 19.8 mmt -93.21 -35.76 12.96 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.569 -0.707 . . . . 0.0 110.457 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -125.57 134.13 52.06 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.509 -0.744 . . . . 0.0 110.432 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.0 p -147.11 121.34 9.54 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.51 -0.744 . . . . 0.0 110.146 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -156.91 116.51 3.45 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.451 -0.781 . . . . 0.0 110.93 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.435 HG22 ' CE2' ' A' ' 56' ' ' TYR . 95.7 t -71.74 -37.1 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.484 -0.76 . . . . 0.0 109.616 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -58.62 -48.16 81.94 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.475 -0.766 . . . . 0.0 109.653 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -84.06 -14.25 51.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.579 -0.701 . . . . 0.0 109.922 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.409 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 61.4 t0 55.31 40.0 31.41 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.242 -0.911 . . . . 0.0 111.053 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 74.9 mt -140.96 147.29 38.54 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.424 -0.798 . . . . 0.0 111.595 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.4 m -142.26 173.87 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -167.23 169.98 41.28 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -128.98 158.92 37.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.709 -0.877 . . . . 0.0 109.648 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -81.04 121.29 25.88 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.539 -0.726 . . . . 0.0 110.059 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -114.09 155.7 45.11 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.583 -0.698 . . . . 0.0 110.316 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.59 153.68 60.01 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 123.42 1.221 . . . . 0.0 110.543 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.59 155.72 54.41 Favored 'Trans proline' 0 C--N 1.317 -1.094 0 O-C-N 123.405 1.213 . . . . 0.0 110.349 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 109.17 31.0 3.43 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -128.65 160.03 33.74 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.489 -1.006 . . . . 0.0 110.371 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 76.6 mtt85 -65.56 140.96 58.59 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.636 -0.665 . . . . 0.0 110.25 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 58.0 m -121.87 146.46 47.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.575 -0.703 . . . . 0.0 110.219 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.4 mt -94.47 144.4 25.6 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.561 -0.712 . . . . 0.0 110.29 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.7 t -104.3 150.73 38.73 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.639 -0.663 . . . . 0.0 110.169 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.76 151.76 69.12 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.384 1.202 . . . . 0.0 110.388 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 18.8 t -80.83 129.97 34.81 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.567 -0.708 . . . . 0.0 110.431 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.7 t -135.44 56.17 1.85 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.632 -0.667 . . . . 0.0 109.859 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.3 p -145.38 11.55 1.31 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.601 -0.687 . . . . 0.0 111.552 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 51.11 51.3 36.05 Favored Glycine 0 N--CA 1.501 2.979 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.33 109.92 15.28 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.463 -1.022 . . . . 0.0 110.506 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 29.6 p -69.92 -34.99 74.21 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.612 -0.68 . . . . 0.0 109.864 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -84.06 110.8 18.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.72 -0.612 . . . . 0.0 109.922 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 88.0 mt -115.68 136.45 53.05 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.555 -0.716 . . . . 0.0 110.198 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -106.82 139.76 40.73 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.447 -0.783 . . . . 0.0 110.177 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.3 tt -111.3 141.91 44.22 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.558 -0.714 . . . . 0.0 110.322 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.8 t -94.6 130.8 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.675 -0.641 . . . . 0.0 110.113 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.0 m -104.04 162.54 13.06 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.549 -0.719 . . . . 0.0 110.082 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -61.04 -23.84 65.74 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.488 -0.758 . . . . 0.0 110.599 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -95.39 26.53 3.79 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.469 -0.769 . . . . 0.0 110.637 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.14 43.35 30.79 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.336 -0.852 . . . . 0.0 110.991 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -111.34 130.91 55.53 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.477 -0.765 . . . . 0.0 109.821 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.3 m -101.43 148.13 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.558 -0.714 . . . . 0.0 110.578 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.4 tt -148.55 132.66 8.67 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.561 -0.712 . . . . 0.0 109.997 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.71 142.74 36.32 Favored 'Trans proline' 0 C--N 1.319 -0.994 0 O-C-N 123.14 1.074 . . . . 0.0 110.693 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.0 t -129.97 130.21 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.66 -0.65 . . . . 0.0 110.007 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -78.07 129.97 35.87 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.491 -0.756 . . . . 0.0 110.222 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -64.23 140.03 58.83 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.568 -0.708 . . . . 0.0 110.031 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -147.56 47.19 1.12 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.587 -0.696 . . . . 0.0 110.265 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 138.53 169.05 11.47 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -60.53 -42.04 95.65 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.569 -0.959 . . . . 0.0 110.196 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.8 m -127.94 25.49 5.93 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.59 -0.694 . . . . 0.0 110.143 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.18 136.93 42.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.533 -0.73 . . . . 0.0 110.242 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -134.26 170.4 22.62 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 14.4 m -120.24 139.81 52.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.525 -0.986 . . . . 0.0 110.362 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 57.9 tp -75.86 137.08 40.2 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.625 -0.672 . . . . 0.0 109.941 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.04 -48.69 80.68 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.544 -0.722 . . . . 0.0 110.584 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 78.5 p -117.72 139.66 26.62 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.537 -0.727 . . . . 0.0 110.012 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -75.55 126.35 9.56 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 O-C-N 123.266 1.14 . . . . 0.0 110.788 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 -129.85 163.04 49.89 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.616 -0.678 . . . . 0.0 109.61 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.79 150.18 67.71 Favored 'Trans proline' 0 C--N 1.315 -1.224 0 O-C-N 123.327 1.172 . . . . 0.0 110.739 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 69.9 t -59.95 -33.55 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.601 -0.687 . . . . 0.0 109.664 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 25.6 t -59.37 -40.05 85.24 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.605 -0.684 . . . . 0.0 110.461 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -61.45 -40.76 95.67 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.546 -0.721 . . . . 0.0 109.753 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 55.6 tp -89.9 -10.3 45.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.783 -0.573 . . . . 0.0 111.282 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.1 tttm -63.7 137.27 58.01 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.271 -0.893 . . . . 0.0 110.622 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 88.65 23.11 37.27 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 70.7 m -120.55 6.34 10.57 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.331 -1.1 . . . . 0.0 111.32 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 50.6 m -58.65 146.17 37.21 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.973 -1.079 . . . . 0.0 110.076 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 96.37 -24.36 30.78 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.16 111.64 3.79 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.24 149.41 45.6 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 O-C-N 123.169 1.089 . . . . 0.0 110.834 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.3 mp -101.21 127.5 47.76 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.7 mp -118.45 122.35 42.54 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.472 -0.767 . . . . 0.0 110.948 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 27.3 p -68.49 162.93 58.22 Favored Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -64.4 -21.0 66.79 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 O-C-N 123.148 1.078 . . . . 0.0 111.327 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.6 m -62.74 -39.97 95.77 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.341 -0.849 . . . . 0.0 109.997 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.401 ' O ' ' CD2' ' A' ' 149' ' ' HIS . . . 118.59 40.17 0.68 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.401 ' CD2' ' O ' ' A' ' 148' ' ' GLY . 29.3 m170 -133.38 153.36 51.66 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.59 -0.947 . . . . 0.0 110.354 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.47 134.06 37.38 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.549 -0.719 . . . . 0.0 110.049 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.7 t -99.81 -59.98 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.527 -0.733 . . . . 0.0 110.365 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -176.31 -163.54 28.96 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 91.4 mt -128.5 139.99 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.639 -0.918 . . . . 0.0 110.159 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -61.75 130.07 44.04 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.55 -0.719 . . . . 0.0 110.023 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -107.62 -63.83 1.27 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.636 -0.665 . . . . 0.0 110.636 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -136.96 152.65 50.42 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.513 -0.742 . . . . 0.0 110.815 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.64 155.37 16.9 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.694 -0.629 . . . . 0.0 109.632 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 48.0 t -121.05 112.38 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.534 -0.728 . . . . 0.0 110.519 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.4 p -141.58 142.3 33.48 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.485 -0.76 . . . . 0.0 110.429 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 25.0 m -80.2 -41.43 25.24 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.492 -0.755 . . . . 0.0 110.122 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -136.02 46.49 2.3 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.534 -0.729 . . . . 0.0 110.498 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 90.1 -10.68 73.28 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.344 -1.103 . . . . 0.0 110.344 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 63.3 t -98.39 120.75 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.141 -1.211 . . . . 0.0 109.386 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.58 114.61 24.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.587 -0.695 . . . . 0.0 110.752 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -101.65 -29.44 11.92 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -130.34 159.96 35.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.711 -0.618 . . . . 0.0 109.444 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.7 m -133.49 141.41 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.429 -0.794 . . . . 0.0 110.571 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -118.02 133.5 55.86 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.537 -0.727 . . . . 0.0 110.176 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -136.52 160.1 39.79 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.462 -0.773 . . . . 0.0 110.506 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 58.8 t -96.68 135.43 22.26 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.522 -0.736 . . . . 0.0 110.161 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.08 150.93 43.75 Favored 'Trans proline' 0 N--CA 1.486 1.043 0 O-C-N 123.216 1.114 . . . . 0.0 110.601 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 61.9 t -71.14 -28.4 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.587 -0.695 . . . . 0.0 110.227 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -60.01 -39.93 87.53 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.451 -0.781 . . . . 0.0 110.67 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 62.2 p -61.79 -28.85 69.75 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.516 -0.74 . . . . 0.0 110.589 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 67.6 mtt -61.59 -34.92 76.45 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.535 -0.728 . . . . 0.0 110.475 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -59.98 -40.79 90.31 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.525 -0.734 . . . . 0.0 110.314 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 92.3 m -63.53 -40.04 95.98 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.514 -0.741 . . . . 0.0 109.925 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 63.6 m -62.67 -41.54 99.14 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.59 -0.694 . . . . 0.0 110.154 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 58.8 ttp -60.04 -40.93 91.05 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.613 -0.68 . . . . 0.0 110.315 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 44.5 ttp85 -60.02 -39.99 87.78 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.59 -0.693 . . . . 0.0 110.087 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.852 0 O-C-N 121.577 -0.702 . . . . 0.0 110.162 179.987 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.024 0.44 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.0 p -137.33 130.46 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.596 -0.69 . . . . 0.0 109.932 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.3 mp0 -104.32 132.48 50.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.568 -0.708 . . . . 0.0 110.273 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.3 m -76.63 135.72 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.659 -0.65 . . . . 0.0 109.934 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.7 p -137.29 138.9 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.56 -0.712 . . . . 0.0 110.148 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.3 t -122.46 136.85 54.98 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.631 -0.668 . . . . 0.0 110.141 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.1 m -100.16 179.97 4.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.567 -0.708 . . . . 0.0 109.979 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.03 -41.23 91.77 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.651 -0.656 . . . . 0.0 111.017 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.4 p -121.59 -25.55 5.1 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.407 -0.808 . . . . 0.0 111.676 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -118.23 159.58 23.08 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.292 -0.88 . . . . 0.0 110.751 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 11.1 m -140.06 120.79 14.35 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.605 -0.684 . . . . 0.0 110.178 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -135.79 176.31 8.8 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.609 -0.682 . . . . 0.0 109.877 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.4 mt -116.86 160.36 20.97 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.451 -0.781 . . . . 0.0 110.398 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -129.37 143.85 51.0 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.481 -0.762 . . . . 0.0 110.478 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.7 m -123.1 136.93 55.0 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.51 -0.743 . . . . 0.0 110.115 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 47.3 t -95.43 111.67 23.52 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.542 -0.724 . . . . 0.0 110.602 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.98 139.35 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.504 -0.748 . . . . 0.0 110.195 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 55.21 37.17 28.49 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.524 -0.735 . . . . 0.0 110.794 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.1 14.15 63.22 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.9 t -131.73 130.0 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.18 -1.188 . . . . 0.0 109.781 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 43.1 t -86.02 113.43 22.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.523 -0.736 . . . . 0.0 109.923 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.444 ' CZ3' ' CD2' ' A' ' 82' ' ' LEU . 80.0 m95 -106.51 137.12 45.08 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.558 -0.714 . . . . 0.0 110.82 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.41 HG23 ' CZ3' ' A' ' 85' ' ' TRP . 7.6 t -136.81 -179.31 5.62 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.47 ' CG1' ' CE1' ' A' ' 57' ' ' HIS . 59.4 t -80.14 142.52 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.398 -0.814 . . . . 0.0 109.194 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.431 ' CE2' ' CG2' ' A' ' 78' ' ' VAL . 28.7 t80 -83.28 -39.99 20.13 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.352 -0.843 . . . . 0.0 111.861 -178.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.47 ' CE1' ' CG1' ' A' ' 55' ' ' VAL . 1.6 p-80 -60.19 -18.66 49.73 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.98 -1.075 . . . . 0.0 110.956 -178.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -97.64 -69.37 0.97 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.62 -36.3 70.72 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.582 -0.952 . . . . 0.0 110.588 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.647 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -179.421 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.1 m . . . . . 0 N--CA 1.494 1.732 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -61.1 124.62 21.05 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.476 -0.765 . . . . 0.0 110.074 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.7 tpt -64.9 -40.04 94.46 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.639 -0.663 . . . . 0.0 110.536 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -124.43 134.27 53.13 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.571 -0.706 . . . . 0.0 110.308 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.0 p -146.37 136.21 23.34 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.5 -0.75 . . . . 0.0 110.391 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -162.0 105.46 1.19 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.522 -0.736 . . . . 0.0 110.027 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.431 ' CG2' ' CE2' ' A' ' 56' ' ' TYR . 72.2 t -68.18 -40.0 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.511 -0.743 . . . . 0.0 110.267 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -57.93 -39.81 78.93 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.546 -0.721 . . . . 0.0 110.762 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -99.06 -7.25 27.05 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.535 -0.728 . . . . 0.0 111.3 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.1 t0 55.81 40.43 30.68 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.881 -1.137 . . . . 0.0 109.616 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.444 ' CD2' ' CZ3' ' A' ' 53' ' ' TRP . 4.7 tp -119.04 132.01 56.01 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.463 0.649 . . . . 0.0 110.114 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.1 p -156.82 160.69 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.721 -0.612 . . . . 0.0 109.427 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -177.33 168.34 40.0 Favored Glycine 0 N--CA 1.495 2.614 0 C-N-CA 119.756 -1.211 . . . . 0.0 110.471 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.41 ' CZ3' HG23 ' A' ' 54' ' ' THR . 13.5 m-90 -117.38 155.17 30.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.789 -0.83 . . . . 0.0 109.925 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.8 mm-40 -76.63 148.12 37.12 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.493 -0.754 . . . . 0.0 110.168 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -113.01 158.95 36.42 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.509 -0.745 . . . . 0.0 110.243 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.47 157.38 56.52 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.41 1.216 . . . . 0.0 110.526 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.46 160.24 44.89 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.49 1.258 . . . . 0.0 110.421 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 80.5 27.34 51.83 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -115.15 159.02 21.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.515 -0.991 . . . . 0.0 110.127 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.9 tpt85 -81.41 131.68 35.29 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.569 -0.707 . . . . 0.0 110.125 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 59.4 m -115.59 150.24 36.98 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.574 -0.704 . . . . 0.0 110.229 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 94.2 mt -92.7 136.57 33.11 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.531 -0.73 . . . . 0.0 110.376 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 73.9 p -81.43 156.92 70.84 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.605 -0.684 . . . . 0.0 110.407 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.81 163.68 36.52 Favored 'Trans proline' 0 C--N 1.318 -1.027 0 O-C-N 123.435 1.229 . . . . 0.0 110.372 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 49.5 t -87.23 123.76 32.58 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.538 -0.726 . . . . 0.0 110.379 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.2 t -132.84 61.78 1.67 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.662 -0.649 . . . . 0.0 109.883 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.3 p -145.27 7.4 1.16 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.61 -0.681 . . . . 0.0 111.955 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 51.22 48.06 48.22 Favored Glycine 0 N--CA 1.501 3.029 0 O-C-N 120.919 -1.113 . . . . 0.0 110.416 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.8 p -85.27 109.91 18.69 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.51 -0.994 . . . . 0.0 110.629 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 68.5 p -66.99 -39.66 87.21 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.603 -0.686 . . . . 0.0 109.611 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -79.14 128.15 32.93 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.585 -0.697 . . . . 0.0 109.591 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 92.9 mt -133.6 150.24 51.61 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.401 -0.812 . . . . 0.0 110.696 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -106.85 128.47 54.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.619 -0.676 . . . . 0.0 109.504 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.9 tt -110.48 142.35 42.35 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.571 -0.705 . . . . 0.0 110.422 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.6 t -107.2 125.26 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.611 -0.681 . . . . 0.0 109.781 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 75.1 p -95.39 168.9 10.43 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.644 -0.66 . . . . 0.0 110.386 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 -66.28 -23.48 66.4 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.71 -0.619 . . . . 0.0 110.161 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -93.16 24.5 3.76 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.425 -0.797 . . . . 0.0 110.79 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.71 50.04 16.69 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.338 -0.851 . . . . 0.0 111.032 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -117.67 127.76 54.25 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.319 -0.863 . . . . 0.0 109.827 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.1 t -93.81 120.0 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.577 -0.702 . . . . 0.0 110.096 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 36.0 mt -123.96 135.06 25.87 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.574 -0.704 . . . . 0.0 109.853 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -77.22 143.77 22.74 Favored 'Trans proline' 0 C--N 1.32 -0.954 0 O-C-N 123.199 1.105 . . . . 0.0 110.277 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.3 t -131.45 139.64 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.568 -0.708 . . . . 0.0 110.158 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.3 tpt85 -96.88 133.59 41.3 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.512 -0.743 . . . . 0.0 110.032 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -70.0 136.85 50.86 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.547 -0.72 . . . . 0.0 110.259 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -136.87 26.2 3.03 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.592 -0.693 . . . . 0.0 110.18 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 151.95 -173.93 31.08 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -70.06 -39.07 75.89 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.593 -0.945 . . . . 0.0 110.429 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.3 m -128.78 23.69 5.75 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.52 -0.737 . . . . 0.0 111.184 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 24.5 ttp180 -141.45 143.66 34.0 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.224 -0.923 . . . . 0.0 110.852 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -139.59 -176.68 15.02 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.6 m -116.29 160.8 19.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.568 -0.96 . . . . 0.0 110.042 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.96 124.1 51.46 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.555 -0.715 . . . . 0.0 110.087 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.5 mp -69.98 -40.04 75.6 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.502 -0.749 . . . . 0.0 110.007 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 67.1 m -103.78 109.92 63.02 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.585 -0.697 . . . . 0.0 109.976 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.92 112.47 3.41 Favored 'Trans proline' 0 C--N 1.319 -1.016 0 O-C-N 123.241 1.127 . . . . 0.0 110.48 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -124.92 162.12 45.16 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.628 -0.67 . . . . 0.0 110.17 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.2 150.56 59.66 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 O-C-N 123.505 1.266 . . . . 0.0 110.503 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 85.9 t -56.66 -34.34 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.558 -0.714 . . . . 0.0 110.27 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.2 t -59.98 -39.98 87.56 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.538 -0.726 . . . . 0.0 110.52 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -64.15 -40.04 95.31 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.574 -0.703 . . . . 0.0 110.048 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 45.3 tp -88.99 -4.33 58.46 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.679 -0.638 . . . . 0.0 111.35 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -71.26 140.44 50.36 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.11 -0.994 . . . . 0.0 110.975 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 98.39 -2.56 59.25 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 45.3 p -100.86 9.16 42.66 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.149 -1.206 . . . . 0.0 110.716 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.21 129.9 42.9 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.281 -0.887 . . . . 0.0 109.732 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 107.37 -20.77 32.06 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.57 128.5 38.39 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -76.94 162.24 32.3 Favored 'Trans proline' 0 C--N 1.319 -0.992 0 O-C-N 123.166 1.087 . . . . 0.0 111.304 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.8 mp -116.56 125.11 51.4 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.403 ' CD1' ' N ' ' A' ' 144' ' ' LEU . 6.5 mp -116.67 129.99 56.47 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.466 -0.771 . . . . 0.0 111.424 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 29.5 p -80.63 163.75 54.81 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.704 -0.623 . . . . 0.0 109.356 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.41 -14.6 44.81 Favored 'Trans proline' 0 N--CA 1.488 1.154 0 O-C-N 123.162 1.085 . . . . 0.0 111.12 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.6 t -66.89 -40.11 87.67 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.284 -0.885 . . . . 0.0 110.004 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 117.05 32.65 1.49 Allowed Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -132.98 148.24 52.27 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.46 -1.023 . . . . 0.0 110.168 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -72.28 134.78 45.75 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.519 -0.738 . . . . 0.0 110.271 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.0 t -98.52 -59.69 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.513 -0.742 . . . . 0.0 110.145 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -176.16 -170.01 38.35 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 45.4 mt -121.34 143.48 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.614 -0.933 . . . . 0.0 110.323 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -61.12 126.76 28.52 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.577 -0.702 . . . . 0.0 109.668 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -106.74 -64.25 1.2 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.474 -0.767 . . . . 0.0 110.972 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -134.1 150.92 51.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.432 -0.792 . . . . 0.0 110.794 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.49 152.9 18.21 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.584 -0.697 . . . . 0.0 109.439 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 46.6 t -120.0 120.01 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.485 -0.759 . . . . 0.0 110.443 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.2 p -140.98 142.16 34.33 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.473 -0.767 . . . . 0.0 110.536 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 92.6 m -70.03 -44.11 69.92 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.58 -0.7 . . . . 0.0 109.865 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -147.93 49.62 1.06 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.651 -0.656 . . . . 0.0 110.133 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 97.74 -11.19 64.61 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 58.0 t -101.6 123.64 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.195 -1.179 . . . . 0.0 108.97 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.24 118.21 26.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.443 -0.786 . . . . 0.0 111.136 -178.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -111.42 -15.12 13.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.742 -0.599 . . . . 0.0 110.158 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -144.31 167.99 21.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.354 -0.841 . . . . 0.0 109.356 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 35.0 m -137.81 145.05 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.319 -0.863 . . . . 0.0 111.131 -179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.47 132.44 54.73 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.71 -0.619 . . . . 0.0 110.082 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -142.11 154.05 44.61 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.493 -0.755 . . . . 0.0 110.502 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 89.5 t -92.46 130.96 35.55 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.588 -0.695 . . . . 0.0 109.803 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.13 160.08 46.2 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 O-C-N 123.193 1.101 . . . . 0.0 110.366 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 61.8 t -69.4 -33.1 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.602 -0.686 . . . . 0.0 109.932 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -60.03 -39.94 87.63 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.475 -0.766 . . . . 0.0 110.595 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.9 m -64.96 -22.91 67.08 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.526 -0.734 . . . . 0.0 111.28 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 65.6 mtt -59.97 -35.63 75.41 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.26 -0.9 . . . . 0.0 110.526 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -59.97 -32.8 71.16 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.576 -0.702 . . . . 0.0 110.652 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 93.9 m -59.94 -40.03 87.55 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.409 -0.807 . . . . 0.0 110.404 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 24.8 m -68.8 -34.19 75.13 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.429 -0.794 . . . . 0.0 110.561 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 44.8 ttp -59.97 -41.86 92.88 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.574 -0.704 . . . . 0.0 110.662 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 58.8 mtt-85 -61.32 -39.92 92.29 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.518 -0.739 . . . . 0.0 110.364 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.764 0 O-C-N 121.528 -0.732 . . . . 0.0 110.245 179.97 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 N--CA 1.497 1.921 0 CA-C-O 121.292 0.568 . . . . 0.0 109.942 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.4 t -119.57 138.93 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.716 -0.615 . . . . 0.0 109.614 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -119.43 142.63 48.05 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.511 -0.743 . . . . 0.0 110.569 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.0 m -85.44 120.4 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.724 -0.61 . . . . 0.0 110.425 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.9 p -130.21 140.0 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.448 -0.783 . . . . 0.0 110.199 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 74.8 m -122.02 149.0 44.13 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.673 -0.642 . . . . 0.0 110.279 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.31 -177.38 3.23 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.639 -0.663 . . . . 0.0 110.004 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.5 -40.05 94.94 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.668 -0.645 . . . . 0.0 111.263 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.2 t -123.72 -11.7 7.7 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.326 -0.859 . . . . 0.0 111.935 -179.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -136.04 162.95 31.46 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.176 -0.952 . . . . 0.0 110.441 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.6 t -140.24 123.47 16.83 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.566 -0.709 . . . . 0.0 110.426 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -136.17 178.03 7.38 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.587 -0.696 . . . . 0.0 110.012 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 82.0 mt -117.46 147.19 42.95 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.523 -0.736 . . . . 0.0 110.636 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -109.97 155.3 21.96 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.719 -0.613 . . . . 0.0 110.081 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.7 p -129.95 144.2 51.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.512 -0.742 . . . . 0.0 110.255 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 34.0 t -100.89 115.82 31.3 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.559 -0.713 . . . . 0.0 110.45 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.4 t -129.98 129.97 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.628 -0.67 . . . . 0.0 109.967 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 52.77 40.12 29.93 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.432 -0.793 . . . . 0.0 111.059 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.2 20.99 71.68 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 62.1 t -130.87 123.35 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.293 -1.122 . . . . 0.0 109.922 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 42.3 t -80.7 110.07 15.85 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.48 -0.763 . . . . 0.0 109.564 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 46.7 m95 -97.27 137.58 36.06 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.528 -0.732 . . . . 0.0 110.994 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.408 HG21 ' CZ3' ' A' ' 85' ' ' TRP . 10.1 t -136.63 173.1 12.07 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.454 ' CG1' ' CE1' ' A' ' 57' ' ' HIS . 45.7 t -80.63 142.57 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.376 -0.827 . . . . 0.0 110.372 -179.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.441 ' CE2' HG23 ' A' ' 78' ' ' VAL . 34.7 t80 -74.96 -43.03 56.36 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.606 -0.684 . . . . 0.0 111.976 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.454 ' CE1' ' CG1' ' A' ' 55' ' ' VAL . 1.8 p-80 -66.35 -13.85 61.2 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.192 -0.942 . . . . 0.0 110.996 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.9 -88.11 1.47 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.33 -39.97 74.41 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.666 -0.902 . . . . 0.0 110.586 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.701 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -179.399 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.0 m . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -77.28 109.29 11.04 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.515 -0.741 . . . . 0.0 110.451 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 48.7 tpp -70.01 -35.77 74.61 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.669 -0.644 . . . . 0.0 110.122 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -109.67 128.42 55.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.615 -0.678 . . . . 0.0 109.924 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.1 p -144.23 121.21 11.37 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.538 -0.726 . . . . 0.0 110.361 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 59.6 t-20 -151.42 110.85 3.97 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.515 -0.74 . . . . 0.0 110.495 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.441 HG23 ' CE2' ' A' ' 56' ' ' TYR . 99.6 t -70.03 -35.36 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.451 -0.781 . . . . 0.0 109.577 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -60.0 -40.17 88.28 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.392 -0.817 . . . . 0.0 109.391 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -89.93 -14.28 34.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.699 -0.626 . . . . 0.0 110.083 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 46.5 t0 55.03 40.01 31.81 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.207 -0.933 . . . . 0.0 110.713 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 48.1 mt -144.09 149.6 36.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.512 -0.743 . . . . 0.0 111.165 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.9 m -141.24 168.21 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -152.37 156.73 26.87 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 119.747 -1.216 . . . . 0.0 110.318 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.408 ' CZ3' HG21 ' A' ' 54' ' ' THR . 3.3 m-90 -121.71 146.05 47.41 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.705 -0.879 . . . . 0.0 109.919 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -68.44 129.9 41.3 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.594 -0.692 . . . . 0.0 110.028 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -114.14 159.71 35.3 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.526 -0.734 . . . . 0.0 110.131 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.58 154.7 64.34 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 O-C-N 123.413 1.218 . . . . 0.0 110.376 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.51 160.14 44.93 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 O-C-N 123.41 1.216 . . . . 0.0 110.465 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 77.9 28.97 55.69 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -110.3 155.01 22.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.534 -0.98 . . . . 0.0 110.22 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -58.86 146.38 37.61 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.622 -0.673 . . . . 0.0 110.401 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.5 t -143.43 161.56 38.07 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.629 -0.67 . . . . 0.0 110.453 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -108.18 144.79 35.12 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.57 -0.706 . . . . 0.0 110.376 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.8 p -95.42 159.42 32.77 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.56 -0.712 . . . . 0.0 110.393 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.84 150.49 49.68 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 O-C-N 123.394 1.207 . . . . 0.0 110.386 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 47.9 t -87.28 128.26 35.17 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.62 -0.675 . . . . 0.0 110.445 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.5 p -136.12 71.79 1.43 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.584 -0.698 . . . . 0.0 109.927 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.6 p -145.4 8.25 1.18 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.473 -0.767 . . . . 0.0 111.916 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 52.59 42.96 58.85 Favored Glycine 0 N--CA 1.499 2.864 0 O-C-N 120.824 -1.172 . . . . 0.0 110.353 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 26.3 t -79.42 116.65 19.78 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.488 -1.007 . . . . 0.0 110.394 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.6 m -70.05 -39.91 75.43 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.603 -0.686 . . . . 0.0 110.275 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -84.27 142.16 30.44 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.609 -0.682 . . . . 0.0 110.402 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 94.9 mt -132.2 152.23 51.41 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.503 -0.748 . . . . 0.0 110.401 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -114.61 136.8 52.65 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.55 -0.719 . . . . 0.0 109.744 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 57.3 tp -110.85 140.13 45.57 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.43 -0.794 . . . . 0.0 110.422 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.3 t -93.69 129.94 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.616 -0.678 . . . . 0.0 109.913 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.4 m -110.01 160.93 16.0 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.47 -0.769 . . . . 0.0 110.519 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 18.0 ptm180 -62.71 -24.58 67.74 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.676 -0.64 . . . . 0.0 110.864 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -95.48 29.19 2.65 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.418 -0.801 . . . . 0.0 110.629 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 55.34 36.28 26.75 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.304 -0.873 . . . . 0.0 110.44 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -109.18 146.43 34.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.644 -0.66 . . . . 0.0 109.849 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.6 p -138.05 135.68 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.511 -0.743 . . . . 0.0 110.526 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 85.4 mt -126.6 143.68 47.16 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.603 -0.685 . . . . 0.0 109.679 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -76.79 139.13 19.53 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 O-C-N 123.274 1.144 . . . . 0.0 110.455 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.3 t -124.79 129.94 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.603 -0.686 . . . . 0.0 109.762 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.0 tpp85 -84.24 139.52 32.31 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.531 -0.731 . . . . 0.0 110.022 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -77.2 129.63 36.2 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.543 -0.723 . . . . 0.0 110.152 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -136.59 25.78 3.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.662 -0.649 . . . . 0.0 110.424 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 175.7 179.8 46.42 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -66.78 -40.11 88.06 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.505 -0.997 . . . . 0.0 110.324 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 67.1 m -136.03 25.94 3.28 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.551 -0.718 . . . . 0.0 110.377 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -136.95 159.99 40.24 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.588 -0.695 . . . . 0.0 110.299 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -150.93 -173.71 21.2 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 97.4 p -120.67 153.44 36.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.62 -0.93 . . . . 0.0 110.245 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.7 tp -106.57 123.6 48.34 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.583 -0.698 . . . . 0.0 110.143 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.7 mp -66.47 -39.99 89.09 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.543 -0.723 . . . . 0.0 110.304 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 30.0 t -100.22 108.47 52.6 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.488 -0.757 . . . . 0.0 110.262 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.33 115.45 4.35 Favored 'Trans proline' 0 C--N 1.319 -0.994 0 O-C-N 123.18 1.094 . . . . 0.0 110.307 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -124.48 160.7 51.93 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.586 -0.696 . . . . 0.0 110.392 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.44 150.52 58.16 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 O-C-N 123.469 1.247 . . . . 0.0 110.567 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 95.0 t -57.72 -30.55 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.564 -0.71 . . . . 0.0 110.258 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.5 t -60.07 -40.61 90.1 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.519 -0.738 . . . . 0.0 110.383 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -64.77 -46.02 83.9 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.579 -0.7 . . . . 0.0 109.868 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 54.1 tp -78.76 -22.59 46.2 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.681 -0.637 . . . . 0.0 110.91 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -60.03 136.38 58.0 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.387 -0.821 . . . . 0.0 110.58 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 98.07 -2.35 59.73 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 68.9 m -109.07 16.23 22.72 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.16 -1.2 . . . . 0.0 110.538 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.8 t -62.43 150.15 40.68 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.415 -0.803 . . . . 0.0 109.842 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 90.1 -12.28 68.23 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.37 113.34 5.36 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -70.64 140.9 40.39 Favored 'Trans proline' 0 C--N 1.318 -1.072 0 O-C-N 123.171 1.09 . . . . 0.0 110.981 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 21.7 mt -87.51 125.22 34.19 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -110.41 160.02 16.96 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.322 0.582 . . . . 0.0 110.856 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -109.6 176.18 1.65 Allowed Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.76 -0.587 . . . . 0.0 109.681 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.77 -35.67 12.18 Favored 'Trans proline' 0 C--N 1.317 -1.081 0 O-C-N 123.292 1.154 . . . . 0.0 110.064 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.8 m -62.43 -40.03 95.24 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.605 -0.684 . . . . 0.0 109.756 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 120.21 36.01 0.84 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 45.5 m170 -126.26 138.14 53.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.523 -0.987 . . . . 0.0 110.146 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.17 140.37 38.97 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.508 -0.745 . . . . 0.0 110.119 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 34.3 m -105.95 -26.51 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.571 -0.705 . . . . 0.0 110.56 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 172.72 -164.49 36.67 Favored Glycine 0 N--CA 1.498 2.77 0 C-N-CA 119.674 -1.25 . . . . 0.0 110.571 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 82.6 mt -130.98 141.83 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.67 -0.9 . . . . 0.0 109.896 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -60.16 130.02 44.61 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.52 -0.737 . . . . 0.0 110.209 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -104.49 -72.96 0.69 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.515 -0.741 . . . . 0.0 110.792 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -132.29 152.96 51.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.306 -0.871 . . . . 0.0 110.867 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.48 156.29 16.53 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.648 -0.658 . . . . 0.0 109.757 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 60.7 t -120.78 115.77 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.601 -0.687 . . . . 0.0 110.248 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.4 p -141.35 146.28 36.46 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.461 -0.774 . . . . 0.0 110.711 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 12.2 m -82.3 -49.16 10.36 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.539 -0.725 . . . . 0.0 110.006 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -129.88 46.44 2.65 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.601 -0.687 . . . . 0.0 110.203 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 91.78 -10.99 73.33 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 67.2 t -97.61 122.78 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.156 -1.202 . . . . 0.0 109.38 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.55 116.36 25.62 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.542 -0.724 . . . . 0.0 110.9 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 67.5 mttt -104.27 -29.1 11.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.688 -0.633 . . . . 0.0 109.586 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -128.44 157.38 41.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.705 -0.622 . . . . 0.0 109.55 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 31.7 m -133.07 139.99 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.442 -0.786 . . . . 0.0 110.774 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -119.32 133.54 55.68 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.606 -0.683 . . . . 0.0 110.347 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -134.5 156.67 48.21 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.554 -0.716 . . . . 0.0 110.146 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 57.5 t -96.2 133.84 24.48 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.507 -0.746 . . . . 0.0 110.254 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.01 159.96 40.68 Favored 'Trans proline' 0 N--CA 1.485 0.988 0 O-C-N 123.253 1.133 . . . . 0.0 110.465 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 59.5 t -72.66 -26.32 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.625 -0.672 . . . . 0.0 110.223 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -59.64 -36.82 77.13 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.458 -0.776 . . . . 0.0 110.46 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 22.9 t -61.17 -38.62 87.15 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.587 -0.696 . . . . 0.0 110.162 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 66.1 mtt -60.04 -34.2 73.07 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.537 -0.727 . . . . 0.0 110.35 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -60.02 -40.34 88.95 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.534 -0.728 . . . . 0.0 110.459 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 94.5 m -65.99 -40.09 90.88 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.523 -0.736 . . . . 0.0 109.67 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 93.9 m -62.89 -40.01 96.23 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.662 -0.649 . . . . 0.0 110.067 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 89.1 mtp -60.08 -40.05 88.22 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.539 -0.726 . . . . 0.0 110.431 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -67.28 -39.97 86.08 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.601 -0.687 . . . . 0.0 110.087 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.798 0 O-C-N 121.593 -0.692 . . . . 0.0 110.251 -179.935 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 120.909 0.385 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.6 t -101.71 124.98 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.42 -0.8 . . . . 0.0 109.978 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -104.62 132.29 51.03 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.521 -0.737 . . . . 0.0 110.362 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.9 m -94.98 129.8 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.644 -0.66 . . . . 0.0 110.116 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.2 m -130.05 159.97 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.353 -0.842 . . . . 0.0 110.772 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 69.0 m -132.76 152.83 51.68 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.544 -0.723 . . . . 0.0 110.152 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.56 -176.53 2.94 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.543 -0.723 . . . . 0.0 110.093 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.09 -49.6 77.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.74 -0.6 . . . . 0.0 111.049 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.6 t -116.99 -22.48 8.43 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.393 -0.817 . . . . 0.0 111.293 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -117.14 164.94 14.0 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.389 -0.819 . . . . 0.0 110.187 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.5 m -147.93 120.19 8.37 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.499 -0.751 . . . . 0.0 110.303 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -130.98 -176.66 4.07 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.629 -0.67 . . . . 0.0 110.049 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 48.9 mt -122.4 173.36 7.7 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.502 -0.748 . . . . 0.0 109.893 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -150.68 160.83 43.57 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.564 -0.71 . . . . 0.0 110.355 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.2 t -136.61 144.1 43.91 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.669 -0.644 . . . . 0.0 110.172 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 28.5 p -87.92 123.71 32.95 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.589 -0.695 . . . . 0.0 110.763 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.6 t -130.61 125.26 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.52 -0.737 . . . . 0.0 110.174 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 51.34 40.72 27.05 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.389 -0.819 . . . . 0.0 111.335 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.95 22.77 77.2 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.416 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 60.8 t -142.26 113.62 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.396 -1.061 . . . . 0.0 109.53 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 93.3 m -79.73 125.27 29.44 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.641 -0.662 . . . . 0.0 110.205 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.416 ' CZ2' HG11 ' A' ' 51' ' ' VAL . 98.5 m95 -114.26 136.48 52.92 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.585 -0.697 . . . . 0.0 110.102 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.415 HG23 ' CZ3' ' A' ' 85' ' ' TRP . 7.9 t -137.85 -179.87 6.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.656 -0.653 . . . . 0.0 109.968 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.466 ' CG1' ' CE1' ' A' ' 57' ' ' HIS . 2.1 t -81.69 141.59 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.503 -0.748 . . . . 0.0 109.415 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.464 ' CZ ' HG23 ' A' ' 78' ' ' VAL . 9.6 t80 -85.49 -43.81 13.25 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.392 -0.818 . . . . 0.0 111.85 -179.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.466 ' CE1' ' CG1' ' A' ' 55' ' ' VAL . 3.1 p-80 -57.76 -17.83 17.89 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.204 -0.935 . . . . 0.0 111.672 -177.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.75 -53.87 2.78 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.2 -63.39 1.42 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.621 -0.929 . . . . 0.0 109.779 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.428 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.501 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.4 m . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 121.145 0.498 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -74.32 131.07 40.81 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.625 -0.672 . . . . 0.0 110.087 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.428 ' HG3' ' CD2' ' A' ' 75' ' ' TYR . 22.8 ptp -119.69 -42.49 2.63 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.45 -0.781 . . . . 0.0 110.751 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.428 ' CD2' ' HG3' ' A' ' 74' ' ' MET . 35.0 m-85 -119.98 114.3 21.82 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.265 -0.897 . . . . 0.0 110.088 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.6 m -152.7 131.62 12.52 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.553 -0.717 . . . . 0.0 110.187 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -169.89 125.39 0.81 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.281 -0.887 . . . . 0.0 111.279 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.464 HG23 ' CZ ' ' A' ' 56' ' ' TYR . 76.3 t -72.48 -38.17 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.395 -0.816 . . . . 0.0 109.593 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -55.65 -34.22 64.76 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.386 -0.821 . . . . 0.0 110.364 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -98.99 -12.21 20.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.655 -0.653 . . . . 0.0 110.628 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 42.8 t0 53.28 40.06 30.71 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.093 -1.004 . . . . 0.0 110.501 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.48 151.03 42.99 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.786 0.803 . . . . 0.0 110.979 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.32 153.07 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -153.14 159.25 28.42 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.474 -1.346 . . . . 0.0 110.816 -178.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.415 ' CZ3' HG23 ' A' ' 54' ' ' THR . 6.3 m-90 -131.43 168.37 17.72 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.997 -0.707 . . . . 0.0 109.307 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -68.82 138.51 54.82 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.429 -0.794 . . . . 0.0 110.425 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.38 148.69 45.13 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.577 -0.702 . . . . 0.0 110.109 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.12 144.43 37.6 Favored 'Trans proline' 0 C--N 1.318 -1.065 0 O-C-N 123.29 1.153 . . . . 0.0 110.394 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -77.39 160.26 32.37 Favored 'Trans proline' 0 C--N 1.318 -1.034 0 O-C-N 123.345 1.182 . . . . 0.0 110.548 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 89.61 30.01 14.7 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -151.99 167.84 27.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.55 -0.971 . . . . 0.0 110.301 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -113.76 159.44 19.75 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.515 -0.74 . . . . 0.0 110.123 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.3 m -129.12 171.11 12.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.492 -0.755 . . . . 0.0 110.523 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -81.25 165.08 21.78 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.703 -0.623 . . . . 0.0 110.557 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.453 ' CG2' ' CD2' ' A' ' 149' ' ' HIS . 9.4 t -110.85 151.73 43.11 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.655 -0.653 . . . . 0.0 109.909 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.07 130.29 21.23 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 O-C-N 123.245 1.129 . . . . 0.0 110.232 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 5.0 t -72.31 145.09 48.06 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.64 -0.663 . . . . 0.0 110.538 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 31.3 m -136.28 66.19 1.5 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.573 -0.704 . . . . 0.0 110.477 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 27.7 p -145.01 -8.01 0.62 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.467 -0.771 . . . . 0.0 112.387 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.94 43.71 97.83 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.4 t -71.92 129.87 39.64 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.528 -0.983 . . . . 0.0 110.268 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 73.4 m -71.34 -40.3 70.81 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.563 -0.71 . . . . 0.0 110.267 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -79.75 130.02 34.98 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.518 -0.739 . . . . 0.0 110.328 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 95.9 mt -136.57 151.97 49.96 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.553 -0.717 . . . . 0.0 110.378 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -106.97 123.27 47.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.462 -0.774 . . . . 0.0 109.75 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 41.0 tp -110.05 140.31 44.24 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.516 -0.74 . . . . 0.0 110.386 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 26.7 m -112.27 141.23 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.584 -0.697 . . . . 0.0 109.954 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.5 p -109.85 -162.65 0.81 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.365 -0.834 . . . . 0.0 109.949 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -70.1 -23.62 63.08 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.653 -0.654 . . . . 0.0 110.353 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -91.68 19.69 6.16 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.37 -0.831 . . . . 0.0 111.01 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.13 24.76 5.08 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.124 -0.985 . . . . 0.0 111.024 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 54.7 p-10 -81.0 161.74 24.12 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.477 -0.764 . . . . 0.0 109.914 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.0 p -129.35 133.11 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.626 -0.671 . . . . 0.0 110.062 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.4 tp -143.59 138.38 15.3 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.529 -0.732 . . . . 0.0 109.929 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.35 139.28 28.71 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 O-C-N 123.201 1.106 . . . . 0.0 110.556 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.3 t -129.93 130.04 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.517 -0.74 . . . . 0.0 109.876 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -81.95 149.02 28.4 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.476 -0.765 . . . . 0.0 110.144 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -83.42 137.18 34.03 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.661 -0.649 . . . . 0.0 110.369 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.6 mmt85 -141.28 26.49 1.99 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.58 -0.7 . . . . 0.0 110.381 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 161.65 171.95 28.39 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -71.66 -45.16 62.81 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.556 -0.967 . . . . 0.0 110.443 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 61.3 p -116.83 20.09 14.09 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.553 -0.717 . . . . 0.0 110.732 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 25.3 ttp180 -147.77 144.21 28.07 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.399 -0.813 . . . . 0.0 110.009 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -139.85 -175.23 14.17 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 57.3 p -119.72 147.53 44.48 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.61 -0.936 . . . . 0.0 110.026 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 34.7 tp -95.06 131.23 41.27 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.584 -0.698 . . . . 0.0 110.205 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.4 tt -63.03 -54.58 35.95 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.612 -0.68 . . . . 0.0 110.258 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 57.8 m -96.51 130.05 31.62 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.445 -0.784 . . . . 0.0 110.156 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -81.25 116.32 3.02 Favored 'Trans proline' 0 C--N 1.32 -0.939 0 O-C-N 123.132 1.07 . . . . 0.0 110.677 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.427 ' HD2' ' CD2' ' A' ' 134' ' ' TYR . 54.6 mtm-85 -125.09 152.6 70.86 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.518 -0.739 . . . . 0.0 109.779 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.3 150.22 64.62 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 123.369 1.194 . . . . 0.0 110.759 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 51.6 t -54.33 -31.72 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.442 -0.786 . . . . 0.0 109.701 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.6 t -59.9 -40.38 88.59 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.746 -0.596 . . . . 0.0 111.095 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.427 ' CD2' ' HD2' ' A' ' 130' ' ' ARG . 86.3 t80 -68.95 -39.81 79.3 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.342 -0.849 . . . . 0.0 109.685 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 23.2 tp -94.67 18.75 11.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.885 -0.51 . . . . 0.0 110.187 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.64 118.47 23.87 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 122.658 1.218 . . . . 0.0 112.317 -178.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.8 26.35 8.04 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.3 p -109.96 20.94 17.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.529 -0.983 . . . . 0.0 110.621 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.6 m -66.39 144.59 56.44 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.337 -0.852 . . . . 0.0 109.342 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.75 -18.2 57.05 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.63 110.37 2.3 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.05 161.45 45.98 Favored 'Trans proline' 0 C--N 1.318 -1.048 0 O-C-N 123.168 1.088 . . . . 0.0 111.054 -179.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.1 mp -113.99 119.71 38.15 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.0 tp -96.51 167.34 11.21 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.426 0.631 . . . . 0.0 110.833 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.2 178.49 1.05 Allowed Pre-proline 0 N--CA 1.493 1.701 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.05 -25.37 31.95 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 O-C-N 123.258 1.136 . . . . 0.0 110.339 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 83.0 p -79.81 -28.58 40.19 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.514 -0.741 . . . . 0.0 110.088 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 115.55 35.01 1.34 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.453 ' CD2' ' CG2' ' A' ' 95' ' ' THR . 22.9 m170 -122.79 153.64 39.27 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.579 -0.953 . . . . 0.0 110.365 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -88.69 144.24 26.4 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.474 -0.766 . . . . 0.0 110.199 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.1 m -119.14 -24.26 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.476 -0.765 . . . . 0.0 111.067 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -179.73 -173.08 44.48 Favored Glycine 0 N--CA 1.498 2.829 0 C-N-CA 119.672 -1.252 . . . . 0.0 110.385 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 64.0 mt -130.0 159.23 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.562 -0.964 . . . . 0.0 110.033 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -73.77 144.62 45.56 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.55 -0.718 . . . . 0.0 110.248 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 -129.57 -75.97 0.55 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.534 -0.729 . . . . 0.0 110.264 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -120.41 142.35 49.29 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.154 -0.966 . . . . 0.0 110.992 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.52 127.33 39.12 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.4 t -97.83 119.5 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.532 -0.73 . . . . 0.0 111.388 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 28.3 p -141.15 151.74 44.13 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.547 -0.721 . . . . 0.0 110.43 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 6.8 p -93.7 -48.19 6.44 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.511 -0.743 . . . . 0.0 109.511 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 50.9 mtt85 -119.97 36.7 4.44 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 91.9 -11.57 71.79 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 63.7 t -89.16 123.66 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.178 -1.189 . . . . 0.0 109.284 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.18 114.3 23.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.526 -0.734 . . . . 0.0 110.838 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -107.14 -29.99 9.04 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.809 -0.557 . . . . 0.0 109.64 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -118.47 168.25 10.83 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.668 -0.645 . . . . 0.0 109.863 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.9 m -143.21 131.83 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.498 -0.751 . . . . 0.0 110.702 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.31 127.84 47.74 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.613 -0.679 . . . . 0.0 110.231 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -136.27 162.15 33.79 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.556 -0.715 . . . . 0.0 110.588 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 90.1 t -104.86 144.71 29.28 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.463 -0.773 . . . . 0.0 110.033 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.41 168.15 24.31 Favored 'Trans proline' 0 N--CA 1.486 1.056 0 O-C-N 123.318 1.168 . . . . 0.0 110.709 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 61.4 t -92.44 -45.99 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.606 -0.684 . . . . 0.0 110.467 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -54.61 -28.88 49.67 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.693 -0.629 . . . . 0.0 111.304 -178.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.3 m -61.62 -25.91 67.65 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.378 -0.826 . . . . 0.0 110.279 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 32.8 mmt -70.12 -27.35 64.5 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.498 -0.751 . . . . 0.0 110.641 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -56.83 -41.78 78.46 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.448 -0.783 . . . . 0.0 111.059 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 7.4 t -73.9 -22.09 59.83 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.405 -0.809 . . . . 0.0 110.556 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 76.7 m -72.0 -39.94 68.87 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.384 -0.823 . . . . 0.0 110.344 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 26.2 ttp -59.98 -44.57 94.41 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.681 -0.637 . . . . 0.0 110.5 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 26.4 mmt85 -60.01 -39.9 87.39 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.531 -0.731 . . . . 0.0 110.389 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.789 0 O-C-N 121.571 -0.706 . . . . 0.0 110.09 179.976 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 . . . . . 0 N--CA 1.501 2.095 0 CA-C-O 120.478 0.18 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.3 m -118.92 162.22 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.182 -0.949 . . . . 0.0 110.947 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 22.2 mm100 -136.87 125.2 23.28 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.5 m -73.76 116.42 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.585 -0.697 . . . . 0.0 109.957 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.413 HG22 ' CE2' ' A' ' 43' ' ' PHE . 35.9 m -110.75 152.03 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.431 -0.793 . . . . 0.0 110.157 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.1 m -115.7 125.38 52.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.581 -0.699 . . . . 0.0 110.366 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.05 -169.61 1.89 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.655 -0.653 . . . . 0.0 109.538 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.16 -51.23 70.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.583 -0.698 . . . . 0.0 110.894 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.9 t -127.65 0.99 6.15 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.404 -0.81 . . . . 0.0 111.817 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -140.38 171.26 14.4 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.004 -1.06 . . . . 0.0 110.499 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 77.7 p -145.4 131.38 19.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.618 -0.676 . . . . 0.0 110.157 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.413 ' CE2' HG22 ' A' ' 36' ' ' VAL . 13.5 p90 -130.21 -175.33 3.6 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.521 -0.737 . . . . 0.0 110.314 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.44 159.0 25.09 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.455 -0.778 . . . . 0.0 110.633 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -126.67 119.56 27.31 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.606 -0.683 . . . . 0.0 110.015 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.0 p -101.8 144.08 30.91 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.496 -0.752 . . . . 0.0 110.504 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 26.3 p -100.68 110.23 22.33 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.683 0.754 . . . . 0.0 110.238 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.3 t -130.25 130.02 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.174 -0.954 . . . . 0.0 110.258 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 52.73 39.43 28.57 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.4 -0.813 . . . . 0.0 111.116 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.46 24.76 71.06 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.5 t -135.15 122.73 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.368 -1.077 . . . . 0.0 109.666 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 54.5 m -79.27 111.38 15.46 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.56 -0.712 . . . . 0.0 109.782 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.417 ' CE3' HD21 ' A' ' 82' ' ' LEU . 52.3 m95 -98.6 136.82 38.14 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.528 -0.733 . . . . 0.0 110.82 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.456 ' CG2' ' CH2' ' A' ' 85' ' ' TRP . 6.4 t -137.36 179.99 6.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.711 -0.618 . . . . 0.0 109.547 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.468 ' CG1' ' CE1' ' A' ' 57' ' ' HIS . 79.0 t -85.47 141.7 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.471 -0.768 . . . . 0.0 109.379 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.455 ' CE2' ' CG2' ' A' ' 78' ' ' VAL . 15.7 t80 -85.37 -43.68 13.45 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.487 -0.758 . . . . 0.0 111.381 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.468 ' CE1' ' CG1' ' A' ' 55' ' ' VAL . 2.0 p-80 -60.68 -17.43 47.74 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.308 -0.87 . . . . 0.0 111.419 -178.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -103.1 -62.11 0.7 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -96.1 -23.57 16.71 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.534 -0.98 . . . . 0.0 111.011 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.657 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -179.495 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.9 t . . . . . 0 N--CA 1.496 1.865 0 CA-C-O 121.138 0.494 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -94.41 131.15 40.38 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.528 -0.732 . . . . 0.0 110.147 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.453 ' CE ' ' CE2' ' A' ' 75' ' ' TYR . 25.4 ptm -116.54 -37.47 3.7 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.555 -0.716 . . . . 0.0 110.165 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.453 ' CE2' ' CE ' ' A' ' 74' ' ' MET . 28.1 m-85 -111.26 119.6 39.44 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.537 -0.727 . . . . 0.0 109.373 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 88.0 m -148.6 126.06 11.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.48 -0.763 . . . . 0.0 110.277 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -165.43 123.48 1.59 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.384 -0.823 . . . . 0.0 111.307 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.455 ' CG2' ' CE2' ' A' ' 56' ' ' TYR . 79.7 t -72.36 -34.08 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.478 -0.764 . . . . 0.0 109.376 178.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -55.7 -44.77 77.72 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.567 -0.708 . . . . 0.0 110.536 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -90.76 -10.38 43.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.606 -0.684 . . . . 0.0 110.522 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.5 t0 53.13 40.36 31.11 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.185 -0.947 . . . . 0.0 110.654 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.417 HD21 ' CE3' ' A' ' 53' ' ' TRP . 1.0 OUTLIER -141.62 160.46 40.11 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.884 0.849 . . . . 0.0 111.098 -179.412 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.4 ' O ' ' CE3' ' A' ' 53' ' ' TRP . 1.6 t -138.35 164.43 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.406 ' O ' ' CD1' ' A' ' 85' ' ' TRP . . . -153.68 155.15 25.98 Favored Glycine 0 N--CA 1.496 2.653 0 C-N-CA 119.497 -1.335 . . . . 0.0 110.87 -179.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.456 ' CH2' ' CG2' ' A' ' 54' ' ' THR . 4.5 m-90 -141.93 163.57 32.52 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.877 -0.778 . . . . 0.0 109.332 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -73.41 122.98 22.97 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.479 -0.763 . . . . 0.0 109.881 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.11 154.88 40.53 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.57 -0.706 . . . . 0.0 110.26 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.98 146.14 41.19 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.467 1.246 . . . . 0.0 110.359 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -76.86 160.08 34.21 Favored 'Trans proline' 0 C--N 1.317 -1.1 0 O-C-N 123.394 1.208 . . . . 0.0 110.43 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.25 28.7 12.6 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -133.34 160.4 37.45 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.519 -0.989 . . . . 0.0 110.165 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -79.57 153.44 29.48 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.551 -0.718 . . . . 0.0 110.229 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.8 m -134.68 158.64 43.56 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.533 -0.729 . . . . 0.0 110.305 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.1 mt -108.24 158.33 17.55 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.584 -0.698 . . . . 0.0 110.408 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.408 ' OG1' ' CE1' ' A' ' 149' ' ' HIS . 71.4 p -137.24 163.21 50.65 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.577 -0.702 . . . . 0.0 110.075 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.79 142.62 43.8 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 O-C-N 123.42 1.221 . . . . 0.0 110.151 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 30.5 p -84.77 157.88 20.88 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.563 -0.711 . . . . 0.0 110.828 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.5 t -115.94 65.4 0.7 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.2 p -144.65 -8.71 0.64 Allowed 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 120.044 -0.663 . . . . 0.0 112.582 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 50.5 26.75 10.5 Favored Glycine 0 N--CA 1.502 3.049 0 O-C-N 120.778 -1.201 . . . . 0.0 110.609 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 41.6 m -59.11 127.63 33.14 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.446 -1.031 . . . . 0.0 110.645 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 73.6 m -68.74 -40.14 80.0 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.701 -0.624 . . . . 0.0 109.992 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -61.66 139.4 58.29 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.57 -0.706 . . . . 0.0 110.02 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.5 mt -141.73 169.23 17.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.649 -0.657 . . . . 0.0 110.513 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -138.36 128.89 26.31 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.681 -0.637 . . . . 0.0 109.598 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.4 tt -114.88 123.56 49.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.437 -0.789 . . . . 0.0 110.476 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 63.0 t -94.96 109.9 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.674 -0.641 . . . . 0.0 109.511 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 75.1 p -81.91 174.89 10.86 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.465 -0.772 . . . . 0.0 110.478 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -59.92 -22.78 62.88 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.64 -0.663 . . . . 0.0 110.585 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.81 20.18 5.86 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.359 -0.838 . . . . 0.0 110.675 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 52.76 41.6 31.63 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.198 -0.938 . . . . 0.0 110.881 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -100.22 121.2 41.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.567 -0.708 . . . . 0.0 110.091 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.9 p -57.07 -79.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.598 -0.689 . . . . 0.0 111.018 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.427 ' CD1' ' N ' ' A' ' 114' ' ' ILE . 2.4 mp 54.69 99.31 0.04 OUTLIER Pre-proline 0 N--CA 1.504 2.238 0 O-C-N 120.726 -1.234 . . . . 0.0 110.227 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.23 164.37 35.24 Favored 'Trans proline' 0 C--N 1.318 -1.051 0 O-C-N 123.226 1.119 . . . . 0.0 110.6 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.2 t -139.9 139.8 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.556 -0.715 . . . . 0.0 109.719 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -93.5 149.9 20.87 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.584 -0.697 . . . . 0.0 110.102 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -76.76 147.51 37.24 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.59 -0.694 . . . . 0.0 110.615 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -154.63 52.34 0.64 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.616 -0.678 . . . . 0.0 109.785 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 126.13 171.25 13.12 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -60.1 -58.89 6.59 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.454 -1.027 . . . . 0.0 109.974 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 57.8 m -112.85 23.74 13.12 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.558 -0.713 . . . . 0.0 109.871 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.41 136.71 53.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.548 -0.72 . . . . 0.0 109.832 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -142.41 169.44 25.46 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 20.2 p -111.06 160.57 16.73 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.571 -0.958 . . . . 0.0 109.989 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 18.1 tp -106.36 126.35 52.13 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.666 -0.646 . . . . 0.0 110.509 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.32 -56.49 14.13 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.596 -0.69 . . . . 0.0 109.999 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 33.1 t -94.81 112.8 59.44 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.61 -0.681 . . . . 0.0 109.872 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.66 107.25 2.27 Favored 'Trans proline' 0 C--N 1.32 -0.969 0 O-C-N 123.25 1.132 . . . . 0.0 110.799 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 -118.84 158.02 48.75 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.63 -0.668 . . . . 0.0 109.9 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.78 150.41 55.93 Favored 'Trans proline' 0 C--N 1.315 -1.204 0 O-C-N 123.433 1.228 . . . . 0.0 110.678 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 55.6 t -53.65 -29.42 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 O-C-N 121.433 -0.792 . . . . 0.0 109.807 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.1 t -59.83 -44.87 93.84 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.656 -0.653 . . . . 0.0 111.213 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -67.32 -38.7 85.34 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.32 -0.862 . . . . 0.0 109.815 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 31.2 tp -92.32 18.43 8.35 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.78 -0.575 . . . . 0.0 110.19 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.7 tttm -82.88 118.28 23.33 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 122.57 1.176 . . . . 0.0 112.145 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.71 26.6 7.95 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 17.0 m -105.35 19.93 19.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.642 -0.916 . . . . 0.0 110.141 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.4 m -74.17 130.27 39.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.31 -0.869 . . . . 0.0 109.466 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 113.59 -26.51 10.1 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.57 131.01 51.84 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -85.7 157.84 10.49 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.117 1.062 . . . . 0.0 111.106 -178.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.8 mp -107.71 123.5 48.62 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.1 tp -105.34 162.33 13.53 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.519 -0.738 . . . . 0.0 110.823 -179.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . 0.446 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 28.9 p -115.39 168.45 8.27 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 37.7 Cg_endo -62.47 -15.36 44.98 Favored 'Trans proline' 0 N--CA 1.488 1.18 0 O-C-N 122.935 0.966 . . . . 0.0 111.103 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.2 t -69.94 -35.09 74.25 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.268 -0.895 . . . . 0.0 109.783 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 117.81 15.36 6.31 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.408 ' CE1' ' OG1' ' A' ' 95' ' ' THR . 0.9 OUTLIER -126.89 170.22 12.46 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.199 -1.177 . . . . 0.0 110.095 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -94.5 153.26 18.0 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.437 -0.789 . . . . 0.0 110.816 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.6 m -119.19 -26.02 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.627 -0.671 . . . . 0.0 110.907 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -172.59 -162.07 24.11 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 11.5 tt -140.11 152.87 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.668 -0.901 . . . . 0.0 109.992 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -64.73 144.35 57.3 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.251 -0.906 . . . . 0.0 111.345 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 9.6 ttt180 -129.81 -70.73 0.63 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.272 0.558 . . . . 0.0 109.851 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -128.82 147.9 50.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.288 -0.882 . . . . 0.0 111.047 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.38 158.46 15.72 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.5 t -123.29 112.38 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.175 -0.953 . . . . 0.0 111.058 -178.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 28.1 p -138.18 144.03 40.52 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.785 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 24.2 m -82.81 -43.98 16.04 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.525 -0.734 . . . . 0.0 109.847 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.52 34.99 4.27 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.638 -0.664 . . . . 0.0 109.974 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 99.55 -11.88 61.36 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 63.3 t -92.81 123.47 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.19 -1.183 . . . . 0.0 109.136 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.12 114.22 23.54 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.559 -0.713 . . . . 0.0 111.071 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -104.15 -25.09 13.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.738 -0.601 . . . . 0.0 110.028 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -131.88 168.38 17.96 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.484 -0.76 . . . . 0.0 109.833 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 36.0 m -141.61 137.36 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.406 -0.809 . . . . 0.0 110.844 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -112.82 140.35 47.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.55 -0.719 . . . . 0.0 110.27 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -140.6 159.97 41.05 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.625 -0.672 . . . . 0.0 110.556 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 59.0 t -93.93 135.89 24.35 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.606 -0.684 . . . . 0.0 109.868 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.54 158.45 43.91 Favored 'Trans proline' 0 C--N 1.318 -1.053 0 O-C-N 123.225 1.119 . . . . 0.0 110.515 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 79.1 t -77.33 -28.73 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.636 -0.665 . . . . 0.0 110.015 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -59.86 -37.48 79.44 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.435 -0.791 . . . . 0.0 110.429 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 39.0 m -61.65 -35.49 78.07 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.652 -0.655 . . . . 0.0 110.397 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 48.7 mtm -59.99 -30.03 68.85 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.6 -0.688 . . . . 0.0 110.424 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.03 -43.55 95.25 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.502 -0.749 . . . . 0.0 110.302 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 85.1 m -63.55 -40.14 96.21 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.577 -0.702 . . . . 0.0 109.969 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 89.1 m -65.4 -37.21 86.29 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.657 -0.652 . . . . 0.0 110.023 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 19.4 ttt -60.05 -37.96 81.38 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.666 -0.646 . . . . 0.0 110.251 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 39.4 mtp-105 -60.03 -39.74 86.93 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.532 -0.73 . . . . 0.0 110.21 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.749 0 O-C-N 121.509 -0.744 . . . . 0.0 110.18 -179.955 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.4 m . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.034 0.445 . . . . 0.0 110.265 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 135.62 175.01 13.61 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -119.96 132.66 55.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.536 -0.979 . . . . 0.0 110.055 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -159.97 169.99 22.28 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.576 -0.703 . . . . 0.0 110.32 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 45.6 pttt -138.56 165.42 26.91 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.641 -0.662 . . . . 0.0 110.274 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 53.69 49.87 18.34 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.377 -0.827 . . . . 0.0 110.804 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -90.28 6.83 41.27 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.56 -0.713 . . . . 0.0 111.23 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.2 t -59.92 -49.97 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.259 -0.9 . . . . 0.0 110.014 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -139.89 135.63 33.09 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.497 -0.752 . . . . 0.0 110.226 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.44 -15.42 7.03 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.7 mp0 -87.38 2.14 51.26 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.179 -1.189 . . . . 0.0 111.298 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 63.3 t -109.97 126.36 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.072 -1.018 . . . . 0.0 109.922 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -115.29 159.47 20.98 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.638 -0.663 . . . . 0.0 110.074 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 62.7 t -116.63 129.94 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.521 -0.737 . . . . 0.0 110.034 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.5 p -136.99 139.57 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.543 -0.723 . . . . 0.0 110.003 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 72.7 m -125.12 141.2 52.25 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.5 -0.75 . . . . 0.0 110.381 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.68 -177.36 3.34 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.565 -0.709 . . . . 0.0 109.988 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.49 -40.01 77.29 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.594 -0.691 . . . . 0.0 111.238 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 67.2 p -114.42 -19.43 11.21 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.341 -0.849 . . . . 0.0 111.569 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -133.58 160.05 38.63 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.205 -0.935 . . . . 0.0 110.725 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.0 t -138.75 119.87 14.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.592 -0.693 . . . . 0.0 110.12 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -135.19 177.11 8.07 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.617 -0.677 . . . . 0.0 109.843 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 65.6 mt -118.68 160.34 22.01 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.486 -0.759 . . . . 0.0 110.36 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -124.99 153.32 42.97 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.544 -0.722 . . . . 0.0 110.043 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.8 m -125.87 140.09 52.94 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.522 -0.736 . . . . 0.0 110.402 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.9 t -88.84 108.76 19.7 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.504 -0.747 . . . . 0.0 110.094 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.6 t -123.0 129.99 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.648 -0.657 . . . . 0.0 109.921 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 54.47 38.71 30.18 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.568 -0.707 . . . . 0.0 110.899 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.87 17.49 69.5 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 65.6 t -130.22 129.94 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.227 -1.161 . . . . 0.0 109.734 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 69.2 m -79.24 130.15 35.18 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.498 -0.751 . . . . 0.0 109.898 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.452 ' CG ' ' CE ' ' A' ' 175' ' ' MET . 97.0 m95 -120.01 137.16 54.25 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.473 -0.767 . . . . 0.0 110.729 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.7 t -137.35 172.39 13.05 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.465 ' CG1' ' CE1' ' A' ' 57' ' ' HIS . 59.4 t -80.81 142.3 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.367 -0.833 . . . . 0.0 109.691 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.445 ' CE2' ' CG2' ' A' ' 78' ' ' VAL . 33.0 t80 -79.28 -39.89 31.85 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.448 -0.783 . . . . 0.0 111.636 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.465 ' CE1' ' CG1' ' A' ' 55' ' ' VAL . 1.4 p-80 -59.72 -23.27 63.03 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.968 -1.083 . . . . 0.0 110.396 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -74.15 -70.64 1.22 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.831 -1.708 . . . . 0.0 108.831 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.52 -52.9 62.57 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.543 -0.975 . . . . 0.0 109.743 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.6 -170.81 54.44 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 59.2 m -60.03 -39.94 87.61 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.659 -0.906 . . . . 0.0 110.38 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -58.58 139.18 56.22 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.486 -0.759 . . . . 0.0 110.153 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.4 t -81.64 169.07 17.47 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.61 -0.681 . . . . 0.0 110.595 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 pp -140.28 140.68 35.76 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.654 -0.653 . . . . 0.0 110.12 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.35 134.06 36.6 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.509 -0.744 . . . . 0.0 110.554 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -103.62 -157.63 24.63 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -71.21 -41.33 2.62 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 123.415 1.218 . . . . 0.0 110.591 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -69.9 -31.4 69.17 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.527 -0.733 . . . . 0.0 110.208 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 144.12 -151.27 23.28 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.12 136.34 24.44 Favored 'Trans proline' 0 C--N 1.316 -1.154 0 O-C-N 123.353 1.186 . . . . 0.0 110.315 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.417 HD12 ' CE2' ' A' ' 85' ' ' TRP . 8.5 pt -132.53 161.26 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.617 -0.677 . . . . 0.0 110.537 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 35.9 m -112.39 132.29 55.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.624 -0.672 . . . . 0.0 109.708 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -60.24 125.1 22.39 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.509 -0.744 . . . . 0.0 110.509 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 91.0 mmm -92.12 -32.55 15.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.716 -0.615 . . . . 0.0 109.91 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -118.95 129.73 55.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.589 -0.694 . . . . 0.0 109.864 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.6 p -141.02 144.95 35.3 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.525 -0.734 . . . . 0.0 110.307 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -168.17 100.93 0.44 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.71 -0.619 . . . . 0.0 109.999 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.445 ' CG2' ' CE2' ' A' ' 56' ' ' TYR . 53.3 t -70.06 -42.84 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.427 -0.796 . . . . 0.0 109.88 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -60.06 -44.2 94.87 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.507 -0.746 . . . . 0.0 110.162 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -90.04 -8.56 51.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.811 -0.556 . . . . 0.0 110.563 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.4 t0 54.16 39.72 30.98 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.998 -1.064 . . . . 0.0 109.684 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.5 tp -119.93 129.98 54.58 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.329 0.585 . . . . 0.0 110.472 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.6 p -153.13 150.29 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.684 -0.635 . . . . 0.0 109.414 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -176.06 -174.31 42.48 Favored Glycine 0 N--CA 1.496 2.65 0 C-N-CA 119.622 -1.275 . . . . 0.0 110.571 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.417 ' CE2' HD12 ' A' ' 71' ' ' ILE . 14.1 m-90 -128.81 160.03 33.86 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.78 -0.836 . . . . 0.0 109.766 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -93.0 131.14 38.26 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.539 -0.726 . . . . 0.0 110.097 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -111.94 159.6 32.96 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.461 -0.774 . . . . 0.0 110.462 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.2 159.16 50.45 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 O-C-N 123.428 1.225 . . . . 0.0 110.608 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.17 160.2 39.85 Favored 'Trans proline' 0 C--N 1.317 -1.101 0 O-C-N 123.506 1.266 . . . . 0.0 110.412 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 115.35 -4.49 21.74 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -109.93 142.4 41.34 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.092 -1.24 . . . . 0.0 110.172 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -60.34 140.06 57.32 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.507 -0.745 . . . . 0.0 110.124 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 52.6 m -133.1 156.87 46.63 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.593 -0.692 . . . . 0.0 110.402 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.9 mt -91.36 162.84 14.43 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.67 -0.644 . . . . 0.0 110.234 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.2 p -120.89 165.07 19.89 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.63 -0.669 . . . . 0.0 110.075 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.34 164.81 32.69 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 O-C-N 123.369 1.194 . . . . 0.0 110.207 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 7.2 t -75.2 128.1 34.7 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.564 -0.71 . . . . 0.0 110.405 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 46.7 p -129.58 45.48 2.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.743 -0.598 . . . . 0.0 109.682 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.3 p -145.07 12.22 1.39 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.642 -0.661 . . . . 0.0 111.474 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.23 50.97 49.89 Favored Glycine 0 N--CA 1.499 2.866 0 O-C-N 121.062 -1.024 . . . . 0.0 110.546 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.1 m -92.7 107.09 18.95 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.42 -1.047 . . . . 0.0 110.4 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.1 p -70.11 -39.95 75.19 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.487 -0.758 . . . . 0.0 109.931 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -75.11 123.09 24.59 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.653 -0.654 . . . . 0.0 109.857 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 73.9 mt -129.99 150.61 51.19 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.607 -0.683 . . . . 0.0 110.2 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -106.84 133.5 51.4 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.49 -0.757 . . . . 0.0 109.874 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.1 tt -98.85 130.3 45.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.536 -0.728 . . . . 0.0 110.467 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.1 t -87.79 123.41 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.691 -0.63 . . . . 0.0 109.707 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.2 m -100.77 166.82 10.67 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.56 -0.713 . . . . 0.0 110.386 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 78.3 ttt-85 -61.89 -27.33 68.73 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.59 -0.694 . . . . 0.0 110.332 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -93.41 25.48 3.4 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.527 -0.733 . . . . 0.0 110.781 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.98 40.03 31.85 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.284 -0.885 . . . . 0.0 110.843 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -93.27 156.24 16.94 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.644 -0.66 . . . . 0.0 109.78 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.9 p -129.93 133.44 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.47 -0.769 . . . . 0.0 110.404 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.4 tp -146.13 134.89 11.04 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.702 -0.624 . . . . 0.0 109.892 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -76.15 139.2 21.16 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 O-C-N 123.155 1.082 . . . . 0.0 110.291 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.3 t -129.92 130.1 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.646 -0.659 . . . . 0.0 109.713 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.62 146.44 34.13 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.567 -0.708 . . . . 0.0 109.853 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -85.71 118.33 25.14 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.567 -0.708 . . . . 0.0 110.202 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.03 21.22 11.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.759 -0.588 . . . . 0.0 110.34 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 162.64 168.15 24.13 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -70.03 -40.02 75.43 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.566 -0.961 . . . . 0.0 110.693 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 89.8 p -114.68 -7.15 12.73 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.496 -0.753 . . . . 0.0 111.474 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -128.55 143.97 51.06 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.09 -1.006 . . . . 0.0 110.484 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -141.49 -174.64 14.5 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 80.1 p -120.53 144.17 48.2 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.558 -0.966 . . . . 0.0 110.165 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 57.8 tp -91.17 131.3 36.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.636 -0.665 . . . . 0.0 109.899 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.7 tp -60.09 -48.66 80.81 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.585 -0.697 . . . . 0.0 110.511 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 45.7 t -106.5 119.54 51.4 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.504 -0.747 . . . . 0.0 110.18 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.87 121.39 7.58 Favored 'Trans proline' 0 N--CA 1.486 1.034 0 O-C-N 123.191 1.101 . . . . 0.0 110.581 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 12.7 mtp85 -132.83 162.81 55.19 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.52 -0.737 . . . . 0.0 110.323 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.6 150.9 63.82 Favored 'Trans proline' 0 N--CA 1.486 1.076 0 O-C-N 123.482 1.254 . . . . 0.0 110.87 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.9 t -56.64 -35.29 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.484 -0.76 . . . . 0.0 110.252 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 34.8 t -58.44 -39.97 81.27 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.47 -0.768 . . . . 0.0 110.745 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -63.28 -39.94 95.98 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.489 -0.757 . . . . 0.0 109.592 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 21.3 tp -94.57 16.2 16.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.781 -0.574 . . . . 0.0 110.593 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 44.7 tttt -89.77 141.06 28.98 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.026 -1.046 . . . . 0.0 110.761 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 87.78 20.51 50.39 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 10.5 p -119.58 15.21 12.81 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.37 -1.077 . . . . 0.0 110.933 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 48.9 m -58.75 144.7 42.94 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.183 -0.948 . . . . 0.0 110.043 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 94.72 -16.67 60.72 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -58.5 111.1 2.94 Favored Glycine 0 N--CA 1.498 2.796 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -73.11 139.63 29.91 Favored 'Trans proline' 0 C--N 1.317 -1.082 0 O-C-N 123.197 1.104 . . . . 0.0 111.099 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.4 mp -93.37 123.71 36.85 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.3 mp -118.38 127.27 53.53 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.184 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.645 ' SG ' 'ZN ' ' A' ' 202' ' ' ' ZN' . 27.2 p -66.61 163.97 36.9 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.7 -0.625 . . . . 0.0 109.384 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.54 -19.86 68.48 Favored 'Trans proline' 0 C--N 1.315 -1.204 0 O-C-N 123.231 1.121 . . . . 0.0 110.952 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.4 m -69.97 -27.33 64.64 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.295 -0.878 . . . . 0.0 110.031 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 121.64 -21.46 8.01 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.466 -1.053 . . . . 0.0 110.466 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -77.56 162.96 26.7 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.253 -1.145 . . . . 0.0 110.632 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -105.09 145.03 31.08 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.65 -0.656 . . . . 0.0 110.353 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 12.5 p -101.51 -29.18 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.552 -0.718 . . . . 0.0 110.809 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 169.26 -161.55 35.12 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 55.9 mt -128.87 155.86 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.566 -0.961 . . . . 0.0 110.255 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -66.61 139.94 57.91 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.621 -0.674 . . . . 0.0 110.076 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -122.59 -67.48 0.95 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.564 -0.71 . . . . 0.0 110.803 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -135.27 150.3 50.01 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.453 -0.779 . . . . 0.0 110.78 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.41 151.74 19.15 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 48.6 t -120.01 119.97 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.507 -0.745 . . . . 0.0 110.432 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.4 p -141.6 157.81 44.63 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.543 -0.723 . . . . 0.0 110.415 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 18.4 p -94.58 -46.07 7.12 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.442 -0.786 . . . . 0.0 109.97 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 55.1 mmm-85 -130.37 35.96 4.01 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.644 -0.66 . . . . 0.0 109.552 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 101.2 -10.11 58.09 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 57.3 t -96.55 123.47 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.184 -1.186 . . . . 0.0 109.473 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.66 117.3 26.38 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.496 -0.753 . . . . 0.0 110.776 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -109.46 -29.96 8.18 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.654 -0.654 . . . . 0.0 109.674 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -126.5 157.22 39.26 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.633 -0.667 . . . . 0.0 109.618 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 31.0 m -129.42 142.89 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.485 -0.759 . . . . 0.0 110.675 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -117.23 132.51 56.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.653 -0.654 . . . . 0.0 110.421 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -141.31 159.57 41.93 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.595 -0.69 . . . . 0.0 110.135 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 12.9 p -93.15 142.85 25.85 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.505 -0.747 . . . . 0.0 110.446 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -77.34 162.43 31.02 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 O-C-N 123.288 1.151 . . . . 0.0 110.559 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 67.1 t -69.91 -32.38 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.627 -0.671 . . . . 0.0 109.881 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -60.03 -40.01 87.87 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.493 -0.755 . . . . 0.0 110.355 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 48.0 t -62.54 -39.95 95.26 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.633 -0.667 . . . . 0.0 109.924 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.452 ' CE ' ' CG ' ' A' ' 53' ' ' TRP . 95.0 mtp -60.25 -40.0 88.77 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.674 -0.641 . . . . 0.0 110.177 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.7 -40.02 90.65 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.706 -0.621 . . . . 0.0 110.322 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 94.0 m -60.11 -40.11 88.55 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.645 -0.659 . . . . 0.0 110.156 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 88.2 m -68.17 -44.21 76.47 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.583 -0.698 . . . . 0.0 110.047 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 33.9 ttp -60.63 -40.99 93.97 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.556 -0.715 . . . . 0.0 110.387 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -61.15 -40.02 92.28 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.609 -0.682 . . . . 0.0 110.178 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.767 0 O-C-N 121.608 -0.682 . . . . 0.0 110.268 179.982 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' 4P2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . 0.645 'ZN ' ' SG ' ' A' ' 145' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.4 t . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.158 0.504 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.37 29.51 11.27 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -118.47 29.21 7.88 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.487 -1.008 . . . . 0.0 110.174 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -96.76 166.04 11.84 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.61 -0.681 . . . . 0.0 110.463 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -136.23 35.45 2.77 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.623 -0.673 . . . . 0.0 110.293 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -92.08 -49.26 6.3 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.546 -0.721 . . . . 0.0 110.519 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -157.6 55.06 0.49 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.506 -0.746 . . . . 0.0 110.456 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.1 m -62.16 132.63 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.483 -0.76 . . . . 0.0 110.349 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 62.31 129.99 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.567 -0.708 . . . . 0.0 110.542 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -126.22 -164.4 11.76 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 66.64 -65.12 0.21 Allowed 'General case' 0 N--CA 1.509 2.495 0 O-C-N 121.694 -0.886 . . . . 0.0 110.746 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.9 t -103.1 133.33 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.385 -0.822 . . . . 0.0 109.892 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -102.86 162.31 13.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.625 -0.672 . . . . 0.0 109.85 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.8 m -117.98 136.59 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.506 -0.746 . . . . 0.0 110.196 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.8 m -144.21 149.27 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.493 -0.755 . . . . 0.0 110.35 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.8 m -119.68 137.8 53.68 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.602 -0.687 . . . . 0.0 110.179 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -99.57 -178.43 3.89 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.577 -0.702 . . . . 0.0 110.001 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.0 -45.99 90.93 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.841 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.4 p -118.67 -27.99 5.74 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.403 -0.811 . . . . 0.0 110.995 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -114.27 173.95 6.19 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.324 -0.86 . . . . 0.0 110.526 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 40.3 t -151.87 121.33 6.85 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.55 -0.719 . . . . 0.0 109.975 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 34.7 p90 -132.65 -179.51 5.5 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.625 -0.672 . . . . 0.0 110.064 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 34.7 mt -118.76 178.62 4.41 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.518 -0.739 . . . . 0.0 109.605 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.0 161.37 38.3 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.474 -0.767 . . . . 0.0 110.98 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.8 p -125.34 144.09 50.66 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.721 -0.612 . . . . 0.0 109.689 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 27.0 p -91.9 111.79 23.46 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 121.72 0.772 . . . . 0.0 111.403 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.9 t -130.73 123.44 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.213 -0.929 . . . . 0.0 110.683 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 51.4 34.88 12.79 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.53 -0.731 . . . . 0.0 112.412 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.43 -17.04 41.19 Favored Glycine 0 N--CA 1.499 2.872 0 C-N-CA 120.1 -1.047 . . . . 0.0 111.659 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 62.8 t -105.82 128.63 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.091 -1.241 . . . . 0.0 110.477 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 78.5 m -84.32 107.78 16.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.634 -0.666 . . . . 0.0 109.532 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -91.85 137.48 32.33 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.509 -0.744 . . . . 0.0 110.59 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.402 ' OG1' ' CZ3' ' A' ' 85' ' ' TRP . 77.8 p -136.51 179.74 6.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.773 -0.58 . . . . 0.0 109.611 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.481 ' CG1' ' CE1' ' A' ' 57' ' ' HIS . 94.5 t -80.93 141.93 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.105 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.445 ' CE2' ' CG2' ' A' ' 78' ' ' VAL . 16.7 t80 -84.98 -43.44 13.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.445 -0.784 . . . . 0.0 111.248 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.481 ' CE1' ' CG1' ' A' ' 55' ' ' VAL . 2.2 p-80 -58.76 -25.02 62.63 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.24 -0.912 . . . . 0.0 110.941 -177.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -81.47 -48.67 5.82 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.52 -63.09 1.47 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.6 -0.941 . . . . 0.0 110.167 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.81 174.1 30.65 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.2 t -69.63 -18.63 63.61 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.574 -0.956 . . . . 0.0 110.757 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.7 ttmm -57.31 143.17 40.76 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.278 -0.889 . . . . 0.0 110.569 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.4 m -67.08 156.43 36.12 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.585 -0.697 . . . . 0.0 110.282 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.445 ' CD1' ' CZ2' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -98.0 143.13 28.89 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.592 -0.693 . . . . 0.0 110.276 -179.895 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -108.86 131.84 54.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.618 -0.676 . . . . 0.0 110.069 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -123.06 160.97 17.51 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.22 -46.87 1.91 Allowed 'Trans proline' 0 C--N 1.317 -1.104 0 O-C-N 123.421 1.222 . . . . 0.0 110.675 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -70.09 -31.08 68.48 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.577 -0.702 . . . . 0.0 109.933 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 169.73 153.67 8.72 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.6 172.25 15.53 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 123.36 1.189 . . . . 0.0 110.362 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.4 mp -126.13 160.34 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.623 -0.673 . . . . 0.0 109.999 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.3 t -101.08 150.24 23.12 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.609 -0.682 . . . . 0.0 110.433 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.5 tm0? -80.08 128.27 33.29 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.611 -0.681 . . . . 0.0 110.163 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.1 tpp -106.36 -51.13 3.01 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.604 -0.685 . . . . 0.0 110.129 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -120.73 138.63 53.89 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.48 -0.763 . . . . 0.0 110.184 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 98.8 m -152.23 127.86 10.11 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.602 -0.686 . . . . 0.0 110.175 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -168.45 120.23 0.81 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.416 -0.802 . . . . 0.0 110.833 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.445 ' CG2' ' CE2' ' A' ' 56' ' ' TYR . 91.8 t -72.25 -39.54 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.35 -0.844 . . . . 0.0 109.735 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.66 -43.01 75.87 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.363 -0.836 . . . . 0.0 109.803 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -92.02 -14.24 29.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.793 -0.567 . . . . 0.0 109.885 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.417 ' HB3' ' NE ' ' A' ' 155' ' ' ARG . 49.5 t0 54.27 35.38 22.61 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.064 -1.022 . . . . 0.0 110.099 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.5 mt -123.2 149.73 44.29 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.836 0.827 . . . . 0.0 111.934 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.42 HG11 ' CZ2' ' A' ' 85' ' ' TRP . 2.7 t -146.64 150.95 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 178.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -138.35 148.19 19.74 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 118.992 -1.575 . . . . 0.0 111.636 -178.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.445 ' CZ2' ' CD1' ' A' ' 64' ' ' LEU . 5.1 m-90 -138.25 124.6 20.54 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.18 135.33 57.69 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.34 -0.85 . . . . 0.0 110.721 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.418 ' CB ' ' CD ' ' A' ' 92' ' ' ARG . . . -101.41 175.44 2.33 Favored Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 121.417 -0.802 . . . . 0.0 109.849 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.45 147.96 59.55 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 O-C-N 123.465 1.245 . . . . 0.0 109.548 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.72 134.46 24.01 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 O-C-N 123.369 1.194 . . . . 0.0 110.245 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 131.59 -25.98 3.93 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -150.81 71.64 1.04 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.102 -1.234 . . . . 0.0 111.761 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.418 ' CD ' ' CB ' ' A' ' 87' ' ' ALA . 12.2 mmt180 -154.25 91.78 1.46 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.061 -1.024 . . . . 0.0 110.498 178.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.4 p -177.04 104.98 0.06 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.211 -0.93 . . . . 0.0 111.166 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 25.6 tp -117.34 131.91 56.7 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.583 -0.698 . . . . 0.0 109.406 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.3 t -76.45 137.28 67.66 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.363 -0.836 . . . . 0.0 110.74 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.04 166.21 28.35 Favored 'Trans proline' 0 N--CA 1.484 0.924 0 O-C-N 123.252 1.132 . . . . 0.0 110.204 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 47.4 t -82.41 132.85 35.21 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.505 -0.747 . . . . 0.0 110.24 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.0 t -135.98 48.87 2.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.655 -0.653 . . . . 0.0 109.797 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.4 p -144.92 0.17 0.94 Allowed 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 120.114 -0.634 . . . . 0.0 112.384 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 52.26 89.27 0.01 OUTLIER Glycine 0 N--CA 1.5 2.924 0 O-C-N 120.811 -1.181 . . . . 0.0 110.553 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.0 m -129.67 128.85 43.42 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.418 -1.048 . . . . 0.0 110.251 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.2 m -69.01 -40.02 78.94 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.577 -0.702 . . . . 0.0 110.122 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.69 142.13 58.24 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.557 -0.714 . . . . 0.0 109.965 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 57.2 mt -143.61 158.27 43.79 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.575 -0.703 . . . . 0.0 110.314 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -126.35 109.86 12.72 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.518 -0.739 . . . . 0.0 109.91 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.4 tt -93.42 133.58 36.55 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.528 -0.733 . . . . 0.0 110.462 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.1 t -98.28 130.03 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.668 -0.645 . . . . 0.0 109.762 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 68.1 p -99.04 169.91 9.08 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.527 -0.733 . . . . 0.0 110.456 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -63.34 -18.96 64.2 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.691 -0.631 . . . . 0.0 110.877 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -94.16 25.95 3.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.31 -0.869 . . . . 0.0 110.661 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 53.42 39.93 30.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.346 -0.846 . . . . 0.0 110.887 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -104.68 167.06 9.97 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.531 -0.731 . . . . 0.0 110.078 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.5 p -133.65 131.53 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.589 -0.694 . . . . 0.0 110.435 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 87.0 mt -133.08 127.99 20.34 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.587 -0.696 . . . . 0.0 109.872 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -74.94 125.05 9.1 Favored 'Trans proline' 0 N--CA 1.485 0.982 0 O-C-N 123.096 1.051 . . . . 0.0 110.392 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.9 t -120.25 129.53 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.567 -0.708 . . . . 0.0 109.771 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -87.53 136.8 32.8 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.506 -0.746 . . . . 0.0 110.197 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -74.39 140.11 44.52 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.657 -0.652 . . . . 0.0 110.293 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.35 9.5 3.45 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.589 -0.694 . . . . 0.0 111.0 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -169.34 -172.44 36.01 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -70.28 -39.97 74.6 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.615 -0.932 . . . . 0.0 110.68 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 96.1 p -130.77 9.81 5.02 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.462 -0.774 . . . . 0.0 111.393 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -123.66 148.72 46.23 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.1 -1.0 . . . . 0.0 110.17 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.15 167.82 24.8 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 19.2 p -107.76 158.9 16.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.52 -0.988 . . . . 0.0 110.21 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 40.1 tp -117.59 133.21 56.2 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.577 -0.702 . . . . 0.0 110.272 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.3 mp -69.28 -43.15 74.44 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.588 -0.695 . . . . 0.0 110.401 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 58.4 p -97.42 111.97 59.84 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.474 -0.766 . . . . 0.0 110.168 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -80.91 106.87 1.85 Allowed 'Trans proline' 0 C--N 1.319 -1.006 0 O-C-N 123.197 1.104 . . . . 0.0 110.607 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.72 157.89 38.12 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.554 -0.716 . . . . 0.0 109.851 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.12 150.25 65.75 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.421 1.221 . . . . 0.0 110.867 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 55.3 t -54.13 -30.47 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.422 -0.799 . . . . 0.0 109.723 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 46.0 t -59.91 -41.94 92.79 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.559 -0.713 . . . . 0.0 110.869 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -67.97 -39.97 83.26 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.482 -0.761 . . . . 0.0 109.719 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 33.0 tp -92.18 15.49 13.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.803 -0.56 . . . . 0.0 110.286 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.464 ' HA ' H481 ' A' ' 201' ' ' 4P2 . 3.8 tttt -79.65 114.65 18.74 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 122.537 1.161 . . . . 0.0 112.128 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.93 37.18 3.72 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 61.3 m -119.26 19.13 12.89 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.705 -0.88 . . . . 0.0 110.454 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 66.3 m -70.54 136.28 49.2 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.25 -0.906 . . . . 0.0 109.169 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 109.77 -25.35 17.2 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.181 -1.567 . . . . 0.0 109.181 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.0 112.63 3.69 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.24 148.8 44.5 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 123.25 1.131 . . . . 0.0 111.105 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 67.7 mt -98.22 116.3 30.15 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.6 mp -103.37 127.71 50.66 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.509 -0.744 . . . . 0.0 111.015 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.716 ' SG ' 'ZN ' ' A' ' 202' ' ' ' ZN' . 27.8 p -67.92 164.85 37.09 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.755 -0.59 . . . . 0.0 109.505 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.401 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 39.4 Cg_endo -65.09 -14.22 44.05 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 O-C-N 123.148 1.078 . . . . 0.0 111.104 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.9 t -69.61 -40.02 76.88 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.147 -0.97 . . . . 0.0 109.768 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 122.17 37.82 0.63 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 28.2 m170 -133.6 -173.28 3.18 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.388 -1.066 . . . . 0.0 110.276 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -104.55 145.39 30.37 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.552 -0.718 . . . . 0.0 110.158 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 50.7 t -115.75 -62.42 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.518 -0.739 . . . . 0.0 110.454 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -157.08 -158.59 8.99 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.2 mt -133.48 146.68 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.565 -0.962 . . . . 0.0 110.003 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -61.97 140.01 58.36 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.369 -0.832 . . . . 0.0 110.479 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.417 ' NE ' ' HB3' ' A' ' 81' ' ' ASP . 0.6 OUTLIER -117.23 -76.13 0.57 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.57 0.7 . . . . 0.0 110.496 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -125.3 147.18 49.22 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 121.377 -0.827 . . . . 0.0 111.234 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.06 124.83 37.31 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.45 ' CG2' H131 ' A' ' 201' ' ' 4P2 . 2.3 t -95.75 119.03 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.585 -0.697 . . . . 0.0 111.026 -177.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.4 p -139.89 146.09 38.84 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.593 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 59.6 m -78.87 -49.92 12.09 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.6 -0.687 . . . . 0.0 109.855 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 5.9 ptt180 -129.11 36.17 4.21 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.614 -0.679 . . . . 0.0 109.915 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 102.7 -11.93 56.39 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 62.9 t -92.33 121.2 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.249 -1.148 . . . . 0.0 109.009 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.17 116.92 25.58 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.5 -0.75 . . . . 0.0 111.218 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -110.98 -29.93 7.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.833 -0.542 . . . . 0.0 109.729 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -120.05 168.27 11.35 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.638 -0.664 . . . . 0.0 109.958 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 35.1 m -146.05 137.2 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.581 -0.699 . . . . 0.0 110.64 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -113.05 143.63 43.99 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.598 -0.689 . . . . 0.0 110.404 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -149.49 162.2 40.61 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.631 -0.668 . . . . 0.0 110.879 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 5.6 m -101.62 143.73 27.19 Favored Pre-proline 0 N--CA 1.505 2.317 0 O-C-N 121.448 -0.783 . . . . 0.0 110.135 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -79.69 168.18 19.8 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 O-C-N 123.339 1.179 . . . . 0.0 110.171 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 64.9 t -66.29 -24.0 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.521 -0.737 . . . . 0.0 110.118 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -54.32 -38.89 66.5 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.429 -0.795 . . . . 0.0 111.449 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 82.2 p -61.66 -24.55 66.81 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.671 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 65.5 mtt -70.11 -28.72 65.62 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.431 -0.793 . . . . 0.0 110.898 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -59.28 -50.85 72.41 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.409 -0.807 . . . . 0.0 110.596 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 22.1 m -72.03 -29.03 63.76 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.49 -0.756 . . . . 0.0 110.334 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 32.5 m -68.0 -32.29 72.58 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.561 -0.712 . . . . 0.0 110.507 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 34.5 mmm -59.45 -52.04 67.31 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.484 -0.76 . . . . 0.0 110.485 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 56.4 mtp85 -63.87 -40.02 95.57 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.528 -0.732 . . . . 0.0 110.115 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.804 0 O-C-N 121.564 -0.71 . . . . 0.0 110.261 -179.891 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' 4P2 . . . . . 0.464 H481 ' HA ' ' A' ' 136' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . 0.716 'ZN ' ' SG ' ' A' ' 145' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.2 m . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.125 0.488 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.47 -154.05 30.45 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 50.7 ttp180 59.35 116.74 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.7 -0.882 . . . . 0.0 110.928 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 53.59 50.1 17.97 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.296 -0.877 . . . . 0.0 110.822 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.7 tttm -114.34 121.87 44.96 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.577 -0.702 . . . . 0.0 110.186 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 51.22 -150.15 0.29 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.396 -0.815 . . . . 0.0 110.796 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 66.28 -73.3 0.07 Allowed 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.155 -0.965 . . . . 0.0 110.749 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.3 t 53.81 69.96 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 O-C-N 121.556 -0.715 . . . . 0.0 110.278 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -65.83 148.91 51.02 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.618 -0.676 . . . . 0.0 110.401 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -147.64 -97.8 0.2 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -169.3 -39.65 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.51 -0.994 . . . . 0.0 110.286 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.4 t -109.83 143.96 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.569 -0.707 . . . . 0.0 109.808 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -116.63 148.25 41.15 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.63 -0.669 . . . . 0.0 110.308 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.8 t -78.43 124.62 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.701 -0.624 . . . . 0.0 109.699 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.6 m -134.12 138.65 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.428 -0.795 . . . . 0.0 110.545 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 74.7 m -119.38 154.56 33.44 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.593 -0.692 . . . . 0.0 110.294 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.5 m -110.99 179.6 4.0 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.63 -0.669 . . . . 0.0 110.121 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.43 -40.03 95.25 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.807 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.7 t -119.78 -28.3 5.26 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.401 -0.812 . . . . 0.0 111.204 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -118.2 178.08 4.56 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.405 -0.81 . . . . 0.0 110.213 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 83.0 p -153.71 117.03 4.59 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.541 -0.724 . . . . 0.0 110.565 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 6.7 p90 -130.4 -176.91 4.11 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.635 -0.665 . . . . 0.0 110.007 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.9 mt -117.3 162.93 17.11 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.433 -0.792 . . . . 0.0 110.545 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -129.53 150.23 50.95 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.668 -0.645 . . . . 0.0 110.504 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 78.9 p -125.69 144.17 50.72 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.602 -0.687 . . . . 0.0 110.077 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 25.9 p -100.51 106.71 18.27 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.741 0.781 . . . . 0.0 110.575 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.8 t -130.64 139.58 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.285 -0.884 . . . . 0.0 110.341 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 10.8 m120 55.02 40.48 32.02 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.57 -0.706 . . . . 0.0 111.529 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 63.78 14.46 55.33 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.43 138.55 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.148 -1.207 . . . . 0.0 109.354 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 43.6 t -87.67 126.28 34.87 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.56 -0.713 . . . . 0.0 110.464 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -111.08 136.78 49.6 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.649 -0.657 . . . . 0.0 110.13 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.9 t -137.37 -179.81 5.95 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.658 -0.651 . . . . 0.0 110.005 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.465 ' CG1' ' CE1' ' A' ' 57' ' ' HIS . 63.6 t -84.13 141.47 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.491 -0.756 . . . . 0.0 109.124 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.456 ' CZ ' HG21 ' A' ' 78' ' ' VAL . 14.4 t80 -85.73 -43.7 13.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.514 -0.741 . . . . 0.0 111.405 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.465 ' CE1' ' CG1' ' A' ' 55' ' ' VAL . 2.6 p-80 -60.53 -22.28 63.44 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.219 -0.926 . . . . 0.0 110.821 -178.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -93.57 -32.64 7.56 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.03 -63.43 1.35 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.55 -0.97 . . . . 0.0 110.274 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.61 -176.5 28.75 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.5 t -70.12 -24.03 63.13 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.635 -0.92 . . . . 0.0 110.546 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.67 139.77 56.96 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.435 -0.79 . . . . 0.0 110.382 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.8 p -76.94 140.22 40.41 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.62 -0.675 . . . . 0.0 110.251 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.43 HD11 ' CH2' ' A' ' 85' ' ' TRP . 2.8 pp -143.13 122.42 13.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.498 -0.751 . . . . 0.0 110.588 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -147.71 108.15 4.12 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.242 -0.911 . . . . 0.0 110.371 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 57.86 163.04 0.05 OUTLIER Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.43 -8.6 22.91 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 O-C-N 123.024 1.013 . . . . 0.0 110.897 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.35 -31.84 67.82 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.297 -0.877 . . . . 0.0 111.255 -179.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 159.54 161.61 11.41 Favored Glycine 0 N--CA 1.496 2.644 0 C-N-CA 119.802 -1.189 . . . . 0.0 110.486 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -75.84 161.64 36.02 Favored 'Trans proline' 0 N--CA 1.488 1.196 0 O-C-N 123.611 1.322 . . . . 0.0 111.059 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.409 HD12 HG23 ' A' ' 71' ' ' ILE . 47.3 pt -128.79 -153.47 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.625 -0.672 . . . . 0.0 109.611 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 58.6 m -94.44 137.31 33.73 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.302 -0.874 . . . . 0.0 109.762 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -86.04 143.53 28.05 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.49 -0.756 . . . . 0.0 110.783 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.9 tpp -119.13 -48.07 2.45 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.549 -0.719 . . . . 0.0 110.742 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -109.62 128.46 55.24 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.355 -0.84 . . . . 0.0 110.32 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 54.7 m -152.19 123.38 7.64 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.527 -0.733 . . . . 0.0 110.147 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -166.09 124.24 1.49 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.405 -0.81 . . . . 0.0 111.32 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.456 HG21 ' CZ ' ' A' ' 56' ' ' TYR . 94.3 t -72.59 -30.83 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.528 -0.732 . . . . 0.0 109.797 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -57.83 -40.05 79.12 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.47 -0.768 . . . . 0.0 110.433 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -97.63 -7.75 30.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.57 -0.706 . . . . 0.0 111.009 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.414 ' HB2' ' H23' ' A' ' 201' ' ' 4P2 . 37.8 t0 53.35 39.66 30.17 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.958 -1.088 . . . . 0.0 110.569 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.14 155.54 46.93 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.574 -0.851 . . . . 0.0 111.314 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.1 t -145.55 156.74 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -155.46 172.59 33.63 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 119.292 -1.432 . . . . 0.0 111.064 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.43 ' CH2' HD11 ' A' ' 64' ' ' LEU . 10.6 m-90 -147.0 159.65 43.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.89 -0.77 . . . . 0.0 109.602 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -70.83 115.64 10.21 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.517 -0.739 . . . . 0.0 110.31 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.57 157.93 54.87 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.623 -0.673 . . . . 0.0 110.056 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.43 155.91 59.21 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.422 1.222 . . . . 0.0 110.396 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -75.22 155.12 41.91 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.466 1.245 . . . . 0.0 110.341 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 97.26 -25.93 25.0 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.5 154.31 24.92 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.396 -1.061 . . . . 0.0 110.063 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.94 135.15 44.99 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.599 -0.688 . . . . 0.0 110.025 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 58.4 m -105.39 130.02 53.58 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.526 -0.734 . . . . 0.0 110.098 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.0 tp -83.81 148.94 26.72 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.552 -0.717 . . . . 0.0 110.435 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.407 HG21 ' CE1' ' A' ' 149' ' ' HIS . 6.5 t -113.22 150.98 43.87 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.606 -0.684 . . . . 0.0 110.196 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.72 154.96 63.63 Favored 'Trans proline' 0 N--CA 1.486 1.071 0 O-C-N 123.319 1.168 . . . . 0.0 110.702 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 1.056 ' SG ' 'ZN ' ' A' ' 202' ' ' ' ZN' . 7.1 t -87.17 144.64 26.75 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.567 -0.708 . . . . 0.0 110.572 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.4 p -136.52 67.97 1.44 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.61 -0.681 . . . . 0.0 110.441 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 28.0 p -145.15 7.16 1.17 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.385 -0.822 . . . . 0.0 111.97 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 52.02 47.84 53.48 Favored Glycine 0 N--CA 1.499 2.881 0 O-C-N 120.863 -1.148 . . . . 0.0 110.384 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.3 t -100.02 120.49 39.9 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.502 -0.999 . . . . 0.0 110.512 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.8 p -69.94 -39.78 75.89 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.629 -0.669 . . . . 0.0 109.918 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -61.58 134.92 57.39 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.561 -0.712 . . . . 0.0 109.881 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 49.9 mt -142.68 160.15 40.86 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.564 -0.71 . . . . 0.0 110.707 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -120.02 134.04 55.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.674 -0.641 . . . . 0.0 109.347 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.6 tt -127.33 112.58 15.21 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.489 -0.757 . . . . 0.0 110.711 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 55.9 t -69.14 147.52 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.49 -0.756 . . . . 0.0 108.993 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.8 p -108.29 -168.25 1.34 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.51 -0.744 . . . . 0.0 110.614 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.73 -22.97 23.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.585 -0.697 . . . . 0.0 110.348 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -102.56 29.23 5.4 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.452 -0.78 . . . . 0.0 110.167 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 56.89 55.65 6.01 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.471 -0.768 . . . . 0.0 111.019 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.95 144.06 49.09 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.476 -0.765 . . . . 0.0 109.297 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.5 t -115.28 128.29 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.364 -0.835 . . . . 0.0 110.461 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.404 HG22 HD11 ' A' ' 114' ' ' ILE . 14.8 tt -137.96 134.91 18.24 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.62 -0.675 . . . . 0.0 109.864 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -74.82 145.52 32.29 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 O-C-N 123.208 1.109 . . . . 0.0 110.569 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.4 t -129.95 129.94 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.576 -0.702 . . . . 0.0 109.684 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -85.26 155.84 21.21 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.587 -0.696 . . . . 0.0 110.171 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 71.6 ttt-85 -99.1 134.55 41.79 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.596 -0.69 . . . . 0.0 110.146 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -118.75 -12.58 9.65 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.598 -0.689 . . . . 0.0 110.936 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -169.05 -160.57 17.48 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -70.04 -37.46 75.58 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.549 -0.971 . . . . 0.0 110.874 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.0 m -134.27 28.02 3.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.356 -0.84 . . . . 0.0 111.07 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 17.4 tpt85 -141.93 139.87 32.64 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.298 -0.876 . . . . 0.0 110.242 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -147.89 161.71 28.61 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 71.4 p -98.78 163.89 12.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.43 -1.041 . . . . 0.0 110.147 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.9 tp -112.63 127.62 56.15 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.649 -0.657 . . . . 0.0 110.151 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.4 mp -64.19 -39.8 94.74 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.587 -0.696 . . . . 0.0 110.408 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.0 t -100.36 106.65 43.71 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.528 -0.732 . . . . 0.0 110.298 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -76.1 113.22 3.66 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 O-C-N 123.275 1.145 . . . . 0.0 110.515 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -119.33 155.19 54.04 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.585 -0.697 . . . . 0.0 109.917 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -70.0 150.42 66.76 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 O-C-N 123.432 1.227 . . . . 0.0 110.013 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 90.8 t -53.39 -34.39 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.252 -0.905 . . . . 0.0 110.002 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 34.5 t -57.87 -49.11 77.83 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.587 -0.695 . . . . 0.0 110.632 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -66.55 -38.37 86.98 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.501 -0.749 . . . . 0.0 109.548 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.405 ' O ' ' HG ' ' A' ' 135' ' ' LEU . 40.7 tp -90.23 16.85 7.86 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.826 -0.547 . . . . 0.0 110.335 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.46 ' HA ' H481 ' A' ' 201' ' ' 4P2 . 5.5 tttt -83.28 121.09 26.66 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.757 -1.214 . . . . 0.0 112.126 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.424 ' HA2' H551 ' A' ' 201' ' ' 4P2 . . . 101.49 33.26 4.87 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.6 m -106.05 13.02 29.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.653 -0.91 . . . . 0.0 110.525 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 18.1 m -62.36 143.58 56.81 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.272 -0.893 . . . . 0.0 109.849 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 83.0 7.06 87.7 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.82 133.54 51.27 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -80.17 117.15 3.46 Favored 'Trans proline' 0 N--CA 1.485 0.999 0 O-C-N 123.24 1.126 . . . . 0.0 110.934 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.8 mp -98.75 104.04 16.04 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.407 -0.808 . . . . 0.0 109.018 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.8 mp -117.74 147.43 42.97 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.498 -0.751 . . . . 0.0 111.065 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.27 178.68 1.69 Allowed Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.746 -0.596 . . . . 0.0 109.455 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -70.01 -24.96 27.92 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.215 1.113 . . . . 0.0 110.416 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 36.4 t -69.9 -40.1 75.81 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.48 -0.762 . . . . 0.0 110.035 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 124.15 45.86 0.27 Allowed Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.407 ' CE1' HG21 ' A' ' 95' ' ' THR . 62.5 m-70 -135.96 134.79 39.01 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.574 -0.956 . . . . 0.0 110.318 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -77.86 140.87 39.38 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.495 -0.753 . . . . 0.0 110.353 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 34.7 m -117.37 -25.82 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.629 -0.67 . . . . 0.0 110.66 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -174.37 -173.77 40.63 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 64.4 mt -129.33 158.17 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.659 -0.907 . . . . 0.0 109.672 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -69.81 148.01 49.66 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.385 -0.822 . . . . 0.0 110.167 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.41 -80.35 0.5 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.781 -0.575 . . . . 0.0 110.354 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -120.66 143.58 48.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.178 -0.951 . . . . 0.0 111.269 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.85 129.82 40.12 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.43 ' CG2' H131 ' A' ' 201' ' ' 4P2 . 2.3 t -100.32 121.27 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.491 -0.756 . . . . 0.0 111.33 -177.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.8 p -140.66 149.54 42.39 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.535 -0.728 . . . . 0.0 110.517 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 37.7 m -88.79 -49.62 6.72 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.553 -0.717 . . . . 0.0 109.804 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -119.71 32.03 6.26 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.52 0.676 . . . . 0.0 109.229 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 97.65 -11.56 64.7 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.244 -1.543 . . . . 0.0 109.244 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 62.4 t -88.11 122.42 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.279 -1.13 . . . . 0.0 109.061 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.55 113.14 22.97 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.528 -0.733 . . . . 0.0 110.784 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -109.14 -30.21 8.15 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.651 -0.656 . . . . 0.0 109.687 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -116.52 168.32 10.27 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.664 -0.648 . . . . 0.0 109.681 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 35.9 m -148.74 135.82 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.541 -0.724 . . . . 0.0 111.085 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.65 134.46 51.93 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.664 -0.647 . . . . 0.0 109.883 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -131.56 159.94 36.74 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.42 -0.8 . . . . 0.0 110.389 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 60.4 t -92.54 140.53 24.02 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.57 -0.707 . . . . 0.0 110.212 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -75.15 162.51 36.64 Favored 'Trans proline' 0 C--N 1.32 -0.966 0 O-C-N 123.131 1.069 . . . . 0.0 110.337 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 87.6 t -79.75 -30.59 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.554 -0.716 . . . . 0.0 110.257 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -60.02 -39.24 85.19 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.493 -0.754 . . . . 0.0 110.605 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 58.4 p -61.7 -25.7 67.58 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.516 -0.74 . . . . 0.0 110.871 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 53.9 mtm -66.99 -36.98 83.38 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.422 -0.799 . . . . 0.0 110.542 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -60.05 -40.01 87.92 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.472 -0.767 . . . . 0.0 110.404 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 31.3 m -61.05 -31.69 71.34 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.536 -0.727 . . . . 0.0 110.511 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 93.2 m -59.95 -40.04 87.64 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.515 -0.74 . . . . 0.0 110.465 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 1.4 ttp -58.82 -36.29 74.26 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.44 -0.787 . . . . 0.0 110.437 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 5.5 ttp180 -59.91 -39.98 87.26 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.433 -0.792 . . . . 0.0 110.212 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.833 0 O-C-N 121.603 -0.686 . . . . 0.0 110.301 179.944 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' 4P2 . . . . . 0.46 H481 ' HA ' ' A' ' 136' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . 1.056 'ZN ' ' SG ' ' A' ' 97' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.2 p . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.193 0.521 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.37 143.23 3.64 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -124.42 178.4 5.41 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.563 -0.963 . . . . 0.0 110.053 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -59.99 139.94 57.09 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.55 -0.719 . . . . 0.0 110.279 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -139.01 34.44 2.14 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.562 -0.711 . . . . 0.0 110.317 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -83.17 126.69 32.89 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.49 -0.756 . . . . 0.0 110.288 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -81.33 159.98 24.27 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.616 -0.678 . . . . 0.0 110.438 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.7 t -111.37 130.03 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.513 -0.742 . . . . 0.0 109.982 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -147.84 162.21 39.72 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.559 -0.713 . . . . 0.0 110.384 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -136.16 170.32 23.29 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -113.1 63.27 0.64 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.611 -0.934 . . . . 0.0 110.458 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 63.3 t -114.63 125.5 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.54 -0.725 . . . . 0.0 109.78 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -103.01 138.98 39.17 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.576 -0.702 . . . . 0.0 110.065 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.5 m -88.38 132.14 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.554 -0.716 . . . . 0.0 110.476 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.1 m -130.6 159.97 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.467 -0.77 . . . . 0.0 110.346 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 64.7 m -135.9 153.49 51.44 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.566 -0.709 . . . . 0.0 110.383 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.424 ' OG1' ' CE1' ' A' ' 43' ' ' PHE . 1.6 m -117.8 179.82 3.96 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.618 -0.677 . . . . 0.0 109.982 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.14 -23.73 62.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.671 -0.643 . . . . 0.0 111.288 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.6 p -119.8 -28.29 5.25 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.32 -0.863 . . . . 0.0 111.418 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -142.34 164.72 29.37 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.371 -0.831 . . . . 0.0 110.639 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.4 t -130.94 124.62 31.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.497 -0.752 . . . . 0.0 110.14 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.424 ' CE1' ' OG1' ' A' ' 38' ' ' THR . 4.5 p90 -133.9 178.32 7.04 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.604 -0.685 . . . . 0.0 110.121 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 25.0 mt -121.16 167.55 12.54 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.574 -0.704 . . . . 0.0 110.026 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.79 152.14 46.33 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.592 -0.692 . . . . 0.0 110.06 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.6 m -119.98 135.42 54.92 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.477 -0.765 . . . . 0.0 110.286 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 45.8 t -93.27 103.82 16.04 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.562 -0.711 . . . . 0.0 110.482 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.0 p -130.44 139.64 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.546 -0.721 . . . . 0.0 110.4 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 57.67 36.17 26.39 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.412 -0.805 . . . . 0.0 110.836 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 63.26 15.76 57.1 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.425 HG12 ' CE2' ' A' ' 53' ' ' TRP . 56.5 t -139.47 119.3 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.266 -1.137 . . . . 0.0 109.657 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 28.5 p -79.98 137.95 36.95 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.587 -0.696 . . . . 0.0 110.41 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.425 ' CE2' HG12 ' A' ' 51' ' ' VAL . 87.0 m95 -125.92 137.43 53.71 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.554 -0.716 . . . . 0.0 110.404 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.9 t -137.16 179.6 6.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.705 -0.622 . . . . 0.0 109.804 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.465 ' CG1' ' CE1' ' A' ' 57' ' ' HIS . 0.5 OUTLIER -81.32 142.65 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.175 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.458 ' CE2' HG23 ' A' ' 78' ' ' VAL . 27.5 t80 -81.02 -42.54 20.95 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.458 -0.776 . . . . 0.0 111.199 -178.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.465 ' CE1' ' CG1' ' A' ' 55' ' ' VAL . 2.2 p-80 -53.72 -21.2 6.64 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.444 -0.785 . . . . 0.0 111.956 -177.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -119.62 -23.63 3.06 Favored Glycine 0 N--CA 1.496 2.677 0 C-N-CA 119.984 -1.103 . . . . 0.0 111.064 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -113.77 -27.14 7.9 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.235 -1.156 . . . . 0.0 111.083 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.434 ' HA3' ' CD1' ' A' ' 56' ' ' TYR . . . -60.0 -18.91 49.29 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 79.8 p -57.62 -22.71 46.99 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.276 -1.132 . . . . 0.0 111.02 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.1 tttm -152.2 161.48 42.55 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.368 -0.832 . . . . 0.0 110.702 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 76.0 p -66.0 149.15 50.69 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.569 -0.707 . . . . 0.0 109.624 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.432 ' HB2' ' CH2' ' A' ' 85' ' ' TRP . 19.4 mt -142.38 144.71 33.27 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.446 -0.784 . . . . 0.0 111.736 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -147.58 164.02 34.76 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.33 -131.91 0.01 OUTLIER Glycine 0 N--CA 1.497 2.74 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.46 -9.45 25.36 Favored 'Trans proline' 0 N--CA 1.491 1.352 0 O-C-N 122.708 0.846 . . . . 0.0 111.988 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.4 tptt -69.79 -31.06 68.77 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.175 -0.953 . . . . 0.0 110.722 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.58 -172.03 19.84 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.65 127.78 15.17 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 123.203 1.107 . . . . 0.0 110.377 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 68.9 mt -129.7 -109.72 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.518 -0.739 . . . . 0.0 110.215 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 40.7 p -120.27 150.57 40.49 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.583 -1.323 . . . . 0.0 111.082 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -87.96 130.95 34.78 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.729 -0.607 . . . . 0.0 109.721 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.7 tpt -119.07 -44.54 2.6 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.464 -0.773 . . . . 0.0 110.976 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -109.81 124.78 51.89 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.271 -0.893 . . . . 0.0 110.083 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 56.9 m -152.17 135.47 15.91 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.609 -0.682 . . . . 0.0 110.355 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -167.28 111.85 0.71 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.504 -0.748 . . . . 0.0 110.813 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.463 ' HA ' ' H24' ' A' ' 201' ' ' 4P2 . 75.7 t -72.25 -29.21 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.297 -0.877 . . . . 0.0 109.322 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -60.0 -42.89 95.23 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.47 -0.769 . . . . 0.0 110.012 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -99.81 -6.99 26.0 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.514 -0.741 . . . . 0.0 110.652 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.409 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 30.4 t0 56.39 33.98 23.38 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.065 -1.022 . . . . 0.0 110.635 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.42 HD22 ' CZ3' ' A' ' 53' ' ' TRP . 7.8 tt -119.83 145.27 46.79 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.249 -0.907 . . . . 0.0 111.751 -178.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.452 ' CG1' ' CZ2' ' A' ' 85' ' ' TRP . 3.1 t -143.97 159.25 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -168.96 164.37 38.02 Favored Glycine 0 N--CA 1.496 2.645 0 C-N-CA 119.46 -1.352 . . . . 0.0 110.624 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.452 ' CZ2' ' CG1' ' A' ' 83' ' ' VAL . 20.3 m-90 -146.75 160.02 42.76 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.793 -0.828 . . . . 0.0 109.47 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -62.21 138.0 58.34 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.575 -0.703 . . . . 0.0 110.08 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.97 148.5 57.06 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.478 -0.764 . . . . 0.0 110.284 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.9 160.0 48.94 Favored 'Trans proline' 0 C--N 1.317 -1.105 0 O-C-N 123.484 1.254 . . . . 0.0 110.359 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -73.31 126.83 11.36 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 123.377 1.199 . . . . 0.0 110.447 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 108.81 30.09 3.86 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -117.42 159.49 22.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.513 -0.993 . . . . 0.0 110.089 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.2 mtp180 -96.29 163.87 12.9 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.53 -0.731 . . . . 0.0 110.378 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 80.7 p -130.89 145.17 51.93 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.678 -0.639 . . . . 0.0 109.901 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -105.09 139.92 39.04 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.588 -0.695 . . . . 0.0 110.303 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 60.3 m -78.07 143.8 66.37 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.747 -0.596 . . . . 0.0 109.917 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.64 161.98 43.82 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 O-C-N 123.302 1.159 . . . . 0.0 110.319 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 45.6 t -72.9 128.01 34.24 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.539 -0.725 . . . . 0.0 110.483 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.3 m -135.73 55.79 1.85 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.662 -0.649 . . . . 0.0 109.531 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.4 p -145.01 4.66 1.1 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.58 -0.7 . . . . 0.0 112.175 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 51.25 91.06 0.01 OUTLIER Glycine 0 N--CA 1.502 3.064 0 O-C-N 120.905 -1.122 . . . . 0.0 110.495 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 98.1 p -139.35 148.06 42.38 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.436 -1.038 . . . . 0.0 110.362 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 63.7 m -95.03 -34.54 12.3 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.64 -0.662 . . . . 0.0 110.176 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -66.37 129.67 40.6 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.642 -0.661 . . . . 0.0 109.915 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 97.3 mt -136.28 156.53 48.53 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.625 -0.672 . . . . 0.0 110.546 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -126.34 108.72 11.5 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.667 -0.646 . . . . 0.0 109.519 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.42 HD12 ' CD1' ' A' ' 154' ' ' PHE . 9.7 tt -89.46 129.39 35.96 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.638 -0.663 . . . . 0.0 110.763 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.5 t -84.91 131.07 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.64 -0.663 . . . . 0.0 109.575 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.7 p -97.82 -175.51 3.19 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.48 -0.762 . . . . 0.0 110.509 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.2 ttt-85 -69.95 -27.01 64.4 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.706 -0.621 . . . . 0.0 110.846 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.437 ' CD2' ' HB2' ' A' ' 112' ' ' ASP . 41.0 p-80 -106.22 29.96 6.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.43 -0.794 . . . . 0.0 110.859 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 55.36 56.84 5.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.532 -0.73 . . . . 0.0 111.884 178.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.437 ' HB2' ' CD2' ' A' ' 110' ' ' HIS . 0.4 OUTLIER -110.8 137.34 48.57 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.401 -0.812 . . . . 0.0 109.88 179.118 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.4 p -84.46 128.34 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.65 -0.656 . . . . 0.0 110.275 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 48.6 mm -129.98 105.86 16.67 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.523 -0.735 . . . . 0.0 110.11 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -70.66 119.84 6.64 Favored 'Trans proline' 0 N--CA 1.487 1.088 0 O-C-N 123.241 1.127 . . . . 0.0 110.242 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.5 t -120.36 129.39 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.515 -0.741 . . . . 0.0 110.137 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -83.03 135.86 34.7 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.566 -0.709 . . . . 0.0 109.809 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -82.24 134.23 35.28 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.522 -0.736 . . . . 0.0 110.431 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.7 18.63 3.3 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.587 -0.696 . . . . 0.0 110.581 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -173.33 178.94 45.05 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -69.55 -39.97 77.11 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.572 -0.958 . . . . 0.0 110.331 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.6 m -130.33 25.06 5.17 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.527 -0.733 . . . . 0.0 110.781 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -142.58 141.83 32.06 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.423 -0.798 . . . . 0.0 110.306 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -142.11 157.16 26.37 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 50.6 p -91.57 157.63 16.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.664 -0.904 . . . . 0.0 110.125 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 39.9 tp -105.77 127.17 52.92 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.531 -0.731 . . . . 0.0 110.36 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.3 mp -68.6 -42.26 78.44 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.581 -0.7 . . . . 0.0 110.092 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.6 p -102.2 99.79 13.58 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.694 -0.629 . . . . 0.0 109.701 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.15 106.94 2.01 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.388 1.204 . . . . 0.0 110.945 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -114.47 161.5 28.25 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.713 -0.617 . . . . 0.0 109.748 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.18 150.59 59.86 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 O-C-N 123.391 1.206 . . . . 0.0 110.354 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 64.6 t -51.03 -29.93 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 O-C-N 121.399 -0.813 . . . . 0.0 109.828 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.2 t -61.43 -40.04 92.97 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.728 -0.608 . . . . 0.0 110.956 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -66.87 -39.97 87.71 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.326 -0.859 . . . . 0.0 109.538 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.426 HD23 ' CZ ' ' A' ' 154' ' ' PHE . 17.6 tp -95.4 18.9 11.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.922 -0.486 . . . . 0.0 110.135 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.459 ' HA ' H481 ' A' ' 201' ' ' 4P2 . 16.1 tttt -81.14 116.67 21.16 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 122.541 1.162 . . . . 0.0 112.412 -178.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.416 ' HA2' H551 ' A' ' 201' ' ' 4P2 . . . 100.72 22.12 11.54 Favored Glycine 0 N--CA 1.492 2.401 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.269 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.3 m -103.44 20.85 17.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.47 -1.018 . . . . 0.0 110.53 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.2 m -69.96 136.12 50.17 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.28 -0.888 . . . . 0.0 109.541 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 100.06 -23.29 36.56 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.79 110.02 1.93 Allowed Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -72.43 138.7 30.35 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 O-C-N 123.18 1.095 . . . . 0.0 111.073 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.1 mp -86.35 146.3 26.53 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.1 mp -126.9 162.23 26.41 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.403 -0.81 . . . . 0.0 111.23 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 27.1 p -119.1 165.12 17.93 Favored Pre-proline 0 N--CA 1.494 1.774 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.42 -12.23 33.98 Favored 'Trans proline' 0 N--CA 1.489 1.218 0 O-C-N 123.082 1.043 . . . . 0.0 111.853 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.7 p -72.01 -32.66 67.39 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.117 -0.989 . . . . 0.0 109.943 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 116.15 20.74 5.1 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -131.34 152.95 50.11 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.325 -1.103 . . . . 0.0 110.377 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.77 152.36 31.5 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.542 -0.724 . . . . 0.0 109.931 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 34.0 m -112.55 -28.81 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.5 -0.75 . . . . 0.0 110.989 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 177.7 -161.01 27.96 Favored Glycine 0 N--CA 1.498 2.776 0 C-N-CA 119.753 -1.213 . . . . 0.0 110.339 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.5 mt -134.42 151.76 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.652 -0.911 . . . . 0.0 110.162 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.426 ' CZ ' HD23 ' A' ' 135' ' ' LEU . 14.5 t80 -70.13 153.49 43.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.685 -0.634 . . . . 0.0 110.14 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 46.6 ttm-85 -135.95 -76.41 0.43 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.659 -0.651 . . . . 0.0 110.327 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -120.53 143.04 48.79 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.38 -0.825 . . . . 0.0 110.616 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.27 127.71 38.97 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.44 ' CG2' H131 ' A' ' 201' ' ' 4P2 . 2.5 t -96.9 117.77 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.602 -0.686 . . . . 0.0 111.535 -177.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 28.9 p -140.06 147.68 40.67 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.414 -0.804 . . . . 0.0 110.565 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 17.9 m -79.49 -50.59 10.53 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.488 -0.758 . . . . 0.0 109.77 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -130.26 36.7 3.96 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.633 -0.667 . . . . 0.0 109.904 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 104.28 -11.76 51.47 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 65.1 t -93.12 121.95 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.259 -1.142 . . . . 0.0 109.158 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.2 121.1 29.2 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.541 -0.725 . . . . 0.0 111.347 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 5.4 mttp -113.29 -30.11 7.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.804 -0.56 . . . . 0.0 109.933 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -123.64 168.4 12.69 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.518 -0.739 . . . . 0.0 109.9 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 35.1 m -140.23 137.34 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.517 -0.74 . . . . 0.0 110.887 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -104.65 126.57 51.85 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.53 -0.731 . . . . 0.0 110.606 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -147.8 162.14 39.83 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.595 -0.691 . . . . 0.0 110.332 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 27.1 m -110.96 149.59 40.65 Favored Pre-proline 0 N--CA 1.502 2.129 0 O-C-N 121.353 -0.842 . . . . 0.0 110.708 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -78.6 161.28 28.03 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.496 1.261 . . . . 0.0 109.378 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 54.0 t -58.9 -25.93 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.385 -0.822 . . . . 0.0 110.051 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -59.92 -35.53 75.08 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.557 -0.715 . . . . 0.0 110.643 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 2.3 t -61.51 -24.35 66.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.468 -0.77 . . . . 0.0 110.568 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 68.0 mtt -69.96 -39.06 76.23 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.431 -0.793 . . . . 0.0 110.507 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -60.11 -39.98 88.08 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.443 -0.786 . . . . 0.0 110.566 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 85.3 m -60.8 -40.04 91.15 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.474 -0.766 . . . . 0.0 110.124 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 61.8 m -67.73 -36.34 80.4 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.559 -0.713 . . . . 0.0 110.321 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 7.9 ttt -60.06 -42.23 94.05 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.553 -0.717 . . . . 0.0 110.539 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -60.07 -39.9 87.66 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.539 -0.726 . . . . 0.0 110.342 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.722 0 O-C-N 121.581 -0.699 . . . . 0.0 110.187 179.956 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' 4P2 . . . . . 0.463 ' H24' ' HA ' ' A' ' 78' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.6 t . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.087 0.47 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.94 28.54 71.7 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 53.79 176.27 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.47 -1.018 . . . . 0.0 110.935 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -147.15 35.51 0.9 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.518 -0.739 . . . . 0.0 110.384 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.8 mmtm 53.14 39.96 30.46 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.465 -0.772 . . . . 0.0 110.858 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 52.23 42.9 31.01 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.468 -0.77 . . . . 0.0 110.886 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -79.11 130.3 35.36 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.56 -0.712 . . . . 0.0 110.157 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.5 p -133.27 131.27 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.547 -0.72 . . . . 0.0 110.248 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -89.43 -38.99 13.68 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.642 -0.662 . . . . 0.0 110.308 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.42 174.0 44.94 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.7 mp0 -90.17 -24.63 20.98 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.556 -0.967 . . . . 0.0 110.485 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.1 p -119.31 143.66 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.566 -0.709 . . . . 0.0 110.069 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 54.9 tp60 -110.39 141.65 43.16 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.582 -0.699 . . . . 0.0 110.181 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.0 p -82.74 130.26 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.643 -0.661 . . . . 0.0 110.212 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.7 m -138.14 144.31 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.509 -0.744 . . . . 0.0 110.48 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.4 m -130.05 144.04 51.12 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.54 -0.725 . . . . 0.0 110.632 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.86 -169.98 1.82 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.602 -0.686 . . . . 0.0 109.768 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.83 -40.04 69.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.614 -0.679 . . . . 0.0 111.597 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 77.6 p -114.59 -18.82 11.34 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.226 -0.922 . . . . 0.0 111.608 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -139.75 161.67 36.99 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.244 -0.91 . . . . 0.0 110.134 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 99.1 p -138.4 123.28 18.87 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.458 -0.776 . . . . 0.0 110.857 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 4.4 p90 -128.05 -174.96 3.35 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.632 -0.668 . . . . 0.0 109.503 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 44.0 mt -126.57 166.08 17.96 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.335 -0.853 . . . . 0.0 110.746 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.49 152.48 44.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.711 -0.618 . . . . 0.0 110.261 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 87.8 m -130.03 139.9 50.94 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.511 -0.743 . . . . 0.0 110.291 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 77.8 m -77.63 120.49 22.65 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.562 -0.712 . . . . 0.0 110.431 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.1 t -130.48 120.82 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.467 -0.771 . . . . 0.0 110.628 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 33.4 m120 50.05 34.47 8.3 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.534 -0.729 . . . . 0.0 111.969 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.25 -23.61 23.53 Favored Glycine 0 N--CA 1.497 2.736 0 C-N-CA 120.198 -1.001 . . . . 0.0 110.8 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.0 p -108.89 133.58 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.3 -1.118 . . . . 0.0 109.781 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 77.1 m -91.55 125.03 36.15 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.392 -0.818 . . . . 0.0 110.159 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 71.9 m95 -99.33 137.17 38.21 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.567 -0.708 . . . . 0.0 110.422 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.456 ' CG2' ' CH2' ' A' ' 85' ' ' TRP . 8.4 t -137.06 173.43 11.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.765 -0.584 . . . . 0.0 109.751 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.482 ' CG1' ' CE1' ' A' ' 57' ' ' HIS . 96.9 t -81.78 142.09 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.462 -0.774 . . . . 0.0 109.26 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.448 ' CE2' ' CG2' ' A' ' 78' ' ' VAL . 15.2 t80 -85.0 -43.37 14.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.63 -0.669 . . . . 0.0 110.806 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.482 ' CE1' ' CG1' ' A' ' 55' ' ' VAL . 2.2 p-80 -59.45 -22.55 61.67 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.167 -0.958 . . . . 0.0 110.476 -178.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -82.28 -65.77 1.61 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.409 ' HA ' ' CE1' ' A' ' 43' ' ' PHE . . . -59.0 -63.28 1.36 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.418 -1.048 . . . . 0.0 110.188 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.02 -153.63 21.22 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 72.8 m -59.78 -52.22 66.4 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.591 -0.946 . . . . 0.0 110.766 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -62.5 137.26 58.22 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.368 -0.832 . . . . 0.0 109.946 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.5 t -114.24 140.94 48.17 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.563 -0.711 . . . . 0.0 110.318 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.401 HD22 ' CZ ' ' A' ' 43' ' ' PHE . 4.4 pp -142.27 140.26 32.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.471 -0.768 . . . . 0.0 110.235 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -147.19 119.53 8.38 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.671 -0.643 . . . . 0.0 109.931 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.57 128.35 0.03 OUTLIER Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.46 -9.19 25.57 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 O-C-N 123.169 1.089 . . . . 0.0 111.454 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -89.0 12.52 15.24 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.243 -0.91 . . . . 0.0 111.27 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 150.6 128.94 1.58 Allowed Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -87.2 168.86 7.54 Favored 'Trans proline' 0 C--N 1.32 -0.926 0 O-C-N 123.156 1.082 . . . . 0.0 110.464 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 45.1 pt -145.42 161.43 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.585 -0.697 . . . . 0.0 110.29 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.9 m -73.18 149.96 42.51 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.525 -0.735 . . . . 0.0 110.272 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -92.36 150.83 20.59 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.551 -0.718 . . . . 0.0 110.565 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 97.8 mmm -116.98 -32.7 4.98 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.65 -0.656 . . . . 0.0 110.35 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -110.11 129.15 55.74 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.374 -0.829 . . . . 0.0 109.436 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 89.3 m -151.44 132.65 14.46 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.399 -0.813 . . . . 0.0 110.456 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -166.73 125.42 1.42 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.372 -0.83 . . . . 0.0 111.141 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.448 ' CG2' ' CE2' ' A' ' 56' ' ' TYR . 78.5 t -72.32 -39.29 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.459 -0.776 . . . . 0.0 109.607 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -55.81 -44.93 78.32 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.354 -0.842 . . . . 0.0 110.268 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.0 tp60 -82.9 -14.0 55.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.754 -0.591 . . . . 0.0 110.279 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.406 ' HB2' ' H23' ' A' ' 201' ' ' 4P2 . 40.2 t0 53.09 39.9 30.31 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.117 -0.989 . . . . 0.0 110.67 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.3 156.98 43.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.406 -0.809 . . . . 0.0 111.065 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.5 t -145.11 145.14 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -130.5 154.69 20.77 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.626 -1.273 . . . . 0.0 110.912 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.456 ' CH2' ' CG2' ' A' ' 54' ' ' THR . 4.4 m-90 -125.07 159.88 30.36 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.904 -0.763 . . . . 0.0 109.431 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -83.15 122.9 28.98 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.474 -0.766 . . . . 0.0 109.877 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -101.28 160.62 26.1 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.457 -0.777 . . . . 0.0 110.538 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.77 160.05 49.06 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 O-C-N 123.484 1.255 . . . . 0.0 110.506 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.52 158.81 47.28 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.448 1.236 . . . . 0.0 110.526 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 74.27 31.12 59.69 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -107.23 151.33 25.58 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.43 -1.041 . . . . 0.0 110.307 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -60.5 152.3 26.22 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.589 -0.694 . . . . 0.0 110.46 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 92.5 p -148.23 155.39 41.3 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.612 -0.68 . . . . 0.0 110.457 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 90.9 mt -111.13 131.92 54.7 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.563 -0.711 . . . . 0.0 110.36 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 72.6 p -76.5 159.91 78.54 Favored Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 121.597 -0.689 . . . . 0.0 110.082 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.0 159.22 50.78 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.38 1.2 . . . . 0.0 110.481 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 47.0 t -86.93 128.15 35.06 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.564 -0.71 . . . . 0.0 110.388 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.5 p -133.69 55.09 1.91 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.603 -0.685 . . . . 0.0 109.989 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.5 p -145.18 7.68 1.18 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.481 -0.762 . . . . 0.0 111.864 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 52.26 41.67 54.72 Favored Glycine 0 N--CA 1.499 2.894 0 O-C-N 121.003 -1.06 . . . . 0.0 110.496 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.8 m -78.92 107.96 12.04 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.519 -0.989 . . . . 0.0 110.386 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.4 m -66.24 -40.01 89.92 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.569 -0.707 . . . . 0.0 110.195 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -67.92 129.12 38.94 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.589 -0.694 . . . . 0.0 109.97 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 90.8 mt -134.99 150.08 50.29 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.609 -0.682 . . . . 0.0 110.356 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -117.5 125.19 50.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.535 -0.728 . . . . 0.0 109.768 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 26.8 tp -102.53 144.22 31.23 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.5 -0.75 . . . . 0.0 110.556 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.6 t -105.92 126.68 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.603 -0.686 . . . . 0.0 109.73 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 69.7 p -93.98 176.49 6.31 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.501 -0.749 . . . . 0.0 110.58 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -60.13 -24.63 64.84 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.598 -0.689 . . . . 0.0 110.722 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -95.32 27.15 3.43 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.474 -0.766 . . . . 0.0 110.555 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 53.21 27.79 6.39 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.296 -0.878 . . . . 0.0 110.916 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -80.68 152.59 28.36 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.546 -0.721 . . . . 0.0 109.913 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 63.2 t -116.05 128.17 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.543 -0.723 . . . . 0.0 109.929 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.415 HD11 HG23 ' A' ' 114' ' ' ILE . 40.1 pt -134.56 139.07 31.5 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.49 -0.756 . . . . 0.0 110.19 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -82.91 146.45 12.98 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 O-C-N 123.177 1.093 . . . . 0.0 110.521 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.1 t -139.36 129.94 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.584 -0.698 . . . . 0.0 109.768 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.7 tpp180 -92.98 130.71 38.47 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.538 -0.726 . . . . 0.0 110.154 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -80.26 121.33 25.5 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.606 -0.684 . . . . 0.0 110.328 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.88 -12.29 9.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.523 -0.736 . . . . 0.0 110.473 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -134.92 -175.55 13.92 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -70.14 -45.09 67.54 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.557 -0.966 . . . . 0.0 110.57 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.6 m -127.67 21.04 6.54 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.45 -0.781 . . . . 0.0 110.819 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.72 142.13 34.86 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.315 -0.866 . . . . 0.0 110.057 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -134.25 166.86 23.99 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 52.9 p -98.72 165.19 11.91 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.541 -0.976 . . . . 0.0 110.222 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 47.7 tp -120.0 124.2 45.33 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.527 -0.733 . . . . 0.0 110.337 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.4 mp -62.13 -41.67 98.49 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.51 -0.744 . . . . 0.0 110.182 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.4 p -102.58 105.9 46.6 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.548 -0.72 . . . . 0.0 109.945 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.36 106.85 2.15 Favored 'Trans proline' 0 C--N 1.319 -0.999 0 O-C-N 123.32 1.169 . . . . 0.0 110.876 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.42 ' HD2' ' CD2' ' A' ' 134' ' ' TYR . 4.4 mtt85 -106.89 153.09 41.05 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.644 -0.66 . . . . 0.0 109.643 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.27 150.38 52.93 Favored 'Trans proline' 0 C--N 1.315 -1.207 0 O-C-N 123.383 1.202 . . . . 0.0 110.884 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 73.6 t -53.6 -31.95 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.473 -0.767 . . . . 0.0 109.565 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 31.2 t -59.85 -39.99 87.07 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.689 -0.632 . . . . 0.0 110.65 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.42 ' CD2' ' HD2' ' A' ' 130' ' ' ARG . 87.3 t80 -70.06 -39.73 75.5 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.444 -0.785 . . . . 0.0 109.604 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 22.1 tp -95.01 13.59 24.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.725 -0.609 . . . . 0.0 110.581 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.462 ' HA ' H481 ' A' ' 201' ' ' 4P2 . 0.0 OUTLIER -76.71 113.03 13.9 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.601 1.191 . . . . 0.0 111.087 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.53 34.3 4.48 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 31.1 m -115.29 19.15 15.76 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.747 -0.855 . . . . 0.0 110.46 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.5 m -68.12 147.47 52.27 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.3 -0.875 . . . . 0.0 109.508 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 94.56 -19.75 52.02 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -58.29 112.69 4.15 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.49 157.56 52.65 Favored 'Trans proline' 0 C--N 1.319 -1.025 0 O-C-N 123.201 1.106 . . . . 0.0 110.955 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.9 mp -109.4 127.66 54.54 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -110.41 160.26 16.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.535 -0.728 . . . . 0.0 111.078 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.933 ' SG ' 'ZN ' ' A' ' 202' ' ' ' ZN' . 27.1 p -119.92 165.64 17.26 Favored Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 38.5 Cg_endo -63.97 -15.21 47.84 Favored 'Trans proline' 0 N--CA 1.488 1.18 0 O-C-N 123.079 1.042 . . . . 0.0 111.454 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.5 t -70.24 -39.95 74.75 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.282 -0.886 . . . . 0.0 110.044 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 114.87 31.61 2.06 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -132.15 155.76 47.6 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.492 -1.005 . . . . 0.0 110.404 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -73.41 146.85 44.78 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.556 -0.715 . . . . 0.0 109.985 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.9 t -112.08 -61.67 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.479 -0.763 . . . . 0.0 110.353 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -163.19 -158.76 10.0 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.8 mt -133.97 155.42 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.594 -0.945 . . . . 0.0 109.882 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -70.04 147.49 49.98 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.45 -0.781 . . . . 0.0 109.861 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 4.6 ttm-85 -128.6 -79.85 0.57 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.602 -0.686 . . . . 0.0 110.829 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -119.5 143.7 47.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.964 . . . . 0.0 111.313 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.56 128.08 39.53 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.437 ' CG2' H131 ' A' ' 201' ' ' 4P2 . 2.4 t -98.86 119.11 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 121.48 -0.762 . . . . 0.0 111.282 -177.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.9 p -139.88 143.59 36.77 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.506 -0.746 . . . . 0.0 110.689 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 87.0 m -76.33 -41.98 46.56 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.596 -0.69 . . . . 0.0 109.872 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -143.24 50.28 1.41 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.646 -0.659 . . . . 0.0 109.897 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 90.77 -11.57 71.41 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 64.3 t -96.07 120.13 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.141 -1.211 . . . . 0.0 108.91 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.63 120.91 29.42 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.529 -0.732 . . . . 0.0 111.243 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -112.81 -32.28 6.46 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.296 0.57 . . . . 0.0 109.678 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -118.6 168.26 10.87 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.669 -0.644 . . . . 0.0 109.685 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 35.6 m -144.02 135.77 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.36 -0.838 . . . . 0.0 110.823 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -110.34 138.37 46.81 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.655 -0.653 . . . . 0.0 110.242 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -141.84 162.07 36.39 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.507 -0.746 . . . . 0.0 110.544 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 51.6 t -101.89 143.39 26.51 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.466 -0.771 . . . . 0.0 110.24 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -75.69 166.38 28.47 Favored 'Trans proline' 0 N--CA 1.485 1.006 0 O-C-N 123.296 1.156 . . . . 0.0 110.389 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 77.3 t -88.46 -25.86 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.536 -0.728 . . . . 0.0 110.536 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -59.33 -32.94 70.54 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.408 -0.808 . . . . 0.0 110.596 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.8 t -69.19 -22.94 63.86 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.469 -0.769 . . . . 0.0 110.49 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 35.1 mmt -63.29 -27.8 69.58 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.334 -0.854 . . . . 0.0 110.411 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -57.37 -49.95 74.53 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.404 -0.81 . . . . 0.0 110.67 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 6.1 t -70.03 -23.33 63.09 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.525 -0.735 . . . . 0.0 110.503 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 87.6 m -72.06 -32.95 67.57 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.427 -0.796 . . . . 0.0 110.243 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 95.7 mtp -60.02 -37.02 78.54 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.568 -0.707 . . . . 0.0 110.419 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -59.92 -39.87 86.94 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.528 -0.732 . . . . 0.0 110.273 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.837 0 O-C-N 121.56 -0.713 . . . . 0.0 110.111 179.954 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' 4P2 . . . . . 0.462 H481 ' HA ' ' A' ' 136' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . 0.933 'ZN ' ' SG ' ' A' ' 145' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.3 t . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.164 0.507 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -132.43 -153.56 7.35 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.37 160.59 42.37 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.498 -1.001 . . . . 0.0 110.326 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -101.47 102.63 13.43 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.537 -0.727 . . . . 0.0 110.187 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.8 tptp -141.47 128.34 20.56 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.551 -0.718 . . . . 0.0 110.187 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -83.42 133.02 34.94 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.527 -0.733 . . . . 0.0 110.026 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 36.1 tp60 -116.67 137.68 52.01 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.446 -0.784 . . . . 0.0 110.407 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.6 p -137.62 141.7 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.542 -0.724 . . . . 0.0 109.959 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -121.58 158.31 28.85 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.479 -0.763 . . . . 0.0 110.512 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.7 28.03 27.76 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -117.04 -27.84 6.42 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.484 -1.01 . . . . 0.0 110.746 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.8 t -126.5 140.57 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.399 -0.813 . . . . 0.0 110.311 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -106.84 159.73 16.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.572 -0.705 . . . . 0.0 110.05 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 62.2 t -107.57 118.34 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.485 -0.76 . . . . 0.0 110.224 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 68.0 t -120.9 133.85 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.468 -0.77 . . . . 0.0 110.158 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.5 t -130.48 135.74 48.28 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.617 -0.677 . . . . 0.0 109.763 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.24 173.6 6.25 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.525 -0.734 . . . . 0.0 110.245 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.84 -34.88 74.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.746 -0.596 . . . . 0.0 111.203 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 68.9 p -103.49 -28.18 11.93 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.362 -0.836 . . . . 0.0 111.049 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -142.93 178.11 7.9 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.38 -0.825 . . . . 0.0 110.619 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 24.0 m -148.74 120.6 8.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.711 -0.618 . . . . 0.0 110.223 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -127.53 172.38 10.76 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.664 -0.647 . . . . 0.0 109.674 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.8 mt -121.14 153.96 36.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.492 -0.755 . . . . 0.0 109.978 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -125.76 154.66 42.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.594 -0.691 . . . . 0.0 110.379 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.4 t -129.11 144.18 51.11 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.667 -0.646 . . . . 0.0 109.902 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 27.9 p -94.84 118.8 32.36 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.696 0.76 . . . . 0.0 110.679 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.4 t -130.27 127.64 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.44 -0.787 . . . . 0.0 109.827 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 52.16 39.13 26.15 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.418 -0.801 . . . . 0.0 110.991 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.71 24.67 75.41 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.3 t -136.64 115.09 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.382 -1.069 . . . . 0.0 109.836 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 47.9 t -77.42 116.35 17.94 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.546 -0.721 . . . . 0.0 109.958 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.455 ' CZ3' ' CE ' ' A' ' 175' ' ' MET . 56.9 m95 -100.09 137.25 38.8 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.446 -0.783 . . . . 0.0 110.578 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.451 ' CG2' ' CH2' ' A' ' 85' ' ' TRP . 7.5 t -137.11 173.59 11.52 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.646 -0.659 . . . . 0.0 109.47 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.48 ' CG1' ' CE1' ' A' ' 57' ' ' HIS . 71.5 t -82.52 143.66 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.362 -0.836 . . . . 0.0 109.495 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.467 ' CE2' ' CG2' ' A' ' 78' ' ' VAL . 21.2 t80 -84.37 -42.21 15.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.754 -0.591 . . . . 0.0 111.027 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.48 ' CE1' ' CG1' ' A' ' 55' ' ' VAL . 1.4 p-80 -56.86 -20.02 20.67 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.967 -1.083 . . . . 0.0 111.227 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -102.16 -65.82 0.76 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.68 -22.83 49.94 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.473 -1.016 . . . . 0.0 111.027 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.95 -30.85 70.76 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 79.2 p -62.51 -50.99 69.21 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.483 -1.01 . . . . 0.0 110.6 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.12 138.85 51.99 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.475 -0.766 . . . . 0.0 110.171 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.1 t -65.86 142.33 57.96 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.512 -0.742 . . . . 0.0 110.27 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -97.45 119.43 35.97 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.455 -0.778 . . . . 0.0 109.957 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -124.7 161.48 26.25 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.508 -0.745 . . . . 0.0 110.933 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.9 -156.73 21.54 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.91 -50.21 0.47 Allowed 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 123.341 1.179 . . . . 0.0 111.336 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -130.76 37.3 3.82 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.372 -0.83 . . . . 0.0 111.083 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -134.19 147.41 19.08 Favored Glycine 0 N--CA 1.496 2.699 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.347 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -76.32 174.68 12.43 Favored 'Trans proline' 0 C--N 1.321 -0.903 0 O-C-N 123.545 1.287 . . . . 0.0 110.252 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.405 ' CD1' ' N ' ' A' ' 71' ' ' ILE . 4.8 mp -102.18 140.22 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.54 -0.725 . . . . 0.0 110.969 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.6 p -115.45 109.86 18.47 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.2 mm-40 -96.8 113.94 25.54 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.493 -0.754 . . . . 0.0 111.123 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.418 ' HG3' ' CD2' ' A' ' 75' ' ' TYR . 19.4 ptt? -113.08 -29.73 7.22 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.658 -0.651 . . . . 0.0 109.783 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.418 ' CD2' ' HG3' ' A' ' 74' ' ' MET . 29.9 m-85 -120.22 116.37 25.47 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.572 -0.705 . . . . 0.0 109.596 179.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.1 m -150.31 130.92 13.96 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.481 -0.762 . . . . 0.0 110.316 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -167.74 123.24 1.04 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.363 -0.836 . . . . 0.0 111.327 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.467 ' CG2' ' CE2' ' A' ' 56' ' ' TYR . 70.1 t -72.67 -38.18 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.49 -0.756 . . . . 0.0 109.5 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -55.66 -33.3 63.97 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.484 -0.76 . . . . 0.0 110.641 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -100.61 -15.28 17.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.579 -0.7 . . . . 0.0 110.642 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.405 ' HB2' ' H23' ' A' ' 201' ' ' 4P2 . 35.3 t0 61.1 39.79 15.73 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.111 -0.993 . . . . 0.0 113.631 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.409 ' C ' ' CD2' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -148.76 160.32 43.31 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.721 -1.237 . . . . 0.0 111.68 176.578 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.2 t -137.6 159.47 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -140.29 137.98 8.73 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.602 -1.285 . . . . 0.0 110.513 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.451 ' CH2' ' CG2' ' A' ' 54' ' ' THR . 5.3 m-90 -111.79 157.92 19.99 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.845 -0.797 . . . . 0.0 109.701 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -68.32 115.08 7.35 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.609 -0.682 . . . . 0.0 109.974 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -99.87 164.84 15.71 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.483 -0.761 . . . . 0.0 110.19 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.42 139.55 31.88 Favored 'Trans proline' 0 C--N 1.317 -1.097 0 O-C-N 123.408 1.215 . . . . 0.0 110.299 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -76.77 160.11 34.49 Favored 'Trans proline' 0 C--N 1.319 -1.003 0 O-C-N 123.26 1.137 . . . . 0.0 110.439 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 70.03 29.82 70.39 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -109.03 168.12 9.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.49 -1.006 . . . . 0.0 110.055 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.8 mtm180 -59.98 138.54 57.82 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.583 -0.698 . . . . 0.0 110.248 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 78.9 p -132.95 152.05 51.97 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.545 -0.722 . . . . 0.0 110.372 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 81.2 mt -97.1 131.58 43.73 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.589 -0.695 . . . . 0.0 110.258 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 44.4 p -85.0 155.54 60.91 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.595 -0.691 . . . . 0.0 110.256 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.67 162.98 39.79 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 O-C-N 123.49 1.258 . . . . 0.0 110.428 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.8 t -82.37 131.23 35.23 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.557 -0.714 . . . . 0.0 110.187 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.2 m -135.77 56.3 1.83 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.596 -0.69 . . . . 0.0 110.088 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.7 p -145.25 6.08 1.12 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.456 -0.778 . . . . 0.0 112.029 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 51.44 51.06 39.03 Favored Glycine 0 N--CA 1.502 3.05 0 O-C-N 120.949 -1.095 . . . . 0.0 110.541 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.2 p -99.06 121.74 41.39 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.441 -1.035 . . . . 0.0 110.525 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 68.2 m -73.42 -40.08 64.52 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.627 -0.671 . . . . 0.0 110.247 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -65.5 131.42 46.36 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.618 -0.676 . . . . 0.0 110.22 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 95.6 mt -135.95 144.95 45.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.543 -0.723 . . . . 0.0 110.379 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -114.11 129.26 56.62 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.502 -0.749 . . . . 0.0 110.203 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 38.1 tp -105.41 140.08 39.06 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.572 -0.705 . . . . 0.0 110.228 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.9 t -91.83 121.89 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.6 -0.688 . . . . 0.0 109.76 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.3 m -85.45 172.69 10.82 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.54 -0.725 . . . . 0.0 110.34 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.9 -26.53 65.99 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.572 -0.705 . . . . 0.0 110.523 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -96.05 26.32 4.25 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.528 -0.732 . . . . 0.0 110.453 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 52.9 39.99 30.1 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.323 -0.861 . . . . 0.0 110.827 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -94.52 162.51 13.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.539 -0.725 . . . . 0.0 110.127 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 63.9 t -110.27 130.34 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.538 -0.726 . . . . 0.0 109.897 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.0 tp -137.88 119.57 10.72 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.606 -0.684 . . . . 0.0 109.994 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -73.07 142.91 35.2 Favored 'Trans proline' 0 N--CA 1.486 1.069 0 O-C-N 123.074 1.039 . . . . 0.0 110.699 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.7 t -139.05 129.06 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.713 -0.617 . . . . 0.0 109.693 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -85.51 129.18 34.88 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.529 -0.732 . . . . 0.0 110.075 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -73.88 135.65 43.36 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.612 -0.68 . . . . 0.0 110.278 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -137.44 26.98 2.84 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.662 -0.649 . . . . 0.0 110.24 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.23 -179.54 43.77 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -70.08 -39.59 75.52 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.592 -0.946 . . . . 0.0 110.562 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 98.4 p -131.44 29.19 4.59 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.431 -0.793 . . . . 0.0 110.875 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.12 160.29 43.05 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.435 -0.791 . . . . 0.0 110.333 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -160.16 -170.14 24.36 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 88.3 p -126.34 164.55 20.82 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.577 -0.955 . . . . 0.0 110.159 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 46.5 tp -119.99 126.37 50.68 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.586 -0.696 . . . . 0.0 110.183 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.0 mp -59.83 -49.84 76.14 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.556 -0.715 . . . . 0.0 110.272 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.1 m -91.28 113.51 58.62 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.549 -0.72 . . . . 0.0 110.063 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.81 107.09 2.33 Favored 'Trans proline' 0 C--N 1.32 -0.939 0 O-C-N 123.153 1.081 . . . . 0.0 110.596 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.411 ' HD3' ' CE2' ' A' ' 134' ' ' TYR . 81.8 mtt-85 -110.98 149.78 40.93 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.599 -0.688 . . . . 0.0 109.929 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.04 150.37 60.31 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.463 1.243 . . . . 0.0 110.89 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 39.3 t -51.92 -30.09 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.461 -0.774 . . . . 0.0 109.79 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.1 t -61.65 -41.03 96.94 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.626 -0.672 . . . . 0.0 111.222 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.411 ' CE2' ' HD3' ' A' ' 130' ' ' ARG . 86.7 t80 -67.69 -39.96 84.41 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.349 -0.844 . . . . 0.0 109.75 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 23.9 tp -93.66 18.94 9.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.838 -0.539 . . . . 0.0 110.253 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.461 ' HA ' H481 ' A' ' 201' ' ' 4P2 . 15.2 tttm -81.34 117.2 21.62 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.542 1.163 . . . . 0.0 112.757 -178.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.2 37.88 3.71 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.0 m -119.55 21.23 12.18 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.715 -0.873 . . . . 0.0 110.44 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.6 m -71.98 129.69 39.17 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.324 -0.86 . . . . 0.0 109.497 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 109.84 -24.4 19.4 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.82 110.69 2.28 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.34 149.11 56.38 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 O-C-N 123.234 1.123 . . . . 0.0 110.857 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.6 mp -99.59 119.33 37.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.708 -0.62 . . . . 0.0 109.535 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.6 tp -105.82 120.91 42.92 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.582 -0.699 . . . . 0.0 110.775 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.692 ' SG ' 'ZN ' ' A' ' 202' ' ' ' ZN' . 26.9 p -64.36 163.34 26.23 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.72 -0.613 . . . . 0.0 109.697 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.09 -15.22 47.74 Favored 'Trans proline' 0 N--CA 1.487 1.118 0 O-C-N 123.245 1.129 . . . . 0.0 111.158 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.2 m -70.0 -27.09 64.41 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.264 -0.898 . . . . 0.0 110.084 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 107.84 43.14 1.35 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -144.7 158.65 43.69 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.497 -1.002 . . . . 0.0 110.267 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.04 148.49 34.29 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.578 -0.701 . . . . 0.0 110.318 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.4 t -119.17 -62.44 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.573 -0.704 . . . . 0.0 110.22 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -156.53 -158.03 8.64 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.6 mt -135.86 145.36 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.597 -0.943 . . . . 0.0 109.675 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -62.55 155.46 25.83 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.438 -0.789 . . . . 0.0 109.605 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 33.2 ttm-85 -140.38 -66.17 0.44 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.945 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -130.57 143.68 50.92 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.935 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.59 127.64 39.36 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.44 ' CG2' H131 ' A' ' 201' ' ' 4P2 . 2.1 t -98.1 119.95 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.617 -0.677 . . . . 0.0 111.305 -177.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.7 p -141.26 158.98 43.16 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.497 -0.752 . . . . 0.0 110.508 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 11.0 m -91.18 -56.86 2.99 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.567 -0.708 . . . . 0.0 109.456 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.5 ptp85 -123.85 36.62 4.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.607 -0.683 . . . . 0.0 109.449 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 103.7 -11.46 53.41 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 63.1 t -92.46 124.23 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.219 -1.165 . . . . 0.0 109.132 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.17 119.84 27.81 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.521 -0.737 . . . . 0.0 110.895 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 12.0 mtpp -110.15 -28.74 8.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.709 -0.619 . . . . 0.0 109.907 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -130.14 168.14 17.26 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.601 -0.687 . . . . 0.0 110.172 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.3 m -139.5 142.48 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.548 -0.72 . . . . 0.0 110.518 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -117.06 137.0 52.55 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.588 -0.695 . . . . 0.0 110.851 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -147.75 159.89 43.31 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.677 -0.64 . . . . 0.0 110.525 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 22.5 t -107.33 143.62 27.55 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 121.481 -0.762 . . . . 0.0 109.441 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -74.35 -179.67 4.99 Favored 'Trans proline' 0 C--N 1.319 -0.985 0 O-C-N 123.336 1.177 . . . . 0.0 110.603 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 57.4 t -94.79 -27.87 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.623 -0.673 . . . . 0.0 110.025 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -59.95 -34.2 72.93 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.581 -0.699 . . . . 0.0 110.552 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 34.7 t -61.7 -31.31 71.45 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.546 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.455 ' CE ' ' CZ3' ' A' ' 53' ' ' TRP . 69.3 mmm -71.6 -27.37 63.07 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.443 -0.786 . . . . 0.0 110.564 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -56.8 -42.99 80.51 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.361 -0.837 . . . . 0.0 110.496 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 86.3 m -69.59 -40.11 76.88 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.471 -0.768 . . . . 0.0 109.684 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 91.0 m -71.68 -34.47 69.69 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.622 -0.674 . . . . 0.0 110.24 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 4.9 tmm? -60.06 -39.93 87.72 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.511 -0.743 . . . . 0.0 110.278 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -60.08 -39.9 87.71 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.527 -0.733 . . . . 0.0 110.132 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.911 0 O-C-N 121.619 -0.676 . . . . 0.0 110.169 179.841 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' 4P2 . . . . . 0.461 H481 ' HA ' ' A' ' 136' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . 0.692 'ZN ' ' SG ' ' A' ' 145' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.4 p . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.045 0.45 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -130.34 26.93 4.07 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 33.4 ptt-85 -143.15 49.12 1.46 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.447 -1.031 . . . . 0.0 110.101 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -69.97 -19.95 63.33 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.579 -0.7 . . . . 0.0 110.808 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.5 ttmt 55.01 33.37 20.12 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.252 -0.905 . . . . 0.0 110.129 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.8 t30 55.22 20.64 3.54 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.652 -0.655 . . . . 0.0 111.178 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 48.12 85.01 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.341 -0.849 . . . . 0.0 111.356 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.9 m -118.3 151.12 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.525 -0.734 . . . . 0.0 110.521 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -139.76 159.96 40.97 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.614 -0.679 . . . . 0.0 110.179 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -137.52 -170.85 12.0 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -58.95 -39.9 83.06 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.573 -0.957 . . . . 0.0 110.425 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 97.8 t -139.3 140.03 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.569 -0.707 . . . . 0.0 109.808 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -133.62 151.49 51.7 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.535 -0.728 . . . . 0.0 110.201 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.435 ' HA ' HD23 ' A' ' 44' ' ' LEU . 91.0 t -93.79 119.45 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.616 -0.677 . . . . 0.0 110.087 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.1 p -134.07 130.07 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.488 -0.757 . . . . 0.0 109.824 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 66.8 m -116.89 155.15 29.56 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.646 -0.659 . . . . 0.0 110.312 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -116.38 -178.65 3.46 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.709 -0.619 . . . . 0.0 110.121 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.29 -25.47 60.68 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.308 -178.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.3 p -119.11 -28.27 5.51 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.312 -0.868 . . . . 0.0 111.19 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.1 pm0 -140.43 171.9 13.48 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.366 -0.834 . . . . 0.0 110.321 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.0 t -142.99 119.06 10.7 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.503 -0.748 . . . . 0.0 110.658 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 3.4 p90 -128.31 177.69 6.78 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.574 -0.704 . . . . 0.0 109.692 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 35' ' ' VAL . 54.7 mt -115.83 160.48 20.1 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.504 -0.747 . . . . 0.0 110.052 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -129.64 153.96 47.59 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.39 -0.819 . . . . 0.0 110.504 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.5 p -130.98 144.08 51.21 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.636 -0.665 . . . . 0.0 110.099 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 28.4 p -93.99 121.41 35.43 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.509 -0.744 . . . . 0.0 110.564 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.4 t -130.34 136.66 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.388 -0.82 . . . . 0.0 110.412 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 43.59 34.32 0.79 Allowed 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.66 -24.23 15.81 Favored Glycine 0 N--CA 1.497 2.74 0 C-N-CA 120.279 -0.962 . . . . 0.0 111.264 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 62.8 t -107.5 129.56 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.179 -1.189 . . . . 0.0 110.073 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -82.45 131.49 35.22 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.653 -0.654 . . . . 0.0 109.955 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.474 ' CE3' ' CD2' ' A' ' 82' ' ' LEU . 90.5 m95 -117.15 137.83 52.06 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.528 -0.733 . . . . 0.0 110.738 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.423 HG22 ' CH2' ' A' ' 85' ' ' TRP . 10.0 t -136.6 -179.1 5.48 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.722 -0.611 . . . . 0.0 109.752 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.455 HG13 ' CE1' ' A' ' 57' ' ' HIS . 18.0 t -80.32 142.29 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.542 -0.724 . . . . 0.0 109.465 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.467 ' CE2' HG21 ' A' ' 78' ' ' VAL . 7.8 t80 -84.86 -42.61 14.91 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.633 -0.667 . . . . 0.0 110.875 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.455 ' CE1' HG13 ' A' ' 55' ' ' VAL . 1.1 p-80 -55.77 -20.55 15.29 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.256 -0.903 . . . . 0.0 111.161 -177.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -73.65 -63.92 2.61 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 108.354 -1.899 . . . . 0.0 108.354 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.83 -63.51 1.29 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.563 -0.963 . . . . 0.0 109.568 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.2 -97.8 0.1 OUTLIER Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.3 p -49.12 -76.89 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.467 -1.019 . . . . 0.0 111.675 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.5 pttp -67.98 171.76 6.39 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.466 -0.771 . . . . 0.0 110.4 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.8 p -113.83 165.87 12.14 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.642 -0.662 . . . . 0.0 110.226 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.437 ' O ' ' CE2' ' A' ' 85' ' ' TRP . 2.4 tp -142.39 126.72 17.64 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.468 -0.77 . . . . 0.0 110.4 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.41 ' CB ' ' CD1' ' A' ' 71' ' ' ILE . . . -146.9 109.35 4.54 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.361 -0.837 . . . . 0.0 110.308 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 57.19 171.15 0.17 Allowed Glycine 0 N--CA 1.494 2.555 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.57 -4.23 14.92 Favored 'Trans proline' 0 N--CA 1.487 1.135 0 O-C-N 123.3 1.158 . . . . 0.0 111.572 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.2 mmtt -69.66 -31.85 70.15 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.088 -1.007 . . . . 0.0 111.123 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 142.92 -176.57 22.43 Favored Glycine 0 N--CA 1.496 2.661 0 C-N-CA 119.862 -1.161 . . . . 0.0 110.267 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -77.16 161.99 31.9 Favored 'Trans proline' 0 N--CA 1.486 1.056 0 O-C-N 123.556 1.293 . . . . 0.0 111.123 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.41 ' CD1' ' CB ' ' A' ' 65' ' ' ALA . 45.4 pt -149.27 -157.64 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.588 -0.695 . . . . 0.0 109.648 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.9 m -79.36 140.02 37.6 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.266 -0.896 . . . . 0.0 109.953 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -96.31 146.21 24.92 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.502 -0.749 . . . . 0.0 110.312 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.406 ' HG3' ' CD2' ' A' ' 75' ' ' TYR . 19.4 ptp -119.22 -38.53 3.02 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.575 -0.703 . . . . 0.0 110.625 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.406 ' CD2' ' HG3' ' A' ' 74' ' ' MET . 31.6 m-85 -112.4 120.46 41.74 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.301 -0.874 . . . . 0.0 109.752 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 85.6 m -148.53 130.13 14.96 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.471 -0.768 . . . . 0.0 110.331 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -167.28 117.99 0.87 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.411 -0.806 . . . . 0.0 111.532 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.467 HG21 ' CE2' ' A' ' 56' ' ' TYR . 73.7 t -72.59 -35.09 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.37 -0.831 . . . . 0.0 109.523 178.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -55.71 -35.48 66.14 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.425 -0.797 . . . . 0.0 110.225 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -106.82 -8.02 16.93 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.624 -0.673 . . . . 0.0 110.659 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.9 t0 53.0 43.28 31.93 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.085 -1.009 . . . . 0.0 110.431 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.474 ' CD2' ' CE3' ' A' ' 53' ' ' TRP . 0.6 OUTLIER -133.15 140.88 47.84 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.928 0.871 . . . . 0.0 111.836 -178.783 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -145.65 154.13 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -162.97 170.6 38.52 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.783 -1.199 . . . . 0.0 110.344 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.437 ' CE2' ' O ' ' A' ' 64' ' ' LEU . 0.3 OUTLIER -136.58 167.78 20.74 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.884 -0.774 . . . . 0.0 109.062 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -78.53 122.29 25.69 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.618 -0.677 . . . . 0.0 110.27 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.58 173.76 5.84 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.523 -0.735 . . . . 0.0 110.101 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.31 142.6 37.65 Favored 'Trans proline' 0 C--N 1.317 -1.124 0 O-C-N 123.396 1.208 . . . . 0.0 110.362 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -76.12 154.38 37.26 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.378 1.199 . . . . 0.0 110.413 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.42 -28.73 14.08 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.74 143.74 45.98 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.522 -0.987 . . . . 0.0 110.223 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.8 ptt-85 -79.28 159.99 27.01 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.579 -0.701 . . . . 0.0 110.288 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.0 m -125.3 159.21 32.27 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.596 -0.69 . . . . 0.0 110.268 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.99 147.12 39.05 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.518 -0.739 . . . . 0.0 110.152 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 86.0 m -91.4 144.0 29.04 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.626 -0.671 . . . . 0.0 110.103 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.54 166.1 30.45 Favored 'Trans proline' 0 C--N 1.318 -1.056 0 O-C-N 123.259 1.137 . . . . 0.0 110.398 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 46.7 t -65.84 140.02 58.35 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.503 -0.748 . . . . 0.0 110.353 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.8 m -134.38 38.52 3.11 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.654 -0.654 . . . . 0.0 110.029 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.8 p -144.78 -8.31 0.64 Allowed 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 119.981 -0.688 . . . . 0.0 112.368 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 55.65 34.62 60.76 Favored Glycine 0 N--CA 1.5 2.91 0 O-C-N 120.769 -1.207 . . . . 0.0 110.322 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 52.4 p -74.6 159.9 31.54 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.366 -1.079 . . . . 0.0 110.339 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.7 m -95.8 -33.51 12.23 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.635 -0.665 . . . . 0.0 110.302 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -70.29 120.83 16.54 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.503 -0.748 . . . . 0.0 110.112 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 58.5 mt -130.86 149.95 52.25 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.578 -0.702 . . . . 0.0 110.4 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -115.16 131.01 57.07 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.62 -0.675 . . . . 0.0 109.587 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 36.8 tp -111.83 143.48 42.7 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.48 -0.763 . . . . 0.0 110.58 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 63.3 t -104.61 129.07 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.679 -0.638 . . . . 0.0 109.392 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 70.1 p -104.35 169.38 8.51 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.475 -0.766 . . . . 0.0 110.852 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.409 ' NH1' ' CG1' ' A' ' 35' ' ' VAL . 16.2 tpt180 -59.99 -21.96 61.95 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.64 -0.662 . . . . 0.0 110.264 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -90.85 20.03 5.1 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.336 -0.852 . . . . 0.0 111.019 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 52.21 36.58 19.69 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.208 -0.932 . . . . 0.0 110.878 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -101.14 149.63 23.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.63 -0.669 . . . . 0.0 110.055 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 62.0 t -109.96 128.73 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.644 -0.66 . . . . 0.0 110.044 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 35.7 pt -138.55 138.91 23.06 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.634 -0.666 . . . . 0.0 110.139 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -79.61 151.6 22.38 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 O-C-N 123.289 1.152 . . . . 0.0 110.495 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.7 t -137.55 134.9 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.605 -0.684 . . . . 0.0 109.92 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 8.4 tpp180 -92.2 135.41 34.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.576 -0.703 . . . . 0.0 110.068 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 54.3 ttt180 -81.34 128.58 33.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.574 -0.703 . . . . 0.0 110.193 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.53 20.63 6.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.651 -0.656 . . . . 0.0 109.811 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 168.28 170.82 33.47 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -60.27 -50.05 75.19 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.499 -1.0 . . . . 0.0 110.032 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 53.1 m -114.75 -15.16 11.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.563 -0.71 . . . . 0.0 110.71 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -95.61 136.99 35.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.435 -0.791 . . . . 0.0 110.016 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -140.72 178.92 19.68 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 88.6 p -132.26 165.02 25.11 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.586 -0.95 . . . . 0.0 110.198 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 38.5 tp -121.18 138.23 54.31 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.503 -0.748 . . . . 0.0 110.218 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.5 mp -68.77 -54.85 13.57 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.516 -0.74 . . . . 0.0 110.03 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.1 p -92.41 109.32 37.4 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.581 -0.699 . . . . 0.0 109.809 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -75.11 120.57 6.08 Favored 'Trans proline' 0 C--N 1.319 -0.978 0 O-C-N 123.223 1.118 . . . . 0.0 111.168 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.422 ' HD2' ' CD2' ' A' ' 134' ' ' TYR . 94.1 mtm-85 -121.06 154.97 58.36 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.649 -0.657 . . . . 0.0 109.603 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -68.09 150.3 77.27 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 O-C-N 123.282 1.148 . . . . 0.0 111.141 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 40.6 t -53.43 -29.91 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 121.511 -0.743 . . . . 0.0 109.773 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.4 t -59.9 -41.57 91.94 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.659 -0.651 . . . . 0.0 111.23 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.422 ' CD2' ' HD2' ' A' ' 130' ' ' ARG . 83.6 t80 -68.16 -40.0 82.44 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.347 -0.845 . . . . 0.0 109.779 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 31.5 tp -92.71 18.2 9.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.787 -0.571 . . . . 0.0 110.122 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.473 ' HA ' H481 ' A' ' 201' ' ' 4P2 . 6.7 tttm -81.92 115.01 20.9 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 122.567 1.175 . . . . 0.0 112.078 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.415 ' HA2' H551 ' A' ' 201' ' ' 4P2 . . . 100.78 28.92 6.76 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 58.1 m -110.66 20.04 18.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.57 -0.959 . . . . 0.0 110.546 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.404 ' OG ' ' C55' ' A' ' 201' ' ' 4P2 . 1.8 m -65.64 145.18 56.36 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.268 -0.895 . . . . 0.0 109.487 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 95.9 -21.66 43.74 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.04 109.76 1.64 Allowed Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -75.69 150.63 35.52 Favored 'Trans proline' 0 C--N 1.32 -0.927 0 O-C-N 123.203 1.107 . . . . 0.0 111.036 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.0 mp -100.72 111.5 23.74 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.2 tp -97.04 140.1 32.07 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.528 -0.732 . . . . 0.0 110.758 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -76.12 174.57 5.4 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.657 -0.652 . . . . 0.0 109.785 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.05 -28.63 28.42 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 O-C-N 123.368 1.193 . . . . 0.0 110.235 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 83.8 p -70.36 -35.35 73.5 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.573 -0.704 . . . . 0.0 110.108 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 118.88 38.95 0.73 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 58.3 m170 -124.53 137.37 54.42 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.541 -0.976 . . . . 0.0 110.403 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.4 140.04 58.6 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.523 -0.736 . . . . 0.0 110.148 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 62.1 t -111.29 -55.99 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.614 -0.679 . . . . 0.0 110.146 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -161.83 -165.25 18.39 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 83.3 mt -131.31 143.71 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.664 -0.903 . . . . 0.0 109.778 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -61.57 147.34 45.91 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.429 -0.795 . . . . 0.0 110.07 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.94 -71.21 0.64 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.597 0.713 . . . . 0.0 110.104 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -126.27 144.57 50.74 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 121.794 0.807 . . . . 0.0 111.269 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.49 128.52 39.63 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.436 ' CG2' H131 ' A' ' 201' ' ' 4P2 . 2.4 t -99.02 120.47 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.531 -0.731 . . . . 0.0 111.671 -177.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 28.2 p -141.29 136.9 32.06 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.507 -0.746 . . . . 0.0 110.622 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 87.1 m -71.28 -42.52 68.64 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.546 -0.721 . . . . 0.0 109.92 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -140.86 49.54 1.68 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.575 -0.703 . . . . 0.0 110.075 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 89.99 -11.64 70.07 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 61.7 t -94.66 120.44 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.245 -1.15 . . . . 0.0 108.925 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.45 117.49 26.28 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.632 -0.668 . . . . 0.0 111.074 -178.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -113.19 -26.23 8.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.751 -0.593 . . . . 0.0 110.008 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -125.98 168.45 13.91 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.485 -0.759 . . . . 0.0 110.394 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 35.3 m -144.73 135.81 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.542 -0.724 . . . . 0.0 110.48 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -112.94 133.87 54.71 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.411 -0.806 . . . . 0.0 110.954 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -147.04 162.32 39.04 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.67 -0.644 . . . . 0.0 110.366 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 4.1 m -104.23 145.21 30.23 Favored Pre-proline 0 N--CA 1.505 2.291 0 O-C-N 121.449 -0.782 . . . . 0.0 110.456 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -75.33 -171.82 1.12 Allowed 'Trans proline' 0 C--N 1.319 -1.019 0 O-C-N 123.436 1.23 . . . . 0.0 109.83 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 57.3 t -87.39 -23.26 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.595 -0.69 . . . . 0.0 110.417 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -61.69 -30.31 70.66 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.412 -0.805 . . . . 0.0 111.28 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 9.5 t -62.67 -24.46 67.64 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.161 -0.962 . . . . 0.0 110.687 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.42 ' HG2' ' CD2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -80.73 -28.25 36.62 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.487 -0.758 . . . . 0.0 111.15 -179.457 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -59.94 -44.62 94.26 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.433 -0.792 . . . . 0.0 110.551 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 90.0 m -69.9 -39.94 75.93 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.433 -0.792 . . . . 0.0 110.492 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 58.9 m -67.77 -31.85 72.03 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.543 -0.723 . . . . 0.0 110.679 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.8 -38.27 81.45 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.377 -0.827 . . . . 0.0 110.556 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -59.92 -39.96 87.22 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.443 -0.785 . . . . 0.0 110.374 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.803 0 O-C-N 121.499 -0.751 . . . . 0.0 110.148 179.871 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' 4P2 . . . . . 0.473 H481 ' HA ' ' A' ' 136' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 56.4 p . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.027 0.441 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.77 27.04 6.15 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 51.68 59.49 4.53 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.278 -1.131 . . . . 0.0 110.869 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.415 ' HA ' ' CE1' ' A' ' 110' ' ' HIS . 41.0 t0 -75.02 116.54 15.87 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.48 -0.763 . . . . 0.0 110.227 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.7 pttt -119.98 -7.02 9.99 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.599 -0.688 . . . . 0.0 111.18 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 53.34 94.26 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.051 -1.03 . . . . 0.0 110.706 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -71.4 162.17 29.86 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.542 -0.724 . . . . 0.0 110.203 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.2 t -60.1 141.48 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.565 -0.709 . . . . 0.0 110.064 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -60.0 134.94 57.52 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.547 -0.72 . . . . 0.0 110.147 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.86 -80.37 0.84 Allowed Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -133.92 -0.46 3.1 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.546 -0.973 . . . . 0.0 111.848 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.3 p -135.0 128.52 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.089 -1.007 . . . . 0.0 109.895 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -107.52 134.56 50.36 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.671 -0.643 . . . . 0.0 110.413 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.2 m -72.54 147.74 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.615 -0.678 . . . . 0.0 110.096 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.5 t -124.9 145.92 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.562 -0.712 . . . . 0.0 109.74 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.6 t -115.85 126.67 54.27 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.656 -0.652 . . . . 0.0 110.36 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.3 m -113.92 175.57 5.41 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.578 -0.701 . . . . 0.0 110.012 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.01 -13.96 59.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.668 -0.645 . . . . 0.0 111.326 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 77.5 p -121.25 -28.21 4.73 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.173 -0.954 . . . . 0.0 111.424 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -154.42 175.86 13.05 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.278 -0.888 . . . . 0.0 110.95 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.5 t -135.91 122.82 21.3 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.71 -0.619 . . . . 0.0 109.935 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -127.78 -169.61 2.09 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.504 -0.748 . . . . 0.0 110.368 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.41 167.83 10.69 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.574 -0.704 . . . . 0.0 110.491 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.61 140.71 35.12 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.604 -0.685 . . . . 0.0 110.151 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 67.7 p -119.26 138.62 52.88 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.428 -0.795 . . . . 0.0 110.057 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.1 t -101.14 115.09 29.68 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.541 -0.725 . . . . 0.0 110.596 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.0 t -129.98 127.1 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.457 -0.777 . . . . 0.0 110.159 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 64.8 t30 53.16 40.21 30.88 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.455 -0.778 . . . . 0.0 111.045 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.01 21.5 71.67 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 62.9 t -130.21 113.75 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.399 -1.059 . . . . 0.0 109.463 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.2 t -82.98 133.02 35.12 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.593 -0.692 . . . . 0.0 109.906 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.401 ' CH2' ' O ' ' A' ' 175' ' ' MET . 92.9 m95 -119.95 136.39 54.55 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.492 -0.755 . . . . 0.0 111.094 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.5 t -137.71 -179.92 6.04 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.47 ' CG1' ' CE1' ' A' ' 57' ' ' HIS . 47.2 t -92.39 147.56 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.294 -0.879 . . . . 0.0 109.979 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.499 ' CE2' HG21 ' A' ' 78' ' ' VAL . 21.6 t80 -84.15 -43.45 14.98 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.539 -0.726 . . . . 0.0 111.407 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.47 ' CE1' ' CG1' ' A' ' 55' ' ' VAL . 1.5 p-80 -52.38 -25.91 11.08 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.116 -0.99 . . . . 0.0 111.114 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.431 ' N ' ' CD2' ' A' ' 57' ' ' HIS . . . -89.59 -55.99 1.95 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.24 -63.38 1.41 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.527 -0.984 . . . . 0.0 110.334 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.12 -144.71 17.28 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 89.1 p -104.94 21.76 16.46 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.591 -0.947 . . . . 0.0 110.654 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.67 160.49 19.55 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.365 -0.834 . . . . 0.0 109.959 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.9 m -77.82 147.92 34.97 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.567 -0.708 . . . . 0.0 110.298 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -97.94 143.01 28.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.523 -0.736 . . . . 0.0 110.113 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.55 127.08 44.35 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.629 -0.669 . . . . 0.0 110.268 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -129.96 158.93 22.5 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.48 -47.0 1.64 Allowed 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.377 1.198 . . . . 0.0 110.731 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -71.55 -31.1 66.63 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.544 -0.722 . . . . 0.0 110.161 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 162.92 156.97 8.8 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.04 164.64 34.95 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 O-C-N 123.384 1.202 . . . . 0.0 110.445 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 85.7 mt -129.42 137.24 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.533 -0.729 . . . . 0.0 109.891 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 64.6 p -83.49 150.3 26.09 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.585 -0.697 . . . . 0.0 110.538 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -82.66 119.95 24.94 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.578 -0.701 . . . . 0.0 110.086 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.2 mtp -83.97 -51.15 7.37 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.526 -0.734 . . . . 0.0 110.473 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.467 ' CD2' ' N ' ' A' ' 75' ' ' TYR . 1.2 p90 -122.54 130.09 52.66 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.672 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.433 ' HA ' HG11 ' A' ' 83' ' ' VAL . 57.0 m -135.28 141.1 45.63 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.659 -0.651 . . . . 0.0 110.501 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -161.34 120.92 2.57 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.234 -0.916 . . . . 0.0 112.133 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.499 HG21 ' CE2' ' A' ' 56' ' ' TYR . 54.2 t -72.88 -39.11 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.295 -0.878 . . . . 0.0 109.34 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -55.54 -43.04 75.45 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.389 -0.82 . . . . 0.0 110.369 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.407 ' HB3' ' CD2' ' A' ' 82' ' ' LEU . 3.3 tp60 -90.92 -9.68 45.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.608 -0.683 . . . . 0.0 110.485 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t0 52.47 42.0 31.09 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.088 -1.007 . . . . 0.0 111.54 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.407 ' CD2' ' HB3' ' A' ' 80' ' ' GLN . 0.3 OUTLIER -148.58 143.1 26.37 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.173 -0.954 . . . . 0.0 111.123 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.433 HG11 ' HA ' ' A' ' 76' ' ' THR . 28.4 m -145.18 144.08 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.448 ' N ' ' CE1' ' A' ' 75' ' ' TYR . . . -142.61 156.83 26.46 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.571 -1.3 . . . . 0.0 110.347 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -113.63 168.11 10.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.901 -0.764 . . . . 0.0 109.331 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -87.29 100.62 12.84 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.494 -0.754 . . . . 0.0 109.299 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.08 158.88 82.6 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.636 -0.665 . . . . 0.0 110.461 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.43 160.13 49.49 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.523 1.275 . . . . 0.0 110.299 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.49 151.01 52.69 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 O-C-N 123.402 1.212 . . . . 0.0 110.283 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.34 -23.72 34.28 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.13 152.76 23.55 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.336 -1.096 . . . . 0.0 110.291 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -70.25 148.01 49.08 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.561 -0.712 . . . . 0.0 110.244 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 80.0 p -126.7 149.71 49.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.58 -0.7 . . . . 0.0 110.093 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.6 mt -109.79 157.4 19.2 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.541 -0.725 . . . . 0.0 110.548 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 89.7 m -98.16 144.4 27.99 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.701 -0.625 . . . . 0.0 109.727 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.48 160.47 49.67 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.256 1.135 . . . . 0.0 110.407 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 45.2 t -60.02 134.64 57.23 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.587 -0.695 . . . . 0.0 110.445 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 21.6 m -136.1 48.29 2.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.673 -0.642 . . . . 0.0 109.977 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.9 p -144.89 -8.31 0.63 Allowed 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 119.949 -0.701 . . . . 0.0 112.383 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.68 72.01 0.61 Allowed Glycine 0 N--CA 1.5 2.928 0 O-C-N 120.766 -1.209 . . . . 0.0 110.288 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.0 m -125.09 129.98 51.31 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.522 -0.987 . . . . 0.0 110.471 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.7 m -67.19 -39.95 86.47 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.492 -0.755 . . . . 0.0 110.138 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -60.17 131.75 51.79 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.589 -0.694 . . . . 0.0 110.356 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 88.3 mt -136.36 160.21 39.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.646 -0.658 . . . . 0.0 110.153 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -122.98 109.45 14.13 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.477 -0.764 . . . . 0.0 110.246 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.413 ' O ' ' CG1' ' A' ' 113' ' ' VAL . 21.1 tp -74.17 148.14 41.96 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.708 -0.62 . . . . 0.0 109.837 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.0 t -126.28 119.99 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.289 -0.882 . . . . 0.0 110.244 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 53.0 p -91.36 -164.93 1.25 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.264 -0.898 . . . . 0.0 110.076 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.26 -18.99 24.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.522 -0.736 . . . . 0.0 111.229 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.428 ' O ' ' CG ' ' A' ' 110' ' ' HIS . 4.5 t60 -109.65 29.4 7.62 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.259 -0.9 . . . . 0.0 110.666 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 57.47 33.62 23.52 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.301 -0.874 . . . . 0.0 112.063 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.423 ' O ' ' CG1' ' A' ' 113' ' ' VAL . 7.0 p-10 -119.39 134.01 55.43 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.285 -0.884 . . . . 0.0 109.727 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -176.37 -173.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.425 0 CA-C-O 121.853 0.835 . . . . 0.0 111.143 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.19 168.8 10.58 Favored Pre-proline 0 N--CA 1.49 1.568 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -70.36 145.12 52.77 Favored 'Trans proline' 0 C--N 1.317 -1.106 0 O-C-N 123.217 1.114 . . . . 0.0 110.066 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.3 t -126.91 130.0 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.569 -0.707 . . . . 0.0 110.116 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.9 mmm180 -83.28 132.39 35.03 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.487 -0.758 . . . . 0.0 110.053 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 49.6 ttm-85 -65.96 133.27 50.49 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.535 -0.728 . . . . 0.0 110.242 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -116.49 -22.44 8.72 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.622 -0.674 . . . . 0.0 110.478 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -155.93 -167.33 17.21 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -70.09 -39.95 75.27 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.598 -0.942 . . . . 0.0 110.565 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 36.9 p -129.9 26.46 5.24 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.396 -0.815 . . . . 0.0 110.801 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.48 152.61 41.7 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.511 -0.743 . . . . 0.0 110.181 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -149.19 -179.98 25.51 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 78.0 p -120.0 151.5 38.88 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.703 -0.881 . . . . 0.0 110.217 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.0 tp -100.0 129.88 46.11 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.653 -0.655 . . . . 0.0 110.195 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.3 mp -61.91 -53.91 49.17 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.581 -0.699 . . . . 0.0 110.404 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.6 t -95.28 129.91 33.87 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.561 -0.712 . . . . 0.0 110.124 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -79.27 106.85 2.1 Favored 'Trans proline' 0 C--N 1.32 -0.97 0 O-C-N 123.175 1.092 . . . . 0.0 110.673 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.415 ' HD2' ' CD2' ' A' ' 134' ' ' TYR . 4.6 mtm180 -114.21 149.91 42.81 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.599 -0.688 . . . . 0.0 109.636 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.36 150.31 70.52 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 123.317 1.167 . . . . 0.0 111.153 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 66.0 t -52.85 -29.26 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.501 -0.749 . . . . 0.0 109.81 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.93 -43.26 95.05 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.605 -0.685 . . . . 0.0 111.279 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.415 ' CD2' ' HD2' ' A' ' 130' ' ' ARG . 88.9 t80 -65.89 -40.01 91.18 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.358 -0.838 . . . . 0.0 109.619 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 21.8 tp -93.26 18.87 8.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.926 -0.484 . . . . 0.0 110.278 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.469 ' HA ' H481 ' A' ' 201' ' ' 4P2 . 8.4 ttmt -82.47 116.64 22.01 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 122.523 1.154 . . . . 0.0 112.514 -178.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.402 ' HA2' H551 ' A' ' 201' ' ' 4P2 . . . 100.97 30.14 6.18 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.0 m -110.57 20.26 17.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.687 -0.89 . . . . 0.0 110.353 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.7 m -76.44 141.81 41.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.311 -0.868 . . . . 0.0 109.557 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 95.91 -26.62 19.74 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.84 128.35 44.83 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 108.911 -1.675 . . . . 0.0 108.911 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.05 172.54 16.16 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 O-C-N 123.201 1.106 . . . . 0.0 111.142 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.3 mp -117.68 115.61 25.41 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.408 ' N ' ' CD2' ' A' ' 144' ' ' LEU . 4.5 mm? -90.09 152.37 21.17 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.701 -0.624 . . . . 0.0 111.017 -178.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.95 179.28 1.28 Allowed Pre-proline 0 N--CA 1.494 1.733 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.63 -26.62 27.99 Favored 'Trans proline' 0 C--N 1.318 -1.069 0 O-C-N 123.202 1.106 . . . . 0.0 110.319 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 66.2 m -79.41 -29.06 41.8 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.519 -0.738 . . . . 0.0 110.043 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 113.43 50.26 0.54 Allowed Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -135.77 148.06 48.63 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.517 -0.99 . . . . 0.0 110.288 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -76.1 136.94 39.86 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.537 -0.727 . . . . 0.0 110.051 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 13.0 p -119.06 -24.45 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.559 -0.713 . . . . 0.0 110.878 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 176.6 -167.74 39.38 Favored Glycine 0 N--CA 1.498 2.784 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.29 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 71.8 mt -130.38 158.88 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.598 -0.942 . . . . 0.0 109.833 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -75.84 151.64 37.42 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.454 -0.779 . . . . 0.0 109.918 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.401 ' CZ ' ' CG2' ' A' ' 170' ' ' VAL . 30.7 ttm180 -131.83 -76.41 0.51 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.572 -0.705 . . . . 0.0 110.797 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -122.46 143.68 49.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.086 -1.009 . . . . 0.0 111.406 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.65 127.87 39.55 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.445 ' CG2' H131 ' A' ' 201' ' ' 4P2 . 2.5 t -97.67 117.98 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 O-C-N 121.506 -0.746 . . . . 0.0 111.673 -177.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 28.9 p -141.07 148.72 40.63 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.371 -0.831 . . . . 0.0 110.672 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 63.7 m -85.56 -50.14 7.47 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.448 -0.782 . . . . 0.0 109.72 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.75 32.79 5.61 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.74 -0.6 . . . . 0.0 109.608 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 101.44 -11.69 58.23 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 63.4 t -89.51 120.92 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.223 -1.163 . . . . 0.0 108.991 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -86.97 113.25 22.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.644 -0.66 . . . . 0.0 110.975 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -108.52 -26.23 10.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.787 -0.571 . . . . 0.0 109.862 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -121.27 164.02 17.65 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.47 -0.769 . . . . 0.0 109.952 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 35.0 m -141.81 131.1 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.534 -0.729 . . . . 0.0 110.659 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -103.83 129.67 51.32 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.477 -0.765 . . . . 0.0 110.709 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -142.65 162.17 36.18 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.568 -0.708 . . . . 0.0 110.188 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.401 ' CG2' ' CZ ' ' A' ' 155' ' ' ARG . 86.1 t -111.93 144.93 31.7 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.427 -0.796 . . . . 0.0 110.089 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.95 175.2 10.09 Favored 'Trans proline' 0 N--CA 1.486 1.061 0 O-C-N 123.319 1.168 . . . . 0.0 110.984 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 59.4 t -79.42 -41.41 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.657 -0.652 . . . . 0.0 110.153 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -54.41 -36.32 63.84 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.835 -0.541 . . . . 0.0 111.045 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 45.2 t -61.84 -33.71 74.66 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.485 -0.76 . . . . 0.0 109.906 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.401 ' O ' ' CH2' ' A' ' 53' ' ' TRP . 67.2 mtt -70.05 -27.94 65.05 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.595 -0.69 . . . . 0.0 110.446 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -59.5 -50.09 75.28 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.495 -0.753 . . . . 0.0 110.64 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 7.1 t -69.98 -22.54 63.14 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.516 -0.74 . . . . 0.0 110.825 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 68.4 m -68.68 -29.08 67.46 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.439 -0.788 . . . . 0.0 110.53 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 91.1 mtp -59.98 -48.49 81.48 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.476 -0.765 . . . . 0.0 110.257 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -59.91 -40.07 87.55 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.606 -0.684 . . . . 0.0 110.315 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.792 0 O-C-N 121.65 -0.656 . . . . 0.0 110.188 -179.961 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' 4P2 . . . . . 0.469 H481 ' HA ' ' A' ' 136' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.2 m . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.022 0.439 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -138.19 -74.84 0.06 OUTLIER Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 53.37 51.28 15.72 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.433 -1.04 . . . . 0.0 110.574 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -84.62 169.97 13.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.688 -0.632 . . . . 0.0 110.367 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.0 mmmt -80.96 -176.72 6.06 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.673 -0.642 . . . . 0.0 110.213 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -60.63 144.64 51.41 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.558 -0.714 . . . . 0.0 110.28 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 64.1 mm-40 -128.02 162.95 25.62 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.527 -0.733 . . . . 0.0 110.329 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.2 t -71.47 140.01 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.608 -0.683 . . . . 0.0 110.093 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -72.35 157.98 36.65 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.526 -0.734 . . . . 0.0 110.46 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -120.31 88.05 0.42 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.1 mp0 54.13 22.02 3.32 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.531 -0.982 . . . . 0.0 111.221 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.4 m -132.77 160.06 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.483 -0.76 . . . . 0.0 109.83 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -143.42 126.53 16.46 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.615 -0.678 . . . . 0.0 110.24 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.0 m -74.39 145.54 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.506 -0.746 . . . . 0.0 109.934 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.427 HG21 ' CE2' ' A' ' 43' ' ' PHE . 33.6 m -136.0 148.07 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.444 -0.785 . . . . 0.0 110.19 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.8 m -116.41 126.09 52.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.613 -0.68 . . . . 0.0 110.412 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.52 -171.01 1.91 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.624 -0.672 . . . . 0.0 109.455 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.08 -51.74 68.32 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.77 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.1 t -128.02 10.78 6.47 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.468 -0.77 . . . . 0.0 111.529 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -148.29 161.24 41.92 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.135 -0.978 . . . . 0.0 110.603 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 81.2 p -143.3 125.71 15.7 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.547 -0.72 . . . . 0.0 110.144 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.427 ' CE2' HG21 ' A' ' 36' ' ' VAL . 27.5 p90 -129.45 -169.69 2.15 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.638 -0.664 . . . . 0.0 110.252 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.1 mt -126.13 164.49 20.79 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.617 -0.677 . . . . 0.0 110.43 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -138.65 140.33 38.83 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.588 -0.695 . . . . 0.0 110.16 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.7 m -115.01 127.86 55.92 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.528 -0.732 . . . . 0.0 110.096 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 26.7 p -75.62 117.02 16.94 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.569 -0.707 . . . . 0.0 110.773 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.7 t -130.29 123.95 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.33 -0.856 . . . . 0.0 110.436 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 50.74 34.06 9.4 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.568 -0.708 . . . . 0.0 111.764 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.76 -24.23 13.49 Favored Glycine 0 N--CA 1.498 2.778 0 C-N-CA 120.365 -0.921 . . . . 0.0 111.216 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.7 t -106.53 113.94 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.155 -1.203 . . . . 0.0 109.781 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 27.5 p -71.12 154.49 41.69 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.438 -0.789 . . . . 0.0 110.259 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.432 ' CZ2' ' HB3' ' A' ' 175' ' ' MET . 79.0 m95 -124.36 137.06 54.51 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.606 -0.684 . . . . 0.0 110.779 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.454 ' CG2' ' CH2' ' A' ' 85' ' ' TRP . 7.5 t -136.99 -179.97 6.02 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.738 -0.601 . . . . 0.0 109.888 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.486 ' CG1' ' CE1' ' A' ' 57' ' ' HIS . 62.4 t -85.41 142.01 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.608 -0.682 . . . . 0.0 109.547 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.475 ' CE2' ' CG2' ' A' ' 78' ' ' VAL . 25.3 t80 -85.2 -44.04 13.27 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.495 -0.753 . . . . 0.0 111.031 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.486 ' CE1' ' CG1' ' A' ' 55' ' ' VAL . 2.3 p-80 -60.68 -20.15 60.25 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.025 -177.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -92.71 -54.49 1.78 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.15 -47.64 19.82 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.49 -1.006 . . . . 0.0 110.58 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.25 -146.15 28.83 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 61.9 m -123.22 43.91 2.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.547 -0.973 . . . . 0.0 110.354 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -115.2 177.31 4.7 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.559 -0.713 . . . . 0.0 110.215 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.6 p -65.97 153.78 41.18 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.639 -0.663 . . . . 0.0 110.08 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.415 HD11 ' CZ2' ' A' ' 85' ' ' TRP . 0.8 OUTLIER -110.01 150.61 28.27 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.615 -0.678 . . . . 0.0 110.419 -179.797 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.84 110.98 23.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.647 -0.658 . . . . 0.0 109.977 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -129.29 170.02 20.42 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.0 -45.84 2.75 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 O-C-N 123.405 1.213 . . . . 0.0 110.484 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.2 tptp -70.47 -31.28 68.35 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.579 -0.701 . . . . 0.0 110.079 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 145.81 -176.15 24.94 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.83 169.32 22.34 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 O-C-N 123.43 1.226 . . . . 0.0 110.509 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 44.3 pt -133.76 -175.4 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.491 -0.756 . . . . 0.0 110.246 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 t -113.8 142.66 45.8 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.524 -0.735 . . . . 0.0 110.541 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.434 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -77.44 124.96 28.58 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.588 -0.695 . . . . 0.0 110.502 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 8.2 ttt -82.78 -52.77 6.44 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.368 -0.832 . . . . 0.0 109.795 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.524 ' CZ ' ' HA3' ' A' ' 84' ' ' GLY . 12.1 p90 -147.08 139.91 25.05 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.294 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 81.7 p -130.52 140.41 50.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.724 -0.61 . . . . 0.0 109.711 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -159.67 120.74 3.17 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.253 -0.904 . . . . 0.0 111.033 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.475 ' CG2' ' CE2' ' A' ' 56' ' ' TYR . 99.0 t -72.22 -35.6 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.411 -0.806 . . . . 0.0 109.769 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -55.87 -35.71 66.8 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.46 -0.775 . . . . 0.0 110.275 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 31.9 tp60 -102.55 -13.79 17.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.736 -0.603 . . . . 0.0 110.469 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 44.9 t0 55.25 38.02 29.77 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.167 -0.958 . . . . 0.0 110.621 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.42 HD21 ' CE3' ' A' ' 53' ' ' TRP . 2.2 mp -136.18 148.93 48.38 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.611 -0.681 . . . . 0.0 110.361 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.42 ' CG2' ' HB2' ' A' ' 56' ' ' TYR . 4.8 t -146.52 129.87 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.524 ' HA3' ' CZ ' ' A' ' 75' ' ' TYR . . . -118.68 163.7 13.1 Favored Glycine 0 N--CA 1.502 3.071 0 C-N-CA 118.817 -1.658 . . . . 0.0 111.307 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.454 ' CH2' ' CG2' ' A' ' 54' ' ' THR . 5.7 m-90 -132.51 158.42 42.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.958 -0.731 . . . . 0.0 109.469 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -74.32 103.98 4.91 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.534 -0.729 . . . . 0.0 110.013 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.4 158.51 87.49 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.645 -0.659 . . . . 0.0 110.274 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.45 160.03 47.77 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 O-C-N 123.453 1.238 . . . . 0.0 110.367 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -74.98 160.05 40.68 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 O-C-N 123.404 1.213 . . . . 0.0 110.391 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 87.64 28.18 24.94 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -123.84 139.45 53.96 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.492 -1.005 . . . . 0.0 110.153 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.39 139.02 38.8 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.514 -0.741 . . . . 0.0 110.209 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.9 p -92.39 145.09 24.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.578 -0.701 . . . . 0.0 110.185 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 40.2 mt -79.08 157.35 28.01 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.594 -0.691 . . . . 0.0 110.175 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.2 t -110.99 150.09 41.39 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.623 -0.673 . . . . 0.0 110.209 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.22 161.38 44.69 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 O-C-N 123.388 1.204 . . . . 0.0 110.708 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 37.3 t -70.56 135.55 48.59 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.626 -0.671 . . . . 0.0 110.267 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.2 t -136.19 50.35 2.07 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.61 -0.681 . . . . 0.0 110.337 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.7 p -145.12 4.12 1.07 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.492 -0.755 . . . . 0.0 112.107 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 50.79 70.29 0.89 Allowed Glycine 0 N--CA 1.5 2.928 0 O-C-N 120.897 -1.127 . . . . 0.0 110.693 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 92.7 p -120.89 133.47 55.3 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.467 -1.02 . . . . 0.0 110.474 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 63.8 m -83.01 -28.81 29.4 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.643 -0.66 . . . . 0.0 110.198 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -66.56 133.58 50.62 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.629 -0.669 . . . . 0.0 110.181 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 91.2 mt -134.9 162.19 33.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.586 -0.696 . . . . 0.0 110.143 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -130.26 108.9 10.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.521 -0.737 . . . . 0.0 110.072 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 21.9 tp -74.11 147.19 42.95 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.668 -0.645 . . . . 0.0 109.524 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.5 t -118.62 127.08 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.385 -0.822 . . . . 0.0 110.054 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 37.5 m -103.19 168.12 9.38 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.348 -0.845 . . . . 0.0 110.344 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 -63.22 -27.63 69.49 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.625 -0.672 . . . . 0.0 110.965 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -96.44 26.97 4.03 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.428 -0.795 . . . . 0.0 110.812 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 52.63 24.18 3.01 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.361 -0.837 . . . . 0.0 111.092 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -115.03 139.33 49.95 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.426 -0.796 . . . . 0.0 109.547 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -175.7 -172.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 CA-C-O 121.803 0.811 . . . . 0.0 111.05 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.01 170.35 8.28 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -76.13 138.21 20.15 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 O-C-N 123.288 1.152 . . . . 0.0 110.439 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.4 t -120.27 130.01 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.619 -0.676 . . . . 0.0 109.889 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -85.44 135.41 33.87 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.525 -0.734 . . . . 0.0 109.965 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -66.8 135.29 53.71 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.582 -0.699 . . . . 0.0 110.489 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -140.27 27.38 2.13 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.633 -0.667 . . . . 0.0 110.144 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 163.6 169.35 26.96 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -62.53 -45.16 94.25 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.592 -0.946 . . . . 0.0 110.272 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.8 m -123.51 27.08 7.57 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.615 -0.678 . . . . 0.0 110.394 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.53 155.84 45.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.505 -0.747 . . . . 0.0 110.114 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -151.52 -177.09 24.96 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 78.9 p -119.67 152.3 37.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.638 -0.919 . . . . 0.0 110.211 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.51 145.44 34.74 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.667 -0.645 . . . . 0.0 109.898 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.5 mp -89.98 -73.79 0.51 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.658 -0.651 . . . . 0.0 109.796 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 43.0 t -72.29 112.63 15.46 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.59 -0.694 . . . . 0.0 109.334 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.68 124.19 9.57 Favored 'Trans proline' 0 C--N 1.319 -0.984 0 O-C-N 123.161 1.085 . . . . 0.0 111.266 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -127.63 153.54 77.66 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.61 150.32 56.77 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 O-C-N 123.338 1.178 . . . . 0.0 110.671 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.6 t -52.38 -29.51 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.387 -0.821 . . . . 0.0 109.577 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 46.8 t -61.24 -46.06 91.96 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.745 -0.597 . . . . 0.0 111.382 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -63.87 -39.42 94.15 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.254 -0.904 . . . . 0.0 109.618 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 35.4 tp -92.2 18.62 7.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.855 -0.528 . . . . 0.0 110.025 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.487 ' HA ' H481 ' A' ' 201' ' ' 4P2 . 19.6 tttm -83.47 119.23 24.42 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.491 1.139 . . . . 0.0 112.837 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.405 ' HA2' H551 ' A' ' 201' ' ' 4P2 . . . 98.79 23.51 11.8 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.5 m -105.09 20.79 18.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.496 -1.002 . . . . 0.0 110.584 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.6 m -73.61 144.41 45.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.316 -0.865 . . . . 0.0 109.243 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 97.31 -25.44 27.09 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -58.5 119.41 17.28 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.65 173.87 13.19 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 O-C-N 123.214 1.112 . . . . 0.0 111.058 -178.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.2 mp -121.18 130.55 53.76 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -115.02 126.15 54.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.597 -0.689 . . . . 0.0 111.093 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.655 ' SG ' 'ZN ' ' A' ' 202' ' ' ' ZN' . 29.2 p -72.24 165.75 47.79 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.438 -0.789 . . . . 0.0 108.878 178.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.423 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 38.1 Cg_endo -63.54 -14.9 45.3 Favored 'Trans proline' 0 N--CA 1.488 1.188 0 O-C-N 123.022 1.011 . . . . 0.0 111.36 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 8.8 t -75.32 -34.14 61.21 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.227 -0.921 . . . . 0.0 110.02 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 114.31 47.47 0.59 Allowed Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -146.29 147.79 31.75 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.645 -0.915 . . . . 0.0 110.136 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -76.98 137.99 39.36 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.485 -0.759 . . . . 0.0 109.89 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.3 p -119.14 -30.87 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.512 -0.742 . . . . 0.0 111.102 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.52 -169.51 32.04 Favored Glycine 0 N--CA 1.498 2.785 0 C-N-CA 119.678 -1.249 . . . . 0.0 110.602 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.4 tt -139.96 148.89 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.701 -0.882 . . . . 0.0 109.588 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -66.42 154.95 38.83 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.156 -0.965 . . . . 0.0 111.654 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -137.82 -70.62 0.44 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.06 0.457 . . . . 0.0 109.998 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -123.29 145.59 48.57 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.26 -0.9 . . . . 0.0 111.743 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.52 129.65 41.23 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.439 ' CG2' H131 ' A' ' 201' ' ' 4P2 . 2.3 t -100.43 122.02 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 121.404 -0.81 . . . . 0.0 111.476 -177.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 28.2 p -141.28 139.48 33.68 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.411 -0.805 . . . . 0.0 110.647 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 86.9 m -71.28 -44.16 65.74 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.579 -0.7 . . . . 0.0 109.693 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -145.23 52.38 1.2 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.606 -0.684 . . . . 0.0 109.872 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 90.78 -11.59 71.37 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 64.3 t -99.41 129.53 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.19 -1.182 . . . . 0.0 108.779 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.15 123.91 32.7 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.464 -0.772 . . . . 0.0 111.536 -178.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -113.32 -28.84 7.45 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.205 0.526 . . . . 0.0 109.775 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -138.52 168.36 19.94 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.581 -0.7 . . . . 0.0 109.452 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.7 m -138.73 148.83 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.338 -0.851 . . . . 0.0 111.297 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -120.11 137.92 53.86 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.67 -0.644 . . . . 0.0 110.146 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -139.0 161.9 36.24 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.589 -0.694 . . . . 0.0 110.853 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 59.0 t -93.37 137.84 23.31 Favored Pre-proline 0 N--CA 1.497 1.905 0 O-C-N 121.504 -0.748 . . . . 0.0 110.017 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -77.53 156.28 32.14 Favored 'Trans proline' 0 C--N 1.32 -0.971 0 O-C-N 123.18 1.095 . . . . 0.0 110.293 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 96.0 t -79.94 -26.99 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.352 -0.842 . . . . 0.0 110.213 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.402 ' HG3' ' N ' ' A' ' 174' ' ' SER . 2.4 pt-20 -59.95 -28.71 67.87 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.367 -0.833 . . . . 0.0 110.375 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.402 ' N ' ' HG3' ' A' ' 173' ' ' GLU . 72.2 m -76.51 -28.83 56.54 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.472 -0.767 . . . . 0.0 110.195 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.432 ' HB3' ' CZ2' ' A' ' 53' ' ' TRP . 64.9 mtt -59.86 -32.82 71.06 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.631 -0.668 . . . . 0.0 110.647 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -59.87 -50.08 75.17 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.433 -0.792 . . . . 0.0 110.168 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 88.1 m -72.05 -39.96 68.69 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.626 -0.671 . . . . 0.0 109.838 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 89.9 m -61.27 -38.06 85.4 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.628 -0.67 . . . . 0.0 110.236 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 5.0 tmm? -59.78 -33.94 72.35 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.509 -0.744 . . . . 0.0 110.372 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 25.9 ttm180 -59.97 -40.07 87.82 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.504 -0.747 . . . . 0.0 110.253 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.734 0 O-C-N 121.579 -0.701 . . . . 0.0 110.229 179.995 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' 4P2 . . . . . 0.487 H481 ' HA ' ' A' ' 136' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . 0.655 'ZN ' ' SG ' ' A' ' 145' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.4 p . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.097 0.475 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.72 170.43 36.12 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -88.11 131.03 34.85 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.574 -0.957 . . . . 0.0 110.259 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -124.15 14.38 9.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.522 -0.736 . . . . 0.0 111.028 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -124.35 139.02 54.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.37 -0.831 . . . . 0.0 110.094 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -121.45 113.39 19.78 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.57 -0.706 . . . . 0.0 110.349 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -64.43 -39.88 94.68 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.612 -0.68 . . . . 0.0 109.979 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.6 m -125.67 157.01 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.74 -0.6 . . . . 0.0 110.158 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -120.29 139.42 52.76 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.594 -0.691 . . . . 0.0 110.053 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.63 41.44 0.03 OUTLIER Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -69.82 -29.03 66.21 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.571 -0.958 . . . . 0.0 110.244 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.3 p -127.14 140.07 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.563 -0.711 . . . . 0.0 110.055 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -102.88 141.61 35.39 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.602 -0.686 . . . . 0.0 110.246 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.7 m -87.05 116.28 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.589 -0.695 . . . . 0.0 110.387 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.2 p -138.57 136.14 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.468 -0.77 . . . . 0.0 109.984 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 75.7 m -131.83 143.26 50.06 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.425 -0.797 . . . . 0.0 110.745 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 70.3 p -96.58 -179.98 4.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.629 -0.669 . . . . 0.0 109.737 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.63 -14.25 61.14 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.302 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 75.2 p -119.27 -25.4 6.13 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.136 -0.977 . . . . 0.0 111.432 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -141.83 168.17 20.4 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.253 -0.905 . . . . 0.0 110.96 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.8 t -138.62 118.94 13.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.582 -0.699 . . . . 0.0 110.342 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -140.26 175.83 9.27 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.532 -0.73 . . . . 0.0 109.995 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 81.5 mt -115.6 152.7 32.6 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.251 -0.906 . . . . 0.0 110.545 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -117.17 141.02 48.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.604 -0.685 . . . . 0.0 110.24 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 86.2 m -117.27 143.06 46.31 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.537 -0.727 . . . . 0.0 110.228 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 93.3 m -94.13 113.75 25.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.576 -0.703 . . . . 0.0 110.654 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.2 t -127.49 129.95 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.599 -0.688 . . . . 0.0 109.905 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 53.84 39.84 30.84 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.522 -0.736 . . . . 0.0 111.175 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.61 17.8 67.27 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 62.3 t -129.95 130.04 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.25 -1.147 . . . . 0.0 109.755 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 97.9 m -82.02 112.72 19.36 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.529 -0.732 . . . . 0.0 110.002 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -101.76 137.48 40.01 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.606 -0.684 . . . . 0.0 110.52 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.416 HG21 ' CZ3' ' A' ' 85' ' ' TRP . 7.4 t -136.55 -179.87 5.94 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.643 -0.661 . . . . 0.0 109.738 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.475 ' CG1' ' CE1' ' A' ' 57' ' ' HIS . 91.0 t -83.23 142.1 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.516 -0.74 . . . . 0.0 109.872 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.432 ' CE2' HG21 ' A' ' 78' ' ' VAL . 43.0 t80 -84.55 -42.52 15.39 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.609 -0.682 . . . . 0.0 111.223 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.475 ' CE1' ' CG1' ' A' ' 55' ' ' VAL . 1.9 p-80 -62.01 -20.83 64.32 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.399 -0.921 . . . . 0.0 110.588 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -83.94 -75.28 1.2 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.77 -48.18 77.99 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.581 -0.952 . . . . 0.0 110.082 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.89 -175.95 35.78 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.2 t -60.04 -39.86 87.37 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.628 -0.925 . . . . 0.0 110.242 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -60.08 134.86 57.45 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.568 -0.708 . . . . 0.0 110.096 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.1 t -92.84 179.18 5.54 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.521 -0.737 . . . . 0.0 110.391 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 93.6 mt -111.9 143.08 43.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.639 -0.663 . . . . 0.0 110.275 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -117.13 130.53 56.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.643 -0.661 . . . . 0.0 110.2 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.97 -149.7 5.68 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -71.1 -42.25 2.17 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.41 1.216 . . . . 0.0 110.466 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -119.99 20.09 12.21 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.592 -0.692 . . . . 0.0 110.646 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -106.11 137.12 13.66 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -81.46 165.1 18.68 Favored 'Trans proline' 0 C--N 1.319 -1.004 0 O-C-N 123.198 1.104 . . . . 0.0 110.642 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 31.3 pt -106.3 2.77 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.701 -0.624 . . . . 0.0 111.016 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.6 t -119.24 150.04 40.75 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.136 -0.978 . . . . 0.0 110.105 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -98.16 126.57 43.68 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.513 -0.742 . . . . 0.0 110.381 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 49.3 tpp -97.22 -47.26 5.81 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.51 -0.744 . . . . 0.0 110.713 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -119.72 134.95 55.03 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.526 -0.734 . . . . 0.0 110.252 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.4 m -151.55 128.09 10.75 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.512 -0.742 . . . . 0.0 110.348 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -158.88 116.31 2.81 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.372 -0.83 . . . . 0.0 111.242 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.432 HG21 ' CE2' ' A' ' 56' ' ' TYR . 54.5 t -69.98 -40.02 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.523 -0.736 . . . . 0.0 109.531 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -59.96 -44.55 94.37 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.414 -0.804 . . . . 0.0 110.294 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -80.88 -13.45 58.91 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.706 -0.621 . . . . 0.0 110.177 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 39.5 t0 53.44 36.89 24.28 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.269 -0.894 . . . . 0.0 110.866 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 80.5 mt -140.13 156.16 46.67 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.492 -0.755 . . . . 0.0 110.677 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.0 t -138.42 155.73 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -137.0 147.49 19.26 Favored Glycine 0 N--CA 1.494 2.561 0 C-N-CA 119.552 -1.308 . . . . 0.0 111.142 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.416 ' CZ3' HG21 ' A' ' 54' ' ' THR . 3.7 m-90 -127.09 139.35 53.05 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.77 -0.841 . . . . 0.0 109.388 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -60.39 137.37 58.15 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.396 -0.815 . . . . 0.0 110.46 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -108.87 162.63 19.3 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.532 -0.73 . . . . 0.0 110.195 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.91 148.83 52.39 Favored 'Trans proline' 0 C--N 1.317 -1.1 0 O-C-N 123.397 1.209 . . . . 0.0 110.613 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -76.15 160.35 36.43 Favored 'Trans proline' 0 C--N 1.319 -1.01 0 O-C-N 123.354 1.186 . . . . 0.0 110.54 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 93.82 -10.67 72.08 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.38 -176.82 5.48 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.108 -1.231 . . . . 0.0 110.328 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.88 157.98 43.72 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.656 -0.653 . . . . 0.0 109.977 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.9 m -137.61 175.19 9.82 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.469 -0.769 . . . . 0.0 110.834 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.6 mt -84.43 170.21 13.77 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.741 -0.599 . . . . 0.0 110.271 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 60.5 p -115.97 158.93 41.15 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.596 -0.69 . . . . 0.0 110.112 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.37 123.41 8.68 Favored 'Trans proline' 0 C--N 1.317 -1.095 0 O-C-N 123.466 1.245 . . . . 0.0 110.675 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 1.272 ' SG ' 'ZN ' ' A' ' 202' ' ' ' ZN' . 10.7 t -70.86 142.13 51.23 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.546 -0.722 . . . . 0.0 110.043 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.4 t -135.39 72.21 1.44 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.506 -0.746 . . . . 0.0 110.464 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 27.3 p -144.86 -0.46 0.91 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.515 -0.741 . . . . 0.0 112.285 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 55.29 39.94 73.91 Favored Glycine 0 N--CA 1.498 2.784 0 O-C-N 120.825 -1.172 . . . . 0.0 110.283 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.3 t -69.97 122.75 19.95 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.434 -1.039 . . . . 0.0 110.246 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 58.4 m -70.34 -39.96 74.39 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.561 -0.712 . . . . 0.0 110.283 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -81.62 119.59 24.0 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.566 -0.709 . . . . 0.0 110.183 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 91.0 mt -129.88 150.73 51.05 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.59 -0.694 . . . . 0.0 110.472 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -115.31 133.31 56.15 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.596 -0.69 . . . . 0.0 109.728 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.6 tt -113.49 138.28 50.35 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.435 -0.791 . . . . 0.0 110.351 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.3 t -97.85 129.15 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.602 -0.686 . . . . 0.0 109.839 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 75.0 p -100.9 169.97 8.62 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.623 -0.673 . . . . 0.0 110.391 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 78.8 ttt-85 -62.5 -23.49 66.97 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.635 -0.666 . . . . 0.0 110.342 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.406 ' O ' ' CG ' ' A' ' 110' ' ' HIS . 81.1 t60 -92.86 25.7 3.06 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.409 -0.807 . . . . 0.0 110.75 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.82 44.8 27.86 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.128 -0.983 . . . . 0.0 110.83 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -113.86 155.5 25.61 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.554 -0.716 . . . . 0.0 109.975 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.2 137.2 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.561 -0.712 . . . . 0.0 110.437 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.407 HD12 HG23 ' A' ' 114' ' ' ILE . 42.2 pt -136.46 141.72 36.77 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.613 -0.679 . . . . 0.0 109.957 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -76.67 139.45 20.13 Favored 'Trans proline' 0 C--N 1.319 -1.021 0 O-C-N 123.25 1.131 . . . . 0.0 110.447 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.5 t -126.66 130.06 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.608 -0.682 . . . . 0.0 109.86 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -89.7 137.33 32.42 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.495 -0.753 . . . . 0.0 110.078 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 79.1 ttt-85 -82.08 124.33 29.73 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.514 -0.741 . . . . 0.0 110.216 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -128.85 25.19 5.64 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.612 -0.68 . . . . 0.0 110.302 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 168.88 179.56 41.07 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -61.23 -41.33 96.68 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.565 -0.962 . . . . 0.0 110.172 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.3 p -137.15 24.17 3.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.518 -0.739 . . . . 0.0 110.572 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -131.0 139.91 50.06 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.409 -0.807 . . . . 0.0 110.479 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -146.56 179.74 23.3 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 46.9 t -129.63 144.98 51.52 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.506 -0.997 . . . . 0.0 110.26 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.2 tp -99.86 136.8 39.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.605 -0.684 . . . . 0.0 110.145 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.4 mp -69.67 -39.99 76.67 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.531 -0.731 . . . . 0.0 110.452 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.6 t -98.63 109.48 53.28 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.424 -0.798 . . . . 0.0 110.099 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -76.82 135.3 15.71 Favored 'Trans proline' 0 C--N 1.32 -0.956 0 O-C-N 123.213 1.112 . . . . 0.0 110.751 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -135.96 162.37 57.17 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.62 -0.675 . . . . 0.0 109.769 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.5 150.29 57.4 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 O-C-N 123.385 1.202 . . . . 0.0 110.263 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 83.9 t -59.09 -34.29 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.431 -0.793 . . . . 0.0 109.796 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 46.7 t -59.91 -40.04 87.47 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.578 -0.701 . . . . 0.0 110.323 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -61.05 -41.47 96.66 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.491 -0.755 . . . . 0.0 109.68 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 43.9 tp -89.97 -10.1 46.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.784 -0.573 . . . . 0.0 111.332 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -62.53 138.31 58.45 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.158 -0.964 . . . . 0.0 110.657 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 87.0 20.71 52.63 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 21.8 m -120.59 13.58 11.71 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.317 -1.107 . . . . 0.0 111.052 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.8 m -59.79 151.99 24.07 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.155 -0.966 . . . . 0.0 110.287 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 92.52 -17.68 56.9 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -58.08 110.62 2.54 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -76.19 143.4 25.38 Favored 'Trans proline' 0 C--N 1.32 -0.943 0 O-C-N 123.134 1.071 . . . . 0.0 110.963 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.5 mp -95.78 131.82 41.66 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.8 mp -110.04 156.36 20.62 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.631 -0.668 . . . . 0.0 110.973 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.0 176.16 1.85 Allowed Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.718 -0.614 . . . . 0.0 109.642 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.59 -26.96 19.24 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 O-C-N 123.324 1.17 . . . . 0.0 110.252 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.53 -30.77 69.65 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.508 -0.745 . . . . 0.0 110.06 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 114.91 27.58 3.18 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -127.73 147.44 50.4 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.38 -1.071 . . . . 0.0 110.218 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -83.38 134.3 34.9 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.465 -0.772 . . . . 0.0 110.276 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 34.4 m -90.98 -22.89 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.594 -0.691 . . . . 0.0 110.868 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 167.74 -163.58 37.25 Favored Glycine 0 N--CA 1.498 2.769 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.43 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 77.0 mt -130.05 156.16 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.641 -0.917 . . . . 0.0 109.97 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -68.23 134.78 50.97 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.496 -0.753 . . . . 0.0 109.914 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -114.26 -64.86 1.25 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.569 -0.707 . . . . 0.0 111.02 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -136.09 149.81 48.87 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.431 -0.793 . . . . 0.0 110.991 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -95.99 126.46 41.25 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.662 -0.648 . . . . 0.0 109.855 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 45.1 t -95.75 118.15 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.595 -0.69 . . . . 0.0 110.453 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 26.7 p -140.05 144.87 37.08 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.464 -0.772 . . . . 0.0 110.632 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 91.8 m -73.95 -49.98 22.1 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.566 -0.709 . . . . 0.0 110.051 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -139.35 50.1 1.8 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.602 -0.686 . . . . 0.0 110.117 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 96.46 -11.25 66.97 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 62.0 t -102.04 121.78 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.237 -1.155 . . . . 0.0 109.151 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.36 118.78 27.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.55 -0.719 . . . . 0.0 111.078 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -103.37 -25.83 13.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.704 -0.622 . . . . 0.0 109.641 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -135.45 167.62 20.72 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.596 -0.69 . . . . 0.0 109.802 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.8 m -133.58 140.0 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.497 -0.752 . . . . 0.0 110.721 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -110.83 131.01 55.41 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.625 -0.672 . . . . 0.0 109.853 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -139.84 158.07 44.68 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.532 -0.73 . . . . 0.0 110.613 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 62.8 t -95.27 134.94 23.74 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.576 -0.703 . . . . 0.0 109.715 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.02 154.05 57.71 Favored 'Trans proline' 0 C--N 1.318 -1.045 0 O-C-N 123.175 1.092 . . . . 0.0 110.77 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 61.8 t -60.03 -38.82 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.645 -0.659 . . . . 0.0 110.062 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -57.22 -34.07 68.18 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.687 -0.633 . . . . 0.0 110.749 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 47.4 t -61.52 -40.05 93.24 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.504 -0.748 . . . . 0.0 109.964 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 61.3 mtt -59.95 -38.64 83.03 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.637 -0.665 . . . . 0.0 110.333 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -59.97 -33.14 71.53 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.667 -0.646 . . . . 0.0 110.578 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 93.9 m -59.88 -40.06 87.41 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.455 -0.778 . . . . 0.0 110.377 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 92.9 m -62.92 -49.78 73.42 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.495 -0.753 . . . . 0.0 110.094 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 76.6 mtm -65.04 -35.84 82.47 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.528 -0.732 . . . . 0.0 110.244 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -60.0 -40.01 87.74 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.524 -0.735 . . . . 0.0 110.148 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.837 0 O-C-N 121.617 -0.677 . . . . 0.0 110.148 179.87 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' 4P2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . 1.272 'ZN ' ' SG ' ' A' ' 97' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 45.9 p . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.069 0.461 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.45 -110.43 3.07 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -77.76 154.28 32.13 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.581 -0.952 . . . . 0.0 110.265 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -137.33 83.71 2.01 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.547 -0.72 . . . . 0.0 110.172 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -66.49 -34.76 78.65 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.556 -0.715 . . . . 0.0 110.384 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -60.01 -40.03 87.87 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.492 -0.755 . . . . 0.0 110.398 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -99.45 109.96 22.48 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.491 -0.756 . . . . 0.0 110.038 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.4 t -76.25 -50.06 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.627 -0.67 . . . . 0.0 110.266 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -128.45 157.88 39.89 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.518 -0.739 . . . . 0.0 110.328 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -106.32 38.32 3.37 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -60.2 -40.65 90.8 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.562 -0.964 . . . . 0.0 110.006 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.4 p -142.39 139.98 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.8 -0.563 . . . . 0.0 109.901 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -103.08 139.98 37.9 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.564 -0.71 . . . . 0.0 110.101 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.0 p -83.48 134.5 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.513 -0.742 . . . . 0.0 110.223 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.8 t -127.93 129.99 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.572 -0.705 . . . . 0.0 110.029 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.9 m -121.96 134.28 54.83 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.608 -0.683 . . . . 0.0 110.026 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.74 -175.11 2.66 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.464 -0.773 . . . . 0.0 110.123 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.04 -38.46 75.85 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.646 -0.659 . . . . 0.0 111.333 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.6 t -118.56 -20.02 8.54 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.305 -0.872 . . . . 0.0 111.738 -178.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -132.38 154.32 49.9 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.21 -0.931 . . . . 0.0 110.743 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 73.6 m -132.34 124.07 28.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.539 -0.726 . . . . 0.0 109.923 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -136.11 170.37 16.12 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.587 -0.696 . . . . 0.0 110.532 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.6 mt -115.63 149.6 38.04 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.693 -0.629 . . . . 0.0 109.836 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -115.91 148.32 40.15 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.496 -0.752 . . . . 0.0 110.189 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 87.3 m -119.9 136.55 54.46 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.557 -0.715 . . . . 0.0 109.873 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 28.3 p -94.57 121.07 35.75 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.337 -0.852 . . . . 0.0 111.073 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.6 t -130.08 129.99 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.512 -0.743 . . . . 0.0 109.751 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 53.44 39.95 30.66 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.46 -0.775 . . . . 0.0 111.099 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.94 16.19 70.19 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 62.5 t -126.07 123.39 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.181 -1.188 . . . . 0.0 109.722 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 36.2 t -79.67 115.87 19.53 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.535 -0.728 . . . . 0.0 110.166 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 71.6 m95 -104.65 137.57 42.28 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.648 -0.658 . . . . 0.0 110.139 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 34.9 p -136.38 179.32 6.43 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.58 -0.7 . . . . 0.0 109.733 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.447 HG12 ' CE1' ' A' ' 57' ' ' HIS . 59.4 t -85.63 142.28 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.525 -0.734 . . . . 0.0 109.528 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.441 ' CE2' HG23 ' A' ' 78' ' ' VAL . 39.4 t80 -79.82 -42.9 23.39 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.424 -0.798 . . . . 0.0 111.598 -178.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.447 ' CE1' HG12 ' A' ' 55' ' ' VAL . 2.2 p-80 -67.02 -20.0 65.79 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.111 -0.993 . . . . 0.0 110.722 -178.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.74 -50.5 1.51 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -102.56 -38.34 7.57 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.498 -1.001 . . . . 0.0 110.399 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.38 -21.61 54.36 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 75.1 m -59.78 -34.04 72.49 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.388 -1.066 . . . . 0.0 110.294 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.1 ptmt -135.08 169.32 17.62 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.506 -0.746 . . . . 0.0 110.493 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 20.8 m -101.38 140.67 35.35 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.71 -0.619 . . . . 0.0 110.237 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.0 mt -103.85 147.84 26.84 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.564 -0.71 . . . . 0.0 110.258 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.77 122.91 42.61 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.525 -0.735 . . . . 0.0 110.44 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.1 159.32 47.09 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -72.43 -41.29 1.79 Allowed 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.433 1.228 . . . . 0.0 110.523 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.6 tptm -69.84 -31.27 69.04 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.613 -0.679 . . . . 0.0 109.982 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 168.89 164.3 24.37 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.4 126.41 11.59 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 123.318 1.167 . . . . 0.0 110.23 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 85.3 mt -119.57 129.98 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.642 -0.661 . . . . 0.0 110.129 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 56.3 m -69.61 150.07 47.45 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.64 -0.663 . . . . 0.0 109.951 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -58.86 124.0 18.38 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.517 -0.739 . . . . 0.0 110.38 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.4 tpt -70.0 -40.03 75.53 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.578 -0.701 . . . . 0.0 110.294 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -126.01 129.99 50.28 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.497 -0.752 . . . . 0.0 110.338 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 60.4 m -137.97 118.8 14.16 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.711 -0.618 . . . . 0.0 110.309 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -157.02 113.01 2.93 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.358 -0.838 . . . . 0.0 111.136 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.441 HG23 ' CE2' ' A' ' 56' ' ' TYR . 56.1 t -70.02 -39.99 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.445 -0.785 . . . . 0.0 109.441 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -58.35 -46.03 87.05 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.442 -0.787 . . . . 0.0 110.033 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.9 -14.25 48.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.681 -0.637 . . . . 0.0 110.076 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 43.8 t0 53.88 39.99 31.04 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.245 -0.909 . . . . 0.0 110.575 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 68.6 mt -137.63 147.83 45.28 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.565 -0.71 . . . . 0.0 111.325 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.8 m -149.96 178.85 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -179.76 171.99 43.63 Favored Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.607 -1.283 . . . . 0.0 110.774 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 7.7 m-90 -130.06 159.53 36.46 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.828 -0.807 . . . . 0.0 109.627 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -81.62 124.14 29.29 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.456 -0.777 . . . . 0.0 110.194 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -97.19 163.85 19.03 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.575 -0.703 . . . . 0.0 110.256 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -70.65 151.52 64.04 Favored 'Trans proline' 0 C--N 1.318 -1.078 0 O-C-N 123.391 1.206 . . . . 0.0 110.476 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.28 157.2 54.05 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.379 1.199 . . . . 0.0 110.404 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.04 30.58 12.44 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -123.66 154.36 39.48 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.529 -0.983 . . . . 0.0 110.244 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -70.52 150.05 46.53 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.572 -0.705 . . . . 0.0 110.161 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 94.8 p -134.07 158.96 42.25 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.596 -0.69 . . . . 0.0 110.202 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 59.8 mt -104.16 141.14 36.78 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.52 -0.738 . . . . 0.0 110.381 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 31.5 p -105.77 160.99 24.2 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.647 -0.658 . . . . 0.0 110.229 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.72 152.48 58.86 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.345 1.182 . . . . 0.0 110.328 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 1.376 ' SG ' 'ZN ' ' A' ' 202' ' ' ' ZN' . 5.5 t -85.69 139.31 31.48 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.476 -0.765 . . . . 0.0 110.271 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.6 m -125.94 72.63 1.3 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.672 -0.643 . . . . 0.0 110.179 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 27.1 p -144.48 -8.29 0.67 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.455 -0.778 . . . . 0.0 112.426 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 55.4 33.2 58.33 Favored Glycine 0 N--CA 1.499 2.841 0 O-C-N 120.773 -1.204 . . . . 0.0 110.318 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.7 t -80.67 118.58 22.35 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.558 -0.966 . . . . 0.0 110.478 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 57.9 m -60.02 -39.97 87.68 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.516 -0.74 . . . . 0.0 110.088 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -64.23 125.59 25.03 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.579 -0.701 . . . . 0.0 109.84 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.6 mt -130.14 155.38 46.3 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.636 -0.665 . . . . 0.0 110.305 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -117.85 135.78 53.87 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.678 -0.639 . . . . 0.0 109.684 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.9 tt -114.31 132.0 56.33 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.581 -0.7 . . . . 0.0 110.488 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.0 t -92.32 119.88 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.615 -0.678 . . . . 0.0 109.643 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.0 m -99.21 161.47 13.6 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.558 -0.714 . . . . 0.0 110.391 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.7 ttp180 -60.47 -24.64 65.42 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.567 -0.708 . . . . 0.0 110.359 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 18.3 m80 -92.59 26.84 2.5 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.314 -0.866 . . . . 0.0 110.942 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.61 31.9 16.04 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.151 -0.968 . . . . 0.0 110.545 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -104.89 129.41 53.26 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.66 -0.65 . . . . 0.0 109.847 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 61.9 t -109.9 125.29 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.592 -0.692 . . . . 0.0 110.238 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 38.3 mt -119.73 135.51 24.23 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.678 -0.639 . . . . 0.0 109.648 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -75.72 135.5 17.87 Favored 'Trans proline' 0 C--N 1.319 -1.026 0 O-C-N 123.213 1.112 . . . . 0.0 110.594 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.1 t -129.82 129.98 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.557 -0.714 . . . . 0.0 109.572 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -80.16 156.04 27.15 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.515 -0.741 . . . . 0.0 110.151 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -99.28 121.45 41.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.63 -0.669 . . . . 0.0 110.249 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 31.0 mtp85 -119.63 24.24 10.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.576 -0.703 . . . . 0.0 110.621 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -177.1 -176.9 45.6 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -64.78 -39.97 94.49 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.544 -0.974 . . . . 0.0 110.435 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 46.6 m -136.54 24.48 3.16 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.516 -0.74 . . . . 0.0 110.522 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -125.21 150.56 46.87 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.436 -0.79 . . . . 0.0 110.4 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -144.02 168.92 26.38 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 82.9 p -112.02 152.43 28.17 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.555 -0.968 . . . . 0.0 110.23 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 35.2 tp -100.13 120.34 39.71 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.553 -0.717 . . . . 0.0 110.179 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.8 mt -59.95 -47.1 87.19 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.49 -0.756 . . . . 0.0 110.683 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 36.2 t -97.93 111.68 59.79 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.632 -0.667 . . . . 0.0 110.168 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.64 113.21 3.72 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 O-C-N 123.173 1.091 . . . . 0.0 110.479 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.424 ' HD3' ' CD2' ' A' ' 134' ' ' TYR . 37.6 mtt180 -120.25 162.78 32.05 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.577 -0.702 . . . . 0.0 110.126 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.04 150.49 66.56 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 123.384 1.202 . . . . 0.0 110.429 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 86.4 t -55.92 -33.25 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.479 -0.763 . . . . 0.0 110.114 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.3 m -58.66 -46.59 86.82 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.62 -0.675 . . . . 0.0 110.763 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.424 ' CD2' ' HD3' ' A' ' 130' ' ' ARG . 64.0 t80 -59.99 -41.61 92.43 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.549 -0.719 . . . . 0.0 110.201 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 58.8 tp -84.87 -9.8 57.76 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.773 -0.579 . . . . 0.0 111.461 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -68.83 143.97 54.41 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.098 -1.002 . . . . 0.0 110.748 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.17 -2.52 65.83 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 89.2 p -102.39 10.49 39.03 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.136 -1.214 . . . . 0.0 110.807 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.97 140.69 56.57 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.252 -0.905 . . . . 0.0 110.188 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 90.51 -10.56 74.15 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.52 129.29 33.62 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -76.86 148.92 28.8 Favored 'Trans proline' 0 C--N 1.318 -1.037 0 O-C-N 123.217 1.114 . . . . 0.0 110.886 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 21.1 mt -99.14 118.16 35.25 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.3 mp -92.0 163.14 14.1 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.586 -0.697 . . . . 0.0 111.157 -179.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.2 177.4 1.36 Allowed Pre-proline 0 N--CA 1.493 1.7 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.06 -26.7 21.25 Favored 'Trans proline' 0 C--N 1.317 -1.106 0 O-C-N 123.264 1.139 . . . . 0.0 110.434 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 90.6 p -69.97 -33.04 71.57 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.544 -0.722 . . . . 0.0 110.236 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 106.21 45.22 1.28 Allowed Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -137.17 160.19 39.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.535 -0.979 . . . . 0.0 110.293 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.48 125.3 29.17 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.588 -0.695 . . . . 0.0 110.34 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 63.3 t -91.55 -53.43 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.565 -0.71 . . . . 0.0 110.133 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -171.08 -161.9 22.51 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.411 HD12 HG22 ' A' ' 153' ' ' ILE . 96.7 mt -130.22 140.06 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.593 -0.945 . . . . 0.0 110.153 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -61.83 128.64 37.19 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.593 -0.692 . . . . 0.0 109.814 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -103.59 -69.6 0.79 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.595 -0.691 . . . . 0.0 110.851 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -133.88 152.41 51.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.528 -0.733 . . . . 0.0 110.692 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.01 149.81 20.9 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 57.9 t -117.79 119.32 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.542 -0.724 . . . . 0.0 110.517 -179.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.2 p -141.5 142.23 33.59 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.565 -0.709 . . . . 0.0 110.55 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 44.4 m -75.38 -40.84 57.58 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.523 -0.735 . . . . 0.0 110.03 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -145.49 51.58 1.19 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.586 -0.697 . . . . 0.0 110.402 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 91.35 -10.36 75.04 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.381 -1.087 . . . . 0.0 110.381 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 96.9 t -101.77 122.31 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.165 -1.197 . . . . 0.0 109.132 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.33 118.49 26.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.586 -0.696 . . . . 0.0 110.899 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -106.21 -27.75 10.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.777 -0.577 . . . . 0.0 109.645 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -132.62 162.41 31.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.534 -0.728 . . . . 0.0 110.017 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.9 m -129.99 139.59 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.583 -0.698 . . . . 0.0 110.232 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -117.76 123.41 45.92 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.534 -0.729 . . . . 0.0 110.485 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -132.49 159.97 37.85 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.575 -0.703 . . . . 0.0 109.796 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 27.1 m -97.54 142.45 24.58 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.516 -0.74 . . . . 0.0 110.414 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -77.65 171.08 18.06 Favored 'Trans proline' 0 C--N 1.318 -1.045 0 O-C-N 123.265 1.139 . . . . 0.0 110.255 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 61.4 t -59.98 -36.14 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.532 -0.73 . . . . 0.0 110.167 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -59.65 -33.22 71.26 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.729 -0.607 . . . . 0.0 110.996 -178.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 64.8 p -61.5 -33.32 73.59 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.387 -0.821 . . . . 0.0 109.984 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 44.8 mtt -69.08 -40.07 78.68 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.643 -0.661 . . . . 0.0 110.134 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -60.0 -38.89 83.94 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.651 -0.656 . . . . 0.0 110.468 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 94.2 m -60.07 -39.97 87.88 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.6 -0.688 . . . . 0.0 110.144 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 87.2 m -60.63 -40.48 92.11 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.469 -0.77 . . . . 0.0 109.985 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 40.8 ttp -61.06 -42.03 97.72 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.658 -0.652 . . . . 0.0 110.218 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -62.25 -40.07 94.95 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.495 -0.753 . . . . 0.0 110.292 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.829 0 O-C-N 121.594 -0.691 . . . . 0.0 110.182 179.942 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' 4P2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . 1.376 'ZN ' ' SG ' ' A' ' 97' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.07 0.462 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -133.53 147.36 18.99 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -115.0 128.79 56.49 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.559 -0.965 . . . . 0.0 109.948 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 53.58 37.51 26.07 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.425 -0.797 . . . . 0.0 110.585 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 49.5 mttm -111.3 35.2 3.68 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.558 -0.714 . . . . 0.0 110.176 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -62.71 -39.02 92.73 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.565 -0.709 . . . . 0.0 109.936 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -88.29 99.85 12.55 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.646 -0.659 . . . . 0.0 110.215 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.7 p -107.32 -26.48 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.553 -0.717 . . . . 0.0 110.355 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -146.15 159.57 43.12 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.463 -0.773 . . . . 0.0 109.835 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -154.3 -124.4 0.94 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -60.02 -39.94 87.55 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.582 -0.951 . . . . 0.0 110.232 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.2 t -99.05 126.37 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.638 -0.664 . . . . 0.0 110.068 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -108.2 142.24 38.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.622 -0.674 . . . . 0.0 110.123 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 65.4 t -87.18 114.16 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.55 -0.719 . . . . 0.0 109.589 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 62.0 t -118.45 131.33 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.448 -0.782 . . . . 0.0 109.98 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.8 m -123.12 135.37 54.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.642 -0.661 . . . . 0.0 110.086 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.22 -179.39 4.02 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.658 -0.651 . . . . 0.0 110.284 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.91 -40.07 83.48 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.898 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 76.6 p -113.79 -28.22 7.51 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.381 -0.824 . . . . 0.0 110.92 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 -126.26 -179.03 4.54 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.473 -0.767 . . . . 0.0 110.452 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 81.2 p -153.47 125.9 8.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.621 -0.674 . . . . 0.0 110.317 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -131.89 -175.98 3.91 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.644 -0.66 . . . . 0.0 109.803 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.4 mt -126.74 150.44 49.07 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.437 -0.789 . . . . 0.0 110.475 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -112.71 162.03 16.2 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.595 -0.69 . . . . 0.0 110.295 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.5 p -131.25 129.03 41.06 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.495 -0.753 . . . . 0.0 110.349 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 98.8 m -78.42 109.5 12.64 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.514 -0.741 . . . . 0.0 110.379 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.6 t -130.07 133.52 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.553 -0.717 . . . . 0.0 110.278 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 12.3 p30 43.91 34.26 0.88 Allowed 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.69 -19.11 38.9 Favored Glycine 0 N--CA 1.498 2.818 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.479 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 63.2 t -109.45 128.75 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.115 -1.227 . . . . 0.0 110.283 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 92.7 m -76.57 149.42 36.63 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.595 -0.691 . . . . 0.0 109.735 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -134.21 136.76 43.9 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.494 -0.754 . . . . 0.0 111.048 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.6 t -137.58 178.29 7.22 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.48 ' CG1' ' CE1' ' A' ' 57' ' ' HIS . 75.9 t -80.54 141.69 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.314 -0.866 . . . . 0.0 108.993 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.446 ' CZ ' HG23 ' A' ' 78' ' ' VAL . 6.5 t80 -85.0 -43.28 14.11 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.506 -0.746 . . . . 0.0 111.327 -179.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.48 ' CE1' ' CG1' ' A' ' 55' ' ' VAL . 1.8 p-80 -58.8 -21.38 56.11 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.291 -0.88 . . . . 0.0 111.366 -177.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -87.87 -53.64 2.66 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.87 -63.08 1.49 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.526 -0.985 . . . . 0.0 110.46 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.61 -142.66 16.1 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 85.3 p -109.86 25.48 11.74 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.521 -0.988 . . . . 0.0 110.564 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? -90.91 163.99 14.18 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.422 -0.799 . . . . 0.0 110.4 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 70.3 p -69.95 156.43 39.11 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.691 -0.63 . . . . 0.0 109.997 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 25.4 mt -118.49 144.42 46.03 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.593 -0.692 . . . . 0.0 110.691 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -95.12 118.68 32.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.635 -0.666 . . . . 0.0 110.004 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -135.21 -162.29 9.67 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.08 -39.8 10.04 Favored 'Trans proline' 0 C--N 1.315 -1.204 0 O-C-N 123.478 1.252 . . . . 0.0 110.606 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -86.8 -31.29 20.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.512 -0.742 . . . . 0.0 110.309 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.78 -148.32 18.99 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.69 163.7 37.72 Favored 'Trans proline' 0 N--CA 1.485 0.99 0 O-C-N 123.389 1.205 . . . . 0.0 110.596 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 86.0 mt -131.96 159.56 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.549 -0.72 . . . . 0.0 109.957 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 64.7 m -81.83 130.59 35.11 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.608 -0.682 . . . . 0.0 110.129 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -68.16 128.73 37.61 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.535 -0.728 . . . . 0.0 110.568 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 40.6 mtm -119.2 -49.71 2.38 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.537 -0.727 . . . . 0.0 110.128 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -110.33 127.98 55.32 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.48 -0.763 . . . . 0.0 110.149 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 90.4 m -151.21 122.58 7.84 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.572 -0.705 . . . . 0.0 110.008 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -162.9 125.13 2.64 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.368 -0.833 . . . . 0.0 111.257 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.446 HG23 ' CZ ' ' A' ' 56' ' ' TYR . 74.3 t -72.36 -38.8 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.548 -0.72 . . . . 0.0 109.647 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -55.69 -39.53 71.11 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.477 -0.764 . . . . 0.0 110.488 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.1 tp60 -91.18 -14.03 31.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.704 -0.622 . . . . 0.0 110.342 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 46.8 t0 53.18 39.94 30.46 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.104 -0.997 . . . . 0.0 110.324 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.3 mt -142.16 160.69 39.74 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.855 0.836 . . . . 0.0 111.391 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.0 t -144.56 160.97 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -155.39 160.42 29.84 Favored Glycine 0 N--CA 1.497 2.731 0 C-N-CA 119.04 -1.553 . . . . 0.0 111.612 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 17.6 m-90 -144.79 168.0 21.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.931 -0.746 . . . . 0.0 109.458 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -69.93 143.74 52.61 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.518 -0.739 . . . . 0.0 109.931 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.54 162.58 29.18 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.445 -0.784 . . . . 0.0 110.524 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.87 149.79 48.24 Favored 'Trans proline' 0 C--N 1.317 -1.093 0 O-C-N 123.581 1.306 . . . . 0.0 110.267 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -76.15 160.07 36.66 Favored 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 123.35 1.184 . . . . 0.0 110.428 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.14 29.03 52.31 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -151.68 137.02 17.6 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.516 -0.99 . . . . 0.0 110.248 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.8 mtm180 -110.81 131.89 54.66 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.553 -0.717 . . . . 0.0 110.219 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.7 m -91.79 175.54 6.85 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.546 -0.721 . . . . 0.0 110.311 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.8 mp -87.02 170.46 11.54 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.53 -0.731 . . . . 0.0 110.222 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.64 172.19 3.73 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.709 -0.62 . . . . 0.0 110.057 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.66 156.85 62.51 Favored 'Trans proline' 0 C--N 1.318 -1.039 0 O-C-N 123.314 1.165 . . . . 0.0 110.173 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.5 t -81.41 154.96 26.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.499 -0.751 . . . . 0.0 110.493 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.5 t -136.05 56.35 1.82 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.695 -0.628 . . . . 0.0 110.312 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 27.3 p -144.81 -8.41 0.63 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.413 -0.804 . . . . 0.0 112.447 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.42 29.2 38.11 Favored Glycine 0 N--CA 1.499 2.869 0 O-C-N 120.753 -1.217 . . . . 0.0 110.532 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.5 p -70.53 150.38 46.19 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.554 -0.968 . . . . 0.0 110.33 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 58.0 m -86.39 -26.63 24.69 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.639 -0.663 . . . . 0.0 110.474 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -71.74 120.46 17.36 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.544 -0.723 . . . . 0.0 110.122 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 94.9 mt -137.06 149.68 47.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.553 -0.717 . . . . 0.0 110.347 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -120.53 129.2 53.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.564 -0.71 . . . . 0.0 109.833 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 47.1 tp -108.09 146.15 33.03 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.554 -0.716 . . . . 0.0 110.276 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.1 t -107.36 122.39 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.655 -0.653 . . . . 0.0 109.812 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.8 p -91.67 178.53 5.89 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.58 -0.7 . . . . 0.0 110.404 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.5 ptt85 -70.2 -15.75 62.97 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.62 -0.675 . . . . 0.0 111.112 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -94.28 26.04 3.54 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.142 -0.974 . . . . 0.0 110.816 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 53.22 25.54 4.43 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.298 -0.876 . . . . 0.0 110.884 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -96.19 155.37 16.79 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.546 -0.721 . . . . 0.0 110.046 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 61.4 t -117.88 125.81 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.511 -0.743 . . . . 0.0 110.053 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 42.9 pt -126.51 142.14 42.18 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.605 -0.685 . . . . 0.0 110.093 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -76.32 153.15 35.47 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 O-C-N 123.289 1.152 . . . . 0.0 110.623 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 63.0 t -140.02 139.64 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.649 -0.657 . . . . 0.0 109.743 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 -105.1 135.04 47.2 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.591 -0.693 . . . . 0.0 110.153 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 14.6 ttt-85 -73.28 139.27 46.01 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.577 -0.702 . . . . 0.0 110.26 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.59 22.05 2.92 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.572 -0.705 . . . . 0.0 110.404 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 166.54 -170.77 41.25 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -71.03 -39.69 72.18 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.591 -0.946 . . . . 0.0 110.284 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 10.6 p -134.43 24.87 3.79 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.527 -0.733 . . . . 0.0 110.703 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -141.62 140.45 33.31 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.507 -0.746 . . . . 0.0 110.317 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -143.7 178.03 22.07 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 81.7 p -111.07 164.18 13.1 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.597 -0.943 . . . . 0.0 110.178 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 30.4 tp -109.42 131.01 55.47 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.5 -0.75 . . . . 0.0 110.366 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.12 -51.74 68.31 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.552 -0.717 . . . . 0.0 110.447 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 67.9 m -100.14 107.86 49.38 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.532 -0.73 . . . . 0.0 109.954 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.78 108.41 2.56 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 O-C-N 123.197 1.104 . . . . 0.0 110.9 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.42 ' HD3' ' CD2' ' A' ' 134' ' ' TYR . 31.9 mtt180 -115.24 161.31 30.3 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.669 -0.644 . . . . 0.0 109.849 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.21 150.39 71.5 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 O-C-N 123.405 1.213 . . . . 0.0 110.996 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 66.2 t -51.84 -30.04 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 121.507 -0.746 . . . . 0.0 109.731 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 36.9 t -60.71 -41.79 95.93 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.682 -0.636 . . . . 0.0 111.056 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.42 ' CD2' ' HD3' ' A' ' 130' ' ' ARG . 88.5 t80 -66.85 -39.97 87.76 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.355 -0.84 . . . . 0.0 109.41 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 23.0 tp -93.61 18.65 9.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.912 -0.493 . . . . 0.0 110.078 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.474 ' HA ' H481 ' A' ' 201' ' ' 4P2 . 11.5 tttt -82.09 117.71 22.48 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.446 1.117 . . . . 0.0 112.066 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.426 ' HA2' H551 ' A' ' 201' ' ' 4P2 . . . 100.65 26.87 7.83 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 36.7 m -112.7 21.61 15.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.579 -0.954 . . . . 0.0 110.405 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.438 ' HB2' ' C55' ' A' ' 201' ' ' 4P2 . 0.6 OUTLIER -68.33 129.89 41.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.312 -0.867 . . . . 0.0 108.851 179.353 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 106.37 -13.35 43.67 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -55.04 112.12 2.68 Favored Glycine 0 N--CA 1.499 2.839 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.13 153.22 51.63 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 O-C-N 123.142 1.075 . . . . 0.0 111.128 -178.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 44.9 mt -108.52 123.42 48.87 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.702 -0.624 . . . . 0.0 109.515 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.41 139.5 53.37 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.432 -0.792 . . . . 0.0 110.849 -179.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 68.4 m -74.08 163.63 66.94 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.638 -0.664 . . . . 0.0 109.484 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.62 -43.12 5.95 Favored 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.411 1.216 . . . . 0.0 109.561 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.7 m -119.42 27.54 8.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.705 -0.622 . . . . 0.0 109.899 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -139.0 -173.55 13.05 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -96.82 -168.11 1.66 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.65 -0.912 . . . . 0.0 110.472 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.56 148.28 51.1 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.573 -0.705 . . . . 0.0 110.892 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 34.4 m -119.13 -29.67 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.701 -0.624 . . . . 0.0 110.722 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.41 -163.42 22.34 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.3 tt -142.51 158.69 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.602 -0.94 . . . . 0.0 109.82 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -71.1 159.31 34.93 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.178 -0.951 . . . . 0.0 111.029 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -145.75 -75.66 0.21 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.757 -0.59 . . . . 0.0 109.95 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -121.68 142.62 49.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.035 -1.04 . . . . 0.0 111.313 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.79 128.89 40.26 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.425 ' CG2' H131 ' A' ' 201' ' ' 4P2 . 2.2 t -100.02 122.94 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.483 -0.76 . . . . 0.0 111.472 -177.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 28.1 p -141.15 142.57 34.04 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.482 -0.761 . . . . 0.0 110.541 178.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 88.7 m -75.93 -41.76 50.77 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.527 -0.733 . . . . 0.0 109.837 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -142.75 50.1 1.46 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.665 -0.647 . . . . 0.0 109.721 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 90.18 -11.68 70.21 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 62.6 t -94.14 120.29 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.142 -1.211 . . . . 0.0 108.997 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.24 113.74 23.23 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.534 -0.729 . . . . 0.0 111.022 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -110.08 -29.68 8.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.747 -0.596 . . . . 0.0 109.661 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -116.6 168.29 10.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.701 -0.624 . . . . 0.0 109.815 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.9 m -145.11 132.9 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.532 -0.73 . . . . 0.0 110.824 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -107.45 132.14 53.52 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.576 -0.703 . . . . 0.0 110.264 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -130.17 161.1 31.88 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.712 -0.618 . . . . 0.0 110.432 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.9 t -96.3 142.05 24.0 Favored Pre-proline 0 N--CA 1.498 1.973 0 O-C-N 121.514 -0.741 . . . . 0.0 109.96 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -74.96 159.99 40.81 Favored 'Trans proline' 0 N--CA 1.486 1.047 0 O-C-N 123.253 1.133 . . . . 0.0 110.186 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 67.7 t -87.55 -28.2 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.453 -0.779 . . . . 0.0 110.748 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -58.8 -28.64 66.17 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.354 -0.841 . . . . 0.0 110.615 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 58.0 m -68.15 -28.49 67.34 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.487 -0.758 . . . . 0.0 110.319 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 57.8 mtt -60.37 -29.46 68.94 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.51 -0.743 . . . . 0.0 110.504 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -60.07 -41.09 91.67 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.459 -0.776 . . . . 0.0 110.196 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 88.1 m -70.1 -41.19 74.35 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.551 -0.718 . . . . 0.0 110.05 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 88.0 m -70.1 -39.87 75.27 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.618 -0.676 . . . . 0.0 110.102 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 5.5 tmm? -59.97 -39.88 87.17 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.582 -0.699 . . . . 0.0 110.195 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.03 -39.84 87.26 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.618 -0.676 . . . . 0.0 110.245 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.845 0 O-C-N 121.651 -0.656 . . . . 0.0 110.227 -179.902 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' 4P2 . . . . . 0.474 H481 ' HA ' ' A' ' 136' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.8 p . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.044 0.45 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.14 -7.17 69.39 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 74.2 ttt-85 -60.05 -43.53 95.3 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.044 -1.268 . . . . 0.0 110.165 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 50.28 37.55 15.35 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.436 -0.79 . . . . 0.0 111.194 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.8 mttm 55.1 170.74 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.632 -0.668 . . . . 0.0 110.97 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -115.56 -9.09 12.08 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.517 -0.739 . . . . 0.0 110.894 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -60.03 -42.85 95.28 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.16 -0.963 . . . . 0.0 110.452 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.0 m -67.74 -32.31 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.633 -0.667 . . . . 0.0 110.393 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -68.26 -39.97 82.04 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.563 -0.71 . . . . 0.0 110.364 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.84 -169.4 53.64 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -112.89 77.32 1.04 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.529 -0.983 . . . . 0.0 110.294 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.1 p -135.2 146.7 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.489 -0.757 . . . . 0.0 110.064 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -104.24 165.53 10.99 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.561 -0.712 . . . . 0.0 110.256 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.8 p -121.69 129.96 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.578 -0.701 . . . . 0.0 110.074 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.8 m -141.11 147.48 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.532 -0.73 . . . . 0.0 110.512 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 54.2 m -120.07 154.72 34.23 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.581 -0.7 . . . . 0.0 110.201 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.78 -178.09 3.84 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.6 -0.687 . . . . 0.0 110.085 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.9 -49.84 76.11 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.553 -0.717 . . . . 0.0 110.744 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.4 p -125.8 8.06 7.49 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.479 -0.763 . . . . 0.0 111.541 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -143.41 159.32 42.6 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.06 -1.025 . . . . 0.0 110.83 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 41.0 m -142.82 121.15 12.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.67 -0.644 . . . . 0.0 109.55 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -135.39 174.81 10.19 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.575 -0.703 . . . . 0.0 110.485 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.8 mt -122.74 163.47 20.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.64 -0.662 . . . . 0.0 110.619 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -132.0 144.98 51.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.648 -0.657 . . . . 0.0 110.125 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.9 m -121.73 140.7 51.99 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.494 -0.754 . . . . 0.0 110.233 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.5 t -83.3 106.88 15.43 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.535 -0.728 . . . . 0.0 110.114 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.1 t -122.32 128.38 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.501 -0.749 . . . . 0.0 110.14 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 53.46 39.95 30.68 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.498 -0.751 . . . . 0.0 111.009 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 64.09 21.56 66.05 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.7 t -130.2 129.62 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.392 -1.064 . . . . 0.0 109.667 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 35.1 t -81.7 104.51 12.15 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.577 -0.702 . . . . 0.0 109.297 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -95.8 136.91 35.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.599 -0.688 . . . . 0.0 110.779 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.5 t -136.97 177.73 7.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.74 -0.6 . . . . 0.0 109.736 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.448 ' CG1' ' CE1' ' A' ' 57' ' ' HIS . 95.2 t -81.47 141.88 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.477 -0.764 . . . . 0.0 109.277 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.446 ' CE2' HG21 ' A' ' 78' ' ' VAL . 43.6 t80 -84.29 -42.28 15.99 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.333 -0.855 . . . . 0.0 111.18 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.448 ' CE1' ' CG1' ' A' ' 55' ' ' VAL . 2.2 p-80 -65.72 -17.13 64.39 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.338 -0.851 . . . . 0.0 111.014 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -99.57 -57.32 0.94 Allowed Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.93 -36.52 27.95 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.468 -1.019 . . . . 0.0 110.586 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.98 -25.22 61.56 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 82.8 p -60.0 -39.95 87.53 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.411 -1.052 . . . . 0.0 110.702 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.1 mtpt -130.18 160.22 34.46 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.482 -0.761 . . . . 0.0 110.639 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.7 p -70.0 164.82 23.13 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.549 -0.719 . . . . 0.0 110.048 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -97.7 134.68 40.56 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.589 -0.694 . . . . 0.0 110.173 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.39 136.15 41.7 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.532 -0.73 . . . . 0.0 110.261 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -143.39 -165.31 10.69 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -71.05 -47.84 0.51 Allowed 'Trans proline' 0 C--N 1.317 -1.13 0 O-C-N 123.417 1.219 . . . . 0.0 110.483 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -69.93 -31.63 69.49 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.548 -0.72 . . . . 0.0 110.407 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 135.44 -143.07 14.54 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.3 161.35 35.04 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 O-C-N 123.343 1.18 . . . . 0.0 110.624 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 44.7 pt -138.97 156.63 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.636 -0.665 . . . . 0.0 110.271 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 72.4 m -100.57 124.63 46.4 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.503 -0.748 . . . . 0.0 110.275 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -68.8 130.29 42.37 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.593 -0.692 . . . . 0.0 110.722 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.6 ttt -72.94 -40.01 65.77 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.621 -0.674 . . . . 0.0 110.632 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -113.18 140.01 48.28 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.451 -0.781 . . . . 0.0 110.414 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.7 m -145.07 127.31 15.75 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.535 -0.728 . . . . 0.0 110.346 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 -155.36 105.81 2.51 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.38 -0.825 . . . . 0.0 111.184 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.446 HG21 ' CE2' ' A' ' 56' ' ' TYR . 54.4 t -69.94 -40.03 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.466 -0.771 . . . . 0.0 109.21 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -57.8 -45.76 85.61 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.464 -0.772 . . . . 0.0 109.958 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -81.69 -12.47 58.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.795 -0.566 . . . . 0.0 110.114 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 39.6 t0 54.39 39.91 31.35 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.163 -0.961 . . . . 0.0 110.756 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 76.5 mt -140.23 151.57 45.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.588 -0.695 . . . . 0.0 110.698 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.8 t -131.94 152.57 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -131.19 156.11 21.63 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.544 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -136.08 159.79 40.63 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.785 -0.833 . . . . 0.0 109.755 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -83.4 123.34 29.58 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.394 -0.816 . . . . 0.0 109.954 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -97.1 149.5 35.77 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.558 -0.714 . . . . 0.0 110.33 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.33 154.95 56.27 Favored 'Trans proline' 0 C--N 1.316 -1.158 0 O-C-N 123.507 1.267 . . . . 0.0 110.272 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.39 160.14 49.55 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 O-C-N 123.377 1.199 . . . . 0.0 110.345 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.21 30.18 13.08 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -129.85 159.14 37.48 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.469 -1.019 . . . . 0.0 110.103 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -87.77 148.44 24.71 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.557 -0.715 . . . . 0.0 110.213 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 71.3 p -120.26 140.22 51.52 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.595 -0.69 . . . . 0.0 110.204 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 70.4 mt -80.01 160.01 26.02 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.601 -0.687 . . . . 0.0 110.17 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 63.8 p -117.26 155.82 49.42 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.655 -0.653 . . . . 0.0 110.131 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.68 164.45 35.39 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 O-C-N 123.374 1.197 . . . . 0.0 110.295 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 7.8 t -68.03 128.45 36.58 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.504 -0.748 . . . . 0.0 110.333 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.0 p -131.93 48.75 2.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.637 -0.664 . . . . 0.0 109.745 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.8 p -144.42 -8.32 0.67 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.63 -0.669 . . . . 0.0 112.428 -179.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.76 32.32 74.06 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.1 t -80.55 113.69 18.92 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.443 -1.034 . . . . 0.0 110.281 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 66.5 m -60.01 -39.96 87.61 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.549 -0.719 . . . . 0.0 110.467 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -68.44 136.21 52.9 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.554 -0.716 . . . . 0.0 110.067 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 48.9 mt -137.44 159.55 41.62 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.563 -0.711 . . . . 0.0 110.61 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -119.98 139.75 52.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.661 -0.649 . . . . 0.0 109.378 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 51.7 tp -115.15 126.74 54.98 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.515 -0.74 . . . . 0.0 110.223 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 89.5 t -90.61 111.73 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.677 -0.639 . . . . 0.0 109.58 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.5 m -90.02 154.29 19.92 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.607 -0.683 . . . . 0.0 110.321 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 72.6 ttt-85 -60.01 -19.27 51.67 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.652 -0.655 . . . . 0.0 110.619 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -94.82 26.97 3.29 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.341 -0.849 . . . . 0.0 110.544 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 55.69 45.79 23.88 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.262 -0.899 . . . . 0.0 110.648 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -119.72 146.05 45.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.62 -0.675 . . . . 0.0 109.975 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.9 p -124.21 129.98 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.44 -0.788 . . . . 0.0 110.743 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 61.5 mt -127.77 137.9 31.74 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.63 -0.669 . . . . 0.0 109.727 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -75.97 140.32 22.78 Favored 'Trans proline' 0 N--CA 1.485 1.018 0 O-C-N 123.197 1.104 . . . . 0.0 110.819 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.5 t -129.94 130.86 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.535 -0.728 . . . . 0.0 110.049 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.8 mmm180 -90.51 135.86 33.43 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.53 -0.732 . . . . 0.0 110.229 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 45.5 ttt85 -67.6 122.57 18.31 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.513 -0.742 . . . . 0.0 110.095 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -127.19 22.17 6.64 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.531 -0.731 . . . . 0.0 110.526 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 167.88 -175.92 42.62 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -70.58 -41.29 72.57 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.588 -0.949 . . . . 0.0 110.672 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.7 p -131.18 13.07 5.14 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.525 -0.734 . . . . 0.0 111.275 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 -130.27 138.58 50.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.187 -0.945 . . . . 0.0 110.269 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -137.29 156.15 23.28 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.3 p -86.3 159.48 19.41 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.509 -0.995 . . . . 0.0 110.16 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 49.4 tp -108.05 128.54 54.76 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.652 -0.655 . . . . 0.0 110.012 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.94 -40.05 91.79 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.618 -0.676 . . . . 0.0 110.338 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 62.3 m -116.15 102.61 53.7 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.447 -0.783 . . . . 0.0 110.35 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.3 123.3 8.13 Favored 'Trans proline' 0 C--N 1.319 -1.003 0 O-C-N 123.319 1.168 . . . . 0.0 110.508 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.465 ' CB ' ' CD1' ' A' ' 134' ' ' TYR . 12.7 mtt-85 -131.91 170.94 10.04 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.588 -0.695 . . . . 0.0 110.161 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -65.86 150.22 85.99 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 O-C-N 123.385 1.203 . . . . 0.0 111.322 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 79.2 t -54.26 -28.44 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.216 -0.927 . . . . 0.0 110.075 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 29.3 t -63.48 -31.04 72.09 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.619 -0.676 . . . . 0.0 109.637 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.465 ' CD1' ' CB ' ' A' ' 130' ' ' ARG . 0.0 OUTLIER -64.76 -40.74 95.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.675 -0.64 . . . . 0.0 109.52 179.784 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.416 ' HB2' ' CE1' ' A' ' 134' ' ' TYR . 13.9 tp -101.93 17.84 22.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.805 -0.559 . . . . 0.0 110.974 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -84.86 136.02 33.83 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.428 -0.795 . . . . 0.0 110.555 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.71 23.89 57.04 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 19.8 m -120.07 11.15 11.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.444 -1.033 . . . . 0.0 110.967 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 12.6 m -59.18 156.49 12.13 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.184 -0.947 . . . . 0.0 110.352 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 89.97 -13.05 65.66 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.574 -1.011 . . . . 0.0 110.574 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -64.62 120.26 18.39 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -78.09 145.03 21.65 Favored 'Trans proline' 0 C--N 1.32 -0.949 0 O-C-N 123.039 1.02 . . . . 0.0 111.12 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.01 121.02 40.72 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.5 mp -118.53 154.48 32.49 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.535 -0.728 . . . . 0.0 111.267 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -96.22 175.3 2.78 Favored Pre-proline 0 N--CA 1.491 1.603 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.97 -24.93 38.91 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.233 1.122 . . . . 0.0 110.415 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 28.8 m -65.59 -39.94 92.14 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.442 -0.786 . . . . 0.0 110.172 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 117.03 39.17 0.83 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -127.54 144.56 51.05 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.532 -0.981 . . . . 0.0 110.334 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -74.66 145.2 43.4 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.574 -0.704 . . . . 0.0 110.492 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 66.4 t -113.47 -51.47 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.612 -0.68 . . . . 0.0 109.93 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -174.64 -164.27 29.22 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 95.2 mt -131.72 144.04 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.522 -0.987 . . . . 0.0 109.981 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -59.95 126.56 28.02 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.55 -0.719 . . . . 0.0 109.825 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 44.5 ttt180 -105.8 -69.2 0.83 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.664 -0.647 . . . . 0.0 110.71 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -132.39 151.07 52.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.525 -0.734 . . . . 0.0 110.749 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -95.15 133.93 38.44 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.726 -0.609 . . . . 0.0 110.162 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 51.8 t -100.7 114.88 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.602 -0.686 . . . . 0.0 110.351 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.3 p -140.26 140.55 35.77 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.491 -0.755 . . . . 0.0 110.709 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 36.0 m -81.23 -47.9 12.77 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.611 -0.681 . . . . 0.0 110.045 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -127.31 42.58 3.29 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.674 -0.641 . . . . 0.0 110.031 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 91.38 -11.33 72.44 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 77.4 t -97.52 122.43 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.141 -1.211 . . . . 0.0 109.198 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -88.84 115.8 26.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.59 -0.694 . . . . 0.0 110.594 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -104.03 -30.1 10.48 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -124.43 155.76 38.3 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.54 139.99 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.539 -0.726 . . . . 0.0 110.384 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -115.3 131.33 56.96 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.657 -0.652 . . . . 0.0 110.408 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -137.14 158.79 43.66 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.652 -0.655 . . . . 0.0 110.015 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 60.2 t -96.52 130.35 30.85 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.555 -0.716 . . . . 0.0 110.361 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.26 167.27 27.76 Favored 'Trans proline' 0 N--CA 1.485 0.989 0 O-C-N 123.157 1.083 . . . . 0.0 110.314 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 67.8 t -70.17 -30.5 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.532 -0.73 . . . . 0.0 110.237 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -59.94 -40.06 87.68 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.546 -0.721 . . . . 0.0 110.586 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 19.8 t -61.74 -38.77 89.19 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.57 -0.706 . . . . 0.0 110.37 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 68.6 mtt -59.93 -29.1 68.16 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.573 -0.704 . . . . 0.0 110.499 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -59.98 -38.11 81.61 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.603 -0.686 . . . . 0.0 110.665 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 91.4 m -60.02 -40.02 87.87 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.409 -0.807 . . . . 0.0 110.615 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 88.0 m -60.01 -36.4 77.14 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.442 -0.786 . . . . 0.0 110.48 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.8 mtt -60.0 -38.96 84.15 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.454 -0.779 . . . . 0.0 110.722 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 53.3 mtt180 -60.05 -39.96 87.79 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.39 -0.819 . . . . 0.0 110.364 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.791 0 O-C-N 121.608 -0.683 . . . . 0.0 110.205 179.894 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' 4P2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.0 t . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 121.127 0.489 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -157.91 163.68 32.85 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -127.07 27.76 5.88 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.542 -0.975 . . . . 0.0 110.34 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -115.78 130.03 56.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.559 -0.713 . . . . 0.0 110.045 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -112.59 135.31 53.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.656 -0.652 . . . . 0.0 110.165 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -128.88 138.75 52.2 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.584 -0.698 . . . . 0.0 110.084 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -66.44 123.25 19.49 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.58 -0.7 . . . . 0.0 110.169 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 91.7 t -69.94 -40.07 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.624 -0.673 . . . . 0.0 109.831 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -71.91 149.97 44.62 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.583 -0.698 . . . . 0.0 110.281 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 177.98 -158.14 22.88 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -59.97 -30.29 69.01 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.465 -1.021 . . . . 0.0 110.368 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 71.7 t -118.08 130.01 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.549 -0.719 . . . . 0.0 110.034 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -104.58 140.5 37.91 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.682 -0.636 . . . . 0.0 110.304 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.1 p -89.62 119.7 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.504 -0.747 . . . . 0.0 110.269 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 62.7 t -124.23 129.9 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.399 -0.813 . . . . 0.0 110.103 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.5 m -119.42 135.67 54.64 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.509 -0.744 . . . . 0.0 110.345 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.43 178.31 4.59 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.469 -0.769 . . . . 0.0 109.892 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.0 -50.18 74.77 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.678 -0.639 . . . . 0.0 110.602 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 74.3 p -117.77 -20.03 9.04 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.575 -0.703 . . . . 0.0 111.041 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -114.81 171.08 7.86 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.313 -0.867 . . . . 0.0 110.394 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 72.1 p -149.84 121.46 8.02 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.642 -0.661 . . . . 0.0 110.034 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.408 ' CE2' ' HB3' ' A' ' 59' ' ' ALA . 41.1 p90 -134.49 171.01 14.91 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.557 -0.715 . . . . 0.0 110.028 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 91.3 mt -119.26 158.37 26.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.568 -0.707 . . . . 0.0 110.529 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -125.64 151.99 45.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.634 -0.666 . . . . 0.0 110.212 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.1 p -125.78 144.12 50.77 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.623 -0.673 . . . . 0.0 110.007 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 35.4 t -94.61 110.08 21.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.448 -0.783 . . . . 0.0 110.434 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.3 t -123.05 126.98 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.589 -0.695 . . . . 0.0 110.144 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.9 m120 53.09 39.02 28.88 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.461 -0.774 . . . . 0.0 111.227 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.44 19.59 72.8 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 63.2 t -130.18 129.87 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.296 -1.12 . . . . 0.0 109.623 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 92.4 m -84.47 133.54 34.47 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.522 -0.736 . . . . 0.0 109.684 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -119.91 136.61 54.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.519 -0.738 . . . . 0.0 110.546 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.8 t -137.96 175.02 9.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.708 -0.62 . . . . 0.0 109.72 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.46 ' CG1' ' CE1' ' A' ' 57' ' ' HIS . 85.8 t -80.98 142.45 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.448 -0.783 . . . . 0.0 109.993 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.435 ' CE2' HG22 ' A' ' 78' ' ' VAL . 31.4 t80 -76.54 -42.75 41.92 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.644 -0.66 . . . . 0.0 111.71 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.46 ' CE1' ' CG1' ' A' ' 55' ' ' VAL . 2.5 p-80 -69.94 -15.22 63.02 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.313 -0.867 . . . . 0.0 111.102 -178.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -104.84 -77.95 1.19 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.408 ' HB3' ' CE2' ' A' ' 43' ' ' PHE . . . -71.16 -39.99 71.58 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.513 -0.993 . . . . 0.0 110.697 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.98 -21.38 58.94 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 57.4 m -60.0 -40.55 89.58 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.252 -1.146 . . . . 0.0 110.786 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.1 mttp -137.28 150.36 47.75 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.348 -0.845 . . . . 0.0 110.614 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 70.9 m -74.14 147.21 42.86 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.593 -0.692 . . . . 0.0 109.907 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 88.4 mt -99.21 140.55 33.21 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.576 -0.702 . . . . 0.0 110.551 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.43 134.97 51.83 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.62 -0.675 . . . . 0.0 110.177 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -132.22 170.2 21.91 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -69.25 -23.29 33.28 Favored 'Trans proline' 0 C--N 1.316 -1.142 0 O-C-N 123.395 1.208 . . . . 0.0 110.593 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -69.92 -31.47 69.26 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.47 -0.769 . . . . 0.0 110.215 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.47 174.12 13.21 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.12 145.56 44.56 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.38 1.2 . . . . 0.0 110.436 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.9 mt -119.93 123.37 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.609 -0.682 . . . . 0.0 109.886 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.3 m -74.29 133.43 42.6 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.554 -0.716 . . . . 0.0 110.366 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -64.13 131.0 46.17 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.595 -0.691 . . . . 0.0 110.009 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 19.8 mmt -93.21 -35.76 12.96 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.569 -0.707 . . . . 0.0 110.457 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -125.57 134.13 52.06 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.509 -0.744 . . . . 0.0 110.432 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.0 p -147.11 121.34 9.54 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.51 -0.744 . . . . 0.0 110.146 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -156.91 116.51 3.45 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.451 -0.781 . . . . 0.0 110.93 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.435 HG22 ' CE2' ' A' ' 56' ' ' TYR . 95.7 t -71.74 -37.1 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.484 -0.76 . . . . 0.0 109.616 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -58.62 -48.16 81.94 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.475 -0.766 . . . . 0.0 109.653 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -84.06 -14.25 51.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.579 -0.701 . . . . 0.0 109.922 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.409 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 61.4 t0 55.31 40.0 31.41 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.242 -0.911 . . . . 0.0 111.053 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 74.9 mt -140.96 147.29 38.54 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.424 -0.798 . . . . 0.0 111.595 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.4 m -142.26 173.87 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -167.23 169.98 41.28 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -128.98 158.92 37.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.709 -0.877 . . . . 0.0 109.648 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -81.04 121.29 25.88 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.539 -0.726 . . . . 0.0 110.059 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -114.09 155.7 45.11 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.583 -0.698 . . . . 0.0 110.316 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.59 153.68 60.01 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 123.42 1.221 . . . . 0.0 110.543 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.59 155.72 54.41 Favored 'Trans proline' 0 C--N 1.317 -1.094 0 O-C-N 123.405 1.213 . . . . 0.0 110.349 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 109.17 31.0 3.43 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -128.65 160.03 33.74 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.489 -1.006 . . . . 0.0 110.371 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 76.6 mtt85 -65.56 140.96 58.59 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.636 -0.665 . . . . 0.0 110.25 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 58.0 m -121.87 146.46 47.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.575 -0.703 . . . . 0.0 110.219 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.4 mt -94.47 144.4 25.6 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.561 -0.712 . . . . 0.0 110.29 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.7 t -104.3 150.73 38.73 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.639 -0.663 . . . . 0.0 110.169 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.76 151.76 69.12 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.384 1.202 . . . . 0.0 110.388 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 18.8 t -80.83 129.97 34.81 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.567 -0.708 . . . . 0.0 110.431 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.7 t -135.44 56.17 1.85 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.632 -0.667 . . . . 0.0 109.859 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.3 p -145.38 11.55 1.31 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.601 -0.687 . . . . 0.0 111.552 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 51.11 51.3 36.05 Favored Glycine 0 N--CA 1.501 2.979 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.33 109.92 15.28 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.463 -1.022 . . . . 0.0 110.506 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 29.6 p -69.92 -34.99 74.21 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.612 -0.68 . . . . 0.0 109.864 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -84.06 110.8 18.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.72 -0.612 . . . . 0.0 109.922 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 88.0 mt -115.68 136.45 53.05 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.555 -0.716 . . . . 0.0 110.198 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -106.82 139.76 40.73 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.447 -0.783 . . . . 0.0 110.177 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.3 tt -111.3 141.91 44.22 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.558 -0.714 . . . . 0.0 110.322 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.8 t -94.6 130.8 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.675 -0.641 . . . . 0.0 110.113 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.0 m -104.04 162.54 13.06 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.549 -0.719 . . . . 0.0 110.082 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -61.04 -23.84 65.74 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.488 -0.758 . . . . 0.0 110.599 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -95.39 26.53 3.79 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.469 -0.769 . . . . 0.0 110.637 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.14 43.35 30.79 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.336 -0.852 . . . . 0.0 110.991 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -111.34 130.91 55.53 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.477 -0.765 . . . . 0.0 109.821 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.3 m -101.43 148.13 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.558 -0.714 . . . . 0.0 110.578 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.4 tt -148.55 132.66 8.67 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.561 -0.712 . . . . 0.0 109.997 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.71 142.74 36.32 Favored 'Trans proline' 0 C--N 1.319 -0.994 0 O-C-N 123.14 1.074 . . . . 0.0 110.693 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.0 t -129.97 130.21 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.66 -0.65 . . . . 0.0 110.007 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -78.07 129.97 35.87 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.491 -0.756 . . . . 0.0 110.222 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -64.23 140.03 58.83 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.568 -0.708 . . . . 0.0 110.031 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -147.56 47.19 1.12 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.587 -0.696 . . . . 0.0 110.265 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 138.53 169.05 11.47 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -60.53 -42.04 95.65 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.569 -0.959 . . . . 0.0 110.196 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.8 m -127.94 25.49 5.93 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.59 -0.694 . . . . 0.0 110.143 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.18 136.93 42.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.533 -0.73 . . . . 0.0 110.242 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -134.26 170.4 22.62 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 14.4 m -120.24 139.81 52.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.525 -0.986 . . . . 0.0 110.362 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 57.9 tp -75.86 137.08 40.2 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.625 -0.672 . . . . 0.0 109.941 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.04 -48.69 80.68 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.544 -0.722 . . . . 0.0 110.584 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 78.5 p -117.72 139.66 26.62 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.537 -0.727 . . . . 0.0 110.012 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -75.55 126.35 9.56 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 O-C-N 123.266 1.14 . . . . 0.0 110.788 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 -129.85 163.04 49.89 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.616 -0.678 . . . . 0.0 109.61 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.79 150.18 67.71 Favored 'Trans proline' 0 C--N 1.315 -1.224 0 O-C-N 123.327 1.172 . . . . 0.0 110.739 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 69.9 t -59.95 -33.55 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.601 -0.687 . . . . 0.0 109.664 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 25.6 t -59.37 -40.05 85.24 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.605 -0.684 . . . . 0.0 110.461 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -61.45 -40.76 95.67 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.546 -0.721 . . . . 0.0 109.753 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 55.6 tp -89.9 -10.3 45.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.783 -0.573 . . . . 0.0 111.282 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.1 tttm -63.7 137.27 58.01 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.271 -0.893 . . . . 0.0 110.622 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 88.65 23.11 37.27 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 70.7 m -120.55 6.34 10.57 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.331 -1.1 . . . . 0.0 111.32 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 50.6 m -58.65 146.17 37.21 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.973 -1.079 . . . . 0.0 110.076 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 96.37 -24.36 30.78 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.16 111.64 3.79 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.24 149.41 45.6 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 O-C-N 123.169 1.089 . . . . 0.0 110.834 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.3 mp -101.21 127.5 47.76 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.7 mp -118.45 122.35 42.54 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.472 -0.767 . . . . 0.0 110.948 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 27.3 p -68.49 162.93 58.22 Favored Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -64.4 -21.0 66.79 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 O-C-N 123.148 1.078 . . . . 0.0 111.327 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.6 m -62.74 -39.97 95.77 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.341 -0.849 . . . . 0.0 109.997 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.401 ' O ' ' CD2' ' A' ' 149' ' ' HIS . . . 118.59 40.17 0.68 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.401 ' CD2' ' O ' ' A' ' 148' ' ' GLY . 29.3 m170 -133.38 153.36 51.66 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.59 -0.947 . . . . 0.0 110.354 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.47 134.06 37.38 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.549 -0.719 . . . . 0.0 110.049 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.7 t -99.81 -59.98 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.527 -0.733 . . . . 0.0 110.365 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -176.31 -163.54 28.96 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 91.4 mt -128.5 139.99 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.639 -0.918 . . . . 0.0 110.159 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -61.75 130.07 44.04 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.55 -0.719 . . . . 0.0 110.023 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -107.62 -63.83 1.27 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.636 -0.665 . . . . 0.0 110.636 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -136.96 152.65 50.42 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.513 -0.742 . . . . 0.0 110.815 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.64 155.37 16.9 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.694 -0.629 . . . . 0.0 109.632 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 48.0 t -121.05 112.38 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.534 -0.728 . . . . 0.0 110.519 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.4 p -141.58 142.3 33.48 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.485 -0.76 . . . . 0.0 110.429 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 25.0 m -80.2 -41.43 25.24 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.492 -0.755 . . . . 0.0 110.122 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -136.02 46.49 2.3 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.534 -0.729 . . . . 0.0 110.498 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 90.1 -10.68 73.28 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.344 -1.103 . . . . 0.0 110.344 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 63.3 t -98.39 120.75 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.141 -1.211 . . . . 0.0 109.386 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.58 114.61 24.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.587 -0.695 . . . . 0.0 110.752 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -101.65 -29.44 11.92 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -130.34 159.96 35.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.711 -0.618 . . . . 0.0 109.444 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.7 m -133.49 141.41 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.429 -0.794 . . . . 0.0 110.571 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -118.02 133.5 55.86 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.537 -0.727 . . . . 0.0 110.176 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -136.52 160.1 39.79 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.462 -0.773 . . . . 0.0 110.506 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 58.8 t -96.68 135.43 22.26 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.522 -0.736 . . . . 0.0 110.161 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.08 150.93 43.75 Favored 'Trans proline' 0 N--CA 1.486 1.043 0 O-C-N 123.216 1.114 . . . . 0.0 110.601 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 61.9 t -71.14 -28.4 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.587 -0.695 . . . . 0.0 110.227 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -60.01 -39.93 87.53 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.451 -0.781 . . . . 0.0 110.67 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 62.2 p -61.79 -28.85 69.75 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.516 -0.74 . . . . 0.0 110.589 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 67.6 mtt -61.59 -34.92 76.45 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.535 -0.728 . . . . 0.0 110.475 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -59.98 -40.79 90.31 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.525 -0.734 . . . . 0.0 110.314 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 92.3 m -63.53 -40.04 95.98 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.514 -0.741 . . . . 0.0 109.925 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 63.6 m -62.67 -41.54 99.14 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.59 -0.694 . . . . 0.0 110.154 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 58.8 ttp -60.04 -40.93 91.05 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.613 -0.68 . . . . 0.0 110.315 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 44.5 ttp85 -60.02 -39.99 87.78 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.59 -0.693 . . . . 0.0 110.087 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.852 0 O-C-N 121.577 -0.702 . . . . 0.0 110.162 179.987 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' 4P2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.1 m . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.079 0.466 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -79.05 -59.96 2.65 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 52.7 ttt85 -128.01 133.65 49.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.506 -0.997 . . . . 0.0 110.238 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -127.22 137.84 52.98 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.652 -0.655 . . . . 0.0 110.177 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.7 mttm -104.07 123.35 47.09 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.634 -0.666 . . . . 0.0 110.2 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -109.09 117.36 33.96 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.483 -0.761 . . . . 0.0 110.142 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -113.91 141.79 46.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.572 -0.705 . . . . 0.0 109.949 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.5 t -106.3 122.89 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.509 -0.744 . . . . 0.0 109.866 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -140.56 157.59 45.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.619 -0.675 . . . . 0.0 110.363 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.48 136.86 8.11 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -120.9 104.79 10.11 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.588 -0.948 . . . . 0.0 110.41 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.0 p -137.33 130.46 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.596 -0.69 . . . . 0.0 109.932 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.3 mp0 -104.32 132.48 50.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.568 -0.708 . . . . 0.0 110.273 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.3 m -76.63 135.72 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.659 -0.65 . . . . 0.0 109.934 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.7 p -137.29 138.9 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.56 -0.712 . . . . 0.0 110.148 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.3 t -122.46 136.85 54.98 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.631 -0.668 . . . . 0.0 110.141 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.1 m -100.16 179.97 4.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.567 -0.708 . . . . 0.0 109.979 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.03 -41.23 91.77 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.651 -0.656 . . . . 0.0 111.017 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.4 p -121.59 -25.55 5.1 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.407 -0.808 . . . . 0.0 111.676 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -118.23 159.58 23.08 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.292 -0.88 . . . . 0.0 110.751 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 11.1 m -140.06 120.79 14.35 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.605 -0.684 . . . . 0.0 110.178 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -135.79 176.31 8.8 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.609 -0.682 . . . . 0.0 109.877 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.4 mt -116.86 160.36 20.97 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.451 -0.781 . . . . 0.0 110.398 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -129.37 143.85 51.0 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.481 -0.762 . . . . 0.0 110.478 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.7 m -123.1 136.93 55.0 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.51 -0.743 . . . . 0.0 110.115 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 47.3 t -95.43 111.67 23.52 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.542 -0.724 . . . . 0.0 110.602 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.98 139.35 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.504 -0.748 . . . . 0.0 110.195 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 55.21 37.17 28.49 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.524 -0.735 . . . . 0.0 110.794 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.1 14.15 63.22 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.9 t -131.73 130.0 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.18 -1.188 . . . . 0.0 109.781 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 43.1 t -86.02 113.43 22.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.523 -0.736 . . . . 0.0 109.923 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.444 ' CZ3' ' CD2' ' A' ' 82' ' ' LEU . 80.0 m95 -106.51 137.12 45.08 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.558 -0.714 . . . . 0.0 110.82 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.41 HG23 ' CZ3' ' A' ' 85' ' ' TRP . 7.6 t -136.81 -179.31 5.62 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.47 ' CG1' ' CE1' ' A' ' 57' ' ' HIS . 59.4 t -80.14 142.52 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.398 -0.814 . . . . 0.0 109.194 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.431 ' CE2' ' CG2' ' A' ' 78' ' ' VAL . 28.7 t80 -83.28 -39.99 20.13 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.352 -0.843 . . . . 0.0 111.861 -178.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.47 ' CE1' ' CG1' ' A' ' 55' ' ' VAL . 1.6 p-80 -60.19 -18.66 49.73 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.98 -1.075 . . . . 0.0 110.956 -178.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -97.64 -69.37 0.97 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.62 -36.3 70.72 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.582 -0.952 . . . . 0.0 110.588 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.69 -29.16 66.6 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.8 t -61.08 -39.94 91.79 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.548 -0.972 . . . . 0.0 110.943 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -127.93 143.29 51.1 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.459 -0.776 . . . . 0.0 110.549 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.3 t -65.92 151.39 46.86 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.534 -0.729 . . . . 0.0 110.539 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 13.6 tp -100.03 133.56 44.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.624 -0.672 . . . . 0.0 109.868 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.05 130.59 36.94 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.497 -0.752 . . . . 0.0 110.499 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -97.44 -179.22 33.89 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.8 -36.1 8.58 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 O-C-N 123.391 1.206 . . . . 0.0 110.445 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -85.29 -12.12 53.13 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.574 -0.704 . . . . 0.0 111.061 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 146.95 -164.99 28.55 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.15 151.44 55.22 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.397 1.209 . . . . 0.0 110.173 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.43 HG23 HD13 ' A' ' 71' ' ' ILE . 44.5 pt -130.0 156.58 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.595 -0.69 . . . . 0.0 110.483 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.1 m -100.65 133.19 45.48 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.643 -0.661 . . . . 0.0 109.743 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -61.1 124.62 21.05 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.476 -0.765 . . . . 0.0 110.074 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.7 tpt -64.9 -40.04 94.46 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.639 -0.663 . . . . 0.0 110.536 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -124.43 134.27 53.13 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.571 -0.706 . . . . 0.0 110.308 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.0 p -146.37 136.21 23.34 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.5 -0.75 . . . . 0.0 110.391 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -162.0 105.46 1.19 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.522 -0.736 . . . . 0.0 110.027 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.431 ' CG2' ' CE2' ' A' ' 56' ' ' TYR . 72.2 t -68.18 -40.0 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.511 -0.743 . . . . 0.0 110.267 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -57.93 -39.81 78.93 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.546 -0.721 . . . . 0.0 110.762 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -99.06 -7.25 27.05 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.535 -0.728 . . . . 0.0 111.3 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.1 t0 55.81 40.43 30.68 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.881 -1.137 . . . . 0.0 109.616 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.444 ' CD2' ' CZ3' ' A' ' 53' ' ' TRP . 4.7 tp -119.04 132.01 56.01 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.463 0.649 . . . . 0.0 110.114 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.1 p -156.82 160.69 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.721 -0.612 . . . . 0.0 109.427 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -177.33 168.34 40.0 Favored Glycine 0 N--CA 1.495 2.614 0 C-N-CA 119.756 -1.211 . . . . 0.0 110.471 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.41 ' CZ3' HG23 ' A' ' 54' ' ' THR . 13.5 m-90 -117.38 155.17 30.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.789 -0.83 . . . . 0.0 109.925 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.8 mm-40 -76.63 148.12 37.12 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.493 -0.754 . . . . 0.0 110.168 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -113.01 158.95 36.42 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.509 -0.745 . . . . 0.0 110.243 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.47 157.38 56.52 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.41 1.216 . . . . 0.0 110.526 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.46 160.24 44.89 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.49 1.258 . . . . 0.0 110.421 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 80.5 27.34 51.83 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -115.15 159.02 21.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.515 -0.991 . . . . 0.0 110.127 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.9 tpt85 -81.41 131.68 35.29 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.569 -0.707 . . . . 0.0 110.125 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 59.4 m -115.59 150.24 36.98 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.574 -0.704 . . . . 0.0 110.229 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 94.2 mt -92.7 136.57 33.11 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.531 -0.73 . . . . 0.0 110.376 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 73.9 p -81.43 156.92 70.84 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.605 -0.684 . . . . 0.0 110.407 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.81 163.68 36.52 Favored 'Trans proline' 0 C--N 1.318 -1.027 0 O-C-N 123.435 1.229 . . . . 0.0 110.372 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 49.5 t -87.23 123.76 32.58 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.538 -0.726 . . . . 0.0 110.379 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.2 t -132.84 61.78 1.67 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.662 -0.649 . . . . 0.0 109.883 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.3 p -145.27 7.4 1.16 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.61 -0.681 . . . . 0.0 111.955 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 51.22 48.06 48.22 Favored Glycine 0 N--CA 1.501 3.029 0 O-C-N 120.919 -1.113 . . . . 0.0 110.416 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.8 p -85.27 109.91 18.69 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.51 -0.994 . . . . 0.0 110.629 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 68.5 p -66.99 -39.66 87.21 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.603 -0.686 . . . . 0.0 109.611 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -79.14 128.15 32.93 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.585 -0.697 . . . . 0.0 109.591 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 92.9 mt -133.6 150.24 51.61 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.401 -0.812 . . . . 0.0 110.696 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -106.85 128.47 54.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.619 -0.676 . . . . 0.0 109.504 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.9 tt -110.48 142.35 42.35 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.571 -0.705 . . . . 0.0 110.422 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.6 t -107.2 125.26 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.611 -0.681 . . . . 0.0 109.781 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 75.1 p -95.39 168.9 10.43 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.644 -0.66 . . . . 0.0 110.386 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 -66.28 -23.48 66.4 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.71 -0.619 . . . . 0.0 110.161 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -93.16 24.5 3.76 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.425 -0.797 . . . . 0.0 110.79 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.71 50.04 16.69 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.338 -0.851 . . . . 0.0 111.032 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -117.67 127.76 54.25 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.319 -0.863 . . . . 0.0 109.827 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.1 t -93.81 120.0 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.577 -0.702 . . . . 0.0 110.096 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 36.0 mt -123.96 135.06 25.87 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.574 -0.704 . . . . 0.0 109.853 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -77.22 143.77 22.74 Favored 'Trans proline' 0 C--N 1.32 -0.954 0 O-C-N 123.199 1.105 . . . . 0.0 110.277 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.3 t -131.45 139.64 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.568 -0.708 . . . . 0.0 110.158 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.3 tpt85 -96.88 133.59 41.3 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.512 -0.743 . . . . 0.0 110.032 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -70.0 136.85 50.86 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.547 -0.72 . . . . 0.0 110.259 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -136.87 26.2 3.03 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.592 -0.693 . . . . 0.0 110.18 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 151.95 -173.93 31.08 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -70.06 -39.07 75.89 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.593 -0.945 . . . . 0.0 110.429 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.3 m -128.78 23.69 5.75 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.52 -0.737 . . . . 0.0 111.184 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 24.5 ttp180 -141.45 143.66 34.0 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.224 -0.923 . . . . 0.0 110.852 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -139.59 -176.68 15.02 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.6 m -116.29 160.8 19.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.568 -0.96 . . . . 0.0 110.042 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.96 124.1 51.46 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.555 -0.715 . . . . 0.0 110.087 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.5 mp -69.98 -40.04 75.6 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.502 -0.749 . . . . 0.0 110.007 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 67.1 m -103.78 109.92 63.02 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.585 -0.697 . . . . 0.0 109.976 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.92 112.47 3.41 Favored 'Trans proline' 0 C--N 1.319 -1.016 0 O-C-N 123.241 1.127 . . . . 0.0 110.48 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -124.92 162.12 45.16 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.628 -0.67 . . . . 0.0 110.17 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.2 150.56 59.66 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 O-C-N 123.505 1.266 . . . . 0.0 110.503 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 85.9 t -56.66 -34.34 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.558 -0.714 . . . . 0.0 110.27 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.2 t -59.98 -39.98 87.56 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.538 -0.726 . . . . 0.0 110.52 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -64.15 -40.04 95.31 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.574 -0.703 . . . . 0.0 110.048 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 45.3 tp -88.99 -4.33 58.46 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.679 -0.638 . . . . 0.0 111.35 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -71.26 140.44 50.36 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.11 -0.994 . . . . 0.0 110.975 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 98.39 -2.56 59.25 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 45.3 p -100.86 9.16 42.66 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.149 -1.206 . . . . 0.0 110.716 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.21 129.9 42.9 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.281 -0.887 . . . . 0.0 109.732 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 107.37 -20.77 32.06 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.57 128.5 38.39 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -76.94 162.24 32.3 Favored 'Trans proline' 0 C--N 1.319 -0.992 0 O-C-N 123.166 1.087 . . . . 0.0 111.304 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.8 mp -116.56 125.11 51.4 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.403 ' CD1' ' N ' ' A' ' 144' ' ' LEU . 6.5 mp -116.67 129.99 56.47 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.466 -0.771 . . . . 0.0 111.424 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 29.5 p -80.63 163.75 54.81 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.704 -0.623 . . . . 0.0 109.356 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.41 -14.6 44.81 Favored 'Trans proline' 0 N--CA 1.488 1.154 0 O-C-N 123.162 1.085 . . . . 0.0 111.12 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.6 t -66.89 -40.11 87.67 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.284 -0.885 . . . . 0.0 110.004 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 117.05 32.65 1.49 Allowed Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -132.98 148.24 52.27 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.46 -1.023 . . . . 0.0 110.168 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -72.28 134.78 45.75 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.519 -0.738 . . . . 0.0 110.271 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.0 t -98.52 -59.69 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.513 -0.742 . . . . 0.0 110.145 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -176.16 -170.01 38.35 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 45.4 mt -121.34 143.48 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.614 -0.933 . . . . 0.0 110.323 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -61.12 126.76 28.52 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.577 -0.702 . . . . 0.0 109.668 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -106.74 -64.25 1.2 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.474 -0.767 . . . . 0.0 110.972 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -134.1 150.92 51.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.432 -0.792 . . . . 0.0 110.794 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.49 152.9 18.21 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.584 -0.697 . . . . 0.0 109.439 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 46.6 t -120.0 120.01 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.485 -0.759 . . . . 0.0 110.443 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.2 p -140.98 142.16 34.33 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.473 -0.767 . . . . 0.0 110.536 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 92.6 m -70.03 -44.11 69.92 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.58 -0.7 . . . . 0.0 109.865 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -147.93 49.62 1.06 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.651 -0.656 . . . . 0.0 110.133 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 97.74 -11.19 64.61 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 58.0 t -101.6 123.64 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.195 -1.179 . . . . 0.0 108.97 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.24 118.21 26.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.443 -0.786 . . . . 0.0 111.136 -178.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -111.42 -15.12 13.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.742 -0.599 . . . . 0.0 110.158 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -144.31 167.99 21.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.354 -0.841 . . . . 0.0 109.356 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 35.0 m -137.81 145.05 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.319 -0.863 . . . . 0.0 111.131 -179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.47 132.44 54.73 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.71 -0.619 . . . . 0.0 110.082 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -142.11 154.05 44.61 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.493 -0.755 . . . . 0.0 110.502 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 89.5 t -92.46 130.96 35.55 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.588 -0.695 . . . . 0.0 109.803 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.13 160.08 46.2 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 O-C-N 123.193 1.101 . . . . 0.0 110.366 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 61.8 t -69.4 -33.1 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.602 -0.686 . . . . 0.0 109.932 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -60.03 -39.94 87.63 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.475 -0.766 . . . . 0.0 110.595 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.9 m -64.96 -22.91 67.08 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.526 -0.734 . . . . 0.0 111.28 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 65.6 mtt -59.97 -35.63 75.41 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.26 -0.9 . . . . 0.0 110.526 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -59.97 -32.8 71.16 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.576 -0.702 . . . . 0.0 110.652 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 93.9 m -59.94 -40.03 87.55 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.409 -0.807 . . . . 0.0 110.404 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 24.8 m -68.8 -34.19 75.13 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.429 -0.794 . . . . 0.0 110.561 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 44.8 ttp -59.97 -41.86 92.88 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.574 -0.704 . . . . 0.0 110.662 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 58.8 mtt-85 -61.32 -39.92 92.29 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.518 -0.739 . . . . 0.0 110.364 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.764 0 O-C-N 121.528 -0.732 . . . . 0.0 110.245 179.97 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' 4P2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.7 p . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.055 0.455 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 145.12 44.82 0.04 OUTLIER Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -61.3 -40.34 93.79 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.449 -1.03 . . . . 0.0 110.304 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -70.03 -41.04 74.79 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.603 -0.685 . . . . 0.0 110.134 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 72.8 tttt 50.2 40.17 21.44 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.39 -0.819 . . . . 0.0 110.943 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -88.77 62.08 6.27 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.471 -0.768 . . . . 0.0 110.202 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -60.1 -40.04 88.26 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.51 -0.744 . . . . 0.0 110.077 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.9 t 50.28 70.01 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.504 -0.747 . . . . 0.0 110.997 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -68.91 140.06 55.12 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.46 -0.775 . . . . 0.0 109.693 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -136.58 44.67 1.13 Allowed Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.3 -40.03 89.05 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.438 -1.037 . . . . 0.0 109.942 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.4 t -119.57 138.93 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.716 -0.615 . . . . 0.0 109.614 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -119.43 142.63 48.05 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.511 -0.743 . . . . 0.0 110.569 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.0 m -85.44 120.4 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.724 -0.61 . . . . 0.0 110.425 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.9 p -130.21 140.0 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.448 -0.783 . . . . 0.0 110.199 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 74.8 m -122.02 149.0 44.13 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.673 -0.642 . . . . 0.0 110.279 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.31 -177.38 3.23 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.639 -0.663 . . . . 0.0 110.004 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.5 -40.05 94.94 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.668 -0.645 . . . . 0.0 111.263 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.2 t -123.72 -11.7 7.7 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.326 -0.859 . . . . 0.0 111.935 -179.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -136.04 162.95 31.46 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.176 -0.952 . . . . 0.0 110.441 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.6 t -140.24 123.47 16.83 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.566 -0.709 . . . . 0.0 110.426 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -136.17 178.03 7.38 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.587 -0.696 . . . . 0.0 110.012 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 82.0 mt -117.46 147.19 42.95 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.523 -0.736 . . . . 0.0 110.636 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -109.97 155.3 21.96 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.719 -0.613 . . . . 0.0 110.081 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.7 p -129.95 144.2 51.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.512 -0.742 . . . . 0.0 110.255 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 34.0 t -100.89 115.82 31.3 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.559 -0.713 . . . . 0.0 110.45 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.4 t -129.98 129.97 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.628 -0.67 . . . . 0.0 109.967 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 52.77 40.12 29.93 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.432 -0.793 . . . . 0.0 111.059 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.2 20.99 71.68 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 62.1 t -130.87 123.35 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.293 -1.122 . . . . 0.0 109.922 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 42.3 t -80.7 110.07 15.85 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.48 -0.763 . . . . 0.0 109.564 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 46.7 m95 -97.27 137.58 36.06 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.528 -0.732 . . . . 0.0 110.994 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.408 HG21 ' CZ3' ' A' ' 85' ' ' TRP . 10.1 t -136.63 173.1 12.07 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.454 ' CG1' ' CE1' ' A' ' 57' ' ' HIS . 45.7 t -80.63 142.57 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.376 -0.827 . . . . 0.0 110.372 -179.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.441 ' CE2' HG23 ' A' ' 78' ' ' VAL . 34.7 t80 -74.96 -43.03 56.36 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.606 -0.684 . . . . 0.0 111.976 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.454 ' CE1' ' CG1' ' A' ' 55' ' ' VAL . 1.8 p-80 -66.35 -13.85 61.2 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.192 -0.942 . . . . 0.0 110.996 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.9 -88.11 1.47 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.33 -39.97 74.41 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.666 -0.902 . . . . 0.0 110.586 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.93 -27.56 56.83 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.7 m -59.97 -40.42 89.05 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.412 -1.052 . . . . 0.0 110.593 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.7 ttpt -138.26 145.05 40.85 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.485 -0.76 . . . . 0.0 110.468 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 74.9 m -65.9 140.99 58.39 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.609 -0.682 . . . . 0.0 109.903 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.5 pp -140.26 147.66 40.3 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.519 -0.738 . . . . 0.0 110.356 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -119.97 136.5 54.51 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.665 -0.647 . . . . 0.0 110.282 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -88.33 -164.44 40.27 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -70.54 -25.9 24.5 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 O-C-N 123.35 1.184 . . . . 0.0 110.454 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -70.03 -31.32 68.91 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.609 -0.682 . . . . 0.0 110.227 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 144.77 -156.27 26.8 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.83 145.41 45.7 Favored 'Trans proline' 0 N--CA 1.486 1.044 0 O-C-N 123.418 1.22 . . . . 0.0 110.613 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 85.5 mt -125.46 131.15 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.597 -0.69 . . . . 0.0 110.127 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.0 m -104.96 131.0 53.03 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.545 -0.722 . . . . 0.0 109.844 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -77.28 109.29 11.04 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.515 -0.741 . . . . 0.0 110.451 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 48.7 tpp -70.01 -35.77 74.61 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.669 -0.644 . . . . 0.0 110.122 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -109.67 128.42 55.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.615 -0.678 . . . . 0.0 109.924 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.1 p -144.23 121.21 11.37 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.538 -0.726 . . . . 0.0 110.361 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 59.6 t-20 -151.42 110.85 3.97 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.515 -0.74 . . . . 0.0 110.495 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.441 HG23 ' CE2' ' A' ' 56' ' ' TYR . 99.6 t -70.03 -35.36 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.451 -0.781 . . . . 0.0 109.577 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -60.0 -40.17 88.28 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.392 -0.817 . . . . 0.0 109.391 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -89.93 -14.28 34.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.699 -0.626 . . . . 0.0 110.083 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 46.5 t0 55.03 40.01 31.81 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.207 -0.933 . . . . 0.0 110.713 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 48.1 mt -144.09 149.6 36.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.512 -0.743 . . . . 0.0 111.165 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.9 m -141.24 168.21 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -152.37 156.73 26.87 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 119.747 -1.216 . . . . 0.0 110.318 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.408 ' CZ3' HG21 ' A' ' 54' ' ' THR . 3.3 m-90 -121.71 146.05 47.41 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.705 -0.879 . . . . 0.0 109.919 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -68.44 129.9 41.3 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.594 -0.692 . . . . 0.0 110.028 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -114.14 159.71 35.3 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.526 -0.734 . . . . 0.0 110.131 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.58 154.7 64.34 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 O-C-N 123.413 1.218 . . . . 0.0 110.376 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.51 160.14 44.93 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 O-C-N 123.41 1.216 . . . . 0.0 110.465 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 77.9 28.97 55.69 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -110.3 155.01 22.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.534 -0.98 . . . . 0.0 110.22 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -58.86 146.38 37.61 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.622 -0.673 . . . . 0.0 110.401 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.5 t -143.43 161.56 38.07 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.629 -0.67 . . . . 0.0 110.453 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -108.18 144.79 35.12 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.57 -0.706 . . . . 0.0 110.376 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.8 p -95.42 159.42 32.77 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.56 -0.712 . . . . 0.0 110.393 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.84 150.49 49.68 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 O-C-N 123.394 1.207 . . . . 0.0 110.386 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 47.9 t -87.28 128.26 35.17 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.62 -0.675 . . . . 0.0 110.445 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.5 p -136.12 71.79 1.43 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.584 -0.698 . . . . 0.0 109.927 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.6 p -145.4 8.25 1.18 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.473 -0.767 . . . . 0.0 111.916 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 52.59 42.96 58.85 Favored Glycine 0 N--CA 1.499 2.864 0 O-C-N 120.824 -1.172 . . . . 0.0 110.353 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 26.3 t -79.42 116.65 19.78 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.488 -1.007 . . . . 0.0 110.394 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.6 m -70.05 -39.91 75.43 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.603 -0.686 . . . . 0.0 110.275 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -84.27 142.16 30.44 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.609 -0.682 . . . . 0.0 110.402 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 94.9 mt -132.2 152.23 51.41 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.503 -0.748 . . . . 0.0 110.401 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -114.61 136.8 52.65 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.55 -0.719 . . . . 0.0 109.744 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 57.3 tp -110.85 140.13 45.57 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.43 -0.794 . . . . 0.0 110.422 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.3 t -93.69 129.94 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.616 -0.678 . . . . 0.0 109.913 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.4 m -110.01 160.93 16.0 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.47 -0.769 . . . . 0.0 110.519 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 18.0 ptm180 -62.71 -24.58 67.74 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.676 -0.64 . . . . 0.0 110.864 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -95.48 29.19 2.65 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.418 -0.801 . . . . 0.0 110.629 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 55.34 36.28 26.75 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.304 -0.873 . . . . 0.0 110.44 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -109.18 146.43 34.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.644 -0.66 . . . . 0.0 109.849 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.6 p -138.05 135.68 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.511 -0.743 . . . . 0.0 110.526 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 85.4 mt -126.6 143.68 47.16 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.603 -0.685 . . . . 0.0 109.679 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -76.79 139.13 19.53 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 O-C-N 123.274 1.144 . . . . 0.0 110.455 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.3 t -124.79 129.94 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.603 -0.686 . . . . 0.0 109.762 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.0 tpp85 -84.24 139.52 32.31 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.531 -0.731 . . . . 0.0 110.022 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -77.2 129.63 36.2 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.543 -0.723 . . . . 0.0 110.152 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -136.59 25.78 3.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.662 -0.649 . . . . 0.0 110.424 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 175.7 179.8 46.42 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -66.78 -40.11 88.06 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.505 -0.997 . . . . 0.0 110.324 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 67.1 m -136.03 25.94 3.28 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.551 -0.718 . . . . 0.0 110.377 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -136.95 159.99 40.24 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.588 -0.695 . . . . 0.0 110.299 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -150.93 -173.71 21.2 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 97.4 p -120.67 153.44 36.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.62 -0.93 . . . . 0.0 110.245 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.7 tp -106.57 123.6 48.34 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.583 -0.698 . . . . 0.0 110.143 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.7 mp -66.47 -39.99 89.09 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.543 -0.723 . . . . 0.0 110.304 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 30.0 t -100.22 108.47 52.6 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.488 -0.757 . . . . 0.0 110.262 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.33 115.45 4.35 Favored 'Trans proline' 0 C--N 1.319 -0.994 0 O-C-N 123.18 1.094 . . . . 0.0 110.307 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -124.48 160.7 51.93 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.586 -0.696 . . . . 0.0 110.392 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.44 150.52 58.16 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 O-C-N 123.469 1.247 . . . . 0.0 110.567 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 95.0 t -57.72 -30.55 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.564 -0.71 . . . . 0.0 110.258 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.5 t -60.07 -40.61 90.1 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.519 -0.738 . . . . 0.0 110.383 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -64.77 -46.02 83.9 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.579 -0.7 . . . . 0.0 109.868 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 54.1 tp -78.76 -22.59 46.2 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.681 -0.637 . . . . 0.0 110.91 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -60.03 136.38 58.0 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.387 -0.821 . . . . 0.0 110.58 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.404 ' HA2' ' C55' ' A' ' 201' ' ' 4P2 . . . 98.07 -2.35 59.73 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 68.9 m -109.07 16.23 22.72 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.16 -1.2 . . . . 0.0 110.538 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.8 t -62.43 150.15 40.68 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.415 -0.803 . . . . 0.0 109.842 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 90.1 -12.28 68.23 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.37 113.34 5.36 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -70.64 140.9 40.39 Favored 'Trans proline' 0 C--N 1.318 -1.072 0 O-C-N 123.171 1.09 . . . . 0.0 110.981 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 21.7 mt -87.51 125.22 34.19 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -110.41 160.02 16.96 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.322 0.582 . . . . 0.0 110.856 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -109.6 176.18 1.65 Allowed Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.76 -0.587 . . . . 0.0 109.681 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.77 -35.67 12.18 Favored 'Trans proline' 0 C--N 1.317 -1.081 0 O-C-N 123.292 1.154 . . . . 0.0 110.064 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.8 m -62.43 -40.03 95.24 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.605 -0.684 . . . . 0.0 109.756 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 120.21 36.01 0.84 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 45.5 m170 -126.26 138.14 53.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.523 -0.987 . . . . 0.0 110.146 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.17 140.37 38.97 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.508 -0.745 . . . . 0.0 110.119 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 34.3 m -105.95 -26.51 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.571 -0.705 . . . . 0.0 110.56 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 172.72 -164.49 36.67 Favored Glycine 0 N--CA 1.498 2.77 0 C-N-CA 119.674 -1.25 . . . . 0.0 110.571 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 82.6 mt -130.98 141.83 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.67 -0.9 . . . . 0.0 109.896 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -60.16 130.02 44.61 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.52 -0.737 . . . . 0.0 110.209 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -104.49 -72.96 0.69 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.515 -0.741 . . . . 0.0 110.792 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -132.29 152.96 51.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.306 -0.871 . . . . 0.0 110.867 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.48 156.29 16.53 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.648 -0.658 . . . . 0.0 109.757 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 60.7 t -120.78 115.77 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.601 -0.687 . . . . 0.0 110.248 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.4 p -141.35 146.28 36.46 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.461 -0.774 . . . . 0.0 110.711 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 12.2 m -82.3 -49.16 10.36 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.539 -0.725 . . . . 0.0 110.006 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -129.88 46.44 2.65 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.601 -0.687 . . . . 0.0 110.203 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 91.78 -10.99 73.33 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 67.2 t -97.61 122.78 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.156 -1.202 . . . . 0.0 109.38 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.55 116.36 25.62 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.542 -0.724 . . . . 0.0 110.9 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 67.5 mttt -104.27 -29.1 11.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.688 -0.633 . . . . 0.0 109.586 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -128.44 157.38 41.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.705 -0.622 . . . . 0.0 109.55 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 31.7 m -133.07 139.99 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.442 -0.786 . . . . 0.0 110.774 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -119.32 133.54 55.68 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.606 -0.683 . . . . 0.0 110.347 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -134.5 156.67 48.21 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.554 -0.716 . . . . 0.0 110.146 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 57.5 t -96.2 133.84 24.48 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.507 -0.746 . . . . 0.0 110.254 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.01 159.96 40.68 Favored 'Trans proline' 0 N--CA 1.485 0.988 0 O-C-N 123.253 1.133 . . . . 0.0 110.465 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 59.5 t -72.66 -26.32 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.625 -0.672 . . . . 0.0 110.223 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -59.64 -36.82 77.13 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.458 -0.776 . . . . 0.0 110.46 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 22.9 t -61.17 -38.62 87.15 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.587 -0.696 . . . . 0.0 110.162 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 66.1 mtt -60.04 -34.2 73.07 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.537 -0.727 . . . . 0.0 110.35 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -60.02 -40.34 88.95 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.534 -0.728 . . . . 0.0 110.459 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 94.5 m -65.99 -40.09 90.88 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.523 -0.736 . . . . 0.0 109.67 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 93.9 m -62.89 -40.01 96.23 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.662 -0.649 . . . . 0.0 110.067 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 89.1 mtp -60.08 -40.05 88.22 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.539 -0.726 . . . . 0.0 110.431 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -67.28 -39.97 86.08 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.601 -0.687 . . . . 0.0 110.087 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.798 0 O-C-N 121.593 -0.692 . . . . 0.0 110.251 -179.935 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' 4P2 . . . . . 0.404 ' C55' ' HA2' ' A' ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.8 p . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.049 0.452 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.01 85.5 1.0 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.92 139.92 50.16 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.568 -0.96 . . . . 0.0 110.712 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -117.76 25.31 10.48 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.506 -0.746 . . . . 0.0 110.362 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.9 mttt -102.67 -55.78 2.37 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.404 -0.81 . . . . 0.0 110.328 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 35.96 -90.9 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.901 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -112.41 -70.89 0.78 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.048 -1.033 . . . . 0.0 110.636 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.6 t 57.53 162.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 CA-C-O 121.569 0.7 . . . . 0.0 110.578 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 50.03 -170.5 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.329 -0.857 . . . . 0.0 111.185 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.63 -88.05 0.43 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -76.87 -23.05 52.63 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.552 -0.969 . . . . 0.0 110.604 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.6 t -101.71 124.98 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.42 -0.8 . . . . 0.0 109.978 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -104.62 132.29 51.03 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.521 -0.737 . . . . 0.0 110.362 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.9 m -94.98 129.8 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.644 -0.66 . . . . 0.0 110.116 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.2 m -130.05 159.97 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.353 -0.842 . . . . 0.0 110.772 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 69.0 m -132.76 152.83 51.68 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.544 -0.723 . . . . 0.0 110.152 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.56 -176.53 2.94 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.543 -0.723 . . . . 0.0 110.093 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.09 -49.6 77.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.74 -0.6 . . . . 0.0 111.049 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.6 t -116.99 -22.48 8.43 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.393 -0.817 . . . . 0.0 111.293 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -117.14 164.94 14.0 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.389 -0.819 . . . . 0.0 110.187 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.5 m -147.93 120.19 8.37 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.499 -0.751 . . . . 0.0 110.303 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -130.98 -176.66 4.07 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.629 -0.67 . . . . 0.0 110.049 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 48.9 mt -122.4 173.36 7.7 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.502 -0.748 . . . . 0.0 109.893 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -150.68 160.83 43.57 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.564 -0.71 . . . . 0.0 110.355 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.2 t -136.61 144.1 43.91 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.669 -0.644 . . . . 0.0 110.172 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 28.5 p -87.92 123.71 32.95 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.589 -0.695 . . . . 0.0 110.763 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.6 t -130.61 125.26 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.52 -0.737 . . . . 0.0 110.174 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 51.34 40.72 27.05 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.389 -0.819 . . . . 0.0 111.335 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.95 22.77 77.2 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.416 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 60.8 t -142.26 113.62 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.396 -1.061 . . . . 0.0 109.53 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 93.3 m -79.73 125.27 29.44 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.641 -0.662 . . . . 0.0 110.205 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.416 ' CZ2' HG11 ' A' ' 51' ' ' VAL . 98.5 m95 -114.26 136.48 52.92 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.585 -0.697 . . . . 0.0 110.102 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.415 HG23 ' CZ3' ' A' ' 85' ' ' TRP . 7.9 t -137.85 -179.87 6.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.656 -0.653 . . . . 0.0 109.968 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.466 ' CG1' ' CE1' ' A' ' 57' ' ' HIS . 2.1 t -81.69 141.59 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.503 -0.748 . . . . 0.0 109.415 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.464 ' CZ ' HG23 ' A' ' 78' ' ' VAL . 9.6 t80 -85.49 -43.81 13.25 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.392 -0.818 . . . . 0.0 111.85 -179.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.466 ' CE1' ' CG1' ' A' ' 55' ' ' VAL . 3.1 p-80 -57.76 -17.83 17.89 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.204 -0.935 . . . . 0.0 111.672 -177.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.75 -53.87 2.78 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.2 -63.39 1.42 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.621 -0.929 . . . . 0.0 109.779 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.89 -169.05 14.19 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 95.8 p -66.13 -35.07 79.53 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.603 -0.939 . . . . 0.0 110.286 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -60.04 136.78 58.12 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.513 -0.742 . . . . 0.0 110.261 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.1 t -80.83 175.55 10.59 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.573 -0.704 . . . . 0.0 110.094 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 61.7 mt -97.9 137.21 37.08 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.571 -0.706 . . . . 0.0 110.622 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -100.54 109.8 21.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.62 -0.675 . . . . 0.0 110.075 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -86.02 -158.48 30.95 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.14 -36.66 16.31 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 O-C-N 123.381 1.201 . . . . 0.0 110.347 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.9 mmmt -76.85 -31.31 56.76 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.556 -0.715 . . . . 0.0 110.377 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 138.26 176.84 14.78 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.34 172.9 14.7 Favored 'Trans proline' 0 N--CA 1.486 1.041 0 O-C-N 123.425 1.224 . . . . 0.0 110.468 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.42 HD12 ' CD1' ' A' ' 85' ' ' TRP . 44.2 pt -131.88 169.99 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.565 -0.71 . . . . 0.0 110.335 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.4 m -72.41 139.21 47.66 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.503 -0.748 . . . . 0.0 110.267 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -74.32 131.07 40.81 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.625 -0.672 . . . . 0.0 110.087 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.428 ' HG3' ' CD2' ' A' ' 75' ' ' TYR . 22.8 ptp -119.69 -42.49 2.63 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.45 -0.781 . . . . 0.0 110.751 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.428 ' CD2' ' HG3' ' A' ' 74' ' ' MET . 35.0 m-85 -119.98 114.3 21.82 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.265 -0.897 . . . . 0.0 110.088 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.6 m -152.7 131.62 12.52 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.553 -0.717 . . . . 0.0 110.187 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -169.89 125.39 0.81 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.281 -0.887 . . . . 0.0 111.279 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.464 HG23 ' CZ ' ' A' ' 56' ' ' TYR . 76.3 t -72.48 -38.17 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.395 -0.816 . . . . 0.0 109.593 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -55.65 -34.22 64.76 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.386 -0.821 . . . . 0.0 110.364 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -98.99 -12.21 20.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.655 -0.653 . . . . 0.0 110.628 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 42.8 t0 53.28 40.06 30.71 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.093 -1.004 . . . . 0.0 110.501 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.48 151.03 42.99 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.786 0.803 . . . . 0.0 110.979 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.32 153.07 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -153.14 159.25 28.42 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.474 -1.346 . . . . 0.0 110.816 -178.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.42 ' CD1' HD12 ' A' ' 71' ' ' ILE . 6.3 m-90 -131.43 168.37 17.72 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.997 -0.707 . . . . 0.0 109.307 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -68.82 138.51 54.82 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.429 -0.794 . . . . 0.0 110.425 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.38 148.69 45.13 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.577 -0.702 . . . . 0.0 110.109 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.12 144.43 37.6 Favored 'Trans proline' 0 C--N 1.318 -1.065 0 O-C-N 123.29 1.153 . . . . 0.0 110.394 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -77.39 160.26 32.37 Favored 'Trans proline' 0 C--N 1.318 -1.034 0 O-C-N 123.345 1.182 . . . . 0.0 110.548 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 89.61 30.01 14.7 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -151.99 167.84 27.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.55 -0.971 . . . . 0.0 110.301 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -113.76 159.44 19.75 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.515 -0.74 . . . . 0.0 110.123 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.3 m -129.12 171.11 12.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.492 -0.755 . . . . 0.0 110.523 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -81.25 165.08 21.78 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.703 -0.623 . . . . 0.0 110.557 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.453 ' CG2' ' CD2' ' A' ' 149' ' ' HIS . 9.4 t -110.85 151.73 43.11 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.655 -0.653 . . . . 0.0 109.909 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.07 130.29 21.23 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 O-C-N 123.245 1.129 . . . . 0.0 110.232 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.864 ' SG ' 'ZN ' ' A' ' 202' ' ' ' ZN' . 5.0 t -72.31 145.09 48.06 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.64 -0.663 . . . . 0.0 110.538 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 31.3 m -136.28 66.19 1.5 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.573 -0.704 . . . . 0.0 110.477 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 27.7 p -145.01 -8.01 0.62 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.467 -0.771 . . . . 0.0 112.387 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.94 43.71 97.83 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.4 t -71.92 129.87 39.64 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.528 -0.983 . . . . 0.0 110.268 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 73.4 m -71.34 -40.3 70.81 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.563 -0.71 . . . . 0.0 110.267 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -79.75 130.02 34.98 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.518 -0.739 . . . . 0.0 110.328 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 95.9 mt -136.57 151.97 49.96 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.553 -0.717 . . . . 0.0 110.378 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -106.97 123.27 47.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.462 -0.774 . . . . 0.0 109.75 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 41.0 tp -110.05 140.31 44.24 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.516 -0.74 . . . . 0.0 110.386 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 26.7 m -112.27 141.23 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.584 -0.697 . . . . 0.0 109.954 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.5 p -109.85 -162.65 0.81 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.365 -0.834 . . . . 0.0 109.949 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -70.1 -23.62 63.08 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.653 -0.654 . . . . 0.0 110.353 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -91.68 19.69 6.16 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.37 -0.831 . . . . 0.0 111.01 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.13 24.76 5.08 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.124 -0.985 . . . . 0.0 111.024 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 54.7 p-10 -81.0 161.74 24.12 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.477 -0.764 . . . . 0.0 109.914 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.0 p -129.35 133.11 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.626 -0.671 . . . . 0.0 110.062 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.4 tp -143.59 138.38 15.3 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.529 -0.732 . . . . 0.0 109.929 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.35 139.28 28.71 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 O-C-N 123.201 1.106 . . . . 0.0 110.556 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.3 t -129.93 130.04 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.517 -0.74 . . . . 0.0 109.876 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -81.95 149.02 28.4 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.476 -0.765 . . . . 0.0 110.144 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -83.42 137.18 34.03 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.661 -0.649 . . . . 0.0 110.369 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.6 mmt85 -141.28 26.49 1.99 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.58 -0.7 . . . . 0.0 110.381 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 161.65 171.95 28.39 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -71.66 -45.16 62.81 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.556 -0.967 . . . . 0.0 110.443 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 61.3 p -116.83 20.09 14.09 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.553 -0.717 . . . . 0.0 110.732 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 25.3 ttp180 -147.77 144.21 28.07 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.399 -0.813 . . . . 0.0 110.009 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -139.85 -175.23 14.17 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 57.3 p -119.72 147.53 44.48 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.61 -0.936 . . . . 0.0 110.026 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 34.7 tp -95.06 131.23 41.27 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.584 -0.698 . . . . 0.0 110.205 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.4 tt -63.03 -54.58 35.95 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.612 -0.68 . . . . 0.0 110.258 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 57.8 m -96.51 130.05 31.62 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.445 -0.784 . . . . 0.0 110.156 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -81.25 116.32 3.02 Favored 'Trans proline' 0 C--N 1.32 -0.939 0 O-C-N 123.132 1.07 . . . . 0.0 110.677 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.427 ' HD2' ' CD2' ' A' ' 134' ' ' TYR . 54.6 mtm-85 -125.09 152.6 70.86 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.518 -0.739 . . . . 0.0 109.779 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.3 150.22 64.62 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 123.369 1.194 . . . . 0.0 110.759 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 51.6 t -54.33 -31.72 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.442 -0.786 . . . . 0.0 109.701 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.6 t -59.9 -40.38 88.59 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.746 -0.596 . . . . 0.0 111.095 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.427 ' CD2' ' HD2' ' A' ' 130' ' ' ARG . 86.3 t80 -68.95 -39.81 79.3 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.342 -0.849 . . . . 0.0 109.685 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 23.2 tp -94.67 18.75 11.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.885 -0.51 . . . . 0.0 110.187 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.478 ' HA ' H481 ' A' ' 201' ' ' 4P2 . 0.2 OUTLIER -83.64 118.47 23.87 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 122.658 1.218 . . . . 0.0 112.317 -178.879 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.407 ' HA2' H551 ' A' ' 201' ' ' 4P2 . . . 100.8 26.35 8.04 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.3 p -109.96 20.94 17.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.529 -0.983 . . . . 0.0 110.621 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.6 m -66.39 144.59 56.44 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.337 -0.852 . . . . 0.0 109.342 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.75 -18.2 57.05 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.63 110.37 2.3 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.05 161.45 45.98 Favored 'Trans proline' 0 C--N 1.318 -1.048 0 O-C-N 123.168 1.088 . . . . 0.0 111.054 -179.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.1 mp -113.99 119.71 38.15 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.0 tp -96.51 167.34 11.21 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.426 0.631 . . . . 0.0 110.833 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.2 178.49 1.05 Allowed Pre-proline 0 N--CA 1.493 1.701 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.05 -25.37 31.95 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 O-C-N 123.258 1.136 . . . . 0.0 110.339 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 83.0 p -79.81 -28.58 40.19 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.514 -0.741 . . . . 0.0 110.088 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 115.55 35.01 1.34 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.453 ' CD2' ' CG2' ' A' ' 95' ' ' THR . 22.9 m170 -122.79 153.64 39.27 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.579 -0.953 . . . . 0.0 110.365 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -88.69 144.24 26.4 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.474 -0.766 . . . . 0.0 110.199 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.1 m -119.14 -24.26 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.476 -0.765 . . . . 0.0 111.067 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -179.73 -173.08 44.48 Favored Glycine 0 N--CA 1.498 2.829 0 C-N-CA 119.672 -1.252 . . . . 0.0 110.385 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 64.0 mt -130.0 159.23 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.562 -0.964 . . . . 0.0 110.033 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -73.77 144.62 45.56 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.55 -0.718 . . . . 0.0 110.248 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 -129.57 -75.97 0.55 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.534 -0.729 . . . . 0.0 110.264 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -120.41 142.35 49.29 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.154 -0.966 . . . . 0.0 110.992 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.52 127.33 39.12 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.445 ' CG2' H131 ' A' ' 201' ' ' 4P2 . 2.4 t -97.83 119.5 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.532 -0.73 . . . . 0.0 111.388 -177.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 28.3 p -141.15 151.74 44.13 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.547 -0.721 . . . . 0.0 110.43 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 6.8 p -93.7 -48.19 6.44 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.511 -0.743 . . . . 0.0 109.511 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 50.9 mtt85 -119.97 36.7 4.44 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 91.9 -11.57 71.79 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 63.7 t -89.16 123.66 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.178 -1.189 . . . . 0.0 109.284 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.18 114.3 23.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.526 -0.734 . . . . 0.0 110.838 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -107.14 -29.99 9.04 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.809 -0.557 . . . . 0.0 109.64 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -118.47 168.25 10.83 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.668 -0.645 . . . . 0.0 109.863 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.9 m -143.21 131.83 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.498 -0.751 . . . . 0.0 110.702 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.31 127.84 47.74 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.613 -0.679 . . . . 0.0 110.231 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -136.27 162.15 33.79 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.556 -0.715 . . . . 0.0 110.588 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 90.1 t -104.86 144.71 29.28 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.463 -0.773 . . . . 0.0 110.033 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.41 168.15 24.31 Favored 'Trans proline' 0 N--CA 1.486 1.056 0 O-C-N 123.318 1.168 . . . . 0.0 110.709 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 61.4 t -92.44 -45.99 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.606 -0.684 . . . . 0.0 110.467 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -54.61 -28.88 49.67 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.693 -0.629 . . . . 0.0 111.304 -178.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.3 m -61.62 -25.91 67.65 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.378 -0.826 . . . . 0.0 110.279 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 32.8 mmt -70.12 -27.35 64.5 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.498 -0.751 . . . . 0.0 110.641 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -56.83 -41.78 78.46 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.448 -0.783 . . . . 0.0 111.059 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 7.4 t -73.9 -22.09 59.83 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.405 -0.809 . . . . 0.0 110.556 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 76.7 m -72.0 -39.94 68.87 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.384 -0.823 . . . . 0.0 110.344 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 26.2 ttp -59.98 -44.57 94.41 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.681 -0.637 . . . . 0.0 110.5 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 26.4 mmt85 -60.01 -39.9 87.39 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.531 -0.731 . . . . 0.0 110.389 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.789 0 O-C-N 121.571 -0.706 . . . . 0.0 110.09 179.976 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' 4P2 . . . . . 0.478 H481 ' HA ' ' A' ' 136' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . 0.864 'ZN ' ' SG ' ' A' ' 97' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.5 m . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.088 0.47 . . . . 0.0 110.15 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.7 -71.41 0.08 OUTLIER Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -39.98 89.07 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.536 -0.979 . . . . 0.0 110.206 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -60.45 131.52 51.02 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.506 -0.746 . . . . 0.0 110.505 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -147.11 27.55 1.04 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.547 -0.72 . . . . 0.0 110.277 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -94.19 152.55 18.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.504 -0.748 . . . . 0.0 110.349 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 32.2 tp60 -99.56 123.1 43.51 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.544 -0.722 . . . . 0.0 110.06 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.7 t -129.98 136.4 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.635 -0.665 . . . . 0.0 110.096 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -60.02 146.0 44.35 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.468 -0.77 . . . . 0.0 110.342 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.53 68.11 0.01 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 56.23 -84.59 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.771 -0.841 . . . . 0.0 111.008 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.3 m -118.92 162.22 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.182 -0.949 . . . . 0.0 110.947 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 22.2 mm100 -136.87 125.2 23.28 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.5 m -73.76 116.42 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.585 -0.697 . . . . 0.0 109.957 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.413 HG22 ' CE2' ' A' ' 43' ' ' PHE . 35.9 m -110.75 152.03 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.431 -0.793 . . . . 0.0 110.157 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.1 m -115.7 125.38 52.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.581 -0.699 . . . . 0.0 110.366 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.05 -169.61 1.89 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.655 -0.653 . . . . 0.0 109.538 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.16 -51.23 70.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.583 -0.698 . . . . 0.0 110.894 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.9 t -127.65 0.99 6.15 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.404 -0.81 . . . . 0.0 111.817 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -140.38 171.26 14.4 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.004 -1.06 . . . . 0.0 110.499 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 77.7 p -145.4 131.38 19.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.618 -0.676 . . . . 0.0 110.157 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.413 ' CE2' HG22 ' A' ' 36' ' ' VAL . 13.5 p90 -130.21 -175.33 3.6 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.521 -0.737 . . . . 0.0 110.314 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.44 159.0 25.09 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.455 -0.778 . . . . 0.0 110.633 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -126.67 119.56 27.31 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.606 -0.683 . . . . 0.0 110.015 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.0 p -101.8 144.08 30.91 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.496 -0.752 . . . . 0.0 110.504 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 26.3 p -100.68 110.23 22.33 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.683 0.754 . . . . 0.0 110.238 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.3 t -130.25 130.02 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.174 -0.954 . . . . 0.0 110.258 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 52.73 39.43 28.57 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.4 -0.813 . . . . 0.0 111.116 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.46 24.76 71.06 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.5 t -135.15 122.73 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.368 -1.077 . . . . 0.0 109.666 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 54.5 m -79.27 111.38 15.46 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.56 -0.712 . . . . 0.0 109.782 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.417 ' CE3' HD21 ' A' ' 82' ' ' LEU . 52.3 m95 -98.6 136.82 38.14 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.528 -0.733 . . . . 0.0 110.82 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.456 ' CG2' ' CH2' ' A' ' 85' ' ' TRP . 6.4 t -137.36 179.99 6.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.711 -0.618 . . . . 0.0 109.547 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.468 ' CG1' ' CE1' ' A' ' 57' ' ' HIS . 79.0 t -85.47 141.7 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.471 -0.768 . . . . 0.0 109.379 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.455 ' CE2' ' CG2' ' A' ' 78' ' ' VAL . 15.7 t80 -85.37 -43.68 13.45 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.487 -0.758 . . . . 0.0 111.381 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.468 ' CE1' ' CG1' ' A' ' 55' ' ' VAL . 2.0 p-80 -60.68 -17.43 47.74 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.308 -0.87 . . . . 0.0 111.419 -178.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -103.1 -62.11 0.7 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -96.1 -23.57 16.71 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.534 -0.98 . . . . 0.0 111.011 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.99 -40.05 96.46 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.1 t -70.14 -39.78 75.17 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.523 -0.986 . . . . 0.0 110.864 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -99.61 178.9 4.72 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.416 -0.803 . . . . 0.0 110.828 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.4 m -81.19 169.94 16.74 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.695 -0.628 . . . . 0.0 110.23 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.438 ' CD2' ' CZ2' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -100.85 147.38 26.17 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.492 -0.755 . . . . 0.0 110.589 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.03 123.81 44.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.643 -0.661 . . . . 0.0 110.005 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -142.66 -174.27 14.98 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.4 -45.15 2.78 Favored 'Trans proline' 0 C--N 1.318 -1.072 0 O-C-N 123.402 1.212 . . . . 0.0 110.619 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 38.6 tptt -70.05 -31.2 68.7 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.511 -0.743 . . . . 0.0 110.133 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.56 -159.89 22.1 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.72 153.09 53.84 Favored 'Trans proline' 0 C--N 1.318 -1.053 0 O-C-N 123.345 1.181 . . . . 0.0 110.344 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 41.6 pt -129.99 160.16 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.577 -0.702 . . . . 0.0 110.345 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.9 t -71.32 150.3 45.26 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.602 -0.687 . . . . 0.0 110.177 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -94.41 131.15 40.38 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.528 -0.732 . . . . 0.0 110.147 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.453 ' CE ' ' CE2' ' A' ' 75' ' ' TYR . 25.4 ptm -116.54 -37.47 3.7 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.555 -0.716 . . . . 0.0 110.165 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.453 ' CE2' ' CE ' ' A' ' 74' ' ' MET . 28.1 m-85 -111.26 119.6 39.44 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.537 -0.727 . . . . 0.0 109.373 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 88.0 m -148.6 126.06 11.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.48 -0.763 . . . . 0.0 110.277 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -165.43 123.48 1.59 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.384 -0.823 . . . . 0.0 111.307 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.455 ' CG2' ' CE2' ' A' ' 56' ' ' TYR . 79.7 t -72.36 -34.08 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.478 -0.764 . . . . 0.0 109.376 178.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -55.7 -44.77 77.72 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.567 -0.708 . . . . 0.0 110.536 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -90.76 -10.38 43.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.606 -0.684 . . . . 0.0 110.522 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.5 t0 53.13 40.36 31.11 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.185 -0.947 . . . . 0.0 110.654 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.417 HD21 ' CE3' ' A' ' 53' ' ' TRP . 1.0 OUTLIER -141.62 160.46 40.11 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.884 0.849 . . . . 0.0 111.098 -179.412 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.4 ' O ' ' CE3' ' A' ' 53' ' ' TRP . 1.6 t -138.35 164.43 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.406 ' O ' ' CD1' ' A' ' 85' ' ' TRP . . . -153.68 155.15 25.98 Favored Glycine 0 N--CA 1.496 2.653 0 C-N-CA 119.497 -1.335 . . . . 0.0 110.87 -179.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.456 ' CH2' ' CG2' ' A' ' 54' ' ' THR . 4.5 m-90 -141.93 163.57 32.52 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.877 -0.778 . . . . 0.0 109.332 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -73.41 122.98 22.97 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.479 -0.763 . . . . 0.0 109.881 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.11 154.88 40.53 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.57 -0.706 . . . . 0.0 110.26 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.98 146.14 41.19 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.467 1.246 . . . . 0.0 110.359 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -76.86 160.08 34.21 Favored 'Trans proline' 0 C--N 1.317 -1.1 0 O-C-N 123.394 1.208 . . . . 0.0 110.43 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.25 28.7 12.6 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -133.34 160.4 37.45 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.519 -0.989 . . . . 0.0 110.165 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -79.57 153.44 29.48 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.551 -0.718 . . . . 0.0 110.229 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.8 m -134.68 158.64 43.56 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.533 -0.729 . . . . 0.0 110.305 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.1 mt -108.24 158.33 17.55 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.584 -0.698 . . . . 0.0 110.408 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.408 ' OG1' ' CE1' ' A' ' 149' ' ' HIS . 71.4 p -137.24 163.21 50.65 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.577 -0.702 . . . . 0.0 110.075 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.79 142.62 43.8 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 O-C-N 123.42 1.221 . . . . 0.0 110.151 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 30.5 p -84.77 157.88 20.88 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.563 -0.711 . . . . 0.0 110.828 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.5 t -115.94 65.4 0.7 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.2 p -144.65 -8.71 0.64 Allowed 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 120.044 -0.663 . . . . 0.0 112.582 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 50.5 26.75 10.5 Favored Glycine 0 N--CA 1.502 3.049 0 O-C-N 120.778 -1.201 . . . . 0.0 110.609 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 41.6 m -59.11 127.63 33.14 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.446 -1.031 . . . . 0.0 110.645 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 73.6 m -68.74 -40.14 80.0 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.701 -0.624 . . . . 0.0 109.992 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -61.66 139.4 58.29 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.57 -0.706 . . . . 0.0 110.02 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.5 mt -141.73 169.23 17.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.649 -0.657 . . . . 0.0 110.513 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -138.36 128.89 26.31 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.681 -0.637 . . . . 0.0 109.598 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.4 tt -114.88 123.56 49.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.437 -0.789 . . . . 0.0 110.476 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 63.0 t -94.96 109.9 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.674 -0.641 . . . . 0.0 109.511 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 75.1 p -81.91 174.89 10.86 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.465 -0.772 . . . . 0.0 110.478 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -59.92 -22.78 62.88 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.64 -0.663 . . . . 0.0 110.585 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.81 20.18 5.86 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.359 -0.838 . . . . 0.0 110.675 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 52.76 41.6 31.63 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.198 -0.938 . . . . 0.0 110.881 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -100.22 121.2 41.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.567 -0.708 . . . . 0.0 110.091 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.9 p -57.07 -79.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.598 -0.689 . . . . 0.0 111.018 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.427 ' CD1' ' N ' ' A' ' 114' ' ' ILE . 2.4 mp 54.69 99.31 0.04 OUTLIER Pre-proline 0 N--CA 1.504 2.238 0 O-C-N 120.726 -1.234 . . . . 0.0 110.227 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.23 164.37 35.24 Favored 'Trans proline' 0 C--N 1.318 -1.051 0 O-C-N 123.226 1.119 . . . . 0.0 110.6 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.2 t -139.9 139.8 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.556 -0.715 . . . . 0.0 109.719 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -93.5 149.9 20.87 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.584 -0.697 . . . . 0.0 110.102 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -76.76 147.51 37.24 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.59 -0.694 . . . . 0.0 110.615 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -154.63 52.34 0.64 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.616 -0.678 . . . . 0.0 109.785 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 126.13 171.25 13.12 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -60.1 -58.89 6.59 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.454 -1.027 . . . . 0.0 109.974 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 57.8 m -112.85 23.74 13.12 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.558 -0.713 . . . . 0.0 109.871 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.41 136.71 53.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.548 -0.72 . . . . 0.0 109.832 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -142.41 169.44 25.46 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 20.2 p -111.06 160.57 16.73 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.571 -0.958 . . . . 0.0 109.989 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 18.1 tp -106.36 126.35 52.13 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.666 -0.646 . . . . 0.0 110.509 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.32 -56.49 14.13 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.596 -0.69 . . . . 0.0 109.999 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 33.1 t -94.81 112.8 59.44 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.61 -0.681 . . . . 0.0 109.872 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.66 107.25 2.27 Favored 'Trans proline' 0 C--N 1.32 -0.969 0 O-C-N 123.25 1.132 . . . . 0.0 110.799 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 -118.84 158.02 48.75 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.63 -0.668 . . . . 0.0 109.9 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.78 150.41 55.93 Favored 'Trans proline' 0 C--N 1.315 -1.204 0 O-C-N 123.433 1.228 . . . . 0.0 110.678 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 55.6 t -53.65 -29.42 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 O-C-N 121.433 -0.792 . . . . 0.0 109.807 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.1 t -59.83 -44.87 93.84 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.656 -0.653 . . . . 0.0 111.213 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -67.32 -38.7 85.34 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.32 -0.862 . . . . 0.0 109.815 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 31.2 tp -92.32 18.43 8.35 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.78 -0.575 . . . . 0.0 110.19 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.47 ' HA ' H481 ' A' ' 201' ' ' 4P2 . 9.7 tttm -82.88 118.28 23.33 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 122.57 1.176 . . . . 0.0 112.145 -179.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.402 ' HA2' H551 ' A' ' 201' ' ' 4P2 . . . 100.71 26.6 7.95 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 17.0 m -105.35 19.93 19.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.642 -0.916 . . . . 0.0 110.141 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.4 m -74.17 130.27 39.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.31 -0.869 . . . . 0.0 109.466 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 113.59 -26.51 10.1 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.57 131.01 51.84 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -85.7 157.84 10.49 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.117 1.062 . . . . 0.0 111.106 -178.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.8 mp -107.71 123.5 48.62 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.1 tp -105.34 162.33 13.53 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.519 -0.738 . . . . 0.0 110.823 -179.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.707 ' SG ' 'ZN ' ' A' ' 202' ' ' ' ZN' . 28.9 p -115.39 168.45 8.27 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 37.7 Cg_endo -62.47 -15.36 44.98 Favored 'Trans proline' 0 N--CA 1.488 1.18 0 O-C-N 122.935 0.966 . . . . 0.0 111.103 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.2 t -69.94 -35.09 74.25 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.268 -0.895 . . . . 0.0 109.783 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 117.81 15.36 6.31 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.408 ' CE1' ' OG1' ' A' ' 95' ' ' THR . 0.9 OUTLIER -126.89 170.22 12.46 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.199 -1.177 . . . . 0.0 110.095 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -94.5 153.26 18.0 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.437 -0.789 . . . . 0.0 110.816 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.6 m -119.19 -26.02 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.627 -0.671 . . . . 0.0 110.907 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -172.59 -162.07 24.11 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 11.5 tt -140.11 152.87 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.668 -0.901 . . . . 0.0 109.992 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -64.73 144.35 57.3 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.251 -0.906 . . . . 0.0 111.345 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 9.6 ttt180 -129.81 -70.73 0.63 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.272 0.558 . . . . 0.0 109.851 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -128.82 147.9 50.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.288 -0.882 . . . . 0.0 111.047 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.38 158.46 15.72 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.412 ' CG2' H131 ' A' ' 201' ' ' 4P2 . 2.5 t -123.29 112.38 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.175 -0.953 . . . . 0.0 111.058 -178.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 28.1 p -138.18 144.03 40.52 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.785 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 24.2 m -82.81 -43.98 16.04 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.525 -0.734 . . . . 0.0 109.847 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.52 34.99 4.27 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.638 -0.664 . . . . 0.0 109.974 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 99.55 -11.88 61.36 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 63.3 t -92.81 123.47 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.19 -1.183 . . . . 0.0 109.136 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.12 114.22 23.54 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.559 -0.713 . . . . 0.0 111.071 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -104.15 -25.09 13.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.738 -0.601 . . . . 0.0 110.028 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -131.88 168.38 17.96 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.484 -0.76 . . . . 0.0 109.833 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 36.0 m -141.61 137.36 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.406 -0.809 . . . . 0.0 110.844 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -112.82 140.35 47.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.55 -0.719 . . . . 0.0 110.27 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -140.6 159.97 41.05 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.625 -0.672 . . . . 0.0 110.556 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 59.0 t -93.93 135.89 24.35 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.606 -0.684 . . . . 0.0 109.868 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.54 158.45 43.91 Favored 'Trans proline' 0 C--N 1.318 -1.053 0 O-C-N 123.225 1.119 . . . . 0.0 110.515 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 79.1 t -77.33 -28.73 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.636 -0.665 . . . . 0.0 110.015 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -59.86 -37.48 79.44 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.435 -0.791 . . . . 0.0 110.429 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 39.0 m -61.65 -35.49 78.07 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.652 -0.655 . . . . 0.0 110.397 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 48.7 mtm -59.99 -30.03 68.85 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.6 -0.688 . . . . 0.0 110.424 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.03 -43.55 95.25 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.502 -0.749 . . . . 0.0 110.302 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 85.1 m -63.55 -40.14 96.21 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.577 -0.702 . . . . 0.0 109.969 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 89.1 m -65.4 -37.21 86.29 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.657 -0.652 . . . . 0.0 110.023 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 19.4 ttt -60.05 -37.96 81.38 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.666 -0.646 . . . . 0.0 110.251 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 39.4 mtp-105 -60.03 -39.74 86.93 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.532 -0.73 . . . . 0.0 110.21 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.749 0 O-C-N 121.509 -0.744 . . . . 0.0 110.18 -179.955 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' 4P2 . . . . . 0.47 H481 ' HA ' ' A' ' 136' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ' ZN' . . . . . 0.707 'ZN ' ' SG ' ' A' ' 145' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.7 mp0 . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 120.526 0.203 . . . . 0.0 111.298 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 63.3 t -109.97 126.36 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.072 -1.018 . . . . 0.0 109.922 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -115.29 159.47 20.98 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.638 -0.663 . . . . 0.0 110.074 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.485 ' HA ' HD22 ' A' ' 44' ' ' LEU . 62.7 t -116.63 129.94 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.521 -0.737 . . . . 0.0 110.034 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.5 p -136.99 139.57 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.543 -0.723 . . . . 0.0 110.003 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 72.7 m -125.12 141.2 52.25 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.5 -0.75 . . . . 0.0 110.381 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.527 HG22 ' H ' ' A' ' 39' ' ' ALA . 0.8 OUTLIER -105.68 -177.36 3.34 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.565 -0.709 . . . . 0.0 109.988 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.527 ' H ' HG22 ' A' ' 38' ' ' THR . . . -69.49 -40.01 77.29 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.594 -0.691 . . . . 0.0 111.238 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 67.2 p -114.42 -19.43 11.21 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.341 -0.849 . . . . 0.0 111.569 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -133.58 160.05 38.63 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.205 -0.935 . . . . 0.0 110.725 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.0 t -138.75 119.87 14.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.592 -0.693 . . . . 0.0 110.12 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -135.19 177.11 8.07 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.617 -0.677 . . . . 0.0 109.843 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.486 HD11 ' HA ' ' A' ' 109' ' ' ARG . 65.6 mt -118.68 160.34 22.01 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.486 -0.759 . . . . 0.0 110.36 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -124.99 153.32 42.97 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.544 -0.722 . . . . 0.0 110.043 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.438 HG21 ' HB3' ' A' ' 142' ' ' PRO . 58.8 m -125.87 140.09 52.94 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.522 -0.736 . . . . 0.0 110.402 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.9 t -88.84 108.76 19.7 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.504 -0.747 . . . . 0.0 110.094 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.6 t -123.0 129.99 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.648 -0.657 . . . . 0.0 109.921 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 54.47 38.71 30.18 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.568 -0.707 . . . . 0.0 110.899 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.522 ' O ' ' HB3' ' A' ' 87' ' ' ALA . . . 67.87 17.49 69.5 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 65.6 t -130.22 129.94 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.227 -1.161 . . . . 0.0 109.734 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 69.2 m -79.24 130.15 35.18 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.498 -0.751 . . . . 0.0 109.898 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.496 ' CD2' ' HE3' ' A' ' 175' ' ' MET . 97.0 m95 -120.01 137.16 54.25 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.473 -0.767 . . . . 0.0 110.729 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.686 HG23 HG13 ' A' ' 83' ' ' VAL . 9.7 t -137.35 172.39 13.05 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.841 HG11 ' CE1' ' A' ' 57' ' ' HIS . 59.4 t -80.81 142.3 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.367 -0.833 . . . . 0.0 109.691 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.863 ' CE2' HG22 ' A' ' 78' ' ' VAL . 33.0 t80 -79.28 -39.89 31.85 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.448 -0.783 . . . . 0.0 111.636 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.841 ' CE1' HG11 ' A' ' 55' ' ' VAL . 1.4 p-80 -59.72 -23.27 63.03 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.968 -1.083 . . . . 0.0 110.396 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -74.15 -70.64 1.22 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.831 -1.708 . . . . 0.0 108.831 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.52 -52.9 62.57 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.543 -0.975 . . . . 0.0 109.743 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.432 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.403 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 35.9 m . . . . . 0 N--CA 1.493 1.714 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -60.24 125.1 22.39 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.509 -0.744 . . . . 0.0 110.509 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 91.0 mmm -92.12 -32.55 15.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.716 -0.615 . . . . 0.0 109.91 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.74 ' O ' HG23 ' A' ' 83' ' ' VAL . 45.5 m-85 -118.95 129.73 55.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.589 -0.694 . . . . 0.0 109.864 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.6 p -141.02 144.95 35.3 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.525 -0.734 . . . . 0.0 110.307 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -168.17 100.93 0.44 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.71 -0.619 . . . . 0.0 109.999 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.863 HG22 ' CE2' ' A' ' 56' ' ' TYR . 53.3 t -70.06 -42.84 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.427 -0.796 . . . . 0.0 109.88 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -60.06 -44.2 94.87 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.507 -0.746 . . . . 0.0 110.162 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -90.04 -8.56 51.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.811 -0.556 . . . . 0.0 110.563 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.4 t0 54.16 39.72 30.98 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.998 -1.064 . . . . 0.0 109.684 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.508 HD21 ' HG2' ' A' ' 175' ' ' MET . 14.5 tp -119.93 129.98 54.58 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.329 0.585 . . . . 0.0 110.472 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 75' ' ' TYR . 14.6 p -153.13 150.29 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.684 -0.635 . . . . 0.0 109.414 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -176.06 -174.31 42.48 Favored Glycine 0 N--CA 1.496 2.65 0 C-N-CA 119.622 -1.275 . . . . 0.0 110.571 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 14.1 m-90 -128.81 160.03 33.86 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.78 -0.836 . . . . 0.0 109.766 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -93.0 131.14 38.26 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.539 -0.726 . . . . 0.0 110.097 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 50' ' ' GLY . . . -111.94 159.6 32.96 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.461 -0.774 . . . . 0.0 110.462 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.2 159.16 50.45 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 O-C-N 123.428 1.225 . . . . 0.0 110.608 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.17 160.2 39.85 Favored 'Trans proline' 0 C--N 1.317 -1.101 0 O-C-N 123.506 1.266 . . . . 0.0 110.412 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 115.35 -4.49 21.74 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -109.93 142.4 41.34 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.092 -1.24 . . . . 0.0 110.172 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -60.34 140.06 57.32 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.507 -0.745 . . . . 0.0 110.124 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 52.6 m -133.1 156.87 46.63 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.593 -0.692 . . . . 0.0 110.402 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.9 mt -91.36 162.84 14.43 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.67 -0.644 . . . . 0.0 110.234 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.2 p -120.89 165.07 19.89 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.63 -0.669 . . . . 0.0 110.075 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.34 164.81 32.69 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 O-C-N 123.369 1.194 . . . . 0.0 110.207 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 7.2 t -75.2 128.1 34.7 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.564 -0.71 . . . . 0.0 110.405 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 46.7 p -129.58 45.48 2.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.743 -0.598 . . . . 0.0 109.682 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.3 p -145.07 12.22 1.39 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.642 -0.661 . . . . 0.0 111.474 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.23 50.97 49.89 Favored Glycine 0 N--CA 1.499 2.866 0 O-C-N 121.062 -1.024 . . . . 0.0 110.546 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.1 m -92.7 107.09 18.95 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.42 -1.047 . . . . 0.0 110.4 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.1 p -70.11 -39.95 75.19 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.487 -0.758 . . . . 0.0 109.931 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -75.11 123.09 24.59 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.653 -0.654 . . . . 0.0 109.857 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.563 HD13 HG11 ' A' ' 151' ' ' VAL . 73.9 mt -129.99 150.61 51.19 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.607 -0.683 . . . . 0.0 110.2 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -106.84 133.5 51.4 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.49 -0.757 . . . . 0.0 109.874 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.1 tt -98.85 130.3 45.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.536 -0.728 . . . . 0.0 110.467 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.1 t -87.79 123.41 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.691 -0.63 . . . . 0.0 109.707 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.2 m -100.77 166.82 10.67 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.56 -0.713 . . . . 0.0 110.386 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.486 ' HA ' HD11 ' A' ' 44' ' ' LEU . 78.3 ttt-85 -61.89 -27.33 68.73 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.59 -0.694 . . . . 0.0 110.332 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -93.41 25.48 3.4 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.527 -0.733 . . . . 0.0 110.781 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.98 40.03 31.85 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.284 -0.885 . . . . 0.0 110.843 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -93.27 156.24 16.94 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.644 -0.66 . . . . 0.0 109.78 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.9 p -129.93 133.44 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.47 -0.769 . . . . 0.0 110.404 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.4 tp -146.13 134.89 11.04 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.702 -0.624 . . . . 0.0 109.892 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.424 ' HG2' HD22 ' A' ' 127' ' ' LEU . 48.5 Cg_endo -76.15 139.2 21.16 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 O-C-N 123.155 1.082 . . . . 0.0 110.291 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.3 t -129.92 130.1 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.646 -0.659 . . . . 0.0 109.713 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.62 146.44 34.13 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.567 -0.708 . . . . 0.0 109.853 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -85.71 118.33 25.14 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.567 -0.708 . . . . 0.0 110.202 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.03 21.22 11.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.759 -0.588 . . . . 0.0 110.34 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 162.64 168.15 24.13 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -70.03 -40.02 75.43 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.566 -0.961 . . . . 0.0 110.693 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 89.8 p -114.68 -7.15 12.73 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.496 -0.753 . . . . 0.0 111.474 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -128.55 143.97 51.06 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.09 -1.006 . . . . 0.0 110.484 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -141.49 -174.64 14.5 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 80.1 p -120.53 144.17 48.2 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.558 -0.966 . . . . 0.0 110.165 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 57.8 tp -91.17 131.3 36.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.636 -0.665 . . . . 0.0 109.899 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.424 HD22 ' HG2' ' A' ' 115' ' ' PRO . 1.7 tp -60.09 -48.66 80.81 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.585 -0.697 . . . . 0.0 110.511 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 45.7 t -106.5 119.54 51.4 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.504 -0.747 . . . . 0.0 110.18 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.87 121.39 7.58 Favored 'Trans proline' 0 N--CA 1.486 1.034 0 O-C-N 123.191 1.101 . . . . 0.0 110.581 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 12.7 mtp85 -132.83 162.81 55.19 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.52 -0.737 . . . . 0.0 110.323 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.6 150.9 63.82 Favored 'Trans proline' 0 N--CA 1.486 1.076 0 O-C-N 123.482 1.254 . . . . 0.0 110.87 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.424 HG21 ' SG ' ' A' ' 159' ' ' CYS . 76.9 t -56.64 -35.29 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.484 -0.76 . . . . 0.0 110.252 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 34.8 t -58.44 -39.97 81.27 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.47 -0.768 . . . . 0.0 110.745 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -63.28 -39.94 95.98 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.489 -0.757 . . . . 0.0 109.592 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 21.3 tp -94.57 16.2 16.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.781 -0.574 . . . . 0.0 110.593 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 44.7 tttt -89.77 141.06 28.98 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.026 -1.046 . . . . 0.0 110.761 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 87.78 20.51 50.39 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 10.5 p -119.58 15.21 12.81 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.37 -1.077 . . . . 0.0 110.933 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.521 ' HB3' HG21 ' A' ' 55' ' ' VAL . 48.9 m -58.75 144.7 42.94 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.183 -0.948 . . . . 0.0 110.043 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 94.72 -16.67 60.72 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -58.5 111.1 2.94 Favored Glycine 0 N--CA 1.498 2.796 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.438 ' HB3' HG21 ' A' ' 46' ' ' THR . 50.1 Cg_endo -73.11 139.63 29.91 Favored 'Trans proline' 0 C--N 1.317 -1.082 0 O-C-N 123.197 1.104 . . . . 0.0 111.099 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.416 ' O ' HG12 ' A' ' 151' ' ' VAL . 4.4 mp -93.37 123.71 36.85 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.3 mp -118.38 127.27 53.53 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.184 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 27.2 p -66.61 163.97 36.9 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.7 -0.625 . . . . 0.0 109.384 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.54 -19.86 68.48 Favored 'Trans proline' 0 C--N 1.315 -1.204 0 O-C-N 123.231 1.121 . . . . 0.0 110.952 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.4 m -69.97 -27.33 64.64 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.295 -0.878 . . . . 0.0 110.031 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 121.64 -21.46 8.01 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.466 -1.053 . . . . 0.0 110.466 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -77.56 162.96 26.7 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.253 -1.145 . . . . 0.0 110.632 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -105.09 145.03 31.08 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.65 -0.656 . . . . 0.0 110.353 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.563 HG11 HD13 ' A' ' 104' ' ' LEU . 12.5 p -101.51 -29.18 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.552 -0.718 . . . . 0.0 110.809 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 169.26 -161.55 35.12 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 55.9 mt -128.87 155.86 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.566 -0.961 . . . . 0.0 110.255 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -66.61 139.94 57.91 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.621 -0.674 . . . . 0.0 110.076 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -122.59 -67.48 0.95 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.564 -0.71 . . . . 0.0 110.803 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -135.27 150.3 50.01 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.453 -0.779 . . . . 0.0 110.78 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.41 151.74 19.15 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 48.6 t -120.01 119.97 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.507 -0.745 . . . . 0.0 110.432 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.424 ' SG ' HG21 ' A' ' 132' ' ' VAL . 27.4 p -141.6 157.81 44.63 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.543 -0.723 . . . . 0.0 110.415 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 18.4 p -94.58 -46.07 7.12 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.442 -0.786 . . . . 0.0 109.97 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 55.1 mmm-85 -130.37 35.96 4.01 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.644 -0.66 . . . . 0.0 109.552 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.402 ' O ' HG23 ' A' ' 132' ' ' VAL . . . 101.2 -10.11 58.09 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 57.3 t -96.55 123.47 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.184 -1.186 . . . . 0.0 109.473 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.66 117.3 26.38 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.496 -0.753 . . . . 0.0 110.776 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -109.46 -29.96 8.18 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.654 -0.654 . . . . 0.0 109.674 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -126.5 157.22 39.26 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.633 -0.667 . . . . 0.0 109.618 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 31.0 m -129.42 142.89 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.485 -0.759 . . . . 0.0 110.675 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -117.23 132.51 56.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.653 -0.654 . . . . 0.0 110.421 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -141.31 159.57 41.93 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.595 -0.69 . . . . 0.0 110.135 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 12.9 p -93.15 142.85 25.85 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.505 -0.747 . . . . 0.0 110.446 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -77.34 162.43 31.02 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 O-C-N 123.288 1.151 . . . . 0.0 110.559 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 67.1 t -69.91 -32.38 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.627 -0.671 . . . . 0.0 109.881 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -60.03 -40.01 87.87 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.493 -0.755 . . . . 0.0 110.355 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 48.0 t -62.54 -39.95 95.26 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.633 -0.667 . . . . 0.0 109.924 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.508 ' HG2' HD21 ' A' ' 82' ' ' LEU . 95.0 mtp -60.25 -40.0 88.77 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.674 -0.641 . . . . 0.0 110.177 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.7 -40.02 90.65 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.706 -0.621 . . . . 0.0 110.322 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 94.0 m -60.11 -40.11 88.55 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.645 -0.659 . . . . 0.0 110.156 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 88.2 m -68.17 -44.21 76.47 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.583 -0.698 . . . . 0.0 110.047 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 33.9 ttp -60.63 -40.99 93.97 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.556 -0.715 . . . . 0.0 110.387 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -61.15 -40.02 92.28 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.609 -0.682 . . . . 0.0 110.178 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.767 0 O-C-N 121.608 -0.682 . . . . 0.0 110.268 179.982 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.725 ' OE2' HD21 ' A' ' 144' ' ' LEU . 52.2 tt0 . . . . . 0 N--CA 1.509 2.495 0 CA-C-O 120.966 0.413 . . . . 0.0 110.746 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.489 HG21 ' HD2' ' A' ' 142' ' ' PRO . 60.9 t -103.1 133.33 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.385 -0.822 . . . . 0.0 109.892 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -102.86 162.31 13.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.625 -0.672 . . . . 0.0 109.85 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.511 ' HA ' HD22 ' A' ' 44' ' ' LEU . 34.8 m -117.98 136.59 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.506 -0.746 . . . . 0.0 110.196 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.8 m -144.21 149.27 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.493 -0.755 . . . . 0.0 110.35 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.8 m -119.68 137.8 53.68 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.602 -0.687 . . . . 0.0 110.179 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.518 HG22 ' H ' ' A' ' 39' ' ' ALA . 1.0 OUTLIER -99.57 -178.43 3.89 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.577 -0.702 . . . . 0.0 110.001 179.909 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.518 ' H ' HG22 ' A' ' 38' ' ' THR . . . -60.0 -45.99 90.93 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.841 -179.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.4 p -118.67 -27.99 5.74 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.403 -0.811 . . . . 0.0 110.995 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -114.27 173.95 6.19 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.324 -0.86 . . . . 0.0 110.526 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 40.3 t -151.87 121.33 6.85 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.55 -0.719 . . . . 0.0 109.975 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 34.7 p90 -132.65 -179.51 5.5 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.625 -0.672 . . . . 0.0 110.064 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.535 HD11 ' HA ' ' A' ' 109' ' ' ARG . 34.7 mt -118.76 178.62 4.41 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.518 -0.739 . . . . 0.0 109.605 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.573 ' CB ' HG22 ' A' ' 54' ' ' THR . . . -143.0 161.37 38.3 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.474 -0.767 . . . . 0.0 110.98 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.8 p -125.34 144.09 50.66 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.721 -0.612 . . . . 0.0 109.689 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.419 ' HB2' ' HA ' ' A' ' 92' ' ' ARG . 27.0 p -91.9 111.79 23.46 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 121.72 0.772 . . . . 0.0 111.403 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.9 t -130.73 123.44 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.213 -0.929 . . . . 0.0 110.683 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 51.4 34.88 12.79 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.53 -0.731 . . . . 0.0 112.412 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.416 ' HA2' ' HB3' ' A' ' 92' ' ' ARG . . . 86.43 -17.04 41.19 Favored Glycine 0 N--CA 1.499 2.872 0 C-N-CA 120.1 -1.047 . . . . 0.0 111.659 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 62.8 t -105.82 128.63 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.091 -1.241 . . . . 0.0 110.477 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.739 ' SG ' ' HB2' ' A' ' 87' ' ' ALA . 78.5 m -84.32 107.78 16.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.634 -0.666 . . . . 0.0 109.532 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.531 ' CE3' HD22 ' A' ' 82' ' ' LEU . 91.1 m95 -91.85 137.48 32.33 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.509 -0.744 . . . . 0.0 110.59 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.573 HG22 ' CB ' ' A' ' 45' ' ' ALA . 77.8 p -136.51 179.74 6.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.773 -0.58 . . . . 0.0 109.611 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.754 HG21 ' HB3' ' A' ' 139' ' ' SER . 94.5 t -80.93 141.93 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.105 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.907 ' CE2' HG22 ' A' ' 78' ' ' VAL . 16.7 t80 -84.98 -43.44 13.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.445 -0.784 . . . . 0.0 111.248 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.688 ' CE1' HG11 ' A' ' 55' ' ' VAL . 2.2 p-80 -58.76 -25.02 62.63 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.24 -0.912 . . . . 0.0 110.941 -177.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -81.47 -48.67 5.82 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.52 -63.09 1.47 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.6 -0.941 . . . . 0.0 110.167 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.45 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 179.84 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.3 t . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 121.162 0.506 . . . . 0.0 110.433 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -80.08 128.27 33.29 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.611 -0.681 . . . . 0.0 110.163 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.1 tpp -106.36 -51.13 3.01 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.604 -0.685 . . . . 0.0 110.129 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.685 ' O ' HG13 ' A' ' 83' ' ' VAL . 35.5 m-85 -120.73 138.63 53.89 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.48 -0.763 . . . . 0.0 110.184 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.452 HG23 ' HE1' ' A' ' 56' ' ' TYR . 98.8 m -152.23 127.86 10.11 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.602 -0.686 . . . . 0.0 110.175 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -168.45 120.23 0.81 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.416 -0.802 . . . . 0.0 110.833 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.907 HG22 ' CE2' ' A' ' 56' ' ' TYR . 91.8 t -72.25 -39.54 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.35 -0.844 . . . . 0.0 109.735 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.66 -43.01 75.87 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.363 -0.836 . . . . 0.0 109.803 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -92.02 -14.24 29.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.793 -0.567 . . . . 0.0 109.885 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.482 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 49.5 t0 54.27 35.38 22.61 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.064 -1.022 . . . . 0.0 110.099 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.531 HD22 ' CE3' ' A' ' 53' ' ' TRP . 2.5 mt -123.2 149.73 44.29 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.836 0.827 . . . . 0.0 111.934 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.685 HG13 ' O ' ' A' ' 75' ' ' TYR . 2.7 t -146.64 150.95 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 178.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -138.35 148.19 19.74 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 118.992 -1.575 . . . . 0.0 111.636 -178.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -138.25 124.6 20.54 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.18 135.33 57.69 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.34 -0.85 . . . . 0.0 110.721 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.836 ' HB3' ' HG3' ' A' ' 92' ' ' ARG . . . -101.41 175.44 2.33 Favored Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 121.417 -0.802 . . . . 0.0 109.849 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.756 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 43.8 Cg_endo -70.45 147.96 59.55 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 O-C-N 123.465 1.245 . . . . 0.0 109.548 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.72 134.46 24.01 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 O-C-N 123.369 1.194 . . . . 0.0 110.245 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 131.59 -25.98 3.93 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -150.81 71.64 1.04 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.102 -1.234 . . . . 0.0 111.761 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.836 ' HG3' ' HB3' ' A' ' 87' ' ' ALA . 12.2 mmt180 -154.25 91.78 1.46 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.061 -1.024 . . . . 0.0 110.498 178.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.4 p -177.04 104.98 0.06 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.211 -0.93 . . . . 0.0 111.166 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.701 HD21 ' HB2' ' A' ' 150' ' ' ALA . 25.6 tp -117.34 131.91 56.7 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.583 -0.698 . . . . 0.0 109.406 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.3 t -76.45 137.28 67.66 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.363 -0.836 . . . . 0.0 110.74 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.04 166.21 28.35 Favored 'Trans proline' 0 N--CA 1.484 0.924 0 O-C-N 123.252 1.132 . . . . 0.0 110.204 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 47.4 t -82.41 132.85 35.21 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.505 -0.747 . . . . 0.0 110.24 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.0 t -135.98 48.87 2.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.655 -0.653 . . . . 0.0 109.797 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.4 p -144.92 0.17 0.94 Allowed 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 120.114 -0.634 . . . . 0.0 112.384 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 52.26 89.27 0.01 OUTLIER Glycine 0 N--CA 1.5 2.924 0 O-C-N 120.811 -1.181 . . . . 0.0 110.553 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.0 m -129.67 128.85 43.42 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.418 -1.048 . . . . 0.0 110.251 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.2 m -69.01 -40.02 78.94 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.577 -0.702 . . . . 0.0 110.122 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.69 142.13 58.24 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.557 -0.714 . . . . 0.0 109.965 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.534 ' CD2' HG21 ' A' ' 151' ' ' VAL . 57.2 mt -143.61 158.27 43.79 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.575 -0.703 . . . . 0.0 110.314 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -126.35 109.86 12.72 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.518 -0.739 . . . . 0.0 109.91 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.554 HD23 ' C ' ' A' ' 106' ' ' LEU . 8.4 tt -93.42 133.58 36.55 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.528 -0.733 . . . . 0.0 110.462 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.496 ' N ' HD23 ' A' ' 106' ' ' LEU . 61.1 t -98.28 130.03 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.668 -0.645 . . . . 0.0 109.762 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 68.1 p -99.04 169.91 9.08 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.527 -0.733 . . . . 0.0 110.456 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.535 ' HA ' HD11 ' A' ' 44' ' ' LEU . 8.5 ptm180 -63.34 -18.96 64.2 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.691 -0.631 . . . . 0.0 110.877 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -94.16 25.95 3.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.31 -0.869 . . . . 0.0 110.661 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 53.42 39.93 30.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.346 -0.846 . . . . 0.0 110.887 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -104.68 167.06 9.97 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.531 -0.731 . . . . 0.0 110.078 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.403 ' O ' HG13 ' A' ' 113' ' ' VAL . 8.5 p -133.65 131.53 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.589 -0.694 . . . . 0.0 110.435 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.681 HG21 HD11 ' A' ' 126' ' ' LEU . 87.0 mt -133.08 127.99 20.34 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.587 -0.696 . . . . 0.0 109.872 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -74.94 125.05 9.1 Favored 'Trans proline' 0 N--CA 1.485 0.982 0 O-C-N 123.096 1.051 . . . . 0.0 110.392 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.666 HG13 ' O ' ' A' ' 125' ' ' SER . 58.9 t -120.25 129.53 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.567 -0.708 . . . . 0.0 109.771 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -87.53 136.8 32.8 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.506 -0.746 . . . . 0.0 110.197 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -74.39 140.11 44.52 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.657 -0.652 . . . . 0.0 110.293 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.35 9.5 3.45 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.589 -0.694 . . . . 0.0 111.0 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -169.34 -172.44 36.01 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -70.28 -39.97 74.6 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.615 -0.932 . . . . 0.0 110.68 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 96.1 p -130.77 9.81 5.02 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.462 -0.774 . . . . 0.0 111.393 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -123.66 148.72 46.23 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.1 -1.0 . . . . 0.0 110.17 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.15 167.82 24.8 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.666 ' O ' HG13 ' A' ' 116' ' ' VAL . 19.2 p -107.76 158.9 16.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.52 -0.988 . . . . 0.0 110.21 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.681 HD11 HG21 ' A' ' 114' ' ' ILE . 40.1 tp -117.59 133.21 56.2 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.577 -0.702 . . . . 0.0 110.272 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.454 ' N ' HD12 ' A' ' 127' ' ' LEU . 6.3 mp -69.28 -43.15 74.44 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.588 -0.695 . . . . 0.0 110.401 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 58.4 p -97.42 111.97 59.84 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.474 -0.766 . . . . 0.0 110.168 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -80.91 106.87 1.85 Allowed 'Trans proline' 0 C--N 1.319 -1.006 0 O-C-N 123.197 1.104 . . . . 0.0 110.607 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.72 157.89 38.12 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.554 -0.716 . . . . 0.0 109.851 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.12 150.25 65.75 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.421 1.221 . . . . 0.0 110.867 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.415 HG21 ' SG ' ' A' ' 159' ' ' CYS . 55.3 t -54.13 -30.47 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.422 -0.799 . . . . 0.0 109.723 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 46.0 t -59.91 -41.94 92.79 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.559 -0.713 . . . . 0.0 110.869 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -67.97 -39.97 83.26 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.482 -0.761 . . . . 0.0 109.719 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 135' ' ' LEU . 33.0 tp -92.18 15.49 13.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.803 -0.56 . . . . 0.0 110.286 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -79.65 114.65 18.74 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 122.537 1.161 . . . . 0.0 112.128 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.93 37.18 3.72 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 61.3 m -119.26 19.13 12.89 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.705 -0.88 . . . . 0.0 110.454 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.754 ' HB3' HG21 ' A' ' 55' ' ' VAL . 66.3 m -70.54 136.28 49.2 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.25 -0.906 . . . . 0.0 109.169 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 109.77 -25.35 17.2 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.181 -1.567 . . . . 0.0 109.181 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.0 112.63 3.69 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.489 ' HD2' HG21 ' A' ' 33' ' ' VAL . 47.6 Cg_endo -73.24 148.8 44.5 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 123.25 1.131 . . . . 0.0 111.105 -179.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.497 HD21 HD12 ' A' ' 106' ' ' LEU . 67.7 mt -98.22 116.3 30.15 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.725 HD21 ' OE2' ' A' ' 32' ' ' GLU . 5.6 mp -103.37 127.71 50.66 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.509 -0.744 . . . . 0.0 111.015 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.407 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 27.8 p -67.92 164.85 37.09 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.755 -0.59 . . . . 0.0 109.505 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 39.4 Cg_endo -65.09 -14.22 44.05 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 O-C-N 123.148 1.078 . . . . 0.0 111.104 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.9 t -69.61 -40.02 76.88 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.147 -0.97 . . . . 0.0 109.768 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 122.17 37.82 0.63 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -133.6 -173.28 3.18 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.388 -1.066 . . . . 0.0 110.276 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.701 ' HB2' HD21 ' A' ' 94' ' ' LEU . . . -104.55 145.39 30.37 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.552 -0.718 . . . . 0.0 110.158 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.534 HG21 ' CD2' ' A' ' 104' ' ' LEU . 50.7 t -115.75 -62.42 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.518 -0.739 . . . . 0.0 110.454 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -157.08 -158.59 8.99 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.2 mt -133.48 146.68 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.565 -0.962 . . . . 0.0 110.003 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -61.97 140.01 58.36 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.369 -0.832 . . . . 0.0 110.479 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.428 ' NE ' ' HB3' ' A' ' 81' ' ' ASP . 0.6 OUTLIER -117.23 -76.13 0.57 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.57 0.7 . . . . 0.0 110.496 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -125.3 147.18 49.22 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 121.377 -0.827 . . . . 0.0 111.234 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.06 124.83 37.31 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.3 t -95.75 119.03 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.585 -0.697 . . . . 0.0 111.026 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.415 ' SG ' HG21 ' A' ' 132' ' ' VAL . 27.4 p -139.89 146.09 38.84 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.593 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 59.6 m -78.87 -49.92 12.09 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.6 -0.687 . . . . 0.0 109.855 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 5.9 ptt180 -129.11 36.17 4.21 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.614 -0.679 . . . . 0.0 109.915 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 102.7 -11.93 56.39 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 62.9 t -92.33 121.2 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.249 -1.148 . . . . 0.0 109.009 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.17 116.92 25.58 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.5 -0.75 . . . . 0.0 111.218 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -110.98 -29.93 7.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.833 -0.542 . . . . 0.0 109.729 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.403 ' C ' HG13 ' A' ' 167' ' ' VAL . . . -120.05 168.27 11.35 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.638 -0.664 . . . . 0.0 109.958 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.413 HG21 HG11 ' A' ' 116' ' ' VAL . 35.1 m -146.05 137.2 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.581 -0.699 . . . . 0.0 110.64 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -113.05 143.63 43.99 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.598 -0.689 . . . . 0.0 110.404 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -149.49 162.2 40.61 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.631 -0.668 . . . . 0.0 110.879 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.406 HG21 ' NH2' ' A' ' 155' ' ' ARG . 5.6 m -101.62 143.73 27.19 Favored Pre-proline 0 N--CA 1.505 2.317 0 O-C-N 121.448 -0.783 . . . . 0.0 110.135 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -79.69 168.18 19.8 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 O-C-N 123.339 1.179 . . . . 0.0 110.171 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 151' ' ' VAL . 64.9 t -66.29 -24.0 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.521 -0.737 . . . . 0.0 110.118 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -54.32 -38.89 66.5 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.429 -0.795 . . . . 0.0 111.449 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 82.2 p -61.66 -24.55 66.81 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.671 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 65.5 mtt -70.11 -28.72 65.62 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.431 -0.793 . . . . 0.0 110.898 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -59.28 -50.85 72.41 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.409 -0.807 . . . . 0.0 110.596 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 22.1 m -72.03 -29.03 63.76 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.49 -0.756 . . . . 0.0 110.334 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 32.5 m -68.0 -32.29 72.58 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.561 -0.712 . . . . 0.0 110.507 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 34.5 mmm -59.45 -52.04 67.31 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.484 -0.76 . . . . 0.0 110.485 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 56.4 mtp85 -63.87 -40.02 95.57 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.528 -0.732 . . . . 0.0 110.115 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.804 0 O-C-N 121.564 -0.71 . . . . 0.0 110.261 -179.891 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.531 ' CG ' HD13 ' A' ' 94' ' ' LEU . 1.3 tp10 . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 121.142 0.496 . . . . 0.0 110.286 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.878 HG22 HG22 ' A' ' 46' ' ' THR . 92.4 t -109.83 143.96 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.569 -0.707 . . . . 0.0 109.808 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -116.63 148.25 41.15 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.63 -0.669 . . . . 0.0 110.308 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.493 ' HA ' HD22 ' A' ' 44' ' ' LEU . 59.8 t -78.43 124.62 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.701 -0.624 . . . . 0.0 109.699 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.6 m -134.12 138.65 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.428 -0.795 . . . . 0.0 110.545 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 74.7 m -119.38 154.56 33.44 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.593 -0.692 . . . . 0.0 110.294 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.526 HG22 ' H ' ' A' ' 39' ' ' ALA . 1.5 m -110.99 179.6 4.0 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.63 -0.669 . . . . 0.0 110.121 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.526 ' H ' HG22 ' A' ' 38' ' ' THR . . . -62.43 -40.03 95.25 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.807 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.408 HG23 ' HG3' ' A' ' 41' ' ' GLN . 7.7 t -119.78 -28.3 5.26 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.401 -0.812 . . . . 0.0 111.204 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.408 ' HG3' HG23 ' A' ' 40' ' ' THR . 50.0 mt-30 -118.2 178.08 4.56 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.405 -0.81 . . . . 0.0 110.213 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 83.0 p -153.71 117.03 4.59 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.541 -0.724 . . . . 0.0 110.565 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 6.7 p90 -130.4 -176.91 4.11 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.635 -0.665 . . . . 0.0 110.007 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.493 HD22 ' HA ' ' A' ' 35' ' ' VAL . 57.9 mt -117.3 162.93 17.11 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.433 -0.792 . . . . 0.0 110.545 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.863 ' O ' HG13 ' A' ' 33' ' ' VAL . . . -129.53 150.23 50.95 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.668 -0.645 . . . . 0.0 110.504 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.878 HG22 HG22 ' A' ' 33' ' ' VAL . 78.9 p -125.69 144.17 50.72 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.602 -0.687 . . . . 0.0 110.077 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 25.9 p -100.51 106.71 18.27 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.741 0.781 . . . . 0.0 110.575 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.504 ' O ' HG12 ' A' ' 51' ' ' VAL . 60.8 t -130.64 139.58 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.285 -0.884 . . . . 0.0 110.341 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.419 ' OD1' HG12 ' A' ' 48' ' ' VAL . 10.8 m120 55.02 40.48 32.02 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.57 -0.706 . . . . 0.0 111.529 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 87' ' ' ALA . . . 63.78 14.46 55.33 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 48' ' ' VAL . 7.2 p -138.43 138.55 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.148 -1.207 . . . . 0.0 109.354 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.582 ' SG ' ' HB1' ' A' ' 45' ' ' ALA . 43.6 t -87.67 126.28 34.87 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.56 -0.713 . . . . 0.0 110.464 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.661 ' CE3' HD23 ' A' ' 82' ' ' LEU . 75.1 m95 -111.08 136.78 49.6 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.649 -0.657 . . . . 0.0 110.13 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.56 HG21 ' CH2' ' A' ' 85' ' ' TRP . 6.9 t -137.37 -179.81 5.95 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.658 -0.651 . . . . 0.0 110.005 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.612 HG21 ' HB3' ' A' ' 139' ' ' SER . 63.6 t -84.13 141.47 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.491 -0.756 . . . . 0.0 109.124 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.893 ' CE2' HG22 ' A' ' 78' ' ' VAL . 14.4 t80 -85.73 -43.7 13.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.514 -0.741 . . . . 0.0 111.405 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.546 ' CE1' HG11 ' A' ' 55' ' ' VAL . 2.6 p-80 -60.53 -22.28 63.44 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.219 -0.926 . . . . 0.0 110.821 -178.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -93.57 -32.64 7.56 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.03 -63.43 1.35 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.55 -0.97 . . . . 0.0 110.274 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.472 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.836 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 58.6 m . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -86.04 143.53 28.05 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.49 -0.756 . . . . 0.0 110.783 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.9 tpp -119.13 -48.07 2.45 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.549 -0.719 . . . . 0.0 110.742 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.641 ' O ' HG13 ' A' ' 83' ' ' VAL . 29.2 m-85 -109.62 128.46 55.24 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.355 -0.84 . . . . 0.0 110.32 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 54.7 m -152.19 123.38 7.64 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.527 -0.733 . . . . 0.0 110.147 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -166.09 124.24 1.49 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.405 -0.81 . . . . 0.0 111.32 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.893 HG22 ' CE2' ' A' ' 56' ' ' TYR . 94.3 t -72.59 -30.83 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.528 -0.732 . . . . 0.0 109.797 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -57.83 -40.05 79.12 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.47 -0.768 . . . . 0.0 110.433 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.457 ' NE2' ' OG1' ' A' ' 178' ' ' THR . 25.6 tt0 -97.63 -7.75 30.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.57 -0.706 . . . . 0.0 111.009 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.5 ' O ' HD12 ' A' ' 82' ' ' LEU . 37.8 t0 53.35 39.66 30.17 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.958 -1.088 . . . . 0.0 110.569 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.661 HD23 ' CE3' ' A' ' 53' ' ' TRP . 0.4 OUTLIER -140.14 155.54 46.93 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.574 -0.851 . . . . 0.0 111.314 -179.071 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.641 HG13 ' O ' ' A' ' 75' ' ' TYR . 3.1 t -145.55 156.74 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -155.46 172.59 33.63 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 119.292 -1.432 . . . . 0.0 111.064 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.56 ' CH2' HG21 ' A' ' 54' ' ' THR . 10.6 m-90 -147.0 159.65 43.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.89 -0.77 . . . . 0.0 109.602 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -70.83 115.64 10.21 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.517 -0.739 . . . . 0.0 110.31 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 50' ' ' GLY . . . -86.57 157.93 54.87 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.623 -0.673 . . . . 0.0 110.056 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.43 155.91 59.21 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.422 1.222 . . . . 0.0 110.396 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -75.22 155.12 41.91 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.466 1.245 . . . . 0.0 110.341 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 97.26 -25.93 25.0 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.5 154.31 24.92 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.396 -1.061 . . . . 0.0 110.063 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.94 135.15 44.99 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.599 -0.688 . . . . 0.0 110.025 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 58.4 m -105.39 130.02 53.58 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.526 -0.734 . . . . 0.0 110.098 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.833 HD23 ' HB2' ' A' ' 150' ' ' ALA . 6.0 tp -83.81 148.94 26.72 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.552 -0.717 . . . . 0.0 110.435 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.577 HG23 ' ND1' ' A' ' 149' ' ' HIS . 6.5 t -113.22 150.98 43.87 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.606 -0.684 . . . . 0.0 110.196 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.72 154.96 63.63 Favored 'Trans proline' 0 N--CA 1.486 1.071 0 O-C-N 123.319 1.168 . . . . 0.0 110.702 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.408 ' HB3' HG12 ' A' ' 151' ' ' VAL . 7.1 t -87.17 144.64 26.75 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.567 -0.708 . . . . 0.0 110.572 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.4 p -136.52 67.97 1.44 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.61 -0.681 . . . . 0.0 110.441 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 28.0 p -145.15 7.16 1.17 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.385 -0.822 . . . . 0.0 111.97 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 52.02 47.84 53.48 Favored Glycine 0 N--CA 1.499 2.881 0 O-C-N 120.863 -1.148 . . . . 0.0 110.384 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.3 t -100.02 120.49 39.9 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.502 -0.999 . . . . 0.0 110.512 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.8 p -69.94 -39.78 75.89 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.629 -0.669 . . . . 0.0 109.918 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -61.58 134.92 57.39 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.561 -0.712 . . . . 0.0 109.881 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 49.9 mt -142.68 160.15 40.86 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.564 -0.71 . . . . 0.0 110.707 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -120.02 134.04 55.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.674 -0.641 . . . . 0.0 109.347 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.457 HD12 ' HG ' ' A' ' 143' ' ' LEU . 3.6 tt -127.33 112.58 15.21 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.489 -0.757 . . . . 0.0 110.711 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.429 ' O ' HD23 ' A' ' 106' ' ' LEU . 55.9 t -69.14 147.52 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.49 -0.756 . . . . 0.0 108.993 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.8 p -108.29 -168.25 1.34 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.51 -0.744 . . . . 0.0 110.614 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.4 ' NH2' HD12 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -88.73 -22.97 23.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.585 -0.697 . . . . 0.0 110.348 -179.662 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -102.56 29.23 5.4 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.452 -0.78 . . . . 0.0 110.167 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 56.89 55.65 6.01 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.471 -0.768 . . . . 0.0 111.019 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.95 144.06 49.09 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.476 -0.765 . . . . 0.0 109.297 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.5 t -115.28 128.29 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.364 -0.835 . . . . 0.0 110.461 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.545 HD11 ' HB3' ' A' ' 128' ' ' SER . 14.8 tt -137.96 134.91 18.24 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.62 -0.675 . . . . 0.0 109.864 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -74.82 145.52 32.29 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 O-C-N 123.208 1.109 . . . . 0.0 110.569 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.4 t -129.95 129.94 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.576 -0.702 . . . . 0.0 109.684 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -85.26 155.84 21.21 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.587 -0.696 . . . . 0.0 110.171 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 71.6 ttt-85 -99.1 134.55 41.79 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.596 -0.69 . . . . 0.0 110.146 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -118.75 -12.58 9.65 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.598 -0.689 . . . . 0.0 110.936 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -169.05 -160.57 17.48 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -70.04 -37.46 75.58 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.549 -0.971 . . . . 0.0 110.874 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.426 ' HA ' ' CE1' ' A' ' 169' ' ' PHE . 50.0 m -134.27 28.02 3.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.356 -0.84 . . . . 0.0 111.07 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.7 ' CZ ' ' HB1' ' A' ' 166' ' ' ALA . 17.4 tpt85 -141.93 139.87 32.64 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.298 -0.876 . . . . 0.0 110.242 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -147.89 161.71 28.61 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 71.4 p -98.78 163.89 12.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.43 -1.041 . . . . 0.0 110.147 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.512 HD11 HD13 ' A' ' 114' ' ' ILE . 22.9 tp -112.63 127.62 56.15 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.649 -0.657 . . . . 0.0 110.151 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.4 mp -64.19 -39.8 94.74 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.587 -0.696 . . . . 0.0 110.408 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.545 ' HB3' HD11 ' A' ' 114' ' ' ILE . 14.0 t -100.36 106.65 43.71 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.528 -0.732 . . . . 0.0 110.298 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -76.1 113.22 3.66 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 O-C-N 123.275 1.145 . . . . 0.0 110.515 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -119.33 155.19 54.04 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.585 -0.697 . . . . 0.0 109.917 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -70.0 150.42 66.76 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 O-C-N 123.432 1.227 . . . . 0.0 110.013 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 90.8 t -53.39 -34.39 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.252 -0.905 . . . . 0.0 110.002 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 34.5 t -57.87 -49.11 77.83 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.587 -0.695 . . . . 0.0 110.632 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -66.55 -38.37 86.98 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.501 -0.749 . . . . 0.0 109.548 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 135' ' ' LEU . 40.7 tp -90.23 16.85 7.86 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.826 -0.547 . . . . 0.0 110.335 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -83.28 121.09 26.66 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.757 -1.214 . . . . 0.0 112.126 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.49 33.26 4.87 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.6 m -106.05 13.02 29.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.653 -0.91 . . . . 0.0 110.525 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.612 ' HB3' HG21 ' A' ' 55' ' ' VAL . 18.1 m -62.36 143.58 56.81 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.272 -0.893 . . . . 0.0 109.849 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 83.0 7.06 87.7 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.409 ' O ' HD12 ' A' ' 143' ' ' LEU . . . -59.82 133.54 51.27 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.584 ' HG3' HG21 ' A' ' 33' ' ' VAL . 56.9 Cg_endo -80.17 117.15 3.46 Favored 'Trans proline' 0 N--CA 1.485 0.999 0 O-C-N 123.24 1.126 . . . . 0.0 110.934 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.688 ' C ' HD12 ' A' ' 144' ' ' LEU . 7.8 mp -98.75 104.04 16.04 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.407 -0.808 . . . . 0.0 109.018 178.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.688 HD12 ' C ' ' A' ' 143' ' ' LEU . 9.8 mp -117.74 147.43 42.97 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.498 -0.751 . . . . 0.0 111.065 -179.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.404 ' CB ' ' HD2' ' A' ' 146' ' ' PRO . 0.1 OUTLIER -75.27 178.68 1.69 Allowed Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.746 -0.596 . . . . 0.0 109.455 179.418 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.404 ' HD2' ' CB ' ' A' ' 145' ' ' CYS . 43.1 Cg_endo -70.01 -24.96 27.92 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.215 1.113 . . . . 0.0 110.416 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 36.4 t -69.9 -40.1 75.81 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.48 -0.762 . . . . 0.0 110.035 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 124.15 45.86 0.27 Allowed Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.577 ' ND1' HG23 ' A' ' 95' ' ' THR . 62.5 m-70 -135.96 134.79 39.01 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.574 -0.956 . . . . 0.0 110.318 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.833 ' HB2' HD23 ' A' ' 94' ' ' LEU . . . -77.86 140.87 39.38 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.495 -0.753 . . . . 0.0 110.353 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.615 ' O ' HG23 ' A' ' 172' ' ' VAL . 34.7 m -117.37 -25.82 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.629 -0.67 . . . . 0.0 110.66 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -174.37 -173.77 40.63 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 64.4 mt -129.33 158.17 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.659 -0.907 . . . . 0.0 109.672 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -69.81 148.01 49.66 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.385 -0.822 . . . . 0.0 110.167 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.41 ' NH1' HG22 ' A' ' 170' ' ' VAL . 0.0 OUTLIER -132.41 -80.35 0.5 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.781 -0.575 . . . . 0.0 110.354 -179.49 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -120.66 143.58 48.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.178 -0.951 . . . . 0.0 111.269 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.85 129.82 40.12 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.3 t -100.32 121.27 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.491 -0.756 . . . . 0.0 111.33 -177.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.8 p -140.66 149.54 42.39 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.535 -0.728 . . . . 0.0 110.517 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 37.7 m -88.79 -49.62 6.72 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.553 -0.717 . . . . 0.0 109.804 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -119.71 32.03 6.26 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.52 0.676 . . . . 0.0 109.229 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 97.65 -11.56 64.7 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.244 -1.543 . . . . 0.0 109.244 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 62.4 t -88.11 122.42 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.279 -1.13 . . . . 0.0 109.061 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.55 113.14 22.97 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.528 -0.733 . . . . 0.0 110.784 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -109.14 -30.21 8.15 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.651 -0.656 . . . . 0.0 109.687 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.7 ' HB1' ' CZ ' ' A' ' 123' ' ' ARG . . . -116.52 168.32 10.27 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.664 -0.648 . . . . 0.0 109.681 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.447 HG13 ' C ' ' A' ' 166' ' ' ALA . 35.9 m -148.74 135.82 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.541 -0.724 . . . . 0.0 111.085 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.65 134.46 51.93 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.664 -0.647 . . . . 0.0 109.883 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.426 ' CE1' ' HA ' ' A' ' 122' ' ' SER . 52.2 p90 -131.56 159.94 36.74 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.42 -0.8 . . . . 0.0 110.389 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.41 HG22 ' NH1' ' A' ' 155' ' ' ARG . 60.4 t -92.54 140.53 24.02 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.57 -0.707 . . . . 0.0 110.212 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -75.15 162.51 36.64 Favored 'Trans proline' 0 C--N 1.32 -0.966 0 O-C-N 123.131 1.069 . . . . 0.0 110.337 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 151' ' ' VAL . 87.6 t -79.75 -30.59 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.554 -0.716 . . . . 0.0 110.257 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -60.02 -39.24 85.19 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.493 -0.754 . . . . 0.0 110.605 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 58.4 p -61.7 -25.7 67.58 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.516 -0.74 . . . . 0.0 110.871 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.428 ' CE ' HG13 ' A' ' 172' ' ' VAL . 53.9 mtm -66.99 -36.98 83.38 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.422 -0.799 . . . . 0.0 110.542 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -60.05 -40.01 87.92 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.472 -0.767 . . . . 0.0 110.404 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 31.3 m -61.05 -31.69 71.34 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.536 -0.727 . . . . 0.0 110.511 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.457 ' OG1' ' NE2' ' A' ' 80' ' ' GLN . 93.2 m -59.95 -40.04 87.64 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.515 -0.74 . . . . 0.0 110.465 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 1.4 ttp -58.82 -36.29 74.26 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.44 -0.787 . . . . 0.0 110.437 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 5.5 ttp180 -59.91 -39.98 87.26 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.433 -0.792 . . . . 0.0 110.212 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.833 0 O-C-N 121.603 -0.686 . . . . 0.0 110.301 179.944 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.435 ' HG2' HD13 ' A' ' 94' ' ' LEU . 8.1 pt-20 . . . . . 0 N--CA 1.498 1.947 0 CA-C-O 121.302 0.572 . . . . 0.0 110.458 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 63.3 t -114.63 125.5 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.54 -0.725 . . . . 0.0 109.78 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -103.01 138.98 39.17 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.576 -0.702 . . . . 0.0 110.065 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.583 ' HA ' HD22 ' A' ' 44' ' ' LEU . 33.5 m -88.38 132.14 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.554 -0.716 . . . . 0.0 110.476 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.1 m -130.6 159.97 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.467 -0.77 . . . . 0.0 110.346 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 64.7 m -135.9 153.49 51.44 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.566 -0.709 . . . . 0.0 110.383 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.529 HG22 ' H ' ' A' ' 39' ' ' ALA . 1.6 m -117.8 179.82 3.96 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.618 -0.677 . . . . 0.0 109.982 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.529 ' H ' HG22 ' A' ' 38' ' ' THR . . . -71.14 -23.73 62.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.671 -0.643 . . . . 0.0 111.288 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.6 p -119.8 -28.29 5.25 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.32 -0.863 . . . . 0.0 111.418 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -142.34 164.72 29.37 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.371 -0.831 . . . . 0.0 110.639 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.4 t -130.94 124.62 31.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.497 -0.752 . . . . 0.0 110.14 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.411 ' CE1' ' OG1' ' A' ' 38' ' ' THR . 4.5 p90 -133.9 178.32 7.04 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.604 -0.685 . . . . 0.0 110.121 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.583 HD22 ' HA ' ' A' ' 35' ' ' VAL . 25.0 mt -121.16 167.55 12.54 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.574 -0.704 . . . . 0.0 110.026 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.79 152.14 46.33 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.592 -0.692 . . . . 0.0 110.06 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.6 m -119.98 135.42 54.92 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.477 -0.765 . . . . 0.0 110.286 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 45.8 t -93.27 103.82 16.04 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.562 -0.711 . . . . 0.0 110.482 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 94' ' ' LEU . 12.0 p -130.44 139.64 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.546 -0.721 . . . . 0.0 110.4 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 57.67 36.17 26.39 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.412 -0.805 . . . . 0.0 110.836 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 63.26 15.76 57.1 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.548 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 56.5 t -139.47 119.3 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.266 -1.137 . . . . 0.0 109.657 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 28.5 p -79.98 137.95 36.95 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.587 -0.696 . . . . 0.0 110.41 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.845 ' CE3' HD21 ' A' ' 82' ' ' LEU . 87.0 m95 -125.92 137.43 53.71 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.554 -0.716 . . . . 0.0 110.404 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.9 t -137.16 179.6 6.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.705 -0.622 . . . . 0.0 109.804 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.601 HG11 ' CE1' ' A' ' 57' ' ' HIS . 0.5 OUTLIER -81.32 142.65 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.175 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.908 ' CE2' HG22 ' A' ' 78' ' ' VAL . 27.5 t80 -81.02 -42.54 20.95 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.458 -0.776 . . . . 0.0 111.199 -178.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.601 ' CE1' HG11 ' A' ' 55' ' ' VAL . 2.2 p-80 -53.72 -21.2 6.64 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.444 -0.785 . . . . 0.0 111.956 -177.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -119.62 -23.63 3.06 Favored Glycine 0 N--CA 1.496 2.677 0 C-N-CA 119.984 -1.103 . . . . 0.0 111.064 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 55' ' ' VAL . . . -113.77 -27.14 7.9 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.235 -1.156 . . . . 0.0 111.083 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.453 ' HA3' ' CD1' ' A' ' 56' ' ' TYR . . . . . . . . 0 N--CA 1.494 2.562 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 40.7 p . . . . . 0 N--CA 1.498 1.947 0 CA-C-O 121.273 0.559 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -87.96 130.95 34.78 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.729 -0.607 . . . . 0.0 109.721 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.7 tpt -119.07 -44.54 2.6 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.464 -0.773 . . . . 0.0 110.976 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.52 ' O ' HG13 ' A' ' 83' ' ' VAL . 24.1 m-85 -109.81 124.78 51.89 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.271 -0.893 . . . . 0.0 110.083 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.503 HG23 ' HE1' ' A' ' 56' ' ' TYR . 56.9 m -152.17 135.47 15.91 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.609 -0.682 . . . . 0.0 110.355 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -167.28 111.85 0.71 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.504 -0.748 . . . . 0.0 110.813 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.908 HG22 ' CE2' ' A' ' 56' ' ' TYR . 75.7 t -72.25 -29.21 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.297 -0.877 . . . . 0.0 109.322 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -60.0 -42.89 95.23 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.47 -0.769 . . . . 0.0 110.012 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.403 ' HB2' HE21 ' A' ' 80' ' ' GLN . 6.1 tt0 -99.81 -6.99 26.0 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.514 -0.741 . . . . 0.0 110.652 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.486 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 30.4 t0 56.39 33.98 23.38 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.065 -1.022 . . . . 0.0 110.635 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.845 HD21 ' CE3' ' A' ' 53' ' ' TRP . 7.8 tt -119.83 145.27 46.79 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.249 -0.907 . . . . 0.0 111.751 -178.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 75' ' ' TYR . 3.1 t -143.97 159.25 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -168.96 164.37 38.02 Favored Glycine 0 N--CA 1.496 2.645 0 C-N-CA 119.46 -1.352 . . . . 0.0 110.624 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.517 ' CZ2' HG12 ' A' ' 83' ' ' VAL . 20.3 m-90 -146.75 160.02 42.76 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.793 -0.828 . . . . 0.0 109.47 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -62.21 138.0 58.34 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.575 -0.703 . . . . 0.0 110.08 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.97 148.5 57.06 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.478 -0.764 . . . . 0.0 110.284 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.9 160.0 48.94 Favored 'Trans proline' 0 C--N 1.317 -1.105 0 O-C-N 123.484 1.254 . . . . 0.0 110.359 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -73.31 126.83 11.36 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 123.377 1.199 . . . . 0.0 110.447 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 108.81 30.09 3.86 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -117.42 159.49 22.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.513 -0.993 . . . . 0.0 110.089 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.2 mtp180 -96.29 163.87 12.9 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.53 -0.731 . . . . 0.0 110.378 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 80.7 p -130.89 145.17 51.93 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.678 -0.639 . . . . 0.0 109.901 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.435 HD13 ' HG2' ' A' ' 32' ' ' GLU . 0.7 OUTLIER -105.09 139.92 39.04 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.588 -0.695 . . . . 0.0 110.303 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 60.3 m -78.07 143.8 66.37 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.747 -0.596 . . . . 0.0 109.917 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.64 161.98 43.82 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 O-C-N 123.302 1.159 . . . . 0.0 110.319 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 45.6 t -72.9 128.01 34.24 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.539 -0.725 . . . . 0.0 110.483 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.3 m -135.73 55.79 1.85 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.662 -0.649 . . . . 0.0 109.531 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.4 p -145.01 4.66 1.1 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.58 -0.7 . . . . 0.0 112.175 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 51.25 91.06 0.01 OUTLIER Glycine 0 N--CA 1.502 3.064 0 O-C-N 120.905 -1.122 . . . . 0.0 110.495 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 98.1 p -139.35 148.06 42.38 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.436 -1.038 . . . . 0.0 110.362 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 63.7 m -95.03 -34.54 12.3 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.64 -0.662 . . . . 0.0 110.176 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -66.37 129.67 40.6 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.642 -0.661 . . . . 0.0 109.915 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.845 HD22 HG21 ' A' ' 151' ' ' VAL . 97.3 mt -136.28 156.53 48.53 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.625 -0.672 . . . . 0.0 110.546 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -126.34 108.72 11.5 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.667 -0.646 . . . . 0.0 109.519 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.473 HD11 ' CD1' ' A' ' 154' ' ' PHE . 9.7 tt -89.46 129.39 35.96 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.638 -0.663 . . . . 0.0 110.763 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.5 t -84.91 131.07 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.64 -0.663 . . . . 0.0 109.575 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.7 p -97.82 -175.51 3.19 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.48 -0.762 . . . . 0.0 110.509 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.2 ttt-85 -69.95 -27.01 64.4 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.706 -0.621 . . . . 0.0 110.846 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.44 ' CD2' ' HB2' ' A' ' 112' ' ' ASP . 41.0 p-80 -106.22 29.96 6.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.43 -0.794 . . . . 0.0 110.859 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 55.36 56.84 5.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.532 -0.73 . . . . 0.0 111.884 178.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.44 ' HB2' ' CD2' ' A' ' 110' ' ' HIS . 0.4 OUTLIER -110.8 137.34 48.57 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.401 -0.812 . . . . 0.0 109.88 179.118 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.44 ' O ' HG13 ' A' ' 113' ' ' VAL . 10.4 p -84.46 128.34 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.65 -0.656 . . . . 0.0 110.275 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.54 ' CG2' HD11 ' A' ' 126' ' ' LEU . 48.6 mm -129.98 105.86 16.67 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.523 -0.735 . . . . 0.0 110.11 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -70.66 119.84 6.64 Favored 'Trans proline' 0 N--CA 1.487 1.088 0 O-C-N 123.241 1.127 . . . . 0.0 110.242 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.635 HG13 ' O ' ' A' ' 125' ' ' SER . 57.5 t -120.36 129.39 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.515 -0.741 . . . . 0.0 110.137 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.514 ' CG ' HD11 ' A' ' 127' ' ' LEU . 4.1 mmt180 -83.03 135.86 34.7 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.566 -0.709 . . . . 0.0 109.809 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -82.24 134.23 35.28 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.522 -0.736 . . . . 0.0 110.431 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.7 18.63 3.3 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.587 -0.696 . . . . 0.0 110.581 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -173.33 178.94 45.05 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -69.55 -39.97 77.11 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.572 -0.958 . . . . 0.0 110.331 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.6 m -130.33 25.06 5.17 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.527 -0.733 . . . . 0.0 110.781 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -142.58 141.83 32.06 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.423 -0.798 . . . . 0.0 110.306 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -142.11 157.16 26.37 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.635 ' O ' HG13 ' A' ' 116' ' ' VAL . 50.6 p -91.57 157.63 16.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.664 -0.904 . . . . 0.0 110.125 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.54 HD11 ' CG2' ' A' ' 114' ' ' ILE . 39.9 tp -105.77 127.17 52.92 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.531 -0.731 . . . . 0.0 110.36 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.514 HD11 ' CG ' ' A' ' 117' ' ' ARG . 4.3 mp -68.6 -42.26 78.44 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.581 -0.7 . . . . 0.0 110.092 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.6 p -102.2 99.79 13.58 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.694 -0.629 . . . . 0.0 109.701 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.15 106.94 2.01 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.388 1.204 . . . . 0.0 110.945 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -114.47 161.5 28.25 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.713 -0.617 . . . . 0.0 109.748 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 44.8 Cg_endo -71.18 150.59 59.86 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 O-C-N 123.391 1.206 . . . . 0.0 110.354 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.413 HG21 ' SG ' ' A' ' 159' ' ' CYS . 64.6 t -51.03 -29.93 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 O-C-N 121.399 -0.813 . . . . 0.0 109.828 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.2 t -61.43 -40.04 92.97 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.728 -0.608 . . . . 0.0 110.956 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -66.87 -39.97 87.71 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.326 -0.859 . . . . 0.0 109.538 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.417 HD21 ' CZ ' ' A' ' 154' ' ' PHE . 17.6 tp -95.4 18.9 11.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.922 -0.486 . . . . 0.0 110.135 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -81.14 116.67 21.16 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 122.541 1.162 . . . . 0.0 112.412 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.72 22.12 11.54 Favored Glycine 0 N--CA 1.492 2.401 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.269 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.3 m -103.44 20.85 17.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.47 -1.018 . . . . 0.0 110.53 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.2 m -69.96 136.12 50.17 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.28 -0.888 . . . . 0.0 109.541 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 100.06 -23.29 36.56 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.79 110.02 1.93 Allowed Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -72.43 138.7 30.35 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 O-C-N 123.18 1.095 . . . . 0.0 111.073 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.459 ' C ' HD12 ' A' ' 144' ' ' LEU . 4.1 mp -86.35 146.3 26.53 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.459 HD12 ' C ' ' A' ' 143' ' ' LEU . 4.1 mp -126.9 162.23 26.41 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.403 -0.81 . . . . 0.0 111.23 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.412 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 27.1 p -119.1 165.12 17.93 Favored Pre-proline 0 N--CA 1.494 1.774 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.412 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 39.9 Cg_endo -65.42 -12.23 33.98 Favored 'Trans proline' 0 N--CA 1.489 1.218 0 O-C-N 123.082 1.043 . . . . 0.0 111.853 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.7 p -72.01 -32.66 67.39 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.117 -0.989 . . . . 0.0 109.943 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 116.15 20.74 5.1 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -131.34 152.95 50.11 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.325 -1.103 . . . . 0.0 110.377 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.403 ' HB2' ' CD2' ' A' ' 94' ' ' LEU . . . -78.77 152.36 31.5 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.542 -0.724 . . . . 0.0 109.931 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.845 HG21 HD22 ' A' ' 104' ' ' LEU . 34.0 m -112.55 -28.81 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.5 -0.75 . . . . 0.0 110.989 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 177.7 -161.01 27.96 Favored Glycine 0 N--CA 1.498 2.776 0 C-N-CA 119.753 -1.213 . . . . 0.0 110.339 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.5 mt -134.42 151.76 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.652 -0.911 . . . . 0.0 110.162 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.473 ' CD1' HD11 ' A' ' 106' ' ' LEU . 14.5 t80 -70.13 153.49 43.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.685 -0.634 . . . . 0.0 110.14 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 46.6 ttm-85 -135.95 -76.41 0.43 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.659 -0.651 . . . . 0.0 110.327 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -120.53 143.04 48.79 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.38 -0.825 . . . . 0.0 110.616 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.27 127.71 38.97 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.5 t -96.9 117.77 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.602 -0.686 . . . . 0.0 111.535 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.413 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.9 p -140.06 147.68 40.67 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.414 -0.804 . . . . 0.0 110.565 178.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 17.9 m -79.49 -50.59 10.53 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.488 -0.758 . . . . 0.0 109.77 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -130.26 36.7 3.96 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.633 -0.667 . . . . 0.0 109.904 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 131' ' ' PRO . . . 104.28 -11.76 51.47 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 65.1 t -93.12 121.95 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.259 -1.142 . . . . 0.0 109.158 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.2 121.1 29.2 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.541 -0.725 . . . . 0.0 111.347 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 5.4 mttp -113.29 -30.11 7.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.804 -0.56 . . . . 0.0 109.933 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -123.64 168.4 12.69 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.518 -0.739 . . . . 0.0 109.9 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.492 HG21 HG11 ' A' ' 116' ' ' VAL . 35.1 m -140.23 137.34 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.517 -0.74 . . . . 0.0 110.887 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -104.65 126.57 51.85 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.53 -0.731 . . . . 0.0 110.606 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -147.8 162.14 39.83 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.595 -0.691 . . . . 0.0 110.332 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 27.1 m -110.96 149.59 40.65 Favored Pre-proline 0 N--CA 1.502 2.129 0 O-C-N 121.353 -0.842 . . . . 0.0 110.708 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -78.6 161.28 28.03 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.496 1.261 . . . . 0.0 109.378 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 54.0 t -58.9 -25.93 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.385 -0.822 . . . . 0.0 110.051 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -59.92 -35.53 75.08 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.557 -0.715 . . . . 0.0 110.643 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 2.3 t -61.51 -24.35 66.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.468 -0.77 . . . . 0.0 110.568 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 68.0 mtt -69.96 -39.06 76.23 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.431 -0.793 . . . . 0.0 110.507 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -60.11 -39.98 88.08 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.443 -0.786 . . . . 0.0 110.566 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 85.3 m -60.8 -40.04 91.15 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.474 -0.766 . . . . 0.0 110.124 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.415 HG21 HD22 ' A' ' 82' ' ' LEU . 61.8 m -67.73 -36.34 80.4 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.559 -0.713 . . . . 0.0 110.321 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 7.9 ttt -60.06 -42.23 94.05 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.553 -0.717 . . . . 0.0 110.539 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -60.07 -39.9 87.66 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.539 -0.726 . . . . 0.0 110.342 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.722 0 O-C-N 121.581 -0.699 . . . . 0.0 110.187 179.956 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.415 ' HG2' HD21 ' A' ' 94' ' ' LEU . 21.7 mp0 . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 120.988 0.423 . . . . 0.0 110.485 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.749 HG23 ' O ' ' A' ' 45' ' ' ALA . 9.1 p -119.31 143.66 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.566 -0.709 . . . . 0.0 110.069 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 54.9 tp60 -110.39 141.65 43.16 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.582 -0.699 . . . . 0.0 110.181 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.609 ' HA ' HD22 ' A' ' 44' ' ' LEU . 10.0 p -82.74 130.26 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.643 -0.661 . . . . 0.0 110.212 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.7 m -138.14 144.31 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.509 -0.744 . . . . 0.0 110.48 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.4 m -130.05 144.04 51.12 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.54 -0.725 . . . . 0.0 110.632 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.526 HG22 ' H ' ' A' ' 39' ' ' ALA . 0.3 OUTLIER -99.86 -169.98 1.82 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.602 -0.686 . . . . 0.0 109.768 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.526 ' H ' HG22 ' A' ' 38' ' ' THR . . . -71.83 -40.04 69.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.614 -0.679 . . . . 0.0 111.597 -178.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 77.6 p -114.59 -18.82 11.34 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.226 -0.922 . . . . 0.0 111.608 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -139.75 161.67 36.99 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.244 -0.91 . . . . 0.0 110.134 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 99.1 p -138.4 123.28 18.87 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.458 -0.776 . . . . 0.0 110.857 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 4.4 p90 -128.05 -174.96 3.35 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.632 -0.668 . . . . 0.0 109.503 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.609 HD22 ' HA ' ' A' ' 35' ' ' VAL . 44.0 mt -126.57 166.08 17.96 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.335 -0.853 . . . . 0.0 110.746 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.749 ' O ' HG23 ' A' ' 33' ' ' VAL . . . -141.49 152.48 44.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.711 -0.618 . . . . 0.0 110.261 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 87.8 m -130.03 139.9 50.94 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.511 -0.743 . . . . 0.0 110.291 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 77.8 m -77.63 120.49 22.65 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.562 -0.712 . . . . 0.0 110.431 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.1 t -130.48 120.82 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.467 -0.771 . . . . 0.0 110.628 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 33.4 m120 50.05 34.47 8.3 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.534 -0.729 . . . . 0.0 111.969 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.75 ' O ' ' HB3' ' A' ' 87' ' ' ALA . . . 91.25 -23.61 23.53 Favored Glycine 0 N--CA 1.497 2.736 0 C-N-CA 120.198 -1.001 . . . . 0.0 110.8 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.0 p -108.89 133.58 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.3 -1.118 . . . . 0.0 109.781 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 77.1 m -91.55 125.03 36.15 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.392 -0.818 . . . . 0.0 110.159 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 71.9 m95 -99.33 137.17 38.21 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.567 -0.708 . . . . 0.0 110.422 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.81 HG21 ' CZ2' ' A' ' 85' ' ' TRP . 8.4 t -137.06 173.43 11.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.765 -0.584 . . . . 0.0 109.751 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.706 HG11 ' CE1' ' A' ' 57' ' ' HIS . 96.9 t -81.78 142.09 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.462 -0.774 . . . . 0.0 109.26 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.903 ' CE2' HG22 ' A' ' 78' ' ' VAL . 15.2 t80 -85.0 -43.37 14.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.63 -0.669 . . . . 0.0 110.806 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.706 ' CE1' HG11 ' A' ' 55' ' ' VAL . 2.2 p-80 -59.45 -22.55 61.67 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.167 -0.958 . . . . 0.0 110.476 -178.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -82.28 -65.77 1.61 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.0 -63.28 1.36 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.418 -1.048 . . . . 0.0 110.188 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.47 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 179.316 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.497 1.901 0 CA-C-O 121.037 0.446 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -92.36 150.83 20.59 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.551 -0.718 . . . . 0.0 110.565 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 97.8 mmm -116.98 -32.7 4.98 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.65 -0.656 . . . . 0.0 110.35 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.582 ' O ' HG13 ' A' ' 83' ' ' VAL . 18.5 m-85 -110.11 129.15 55.74 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.374 -0.829 . . . . 0.0 109.436 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 89.3 m -151.44 132.65 14.46 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.399 -0.813 . . . . 0.0 110.456 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -166.73 125.42 1.42 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.372 -0.83 . . . . 0.0 111.141 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.903 HG22 ' CE2' ' A' ' 56' ' ' TYR . 78.5 t -72.32 -39.29 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.459 -0.776 . . . . 0.0 109.607 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -55.81 -44.93 78.32 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.354 -0.842 . . . . 0.0 110.268 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.576 ' O ' HD12 ' A' ' 82' ' ' LEU . 2.4 tp-100 -82.9 -14.0 55.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.754 -0.591 . . . . 0.0 110.279 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 40.2 t0 53.09 39.9 30.31 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.117 -0.989 . . . . 0.0 110.67 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.684 HD13 ' CE ' ' A' ' 175' ' ' MET . 0.3 OUTLIER -146.3 156.98 43.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.406 -0.809 . . . . 0.0 111.065 -179.545 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.733 ' O ' HG22 ' A' ' 54' ' ' THR . 3.5 t -145.11 145.14 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -130.5 154.69 20.77 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.626 -1.273 . . . . 0.0 110.912 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.81 ' CZ2' HG21 ' A' ' 54' ' ' THR . 4.4 m-90 -125.07 159.88 30.36 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.904 -0.763 . . . . 0.0 109.431 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -83.15 122.9 28.98 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.474 -0.766 . . . . 0.0 109.877 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.75 ' HB3' ' O ' ' A' ' 50' ' ' GLY . . . -101.28 160.62 26.1 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.457 -0.777 . . . . 0.0 110.538 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.77 160.05 49.06 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 O-C-N 123.484 1.255 . . . . 0.0 110.506 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.52 158.81 47.28 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.448 1.236 . . . . 0.0 110.526 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 74.27 31.12 59.69 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -107.23 151.33 25.58 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.43 -1.041 . . . . 0.0 110.307 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -60.5 152.3 26.22 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.589 -0.694 . . . . 0.0 110.46 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 92.5 p -148.23 155.39 41.3 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.612 -0.68 . . . . 0.0 110.457 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.626 ' HB3' ' HB2' ' A' ' 150' ' ' ALA . 90.9 mt -111.13 131.92 54.7 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.563 -0.711 . . . . 0.0 110.36 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 72.6 p -76.5 159.91 78.54 Favored Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 121.597 -0.689 . . . . 0.0 110.082 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.0 159.22 50.78 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.38 1.2 . . . . 0.0 110.481 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 47.0 t -86.93 128.15 35.06 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.564 -0.71 . . . . 0.0 110.388 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.5 p -133.69 55.09 1.91 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.603 -0.685 . . . . 0.0 109.989 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.5 p -145.18 7.68 1.18 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.481 -0.762 . . . . 0.0 111.864 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 52.26 41.67 54.72 Favored Glycine 0 N--CA 1.499 2.894 0 O-C-N 121.003 -1.06 . . . . 0.0 110.496 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.8 m -78.92 107.96 12.04 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.519 -0.989 . . . . 0.0 110.386 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.4 m -66.24 -40.01 89.92 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.569 -0.707 . . . . 0.0 110.195 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -67.92 129.12 38.94 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.589 -0.694 . . . . 0.0 109.97 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.579 HD22 HG21 ' A' ' 151' ' ' VAL . 90.8 mt -134.99 150.08 50.29 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.609 -0.682 . . . . 0.0 110.356 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -117.5 125.19 50.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.535 -0.728 . . . . 0.0 109.768 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.686 HD11 ' HB2' ' A' ' 154' ' ' PHE . 26.8 tp -102.53 144.22 31.23 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.5 -0.75 . . . . 0.0 110.556 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.6 t -105.92 126.68 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.603 -0.686 . . . . 0.0 109.73 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 69.7 p -93.98 176.49 6.31 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.501 -0.749 . . . . 0.0 110.58 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -60.13 -24.63 64.84 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.598 -0.689 . . . . 0.0 110.722 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -95.32 27.15 3.43 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.474 -0.766 . . . . 0.0 110.555 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 53.21 27.79 6.39 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.296 -0.878 . . . . 0.0 110.916 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -80.68 152.59 28.36 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.546 -0.721 . . . . 0.0 109.913 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 63.2 t -116.05 128.17 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.543 -0.723 . . . . 0.0 109.929 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.548 HD11 HD23 ' A' ' 106' ' ' LEU . 40.1 pt -134.56 139.07 31.5 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.49 -0.756 . . . . 0.0 110.19 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -82.91 146.45 12.98 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 O-C-N 123.177 1.093 . . . . 0.0 110.521 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.1 t -139.36 129.94 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.584 -0.698 . . . . 0.0 109.768 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.7 tpp180 -92.98 130.71 38.47 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.538 -0.726 . . . . 0.0 110.154 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -80.26 121.33 25.5 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.606 -0.684 . . . . 0.0 110.328 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.88 -12.29 9.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.523 -0.736 . . . . 0.0 110.473 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -134.92 -175.55 13.92 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -70.14 -45.09 67.54 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.557 -0.966 . . . . 0.0 110.57 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.6 m -127.67 21.04 6.54 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.45 -0.781 . . . . 0.0 110.819 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.72 142.13 34.86 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.315 -0.866 . . . . 0.0 110.057 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -134.25 166.86 23.99 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 52.9 p -98.72 165.19 11.91 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.541 -0.976 . . . . 0.0 110.222 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.444 HD21 ' NH1' ' A' ' 130' ' ' ARG . 47.7 tp -120.0 124.2 45.33 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.527 -0.733 . . . . 0.0 110.337 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.459 ' H ' HD12 ' A' ' 127' ' ' LEU . 5.4 mp -62.13 -41.67 98.49 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.51 -0.744 . . . . 0.0 110.182 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.4 p -102.58 105.9 46.6 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.548 -0.72 . . . . 0.0 109.945 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.36 106.85 2.15 Favored 'Trans proline' 0 C--N 1.319 -0.999 0 O-C-N 123.32 1.169 . . . . 0.0 110.876 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.657 ' O ' ' HB3' ' A' ' 164' ' ' ALA . 4.4 mtt85 -106.89 153.09 41.05 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.644 -0.66 . . . . 0.0 109.643 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.27 150.38 52.93 Favored 'Trans proline' 0 C--N 1.315 -1.207 0 O-C-N 123.383 1.202 . . . . 0.0 110.884 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.421 HG21 ' SG ' ' A' ' 159' ' ' CYS . 73.6 t -53.6 -31.95 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.473 -0.767 . . . . 0.0 109.565 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 31.2 t -59.85 -39.99 87.07 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.689 -0.632 . . . . 0.0 110.65 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.448 ' CD2' ' HD2' ' A' ' 130' ' ' ARG . 87.3 t80 -70.06 -39.73 75.5 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.444 -0.785 . . . . 0.0 109.604 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 22.1 tp -95.01 13.59 24.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.725 -0.609 . . . . 0.0 110.581 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.71 113.03 13.9 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.601 1.191 . . . . 0.0 111.087 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.53 34.3 4.48 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 31.1 m -115.29 19.15 15.76 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.747 -0.855 . . . . 0.0 110.46 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.539 ' HB3' HG21 ' A' ' 55' ' ' VAL . 4.5 m -68.12 147.47 52.27 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.3 -0.875 . . . . 0.0 109.508 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.405 ' C ' HG23 ' A' ' 153' ' ' ILE . . . 94.56 -19.75 52.02 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -58.29 112.69 4.15 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.49 157.56 52.65 Favored 'Trans proline' 0 C--N 1.319 -1.025 0 O-C-N 123.201 1.106 . . . . 0.0 110.955 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.575 HD11 HD13 ' A' ' 106' ' ' LEU . 5.9 mp -109.4 127.66 54.54 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.543 HD13 ' O ' ' A' ' 149' ' ' HIS . 2.9 mm? -110.41 160.26 16.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.535 -0.728 . . . . 0.0 111.078 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.421 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 27.1 p -119.92 165.64 17.26 Favored Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 38.5 Cg_endo -63.97 -15.21 47.84 Favored 'Trans proline' 0 N--CA 1.488 1.18 0 O-C-N 123.079 1.042 . . . . 0.0 111.454 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.5 t -70.24 -39.95 74.75 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.282 -0.886 . . . . 0.0 110.044 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 114.87 31.61 2.06 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.543 ' O ' HD13 ' A' ' 144' ' ' LEU . 19.7 m-70 -132.15 155.76 47.6 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.492 -1.005 . . . . 0.0 110.404 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.626 ' HB2' ' HB3' ' A' ' 94' ' ' LEU . . . -73.41 146.85 44.78 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.556 -0.715 . . . . 0.0 109.985 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.766 ' O ' HG23 ' A' ' 172' ' ' VAL . 58.9 t -112.08 -61.67 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.479 -0.763 . . . . 0.0 110.353 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -163.19 -158.76 10.0 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.405 HG23 ' C ' ' A' ' 140' ' ' GLY . 96.8 mt -133.97 155.42 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.594 -0.945 . . . . 0.0 109.882 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.686 ' HB2' HD11 ' A' ' 106' ' ' LEU . 19.6 t80 -70.04 147.49 49.98 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.45 -0.781 . . . . 0.0 109.861 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.545 ' NH2' HG22 ' A' ' 170' ' ' VAL . 4.6 ttm-85 -128.6 -79.85 0.57 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.602 -0.686 . . . . 0.0 110.829 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -119.5 143.7 47.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.964 . . . . 0.0 111.313 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.56 128.08 39.53 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.4 t -98.86 119.11 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 121.48 -0.762 . . . . 0.0 111.282 -177.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.421 ' SG ' HG21 ' A' ' 132' ' ' VAL . 27.9 p -139.88 143.59 36.77 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.506 -0.746 . . . . 0.0 110.689 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 87.0 m -76.33 -41.98 46.56 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.596 -0.69 . . . . 0.0 109.872 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -143.24 50.28 1.41 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.646 -0.659 . . . . 0.0 109.897 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 90.77 -11.57 71.41 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 64.3 t -96.07 120.13 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.141 -1.211 . . . . 0.0 108.91 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.657 ' HB3' ' O ' ' A' ' 130' ' ' ARG . . . -87.63 120.91 29.42 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.529 -0.732 . . . . 0.0 111.243 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -112.81 -32.28 6.46 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.296 0.57 . . . . 0.0 109.678 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -118.6 168.26 10.87 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.669 -0.644 . . . . 0.0 109.685 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 35.6 m -144.02 135.77 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.36 -0.838 . . . . 0.0 110.823 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -110.34 138.37 46.81 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.655 -0.653 . . . . 0.0 110.242 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -141.84 162.07 36.39 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.507 -0.746 . . . . 0.0 110.544 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.545 HG22 ' NH2' ' A' ' 155' ' ' ARG . 51.6 t -101.89 143.39 26.51 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.466 -0.771 . . . . 0.0 110.24 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -75.69 166.38 28.47 Favored 'Trans proline' 0 N--CA 1.485 1.006 0 O-C-N 123.296 1.156 . . . . 0.0 110.389 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 151' ' ' VAL . 77.3 t -88.46 -25.86 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.536 -0.728 . . . . 0.0 110.536 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -59.33 -32.94 70.54 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.408 -0.808 . . . . 0.0 110.596 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.611 ' O ' HG22 ' A' ' 177' ' ' THR . 5.8 t -69.19 -22.94 63.86 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.469 -0.769 . . . . 0.0 110.49 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.684 ' CE ' HD13 ' A' ' 82' ' ' LEU . 35.1 mmt -63.29 -27.8 69.58 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.334 -0.854 . . . . 0.0 110.411 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -57.37 -49.95 74.53 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.404 -0.81 . . . . 0.0 110.67 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.611 HG22 ' O ' ' A' ' 174' ' ' SER . 6.1 t -70.03 -23.33 63.09 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.525 -0.735 . . . . 0.0 110.503 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 87.6 m -72.06 -32.95 67.57 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.427 -0.796 . . . . 0.0 110.243 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 95.7 mtp -60.02 -37.02 78.54 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.568 -0.707 . . . . 0.0 110.419 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -59.92 -39.87 86.94 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.528 -0.732 . . . . 0.0 110.273 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.837 0 O-C-N 121.56 -0.713 . . . . 0.0 110.111 179.954 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.795 ' HG3' HG23 ' A' ' 33' ' ' VAL . 12.4 pt-20 . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 120.908 0.385 . . . . 0.0 110.746 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.795 HG23 ' HG3' ' A' ' 32' ' ' GLU . 58.8 t -126.5 140.57 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.399 -0.813 . . . . 0.0 110.311 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -106.84 159.73 16.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.572 -0.705 . . . . 0.0 110.05 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.459 ' HA ' HD22 ' A' ' 44' ' ' LEU . 62.2 t -107.57 118.34 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.485 -0.76 . . . . 0.0 110.224 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 68.0 t -120.9 133.85 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.468 -0.77 . . . . 0.0 110.158 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.5 t -130.48 135.74 48.28 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.617 -0.677 . . . . 0.0 109.763 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.24 173.6 6.25 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.525 -0.734 . . . . 0.0 110.245 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.84 -34.88 74.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.746 -0.596 . . . . 0.0 111.203 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 68.9 p -103.49 -28.18 11.93 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.362 -0.836 . . . . 0.0 111.049 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -142.93 178.11 7.9 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.38 -0.825 . . . . 0.0 110.619 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 24.0 m -148.74 120.6 8.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.711 -0.618 . . . . 0.0 110.223 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.454 ' O ' HD23 ' A' ' 44' ' ' LEU . 27.6 p90 -127.53 172.38 10.76 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.664 -0.647 . . . . 0.0 109.674 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.459 HD22 ' HA ' ' A' ' 35' ' ' VAL . 46.8 mt -121.14 153.96 36.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.492 -0.755 . . . . 0.0 109.978 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.589 ' HB1' ' SG ' ' A' ' 52' ' ' CYS . . . -125.76 154.66 42.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.594 -0.691 . . . . 0.0 110.379 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.4 t -129.11 144.18 51.11 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.667 -0.646 . . . . 0.0 109.902 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 27.9 p -94.84 118.8 32.36 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.696 0.76 . . . . 0.0 110.679 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.4 t -130.27 127.64 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.44 -0.787 . . . . 0.0 109.827 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.0 t30 52.16 39.13 26.15 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.418 -0.801 . . . . 0.0 110.991 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.593 ' O ' ' HB3' ' A' ' 87' ' ' ALA . . . 68.71 24.67 75.41 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.3 t -136.64 115.09 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.382 -1.069 . . . . 0.0 109.836 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.589 ' SG ' ' HB1' ' A' ' 45' ' ' ALA . 47.9 t -77.42 116.35 17.94 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.546 -0.721 . . . . 0.0 109.958 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.455 ' CZ3' ' CE ' ' A' ' 175' ' ' MET . 56.9 m95 -100.09 137.25 38.8 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.446 -0.783 . . . . 0.0 110.578 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.958 HG21 ' CH2' ' A' ' 85' ' ' TRP . 7.5 t -137.11 173.59 11.52 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.646 -0.659 . . . . 0.0 109.47 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.84 HG11 ' CE1' ' A' ' 57' ' ' HIS . 71.5 t -82.52 143.66 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.362 -0.836 . . . . 0.0 109.495 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.887 ' CE2' HG22 ' A' ' 78' ' ' VAL . 21.2 t80 -84.37 -42.21 15.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.754 -0.591 . . . . 0.0 111.027 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.84 ' CE1' HG11 ' A' ' 55' ' ' VAL . 1.4 p-80 -56.86 -20.02 20.67 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.967 -1.083 . . . . 0.0 111.227 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -102.16 -65.82 0.76 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.68 -22.83 49.94 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.473 -1.016 . . . . 0.0 111.027 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.603 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -179.75 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.6 p . . . . . 0 N--CA 1.493 1.718 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.2 mm-40 -96.8 113.94 25.54 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.493 -0.754 . . . . 0.0 111.123 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.415 ' HG3' ' CD2' ' A' ' 75' ' ' TYR . 19.4 ptt? -113.08 -29.73 7.22 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.658 -0.651 . . . . 0.0 109.783 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.469 ' O ' HG13 ' A' ' 83' ' ' VAL . 29.9 m-85 -120.22 116.37 25.47 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.572 -0.705 . . . . 0.0 109.596 179.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.1 m -150.31 130.92 13.96 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.481 -0.762 . . . . 0.0 110.316 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -167.74 123.24 1.04 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.363 -0.836 . . . . 0.0 111.327 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.887 HG22 ' CE2' ' A' ' 56' ' ' TYR . 70.1 t -72.67 -38.18 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.49 -0.756 . . . . 0.0 109.5 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -55.66 -33.3 63.97 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.484 -0.76 . . . . 0.0 110.641 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.805 ' HG2' HD11 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -100.61 -15.28 17.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.579 -0.7 . . . . 0.0 110.642 179.71 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.3 t0 61.1 39.79 15.73 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.111 -0.993 . . . . 0.0 113.631 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.805 HD11 ' HG2' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -148.76 160.32 43.31 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.721 -1.237 . . . . 0.0 111.68 176.578 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 75' ' ' TYR . 2.2 t -137.6 159.47 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -140.29 137.98 8.73 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.602 -1.285 . . . . 0.0 110.513 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.958 ' CH2' HG21 ' A' ' 54' ' ' THR . 5.3 m-90 -111.79 157.92 19.99 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.845 -0.797 . . . . 0.0 109.701 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -68.32 115.08 7.35 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.609 -0.682 . . . . 0.0 109.974 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.593 ' HB3' ' O ' ' A' ' 50' ' ' GLY . . . -99.87 164.84 15.71 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.483 -0.761 . . . . 0.0 110.19 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.419 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 46.7 Cg_endo -72.42 139.55 31.88 Favored 'Trans proline' 0 C--N 1.317 -1.097 0 O-C-N 123.408 1.215 . . . . 0.0 110.299 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -76.77 160.11 34.49 Favored 'Trans proline' 0 C--N 1.319 -1.003 0 O-C-N 123.26 1.137 . . . . 0.0 110.439 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 70.03 29.82 70.39 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -109.03 168.12 9.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.49 -1.006 . . . . 0.0 110.055 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.8 mtm180 -59.98 138.54 57.82 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.583 -0.698 . . . . 0.0 110.248 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 78.9 p -132.95 152.05 51.97 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.545 -0.722 . . . . 0.0 110.372 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.518 HD21 ' HB2' ' A' ' 32' ' ' GLU . 81.2 mt -97.1 131.58 43.73 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.589 -0.695 . . . . 0.0 110.258 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 44.4 p -85.0 155.54 60.91 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.595 -0.691 . . . . 0.0 110.256 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.67 162.98 39.79 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 O-C-N 123.49 1.258 . . . . 0.0 110.428 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.8 t -82.37 131.23 35.23 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.557 -0.714 . . . . 0.0 110.187 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.2 m -135.77 56.3 1.83 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.596 -0.69 . . . . 0.0 110.088 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.7 p -145.25 6.08 1.12 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.456 -0.778 . . . . 0.0 112.029 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 51.44 51.06 39.03 Favored Glycine 0 N--CA 1.502 3.05 0 O-C-N 120.949 -1.095 . . . . 0.0 110.541 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.2 p -99.06 121.74 41.39 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.441 -1.035 . . . . 0.0 110.525 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 68.2 m -73.42 -40.08 64.52 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.627 -0.671 . . . . 0.0 110.247 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -65.5 131.42 46.36 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.618 -0.676 . . . . 0.0 110.22 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.599 HD22 HG21 ' A' ' 151' ' ' VAL . 95.6 mt -135.95 144.95 45.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.543 -0.723 . . . . 0.0 110.379 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -114.11 129.26 56.62 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.502 -0.749 . . . . 0.0 110.203 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.51 HD13 HD11 ' A' ' 143' ' ' LEU . 38.1 tp -105.41 140.08 39.06 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.572 -0.705 . . . . 0.0 110.228 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.9 t -91.83 121.89 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.6 -0.688 . . . . 0.0 109.76 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.415 HG22 ' H ' ' A' ' 109' ' ' ARG . 4.3 m -85.45 172.69 10.82 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.54 -0.725 . . . . 0.0 110.34 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.415 ' H ' HG22 ' A' ' 108' ' ' THR . 0.0 OUTLIER -59.9 -26.53 65.99 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.572 -0.705 . . . . 0.0 110.523 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -96.05 26.32 4.25 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.528 -0.732 . . . . 0.0 110.453 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 52.9 39.99 30.1 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.323 -0.861 . . . . 0.0 110.827 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -94.52 162.51 13.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.539 -0.725 . . . . 0.0 110.127 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 63.9 t -110.27 130.34 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.538 -0.726 . . . . 0.0 109.897 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.553 HG23 ' O ' ' A' ' 114' ' ' ILE . 4.0 tp -137.88 119.57 10.72 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.606 -0.684 . . . . 0.0 109.994 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -73.07 142.91 35.2 Favored 'Trans proline' 0 N--CA 1.486 1.069 0 O-C-N 123.074 1.039 . . . . 0.0 110.699 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.7 t -139.05 129.06 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.713 -0.617 . . . . 0.0 109.693 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -85.51 129.18 34.88 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.529 -0.732 . . . . 0.0 110.075 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -73.88 135.65 43.36 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.612 -0.68 . . . . 0.0 110.278 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -137.44 26.98 2.84 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.662 -0.649 . . . . 0.0 110.24 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.23 -179.54 43.77 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -70.08 -39.59 75.52 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.592 -0.946 . . . . 0.0 110.562 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 98.4 p -131.44 29.19 4.59 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.431 -0.793 . . . . 0.0 110.875 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.591 HH11 ' HB1' ' A' ' 166' ' ' ALA . 0.0 OUTLIER -148.12 160.29 43.05 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.435 -0.791 . . . . 0.0 110.333 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -160.16 -170.14 24.36 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 88.3 p -126.34 164.55 20.82 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.577 -0.955 . . . . 0.0 110.159 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 46.5 tp -119.99 126.37 50.68 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.586 -0.696 . . . . 0.0 110.183 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.415 HD12 ' H ' ' A' ' 127' ' ' LEU . 5.0 mp -59.83 -49.84 76.14 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.556 -0.715 . . . . 0.0 110.272 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.1 m -91.28 113.51 58.62 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.549 -0.72 . . . . 0.0 110.063 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.81 107.09 2.33 Favored 'Trans proline' 0 C--N 1.32 -0.939 0 O-C-N 123.153 1.081 . . . . 0.0 110.596 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.615 ' O ' ' HB3' ' A' ' 164' ' ' ALA . 81.8 mtt-85 -110.98 149.78 40.93 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.599 -0.688 . . . . 0.0 109.929 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.04 150.37 60.31 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.463 1.243 . . . . 0.0 110.89 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.449 HG21 ' SG ' ' A' ' 159' ' ' CYS . 39.3 t -51.92 -30.09 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.461 -0.774 . . . . 0.0 109.79 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.1 t -61.65 -41.03 96.94 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.626 -0.672 . . . . 0.0 111.222 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.441 ' CE2' ' HD3' ' A' ' 130' ' ' ARG . 86.7 t80 -67.69 -39.96 84.41 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.349 -0.844 . . . . 0.0 109.75 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 135' ' ' LEU . 23.9 tp -93.66 18.94 9.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.838 -0.539 . . . . 0.0 110.253 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -81.34 117.2 21.62 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.542 1.163 . . . . 0.0 112.757 -178.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.2 37.88 3.71 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.0 m -119.55 21.23 12.18 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.715 -0.873 . . . . 0.0 110.44 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.556 ' HB3' HG21 ' A' ' 55' ' ' VAL . 2.6 m -71.98 129.69 39.17 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.324 -0.86 . . . . 0.0 109.497 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 109.84 -24.4 19.4 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.82 110.69 2.28 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.34 149.11 56.38 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 O-C-N 123.234 1.123 . . . . 0.0 110.857 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.605 ' N ' HD12 ' A' ' 143' ' ' LEU . 6.6 mp -99.59 119.33 37.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.708 -0.62 . . . . 0.0 109.535 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.685 HD12 ' HA ' ' A' ' 150' ' ' ALA . 2.6 tp -105.82 120.91 42.92 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.582 -0.699 . . . . 0.0 110.775 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 26.9 p -64.36 163.34 26.23 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.72 -0.613 . . . . 0.0 109.697 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.09 -15.22 47.74 Favored 'Trans proline' 0 N--CA 1.487 1.118 0 O-C-N 123.245 1.129 . . . . 0.0 111.158 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.2 m -70.0 -27.09 64.41 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.264 -0.898 . . . . 0.0 110.084 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 107.84 43.14 1.35 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -144.7 158.65 43.69 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.497 -1.002 . . . . 0.0 110.267 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.685 ' HA ' HD12 ' A' ' 144' ' ' LEU . . . -78.04 148.49 34.29 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.578 -0.701 . . . . 0.0 110.318 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.599 HG21 HD22 ' A' ' 104' ' ' LEU . 59.4 t -119.17 -62.44 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.573 -0.704 . . . . 0.0 110.22 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -156.53 -158.03 8.64 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.6 mt -135.86 145.36 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.597 -0.943 . . . . 0.0 109.675 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.509 ' HB2' HD11 ' A' ' 106' ' ' LEU . 12.7 t80 -62.55 155.46 25.83 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.438 -0.789 . . . . 0.0 109.605 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 33.2 ttm-85 -140.38 -66.17 0.44 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.945 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -130.57 143.68 50.92 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.935 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.59 127.64 39.36 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.1 119.95 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.617 -0.677 . . . . 0.0 111.305 -177.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.449 ' SG ' HG21 ' A' ' 132' ' ' VAL . 27.7 p -141.26 158.98 43.16 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.497 -0.752 . . . . 0.0 110.508 178.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 11.0 m -91.18 -56.86 2.99 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.567 -0.708 . . . . 0.0 109.456 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.5 ptp85 -123.85 36.62 4.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.607 -0.683 . . . . 0.0 109.449 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 103.7 -11.46 53.41 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 63.1 t -92.46 124.23 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.219 -1.165 . . . . 0.0 109.132 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 130' ' ' ARG . . . -87.17 119.84 27.81 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.521 -0.737 . . . . 0.0 110.895 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 12.0 mtpp -110.15 -28.74 8.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.709 -0.619 . . . . 0.0 109.907 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.591 ' HB1' HH11 ' A' ' 123' ' ' ARG . . . -130.14 168.14 17.26 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.601 -0.687 . . . . 0.0 110.172 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.3 m -139.5 142.48 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.548 -0.72 . . . . 0.0 110.518 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -117.06 137.0 52.55 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.588 -0.695 . . . . 0.0 110.851 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -147.75 159.89 43.31 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.677 -0.64 . . . . 0.0 110.525 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.406 HG13 ' HD2' ' A' ' 171' ' ' PRO . 22.5 t -107.33 143.62 27.55 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 121.481 -0.762 . . . . 0.0 109.441 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.406 ' HD2' HG13 ' A' ' 170' ' ' VAL . 47.0 Cg_endo -74.35 -179.67 4.99 Favored 'Trans proline' 0 C--N 1.319 -0.985 0 O-C-N 123.336 1.177 . . . . 0.0 110.603 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 57.4 t -94.79 -27.87 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.623 -0.673 . . . . 0.0 110.025 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -59.95 -34.2 72.93 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.581 -0.699 . . . . 0.0 110.552 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 34.7 t -61.7 -31.31 71.45 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.546 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.455 ' CE ' ' CZ3' ' A' ' 53' ' ' TRP . 69.3 mmm -71.6 -27.37 63.07 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.443 -0.786 . . . . 0.0 110.564 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -56.8 -42.99 80.51 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.361 -0.837 . . . . 0.0 110.496 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 86.3 m -69.59 -40.11 76.88 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.471 -0.768 . . . . 0.0 109.684 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 91.0 m -71.68 -34.47 69.69 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.622 -0.674 . . . . 0.0 110.24 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 4.9 tmm? -60.06 -39.93 87.72 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.511 -0.743 . . . . 0.0 110.278 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -60.08 -39.9 87.71 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.527 -0.733 . . . . 0.0 110.132 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.911 0 O-C-N 121.619 -0.676 . . . . 0.0 110.169 179.841 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 . . . . . 0 N--CA 1.498 1.965 0 CA-C-O 121.062 0.458 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 97.8 t -139.3 140.03 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.569 -0.707 . . . . 0.0 109.808 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -133.62 151.49 51.7 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.535 -0.728 . . . . 0.0 110.201 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.434 ' HA ' HD22 ' A' ' 44' ' ' LEU . 91.0 t -93.79 119.45 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.616 -0.677 . . . . 0.0 110.087 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.1 p -134.07 130.07 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.488 -0.757 . . . . 0.0 109.824 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 66.8 m -116.89 155.15 29.56 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.646 -0.659 . . . . 0.0 110.312 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.514 HG22 ' H ' ' A' ' 39' ' ' ALA . 0.9 OUTLIER -116.38 -178.65 3.46 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.709 -0.619 . . . . 0.0 110.121 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.514 ' H ' HG22 ' A' ' 38' ' ' THR . . . -73.29 -25.47 60.68 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.308 -178.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.3 p -119.11 -28.27 5.51 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.312 -0.868 . . . . 0.0 111.19 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.1 pm0 -140.43 171.9 13.48 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.366 -0.834 . . . . 0.0 110.321 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.0 t -142.99 119.06 10.7 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.503 -0.748 . . . . 0.0 110.658 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.452 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 3.4 p90 -128.31 177.69 6.78 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.574 -0.704 . . . . 0.0 109.692 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.434 HD22 ' HA ' ' A' ' 35' ' ' VAL . 54.7 mt -115.83 160.48 20.1 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.504 -0.747 . . . . 0.0 110.052 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -129.64 153.96 47.59 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.39 -0.819 . . . . 0.0 110.504 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.5 p -130.98 144.08 51.21 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.636 -0.665 . . . . 0.0 110.099 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 28.4 p -93.99 121.41 35.43 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.509 -0.744 . . . . 0.0 110.564 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.4 t -130.34 136.66 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.388 -0.82 . . . . 0.0 110.412 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 43.59 34.32 0.79 Allowed 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.573 ' O ' ' HB3' ' A' ' 87' ' ' ALA . . . 89.66 -24.23 15.81 Favored Glycine 0 N--CA 1.497 2.74 0 C-N-CA 120.279 -0.962 . . . . 0.0 111.264 178.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 62.8 t -107.5 129.56 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.179 -1.189 . . . . 0.0 110.073 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -82.45 131.49 35.22 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.653 -0.654 . . . . 0.0 109.955 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.681 ' CE3' HD23 ' A' ' 82' ' ' LEU . 90.5 m95 -117.15 137.83 52.06 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.528 -0.733 . . . . 0.0 110.738 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.751 HG23 HG23 ' A' ' 83' ' ' VAL . 10.0 t -136.6 -179.1 5.48 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.722 -0.611 . . . . 0.0 109.752 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.63 HG11 ' CE1' ' A' ' 57' ' ' HIS . 18.0 t -80.32 142.29 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.542 -0.724 . . . . 0.0 109.465 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.894 ' CE2' HG22 ' A' ' 78' ' ' VAL . 7.8 t80 -84.86 -42.61 14.91 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.633 -0.667 . . . . 0.0 110.875 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.63 ' CE1' HG11 ' A' ' 55' ' ' VAL . 1.1 p-80 -55.77 -20.55 15.29 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.256 -0.903 . . . . 0.0 111.161 -177.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -73.65 -63.92 2.61 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 108.354 -1.899 . . . . 0.0 108.354 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.83 -63.51 1.29 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.563 -0.963 . . . . 0.0 109.568 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.548 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 178.919 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.9 m . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 120.948 0.404 . . . . 0.0 109.953 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -96.31 146.21 24.92 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.502 -0.749 . . . . 0.0 110.312 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.408 ' HG3' ' CD2' ' A' ' 75' ' ' TYR . 19.4 ptp -119.22 -38.53 3.02 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.575 -0.703 . . . . 0.0 110.625 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.5 ' O ' HG12 ' A' ' 83' ' ' VAL . 31.6 m-85 -112.4 120.46 41.74 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.301 -0.874 . . . . 0.0 109.752 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.529 ' HA ' HG12 ' A' ' 83' ' ' VAL . 85.6 m -148.53 130.13 14.96 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.471 -0.768 . . . . 0.0 110.331 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -167.28 117.99 0.87 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.411 -0.806 . . . . 0.0 111.532 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.894 HG22 ' CE2' ' A' ' 56' ' ' TYR . 73.7 t -72.59 -35.09 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.37 -0.831 . . . . 0.0 109.523 178.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -55.71 -35.48 66.14 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.425 -0.797 . . . . 0.0 110.225 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -106.82 -8.02 16.93 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.624 -0.673 . . . . 0.0 110.659 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.462 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 30.9 t0 53.0 43.28 31.93 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.085 -1.009 . . . . 0.0 110.431 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.681 HD23 ' CE3' ' A' ' 53' ' ' TRP . 0.6 OUTLIER -133.15 140.88 47.84 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.928 0.871 . . . . 0.0 111.836 -178.783 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.751 HG23 HG23 ' A' ' 54' ' ' THR . 1.0 OUTLIER -145.65 154.13 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.762 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -162.97 170.6 38.52 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.783 -1.199 . . . . 0.0 110.344 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -136.58 167.78 20.74 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.884 -0.774 . . . . 0.0 109.062 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -78.53 122.29 25.69 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.618 -0.677 . . . . 0.0 110.27 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.677 ' HB1' ' HD2' ' A' ' 88' ' ' PRO . . . -88.58 173.76 5.84 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.523 -0.735 . . . . 0.0 110.101 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.677 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 45.7 Cg_endo -72.31 142.6 37.65 Favored 'Trans proline' 0 C--N 1.317 -1.124 0 O-C-N 123.396 1.208 . . . . 0.0 110.362 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -76.12 154.38 37.26 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.378 1.199 . . . . 0.0 110.413 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.42 -28.73 14.08 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.74 143.74 45.98 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.522 -0.987 . . . . 0.0 110.223 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.8 ptt-85 -79.28 159.99 27.01 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.579 -0.701 . . . . 0.0 110.288 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.0 m -125.3 159.21 32.27 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.596 -0.69 . . . . 0.0 110.268 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.99 147.12 39.05 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.518 -0.739 . . . . 0.0 110.152 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.414 HG23 ' HD2' ' A' ' 96' ' ' PRO . 86.0 m -91.4 144.0 29.04 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.626 -0.671 . . . . 0.0 110.103 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.414 ' HD2' HG23 ' A' ' 95' ' ' THR . 45.0 Cg_endo -71.54 166.1 30.45 Favored 'Trans proline' 0 C--N 1.318 -1.056 0 O-C-N 123.259 1.137 . . . . 0.0 110.398 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.464 ' HB2' HG22 ' A' ' 151' ' ' VAL . 46.7 t -65.84 140.02 58.35 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.503 -0.748 . . . . 0.0 110.353 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.8 m -134.38 38.52 3.11 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.654 -0.654 . . . . 0.0 110.029 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.8 p -144.78 -8.31 0.64 Allowed 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 119.981 -0.688 . . . . 0.0 112.368 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 55.65 34.62 60.76 Favored Glycine 0 N--CA 1.5 2.91 0 O-C-N 120.769 -1.207 . . . . 0.0 110.322 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 52.4 p -74.6 159.9 31.54 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.366 -1.079 . . . . 0.0 110.339 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.7 m -95.8 -33.51 12.23 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.635 -0.665 . . . . 0.0 110.302 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -70.29 120.83 16.54 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.503 -0.748 . . . . 0.0 110.112 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.475 HD22 HG21 ' A' ' 151' ' ' VAL . 58.5 mt -130.86 149.95 52.25 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.578 -0.702 . . . . 0.0 110.4 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -115.16 131.01 57.07 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.62 -0.675 . . . . 0.0 109.587 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.421 HD13 ' HG ' ' A' ' 143' ' ' LEU . 36.8 tp -111.83 143.48 42.7 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.48 -0.763 . . . . 0.0 110.58 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 63.3 t -104.61 129.07 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.679 -0.638 . . . . 0.0 109.392 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 70.1 p -104.35 169.38 8.51 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.475 -0.766 . . . . 0.0 110.852 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.409 ' NH1' ' CG1' ' A' ' 35' ' ' VAL . 16.2 tpt180 -59.99 -21.96 61.95 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.64 -0.662 . . . . 0.0 110.264 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -90.85 20.03 5.1 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.336 -0.852 . . . . 0.0 111.019 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 52.21 36.58 19.69 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.208 -0.932 . . . . 0.0 110.878 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -101.14 149.63 23.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.63 -0.669 . . . . 0.0 110.055 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 62.0 t -109.96 128.73 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.644 -0.66 . . . . 0.0 110.044 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 35.7 pt -138.55 138.91 23.06 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.634 -0.666 . . . . 0.0 110.139 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -79.61 151.6 22.38 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 O-C-N 123.289 1.152 . . . . 0.0 110.495 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.7 t -137.55 134.9 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.605 -0.684 . . . . 0.0 109.92 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 8.4 tpp180 -92.2 135.41 34.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.576 -0.703 . . . . 0.0 110.068 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 54.3 ttt180 -81.34 128.58 33.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.574 -0.703 . . . . 0.0 110.193 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.53 20.63 6.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.651 -0.656 . . . . 0.0 109.811 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 168.28 170.82 33.47 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -60.27 -50.05 75.19 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.499 -1.0 . . . . 0.0 110.032 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 53.1 m -114.75 -15.16 11.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.563 -0.71 . . . . 0.0 110.71 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.576 ' NH2' HG21 ' A' ' 158' ' ' VAL . 0.2 OUTLIER -95.61 136.99 35.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.435 -0.791 . . . . 0.0 110.016 -179.88 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -140.72 178.92 19.68 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 88.6 p -132.26 165.02 25.11 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.586 -0.95 . . . . 0.0 110.198 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 38.5 tp -121.18 138.23 54.31 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.503 -0.748 . . . . 0.0 110.218 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.556 ' N ' HD12 ' A' ' 127' ' ' LEU . 8.5 mp -68.77 -54.85 13.57 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.516 -0.74 . . . . 0.0 110.03 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.1 p -92.41 109.32 37.4 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.581 -0.699 . . . . 0.0 109.809 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -75.11 120.57 6.08 Favored 'Trans proline' 0 C--N 1.319 -0.978 0 O-C-N 123.223 1.118 . . . . 0.0 111.168 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.605 ' O ' ' HB3' ' A' ' 164' ' ' ALA . 94.1 mtm-85 -121.06 154.97 58.36 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.649 -0.657 . . . . 0.0 109.603 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -68.09 150.3 77.27 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 O-C-N 123.282 1.148 . . . . 0.0 111.141 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.447 HG21 ' SG ' ' A' ' 159' ' ' CYS . 40.6 t -53.43 -29.91 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 121.511 -0.743 . . . . 0.0 109.773 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.4 t -59.9 -41.57 91.94 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.659 -0.651 . . . . 0.0 111.23 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.42 ' CD2' ' HD2' ' A' ' 130' ' ' ARG . 83.6 t80 -68.16 -40.0 82.44 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.347 -0.845 . . . . 0.0 109.779 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 135' ' ' LEU . 31.5 tp -92.71 18.2 9.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.787 -0.571 . . . . 0.0 110.122 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -81.92 115.01 20.9 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 122.567 1.175 . . . . 0.0 112.078 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.78 28.92 6.76 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 58.1 m -110.66 20.04 18.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.57 -0.959 . . . . 0.0 110.546 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.8 m -65.64 145.18 56.36 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.268 -0.895 . . . . 0.0 109.487 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 95.9 -21.66 43.74 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.04 109.76 1.64 Allowed Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -75.69 150.63 35.52 Favored 'Trans proline' 0 C--N 1.32 -0.927 0 O-C-N 123.203 1.107 . . . . 0.0 111.036 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.421 ' HG ' HD13 ' A' ' 106' ' ' LEU . 5.0 mp -100.72 111.5 23.74 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 150' ' ' ALA . 2.2 tp -97.04 140.1 32.07 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.528 -0.732 . . . . 0.0 110.758 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -76.12 174.57 5.4 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.657 -0.652 . . . . 0.0 109.785 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.05 -28.63 28.42 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 O-C-N 123.368 1.193 . . . . 0.0 110.235 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 83.8 p -70.36 -35.35 73.5 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.573 -0.704 . . . . 0.0 110.108 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 118.88 38.95 0.73 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 58.3 m170 -124.53 137.37 54.42 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.541 -0.976 . . . . 0.0 110.403 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.434 ' HA ' HD12 ' A' ' 144' ' ' LEU . . . -65.4 140.04 58.6 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.523 -0.736 . . . . 0.0 110.148 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.475 HG21 HD22 ' A' ' 104' ' ' LEU . 62.1 t -111.29 -55.99 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.614 -0.679 . . . . 0.0 110.146 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -161.83 -165.25 18.39 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 83.3 mt -131.31 143.71 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.664 -0.903 . . . . 0.0 109.778 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -61.57 147.34 45.91 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.429 -0.795 . . . . 0.0 110.07 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.94 -71.21 0.64 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.597 0.713 . . . . 0.0 110.104 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -126.27 144.57 50.74 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 121.794 0.807 . . . . 0.0 111.269 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.49 128.52 39.63 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.576 HG21 ' NH2' ' A' ' 123' ' ' ARG . 2.4 t -99.02 120.47 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.531 -0.731 . . . . 0.0 111.671 -177.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.447 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.2 p -141.29 136.9 32.06 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.507 -0.746 . . . . 0.0 110.622 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 87.1 m -71.28 -42.52 68.64 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.546 -0.721 . . . . 0.0 109.92 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -140.86 49.54 1.68 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.575 -0.703 . . . . 0.0 110.075 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 89.99 -11.64 70.07 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 61.7 t -94.66 120.44 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.245 -1.15 . . . . 0.0 108.925 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 130' ' ' ARG . . . -87.45 117.49 26.28 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.632 -0.668 . . . . 0.0 111.074 -178.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -113.19 -26.23 8.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.751 -0.593 . . . . 0.0 110.008 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -125.98 168.45 13.91 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.485 -0.759 . . . . 0.0 110.394 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 35.3 m -144.73 135.81 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.542 -0.724 . . . . 0.0 110.48 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -112.94 133.87 54.71 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.411 -0.806 . . . . 0.0 110.954 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -147.04 162.32 39.04 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.67 -0.644 . . . . 0.0 110.366 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 4.1 m -104.23 145.21 30.23 Favored Pre-proline 0 N--CA 1.505 2.291 0 O-C-N 121.449 -0.782 . . . . 0.0 110.456 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -75.33 -171.82 1.12 Allowed 'Trans proline' 0 C--N 1.319 -1.019 0 O-C-N 123.436 1.23 . . . . 0.0 109.83 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 57.3 t -87.39 -23.26 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.595 -0.69 . . . . 0.0 110.417 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -61.69 -30.31 70.66 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.412 -0.805 . . . . 0.0 111.28 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 9.5 t -62.67 -24.46 67.64 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.161 -0.962 . . . . 0.0 110.687 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.427 ' HG2' ' CD2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -80.73 -28.25 36.62 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.487 -0.758 . . . . 0.0 111.15 -179.457 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -59.94 -44.62 94.26 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.433 -0.792 . . . . 0.0 110.551 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 90.0 m -69.9 -39.94 75.93 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.433 -0.792 . . . . 0.0 110.492 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 58.9 m -67.77 -31.85 72.03 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.543 -0.723 . . . . 0.0 110.679 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.8 -38.27 81.45 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.377 -0.827 . . . . 0.0 110.556 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -59.92 -39.96 87.22 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.443 -0.785 . . . . 0.0 110.374 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.803 0 O-C-N 121.499 -0.751 . . . . 0.0 110.148 179.871 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.467 ' CB ' HD11 ' A' ' 94' ' ' LEU . 2.8 pp20? . . . . . 0 N--CA 1.497 1.921 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.794 HG22 HD23 ' A' ' 44' ' ' LEU . 11.3 p -135.0 128.52 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.089 -1.007 . . . . 0.0 109.895 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -107.52 134.56 50.36 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.671 -0.643 . . . . 0.0 110.413 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.2 m -72.54 147.74 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.615 -0.678 . . . . 0.0 110.096 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.5 t -124.9 145.92 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.562 -0.712 . . . . 0.0 109.74 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.6 t -115.85 126.67 54.27 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.656 -0.652 . . . . 0.0 110.36 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.482 HG22 ' H ' ' A' ' 39' ' ' ALA . 2.3 m -113.92 175.57 5.41 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.578 -0.701 . . . . 0.0 110.012 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.482 ' H ' HG22 ' A' ' 38' ' ' THR . . . -77.01 -13.96 59.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.668 -0.645 . . . . 0.0 111.326 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 77.5 p -121.25 -28.21 4.73 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.173 -0.954 . . . . 0.0 111.424 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -154.42 175.86 13.05 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.278 -0.888 . . . . 0.0 110.95 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.5 t -135.91 122.82 21.3 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.71 -0.619 . . . . 0.0 109.935 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -127.78 -169.61 2.09 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.504 -0.748 . . . . 0.0 110.368 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.794 HD23 HG22 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -116.41 167.83 10.69 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.574 -0.704 . . . . 0.0 110.491 -179.455 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.661 ' O ' HG23 ' A' ' 33' ' ' VAL . . . -140.61 140.71 35.12 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.604 -0.685 . . . . 0.0 110.151 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.408 HG21 ' HB3' ' A' ' 142' ' ' PRO . 67.7 p -119.26 138.62 52.88 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.428 -0.795 . . . . 0.0 110.057 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.1 t -101.14 115.09 29.68 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.541 -0.725 . . . . 0.0 110.596 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.0 t -129.98 127.1 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.457 -0.777 . . . . 0.0 110.159 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 64.8 t30 53.16 40.21 30.88 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.455 -0.778 . . . . 0.0 111.045 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.01 21.5 71.67 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.507 HG12 ' NE1' ' A' ' 53' ' ' TRP . 62.9 t -130.21 113.75 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.399 -1.059 . . . . 0.0 109.463 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.2 t -82.98 133.02 35.12 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.593 -0.692 . . . . 0.0 109.906 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.507 ' NE1' HG12 ' A' ' 51' ' ' VAL . 92.9 m95 -119.95 136.39 54.55 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.492 -0.755 . . . . 0.0 111.094 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.665 HG22 ' O ' ' A' ' 83' ' ' VAL . 6.5 t -137.71 -179.92 6.04 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.918 HG11 ' CE1' ' A' ' 57' ' ' HIS . 47.2 t -92.39 147.56 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.294 -0.879 . . . . 0.0 109.979 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.89 ' CE2' HG22 ' A' ' 78' ' ' VAL . 21.6 t80 -84.15 -43.45 14.98 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.539 -0.726 . . . . 0.0 111.407 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.918 ' CE1' HG11 ' A' ' 55' ' ' VAL . 1.5 p-80 -52.38 -25.91 11.08 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.116 -0.99 . . . . 0.0 111.114 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.431 ' N ' ' CD2' ' A' ' 57' ' ' HIS . . . -89.59 -55.99 1.95 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.24 -63.38 1.41 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.527 -0.984 . . . . 0.0 110.334 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.433 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.961 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 64.6 p . . . . . 0 N--CA 1.498 1.938 0 CA-C-O 121.221 0.534 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -82.66 119.95 24.94 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.578 -0.701 . . . . 0.0 110.086 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.2 mtp -83.97 -51.15 7.37 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.526 -0.734 . . . . 0.0 110.473 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.467 ' CD2' ' N ' ' A' ' 75' ' ' TYR . 1.2 p90 -122.54 130.09 52.66 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.672 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.939 ' HA ' HG12 ' A' ' 83' ' ' VAL . 57.0 m -135.28 141.1 45.63 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.659 -0.651 . . . . 0.0 110.501 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -161.34 120.92 2.57 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.234 -0.916 . . . . 0.0 112.133 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.89 HG22 ' CE2' ' A' ' 56' ' ' TYR . 54.2 t -72.88 -39.11 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.295 -0.878 . . . . 0.0 109.34 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -55.54 -43.04 75.45 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.389 -0.82 . . . . 0.0 110.369 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.708 ' HB3' HD22 ' A' ' 82' ' ' LEU . 3.3 tp60 -90.92 -9.68 45.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.608 -0.683 . . . . 0.0 110.485 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.416 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 37.5 t0 52.47 42.0 31.09 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.088 -1.007 . . . . 0.0 111.54 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 1.062 HD21 HG21 ' A' ' 178' ' ' THR . 0.3 OUTLIER -148.58 143.1 26.37 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.173 -0.954 . . . . 0.0 111.123 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.939 HG12 ' HA ' ' A' ' 76' ' ' THR . 28.4 m -145.18 144.08 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.448 ' N ' ' CE1' ' A' ' 75' ' ' TYR . . . -142.61 156.83 26.46 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.571 -1.3 . . . . 0.0 110.347 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.49 ' CH2' HG21 ' A' ' 54' ' ' THR . 3.6 m-90 -113.63 168.11 10.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.901 -0.764 . . . . 0.0 109.331 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -87.29 100.62 12.84 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.494 -0.754 . . . . 0.0 109.299 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.08 158.88 82.6 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.636 -0.665 . . . . 0.0 110.461 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.43 160.13 49.49 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.523 1.275 . . . . 0.0 110.299 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.49 151.01 52.69 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 O-C-N 123.402 1.212 . . . . 0.0 110.283 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.34 -23.72 34.28 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.13 152.76 23.55 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.336 -1.096 . . . . 0.0 110.291 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -70.25 148.01 49.08 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.561 -0.712 . . . . 0.0 110.244 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 80.0 p -126.7 149.71 49.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.58 -0.7 . . . . 0.0 110.093 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.467 HD11 ' CB ' ' A' ' 32' ' ' GLU . 6.6 mt -109.79 157.4 19.2 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.541 -0.725 . . . . 0.0 110.548 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.43 HG23 ' HD2' ' A' ' 96' ' ' PRO . 89.7 m -98.16 144.4 27.99 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.701 -0.625 . . . . 0.0 109.727 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.43 ' HD2' HG23 ' A' ' 95' ' ' THR . 43.5 Cg_endo -69.48 160.47 49.67 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.256 1.135 . . . . 0.0 110.407 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 45.2 t -60.02 134.64 57.23 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.587 -0.695 . . . . 0.0 110.445 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 21.6 m -136.1 48.29 2.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.673 -0.642 . . . . 0.0 109.977 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.9 p -144.89 -8.31 0.63 Allowed 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 119.949 -0.701 . . . . 0.0 112.383 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.68 72.01 0.61 Allowed Glycine 0 N--CA 1.5 2.928 0 O-C-N 120.766 -1.209 . . . . 0.0 110.288 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.0 m -125.09 129.98 51.31 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.522 -0.987 . . . . 0.0 110.471 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.7 m -67.19 -39.95 86.47 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.492 -0.755 . . . . 0.0 110.138 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -60.17 131.75 51.79 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.589 -0.694 . . . . 0.0 110.356 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.708 HD22 HG11 ' A' ' 151' ' ' VAL . 88.3 mt -136.36 160.21 39.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.646 -0.658 . . . . 0.0 110.153 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -122.98 109.45 14.13 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.477 -0.764 . . . . 0.0 110.246 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.653 ' O ' HG11 ' A' ' 113' ' ' VAL . 21.1 tp -74.17 148.14 41.96 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.708 -0.62 . . . . 0.0 109.837 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.454 HG21 HD23 ' A' ' 144' ' ' LEU . 61.0 t -126.28 119.99 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.289 -0.882 . . . . 0.0 110.244 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.887 HG23 HG13 ' A' ' 113' ' ' VAL . 53.0 p -91.36 -164.93 1.25 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.264 -0.898 . . . . 0.0 110.076 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.26 -18.99 24.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.522 -0.736 . . . . 0.0 111.229 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.428 ' O ' ' CG ' ' A' ' 110' ' ' HIS . 4.5 t60 -109.65 29.4 7.62 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.259 -0.9 . . . . 0.0 110.666 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 57.47 33.62 23.52 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.301 -0.874 . . . . 0.0 112.063 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.784 ' O ' HG13 ' A' ' 113' ' ' VAL . 7.0 p-10 -119.39 134.01 55.43 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.285 -0.884 . . . . 0.0 109.727 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.887 HG13 HG23 ' A' ' 108' ' ' THR . 0.0 OUTLIER -176.37 -173.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.425 0 CA-C-O 121.853 0.835 . . . . 0.0 111.143 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.407 ' CG1' ' HD2' ' A' ' 115' ' ' PRO . 0.0 OUTLIER -152.19 168.8 10.58 Favored Pre-proline 0 N--CA 1.49 1.568 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.445 ' O ' HD13 ' A' ' 127' ' ' LEU . 43.0 Cg_endo -70.36 145.12 52.77 Favored 'Trans proline' 0 C--N 1.317 -1.106 0 O-C-N 123.217 1.114 . . . . 0.0 110.066 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.615 HG13 ' O ' ' A' ' 125' ' ' SER . 57.3 t -126.91 130.0 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.569 -0.707 . . . . 0.0 110.116 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.9 mmm180 -83.28 132.39 35.03 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.487 -0.758 . . . . 0.0 110.053 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 49.6 ttm-85 -65.96 133.27 50.49 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.535 -0.728 . . . . 0.0 110.242 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -116.49 -22.44 8.72 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.622 -0.674 . . . . 0.0 110.478 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -155.93 -167.33 17.21 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -70.09 -39.95 75.27 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.598 -0.942 . . . . 0.0 110.565 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 36.9 p -129.9 26.46 5.24 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.396 -0.815 . . . . 0.0 110.801 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.48 152.61 41.7 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.511 -0.743 . . . . 0.0 110.181 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -149.19 -179.98 25.51 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.615 ' O ' HG13 ' A' ' 116' ' ' VAL . 78.0 p -120.0 151.5 38.88 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.703 -0.881 . . . . 0.0 110.217 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.0 tp -100.0 129.88 46.11 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.653 -0.655 . . . . 0.0 110.195 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.445 HD13 ' O ' ' A' ' 115' ' ' PRO . 4.3 mp -61.91 -53.91 49.17 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.581 -0.699 . . . . 0.0 110.404 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.6 t -95.28 129.91 33.87 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.561 -0.712 . . . . 0.0 110.124 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -79.27 106.85 2.1 Favored 'Trans proline' 0 C--N 1.32 -0.97 0 O-C-N 123.175 1.092 . . . . 0.0 110.673 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.418 ' HD2' ' CD2' ' A' ' 134' ' ' TYR . 4.6 mtm180 -114.21 149.91 42.81 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.599 -0.688 . . . . 0.0 109.636 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.36 150.31 70.52 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 123.317 1.167 . . . . 0.0 111.153 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.775 HG12 ' CE ' ' A' ' 136' ' ' LYS . 66.0 t -52.85 -29.26 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.501 -0.749 . . . . 0.0 109.81 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.93 -43.26 95.05 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.605 -0.685 . . . . 0.0 111.279 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.418 ' CD2' ' HD2' ' A' ' 130' ' ' ARG . 88.9 t80 -65.89 -40.01 91.18 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.358 -0.838 . . . . 0.0 109.619 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.42 ' HA ' HD12 ' A' ' 135' ' ' LEU . 21.8 tp -93.26 18.87 8.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.926 -0.484 . . . . 0.0 110.278 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.775 ' CE ' HG12 ' A' ' 132' ' ' VAL . 8.4 ttmt -82.47 116.64 22.01 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 122.523 1.154 . . . . 0.0 112.514 -178.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.97 30.14 6.18 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.0 m -110.57 20.26 17.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.687 -0.89 . . . . 0.0 110.353 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.7 m -76.44 141.81 41.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.311 -0.868 . . . . 0.0 109.557 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.467 ' C ' HG23 ' A' ' 153' ' ' ILE . . . 95.91 -26.62 19.74 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.84 128.35 44.83 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 108.911 -1.675 . . . . 0.0 108.911 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.408 ' HB3' HG21 ' A' ' 46' ' ' THR . 48.4 Cg_endo -75.05 172.54 16.16 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 O-C-N 123.201 1.106 . . . . 0.0 111.142 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.916 ' O ' HG12 ' A' ' 151' ' ' VAL . 3.3 mp -117.68 115.61 25.41 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.455 HD22 ' N ' ' A' ' 144' ' ' LEU . 4.5 mm? -90.09 152.37 21.17 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.701 -0.624 . . . . 0.0 111.017 -178.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.407 ' CB ' ' HD2' ' A' ' 146' ' ' PRO . 0.1 OUTLIER -93.95 179.28 1.28 Allowed Pre-proline 0 N--CA 1.494 1.733 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.375 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.407 ' HD2' ' CB ' ' A' ' 145' ' ' CYS . 43.0 Cg_endo -69.63 -26.62 27.99 Favored 'Trans proline' 0 C--N 1.318 -1.069 0 O-C-N 123.202 1.106 . . . . 0.0 110.319 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 66.2 m -79.41 -29.06 41.8 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.519 -0.738 . . . . 0.0 110.043 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 113.43 50.26 0.54 Allowed Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 43.7 m80 -135.77 148.06 48.63 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.517 -0.99 . . . . 0.0 110.288 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -76.1 136.94 39.86 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.537 -0.727 . . . . 0.0 110.051 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.916 HG12 ' O ' ' A' ' 143' ' ' LEU . 13.0 p -119.06 -24.45 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.559 -0.713 . . . . 0.0 110.878 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 176.6 -167.74 39.38 Favored Glycine 0 N--CA 1.498 2.784 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.29 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.556 HD12 ' CE ' ' A' ' 175' ' ' MET . 71.8 mt -130.38 158.88 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.598 -0.942 . . . . 0.0 109.833 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -75.84 151.64 37.42 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.454 -0.779 . . . . 0.0 109.918 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.646 ' CZ ' HG21 ' A' ' 170' ' ' VAL . 30.7 ttm180 -131.83 -76.41 0.51 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.572 -0.705 . . . . 0.0 110.797 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -122.46 143.68 49.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.086 -1.009 . . . . 0.0 111.406 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.65 127.87 39.55 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.5 t -97.67 117.98 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 O-C-N 121.506 -0.746 . . . . 0.0 111.673 -177.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.429 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.9 p -141.07 148.72 40.63 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.371 -0.831 . . . . 0.0 110.672 178.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 63.7 m -85.56 -50.14 7.47 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.448 -0.782 . . . . 0.0 109.72 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.75 32.79 5.61 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.74 -0.6 . . . . 0.0 109.608 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 101.44 -11.69 58.23 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 63.4 t -89.51 120.92 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.223 -1.163 . . . . 0.0 108.991 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -86.97 113.25 22.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.644 -0.66 . . . . 0.0 110.975 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -108.52 -26.23 10.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.787 -0.571 . . . . 0.0 109.862 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -121.27 164.02 17.65 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.47 -0.769 . . . . 0.0 109.952 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 167' ' ' VAL . 35.0 m -141.81 131.1 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.534 -0.729 . . . . 0.0 110.659 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -103.83 129.67 51.32 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.477 -0.765 . . . . 0.0 110.709 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -142.65 162.17 36.18 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.568 -0.708 . . . . 0.0 110.188 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.646 HG21 ' CZ ' ' A' ' 155' ' ' ARG . 86.1 t -111.93 144.93 31.7 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.427 -0.796 . . . . 0.0 110.089 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.474 ' HD2' HG13 ' A' ' 170' ' ' VAL . 45.9 Cg_endo -71.95 175.2 10.09 Favored 'Trans proline' 0 N--CA 1.486 1.061 0 O-C-N 123.319 1.168 . . . . 0.0 110.984 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 151' ' ' VAL . 59.4 t -79.42 -41.41 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.657 -0.652 . . . . 0.0 110.153 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -54.41 -36.32 63.84 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.835 -0.541 . . . . 0.0 111.045 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.435 ' O ' HG22 ' A' ' 177' ' ' THR . 45.2 t -61.84 -33.71 74.66 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.485 -0.76 . . . . 0.0 109.906 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.556 ' CE ' HD12 ' A' ' 153' ' ' ILE . 67.2 mtt -70.05 -27.94 65.05 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.595 -0.69 . . . . 0.0 110.446 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -59.5 -50.09 75.28 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.495 -0.753 . . . . 0.0 110.64 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.435 HG22 ' O ' ' A' ' 174' ' ' SER . 7.1 t -69.98 -22.54 63.14 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.516 -0.74 . . . . 0.0 110.825 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' THR . . . . . 1.062 HG21 HD21 ' A' ' 82' ' ' LEU . 68.4 m -68.68 -29.08 67.46 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.439 -0.788 . . . . 0.0 110.53 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 91.1 mtp -59.98 -48.49 81.48 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.476 -0.765 . . . . 0.0 110.257 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -59.91 -40.07 87.55 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.606 -0.684 . . . . 0.0 110.315 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.792 0 O-C-N 121.65 -0.656 . . . . 0.0 110.188 -179.961 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.729 ' HG2' HD21 ' A' ' 94' ' ' LEU . 26.1 mp0 . . . . . 0 N--CA 1.501 2.124 0 CA-C-O 120.79 0.328 . . . . 0.0 111.221 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.472 HG11 ' CD ' ' A' ' 142' ' ' PRO . 27.4 m -132.77 160.06 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.483 -0.76 . . . . 0.0 109.83 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.547 ' O ' HD23 ' A' ' 44' ' ' LEU . 9.9 pt20 -143.42 126.53 16.46 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.615 -0.678 . . . . 0.0 110.24 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.0 m -74.39 145.54 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.506 -0.746 . . . . 0.0 109.934 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.72 HG22 ' O ' ' A' ' 43' ' ' PHE . 33.6 m -136.0 148.07 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.444 -0.785 . . . . 0.0 110.19 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.8 m -116.41 126.09 52.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.613 -0.68 . . . . 0.0 110.412 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.502 HG22 ' H ' ' A' ' 39' ' ' ALA . 0.3 OUTLIER -101.52 -171.01 1.91 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.624 -0.672 . . . . 0.0 109.455 179.682 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.502 ' H ' HG22 ' A' ' 38' ' ' THR . . . -60.08 -51.74 68.32 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.77 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.1 t -128.02 10.78 6.47 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.468 -0.77 . . . . 0.0 111.529 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -148.29 161.24 41.92 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.135 -0.978 . . . . 0.0 110.603 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 81.2 p -143.3 125.71 15.7 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.547 -0.72 . . . . 0.0 110.144 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.72 ' O ' HG22 ' A' ' 36' ' ' VAL . 27.5 p90 -129.45 -169.69 2.15 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.638 -0.664 . . . . 0.0 110.252 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.547 HD23 ' O ' ' A' ' 34' ' ' GLN . 3.1 mt -126.13 164.49 20.79 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.617 -0.677 . . . . 0.0 110.43 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -138.65 140.33 38.83 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.588 -0.695 . . . . 0.0 110.16 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.7 m -115.01 127.86 55.92 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.528 -0.732 . . . . 0.0 110.096 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.554 ' O ' HD12 ' A' ' 94' ' ' LEU . 26.7 p -75.62 117.02 16.94 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.569 -0.707 . . . . 0.0 110.773 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.7 t -130.29 123.95 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.33 -0.856 . . . . 0.0 110.436 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 50.74 34.06 9.4 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.568 -0.708 . . . . 0.0 111.764 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 87' ' ' ALA . . . 88.76 -24.23 13.49 Favored Glycine 0 N--CA 1.498 2.778 0 C-N-CA 120.365 -0.921 . . . . 0.0 111.216 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.7 t -106.53 113.94 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.155 -1.203 . . . . 0.0 109.781 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 27.5 p -71.12 154.49 41.69 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.438 -0.789 . . . . 0.0 110.259 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.567 ' CE3' HD23 ' A' ' 82' ' ' LEU . 79.0 m95 -124.36 137.06 54.51 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.606 -0.684 . . . . 0.0 110.779 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.951 HG21 ' CH2' ' A' ' 85' ' ' TRP . 7.5 t -136.99 -179.97 6.02 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.738 -0.601 . . . . 0.0 109.888 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.911 HG21 ' HB3' ' A' ' 139' ' ' SER . 62.4 t -85.41 142.01 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.608 -0.682 . . . . 0.0 109.547 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.903 ' CE2' HG22 ' A' ' 78' ' ' VAL . 25.3 t80 -85.2 -44.04 13.27 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.495 -0.753 . . . . 0.0 111.031 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.625 ' CE1' HG11 ' A' ' 55' ' ' VAL . 2.3 p-80 -60.68 -20.15 60.25 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.025 -177.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -92.71 -54.49 1.78 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.15 -47.64 19.82 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.49 -1.006 . . . . 0.0 110.58 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.412 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.801 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 t . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 121.154 0.502 . . . . 0.0 110.541 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.461 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -77.44 124.96 28.58 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.588 -0.695 . . . . 0.0 110.502 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 8.2 ttt -82.78 -52.77 6.44 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.368 -0.832 . . . . 0.0 109.795 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.606 ' O ' HG13 ' A' ' 83' ' ' VAL . 12.1 p90 -147.08 139.91 25.05 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.294 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.493 HG22 HG13 ' A' ' 83' ' ' VAL . 81.7 p -130.52 140.41 50.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.724 -0.61 . . . . 0.0 109.711 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -159.67 120.74 3.17 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.253 -0.904 . . . . 0.0 111.033 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.903 HG22 ' CE2' ' A' ' 56' ' ' TYR . 99.0 t -72.22 -35.6 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.411 -0.806 . . . . 0.0 109.769 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -55.87 -35.71 66.8 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.46 -0.775 . . . . 0.0 110.275 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 31.9 tp60 -102.55 -13.79 17.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.736 -0.603 . . . . 0.0 110.469 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.828 ' O ' HD12 ' A' ' 82' ' ' LEU . 44.9 t0 55.25 38.02 29.77 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.167 -0.958 . . . . 0.0 110.621 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.828 HD12 ' O ' ' A' ' 81' ' ' ASP . 2.2 mp -136.18 148.93 48.38 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.611 -0.681 . . . . 0.0 110.361 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.787 ' O ' HG22 ' A' ' 54' ' ' THR . 4.8 t -146.52 129.87 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.534 ' HA3' ' CZ ' ' A' ' 75' ' ' TYR . . . -118.68 163.7 13.1 Favored Glycine 0 N--CA 1.502 3.071 0 C-N-CA 118.817 -1.658 . . . . 0.0 111.307 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.951 ' CH2' HG21 ' A' ' 54' ' ' THR . 5.7 m-90 -132.51 158.42 42.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.958 -0.731 . . . . 0.0 109.469 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -74.32 103.98 4.91 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.534 -0.729 . . . . 0.0 110.013 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 50' ' ' GLY . . . -70.4 158.51 87.49 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.645 -0.659 . . . . 0.0 110.274 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.45 160.03 47.77 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 O-C-N 123.453 1.238 . . . . 0.0 110.367 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -74.98 160.05 40.68 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 O-C-N 123.404 1.213 . . . . 0.0 110.391 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 87.64 28.18 24.94 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -123.84 139.45 53.96 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.492 -1.005 . . . . 0.0 110.153 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.39 139.02 38.8 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.514 -0.741 . . . . 0.0 110.209 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.9 p -92.39 145.09 24.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.578 -0.701 . . . . 0.0 110.185 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.729 HD21 ' HG2' ' A' ' 32' ' ' GLU . 40.2 mt -79.08 157.35 28.01 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.594 -0.691 . . . . 0.0 110.175 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.2 t -110.99 150.09 41.39 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.623 -0.673 . . . . 0.0 110.209 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.22 161.38 44.69 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 O-C-N 123.388 1.204 . . . . 0.0 110.708 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 37.3 t -70.56 135.55 48.59 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.626 -0.671 . . . . 0.0 110.267 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.2 t -136.19 50.35 2.07 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.61 -0.681 . . . . 0.0 110.337 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.7 p -145.12 4.12 1.07 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.492 -0.755 . . . . 0.0 112.107 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 50.79 70.29 0.89 Allowed Glycine 0 N--CA 1.5 2.928 0 O-C-N 120.897 -1.127 . . . . 0.0 110.693 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 92.7 p -120.89 133.47 55.3 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.467 -1.02 . . . . 0.0 110.474 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 63.8 m -83.01 -28.81 29.4 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.643 -0.66 . . . . 0.0 110.198 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -66.56 133.58 50.62 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.629 -0.669 . . . . 0.0 110.181 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.772 HD22 HG11 ' A' ' 151' ' ' VAL . 91.2 mt -134.9 162.19 33.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.586 -0.696 . . . . 0.0 110.143 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -130.26 108.9 10.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.521 -0.737 . . . . 0.0 110.072 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.612 ' O ' HG11 ' A' ' 113' ' ' VAL . 21.9 tp -74.11 147.19 42.95 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.668 -0.645 . . . . 0.0 109.524 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.5 t -118.62 127.08 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.385 -0.822 . . . . 0.0 110.054 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.688 ' OG1' HG13 ' A' ' 113' ' ' VAL . 37.5 m -103.19 168.12 9.38 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.348 -0.845 . . . . 0.0 110.344 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.48 ' HA ' HD11 ' A' ' 44' ' ' LEU . 5.1 ptm180 -63.22 -27.63 69.49 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.625 -0.672 . . . . 0.0 110.965 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -96.44 26.97 4.03 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.428 -0.795 . . . . 0.0 110.812 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 52.63 24.18 3.01 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.361 -0.837 . . . . 0.0 111.092 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.761 ' O ' HG13 ' A' ' 113' ' ' VAL . 78.3 m-20 -115.03 139.33 49.95 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.426 -0.796 . . . . 0.0 109.547 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.761 HG13 ' O ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -175.7 -172.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 CA-C-O 121.803 0.811 . . . . 0.0 111.05 -179.343 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.412 ' CG1' ' HD2' ' A' ' 115' ' ' PRO . 0.2 OUTLIER -145.01 170.35 8.28 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.775 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.412 ' HD2' ' CG1' ' A' ' 114' ' ' ILE . 47.7 Cg_endo -76.13 138.21 20.15 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 O-C-N 123.288 1.152 . . . . 0.0 110.439 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.77 HG13 ' O ' ' A' ' 125' ' ' SER . 62.4 t -120.27 130.01 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.619 -0.676 . . . . 0.0 109.889 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -85.44 135.41 33.87 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.525 -0.734 . . . . 0.0 109.965 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -66.8 135.29 53.71 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.582 -0.699 . . . . 0.0 110.489 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -140.27 27.38 2.13 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.633 -0.667 . . . . 0.0 110.144 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 163.6 169.35 26.96 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -62.53 -45.16 94.25 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.592 -0.946 . . . . 0.0 110.272 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.8 m -123.51 27.08 7.57 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.615 -0.678 . . . . 0.0 110.394 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.53 155.84 45.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.505 -0.747 . . . . 0.0 110.114 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -151.52 -177.09 24.96 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.77 ' O ' HG13 ' A' ' 116' ' ' VAL . 78.9 p -119.67 152.3 37.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.638 -0.919 . . . . 0.0 110.211 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.697 HD21 ' HA ' ' A' ' 129' ' ' PRO . 0.3 OUTLIER -108.51 145.44 34.74 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.667 -0.645 . . . . 0.0 109.898 -179.719 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.5 mp -89.98 -73.79 0.51 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.658 -0.651 . . . . 0.0 109.796 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 43.0 t -72.29 112.63 15.46 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.59 -0.694 . . . . 0.0 109.334 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.697 ' HA ' HD21 ' A' ' 126' ' ' LEU . 46.0 Cg_endo -72.68 124.19 9.57 Favored 'Trans proline' 0 C--N 1.319 -0.984 0 O-C-N 123.161 1.085 . . . . 0.0 111.266 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.521 ' O ' ' HB3' ' A' ' 164' ' ' ALA . 62.6 mtm180 -127.63 153.54 77.66 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.61 150.32 56.77 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 O-C-N 123.338 1.178 . . . . 0.0 110.671 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.475 HG21 ' SG ' ' A' ' 159' ' ' CYS . 19.6 t -52.38 -29.51 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.387 -0.821 . . . . 0.0 109.577 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 46.8 t -61.24 -46.06 91.96 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.745 -0.597 . . . . 0.0 111.382 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -63.87 -39.42 94.15 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.254 -0.904 . . . . 0.0 109.618 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 135' ' ' LEU . 35.4 tp -92.2 18.62 7.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.855 -0.528 . . . . 0.0 110.025 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 19.6 tttm -83.47 119.23 24.42 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.491 1.139 . . . . 0.0 112.837 -178.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 98.79 23.51 11.8 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.5 m -105.09 20.79 18.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.496 -1.002 . . . . 0.0 110.584 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.911 ' HB3' HG21 ' A' ' 55' ' ' VAL . 2.6 m -73.61 144.41 45.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.316 -0.865 . . . . 0.0 109.243 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.656 ' HA2' HD11 ' A' ' 153' ' ' ILE . . . 97.31 -25.44 27.09 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -58.5 119.41 17.28 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.472 ' CD ' HG11 ' A' ' 33' ' ' VAL . 48.2 Cg_endo -73.65 173.87 13.19 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 O-C-N 123.214 1.112 . . . . 0.0 111.058 -178.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.427 ' C ' HD22 ' A' ' 144' ' ' LEU . 4.2 mp -121.18 130.55 53.76 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.583 HD13 ' C ' ' A' ' 149' ' ' HIS . 3.8 mm? -115.02 126.15 54.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.597 -0.689 . . . . 0.0 111.093 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.433 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 29.2 p -72.24 165.75 47.79 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.438 -0.789 . . . . 0.0 108.878 178.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.433 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 38.1 Cg_endo -63.54 -14.9 45.3 Favored 'Trans proline' 0 N--CA 1.488 1.188 0 O-C-N 123.022 1.011 . . . . 0.0 111.36 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 8.8 t -75.32 -34.14 61.21 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.227 -0.921 . . . . 0.0 110.02 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 114.31 47.47 0.59 Allowed Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.583 ' C ' HD13 ' A' ' 144' ' ' LEU . 67.6 m-70 -146.29 147.79 31.75 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.645 -0.915 . . . . 0.0 110.136 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -76.98 137.99 39.36 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.485 -0.759 . . . . 0.0 109.89 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.772 HG11 HD22 ' A' ' 104' ' ' LEU . 10.3 p -119.14 -30.87 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.512 -0.742 . . . . 0.0 111.102 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.52 -169.51 32.04 Favored Glycine 0 N--CA 1.498 2.785 0 C-N-CA 119.678 -1.249 . . . . 0.0 110.602 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.656 HD11 ' HA2' ' A' ' 140' ' ' GLY . 12.4 tt -139.96 148.89 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.701 -0.882 . . . . 0.0 109.588 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -66.42 154.95 38.83 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.156 -0.965 . . . . 0.0 111.654 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -137.82 -70.62 0.44 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.06 0.457 . . . . 0.0 109.998 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.489 ' HB3' ' OD1' ' A' ' 168' ' ' ASP . . . -123.29 145.59 48.57 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.26 -0.9 . . . . 0.0 111.743 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.52 129.65 41.23 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.3 t -100.43 122.02 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 121.404 -0.81 . . . . 0.0 111.476 -177.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.475 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.2 p -141.28 139.48 33.68 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.411 -0.805 . . . . 0.0 110.647 178.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 86.9 m -71.28 -44.16 65.74 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.579 -0.7 . . . . 0.0 109.693 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -145.23 52.38 1.2 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.606 -0.684 . . . . 0.0 109.872 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 90.78 -11.59 71.37 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 64.3 t -99.41 129.53 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.19 -1.182 . . . . 0.0 108.779 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 130' ' ' ARG . . . -87.15 123.91 32.7 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.464 -0.772 . . . . 0.0 111.536 -178.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -113.32 -28.84 7.45 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.205 0.526 . . . . 0.0 109.775 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -138.52 168.36 19.94 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.581 -0.7 . . . . 0.0 109.452 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.7 m -138.73 148.83 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.338 -0.851 . . . . 0.0 111.297 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.489 ' OD1' ' HB3' ' A' ' 156' ' ' ALA . 1.4 p30 -120.11 137.92 53.86 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.67 -0.644 . . . . 0.0 110.146 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -139.0 161.9 36.24 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.589 -0.694 . . . . 0.0 110.853 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 59.0 t -93.37 137.84 23.31 Favored Pre-proline 0 N--CA 1.497 1.905 0 O-C-N 121.504 -0.748 . . . . 0.0 110.017 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -77.53 156.28 32.14 Favored 'Trans proline' 0 C--N 1.32 -0.971 0 O-C-N 123.18 1.095 . . . . 0.0 110.293 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 96.0 t -79.94 -26.99 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.352 -0.842 . . . . 0.0 110.213 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 174' ' ' SER . 2.4 pt-20 -59.95 -28.71 67.87 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.367 -0.833 . . . . 0.0 110.375 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.41 ' N ' ' HG3' ' A' ' 173' ' ' GLU . 72.2 m -76.51 -28.83 56.54 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.472 -0.767 . . . . 0.0 110.195 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.575 ' CE ' HD21 ' A' ' 82' ' ' LEU . 64.9 mtt -59.86 -32.82 71.06 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.631 -0.668 . . . . 0.0 110.647 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -59.87 -50.08 75.17 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.433 -0.792 . . . . 0.0 110.168 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 88.1 m -72.05 -39.96 68.69 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.626 -0.671 . . . . 0.0 109.838 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 89.9 m -61.27 -38.06 85.4 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.628 -0.67 . . . . 0.0 110.236 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 5.0 tmm? -59.78 -33.94 72.35 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.509 -0.744 . . . . 0.0 110.372 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 25.9 ttm180 -59.97 -40.07 87.82 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.504 -0.747 . . . . 0.0 110.253 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.734 0 O-C-N 121.579 -0.701 . . . . 0.0 110.229 179.995 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.763 ' OE2' HD21 ' A' ' 144' ' ' LEU . 96.7 mt-10 . . . . . 0 N--CA 1.498 1.926 0 CA-C-O 121.029 0.442 . . . . 0.0 110.244 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.3 p -127.14 140.07 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.563 -0.711 . . . . 0.0 110.055 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -102.88 141.61 35.39 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.602 -0.686 . . . . 0.0 110.246 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.553 ' O ' HG23 ' A' ' 35' ' ' VAL . 33.7 m -87.05 116.28 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.589 -0.695 . . . . 0.0 110.387 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.2 p -138.57 136.14 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.468 -0.77 . . . . 0.0 109.984 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 75.7 m -131.83 143.26 50.06 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.425 -0.797 . . . . 0.0 110.745 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 70.3 p -96.58 -179.98 4.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.629 -0.669 . . . . 0.0 109.737 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.63 -14.25 61.14 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.302 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 75.2 p -119.27 -25.4 6.13 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.136 -0.977 . . . . 0.0 111.432 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -141.83 168.17 20.4 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.253 -0.905 . . . . 0.0 110.96 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.8 t -138.62 118.94 13.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.582 -0.699 . . . . 0.0 110.342 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -140.26 175.83 9.27 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.532 -0.73 . . . . 0.0 109.995 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.477 HD11 ' HA ' ' A' ' 109' ' ' ARG . 81.5 mt -115.6 152.7 32.6 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.251 -0.906 . . . . 0.0 110.545 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -117.17 141.02 48.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.604 -0.685 . . . . 0.0 110.24 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 86.2 m -117.27 143.06 46.31 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.537 -0.727 . . . . 0.0 110.228 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 93.3 m -94.13 113.75 25.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.576 -0.703 . . . . 0.0 110.654 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.2 t -127.49 129.95 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.599 -0.688 . . . . 0.0 109.905 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 53.84 39.84 30.84 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.522 -0.736 . . . . 0.0 111.175 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.639 ' O ' ' HB3' ' A' ' 87' ' ' ALA . . . 66.61 17.8 67.27 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 62.3 t -129.95 130.04 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.25 -1.147 . . . . 0.0 109.755 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 97.9 m -82.02 112.72 19.36 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.529 -0.732 . . . . 0.0 110.002 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -101.76 137.48 40.01 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.606 -0.684 . . . . 0.0 110.52 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.71 HG21 ' CZ3' ' A' ' 85' ' ' TRP . 7.4 t -136.55 -179.87 5.94 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.643 -0.661 . . . . 0.0 109.738 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.601 HG21 ' HB3' ' A' ' 139' ' ' SER . 91.0 t -83.23 142.1 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.516 -0.74 . . . . 0.0 109.872 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.839 ' CE2' HG22 ' A' ' 78' ' ' VAL . 43.0 t80 -84.55 -42.52 15.39 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.609 -0.682 . . . . 0.0 111.223 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.598 ' CE1' HG11 ' A' ' 55' ' ' VAL . 1.9 p-80 -62.01 -20.83 64.32 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.399 -0.921 . . . . 0.0 110.588 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -83.94 -75.28 1.2 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.77 -48.18 77.99 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.581 -0.952 . . . . 0.0 110.082 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.379 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.923 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.6 t . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 120.996 0.427 . . . . 0.0 110.105 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -98.16 126.57 43.68 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.513 -0.742 . . . . 0.0 110.381 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 49.3 tpp -97.22 -47.26 5.81 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.51 -0.744 . . . . 0.0 110.713 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -119.72 134.95 55.03 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.526 -0.734 . . . . 0.0 110.252 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.4 m -151.55 128.09 10.75 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.512 -0.742 . . . . 0.0 110.348 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -158.88 116.31 2.81 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.372 -0.83 . . . . 0.0 111.242 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.839 HG22 ' CE2' ' A' ' 56' ' ' TYR . 54.5 t -69.98 -40.02 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.523 -0.736 . . . . 0.0 109.531 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -59.96 -44.55 94.37 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.414 -0.804 . . . . 0.0 110.294 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.557 ' HG2' HD12 ' A' ' 82' ' ' LEU . 49.4 tt0 -80.88 -13.45 58.91 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.706 -0.621 . . . . 0.0 110.177 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.403 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 39.5 t0 53.44 36.89 24.28 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.269 -0.894 . . . . 0.0 110.866 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.557 HD12 ' HG2' ' A' ' 80' ' ' GLN . 80.5 mt -140.13 156.16 46.67 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.492 -0.755 . . . . 0.0 110.677 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.0 t -138.42 155.73 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -137.0 147.49 19.26 Favored Glycine 0 N--CA 1.494 2.561 0 C-N-CA 119.552 -1.308 . . . . 0.0 111.142 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.71 ' CZ3' HG21 ' A' ' 54' ' ' THR . 3.7 m-90 -127.09 139.35 53.05 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.77 -0.841 . . . . 0.0 109.388 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -60.39 137.37 58.15 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.396 -0.815 . . . . 0.0 110.46 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 50' ' ' GLY . . . -108.87 162.63 19.3 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.532 -0.73 . . . . 0.0 110.195 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.91 148.83 52.39 Favored 'Trans proline' 0 C--N 1.317 -1.1 0 O-C-N 123.397 1.209 . . . . 0.0 110.613 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -76.15 160.35 36.43 Favored 'Trans proline' 0 C--N 1.319 -1.01 0 O-C-N 123.354 1.186 . . . . 0.0 110.54 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 93.82 -10.67 72.08 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.38 -176.82 5.48 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.108 -1.231 . . . . 0.0 110.328 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.88 157.98 43.72 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.656 -0.653 . . . . 0.0 109.977 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.9 m -137.61 175.19 9.82 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.469 -0.769 . . . . 0.0 110.834 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.446 HD11 ' HB3' ' A' ' 32' ' ' GLU . 52.6 mt -84.43 170.21 13.77 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.741 -0.599 . . . . 0.0 110.271 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 60.5 p -115.97 158.93 41.15 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.596 -0.69 . . . . 0.0 110.112 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.37 123.41 8.68 Favored 'Trans proline' 0 C--N 1.317 -1.095 0 O-C-N 123.466 1.245 . . . . 0.0 110.675 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 10.7 t -70.86 142.13 51.23 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.546 -0.722 . . . . 0.0 110.043 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.575 HG23 ' O ' ' A' ' 98' ' ' THR . 7.4 t -135.39 72.21 1.44 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.506 -0.746 . . . . 0.0 110.464 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 27.3 p -144.86 -0.46 0.91 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.515 -0.741 . . . . 0.0 112.285 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 55.29 39.94 73.91 Favored Glycine 0 N--CA 1.498 2.784 0 O-C-N 120.825 -1.172 . . . . 0.0 110.283 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.3 t -69.97 122.75 19.95 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.434 -1.039 . . . . 0.0 110.246 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 58.4 m -70.34 -39.96 74.39 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.561 -0.712 . . . . 0.0 110.283 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -81.62 119.59 24.0 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.566 -0.709 . . . . 0.0 110.183 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 91.0 mt -129.88 150.73 51.05 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.59 -0.694 . . . . 0.0 110.472 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -115.31 133.31 56.15 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.596 -0.69 . . . . 0.0 109.728 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.789 HD12 HD11 ' A' ' 143' ' ' LEU . 9.6 tt -113.49 138.28 50.35 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.435 -0.791 . . . . 0.0 110.351 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.3 t -97.85 129.15 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.602 -0.686 . . . . 0.0 109.839 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 75.0 p -100.9 169.97 8.62 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.623 -0.673 . . . . 0.0 110.391 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.477 ' HA ' HD11 ' A' ' 44' ' ' LEU . 78.8 ttt-85 -62.5 -23.49 66.97 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.635 -0.666 . . . . 0.0 110.342 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.406 ' O ' ' CG ' ' A' ' 110' ' ' HIS . 81.1 t60 -92.86 25.7 3.06 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.409 -0.807 . . . . 0.0 110.75 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.82 44.8 27.86 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.128 -0.983 . . . . 0.0 110.83 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -113.86 155.5 25.61 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.554 -0.716 . . . . 0.0 109.975 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.2 137.2 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.561 -0.712 . . . . 0.0 110.437 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 42.2 pt -136.46 141.72 36.77 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.613 -0.679 . . . . 0.0 109.957 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -76.67 139.45 20.13 Favored 'Trans proline' 0 C--N 1.319 -1.021 0 O-C-N 123.25 1.131 . . . . 0.0 110.447 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.5 t -126.66 130.06 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.608 -0.682 . . . . 0.0 109.86 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -89.7 137.33 32.42 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.495 -0.753 . . . . 0.0 110.078 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 79.1 ttt-85 -82.08 124.33 29.73 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.514 -0.741 . . . . 0.0 110.216 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -128.85 25.19 5.64 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.612 -0.68 . . . . 0.0 110.302 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 168.88 179.56 41.07 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -61.23 -41.33 96.68 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.565 -0.962 . . . . 0.0 110.172 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.3 p -137.15 24.17 3.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.518 -0.739 . . . . 0.0 110.572 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -131.0 139.91 50.06 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.409 -0.807 . . . . 0.0 110.479 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.576 ' O ' ' HB1' ' A' ' 166' ' ' ALA . . . -146.56 179.74 23.3 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 46.9 t -129.63 144.98 51.52 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.506 -0.997 . . . . 0.0 110.26 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.419 HD23 ' O ' ' A' ' 128' ' ' SER . 19.2 tp -99.86 136.8 39.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.605 -0.684 . . . . 0.0 110.145 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.4 mp -69.67 -39.99 76.67 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.531 -0.731 . . . . 0.0 110.452 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.419 ' O ' HD23 ' A' ' 126' ' ' LEU . 47.6 t -98.63 109.48 53.28 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.424 -0.798 . . . . 0.0 110.099 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -76.82 135.3 15.71 Favored 'Trans proline' 0 C--N 1.32 -0.956 0 O-C-N 123.213 1.112 . . . . 0.0 110.751 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -135.96 162.37 57.17 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.62 -0.675 . . . . 0.0 109.769 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.5 150.29 57.4 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 O-C-N 123.385 1.202 . . . . 0.0 110.263 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 162' ' ' GLY . 83.9 t -59.09 -34.29 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.431 -0.793 . . . . 0.0 109.796 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 46.7 t -59.91 -40.04 87.47 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.578 -0.701 . . . . 0.0 110.323 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -61.05 -41.47 96.66 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.491 -0.755 . . . . 0.0 109.68 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.553 HD21 ' CZ ' ' A' ' 154' ' ' PHE . 43.9 tp -89.97 -10.1 46.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.784 -0.573 . . . . 0.0 111.332 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -62.53 138.31 58.45 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.158 -0.964 . . . . 0.0 110.657 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 87.0 20.71 52.63 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 21.8 m -120.59 13.58 11.71 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.317 -1.107 . . . . 0.0 111.052 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.601 ' HB3' HG21 ' A' ' 55' ' ' VAL . 19.8 m -59.79 151.99 24.07 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.155 -0.966 . . . . 0.0 110.287 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 92.52 -17.68 56.9 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -58.08 110.62 2.54 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -76.19 143.4 25.38 Favored 'Trans proline' 0 C--N 1.32 -0.943 0 O-C-N 123.134 1.071 . . . . 0.0 110.963 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.789 HD11 HD12 ' A' ' 106' ' ' LEU . 5.5 mp -95.78 131.82 41.66 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.763 HD21 ' OE2' ' A' ' 32' ' ' GLU . 8.8 mp -110.04 156.36 20.62 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.631 -0.668 . . . . 0.0 110.973 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.0 176.16 1.85 Allowed Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.718 -0.614 . . . . 0.0 109.642 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.59 -26.96 19.24 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 O-C-N 123.324 1.17 . . . . 0.0 110.252 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.53 -30.77 69.65 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.508 -0.745 . . . . 0.0 110.06 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 114.91 27.58 3.18 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -127.73 147.44 50.4 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.38 -1.071 . . . . 0.0 110.218 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -83.38 134.3 34.9 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.465 -0.772 . . . . 0.0 110.276 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 151' ' ' VAL . 34.4 m -90.98 -22.89 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.594 -0.691 . . . . 0.0 110.868 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 167.74 -163.58 37.25 Favored Glycine 0 N--CA 1.498 2.769 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.43 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 77.0 mt -130.05 156.16 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.641 -0.917 . . . . 0.0 109.97 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.553 ' CZ ' HD21 ' A' ' 135' ' ' LEU . 13.5 t80 -68.23 134.78 50.97 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.496 -0.753 . . . . 0.0 109.914 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.443 ' HD3' HG23 ' A' ' 170' ' ' VAL . 59.2 ttp180 -114.26 -64.86 1.25 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.569 -0.707 . . . . 0.0 111.02 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -136.09 149.81 48.87 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.431 -0.793 . . . . 0.0 110.991 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -95.99 126.46 41.25 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.662 -0.648 . . . . 0.0 109.855 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 45.1 t -95.75 118.15 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.595 -0.69 . . . . 0.0 110.453 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 26.7 p -140.05 144.87 37.08 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.464 -0.772 . . . . 0.0 110.632 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 91.8 m -73.95 -49.98 22.1 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.566 -0.709 . . . . 0.0 110.051 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -139.35 50.1 1.8 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.602 -0.686 . . . . 0.0 110.117 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.417 ' O ' HG23 ' A' ' 132' ' ' VAL . . . 96.46 -11.25 66.97 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 62.0 t -102.04 121.78 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.237 -1.155 . . . . 0.0 109.151 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.36 118.78 27.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.55 -0.719 . . . . 0.0 111.078 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -103.37 -25.83 13.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.704 -0.622 . . . . 0.0 109.641 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.576 ' HB1' ' O ' ' A' ' 124' ' ' GLY . . . -135.45 167.62 20.72 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.596 -0.69 . . . . 0.0 109.802 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.8 m -133.58 140.0 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.497 -0.752 . . . . 0.0 110.721 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -110.83 131.01 55.41 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.625 -0.672 . . . . 0.0 109.853 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -139.84 158.07 44.68 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.532 -0.73 . . . . 0.0 110.613 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.443 HG23 ' HD3' ' A' ' 155' ' ' ARG . 62.8 t -95.27 134.94 23.74 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.576 -0.703 . . . . 0.0 109.715 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.02 154.05 57.71 Favored 'Trans proline' 0 C--N 1.318 -1.045 0 O-C-N 123.175 1.092 . . . . 0.0 110.77 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 61.8 t -60.03 -38.82 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.645 -0.659 . . . . 0.0 110.062 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -57.22 -34.07 68.18 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.687 -0.633 . . . . 0.0 110.749 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 47.4 t -61.52 -40.05 93.24 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.504 -0.748 . . . . 0.0 109.964 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 61.3 mtt -59.95 -38.64 83.03 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.637 -0.665 . . . . 0.0 110.333 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -59.97 -33.14 71.53 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.667 -0.646 . . . . 0.0 110.578 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 93.9 m -59.88 -40.06 87.41 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.455 -0.778 . . . . 0.0 110.377 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 92.9 m -62.92 -49.78 73.42 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.495 -0.753 . . . . 0.0 110.094 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 76.6 mtm -65.04 -35.84 82.47 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.528 -0.732 . . . . 0.0 110.244 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -60.0 -40.01 87.74 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.524 -0.735 . . . . 0.0 110.148 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.837 0 O-C-N 121.617 -0.677 . . . . 0.0 110.148 179.87 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.645 ' OE2' HD21 ' A' ' 94' ' ' LEU . 49.5 mm-40 . . . . . 0 N--CA 1.498 1.941 0 CA-C-O 121.304 0.573 . . . . 0.0 110.006 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 45' ' ' ALA . 9.4 p -142.39 139.98 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.8 -0.563 . . . . 0.0 109.901 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -103.08 139.98 37.9 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.564 -0.71 . . . . 0.0 110.101 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.418 ' HA ' HD22 ' A' ' 44' ' ' LEU . 10.0 p -83.48 134.5 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.513 -0.742 . . . . 0.0 110.223 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.8 t -127.93 129.99 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.572 -0.705 . . . . 0.0 110.029 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.9 m -121.96 134.28 54.83 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.608 -0.683 . . . . 0.0 110.026 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.482 HG22 ' H ' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -109.74 -175.11 2.66 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.464 -0.773 . . . . 0.0 110.123 -179.865 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.482 ' H ' HG22 ' A' ' 38' ' ' THR . . . -70.04 -38.46 75.85 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.646 -0.659 . . . . 0.0 111.333 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.468 HG23 ' HG3' ' A' ' 41' ' ' GLN . 6.6 t -118.56 -20.02 8.54 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.305 -0.872 . . . . 0.0 111.738 -178.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.468 ' HG3' HG23 ' A' ' 40' ' ' THR . 79.0 mt-30 -132.38 154.32 49.9 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.21 -0.931 . . . . 0.0 110.743 -179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 73.6 m -132.34 124.07 28.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.539 -0.726 . . . . 0.0 109.923 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -136.11 170.37 16.12 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.587 -0.696 . . . . 0.0 110.532 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.418 HD22 ' HA ' ' A' ' 35' ' ' VAL . 55.6 mt -115.63 149.6 38.04 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.693 -0.629 . . . . 0.0 109.836 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.672 ' O ' HG23 ' A' ' 33' ' ' VAL . . . -115.91 148.32 40.15 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.496 -0.752 . . . . 0.0 110.189 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.629 HG21 ' HB3' ' A' ' 142' ' ' PRO . 87.3 m -119.9 136.55 54.46 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.557 -0.715 . . . . 0.0 109.873 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.415 ' O ' HD12 ' A' ' 94' ' ' LEU . 28.3 p -94.57 121.07 35.75 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.337 -0.852 . . . . 0.0 111.073 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.6 t -130.08 129.99 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.512 -0.743 . . . . 0.0 109.751 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 53.44 39.95 30.66 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.46 -0.775 . . . . 0.0 111.099 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.94 16.19 70.19 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 62.5 t -126.07 123.39 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.181 -1.188 . . . . 0.0 109.722 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 36.2 t -79.67 115.87 19.53 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.535 -0.728 . . . . 0.0 110.166 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 71.6 m95 -104.65 137.57 42.28 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.648 -0.658 . . . . 0.0 110.139 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.573 ' OG1' HG23 ' A' ' 83' ' ' VAL . 34.9 p -136.38 179.32 6.43 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.58 -0.7 . . . . 0.0 109.733 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.582 HG11 ' CE1' ' A' ' 57' ' ' HIS . 59.4 t -85.63 142.28 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.525 -0.734 . . . . 0.0 109.528 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.864 ' CE2' HG22 ' A' ' 78' ' ' VAL . 39.4 t80 -79.82 -42.9 23.39 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.424 -0.798 . . . . 0.0 111.598 -178.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.582 ' CE1' HG11 ' A' ' 55' ' ' VAL . 2.2 p-80 -67.02 -20.0 65.79 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.111 -0.993 . . . . 0.0 110.722 -178.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.74 -50.5 1.51 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -102.56 -38.34 7.57 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.498 -1.001 . . . . 0.0 110.399 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.583 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.853 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 56.3 m . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 121.012 0.434 . . . . 0.0 109.951 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -58.86 124.0 18.38 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.517 -0.739 . . . . 0.0 110.38 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.4 tpt -70.0 -40.03 75.53 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.578 -0.701 . . . . 0.0 110.294 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.536 ' O ' HG12 ' A' ' 83' ' ' VAL . 51.1 m-85 -126.01 129.99 50.28 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.497 -0.752 . . . . 0.0 110.338 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.607 ' HA ' HG12 ' A' ' 83' ' ' VAL . 60.4 m -137.97 118.8 14.16 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.711 -0.618 . . . . 0.0 110.309 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -157.02 113.01 2.93 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.358 -0.838 . . . . 0.0 111.136 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.864 HG22 ' CE2' ' A' ' 56' ' ' TYR . 56.1 t -70.02 -39.99 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.445 -0.785 . . . . 0.0 109.441 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -58.35 -46.03 87.05 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.442 -0.787 . . . . 0.0 110.033 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.9 -14.25 48.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.681 -0.637 . . . . 0.0 110.076 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.419 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 43.8 t0 53.88 39.99 31.04 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.245 -0.909 . . . . 0.0 110.575 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.831 HD11 HG21 ' A' ' 170' ' ' VAL . 68.6 mt -137.63 147.83 45.28 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.565 -0.71 . . . . 0.0 111.325 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.607 HG12 ' HA ' ' A' ' 76' ' ' THR . 11.8 m -149.96 178.85 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -179.76 171.99 43.63 Favored Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.607 -1.283 . . . . 0.0 110.774 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 7.7 m-90 -130.06 159.53 36.46 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.828 -0.807 . . . . 0.0 109.627 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -81.62 124.14 29.29 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.456 -0.777 . . . . 0.0 110.194 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -97.19 163.85 19.03 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.575 -0.703 . . . . 0.0 110.256 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -70.65 151.52 64.04 Favored 'Trans proline' 0 C--N 1.318 -1.078 0 O-C-N 123.391 1.206 . . . . 0.0 110.476 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.28 157.2 54.05 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.379 1.199 . . . . 0.0 110.404 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.04 30.58 12.44 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -123.66 154.36 39.48 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.529 -0.983 . . . . 0.0 110.244 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -70.52 150.05 46.53 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.572 -0.705 . . . . 0.0 110.161 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 94.8 p -134.07 158.96 42.25 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.596 -0.69 . . . . 0.0 110.202 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.645 HD21 ' OE2' ' A' ' 32' ' ' GLU . 59.8 mt -104.16 141.14 36.78 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.52 -0.738 . . . . 0.0 110.381 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 31.5 p -105.77 160.99 24.2 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.647 -0.658 . . . . 0.0 110.229 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.72 152.48 58.86 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.345 1.182 . . . . 0.0 110.328 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 5.5 t -85.69 139.31 31.48 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.476 -0.765 . . . . 0.0 110.271 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.6 m -125.94 72.63 1.3 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.672 -0.643 . . . . 0.0 110.179 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 27.1 p -144.48 -8.29 0.67 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.455 -0.778 . . . . 0.0 112.426 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 55.4 33.2 58.33 Favored Glycine 0 N--CA 1.499 2.841 0 O-C-N 120.773 -1.204 . . . . 0.0 110.318 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.7 t -80.67 118.58 22.35 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.558 -0.966 . . . . 0.0 110.478 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 57.9 m -60.02 -39.97 87.68 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.516 -0.74 . . . . 0.0 110.088 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -64.23 125.59 25.03 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.579 -0.701 . . . . 0.0 109.84 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.6 mt -130.14 155.38 46.3 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.636 -0.665 . . . . 0.0 110.305 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -117.85 135.78 53.87 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.678 -0.639 . . . . 0.0 109.684 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.553 ' HA ' HD23 ' A' ' 143' ' ' LEU . 9.9 tt -114.31 132.0 56.33 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.581 -0.7 . . . . 0.0 110.488 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.0 t -92.32 119.88 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.615 -0.678 . . . . 0.0 109.643 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.0 m -99.21 161.47 13.6 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.558 -0.714 . . . . 0.0 110.391 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.7 ttp180 -60.47 -24.64 65.42 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.567 -0.708 . . . . 0.0 110.359 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 18.3 m80 -92.59 26.84 2.5 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.314 -0.866 . . . . 0.0 110.942 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.61 31.9 16.04 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.151 -0.968 . . . . 0.0 110.545 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -104.89 129.41 53.26 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.66 -0.65 . . . . 0.0 109.847 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 61.9 t -109.9 125.29 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.592 -0.692 . . . . 0.0 110.238 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 38.3 mt -119.73 135.51 24.23 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.678 -0.639 . . . . 0.0 109.648 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -75.72 135.5 17.87 Favored 'Trans proline' 0 C--N 1.319 -1.026 0 O-C-N 123.213 1.112 . . . . 0.0 110.594 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.644 HG13 ' O ' ' A' ' 125' ' ' SER . 60.1 t -129.82 129.98 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.557 -0.714 . . . . 0.0 109.572 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -80.16 156.04 27.15 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.515 -0.741 . . . . 0.0 110.151 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -99.28 121.45 41.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.63 -0.669 . . . . 0.0 110.249 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 31.0 mtp85 -119.63 24.24 10.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.576 -0.703 . . . . 0.0 110.621 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -177.1 -176.9 45.6 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -64.78 -39.97 94.49 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.544 -0.974 . . . . 0.0 110.435 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 46.6 m -136.54 24.48 3.16 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.516 -0.74 . . . . 0.0 110.522 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -125.21 150.56 46.87 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.436 -0.79 . . . . 0.0 110.4 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -144.02 168.92 26.38 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.644 ' O ' HG13 ' A' ' 116' ' ' VAL . 82.9 p -112.02 152.43 28.17 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.555 -0.968 . . . . 0.0 110.23 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 35.2 tp -100.13 120.34 39.71 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.553 -0.717 . . . . 0.0 110.179 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.8 mt -59.95 -47.1 87.19 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.49 -0.756 . . . . 0.0 110.683 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 36.2 t -97.93 111.68 59.79 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.632 -0.667 . . . . 0.0 110.168 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.64 113.21 3.72 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 O-C-N 123.173 1.091 . . . . 0.0 110.479 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.431 ' HD3' ' CD2' ' A' ' 134' ' ' TYR . 37.6 mtt180 -120.25 162.78 32.05 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.577 -0.702 . . . . 0.0 110.126 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.04 150.49 66.56 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 123.384 1.202 . . . . 0.0 110.429 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 162' ' ' GLY . 86.4 t -55.92 -33.25 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.479 -0.763 . . . . 0.0 110.114 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.3 m -58.66 -46.59 86.82 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.62 -0.675 . . . . 0.0 110.763 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.431 ' CD2' ' HD3' ' A' ' 130' ' ' ARG . 64.0 t80 -59.99 -41.61 92.43 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.549 -0.719 . . . . 0.0 110.201 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 58.8 tp -84.87 -9.8 57.76 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.773 -0.579 . . . . 0.0 111.461 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -68.83 143.97 54.41 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.098 -1.002 . . . . 0.0 110.748 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.17 -2.52 65.83 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 89.2 p -102.39 10.49 39.03 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.136 -1.214 . . . . 0.0 110.807 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.97 140.69 56.57 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.252 -0.905 . . . . 0.0 110.188 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 90.51 -10.56 74.15 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.52 129.29 33.62 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.629 ' HB3' HG21 ' A' ' 46' ' ' THR . 50.5 Cg_endo -76.86 148.92 28.8 Favored 'Trans proline' 0 C--N 1.318 -1.037 0 O-C-N 123.217 1.114 . . . . 0.0 110.886 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.553 HD23 ' HA ' ' A' ' 106' ' ' LEU . 21.1 mt -99.14 118.16 35.25 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.448 ' N ' HD12 ' A' ' 144' ' ' LEU . 9.3 mp -92.0 163.14 14.1 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.586 -0.697 . . . . 0.0 111.157 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.2 177.4 1.36 Allowed Pre-proline 0 N--CA 1.493 1.7 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.06 -26.7 21.25 Favored 'Trans proline' 0 C--N 1.317 -1.106 0 O-C-N 123.264 1.139 . . . . 0.0 110.434 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 90.6 p -69.97 -33.04 71.57 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.544 -0.722 . . . . 0.0 110.236 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 106.21 45.22 1.28 Allowed Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -137.17 160.19 39.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.535 -0.979 . . . . 0.0 110.293 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.413 ' HB2' ' HB3' ' A' ' 94' ' ' LEU . . . -78.48 125.3 29.17 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.588 -0.695 . . . . 0.0 110.34 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 63.3 t -91.55 -53.43 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.565 -0.71 . . . . 0.0 110.133 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -171.08 -161.9 22.51 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.471 HD12 ' HE2' ' A' ' 175' ' ' MET . 96.7 mt -130.22 140.06 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.593 -0.945 . . . . 0.0 110.153 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -61.83 128.64 37.19 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.593 -0.692 . . . . 0.0 109.814 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -103.59 -69.6 0.79 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.595 -0.691 . . . . 0.0 110.851 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -133.88 152.41 51.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.528 -0.733 . . . . 0.0 110.692 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.01 149.81 20.9 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 57.9 t -117.79 119.32 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.542 -0.724 . . . . 0.0 110.517 -179.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.2 p -141.5 142.23 33.59 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.565 -0.709 . . . . 0.0 110.55 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 44.4 m -75.38 -40.84 57.58 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.523 -0.735 . . . . 0.0 110.03 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -145.49 51.58 1.19 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.586 -0.697 . . . . 0.0 110.402 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.476 ' O ' HG23 ' A' ' 132' ' ' VAL . . . 91.35 -10.36 75.04 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.381 -1.087 . . . . 0.0 110.381 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 96.9 t -101.77 122.31 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.165 -1.197 . . . . 0.0 109.132 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.33 118.49 26.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.586 -0.696 . . . . 0.0 110.899 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -106.21 -27.75 10.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.777 -0.577 . . . . 0.0 109.645 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -132.62 162.41 31.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.534 -0.728 . . . . 0.0 110.017 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.565 HG21 HG11 ' A' ' 116' ' ' VAL . 34.9 m -129.99 139.59 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.583 -0.698 . . . . 0.0 110.232 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -117.76 123.41 45.92 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.534 -0.729 . . . . 0.0 110.485 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -132.49 159.97 37.85 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.575 -0.703 . . . . 0.0 109.796 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.831 HG21 HD11 ' A' ' 82' ' ' LEU . 27.1 m -97.54 142.45 24.58 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.516 -0.74 . . . . 0.0 110.414 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -77.65 171.08 18.06 Favored 'Trans proline' 0 C--N 1.318 -1.045 0 O-C-N 123.265 1.139 . . . . 0.0 110.255 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 61.4 t -59.98 -36.14 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.532 -0.73 . . . . 0.0 110.167 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -59.65 -33.22 71.26 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.729 -0.607 . . . . 0.0 110.996 -178.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 64.8 p -61.5 -33.32 73.59 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.387 -0.821 . . . . 0.0 109.984 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.471 ' HE2' HD12 ' A' ' 153' ' ' ILE . 44.8 mtt -69.08 -40.07 78.68 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.643 -0.661 . . . . 0.0 110.134 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -60.0 -38.89 83.94 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.651 -0.656 . . . . 0.0 110.468 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 94.2 m -60.07 -39.97 87.88 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.6 -0.688 . . . . 0.0 110.144 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 87.2 m -60.63 -40.48 92.11 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.469 -0.77 . . . . 0.0 109.985 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 40.8 ttp -61.06 -42.03 97.72 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.658 -0.652 . . . . 0.0 110.218 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -62.25 -40.07 94.95 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.495 -0.753 . . . . 0.0 110.292 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.829 0 O-C-N 121.594 -0.691 . . . . 0.0 110.182 179.942 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.563 ' OE1' HD13 ' A' ' 94' ' ' LEU . 44.3 tp10 . . . . . 0 N--CA 1.496 1.854 0 CA-C-O 121.074 0.464 . . . . 0.0 110.232 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.466 HG21 HG11 ' A' ' 107' ' ' VAL . 61.2 t -99.05 126.37 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.638 -0.664 . . . . 0.0 110.068 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -108.2 142.24 38.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.622 -0.674 . . . . 0.0 110.123 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.474 ' HA ' HD22 ' A' ' 44' ' ' LEU . 65.4 t -87.18 114.16 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.55 -0.719 . . . . 0.0 109.589 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 62.0 t -118.45 131.33 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.448 -0.782 . . . . 0.0 109.98 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.8 m -123.12 135.37 54.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.642 -0.661 . . . . 0.0 110.086 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.472 HG22 ' H ' ' A' ' 39' ' ' ALA . 0.3 OUTLIER -101.22 -179.39 4.02 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.658 -0.651 . . . . 0.0 110.284 -179.739 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.472 ' H ' HG22 ' A' ' 38' ' ' THR . . . -67.91 -40.07 83.48 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.898 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 76.6 p -113.79 -28.22 7.51 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.381 -0.824 . . . . 0.0 110.92 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 -126.26 -179.03 4.54 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.473 -0.767 . . . . 0.0 110.452 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 81.2 p -153.47 125.9 8.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.621 -0.674 . . . . 0.0 110.317 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.458 ' O ' HD23 ' A' ' 44' ' ' LEU . 29.1 p90 -131.89 -175.98 3.91 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.644 -0.66 . . . . 0.0 109.803 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.474 HD22 ' HA ' ' A' ' 35' ' ' VAL . 78.4 mt -126.74 150.44 49.07 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.437 -0.789 . . . . 0.0 110.475 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -112.71 162.03 16.2 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.595 -0.69 . . . . 0.0 110.295 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.5 p -131.25 129.03 41.06 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.495 -0.753 . . . . 0.0 110.349 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 98.8 m -78.42 109.5 12.64 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.514 -0.741 . . . . 0.0 110.379 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.6 t -130.07 133.52 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.553 -0.717 . . . . 0.0 110.278 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.441 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 0.5 OUTLIER 43.91 34.26 0.88 Allowed 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 179.666 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' A' ' 87' ' ' ALA . . . 88.69 -19.11 38.9 Favored Glycine 0 N--CA 1.498 2.818 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.479 178.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 63.2 t -109.45 128.75 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.115 -1.227 . . . . 0.0 110.283 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 92.7 m -76.57 149.42 36.63 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.595 -0.691 . . . . 0.0 109.735 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -134.21 136.76 43.9 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.494 -0.754 . . . . 0.0 111.048 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.657 ' O ' HD23 ' A' ' 82' ' ' LEU . 7.6 t -137.58 178.29 7.22 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.659 HG11 ' CE1' ' A' ' 57' ' ' HIS . 75.9 t -80.54 141.69 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.314 -0.866 . . . . 0.0 108.993 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.875 ' CE2' HG22 ' A' ' 78' ' ' VAL . 6.5 t80 -85.0 -43.28 14.11 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.506 -0.746 . . . . 0.0 111.327 -179.01 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.659 ' CE1' HG11 ' A' ' 55' ' ' VAL . 1.8 p-80 -58.8 -21.38 56.11 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.291 -0.88 . . . . 0.0 111.366 -177.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -87.87 -53.64 2.66 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.87 -63.08 1.49 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.526 -0.985 . . . . 0.0 110.46 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.448 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.907 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 64.7 m . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 121.062 0.458 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -68.16 128.73 37.61 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.535 -0.728 . . . . 0.0 110.568 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 40.6 mtm -119.2 -49.71 2.38 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.537 -0.727 . . . . 0.0 110.128 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.565 ' O ' HG13 ' A' ' 83' ' ' VAL . 54.1 m-85 -110.33 127.98 55.32 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.48 -0.763 . . . . 0.0 110.149 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 90.4 m -151.21 122.58 7.84 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.572 -0.705 . . . . 0.0 110.008 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -162.9 125.13 2.64 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.368 -0.833 . . . . 0.0 111.257 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.875 HG22 ' CE2' ' A' ' 56' ' ' TYR . 74.3 t -72.36 -38.8 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.548 -0.72 . . . . 0.0 109.647 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -55.69 -39.53 71.11 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.477 -0.764 . . . . 0.0 110.488 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.1 tp60 -91.18 -14.03 31.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.704 -0.622 . . . . 0.0 110.342 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.403 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 46.8 t0 53.18 39.94 30.46 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.104 -0.997 . . . . 0.0 110.324 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.657 HD23 ' O ' ' A' ' 54' ' ' THR . 5.3 mt -142.16 160.69 39.74 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.855 0.836 . . . . 0.0 111.391 -179.247 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 75' ' ' TYR . 2.0 t -144.56 160.97 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -155.39 160.42 29.84 Favored Glycine 0 N--CA 1.497 2.731 0 C-N-CA 119.04 -1.553 . . . . 0.0 111.612 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 17.6 m-90 -144.79 168.0 21.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.931 -0.746 . . . . 0.0 109.458 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -69.93 143.74 52.61 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.518 -0.739 . . . . 0.0 109.931 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 50' ' ' GLY . . . -92.54 162.58 29.18 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.445 -0.784 . . . . 0.0 110.524 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.87 149.79 48.24 Favored 'Trans proline' 0 C--N 1.317 -1.093 0 O-C-N 123.581 1.306 . . . . 0.0 110.267 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -76.15 160.07 36.66 Favored 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 123.35 1.184 . . . . 0.0 110.428 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.14 29.03 52.31 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -151.68 137.02 17.6 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.516 -0.99 . . . . 0.0 110.248 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.8 mtm180 -110.81 131.89 54.66 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.553 -0.717 . . . . 0.0 110.219 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.7 m -91.79 175.54 6.85 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.546 -0.721 . . . . 0.0 110.311 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.563 HD13 ' OE1' ' A' ' 32' ' ' GLU . 3.8 mp -87.02 170.46 11.54 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.53 -0.731 . . . . 0.0 110.222 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.64 172.19 3.73 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.709 -0.62 . . . . 0.0 110.057 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.66 156.85 62.51 Favored 'Trans proline' 0 C--N 1.318 -1.039 0 O-C-N 123.314 1.165 . . . . 0.0 110.173 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.694 ' CB ' HG12 ' A' ' 151' ' ' VAL . 1.5 t -81.41 154.96 26.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.499 -0.751 . . . . 0.0 110.493 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 98' ' ' THR . 7.5 t -136.05 56.35 1.82 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.695 -0.628 . . . . 0.0 110.312 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 27.3 p -144.81 -8.41 0.63 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.413 -0.804 . . . . 0.0 112.447 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.42 29.2 38.11 Favored Glycine 0 N--CA 1.499 2.869 0 O-C-N 120.753 -1.217 . . . . 0.0 110.532 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.5 p -70.53 150.38 46.19 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.554 -0.968 . . . . 0.0 110.33 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 58.0 m -86.39 -26.63 24.69 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.639 -0.663 . . . . 0.0 110.474 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -71.74 120.46 17.36 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.544 -0.723 . . . . 0.0 110.122 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.658 HD22 HG21 ' A' ' 151' ' ' VAL . 94.9 mt -137.06 149.68 47.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.553 -0.717 . . . . 0.0 110.347 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -120.53 129.2 53.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.564 -0.71 . . . . 0.0 109.833 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.43 HD13 HD21 ' A' ' 143' ' ' LEU . 47.1 tp -108.09 146.15 33.03 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.554 -0.716 . . . . 0.0 110.276 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.466 HG11 HG21 ' A' ' 33' ' ' VAL . 59.1 t -107.36 122.39 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.655 -0.653 . . . . 0.0 109.812 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.8 p -91.67 178.53 5.89 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.58 -0.7 . . . . 0.0 110.404 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.5 ptt85 -70.2 -15.75 62.97 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.62 -0.675 . . . . 0.0 111.112 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -94.28 26.04 3.54 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.142 -0.974 . . . . 0.0 110.816 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 53.22 25.54 4.43 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.298 -0.876 . . . . 0.0 110.884 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -96.19 155.37 16.79 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.546 -0.721 . . . . 0.0 110.046 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 61.4 t -117.88 125.81 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.511 -0.743 . . . . 0.0 110.053 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 42.9 pt -126.51 142.14 42.18 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.605 -0.685 . . . . 0.0 110.093 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -76.32 153.15 35.47 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 O-C-N 123.289 1.152 . . . . 0.0 110.623 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 63.0 t -140.02 139.64 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.649 -0.657 . . . . 0.0 109.743 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 -105.1 135.04 47.2 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.591 -0.693 . . . . 0.0 110.153 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 14.6 ttt-85 -73.28 139.27 46.01 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.577 -0.702 . . . . 0.0 110.26 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.59 22.05 2.92 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.572 -0.705 . . . . 0.0 110.404 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 166.54 -170.77 41.25 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -71.03 -39.69 72.18 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.591 -0.946 . . . . 0.0 110.284 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 10.6 p -134.43 24.87 3.79 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.527 -0.733 . . . . 0.0 110.703 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.422 HH21 HG11 ' A' ' 158' ' ' VAL . 0.6 OUTLIER -141.62 140.45 33.31 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.507 -0.746 . . . . 0.0 110.317 179.941 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -143.7 178.03 22.07 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 81.7 p -111.07 164.18 13.1 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.597 -0.943 . . . . 0.0 110.178 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 30.4 tp -109.42 131.01 55.47 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.5 -0.75 . . . . 0.0 110.366 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.12 -51.74 68.31 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.552 -0.717 . . . . 0.0 110.447 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 67.9 m -100.14 107.86 49.38 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.532 -0.73 . . . . 0.0 109.954 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.78 108.41 2.56 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 O-C-N 123.197 1.104 . . . . 0.0 110.9 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.457 ' O ' ' HB3' ' A' ' 164' ' ' ALA . 31.9 mtt180 -115.24 161.31 30.3 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.669 -0.644 . . . . 0.0 109.849 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.21 150.39 71.5 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 O-C-N 123.405 1.213 . . . . 0.0 110.996 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.43 HG21 ' SG ' ' A' ' 159' ' ' CYS . 66.2 t -51.84 -30.04 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 121.507 -0.746 . . . . 0.0 109.731 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 36.9 t -60.71 -41.79 95.93 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.682 -0.636 . . . . 0.0 111.056 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.411 ' CD2' ' HD3' ' A' ' 130' ' ' ARG . 88.5 t80 -66.85 -39.97 87.76 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.355 -0.84 . . . . 0.0 109.41 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 23.0 tp -93.61 18.65 9.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.912 -0.493 . . . . 0.0 110.078 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -82.09 117.71 22.48 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.446 1.117 . . . . 0.0 112.066 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.65 26.87 7.83 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 36.7 m -112.7 21.61 15.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.579 -0.954 . . . . 0.0 110.405 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.544 ' CB ' HG21 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -68.33 129.89 41.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.312 -0.867 . . . . 0.0 108.851 179.353 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 106.37 -13.35 43.67 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -55.04 112.12 2.68 Favored Glycine 0 N--CA 1.499 2.839 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.13 153.22 51.63 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 O-C-N 123.142 1.075 . . . . 0.0 111.128 -178.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.43 HD21 HD13 ' A' ' 106' ' ' LEU . 44.9 mt -108.52 123.42 48.87 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.702 -0.624 . . . . 0.0 109.515 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.504 HD23 ' C ' ' A' ' 149' ' ' HIS . 0.6 OUTLIER -121.41 139.5 53.37 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.432 -0.792 . . . . 0.0 110.849 -179.378 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 68.4 m -74.08 163.63 66.94 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.638 -0.664 . . . . 0.0 109.484 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.62 -43.12 5.95 Favored 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.411 1.216 . . . . 0.0 109.561 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.7 m -119.42 27.54 8.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.705 -0.622 . . . . 0.0 109.899 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -139.0 -173.55 13.05 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.504 ' C ' HD23 ' A' ' 144' ' ' LEU . 30.2 m170 -96.82 -168.11 1.66 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.65 -0.912 . . . . 0.0 110.472 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.56 148.28 51.1 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.573 -0.705 . . . . 0.0 110.892 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.694 HG12 ' CB ' ' A' ' 97' ' ' CYS . 34.4 m -119.13 -29.67 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.701 -0.624 . . . . 0.0 110.722 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.41 -163.42 22.34 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.3 tt -142.51 158.69 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.602 -0.94 . . . . 0.0 109.82 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -71.1 159.31 34.93 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.178 -0.951 . . . . 0.0 111.029 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.56 HH21 HG22 ' A' ' 170' ' ' VAL . 10.2 ttm180 -145.75 -75.66 0.21 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.757 -0.59 . . . . 0.0 109.95 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -121.68 142.62 49.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.035 -1.04 . . . . 0.0 111.313 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.79 128.89 40.26 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.422 HG11 HH21 ' A' ' 123' ' ' ARG . 2.2 t -100.02 122.94 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.483 -0.76 . . . . 0.0 111.472 -177.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.43 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.1 p -141.15 142.57 34.04 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.482 -0.761 . . . . 0.0 110.541 178.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 88.7 m -75.93 -41.76 50.77 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.527 -0.733 . . . . 0.0 109.837 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -142.75 50.1 1.46 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.665 -0.647 . . . . 0.0 109.721 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 90.18 -11.68 70.21 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 62.6 t -94.14 120.29 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.142 -1.211 . . . . 0.0 108.997 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 130' ' ' ARG . . . -87.24 113.74 23.23 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.534 -0.729 . . . . 0.0 111.022 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -110.08 -29.68 8.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.747 -0.596 . . . . 0.0 109.661 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -116.6 168.29 10.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.701 -0.624 . . . . 0.0 109.815 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.9 m -145.11 132.9 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.532 -0.73 . . . . 0.0 110.824 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -107.45 132.14 53.52 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.576 -0.703 . . . . 0.0 110.264 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -130.17 161.1 31.88 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.712 -0.618 . . . . 0.0 110.432 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.56 HG22 HH21 ' A' ' 155' ' ' ARG . 21.9 t -96.3 142.05 24.0 Favored Pre-proline 0 N--CA 1.498 1.973 0 O-C-N 121.514 -0.741 . . . . 0.0 109.96 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.418 ' HB2' ' HG2' ' A' ' 173' ' ' GLU . 49.5 Cg_endo -74.96 159.99 40.81 Favored 'Trans proline' 0 N--CA 1.486 1.047 0 O-C-N 123.253 1.133 . . . . 0.0 110.186 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 151' ' ' VAL . 67.7 t -87.55 -28.2 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.453 -0.779 . . . . 0.0 110.748 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.418 ' HG2' ' HB2' ' A' ' 171' ' ' PRO . 9.0 pt-20 -58.8 -28.64 66.17 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.354 -0.841 . . . . 0.0 110.615 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.404 ' N ' ' HG3' ' A' ' 173' ' ' GLU . 58.0 m -68.15 -28.49 67.34 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.487 -0.758 . . . . 0.0 110.319 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 57.8 mtt -60.37 -29.46 68.94 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.51 -0.743 . . . . 0.0 110.504 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -60.07 -41.09 91.67 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.459 -0.776 . . . . 0.0 110.196 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 88.1 m -70.1 -41.19 74.35 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.551 -0.718 . . . . 0.0 110.05 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 88.0 m -70.1 -39.87 75.27 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.618 -0.676 . . . . 0.0 110.102 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 5.5 tmm? -59.97 -39.88 87.17 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.582 -0.699 . . . . 0.0 110.195 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.03 -39.84 87.26 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.618 -0.676 . . . . 0.0 110.245 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.845 0 O-C-N 121.651 -0.656 . . . . 0.0 110.227 -179.902 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 121.191 0.519 . . . . 0.0 110.294 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.1 p -135.2 146.7 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.489 -0.757 . . . . 0.0 110.064 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -104.24 165.53 10.99 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.561 -0.712 . . . . 0.0 110.256 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.8 p -121.69 129.96 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.578 -0.701 . . . . 0.0 110.074 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.8 m -141.11 147.48 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.532 -0.73 . . . . 0.0 110.512 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 54.2 m -120.07 154.72 34.23 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.581 -0.7 . . . . 0.0 110.201 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.481 HG22 ' H ' ' A' ' 39' ' ' ALA . 0.7 OUTLIER -122.78 -178.09 3.84 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.6 -0.687 . . . . 0.0 110.085 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.481 ' H ' HG22 ' A' ' 38' ' ' THR . . . -59.9 -49.84 76.11 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.553 -0.717 . . . . 0.0 110.744 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.4 p -125.8 8.06 7.49 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.479 -0.763 . . . . 0.0 111.541 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -143.41 159.32 42.6 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.06 -1.025 . . . . 0.0 110.83 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 41.0 m -142.82 121.15 12.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.67 -0.644 . . . . 0.0 109.55 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -135.39 174.81 10.19 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.575 -0.703 . . . . 0.0 110.485 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.8 mt -122.74 163.47 20.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.64 -0.662 . . . . 0.0 110.619 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -132.0 144.98 51.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.648 -0.657 . . . . 0.0 110.125 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.452 HG21 ' HB3' ' A' ' 142' ' ' PRO . 88.9 m -121.73 140.7 51.99 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.494 -0.754 . . . . 0.0 110.233 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.5 t -83.3 106.88 15.43 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.535 -0.728 . . . . 0.0 110.114 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.1 t -122.32 128.38 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.501 -0.749 . . . . 0.0 110.14 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.446 ' O ' HG23 ' A' ' 51' ' ' VAL . 13.1 t-20 53.46 39.95 30.68 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.498 -0.751 . . . . 0.0 111.009 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.638 ' O ' ' HB3' ' A' ' 87' ' ' ALA . . . 64.09 21.56 66.05 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 49' ' ' ASN . 96.7 t -130.2 129.62 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.392 -1.064 . . . . 0.0 109.667 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 35.1 t -81.7 104.51 12.15 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.577 -0.702 . . . . 0.0 109.297 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -95.8 136.91 35.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.599 -0.688 . . . . 0.0 110.779 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.606 HG21 ' CZ3' ' A' ' 85' ' ' TRP . 7.5 t -136.97 177.73 7.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.74 -0.6 . . . . 0.0 109.736 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.652 HG21 ' HB3' ' A' ' 139' ' ' SER . 95.2 t -81.47 141.88 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.477 -0.764 . . . . 0.0 109.277 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.867 ' CE2' HG22 ' A' ' 78' ' ' VAL . 43.6 t80 -84.29 -42.28 15.99 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.333 -0.855 . . . . 0.0 111.18 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.489 ' CE1' HG11 ' A' ' 55' ' ' VAL . 2.2 p-80 -65.72 -17.13 64.39 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.338 -0.851 . . . . 0.0 111.014 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -99.57 -57.32 0.94 Allowed Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.93 -36.52 27.95 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.468 -1.019 . . . . 0.0 110.586 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.531 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -179.703 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 72.4 m . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 121.165 0.507 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -68.8 130.29 42.37 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.593 -0.692 . . . . 0.0 110.722 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.6 ttt -72.94 -40.01 65.77 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.621 -0.674 . . . . 0.0 110.632 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -113.18 140.01 48.28 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.451 -0.781 . . . . 0.0 110.414 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.7 m -145.07 127.31 15.75 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.535 -0.728 . . . . 0.0 110.346 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 -155.36 105.81 2.51 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.38 -0.825 . . . . 0.0 111.184 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.867 HG22 ' CE2' ' A' ' 56' ' ' TYR . 54.4 t -69.94 -40.03 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.466 -0.771 . . . . 0.0 109.21 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -57.8 -45.76 85.61 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.464 -0.772 . . . . 0.0 109.958 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.755 ' HG2' HD12 ' A' ' 82' ' ' LEU . 31.5 tt0 -81.69 -12.47 58.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.795 -0.566 . . . . 0.0 110.114 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 39.6 t0 54.39 39.91 31.35 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.163 -0.961 . . . . 0.0 110.756 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.755 HD12 ' HG2' ' A' ' 80' ' ' GLN . 76.5 mt -140.23 151.57 45.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.588 -0.695 . . . . 0.0 110.698 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.465 HG22 ' HD1' ' A' ' 56' ' ' TYR . 9.8 t -131.94 152.57 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -131.19 156.11 21.63 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.544 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.606 ' CZ3' HG21 ' A' ' 54' ' ' THR . 1.7 m0 -136.08 159.79 40.63 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.785 -0.833 . . . . 0.0 109.755 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -83.4 123.34 29.58 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.394 -0.816 . . . . 0.0 109.954 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 50' ' ' GLY . . . -97.1 149.5 35.77 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.558 -0.714 . . . . 0.0 110.33 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.33 154.95 56.27 Favored 'Trans proline' 0 C--N 1.316 -1.158 0 O-C-N 123.507 1.267 . . . . 0.0 110.272 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.39 160.14 49.55 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 O-C-N 123.377 1.199 . . . . 0.0 110.345 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.21 30.18 13.08 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -129.85 159.14 37.48 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.469 -1.019 . . . . 0.0 110.103 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -87.77 148.44 24.71 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.557 -0.715 . . . . 0.0 110.213 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 71.3 p -120.26 140.22 51.52 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.595 -0.69 . . . . 0.0 110.204 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 70.4 mt -80.01 160.01 26.02 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.601 -0.687 . . . . 0.0 110.17 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 63.8 p -117.26 155.82 49.42 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.655 -0.653 . . . . 0.0 110.131 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.68 164.45 35.39 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 O-C-N 123.374 1.197 . . . . 0.0 110.295 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.639 ' HB2' HG22 ' A' ' 151' ' ' VAL . 7.8 t -68.03 128.45 36.58 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.504 -0.748 . . . . 0.0 110.333 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.0 p -131.93 48.75 2.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.637 -0.664 . . . . 0.0 109.745 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.8 p -144.42 -8.32 0.67 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.63 -0.669 . . . . 0.0 112.428 -179.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.76 32.32 74.06 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.1 t -80.55 113.69 18.92 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.443 -1.034 . . . . 0.0 110.281 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 66.5 m -60.01 -39.96 87.61 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.549 -0.719 . . . . 0.0 110.467 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -68.44 136.21 52.9 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.554 -0.716 . . . . 0.0 110.067 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.432 HD23 ' SG ' ' A' ' 145' ' ' CYS . 48.9 mt -137.44 159.55 41.62 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.563 -0.711 . . . . 0.0 110.61 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -119.98 139.75 52.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.661 -0.649 . . . . 0.0 109.378 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.529 HD13 HD21 ' A' ' 143' ' ' LEU . 51.7 tp -115.15 126.74 54.98 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.515 -0.74 . . . . 0.0 110.223 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 89.5 t -90.61 111.73 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.677 -0.639 . . . . 0.0 109.58 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.5 m -90.02 154.29 19.92 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.607 -0.683 . . . . 0.0 110.321 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 72.6 ttt-85 -60.01 -19.27 51.67 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.652 -0.655 . . . . 0.0 110.619 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -94.82 26.97 3.29 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.341 -0.849 . . . . 0.0 110.544 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 55.69 45.79 23.88 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.262 -0.899 . . . . 0.0 110.648 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -119.72 146.05 45.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.62 -0.675 . . . . 0.0 109.975 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 113' ' ' VAL . 13.9 p -124.21 129.98 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.44 -0.788 . . . . 0.0 110.743 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 61.5 mt -127.77 137.9 31.74 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.63 -0.669 . . . . 0.0 109.727 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -75.97 140.32 22.78 Favored 'Trans proline' 0 N--CA 1.485 1.018 0 O-C-N 123.197 1.104 . . . . 0.0 110.819 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.5 t -129.94 130.86 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.535 -0.728 . . . . 0.0 110.049 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.8 mmm180 -90.51 135.86 33.43 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.53 -0.732 . . . . 0.0 110.229 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 45.5 ttt85 -67.6 122.57 18.31 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.513 -0.742 . . . . 0.0 110.095 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -127.19 22.17 6.64 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.531 -0.731 . . . . 0.0 110.526 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 167.88 -175.92 42.62 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -70.58 -41.29 72.57 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.588 -0.949 . . . . 0.0 110.672 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.7 p -131.18 13.07 5.14 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.525 -0.734 . . . . 0.0 111.275 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 -130.27 138.58 50.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.187 -0.945 . . . . 0.0 110.269 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -137.29 156.15 23.28 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.3 p -86.3 159.48 19.41 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.509 -0.995 . . . . 0.0 110.16 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 49.4 tp -108.05 128.54 54.76 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.652 -0.655 . . . . 0.0 110.012 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.94 -40.05 91.79 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.618 -0.676 . . . . 0.0 110.338 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 62.3 m -116.15 102.61 53.7 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.447 -0.783 . . . . 0.0 110.35 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.3 123.3 8.13 Favored 'Trans proline' 0 C--N 1.319 -1.003 0 O-C-N 123.319 1.168 . . . . 0.0 110.508 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.465 ' CB ' ' CD1' ' A' ' 134' ' ' TYR . 12.7 mtt-85 -131.91 170.94 10.04 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.588 -0.695 . . . . 0.0 110.161 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 41.5 Cg_endo -65.86 150.22 85.99 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 O-C-N 123.385 1.203 . . . . 0.0 111.322 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 162' ' ' GLY . 79.2 t -54.26 -28.44 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.216 -0.927 . . . . 0.0 110.075 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 29.3 t -63.48 -31.04 72.09 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.619 -0.676 . . . . 0.0 109.637 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.465 ' CD1' ' CB ' ' A' ' 130' ' ' ARG . 0.0 OUTLIER -64.76 -40.74 95.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.675 -0.64 . . . . 0.0 109.52 179.784 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 135' ' ' LEU . 13.9 tp -101.93 17.84 22.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.805 -0.559 . . . . 0.0 110.974 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -84.86 136.02 33.83 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.428 -0.795 . . . . 0.0 110.555 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.71 23.89 57.04 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 19.8 m -120.07 11.15 11.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.444 -1.033 . . . . 0.0 110.967 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.652 ' HB3' HG21 ' A' ' 55' ' ' VAL . 12.6 m -59.18 156.49 12.13 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.184 -0.947 . . . . 0.0 110.352 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 89.97 -13.05 65.66 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.574 -1.011 . . . . 0.0 110.574 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -64.62 120.26 18.39 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.452 ' HB3' HG21 ' A' ' 46' ' ' THR . 51.0 Cg_endo -78.09 145.03 21.65 Favored 'Trans proline' 0 C--N 1.32 -0.949 0 O-C-N 123.039 1.02 . . . . 0.0 111.12 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.529 HD21 HD13 ' A' ' 106' ' ' LEU . 1.0 OUTLIER -100.01 121.02 40.72 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.265 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.5 mp -118.53 154.48 32.49 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.535 -0.728 . . . . 0.0 111.267 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.432 ' SG ' HD23 ' A' ' 104' ' ' LEU . 0.9 OUTLIER -96.22 175.3 2.78 Favored Pre-proline 0 N--CA 1.491 1.603 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.358 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.97 -24.93 38.91 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.233 1.122 . . . . 0.0 110.415 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 28.8 m -65.59 -39.94 92.14 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.442 -0.786 . . . . 0.0 110.172 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 117.03 39.17 0.83 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -127.54 144.56 51.05 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.532 -0.981 . . . . 0.0 110.334 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -74.66 145.2 43.4 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.574 -0.704 . . . . 0.0 110.492 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.639 HG22 ' HB2' ' A' ' 97' ' ' CYS . 66.4 t -113.47 -51.47 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.612 -0.68 . . . . 0.0 109.93 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -174.64 -164.27 29.22 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 95.2 mt -131.72 144.04 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.522 -0.987 . . . . 0.0 109.981 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -59.95 126.56 28.02 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.55 -0.719 . . . . 0.0 109.825 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 44.5 ttt180 -105.8 -69.2 0.83 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.664 -0.647 . . . . 0.0 110.71 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -132.39 151.07 52.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.525 -0.734 . . . . 0.0 110.749 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -95.15 133.93 38.44 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.726 -0.609 . . . . 0.0 110.162 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 51.8 t -100.7 114.88 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.602 -0.686 . . . . 0.0 110.351 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.3 p -140.26 140.55 35.77 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.491 -0.755 . . . . 0.0 110.709 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 36.0 m -81.23 -47.9 12.77 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.611 -0.681 . . . . 0.0 110.045 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -127.31 42.58 3.29 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.674 -0.641 . . . . 0.0 110.031 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.525 ' O ' HG23 ' A' ' 132' ' ' VAL . . . 91.38 -11.33 72.44 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 77.4 t -97.52 122.43 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.141 -1.211 . . . . 0.0 109.198 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -88.84 115.8 26.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.59 -0.694 . . . . 0.0 110.594 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -104.03 -30.1 10.48 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -124.43 155.76 38.3 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.54 139.99 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.539 -0.726 . . . . 0.0 110.384 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -115.3 131.33 56.96 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.657 -0.652 . . . . 0.0 110.408 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -137.14 158.79 43.66 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.652 -0.655 . . . . 0.0 110.015 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 60.2 t -96.52 130.35 30.85 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.555 -0.716 . . . . 0.0 110.361 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.26 167.27 27.76 Favored 'Trans proline' 0 N--CA 1.485 0.989 0 O-C-N 123.157 1.083 . . . . 0.0 110.314 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 67.8 t -70.17 -30.5 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.532 -0.73 . . . . 0.0 110.237 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -59.94 -40.06 87.68 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.546 -0.721 . . . . 0.0 110.586 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 19.8 t -61.74 -38.77 89.19 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.57 -0.706 . . . . 0.0 110.37 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 68.6 mtt -59.93 -29.1 68.16 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.573 -0.704 . . . . 0.0 110.499 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -59.98 -38.11 81.61 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.603 -0.686 . . . . 0.0 110.665 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 91.4 m -60.02 -40.02 87.87 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.409 -0.807 . . . . 0.0 110.615 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 88.0 m -60.01 -36.4 77.14 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.442 -0.786 . . . . 0.0 110.48 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.8 mtt -60.0 -38.96 84.15 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.454 -0.779 . . . . 0.0 110.722 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 53.3 mtt180 -60.05 -39.96 87.79 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.39 -0.819 . . . . 0.0 110.364 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.791 0 O-C-N 121.608 -0.683 . . . . 0.0 110.205 179.894 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.848 ' HG3' HG23 ' A' ' 33' ' ' VAL . 14.6 pt-20 . . . . . 0 N--CA 1.497 1.888 0 CA-C-O 121.106 0.479 . . . . 0.0 110.368 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.848 HG23 ' HG3' ' A' ' 32' ' ' GLU . 71.7 t -118.08 130.01 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.549 -0.719 . . . . 0.0 110.034 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -104.58 140.5 37.91 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.682 -0.636 . . . . 0.0 110.304 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.528 HG13 ' O ' ' A' ' 35' ' ' VAL . 11.1 p -89.62 119.7 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.504 -0.747 . . . . 0.0 110.269 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 62.7 t -124.23 129.9 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.399 -0.813 . . . . 0.0 110.103 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.5 m -119.42 135.67 54.64 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.509 -0.744 . . . . 0.0 110.345 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.43 178.31 4.59 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.469 -0.769 . . . . 0.0 109.892 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.0 -50.18 74.77 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.678 -0.639 . . . . 0.0 110.602 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 74.3 p -117.77 -20.03 9.04 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.575 -0.703 . . . . 0.0 111.041 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -114.81 171.08 7.86 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.313 -0.867 . . . . 0.0 110.394 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 72.1 p -149.84 121.46 8.02 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.642 -0.661 . . . . 0.0 110.034 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 59' ' ' ALA . 41.1 p90 -134.49 171.01 14.91 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.557 -0.715 . . . . 0.0 110.028 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 91.3 mt -119.26 158.37 26.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.568 -0.707 . . . . 0.0 110.529 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -125.64 151.99 45.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.634 -0.666 . . . . 0.0 110.212 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.1 p -125.78 144.12 50.77 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.623 -0.673 . . . . 0.0 110.007 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 35.4 t -94.61 110.08 21.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.448 -0.783 . . . . 0.0 110.434 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.423 HG22 ' HB2' ' A' ' 94' ' ' LEU . 63.3 t -123.05 126.98 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.589 -0.695 . . . . 0.0 110.144 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.9 m120 53.09 39.02 28.88 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.461 -0.774 . . . . 0.0 111.227 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.44 19.59 72.8 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 63.2 t -130.18 129.87 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.296 -1.12 . . . . 0.0 109.623 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 92.4 m -84.47 133.54 34.47 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.522 -0.736 . . . . 0.0 109.684 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -119.91 136.61 54.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.519 -0.738 . . . . 0.0 110.546 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.872 HG23 HG23 ' A' ' 83' ' ' VAL . 9.8 t -137.96 175.02 9.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.708 -0.62 . . . . 0.0 109.72 179.05 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.643 HG11 ' CE1' ' A' ' 57' ' ' HIS . 85.8 t -80.98 142.45 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.448 -0.783 . . . . 0.0 109.993 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.797 ' CE2' HG22 ' A' ' 78' ' ' VAL . 31.4 t80 -76.54 -42.75 41.92 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.644 -0.66 . . . . 0.0 111.71 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.643 ' CE1' HG11 ' A' ' 55' ' ' VAL . 2.5 p-80 -69.94 -15.22 63.02 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.313 -0.867 . . . . 0.0 111.102 -178.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -104.84 -77.95 1.19 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.417 ' HB2' ' CE2' ' A' ' 43' ' ' PHE . . . -71.16 -39.99 71.58 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.513 -0.993 . . . . 0.0 110.697 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.505 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -179.657 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.3 m . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 121.064 0.459 . . . . 0.0 110.366 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -64.13 131.0 46.17 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.595 -0.691 . . . . 0.0 110.009 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 19.8 mmt -93.21 -35.76 12.96 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.569 -0.707 . . . . 0.0 110.457 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.594 ' O ' HG12 ' A' ' 83' ' ' VAL . 64.3 m-85 -125.57 134.13 52.06 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.509 -0.744 . . . . 0.0 110.432 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.705 ' HA ' HG12 ' A' ' 83' ' ' VAL . 15.0 p -147.11 121.34 9.54 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.51 -0.744 . . . . 0.0 110.146 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -156.91 116.51 3.45 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.451 -0.781 . . . . 0.0 110.93 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.797 HG22 ' CE2' ' A' ' 56' ' ' TYR . 95.7 t -71.74 -37.1 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.484 -0.76 . . . . 0.0 109.616 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -58.62 -48.16 81.94 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.475 -0.766 . . . . 0.0 109.653 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.532 ' HG2' HD12 ' A' ' 82' ' ' LEU . 37.9 tt0 -84.06 -14.25 51.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.579 -0.701 . . . . 0.0 109.922 178.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.492 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 61.4 t0 55.31 40.0 31.41 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.242 -0.911 . . . . 0.0 111.053 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.568 HD11 HG11 ' A' ' 170' ' ' VAL . 74.9 mt -140.96 147.29 38.54 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.424 -0.798 . . . . 0.0 111.595 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.872 HG23 HG23 ' A' ' 54' ' ' THR . 2.4 m -142.26 173.87 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.059 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -167.23 169.98 41.28 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -128.98 158.92 37.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.709 -0.877 . . . . 0.0 109.648 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -81.04 121.29 25.88 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.539 -0.726 . . . . 0.0 110.059 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -114.09 155.7 45.11 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.583 -0.698 . . . . 0.0 110.316 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.59 153.68 60.01 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 123.42 1.221 . . . . 0.0 110.543 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.59 155.72 54.41 Favored 'Trans proline' 0 C--N 1.317 -1.094 0 O-C-N 123.405 1.213 . . . . 0.0 110.349 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 109.17 31.0 3.43 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -128.65 160.03 33.74 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.489 -1.006 . . . . 0.0 110.371 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 76.6 mtt85 -65.56 140.96 58.59 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.636 -0.665 . . . . 0.0 110.25 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 58.0 m -121.87 146.46 47.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.575 -0.703 . . . . 0.0 110.219 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.423 ' HB2' HG22 ' A' ' 48' ' ' VAL . 95.4 mt -94.47 144.4 25.6 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.561 -0.712 . . . . 0.0 110.29 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.645 ' O ' ' HB3' ' A' ' 150' ' ' ALA . 7.7 t -104.3 150.73 38.73 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.639 -0.663 . . . . 0.0 110.169 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.76 151.76 69.12 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.384 1.202 . . . . 0.0 110.388 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 18.8 t -80.83 129.97 34.81 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.567 -0.708 . . . . 0.0 110.431 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 98' ' ' THR . 7.7 t -135.44 56.17 1.85 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.632 -0.667 . . . . 0.0 109.859 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.3 p -145.38 11.55 1.31 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.601 -0.687 . . . . 0.0 111.552 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 51.11 51.3 36.05 Favored Glycine 0 N--CA 1.501 2.979 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.33 109.92 15.28 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.463 -1.022 . . . . 0.0 110.506 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 29.6 p -69.92 -34.99 74.21 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.612 -0.68 . . . . 0.0 109.864 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -84.06 110.8 18.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.72 -0.612 . . . . 0.0 109.922 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.515 HD22 HG21 ' A' ' 151' ' ' VAL . 88.0 mt -115.68 136.45 53.05 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.555 -0.716 . . . . 0.0 110.198 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -106.82 139.76 40.73 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.447 -0.783 . . . . 0.0 110.177 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.428 HD12 HD21 ' A' ' 143' ' ' LEU . 7.3 tt -111.3 141.91 44.22 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.558 -0.714 . . . . 0.0 110.322 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.8 t -94.6 130.8 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.675 -0.641 . . . . 0.0 110.113 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.0 m -104.04 162.54 13.06 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.549 -0.719 . . . . 0.0 110.082 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -61.04 -23.84 65.74 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.488 -0.758 . . . . 0.0 110.599 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -95.39 26.53 3.79 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.469 -0.769 . . . . 0.0 110.637 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.14 43.35 30.79 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.336 -0.852 . . . . 0.0 110.991 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -111.34 130.91 55.53 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.477 -0.765 . . . . 0.0 109.821 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.3 m -101.43 148.13 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.558 -0.714 . . . . 0.0 110.578 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.403 ' O ' HG23 ' A' ' 114' ' ' ILE . 7.4 tt -148.55 132.66 8.67 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.561 -0.712 . . . . 0.0 109.997 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.71 142.74 36.32 Favored 'Trans proline' 0 C--N 1.319 -0.994 0 O-C-N 123.14 1.074 . . . . 0.0 110.693 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.0 t -129.97 130.21 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.66 -0.65 . . . . 0.0 110.007 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -78.07 129.97 35.87 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.491 -0.756 . . . . 0.0 110.222 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -64.23 140.03 58.83 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.568 -0.708 . . . . 0.0 110.031 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -147.56 47.19 1.12 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.587 -0.696 . . . . 0.0 110.265 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 138.53 169.05 11.47 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -60.53 -42.04 95.65 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.569 -0.959 . . . . 0.0 110.196 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.8 m -127.94 25.49 5.93 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.59 -0.694 . . . . 0.0 110.143 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.18 136.93 42.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.533 -0.73 . . . . 0.0 110.242 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -134.26 170.4 22.62 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 14.4 m -120.24 139.81 52.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.525 -0.986 . . . . 0.0 110.362 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 57.9 tp -75.86 137.08 40.2 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.625 -0.672 . . . . 0.0 109.941 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.04 -48.69 80.68 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.544 -0.722 . . . . 0.0 110.584 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 78.5 p -117.72 139.66 26.62 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.537 -0.727 . . . . 0.0 110.012 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -75.55 126.35 9.56 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 O-C-N 123.266 1.14 . . . . 0.0 110.788 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 -129.85 163.04 49.89 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.616 -0.678 . . . . 0.0 109.61 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.79 150.18 67.71 Favored 'Trans proline' 0 C--N 1.315 -1.224 0 O-C-N 123.327 1.172 . . . . 0.0 110.739 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 69.9 t -59.95 -33.55 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.601 -0.687 . . . . 0.0 109.664 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 25.6 t -59.37 -40.05 85.24 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.605 -0.684 . . . . 0.0 110.461 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -61.45 -40.76 95.67 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.546 -0.721 . . . . 0.0 109.753 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.545 HD21 ' CZ ' ' A' ' 154' ' ' PHE . 55.6 tp -89.9 -10.3 45.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.783 -0.573 . . . . 0.0 111.282 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.1 tttm -63.7 137.27 58.01 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.271 -0.893 . . . . 0.0 110.622 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 88.65 23.11 37.27 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 70.7 m -120.55 6.34 10.57 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.331 -1.1 . . . . 0.0 111.32 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.592 ' HB3' HG21 ' A' ' 55' ' ' VAL . 50.6 m -58.65 146.17 37.21 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.973 -1.079 . . . . 0.0 110.076 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 96.37 -24.36 30.78 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.16 111.64 3.79 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.24 149.41 45.6 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 O-C-N 123.169 1.089 . . . . 0.0 110.834 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.504 ' N ' HD12 ' A' ' 143' ' ' LEU . 6.3 mp -101.21 127.5 47.76 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.7 mp -118.45 122.35 42.54 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.472 -0.767 . . . . 0.0 110.948 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 27.3 p -68.49 162.93 58.22 Favored Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -64.4 -21.0 66.79 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 O-C-N 123.148 1.078 . . . . 0.0 111.327 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.6 m -62.74 -39.97 95.77 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.341 -0.849 . . . . 0.0 109.997 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 118.59 40.17 0.68 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -133.38 153.36 51.66 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.59 -0.947 . . . . 0.0 110.354 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.645 ' HB3' ' O ' ' A' ' 95' ' ' THR . . . -78.47 134.06 37.38 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.549 -0.719 . . . . 0.0 110.049 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.515 HG21 HD22 ' A' ' 104' ' ' LEU . 59.7 t -99.81 -59.98 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.527 -0.733 . . . . 0.0 110.365 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.528 ' HA2' HG23 ' A' ' 172' ' ' VAL . . . -176.31 -163.54 28.96 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 91.4 mt -128.5 139.99 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.639 -0.918 . . . . 0.0 110.159 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.545 ' CZ ' HD21 ' A' ' 135' ' ' LEU . 15.4 t80 -61.75 130.07 44.04 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.55 -0.719 . . . . 0.0 110.023 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -107.62 -63.83 1.27 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.636 -0.665 . . . . 0.0 110.636 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -136.96 152.65 50.42 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.513 -0.742 . . . . 0.0 110.815 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.64 155.37 16.9 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.694 -0.629 . . . . 0.0 109.632 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 48.0 t -121.05 112.38 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.534 -0.728 . . . . 0.0 110.519 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.4 p -141.58 142.3 33.48 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.485 -0.76 . . . . 0.0 110.429 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 25.0 m -80.2 -41.43 25.24 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.492 -0.755 . . . . 0.0 110.122 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -136.02 46.49 2.3 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.534 -0.729 . . . . 0.0 110.498 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 90.1 -10.68 73.28 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.344 -1.103 . . . . 0.0 110.344 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 63.3 t -98.39 120.75 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.141 -1.211 . . . . 0.0 109.386 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.58 114.61 24.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.587 -0.695 . . . . 0.0 110.752 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -101.65 -29.44 11.92 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 125' ' ' SER . . . -130.34 159.96 35.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.711 -0.618 . . . . 0.0 109.444 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.7 m -133.49 141.41 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.429 -0.794 . . . . 0.0 110.571 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -118.02 133.5 55.86 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.537 -0.727 . . . . 0.0 110.176 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -136.52 160.1 39.79 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.462 -0.773 . . . . 0.0 110.506 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.568 HG11 HD11 ' A' ' 82' ' ' LEU . 58.8 t -96.68 135.43 22.26 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.522 -0.736 . . . . 0.0 110.161 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.08 150.93 43.75 Favored 'Trans proline' 0 N--CA 1.486 1.043 0 O-C-N 123.216 1.114 . . . . 0.0 110.601 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.528 HG23 ' HA2' ' A' ' 152' ' ' GLY . 61.9 t -71.14 -28.4 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.587 -0.695 . . . . 0.0 110.227 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -60.01 -39.93 87.53 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.451 -0.781 . . . . 0.0 110.67 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 62.2 p -61.79 -28.85 69.75 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.516 -0.74 . . . . 0.0 110.589 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 67.6 mtt -61.59 -34.92 76.45 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.535 -0.728 . . . . 0.0 110.475 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -59.98 -40.79 90.31 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.525 -0.734 . . . . 0.0 110.314 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 92.3 m -63.53 -40.04 95.98 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.514 -0.741 . . . . 0.0 109.925 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 63.6 m -62.67 -41.54 99.14 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.59 -0.694 . . . . 0.0 110.154 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 58.8 ttp -60.04 -40.93 91.05 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.613 -0.68 . . . . 0.0 110.315 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 44.5 ttp85 -60.02 -39.99 87.78 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.59 -0.693 . . . . 0.0 110.087 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.852 0 O-C-N 121.577 -0.702 . . . . 0.0 110.162 179.987 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.024 0.44 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 45' ' ' ALA . 11.0 p -137.33 130.46 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.596 -0.69 . . . . 0.0 109.932 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.3 mp0 -104.32 132.48 50.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.568 -0.708 . . . . 0.0 110.273 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.3 m -76.63 135.72 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.659 -0.65 . . . . 0.0 109.934 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.7 p -137.29 138.9 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.56 -0.712 . . . . 0.0 110.148 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.3 t -122.46 136.85 54.98 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.631 -0.668 . . . . 0.0 110.141 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.508 HG22 ' H ' ' A' ' 39' ' ' ALA . 1.1 m -100.16 179.97 4.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.567 -0.708 . . . . 0.0 109.979 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.508 ' H ' HG22 ' A' ' 38' ' ' THR . . . -60.03 -41.23 91.77 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.651 -0.656 . . . . 0.0 111.017 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.4 p -121.59 -25.55 5.1 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.407 -0.808 . . . . 0.0 111.676 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -118.23 159.58 23.08 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.292 -0.88 . . . . 0.0 110.751 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 11.1 m -140.06 120.79 14.35 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.605 -0.684 . . . . 0.0 110.178 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -135.79 176.31 8.8 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.609 -0.682 . . . . 0.0 109.877 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.4 mt -116.86 160.36 20.97 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.451 -0.781 . . . . 0.0 110.398 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.645 ' O ' HG23 ' A' ' 33' ' ' VAL . . . -129.37 143.85 51.0 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.481 -0.762 . . . . 0.0 110.478 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.579 HG21 ' HB3' ' A' ' 142' ' ' PRO . 89.7 m -123.1 136.93 55.0 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.51 -0.743 . . . . 0.0 110.115 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 47.3 t -95.43 111.67 23.52 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.542 -0.724 . . . . 0.0 110.602 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.98 139.35 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.504 -0.748 . . . . 0.0 110.195 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 55.21 37.17 28.49 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.524 -0.735 . . . . 0.0 110.794 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.1 14.15 63.22 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.9 t -131.73 130.0 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.18 -1.188 . . . . 0.0 109.781 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.419 ' SG ' ' HB1' ' A' ' 45' ' ' ALA . 43.1 t -86.02 113.43 22.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.523 -0.736 . . . . 0.0 109.923 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.444 ' CZ3' ' CD2' ' A' ' 82' ' ' LEU . 80.0 m95 -106.51 137.12 45.08 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.558 -0.714 . . . . 0.0 110.82 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.546 HG23 HG13 ' A' ' 83' ' ' VAL . 7.6 t -136.81 -179.31 5.62 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.66 HG11 ' CE1' ' A' ' 57' ' ' HIS . 59.4 t -80.14 142.52 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.398 -0.814 . . . . 0.0 109.194 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.883 ' CE2' HG22 ' A' ' 78' ' ' VAL . 28.7 t80 -83.28 -39.99 20.13 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.352 -0.843 . . . . 0.0 111.861 -178.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.66 ' CE1' HG11 ' A' ' 55' ' ' VAL . 1.2 p80 -60.19 -18.66 49.73 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.98 -1.075 . . . . 0.0 110.956 -178.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -97.64 -69.37 0.97 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.62 -36.3 70.72 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.582 -0.952 . . . . 0.0 110.588 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.647 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -179.421 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.1 m . . . . . 0 N--CA 1.494 1.732 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -61.1 124.62 21.05 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.476 -0.765 . . . . 0.0 110.074 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.7 tpt -64.9 -40.04 94.46 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.639 -0.663 . . . . 0.0 110.536 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.408 ' O ' HG23 ' A' ' 83' ' ' VAL . 43.2 m-85 -124.43 134.27 53.13 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.571 -0.706 . . . . 0.0 110.308 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.0 p -146.37 136.21 23.34 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.5 -0.75 . . . . 0.0 110.391 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -162.0 105.46 1.19 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.522 -0.736 . . . . 0.0 110.027 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.883 HG22 ' CE2' ' A' ' 56' ' ' TYR . 72.2 t -68.18 -40.0 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.511 -0.743 . . . . 0.0 110.267 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -57.93 -39.81 78.93 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.546 -0.721 . . . . 0.0 110.762 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -99.06 -7.25 27.05 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.535 -0.728 . . . . 0.0 111.3 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.1 t0 55.81 40.43 30.68 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.881 -1.137 . . . . 0.0 109.616 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.584 HD13 HG11 ' A' ' 170' ' ' VAL . 4.7 tp -119.04 132.01 56.01 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.463 0.649 . . . . 0.0 110.114 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.595 HG11 ' HA ' ' A' ' 56' ' ' TYR . 7.1 p -156.82 160.69 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.721 -0.612 . . . . 0.0 109.427 -179.291 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -177.33 168.34 40.0 Favored Glycine 0 N--CA 1.495 2.614 0 C-N-CA 119.756 -1.211 . . . . 0.0 110.471 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.406 ' CH2' HG21 ' A' ' 54' ' ' THR . 13.5 m-90 -117.38 155.17 30.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.789 -0.83 . . . . 0.0 109.925 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.8 mm-40 -76.63 148.12 37.12 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.493 -0.754 . . . . 0.0 110.168 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -113.01 158.95 36.42 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.509 -0.745 . . . . 0.0 110.243 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.47 157.38 56.52 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.41 1.216 . . . . 0.0 110.526 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.46 160.24 44.89 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.49 1.258 . . . . 0.0 110.421 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 80.5 27.34 51.83 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -115.15 159.02 21.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.515 -0.991 . . . . 0.0 110.127 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.9 tpt85 -81.41 131.68 35.29 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.569 -0.707 . . . . 0.0 110.125 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 59.4 m -115.59 150.24 36.98 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.574 -0.704 . . . . 0.0 110.229 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 94.2 mt -92.7 136.57 33.11 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.531 -0.73 . . . . 0.0 110.376 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 73.9 p -81.43 156.92 70.84 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.605 -0.684 . . . . 0.0 110.407 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.81 163.68 36.52 Favored 'Trans proline' 0 C--N 1.318 -1.027 0 O-C-N 123.435 1.229 . . . . 0.0 110.372 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 49.5 t -87.23 123.76 32.58 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.538 -0.726 . . . . 0.0 110.379 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 98' ' ' THR . 7.2 t -132.84 61.78 1.67 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.662 -0.649 . . . . 0.0 109.883 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.3 p -145.27 7.4 1.16 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.61 -0.681 . . . . 0.0 111.955 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 51.22 48.06 48.22 Favored Glycine 0 N--CA 1.501 3.029 0 O-C-N 120.919 -1.113 . . . . 0.0 110.416 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.8 p -85.27 109.91 18.69 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.51 -0.994 . . . . 0.0 110.629 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 68.5 p -66.99 -39.66 87.21 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.603 -0.686 . . . . 0.0 109.611 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -79.14 128.15 32.93 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.585 -0.697 . . . . 0.0 109.591 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.549 HD22 HG21 ' A' ' 151' ' ' VAL . 92.9 mt -133.6 150.24 51.61 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.401 -0.812 . . . . 0.0 110.696 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -106.85 128.47 54.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.619 -0.676 . . . . 0.0 109.504 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.747 HD12 HD21 ' A' ' 143' ' ' LEU . 7.9 tt -110.48 142.35 42.35 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.571 -0.705 . . . . 0.0 110.422 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.6 t -107.2 125.26 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.611 -0.681 . . . . 0.0 109.781 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 75.1 p -95.39 168.9 10.43 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.644 -0.66 . . . . 0.0 110.386 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 -66.28 -23.48 66.4 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.71 -0.619 . . . . 0.0 110.161 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -93.16 24.5 3.76 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.425 -0.797 . . . . 0.0 110.79 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.71 50.04 16.69 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.338 -0.851 . . . . 0.0 111.032 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -117.67 127.76 54.25 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.319 -0.863 . . . . 0.0 109.827 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.1 t -93.81 120.0 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.577 -0.702 . . . . 0.0 110.096 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 36.0 mt -123.96 135.06 25.87 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.574 -0.704 . . . . 0.0 109.853 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -77.22 143.77 22.74 Favored 'Trans proline' 0 C--N 1.32 -0.954 0 O-C-N 123.199 1.105 . . . . 0.0 110.277 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.3 t -131.45 139.64 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.568 -0.708 . . . . 0.0 110.158 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.3 tpt85 -96.88 133.59 41.3 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.512 -0.743 . . . . 0.0 110.032 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -70.0 136.85 50.86 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.547 -0.72 . . . . 0.0 110.259 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -136.87 26.2 3.03 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.592 -0.693 . . . . 0.0 110.18 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 151.95 -173.93 31.08 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -70.06 -39.07 75.89 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.593 -0.945 . . . . 0.0 110.429 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.3 m -128.78 23.69 5.75 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.52 -0.737 . . . . 0.0 111.184 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 24.5 ttp180 -141.45 143.66 34.0 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.224 -0.923 . . . . 0.0 110.852 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -139.59 -176.68 15.02 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 1.6 m -116.29 160.8 19.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.568 -0.96 . . . . 0.0 110.042 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.463 HD12 HG13 ' A' ' 167' ' ' VAL . 0.3 OUTLIER -110.96 124.1 51.46 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.555 -0.715 . . . . 0.0 110.087 179.791 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.515 ' N ' HD12 ' A' ' 127' ' ' LEU . 6.5 mp -69.98 -40.04 75.6 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.502 -0.749 . . . . 0.0 110.007 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 67.1 m -103.78 109.92 63.02 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.585 -0.697 . . . . 0.0 109.976 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.92 112.47 3.41 Favored 'Trans proline' 0 C--N 1.319 -1.016 0 O-C-N 123.241 1.127 . . . . 0.0 110.48 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -124.92 162.12 45.16 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.628 -0.67 . . . . 0.0 110.17 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.2 150.56 59.66 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 O-C-N 123.505 1.266 . . . . 0.0 110.503 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 162' ' ' GLY . 85.9 t -56.66 -34.34 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.558 -0.714 . . . . 0.0 110.27 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.2 t -59.98 -39.98 87.56 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.538 -0.726 . . . . 0.0 110.52 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -64.15 -40.04 95.31 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.574 -0.703 . . . . 0.0 110.048 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 45.3 tp -88.99 -4.33 58.46 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.679 -0.638 . . . . 0.0 111.35 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -71.26 140.44 50.36 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.11 -0.994 . . . . 0.0 110.975 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 98.39 -2.56 59.25 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 45.3 p -100.86 9.16 42.66 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.149 -1.206 . . . . 0.0 110.716 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.21 129.9 42.9 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.281 -0.887 . . . . 0.0 109.732 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 107.37 -20.77 32.06 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.57 128.5 38.39 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.579 ' HB3' HG21 ' A' ' 46' ' ' THR . 52.0 Cg_endo -76.94 162.24 32.3 Favored 'Trans proline' 0 C--N 1.319 -0.992 0 O-C-N 123.166 1.087 . . . . 0.0 111.304 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.747 HD21 HD12 ' A' ' 106' ' ' LEU . 2.8 mp -116.56 125.11 51.4 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.63 ' N ' HD12 ' A' ' 144' ' ' LEU . 6.5 mp -116.67 129.99 56.47 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.466 -0.771 . . . . 0.0 111.424 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 29.5 p -80.63 163.75 54.81 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.704 -0.623 . . . . 0.0 109.356 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.41 -14.6 44.81 Favored 'Trans proline' 0 N--CA 1.488 1.154 0 O-C-N 123.162 1.085 . . . . 0.0 111.12 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.6 t -66.89 -40.11 87.67 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.284 -0.885 . . . . 0.0 110.004 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 117.05 32.65 1.49 Allowed Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -132.98 148.24 52.27 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.46 -1.023 . . . . 0.0 110.168 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -72.28 134.78 45.75 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.519 -0.738 . . . . 0.0 110.271 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.549 HG21 HD22 ' A' ' 104' ' ' LEU . 58.0 t -98.52 -59.69 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.513 -0.742 . . . . 0.0 110.145 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -176.16 -170.01 38.35 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 45.4 mt -121.34 143.48 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.614 -0.933 . . . . 0.0 110.323 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -61.12 126.76 28.52 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.577 -0.702 . . . . 0.0 109.668 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -106.74 -64.25 1.2 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.474 -0.767 . . . . 0.0 110.972 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -134.1 150.92 51.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.432 -0.792 . . . . 0.0 110.794 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.49 152.9 18.21 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.584 -0.697 . . . . 0.0 109.439 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 46.6 t -120.0 120.01 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.485 -0.759 . . . . 0.0 110.443 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.2 p -140.98 142.16 34.33 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.473 -0.767 . . . . 0.0 110.536 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 92.6 m -70.03 -44.11 69.92 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.58 -0.7 . . . . 0.0 109.865 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -147.93 49.62 1.06 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.651 -0.656 . . . . 0.0 110.133 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.406 ' O ' HG23 ' A' ' 132' ' ' VAL . . . 97.74 -11.19 64.61 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 58.0 t -101.6 123.64 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.195 -1.179 . . . . 0.0 108.97 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.24 118.21 26.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.443 -0.786 . . . . 0.0 111.136 -178.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -111.42 -15.12 13.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.742 -0.599 . . . . 0.0 110.158 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 125' ' ' SER . . . -144.31 167.99 21.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.354 -0.841 . . . . 0.0 109.356 179.348 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.463 HG13 HD12 ' A' ' 126' ' ' LEU . 35.0 m -137.81 145.05 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.319 -0.863 . . . . 0.0 111.131 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.47 132.44 54.73 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.71 -0.619 . . . . 0.0 110.082 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -142.11 154.05 44.61 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.493 -0.755 . . . . 0.0 110.502 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.584 HG11 HD13 ' A' ' 82' ' ' LEU . 89.5 t -92.46 130.96 35.55 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.588 -0.695 . . . . 0.0 109.803 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.13 160.08 46.2 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 O-C-N 123.193 1.101 . . . . 0.0 110.366 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 61.8 t -69.4 -33.1 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.602 -0.686 . . . . 0.0 109.932 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -60.03 -39.94 87.63 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.475 -0.766 . . . . 0.0 110.595 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.9 m -64.96 -22.91 67.08 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.526 -0.734 . . . . 0.0 111.28 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.436 ' HG2' HD11 ' A' ' 82' ' ' LEU . 65.6 mtt -59.97 -35.63 75.41 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.26 -0.9 . . . . 0.0 110.526 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -59.97 -32.8 71.16 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.576 -0.702 . . . . 0.0 110.652 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 93.9 m -59.94 -40.03 87.55 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.409 -0.807 . . . . 0.0 110.404 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 24.8 m -68.8 -34.19 75.13 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.429 -0.794 . . . . 0.0 110.561 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 44.8 ttp -59.97 -41.86 92.88 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.574 -0.704 . . . . 0.0 110.662 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 58.8 mtt-85 -61.32 -39.92 92.29 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.518 -0.739 . . . . 0.0 110.364 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.764 0 O-C-N 121.528 -0.732 . . . . 0.0 110.245 179.97 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 N--CA 1.497 1.921 0 CA-C-O 121.292 0.568 . . . . 0.0 109.942 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.4 t -119.57 138.93 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.716 -0.615 . . . . 0.0 109.614 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -119.43 142.63 48.05 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.511 -0.743 . . . . 0.0 110.569 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.524 ' O ' HG23 ' A' ' 35' ' ' VAL . 34.0 m -85.44 120.4 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.724 -0.61 . . . . 0.0 110.425 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.9 p -130.21 140.0 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.448 -0.783 . . . . 0.0 110.199 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 74.8 m -122.02 149.0 44.13 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.673 -0.642 . . . . 0.0 110.279 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.531 HG22 ' H ' ' A' ' 39' ' ' ALA . 1.0 OUTLIER -110.31 -177.38 3.23 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.639 -0.663 . . . . 0.0 110.004 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.531 ' H ' HG22 ' A' ' 38' ' ' THR . . . -64.5 -40.05 94.94 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.668 -0.645 . . . . 0.0 111.263 -179.284 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.564 HG23 ' HG3' ' A' ' 41' ' ' GLN . 7.2 t -123.72 -11.7 7.7 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.326 -0.859 . . . . 0.0 111.935 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.564 ' HG3' HG23 ' A' ' 40' ' ' THR . 97.0 mt-30 -136.04 162.95 31.46 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.176 -0.952 . . . . 0.0 110.441 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.6 t -140.24 123.47 16.83 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.566 -0.709 . . . . 0.0 110.426 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -136.17 178.03 7.38 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.587 -0.696 . . . . 0.0 110.012 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.402 ' CD2' ' HA ' ' A' ' 35' ' ' VAL . 82.0 mt -117.46 147.19 42.95 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.523 -0.736 . . . . 0.0 110.636 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -109.97 155.3 21.96 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.719 -0.613 . . . . 0.0 110.081 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.7 p -129.95 144.2 51.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.512 -0.742 . . . . 0.0 110.255 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 34.0 t -100.89 115.82 31.3 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.559 -0.713 . . . . 0.0 110.45 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.4 t -129.98 129.97 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.628 -0.67 . . . . 0.0 109.967 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 52.77 40.12 29.93 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.432 -0.793 . . . . 0.0 111.059 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.623 ' O ' ' HB3' ' A' ' 87' ' ' ALA . . . 67.2 20.99 71.68 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 62.1 t -130.87 123.35 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.293 -1.122 . . . . 0.0 109.922 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 42.3 t -80.7 110.07 15.85 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.48 -0.763 . . . . 0.0 109.564 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 46.7 m95 -97.27 137.58 36.06 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.528 -0.732 . . . . 0.0 110.994 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.882 HG23 HG23 ' A' ' 83' ' ' VAL . 10.1 t -136.63 173.1 12.07 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.173 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.727 HG11 ' CE1' ' A' ' 57' ' ' HIS . 45.7 t -80.63 142.57 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.376 -0.827 . . . . 0.0 110.372 -179.297 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.772 ' CE2' HG22 ' A' ' 78' ' ' VAL . 34.7 t80 -74.96 -43.03 56.36 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.606 -0.684 . . . . 0.0 111.976 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.727 ' CE1' HG11 ' A' ' 55' ' ' VAL . 1.8 p-80 -66.35 -13.85 61.2 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.192 -0.942 . . . . 0.0 110.996 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.9 -88.11 1.47 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.33 -39.97 74.41 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.666 -0.902 . . . . 0.0 110.586 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.701 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -179.399 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.0 m . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -77.28 109.29 11.04 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.515 -0.741 . . . . 0.0 110.451 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 48.7 tpp -70.01 -35.77 74.61 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.669 -0.644 . . . . 0.0 110.122 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.581 ' O ' HG12 ' A' ' 83' ' ' VAL . 62.5 m-85 -109.67 128.42 55.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.615 -0.678 . . . . 0.0 109.924 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.637 ' HA ' HG12 ' A' ' 83' ' ' VAL . 11.1 p -144.23 121.21 11.37 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.538 -0.726 . . . . 0.0 110.361 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 59.6 t-20 -151.42 110.85 3.97 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.515 -0.74 . . . . 0.0 110.495 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.772 HG22 ' CE2' ' A' ' 56' ' ' TYR . 99.6 t -70.03 -35.36 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.451 -0.781 . . . . 0.0 109.577 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -60.0 -40.17 88.28 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.392 -0.817 . . . . 0.0 109.391 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.503 ' HG2' HD12 ' A' ' 82' ' ' LEU . 66.7 tt0 -89.93 -14.28 34.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.699 -0.626 . . . . 0.0 110.083 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.47 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 46.5 t0 55.03 40.01 31.81 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.207 -0.933 . . . . 0.0 110.713 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.503 HD12 ' HG2' ' A' ' 80' ' ' GLN . 48.1 mt -144.09 149.6 36.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.512 -0.743 . . . . 0.0 111.165 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.882 HG23 HG23 ' A' ' 54' ' ' THR . 1.9 m -141.24 168.21 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.167 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -152.37 156.73 26.87 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 119.747 -1.216 . . . . 0.0 110.318 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -121.71 146.05 47.41 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.705 -0.879 . . . . 0.0 109.919 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -68.44 129.9 41.3 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.594 -0.692 . . . . 0.0 110.028 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.623 ' HB3' ' O ' ' A' ' 50' ' ' GLY . . . -114.14 159.71 35.3 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.526 -0.734 . . . . 0.0 110.131 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.58 154.7 64.34 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 O-C-N 123.413 1.218 . . . . 0.0 110.376 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.51 160.14 44.93 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 O-C-N 123.41 1.216 . . . . 0.0 110.465 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 77.9 28.97 55.69 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -110.3 155.01 22.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.534 -0.98 . . . . 0.0 110.22 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -58.86 146.38 37.61 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.622 -0.673 . . . . 0.0 110.401 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.5 t -143.43 161.56 38.07 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.629 -0.67 . . . . 0.0 110.453 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.452 HD13 ' HA ' ' A' ' 94' ' ' LEU . 2.5 mm? -108.18 144.79 35.12 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.57 -0.706 . . . . 0.0 110.376 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.8 p -95.42 159.42 32.77 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.56 -0.712 . . . . 0.0 110.393 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.84 150.49 49.68 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 O-C-N 123.394 1.207 . . . . 0.0 110.386 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.617 ' CB ' HG12 ' A' ' 151' ' ' VAL . 47.9 t -87.28 128.26 35.17 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.62 -0.675 . . . . 0.0 110.445 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.5 p -136.12 71.79 1.43 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.584 -0.698 . . . . 0.0 109.927 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.6 p -145.4 8.25 1.18 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.473 -0.767 . . . . 0.0 111.916 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 52.59 42.96 58.85 Favored Glycine 0 N--CA 1.499 2.864 0 O-C-N 120.824 -1.172 . . . . 0.0 110.353 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 26.3 t -79.42 116.65 19.78 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.488 -1.007 . . . . 0.0 110.394 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.6 m -70.05 -39.91 75.43 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.603 -0.686 . . . . 0.0 110.275 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -84.27 142.16 30.44 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.609 -0.682 . . . . 0.0 110.402 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 94.9 mt -132.2 152.23 51.41 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.503 -0.748 . . . . 0.0 110.401 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -114.61 136.8 52.65 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.55 -0.719 . . . . 0.0 109.744 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 57.3 tp -110.85 140.13 45.57 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.43 -0.794 . . . . 0.0 110.422 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.3 t -93.69 129.94 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.616 -0.678 . . . . 0.0 109.913 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.4 m -110.01 160.93 16.0 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.47 -0.769 . . . . 0.0 110.519 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 18.0 ptm180 -62.71 -24.58 67.74 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.676 -0.64 . . . . 0.0 110.864 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -95.48 29.19 2.65 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.418 -0.801 . . . . 0.0 110.629 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 55.34 36.28 26.75 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.304 -0.873 . . . . 0.0 110.44 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -109.18 146.43 34.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.644 -0.66 . . . . 0.0 109.849 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.6 p -138.05 135.68 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.511 -0.743 . . . . 0.0 110.526 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.404 HG23 ' HD2' ' A' ' 115' ' ' PRO . 85.4 mt -126.6 143.68 47.16 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.603 -0.685 . . . . 0.0 109.679 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.404 ' HD2' HG23 ' A' ' 114' ' ' ILE . 49.9 Cg_endo -76.79 139.13 19.53 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 O-C-N 123.274 1.144 . . . . 0.0 110.455 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.3 t -124.79 129.94 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.603 -0.686 . . . . 0.0 109.762 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.0 tpp85 -84.24 139.52 32.31 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.531 -0.731 . . . . 0.0 110.022 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -77.2 129.63 36.2 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.543 -0.723 . . . . 0.0 110.152 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -136.59 25.78 3.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.662 -0.649 . . . . 0.0 110.424 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 175.7 179.8 46.42 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -66.78 -40.11 88.06 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.505 -0.997 . . . . 0.0 110.324 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 67.1 m -136.03 25.94 3.28 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.551 -0.718 . . . . 0.0 110.377 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -136.95 159.99 40.24 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.588 -0.695 . . . . 0.0 110.299 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -150.93 -173.71 21.2 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 97.4 p -120.67 153.44 36.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.62 -0.93 . . . . 0.0 110.245 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.7 tp -106.57 123.6 48.34 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.583 -0.698 . . . . 0.0 110.143 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.494 ' H ' HD12 ' A' ' 127' ' ' LEU . 4.7 mp -66.47 -39.99 89.09 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.543 -0.723 . . . . 0.0 110.304 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 30.0 t -100.22 108.47 52.6 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.488 -0.757 . . . . 0.0 110.262 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.33 115.45 4.35 Favored 'Trans proline' 0 C--N 1.319 -0.994 0 O-C-N 123.18 1.094 . . . . 0.0 110.307 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -124.48 160.7 51.93 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.586 -0.696 . . . . 0.0 110.392 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.44 150.52 58.16 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 O-C-N 123.469 1.247 . . . . 0.0 110.567 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 162' ' ' GLY . 95.0 t -57.72 -30.55 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.564 -0.71 . . . . 0.0 110.258 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.5 t -60.07 -40.61 90.1 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.519 -0.738 . . . . 0.0 110.383 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -64.77 -46.02 83.9 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.579 -0.7 . . . . 0.0 109.868 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.474 HD21 ' CZ ' ' A' ' 154' ' ' PHE . 54.1 tp -78.76 -22.59 46.2 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.681 -0.637 . . . . 0.0 110.91 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.468 ' CD ' HG12 ' A' ' 132' ' ' VAL . 22.8 mttt -60.03 136.38 58.0 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.387 -0.821 . . . . 0.0 110.58 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 98.07 -2.35 59.73 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 68.9 m -109.07 16.23 22.72 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.16 -1.2 . . . . 0.0 110.538 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.8 t -62.43 150.15 40.68 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.415 -0.803 . . . . 0.0 109.842 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 90.1 -12.28 68.23 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.37 113.34 5.36 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -70.64 140.9 40.39 Favored 'Trans proline' 0 C--N 1.318 -1.072 0 O-C-N 123.171 1.09 . . . . 0.0 110.981 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.45 ' O ' HG22 ' A' ' 151' ' ' VAL . 21.7 mt -87.51 125.22 34.19 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.141 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.468 ' HA ' HD13 ' A' ' 144' ' ' LEU . 4.1 mm? -110.41 160.02 16.96 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.322 0.582 . . . . 0.0 110.856 -178.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -109.6 176.18 1.65 Allowed Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.76 -0.587 . . . . 0.0 109.681 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.77 -35.67 12.18 Favored 'Trans proline' 0 C--N 1.317 -1.081 0 O-C-N 123.292 1.154 . . . . 0.0 110.064 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.8 m -62.43 -40.03 95.24 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.605 -0.684 . . . . 0.0 109.756 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 120.21 36.01 0.84 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -126.26 138.14 53.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.523 -0.987 . . . . 0.0 110.146 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.17 140.37 38.97 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.508 -0.745 . . . . 0.0 110.119 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.617 HG12 ' CB ' ' A' ' 97' ' ' CYS . 34.3 m -105.95 -26.51 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.571 -0.705 . . . . 0.0 110.56 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 172.72 -164.49 36.67 Favored Glycine 0 N--CA 1.498 2.77 0 C-N-CA 119.674 -1.25 . . . . 0.0 110.571 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 82.6 mt -130.98 141.83 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.67 -0.9 . . . . 0.0 109.896 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.474 ' CZ ' HD21 ' A' ' 135' ' ' LEU . 20.3 t80 -60.16 130.02 44.61 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.52 -0.737 . . . . 0.0 110.209 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.408 ' HD2' ' CG2' ' A' ' 170' ' ' VAL . 67.8 ttt180 -104.49 -72.96 0.69 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.515 -0.741 . . . . 0.0 110.792 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -132.29 152.96 51.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.306 -0.871 . . . . 0.0 110.867 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.48 156.29 16.53 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.648 -0.658 . . . . 0.0 109.757 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 60.7 t -120.78 115.77 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.601 -0.687 . . . . 0.0 110.248 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.4 p -141.35 146.28 36.46 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.461 -0.774 . . . . 0.0 110.711 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 12.2 m -82.3 -49.16 10.36 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.539 -0.725 . . . . 0.0 110.006 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -129.88 46.44 2.65 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.601 -0.687 . . . . 0.0 110.203 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.516 ' O ' HG23 ' A' ' 132' ' ' VAL . . . 91.78 -10.99 73.33 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 67.2 t -97.61 122.78 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.156 -1.202 . . . . 0.0 109.38 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.55 116.36 25.62 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.542 -0.724 . . . . 0.0 110.9 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 67.5 mttt -104.27 -29.1 11.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.688 -0.633 . . . . 0.0 109.586 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -128.44 157.38 41.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.705 -0.622 . . . . 0.0 109.55 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 31.7 m -133.07 139.99 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.442 -0.786 . . . . 0.0 110.774 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -119.32 133.54 55.68 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.606 -0.683 . . . . 0.0 110.347 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -134.5 156.67 48.21 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.554 -0.716 . . . . 0.0 110.146 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.408 ' CG2' ' HD2' ' A' ' 155' ' ' ARG . 57.5 t -96.2 133.84 24.48 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.507 -0.746 . . . . 0.0 110.254 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.01 159.96 40.68 Favored 'Trans proline' 0 N--CA 1.485 0.988 0 O-C-N 123.253 1.133 . . . . 0.0 110.465 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 59.5 t -72.66 -26.32 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.625 -0.672 . . . . 0.0 110.223 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -59.64 -36.82 77.13 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.458 -0.776 . . . . 0.0 110.46 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 22.9 t -61.17 -38.62 87.15 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.587 -0.696 . . . . 0.0 110.162 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.475 ' HE2' HD13 ' A' ' 82' ' ' LEU . 66.1 mtt -60.04 -34.2 73.07 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.537 -0.727 . . . . 0.0 110.35 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -60.02 -40.34 88.95 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.534 -0.728 . . . . 0.0 110.459 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 94.5 m -65.99 -40.09 90.88 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.523 -0.736 . . . . 0.0 109.67 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 93.9 m -62.89 -40.01 96.23 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.662 -0.649 . . . . 0.0 110.067 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 89.1 mtp -60.08 -40.05 88.22 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.539 -0.726 . . . . 0.0 110.431 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -67.28 -39.97 86.08 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.601 -0.687 . . . . 0.0 110.087 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.798 0 O-C-N 121.593 -0.692 . . . . 0.0 110.251 -179.935 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 120.909 0.385 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.6 t -101.71 124.98 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.42 -0.8 . . . . 0.0 109.978 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -104.62 132.29 51.03 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.521 -0.737 . . . . 0.0 110.362 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.596 HG12 HD22 ' A' ' 44' ' ' LEU . 32.9 m -94.98 129.8 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.644 -0.66 . . . . 0.0 110.116 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.2 m -130.05 159.97 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.353 -0.842 . . . . 0.0 110.772 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 69.0 m -132.76 152.83 51.68 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.544 -0.723 . . . . 0.0 110.152 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.521 HG22 ' H ' ' A' ' 39' ' ' ALA . 0.7 OUTLIER -115.56 -176.53 2.94 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.543 -0.723 . . . . 0.0 110.093 -179.803 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.521 ' H ' HG22 ' A' ' 38' ' ' THR . . . -60.09 -49.6 77.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.74 -0.6 . . . . 0.0 111.049 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.68 HG23 ' HG3' ' A' ' 41' ' ' GLN . 7.6 t -116.99 -22.48 8.43 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.393 -0.817 . . . . 0.0 111.293 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.68 ' HG3' HG23 ' A' ' 40' ' ' THR . 59.9 mt-30 -117.14 164.94 14.0 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.389 -0.819 . . . . 0.0 110.187 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.5 m -147.93 120.19 8.37 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.499 -0.751 . . . . 0.0 110.303 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.412 ' CZ ' ' HB2' ' A' ' 59' ' ' ALA . 27.3 p90 -130.98 -176.66 4.07 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.629 -0.67 . . . . 0.0 110.049 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.596 HD22 HG12 ' A' ' 35' ' ' VAL . 48.9 mt -122.4 173.36 7.7 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.502 -0.748 . . . . 0.0 109.893 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -150.68 160.83 43.57 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.564 -0.71 . . . . 0.0 110.355 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.451 HG21 ' HB3' ' A' ' 142' ' ' PRO . 8.2 t -136.61 144.1 43.91 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.669 -0.644 . . . . 0.0 110.172 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 28.5 p -87.92 123.71 32.95 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.589 -0.695 . . . . 0.0 110.763 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.6 t -130.61 125.26 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.52 -0.737 . . . . 0.0 110.174 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 51.34 40.72 27.05 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.389 -0.819 . . . . 0.0 111.335 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.95 22.77 77.2 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.439 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 60.8 t -142.26 113.62 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.396 -1.061 . . . . 0.0 109.53 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 93.3 m -79.73 125.27 29.44 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.641 -0.662 . . . . 0.0 110.205 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.439 ' CZ2' HG11 ' A' ' 51' ' ' VAL . 98.5 m95 -114.26 136.48 52.92 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.585 -0.697 . . . . 0.0 110.102 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.805 HG23 HG23 ' A' ' 83' ' ' VAL . 7.9 t -137.85 -179.87 6.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.656 -0.653 . . . . 0.0 109.968 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.469 HG11 ' CE1' ' A' ' 57' ' ' HIS . 2.1 t -81.69 141.59 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.503 -0.748 . . . . 0.0 109.415 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.862 ' CE2' HG22 ' A' ' 78' ' ' VAL . 9.6 t80 -85.49 -43.81 13.25 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.392 -0.818 . . . . 0.0 111.85 -179.224 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.469 ' CE1' HG11 ' A' ' 55' ' ' VAL . 3.1 p-80 -57.76 -17.83 17.89 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.204 -0.935 . . . . 0.0 111.672 -177.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.75 -53.87 2.78 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.412 ' HB2' ' CZ ' ' A' ' 43' ' ' PHE . . . -80.2 -63.39 1.42 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.621 -0.929 . . . . 0.0 109.779 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.428 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.501 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.4 m . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 121.145 0.498 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -74.32 131.07 40.81 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.625 -0.672 . . . . 0.0 110.087 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.426 ' HG3' ' CD2' ' A' ' 75' ' ' TYR . 22.8 ptp -119.69 -42.49 2.63 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.45 -0.781 . . . . 0.0 110.751 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.491 ' O ' HG12 ' A' ' 83' ' ' VAL . 35.0 m-85 -119.98 114.3 21.82 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.265 -0.897 . . . . 0.0 110.088 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.6 m -152.7 131.62 12.52 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.553 -0.717 . . . . 0.0 110.187 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -169.89 125.39 0.81 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.281 -0.887 . . . . 0.0 111.279 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.862 HG22 ' CE2' ' A' ' 56' ' ' TYR . 76.3 t -72.48 -38.17 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.395 -0.816 . . . . 0.0 109.593 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -55.65 -34.22 64.76 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.386 -0.821 . . . . 0.0 110.364 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -98.99 -12.21 20.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.655 -0.653 . . . . 0.0 110.628 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.536 ' O ' HD12 ' A' ' 82' ' ' LEU . 42.8 t0 53.28 40.06 30.71 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.093 -1.004 . . . . 0.0 110.501 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.546 HD22 ' CE ' ' A' ' 175' ' ' MET . 0.2 OUTLIER -141.48 151.03 42.99 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.786 0.803 . . . . 0.0 110.979 -179.608 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.805 HG23 HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -146.32 153.07 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.349 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -153.14 159.25 28.42 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.474 -1.346 . . . . 0.0 110.816 -178.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.473 ' CH2' HG21 ' A' ' 54' ' ' THR . 6.3 m-90 -131.43 168.37 17.72 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.997 -0.707 . . . . 0.0 109.307 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.419 ' H ' ' HE1' ' A' ' 74' ' ' MET . 8.1 mm-40 -68.82 138.51 54.82 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.429 -0.794 . . . . 0.0 110.425 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.38 148.69 45.13 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.577 -0.702 . . . . 0.0 110.109 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.12 144.43 37.6 Favored 'Trans proline' 0 C--N 1.318 -1.065 0 O-C-N 123.29 1.153 . . . . 0.0 110.394 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -77.39 160.26 32.37 Favored 'Trans proline' 0 C--N 1.318 -1.034 0 O-C-N 123.345 1.182 . . . . 0.0 110.548 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 89.61 30.01 14.7 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -151.99 167.84 27.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.55 -0.971 . . . . 0.0 110.301 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -113.76 159.44 19.75 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.515 -0.74 . . . . 0.0 110.123 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.3 m -129.12 171.11 12.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.492 -0.755 . . . . 0.0 110.523 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -81.25 165.08 21.78 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.703 -0.623 . . . . 0.0 110.557 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.453 ' CG2' ' CD2' ' A' ' 149' ' ' HIS . 9.4 t -110.85 151.73 43.11 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.655 -0.653 . . . . 0.0 109.909 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.07 130.29 21.23 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 O-C-N 123.245 1.129 . . . . 0.0 110.232 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.447 ' HB3' HG12 ' A' ' 151' ' ' VAL . 5.0 t -72.31 145.09 48.06 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.64 -0.663 . . . . 0.0 110.538 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 31.3 m -136.28 66.19 1.5 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.573 -0.704 . . . . 0.0 110.477 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 27.7 p -145.01 -8.01 0.62 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.467 -0.771 . . . . 0.0 112.387 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.94 43.71 97.83 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.4 t -71.92 129.87 39.64 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.528 -0.983 . . . . 0.0 110.268 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 73.4 m -71.34 -40.3 70.81 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.563 -0.71 . . . . 0.0 110.267 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -79.75 130.02 34.98 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.518 -0.739 . . . . 0.0 110.328 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 95.9 mt -136.57 151.97 49.96 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.553 -0.717 . . . . 0.0 110.378 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -106.97 123.27 47.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.462 -0.774 . . . . 0.0 109.75 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.482 HD13 HD11 ' A' ' 143' ' ' LEU . 41.0 tp -110.05 140.31 44.24 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.516 -0.74 . . . . 0.0 110.386 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 26.7 m -112.27 141.23 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.584 -0.697 . . . . 0.0 109.954 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.495 HG23 ' OD1' ' A' ' 112' ' ' ASP . 15.5 p -109.85 -162.65 0.81 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.365 -0.834 . . . . 0.0 109.949 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.448 ' HA ' HD11 ' A' ' 44' ' ' LEU . 23.2 ttp180 -70.1 -23.62 63.08 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.653 -0.654 . . . . 0.0 110.353 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -91.68 19.69 6.16 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.37 -0.831 . . . . 0.0 111.01 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.13 24.76 5.08 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.124 -0.985 . . . . 0.0 111.024 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.495 ' OD1' HG23 ' A' ' 108' ' ' THR . 54.7 p-10 -81.0 161.74 24.12 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.477 -0.764 . . . . 0.0 109.914 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.0 p -129.35 133.11 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.626 -0.671 . . . . 0.0 110.062 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.4 tp -143.59 138.38 15.3 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.529 -0.732 . . . . 0.0 109.929 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.464 ' HG2' HD13 ' A' ' 127' ' ' LEU . 47.0 Cg_endo -73.35 139.28 28.71 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 O-C-N 123.201 1.106 . . . . 0.0 110.556 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.578 HG13 ' O ' ' A' ' 125' ' ' SER . 62.3 t -129.93 130.04 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.517 -0.74 . . . . 0.0 109.876 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -81.95 149.02 28.4 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.476 -0.765 . . . . 0.0 110.144 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -83.42 137.18 34.03 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.661 -0.649 . . . . 0.0 110.369 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.6 mmt85 -141.28 26.49 1.99 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.58 -0.7 . . . . 0.0 110.381 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 161.65 171.95 28.39 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -71.66 -45.16 62.81 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.556 -0.967 . . . . 0.0 110.443 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 61.3 p -116.83 20.09 14.09 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.553 -0.717 . . . . 0.0 110.732 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 25.3 ttp180 -147.77 144.21 28.07 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.399 -0.813 . . . . 0.0 110.009 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -139.85 -175.23 14.17 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.578 ' O ' HG13 ' A' ' 116' ' ' VAL . 57.3 p -119.72 147.53 44.48 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.61 -0.936 . . . . 0.0 110.026 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 34.7 tp -95.06 131.23 41.27 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.584 -0.698 . . . . 0.0 110.205 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.464 HD13 ' HG2' ' A' ' 115' ' ' PRO . 1.4 tt -63.03 -54.58 35.95 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.612 -0.68 . . . . 0.0 110.258 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 57.8 m -96.51 130.05 31.62 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.445 -0.784 . . . . 0.0 110.156 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -81.25 116.32 3.02 Favored 'Trans proline' 0 C--N 1.32 -0.939 0 O-C-N 123.132 1.07 . . . . 0.0 110.677 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.422 ' HD2' ' CD2' ' A' ' 134' ' ' TYR . 54.6 mtm-85 -125.09 152.6 70.86 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.518 -0.739 . . . . 0.0 109.779 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.3 150.22 64.62 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 123.369 1.194 . . . . 0.0 110.759 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.421 HG21 ' SG ' ' A' ' 159' ' ' CYS . 51.6 t -54.33 -31.72 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.442 -0.786 . . . . 0.0 109.701 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.6 t -59.9 -40.38 88.59 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.746 -0.596 . . . . 0.0 111.095 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.422 ' CD2' ' HD2' ' A' ' 130' ' ' ARG . 86.3 t80 -68.95 -39.81 79.3 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.342 -0.849 . . . . 0.0 109.685 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 23.2 tp -94.67 18.75 11.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.885 -0.51 . . . . 0.0 110.187 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.64 118.47 23.87 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 122.658 1.218 . . . . 0.0 112.317 -178.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.8 26.35 8.04 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.3 p -109.96 20.94 17.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.529 -0.983 . . . . 0.0 110.621 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.6 m -66.39 144.59 56.44 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.337 -0.852 . . . . 0.0 109.342 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.75 -18.2 57.05 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.63 110.37 2.3 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.451 ' HB3' HG21 ' A' ' 46' ' ' THR . 44.3 Cg_endo -71.05 161.45 45.98 Favored 'Trans proline' 0 C--N 1.318 -1.048 0 O-C-N 123.168 1.088 . . . . 0.0 111.054 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.553 ' O ' HG22 ' A' ' 151' ' ' VAL . 5.1 mp -113.99 119.71 38.15 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.0 tp -96.51 167.34 11.21 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.426 0.631 . . . . 0.0 110.833 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.407 ' CB ' ' HD2' ' A' ' 146' ' ' PRO . 0.1 OUTLIER -108.2 178.49 1.05 Allowed Pre-proline 0 N--CA 1.493 1.701 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.7 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.407 ' HD2' ' CB ' ' A' ' 145' ' ' CYS . 42.9 Cg_endo -69.05 -25.37 31.95 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 O-C-N 123.258 1.136 . . . . 0.0 110.339 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 83.0 p -79.81 -28.58 40.19 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.514 -0.741 . . . . 0.0 110.088 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 115.55 35.01 1.34 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.453 ' CD2' ' CG2' ' A' ' 95' ' ' THR . 22.9 m170 -122.79 153.64 39.27 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.579 -0.953 . . . . 0.0 110.365 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -88.69 144.24 26.4 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.474 -0.766 . . . . 0.0 110.199 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.648 ' O ' HG23 ' A' ' 172' ' ' VAL . 35.1 m -119.14 -24.26 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.476 -0.765 . . . . 0.0 111.067 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -179.73 -173.08 44.48 Favored Glycine 0 N--CA 1.498 2.829 0 C-N-CA 119.672 -1.252 . . . . 0.0 110.385 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 64.0 mt -130.0 159.23 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.562 -0.964 . . . . 0.0 110.033 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -73.77 144.62 45.56 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.55 -0.718 . . . . 0.0 110.248 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 -129.57 -75.97 0.55 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.534 -0.729 . . . . 0.0 110.264 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -120.41 142.35 49.29 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.154 -0.966 . . . . 0.0 110.992 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.52 127.33 39.12 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.4 t -97.83 119.5 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.532 -0.73 . . . . 0.0 111.388 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.421 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.3 p -141.15 151.74 44.13 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.547 -0.721 . . . . 0.0 110.43 178.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 6.8 p -93.7 -48.19 6.44 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.511 -0.743 . . . . 0.0 109.511 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 50.9 mtt85 -119.97 36.7 4.44 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 91.9 -11.57 71.79 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 63.7 t -89.16 123.66 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.178 -1.189 . . . . 0.0 109.284 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.18 114.3 23.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.526 -0.734 . . . . 0.0 110.838 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -107.14 -29.99 9.04 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.809 -0.557 . . . . 0.0 109.64 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -118.47 168.25 10.83 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.668 -0.645 . . . . 0.0 109.863 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.9 m -143.21 131.83 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.498 -0.751 . . . . 0.0 110.702 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.31 127.84 47.74 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.613 -0.679 . . . . 0.0 110.231 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -136.27 162.15 33.79 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.556 -0.715 . . . . 0.0 110.588 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.47 HG13 ' HD2' ' A' ' 171' ' ' PRO . 90.1 t -104.86 144.71 29.28 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.463 -0.773 . . . . 0.0 110.033 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.47 ' HD2' HG13 ' A' ' 170' ' ' VAL . 45.1 Cg_endo -71.41 168.15 24.31 Favored 'Trans proline' 0 N--CA 1.486 1.056 0 O-C-N 123.318 1.168 . . . . 0.0 110.709 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 151' ' ' VAL . 61.4 t -92.44 -45.99 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.606 -0.684 . . . . 0.0 110.467 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -54.61 -28.88 49.67 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.693 -0.629 . . . . 0.0 111.304 -178.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.661 ' O ' HG22 ' A' ' 177' ' ' THR . 4.3 m -61.62 -25.91 67.65 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.378 -0.826 . . . . 0.0 110.279 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.546 ' CE ' HD22 ' A' ' 82' ' ' LEU . 32.8 mmt -70.12 -27.35 64.5 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.498 -0.751 . . . . 0.0 110.641 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -56.83 -41.78 78.46 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.448 -0.783 . . . . 0.0 111.059 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.661 HG22 ' O ' ' A' ' 174' ' ' SER . 7.4 t -73.9 -22.09 59.83 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.405 -0.809 . . . . 0.0 110.556 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 76.7 m -72.0 -39.94 68.87 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.384 -0.823 . . . . 0.0 110.344 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 26.2 ttp -59.98 -44.57 94.41 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.681 -0.637 . . . . 0.0 110.5 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 26.4 mmt85 -60.01 -39.9 87.39 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.531 -0.731 . . . . 0.0 110.389 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.789 0 O-C-N 121.571 -0.706 . . . . 0.0 110.09 179.976 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 . . . . . 0 N--CA 1.501 2.095 0 CA-C-O 120.478 0.18 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.854 HG11 ' HD3' ' A' ' 142' ' ' PRO . 19.3 m -118.92 162.22 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.182 -0.949 . . . . 0.0 110.947 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 22.2 mm100 -136.87 125.2 23.28 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.572 ' O ' HG23 ' A' ' 35' ' ' VAL . 34.5 m -73.76 116.42 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.585 -0.697 . . . . 0.0 109.957 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.587 HG22 ' O ' ' A' ' 43' ' ' PHE . 35.9 m -110.75 152.03 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.431 -0.793 . . . . 0.0 110.157 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.1 m -115.7 125.38 52.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.581 -0.699 . . . . 0.0 110.366 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.05 -169.61 1.89 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.655 -0.653 . . . . 0.0 109.538 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.16 -51.23 70.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.583 -0.698 . . . . 0.0 110.894 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.662 HG23 ' HG3' ' A' ' 41' ' ' GLN . 7.9 t -127.65 0.99 6.15 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.404 -0.81 . . . . 0.0 111.817 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.662 ' HG3' HG23 ' A' ' 40' ' ' THR . 70.1 mt-30 -140.38 171.26 14.4 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.004 -1.06 . . . . 0.0 110.499 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 77.7 p -145.4 131.38 19.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.618 -0.676 . . . . 0.0 110.157 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.587 ' O ' HG22 ' A' ' 36' ' ' VAL . 13.5 p90 -130.21 -175.33 3.6 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.521 -0.737 . . . . 0.0 110.314 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.447 HD23 ' HB ' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -119.44 159.0 25.09 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.455 -0.778 . . . . 0.0 110.633 -179.511 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -126.67 119.56 27.31 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.606 -0.683 . . . . 0.0 110.015 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.772 HG22 HG12 ' A' ' 33' ' ' VAL . 19.0 p -101.8 144.08 30.91 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.496 -0.752 . . . . 0.0 110.504 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 26.3 p -100.68 110.23 22.33 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.683 0.754 . . . . 0.0 110.238 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.3 t -130.25 130.02 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.174 -0.954 . . . . 0.0 110.258 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.427 ' O ' HG23 ' A' ' 51' ' ' VAL . 97.0 m-20 52.73 39.43 28.57 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.4 -0.813 . . . . 0.0 111.116 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.46 24.76 71.06 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 49' ' ' ASN . 60.5 t -135.15 122.73 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.368 -1.077 . . . . 0.0 109.666 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 54.5 m -79.27 111.38 15.46 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.56 -0.712 . . . . 0.0 109.782 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.434 ' CE3' HD23 ' A' ' 82' ' ' LEU . 52.3 m95 -98.6 136.82 38.14 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.528 -0.733 . . . . 0.0 110.82 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.878 HG21 ' CH2' ' A' ' 85' ' ' TRP . 6.4 t -137.36 179.99 6.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.711 -0.618 . . . . 0.0 109.547 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.855 HG21 ' HB3' ' A' ' 139' ' ' SER . 79.0 t -85.47 141.7 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.471 -0.768 . . . . 0.0 109.379 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.886 ' CE2' HG22 ' A' ' 78' ' ' VAL . 15.7 t80 -85.37 -43.68 13.45 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.487 -0.758 . . . . 0.0 111.381 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.59 ' CE1' HG11 ' A' ' 55' ' ' VAL . 2.0 p-80 -60.68 -17.43 47.74 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.308 -0.87 . . . . 0.0 111.419 -178.033 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -103.1 -62.11 0.7 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -96.1 -23.57 16.71 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.534 -0.98 . . . . 0.0 111.011 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.414 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . . . . . . 0 N--CA 1.496 2.657 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.9 t . . . . . 0 N--CA 1.496 1.865 0 CA-C-O 121.138 0.494 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -94.41 131.15 40.38 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.528 -0.732 . . . . 0.0 110.147 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.453 ' CE ' ' CE2' ' A' ' 75' ' ' TYR . 25.4 ptm -116.54 -37.47 3.7 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.555 -0.716 . . . . 0.0 110.165 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.453 ' CE2' ' CE ' ' A' ' 74' ' ' MET . 28.1 m-85 -111.26 119.6 39.44 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.537 -0.727 . . . . 0.0 109.373 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 88.0 m -148.6 126.06 11.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.48 -0.763 . . . . 0.0 110.277 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -165.43 123.48 1.59 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.384 -0.823 . . . . 0.0 111.307 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.886 HG22 ' CE2' ' A' ' 56' ' ' TYR . 79.7 t -72.36 -34.08 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.478 -0.764 . . . . 0.0 109.376 178.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -55.7 -44.77 77.72 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.567 -0.708 . . . . 0.0 110.536 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -90.76 -10.38 43.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.606 -0.684 . . . . 0.0 110.522 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.82 ' O ' HD12 ' A' ' 82' ' ' LEU . 48.5 t0 53.13 40.36 31.11 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.185 -0.947 . . . . 0.0 110.654 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.82 HD12 ' O ' ' A' ' 81' ' ' ASP . 1.0 OUTLIER -141.62 160.46 40.11 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.884 0.849 . . . . 0.0 111.098 -179.412 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.402 ' HB ' ' CG2' ' A' ' 54' ' ' THR . 1.6 t -138.35 164.43 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.406 ' O ' ' CD1' ' A' ' 85' ' ' TRP . . . -153.68 155.15 25.98 Favored Glycine 0 N--CA 1.496 2.653 0 C-N-CA 119.497 -1.335 . . . . 0.0 110.87 -179.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.878 ' CH2' HG21 ' A' ' 54' ' ' THR . 4.5 m-90 -141.93 163.57 32.52 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.877 -0.778 . . . . 0.0 109.332 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -73.41 122.98 22.97 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.479 -0.763 . . . . 0.0 109.881 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.11 154.88 40.53 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.57 -0.706 . . . . 0.0 110.26 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.98 146.14 41.19 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.467 1.246 . . . . 0.0 110.359 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -76.86 160.08 34.21 Favored 'Trans proline' 0 C--N 1.317 -1.1 0 O-C-N 123.394 1.208 . . . . 0.0 110.43 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.25 28.7 12.6 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -133.34 160.4 37.45 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.519 -0.989 . . . . 0.0 110.165 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -79.57 153.44 29.48 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.551 -0.718 . . . . 0.0 110.229 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.8 m -134.68 158.64 43.56 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.533 -0.729 . . . . 0.0 110.305 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.1 mt -108.24 158.33 17.55 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.584 -0.698 . . . . 0.0 110.408 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 71.4 p -137.24 163.21 50.65 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.577 -0.702 . . . . 0.0 110.075 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.79 142.62 43.8 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 O-C-N 123.42 1.221 . . . . 0.0 110.151 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.41 ' CB ' ' HG ' ' A' ' 145' ' ' CYS . 30.5 p -84.77 157.88 20.88 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.563 -0.711 . . . . 0.0 110.828 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 98' ' ' THR . 6.5 t -115.94 65.4 0.7 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.2 p -144.65 -8.71 0.64 Allowed 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 120.044 -0.663 . . . . 0.0 112.582 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 50.5 26.75 10.5 Favored Glycine 0 N--CA 1.502 3.049 0 O-C-N 120.778 -1.201 . . . . 0.0 110.609 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 41.6 m -59.11 127.63 33.14 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.446 -1.031 . . . . 0.0 110.645 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 73.6 m -68.74 -40.14 80.0 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.701 -0.624 . . . . 0.0 109.992 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -61.66 139.4 58.29 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.57 -0.706 . . . . 0.0 110.02 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.5 mt -141.73 169.23 17.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.649 -0.657 . . . . 0.0 110.513 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -138.36 128.89 26.31 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.681 -0.637 . . . . 0.0 109.598 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.4 tt -114.88 123.56 49.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.437 -0.789 . . . . 0.0 110.476 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 63.0 t -94.96 109.9 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.674 -0.641 . . . . 0.0 109.511 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 75.1 p -81.91 174.89 10.86 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.465 -0.772 . . . . 0.0 110.478 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -59.92 -22.78 62.88 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.64 -0.663 . . . . 0.0 110.585 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.81 20.18 5.86 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.359 -0.838 . . . . 0.0 110.675 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 52.76 41.6 31.63 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.198 -0.938 . . . . 0.0 110.881 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.758 ' HB3' HD13 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -100.22 121.2 41.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.567 -0.708 . . . . 0.0 110.091 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.697 HG13 ' H ' ' A' ' 114' ' ' ILE . 1.9 p -57.07 -79.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.598 -0.689 . . . . 0.0 111.018 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.758 HD13 ' HB3' ' A' ' 112' ' ' ASP . 2.4 mp 54.69 99.31 0.04 OUTLIER Pre-proline 0 N--CA 1.504 2.238 0 O-C-N 120.726 -1.234 . . . . 0.0 110.227 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.23 164.37 35.24 Favored 'Trans proline' 0 C--N 1.318 -1.051 0 O-C-N 123.226 1.119 . . . . 0.0 110.6 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.58 HG13 ' O ' ' A' ' 125' ' ' SER . 58.2 t -139.9 139.8 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.556 -0.715 . . . . 0.0 109.719 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -93.5 149.9 20.87 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.584 -0.697 . . . . 0.0 110.102 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -76.76 147.51 37.24 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.59 -0.694 . . . . 0.0 110.615 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -154.63 52.34 0.64 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.616 -0.678 . . . . 0.0 109.785 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 126.13 171.25 13.12 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -60.1 -58.89 6.59 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.454 -1.027 . . . . 0.0 109.974 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 57.8 m -112.85 23.74 13.12 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.558 -0.713 . . . . 0.0 109.871 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.682 ' NH2' HG21 ' A' ' 158' ' ' VAL . 0.3 OUTLIER -126.41 136.71 53.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.548 -0.72 . . . . 0.0 109.832 -179.699 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -142.41 169.44 25.46 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.58 ' O ' HG13 ' A' ' 116' ' ' VAL . 20.2 p -111.06 160.57 16.73 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.571 -0.958 . . . . 0.0 109.989 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.73 HD13 HG11 ' A' ' 167' ' ' VAL . 18.1 tp -106.36 126.35 52.13 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.666 -0.646 . . . . 0.0 110.509 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.32 -56.49 14.13 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.596 -0.69 . . . . 0.0 109.999 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 33.1 t -94.81 112.8 59.44 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.61 -0.681 . . . . 0.0 109.872 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.66 107.25 2.27 Favored 'Trans proline' 0 C--N 1.32 -0.969 0 O-C-N 123.25 1.132 . . . . 0.0 110.799 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.516 ' NH2' HD11 ' A' ' 126' ' ' LEU . 80.2 mtm180 -118.84 158.02 48.75 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.63 -0.668 . . . . 0.0 109.9 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.78 150.41 55.93 Favored 'Trans proline' 0 C--N 1.315 -1.204 0 O-C-N 123.433 1.228 . . . . 0.0 110.678 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.416 HG21 ' SG ' ' A' ' 159' ' ' CYS . 55.6 t -53.65 -29.42 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 O-C-N 121.433 -0.792 . . . . 0.0 109.807 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.1 t -59.83 -44.87 93.84 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.656 -0.653 . . . . 0.0 111.213 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -67.32 -38.7 85.34 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.32 -0.862 . . . . 0.0 109.815 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 135' ' ' LEU . 31.2 tp -92.32 18.43 8.35 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.78 -0.575 . . . . 0.0 110.19 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.7 tttm -82.88 118.28 23.33 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 122.57 1.176 . . . . 0.0 112.145 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.71 26.6 7.95 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 17.0 m -105.35 19.93 19.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.642 -0.916 . . . . 0.0 110.141 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.855 ' HB3' HG21 ' A' ' 55' ' ' VAL . 2.4 m -74.17 130.27 39.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.31 -0.869 . . . . 0.0 109.466 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.412 ' HA2' HD11 ' A' ' 153' ' ' ILE . . . 113.59 -26.51 10.1 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.57 131.01 51.84 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.854 ' HD3' HG11 ' A' ' 33' ' ' VAL . 52.2 Cg_endo -85.7 157.84 10.49 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.117 1.062 . . . . 0.0 111.106 -178.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 143' ' ' LEU . 6.8 mp -107.71 123.5 48.62 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.14 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 150' ' ' ALA . 4.1 tp -105.34 162.33 13.53 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.519 -0.738 . . . . 0.0 110.823 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.458 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 28.9 p -115.39 168.45 8.27 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 37.7 Cg_endo -62.47 -15.36 44.98 Favored 'Trans proline' 0 N--CA 1.488 1.18 0 O-C-N 122.935 0.966 . . . . 0.0 111.103 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.2 t -69.94 -35.09 74.25 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.268 -0.895 . . . . 0.0 109.783 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 117.81 15.36 6.31 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.408 ' HB2' ' HB3' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -126.89 170.22 12.46 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.199 -1.177 . . . . 0.0 110.095 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.406 ' HA ' HD12 ' A' ' 144' ' ' LEU . . . -94.5 153.26 18.0 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.437 -0.789 . . . . 0.0 110.816 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 143' ' ' LEU . 35.6 m -119.19 -26.02 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.627 -0.671 . . . . 0.0 110.907 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -172.59 -162.07 24.11 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.412 HD11 ' HA2' ' A' ' 140' ' ' GLY . 11.5 tt -140.11 152.87 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.668 -0.901 . . . . 0.0 109.992 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -64.73 144.35 57.3 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.251 -0.906 . . . . 0.0 111.345 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 9.6 ttt180 -129.81 -70.73 0.63 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.272 0.558 . . . . 0.0 109.851 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -128.82 147.9 50.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.288 -0.882 . . . . 0.0 111.047 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.38 158.46 15.72 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.682 HG21 ' NH2' ' A' ' 123' ' ' ARG . 2.5 t -123.29 112.38 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.175 -0.953 . . . . 0.0 111.058 -178.107 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.416 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.1 p -138.18 144.03 40.52 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.785 179.188 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 24.2 m -82.81 -43.98 16.04 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.525 -0.734 . . . . 0.0 109.847 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.52 34.99 4.27 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.638 -0.664 . . . . 0.0 109.974 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 99.55 -11.88 61.36 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 63.3 t -92.81 123.47 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.19 -1.183 . . . . 0.0 109.136 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.12 114.22 23.54 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.559 -0.713 . . . . 0.0 111.071 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -104.15 -25.09 13.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.738 -0.601 . . . . 0.0 110.028 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -131.88 168.38 17.96 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.484 -0.76 . . . . 0.0 109.833 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.73 HG11 HD13 ' A' ' 126' ' ' LEU . 36.0 m -141.61 137.36 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.406 -0.809 . . . . 0.0 110.844 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -112.82 140.35 47.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.55 -0.719 . . . . 0.0 110.27 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.4 ' CG ' HD22 ' A' ' 143' ' ' LEU . 50.7 p90 -140.6 159.97 41.05 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.625 -0.672 . . . . 0.0 110.556 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 59.0 t -93.93 135.89 24.35 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.606 -0.684 . . . . 0.0 109.868 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.54 158.45 43.91 Favored 'Trans proline' 0 C--N 1.318 -1.053 0 O-C-N 123.225 1.119 . . . . 0.0 110.515 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.547 HG13 ' CE ' ' A' ' 175' ' ' MET . 79.1 t -77.33 -28.73 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.636 -0.665 . . . . 0.0 110.015 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -59.86 -37.48 79.44 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.435 -0.791 . . . . 0.0 110.429 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 39.0 m -61.65 -35.49 78.07 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.652 -0.655 . . . . 0.0 110.397 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.547 ' CE ' HG13 ' A' ' 172' ' ' VAL . 48.7 mtm -59.99 -30.03 68.85 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.6 -0.688 . . . . 0.0 110.424 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.03 -43.55 95.25 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.502 -0.749 . . . . 0.0 110.302 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 85.1 m -63.55 -40.14 96.21 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.577 -0.702 . . . . 0.0 109.969 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 89.1 m -65.4 -37.21 86.29 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.657 -0.652 . . . . 0.0 110.023 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 19.4 ttt -60.05 -37.96 81.38 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.666 -0.646 . . . . 0.0 110.251 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 39.4 mtp-105 -60.03 -39.74 86.93 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.532 -0.73 . . . . 0.0 110.21 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.749 0 O-C-N 121.509 -0.744 . . . . 0.0 110.18 -179.955 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.4 m . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.034 0.445 . . . . 0.0 110.265 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 135.62 175.01 13.61 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -119.96 132.66 55.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.536 -0.979 . . . . 0.0 110.055 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -159.97 169.99 22.28 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.576 -0.703 . . . . 0.0 110.32 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 45.6 pttt -138.56 165.42 26.91 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.641 -0.662 . . . . 0.0 110.274 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 53.69 49.87 18.34 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.377 -0.827 . . . . 0.0 110.804 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -90.28 6.83 41.27 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.56 -0.713 . . . . 0.0 111.23 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.2 t -59.92 -49.97 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.259 -0.9 . . . . 0.0 110.014 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -139.89 135.63 33.09 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.497 -0.752 . . . . 0.0 110.226 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.44 -15.42 7.03 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.7 mp0 -87.38 2.14 51.26 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.179 -1.189 . . . . 0.0 111.298 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 63.3 t -109.97 126.36 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.072 -1.018 . . . . 0.0 109.922 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -115.29 159.47 20.98 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.638 -0.663 . . . . 0.0 110.074 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.485 ' HA ' HD22 ' A' ' 44' ' ' LEU . 62.7 t -116.63 129.94 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.521 -0.737 . . . . 0.0 110.034 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.5 p -136.99 139.57 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.543 -0.723 . . . . 0.0 110.003 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 72.7 m -125.12 141.2 52.25 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.5 -0.75 . . . . 0.0 110.381 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.527 HG22 ' H ' ' A' ' 39' ' ' ALA . 0.8 OUTLIER -105.68 -177.36 3.34 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.565 -0.709 . . . . 0.0 109.988 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.527 ' H ' HG22 ' A' ' 38' ' ' THR . . . -69.49 -40.01 77.29 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.594 -0.691 . . . . 0.0 111.238 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 67.2 p -114.42 -19.43 11.21 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.341 -0.849 . . . . 0.0 111.569 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -133.58 160.05 38.63 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.205 -0.935 . . . . 0.0 110.725 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.0 t -138.75 119.87 14.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.592 -0.693 . . . . 0.0 110.12 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -135.19 177.11 8.07 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.617 -0.677 . . . . 0.0 109.843 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.486 HD11 ' HA ' ' A' ' 109' ' ' ARG . 65.6 mt -118.68 160.34 22.01 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.486 -0.759 . . . . 0.0 110.36 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -124.99 153.32 42.97 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.544 -0.722 . . . . 0.0 110.043 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.438 HG21 ' HB3' ' A' ' 142' ' ' PRO . 58.8 m -125.87 140.09 52.94 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.522 -0.736 . . . . 0.0 110.402 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.9 t -88.84 108.76 19.7 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.504 -0.747 . . . . 0.0 110.094 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.6 t -123.0 129.99 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.648 -0.657 . . . . 0.0 109.921 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 54.47 38.71 30.18 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.568 -0.707 . . . . 0.0 110.899 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.522 ' O ' ' HB3' ' A' ' 87' ' ' ALA . . . 67.87 17.49 69.5 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 65.6 t -130.22 129.94 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.227 -1.161 . . . . 0.0 109.734 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 69.2 m -79.24 130.15 35.18 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.498 -0.751 . . . . 0.0 109.898 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.496 ' CD2' ' HE3' ' A' ' 175' ' ' MET . 97.0 m95 -120.01 137.16 54.25 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.473 -0.767 . . . . 0.0 110.729 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.686 HG23 HG13 ' A' ' 83' ' ' VAL . 9.7 t -137.35 172.39 13.05 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.841 HG11 ' CE1' ' A' ' 57' ' ' HIS . 59.4 t -80.81 142.3 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.367 -0.833 . . . . 0.0 109.691 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.863 ' CE2' HG22 ' A' ' 78' ' ' VAL . 33.0 t80 -79.28 -39.89 31.85 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.448 -0.783 . . . . 0.0 111.636 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.841 ' CE1' HG11 ' A' ' 55' ' ' VAL . 1.4 p-80 -59.72 -23.27 63.03 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.968 -1.083 . . . . 0.0 110.396 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -74.15 -70.64 1.22 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.831 -1.708 . . . . 0.0 108.831 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.52 -52.9 62.57 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.543 -0.975 . . . . 0.0 109.743 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.6 -170.81 54.44 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 59.2 m -60.03 -39.94 87.61 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.659 -0.906 . . . . 0.0 110.38 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -58.58 139.18 56.22 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.486 -0.759 . . . . 0.0 110.153 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.412 ' H ' HG22 ' A' ' 63' ' ' THR . 8.4 t -81.64 169.07 17.47 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.61 -0.681 . . . . 0.0 110.595 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 pp -140.28 140.68 35.76 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.654 -0.653 . . . . 0.0 110.12 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.35 134.06 36.6 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.509 -0.744 . . . . 0.0 110.554 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -103.62 -157.63 24.63 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -71.21 -41.33 2.62 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 123.415 1.218 . . . . 0.0 110.591 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -69.9 -31.4 69.17 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.527 -0.733 . . . . 0.0 110.208 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 144.12 -151.27 23.28 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.12 136.34 24.44 Favored 'Trans proline' 0 C--N 1.316 -1.154 0 O-C-N 123.353 1.186 . . . . 0.0 110.315 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.512 HD12 ' NE1' ' A' ' 85' ' ' TRP . 8.5 pt -132.53 161.26 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.617 -0.677 . . . . 0.0 110.537 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 35.9 m -112.39 132.29 55.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.624 -0.672 . . . . 0.0 109.708 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -60.24 125.1 22.39 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.509 -0.744 . . . . 0.0 110.509 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 91.0 mmm -92.12 -32.55 15.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.716 -0.615 . . . . 0.0 109.91 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.74 ' O ' HG23 ' A' ' 83' ' ' VAL . 45.5 m-85 -118.95 129.73 55.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.589 -0.694 . . . . 0.0 109.864 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.6 p -141.02 144.95 35.3 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.525 -0.734 . . . . 0.0 110.307 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -168.17 100.93 0.44 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.71 -0.619 . . . . 0.0 109.999 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.863 HG22 ' CE2' ' A' ' 56' ' ' TYR . 53.3 t -70.06 -42.84 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.427 -0.796 . . . . 0.0 109.88 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -60.06 -44.2 94.87 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.507 -0.746 . . . . 0.0 110.162 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -90.04 -8.56 51.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.811 -0.556 . . . . 0.0 110.563 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.4 t0 54.16 39.72 30.98 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.998 -1.064 . . . . 0.0 109.684 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.508 HD21 ' HG2' ' A' ' 175' ' ' MET . 14.5 tp -119.93 129.98 54.58 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.329 0.585 . . . . 0.0 110.472 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 75' ' ' TYR . 14.6 p -153.13 150.29 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.684 -0.635 . . . . 0.0 109.414 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -176.06 -174.31 42.48 Favored Glycine 0 N--CA 1.496 2.65 0 C-N-CA 119.622 -1.275 . . . . 0.0 110.571 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.512 ' NE1' HD12 ' A' ' 71' ' ' ILE . 14.1 m-90 -128.81 160.03 33.86 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.78 -0.836 . . . . 0.0 109.766 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -93.0 131.14 38.26 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.539 -0.726 . . . . 0.0 110.097 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 50' ' ' GLY . . . -111.94 159.6 32.96 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.461 -0.774 . . . . 0.0 110.462 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.2 159.16 50.45 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 O-C-N 123.428 1.225 . . . . 0.0 110.608 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.17 160.2 39.85 Favored 'Trans proline' 0 C--N 1.317 -1.101 0 O-C-N 123.506 1.266 . . . . 0.0 110.412 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 115.35 -4.49 21.74 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -109.93 142.4 41.34 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.092 -1.24 . . . . 0.0 110.172 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -60.34 140.06 57.32 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.507 -0.745 . . . . 0.0 110.124 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 52.6 m -133.1 156.87 46.63 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.593 -0.692 . . . . 0.0 110.402 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.9 mt -91.36 162.84 14.43 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.67 -0.644 . . . . 0.0 110.234 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.2 p -120.89 165.07 19.89 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.63 -0.669 . . . . 0.0 110.075 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.34 164.81 32.69 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 O-C-N 123.369 1.194 . . . . 0.0 110.207 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 7.2 t -75.2 128.1 34.7 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.564 -0.71 . . . . 0.0 110.405 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 46.7 p -129.58 45.48 2.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.743 -0.598 . . . . 0.0 109.682 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.3 p -145.07 12.22 1.39 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.642 -0.661 . . . . 0.0 111.474 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.23 50.97 49.89 Favored Glycine 0 N--CA 1.499 2.866 0 O-C-N 121.062 -1.024 . . . . 0.0 110.546 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.1 m -92.7 107.09 18.95 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.42 -1.047 . . . . 0.0 110.4 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.1 p -70.11 -39.95 75.19 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.487 -0.758 . . . . 0.0 109.931 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -75.11 123.09 24.59 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.653 -0.654 . . . . 0.0 109.857 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.563 HD13 HG11 ' A' ' 151' ' ' VAL . 73.9 mt -129.99 150.61 51.19 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.607 -0.683 . . . . 0.0 110.2 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -106.84 133.5 51.4 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.49 -0.757 . . . . 0.0 109.874 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.1 tt -98.85 130.3 45.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.536 -0.728 . . . . 0.0 110.467 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.1 t -87.79 123.41 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.691 -0.63 . . . . 0.0 109.707 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.2 m -100.77 166.82 10.67 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.56 -0.713 . . . . 0.0 110.386 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.486 ' HA ' HD11 ' A' ' 44' ' ' LEU . 78.3 ttt-85 -61.89 -27.33 68.73 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.59 -0.694 . . . . 0.0 110.332 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -93.41 25.48 3.4 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.527 -0.733 . . . . 0.0 110.781 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.98 40.03 31.85 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.284 -0.885 . . . . 0.0 110.843 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -93.27 156.24 16.94 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.644 -0.66 . . . . 0.0 109.78 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.9 p -129.93 133.44 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.47 -0.769 . . . . 0.0 110.404 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.4 tp -146.13 134.89 11.04 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.702 -0.624 . . . . 0.0 109.892 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.424 ' HG2' HD22 ' A' ' 127' ' ' LEU . 48.5 Cg_endo -76.15 139.2 21.16 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 O-C-N 123.155 1.082 . . . . 0.0 110.291 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.3 t -129.92 130.1 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.646 -0.659 . . . . 0.0 109.713 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.62 146.44 34.13 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.567 -0.708 . . . . 0.0 109.853 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -85.71 118.33 25.14 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.567 -0.708 . . . . 0.0 110.202 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.03 21.22 11.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.759 -0.588 . . . . 0.0 110.34 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 162.64 168.15 24.13 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -70.03 -40.02 75.43 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.566 -0.961 . . . . 0.0 110.693 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 89.8 p -114.68 -7.15 12.73 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.496 -0.753 . . . . 0.0 111.474 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -128.55 143.97 51.06 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.09 -1.006 . . . . 0.0 110.484 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -141.49 -174.64 14.5 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 80.1 p -120.53 144.17 48.2 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.558 -0.966 . . . . 0.0 110.165 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 57.8 tp -91.17 131.3 36.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.636 -0.665 . . . . 0.0 109.899 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.424 HD22 ' HG2' ' A' ' 115' ' ' PRO . 1.7 tp -60.09 -48.66 80.81 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.585 -0.697 . . . . 0.0 110.511 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 45.7 t -106.5 119.54 51.4 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.504 -0.747 . . . . 0.0 110.18 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.87 121.39 7.58 Favored 'Trans proline' 0 N--CA 1.486 1.034 0 O-C-N 123.191 1.101 . . . . 0.0 110.581 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 12.7 mtp85 -132.83 162.81 55.19 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.52 -0.737 . . . . 0.0 110.323 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.6 150.9 63.82 Favored 'Trans proline' 0 N--CA 1.486 1.076 0 O-C-N 123.482 1.254 . . . . 0.0 110.87 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.424 HG21 ' SG ' ' A' ' 159' ' ' CYS . 76.9 t -56.64 -35.29 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.484 -0.76 . . . . 0.0 110.252 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 34.8 t -58.44 -39.97 81.27 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.47 -0.768 . . . . 0.0 110.745 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -63.28 -39.94 95.98 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.489 -0.757 . . . . 0.0 109.592 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 21.3 tp -94.57 16.2 16.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.781 -0.574 . . . . 0.0 110.593 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 44.7 tttt -89.77 141.06 28.98 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.026 -1.046 . . . . 0.0 110.761 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 87.78 20.51 50.39 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 10.5 p -119.58 15.21 12.81 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.37 -1.077 . . . . 0.0 110.933 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.521 ' HB3' HG21 ' A' ' 55' ' ' VAL . 48.9 m -58.75 144.7 42.94 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.183 -0.948 . . . . 0.0 110.043 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 94.72 -16.67 60.72 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -58.5 111.1 2.94 Favored Glycine 0 N--CA 1.498 2.796 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.438 ' HB3' HG21 ' A' ' 46' ' ' THR . 50.1 Cg_endo -73.11 139.63 29.91 Favored 'Trans proline' 0 C--N 1.317 -1.082 0 O-C-N 123.197 1.104 . . . . 0.0 111.099 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.416 ' O ' HG12 ' A' ' 151' ' ' VAL . 4.4 mp -93.37 123.71 36.85 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.3 mp -118.38 127.27 53.53 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.184 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.645 ' SG ' 'ZN ' ' A' ' 202' ' ' ' ZN' . 27.2 p -66.61 163.97 36.9 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.7 -0.625 . . . . 0.0 109.384 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.54 -19.86 68.48 Favored 'Trans proline' 0 C--N 1.315 -1.204 0 O-C-N 123.231 1.121 . . . . 0.0 110.952 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.4 m -69.97 -27.33 64.64 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.295 -0.878 . . . . 0.0 110.031 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 121.64 -21.46 8.01 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.466 -1.053 . . . . 0.0 110.466 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -77.56 162.96 26.7 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.253 -1.145 . . . . 0.0 110.632 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -105.09 145.03 31.08 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.65 -0.656 . . . . 0.0 110.353 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.563 HG11 HD13 ' A' ' 104' ' ' LEU . 12.5 p -101.51 -29.18 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.552 -0.718 . . . . 0.0 110.809 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 169.26 -161.55 35.12 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 55.9 mt -128.87 155.86 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.566 -0.961 . . . . 0.0 110.255 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -66.61 139.94 57.91 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.621 -0.674 . . . . 0.0 110.076 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -122.59 -67.48 0.95 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.564 -0.71 . . . . 0.0 110.803 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.578 ' HB1' ' O32' ' A' ' 201' ' ' 4P2 . . . -135.27 150.3 50.01 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.453 -0.779 . . . . 0.0 110.78 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.41 151.74 19.15 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 48.6 t -120.01 119.97 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.507 -0.745 . . . . 0.0 110.432 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.424 ' SG ' HG21 ' A' ' 132' ' ' VAL . 27.4 p -141.6 157.81 44.63 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.543 -0.723 . . . . 0.0 110.415 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 18.4 p -94.58 -46.07 7.12 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.442 -0.786 . . . . 0.0 109.97 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 55.1 mmm-85 -130.37 35.96 4.01 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.644 -0.66 . . . . 0.0 109.552 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.402 ' O ' HG23 ' A' ' 132' ' ' VAL . . . 101.2 -10.11 58.09 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 57.3 t -96.55 123.47 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.184 -1.186 . . . . 0.0 109.473 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.66 117.3 26.38 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.496 -0.753 . . . . 0.0 110.776 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -109.46 -29.96 8.18 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.654 -0.654 . . . . 0.0 109.674 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -126.5 157.22 39.26 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.633 -0.667 . . . . 0.0 109.618 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 31.0 m -129.42 142.89 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.485 -0.759 . . . . 0.0 110.675 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -117.23 132.51 56.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.653 -0.654 . . . . 0.0 110.421 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -141.31 159.57 41.93 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.595 -0.69 . . . . 0.0 110.135 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 12.9 p -93.15 142.85 25.85 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.505 -0.747 . . . . 0.0 110.446 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -77.34 162.43 31.02 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 O-C-N 123.288 1.151 . . . . 0.0 110.559 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 67.1 t -69.91 -32.38 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.627 -0.671 . . . . 0.0 109.881 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -60.03 -40.01 87.87 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.493 -0.755 . . . . 0.0 110.355 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 48.0 t -62.54 -39.95 95.26 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.633 -0.667 . . . . 0.0 109.924 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.508 ' HG2' HD21 ' A' ' 82' ' ' LEU . 95.0 mtp -60.25 -40.0 88.77 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.674 -0.641 . . . . 0.0 110.177 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.7 -40.02 90.65 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.706 -0.621 . . . . 0.0 110.322 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 94.0 m -60.11 -40.11 88.55 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.645 -0.659 . . . . 0.0 110.156 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 88.2 m -68.17 -44.21 76.47 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.583 -0.698 . . . . 0.0 110.047 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 33.9 ttp -60.63 -40.99 93.97 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.556 -0.715 . . . . 0.0 110.387 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -61.15 -40.02 92.28 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.609 -0.682 . . . . 0.0 110.178 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.767 0 O-C-N 121.608 -0.682 . . . . 0.0 110.268 179.982 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 201' ' ' 4P2 . . . . . 0.578 ' O32' ' HB1' ' A' ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . 0.645 'ZN ' ' SG ' ' A' ' 145' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.567 HG23 ' O ' ' A' ' 22' ' ' THR . 7.4 t . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.158 0.504 . . . . 0.0 110.196 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.37 29.51 11.27 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -118.47 29.21 7.88 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.487 -1.008 . . . . 0.0 110.174 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -96.76 166.04 11.84 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.61 -0.681 . . . . 0.0 110.463 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -136.23 35.45 2.77 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.623 -0.673 . . . . 0.0 110.293 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -92.08 -49.26 6.3 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.546 -0.721 . . . . 0.0 110.519 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -157.6 55.06 0.49 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.506 -0.746 . . . . 0.0 110.456 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.1 m -62.16 132.63 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.483 -0.76 . . . . 0.0 110.349 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 62.31 129.99 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.567 -0.708 . . . . 0.0 110.542 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -126.22 -164.4 11.76 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.725 ' OE2' HD21 ' A' ' 144' ' ' LEU . 52.2 tt0 66.64 -65.12 0.21 Allowed 'General case' 0 N--CA 1.509 2.495 0 O-C-N 121.694 -0.886 . . . . 0.0 110.746 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.489 HG21 ' HD2' ' A' ' 142' ' ' PRO . 60.9 t -103.1 133.33 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.385 -0.822 . . . . 0.0 109.892 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -102.86 162.31 13.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.625 -0.672 . . . . 0.0 109.85 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.511 ' HA ' HD22 ' A' ' 44' ' ' LEU . 34.8 m -117.98 136.59 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.506 -0.746 . . . . 0.0 110.196 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.8 m -144.21 149.27 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.493 -0.755 . . . . 0.0 110.35 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.8 m -119.68 137.8 53.68 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.602 -0.687 . . . . 0.0 110.179 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.518 HG22 ' H ' ' A' ' 39' ' ' ALA . 1.0 OUTLIER -99.57 -178.43 3.89 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.577 -0.702 . . . . 0.0 110.001 179.909 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.518 ' H ' HG22 ' A' ' 38' ' ' THR . . . -60.0 -45.99 90.93 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.841 -179.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.4 p -118.67 -27.99 5.74 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.403 -0.811 . . . . 0.0 110.995 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -114.27 173.95 6.19 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.324 -0.86 . . . . 0.0 110.526 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 40.3 t -151.87 121.33 6.85 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.55 -0.719 . . . . 0.0 109.975 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 34.7 p90 -132.65 -179.51 5.5 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.625 -0.672 . . . . 0.0 110.064 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.535 HD11 ' HA ' ' A' ' 109' ' ' ARG . 34.7 mt -118.76 178.62 4.41 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.518 -0.739 . . . . 0.0 109.605 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.573 ' CB ' HG22 ' A' ' 54' ' ' THR . . . -143.0 161.37 38.3 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.474 -0.767 . . . . 0.0 110.98 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.8 p -125.34 144.09 50.66 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.721 -0.612 . . . . 0.0 109.689 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.419 ' HB2' ' HA ' ' A' ' 92' ' ' ARG . 27.0 p -91.9 111.79 23.46 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 121.72 0.772 . . . . 0.0 111.403 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.9 t -130.73 123.44 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.213 -0.929 . . . . 0.0 110.683 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 51.4 34.88 12.79 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.53 -0.731 . . . . 0.0 112.412 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.416 ' HA2' ' HB3' ' A' ' 92' ' ' ARG . . . 86.43 -17.04 41.19 Favored Glycine 0 N--CA 1.499 2.872 0 C-N-CA 120.1 -1.047 . . . . 0.0 111.659 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 62.8 t -105.82 128.63 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.091 -1.241 . . . . 0.0 110.477 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.739 ' SG ' ' HB2' ' A' ' 87' ' ' ALA . 78.5 m -84.32 107.78 16.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.634 -0.666 . . . . 0.0 109.532 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.531 ' CE3' HD22 ' A' ' 82' ' ' LEU . 91.1 m95 -91.85 137.48 32.33 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.509 -0.744 . . . . 0.0 110.59 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.573 HG22 ' CB ' ' A' ' 45' ' ' ALA . 77.8 p -136.51 179.74 6.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.773 -0.58 . . . . 0.0 109.611 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.754 HG21 ' HB3' ' A' ' 139' ' ' SER . 94.5 t -80.93 141.93 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.105 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.907 ' CE2' HG22 ' A' ' 78' ' ' VAL . 16.7 t80 -84.98 -43.44 13.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.445 -0.784 . . . . 0.0 111.248 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.688 ' CE1' HG11 ' A' ' 55' ' ' VAL . 2.2 p-80 -58.76 -25.02 62.63 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.24 -0.912 . . . . 0.0 110.941 -177.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -81.47 -48.67 5.82 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.52 -63.09 1.47 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.6 -0.941 . . . . 0.0 110.167 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.81 174.1 30.65 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.2 t -69.63 -18.63 63.61 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.574 -0.956 . . . . 0.0 110.757 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.7 ttmm -57.31 143.17 40.76 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.278 -0.889 . . . . 0.0 110.569 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.4 m -67.08 156.43 36.12 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.585 -0.697 . . . . 0.0 110.282 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.624 HD12 ' CZ2' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -98.0 143.13 28.89 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.592 -0.693 . . . . 0.0 110.276 -179.895 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -108.86 131.84 54.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.618 -0.676 . . . . 0.0 110.069 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -123.06 160.97 17.51 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.22 -46.87 1.91 Allowed 'Trans proline' 0 C--N 1.317 -1.104 0 O-C-N 123.421 1.222 . . . . 0.0 110.675 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -70.09 -31.08 68.48 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.577 -0.702 . . . . 0.0 109.933 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 169.73 153.67 8.72 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.6 172.25 15.53 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 123.36 1.189 . . . . 0.0 110.362 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.402 ' N ' HD12 ' A' ' 71' ' ' ILE . 4.4 mp -126.13 160.34 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.623 -0.673 . . . . 0.0 109.999 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.3 t -101.08 150.24 23.12 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.609 -0.682 . . . . 0.0 110.433 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -80.08 128.27 33.29 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.611 -0.681 . . . . 0.0 110.163 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.1 tpp -106.36 -51.13 3.01 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.604 -0.685 . . . . 0.0 110.129 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.685 ' O ' HG13 ' A' ' 83' ' ' VAL . 35.5 m-85 -120.73 138.63 53.89 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.48 -0.763 . . . . 0.0 110.184 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.452 HG23 ' HE1' ' A' ' 56' ' ' TYR . 98.8 m -152.23 127.86 10.11 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.602 -0.686 . . . . 0.0 110.175 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -168.45 120.23 0.81 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.416 -0.802 . . . . 0.0 110.833 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.907 HG22 ' CE2' ' A' ' 56' ' ' TYR . 91.8 t -72.25 -39.54 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.35 -0.844 . . . . 0.0 109.735 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.66 -43.01 75.87 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.363 -0.836 . . . . 0.0 109.803 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -92.02 -14.24 29.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.793 -0.567 . . . . 0.0 109.885 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.482 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 49.5 t0 54.27 35.38 22.61 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.064 -1.022 . . . . 0.0 110.099 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.531 HD22 ' CE3' ' A' ' 53' ' ' TRP . 2.5 mt -123.2 149.73 44.29 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.836 0.827 . . . . 0.0 111.934 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.685 HG13 ' O ' ' A' ' 75' ' ' TYR . 2.7 t -146.64 150.95 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 178.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -138.35 148.19 19.74 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 118.992 -1.575 . . . . 0.0 111.636 -178.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.624 ' CZ2' HD12 ' A' ' 64' ' ' LEU . 5.1 m-90 -138.25 124.6 20.54 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.18 135.33 57.69 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.34 -0.85 . . . . 0.0 110.721 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.836 ' HB3' ' HG3' ' A' ' 92' ' ' ARG . . . -101.41 175.44 2.33 Favored Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 121.417 -0.802 . . . . 0.0 109.849 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.756 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 43.8 Cg_endo -70.45 147.96 59.55 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 O-C-N 123.465 1.245 . . . . 0.0 109.548 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.72 134.46 24.01 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 O-C-N 123.369 1.194 . . . . 0.0 110.245 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 131.59 -25.98 3.93 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -150.81 71.64 1.04 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.102 -1.234 . . . . 0.0 111.761 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.836 ' HG3' ' HB3' ' A' ' 87' ' ' ALA . 12.2 mmt180 -154.25 91.78 1.46 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.061 -1.024 . . . . 0.0 110.498 178.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.4 p -177.04 104.98 0.06 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.211 -0.93 . . . . 0.0 111.166 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.701 HD21 ' HB2' ' A' ' 150' ' ' ALA . 25.6 tp -117.34 131.91 56.7 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.583 -0.698 . . . . 0.0 109.406 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.3 t -76.45 137.28 67.66 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.363 -0.836 . . . . 0.0 110.74 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.04 166.21 28.35 Favored 'Trans proline' 0 N--CA 1.484 0.924 0 O-C-N 123.252 1.132 . . . . 0.0 110.204 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 47.4 t -82.41 132.85 35.21 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.505 -0.747 . . . . 0.0 110.24 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.0 t -135.98 48.87 2.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.655 -0.653 . . . . 0.0 109.797 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.4 p -144.92 0.17 0.94 Allowed 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 120.114 -0.634 . . . . 0.0 112.384 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 52.26 89.27 0.01 OUTLIER Glycine 0 N--CA 1.5 2.924 0 O-C-N 120.811 -1.181 . . . . 0.0 110.553 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.0 m -129.67 128.85 43.42 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.418 -1.048 . . . . 0.0 110.251 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.2 m -69.01 -40.02 78.94 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.577 -0.702 . . . . 0.0 110.122 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.69 142.13 58.24 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.557 -0.714 . . . . 0.0 109.965 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.534 ' CD2' HG21 ' A' ' 151' ' ' VAL . 57.2 mt -143.61 158.27 43.79 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.575 -0.703 . . . . 0.0 110.314 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -126.35 109.86 12.72 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.518 -0.739 . . . . 0.0 109.91 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.554 HD23 ' C ' ' A' ' 106' ' ' LEU . 8.4 tt -93.42 133.58 36.55 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.528 -0.733 . . . . 0.0 110.462 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.496 ' N ' HD23 ' A' ' 106' ' ' LEU . 61.1 t -98.28 130.03 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.668 -0.645 . . . . 0.0 109.762 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 68.1 p -99.04 169.91 9.08 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.527 -0.733 . . . . 0.0 110.456 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.535 ' HA ' HD11 ' A' ' 44' ' ' LEU . 8.5 ptm180 -63.34 -18.96 64.2 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.691 -0.631 . . . . 0.0 110.877 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -94.16 25.95 3.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.31 -0.869 . . . . 0.0 110.661 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 53.42 39.93 30.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.346 -0.846 . . . . 0.0 110.887 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -104.68 167.06 9.97 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.531 -0.731 . . . . 0.0 110.078 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.403 ' O ' HG13 ' A' ' 113' ' ' VAL . 8.5 p -133.65 131.53 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.589 -0.694 . . . . 0.0 110.435 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.681 HG21 HD11 ' A' ' 126' ' ' LEU . 87.0 mt -133.08 127.99 20.34 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.587 -0.696 . . . . 0.0 109.872 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -74.94 125.05 9.1 Favored 'Trans proline' 0 N--CA 1.485 0.982 0 O-C-N 123.096 1.051 . . . . 0.0 110.392 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.666 HG13 ' O ' ' A' ' 125' ' ' SER . 58.9 t -120.25 129.53 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.567 -0.708 . . . . 0.0 109.771 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -87.53 136.8 32.8 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.506 -0.746 . . . . 0.0 110.197 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -74.39 140.11 44.52 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.657 -0.652 . . . . 0.0 110.293 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.35 9.5 3.45 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.589 -0.694 . . . . 0.0 111.0 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -169.34 -172.44 36.01 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -70.28 -39.97 74.6 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.615 -0.932 . . . . 0.0 110.68 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 96.1 p -130.77 9.81 5.02 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.462 -0.774 . . . . 0.0 111.393 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -123.66 148.72 46.23 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.1 -1.0 . . . . 0.0 110.17 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.15 167.82 24.8 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.666 ' O ' HG13 ' A' ' 116' ' ' VAL . 19.2 p -107.76 158.9 16.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.52 -0.988 . . . . 0.0 110.21 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.681 HD11 HG21 ' A' ' 114' ' ' ILE . 40.1 tp -117.59 133.21 56.2 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.577 -0.702 . . . . 0.0 110.272 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.454 ' N ' HD12 ' A' ' 127' ' ' LEU . 6.3 mp -69.28 -43.15 74.44 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.588 -0.695 . . . . 0.0 110.401 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 58.4 p -97.42 111.97 59.84 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.474 -0.766 . . . . 0.0 110.168 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -80.91 106.87 1.85 Allowed 'Trans proline' 0 C--N 1.319 -1.006 0 O-C-N 123.197 1.104 . . . . 0.0 110.607 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.72 157.89 38.12 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.554 -0.716 . . . . 0.0 109.851 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.12 150.25 65.75 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.421 1.221 . . . . 0.0 110.867 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.415 HG21 ' SG ' ' A' ' 159' ' ' CYS . 55.3 t -54.13 -30.47 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.422 -0.799 . . . . 0.0 109.723 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 46.0 t -59.91 -41.94 92.79 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.559 -0.713 . . . . 0.0 110.869 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -67.97 -39.97 83.26 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.482 -0.761 . . . . 0.0 109.719 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 135' ' ' LEU . 33.0 tp -92.18 15.49 13.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.803 -0.56 . . . . 0.0 110.286 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -79.65 114.65 18.74 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 122.537 1.161 . . . . 0.0 112.128 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.93 37.18 3.72 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 61.3 m -119.26 19.13 12.89 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.705 -0.88 . . . . 0.0 110.454 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.754 ' HB3' HG21 ' A' ' 55' ' ' VAL . 66.3 m -70.54 136.28 49.2 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.25 -0.906 . . . . 0.0 109.169 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 109.77 -25.35 17.2 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.181 -1.567 . . . . 0.0 109.181 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.0 112.63 3.69 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.489 ' HD2' HG21 ' A' ' 33' ' ' VAL . 47.6 Cg_endo -73.24 148.8 44.5 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 123.25 1.131 . . . . 0.0 111.105 -179.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.497 HD21 HD12 ' A' ' 106' ' ' LEU . 67.7 mt -98.22 116.3 30.15 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.725 HD21 ' OE2' ' A' ' 32' ' ' GLU . 5.6 mp -103.37 127.71 50.66 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.509 -0.744 . . . . 0.0 111.015 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.716 ' SG ' 'ZN ' ' A' ' 202' ' ' ' ZN' . 27.8 p -67.92 164.85 37.09 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.755 -0.59 . . . . 0.0 109.505 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 39.4 Cg_endo -65.09 -14.22 44.05 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 O-C-N 123.148 1.078 . . . . 0.0 111.104 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.9 t -69.61 -40.02 76.88 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.147 -0.97 . . . . 0.0 109.768 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 122.17 37.82 0.63 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -133.6 -173.28 3.18 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.388 -1.066 . . . . 0.0 110.276 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.701 ' HB2' HD21 ' A' ' 94' ' ' LEU . . . -104.55 145.39 30.37 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.552 -0.718 . . . . 0.0 110.158 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.534 HG21 ' CD2' ' A' ' 104' ' ' LEU . 50.7 t -115.75 -62.42 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.518 -0.739 . . . . 0.0 110.454 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -157.08 -158.59 8.99 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.2 mt -133.48 146.68 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.565 -0.962 . . . . 0.0 110.003 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -61.97 140.01 58.36 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.369 -0.832 . . . . 0.0 110.479 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.428 ' NE ' ' HB3' ' A' ' 81' ' ' ASP . 0.6 OUTLIER -117.23 -76.13 0.57 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.57 0.7 . . . . 0.0 110.496 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -125.3 147.18 49.22 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 121.377 -0.827 . . . . 0.0 111.234 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.06 124.83 37.31 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.449 HG13 ' C11' ' A' ' 201' ' ' 4P2 . 2.3 t -95.75 119.03 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.585 -0.697 . . . . 0.0 111.026 -177.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.415 ' SG ' HG21 ' A' ' 132' ' ' VAL . 27.4 p -139.89 146.09 38.84 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.593 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 59.6 m -78.87 -49.92 12.09 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.6 -0.687 . . . . 0.0 109.855 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 5.9 ptt180 -129.11 36.17 4.21 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.614 -0.679 . . . . 0.0 109.915 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 102.7 -11.93 56.39 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 62.9 t -92.33 121.2 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.249 -1.148 . . . . 0.0 109.009 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.17 116.92 25.58 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.5 -0.75 . . . . 0.0 111.218 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -110.98 -29.93 7.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.833 -0.542 . . . . 0.0 109.729 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.403 ' C ' HG13 ' A' ' 167' ' ' VAL . . . -120.05 168.27 11.35 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.638 -0.664 . . . . 0.0 109.958 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.413 HG21 HG11 ' A' ' 116' ' ' VAL . 35.1 m -146.05 137.2 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.581 -0.699 . . . . 0.0 110.64 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -113.05 143.63 43.99 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.598 -0.689 . . . . 0.0 110.404 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -149.49 162.2 40.61 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.631 -0.668 . . . . 0.0 110.879 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.406 HG21 ' NH2' ' A' ' 155' ' ' ARG . 5.6 m -101.62 143.73 27.19 Favored Pre-proline 0 N--CA 1.505 2.317 0 O-C-N 121.448 -0.783 . . . . 0.0 110.135 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -79.69 168.18 19.8 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 O-C-N 123.339 1.179 . . . . 0.0 110.171 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 151' ' ' VAL . 64.9 t -66.29 -24.0 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.521 -0.737 . . . . 0.0 110.118 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -54.32 -38.89 66.5 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.429 -0.795 . . . . 0.0 111.449 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 82.2 p -61.66 -24.55 66.81 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.671 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 65.5 mtt -70.11 -28.72 65.62 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.431 -0.793 . . . . 0.0 110.898 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -59.28 -50.85 72.41 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.409 -0.807 . . . . 0.0 110.596 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 22.1 m -72.03 -29.03 63.76 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.49 -0.756 . . . . 0.0 110.334 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 32.5 m -68.0 -32.29 72.58 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.561 -0.712 . . . . 0.0 110.507 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 34.5 mmm -59.45 -52.04 67.31 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.484 -0.76 . . . . 0.0 110.485 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 56.4 mtp85 -63.87 -40.02 95.57 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.528 -0.732 . . . . 0.0 110.115 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.804 0 O-C-N 121.564 -0.71 . . . . 0.0 110.261 -179.891 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 201' ' ' 4P2 . . . . . 0.683 ' C24' HG13 ' A' ' 78' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . 0.716 'ZN ' ' SG ' ' A' ' 145' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.2 m . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.125 0.488 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.47 -154.05 30.45 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 50.7 ttp180 59.35 116.74 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.7 -0.882 . . . . 0.0 110.928 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 53.59 50.1 17.97 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.296 -0.877 . . . . 0.0 110.822 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.7 tttm -114.34 121.87 44.96 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.577 -0.702 . . . . 0.0 110.186 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 51.22 -150.15 0.29 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.396 -0.815 . . . . 0.0 110.796 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 66.28 -73.3 0.07 Allowed 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.155 -0.965 . . . . 0.0 110.749 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.3 t 53.81 69.96 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 O-C-N 121.556 -0.715 . . . . 0.0 110.278 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -65.83 148.91 51.02 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.618 -0.676 . . . . 0.0 110.401 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -147.64 -97.8 0.2 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.531 ' CG ' HD13 ' A' ' 94' ' ' LEU . 1.3 tp10 -169.3 -39.65 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.51 -0.994 . . . . 0.0 110.286 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.878 HG22 HG22 ' A' ' 46' ' ' THR . 92.4 t -109.83 143.96 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.569 -0.707 . . . . 0.0 109.808 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -116.63 148.25 41.15 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.63 -0.669 . . . . 0.0 110.308 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.493 ' HA ' HD22 ' A' ' 44' ' ' LEU . 59.8 t -78.43 124.62 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.701 -0.624 . . . . 0.0 109.699 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.6 m -134.12 138.65 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.428 -0.795 . . . . 0.0 110.545 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 74.7 m -119.38 154.56 33.44 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.593 -0.692 . . . . 0.0 110.294 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.526 HG22 ' H ' ' A' ' 39' ' ' ALA . 1.5 m -110.99 179.6 4.0 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.63 -0.669 . . . . 0.0 110.121 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.526 ' H ' HG22 ' A' ' 38' ' ' THR . . . -62.43 -40.03 95.25 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.807 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.408 HG23 ' HG3' ' A' ' 41' ' ' GLN . 7.7 t -119.78 -28.3 5.26 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.401 -0.812 . . . . 0.0 111.204 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.408 ' HG3' HG23 ' A' ' 40' ' ' THR . 50.0 mt-30 -118.2 178.08 4.56 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.405 -0.81 . . . . 0.0 110.213 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 83.0 p -153.71 117.03 4.59 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.541 -0.724 . . . . 0.0 110.565 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.639 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 6.7 p90 -130.4 -176.91 4.11 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.635 -0.665 . . . . 0.0 110.007 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.493 HD22 ' HA ' ' A' ' 35' ' ' VAL . 57.9 mt -117.3 162.93 17.11 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.433 -0.792 . . . . 0.0 110.545 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.863 ' O ' HG13 ' A' ' 33' ' ' VAL . . . -129.53 150.23 50.95 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.668 -0.645 . . . . 0.0 110.504 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.878 HG22 HG22 ' A' ' 33' ' ' VAL . 78.9 p -125.69 144.17 50.72 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.602 -0.687 . . . . 0.0 110.077 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 25.9 p -100.51 106.71 18.27 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.741 0.781 . . . . 0.0 110.575 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.504 ' O ' HG12 ' A' ' 51' ' ' VAL . 60.8 t -130.64 139.58 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.285 -0.884 . . . . 0.0 110.341 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.419 ' OD1' HG12 ' A' ' 48' ' ' VAL . 10.8 m120 55.02 40.48 32.02 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.57 -0.706 . . . . 0.0 111.529 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 87' ' ' ALA . . . 63.78 14.46 55.33 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 48' ' ' VAL . 7.2 p -138.43 138.55 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.148 -1.207 . . . . 0.0 109.354 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.582 ' SG ' ' HB1' ' A' ' 45' ' ' ALA . 43.6 t -87.67 126.28 34.87 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.56 -0.713 . . . . 0.0 110.464 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.661 ' CE3' HD23 ' A' ' 82' ' ' LEU . 75.1 m95 -111.08 136.78 49.6 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.649 -0.657 . . . . 0.0 110.13 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.56 HG21 ' CH2' ' A' ' 85' ' ' TRP . 6.9 t -137.37 -179.81 5.95 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.658 -0.651 . . . . 0.0 110.005 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.612 HG21 ' HB3' ' A' ' 139' ' ' SER . 63.6 t -84.13 141.47 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.491 -0.756 . . . . 0.0 109.124 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.893 ' CE2' HG22 ' A' ' 78' ' ' VAL . 14.4 t80 -85.73 -43.7 13.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.514 -0.741 . . . . 0.0 111.405 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.546 ' CE1' HG11 ' A' ' 55' ' ' VAL . 2.6 p-80 -60.53 -22.28 63.44 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.219 -0.926 . . . . 0.0 110.821 -178.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -93.57 -32.64 7.56 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.507 ' HB1' ' CD2' ' A' ' 64' ' ' LEU . . . -84.03 -63.43 1.35 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.55 -0.97 . . . . 0.0 110.274 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.61 -176.5 28.75 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.5 t -70.12 -24.03 63.13 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.635 -0.92 . . . . 0.0 110.546 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.67 139.77 56.96 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.435 -0.79 . . . . 0.0 110.382 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.49 HG22 ' HB2' ' A' ' 73' ' ' GLN . 1.8 p -76.94 140.22 40.41 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.62 -0.675 . . . . 0.0 110.251 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.639 HD22 ' HZ ' ' A' ' 43' ' ' PHE . 2.8 pp -143.13 122.42 13.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.498 -0.751 . . . . 0.0 110.588 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.729 ' HB3' HG23 ' A' ' 71' ' ' ILE . . . -147.71 108.15 4.12 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.242 -0.911 . . . . 0.0 110.371 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 57.86 163.04 0.05 OUTLIER Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.43 -8.6 22.91 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 O-C-N 123.024 1.013 . . . . 0.0 110.897 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.35 -31.84 67.82 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.297 -0.877 . . . . 0.0 111.255 -179.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 159.54 161.61 11.41 Favored Glycine 0 N--CA 1.496 2.644 0 C-N-CA 119.802 -1.189 . . . . 0.0 110.486 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -75.84 161.64 36.02 Favored 'Trans proline' 0 N--CA 1.488 1.196 0 O-C-N 123.611 1.322 . . . . 0.0 111.059 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.729 HG23 ' HB3' ' A' ' 65' ' ' ALA . 47.3 pt -128.79 -153.47 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.625 -0.672 . . . . 0.0 109.611 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 58.6 m -94.44 137.31 33.73 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.302 -0.874 . . . . 0.0 109.762 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.49 ' HB2' HG22 ' A' ' 63' ' ' THR . 13.3 tt0 -86.04 143.53 28.05 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.49 -0.756 . . . . 0.0 110.783 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.9 tpp -119.13 -48.07 2.45 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.549 -0.719 . . . . 0.0 110.742 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.641 ' O ' HG13 ' A' ' 83' ' ' VAL . 29.2 m-85 -109.62 128.46 55.24 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.355 -0.84 . . . . 0.0 110.32 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 54.7 m -152.19 123.38 7.64 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.527 -0.733 . . . . 0.0 110.147 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -166.09 124.24 1.49 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.405 -0.81 . . . . 0.0 111.32 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.893 HG22 ' CE2' ' A' ' 56' ' ' TYR . 94.3 t -72.59 -30.83 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.528 -0.732 . . . . 0.0 109.797 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -57.83 -40.05 79.12 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.47 -0.768 . . . . 0.0 110.433 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.457 ' NE2' ' OG1' ' A' ' 178' ' ' THR . 25.6 tt0 -97.63 -7.75 30.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.57 -0.706 . . . . 0.0 111.009 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.5 ' O ' HD12 ' A' ' 82' ' ' LEU . 37.8 t0 53.35 39.66 30.17 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.958 -1.088 . . . . 0.0 110.569 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.661 HD23 ' CE3' ' A' ' 53' ' ' TRP . 0.4 OUTLIER -140.14 155.54 46.93 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.574 -0.851 . . . . 0.0 111.314 -179.071 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.641 HG13 ' O ' ' A' ' 75' ' ' TYR . 3.1 t -145.55 156.74 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -155.46 172.59 33.63 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 119.292 -1.432 . . . . 0.0 111.064 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.56 ' CH2' HG21 ' A' ' 54' ' ' THR . 10.6 m-90 -147.0 159.65 43.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.89 -0.77 . . . . 0.0 109.602 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -70.83 115.64 10.21 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.517 -0.739 . . . . 0.0 110.31 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 50' ' ' GLY . . . -86.57 157.93 54.87 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.623 -0.673 . . . . 0.0 110.056 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.43 155.91 59.21 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.422 1.222 . . . . 0.0 110.396 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -75.22 155.12 41.91 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.466 1.245 . . . . 0.0 110.341 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 97.26 -25.93 25.0 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.5 154.31 24.92 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.396 -1.061 . . . . 0.0 110.063 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.94 135.15 44.99 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.599 -0.688 . . . . 0.0 110.025 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 58.4 m -105.39 130.02 53.58 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.526 -0.734 . . . . 0.0 110.098 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.833 HD23 ' HB2' ' A' ' 150' ' ' ALA . 6.0 tp -83.81 148.94 26.72 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.552 -0.717 . . . . 0.0 110.435 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.577 HG23 ' ND1' ' A' ' 149' ' ' HIS . 6.5 t -113.22 150.98 43.87 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.606 -0.684 . . . . 0.0 110.196 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.72 154.96 63.63 Favored 'Trans proline' 0 N--CA 1.486 1.071 0 O-C-N 123.319 1.168 . . . . 0.0 110.702 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 1.056 ' SG ' 'ZN ' ' A' ' 202' ' ' ' ZN' . 7.1 t -87.17 144.64 26.75 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.567 -0.708 . . . . 0.0 110.572 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.4 p -136.52 67.97 1.44 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.61 -0.681 . . . . 0.0 110.441 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 28.0 p -145.15 7.16 1.17 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.385 -0.822 . . . . 0.0 111.97 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 52.02 47.84 53.48 Favored Glycine 0 N--CA 1.499 2.881 0 O-C-N 120.863 -1.148 . . . . 0.0 110.384 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.3 t -100.02 120.49 39.9 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.502 -0.999 . . . . 0.0 110.512 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.8 p -69.94 -39.78 75.89 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.629 -0.669 . . . . 0.0 109.918 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -61.58 134.92 57.39 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.561 -0.712 . . . . 0.0 109.881 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 49.9 mt -142.68 160.15 40.86 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.564 -0.71 . . . . 0.0 110.707 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -120.02 134.04 55.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.674 -0.641 . . . . 0.0 109.347 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.457 HD12 ' HG ' ' A' ' 143' ' ' LEU . 3.6 tt -127.33 112.58 15.21 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.489 -0.757 . . . . 0.0 110.711 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.429 ' O ' HD23 ' A' ' 106' ' ' LEU . 55.9 t -69.14 147.52 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.49 -0.756 . . . . 0.0 108.993 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.8 p -108.29 -168.25 1.34 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.51 -0.744 . . . . 0.0 110.614 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.4 ' NH2' HD12 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -88.73 -22.97 23.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.585 -0.697 . . . . 0.0 110.348 -179.662 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -102.56 29.23 5.4 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.452 -0.78 . . . . 0.0 110.167 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 56.89 55.65 6.01 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.471 -0.768 . . . . 0.0 111.019 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.95 144.06 49.09 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.476 -0.765 . . . . 0.0 109.297 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.5 t -115.28 128.29 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.364 -0.835 . . . . 0.0 110.461 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.545 HD11 ' HB3' ' A' ' 128' ' ' SER . 14.8 tt -137.96 134.91 18.24 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.62 -0.675 . . . . 0.0 109.864 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -74.82 145.52 32.29 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 O-C-N 123.208 1.109 . . . . 0.0 110.569 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.4 t -129.95 129.94 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.576 -0.702 . . . . 0.0 109.684 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -85.26 155.84 21.21 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.587 -0.696 . . . . 0.0 110.171 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 71.6 ttt-85 -99.1 134.55 41.79 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.596 -0.69 . . . . 0.0 110.146 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -118.75 -12.58 9.65 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.598 -0.689 . . . . 0.0 110.936 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -169.05 -160.57 17.48 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -70.04 -37.46 75.58 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.549 -0.971 . . . . 0.0 110.874 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.426 ' HA ' ' CE1' ' A' ' 169' ' ' PHE . 50.0 m -134.27 28.02 3.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.356 -0.84 . . . . 0.0 111.07 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.7 ' CZ ' ' HB1' ' A' ' 166' ' ' ALA . 17.4 tpt85 -141.93 139.87 32.64 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.298 -0.876 . . . . 0.0 110.242 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -147.89 161.71 28.61 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 71.4 p -98.78 163.89 12.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.43 -1.041 . . . . 0.0 110.147 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.512 HD11 HD13 ' A' ' 114' ' ' ILE . 22.9 tp -112.63 127.62 56.15 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.649 -0.657 . . . . 0.0 110.151 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.4 mp -64.19 -39.8 94.74 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.587 -0.696 . . . . 0.0 110.408 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.545 ' HB3' HD11 ' A' ' 114' ' ' ILE . 14.0 t -100.36 106.65 43.71 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.528 -0.732 . . . . 0.0 110.298 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -76.1 113.22 3.66 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 O-C-N 123.275 1.145 . . . . 0.0 110.515 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -119.33 155.19 54.04 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.585 -0.697 . . . . 0.0 109.917 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -70.0 150.42 66.76 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 O-C-N 123.432 1.227 . . . . 0.0 110.013 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 90.8 t -53.39 -34.39 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.252 -0.905 . . . . 0.0 110.002 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 34.5 t -57.87 -49.11 77.83 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.587 -0.695 . . . . 0.0 110.632 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -66.55 -38.37 86.98 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.501 -0.749 . . . . 0.0 109.548 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 135' ' ' LEU . 40.7 tp -90.23 16.85 7.86 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.826 -0.547 . . . . 0.0 110.335 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -83.28 121.09 26.66 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.757 -1.214 . . . . 0.0 112.126 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.49 33.26 4.87 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.6 m -106.05 13.02 29.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.653 -0.91 . . . . 0.0 110.525 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.612 ' HB3' HG21 ' A' ' 55' ' ' VAL . 18.1 m -62.36 143.58 56.81 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.272 -0.893 . . . . 0.0 109.849 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 83.0 7.06 87.7 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.409 ' O ' HD12 ' A' ' 143' ' ' LEU . . . -59.82 133.54 51.27 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.584 ' HG3' HG21 ' A' ' 33' ' ' VAL . 56.9 Cg_endo -80.17 117.15 3.46 Favored 'Trans proline' 0 N--CA 1.485 0.999 0 O-C-N 123.24 1.126 . . . . 0.0 110.934 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.688 ' C ' HD12 ' A' ' 144' ' ' LEU . 7.8 mp -98.75 104.04 16.04 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.407 -0.808 . . . . 0.0 109.018 178.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.688 HD12 ' C ' ' A' ' 143' ' ' LEU . 9.8 mp -117.74 147.43 42.97 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.498 -0.751 . . . . 0.0 111.065 -179.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.404 ' CB ' ' HD2' ' A' ' 146' ' ' PRO . 0.1 OUTLIER -75.27 178.68 1.69 Allowed Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.746 -0.596 . . . . 0.0 109.455 179.418 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.404 ' HD2' ' CB ' ' A' ' 145' ' ' CYS . 43.1 Cg_endo -70.01 -24.96 27.92 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.215 1.113 . . . . 0.0 110.416 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 36.4 t -69.9 -40.1 75.81 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.48 -0.762 . . . . 0.0 110.035 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 124.15 45.86 0.27 Allowed Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.577 ' ND1' HG23 ' A' ' 95' ' ' THR . 62.5 m-70 -135.96 134.79 39.01 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.574 -0.956 . . . . 0.0 110.318 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.833 ' HB2' HD23 ' A' ' 94' ' ' LEU . . . -77.86 140.87 39.38 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.495 -0.753 . . . . 0.0 110.353 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.615 ' O ' HG23 ' A' ' 172' ' ' VAL . 34.7 m -117.37 -25.82 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.629 -0.67 . . . . 0.0 110.66 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -174.37 -173.77 40.63 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 64.4 mt -129.33 158.17 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.659 -0.907 . . . . 0.0 109.672 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -69.81 148.01 49.66 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.385 -0.822 . . . . 0.0 110.167 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.41 ' NH1' HG22 ' A' ' 170' ' ' VAL . 0.0 OUTLIER -132.41 -80.35 0.5 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.781 -0.575 . . . . 0.0 110.354 -179.49 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -120.66 143.58 48.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.178 -0.951 . . . . 0.0 111.269 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.85 129.82 40.12 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.449 HG13 ' C11' ' A' ' 201' ' ' 4P2 . 2.3 t -100.32 121.27 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.491 -0.756 . . . . 0.0 111.33 -177.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.8 p -140.66 149.54 42.39 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.535 -0.728 . . . . 0.0 110.517 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 37.7 m -88.79 -49.62 6.72 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.553 -0.717 . . . . 0.0 109.804 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -119.71 32.03 6.26 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.52 0.676 . . . . 0.0 109.229 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 97.65 -11.56 64.7 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.244 -1.543 . . . . 0.0 109.244 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 62.4 t -88.11 122.42 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.279 -1.13 . . . . 0.0 109.061 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.55 113.14 22.97 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.528 -0.733 . . . . 0.0 110.784 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -109.14 -30.21 8.15 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.651 -0.656 . . . . 0.0 109.687 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.7 ' HB1' ' CZ ' ' A' ' 123' ' ' ARG . . . -116.52 168.32 10.27 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.664 -0.648 . . . . 0.0 109.681 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.447 HG13 ' C ' ' A' ' 166' ' ' ALA . 35.9 m -148.74 135.82 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.541 -0.724 . . . . 0.0 111.085 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.65 134.46 51.93 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.664 -0.647 . . . . 0.0 109.883 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.426 ' CE1' ' HA ' ' A' ' 122' ' ' SER . 52.2 p90 -131.56 159.94 36.74 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.42 -0.8 . . . . 0.0 110.389 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.41 HG22 ' NH1' ' A' ' 155' ' ' ARG . 60.4 t -92.54 140.53 24.02 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.57 -0.707 . . . . 0.0 110.212 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -75.15 162.51 36.64 Favored 'Trans proline' 0 C--N 1.32 -0.966 0 O-C-N 123.131 1.069 . . . . 0.0 110.337 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 151' ' ' VAL . 87.6 t -79.75 -30.59 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.554 -0.716 . . . . 0.0 110.257 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -60.02 -39.24 85.19 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.493 -0.754 . . . . 0.0 110.605 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 58.4 p -61.7 -25.7 67.58 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.516 -0.74 . . . . 0.0 110.871 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.428 ' CE ' HG13 ' A' ' 172' ' ' VAL . 53.9 mtm -66.99 -36.98 83.38 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.422 -0.799 . . . . 0.0 110.542 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -60.05 -40.01 87.92 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.472 -0.767 . . . . 0.0 110.404 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 31.3 m -61.05 -31.69 71.34 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.536 -0.727 . . . . 0.0 110.511 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.457 ' OG1' ' NE2' ' A' ' 80' ' ' GLN . 93.2 m -59.95 -40.04 87.64 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.515 -0.74 . . . . 0.0 110.465 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 1.4 ttp -58.82 -36.29 74.26 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.44 -0.787 . . . . 0.0 110.437 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 5.5 ttp180 -59.91 -39.98 87.26 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.433 -0.792 . . . . 0.0 110.212 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.833 0 O-C-N 121.603 -0.686 . . . . 0.0 110.301 179.944 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 201' ' ' 4P2 . . . . . 0.734 ' C24' HG13 ' A' ' 78' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . 1.056 'ZN ' ' SG ' ' A' ' 97' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.2 p . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.193 0.521 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.37 143.23 3.64 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -124.42 178.4 5.41 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.563 -0.963 . . . . 0.0 110.053 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -59.99 139.94 57.09 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.55 -0.719 . . . . 0.0 110.279 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -139.01 34.44 2.14 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.562 -0.711 . . . . 0.0 110.317 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -83.17 126.69 32.89 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.49 -0.756 . . . . 0.0 110.288 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -81.33 159.98 24.27 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.616 -0.678 . . . . 0.0 110.438 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.7 t -111.37 130.03 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.513 -0.742 . . . . 0.0 109.982 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -147.84 162.21 39.72 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.559 -0.713 . . . . 0.0 110.384 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -136.16 170.32 23.29 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.435 ' HG2' HD13 ' A' ' 94' ' ' LEU . 8.1 pt-20 -113.1 63.27 0.64 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.611 -0.934 . . . . 0.0 110.458 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 63.3 t -114.63 125.5 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.54 -0.725 . . . . 0.0 109.78 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -103.01 138.98 39.17 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.576 -0.702 . . . . 0.0 110.065 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.583 ' HA ' HD22 ' A' ' 44' ' ' LEU . 33.5 m -88.38 132.14 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.554 -0.716 . . . . 0.0 110.476 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.1 m -130.6 159.97 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.467 -0.77 . . . . 0.0 110.346 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 64.7 m -135.9 153.49 51.44 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.566 -0.709 . . . . 0.0 110.383 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.529 HG22 ' H ' ' A' ' 39' ' ' ALA . 1.6 m -117.8 179.82 3.96 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.618 -0.677 . . . . 0.0 109.982 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.529 ' H ' HG22 ' A' ' 38' ' ' THR . . . -71.14 -23.73 62.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.671 -0.643 . . . . 0.0 111.288 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.6 p -119.8 -28.29 5.25 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.32 -0.863 . . . . 0.0 111.418 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -142.34 164.72 29.37 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.371 -0.831 . . . . 0.0 110.639 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.4 t -130.94 124.62 31.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.497 -0.752 . . . . 0.0 110.14 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.411 ' CE1' ' OG1' ' A' ' 38' ' ' THR . 4.5 p90 -133.9 178.32 7.04 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.604 -0.685 . . . . 0.0 110.121 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.583 HD22 ' HA ' ' A' ' 35' ' ' VAL . 25.0 mt -121.16 167.55 12.54 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.574 -0.704 . . . . 0.0 110.026 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.79 152.14 46.33 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.592 -0.692 . . . . 0.0 110.06 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.6 m -119.98 135.42 54.92 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.477 -0.765 . . . . 0.0 110.286 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 45.8 t -93.27 103.82 16.04 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.562 -0.711 . . . . 0.0 110.482 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 94' ' ' LEU . 12.0 p -130.44 139.64 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.546 -0.721 . . . . 0.0 110.4 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 57.67 36.17 26.39 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.412 -0.805 . . . . 0.0 110.836 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 63.26 15.76 57.1 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.548 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 56.5 t -139.47 119.3 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.266 -1.137 . . . . 0.0 109.657 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 28.5 p -79.98 137.95 36.95 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.587 -0.696 . . . . 0.0 110.41 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.845 ' CE3' HD21 ' A' ' 82' ' ' LEU . 87.0 m95 -125.92 137.43 53.71 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.554 -0.716 . . . . 0.0 110.404 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.9 t -137.16 179.6 6.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.705 -0.622 . . . . 0.0 109.804 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.601 HG11 ' CE1' ' A' ' 57' ' ' HIS . 0.5 OUTLIER -81.32 142.65 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.175 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.908 ' CE2' HG22 ' A' ' 78' ' ' VAL . 27.5 t80 -81.02 -42.54 20.95 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.458 -0.776 . . . . 0.0 111.199 -178.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.601 ' CE1' HG11 ' A' ' 55' ' ' VAL . 2.2 p-80 -53.72 -21.2 6.64 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.444 -0.785 . . . . 0.0 111.956 -177.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -119.62 -23.63 3.06 Favored Glycine 0 N--CA 1.496 2.677 0 C-N-CA 119.984 -1.103 . . . . 0.0 111.064 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 55' ' ' VAL . . . -113.77 -27.14 7.9 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.235 -1.156 . . . . 0.0 111.083 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.453 ' HA3' ' CD1' ' A' ' 56' ' ' TYR . . . -60.0 -18.91 49.29 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 79.8 p -57.62 -22.71 46.99 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.276 -1.132 . . . . 0.0 111.02 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.1 tttm -152.2 161.48 42.55 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.368 -0.832 . . . . 0.0 110.702 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.822 HG22 ' HB2' ' A' ' 73' ' ' GLN . 76.0 p -66.0 149.15 50.69 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.569 -0.707 . . . . 0.0 109.624 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.451 ' HB2' ' CH2' ' A' ' 85' ' ' TRP . 19.4 mt -142.38 144.71 33.27 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.446 -0.784 . . . . 0.0 111.736 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.854 ' HB3' ' O ' ' A' ' 69' ' ' GLY . . . -147.58 164.02 34.76 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.33 -131.91 0.01 OUTLIER Glycine 0 N--CA 1.497 2.74 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.46 -9.45 25.36 Favored 'Trans proline' 0 N--CA 1.491 1.352 0 O-C-N 122.708 0.846 . . . . 0.0 111.988 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.493 ' HB3' HD11 ' A' ' 71' ' ' ILE . 24.4 tptt -69.79 -31.06 68.77 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.175 -0.953 . . . . 0.0 110.722 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.854 ' O ' ' HB3' ' A' ' 65' ' ' ALA . . . 104.58 -172.03 19.84 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.65 127.78 15.17 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 123.203 1.107 . . . . 0.0 110.377 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.493 HD11 ' HB3' ' A' ' 68' ' ' LYS . 68.9 mt -129.7 -109.72 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.518 -0.739 . . . . 0.0 110.215 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.452 ' N ' HG22 ' A' ' 71' ' ' ILE . 40.7 p -120.27 150.57 40.49 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.583 -1.323 . . . . 0.0 111.082 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.822 ' HB2' HG22 ' A' ' 63' ' ' THR . 0.4 OUTLIER -87.96 130.95 34.78 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.729 -0.607 . . . . 0.0 109.721 179.275 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.7 tpt -119.07 -44.54 2.6 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.464 -0.773 . . . . 0.0 110.976 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.52 ' O ' HG13 ' A' ' 83' ' ' VAL . 24.1 m-85 -109.81 124.78 51.89 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.271 -0.893 . . . . 0.0 110.083 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.503 HG23 ' HE1' ' A' ' 56' ' ' TYR . 56.9 m -152.17 135.47 15.91 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.609 -0.682 . . . . 0.0 110.355 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -167.28 111.85 0.71 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.504 -0.748 . . . . 0.0 110.813 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.908 HG22 ' CE2' ' A' ' 56' ' ' TYR . 75.7 t -72.25 -29.21 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.297 -0.877 . . . . 0.0 109.322 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -60.0 -42.89 95.23 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.47 -0.769 . . . . 0.0 110.012 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.403 ' HB2' HE21 ' A' ' 80' ' ' GLN . 6.1 tt0 -99.81 -6.99 26.0 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.514 -0.741 . . . . 0.0 110.652 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.486 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 30.4 t0 56.39 33.98 23.38 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.065 -1.022 . . . . 0.0 110.635 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.845 HD21 ' CE3' ' A' ' 53' ' ' TRP . 7.8 tt -119.83 145.27 46.79 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.249 -0.907 . . . . 0.0 111.751 -178.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 75' ' ' TYR . 3.1 t -143.97 159.25 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -168.96 164.37 38.02 Favored Glycine 0 N--CA 1.496 2.645 0 C-N-CA 119.46 -1.352 . . . . 0.0 110.624 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.517 ' CZ2' HG12 ' A' ' 83' ' ' VAL . 20.3 m-90 -146.75 160.02 42.76 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.793 -0.828 . . . . 0.0 109.47 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -62.21 138.0 58.34 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.575 -0.703 . . . . 0.0 110.08 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.97 148.5 57.06 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.478 -0.764 . . . . 0.0 110.284 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.9 160.0 48.94 Favored 'Trans proline' 0 C--N 1.317 -1.105 0 O-C-N 123.484 1.254 . . . . 0.0 110.359 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -73.31 126.83 11.36 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 123.377 1.199 . . . . 0.0 110.447 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 108.81 30.09 3.86 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -117.42 159.49 22.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.513 -0.993 . . . . 0.0 110.089 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.2 mtp180 -96.29 163.87 12.9 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.53 -0.731 . . . . 0.0 110.378 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 80.7 p -130.89 145.17 51.93 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.678 -0.639 . . . . 0.0 109.901 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.435 HD13 ' HG2' ' A' ' 32' ' ' GLU . 0.7 OUTLIER -105.09 139.92 39.04 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.588 -0.695 . . . . 0.0 110.303 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 60.3 m -78.07 143.8 66.37 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.747 -0.596 . . . . 0.0 109.917 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.64 161.98 43.82 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 O-C-N 123.302 1.159 . . . . 0.0 110.319 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 45.6 t -72.9 128.01 34.24 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.539 -0.725 . . . . 0.0 110.483 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.3 m -135.73 55.79 1.85 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.662 -0.649 . . . . 0.0 109.531 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.4 p -145.01 4.66 1.1 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.58 -0.7 . . . . 0.0 112.175 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 51.25 91.06 0.01 OUTLIER Glycine 0 N--CA 1.502 3.064 0 O-C-N 120.905 -1.122 . . . . 0.0 110.495 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 98.1 p -139.35 148.06 42.38 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.436 -1.038 . . . . 0.0 110.362 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 63.7 m -95.03 -34.54 12.3 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.64 -0.662 . . . . 0.0 110.176 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -66.37 129.67 40.6 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.642 -0.661 . . . . 0.0 109.915 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.845 HD22 HG21 ' A' ' 151' ' ' VAL . 97.3 mt -136.28 156.53 48.53 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.625 -0.672 . . . . 0.0 110.546 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -126.34 108.72 11.5 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.667 -0.646 . . . . 0.0 109.519 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.473 HD11 ' CD1' ' A' ' 154' ' ' PHE . 9.7 tt -89.46 129.39 35.96 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.638 -0.663 . . . . 0.0 110.763 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.5 t -84.91 131.07 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.64 -0.663 . . . . 0.0 109.575 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.7 p -97.82 -175.51 3.19 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.48 -0.762 . . . . 0.0 110.509 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.2 ttt-85 -69.95 -27.01 64.4 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.706 -0.621 . . . . 0.0 110.846 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.44 ' CD2' ' HB2' ' A' ' 112' ' ' ASP . 41.0 p-80 -106.22 29.96 6.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.43 -0.794 . . . . 0.0 110.859 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 55.36 56.84 5.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.532 -0.73 . . . . 0.0 111.884 178.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.44 ' HB2' ' CD2' ' A' ' 110' ' ' HIS . 0.4 OUTLIER -110.8 137.34 48.57 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.401 -0.812 . . . . 0.0 109.88 179.118 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.44 ' O ' HG13 ' A' ' 113' ' ' VAL . 10.4 p -84.46 128.34 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.65 -0.656 . . . . 0.0 110.275 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.54 ' CG2' HD11 ' A' ' 126' ' ' LEU . 48.6 mm -129.98 105.86 16.67 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.523 -0.735 . . . . 0.0 110.11 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -70.66 119.84 6.64 Favored 'Trans proline' 0 N--CA 1.487 1.088 0 O-C-N 123.241 1.127 . . . . 0.0 110.242 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.635 HG13 ' O ' ' A' ' 125' ' ' SER . 57.5 t -120.36 129.39 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.515 -0.741 . . . . 0.0 110.137 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.514 ' CG ' HD11 ' A' ' 127' ' ' LEU . 4.1 mmt180 -83.03 135.86 34.7 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.566 -0.709 . . . . 0.0 109.809 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -82.24 134.23 35.28 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.522 -0.736 . . . . 0.0 110.431 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.7 18.63 3.3 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.587 -0.696 . . . . 0.0 110.581 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -173.33 178.94 45.05 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -69.55 -39.97 77.11 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.572 -0.958 . . . . 0.0 110.331 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.6 m -130.33 25.06 5.17 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.527 -0.733 . . . . 0.0 110.781 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -142.58 141.83 32.06 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.423 -0.798 . . . . 0.0 110.306 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -142.11 157.16 26.37 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.635 ' O ' HG13 ' A' ' 116' ' ' VAL . 50.6 p -91.57 157.63 16.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.664 -0.904 . . . . 0.0 110.125 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.54 HD11 ' CG2' ' A' ' 114' ' ' ILE . 39.9 tp -105.77 127.17 52.92 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.531 -0.731 . . . . 0.0 110.36 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.514 HD11 ' CG ' ' A' ' 117' ' ' ARG . 4.3 mp -68.6 -42.26 78.44 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.581 -0.7 . . . . 0.0 110.092 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.6 p -102.2 99.79 13.58 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.694 -0.629 . . . . 0.0 109.701 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.15 106.94 2.01 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.388 1.204 . . . . 0.0 110.945 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -114.47 161.5 28.25 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.713 -0.617 . . . . 0.0 109.748 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 44.8 Cg_endo -71.18 150.59 59.86 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 O-C-N 123.391 1.206 . . . . 0.0 110.354 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.413 HG21 ' SG ' ' A' ' 159' ' ' CYS . 64.6 t -51.03 -29.93 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 O-C-N 121.399 -0.813 . . . . 0.0 109.828 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.2 t -61.43 -40.04 92.97 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.728 -0.608 . . . . 0.0 110.956 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -66.87 -39.97 87.71 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.326 -0.859 . . . . 0.0 109.538 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.417 HD21 ' CZ ' ' A' ' 154' ' ' PHE . 17.6 tp -95.4 18.9 11.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.922 -0.486 . . . . 0.0 110.135 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -81.14 116.67 21.16 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 122.541 1.162 . . . . 0.0 112.412 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.72 22.12 11.54 Favored Glycine 0 N--CA 1.492 2.401 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.269 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.3 m -103.44 20.85 17.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.47 -1.018 . . . . 0.0 110.53 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.2 m -69.96 136.12 50.17 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.28 -0.888 . . . . 0.0 109.541 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 100.06 -23.29 36.56 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.79 110.02 1.93 Allowed Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -72.43 138.7 30.35 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 O-C-N 123.18 1.095 . . . . 0.0 111.073 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.459 ' C ' HD12 ' A' ' 144' ' ' LEU . 4.1 mp -86.35 146.3 26.53 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.459 HD12 ' C ' ' A' ' 143' ' ' LEU . 4.1 mp -126.9 162.23 26.41 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.403 -0.81 . . . . 0.0 111.23 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.412 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 27.1 p -119.1 165.12 17.93 Favored Pre-proline 0 N--CA 1.494 1.774 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.412 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 39.9 Cg_endo -65.42 -12.23 33.98 Favored 'Trans proline' 0 N--CA 1.489 1.218 0 O-C-N 123.082 1.043 . . . . 0.0 111.853 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.7 p -72.01 -32.66 67.39 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.117 -0.989 . . . . 0.0 109.943 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 116.15 20.74 5.1 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -131.34 152.95 50.11 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.325 -1.103 . . . . 0.0 110.377 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.403 ' HB2' ' CD2' ' A' ' 94' ' ' LEU . . . -78.77 152.36 31.5 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.542 -0.724 . . . . 0.0 109.931 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.845 HG21 HD22 ' A' ' 104' ' ' LEU . 34.0 m -112.55 -28.81 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.5 -0.75 . . . . 0.0 110.989 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 177.7 -161.01 27.96 Favored Glycine 0 N--CA 1.498 2.776 0 C-N-CA 119.753 -1.213 . . . . 0.0 110.339 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.5 mt -134.42 151.76 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.652 -0.911 . . . . 0.0 110.162 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.473 ' CD1' HD11 ' A' ' 106' ' ' LEU . 14.5 t80 -70.13 153.49 43.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.685 -0.634 . . . . 0.0 110.14 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 46.6 ttm-85 -135.95 -76.41 0.43 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.659 -0.651 . . . . 0.0 110.327 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -120.53 143.04 48.79 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.38 -0.825 . . . . 0.0 110.616 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.27 127.71 38.97 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.491 HG13 ' C11' ' A' ' 201' ' ' 4P2 . 2.5 t -96.9 117.77 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.602 -0.686 . . . . 0.0 111.535 -177.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.413 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.9 p -140.06 147.68 40.67 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.414 -0.804 . . . . 0.0 110.565 178.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 17.9 m -79.49 -50.59 10.53 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.488 -0.758 . . . . 0.0 109.77 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -130.26 36.7 3.96 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.633 -0.667 . . . . 0.0 109.904 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 131' ' ' PRO . . . 104.28 -11.76 51.47 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 65.1 t -93.12 121.95 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.259 -1.142 . . . . 0.0 109.158 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.2 121.1 29.2 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.541 -0.725 . . . . 0.0 111.347 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 5.4 mttp -113.29 -30.11 7.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.804 -0.56 . . . . 0.0 109.933 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -123.64 168.4 12.69 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.518 -0.739 . . . . 0.0 109.9 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.492 HG21 HG11 ' A' ' 116' ' ' VAL . 35.1 m -140.23 137.34 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.517 -0.74 . . . . 0.0 110.887 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -104.65 126.57 51.85 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.53 -0.731 . . . . 0.0 110.606 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -147.8 162.14 39.83 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.595 -0.691 . . . . 0.0 110.332 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 27.1 m -110.96 149.59 40.65 Favored Pre-proline 0 N--CA 1.502 2.129 0 O-C-N 121.353 -0.842 . . . . 0.0 110.708 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -78.6 161.28 28.03 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.496 1.261 . . . . 0.0 109.378 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 54.0 t -58.9 -25.93 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.385 -0.822 . . . . 0.0 110.051 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -59.92 -35.53 75.08 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.557 -0.715 . . . . 0.0 110.643 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 2.3 t -61.51 -24.35 66.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.468 -0.77 . . . . 0.0 110.568 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 68.0 mtt -69.96 -39.06 76.23 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.431 -0.793 . . . . 0.0 110.507 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -60.11 -39.98 88.08 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.443 -0.786 . . . . 0.0 110.566 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 85.3 m -60.8 -40.04 91.15 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.474 -0.766 . . . . 0.0 110.124 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.415 HG21 HD22 ' A' ' 82' ' ' LEU . 61.8 m -67.73 -36.34 80.4 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.559 -0.713 . . . . 0.0 110.321 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 7.9 ttt -60.06 -42.23 94.05 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.553 -0.717 . . . . 0.0 110.539 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -60.07 -39.9 87.66 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.539 -0.726 . . . . 0.0 110.342 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.722 0 O-C-N 121.581 -0.699 . . . . 0.0 110.187 179.956 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 201' ' ' 4P2 . . . . . 0.765 ' C24' HG13 ' A' ' 78' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.6 t . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.087 0.47 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.94 28.54 71.7 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 53.79 176.27 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.47 -1.018 . . . . 0.0 110.935 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -147.15 35.51 0.9 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.518 -0.739 . . . . 0.0 110.384 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.8 mmtm 53.14 39.96 30.46 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.465 -0.772 . . . . 0.0 110.858 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 52.23 42.9 31.01 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.468 -0.77 . . . . 0.0 110.886 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -79.11 130.3 35.36 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.56 -0.712 . . . . 0.0 110.157 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.5 p -133.27 131.27 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.547 -0.72 . . . . 0.0 110.248 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -89.43 -38.99 13.68 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.642 -0.662 . . . . 0.0 110.308 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.42 174.0 44.94 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.415 ' HG2' HD21 ' A' ' 94' ' ' LEU . 21.7 mp0 -90.17 -24.63 20.98 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.556 -0.967 . . . . 0.0 110.485 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.749 HG23 ' O ' ' A' ' 45' ' ' ALA . 9.1 p -119.31 143.66 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.566 -0.709 . . . . 0.0 110.069 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 54.9 tp60 -110.39 141.65 43.16 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.582 -0.699 . . . . 0.0 110.181 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.609 ' HA ' HD22 ' A' ' 44' ' ' LEU . 10.0 p -82.74 130.26 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.643 -0.661 . . . . 0.0 110.212 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.7 m -138.14 144.31 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.509 -0.744 . . . . 0.0 110.48 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.4 m -130.05 144.04 51.12 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.54 -0.725 . . . . 0.0 110.632 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.575 HG23 ' CD2' ' A' ' 64' ' ' LEU . 0.3 OUTLIER -99.86 -169.98 1.82 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.602 -0.686 . . . . 0.0 109.768 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.526 ' H ' HG22 ' A' ' 38' ' ' THR . . . -71.83 -40.04 69.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.614 -0.679 . . . . 0.0 111.597 -178.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 77.6 p -114.59 -18.82 11.34 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.226 -0.922 . . . . 0.0 111.608 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -139.75 161.67 36.99 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.244 -0.91 . . . . 0.0 110.134 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 99.1 p -138.4 123.28 18.87 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.458 -0.776 . . . . 0.0 110.857 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.618 ' CZ ' HD21 ' A' ' 64' ' ' LEU . 4.4 p90 -128.05 -174.96 3.35 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.632 -0.668 . . . . 0.0 109.503 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.609 HD22 ' HA ' ' A' ' 35' ' ' VAL . 44.0 mt -126.57 166.08 17.96 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.335 -0.853 . . . . 0.0 110.746 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.749 ' O ' HG23 ' A' ' 33' ' ' VAL . . . -141.49 152.48 44.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.711 -0.618 . . . . 0.0 110.261 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 87.8 m -130.03 139.9 50.94 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.511 -0.743 . . . . 0.0 110.291 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 77.8 m -77.63 120.49 22.65 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.562 -0.712 . . . . 0.0 110.431 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.1 t -130.48 120.82 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.467 -0.771 . . . . 0.0 110.628 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 33.4 m120 50.05 34.47 8.3 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.534 -0.729 . . . . 0.0 111.969 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.75 ' O ' ' HB3' ' A' ' 87' ' ' ALA . . . 91.25 -23.61 23.53 Favored Glycine 0 N--CA 1.497 2.736 0 C-N-CA 120.198 -1.001 . . . . 0.0 110.8 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.0 p -108.89 133.58 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.3 -1.118 . . . . 0.0 109.781 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 77.1 m -91.55 125.03 36.15 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.392 -0.818 . . . . 0.0 110.159 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 71.9 m95 -99.33 137.17 38.21 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.567 -0.708 . . . . 0.0 110.422 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.81 HG21 ' CZ2' ' A' ' 85' ' ' TRP . 8.4 t -137.06 173.43 11.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.765 -0.584 . . . . 0.0 109.751 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.706 HG11 ' CE1' ' A' ' 57' ' ' HIS . 96.9 t -81.78 142.09 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.462 -0.774 . . . . 0.0 109.26 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.903 ' CE2' HG22 ' A' ' 78' ' ' VAL . 15.2 t80 -85.0 -43.37 14.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.63 -0.669 . . . . 0.0 110.806 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.706 ' CE1' HG11 ' A' ' 55' ' ' VAL . 2.2 p-80 -59.45 -22.55 61.67 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.167 -0.958 . . . . 0.0 110.476 -178.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -82.28 -65.77 1.61 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.0 -63.28 1.36 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.418 -1.048 . . . . 0.0 110.188 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.02 -153.63 21.22 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 72.8 m -59.78 -52.22 66.4 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.591 -0.946 . . . . 0.0 110.766 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -62.5 137.26 58.22 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.368 -0.832 . . . . 0.0 109.946 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 71' ' ' ILE . 8.5 t -114.24 140.94 48.17 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.563 -0.711 . . . . 0.0 110.318 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.742 ' O ' HD12 ' A' ' 64' ' ' LEU . 4.4 pp -142.27 140.26 32.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.471 -0.768 . . . . 0.0 110.235 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.608 ' HB3' HG12 ' A' ' 71' ' ' ILE . . . -147.19 119.53 8.38 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.671 -0.643 . . . . 0.0 109.931 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.57 128.35 0.03 OUTLIER Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.46 -9.19 25.57 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 O-C-N 123.169 1.089 . . . . 0.0 111.454 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -89.0 12.52 15.24 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.243 -0.91 . . . . 0.0 111.27 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 150.6 128.94 1.58 Allowed Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -87.2 168.86 7.54 Favored 'Trans proline' 0 C--N 1.32 -0.926 0 O-C-N 123.156 1.082 . . . . 0.0 110.464 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.608 HG12 ' HB3' ' A' ' 65' ' ' ALA . 45.1 pt -145.42 161.43 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.585 -0.697 . . . . 0.0 110.29 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.9 m -73.18 149.96 42.51 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.525 -0.735 . . . . 0.0 110.272 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -92.36 150.83 20.59 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.551 -0.718 . . . . 0.0 110.565 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 97.8 mmm -116.98 -32.7 4.98 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.65 -0.656 . . . . 0.0 110.35 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.582 ' O ' HG13 ' A' ' 83' ' ' VAL . 18.5 m-85 -110.11 129.15 55.74 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.374 -0.829 . . . . 0.0 109.436 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 89.3 m -151.44 132.65 14.46 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.399 -0.813 . . . . 0.0 110.456 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -166.73 125.42 1.42 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.372 -0.83 . . . . 0.0 111.141 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.903 HG22 ' CE2' ' A' ' 56' ' ' TYR . 78.5 t -72.32 -39.29 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.459 -0.776 . . . . 0.0 109.607 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -55.81 -44.93 78.32 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.354 -0.842 . . . . 0.0 110.268 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.576 ' O ' HD12 ' A' ' 82' ' ' LEU . 2.4 tp-100 -82.9 -14.0 55.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.754 -0.591 . . . . 0.0 110.279 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 40.2 t0 53.09 39.9 30.31 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.117 -0.989 . . . . 0.0 110.67 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.684 HD13 ' CE ' ' A' ' 175' ' ' MET . 0.3 OUTLIER -146.3 156.98 43.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.406 -0.809 . . . . 0.0 111.065 -179.545 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.733 ' O ' HG22 ' A' ' 54' ' ' THR . 3.5 t -145.11 145.14 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -130.5 154.69 20.77 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.626 -1.273 . . . . 0.0 110.912 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.81 ' CZ2' HG21 ' A' ' 54' ' ' THR . 4.4 m-90 -125.07 159.88 30.36 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.904 -0.763 . . . . 0.0 109.431 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -83.15 122.9 28.98 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.474 -0.766 . . . . 0.0 109.877 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.75 ' HB3' ' O ' ' A' ' 50' ' ' GLY . . . -101.28 160.62 26.1 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.457 -0.777 . . . . 0.0 110.538 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.77 160.05 49.06 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 O-C-N 123.484 1.255 . . . . 0.0 110.506 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.52 158.81 47.28 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.448 1.236 . . . . 0.0 110.526 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 74.27 31.12 59.69 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -107.23 151.33 25.58 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.43 -1.041 . . . . 0.0 110.307 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -60.5 152.3 26.22 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.589 -0.694 . . . . 0.0 110.46 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 92.5 p -148.23 155.39 41.3 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.612 -0.68 . . . . 0.0 110.457 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.626 ' HB3' ' HB2' ' A' ' 150' ' ' ALA . 90.9 mt -111.13 131.92 54.7 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.563 -0.711 . . . . 0.0 110.36 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 72.6 p -76.5 159.91 78.54 Favored Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 121.597 -0.689 . . . . 0.0 110.082 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.0 159.22 50.78 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.38 1.2 . . . . 0.0 110.481 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 47.0 t -86.93 128.15 35.06 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.564 -0.71 . . . . 0.0 110.388 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.5 p -133.69 55.09 1.91 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.603 -0.685 . . . . 0.0 109.989 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.5 p -145.18 7.68 1.18 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.481 -0.762 . . . . 0.0 111.864 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 52.26 41.67 54.72 Favored Glycine 0 N--CA 1.499 2.894 0 O-C-N 121.003 -1.06 . . . . 0.0 110.496 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.8 m -78.92 107.96 12.04 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.519 -0.989 . . . . 0.0 110.386 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.4 m -66.24 -40.01 89.92 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.569 -0.707 . . . . 0.0 110.195 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -67.92 129.12 38.94 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.589 -0.694 . . . . 0.0 109.97 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.579 HD22 HG21 ' A' ' 151' ' ' VAL . 90.8 mt -134.99 150.08 50.29 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.609 -0.682 . . . . 0.0 110.356 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -117.5 125.19 50.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.535 -0.728 . . . . 0.0 109.768 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.686 HD11 ' HB2' ' A' ' 154' ' ' PHE . 26.8 tp -102.53 144.22 31.23 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.5 -0.75 . . . . 0.0 110.556 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.6 t -105.92 126.68 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.603 -0.686 . . . . 0.0 109.73 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 69.7 p -93.98 176.49 6.31 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.501 -0.749 . . . . 0.0 110.58 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -60.13 -24.63 64.84 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.598 -0.689 . . . . 0.0 110.722 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -95.32 27.15 3.43 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.474 -0.766 . . . . 0.0 110.555 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 53.21 27.79 6.39 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.296 -0.878 . . . . 0.0 110.916 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -80.68 152.59 28.36 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.546 -0.721 . . . . 0.0 109.913 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 63.2 t -116.05 128.17 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.543 -0.723 . . . . 0.0 109.929 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.548 HD11 HD23 ' A' ' 106' ' ' LEU . 40.1 pt -134.56 139.07 31.5 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.49 -0.756 . . . . 0.0 110.19 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -82.91 146.45 12.98 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 O-C-N 123.177 1.093 . . . . 0.0 110.521 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.1 t -139.36 129.94 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.584 -0.698 . . . . 0.0 109.768 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.7 tpp180 -92.98 130.71 38.47 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.538 -0.726 . . . . 0.0 110.154 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -80.26 121.33 25.5 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.606 -0.684 . . . . 0.0 110.328 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.88 -12.29 9.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.523 -0.736 . . . . 0.0 110.473 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -134.92 -175.55 13.92 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -70.14 -45.09 67.54 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.557 -0.966 . . . . 0.0 110.57 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.6 m -127.67 21.04 6.54 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.45 -0.781 . . . . 0.0 110.819 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.72 142.13 34.86 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.315 -0.866 . . . . 0.0 110.057 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -134.25 166.86 23.99 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 52.9 p -98.72 165.19 11.91 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.541 -0.976 . . . . 0.0 110.222 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.444 HD21 ' NH1' ' A' ' 130' ' ' ARG . 47.7 tp -120.0 124.2 45.33 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.527 -0.733 . . . . 0.0 110.337 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.459 ' H ' HD12 ' A' ' 127' ' ' LEU . 5.4 mp -62.13 -41.67 98.49 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.51 -0.744 . . . . 0.0 110.182 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.4 p -102.58 105.9 46.6 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.548 -0.72 . . . . 0.0 109.945 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.36 106.85 2.15 Favored 'Trans proline' 0 C--N 1.319 -0.999 0 O-C-N 123.32 1.169 . . . . 0.0 110.876 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.657 ' O ' ' HB3' ' A' ' 164' ' ' ALA . 4.4 mtt85 -106.89 153.09 41.05 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.644 -0.66 . . . . 0.0 109.643 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.27 150.38 52.93 Favored 'Trans proline' 0 C--N 1.315 -1.207 0 O-C-N 123.383 1.202 . . . . 0.0 110.884 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.421 HG21 ' SG ' ' A' ' 159' ' ' CYS . 73.6 t -53.6 -31.95 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.473 -0.767 . . . . 0.0 109.565 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 31.2 t -59.85 -39.99 87.07 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.689 -0.632 . . . . 0.0 110.65 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.448 ' CD2' ' HD2' ' A' ' 130' ' ' ARG . 87.3 t80 -70.06 -39.73 75.5 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.444 -0.785 . . . . 0.0 109.604 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 22.1 tp -95.01 13.59 24.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.725 -0.609 . . . . 0.0 110.581 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.71 113.03 13.9 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.601 1.191 . . . . 0.0 111.087 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.53 34.3 4.48 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 31.1 m -115.29 19.15 15.76 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.747 -0.855 . . . . 0.0 110.46 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.539 ' HB3' HG21 ' A' ' 55' ' ' VAL . 4.5 m -68.12 147.47 52.27 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.3 -0.875 . . . . 0.0 109.508 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.405 ' C ' HG23 ' A' ' 153' ' ' ILE . . . 94.56 -19.75 52.02 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -58.29 112.69 4.15 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.49 157.56 52.65 Favored 'Trans proline' 0 C--N 1.319 -1.025 0 O-C-N 123.201 1.106 . . . . 0.0 110.955 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.575 HD11 HD13 ' A' ' 106' ' ' LEU . 5.9 mp -109.4 127.66 54.54 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.543 HD13 ' O ' ' A' ' 149' ' ' HIS . 2.9 mm? -110.41 160.26 16.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.535 -0.728 . . . . 0.0 111.078 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.933 ' SG ' 'ZN ' ' A' ' 202' ' ' ' ZN' . 27.1 p -119.92 165.64 17.26 Favored Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 38.5 Cg_endo -63.97 -15.21 47.84 Favored 'Trans proline' 0 N--CA 1.488 1.18 0 O-C-N 123.079 1.042 . . . . 0.0 111.454 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.5 t -70.24 -39.95 74.75 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.282 -0.886 . . . . 0.0 110.044 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 114.87 31.61 2.06 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.543 ' O ' HD13 ' A' ' 144' ' ' LEU . 19.7 m-70 -132.15 155.76 47.6 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.492 -1.005 . . . . 0.0 110.404 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.626 ' HB2' ' HB3' ' A' ' 94' ' ' LEU . . . -73.41 146.85 44.78 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.556 -0.715 . . . . 0.0 109.985 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.766 ' O ' HG23 ' A' ' 172' ' ' VAL . 58.9 t -112.08 -61.67 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.479 -0.763 . . . . 0.0 110.353 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -163.19 -158.76 10.0 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.405 HG23 ' C ' ' A' ' 140' ' ' GLY . 96.8 mt -133.97 155.42 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.594 -0.945 . . . . 0.0 109.882 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.686 ' HB2' HD11 ' A' ' 106' ' ' LEU . 19.6 t80 -70.04 147.49 49.98 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.45 -0.781 . . . . 0.0 109.861 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.545 ' NH2' HG22 ' A' ' 170' ' ' VAL . 4.6 ttm-85 -128.6 -79.85 0.57 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.602 -0.686 . . . . 0.0 110.829 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -119.5 143.7 47.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.964 . . . . 0.0 111.313 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.56 128.08 39.53 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.458 HG13 ' C11' ' A' ' 201' ' ' 4P2 . 2.4 t -98.86 119.11 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 121.48 -0.762 . . . . 0.0 111.282 -177.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.421 ' SG ' HG21 ' A' ' 132' ' ' VAL . 27.9 p -139.88 143.59 36.77 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.506 -0.746 . . . . 0.0 110.689 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 87.0 m -76.33 -41.98 46.56 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.596 -0.69 . . . . 0.0 109.872 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -143.24 50.28 1.41 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.646 -0.659 . . . . 0.0 109.897 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 90.77 -11.57 71.41 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 64.3 t -96.07 120.13 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.141 -1.211 . . . . 0.0 108.91 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.657 ' HB3' ' O ' ' A' ' 130' ' ' ARG . . . -87.63 120.91 29.42 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.529 -0.732 . . . . 0.0 111.243 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -112.81 -32.28 6.46 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.296 0.57 . . . . 0.0 109.678 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -118.6 168.26 10.87 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.669 -0.644 . . . . 0.0 109.685 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 35.6 m -144.02 135.77 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.36 -0.838 . . . . 0.0 110.823 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -110.34 138.37 46.81 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.655 -0.653 . . . . 0.0 110.242 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -141.84 162.07 36.39 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.507 -0.746 . . . . 0.0 110.544 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.545 HG22 ' NH2' ' A' ' 155' ' ' ARG . 51.6 t -101.89 143.39 26.51 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.466 -0.771 . . . . 0.0 110.24 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -75.69 166.38 28.47 Favored 'Trans proline' 0 N--CA 1.485 1.006 0 O-C-N 123.296 1.156 . . . . 0.0 110.389 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 151' ' ' VAL . 77.3 t -88.46 -25.86 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.536 -0.728 . . . . 0.0 110.536 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -59.33 -32.94 70.54 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.408 -0.808 . . . . 0.0 110.596 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.611 ' O ' HG22 ' A' ' 177' ' ' THR . 5.8 t -69.19 -22.94 63.86 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.469 -0.769 . . . . 0.0 110.49 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.684 ' CE ' HD13 ' A' ' 82' ' ' LEU . 35.1 mmt -63.29 -27.8 69.58 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.334 -0.854 . . . . 0.0 110.411 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -57.37 -49.95 74.53 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.404 -0.81 . . . . 0.0 110.67 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.611 HG22 ' O ' ' A' ' 174' ' ' SER . 6.1 t -70.03 -23.33 63.09 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.525 -0.735 . . . . 0.0 110.503 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 87.6 m -72.06 -32.95 67.57 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.427 -0.796 . . . . 0.0 110.243 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 95.7 mtp -60.02 -37.02 78.54 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.568 -0.707 . . . . 0.0 110.419 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -59.92 -39.87 86.94 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.528 -0.732 . . . . 0.0 110.273 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.837 0 O-C-N 121.56 -0.713 . . . . 0.0 110.111 179.954 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 201' ' ' 4P2 . . . . . 0.709 ' C24' HG13 ' A' ' 78' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . 0.933 'ZN ' ' SG ' ' A' ' 145' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.3 t . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.164 0.507 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -132.43 -153.56 7.35 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.37 160.59 42.37 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.498 -1.001 . . . . 0.0 110.326 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -101.47 102.63 13.43 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.537 -0.727 . . . . 0.0 110.187 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.8 tptp -141.47 128.34 20.56 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.551 -0.718 . . . . 0.0 110.187 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -83.42 133.02 34.94 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.527 -0.733 . . . . 0.0 110.026 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 36.1 tp60 -116.67 137.68 52.01 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.446 -0.784 . . . . 0.0 110.407 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.6 p -137.62 141.7 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.542 -0.724 . . . . 0.0 109.959 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -121.58 158.31 28.85 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.479 -0.763 . . . . 0.0 110.512 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.7 28.03 27.76 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.795 ' HG3' HG23 ' A' ' 33' ' ' VAL . 12.4 pt-20 -117.04 -27.84 6.42 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.484 -1.01 . . . . 0.0 110.746 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.795 HG23 ' HG3' ' A' ' 32' ' ' GLU . 58.8 t -126.5 140.57 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.399 -0.813 . . . . 0.0 110.311 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -106.84 159.73 16.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.572 -0.705 . . . . 0.0 110.05 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.459 ' HA ' HD22 ' A' ' 44' ' ' LEU . 62.2 t -107.57 118.34 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.485 -0.76 . . . . 0.0 110.224 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 68.0 t -120.9 133.85 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.468 -0.77 . . . . 0.0 110.158 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.5 t -130.48 135.74 48.28 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.617 -0.677 . . . . 0.0 109.763 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.24 173.6 6.25 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.525 -0.734 . . . . 0.0 110.245 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.84 -34.88 74.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.746 -0.596 . . . . 0.0 111.203 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 68.9 p -103.49 -28.18 11.93 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.362 -0.836 . . . . 0.0 111.049 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -142.93 178.11 7.9 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.38 -0.825 . . . . 0.0 110.619 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 24.0 m -148.74 120.6 8.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.711 -0.618 . . . . 0.0 110.223 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.463 ' HZ ' HD11 ' A' ' 64' ' ' LEU . 27.6 p90 -127.53 172.38 10.76 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.664 -0.647 . . . . 0.0 109.674 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.459 HD22 ' HA ' ' A' ' 35' ' ' VAL . 46.8 mt -121.14 153.96 36.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.492 -0.755 . . . . 0.0 109.978 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.589 ' HB1' ' SG ' ' A' ' 52' ' ' CYS . . . -125.76 154.66 42.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.594 -0.691 . . . . 0.0 110.379 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.4 t -129.11 144.18 51.11 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.667 -0.646 . . . . 0.0 109.902 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 27.9 p -94.84 118.8 32.36 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.696 0.76 . . . . 0.0 110.679 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.4 t -130.27 127.64 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.44 -0.787 . . . . 0.0 109.827 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.0 t30 52.16 39.13 26.15 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.418 -0.801 . . . . 0.0 110.991 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.593 ' O ' ' HB3' ' A' ' 87' ' ' ALA . . . 68.71 24.67 75.41 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.3 t -136.64 115.09 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.382 -1.069 . . . . 0.0 109.836 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.589 ' SG ' ' HB1' ' A' ' 45' ' ' ALA . 47.9 t -77.42 116.35 17.94 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.546 -0.721 . . . . 0.0 109.958 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.455 ' CZ3' ' CE ' ' A' ' 175' ' ' MET . 56.9 m95 -100.09 137.25 38.8 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.446 -0.783 . . . . 0.0 110.578 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.958 HG21 ' CH2' ' A' ' 85' ' ' TRP . 7.5 t -137.11 173.59 11.52 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.646 -0.659 . . . . 0.0 109.47 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.84 HG11 ' CE1' ' A' ' 57' ' ' HIS . 71.5 t -82.52 143.66 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.362 -0.836 . . . . 0.0 109.495 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.887 ' CE2' HG22 ' A' ' 78' ' ' VAL . 21.2 t80 -84.37 -42.21 15.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.754 -0.591 . . . . 0.0 111.027 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.84 ' CE1' HG11 ' A' ' 55' ' ' VAL . 1.4 p-80 -56.86 -20.02 20.67 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.967 -1.083 . . . . 0.0 111.227 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -102.16 -65.82 0.76 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.68 -22.83 49.94 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.473 -1.016 . . . . 0.0 111.027 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.95 -30.85 70.76 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 79.2 p -62.51 -50.99 69.21 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.483 -1.01 . . . . 0.0 110.6 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.12 138.85 51.99 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.475 -0.766 . . . . 0.0 110.171 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.614 ' CG2' HD13 ' A' ' 71' ' ' ILE . 5.1 t -65.86 142.33 57.96 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.512 -0.742 . . . . 0.0 110.27 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.463 HD11 ' HZ ' ' A' ' 43' ' ' PHE . 4.2 mm? -97.45 119.43 35.97 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.455 -0.778 . . . . 0.0 109.957 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.899 ' HB2' HD11 ' A' ' 71' ' ' ILE . . . -124.7 161.48 26.25 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.508 -0.745 . . . . 0.0 110.933 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.9 -156.73 21.54 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.91 -50.21 0.47 Allowed 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 123.341 1.179 . . . . 0.0 111.336 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -130.76 37.3 3.82 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.372 -0.83 . . . . 0.0 111.083 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -134.19 147.41 19.08 Favored Glycine 0 N--CA 1.496 2.699 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.347 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -76.32 174.68 12.43 Favored 'Trans proline' 0 C--N 1.321 -0.903 0 O-C-N 123.545 1.287 . . . . 0.0 110.252 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.899 HD11 ' HB2' ' A' ' 65' ' ' ALA . 4.8 mp -102.18 140.22 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.54 -0.725 . . . . 0.0 110.969 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.6 p -115.45 109.86 18.47 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.2 mm-40 -96.8 113.94 25.54 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.493 -0.754 . . . . 0.0 111.123 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.415 ' HG3' ' CD2' ' A' ' 75' ' ' TYR . 19.4 ptt? -113.08 -29.73 7.22 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.658 -0.651 . . . . 0.0 109.783 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.469 ' O ' HG13 ' A' ' 83' ' ' VAL . 29.9 m-85 -120.22 116.37 25.47 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.572 -0.705 . . . . 0.0 109.596 179.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.1 m -150.31 130.92 13.96 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.481 -0.762 . . . . 0.0 110.316 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -167.74 123.24 1.04 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.363 -0.836 . . . . 0.0 111.327 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.887 HG22 ' CE2' ' A' ' 56' ' ' TYR . 70.1 t -72.67 -38.18 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.49 -0.756 . . . . 0.0 109.5 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -55.66 -33.3 63.97 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.484 -0.76 . . . . 0.0 110.641 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.805 ' HG2' HD11 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -100.61 -15.28 17.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.579 -0.7 . . . . 0.0 110.642 179.71 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.3 t0 61.1 39.79 15.73 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.111 -0.993 . . . . 0.0 113.631 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.805 HD11 ' HG2' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -148.76 160.32 43.31 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.721 -1.237 . . . . 0.0 111.68 176.578 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 75' ' ' TYR . 2.2 t -137.6 159.47 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -140.29 137.98 8.73 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.602 -1.285 . . . . 0.0 110.513 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.958 ' CH2' HG21 ' A' ' 54' ' ' THR . 5.3 m-90 -111.79 157.92 19.99 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.845 -0.797 . . . . 0.0 109.701 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -68.32 115.08 7.35 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.609 -0.682 . . . . 0.0 109.974 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.593 ' HB3' ' O ' ' A' ' 50' ' ' GLY . . . -99.87 164.84 15.71 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.483 -0.761 . . . . 0.0 110.19 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.419 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 46.7 Cg_endo -72.42 139.55 31.88 Favored 'Trans proline' 0 C--N 1.317 -1.097 0 O-C-N 123.408 1.215 . . . . 0.0 110.299 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -76.77 160.11 34.49 Favored 'Trans proline' 0 C--N 1.319 -1.003 0 O-C-N 123.26 1.137 . . . . 0.0 110.439 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 70.03 29.82 70.39 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -109.03 168.12 9.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.49 -1.006 . . . . 0.0 110.055 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.8 mtm180 -59.98 138.54 57.82 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.583 -0.698 . . . . 0.0 110.248 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 78.9 p -132.95 152.05 51.97 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.545 -0.722 . . . . 0.0 110.372 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.518 HD21 ' HB2' ' A' ' 32' ' ' GLU . 81.2 mt -97.1 131.58 43.73 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.589 -0.695 . . . . 0.0 110.258 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 44.4 p -85.0 155.54 60.91 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.595 -0.691 . . . . 0.0 110.256 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.67 162.98 39.79 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 O-C-N 123.49 1.258 . . . . 0.0 110.428 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.8 t -82.37 131.23 35.23 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.557 -0.714 . . . . 0.0 110.187 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.2 m -135.77 56.3 1.83 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.596 -0.69 . . . . 0.0 110.088 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.7 p -145.25 6.08 1.12 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.456 -0.778 . . . . 0.0 112.029 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 51.44 51.06 39.03 Favored Glycine 0 N--CA 1.502 3.05 0 O-C-N 120.949 -1.095 . . . . 0.0 110.541 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.2 p -99.06 121.74 41.39 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.441 -1.035 . . . . 0.0 110.525 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 68.2 m -73.42 -40.08 64.52 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.627 -0.671 . . . . 0.0 110.247 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -65.5 131.42 46.36 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.618 -0.676 . . . . 0.0 110.22 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.599 HD22 HG21 ' A' ' 151' ' ' VAL . 95.6 mt -135.95 144.95 45.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.543 -0.723 . . . . 0.0 110.379 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -114.11 129.26 56.62 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.502 -0.749 . . . . 0.0 110.203 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.51 HD13 HD11 ' A' ' 143' ' ' LEU . 38.1 tp -105.41 140.08 39.06 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.572 -0.705 . . . . 0.0 110.228 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.9 t -91.83 121.89 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.6 -0.688 . . . . 0.0 109.76 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.415 HG22 ' H ' ' A' ' 109' ' ' ARG . 4.3 m -85.45 172.69 10.82 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.54 -0.725 . . . . 0.0 110.34 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.415 ' H ' HG22 ' A' ' 108' ' ' THR . 0.0 OUTLIER -59.9 -26.53 65.99 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.572 -0.705 . . . . 0.0 110.523 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -96.05 26.32 4.25 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.528 -0.732 . . . . 0.0 110.453 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 52.9 39.99 30.1 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.323 -0.861 . . . . 0.0 110.827 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -94.52 162.51 13.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.539 -0.725 . . . . 0.0 110.127 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 63.9 t -110.27 130.34 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.538 -0.726 . . . . 0.0 109.897 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.553 HG23 ' O ' ' A' ' 114' ' ' ILE . 4.0 tp -137.88 119.57 10.72 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.606 -0.684 . . . . 0.0 109.994 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -73.07 142.91 35.2 Favored 'Trans proline' 0 N--CA 1.486 1.069 0 O-C-N 123.074 1.039 . . . . 0.0 110.699 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.7 t -139.05 129.06 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.713 -0.617 . . . . 0.0 109.693 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -85.51 129.18 34.88 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.529 -0.732 . . . . 0.0 110.075 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -73.88 135.65 43.36 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.612 -0.68 . . . . 0.0 110.278 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -137.44 26.98 2.84 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.662 -0.649 . . . . 0.0 110.24 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.23 -179.54 43.77 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -70.08 -39.59 75.52 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.592 -0.946 . . . . 0.0 110.562 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 98.4 p -131.44 29.19 4.59 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.431 -0.793 . . . . 0.0 110.875 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.591 HH11 ' HB1' ' A' ' 166' ' ' ALA . 0.0 OUTLIER -148.12 160.29 43.05 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.435 -0.791 . . . . 0.0 110.333 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -160.16 -170.14 24.36 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 88.3 p -126.34 164.55 20.82 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.577 -0.955 . . . . 0.0 110.159 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 46.5 tp -119.99 126.37 50.68 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.586 -0.696 . . . . 0.0 110.183 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.415 HD12 ' H ' ' A' ' 127' ' ' LEU . 5.0 mp -59.83 -49.84 76.14 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.556 -0.715 . . . . 0.0 110.272 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.1 m -91.28 113.51 58.62 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.549 -0.72 . . . . 0.0 110.063 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.81 107.09 2.33 Favored 'Trans proline' 0 C--N 1.32 -0.939 0 O-C-N 123.153 1.081 . . . . 0.0 110.596 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.615 ' O ' ' HB3' ' A' ' 164' ' ' ALA . 81.8 mtt-85 -110.98 149.78 40.93 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.599 -0.688 . . . . 0.0 109.929 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.04 150.37 60.31 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.463 1.243 . . . . 0.0 110.89 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.449 HG21 ' SG ' ' A' ' 159' ' ' CYS . 39.3 t -51.92 -30.09 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.461 -0.774 . . . . 0.0 109.79 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.1 t -61.65 -41.03 96.94 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.626 -0.672 . . . . 0.0 111.222 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.441 ' CE2' ' HD3' ' A' ' 130' ' ' ARG . 86.7 t80 -67.69 -39.96 84.41 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.349 -0.844 . . . . 0.0 109.75 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 135' ' ' LEU . 23.9 tp -93.66 18.94 9.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.838 -0.539 . . . . 0.0 110.253 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.405 ' HA ' ' C48' ' A' ' 201' ' ' 4P2 . 15.2 tttm -81.34 117.2 21.62 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.542 1.163 . . . . 0.0 112.757 -178.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.2 37.88 3.71 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.0 m -119.55 21.23 12.18 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.715 -0.873 . . . . 0.0 110.44 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.556 ' HB3' HG21 ' A' ' 55' ' ' VAL . 2.6 m -71.98 129.69 39.17 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.324 -0.86 . . . . 0.0 109.497 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 109.84 -24.4 19.4 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.82 110.69 2.28 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.34 149.11 56.38 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 O-C-N 123.234 1.123 . . . . 0.0 110.857 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.605 ' N ' HD12 ' A' ' 143' ' ' LEU . 6.6 mp -99.59 119.33 37.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.708 -0.62 . . . . 0.0 109.535 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.685 HD12 ' HA ' ' A' ' 150' ' ' ALA . 2.6 tp -105.82 120.91 42.92 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.582 -0.699 . . . . 0.0 110.775 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.692 ' SG ' 'ZN ' ' A' ' 202' ' ' ' ZN' . 26.9 p -64.36 163.34 26.23 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.72 -0.613 . . . . 0.0 109.697 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.09 -15.22 47.74 Favored 'Trans proline' 0 N--CA 1.487 1.118 0 O-C-N 123.245 1.129 . . . . 0.0 111.158 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.2 m -70.0 -27.09 64.41 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.264 -0.898 . . . . 0.0 110.084 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 107.84 43.14 1.35 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -144.7 158.65 43.69 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.497 -1.002 . . . . 0.0 110.267 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.685 ' HA ' HD12 ' A' ' 144' ' ' LEU . . . -78.04 148.49 34.29 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.578 -0.701 . . . . 0.0 110.318 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.599 HG21 HD22 ' A' ' 104' ' ' LEU . 59.4 t -119.17 -62.44 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.573 -0.704 . . . . 0.0 110.22 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -156.53 -158.03 8.64 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.6 mt -135.86 145.36 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.597 -0.943 . . . . 0.0 109.675 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.509 ' HB2' HD11 ' A' ' 106' ' ' LEU . 12.7 t80 -62.55 155.46 25.83 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.438 -0.789 . . . . 0.0 109.605 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 33.2 ttm-85 -140.38 -66.17 0.44 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.945 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -130.57 143.68 50.92 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.935 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.59 127.64 39.36 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.456 HG13 ' C11' ' A' ' 201' ' ' 4P2 . 2.1 t -98.1 119.95 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.617 -0.677 . . . . 0.0 111.305 -177.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.449 ' SG ' HG21 ' A' ' 132' ' ' VAL . 27.7 p -141.26 158.98 43.16 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.497 -0.752 . . . . 0.0 110.508 178.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 11.0 m -91.18 -56.86 2.99 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.567 -0.708 . . . . 0.0 109.456 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.5 ptp85 -123.85 36.62 4.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.607 -0.683 . . . . 0.0 109.449 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 103.7 -11.46 53.41 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 63.1 t -92.46 124.23 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.219 -1.165 . . . . 0.0 109.132 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 130' ' ' ARG . . . -87.17 119.84 27.81 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.521 -0.737 . . . . 0.0 110.895 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 12.0 mtpp -110.15 -28.74 8.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.709 -0.619 . . . . 0.0 109.907 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.591 ' HB1' HH11 ' A' ' 123' ' ' ARG . . . -130.14 168.14 17.26 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.601 -0.687 . . . . 0.0 110.172 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.3 m -139.5 142.48 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.548 -0.72 . . . . 0.0 110.518 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -117.06 137.0 52.55 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.588 -0.695 . . . . 0.0 110.851 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -147.75 159.89 43.31 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.677 -0.64 . . . . 0.0 110.525 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.406 HG13 ' HD2' ' A' ' 171' ' ' PRO . 22.5 t -107.33 143.62 27.55 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 121.481 -0.762 . . . . 0.0 109.441 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.406 ' HD2' HG13 ' A' ' 170' ' ' VAL . 47.0 Cg_endo -74.35 -179.67 4.99 Favored 'Trans proline' 0 C--N 1.319 -0.985 0 O-C-N 123.336 1.177 . . . . 0.0 110.603 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 57.4 t -94.79 -27.87 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.623 -0.673 . . . . 0.0 110.025 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -59.95 -34.2 72.93 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.581 -0.699 . . . . 0.0 110.552 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 34.7 t -61.7 -31.31 71.45 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.546 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.455 ' CE ' ' CZ3' ' A' ' 53' ' ' TRP . 69.3 mmm -71.6 -27.37 63.07 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.443 -0.786 . . . . 0.0 110.564 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -56.8 -42.99 80.51 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.361 -0.837 . . . . 0.0 110.496 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 86.3 m -69.59 -40.11 76.88 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.471 -0.768 . . . . 0.0 109.684 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 91.0 m -71.68 -34.47 69.69 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.622 -0.674 . . . . 0.0 110.24 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 4.9 tmm? -60.06 -39.93 87.72 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.511 -0.743 . . . . 0.0 110.278 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -60.08 -39.9 87.71 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.527 -0.733 . . . . 0.0 110.132 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.911 0 O-C-N 121.619 -0.676 . . . . 0.0 110.169 179.841 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 201' ' ' 4P2 . . . . . 0.755 ' C24' HG13 ' A' ' 78' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . 0.692 'ZN ' ' SG ' ' A' ' 145' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.4 p . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.045 0.45 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -130.34 26.93 4.07 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 33.4 ptt-85 -143.15 49.12 1.46 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.447 -1.031 . . . . 0.0 110.101 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -69.97 -19.95 63.33 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.579 -0.7 . . . . 0.0 110.808 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.5 ttmt 55.01 33.37 20.12 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.252 -0.905 . . . . 0.0 110.129 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.8 t30 55.22 20.64 3.54 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.652 -0.655 . . . . 0.0 111.178 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 48.12 85.01 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.341 -0.849 . . . . 0.0 111.356 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.9 m -118.3 151.12 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.525 -0.734 . . . . 0.0 110.521 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -139.76 159.96 40.97 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.614 -0.679 . . . . 0.0 110.179 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -137.52 -170.85 12.0 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -58.95 -39.9 83.06 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.573 -0.957 . . . . 0.0 110.425 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 97.8 t -139.3 140.03 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.569 -0.707 . . . . 0.0 109.808 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -133.62 151.49 51.7 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.535 -0.728 . . . . 0.0 110.201 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.434 ' HA ' HD22 ' A' ' 44' ' ' LEU . 91.0 t -93.79 119.45 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.616 -0.677 . . . . 0.0 110.087 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.554 HG21 HD21 ' A' ' 64' ' ' LEU . 8.1 p -134.07 130.07 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.488 -0.757 . . . . 0.0 109.824 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 66.8 m -116.89 155.15 29.56 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.646 -0.659 . . . . 0.0 110.312 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.784 HG21 ' NZ ' ' A' ' 62' ' ' LYS . 0.9 OUTLIER -116.38 -178.65 3.46 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.709 -0.619 . . . . 0.0 110.121 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.514 ' H ' HG22 ' A' ' 38' ' ' THR . . . -73.29 -25.47 60.68 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.308 -178.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.3 p -119.11 -28.27 5.51 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.312 -0.868 . . . . 0.0 111.19 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.1 pm0 -140.43 171.9 13.48 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.366 -0.834 . . . . 0.0 110.321 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.0 t -142.99 119.06 10.7 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.503 -0.748 . . . . 0.0 110.658 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.777 ' CE2' HD22 ' A' ' 64' ' ' LEU . 3.4 p90 -128.31 177.69 6.78 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.574 -0.704 . . . . 0.0 109.692 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.434 HD22 ' HA ' ' A' ' 35' ' ' VAL . 54.7 mt -115.83 160.48 20.1 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.504 -0.747 . . . . 0.0 110.052 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -129.64 153.96 47.59 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.39 -0.819 . . . . 0.0 110.504 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.5 p -130.98 144.08 51.21 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.636 -0.665 . . . . 0.0 110.099 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 28.4 p -93.99 121.41 35.43 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.509 -0.744 . . . . 0.0 110.564 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.4 t -130.34 136.66 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.388 -0.82 . . . . 0.0 110.412 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 43.59 34.32 0.79 Allowed 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.573 ' O ' ' HB3' ' A' ' 87' ' ' ALA . . . 89.66 -24.23 15.81 Favored Glycine 0 N--CA 1.497 2.74 0 C-N-CA 120.279 -0.962 . . . . 0.0 111.264 178.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 62.8 t -107.5 129.56 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.179 -1.189 . . . . 0.0 110.073 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -82.45 131.49 35.22 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.653 -0.654 . . . . 0.0 109.955 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.681 ' CE3' HD23 ' A' ' 82' ' ' LEU . 90.5 m95 -117.15 137.83 52.06 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.528 -0.733 . . . . 0.0 110.738 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.751 HG23 HG23 ' A' ' 83' ' ' VAL . 10.0 t -136.6 -179.1 5.48 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.722 -0.611 . . . . 0.0 109.752 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.63 HG11 ' CE1' ' A' ' 57' ' ' HIS . 18.0 t -80.32 142.29 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.542 -0.724 . . . . 0.0 109.465 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.894 ' CE2' HG22 ' A' ' 78' ' ' VAL . 7.8 t80 -84.86 -42.61 14.91 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.633 -0.667 . . . . 0.0 110.875 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.63 ' CE1' HG11 ' A' ' 55' ' ' VAL . 1.1 p-80 -55.77 -20.55 15.29 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.256 -0.903 . . . . 0.0 111.161 -177.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -73.65 -63.92 2.61 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 108.354 -1.899 . . . . 0.0 108.354 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.83 -63.51 1.29 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.563 -0.963 . . . . 0.0 109.568 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.2 -97.8 0.1 OUTLIER Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.3 p -49.12 -76.89 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.467 -1.019 . . . . 0.0 111.675 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.784 ' NZ ' HG21 ' A' ' 38' ' ' THR . 10.5 pttp -67.98 171.76 6.39 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.466 -0.771 . . . . 0.0 110.4 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.547 HG22 ' CG ' ' A' ' 73' ' ' GLN . 69.8 p -113.83 165.87 12.14 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.642 -0.662 . . . . 0.0 110.226 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.777 HD22 ' CE2' ' A' ' 43' ' ' PHE . 2.4 tp -142.39 126.72 17.64 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.468 -0.77 . . . . 0.0 110.4 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.41 ' CB ' ' CD1' ' A' ' 71' ' ' ILE . . . -146.9 109.35 4.54 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.361 -0.837 . . . . 0.0 110.308 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 57.19 171.15 0.17 Allowed Glycine 0 N--CA 1.494 2.555 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.57 -4.23 14.92 Favored 'Trans proline' 0 N--CA 1.487 1.135 0 O-C-N 123.3 1.158 . . . . 0.0 111.572 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.2 mmtt -69.66 -31.85 70.15 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.088 -1.007 . . . . 0.0 111.123 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 142.92 -176.57 22.43 Favored Glycine 0 N--CA 1.496 2.661 0 C-N-CA 119.862 -1.161 . . . . 0.0 110.267 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.445 ' C ' HG23 ' A' ' 71' ' ' ILE . 53.5 Cg_endo -77.16 161.99 31.9 Favored 'Trans proline' 0 N--CA 1.486 1.056 0 O-C-N 123.556 1.293 . . . . 0.0 111.123 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.445 HG23 ' C ' ' A' ' 70' ' ' PRO . 45.4 pt -149.27 -157.64 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.588 -0.695 . . . . 0.0 109.648 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.9 m -79.36 140.02 37.6 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.266 -0.896 . . . . 0.0 109.953 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.547 ' CG ' HG22 ' A' ' 63' ' ' THR . 1.0 OUTLIER -96.31 146.21 24.92 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.502 -0.749 . . . . 0.0 110.312 -179.759 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.408 ' HG3' ' CD2' ' A' ' 75' ' ' TYR . 19.4 ptp -119.22 -38.53 3.02 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.575 -0.703 . . . . 0.0 110.625 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.5 ' O ' HG12 ' A' ' 83' ' ' VAL . 31.6 m-85 -112.4 120.46 41.74 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.301 -0.874 . . . . 0.0 109.752 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.529 ' HA ' HG12 ' A' ' 83' ' ' VAL . 85.6 m -148.53 130.13 14.96 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.471 -0.768 . . . . 0.0 110.331 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -167.28 117.99 0.87 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.411 -0.806 . . . . 0.0 111.532 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.894 HG22 ' CE2' ' A' ' 56' ' ' TYR . 73.7 t -72.59 -35.09 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.37 -0.831 . . . . 0.0 109.523 178.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -55.71 -35.48 66.14 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.425 -0.797 . . . . 0.0 110.225 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -106.82 -8.02 16.93 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.624 -0.673 . . . . 0.0 110.659 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.462 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 30.9 t0 53.0 43.28 31.93 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.085 -1.009 . . . . 0.0 110.431 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.681 HD23 ' CE3' ' A' ' 53' ' ' TRP . 0.6 OUTLIER -133.15 140.88 47.84 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.928 0.871 . . . . 0.0 111.836 -178.783 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.751 HG23 HG23 ' A' ' 54' ' ' THR . 1.0 OUTLIER -145.65 154.13 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.762 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -162.97 170.6 38.52 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.783 -1.199 . . . . 0.0 110.344 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.437 ' CE2' ' O ' ' A' ' 64' ' ' LEU . 0.3 OUTLIER -136.58 167.78 20.74 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.884 -0.774 . . . . 0.0 109.062 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -78.53 122.29 25.69 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.618 -0.677 . . . . 0.0 110.27 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.677 ' HB1' ' HD2' ' A' ' 88' ' ' PRO . . . -88.58 173.76 5.84 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.523 -0.735 . . . . 0.0 110.101 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.677 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 45.7 Cg_endo -72.31 142.6 37.65 Favored 'Trans proline' 0 C--N 1.317 -1.124 0 O-C-N 123.396 1.208 . . . . 0.0 110.362 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -76.12 154.38 37.26 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.378 1.199 . . . . 0.0 110.413 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.42 -28.73 14.08 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.74 143.74 45.98 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.522 -0.987 . . . . 0.0 110.223 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.8 ptt-85 -79.28 159.99 27.01 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.579 -0.701 . . . . 0.0 110.288 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.0 m -125.3 159.21 32.27 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.596 -0.69 . . . . 0.0 110.268 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.99 147.12 39.05 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.518 -0.739 . . . . 0.0 110.152 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.414 HG23 ' HD2' ' A' ' 96' ' ' PRO . 86.0 m -91.4 144.0 29.04 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.626 -0.671 . . . . 0.0 110.103 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.414 ' HD2' HG23 ' A' ' 95' ' ' THR . 45.0 Cg_endo -71.54 166.1 30.45 Favored 'Trans proline' 0 C--N 1.318 -1.056 0 O-C-N 123.259 1.137 . . . . 0.0 110.398 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.464 ' HB2' HG22 ' A' ' 151' ' ' VAL . 46.7 t -65.84 140.02 58.35 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.503 -0.748 . . . . 0.0 110.353 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.8 m -134.38 38.52 3.11 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.654 -0.654 . . . . 0.0 110.029 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.8 p -144.78 -8.31 0.64 Allowed 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 119.981 -0.688 . . . . 0.0 112.368 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 55.65 34.62 60.76 Favored Glycine 0 N--CA 1.5 2.91 0 O-C-N 120.769 -1.207 . . . . 0.0 110.322 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 52.4 p -74.6 159.9 31.54 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.366 -1.079 . . . . 0.0 110.339 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.7 m -95.8 -33.51 12.23 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.635 -0.665 . . . . 0.0 110.302 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -70.29 120.83 16.54 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.503 -0.748 . . . . 0.0 110.112 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.475 HD22 HG21 ' A' ' 151' ' ' VAL . 58.5 mt -130.86 149.95 52.25 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.578 -0.702 . . . . 0.0 110.4 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -115.16 131.01 57.07 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.62 -0.675 . . . . 0.0 109.587 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.421 HD13 ' HG ' ' A' ' 143' ' ' LEU . 36.8 tp -111.83 143.48 42.7 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.48 -0.763 . . . . 0.0 110.58 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 63.3 t -104.61 129.07 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.679 -0.638 . . . . 0.0 109.392 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 70.1 p -104.35 169.38 8.51 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.475 -0.766 . . . . 0.0 110.852 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.409 ' NH1' ' CG1' ' A' ' 35' ' ' VAL . 16.2 tpt180 -59.99 -21.96 61.95 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.64 -0.662 . . . . 0.0 110.264 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -90.85 20.03 5.1 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.336 -0.852 . . . . 0.0 111.019 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 52.21 36.58 19.69 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.208 -0.932 . . . . 0.0 110.878 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -101.14 149.63 23.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.63 -0.669 . . . . 0.0 110.055 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 62.0 t -109.96 128.73 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.644 -0.66 . . . . 0.0 110.044 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 35.7 pt -138.55 138.91 23.06 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.634 -0.666 . . . . 0.0 110.139 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -79.61 151.6 22.38 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 O-C-N 123.289 1.152 . . . . 0.0 110.495 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.7 t -137.55 134.9 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.605 -0.684 . . . . 0.0 109.92 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 8.4 tpp180 -92.2 135.41 34.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.576 -0.703 . . . . 0.0 110.068 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 54.3 ttt180 -81.34 128.58 33.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.574 -0.703 . . . . 0.0 110.193 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.53 20.63 6.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.651 -0.656 . . . . 0.0 109.811 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 168.28 170.82 33.47 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -60.27 -50.05 75.19 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.499 -1.0 . . . . 0.0 110.032 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 53.1 m -114.75 -15.16 11.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.563 -0.71 . . . . 0.0 110.71 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.576 ' NH2' HG21 ' A' ' 158' ' ' VAL . 0.2 OUTLIER -95.61 136.99 35.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.435 -0.791 . . . . 0.0 110.016 -179.88 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -140.72 178.92 19.68 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 88.6 p -132.26 165.02 25.11 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.586 -0.95 . . . . 0.0 110.198 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 38.5 tp -121.18 138.23 54.31 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.503 -0.748 . . . . 0.0 110.218 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.556 ' N ' HD12 ' A' ' 127' ' ' LEU . 8.5 mp -68.77 -54.85 13.57 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.516 -0.74 . . . . 0.0 110.03 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.1 p -92.41 109.32 37.4 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.581 -0.699 . . . . 0.0 109.809 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -75.11 120.57 6.08 Favored 'Trans proline' 0 C--N 1.319 -0.978 0 O-C-N 123.223 1.118 . . . . 0.0 111.168 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.605 ' O ' ' HB3' ' A' ' 164' ' ' ALA . 94.1 mtm-85 -121.06 154.97 58.36 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.649 -0.657 . . . . 0.0 109.603 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -68.09 150.3 77.27 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 O-C-N 123.282 1.148 . . . . 0.0 111.141 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.447 HG21 ' SG ' ' A' ' 159' ' ' CYS . 40.6 t -53.43 -29.91 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 121.511 -0.743 . . . . 0.0 109.773 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.4 t -59.9 -41.57 91.94 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.659 -0.651 . . . . 0.0 111.23 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.42 ' CD2' ' HD2' ' A' ' 130' ' ' ARG . 83.6 t80 -68.16 -40.0 82.44 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.347 -0.845 . . . . 0.0 109.779 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 135' ' ' LEU . 31.5 tp -92.71 18.2 9.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.787 -0.571 . . . . 0.0 110.122 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -81.92 115.01 20.9 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 122.567 1.175 . . . . 0.0 112.078 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.78 28.92 6.76 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 58.1 m -110.66 20.04 18.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.57 -0.959 . . . . 0.0 110.546 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.404 ' OG ' ' C55' ' A' ' 201' ' ' 4P2 . 1.8 m -65.64 145.18 56.36 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.268 -0.895 . . . . 0.0 109.487 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 95.9 -21.66 43.74 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.04 109.76 1.64 Allowed Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -75.69 150.63 35.52 Favored 'Trans proline' 0 C--N 1.32 -0.927 0 O-C-N 123.203 1.107 . . . . 0.0 111.036 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.421 ' HG ' HD13 ' A' ' 106' ' ' LEU . 5.0 mp -100.72 111.5 23.74 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 150' ' ' ALA . 2.2 tp -97.04 140.1 32.07 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.528 -0.732 . . . . 0.0 110.758 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -76.12 174.57 5.4 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.657 -0.652 . . . . 0.0 109.785 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.05 -28.63 28.42 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 O-C-N 123.368 1.193 . . . . 0.0 110.235 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 83.8 p -70.36 -35.35 73.5 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.573 -0.704 . . . . 0.0 110.108 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 118.88 38.95 0.73 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 58.3 m170 -124.53 137.37 54.42 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.541 -0.976 . . . . 0.0 110.403 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.434 ' HA ' HD12 ' A' ' 144' ' ' LEU . . . -65.4 140.04 58.6 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.523 -0.736 . . . . 0.0 110.148 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.475 HG21 HD22 ' A' ' 104' ' ' LEU . 62.1 t -111.29 -55.99 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.614 -0.679 . . . . 0.0 110.146 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -161.83 -165.25 18.39 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 83.3 mt -131.31 143.71 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.664 -0.903 . . . . 0.0 109.778 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -61.57 147.34 45.91 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.429 -0.795 . . . . 0.0 110.07 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.94 -71.21 0.64 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.597 0.713 . . . . 0.0 110.104 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -126.27 144.57 50.74 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 121.794 0.807 . . . . 0.0 111.269 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.49 128.52 39.63 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.576 HG21 ' NH2' ' A' ' 123' ' ' ARG . 2.4 t -99.02 120.47 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.531 -0.731 . . . . 0.0 111.671 -177.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.447 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.2 p -141.29 136.9 32.06 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.507 -0.746 . . . . 0.0 110.622 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 87.1 m -71.28 -42.52 68.64 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.546 -0.721 . . . . 0.0 109.92 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -140.86 49.54 1.68 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.575 -0.703 . . . . 0.0 110.075 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 89.99 -11.64 70.07 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 61.7 t -94.66 120.44 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.245 -1.15 . . . . 0.0 108.925 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 130' ' ' ARG . . . -87.45 117.49 26.28 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.632 -0.668 . . . . 0.0 111.074 -178.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -113.19 -26.23 8.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.751 -0.593 . . . . 0.0 110.008 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -125.98 168.45 13.91 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.485 -0.759 . . . . 0.0 110.394 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 35.3 m -144.73 135.81 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.542 -0.724 . . . . 0.0 110.48 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -112.94 133.87 54.71 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.411 -0.806 . . . . 0.0 110.954 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -147.04 162.32 39.04 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.67 -0.644 . . . . 0.0 110.366 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 4.1 m -104.23 145.21 30.23 Favored Pre-proline 0 N--CA 1.505 2.291 0 O-C-N 121.449 -0.782 . . . . 0.0 110.456 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -75.33 -171.82 1.12 Allowed 'Trans proline' 0 C--N 1.319 -1.019 0 O-C-N 123.436 1.23 . . . . 0.0 109.83 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 57.3 t -87.39 -23.26 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.595 -0.69 . . . . 0.0 110.417 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -61.69 -30.31 70.66 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.412 -0.805 . . . . 0.0 111.28 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 9.5 t -62.67 -24.46 67.64 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.161 -0.962 . . . . 0.0 110.687 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.427 ' HG2' ' CD2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -80.73 -28.25 36.62 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.487 -0.758 . . . . 0.0 111.15 -179.457 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -59.94 -44.62 94.26 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.433 -0.792 . . . . 0.0 110.551 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 90.0 m -69.9 -39.94 75.93 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.433 -0.792 . . . . 0.0 110.492 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 58.9 m -67.77 -31.85 72.03 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.543 -0.723 . . . . 0.0 110.679 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.8 -38.27 81.45 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.377 -0.827 . . . . 0.0 110.556 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -59.92 -39.96 87.22 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.443 -0.785 . . . . 0.0 110.374 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.803 0 O-C-N 121.499 -0.751 . . . . 0.0 110.148 179.871 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 201' ' ' 4P2 . . . . . 0.775 ' C24' HG13 ' A' ' 78' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 56.4 p . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.027 0.441 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.77 27.04 6.15 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 51.68 59.49 4.53 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.278 -1.131 . . . . 0.0 110.869 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.428 ' HA ' ' CE1' ' A' ' 110' ' ' HIS . 41.0 t0 -75.02 116.54 15.87 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.48 -0.763 . . . . 0.0 110.227 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.7 pttt -119.98 -7.02 9.99 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.599 -0.688 . . . . 0.0 111.18 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 53.34 94.26 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.051 -1.03 . . . . 0.0 110.706 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -71.4 162.17 29.86 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.542 -0.724 . . . . 0.0 110.203 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.2 t -60.1 141.48 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.565 -0.709 . . . . 0.0 110.064 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -60.0 134.94 57.52 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.547 -0.72 . . . . 0.0 110.147 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.86 -80.37 0.84 Allowed Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.467 ' CB ' HD11 ' A' ' 94' ' ' LEU . 2.8 pp20? -133.92 -0.46 3.1 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.546 -0.973 . . . . 0.0 111.848 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.794 HG22 HD23 ' A' ' 44' ' ' LEU . 11.3 p -135.0 128.52 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.089 -1.007 . . . . 0.0 109.895 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -107.52 134.56 50.36 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.671 -0.643 . . . . 0.0 110.413 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.2 m -72.54 147.74 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.615 -0.678 . . . . 0.0 110.096 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.5 t -124.9 145.92 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.562 -0.712 . . . . 0.0 109.74 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.6 t -115.85 126.67 54.27 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.656 -0.652 . . . . 0.0 110.36 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.482 HG22 ' H ' ' A' ' 39' ' ' ALA . 2.3 m -113.92 175.57 5.41 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.578 -0.701 . . . . 0.0 110.012 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.482 ' H ' HG22 ' A' ' 38' ' ' THR . . . -77.01 -13.96 59.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.668 -0.645 . . . . 0.0 111.326 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 77.5 p -121.25 -28.21 4.73 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.173 -0.954 . . . . 0.0 111.424 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -154.42 175.86 13.05 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.278 -0.888 . . . . 0.0 110.95 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.5 t -135.91 122.82 21.3 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.71 -0.619 . . . . 0.0 109.935 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -127.78 -169.61 2.09 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.504 -0.748 . . . . 0.0 110.368 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.794 HD23 HG22 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -116.41 167.83 10.69 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.574 -0.704 . . . . 0.0 110.491 -179.455 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.661 ' O ' HG23 ' A' ' 33' ' ' VAL . . . -140.61 140.71 35.12 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.604 -0.685 . . . . 0.0 110.151 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.408 HG21 ' HB3' ' A' ' 142' ' ' PRO . 67.7 p -119.26 138.62 52.88 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.428 -0.795 . . . . 0.0 110.057 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.1 t -101.14 115.09 29.68 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.541 -0.725 . . . . 0.0 110.596 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.0 t -129.98 127.1 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.457 -0.777 . . . . 0.0 110.159 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 64.8 t30 53.16 40.21 30.88 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.455 -0.778 . . . . 0.0 111.045 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.01 21.5 71.67 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.507 HG12 ' NE1' ' A' ' 53' ' ' TRP . 62.9 t -130.21 113.75 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.399 -1.059 . . . . 0.0 109.463 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.2 t -82.98 133.02 35.12 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.593 -0.692 . . . . 0.0 109.906 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.507 ' NE1' HG12 ' A' ' 51' ' ' VAL . 92.9 m95 -119.95 136.39 54.55 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.492 -0.755 . . . . 0.0 111.094 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.665 HG22 ' O ' ' A' ' 83' ' ' VAL . 6.5 t -137.71 -179.92 6.04 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.918 HG11 ' CE1' ' A' ' 57' ' ' HIS . 47.2 t -92.39 147.56 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.294 -0.879 . . . . 0.0 109.979 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.89 ' CE2' HG22 ' A' ' 78' ' ' VAL . 21.6 t80 -84.15 -43.45 14.98 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.539 -0.726 . . . . 0.0 111.407 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.918 ' CE1' HG11 ' A' ' 55' ' ' VAL . 1.5 p-80 -52.38 -25.91 11.08 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.116 -0.99 . . . . 0.0 111.114 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.431 ' N ' ' CD2' ' A' ' 57' ' ' HIS . . . -89.59 -55.99 1.95 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.24 -63.38 1.41 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.527 -0.984 . . . . 0.0 110.334 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.12 -144.71 17.28 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 89.1 p -104.94 21.76 16.46 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.591 -0.947 . . . . 0.0 110.654 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.67 160.49 19.55 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.365 -0.834 . . . . 0.0 109.959 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.9 m -77.82 147.92 34.97 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.567 -0.708 . . . . 0.0 110.298 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.471 HD13 ' HA ' ' A' ' 64' ' ' LEU . 3.6 mm? -97.94 143.01 28.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.523 -0.736 . . . . 0.0 110.113 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.55 127.08 44.35 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.629 -0.669 . . . . 0.0 110.268 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -129.96 158.93 22.5 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.48 -47.0 1.64 Allowed 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.377 1.198 . . . . 0.0 110.731 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -71.55 -31.1 66.63 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.544 -0.722 . . . . 0.0 110.161 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 162.92 156.97 8.8 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.04 164.64 34.95 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 O-C-N 123.384 1.202 . . . . 0.0 110.445 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 85.7 mt -129.42 137.24 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.533 -0.729 . . . . 0.0 109.891 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 64.6 p -83.49 150.3 26.09 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.585 -0.697 . . . . 0.0 110.538 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -82.66 119.95 24.94 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.578 -0.701 . . . . 0.0 110.086 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.2 mtp -83.97 -51.15 7.37 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.526 -0.734 . . . . 0.0 110.473 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.467 ' CD2' ' N ' ' A' ' 75' ' ' TYR . 1.2 p90 -122.54 130.09 52.66 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.672 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.939 ' HA ' HG12 ' A' ' 83' ' ' VAL . 57.0 m -135.28 141.1 45.63 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.659 -0.651 . . . . 0.0 110.501 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -161.34 120.92 2.57 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.234 -0.916 . . . . 0.0 112.133 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.89 HG22 ' CE2' ' A' ' 56' ' ' TYR . 54.2 t -72.88 -39.11 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.295 -0.878 . . . . 0.0 109.34 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -55.54 -43.04 75.45 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.389 -0.82 . . . . 0.0 110.369 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.708 ' HB3' HD22 ' A' ' 82' ' ' LEU . 3.3 tp60 -90.92 -9.68 45.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.608 -0.683 . . . . 0.0 110.485 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.416 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 37.5 t0 52.47 42.0 31.09 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.088 -1.007 . . . . 0.0 111.54 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 1.062 HD21 HG21 ' A' ' 178' ' ' THR . 0.3 OUTLIER -148.58 143.1 26.37 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.173 -0.954 . . . . 0.0 111.123 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.939 HG12 ' HA ' ' A' ' 76' ' ' THR . 28.4 m -145.18 144.08 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.448 ' N ' ' CE1' ' A' ' 75' ' ' TYR . . . -142.61 156.83 26.46 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.571 -1.3 . . . . 0.0 110.347 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.49 ' CH2' HG21 ' A' ' 54' ' ' THR . 3.6 m-90 -113.63 168.11 10.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.901 -0.764 . . . . 0.0 109.331 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -87.29 100.62 12.84 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.494 -0.754 . . . . 0.0 109.299 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.08 158.88 82.6 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.636 -0.665 . . . . 0.0 110.461 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.43 160.13 49.49 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.523 1.275 . . . . 0.0 110.299 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.49 151.01 52.69 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 O-C-N 123.402 1.212 . . . . 0.0 110.283 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.34 -23.72 34.28 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.13 152.76 23.55 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.336 -1.096 . . . . 0.0 110.291 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -70.25 148.01 49.08 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.561 -0.712 . . . . 0.0 110.244 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 80.0 p -126.7 149.71 49.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.58 -0.7 . . . . 0.0 110.093 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.467 HD11 ' CB ' ' A' ' 32' ' ' GLU . 6.6 mt -109.79 157.4 19.2 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.541 -0.725 . . . . 0.0 110.548 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.43 HG23 ' HD2' ' A' ' 96' ' ' PRO . 89.7 m -98.16 144.4 27.99 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.701 -0.625 . . . . 0.0 109.727 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.43 ' HD2' HG23 ' A' ' 95' ' ' THR . 43.5 Cg_endo -69.48 160.47 49.67 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.256 1.135 . . . . 0.0 110.407 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 45.2 t -60.02 134.64 57.23 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.587 -0.695 . . . . 0.0 110.445 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 21.6 m -136.1 48.29 2.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.673 -0.642 . . . . 0.0 109.977 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.9 p -144.89 -8.31 0.63 Allowed 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 119.949 -0.701 . . . . 0.0 112.383 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.68 72.01 0.61 Allowed Glycine 0 N--CA 1.5 2.928 0 O-C-N 120.766 -1.209 . . . . 0.0 110.288 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.0 m -125.09 129.98 51.31 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.522 -0.987 . . . . 0.0 110.471 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.7 m -67.19 -39.95 86.47 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.492 -0.755 . . . . 0.0 110.138 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -60.17 131.75 51.79 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.589 -0.694 . . . . 0.0 110.356 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.708 HD22 HG11 ' A' ' 151' ' ' VAL . 88.3 mt -136.36 160.21 39.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.646 -0.658 . . . . 0.0 110.153 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -122.98 109.45 14.13 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.477 -0.764 . . . . 0.0 110.246 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.653 ' O ' HG11 ' A' ' 113' ' ' VAL . 21.1 tp -74.17 148.14 41.96 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.708 -0.62 . . . . 0.0 109.837 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.454 HG21 HD23 ' A' ' 144' ' ' LEU . 61.0 t -126.28 119.99 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.289 -0.882 . . . . 0.0 110.244 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.887 HG23 HG13 ' A' ' 113' ' ' VAL . 53.0 p -91.36 -164.93 1.25 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.264 -0.898 . . . . 0.0 110.076 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.26 -18.99 24.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.522 -0.736 . . . . 0.0 111.229 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.428 ' CE1' ' HA ' ' A' ' 25' ' ' ASP . 4.5 t60 -109.65 29.4 7.62 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.259 -0.9 . . . . 0.0 110.666 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 57.47 33.62 23.52 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.301 -0.874 . . . . 0.0 112.063 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.784 ' O ' HG13 ' A' ' 113' ' ' VAL . 7.0 p-10 -119.39 134.01 55.43 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.285 -0.884 . . . . 0.0 109.727 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.887 HG13 HG23 ' A' ' 108' ' ' THR . 0.0 OUTLIER -176.37 -173.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.425 0 CA-C-O 121.853 0.835 . . . . 0.0 111.143 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.407 ' CG1' ' HD2' ' A' ' 115' ' ' PRO . 0.0 OUTLIER -152.19 168.8 10.58 Favored Pre-proline 0 N--CA 1.49 1.568 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.445 ' O ' HD13 ' A' ' 127' ' ' LEU . 43.0 Cg_endo -70.36 145.12 52.77 Favored 'Trans proline' 0 C--N 1.317 -1.106 0 O-C-N 123.217 1.114 . . . . 0.0 110.066 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.615 HG13 ' O ' ' A' ' 125' ' ' SER . 57.3 t -126.91 130.0 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.569 -0.707 . . . . 0.0 110.116 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.9 mmm180 -83.28 132.39 35.03 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.487 -0.758 . . . . 0.0 110.053 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 49.6 ttm-85 -65.96 133.27 50.49 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.535 -0.728 . . . . 0.0 110.242 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -116.49 -22.44 8.72 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.622 -0.674 . . . . 0.0 110.478 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -155.93 -167.33 17.21 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -70.09 -39.95 75.27 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.598 -0.942 . . . . 0.0 110.565 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 36.9 p -129.9 26.46 5.24 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.396 -0.815 . . . . 0.0 110.801 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.48 152.61 41.7 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.511 -0.743 . . . . 0.0 110.181 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -149.19 -179.98 25.51 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.615 ' O ' HG13 ' A' ' 116' ' ' VAL . 78.0 p -120.0 151.5 38.88 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.703 -0.881 . . . . 0.0 110.217 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.0 tp -100.0 129.88 46.11 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.653 -0.655 . . . . 0.0 110.195 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.445 HD13 ' O ' ' A' ' 115' ' ' PRO . 4.3 mp -61.91 -53.91 49.17 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.581 -0.699 . . . . 0.0 110.404 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.6 t -95.28 129.91 33.87 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.561 -0.712 . . . . 0.0 110.124 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -79.27 106.85 2.1 Favored 'Trans proline' 0 C--N 1.32 -0.97 0 O-C-N 123.175 1.092 . . . . 0.0 110.673 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.418 ' HD2' ' CD2' ' A' ' 134' ' ' TYR . 4.6 mtm180 -114.21 149.91 42.81 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.599 -0.688 . . . . 0.0 109.636 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.36 150.31 70.52 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 123.317 1.167 . . . . 0.0 111.153 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.775 HG12 ' CE ' ' A' ' 136' ' ' LYS . 66.0 t -52.85 -29.26 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.501 -0.749 . . . . 0.0 109.81 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.93 -43.26 95.05 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.605 -0.685 . . . . 0.0 111.279 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.418 ' CD2' ' HD2' ' A' ' 130' ' ' ARG . 88.9 t80 -65.89 -40.01 91.18 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.358 -0.838 . . . . 0.0 109.619 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.42 ' HA ' HD12 ' A' ' 135' ' ' LEU . 21.8 tp -93.26 18.87 8.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.926 -0.484 . . . . 0.0 110.278 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.775 ' CE ' HG12 ' A' ' 132' ' ' VAL . 8.4 ttmt -82.47 116.64 22.01 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 122.523 1.154 . . . . 0.0 112.514 -178.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.97 30.14 6.18 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.0 m -110.57 20.26 17.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.687 -0.89 . . . . 0.0 110.353 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.7 m -76.44 141.81 41.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.311 -0.868 . . . . 0.0 109.557 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.467 ' C ' HG23 ' A' ' 153' ' ' ILE . . . 95.91 -26.62 19.74 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.84 128.35 44.83 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 108.911 -1.675 . . . . 0.0 108.911 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.408 ' HB3' HG21 ' A' ' 46' ' ' THR . 48.4 Cg_endo -75.05 172.54 16.16 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 O-C-N 123.201 1.106 . . . . 0.0 111.142 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.916 ' O ' HG12 ' A' ' 151' ' ' VAL . 3.3 mp -117.68 115.61 25.41 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.455 HD22 ' N ' ' A' ' 144' ' ' LEU . 4.5 mm? -90.09 152.37 21.17 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.701 -0.624 . . . . 0.0 111.017 -178.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.407 ' CB ' ' HD2' ' A' ' 146' ' ' PRO . 0.1 OUTLIER -93.95 179.28 1.28 Allowed Pre-proline 0 N--CA 1.494 1.733 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.375 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.407 ' HD2' ' CB ' ' A' ' 145' ' ' CYS . 43.0 Cg_endo -69.63 -26.62 27.99 Favored 'Trans proline' 0 C--N 1.318 -1.069 0 O-C-N 123.202 1.106 . . . . 0.0 110.319 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 66.2 m -79.41 -29.06 41.8 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.519 -0.738 . . . . 0.0 110.043 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 113.43 50.26 0.54 Allowed Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 43.7 m80 -135.77 148.06 48.63 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.517 -0.99 . . . . 0.0 110.288 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -76.1 136.94 39.86 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.537 -0.727 . . . . 0.0 110.051 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.916 HG12 ' O ' ' A' ' 143' ' ' LEU . 13.0 p -119.06 -24.45 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.559 -0.713 . . . . 0.0 110.878 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 176.6 -167.74 39.38 Favored Glycine 0 N--CA 1.498 2.784 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.29 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.556 HD12 ' CE ' ' A' ' 175' ' ' MET . 71.8 mt -130.38 158.88 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.598 -0.942 . . . . 0.0 109.833 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -75.84 151.64 37.42 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.454 -0.779 . . . . 0.0 109.918 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.646 ' CZ ' HG21 ' A' ' 170' ' ' VAL . 30.7 ttm180 -131.83 -76.41 0.51 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.572 -0.705 . . . . 0.0 110.797 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -122.46 143.68 49.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.086 -1.009 . . . . 0.0 111.406 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.65 127.87 39.55 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.489 HG13 ' C11' ' A' ' 201' ' ' 4P2 . 2.5 t -97.67 117.98 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 O-C-N 121.506 -0.746 . . . . 0.0 111.673 -177.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.429 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.9 p -141.07 148.72 40.63 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.371 -0.831 . . . . 0.0 110.672 178.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 63.7 m -85.56 -50.14 7.47 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.448 -0.782 . . . . 0.0 109.72 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.75 32.79 5.61 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.74 -0.6 . . . . 0.0 109.608 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 101.44 -11.69 58.23 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 63.4 t -89.51 120.92 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.223 -1.163 . . . . 0.0 108.991 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -86.97 113.25 22.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.644 -0.66 . . . . 0.0 110.975 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -108.52 -26.23 10.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.787 -0.571 . . . . 0.0 109.862 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -121.27 164.02 17.65 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.47 -0.769 . . . . 0.0 109.952 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 167' ' ' VAL . 35.0 m -141.81 131.1 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.534 -0.729 . . . . 0.0 110.659 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -103.83 129.67 51.32 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.477 -0.765 . . . . 0.0 110.709 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -142.65 162.17 36.18 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.568 -0.708 . . . . 0.0 110.188 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.646 HG21 ' CZ ' ' A' ' 155' ' ' ARG . 86.1 t -111.93 144.93 31.7 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.427 -0.796 . . . . 0.0 110.089 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.474 ' HD2' HG13 ' A' ' 170' ' ' VAL . 45.9 Cg_endo -71.95 175.2 10.09 Favored 'Trans proline' 0 N--CA 1.486 1.061 0 O-C-N 123.319 1.168 . . . . 0.0 110.984 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 151' ' ' VAL . 59.4 t -79.42 -41.41 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.657 -0.652 . . . . 0.0 110.153 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -54.41 -36.32 63.84 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.835 -0.541 . . . . 0.0 111.045 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.435 ' O ' HG22 ' A' ' 177' ' ' THR . 45.2 t -61.84 -33.71 74.66 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.485 -0.76 . . . . 0.0 109.906 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.556 ' CE ' HD12 ' A' ' 153' ' ' ILE . 67.2 mtt -70.05 -27.94 65.05 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.595 -0.69 . . . . 0.0 110.446 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -59.5 -50.09 75.28 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.495 -0.753 . . . . 0.0 110.64 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.435 HG22 ' O ' ' A' ' 174' ' ' SER . 7.1 t -69.98 -22.54 63.14 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.516 -0.74 . . . . 0.0 110.825 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' THR . . . . . 1.062 HG21 HD21 ' A' ' 82' ' ' LEU . 68.4 m -68.68 -29.08 67.46 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.439 -0.788 . . . . 0.0 110.53 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 91.1 mtp -59.98 -48.49 81.48 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.476 -0.765 . . . . 0.0 110.257 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -59.91 -40.07 87.55 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.606 -0.684 . . . . 0.0 110.315 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.792 0 O-C-N 121.65 -0.656 . . . . 0.0 110.188 -179.961 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 201' ' ' 4P2 . . . . . 0.731 ' C24' HG13 ' A' ' 78' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.2 m . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.022 0.439 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -138.19 -74.84 0.06 OUTLIER Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 53.37 51.28 15.72 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.433 -1.04 . . . . 0.0 110.574 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -84.62 169.97 13.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.688 -0.632 . . . . 0.0 110.367 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.0 mmmt -80.96 -176.72 6.06 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.673 -0.642 . . . . 0.0 110.213 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -60.63 144.64 51.41 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.558 -0.714 . . . . 0.0 110.28 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 64.1 mm-40 -128.02 162.95 25.62 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.527 -0.733 . . . . 0.0 110.329 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.2 t -71.47 140.01 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.608 -0.683 . . . . 0.0 110.093 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -72.35 157.98 36.65 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.526 -0.734 . . . . 0.0 110.46 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.497 ' O ' HG13 ' A' ' 33' ' ' VAL . . . -120.31 88.05 0.42 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.729 ' HG2' HD21 ' A' ' 94' ' ' LEU . 26.1 mp0 54.13 22.02 3.32 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.531 -0.982 . . . . 0.0 111.221 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 31' ' ' GLY . 27.4 m -132.77 160.06 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.483 -0.76 . . . . 0.0 109.83 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.547 ' O ' HD23 ' A' ' 44' ' ' LEU . 9.9 pt20 -143.42 126.53 16.46 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.615 -0.678 . . . . 0.0 110.24 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.0 m -74.39 145.54 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.506 -0.746 . . . . 0.0 109.934 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.72 HG22 ' O ' ' A' ' 43' ' ' PHE . 33.6 m -136.0 148.07 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.444 -0.785 . . . . 0.0 110.19 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.501 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 45.8 m -116.41 126.09 52.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.613 -0.68 . . . . 0.0 110.412 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.502 HG22 ' H ' ' A' ' 39' ' ' ALA . 0.3 OUTLIER -101.52 -171.01 1.91 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.624 -0.672 . . . . 0.0 109.455 179.682 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.502 ' H ' HG22 ' A' ' 38' ' ' THR . . . -60.08 -51.74 68.32 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.77 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.1 t -128.02 10.78 6.47 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.468 -0.77 . . . . 0.0 111.529 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -148.29 161.24 41.92 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.135 -0.978 . . . . 0.0 110.603 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 81.2 p -143.3 125.71 15.7 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.547 -0.72 . . . . 0.0 110.144 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.72 ' O ' HG22 ' A' ' 36' ' ' VAL . 27.5 p90 -129.45 -169.69 2.15 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.638 -0.664 . . . . 0.0 110.252 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.547 HD23 ' O ' ' A' ' 34' ' ' GLN . 3.1 mt -126.13 164.49 20.79 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.617 -0.677 . . . . 0.0 110.43 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -138.65 140.33 38.83 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.588 -0.695 . . . . 0.0 110.16 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.7 m -115.01 127.86 55.92 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.528 -0.732 . . . . 0.0 110.096 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.554 ' O ' HD12 ' A' ' 94' ' ' LEU . 26.7 p -75.62 117.02 16.94 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.569 -0.707 . . . . 0.0 110.773 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.7 t -130.29 123.95 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.33 -0.856 . . . . 0.0 110.436 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 50.74 34.06 9.4 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.568 -0.708 . . . . 0.0 111.764 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 87' ' ' ALA . . . 88.76 -24.23 13.49 Favored Glycine 0 N--CA 1.498 2.778 0 C-N-CA 120.365 -0.921 . . . . 0.0 111.216 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.7 t -106.53 113.94 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.155 -1.203 . . . . 0.0 109.781 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 27.5 p -71.12 154.49 41.69 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.438 -0.789 . . . . 0.0 110.259 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.567 ' CE3' HD23 ' A' ' 82' ' ' LEU . 79.0 m95 -124.36 137.06 54.51 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.606 -0.684 . . . . 0.0 110.779 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.951 HG21 ' CH2' ' A' ' 85' ' ' TRP . 7.5 t -136.99 -179.97 6.02 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.738 -0.601 . . . . 0.0 109.888 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.911 HG21 ' HB3' ' A' ' 139' ' ' SER . 62.4 t -85.41 142.01 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.608 -0.682 . . . . 0.0 109.547 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.903 ' CE2' HG22 ' A' ' 78' ' ' VAL . 25.3 t80 -85.2 -44.04 13.27 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.495 -0.753 . . . . 0.0 111.031 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.625 ' CE1' HG11 ' A' ' 55' ' ' VAL . 2.3 p-80 -60.68 -20.15 60.25 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.025 -177.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -92.71 -54.49 1.78 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.15 -47.64 19.82 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.49 -1.006 . . . . 0.0 110.58 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.25 -146.15 28.83 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 61.9 m -123.22 43.91 2.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.547 -0.973 . . . . 0.0 110.354 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -115.2 177.31 4.7 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.559 -0.713 . . . . 0.0 110.215 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.6 p -65.97 153.78 41.18 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.639 -0.663 . . . . 0.0 110.08 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.431 HD21 ' CZ ' ' A' ' 43' ' ' PHE . 0.8 OUTLIER -110.01 150.61 28.27 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.615 -0.678 . . . . 0.0 110.419 -179.797 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 37' ' ' SER . . . -99.84 110.98 23.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.647 -0.658 . . . . 0.0 109.977 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -129.29 170.02 20.42 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.0 -45.84 2.75 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 O-C-N 123.405 1.213 . . . . 0.0 110.484 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.2 tptp -70.47 -31.28 68.35 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.579 -0.701 . . . . 0.0 110.079 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 145.81 -176.15 24.94 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.83 169.32 22.34 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 O-C-N 123.43 1.226 . . . . 0.0 110.509 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 44.3 pt -133.76 -175.4 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.491 -0.756 . . . . 0.0 110.246 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 t -113.8 142.66 45.8 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.524 -0.735 . . . . 0.0 110.541 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.461 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -77.44 124.96 28.58 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.588 -0.695 . . . . 0.0 110.502 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 8.2 ttt -82.78 -52.77 6.44 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.368 -0.832 . . . . 0.0 109.795 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.606 ' O ' HG13 ' A' ' 83' ' ' VAL . 12.1 p90 -147.08 139.91 25.05 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.294 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.493 HG22 HG13 ' A' ' 83' ' ' VAL . 81.7 p -130.52 140.41 50.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.724 -0.61 . . . . 0.0 109.711 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -159.67 120.74 3.17 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.253 -0.904 . . . . 0.0 111.033 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.903 HG22 ' CE2' ' A' ' 56' ' ' TYR . 99.0 t -72.22 -35.6 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.411 -0.806 . . . . 0.0 109.769 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -55.87 -35.71 66.8 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.46 -0.775 . . . . 0.0 110.275 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 31.9 tp60 -102.55 -13.79 17.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.736 -0.603 . . . . 0.0 110.469 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.828 ' O ' HD12 ' A' ' 82' ' ' LEU . 44.9 t0 55.25 38.02 29.77 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.167 -0.958 . . . . 0.0 110.621 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.828 HD12 ' O ' ' A' ' 81' ' ' ASP . 2.2 mp -136.18 148.93 48.38 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.611 -0.681 . . . . 0.0 110.361 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.787 ' O ' HG22 ' A' ' 54' ' ' THR . 4.8 t -146.52 129.87 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.534 ' HA3' ' CZ ' ' A' ' 75' ' ' TYR . . . -118.68 163.7 13.1 Favored Glycine 0 N--CA 1.502 3.071 0 C-N-CA 118.817 -1.658 . . . . 0.0 111.307 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.951 ' CH2' HG21 ' A' ' 54' ' ' THR . 5.7 m-90 -132.51 158.42 42.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.958 -0.731 . . . . 0.0 109.469 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -74.32 103.98 4.91 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.534 -0.729 . . . . 0.0 110.013 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 50' ' ' GLY . . . -70.4 158.51 87.49 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.645 -0.659 . . . . 0.0 110.274 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.45 160.03 47.77 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 O-C-N 123.453 1.238 . . . . 0.0 110.367 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -74.98 160.05 40.68 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 O-C-N 123.404 1.213 . . . . 0.0 110.391 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 87.64 28.18 24.94 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -123.84 139.45 53.96 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.492 -1.005 . . . . 0.0 110.153 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.39 139.02 38.8 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.514 -0.741 . . . . 0.0 110.209 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.9 p -92.39 145.09 24.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.578 -0.701 . . . . 0.0 110.185 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.729 HD21 ' HG2' ' A' ' 32' ' ' GLU . 40.2 mt -79.08 157.35 28.01 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.594 -0.691 . . . . 0.0 110.175 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.2 t -110.99 150.09 41.39 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.623 -0.673 . . . . 0.0 110.209 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.22 161.38 44.69 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 O-C-N 123.388 1.204 . . . . 0.0 110.708 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 37.3 t -70.56 135.55 48.59 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.626 -0.671 . . . . 0.0 110.267 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.2 t -136.19 50.35 2.07 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.61 -0.681 . . . . 0.0 110.337 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.7 p -145.12 4.12 1.07 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.492 -0.755 . . . . 0.0 112.107 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 50.79 70.29 0.89 Allowed Glycine 0 N--CA 1.5 2.928 0 O-C-N 120.897 -1.127 . . . . 0.0 110.693 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 92.7 p -120.89 133.47 55.3 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.467 -1.02 . . . . 0.0 110.474 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 63.8 m -83.01 -28.81 29.4 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.643 -0.66 . . . . 0.0 110.198 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -66.56 133.58 50.62 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.629 -0.669 . . . . 0.0 110.181 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.772 HD22 HG11 ' A' ' 151' ' ' VAL . 91.2 mt -134.9 162.19 33.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.586 -0.696 . . . . 0.0 110.143 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -130.26 108.9 10.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.521 -0.737 . . . . 0.0 110.072 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.612 ' O ' HG11 ' A' ' 113' ' ' VAL . 21.9 tp -74.11 147.19 42.95 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.668 -0.645 . . . . 0.0 109.524 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.5 t -118.62 127.08 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.385 -0.822 . . . . 0.0 110.054 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.688 ' OG1' HG13 ' A' ' 113' ' ' VAL . 37.5 m -103.19 168.12 9.38 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.348 -0.845 . . . . 0.0 110.344 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.48 ' HA ' HD11 ' A' ' 44' ' ' LEU . 5.1 ptm180 -63.22 -27.63 69.49 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.625 -0.672 . . . . 0.0 110.965 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -96.44 26.97 4.03 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.428 -0.795 . . . . 0.0 110.812 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 52.63 24.18 3.01 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.361 -0.837 . . . . 0.0 111.092 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.761 ' O ' HG13 ' A' ' 113' ' ' VAL . 78.3 m-20 -115.03 139.33 49.95 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.426 -0.796 . . . . 0.0 109.547 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.761 HG13 ' O ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -175.7 -172.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 CA-C-O 121.803 0.811 . . . . 0.0 111.05 -179.343 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.412 ' CG1' ' HD2' ' A' ' 115' ' ' PRO . 0.2 OUTLIER -145.01 170.35 8.28 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.775 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.412 ' HD2' ' CG1' ' A' ' 114' ' ' ILE . 47.7 Cg_endo -76.13 138.21 20.15 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 O-C-N 123.288 1.152 . . . . 0.0 110.439 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.77 HG13 ' O ' ' A' ' 125' ' ' SER . 62.4 t -120.27 130.01 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.619 -0.676 . . . . 0.0 109.889 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -85.44 135.41 33.87 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.525 -0.734 . . . . 0.0 109.965 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -66.8 135.29 53.71 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.582 -0.699 . . . . 0.0 110.489 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -140.27 27.38 2.13 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.633 -0.667 . . . . 0.0 110.144 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 163.6 169.35 26.96 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -62.53 -45.16 94.25 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.592 -0.946 . . . . 0.0 110.272 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.8 m -123.51 27.08 7.57 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.615 -0.678 . . . . 0.0 110.394 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.53 155.84 45.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.505 -0.747 . . . . 0.0 110.114 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -151.52 -177.09 24.96 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.77 ' O ' HG13 ' A' ' 116' ' ' VAL . 78.9 p -119.67 152.3 37.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.638 -0.919 . . . . 0.0 110.211 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.697 HD21 ' HA ' ' A' ' 129' ' ' PRO . 0.3 OUTLIER -108.51 145.44 34.74 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.667 -0.645 . . . . 0.0 109.898 -179.719 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.5 mp -89.98 -73.79 0.51 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.658 -0.651 . . . . 0.0 109.796 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 43.0 t -72.29 112.63 15.46 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.59 -0.694 . . . . 0.0 109.334 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.697 ' HA ' HD21 ' A' ' 126' ' ' LEU . 46.0 Cg_endo -72.68 124.19 9.57 Favored 'Trans proline' 0 C--N 1.319 -0.984 0 O-C-N 123.161 1.085 . . . . 0.0 111.266 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.521 ' O ' ' HB3' ' A' ' 164' ' ' ALA . 62.6 mtm180 -127.63 153.54 77.66 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.61 150.32 56.77 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 O-C-N 123.338 1.178 . . . . 0.0 110.671 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.475 HG21 ' SG ' ' A' ' 159' ' ' CYS . 19.6 t -52.38 -29.51 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.387 -0.821 . . . . 0.0 109.577 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 46.8 t -61.24 -46.06 91.96 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.745 -0.597 . . . . 0.0 111.382 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -63.87 -39.42 94.15 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.254 -0.904 . . . . 0.0 109.618 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 135' ' ' LEU . 35.4 tp -92.2 18.62 7.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.855 -0.528 . . . . 0.0 110.025 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.415 ' HA ' ' C48' ' A' ' 201' ' ' 4P2 . 19.6 tttm -83.47 119.23 24.42 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.491 1.139 . . . . 0.0 112.837 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 98.79 23.51 11.8 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.5 m -105.09 20.79 18.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.496 -1.002 . . . . 0.0 110.584 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.911 ' HB3' HG21 ' A' ' 55' ' ' VAL . 2.6 m -73.61 144.41 45.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.316 -0.865 . . . . 0.0 109.243 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.656 ' HA2' HD11 ' A' ' 153' ' ' ILE . . . 97.31 -25.44 27.09 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -58.5 119.41 17.28 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.472 ' CD ' HG11 ' A' ' 33' ' ' VAL . 48.2 Cg_endo -73.65 173.87 13.19 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 O-C-N 123.214 1.112 . . . . 0.0 111.058 -178.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.427 ' C ' HD22 ' A' ' 144' ' ' LEU . 4.2 mp -121.18 130.55 53.76 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.583 HD13 ' C ' ' A' ' 149' ' ' HIS . 3.8 mm? -115.02 126.15 54.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.597 -0.689 . . . . 0.0 111.093 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.655 ' SG ' 'ZN ' ' A' ' 202' ' ' ' ZN' . 29.2 p -72.24 165.75 47.79 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.438 -0.789 . . . . 0.0 108.878 178.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.433 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 38.1 Cg_endo -63.54 -14.9 45.3 Favored 'Trans proline' 0 N--CA 1.488 1.188 0 O-C-N 123.022 1.011 . . . . 0.0 111.36 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 8.8 t -75.32 -34.14 61.21 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.227 -0.921 . . . . 0.0 110.02 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 114.31 47.47 0.59 Allowed Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.583 ' C ' HD13 ' A' ' 144' ' ' LEU . 67.6 m-70 -146.29 147.79 31.75 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.645 -0.915 . . . . 0.0 110.136 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -76.98 137.99 39.36 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.485 -0.759 . . . . 0.0 109.89 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.772 HG11 HD22 ' A' ' 104' ' ' LEU . 10.3 p -119.14 -30.87 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.512 -0.742 . . . . 0.0 111.102 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.52 -169.51 32.04 Favored Glycine 0 N--CA 1.498 2.785 0 C-N-CA 119.678 -1.249 . . . . 0.0 110.602 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.656 HD11 ' HA2' ' A' ' 140' ' ' GLY . 12.4 tt -139.96 148.89 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.701 -0.882 . . . . 0.0 109.588 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -66.42 154.95 38.83 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.156 -0.965 . . . . 0.0 111.654 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -137.82 -70.62 0.44 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.06 0.457 . . . . 0.0 109.998 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.489 ' HB3' ' OD1' ' A' ' 168' ' ' ASP . . . -123.29 145.59 48.57 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.26 -0.9 . . . . 0.0 111.743 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.52 129.65 41.23 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.463 HG13 ' C11' ' A' ' 201' ' ' 4P2 . 2.3 t -100.43 122.02 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 121.404 -0.81 . . . . 0.0 111.476 -177.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.475 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.2 p -141.28 139.48 33.68 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.411 -0.805 . . . . 0.0 110.647 178.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 86.9 m -71.28 -44.16 65.74 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.579 -0.7 . . . . 0.0 109.693 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -145.23 52.38 1.2 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.606 -0.684 . . . . 0.0 109.872 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 90.78 -11.59 71.37 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 64.3 t -99.41 129.53 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.19 -1.182 . . . . 0.0 108.779 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 130' ' ' ARG . . . -87.15 123.91 32.7 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.464 -0.772 . . . . 0.0 111.536 -178.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -113.32 -28.84 7.45 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.205 0.526 . . . . 0.0 109.775 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -138.52 168.36 19.94 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.581 -0.7 . . . . 0.0 109.452 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.7 m -138.73 148.83 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.338 -0.851 . . . . 0.0 111.297 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.489 ' OD1' ' HB3' ' A' ' 156' ' ' ALA . 1.4 p30 -120.11 137.92 53.86 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.67 -0.644 . . . . 0.0 110.146 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -139.0 161.9 36.24 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.589 -0.694 . . . . 0.0 110.853 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 59.0 t -93.37 137.84 23.31 Favored Pre-proline 0 N--CA 1.497 1.905 0 O-C-N 121.504 -0.748 . . . . 0.0 110.017 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -77.53 156.28 32.14 Favored 'Trans proline' 0 C--N 1.32 -0.971 0 O-C-N 123.18 1.095 . . . . 0.0 110.293 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 96.0 t -79.94 -26.99 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.352 -0.842 . . . . 0.0 110.213 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 174' ' ' SER . 2.4 pt-20 -59.95 -28.71 67.87 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.367 -0.833 . . . . 0.0 110.375 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.41 ' N ' ' HG3' ' A' ' 173' ' ' GLU . 72.2 m -76.51 -28.83 56.54 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.472 -0.767 . . . . 0.0 110.195 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.575 ' CE ' HD21 ' A' ' 82' ' ' LEU . 64.9 mtt -59.86 -32.82 71.06 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.631 -0.668 . . . . 0.0 110.647 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -59.87 -50.08 75.17 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.433 -0.792 . . . . 0.0 110.168 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 88.1 m -72.05 -39.96 68.69 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.626 -0.671 . . . . 0.0 109.838 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 89.9 m -61.27 -38.06 85.4 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.628 -0.67 . . . . 0.0 110.236 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 5.0 tmm? -59.78 -33.94 72.35 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.509 -0.744 . . . . 0.0 110.372 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 25.9 ttm180 -59.97 -40.07 87.82 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.504 -0.747 . . . . 0.0 110.253 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.734 0 O-C-N 121.579 -0.701 . . . . 0.0 110.229 179.995 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 201' ' ' 4P2 . . . . . 0.749 ' C24' HG13 ' A' ' 78' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . 0.655 'ZN ' ' SG ' ' A' ' 145' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.4 p . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.097 0.475 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.72 170.43 36.12 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -88.11 131.03 34.85 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.574 -0.957 . . . . 0.0 110.259 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -124.15 14.38 9.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.522 -0.736 . . . . 0.0 111.028 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -124.35 139.02 54.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.37 -0.831 . . . . 0.0 110.094 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -121.45 113.39 19.78 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.57 -0.706 . . . . 0.0 110.349 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -64.43 -39.88 94.68 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.612 -0.68 . . . . 0.0 109.979 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.6 m -125.67 157.01 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.74 -0.6 . . . . 0.0 110.158 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -120.29 139.42 52.76 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.594 -0.691 . . . . 0.0 110.053 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.63 41.44 0.03 OUTLIER Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.763 ' OE2' HD21 ' A' ' 144' ' ' LEU . 96.7 mt-10 -69.82 -29.03 66.21 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.571 -0.958 . . . . 0.0 110.244 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.3 p -127.14 140.07 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.563 -0.711 . . . . 0.0 110.055 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -102.88 141.61 35.39 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.602 -0.686 . . . . 0.0 110.246 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.553 ' O ' HG23 ' A' ' 35' ' ' VAL . 33.7 m -87.05 116.28 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.589 -0.695 . . . . 0.0 110.387 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.2 p -138.57 136.14 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.468 -0.77 . . . . 0.0 109.984 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 75.7 m -131.83 143.26 50.06 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.425 -0.797 . . . . 0.0 110.745 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 70.3 p -96.58 -179.98 4.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.629 -0.669 . . . . 0.0 109.737 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.63 -14.25 61.14 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.302 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 75.2 p -119.27 -25.4 6.13 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.136 -0.977 . . . . 0.0 111.432 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -141.83 168.17 20.4 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.253 -0.905 . . . . 0.0 110.96 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.8 t -138.62 118.94 13.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.582 -0.699 . . . . 0.0 110.342 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -140.26 175.83 9.27 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.532 -0.73 . . . . 0.0 109.995 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.477 HD11 ' HA ' ' A' ' 109' ' ' ARG . 81.5 mt -115.6 152.7 32.6 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.251 -0.906 . . . . 0.0 110.545 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -117.17 141.02 48.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.604 -0.685 . . . . 0.0 110.24 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 86.2 m -117.27 143.06 46.31 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.537 -0.727 . . . . 0.0 110.228 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 93.3 m -94.13 113.75 25.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.576 -0.703 . . . . 0.0 110.654 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.2 t -127.49 129.95 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.599 -0.688 . . . . 0.0 109.905 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 53.84 39.84 30.84 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.522 -0.736 . . . . 0.0 111.175 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.639 ' O ' ' HB3' ' A' ' 87' ' ' ALA . . . 66.61 17.8 67.27 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 62.3 t -129.95 130.04 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.25 -1.147 . . . . 0.0 109.755 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 97.9 m -82.02 112.72 19.36 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.529 -0.732 . . . . 0.0 110.002 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -101.76 137.48 40.01 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.606 -0.684 . . . . 0.0 110.52 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.71 HG21 ' CZ3' ' A' ' 85' ' ' TRP . 7.4 t -136.55 -179.87 5.94 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.643 -0.661 . . . . 0.0 109.738 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.601 HG21 ' HB3' ' A' ' 139' ' ' SER . 91.0 t -83.23 142.1 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.516 -0.74 . . . . 0.0 109.872 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.839 ' CE2' HG22 ' A' ' 78' ' ' VAL . 43.0 t80 -84.55 -42.52 15.39 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.609 -0.682 . . . . 0.0 111.223 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.598 ' CE1' HG11 ' A' ' 55' ' ' VAL . 1.9 p-80 -62.01 -20.83 64.32 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.399 -0.921 . . . . 0.0 110.588 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -83.94 -75.28 1.2 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.77 -48.18 77.99 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.581 -0.952 . . . . 0.0 110.082 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.89 -175.95 35.78 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.2 t -60.04 -39.86 87.37 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.628 -0.925 . . . . 0.0 110.242 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -60.08 134.86 57.45 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.568 -0.708 . . . . 0.0 110.096 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.1 t -92.84 179.18 5.54 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.521 -0.737 . . . . 0.0 110.391 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 93.6 mt -111.9 143.08 43.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.639 -0.663 . . . . 0.0 110.275 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -117.13 130.53 56.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.643 -0.661 . . . . 0.0 110.2 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.97 -149.7 5.68 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -71.1 -42.25 2.17 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.41 1.216 . . . . 0.0 110.466 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -119.99 20.09 12.21 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.592 -0.692 . . . . 0.0 110.646 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -106.11 137.12 13.66 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -81.46 165.1 18.68 Favored 'Trans proline' 0 C--N 1.319 -1.004 0 O-C-N 123.198 1.104 . . . . 0.0 110.642 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 31.3 pt -106.3 2.77 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.701 -0.624 . . . . 0.0 111.016 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.6 t -119.24 150.04 40.75 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.136 -0.978 . . . . 0.0 110.105 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -98.16 126.57 43.68 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.513 -0.742 . . . . 0.0 110.381 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 49.3 tpp -97.22 -47.26 5.81 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.51 -0.744 . . . . 0.0 110.713 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -119.72 134.95 55.03 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.526 -0.734 . . . . 0.0 110.252 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.4 m -151.55 128.09 10.75 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.512 -0.742 . . . . 0.0 110.348 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -158.88 116.31 2.81 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.372 -0.83 . . . . 0.0 111.242 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.839 HG22 ' CE2' ' A' ' 56' ' ' TYR . 54.5 t -69.98 -40.02 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.523 -0.736 . . . . 0.0 109.531 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -59.96 -44.55 94.37 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.414 -0.804 . . . . 0.0 110.294 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.557 ' HG2' HD12 ' A' ' 82' ' ' LEU . 49.4 tt0 -80.88 -13.45 58.91 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.706 -0.621 . . . . 0.0 110.177 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.403 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 39.5 t0 53.44 36.89 24.28 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.269 -0.894 . . . . 0.0 110.866 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.557 HD12 ' HG2' ' A' ' 80' ' ' GLN . 80.5 mt -140.13 156.16 46.67 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.492 -0.755 . . . . 0.0 110.677 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.0 t -138.42 155.73 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -137.0 147.49 19.26 Favored Glycine 0 N--CA 1.494 2.561 0 C-N-CA 119.552 -1.308 . . . . 0.0 111.142 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.71 ' CZ3' HG21 ' A' ' 54' ' ' THR . 3.7 m-90 -127.09 139.35 53.05 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.77 -0.841 . . . . 0.0 109.388 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -60.39 137.37 58.15 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.396 -0.815 . . . . 0.0 110.46 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 50' ' ' GLY . . . -108.87 162.63 19.3 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.532 -0.73 . . . . 0.0 110.195 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.91 148.83 52.39 Favored 'Trans proline' 0 C--N 1.317 -1.1 0 O-C-N 123.397 1.209 . . . . 0.0 110.613 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -76.15 160.35 36.43 Favored 'Trans proline' 0 C--N 1.319 -1.01 0 O-C-N 123.354 1.186 . . . . 0.0 110.54 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 93.82 -10.67 72.08 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.38 -176.82 5.48 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.108 -1.231 . . . . 0.0 110.328 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.88 157.98 43.72 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.656 -0.653 . . . . 0.0 109.977 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.9 m -137.61 175.19 9.82 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.469 -0.769 . . . . 0.0 110.834 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.446 HD11 ' HB3' ' A' ' 32' ' ' GLU . 52.6 mt -84.43 170.21 13.77 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.741 -0.599 . . . . 0.0 110.271 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 60.5 p -115.97 158.93 41.15 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.596 -0.69 . . . . 0.0 110.112 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.37 123.41 8.68 Favored 'Trans proline' 0 C--N 1.317 -1.095 0 O-C-N 123.466 1.245 . . . . 0.0 110.675 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 1.272 ' SG ' 'ZN ' ' A' ' 202' ' ' ' ZN' . 10.7 t -70.86 142.13 51.23 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.546 -0.722 . . . . 0.0 110.043 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.575 HG23 ' O ' ' A' ' 98' ' ' THR . 7.4 t -135.39 72.21 1.44 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.506 -0.746 . . . . 0.0 110.464 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 27.3 p -144.86 -0.46 0.91 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.515 -0.741 . . . . 0.0 112.285 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 55.29 39.94 73.91 Favored Glycine 0 N--CA 1.498 2.784 0 O-C-N 120.825 -1.172 . . . . 0.0 110.283 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.3 t -69.97 122.75 19.95 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.434 -1.039 . . . . 0.0 110.246 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 58.4 m -70.34 -39.96 74.39 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.561 -0.712 . . . . 0.0 110.283 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -81.62 119.59 24.0 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.566 -0.709 . . . . 0.0 110.183 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 91.0 mt -129.88 150.73 51.05 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.59 -0.694 . . . . 0.0 110.472 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -115.31 133.31 56.15 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.596 -0.69 . . . . 0.0 109.728 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.789 HD12 HD11 ' A' ' 143' ' ' LEU . 9.6 tt -113.49 138.28 50.35 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.435 -0.791 . . . . 0.0 110.351 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.3 t -97.85 129.15 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.602 -0.686 . . . . 0.0 109.839 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 75.0 p -100.9 169.97 8.62 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.623 -0.673 . . . . 0.0 110.391 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.477 ' HA ' HD11 ' A' ' 44' ' ' LEU . 78.8 ttt-85 -62.5 -23.49 66.97 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.635 -0.666 . . . . 0.0 110.342 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.406 ' O ' ' CG ' ' A' ' 110' ' ' HIS . 81.1 t60 -92.86 25.7 3.06 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.409 -0.807 . . . . 0.0 110.75 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.82 44.8 27.86 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.128 -0.983 . . . . 0.0 110.83 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -113.86 155.5 25.61 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.554 -0.716 . . . . 0.0 109.975 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.2 137.2 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.561 -0.712 . . . . 0.0 110.437 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 42.2 pt -136.46 141.72 36.77 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.613 -0.679 . . . . 0.0 109.957 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -76.67 139.45 20.13 Favored 'Trans proline' 0 C--N 1.319 -1.021 0 O-C-N 123.25 1.131 . . . . 0.0 110.447 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.5 t -126.66 130.06 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.608 -0.682 . . . . 0.0 109.86 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -89.7 137.33 32.42 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.495 -0.753 . . . . 0.0 110.078 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 79.1 ttt-85 -82.08 124.33 29.73 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.514 -0.741 . . . . 0.0 110.216 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -128.85 25.19 5.64 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.612 -0.68 . . . . 0.0 110.302 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 168.88 179.56 41.07 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -61.23 -41.33 96.68 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.565 -0.962 . . . . 0.0 110.172 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.3 p -137.15 24.17 3.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.518 -0.739 . . . . 0.0 110.572 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -131.0 139.91 50.06 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.409 -0.807 . . . . 0.0 110.479 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.576 ' O ' ' HB1' ' A' ' 166' ' ' ALA . . . -146.56 179.74 23.3 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 46.9 t -129.63 144.98 51.52 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.506 -0.997 . . . . 0.0 110.26 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.419 HD23 ' O ' ' A' ' 128' ' ' SER . 19.2 tp -99.86 136.8 39.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.605 -0.684 . . . . 0.0 110.145 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.4 mp -69.67 -39.99 76.67 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.531 -0.731 . . . . 0.0 110.452 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.419 ' O ' HD23 ' A' ' 126' ' ' LEU . 47.6 t -98.63 109.48 53.28 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.424 -0.798 . . . . 0.0 110.099 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -76.82 135.3 15.71 Favored 'Trans proline' 0 C--N 1.32 -0.956 0 O-C-N 123.213 1.112 . . . . 0.0 110.751 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -135.96 162.37 57.17 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.62 -0.675 . . . . 0.0 109.769 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.5 150.29 57.4 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 O-C-N 123.385 1.202 . . . . 0.0 110.263 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 162' ' ' GLY . 83.9 t -59.09 -34.29 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.431 -0.793 . . . . 0.0 109.796 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 46.7 t -59.91 -40.04 87.47 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.578 -0.701 . . . . 0.0 110.323 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -61.05 -41.47 96.66 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.491 -0.755 . . . . 0.0 109.68 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.553 HD21 ' CZ ' ' A' ' 154' ' ' PHE . 43.9 tp -89.97 -10.1 46.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.784 -0.573 . . . . 0.0 111.332 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -62.53 138.31 58.45 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.158 -0.964 . . . . 0.0 110.657 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 87.0 20.71 52.63 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 21.8 m -120.59 13.58 11.71 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.317 -1.107 . . . . 0.0 111.052 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.601 ' HB3' HG21 ' A' ' 55' ' ' VAL . 19.8 m -59.79 151.99 24.07 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.155 -0.966 . . . . 0.0 110.287 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 92.52 -17.68 56.9 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -58.08 110.62 2.54 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -76.19 143.4 25.38 Favored 'Trans proline' 0 C--N 1.32 -0.943 0 O-C-N 123.134 1.071 . . . . 0.0 110.963 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.789 HD11 HD12 ' A' ' 106' ' ' LEU . 5.5 mp -95.78 131.82 41.66 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.763 HD21 ' OE2' ' A' ' 32' ' ' GLU . 8.8 mp -110.04 156.36 20.62 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.631 -0.668 . . . . 0.0 110.973 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.0 176.16 1.85 Allowed Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.718 -0.614 . . . . 0.0 109.642 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.59 -26.96 19.24 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 O-C-N 123.324 1.17 . . . . 0.0 110.252 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.53 -30.77 69.65 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.508 -0.745 . . . . 0.0 110.06 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 114.91 27.58 3.18 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -127.73 147.44 50.4 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.38 -1.071 . . . . 0.0 110.218 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -83.38 134.3 34.9 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.465 -0.772 . . . . 0.0 110.276 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 151' ' ' VAL . 34.4 m -90.98 -22.89 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.594 -0.691 . . . . 0.0 110.868 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 167.74 -163.58 37.25 Favored Glycine 0 N--CA 1.498 2.769 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.43 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 77.0 mt -130.05 156.16 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.641 -0.917 . . . . 0.0 109.97 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.553 ' CZ ' HD21 ' A' ' 135' ' ' LEU . 13.5 t80 -68.23 134.78 50.97 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.496 -0.753 . . . . 0.0 109.914 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.443 ' HD3' HG23 ' A' ' 170' ' ' VAL . 59.2 ttp180 -114.26 -64.86 1.25 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.569 -0.707 . . . . 0.0 111.02 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.733 ' HB1' ' O32' ' A' ' 201' ' ' 4P2 . . . -136.09 149.81 48.87 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.431 -0.793 . . . . 0.0 110.991 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -95.99 126.46 41.25 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.662 -0.648 . . . . 0.0 109.855 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 45.1 t -95.75 118.15 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.595 -0.69 . . . . 0.0 110.453 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 26.7 p -140.05 144.87 37.08 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.464 -0.772 . . . . 0.0 110.632 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 91.8 m -73.95 -49.98 22.1 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.566 -0.709 . . . . 0.0 110.051 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -139.35 50.1 1.8 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.602 -0.686 . . . . 0.0 110.117 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.417 ' O ' HG23 ' A' ' 132' ' ' VAL . . . 96.46 -11.25 66.97 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 62.0 t -102.04 121.78 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.237 -1.155 . . . . 0.0 109.151 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.36 118.78 27.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.55 -0.719 . . . . 0.0 111.078 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -103.37 -25.83 13.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.704 -0.622 . . . . 0.0 109.641 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.576 ' HB1' ' O ' ' A' ' 124' ' ' GLY . . . -135.45 167.62 20.72 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.596 -0.69 . . . . 0.0 109.802 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.8 m -133.58 140.0 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.497 -0.752 . . . . 0.0 110.721 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -110.83 131.01 55.41 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.625 -0.672 . . . . 0.0 109.853 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -139.84 158.07 44.68 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.532 -0.73 . . . . 0.0 110.613 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.443 HG23 ' HD3' ' A' ' 155' ' ' ARG . 62.8 t -95.27 134.94 23.74 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.576 -0.703 . . . . 0.0 109.715 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.02 154.05 57.71 Favored 'Trans proline' 0 C--N 1.318 -1.045 0 O-C-N 123.175 1.092 . . . . 0.0 110.77 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 61.8 t -60.03 -38.82 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.645 -0.659 . . . . 0.0 110.062 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -57.22 -34.07 68.18 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.687 -0.633 . . . . 0.0 110.749 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 47.4 t -61.52 -40.05 93.24 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.504 -0.748 . . . . 0.0 109.964 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 61.3 mtt -59.95 -38.64 83.03 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.637 -0.665 . . . . 0.0 110.333 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -59.97 -33.14 71.53 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.667 -0.646 . . . . 0.0 110.578 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 93.9 m -59.88 -40.06 87.41 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.455 -0.778 . . . . 0.0 110.377 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 92.9 m -62.92 -49.78 73.42 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.495 -0.753 . . . . 0.0 110.094 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 76.6 mtm -65.04 -35.84 82.47 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.528 -0.732 . . . . 0.0 110.244 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -60.0 -40.01 87.74 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.524 -0.735 . . . . 0.0 110.148 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.837 0 O-C-N 121.617 -0.677 . . . . 0.0 110.148 179.87 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 201' ' ' 4P2 . . . . . 0.733 ' O32' ' HB1' ' A' ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . 1.272 'ZN ' ' SG ' ' A' ' 97' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 45.9 p . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.069 0.461 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.45 -110.43 3.07 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -77.76 154.28 32.13 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.581 -0.952 . . . . 0.0 110.265 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -137.33 83.71 2.01 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.547 -0.72 . . . . 0.0 110.172 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -66.49 -34.76 78.65 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.556 -0.715 . . . . 0.0 110.384 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -60.01 -40.03 87.87 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.492 -0.755 . . . . 0.0 110.398 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -99.45 109.96 22.48 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.491 -0.756 . . . . 0.0 110.038 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.494 HG12 ' HG3' ' A' ' 30' ' ' GLU . 58.4 t -76.25 -50.06 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.627 -0.67 . . . . 0.0 110.266 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.494 ' HG3' HG12 ' A' ' 29' ' ' VAL . 49.2 mt-10 -128.45 157.88 39.89 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.518 -0.739 . . . . 0.0 110.328 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -106.32 38.32 3.37 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.645 ' OE2' HD21 ' A' ' 94' ' ' LEU . 49.5 mm-40 -60.2 -40.65 90.8 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.562 -0.964 . . . . 0.0 110.006 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 45' ' ' ALA . 9.4 p -142.39 139.98 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.8 -0.563 . . . . 0.0 109.901 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -103.08 139.98 37.9 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.564 -0.71 . . . . 0.0 110.101 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.418 ' HA ' HD22 ' A' ' 44' ' ' LEU . 10.0 p -83.48 134.5 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.513 -0.742 . . . . 0.0 110.223 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.8 t -127.93 129.99 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.572 -0.705 . . . . 0.0 110.029 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.9 m -121.96 134.28 54.83 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.608 -0.683 . . . . 0.0 110.026 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.482 HG22 ' H ' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -109.74 -175.11 2.66 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.464 -0.773 . . . . 0.0 110.123 -179.865 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.482 ' H ' HG22 ' A' ' 38' ' ' THR . . . -70.04 -38.46 75.85 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.646 -0.659 . . . . 0.0 111.333 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.468 HG23 ' HG3' ' A' ' 41' ' ' GLN . 6.6 t -118.56 -20.02 8.54 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.305 -0.872 . . . . 0.0 111.738 -178.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.468 ' HG3' HG23 ' A' ' 40' ' ' THR . 79.0 mt-30 -132.38 154.32 49.9 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.21 -0.931 . . . . 0.0 110.743 -179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 73.6 m -132.34 124.07 28.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.539 -0.726 . . . . 0.0 109.923 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -136.11 170.37 16.12 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.587 -0.696 . . . . 0.0 110.532 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.418 HD22 ' HA ' ' A' ' 35' ' ' VAL . 55.6 mt -115.63 149.6 38.04 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.693 -0.629 . . . . 0.0 109.836 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.672 ' O ' HG23 ' A' ' 33' ' ' VAL . . . -115.91 148.32 40.15 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.496 -0.752 . . . . 0.0 110.189 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.629 HG21 ' HB3' ' A' ' 142' ' ' PRO . 87.3 m -119.9 136.55 54.46 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.557 -0.715 . . . . 0.0 109.873 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.415 ' O ' HD12 ' A' ' 94' ' ' LEU . 28.3 p -94.57 121.07 35.75 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.337 -0.852 . . . . 0.0 111.073 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.6 t -130.08 129.99 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.512 -0.743 . . . . 0.0 109.751 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 53.44 39.95 30.66 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.46 -0.775 . . . . 0.0 111.099 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.94 16.19 70.19 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 62.5 t -126.07 123.39 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.181 -1.188 . . . . 0.0 109.722 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 36.2 t -79.67 115.87 19.53 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.535 -0.728 . . . . 0.0 110.166 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 71.6 m95 -104.65 137.57 42.28 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.648 -0.658 . . . . 0.0 110.139 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.573 ' OG1' HG23 ' A' ' 83' ' ' VAL . 34.9 p -136.38 179.32 6.43 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.58 -0.7 . . . . 0.0 109.733 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.582 HG11 ' CE1' ' A' ' 57' ' ' HIS . 59.4 t -85.63 142.28 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.525 -0.734 . . . . 0.0 109.528 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.864 ' CE2' HG22 ' A' ' 78' ' ' VAL . 39.4 t80 -79.82 -42.9 23.39 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.424 -0.798 . . . . 0.0 111.598 -178.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.582 ' CE1' HG11 ' A' ' 55' ' ' VAL . 2.2 p-80 -67.02 -20.0 65.79 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.111 -0.993 . . . . 0.0 110.722 -178.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.74 -50.5 1.51 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -102.56 -38.34 7.57 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.498 -1.001 . . . . 0.0 110.399 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.38 -21.61 54.36 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 75.1 m -59.78 -34.04 72.49 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.388 -1.066 . . . . 0.0 110.294 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.1 ptmt -135.08 169.32 17.62 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.506 -0.746 . . . . 0.0 110.493 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 20.8 m -101.38 140.67 35.35 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.71 -0.619 . . . . 0.0 110.237 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.0 mt -103.85 147.84 26.84 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.564 -0.71 . . . . 0.0 110.258 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.77 122.91 42.61 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.525 -0.735 . . . . 0.0 110.44 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.1 159.32 47.09 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -72.43 -41.29 1.79 Allowed 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.433 1.228 . . . . 0.0 110.523 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.6 tptm -69.84 -31.27 69.04 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.613 -0.679 . . . . 0.0 109.982 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 168.89 164.3 24.37 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.4 126.41 11.59 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 123.318 1.167 . . . . 0.0 110.23 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 85.3 mt -119.57 129.98 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.642 -0.661 . . . . 0.0 110.129 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 56.3 m -69.61 150.07 47.45 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.64 -0.663 . . . . 0.0 109.951 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -58.86 124.0 18.38 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.517 -0.739 . . . . 0.0 110.38 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.4 tpt -70.0 -40.03 75.53 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.578 -0.701 . . . . 0.0 110.294 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.536 ' O ' HG12 ' A' ' 83' ' ' VAL . 51.1 m-85 -126.01 129.99 50.28 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.497 -0.752 . . . . 0.0 110.338 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.607 ' HA ' HG12 ' A' ' 83' ' ' VAL . 60.4 m -137.97 118.8 14.16 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.711 -0.618 . . . . 0.0 110.309 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -157.02 113.01 2.93 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.358 -0.838 . . . . 0.0 111.136 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.864 HG22 ' CE2' ' A' ' 56' ' ' TYR . 56.1 t -70.02 -39.99 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.445 -0.785 . . . . 0.0 109.441 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -58.35 -46.03 87.05 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.442 -0.787 . . . . 0.0 110.033 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.9 -14.25 48.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.681 -0.637 . . . . 0.0 110.076 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.419 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 43.8 t0 53.88 39.99 31.04 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.245 -0.909 . . . . 0.0 110.575 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.831 HD11 HG21 ' A' ' 170' ' ' VAL . 68.6 mt -137.63 147.83 45.28 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.565 -0.71 . . . . 0.0 111.325 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.607 HG12 ' HA ' ' A' ' 76' ' ' THR . 11.8 m -149.96 178.85 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -179.76 171.99 43.63 Favored Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.607 -1.283 . . . . 0.0 110.774 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 7.7 m-90 -130.06 159.53 36.46 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.828 -0.807 . . . . 0.0 109.627 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -81.62 124.14 29.29 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.456 -0.777 . . . . 0.0 110.194 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -97.19 163.85 19.03 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.575 -0.703 . . . . 0.0 110.256 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -70.65 151.52 64.04 Favored 'Trans proline' 0 C--N 1.318 -1.078 0 O-C-N 123.391 1.206 . . . . 0.0 110.476 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.28 157.2 54.05 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.379 1.199 . . . . 0.0 110.404 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.04 30.58 12.44 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -123.66 154.36 39.48 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.529 -0.983 . . . . 0.0 110.244 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -70.52 150.05 46.53 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.572 -0.705 . . . . 0.0 110.161 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 94.8 p -134.07 158.96 42.25 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.596 -0.69 . . . . 0.0 110.202 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.645 HD21 ' OE2' ' A' ' 32' ' ' GLU . 59.8 mt -104.16 141.14 36.78 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.52 -0.738 . . . . 0.0 110.381 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 31.5 p -105.77 160.99 24.2 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.647 -0.658 . . . . 0.0 110.229 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.72 152.48 58.86 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.345 1.182 . . . . 0.0 110.328 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 1.376 ' SG ' 'ZN ' ' A' ' 202' ' ' ' ZN' . 5.5 t -85.69 139.31 31.48 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.476 -0.765 . . . . 0.0 110.271 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.6 m -125.94 72.63 1.3 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.672 -0.643 . . . . 0.0 110.179 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 27.1 p -144.48 -8.29 0.67 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.455 -0.778 . . . . 0.0 112.426 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 55.4 33.2 58.33 Favored Glycine 0 N--CA 1.499 2.841 0 O-C-N 120.773 -1.204 . . . . 0.0 110.318 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.7 t -80.67 118.58 22.35 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.558 -0.966 . . . . 0.0 110.478 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 57.9 m -60.02 -39.97 87.68 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.516 -0.74 . . . . 0.0 110.088 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -64.23 125.59 25.03 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.579 -0.701 . . . . 0.0 109.84 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.6 mt -130.14 155.38 46.3 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.636 -0.665 . . . . 0.0 110.305 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -117.85 135.78 53.87 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.678 -0.639 . . . . 0.0 109.684 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.553 ' HA ' HD23 ' A' ' 143' ' ' LEU . 9.9 tt -114.31 132.0 56.33 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.581 -0.7 . . . . 0.0 110.488 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.0 t -92.32 119.88 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.615 -0.678 . . . . 0.0 109.643 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.0 m -99.21 161.47 13.6 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.558 -0.714 . . . . 0.0 110.391 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.7 ttp180 -60.47 -24.64 65.42 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.567 -0.708 . . . . 0.0 110.359 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 18.3 m80 -92.59 26.84 2.5 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.314 -0.866 . . . . 0.0 110.942 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.61 31.9 16.04 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.151 -0.968 . . . . 0.0 110.545 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -104.89 129.41 53.26 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.66 -0.65 . . . . 0.0 109.847 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 61.9 t -109.9 125.29 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.592 -0.692 . . . . 0.0 110.238 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 38.3 mt -119.73 135.51 24.23 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.678 -0.639 . . . . 0.0 109.648 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -75.72 135.5 17.87 Favored 'Trans proline' 0 C--N 1.319 -1.026 0 O-C-N 123.213 1.112 . . . . 0.0 110.594 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.644 HG13 ' O ' ' A' ' 125' ' ' SER . 60.1 t -129.82 129.98 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.557 -0.714 . . . . 0.0 109.572 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -80.16 156.04 27.15 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.515 -0.741 . . . . 0.0 110.151 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -99.28 121.45 41.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.63 -0.669 . . . . 0.0 110.249 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 31.0 mtp85 -119.63 24.24 10.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.576 -0.703 . . . . 0.0 110.621 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -177.1 -176.9 45.6 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -64.78 -39.97 94.49 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.544 -0.974 . . . . 0.0 110.435 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 46.6 m -136.54 24.48 3.16 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.516 -0.74 . . . . 0.0 110.522 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -125.21 150.56 46.87 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.436 -0.79 . . . . 0.0 110.4 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -144.02 168.92 26.38 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.644 ' O ' HG13 ' A' ' 116' ' ' VAL . 82.9 p -112.02 152.43 28.17 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.555 -0.968 . . . . 0.0 110.23 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 35.2 tp -100.13 120.34 39.71 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.553 -0.717 . . . . 0.0 110.179 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.8 mt -59.95 -47.1 87.19 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.49 -0.756 . . . . 0.0 110.683 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 36.2 t -97.93 111.68 59.79 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.632 -0.667 . . . . 0.0 110.168 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.64 113.21 3.72 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 O-C-N 123.173 1.091 . . . . 0.0 110.479 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.431 ' HD3' ' CD2' ' A' ' 134' ' ' TYR . 37.6 mtt180 -120.25 162.78 32.05 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.577 -0.702 . . . . 0.0 110.126 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.04 150.49 66.56 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 123.384 1.202 . . . . 0.0 110.429 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 162' ' ' GLY . 86.4 t -55.92 -33.25 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.479 -0.763 . . . . 0.0 110.114 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.3 m -58.66 -46.59 86.82 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.62 -0.675 . . . . 0.0 110.763 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.431 ' CD2' ' HD3' ' A' ' 130' ' ' ARG . 64.0 t80 -59.99 -41.61 92.43 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.549 -0.719 . . . . 0.0 110.201 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 58.8 tp -84.87 -9.8 57.76 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.773 -0.579 . . . . 0.0 111.461 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -68.83 143.97 54.41 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.098 -1.002 . . . . 0.0 110.748 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.17 -2.52 65.83 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 89.2 p -102.39 10.49 39.03 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.136 -1.214 . . . . 0.0 110.807 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.97 140.69 56.57 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.252 -0.905 . . . . 0.0 110.188 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 90.51 -10.56 74.15 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.52 129.29 33.62 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.629 ' HB3' HG21 ' A' ' 46' ' ' THR . 50.5 Cg_endo -76.86 148.92 28.8 Favored 'Trans proline' 0 C--N 1.318 -1.037 0 O-C-N 123.217 1.114 . . . . 0.0 110.886 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.553 HD23 ' HA ' ' A' ' 106' ' ' LEU . 21.1 mt -99.14 118.16 35.25 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.448 ' N ' HD12 ' A' ' 144' ' ' LEU . 9.3 mp -92.0 163.14 14.1 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.586 -0.697 . . . . 0.0 111.157 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.2 177.4 1.36 Allowed Pre-proline 0 N--CA 1.493 1.7 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.06 -26.7 21.25 Favored 'Trans proline' 0 C--N 1.317 -1.106 0 O-C-N 123.264 1.139 . . . . 0.0 110.434 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 90.6 p -69.97 -33.04 71.57 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.544 -0.722 . . . . 0.0 110.236 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 106.21 45.22 1.28 Allowed Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -137.17 160.19 39.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.535 -0.979 . . . . 0.0 110.293 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.413 ' HB2' ' HB3' ' A' ' 94' ' ' LEU . . . -78.48 125.3 29.17 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.588 -0.695 . . . . 0.0 110.34 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 63.3 t -91.55 -53.43 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.565 -0.71 . . . . 0.0 110.133 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -171.08 -161.9 22.51 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.471 HD12 ' HE2' ' A' ' 175' ' ' MET . 96.7 mt -130.22 140.06 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.593 -0.945 . . . . 0.0 110.153 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -61.83 128.64 37.19 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.593 -0.692 . . . . 0.0 109.814 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -103.59 -69.6 0.79 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.595 -0.691 . . . . 0.0 110.851 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.683 ' HB1' ' O32' ' A' ' 201' ' ' 4P2 . . . -133.88 152.41 51.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.528 -0.733 . . . . 0.0 110.692 -179.109 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.01 149.81 20.9 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 57.9 t -117.79 119.32 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.542 -0.724 . . . . 0.0 110.517 -179.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.2 p -141.5 142.23 33.59 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.565 -0.709 . . . . 0.0 110.55 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 44.4 m -75.38 -40.84 57.58 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.523 -0.735 . . . . 0.0 110.03 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -145.49 51.58 1.19 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.586 -0.697 . . . . 0.0 110.402 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.476 ' O ' HG23 ' A' ' 132' ' ' VAL . . . 91.35 -10.36 75.04 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.381 -1.087 . . . . 0.0 110.381 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 96.9 t -101.77 122.31 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.165 -1.197 . . . . 0.0 109.132 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.33 118.49 26.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.586 -0.696 . . . . 0.0 110.899 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -106.21 -27.75 10.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.777 -0.577 . . . . 0.0 109.645 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -132.62 162.41 31.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.534 -0.728 . . . . 0.0 110.017 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.565 HG21 HG11 ' A' ' 116' ' ' VAL . 34.9 m -129.99 139.59 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.583 -0.698 . . . . 0.0 110.232 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -117.76 123.41 45.92 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.534 -0.729 . . . . 0.0 110.485 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -132.49 159.97 37.85 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.575 -0.703 . . . . 0.0 109.796 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.831 HG21 HD11 ' A' ' 82' ' ' LEU . 27.1 m -97.54 142.45 24.58 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.516 -0.74 . . . . 0.0 110.414 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -77.65 171.08 18.06 Favored 'Trans proline' 0 C--N 1.318 -1.045 0 O-C-N 123.265 1.139 . . . . 0.0 110.255 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 61.4 t -59.98 -36.14 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.532 -0.73 . . . . 0.0 110.167 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -59.65 -33.22 71.26 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.729 -0.607 . . . . 0.0 110.996 -178.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 64.8 p -61.5 -33.32 73.59 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.387 -0.821 . . . . 0.0 109.984 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.471 ' HE2' HD12 ' A' ' 153' ' ' ILE . 44.8 mtt -69.08 -40.07 78.68 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.643 -0.661 . . . . 0.0 110.134 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -60.0 -38.89 83.94 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.651 -0.656 . . . . 0.0 110.468 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 94.2 m -60.07 -39.97 87.88 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.6 -0.688 . . . . 0.0 110.144 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 87.2 m -60.63 -40.48 92.11 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.469 -0.77 . . . . 0.0 109.985 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 40.8 ttp -61.06 -42.03 97.72 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.658 -0.652 . . . . 0.0 110.218 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -62.25 -40.07 94.95 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.495 -0.753 . . . . 0.0 110.292 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.829 0 O-C-N 121.594 -0.691 . . . . 0.0 110.182 179.942 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 201' ' ' 4P2 . . . . . 0.683 ' O32' ' HB1' ' A' ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . 1.376 'ZN ' ' SG ' ' A' ' 97' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.07 0.462 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -133.53 147.36 18.99 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -115.0 128.79 56.49 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.559 -0.965 . . . . 0.0 109.948 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 53.58 37.51 26.07 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.425 -0.797 . . . . 0.0 110.585 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 49.5 mttm -111.3 35.2 3.68 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.558 -0.714 . . . . 0.0 110.176 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -62.71 -39.02 92.73 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.565 -0.709 . . . . 0.0 109.936 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -88.29 99.85 12.55 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.646 -0.659 . . . . 0.0 110.215 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.7 p -107.32 -26.48 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.553 -0.717 . . . . 0.0 110.355 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -146.15 159.57 43.12 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.463 -0.773 . . . . 0.0 109.835 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -154.3 -124.4 0.94 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.563 ' OE1' HD13 ' A' ' 94' ' ' LEU . 44.3 tp10 -60.02 -39.94 87.55 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.582 -0.951 . . . . 0.0 110.232 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.466 HG21 HG11 ' A' ' 107' ' ' VAL . 61.2 t -99.05 126.37 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.638 -0.664 . . . . 0.0 110.068 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -108.2 142.24 38.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.622 -0.674 . . . . 0.0 110.123 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.474 ' HA ' HD22 ' A' ' 44' ' ' LEU . 65.4 t -87.18 114.16 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.55 -0.719 . . . . 0.0 109.589 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 62.0 t -118.45 131.33 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.448 -0.782 . . . . 0.0 109.98 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.8 m -123.12 135.37 54.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.642 -0.661 . . . . 0.0 110.086 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.472 HG22 ' H ' ' A' ' 39' ' ' ALA . 0.3 OUTLIER -101.22 -179.39 4.02 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.658 -0.651 . . . . 0.0 110.284 -179.739 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.472 ' H ' HG22 ' A' ' 38' ' ' THR . . . -67.91 -40.07 83.48 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.898 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 76.6 p -113.79 -28.22 7.51 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.381 -0.824 . . . . 0.0 110.92 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 -126.26 -179.03 4.54 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.473 -0.767 . . . . 0.0 110.452 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 81.2 p -153.47 125.9 8.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.621 -0.674 . . . . 0.0 110.317 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.458 ' O ' HD23 ' A' ' 44' ' ' LEU . 29.1 p90 -131.89 -175.98 3.91 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.644 -0.66 . . . . 0.0 109.803 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.474 HD22 ' HA ' ' A' ' 35' ' ' VAL . 78.4 mt -126.74 150.44 49.07 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.437 -0.789 . . . . 0.0 110.475 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -112.71 162.03 16.2 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.595 -0.69 . . . . 0.0 110.295 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.5 p -131.25 129.03 41.06 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.495 -0.753 . . . . 0.0 110.349 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 98.8 m -78.42 109.5 12.64 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.514 -0.741 . . . . 0.0 110.379 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.6 t -130.07 133.52 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.553 -0.717 . . . . 0.0 110.278 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.441 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 0.5 OUTLIER 43.91 34.26 0.88 Allowed 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 179.666 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' A' ' 87' ' ' ALA . . . 88.69 -19.11 38.9 Favored Glycine 0 N--CA 1.498 2.818 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.479 178.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 63.2 t -109.45 128.75 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.115 -1.227 . . . . 0.0 110.283 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 92.7 m -76.57 149.42 36.63 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.595 -0.691 . . . . 0.0 109.735 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -134.21 136.76 43.9 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.494 -0.754 . . . . 0.0 111.048 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.657 ' O ' HD23 ' A' ' 82' ' ' LEU . 7.6 t -137.58 178.29 7.22 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.659 HG11 ' CE1' ' A' ' 57' ' ' HIS . 75.9 t -80.54 141.69 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.314 -0.866 . . . . 0.0 108.993 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.875 ' CE2' HG22 ' A' ' 78' ' ' VAL . 6.5 t80 -85.0 -43.28 14.11 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.506 -0.746 . . . . 0.0 111.327 -179.01 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.659 ' CE1' HG11 ' A' ' 55' ' ' VAL . 1.8 p-80 -58.8 -21.38 56.11 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.291 -0.88 . . . . 0.0 111.366 -177.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -87.87 -53.64 2.66 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.87 -63.08 1.49 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.526 -0.985 . . . . 0.0 110.46 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.61 -142.66 16.1 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 85.3 p -109.86 25.48 11.74 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.521 -0.988 . . . . 0.0 110.564 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? -90.91 163.99 14.18 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.422 -0.799 . . . . 0.0 110.4 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.456 ' O ' HD23 ' A' ' 64' ' ' LEU . 70.3 p -69.95 156.43 39.11 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.691 -0.63 . . . . 0.0 109.997 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 63' ' ' THR . 25.4 mt -118.49 144.42 46.03 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.593 -0.692 . . . . 0.0 110.691 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -95.12 118.68 32.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.635 -0.666 . . . . 0.0 110.004 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -135.21 -162.29 9.67 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.08 -39.8 10.04 Favored 'Trans proline' 0 C--N 1.315 -1.204 0 O-C-N 123.478 1.252 . . . . 0.0 110.606 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -86.8 -31.29 20.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.512 -0.742 . . . . 0.0 110.309 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.78 -148.32 18.99 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.69 163.7 37.72 Favored 'Trans proline' 0 N--CA 1.485 0.99 0 O-C-N 123.389 1.205 . . . . 0.0 110.596 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 86.0 mt -131.96 159.56 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.549 -0.72 . . . . 0.0 109.957 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 64.7 m -81.83 130.59 35.11 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.608 -0.682 . . . . 0.0 110.129 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -68.16 128.73 37.61 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.535 -0.728 . . . . 0.0 110.568 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 40.6 mtm -119.2 -49.71 2.38 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.537 -0.727 . . . . 0.0 110.128 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.565 ' O ' HG13 ' A' ' 83' ' ' VAL . 54.1 m-85 -110.33 127.98 55.32 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.48 -0.763 . . . . 0.0 110.149 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 90.4 m -151.21 122.58 7.84 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.572 -0.705 . . . . 0.0 110.008 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -162.9 125.13 2.64 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.368 -0.833 . . . . 0.0 111.257 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.875 HG22 ' CE2' ' A' ' 56' ' ' TYR . 74.3 t -72.36 -38.8 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.548 -0.72 . . . . 0.0 109.647 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -55.69 -39.53 71.11 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.477 -0.764 . . . . 0.0 110.488 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.1 tp60 -91.18 -14.03 31.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.704 -0.622 . . . . 0.0 110.342 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.403 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 46.8 t0 53.18 39.94 30.46 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.104 -0.997 . . . . 0.0 110.324 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.657 HD23 ' O ' ' A' ' 54' ' ' THR . 5.3 mt -142.16 160.69 39.74 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.855 0.836 . . . . 0.0 111.391 -179.247 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 75' ' ' TYR . 2.0 t -144.56 160.97 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -155.39 160.42 29.84 Favored Glycine 0 N--CA 1.497 2.731 0 C-N-CA 119.04 -1.553 . . . . 0.0 111.612 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 17.6 m-90 -144.79 168.0 21.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.931 -0.746 . . . . 0.0 109.458 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -69.93 143.74 52.61 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.518 -0.739 . . . . 0.0 109.931 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 50' ' ' GLY . . . -92.54 162.58 29.18 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.445 -0.784 . . . . 0.0 110.524 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.87 149.79 48.24 Favored 'Trans proline' 0 C--N 1.317 -1.093 0 O-C-N 123.581 1.306 . . . . 0.0 110.267 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -76.15 160.07 36.66 Favored 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 123.35 1.184 . . . . 0.0 110.428 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.14 29.03 52.31 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -151.68 137.02 17.6 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.516 -0.99 . . . . 0.0 110.248 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.8 mtm180 -110.81 131.89 54.66 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.553 -0.717 . . . . 0.0 110.219 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.7 m -91.79 175.54 6.85 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.546 -0.721 . . . . 0.0 110.311 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.563 HD13 ' OE1' ' A' ' 32' ' ' GLU . 3.8 mp -87.02 170.46 11.54 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.53 -0.731 . . . . 0.0 110.222 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.64 172.19 3.73 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.709 -0.62 . . . . 0.0 110.057 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.66 156.85 62.51 Favored 'Trans proline' 0 C--N 1.318 -1.039 0 O-C-N 123.314 1.165 . . . . 0.0 110.173 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.694 ' CB ' HG12 ' A' ' 151' ' ' VAL . 1.5 t -81.41 154.96 26.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.499 -0.751 . . . . 0.0 110.493 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 98' ' ' THR . 7.5 t -136.05 56.35 1.82 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.695 -0.628 . . . . 0.0 110.312 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 27.3 p -144.81 -8.41 0.63 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.413 -0.804 . . . . 0.0 112.447 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.42 29.2 38.11 Favored Glycine 0 N--CA 1.499 2.869 0 O-C-N 120.753 -1.217 . . . . 0.0 110.532 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.5 p -70.53 150.38 46.19 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.554 -0.968 . . . . 0.0 110.33 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 58.0 m -86.39 -26.63 24.69 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.639 -0.663 . . . . 0.0 110.474 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -71.74 120.46 17.36 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.544 -0.723 . . . . 0.0 110.122 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.658 HD22 HG21 ' A' ' 151' ' ' VAL . 94.9 mt -137.06 149.68 47.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.553 -0.717 . . . . 0.0 110.347 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -120.53 129.2 53.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.564 -0.71 . . . . 0.0 109.833 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.43 HD13 HD21 ' A' ' 143' ' ' LEU . 47.1 tp -108.09 146.15 33.03 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.554 -0.716 . . . . 0.0 110.276 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.466 HG11 HG21 ' A' ' 33' ' ' VAL . 59.1 t -107.36 122.39 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.655 -0.653 . . . . 0.0 109.812 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.8 p -91.67 178.53 5.89 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.58 -0.7 . . . . 0.0 110.404 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.5 ptt85 -70.2 -15.75 62.97 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.62 -0.675 . . . . 0.0 111.112 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -94.28 26.04 3.54 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.142 -0.974 . . . . 0.0 110.816 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 53.22 25.54 4.43 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.298 -0.876 . . . . 0.0 110.884 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -96.19 155.37 16.79 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.546 -0.721 . . . . 0.0 110.046 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 61.4 t -117.88 125.81 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.511 -0.743 . . . . 0.0 110.053 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 42.9 pt -126.51 142.14 42.18 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.605 -0.685 . . . . 0.0 110.093 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -76.32 153.15 35.47 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 O-C-N 123.289 1.152 . . . . 0.0 110.623 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 63.0 t -140.02 139.64 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.649 -0.657 . . . . 0.0 109.743 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 -105.1 135.04 47.2 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.591 -0.693 . . . . 0.0 110.153 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 14.6 ttt-85 -73.28 139.27 46.01 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.577 -0.702 . . . . 0.0 110.26 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.59 22.05 2.92 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.572 -0.705 . . . . 0.0 110.404 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 166.54 -170.77 41.25 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -71.03 -39.69 72.18 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.591 -0.946 . . . . 0.0 110.284 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 10.6 p -134.43 24.87 3.79 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.527 -0.733 . . . . 0.0 110.703 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.422 HH21 HG11 ' A' ' 158' ' ' VAL . 0.6 OUTLIER -141.62 140.45 33.31 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.507 -0.746 . . . . 0.0 110.317 179.941 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -143.7 178.03 22.07 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 81.7 p -111.07 164.18 13.1 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.597 -0.943 . . . . 0.0 110.178 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 30.4 tp -109.42 131.01 55.47 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.5 -0.75 . . . . 0.0 110.366 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.12 -51.74 68.31 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.552 -0.717 . . . . 0.0 110.447 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 67.9 m -100.14 107.86 49.38 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.532 -0.73 . . . . 0.0 109.954 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.78 108.41 2.56 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 O-C-N 123.197 1.104 . . . . 0.0 110.9 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.457 ' O ' ' HB3' ' A' ' 164' ' ' ALA . 31.9 mtt180 -115.24 161.31 30.3 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.669 -0.644 . . . . 0.0 109.849 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.21 150.39 71.5 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 O-C-N 123.405 1.213 . . . . 0.0 110.996 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.43 HG21 ' SG ' ' A' ' 159' ' ' CYS . 66.2 t -51.84 -30.04 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 121.507 -0.746 . . . . 0.0 109.731 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 36.9 t -60.71 -41.79 95.93 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.682 -0.636 . . . . 0.0 111.056 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.411 ' CD2' ' HD3' ' A' ' 130' ' ' ARG . 88.5 t80 -66.85 -39.97 87.76 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.355 -0.84 . . . . 0.0 109.41 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 23.0 tp -93.61 18.65 9.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.912 -0.493 . . . . 0.0 110.078 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -82.09 117.71 22.48 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.446 1.117 . . . . 0.0 112.066 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.65 26.87 7.83 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 36.7 m -112.7 21.61 15.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.579 -0.954 . . . . 0.0 110.405 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.544 ' CB ' HG21 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -68.33 129.89 41.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.312 -0.867 . . . . 0.0 108.851 179.353 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 106.37 -13.35 43.67 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -55.04 112.12 2.68 Favored Glycine 0 N--CA 1.499 2.839 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.13 153.22 51.63 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 O-C-N 123.142 1.075 . . . . 0.0 111.128 -178.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.43 HD21 HD13 ' A' ' 106' ' ' LEU . 44.9 mt -108.52 123.42 48.87 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.702 -0.624 . . . . 0.0 109.515 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.504 HD23 ' C ' ' A' ' 149' ' ' HIS . 0.6 OUTLIER -121.41 139.5 53.37 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.432 -0.792 . . . . 0.0 110.849 -179.378 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 68.4 m -74.08 163.63 66.94 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.638 -0.664 . . . . 0.0 109.484 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.62 -43.12 5.95 Favored 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.411 1.216 . . . . 0.0 109.561 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.7 m -119.42 27.54 8.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.705 -0.622 . . . . 0.0 109.899 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -139.0 -173.55 13.05 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.504 ' C ' HD23 ' A' ' 144' ' ' LEU . 30.2 m170 -96.82 -168.11 1.66 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.65 -0.912 . . . . 0.0 110.472 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.56 148.28 51.1 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.573 -0.705 . . . . 0.0 110.892 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.694 HG12 ' CB ' ' A' ' 97' ' ' CYS . 34.4 m -119.13 -29.67 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.701 -0.624 . . . . 0.0 110.722 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.41 -163.42 22.34 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.3 tt -142.51 158.69 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.602 -0.94 . . . . 0.0 109.82 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -71.1 159.31 34.93 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.178 -0.951 . . . . 0.0 111.029 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.56 HH21 HG22 ' A' ' 170' ' ' VAL . 10.2 ttm180 -145.75 -75.66 0.21 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.757 -0.59 . . . . 0.0 109.95 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -121.68 142.62 49.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.035 -1.04 . . . . 0.0 111.313 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.79 128.89 40.26 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.453 HG13 ' C11' ' A' ' 201' ' ' 4P2 . 2.2 t -100.02 122.94 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.483 -0.76 . . . . 0.0 111.472 -177.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.43 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.1 p -141.15 142.57 34.04 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.482 -0.761 . . . . 0.0 110.541 178.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 88.7 m -75.93 -41.76 50.77 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.527 -0.733 . . . . 0.0 109.837 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -142.75 50.1 1.46 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.665 -0.647 . . . . 0.0 109.721 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 90.18 -11.68 70.21 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 62.6 t -94.14 120.29 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.142 -1.211 . . . . 0.0 108.997 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 130' ' ' ARG . . . -87.24 113.74 23.23 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.534 -0.729 . . . . 0.0 111.022 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -110.08 -29.68 8.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.747 -0.596 . . . . 0.0 109.661 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -116.6 168.29 10.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.701 -0.624 . . . . 0.0 109.815 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.9 m -145.11 132.9 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.532 -0.73 . . . . 0.0 110.824 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -107.45 132.14 53.52 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.576 -0.703 . . . . 0.0 110.264 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -130.17 161.1 31.88 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.712 -0.618 . . . . 0.0 110.432 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.56 HG22 HH21 ' A' ' 155' ' ' ARG . 21.9 t -96.3 142.05 24.0 Favored Pre-proline 0 N--CA 1.498 1.973 0 O-C-N 121.514 -0.741 . . . . 0.0 109.96 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.418 ' HB2' ' HG2' ' A' ' 173' ' ' GLU . 49.5 Cg_endo -74.96 159.99 40.81 Favored 'Trans proline' 0 N--CA 1.486 1.047 0 O-C-N 123.253 1.133 . . . . 0.0 110.186 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 151' ' ' VAL . 67.7 t -87.55 -28.2 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.453 -0.779 . . . . 0.0 110.748 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.418 ' HG2' ' HB2' ' A' ' 171' ' ' PRO . 9.0 pt-20 -58.8 -28.64 66.17 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.354 -0.841 . . . . 0.0 110.615 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.404 ' N ' ' HG3' ' A' ' 173' ' ' GLU . 58.0 m -68.15 -28.49 67.34 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.487 -0.758 . . . . 0.0 110.319 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 57.8 mtt -60.37 -29.46 68.94 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.51 -0.743 . . . . 0.0 110.504 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -60.07 -41.09 91.67 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.459 -0.776 . . . . 0.0 110.196 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 88.1 m -70.1 -41.19 74.35 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.551 -0.718 . . . . 0.0 110.05 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 88.0 m -70.1 -39.87 75.27 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.618 -0.676 . . . . 0.0 110.102 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 5.5 tmm? -59.97 -39.88 87.17 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.582 -0.699 . . . . 0.0 110.195 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.03 -39.84 87.26 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.618 -0.676 . . . . 0.0 110.245 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.845 0 O-C-N 121.651 -0.656 . . . . 0.0 110.227 -179.902 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 201' ' ' 4P2 . . . . . 0.701 ' C24' HG13 ' A' ' 78' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.8 p . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.044 0.45 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.14 -7.17 69.39 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.4 ' NH1' ' HA ' ' A' ' 26' ' ' LYS . 74.2 ttt-85 -60.05 -43.53 95.3 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.044 -1.268 . . . . 0.0 110.165 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 50.28 37.55 15.35 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.436 -0.79 . . . . 0.0 111.194 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.4 ' HA ' ' NH1' ' A' ' 24' ' ' ARG . 32.8 mttm 55.1 170.74 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.632 -0.668 . . . . 0.0 110.97 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -115.56 -9.09 12.08 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.517 -0.739 . . . . 0.0 110.894 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -60.03 -42.85 95.28 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.16 -0.963 . . . . 0.0 110.452 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.0 m -67.74 -32.31 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.633 -0.667 . . . . 0.0 110.393 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -68.26 -39.97 82.04 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.563 -0.71 . . . . 0.0 110.364 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.84 -169.4 53.64 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -112.89 77.32 1.04 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.529 -0.983 . . . . 0.0 110.294 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.1 p -135.2 146.7 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.489 -0.757 . . . . 0.0 110.064 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -104.24 165.53 10.99 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.561 -0.712 . . . . 0.0 110.256 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.8 p -121.69 129.96 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.578 -0.701 . . . . 0.0 110.074 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.8 m -141.11 147.48 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.532 -0.73 . . . . 0.0 110.512 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 54.2 m -120.07 154.72 34.23 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.581 -0.7 . . . . 0.0 110.201 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.481 HG22 ' H ' ' A' ' 39' ' ' ALA . 0.7 OUTLIER -122.78 -178.09 3.84 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.6 -0.687 . . . . 0.0 110.085 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.481 ' H ' HG22 ' A' ' 38' ' ' THR . . . -59.9 -49.84 76.11 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.553 -0.717 . . . . 0.0 110.744 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.4 p -125.8 8.06 7.49 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.479 -0.763 . . . . 0.0 111.541 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -143.41 159.32 42.6 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.06 -1.025 . . . . 0.0 110.83 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 41.0 m -142.82 121.15 12.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.67 -0.644 . . . . 0.0 109.55 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -135.39 174.81 10.19 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.575 -0.703 . . . . 0.0 110.485 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.8 mt -122.74 163.47 20.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.64 -0.662 . . . . 0.0 110.619 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -132.0 144.98 51.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.648 -0.657 . . . . 0.0 110.125 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.452 HG21 ' HB3' ' A' ' 142' ' ' PRO . 88.9 m -121.73 140.7 51.99 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.494 -0.754 . . . . 0.0 110.233 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.5 t -83.3 106.88 15.43 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.535 -0.728 . . . . 0.0 110.114 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.1 t -122.32 128.38 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.501 -0.749 . . . . 0.0 110.14 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.446 ' O ' HG23 ' A' ' 51' ' ' VAL . 13.1 t-20 53.46 39.95 30.68 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.498 -0.751 . . . . 0.0 111.009 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.638 ' O ' ' HB3' ' A' ' 87' ' ' ALA . . . 64.09 21.56 66.05 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 49' ' ' ASN . 96.7 t -130.2 129.62 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.392 -1.064 . . . . 0.0 109.667 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 35.1 t -81.7 104.51 12.15 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.577 -0.702 . . . . 0.0 109.297 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -95.8 136.91 35.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.599 -0.688 . . . . 0.0 110.779 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.606 HG21 ' CZ3' ' A' ' 85' ' ' TRP . 7.5 t -136.97 177.73 7.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.74 -0.6 . . . . 0.0 109.736 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.652 HG21 ' HB3' ' A' ' 139' ' ' SER . 95.2 t -81.47 141.88 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.477 -0.764 . . . . 0.0 109.277 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.867 ' CE2' HG22 ' A' ' 78' ' ' VAL . 43.6 t80 -84.29 -42.28 15.99 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.333 -0.855 . . . . 0.0 111.18 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.489 ' CE1' HG11 ' A' ' 55' ' ' VAL . 2.2 p-80 -65.72 -17.13 64.39 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.338 -0.851 . . . . 0.0 111.014 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -99.57 -57.32 0.94 Allowed Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.93 -36.52 27.95 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.468 -1.019 . . . . 0.0 110.586 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.98 -25.22 61.56 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 82.8 p -60.0 -39.95 87.53 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.411 -1.052 . . . . 0.0 110.702 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.1 mtpt -130.18 160.22 34.46 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.482 -0.761 . . . . 0.0 110.639 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.7 p -70.0 164.82 23.13 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.549 -0.719 . . . . 0.0 110.048 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.433 HD13 ' HA ' ' A' ' 64' ' ' LEU . 4.2 mm? -97.7 134.68 40.56 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.589 -0.694 . . . . 0.0 110.173 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.39 136.15 41.7 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.532 -0.73 . . . . 0.0 110.261 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -143.39 -165.31 10.69 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -71.05 -47.84 0.51 Allowed 'Trans proline' 0 C--N 1.317 -1.13 0 O-C-N 123.417 1.219 . . . . 0.0 110.483 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -69.93 -31.63 69.49 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.548 -0.72 . . . . 0.0 110.407 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 135.44 -143.07 14.54 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.3 161.35 35.04 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 O-C-N 123.343 1.18 . . . . 0.0 110.624 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 44.7 pt -138.97 156.63 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.636 -0.665 . . . . 0.0 110.271 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 72.4 m -100.57 124.63 46.4 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.503 -0.748 . . . . 0.0 110.275 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -68.8 130.29 42.37 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.593 -0.692 . . . . 0.0 110.722 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.6 ttt -72.94 -40.01 65.77 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.621 -0.674 . . . . 0.0 110.632 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -113.18 140.01 48.28 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.451 -0.781 . . . . 0.0 110.414 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.7 m -145.07 127.31 15.75 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.535 -0.728 . . . . 0.0 110.346 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 -155.36 105.81 2.51 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.38 -0.825 . . . . 0.0 111.184 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.867 HG22 ' CE2' ' A' ' 56' ' ' TYR . 54.4 t -69.94 -40.03 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.466 -0.771 . . . . 0.0 109.21 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -57.8 -45.76 85.61 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.464 -0.772 . . . . 0.0 109.958 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.755 ' HG2' HD12 ' A' ' 82' ' ' LEU . 31.5 tt0 -81.69 -12.47 58.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.795 -0.566 . . . . 0.0 110.114 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 39.6 t0 54.39 39.91 31.35 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.163 -0.961 . . . . 0.0 110.756 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.755 HD12 ' HG2' ' A' ' 80' ' ' GLN . 76.5 mt -140.23 151.57 45.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.588 -0.695 . . . . 0.0 110.698 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.465 HG22 ' HD1' ' A' ' 56' ' ' TYR . 9.8 t -131.94 152.57 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -131.19 156.11 21.63 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.544 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.606 ' CZ3' HG21 ' A' ' 54' ' ' THR . 1.7 m0 -136.08 159.79 40.63 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.785 -0.833 . . . . 0.0 109.755 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -83.4 123.34 29.58 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.394 -0.816 . . . . 0.0 109.954 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 50' ' ' GLY . . . -97.1 149.5 35.77 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.558 -0.714 . . . . 0.0 110.33 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.33 154.95 56.27 Favored 'Trans proline' 0 C--N 1.316 -1.158 0 O-C-N 123.507 1.267 . . . . 0.0 110.272 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.39 160.14 49.55 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 O-C-N 123.377 1.199 . . . . 0.0 110.345 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.21 30.18 13.08 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -129.85 159.14 37.48 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.469 -1.019 . . . . 0.0 110.103 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -87.77 148.44 24.71 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.557 -0.715 . . . . 0.0 110.213 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 71.3 p -120.26 140.22 51.52 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.595 -0.69 . . . . 0.0 110.204 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 70.4 mt -80.01 160.01 26.02 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.601 -0.687 . . . . 0.0 110.17 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 63.8 p -117.26 155.82 49.42 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.655 -0.653 . . . . 0.0 110.131 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.68 164.45 35.39 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 O-C-N 123.374 1.197 . . . . 0.0 110.295 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.639 ' HB2' HG22 ' A' ' 151' ' ' VAL . 7.8 t -68.03 128.45 36.58 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.504 -0.748 . . . . 0.0 110.333 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.0 p -131.93 48.75 2.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.637 -0.664 . . . . 0.0 109.745 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.8 p -144.42 -8.32 0.67 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.63 -0.669 . . . . 0.0 112.428 -179.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.76 32.32 74.06 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.1 t -80.55 113.69 18.92 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.443 -1.034 . . . . 0.0 110.281 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 66.5 m -60.01 -39.96 87.61 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.549 -0.719 . . . . 0.0 110.467 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -68.44 136.21 52.9 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.554 -0.716 . . . . 0.0 110.067 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.432 HD23 ' SG ' ' A' ' 145' ' ' CYS . 48.9 mt -137.44 159.55 41.62 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.563 -0.711 . . . . 0.0 110.61 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -119.98 139.75 52.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.661 -0.649 . . . . 0.0 109.378 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.529 HD13 HD21 ' A' ' 143' ' ' LEU . 51.7 tp -115.15 126.74 54.98 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.515 -0.74 . . . . 0.0 110.223 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 89.5 t -90.61 111.73 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.677 -0.639 . . . . 0.0 109.58 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.5 m -90.02 154.29 19.92 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.607 -0.683 . . . . 0.0 110.321 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 72.6 ttt-85 -60.01 -19.27 51.67 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.652 -0.655 . . . . 0.0 110.619 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -94.82 26.97 3.29 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.341 -0.849 . . . . 0.0 110.544 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 55.69 45.79 23.88 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.262 -0.899 . . . . 0.0 110.648 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -119.72 146.05 45.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.62 -0.675 . . . . 0.0 109.975 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 113' ' ' VAL . 13.9 p -124.21 129.98 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.44 -0.788 . . . . 0.0 110.743 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 61.5 mt -127.77 137.9 31.74 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.63 -0.669 . . . . 0.0 109.727 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -75.97 140.32 22.78 Favored 'Trans proline' 0 N--CA 1.485 1.018 0 O-C-N 123.197 1.104 . . . . 0.0 110.819 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.5 t -129.94 130.86 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.535 -0.728 . . . . 0.0 110.049 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.8 mmm180 -90.51 135.86 33.43 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.53 -0.732 . . . . 0.0 110.229 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 45.5 ttt85 -67.6 122.57 18.31 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.513 -0.742 . . . . 0.0 110.095 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -127.19 22.17 6.64 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.531 -0.731 . . . . 0.0 110.526 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 167.88 -175.92 42.62 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -70.58 -41.29 72.57 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.588 -0.949 . . . . 0.0 110.672 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.7 p -131.18 13.07 5.14 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.525 -0.734 . . . . 0.0 111.275 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 -130.27 138.58 50.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.187 -0.945 . . . . 0.0 110.269 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -137.29 156.15 23.28 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.3 p -86.3 159.48 19.41 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.509 -0.995 . . . . 0.0 110.16 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 49.4 tp -108.05 128.54 54.76 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.652 -0.655 . . . . 0.0 110.012 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.94 -40.05 91.79 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.618 -0.676 . . . . 0.0 110.338 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 62.3 m -116.15 102.61 53.7 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.447 -0.783 . . . . 0.0 110.35 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.3 123.3 8.13 Favored 'Trans proline' 0 C--N 1.319 -1.003 0 O-C-N 123.319 1.168 . . . . 0.0 110.508 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.465 ' CB ' ' CD1' ' A' ' 134' ' ' TYR . 12.7 mtt-85 -131.91 170.94 10.04 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.588 -0.695 . . . . 0.0 110.161 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 41.5 Cg_endo -65.86 150.22 85.99 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 O-C-N 123.385 1.203 . . . . 0.0 111.322 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 162' ' ' GLY . 79.2 t -54.26 -28.44 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.216 -0.927 . . . . 0.0 110.075 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 29.3 t -63.48 -31.04 72.09 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.619 -0.676 . . . . 0.0 109.637 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.465 ' CD1' ' CB ' ' A' ' 130' ' ' ARG . 0.0 OUTLIER -64.76 -40.74 95.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.675 -0.64 . . . . 0.0 109.52 179.784 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 135' ' ' LEU . 13.9 tp -101.93 17.84 22.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.805 -0.559 . . . . 0.0 110.974 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -84.86 136.02 33.83 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.428 -0.795 . . . . 0.0 110.555 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.71 23.89 57.04 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 19.8 m -120.07 11.15 11.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.444 -1.033 . . . . 0.0 110.967 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.652 ' HB3' HG21 ' A' ' 55' ' ' VAL . 12.6 m -59.18 156.49 12.13 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.184 -0.947 . . . . 0.0 110.352 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 89.97 -13.05 65.66 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.574 -1.011 . . . . 0.0 110.574 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -64.62 120.26 18.39 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.452 ' HB3' HG21 ' A' ' 46' ' ' THR . 51.0 Cg_endo -78.09 145.03 21.65 Favored 'Trans proline' 0 C--N 1.32 -0.949 0 O-C-N 123.039 1.02 . . . . 0.0 111.12 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.529 HD21 HD13 ' A' ' 106' ' ' LEU . 1.0 OUTLIER -100.01 121.02 40.72 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.265 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.5 mp -118.53 154.48 32.49 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.535 -0.728 . . . . 0.0 111.267 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.432 ' SG ' HD23 ' A' ' 104' ' ' LEU . 0.9 OUTLIER -96.22 175.3 2.78 Favored Pre-proline 0 N--CA 1.491 1.603 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.358 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.97 -24.93 38.91 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.233 1.122 . . . . 0.0 110.415 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 28.8 m -65.59 -39.94 92.14 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.442 -0.786 . . . . 0.0 110.172 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 117.03 39.17 0.83 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -127.54 144.56 51.05 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.532 -0.981 . . . . 0.0 110.334 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -74.66 145.2 43.4 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.574 -0.704 . . . . 0.0 110.492 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.639 HG22 ' HB2' ' A' ' 97' ' ' CYS . 66.4 t -113.47 -51.47 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.612 -0.68 . . . . 0.0 109.93 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -174.64 -164.27 29.22 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 95.2 mt -131.72 144.04 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.522 -0.987 . . . . 0.0 109.981 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -59.95 126.56 28.02 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.55 -0.719 . . . . 0.0 109.825 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 44.5 ttt180 -105.8 -69.2 0.83 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.664 -0.647 . . . . 0.0 110.71 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.731 ' HB1' ' O32' ' A' ' 201' ' ' 4P2 . . . -132.39 151.07 52.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.525 -0.734 . . . . 0.0 110.749 -179.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -95.15 133.93 38.44 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.726 -0.609 . . . . 0.0 110.162 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 51.8 t -100.7 114.88 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.602 -0.686 . . . . 0.0 110.351 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.3 p -140.26 140.55 35.77 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.491 -0.755 . . . . 0.0 110.709 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 36.0 m -81.23 -47.9 12.77 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.611 -0.681 . . . . 0.0 110.045 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -127.31 42.58 3.29 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.674 -0.641 . . . . 0.0 110.031 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.525 ' O ' HG23 ' A' ' 132' ' ' VAL . . . 91.38 -11.33 72.44 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 77.4 t -97.52 122.43 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.141 -1.211 . . . . 0.0 109.198 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -88.84 115.8 26.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.59 -0.694 . . . . 0.0 110.594 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -104.03 -30.1 10.48 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -124.43 155.76 38.3 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.54 139.99 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.539 -0.726 . . . . 0.0 110.384 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -115.3 131.33 56.96 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.657 -0.652 . . . . 0.0 110.408 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -137.14 158.79 43.66 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.652 -0.655 . . . . 0.0 110.015 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 60.2 t -96.52 130.35 30.85 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.555 -0.716 . . . . 0.0 110.361 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.26 167.27 27.76 Favored 'Trans proline' 0 N--CA 1.485 0.989 0 O-C-N 123.157 1.083 . . . . 0.0 110.314 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 67.8 t -70.17 -30.5 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.532 -0.73 . . . . 0.0 110.237 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -59.94 -40.06 87.68 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.546 -0.721 . . . . 0.0 110.586 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 19.8 t -61.74 -38.77 89.19 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.57 -0.706 . . . . 0.0 110.37 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 68.6 mtt -59.93 -29.1 68.16 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.573 -0.704 . . . . 0.0 110.499 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -59.98 -38.11 81.61 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.603 -0.686 . . . . 0.0 110.665 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 91.4 m -60.02 -40.02 87.87 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.409 -0.807 . . . . 0.0 110.615 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 88.0 m -60.01 -36.4 77.14 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.442 -0.786 . . . . 0.0 110.48 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.8 mtt -60.0 -38.96 84.15 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.454 -0.779 . . . . 0.0 110.722 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 53.3 mtt180 -60.05 -39.96 87.79 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.39 -0.819 . . . . 0.0 110.364 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.791 0 O-C-N 121.608 -0.683 . . . . 0.0 110.205 179.894 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 201' ' ' 4P2 . . . . . 0.731 ' O32' ' HB1' ' A' ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.0 t . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 121.127 0.489 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -157.91 163.68 32.85 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -127.07 27.76 5.88 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.542 -0.975 . . . . 0.0 110.34 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -115.78 130.03 56.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.559 -0.713 . . . . 0.0 110.045 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -112.59 135.31 53.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.656 -0.652 . . . . 0.0 110.165 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -128.88 138.75 52.2 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.584 -0.698 . . . . 0.0 110.084 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -66.44 123.25 19.49 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.58 -0.7 . . . . 0.0 110.169 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 91.7 t -69.94 -40.07 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.624 -0.673 . . . . 0.0 109.831 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -71.91 149.97 44.62 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.583 -0.698 . . . . 0.0 110.281 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 177.98 -158.14 22.88 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.848 ' HG3' HG23 ' A' ' 33' ' ' VAL . 14.6 pt-20 -59.97 -30.29 69.01 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.465 -1.021 . . . . 0.0 110.368 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.848 HG23 ' HG3' ' A' ' 32' ' ' GLU . 71.7 t -118.08 130.01 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.549 -0.719 . . . . 0.0 110.034 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -104.58 140.5 37.91 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.682 -0.636 . . . . 0.0 110.304 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.528 HG13 ' O ' ' A' ' 35' ' ' VAL . 11.1 p -89.62 119.7 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.504 -0.747 . . . . 0.0 110.269 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 62.7 t -124.23 129.9 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.399 -0.813 . . . . 0.0 110.103 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.5 m -119.42 135.67 54.64 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.509 -0.744 . . . . 0.0 110.345 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.43 178.31 4.59 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.469 -0.769 . . . . 0.0 109.892 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.0 -50.18 74.77 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.678 -0.639 . . . . 0.0 110.602 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 74.3 p -117.77 -20.03 9.04 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.575 -0.703 . . . . 0.0 111.041 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -114.81 171.08 7.86 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.313 -0.867 . . . . 0.0 110.394 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 72.1 p -149.84 121.46 8.02 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.642 -0.661 . . . . 0.0 110.034 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 59' ' ' ALA . 41.1 p90 -134.49 171.01 14.91 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.557 -0.715 . . . . 0.0 110.028 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 91.3 mt -119.26 158.37 26.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.568 -0.707 . . . . 0.0 110.529 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -125.64 151.99 45.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.634 -0.666 . . . . 0.0 110.212 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.1 p -125.78 144.12 50.77 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.623 -0.673 . . . . 0.0 110.007 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 35.4 t -94.61 110.08 21.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.448 -0.783 . . . . 0.0 110.434 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.423 HG22 ' HB2' ' A' ' 94' ' ' LEU . 63.3 t -123.05 126.98 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.589 -0.695 . . . . 0.0 110.144 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.9 m120 53.09 39.02 28.88 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.461 -0.774 . . . . 0.0 111.227 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.44 19.59 72.8 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 63.2 t -130.18 129.87 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.296 -1.12 . . . . 0.0 109.623 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 92.4 m -84.47 133.54 34.47 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.522 -0.736 . . . . 0.0 109.684 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -119.91 136.61 54.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.519 -0.738 . . . . 0.0 110.546 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.872 HG23 HG23 ' A' ' 83' ' ' VAL . 9.8 t -137.96 175.02 9.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.708 -0.62 . . . . 0.0 109.72 179.05 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.643 HG11 ' CE1' ' A' ' 57' ' ' HIS . 85.8 t -80.98 142.45 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.448 -0.783 . . . . 0.0 109.993 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.797 ' CE2' HG22 ' A' ' 78' ' ' VAL . 31.4 t80 -76.54 -42.75 41.92 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.644 -0.66 . . . . 0.0 111.71 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.643 ' CE1' HG11 ' A' ' 55' ' ' VAL . 2.5 p-80 -69.94 -15.22 63.02 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.313 -0.867 . . . . 0.0 111.102 -178.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -104.84 -77.95 1.19 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.417 ' HB2' ' CE2' ' A' ' 43' ' ' PHE . . . -71.16 -39.99 71.58 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.513 -0.993 . . . . 0.0 110.697 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.98 -21.38 58.94 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 57.4 m -60.0 -40.55 89.58 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.252 -1.146 . . . . 0.0 110.786 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.1 mttp -137.28 150.36 47.75 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.348 -0.845 . . . . 0.0 110.614 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 70.9 m -74.14 147.21 42.86 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.593 -0.692 . . . . 0.0 109.907 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.424 HD12 ' CH2' ' A' ' 85' ' ' TRP . 88.4 mt -99.21 140.55 33.21 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.576 -0.702 . . . . 0.0 110.551 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.43 134.97 51.83 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.62 -0.675 . . . . 0.0 110.177 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -132.22 170.2 21.91 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -69.25 -23.29 33.28 Favored 'Trans proline' 0 C--N 1.316 -1.142 0 O-C-N 123.395 1.208 . . . . 0.0 110.593 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -69.92 -31.47 69.26 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.47 -0.769 . . . . 0.0 110.215 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.47 174.12 13.21 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.12 145.56 44.56 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.38 1.2 . . . . 0.0 110.436 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.9 mt -119.93 123.37 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.609 -0.682 . . . . 0.0 109.886 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.3 m -74.29 133.43 42.6 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.554 -0.716 . . . . 0.0 110.366 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -64.13 131.0 46.17 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.595 -0.691 . . . . 0.0 110.009 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 19.8 mmt -93.21 -35.76 12.96 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.569 -0.707 . . . . 0.0 110.457 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.594 ' O ' HG12 ' A' ' 83' ' ' VAL . 64.3 m-85 -125.57 134.13 52.06 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.509 -0.744 . . . . 0.0 110.432 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.705 ' HA ' HG12 ' A' ' 83' ' ' VAL . 15.0 p -147.11 121.34 9.54 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.51 -0.744 . . . . 0.0 110.146 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -156.91 116.51 3.45 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.451 -0.781 . . . . 0.0 110.93 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.797 HG22 ' CE2' ' A' ' 56' ' ' TYR . 95.7 t -71.74 -37.1 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.484 -0.76 . . . . 0.0 109.616 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -58.62 -48.16 81.94 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.475 -0.766 . . . . 0.0 109.653 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.532 ' HG2' HD12 ' A' ' 82' ' ' LEU . 37.9 tt0 -84.06 -14.25 51.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.579 -0.701 . . . . 0.0 109.922 178.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.492 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 61.4 t0 55.31 40.0 31.41 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.242 -0.911 . . . . 0.0 111.053 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.568 HD11 HG11 ' A' ' 170' ' ' VAL . 74.9 mt -140.96 147.29 38.54 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.424 -0.798 . . . . 0.0 111.595 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.872 HG23 HG23 ' A' ' 54' ' ' THR . 2.4 m -142.26 173.87 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -167.23 169.98 41.28 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.424 ' CH2' HD12 ' A' ' 64' ' ' LEU . 5.3 m-90 -128.98 158.92 37.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.709 -0.877 . . . . 0.0 109.648 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -81.04 121.29 25.88 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.539 -0.726 . . . . 0.0 110.059 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -114.09 155.7 45.11 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.583 -0.698 . . . . 0.0 110.316 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.59 153.68 60.01 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 123.42 1.221 . . . . 0.0 110.543 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.59 155.72 54.41 Favored 'Trans proline' 0 C--N 1.317 -1.094 0 O-C-N 123.405 1.213 . . . . 0.0 110.349 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 109.17 31.0 3.43 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -128.65 160.03 33.74 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.489 -1.006 . . . . 0.0 110.371 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 76.6 mtt85 -65.56 140.96 58.59 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.636 -0.665 . . . . 0.0 110.25 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 58.0 m -121.87 146.46 47.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.575 -0.703 . . . . 0.0 110.219 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.423 ' HB2' HG22 ' A' ' 48' ' ' VAL . 95.4 mt -94.47 144.4 25.6 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.561 -0.712 . . . . 0.0 110.29 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.645 ' O ' ' HB3' ' A' ' 150' ' ' ALA . 7.7 t -104.3 150.73 38.73 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.639 -0.663 . . . . 0.0 110.169 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.76 151.76 69.12 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.384 1.202 . . . . 0.0 110.388 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 18.8 t -80.83 129.97 34.81 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.567 -0.708 . . . . 0.0 110.431 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 98' ' ' THR . 7.7 t -135.44 56.17 1.85 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.632 -0.667 . . . . 0.0 109.859 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.3 p -145.38 11.55 1.31 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.601 -0.687 . . . . 0.0 111.552 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 51.11 51.3 36.05 Favored Glycine 0 N--CA 1.501 2.979 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.33 109.92 15.28 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.463 -1.022 . . . . 0.0 110.506 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 29.6 p -69.92 -34.99 74.21 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.612 -0.68 . . . . 0.0 109.864 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -84.06 110.8 18.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.72 -0.612 . . . . 0.0 109.922 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.515 HD22 HG21 ' A' ' 151' ' ' VAL . 88.0 mt -115.68 136.45 53.05 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.555 -0.716 . . . . 0.0 110.198 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -106.82 139.76 40.73 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.447 -0.783 . . . . 0.0 110.177 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.428 HD12 HD21 ' A' ' 143' ' ' LEU . 7.3 tt -111.3 141.91 44.22 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.558 -0.714 . . . . 0.0 110.322 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.8 t -94.6 130.8 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.675 -0.641 . . . . 0.0 110.113 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.0 m -104.04 162.54 13.06 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.549 -0.719 . . . . 0.0 110.082 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -61.04 -23.84 65.74 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.488 -0.758 . . . . 0.0 110.599 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -95.39 26.53 3.79 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.469 -0.769 . . . . 0.0 110.637 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.14 43.35 30.79 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.336 -0.852 . . . . 0.0 110.991 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -111.34 130.91 55.53 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.477 -0.765 . . . . 0.0 109.821 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.3 m -101.43 148.13 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.558 -0.714 . . . . 0.0 110.578 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.403 ' O ' HG23 ' A' ' 114' ' ' ILE . 7.4 tt -148.55 132.66 8.67 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.561 -0.712 . . . . 0.0 109.997 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.71 142.74 36.32 Favored 'Trans proline' 0 C--N 1.319 -0.994 0 O-C-N 123.14 1.074 . . . . 0.0 110.693 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.0 t -129.97 130.21 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.66 -0.65 . . . . 0.0 110.007 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -78.07 129.97 35.87 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.491 -0.756 . . . . 0.0 110.222 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -64.23 140.03 58.83 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.568 -0.708 . . . . 0.0 110.031 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -147.56 47.19 1.12 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.587 -0.696 . . . . 0.0 110.265 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 138.53 169.05 11.47 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -60.53 -42.04 95.65 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.569 -0.959 . . . . 0.0 110.196 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.8 m -127.94 25.49 5.93 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.59 -0.694 . . . . 0.0 110.143 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.18 136.93 42.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.533 -0.73 . . . . 0.0 110.242 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -134.26 170.4 22.62 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 14.4 m -120.24 139.81 52.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.525 -0.986 . . . . 0.0 110.362 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 57.9 tp -75.86 137.08 40.2 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.625 -0.672 . . . . 0.0 109.941 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.04 -48.69 80.68 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.544 -0.722 . . . . 0.0 110.584 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 78.5 p -117.72 139.66 26.62 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.537 -0.727 . . . . 0.0 110.012 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -75.55 126.35 9.56 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 O-C-N 123.266 1.14 . . . . 0.0 110.788 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 -129.85 163.04 49.89 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.616 -0.678 . . . . 0.0 109.61 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.79 150.18 67.71 Favored 'Trans proline' 0 C--N 1.315 -1.224 0 O-C-N 123.327 1.172 . . . . 0.0 110.739 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 69.9 t -59.95 -33.55 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.601 -0.687 . . . . 0.0 109.664 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 25.6 t -59.37 -40.05 85.24 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.605 -0.684 . . . . 0.0 110.461 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -61.45 -40.76 95.67 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.546 -0.721 . . . . 0.0 109.753 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.545 HD21 ' CZ ' ' A' ' 154' ' ' PHE . 55.6 tp -89.9 -10.3 45.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.783 -0.573 . . . . 0.0 111.282 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.1 tttm -63.7 137.27 58.01 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.271 -0.893 . . . . 0.0 110.622 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 88.65 23.11 37.27 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 70.7 m -120.55 6.34 10.57 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.331 -1.1 . . . . 0.0 111.32 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.592 ' HB3' HG21 ' A' ' 55' ' ' VAL . 50.6 m -58.65 146.17 37.21 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.973 -1.079 . . . . 0.0 110.076 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 96.37 -24.36 30.78 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.16 111.64 3.79 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.24 149.41 45.6 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 O-C-N 123.169 1.089 . . . . 0.0 110.834 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.504 ' N ' HD12 ' A' ' 143' ' ' LEU . 6.3 mp -101.21 127.5 47.76 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.7 mp -118.45 122.35 42.54 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.472 -0.767 . . . . 0.0 110.948 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 27.3 p -68.49 162.93 58.22 Favored Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -64.4 -21.0 66.79 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 O-C-N 123.148 1.078 . . . . 0.0 111.327 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.6 m -62.74 -39.97 95.77 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.341 -0.849 . . . . 0.0 109.997 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 118.59 40.17 0.68 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -133.38 153.36 51.66 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.59 -0.947 . . . . 0.0 110.354 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.645 ' HB3' ' O ' ' A' ' 95' ' ' THR . . . -78.47 134.06 37.38 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.549 -0.719 . . . . 0.0 110.049 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.515 HG21 HD22 ' A' ' 104' ' ' LEU . 59.7 t -99.81 -59.98 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.527 -0.733 . . . . 0.0 110.365 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.528 ' HA2' HG23 ' A' ' 172' ' ' VAL . . . -176.31 -163.54 28.96 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 91.4 mt -128.5 139.99 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.639 -0.918 . . . . 0.0 110.159 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.545 ' CZ ' HD21 ' A' ' 135' ' ' LEU . 15.4 t80 -61.75 130.07 44.04 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.55 -0.719 . . . . 0.0 110.023 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -107.62 -63.83 1.27 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.636 -0.665 . . . . 0.0 110.636 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.575 ' HB1' ' O32' ' A' ' 201' ' ' 4P2 . . . -136.96 152.65 50.42 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.513 -0.742 . . . . 0.0 110.815 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.64 155.37 16.9 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.694 -0.629 . . . . 0.0 109.632 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 48.0 t -121.05 112.38 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.534 -0.728 . . . . 0.0 110.519 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.4 p -141.58 142.3 33.48 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.485 -0.76 . . . . 0.0 110.429 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 25.0 m -80.2 -41.43 25.24 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.492 -0.755 . . . . 0.0 110.122 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -136.02 46.49 2.3 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.534 -0.729 . . . . 0.0 110.498 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 90.1 -10.68 73.28 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.344 -1.103 . . . . 0.0 110.344 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 63.3 t -98.39 120.75 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.141 -1.211 . . . . 0.0 109.386 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.58 114.61 24.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.587 -0.695 . . . . 0.0 110.752 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -101.65 -29.44 11.92 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 125' ' ' SER . . . -130.34 159.96 35.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.711 -0.618 . . . . 0.0 109.444 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.7 m -133.49 141.41 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.429 -0.794 . . . . 0.0 110.571 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -118.02 133.5 55.86 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.537 -0.727 . . . . 0.0 110.176 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -136.52 160.1 39.79 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.462 -0.773 . . . . 0.0 110.506 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.568 HG11 HD11 ' A' ' 82' ' ' LEU . 58.8 t -96.68 135.43 22.26 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.522 -0.736 . . . . 0.0 110.161 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.08 150.93 43.75 Favored 'Trans proline' 0 N--CA 1.486 1.043 0 O-C-N 123.216 1.114 . . . . 0.0 110.601 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.528 HG23 ' HA2' ' A' ' 152' ' ' GLY . 61.9 t -71.14 -28.4 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.587 -0.695 . . . . 0.0 110.227 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -60.01 -39.93 87.53 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.451 -0.781 . . . . 0.0 110.67 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 62.2 p -61.79 -28.85 69.75 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.516 -0.74 . . . . 0.0 110.589 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 67.6 mtt -61.59 -34.92 76.45 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.535 -0.728 . . . . 0.0 110.475 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -59.98 -40.79 90.31 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.525 -0.734 . . . . 0.0 110.314 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 92.3 m -63.53 -40.04 95.98 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.514 -0.741 . . . . 0.0 109.925 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 63.6 m -62.67 -41.54 99.14 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.59 -0.694 . . . . 0.0 110.154 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 58.8 ttp -60.04 -40.93 91.05 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.613 -0.68 . . . . 0.0 110.315 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 44.5 ttp85 -60.02 -39.99 87.78 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.59 -0.693 . . . . 0.0 110.087 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.852 0 O-C-N 121.577 -0.702 . . . . 0.0 110.162 179.987 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 201' ' ' 4P2 . . . . . 0.649 ' C24' HG13 ' A' ' 78' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.1 m . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.079 0.466 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -79.05 -59.96 2.65 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 52.7 ttt85 -128.01 133.65 49.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.506 -0.997 . . . . 0.0 110.238 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -127.22 137.84 52.98 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.652 -0.655 . . . . 0.0 110.177 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.7 mttm -104.07 123.35 47.09 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.634 -0.666 . . . . 0.0 110.2 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -109.09 117.36 33.96 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.483 -0.761 . . . . 0.0 110.142 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -113.91 141.79 46.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.572 -0.705 . . . . 0.0 109.949 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.5 t -106.3 122.89 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.509 -0.744 . . . . 0.0 109.866 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -140.56 157.59 45.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.619 -0.675 . . . . 0.0 110.363 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.48 136.86 8.11 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -120.9 104.79 10.11 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.588 -0.948 . . . . 0.0 110.41 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 45' ' ' ALA . 11.0 p -137.33 130.46 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.596 -0.69 . . . . 0.0 109.932 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.3 mp0 -104.32 132.48 50.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.568 -0.708 . . . . 0.0 110.273 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.3 m -76.63 135.72 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.659 -0.65 . . . . 0.0 109.934 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.7 p -137.29 138.9 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.56 -0.712 . . . . 0.0 110.148 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.3 t -122.46 136.85 54.98 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.631 -0.668 . . . . 0.0 110.141 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.508 HG22 ' H ' ' A' ' 39' ' ' ALA . 1.1 m -100.16 179.97 4.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.567 -0.708 . . . . 0.0 109.979 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.508 ' H ' HG22 ' A' ' 38' ' ' THR . . . -60.03 -41.23 91.77 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.651 -0.656 . . . . 0.0 111.017 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.4 p -121.59 -25.55 5.1 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.407 -0.808 . . . . 0.0 111.676 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -118.23 159.58 23.08 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.292 -0.88 . . . . 0.0 110.751 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 11.1 m -140.06 120.79 14.35 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.605 -0.684 . . . . 0.0 110.178 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -135.79 176.31 8.8 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.609 -0.682 . . . . 0.0 109.877 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.4 mt -116.86 160.36 20.97 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.451 -0.781 . . . . 0.0 110.398 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.645 ' O ' HG23 ' A' ' 33' ' ' VAL . . . -129.37 143.85 51.0 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.481 -0.762 . . . . 0.0 110.478 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.579 HG21 ' HB3' ' A' ' 142' ' ' PRO . 89.7 m -123.1 136.93 55.0 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.51 -0.743 . . . . 0.0 110.115 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 47.3 t -95.43 111.67 23.52 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.542 -0.724 . . . . 0.0 110.602 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.98 139.35 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.504 -0.748 . . . . 0.0 110.195 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 55.21 37.17 28.49 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.524 -0.735 . . . . 0.0 110.794 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.1 14.15 63.22 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.9 t -131.73 130.0 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.18 -1.188 . . . . 0.0 109.781 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.419 ' SG ' ' HB1' ' A' ' 45' ' ' ALA . 43.1 t -86.02 113.43 22.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.523 -0.736 . . . . 0.0 109.923 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.444 ' CZ3' ' CD2' ' A' ' 82' ' ' LEU . 80.0 m95 -106.51 137.12 45.08 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.558 -0.714 . . . . 0.0 110.82 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.546 HG23 HG13 ' A' ' 83' ' ' VAL . 7.6 t -136.81 -179.31 5.62 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.739 HG11 ' CE1' ' A' ' 57' ' ' HIS . 59.4 t -80.14 142.52 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.398 -0.814 . . . . 0.0 109.194 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.883 ' CE2' HG22 ' A' ' 78' ' ' VAL . 28.7 t80 -83.28 -39.99 20.13 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.352 -0.843 . . . . 0.0 111.861 -178.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.739 ' CE1' HG11 ' A' ' 55' ' ' VAL . 1.6 p-80 -60.19 -18.66 49.73 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.98 -1.075 . . . . 0.0 110.956 -178.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -97.64 -69.37 0.97 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.62 -36.3 70.72 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.582 -0.952 . . . . 0.0 110.588 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.69 -29.16 66.6 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.8 t -61.08 -39.94 91.79 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.548 -0.972 . . . . 0.0 110.943 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -127.93 143.29 51.1 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.459 -0.776 . . . . 0.0 110.549 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.3 t -65.92 151.39 46.86 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.534 -0.729 . . . . 0.0 110.539 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 13.6 tp -100.03 133.56 44.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.624 -0.672 . . . . 0.0 109.868 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.05 130.59 36.94 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.497 -0.752 . . . . 0.0 110.499 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -97.44 -179.22 33.89 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.8 -36.1 8.58 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 O-C-N 123.391 1.206 . . . . 0.0 110.445 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -85.29 -12.12 53.13 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.574 -0.704 . . . . 0.0 111.061 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 146.95 -164.99 28.55 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.15 151.44 55.22 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.397 1.209 . . . . 0.0 110.173 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 44.5 pt -130.0 156.58 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.595 -0.69 . . . . 0.0 110.483 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.1 m -100.65 133.19 45.48 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.643 -0.661 . . . . 0.0 109.743 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -61.1 124.62 21.05 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.476 -0.765 . . . . 0.0 110.074 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.7 tpt -64.9 -40.04 94.46 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.639 -0.663 . . . . 0.0 110.536 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.408 ' O ' HG23 ' A' ' 83' ' ' VAL . 43.2 m-85 -124.43 134.27 53.13 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.571 -0.706 . . . . 0.0 110.308 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.0 p -146.37 136.21 23.34 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.5 -0.75 . . . . 0.0 110.391 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -162.0 105.46 1.19 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.522 -0.736 . . . . 0.0 110.027 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.883 HG22 ' CE2' ' A' ' 56' ' ' TYR . 72.2 t -68.18 -40.0 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.511 -0.743 . . . . 0.0 110.267 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -57.93 -39.81 78.93 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.546 -0.721 . . . . 0.0 110.762 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -99.06 -7.25 27.05 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.535 -0.728 . . . . 0.0 111.3 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.1 t0 55.81 40.43 30.68 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.881 -1.137 . . . . 0.0 109.616 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.584 HD13 HG11 ' A' ' 170' ' ' VAL . 4.7 tp -119.04 132.01 56.01 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.463 0.649 . . . . 0.0 110.114 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.595 HG11 ' HA ' ' A' ' 56' ' ' TYR . 7.1 p -156.82 160.69 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.721 -0.612 . . . . 0.0 109.427 -179.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -177.33 168.34 40.0 Favored Glycine 0 N--CA 1.495 2.614 0 C-N-CA 119.756 -1.211 . . . . 0.0 110.471 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.406 ' CH2' HG21 ' A' ' 54' ' ' THR . 13.5 m-90 -117.38 155.17 30.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.789 -0.83 . . . . 0.0 109.925 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.8 mm-40 -76.63 148.12 37.12 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.493 -0.754 . . . . 0.0 110.168 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -113.01 158.95 36.42 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.509 -0.745 . . . . 0.0 110.243 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.47 157.38 56.52 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.41 1.216 . . . . 0.0 110.526 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.46 160.24 44.89 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.49 1.258 . . . . 0.0 110.421 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 80.5 27.34 51.83 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -115.15 159.02 21.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.515 -0.991 . . . . 0.0 110.127 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.9 tpt85 -81.41 131.68 35.29 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.569 -0.707 . . . . 0.0 110.125 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 59.4 m -115.59 150.24 36.98 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.574 -0.704 . . . . 0.0 110.229 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 94.2 mt -92.7 136.57 33.11 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.531 -0.73 . . . . 0.0 110.376 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 73.9 p -81.43 156.92 70.84 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.605 -0.684 . . . . 0.0 110.407 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.81 163.68 36.52 Favored 'Trans proline' 0 C--N 1.318 -1.027 0 O-C-N 123.435 1.229 . . . . 0.0 110.372 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 49.5 t -87.23 123.76 32.58 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.538 -0.726 . . . . 0.0 110.379 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 98' ' ' THR . 7.2 t -132.84 61.78 1.67 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.662 -0.649 . . . . 0.0 109.883 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.3 p -145.27 7.4 1.16 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.61 -0.681 . . . . 0.0 111.955 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 51.22 48.06 48.22 Favored Glycine 0 N--CA 1.501 3.029 0 O-C-N 120.919 -1.113 . . . . 0.0 110.416 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.8 p -85.27 109.91 18.69 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.51 -0.994 . . . . 0.0 110.629 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 68.5 p -66.99 -39.66 87.21 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.603 -0.686 . . . . 0.0 109.611 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -79.14 128.15 32.93 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.585 -0.697 . . . . 0.0 109.591 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.549 HD22 HG21 ' A' ' 151' ' ' VAL . 92.9 mt -133.6 150.24 51.61 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.401 -0.812 . . . . 0.0 110.696 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -106.85 128.47 54.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.619 -0.676 . . . . 0.0 109.504 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.747 HD12 HD21 ' A' ' 143' ' ' LEU . 7.9 tt -110.48 142.35 42.35 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.571 -0.705 . . . . 0.0 110.422 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.6 t -107.2 125.26 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.611 -0.681 . . . . 0.0 109.781 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 75.1 p -95.39 168.9 10.43 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.644 -0.66 . . . . 0.0 110.386 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 -66.28 -23.48 66.4 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.71 -0.619 . . . . 0.0 110.161 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -93.16 24.5 3.76 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.425 -0.797 . . . . 0.0 110.79 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.71 50.04 16.69 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.338 -0.851 . . . . 0.0 111.032 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -117.67 127.76 54.25 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.319 -0.863 . . . . 0.0 109.827 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.1 t -93.81 120.0 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.577 -0.702 . . . . 0.0 110.096 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 36.0 mt -123.96 135.06 25.87 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.574 -0.704 . . . . 0.0 109.853 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -77.22 143.77 22.74 Favored 'Trans proline' 0 C--N 1.32 -0.954 0 O-C-N 123.199 1.105 . . . . 0.0 110.277 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.3 t -131.45 139.64 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.568 -0.708 . . . . 0.0 110.158 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.3 tpt85 -96.88 133.59 41.3 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.512 -0.743 . . . . 0.0 110.032 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -70.0 136.85 50.86 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.547 -0.72 . . . . 0.0 110.259 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -136.87 26.2 3.03 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.592 -0.693 . . . . 0.0 110.18 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 151.95 -173.93 31.08 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -70.06 -39.07 75.89 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.593 -0.945 . . . . 0.0 110.429 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.3 m -128.78 23.69 5.75 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.52 -0.737 . . . . 0.0 111.184 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 24.5 ttp180 -141.45 143.66 34.0 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.224 -0.923 . . . . 0.0 110.852 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -139.59 -176.68 15.02 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 1.6 m -116.29 160.8 19.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.568 -0.96 . . . . 0.0 110.042 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.463 HD12 HG13 ' A' ' 167' ' ' VAL . 0.3 OUTLIER -110.96 124.1 51.46 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.555 -0.715 . . . . 0.0 110.087 179.791 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.515 ' N ' HD12 ' A' ' 127' ' ' LEU . 6.5 mp -69.98 -40.04 75.6 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.502 -0.749 . . . . 0.0 110.007 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 67.1 m -103.78 109.92 63.02 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.585 -0.697 . . . . 0.0 109.976 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.92 112.47 3.41 Favored 'Trans proline' 0 C--N 1.319 -1.016 0 O-C-N 123.241 1.127 . . . . 0.0 110.48 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -124.92 162.12 45.16 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.628 -0.67 . . . . 0.0 110.17 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.2 150.56 59.66 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 O-C-N 123.505 1.266 . . . . 0.0 110.503 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 162' ' ' GLY . 85.9 t -56.66 -34.34 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.558 -0.714 . . . . 0.0 110.27 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.2 t -59.98 -39.98 87.56 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.538 -0.726 . . . . 0.0 110.52 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -64.15 -40.04 95.31 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.574 -0.703 . . . . 0.0 110.048 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 45.3 tp -88.99 -4.33 58.46 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.679 -0.638 . . . . 0.0 111.35 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -71.26 140.44 50.36 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.11 -0.994 . . . . 0.0 110.975 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 98.39 -2.56 59.25 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 45.3 p -100.86 9.16 42.66 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.149 -1.206 . . . . 0.0 110.716 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.21 129.9 42.9 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.281 -0.887 . . . . 0.0 109.732 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 107.37 -20.77 32.06 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.57 128.5 38.39 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.579 ' HB3' HG21 ' A' ' 46' ' ' THR . 52.0 Cg_endo -76.94 162.24 32.3 Favored 'Trans proline' 0 C--N 1.319 -0.992 0 O-C-N 123.166 1.087 . . . . 0.0 111.304 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.747 HD21 HD12 ' A' ' 106' ' ' LEU . 2.8 mp -116.56 125.11 51.4 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.63 ' N ' HD12 ' A' ' 144' ' ' LEU . 6.5 mp -116.67 129.99 56.47 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.466 -0.771 . . . . 0.0 111.424 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 29.5 p -80.63 163.75 54.81 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.704 -0.623 . . . . 0.0 109.356 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.41 -14.6 44.81 Favored 'Trans proline' 0 N--CA 1.488 1.154 0 O-C-N 123.162 1.085 . . . . 0.0 111.12 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.6 t -66.89 -40.11 87.67 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.284 -0.885 . . . . 0.0 110.004 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 117.05 32.65 1.49 Allowed Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -132.98 148.24 52.27 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.46 -1.023 . . . . 0.0 110.168 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -72.28 134.78 45.75 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.519 -0.738 . . . . 0.0 110.271 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.549 HG21 HD22 ' A' ' 104' ' ' LEU . 58.0 t -98.52 -59.69 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.513 -0.742 . . . . 0.0 110.145 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -176.16 -170.01 38.35 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 45.4 mt -121.34 143.48 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.614 -0.933 . . . . 0.0 110.323 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -61.12 126.76 28.52 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.577 -0.702 . . . . 0.0 109.668 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -106.74 -64.25 1.2 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.474 -0.767 . . . . 0.0 110.972 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.584 ' HB1' ' O32' ' A' ' 201' ' ' 4P2 . . . -134.1 150.92 51.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.432 -0.792 . . . . 0.0 110.794 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.49 152.9 18.21 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.584 -0.697 . . . . 0.0 109.439 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 46.6 t -120.0 120.01 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.485 -0.759 . . . . 0.0 110.443 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.2 p -140.98 142.16 34.33 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.473 -0.767 . . . . 0.0 110.536 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 92.6 m -70.03 -44.11 69.92 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.58 -0.7 . . . . 0.0 109.865 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -147.93 49.62 1.06 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.651 -0.656 . . . . 0.0 110.133 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.406 ' O ' HG23 ' A' ' 132' ' ' VAL . . . 97.74 -11.19 64.61 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 58.0 t -101.6 123.64 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.195 -1.179 . . . . 0.0 108.97 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.24 118.21 26.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.443 -0.786 . . . . 0.0 111.136 -178.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -111.42 -15.12 13.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.742 -0.599 . . . . 0.0 110.158 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 125' ' ' SER . . . -144.31 167.99 21.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.354 -0.841 . . . . 0.0 109.356 179.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.463 HG13 HD12 ' A' ' 126' ' ' LEU . 35.0 m -137.81 145.05 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.319 -0.863 . . . . 0.0 111.131 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.47 132.44 54.73 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.71 -0.619 . . . . 0.0 110.082 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -142.11 154.05 44.61 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.493 -0.755 . . . . 0.0 110.502 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.584 HG11 HD13 ' A' ' 82' ' ' LEU . 89.5 t -92.46 130.96 35.55 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.588 -0.695 . . . . 0.0 109.803 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.13 160.08 46.2 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 O-C-N 123.193 1.101 . . . . 0.0 110.366 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 61.8 t -69.4 -33.1 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.602 -0.686 . . . . 0.0 109.932 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -60.03 -39.94 87.63 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.475 -0.766 . . . . 0.0 110.595 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.9 m -64.96 -22.91 67.08 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.526 -0.734 . . . . 0.0 111.28 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.436 ' HG2' HD11 ' A' ' 82' ' ' LEU . 65.6 mtt -59.97 -35.63 75.41 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.26 -0.9 . . . . 0.0 110.526 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -59.97 -32.8 71.16 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.576 -0.702 . . . . 0.0 110.652 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 93.9 m -59.94 -40.03 87.55 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.409 -0.807 . . . . 0.0 110.404 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 24.8 m -68.8 -34.19 75.13 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.429 -0.794 . . . . 0.0 110.561 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 44.8 ttp -59.97 -41.86 92.88 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.574 -0.704 . . . . 0.0 110.662 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 58.8 mtt-85 -61.32 -39.92 92.29 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.518 -0.739 . . . . 0.0 110.364 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.764 0 O-C-N 121.528 -0.732 . . . . 0.0 110.245 179.97 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 201' ' ' 4P2 . . . . . 0.584 ' O32' ' HB1' ' A' ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.7 p . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.055 0.455 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 145.12 44.82 0.04 OUTLIER Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -61.3 -40.34 93.79 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.449 -1.03 . . . . 0.0 110.304 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -70.03 -41.04 74.79 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.603 -0.685 . . . . 0.0 110.134 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 72.8 tttt 50.2 40.17 21.44 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.39 -0.819 . . . . 0.0 110.943 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -88.77 62.08 6.27 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.471 -0.768 . . . . 0.0 110.202 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -60.1 -40.04 88.26 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.51 -0.744 . . . . 0.0 110.077 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.421 ' O ' HG12 ' A' ' 29' ' ' VAL . 58.9 t 50.28 70.01 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.504 -0.747 . . . . 0.0 110.997 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -68.91 140.06 55.12 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.46 -0.775 . . . . 0.0 109.693 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -136.58 44.67 1.13 Allowed Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.3 -40.03 89.05 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.438 -1.037 . . . . 0.0 109.942 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.4 t -119.57 138.93 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.716 -0.615 . . . . 0.0 109.614 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -119.43 142.63 48.05 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.511 -0.743 . . . . 0.0 110.569 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.524 ' O ' HG23 ' A' ' 35' ' ' VAL . 34.0 m -85.44 120.4 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.724 -0.61 . . . . 0.0 110.425 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.9 p -130.21 140.0 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.448 -0.783 . . . . 0.0 110.199 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 74.8 m -122.02 149.0 44.13 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.673 -0.642 . . . . 0.0 110.279 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.531 HG22 ' H ' ' A' ' 39' ' ' ALA . 1.0 OUTLIER -110.31 -177.38 3.23 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.639 -0.663 . . . . 0.0 110.004 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.531 ' H ' HG22 ' A' ' 38' ' ' THR . . . -64.5 -40.05 94.94 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.668 -0.645 . . . . 0.0 111.263 -179.284 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.564 HG23 ' HG3' ' A' ' 41' ' ' GLN . 7.2 t -123.72 -11.7 7.7 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.326 -0.859 . . . . 0.0 111.935 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.564 ' HG3' HG23 ' A' ' 40' ' ' THR . 97.0 mt-30 -136.04 162.95 31.46 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.176 -0.952 . . . . 0.0 110.441 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.6 t -140.24 123.47 16.83 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.566 -0.709 . . . . 0.0 110.426 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -136.17 178.03 7.38 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.587 -0.696 . . . . 0.0 110.012 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.402 ' CD2' ' HA ' ' A' ' 35' ' ' VAL . 82.0 mt -117.46 147.19 42.95 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.523 -0.736 . . . . 0.0 110.636 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -109.97 155.3 21.96 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.719 -0.613 . . . . 0.0 110.081 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.7 p -129.95 144.2 51.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.512 -0.742 . . . . 0.0 110.255 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 34.0 t -100.89 115.82 31.3 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.559 -0.713 . . . . 0.0 110.45 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.4 t -129.98 129.97 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.628 -0.67 . . . . 0.0 109.967 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 52.77 40.12 29.93 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.432 -0.793 . . . . 0.0 111.059 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.623 ' O ' ' HB3' ' A' ' 87' ' ' ALA . . . 67.2 20.99 71.68 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 62.1 t -130.87 123.35 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.293 -1.122 . . . . 0.0 109.922 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 42.3 t -80.7 110.07 15.85 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.48 -0.763 . . . . 0.0 109.564 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 46.7 m95 -97.27 137.58 36.06 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.528 -0.732 . . . . 0.0 110.994 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.882 HG23 HG23 ' A' ' 83' ' ' VAL . 10.1 t -136.63 173.1 12.07 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.173 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.727 HG11 ' CE1' ' A' ' 57' ' ' HIS . 45.7 t -80.63 142.57 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.376 -0.827 . . . . 0.0 110.372 -179.297 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.772 ' CE2' HG22 ' A' ' 78' ' ' VAL . 34.7 t80 -74.96 -43.03 56.36 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.606 -0.684 . . . . 0.0 111.976 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.727 ' CE1' HG11 ' A' ' 55' ' ' VAL . 1.8 p-80 -66.35 -13.85 61.2 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.192 -0.942 . . . . 0.0 110.996 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.9 -88.11 1.47 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.736 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -70.33 -39.97 74.41 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.666 -0.902 . . . . 0.0 110.586 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.93 -27.56 56.83 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.7 m -59.97 -40.42 89.05 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.412 -1.052 . . . . 0.0 110.593 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.7 ttpt -138.26 145.05 40.85 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.485 -0.76 . . . . 0.0 110.468 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 74.9 m -65.9 140.99 58.39 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.609 -0.682 . . . . 0.0 109.903 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.736 HD21 ' HB1' ' A' ' 59' ' ' ALA . 2.5 pp -140.26 147.66 40.3 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.519 -0.738 . . . . 0.0 110.356 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -119.97 136.5 54.51 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.665 -0.647 . . . . 0.0 110.282 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -88.33 -164.44 40.27 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -70.54 -25.9 24.5 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 O-C-N 123.35 1.184 . . . . 0.0 110.454 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -70.03 -31.32 68.91 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.609 -0.682 . . . . 0.0 110.227 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 144.77 -156.27 26.8 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.83 145.41 45.7 Favored 'Trans proline' 0 N--CA 1.486 1.044 0 O-C-N 123.418 1.22 . . . . 0.0 110.613 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 85.5 mt -125.46 131.15 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.597 -0.69 . . . . 0.0 110.127 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.0 m -104.96 131.0 53.03 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.545 -0.722 . . . . 0.0 109.844 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -77.28 109.29 11.04 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.515 -0.741 . . . . 0.0 110.451 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 48.7 tpp -70.01 -35.77 74.61 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.669 -0.644 . . . . 0.0 110.122 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.581 ' O ' HG12 ' A' ' 83' ' ' VAL . 62.5 m-85 -109.67 128.42 55.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.615 -0.678 . . . . 0.0 109.924 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.637 ' HA ' HG12 ' A' ' 83' ' ' VAL . 11.1 p -144.23 121.21 11.37 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.538 -0.726 . . . . 0.0 110.361 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 59.6 t-20 -151.42 110.85 3.97 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.515 -0.74 . . . . 0.0 110.495 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.772 HG22 ' CE2' ' A' ' 56' ' ' TYR . 99.6 t -70.03 -35.36 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.451 -0.781 . . . . 0.0 109.577 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -60.0 -40.17 88.28 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.392 -0.817 . . . . 0.0 109.391 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.503 ' HG2' HD12 ' A' ' 82' ' ' LEU . 66.7 tt0 -89.93 -14.28 34.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.699 -0.626 . . . . 0.0 110.083 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.47 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 46.5 t0 55.03 40.01 31.81 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.207 -0.933 . . . . 0.0 110.713 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.503 HD12 ' HG2' ' A' ' 80' ' ' GLN . 48.1 mt -144.09 149.6 36.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.512 -0.743 . . . . 0.0 111.165 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.882 HG23 HG23 ' A' ' 54' ' ' THR . 1.9 m -141.24 168.21 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -152.37 156.73 26.87 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 119.747 -1.216 . . . . 0.0 110.318 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -121.71 146.05 47.41 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.705 -0.879 . . . . 0.0 109.919 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -68.44 129.9 41.3 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.594 -0.692 . . . . 0.0 110.028 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.623 ' HB3' ' O ' ' A' ' 50' ' ' GLY . . . -114.14 159.71 35.3 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.526 -0.734 . . . . 0.0 110.131 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.58 154.7 64.34 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 O-C-N 123.413 1.218 . . . . 0.0 110.376 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.51 160.14 44.93 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 O-C-N 123.41 1.216 . . . . 0.0 110.465 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 77.9 28.97 55.69 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -110.3 155.01 22.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.534 -0.98 . . . . 0.0 110.22 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -58.86 146.38 37.61 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.622 -0.673 . . . . 0.0 110.401 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.5 t -143.43 161.56 38.07 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.629 -0.67 . . . . 0.0 110.453 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.452 HD13 ' HA ' ' A' ' 94' ' ' LEU . 2.5 mm? -108.18 144.79 35.12 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.57 -0.706 . . . . 0.0 110.376 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.8 p -95.42 159.42 32.77 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.56 -0.712 . . . . 0.0 110.393 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.84 150.49 49.68 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 O-C-N 123.394 1.207 . . . . 0.0 110.386 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.617 ' CB ' HG12 ' A' ' 151' ' ' VAL . 47.9 t -87.28 128.26 35.17 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.62 -0.675 . . . . 0.0 110.445 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.5 p -136.12 71.79 1.43 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.584 -0.698 . . . . 0.0 109.927 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.6 p -145.4 8.25 1.18 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.473 -0.767 . . . . 0.0 111.916 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 52.59 42.96 58.85 Favored Glycine 0 N--CA 1.499 2.864 0 O-C-N 120.824 -1.172 . . . . 0.0 110.353 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 26.3 t -79.42 116.65 19.78 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.488 -1.007 . . . . 0.0 110.394 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.6 m -70.05 -39.91 75.43 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.603 -0.686 . . . . 0.0 110.275 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -84.27 142.16 30.44 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.609 -0.682 . . . . 0.0 110.402 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 94.9 mt -132.2 152.23 51.41 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.503 -0.748 . . . . 0.0 110.401 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -114.61 136.8 52.65 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.55 -0.719 . . . . 0.0 109.744 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 57.3 tp -110.85 140.13 45.57 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.43 -0.794 . . . . 0.0 110.422 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.3 t -93.69 129.94 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.616 -0.678 . . . . 0.0 109.913 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.4 m -110.01 160.93 16.0 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.47 -0.769 . . . . 0.0 110.519 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 18.0 ptm180 -62.71 -24.58 67.74 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.676 -0.64 . . . . 0.0 110.864 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -95.48 29.19 2.65 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.418 -0.801 . . . . 0.0 110.629 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 55.34 36.28 26.75 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.304 -0.873 . . . . 0.0 110.44 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -109.18 146.43 34.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.644 -0.66 . . . . 0.0 109.849 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.6 p -138.05 135.68 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.511 -0.743 . . . . 0.0 110.526 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.404 HG23 ' HD2' ' A' ' 115' ' ' PRO . 85.4 mt -126.6 143.68 47.16 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.603 -0.685 . . . . 0.0 109.679 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.404 ' HD2' HG23 ' A' ' 114' ' ' ILE . 49.9 Cg_endo -76.79 139.13 19.53 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 O-C-N 123.274 1.144 . . . . 0.0 110.455 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.3 t -124.79 129.94 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.603 -0.686 . . . . 0.0 109.762 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.0 tpp85 -84.24 139.52 32.31 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.531 -0.731 . . . . 0.0 110.022 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -77.2 129.63 36.2 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.543 -0.723 . . . . 0.0 110.152 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -136.59 25.78 3.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.662 -0.649 . . . . 0.0 110.424 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 175.7 179.8 46.42 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -66.78 -40.11 88.06 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.505 -0.997 . . . . 0.0 110.324 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 67.1 m -136.03 25.94 3.28 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.551 -0.718 . . . . 0.0 110.377 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -136.95 159.99 40.24 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.588 -0.695 . . . . 0.0 110.299 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -150.93 -173.71 21.2 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 97.4 p -120.67 153.44 36.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.62 -0.93 . . . . 0.0 110.245 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.7 tp -106.57 123.6 48.34 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.583 -0.698 . . . . 0.0 110.143 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.494 ' H ' HD12 ' A' ' 127' ' ' LEU . 4.7 mp -66.47 -39.99 89.09 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.543 -0.723 . . . . 0.0 110.304 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 30.0 t -100.22 108.47 52.6 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.488 -0.757 . . . . 0.0 110.262 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.33 115.45 4.35 Favored 'Trans proline' 0 C--N 1.319 -0.994 0 O-C-N 123.18 1.094 . . . . 0.0 110.307 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -124.48 160.7 51.93 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.586 -0.696 . . . . 0.0 110.392 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.44 150.52 58.16 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 O-C-N 123.469 1.247 . . . . 0.0 110.567 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 162' ' ' GLY . 95.0 t -57.72 -30.55 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.564 -0.71 . . . . 0.0 110.258 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.5 t -60.07 -40.61 90.1 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.519 -0.738 . . . . 0.0 110.383 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -64.77 -46.02 83.9 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.579 -0.7 . . . . 0.0 109.868 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.474 HD21 ' CZ ' ' A' ' 154' ' ' PHE . 54.1 tp -78.76 -22.59 46.2 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.681 -0.637 . . . . 0.0 110.91 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.468 ' CD ' HG12 ' A' ' 132' ' ' VAL . 22.8 mttt -60.03 136.38 58.0 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.387 -0.821 . . . . 0.0 110.58 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 98.07 -2.35 59.73 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 68.9 m -109.07 16.23 22.72 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.16 -1.2 . . . . 0.0 110.538 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.8 t -62.43 150.15 40.68 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.415 -0.803 . . . . 0.0 109.842 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 90.1 -12.28 68.23 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.37 113.34 5.36 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -70.64 140.9 40.39 Favored 'Trans proline' 0 C--N 1.318 -1.072 0 O-C-N 123.171 1.09 . . . . 0.0 110.981 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.45 ' O ' HG22 ' A' ' 151' ' ' VAL . 21.7 mt -87.51 125.22 34.19 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.141 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.468 ' HA ' HD13 ' A' ' 144' ' ' LEU . 4.1 mm? -110.41 160.02 16.96 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.322 0.582 . . . . 0.0 110.856 -178.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -109.6 176.18 1.65 Allowed Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.76 -0.587 . . . . 0.0 109.681 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.77 -35.67 12.18 Favored 'Trans proline' 0 C--N 1.317 -1.081 0 O-C-N 123.292 1.154 . . . . 0.0 110.064 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.8 m -62.43 -40.03 95.24 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.605 -0.684 . . . . 0.0 109.756 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 120.21 36.01 0.84 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -126.26 138.14 53.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.523 -0.987 . . . . 0.0 110.146 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.17 140.37 38.97 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.508 -0.745 . . . . 0.0 110.119 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.617 HG12 ' CB ' ' A' ' 97' ' ' CYS . 34.3 m -105.95 -26.51 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.571 -0.705 . . . . 0.0 110.56 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 172.72 -164.49 36.67 Favored Glycine 0 N--CA 1.498 2.77 0 C-N-CA 119.674 -1.25 . . . . 0.0 110.571 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 82.6 mt -130.98 141.83 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.67 -0.9 . . . . 0.0 109.896 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.474 ' CZ ' HD21 ' A' ' 135' ' ' LEU . 20.3 t80 -60.16 130.02 44.61 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.52 -0.737 . . . . 0.0 110.209 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.408 ' HD2' ' CG2' ' A' ' 170' ' ' VAL . 67.8 ttt180 -104.49 -72.96 0.69 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.515 -0.741 . . . . 0.0 110.792 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.683 ' HB1' ' O32' ' A' ' 201' ' ' 4P2 . . . -132.29 152.96 51.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.306 -0.871 . . . . 0.0 110.867 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.48 156.29 16.53 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.648 -0.658 . . . . 0.0 109.757 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 60.7 t -120.78 115.77 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.601 -0.687 . . . . 0.0 110.248 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.4 p -141.35 146.28 36.46 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.461 -0.774 . . . . 0.0 110.711 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 12.2 m -82.3 -49.16 10.36 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.539 -0.725 . . . . 0.0 110.006 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -129.88 46.44 2.65 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.601 -0.687 . . . . 0.0 110.203 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.516 ' O ' HG23 ' A' ' 132' ' ' VAL . . . 91.78 -10.99 73.33 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 67.2 t -97.61 122.78 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.156 -1.202 . . . . 0.0 109.38 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.55 116.36 25.62 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.542 -0.724 . . . . 0.0 110.9 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 67.5 mttt -104.27 -29.1 11.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.688 -0.633 . . . . 0.0 109.586 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -128.44 157.38 41.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.705 -0.622 . . . . 0.0 109.55 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 31.7 m -133.07 139.99 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.442 -0.786 . . . . 0.0 110.774 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -119.32 133.54 55.68 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.606 -0.683 . . . . 0.0 110.347 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -134.5 156.67 48.21 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.554 -0.716 . . . . 0.0 110.146 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.408 ' CG2' ' HD2' ' A' ' 155' ' ' ARG . 57.5 t -96.2 133.84 24.48 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.507 -0.746 . . . . 0.0 110.254 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.01 159.96 40.68 Favored 'Trans proline' 0 N--CA 1.485 0.988 0 O-C-N 123.253 1.133 . . . . 0.0 110.465 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 59.5 t -72.66 -26.32 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.625 -0.672 . . . . 0.0 110.223 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -59.64 -36.82 77.13 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.458 -0.776 . . . . 0.0 110.46 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 22.9 t -61.17 -38.62 87.15 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.587 -0.696 . . . . 0.0 110.162 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.475 ' HE2' HD13 ' A' ' 82' ' ' LEU . 66.1 mtt -60.04 -34.2 73.07 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.537 -0.727 . . . . 0.0 110.35 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -60.02 -40.34 88.95 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.534 -0.728 . . . . 0.0 110.459 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 94.5 m -65.99 -40.09 90.88 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.523 -0.736 . . . . 0.0 109.67 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 93.9 m -62.89 -40.01 96.23 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.662 -0.649 . . . . 0.0 110.067 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 89.1 mtp -60.08 -40.05 88.22 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.539 -0.726 . . . . 0.0 110.431 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -67.28 -39.97 86.08 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.601 -0.687 . . . . 0.0 110.087 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.798 0 O-C-N 121.593 -0.692 . . . . 0.0 110.251 -179.935 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 201' ' ' 4P2 . . . . . 0.689 ' C24' HG13 ' A' ' 78' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.8 p . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.049 0.452 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.01 85.5 1.0 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.92 139.92 50.16 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.568 -0.96 . . . . 0.0 110.712 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -117.76 25.31 10.48 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.506 -0.746 . . . . 0.0 110.362 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.719 ' O ' HG23 ' A' ' 29' ' ' VAL . 57.9 mttt -102.67 -55.78 2.37 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.404 -0.81 . . . . 0.0 110.328 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 35.96 -90.9 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.901 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -112.41 -70.89 0.78 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.048 -1.033 . . . . 0.0 110.636 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 26' ' ' LYS . 57.6 t 57.53 162.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 CA-C-O 121.569 0.7 . . . . 0.0 110.578 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.416 ' N ' HG12 ' A' ' 29' ' ' VAL . 20.5 mt-10 50.03 -170.5 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.329 -0.857 . . . . 0.0 111.185 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.63 -88.05 0.43 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -76.87 -23.05 52.63 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.552 -0.969 . . . . 0.0 110.604 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.6 t -101.71 124.98 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.42 -0.8 . . . . 0.0 109.978 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -104.62 132.29 51.03 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.521 -0.737 . . . . 0.0 110.362 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.596 HG12 HD22 ' A' ' 44' ' ' LEU . 32.9 m -94.98 129.8 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.644 -0.66 . . . . 0.0 110.116 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.2 m -130.05 159.97 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.353 -0.842 . . . . 0.0 110.772 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 69.0 m -132.76 152.83 51.68 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.544 -0.723 . . . . 0.0 110.152 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.521 HG22 ' H ' ' A' ' 39' ' ' ALA . 0.7 OUTLIER -115.56 -176.53 2.94 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.543 -0.723 . . . . 0.0 110.093 -179.803 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.521 ' H ' HG22 ' A' ' 38' ' ' THR . . . -60.09 -49.6 77.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.74 -0.6 . . . . 0.0 111.049 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.68 HG23 ' HG3' ' A' ' 41' ' ' GLN . 7.6 t -116.99 -22.48 8.43 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.393 -0.817 . . . . 0.0 111.293 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.68 ' HG3' HG23 ' A' ' 40' ' ' THR . 59.9 mt-30 -117.14 164.94 14.0 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.389 -0.819 . . . . 0.0 110.187 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.5 m -147.93 120.19 8.37 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.499 -0.751 . . . . 0.0 110.303 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.454 ' HZ ' HD11 ' A' ' 64' ' ' LEU . 27.3 p90 -130.98 -176.66 4.07 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.629 -0.67 . . . . 0.0 110.049 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.596 HD22 HG12 ' A' ' 35' ' ' VAL . 48.9 mt -122.4 173.36 7.7 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.502 -0.748 . . . . 0.0 109.893 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -150.68 160.83 43.57 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.564 -0.71 . . . . 0.0 110.355 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.451 HG21 ' HB3' ' A' ' 142' ' ' PRO . 8.2 t -136.61 144.1 43.91 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.669 -0.644 . . . . 0.0 110.172 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 28.5 p -87.92 123.71 32.95 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.589 -0.695 . . . . 0.0 110.763 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.6 t -130.61 125.26 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.52 -0.737 . . . . 0.0 110.174 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 51.34 40.72 27.05 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.389 -0.819 . . . . 0.0 111.335 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.95 22.77 77.2 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.439 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 60.8 t -142.26 113.62 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.396 -1.061 . . . . 0.0 109.53 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 93.3 m -79.73 125.27 29.44 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.641 -0.662 . . . . 0.0 110.205 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.439 ' CZ2' HG11 ' A' ' 51' ' ' VAL . 98.5 m95 -114.26 136.48 52.92 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.585 -0.697 . . . . 0.0 110.102 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.805 HG23 HG23 ' A' ' 83' ' ' VAL . 7.9 t -137.85 -179.87 6.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.656 -0.653 . . . . 0.0 109.968 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.469 HG11 ' CE1' ' A' ' 57' ' ' HIS . 2.1 t -81.69 141.59 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.503 -0.748 . . . . 0.0 109.415 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.862 ' CE2' HG22 ' A' ' 78' ' ' VAL . 9.6 t80 -85.49 -43.81 13.25 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.392 -0.818 . . . . 0.0 111.85 -179.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.469 ' CE1' HG11 ' A' ' 55' ' ' VAL . 3.1 p-80 -57.76 -17.83 17.89 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.204 -0.935 . . . . 0.0 111.672 -177.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.75 -53.87 2.78 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.412 ' HB2' ' CZ ' ' A' ' 43' ' ' PHE . . . -80.2 -63.39 1.42 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.621 -0.929 . . . . 0.0 109.779 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.89 -169.05 14.19 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 95.8 p -66.13 -35.07 79.53 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.603 -0.939 . . . . 0.0 110.286 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -60.04 136.78 58.12 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.513 -0.742 . . . . 0.0 110.261 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.449 ' HB ' HE21 ' A' ' 73' ' ' GLN . 9.1 t -80.83 175.55 10.59 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.573 -0.704 . . . . 0.0 110.094 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.454 HD11 ' HZ ' ' A' ' 43' ' ' PHE . 61.7 mt -97.9 137.21 37.08 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.571 -0.706 . . . . 0.0 110.622 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -100.54 109.8 21.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.62 -0.675 . . . . 0.0 110.075 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -86.02 -158.48 30.95 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.14 -36.66 16.31 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 O-C-N 123.381 1.201 . . . . 0.0 110.347 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.9 mmmt -76.85 -31.31 56.76 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.556 -0.715 . . . . 0.0 110.377 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 138.26 176.84 14.78 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.34 172.9 14.7 Favored 'Trans proline' 0 N--CA 1.486 1.041 0 O-C-N 123.425 1.224 . . . . 0.0 110.468 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.449 HD11 ' CD1' ' A' ' 85' ' ' TRP . 44.2 pt -131.88 169.99 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.565 -0.71 . . . . 0.0 110.335 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.4 m -72.41 139.21 47.66 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.503 -0.748 . . . . 0.0 110.267 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.449 HE21 ' HB ' ' A' ' 63' ' ' THR . 36.2 mm-40 -74.32 131.07 40.81 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.625 -0.672 . . . . 0.0 110.087 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.426 ' HG3' ' CD2' ' A' ' 75' ' ' TYR . 22.8 ptp -119.69 -42.49 2.63 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.45 -0.781 . . . . 0.0 110.751 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.491 ' O ' HG12 ' A' ' 83' ' ' VAL . 35.0 m-85 -119.98 114.3 21.82 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.265 -0.897 . . . . 0.0 110.088 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.6 m -152.7 131.62 12.52 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.553 -0.717 . . . . 0.0 110.187 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -169.89 125.39 0.81 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.281 -0.887 . . . . 0.0 111.279 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.862 HG22 ' CE2' ' A' ' 56' ' ' TYR . 76.3 t -72.48 -38.17 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.395 -0.816 . . . . 0.0 109.593 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -55.65 -34.22 64.76 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.386 -0.821 . . . . 0.0 110.364 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -98.99 -12.21 20.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.655 -0.653 . . . . 0.0 110.628 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.536 ' O ' HD12 ' A' ' 82' ' ' LEU . 42.8 t0 53.28 40.06 30.71 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.093 -1.004 . . . . 0.0 110.501 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.546 HD22 ' CE ' ' A' ' 175' ' ' MET . 0.2 OUTLIER -141.48 151.03 42.99 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.786 0.803 . . . . 0.0 110.979 -179.608 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.805 HG23 HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -146.32 153.07 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.349 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -153.14 159.25 28.42 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.474 -1.346 . . . . 0.0 110.816 -178.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.473 ' CH2' HG21 ' A' ' 54' ' ' THR . 6.3 m-90 -131.43 168.37 17.72 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.997 -0.707 . . . . 0.0 109.307 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.419 ' H ' ' HE1' ' A' ' 74' ' ' MET . 8.1 mm-40 -68.82 138.51 54.82 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.429 -0.794 . . . . 0.0 110.425 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.38 148.69 45.13 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.577 -0.702 . . . . 0.0 110.109 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.12 144.43 37.6 Favored 'Trans proline' 0 C--N 1.318 -1.065 0 O-C-N 123.29 1.153 . . . . 0.0 110.394 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -77.39 160.26 32.37 Favored 'Trans proline' 0 C--N 1.318 -1.034 0 O-C-N 123.345 1.182 . . . . 0.0 110.548 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 89.61 30.01 14.7 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -151.99 167.84 27.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.55 -0.971 . . . . 0.0 110.301 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -113.76 159.44 19.75 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.515 -0.74 . . . . 0.0 110.123 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.3 m -129.12 171.11 12.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.492 -0.755 . . . . 0.0 110.523 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -81.25 165.08 21.78 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.703 -0.623 . . . . 0.0 110.557 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.453 ' CG2' ' CD2' ' A' ' 149' ' ' HIS . 9.4 t -110.85 151.73 43.11 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.655 -0.653 . . . . 0.0 109.909 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.07 130.29 21.23 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 O-C-N 123.245 1.129 . . . . 0.0 110.232 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.864 ' SG ' 'ZN ' ' A' ' 202' ' ' ' ZN' . 5.0 t -72.31 145.09 48.06 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.64 -0.663 . . . . 0.0 110.538 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 31.3 m -136.28 66.19 1.5 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.573 -0.704 . . . . 0.0 110.477 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 27.7 p -145.01 -8.01 0.62 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.467 -0.771 . . . . 0.0 112.387 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.94 43.71 97.83 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.4 t -71.92 129.87 39.64 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.528 -0.983 . . . . 0.0 110.268 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 73.4 m -71.34 -40.3 70.81 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.563 -0.71 . . . . 0.0 110.267 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -79.75 130.02 34.98 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.518 -0.739 . . . . 0.0 110.328 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 95.9 mt -136.57 151.97 49.96 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.553 -0.717 . . . . 0.0 110.378 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -106.97 123.27 47.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.462 -0.774 . . . . 0.0 109.75 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.482 HD13 HD11 ' A' ' 143' ' ' LEU . 41.0 tp -110.05 140.31 44.24 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.516 -0.74 . . . . 0.0 110.386 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 26.7 m -112.27 141.23 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.584 -0.697 . . . . 0.0 109.954 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.495 HG23 ' OD1' ' A' ' 112' ' ' ASP . 15.5 p -109.85 -162.65 0.81 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.365 -0.834 . . . . 0.0 109.949 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.448 ' HA ' HD11 ' A' ' 44' ' ' LEU . 23.2 ttp180 -70.1 -23.62 63.08 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.653 -0.654 . . . . 0.0 110.353 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -91.68 19.69 6.16 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.37 -0.831 . . . . 0.0 111.01 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.13 24.76 5.08 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.124 -0.985 . . . . 0.0 111.024 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.495 ' OD1' HG23 ' A' ' 108' ' ' THR . 54.7 p-10 -81.0 161.74 24.12 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.477 -0.764 . . . . 0.0 109.914 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.0 p -129.35 133.11 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.626 -0.671 . . . . 0.0 110.062 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.4 tp -143.59 138.38 15.3 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.529 -0.732 . . . . 0.0 109.929 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.464 ' HG2' HD13 ' A' ' 127' ' ' LEU . 47.0 Cg_endo -73.35 139.28 28.71 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 O-C-N 123.201 1.106 . . . . 0.0 110.556 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.578 HG13 ' O ' ' A' ' 125' ' ' SER . 62.3 t -129.93 130.04 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.517 -0.74 . . . . 0.0 109.876 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -81.95 149.02 28.4 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.476 -0.765 . . . . 0.0 110.144 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -83.42 137.18 34.03 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.661 -0.649 . . . . 0.0 110.369 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.6 mmt85 -141.28 26.49 1.99 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.58 -0.7 . . . . 0.0 110.381 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 161.65 171.95 28.39 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -71.66 -45.16 62.81 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.556 -0.967 . . . . 0.0 110.443 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 61.3 p -116.83 20.09 14.09 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.553 -0.717 . . . . 0.0 110.732 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 25.3 ttp180 -147.77 144.21 28.07 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.399 -0.813 . . . . 0.0 110.009 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -139.85 -175.23 14.17 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.578 ' O ' HG13 ' A' ' 116' ' ' VAL . 57.3 p -119.72 147.53 44.48 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.61 -0.936 . . . . 0.0 110.026 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 34.7 tp -95.06 131.23 41.27 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.584 -0.698 . . . . 0.0 110.205 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.464 HD13 ' HG2' ' A' ' 115' ' ' PRO . 1.4 tt -63.03 -54.58 35.95 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.612 -0.68 . . . . 0.0 110.258 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 57.8 m -96.51 130.05 31.62 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.445 -0.784 . . . . 0.0 110.156 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -81.25 116.32 3.02 Favored 'Trans proline' 0 C--N 1.32 -0.939 0 O-C-N 123.132 1.07 . . . . 0.0 110.677 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.422 ' HD2' ' CD2' ' A' ' 134' ' ' TYR . 54.6 mtm-85 -125.09 152.6 70.86 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.518 -0.739 . . . . 0.0 109.779 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.3 150.22 64.62 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 123.369 1.194 . . . . 0.0 110.759 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.421 HG21 ' SG ' ' A' ' 159' ' ' CYS . 51.6 t -54.33 -31.72 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.442 -0.786 . . . . 0.0 109.701 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.6 t -59.9 -40.38 88.59 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.746 -0.596 . . . . 0.0 111.095 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.422 ' CD2' ' HD2' ' A' ' 130' ' ' ARG . 86.3 t80 -68.95 -39.81 79.3 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.342 -0.849 . . . . 0.0 109.685 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 23.2 tp -94.67 18.75 11.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.885 -0.51 . . . . 0.0 110.187 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.408 ' HA ' ' C48' ' A' ' 201' ' ' 4P2 . 0.2 OUTLIER -83.64 118.47 23.87 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 122.658 1.218 . . . . 0.0 112.317 -178.879 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.8 26.35 8.04 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.3 p -109.96 20.94 17.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.529 -0.983 . . . . 0.0 110.621 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.6 m -66.39 144.59 56.44 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.337 -0.852 . . . . 0.0 109.342 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.75 -18.2 57.05 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.63 110.37 2.3 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.451 ' HB3' HG21 ' A' ' 46' ' ' THR . 44.3 Cg_endo -71.05 161.45 45.98 Favored 'Trans proline' 0 C--N 1.318 -1.048 0 O-C-N 123.168 1.088 . . . . 0.0 111.054 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.553 ' O ' HG22 ' A' ' 151' ' ' VAL . 5.1 mp -113.99 119.71 38.15 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.0 tp -96.51 167.34 11.21 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.426 0.631 . . . . 0.0 110.833 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.407 ' CB ' ' HD2' ' A' ' 146' ' ' PRO . 0.1 OUTLIER -108.2 178.49 1.05 Allowed Pre-proline 0 N--CA 1.493 1.701 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.7 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.407 ' HD2' ' CB ' ' A' ' 145' ' ' CYS . 42.9 Cg_endo -69.05 -25.37 31.95 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 O-C-N 123.258 1.136 . . . . 0.0 110.339 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 83.0 p -79.81 -28.58 40.19 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.514 -0.741 . . . . 0.0 110.088 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 115.55 35.01 1.34 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.453 ' CD2' ' CG2' ' A' ' 95' ' ' THR . 22.9 m170 -122.79 153.64 39.27 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.579 -0.953 . . . . 0.0 110.365 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -88.69 144.24 26.4 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.474 -0.766 . . . . 0.0 110.199 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.648 ' O ' HG23 ' A' ' 172' ' ' VAL . 35.1 m -119.14 -24.26 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.476 -0.765 . . . . 0.0 111.067 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -179.73 -173.08 44.48 Favored Glycine 0 N--CA 1.498 2.829 0 C-N-CA 119.672 -1.252 . . . . 0.0 110.385 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 64.0 mt -130.0 159.23 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.562 -0.964 . . . . 0.0 110.033 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -73.77 144.62 45.56 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.55 -0.718 . . . . 0.0 110.248 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 -129.57 -75.97 0.55 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.534 -0.729 . . . . 0.0 110.264 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -120.41 142.35 49.29 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.154 -0.966 . . . . 0.0 110.992 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.52 127.33 39.12 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.471 HG13 ' C11' ' A' ' 201' ' ' 4P2 . 2.4 t -97.83 119.5 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.532 -0.73 . . . . 0.0 111.388 -177.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.421 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.3 p -141.15 151.74 44.13 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.547 -0.721 . . . . 0.0 110.43 178.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 6.8 p -93.7 -48.19 6.44 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.511 -0.743 . . . . 0.0 109.511 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 50.9 mtt85 -119.97 36.7 4.44 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 91.9 -11.57 71.79 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 63.7 t -89.16 123.66 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.178 -1.189 . . . . 0.0 109.284 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.18 114.3 23.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.526 -0.734 . . . . 0.0 110.838 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -107.14 -29.99 9.04 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.809 -0.557 . . . . 0.0 109.64 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -118.47 168.25 10.83 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.668 -0.645 . . . . 0.0 109.863 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.9 m -143.21 131.83 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.498 -0.751 . . . . 0.0 110.702 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.31 127.84 47.74 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.613 -0.679 . . . . 0.0 110.231 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -136.27 162.15 33.79 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.556 -0.715 . . . . 0.0 110.588 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.47 HG13 ' HD2' ' A' ' 171' ' ' PRO . 90.1 t -104.86 144.71 29.28 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.463 -0.773 . . . . 0.0 110.033 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.47 ' HD2' HG13 ' A' ' 170' ' ' VAL . 45.1 Cg_endo -71.41 168.15 24.31 Favored 'Trans proline' 0 N--CA 1.486 1.056 0 O-C-N 123.318 1.168 . . . . 0.0 110.709 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 151' ' ' VAL . 61.4 t -92.44 -45.99 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.606 -0.684 . . . . 0.0 110.467 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -54.61 -28.88 49.67 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.693 -0.629 . . . . 0.0 111.304 -178.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.661 ' O ' HG22 ' A' ' 177' ' ' THR . 4.3 m -61.62 -25.91 67.65 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.378 -0.826 . . . . 0.0 110.279 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.546 ' CE ' HD22 ' A' ' 82' ' ' LEU . 32.8 mmt -70.12 -27.35 64.5 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.498 -0.751 . . . . 0.0 110.641 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -56.83 -41.78 78.46 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.448 -0.783 . . . . 0.0 111.059 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.661 HG22 ' O ' ' A' ' 174' ' ' SER . 7.4 t -73.9 -22.09 59.83 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.405 -0.809 . . . . 0.0 110.556 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 76.7 m -72.0 -39.94 68.87 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.384 -0.823 . . . . 0.0 110.344 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 26.2 ttp -59.98 -44.57 94.41 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.681 -0.637 . . . . 0.0 110.5 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 26.4 mmt85 -60.01 -39.9 87.39 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.531 -0.731 . . . . 0.0 110.389 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.789 0 O-C-N 121.571 -0.706 . . . . 0.0 110.09 179.976 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 201' ' ' 4P2 . . . . . 0.759 ' C24' HG13 ' A' ' 78' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . 0.864 'ZN ' ' SG ' ' A' ' 97' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.5 m . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.088 0.47 . . . . 0.0 110.15 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.7 -71.41 0.08 OUTLIER Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -39.98 89.07 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.536 -0.979 . . . . 0.0 110.206 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -60.45 131.52 51.02 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.506 -0.746 . . . . 0.0 110.505 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -147.11 27.55 1.04 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.547 -0.72 . . . . 0.0 110.277 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -94.19 152.55 18.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.504 -0.748 . . . . 0.0 110.349 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -99.56 123.1 43.51 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.544 -0.722 . . . . 0.0 110.06 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.7 t -129.98 136.4 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.635 -0.665 . . . . 0.0 110.096 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -60.02 146.0 44.35 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.468 -0.77 . . . . 0.0 110.342 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.53 68.11 0.01 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 56.23 -84.59 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.771 -0.841 . . . . 0.0 111.008 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.854 HG11 ' HD3' ' A' ' 142' ' ' PRO . 19.3 m -118.92 162.22 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.182 -0.949 . . . . 0.0 110.947 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 22.2 mm100 -136.87 125.2 23.28 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.572 ' O ' HG23 ' A' ' 35' ' ' VAL . 34.5 m -73.76 116.42 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.585 -0.697 . . . . 0.0 109.957 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.587 HG22 ' O ' ' A' ' 43' ' ' PHE . 35.9 m -110.75 152.03 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.431 -0.793 . . . . 0.0 110.157 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.1 m -115.7 125.38 52.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.581 -0.699 . . . . 0.0 110.366 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.05 -169.61 1.89 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.655 -0.653 . . . . 0.0 109.538 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.16 -51.23 70.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.583 -0.698 . . . . 0.0 110.894 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.662 HG23 ' HG3' ' A' ' 41' ' ' GLN . 7.9 t -127.65 0.99 6.15 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.404 -0.81 . . . . 0.0 111.817 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.662 ' HG3' HG23 ' A' ' 40' ' ' THR . 70.1 mt-30 -140.38 171.26 14.4 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.004 -1.06 . . . . 0.0 110.499 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 77.7 p -145.4 131.38 19.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.618 -0.676 . . . . 0.0 110.157 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.587 ' O ' HG22 ' A' ' 36' ' ' VAL . 13.5 p90 -130.21 -175.33 3.6 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.521 -0.737 . . . . 0.0 110.314 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.447 HD23 ' HB ' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -119.44 159.0 25.09 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.455 -0.778 . . . . 0.0 110.633 -179.511 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -126.67 119.56 27.31 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.606 -0.683 . . . . 0.0 110.015 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.772 HG22 HG12 ' A' ' 33' ' ' VAL . 19.0 p -101.8 144.08 30.91 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.496 -0.752 . . . . 0.0 110.504 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 26.3 p -100.68 110.23 22.33 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.683 0.754 . . . . 0.0 110.238 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.3 t -130.25 130.02 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.174 -0.954 . . . . 0.0 110.258 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.427 ' O ' HG23 ' A' ' 51' ' ' VAL . 97.0 m-20 52.73 39.43 28.57 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.4 -0.813 . . . . 0.0 111.116 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.46 24.76 71.06 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 49' ' ' ASN . 60.5 t -135.15 122.73 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.368 -1.077 . . . . 0.0 109.666 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 54.5 m -79.27 111.38 15.46 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.56 -0.712 . . . . 0.0 109.782 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.434 ' CE3' HD23 ' A' ' 82' ' ' LEU . 52.3 m95 -98.6 136.82 38.14 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.528 -0.733 . . . . 0.0 110.82 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.878 HG21 ' CH2' ' A' ' 85' ' ' TRP . 6.4 t -137.36 179.99 6.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.711 -0.618 . . . . 0.0 109.547 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.855 HG21 ' HB3' ' A' ' 139' ' ' SER . 79.0 t -85.47 141.7 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.471 -0.768 . . . . 0.0 109.379 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.886 ' CE2' HG22 ' A' ' 78' ' ' VAL . 15.7 t80 -85.37 -43.68 13.45 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.487 -0.758 . . . . 0.0 111.381 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.59 ' CE1' HG11 ' A' ' 55' ' ' VAL . 2.0 p-80 -60.68 -17.43 47.74 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.308 -0.87 . . . . 0.0 111.419 -178.033 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -103.1 -62.11 0.7 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -96.1 -23.57 16.71 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.534 -0.98 . . . . 0.0 111.011 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.414 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -59.99 -40.05 96.46 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.1 t -70.14 -39.78 75.17 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.523 -0.986 . . . . 0.0 110.864 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.496 ' NZ ' HG22 ' A' ' 40' ' ' THR . 47.3 mtpt -99.61 178.9 4.72 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.416 -0.803 . . . . 0.0 110.828 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.417 HG22 ' N ' ' A' ' 64' ' ' LEU . 15.4 m -81.19 169.94 16.74 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.695 -0.628 . . . . 0.0 110.23 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.438 ' CD2' ' CZ2' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -100.85 147.38 26.17 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.492 -0.755 . . . . 0.0 110.589 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.03 123.81 44.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.643 -0.661 . . . . 0.0 110.005 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -142.66 -174.27 14.98 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.4 -45.15 2.78 Favored 'Trans proline' 0 C--N 1.318 -1.072 0 O-C-N 123.402 1.212 . . . . 0.0 110.619 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 38.6 tptt -70.05 -31.2 68.7 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.511 -0.743 . . . . 0.0 110.133 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.56 -159.89 22.1 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.72 153.09 53.84 Favored 'Trans proline' 0 C--N 1.318 -1.053 0 O-C-N 123.345 1.181 . . . . 0.0 110.344 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 41.6 pt -129.99 160.16 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.577 -0.702 . . . . 0.0 110.345 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.9 t -71.32 150.3 45.26 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.602 -0.687 . . . . 0.0 110.177 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -94.41 131.15 40.38 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.528 -0.732 . . . . 0.0 110.147 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.453 ' CE ' ' CE2' ' A' ' 75' ' ' TYR . 25.4 ptm -116.54 -37.47 3.7 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.555 -0.716 . . . . 0.0 110.165 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.453 ' CE2' ' CE ' ' A' ' 74' ' ' MET . 28.1 m-85 -111.26 119.6 39.44 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.537 -0.727 . . . . 0.0 109.373 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 88.0 m -148.6 126.06 11.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.48 -0.763 . . . . 0.0 110.277 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -165.43 123.48 1.59 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.384 -0.823 . . . . 0.0 111.307 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.886 HG22 ' CE2' ' A' ' 56' ' ' TYR . 79.7 t -72.36 -34.08 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.478 -0.764 . . . . 0.0 109.376 178.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -55.7 -44.77 77.72 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.567 -0.708 . . . . 0.0 110.536 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -90.76 -10.38 43.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.606 -0.684 . . . . 0.0 110.522 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.82 ' O ' HD12 ' A' ' 82' ' ' LEU . 48.5 t0 53.13 40.36 31.11 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.185 -0.947 . . . . 0.0 110.654 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.82 HD12 ' O ' ' A' ' 81' ' ' ASP . 1.0 OUTLIER -141.62 160.46 40.11 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.884 0.849 . . . . 0.0 111.098 -179.412 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.402 ' HB ' ' CG2' ' A' ' 54' ' ' THR . 1.6 t -138.35 164.43 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.406 ' O ' ' CD1' ' A' ' 85' ' ' TRP . . . -153.68 155.15 25.98 Favored Glycine 0 N--CA 1.496 2.653 0 C-N-CA 119.497 -1.335 . . . . 0.0 110.87 -179.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.878 ' CH2' HG21 ' A' ' 54' ' ' THR . 4.5 m-90 -141.93 163.57 32.52 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.877 -0.778 . . . . 0.0 109.332 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -73.41 122.98 22.97 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.479 -0.763 . . . . 0.0 109.881 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.11 154.88 40.53 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.57 -0.706 . . . . 0.0 110.26 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.98 146.14 41.19 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.467 1.246 . . . . 0.0 110.359 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -76.86 160.08 34.21 Favored 'Trans proline' 0 C--N 1.317 -1.1 0 O-C-N 123.394 1.208 . . . . 0.0 110.43 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.25 28.7 12.6 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -133.34 160.4 37.45 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.519 -0.989 . . . . 0.0 110.165 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -79.57 153.44 29.48 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.551 -0.718 . . . . 0.0 110.229 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.8 m -134.68 158.64 43.56 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.533 -0.729 . . . . 0.0 110.305 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.1 mt -108.24 158.33 17.55 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.584 -0.698 . . . . 0.0 110.408 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 71.4 p -137.24 163.21 50.65 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.577 -0.702 . . . . 0.0 110.075 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.79 142.62 43.8 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 O-C-N 123.42 1.221 . . . . 0.0 110.151 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.408 ' HB3' ' HB2' ' A' ' 149' ' ' HIS . 30.5 p -84.77 157.88 20.88 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.563 -0.711 . . . . 0.0 110.828 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 98' ' ' THR . 6.5 t -115.94 65.4 0.7 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.2 p -144.65 -8.71 0.64 Allowed 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 120.044 -0.663 . . . . 0.0 112.582 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 50.5 26.75 10.5 Favored Glycine 0 N--CA 1.502 3.049 0 O-C-N 120.778 -1.201 . . . . 0.0 110.609 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 41.6 m -59.11 127.63 33.14 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.446 -1.031 . . . . 0.0 110.645 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 73.6 m -68.74 -40.14 80.0 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.701 -0.624 . . . . 0.0 109.992 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -61.66 139.4 58.29 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.57 -0.706 . . . . 0.0 110.02 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.5 mt -141.73 169.23 17.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.649 -0.657 . . . . 0.0 110.513 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -138.36 128.89 26.31 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.681 -0.637 . . . . 0.0 109.598 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.4 tt -114.88 123.56 49.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.437 -0.789 . . . . 0.0 110.476 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 63.0 t -94.96 109.9 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.674 -0.641 . . . . 0.0 109.511 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 75.1 p -81.91 174.89 10.86 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.465 -0.772 . . . . 0.0 110.478 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -59.92 -22.78 62.88 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.64 -0.663 . . . . 0.0 110.585 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.81 20.18 5.86 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.359 -0.838 . . . . 0.0 110.675 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 52.76 41.6 31.63 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.198 -0.938 . . . . 0.0 110.881 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.758 ' HB3' HD13 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -100.22 121.2 41.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.567 -0.708 . . . . 0.0 110.091 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.697 HG13 ' H ' ' A' ' 114' ' ' ILE . 1.9 p -57.07 -79.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.598 -0.689 . . . . 0.0 111.018 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.758 HD13 ' HB3' ' A' ' 112' ' ' ASP . 2.4 mp 54.69 99.31 0.04 OUTLIER Pre-proline 0 N--CA 1.504 2.238 0 O-C-N 120.726 -1.234 . . . . 0.0 110.227 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.23 164.37 35.24 Favored 'Trans proline' 0 C--N 1.318 -1.051 0 O-C-N 123.226 1.119 . . . . 0.0 110.6 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.58 HG13 ' O ' ' A' ' 125' ' ' SER . 58.2 t -139.9 139.8 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.556 -0.715 . . . . 0.0 109.719 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -93.5 149.9 20.87 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.584 -0.697 . . . . 0.0 110.102 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -76.76 147.51 37.24 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.59 -0.694 . . . . 0.0 110.615 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -154.63 52.34 0.64 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.616 -0.678 . . . . 0.0 109.785 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 126.13 171.25 13.12 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -60.1 -58.89 6.59 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.454 -1.027 . . . . 0.0 109.974 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 57.8 m -112.85 23.74 13.12 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.558 -0.713 . . . . 0.0 109.871 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.682 ' NH2' HG21 ' A' ' 158' ' ' VAL . 0.3 OUTLIER -126.41 136.71 53.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.548 -0.72 . . . . 0.0 109.832 -179.699 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -142.41 169.44 25.46 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.58 ' O ' HG13 ' A' ' 116' ' ' VAL . 20.2 p -111.06 160.57 16.73 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.571 -0.958 . . . . 0.0 109.989 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.73 HD13 HG11 ' A' ' 167' ' ' VAL . 18.1 tp -106.36 126.35 52.13 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.666 -0.646 . . . . 0.0 110.509 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.32 -56.49 14.13 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.596 -0.69 . . . . 0.0 109.999 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 33.1 t -94.81 112.8 59.44 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.61 -0.681 . . . . 0.0 109.872 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.66 107.25 2.27 Favored 'Trans proline' 0 C--N 1.32 -0.969 0 O-C-N 123.25 1.132 . . . . 0.0 110.799 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.516 ' NH2' HD11 ' A' ' 126' ' ' LEU . 80.2 mtm180 -118.84 158.02 48.75 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.63 -0.668 . . . . 0.0 109.9 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.78 150.41 55.93 Favored 'Trans proline' 0 C--N 1.315 -1.204 0 O-C-N 123.433 1.228 . . . . 0.0 110.678 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.416 HG21 ' SG ' ' A' ' 159' ' ' CYS . 55.6 t -53.65 -29.42 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 O-C-N 121.433 -0.792 . . . . 0.0 109.807 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.1 t -59.83 -44.87 93.84 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.656 -0.653 . . . . 0.0 111.213 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -67.32 -38.7 85.34 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.32 -0.862 . . . . 0.0 109.815 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 135' ' ' LEU . 31.2 tp -92.32 18.43 8.35 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.78 -0.575 . . . . 0.0 110.19 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.7 tttm -82.88 118.28 23.33 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 122.57 1.176 . . . . 0.0 112.145 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.71 26.6 7.95 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 17.0 m -105.35 19.93 19.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.642 -0.916 . . . . 0.0 110.141 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.855 ' HB3' HG21 ' A' ' 55' ' ' VAL . 2.4 m -74.17 130.27 39.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.31 -0.869 . . . . 0.0 109.466 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.412 ' HA2' HD11 ' A' ' 153' ' ' ILE . . . 113.59 -26.51 10.1 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.57 131.01 51.84 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.854 ' HD3' HG11 ' A' ' 33' ' ' VAL . 52.2 Cg_endo -85.7 157.84 10.49 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.117 1.062 . . . . 0.0 111.106 -178.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 143' ' ' LEU . 6.8 mp -107.71 123.5 48.62 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.14 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 150' ' ' ALA . 4.1 tp -105.34 162.33 13.53 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.519 -0.738 . . . . 0.0 110.823 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.707 ' SG ' 'ZN ' ' A' ' 202' ' ' ' ZN' . 28.9 p -115.39 168.45 8.27 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 37.7 Cg_endo -62.47 -15.36 44.98 Favored 'Trans proline' 0 N--CA 1.488 1.18 0 O-C-N 122.935 0.966 . . . . 0.0 111.103 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.2 t -69.94 -35.09 74.25 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.268 -0.895 . . . . 0.0 109.783 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 117.81 15.36 6.31 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.408 ' HB2' ' HB3' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -126.89 170.22 12.46 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.199 -1.177 . . . . 0.0 110.095 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.406 ' HA ' HD12 ' A' ' 144' ' ' LEU . . . -94.5 153.26 18.0 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.437 -0.789 . . . . 0.0 110.816 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 143' ' ' LEU . 35.6 m -119.19 -26.02 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.627 -0.671 . . . . 0.0 110.907 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -172.59 -162.07 24.11 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.412 HD11 ' HA2' ' A' ' 140' ' ' GLY . 11.5 tt -140.11 152.87 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.668 -0.901 . . . . 0.0 109.992 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -64.73 144.35 57.3 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.251 -0.906 . . . . 0.0 111.345 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 9.6 ttt180 -129.81 -70.73 0.63 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.272 0.558 . . . . 0.0 109.851 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -128.82 147.9 50.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.288 -0.882 . . . . 0.0 111.047 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.38 158.46 15.72 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.682 HG21 ' NH2' ' A' ' 123' ' ' ARG . 2.5 t -123.29 112.38 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.175 -0.953 . . . . 0.0 111.058 -178.107 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.416 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.1 p -138.18 144.03 40.52 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.785 179.188 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 24.2 m -82.81 -43.98 16.04 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.525 -0.734 . . . . 0.0 109.847 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.52 34.99 4.27 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.638 -0.664 . . . . 0.0 109.974 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 99.55 -11.88 61.36 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 63.3 t -92.81 123.47 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.19 -1.183 . . . . 0.0 109.136 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.12 114.22 23.54 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.559 -0.713 . . . . 0.0 111.071 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -104.15 -25.09 13.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.738 -0.601 . . . . 0.0 110.028 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -131.88 168.38 17.96 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.484 -0.76 . . . . 0.0 109.833 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.73 HG11 HD13 ' A' ' 126' ' ' LEU . 36.0 m -141.61 137.36 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.406 -0.809 . . . . 0.0 110.844 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -112.82 140.35 47.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.55 -0.719 . . . . 0.0 110.27 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.4 ' CG ' HD22 ' A' ' 143' ' ' LEU . 50.7 p90 -140.6 159.97 41.05 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.625 -0.672 . . . . 0.0 110.556 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 59.0 t -93.93 135.89 24.35 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.606 -0.684 . . . . 0.0 109.868 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.54 158.45 43.91 Favored 'Trans proline' 0 C--N 1.318 -1.053 0 O-C-N 123.225 1.119 . . . . 0.0 110.515 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.547 HG13 ' CE ' ' A' ' 175' ' ' MET . 79.1 t -77.33 -28.73 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.636 -0.665 . . . . 0.0 110.015 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -59.86 -37.48 79.44 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.435 -0.791 . . . . 0.0 110.429 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 39.0 m -61.65 -35.49 78.07 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.652 -0.655 . . . . 0.0 110.397 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.547 ' CE ' HG13 ' A' ' 172' ' ' VAL . 48.7 mtm -59.99 -30.03 68.85 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.6 -0.688 . . . . 0.0 110.424 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.03 -43.55 95.25 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.502 -0.749 . . . . 0.0 110.302 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 85.1 m -63.55 -40.14 96.21 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.577 -0.702 . . . . 0.0 109.969 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 89.1 m -65.4 -37.21 86.29 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.657 -0.652 . . . . 0.0 110.023 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 19.4 ttt -60.05 -37.96 81.38 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.666 -0.646 . . . . 0.0 110.251 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 39.4 mtp-105 -60.03 -39.74 86.93 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.532 -0.73 . . . . 0.0 110.21 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.749 0 O-C-N 121.509 -0.744 . . . . 0.0 110.18 -179.955 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 201' ' ' 4P2 . . . . . 0.753 ' C24' HG13 ' A' ' 78' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ' ZN' . . . . . 0.707 'ZN ' ' SG ' ' A' ' 145' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.7 mp0 . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 120.526 0.203 . . . . 0.0 111.298 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 63.3 t -109.97 126.36 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.072 -1.018 . . . . 0.0 109.922 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -115.29 159.47 20.98 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.638 -0.663 . . . . 0.0 110.074 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.485 ' HA ' HD22 ' A' ' 44' ' ' LEU . 62.7 t -116.63 129.94 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.521 -0.737 . . . . 0.0 110.034 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.5 p -136.99 139.57 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.543 -0.723 . . . . 0.0 110.003 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 72.7 m -125.12 141.2 52.25 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.5 -0.75 . . . . 0.0 110.381 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.527 HG22 ' H ' ' A' ' 39' ' ' ALA . 0.8 OUTLIER -105.68 -177.36 3.34 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.565 -0.709 . . . . 0.0 109.988 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.527 ' H ' HG22 ' A' ' 38' ' ' THR . . . -69.49 -40.01 77.29 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.594 -0.691 . . . . 0.0 111.238 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 67.2 p -114.42 -19.43 11.21 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.341 -0.849 . . . . 0.0 111.569 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -133.58 160.05 38.63 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.205 -0.935 . . . . 0.0 110.725 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.0 t -138.75 119.87 14.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.592 -0.693 . . . . 0.0 110.12 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -135.19 177.11 8.07 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.617 -0.677 . . . . 0.0 109.843 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.486 HD11 ' HA ' ' A' ' 109' ' ' ARG . 65.6 mt -118.68 160.34 22.01 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.486 -0.759 . . . . 0.0 110.36 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -124.99 153.32 42.97 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.544 -0.722 . . . . 0.0 110.043 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.438 HG21 ' HB3' ' A' ' 142' ' ' PRO . 58.8 m -125.87 140.09 52.94 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.522 -0.736 . . . . 0.0 110.402 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.9 t -88.84 108.76 19.7 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.504 -0.747 . . . . 0.0 110.094 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.6 t -123.0 129.99 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.648 -0.657 . . . . 0.0 109.921 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 54.47 38.71 30.18 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.568 -0.707 . . . . 0.0 110.899 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.522 ' O ' ' HB3' ' A' ' 87' ' ' ALA . . . 67.87 17.49 69.5 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 65.6 t -130.22 129.94 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.227 -1.161 . . . . 0.0 109.734 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 69.2 m -79.24 130.15 35.18 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.498 -0.751 . . . . 0.0 109.898 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.496 ' CD2' ' HE3' ' A' ' 175' ' ' MET . 97.0 m95 -120.01 137.16 54.25 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.473 -0.767 . . . . 0.0 110.729 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.686 HG23 HG13 ' A' ' 83' ' ' VAL . 9.7 t -137.35 172.39 13.05 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.841 HG11 ' CE1' ' A' ' 57' ' ' HIS . 59.4 t -80.81 142.3 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.367 -0.833 . . . . 0.0 109.691 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.863 ' CE2' HG22 ' A' ' 78' ' ' VAL . 33.0 t80 -79.28 -39.89 31.85 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.448 -0.783 . . . . 0.0 111.636 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.841 ' CE1' HG11 ' A' ' 55' ' ' VAL . 1.4 p-80 -59.72 -23.27 63.03 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.968 -1.083 . . . . 0.0 110.396 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -74.15 -70.64 1.22 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.831 -1.708 . . . . 0.0 108.831 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.52 -52.9 62.57 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.543 -0.975 . . . . 0.0 109.743 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.432 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.403 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 35.9 m . . . . . 0 N--CA 1.493 1.714 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -60.24 125.1 22.39 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.509 -0.744 . . . . 0.0 110.509 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 91.0 mmm -92.12 -32.55 15.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.716 -0.615 . . . . 0.0 109.91 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.74 ' O ' HG23 ' A' ' 83' ' ' VAL . 45.5 m-85 -118.95 129.73 55.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.589 -0.694 . . . . 0.0 109.864 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.6 p -141.02 144.95 35.3 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.525 -0.734 . . . . 0.0 110.307 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -168.17 100.93 0.44 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.71 -0.619 . . . . 0.0 109.999 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.863 HG22 ' CE2' ' A' ' 56' ' ' TYR . 53.3 t -70.06 -42.84 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.427 -0.796 . . . . 0.0 109.88 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -60.06 -44.2 94.87 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.507 -0.746 . . . . 0.0 110.162 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -90.04 -8.56 51.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.811 -0.556 . . . . 0.0 110.563 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.4 t0 54.16 39.72 30.98 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.998 -1.064 . . . . 0.0 109.684 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.508 HD21 ' HG2' ' A' ' 175' ' ' MET . 14.5 tp -119.93 129.98 54.58 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.329 0.585 . . . . 0.0 110.472 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 75' ' ' TYR . 14.6 p -153.13 150.29 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.684 -0.635 . . . . 0.0 109.414 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -176.06 -174.31 42.48 Favored Glycine 0 N--CA 1.496 2.65 0 C-N-CA 119.622 -1.275 . . . . 0.0 110.571 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 14.1 m-90 -128.81 160.03 33.86 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.78 -0.836 . . . . 0.0 109.766 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -93.0 131.14 38.26 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.539 -0.726 . . . . 0.0 110.097 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 50' ' ' GLY . . . -111.94 159.6 32.96 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.461 -0.774 . . . . 0.0 110.462 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.2 159.16 50.45 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 O-C-N 123.428 1.225 . . . . 0.0 110.608 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.17 160.2 39.85 Favored 'Trans proline' 0 C--N 1.317 -1.101 0 O-C-N 123.506 1.266 . . . . 0.0 110.412 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 115.35 -4.49 21.74 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -109.93 142.4 41.34 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.092 -1.24 . . . . 0.0 110.172 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -60.34 140.06 57.32 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.507 -0.745 . . . . 0.0 110.124 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 52.6 m -133.1 156.87 46.63 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.593 -0.692 . . . . 0.0 110.402 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.9 mt -91.36 162.84 14.43 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.67 -0.644 . . . . 0.0 110.234 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.2 p -120.89 165.07 19.89 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.63 -0.669 . . . . 0.0 110.075 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.34 164.81 32.69 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 O-C-N 123.369 1.194 . . . . 0.0 110.207 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 7.2 t -75.2 128.1 34.7 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.564 -0.71 . . . . 0.0 110.405 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 46.7 p -129.58 45.48 2.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.743 -0.598 . . . . 0.0 109.682 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.3 p -145.07 12.22 1.39 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.642 -0.661 . . . . 0.0 111.474 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.23 50.97 49.89 Favored Glycine 0 N--CA 1.499 2.866 0 O-C-N 121.062 -1.024 . . . . 0.0 110.546 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.1 m -92.7 107.09 18.95 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.42 -1.047 . . . . 0.0 110.4 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.1 p -70.11 -39.95 75.19 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.487 -0.758 . . . . 0.0 109.931 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -75.11 123.09 24.59 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.653 -0.654 . . . . 0.0 109.857 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.563 HD13 HG11 ' A' ' 151' ' ' VAL . 73.9 mt -129.99 150.61 51.19 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.607 -0.683 . . . . 0.0 110.2 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -106.84 133.5 51.4 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.49 -0.757 . . . . 0.0 109.874 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.1 tt -98.85 130.3 45.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.536 -0.728 . . . . 0.0 110.467 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.1 t -87.79 123.41 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.691 -0.63 . . . . 0.0 109.707 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.2 m -100.77 166.82 10.67 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.56 -0.713 . . . . 0.0 110.386 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.486 ' HA ' HD11 ' A' ' 44' ' ' LEU . 78.3 ttt-85 -61.89 -27.33 68.73 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.59 -0.694 . . . . 0.0 110.332 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -93.41 25.48 3.4 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.527 -0.733 . . . . 0.0 110.781 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.98 40.03 31.85 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.284 -0.885 . . . . 0.0 110.843 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -93.27 156.24 16.94 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.644 -0.66 . . . . 0.0 109.78 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.9 p -129.93 133.44 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.47 -0.769 . . . . 0.0 110.404 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.4 tp -146.13 134.89 11.04 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.702 -0.624 . . . . 0.0 109.892 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.424 ' HG2' HD22 ' A' ' 127' ' ' LEU . 48.5 Cg_endo -76.15 139.2 21.16 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 O-C-N 123.155 1.082 . . . . 0.0 110.291 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.3 t -129.92 130.1 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.646 -0.659 . . . . 0.0 109.713 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.62 146.44 34.13 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.567 -0.708 . . . . 0.0 109.853 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -85.71 118.33 25.14 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.567 -0.708 . . . . 0.0 110.202 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.03 21.22 11.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.759 -0.588 . . . . 0.0 110.34 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 162.64 168.15 24.13 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -70.03 -40.02 75.43 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.566 -0.961 . . . . 0.0 110.693 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 89.8 p -114.68 -7.15 12.73 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.496 -0.753 . . . . 0.0 111.474 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -128.55 143.97 51.06 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.09 -1.006 . . . . 0.0 110.484 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -141.49 -174.64 14.5 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 80.1 p -120.53 144.17 48.2 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.558 -0.966 . . . . 0.0 110.165 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 57.8 tp -91.17 131.3 36.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.636 -0.665 . . . . 0.0 109.899 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.424 HD22 ' HG2' ' A' ' 115' ' ' PRO . 1.7 tp -60.09 -48.66 80.81 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.585 -0.697 . . . . 0.0 110.511 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 45.7 t -106.5 119.54 51.4 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.504 -0.747 . . . . 0.0 110.18 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.87 121.39 7.58 Favored 'Trans proline' 0 N--CA 1.486 1.034 0 O-C-N 123.191 1.101 . . . . 0.0 110.581 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 12.7 mtp85 -132.83 162.81 55.19 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.52 -0.737 . . . . 0.0 110.323 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.6 150.9 63.82 Favored 'Trans proline' 0 N--CA 1.486 1.076 0 O-C-N 123.482 1.254 . . . . 0.0 110.87 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.424 HG21 ' SG ' ' A' ' 159' ' ' CYS . 76.9 t -56.64 -35.29 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.484 -0.76 . . . . 0.0 110.252 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 34.8 t -58.44 -39.97 81.27 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.47 -0.768 . . . . 0.0 110.745 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -63.28 -39.94 95.98 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.489 -0.757 . . . . 0.0 109.592 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 21.3 tp -94.57 16.2 16.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.781 -0.574 . . . . 0.0 110.593 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 44.7 tttt -89.77 141.06 28.98 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.026 -1.046 . . . . 0.0 110.761 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 87.78 20.51 50.39 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 10.5 p -119.58 15.21 12.81 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.37 -1.077 . . . . 0.0 110.933 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.521 ' HB3' HG21 ' A' ' 55' ' ' VAL . 48.9 m -58.75 144.7 42.94 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.183 -0.948 . . . . 0.0 110.043 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 94.72 -16.67 60.72 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -58.5 111.1 2.94 Favored Glycine 0 N--CA 1.498 2.796 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.438 ' HB3' HG21 ' A' ' 46' ' ' THR . 50.1 Cg_endo -73.11 139.63 29.91 Favored 'Trans proline' 0 C--N 1.317 -1.082 0 O-C-N 123.197 1.104 . . . . 0.0 111.099 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.416 ' O ' HG12 ' A' ' 151' ' ' VAL . 4.4 mp -93.37 123.71 36.85 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.3 mp -118.38 127.27 53.53 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.184 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 27.2 p -66.61 163.97 36.9 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.7 -0.625 . . . . 0.0 109.384 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.54 -19.86 68.48 Favored 'Trans proline' 0 C--N 1.315 -1.204 0 O-C-N 123.231 1.121 . . . . 0.0 110.952 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.4 m -69.97 -27.33 64.64 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.295 -0.878 . . . . 0.0 110.031 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 121.64 -21.46 8.01 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.466 -1.053 . . . . 0.0 110.466 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -77.56 162.96 26.7 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.253 -1.145 . . . . 0.0 110.632 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -105.09 145.03 31.08 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.65 -0.656 . . . . 0.0 110.353 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.563 HG11 HD13 ' A' ' 104' ' ' LEU . 12.5 p -101.51 -29.18 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.552 -0.718 . . . . 0.0 110.809 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 169.26 -161.55 35.12 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 55.9 mt -128.87 155.86 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.566 -0.961 . . . . 0.0 110.255 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -66.61 139.94 57.91 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.621 -0.674 . . . . 0.0 110.076 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -122.59 -67.48 0.95 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.564 -0.71 . . . . 0.0 110.803 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -135.27 150.3 50.01 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.453 -0.779 . . . . 0.0 110.78 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.41 151.74 19.15 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 48.6 t -120.01 119.97 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.507 -0.745 . . . . 0.0 110.432 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.424 ' SG ' HG21 ' A' ' 132' ' ' VAL . 27.4 p -141.6 157.81 44.63 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.543 -0.723 . . . . 0.0 110.415 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 18.4 p -94.58 -46.07 7.12 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.442 -0.786 . . . . 0.0 109.97 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 55.1 mmm-85 -130.37 35.96 4.01 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.644 -0.66 . . . . 0.0 109.552 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.402 ' O ' HG23 ' A' ' 132' ' ' VAL . . . 101.2 -10.11 58.09 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 57.3 t -96.55 123.47 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.184 -1.186 . . . . 0.0 109.473 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.66 117.3 26.38 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.496 -0.753 . . . . 0.0 110.776 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -109.46 -29.96 8.18 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.654 -0.654 . . . . 0.0 109.674 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -126.5 157.22 39.26 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.633 -0.667 . . . . 0.0 109.618 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 31.0 m -129.42 142.89 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.485 -0.759 . . . . 0.0 110.675 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -117.23 132.51 56.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.653 -0.654 . . . . 0.0 110.421 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -141.31 159.57 41.93 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.595 -0.69 . . . . 0.0 110.135 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 12.9 p -93.15 142.85 25.85 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.505 -0.747 . . . . 0.0 110.446 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -77.34 162.43 31.02 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 O-C-N 123.288 1.151 . . . . 0.0 110.559 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 67.1 t -69.91 -32.38 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.627 -0.671 . . . . 0.0 109.881 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -60.03 -40.01 87.87 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.493 -0.755 . . . . 0.0 110.355 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 48.0 t -62.54 -39.95 95.26 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.633 -0.667 . . . . 0.0 109.924 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.508 ' HG2' HD21 ' A' ' 82' ' ' LEU . 95.0 mtp -60.25 -40.0 88.77 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.674 -0.641 . . . . 0.0 110.177 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.7 -40.02 90.65 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.706 -0.621 . . . . 0.0 110.322 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 94.0 m -60.11 -40.11 88.55 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.645 -0.659 . . . . 0.0 110.156 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 88.2 m -68.17 -44.21 76.47 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.583 -0.698 . . . . 0.0 110.047 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 33.9 ttp -60.63 -40.99 93.97 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.556 -0.715 . . . . 0.0 110.387 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -61.15 -40.02 92.28 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.609 -0.682 . . . . 0.0 110.178 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.767 0 O-C-N 121.608 -0.682 . . . . 0.0 110.268 179.982 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.725 ' OE2' HD21 ' A' ' 144' ' ' LEU . 52.2 tt0 . . . . . 0 N--CA 1.509 2.495 0 CA-C-O 120.966 0.413 . . . . 0.0 110.746 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.489 HG21 ' HD2' ' A' ' 142' ' ' PRO . 60.9 t -103.1 133.33 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.385 -0.822 . . . . 0.0 109.892 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -102.86 162.31 13.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.625 -0.672 . . . . 0.0 109.85 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.511 ' HA ' HD22 ' A' ' 44' ' ' LEU . 34.8 m -117.98 136.59 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.506 -0.746 . . . . 0.0 110.196 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.8 m -144.21 149.27 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.493 -0.755 . . . . 0.0 110.35 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.8 m -119.68 137.8 53.68 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.602 -0.687 . . . . 0.0 110.179 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.518 HG22 ' H ' ' A' ' 39' ' ' ALA . 1.0 OUTLIER -99.57 -178.43 3.89 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.577 -0.702 . . . . 0.0 110.001 179.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.518 ' H ' HG22 ' A' ' 38' ' ' THR . . . -60.0 -45.99 90.93 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.841 -179.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.4 p -118.67 -27.99 5.74 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.403 -0.811 . . . . 0.0 110.995 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -114.27 173.95 6.19 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.324 -0.86 . . . . 0.0 110.526 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 40.3 t -151.87 121.33 6.85 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.55 -0.719 . . . . 0.0 109.975 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 34.7 p90 -132.65 -179.51 5.5 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.625 -0.672 . . . . 0.0 110.064 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.535 HD11 ' HA ' ' A' ' 109' ' ' ARG . 34.7 mt -118.76 178.62 4.41 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.518 -0.739 . . . . 0.0 109.605 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.573 ' CB ' HG22 ' A' ' 54' ' ' THR . . . -143.0 161.37 38.3 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.474 -0.767 . . . . 0.0 110.98 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.8 p -125.34 144.09 50.66 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.721 -0.612 . . . . 0.0 109.689 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.419 ' HB2' ' HA ' ' A' ' 92' ' ' ARG . 27.0 p -91.9 111.79 23.46 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 121.72 0.772 . . . . 0.0 111.403 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.9 t -130.73 123.44 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.213 -0.929 . . . . 0.0 110.683 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 51.4 34.88 12.79 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.53 -0.731 . . . . 0.0 112.412 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.416 ' HA2' ' HB3' ' A' ' 92' ' ' ARG . . . 86.43 -17.04 41.19 Favored Glycine 0 N--CA 1.499 2.872 0 C-N-CA 120.1 -1.047 . . . . 0.0 111.659 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 62.8 t -105.82 128.63 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.091 -1.241 . . . . 0.0 110.477 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.739 ' SG ' ' HB2' ' A' ' 87' ' ' ALA . 78.5 m -84.32 107.78 16.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.634 -0.666 . . . . 0.0 109.532 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.531 ' CE3' HD22 ' A' ' 82' ' ' LEU . 91.1 m95 -91.85 137.48 32.33 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.509 -0.744 . . . . 0.0 110.59 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.573 HG22 ' CB ' ' A' ' 45' ' ' ALA . 77.8 p -136.51 179.74 6.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.773 -0.58 . . . . 0.0 109.611 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.754 HG21 ' HB3' ' A' ' 139' ' ' SER . 94.5 t -80.93 141.93 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.105 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.907 ' CE2' HG22 ' A' ' 78' ' ' VAL . 16.7 t80 -84.98 -43.44 13.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.445 -0.784 . . . . 0.0 111.248 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.688 ' CE1' HG11 ' A' ' 55' ' ' VAL . 2.2 p-80 -58.76 -25.02 62.63 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.24 -0.912 . . . . 0.0 110.941 -177.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -81.47 -48.67 5.82 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.52 -63.09 1.47 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.6 -0.941 . . . . 0.0 110.167 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.45 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 179.84 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.3 t . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 121.162 0.506 . . . . 0.0 110.433 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.5 tm0? -80.08 128.27 33.29 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.611 -0.681 . . . . 0.0 110.163 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.1 tpp -106.36 -51.13 3.01 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.604 -0.685 . . . . 0.0 110.129 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.685 ' O ' HG13 ' A' ' 83' ' ' VAL . 35.5 m-85 -120.73 138.63 53.89 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.48 -0.763 . . . . 0.0 110.184 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.452 HG23 ' HE1' ' A' ' 56' ' ' TYR . 98.8 m -152.23 127.86 10.11 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.602 -0.686 . . . . 0.0 110.175 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -168.45 120.23 0.81 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.416 -0.802 . . . . 0.0 110.833 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.907 HG22 ' CE2' ' A' ' 56' ' ' TYR . 91.8 t -72.25 -39.54 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.35 -0.844 . . . . 0.0 109.735 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.66 -43.01 75.87 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.363 -0.836 . . . . 0.0 109.803 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -92.02 -14.24 29.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.793 -0.567 . . . . 0.0 109.885 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.482 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 49.5 t0 54.27 35.38 22.61 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.064 -1.022 . . . . 0.0 110.099 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.531 HD22 ' CE3' ' A' ' 53' ' ' TRP . 2.5 mt -123.2 149.73 44.29 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.836 0.827 . . . . 0.0 111.934 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.685 HG13 ' O ' ' A' ' 75' ' ' TYR . 2.7 t -146.64 150.95 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 178.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -138.35 148.19 19.74 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 118.992 -1.575 . . . . 0.0 111.636 -178.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -138.25 124.6 20.54 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.18 135.33 57.69 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.34 -0.85 . . . . 0.0 110.721 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.836 ' HB3' ' HG3' ' A' ' 92' ' ' ARG . . . -101.41 175.44 2.33 Favored Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 121.417 -0.802 . . . . 0.0 109.849 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.756 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 43.8 Cg_endo -70.45 147.96 59.55 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 O-C-N 123.465 1.245 . . . . 0.0 109.548 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.72 134.46 24.01 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 O-C-N 123.369 1.194 . . . . 0.0 110.245 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 131.59 -25.98 3.93 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -150.81 71.64 1.04 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.102 -1.234 . . . . 0.0 111.761 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.836 ' HG3' ' HB3' ' A' ' 87' ' ' ALA . 12.2 mmt180 -154.25 91.78 1.46 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.061 -1.024 . . . . 0.0 110.498 178.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.4 p -177.04 104.98 0.06 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.211 -0.93 . . . . 0.0 111.166 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.701 HD21 ' HB2' ' A' ' 150' ' ' ALA . 25.6 tp -117.34 131.91 56.7 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.583 -0.698 . . . . 0.0 109.406 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.3 t -76.45 137.28 67.66 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.363 -0.836 . . . . 0.0 110.74 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.04 166.21 28.35 Favored 'Trans proline' 0 N--CA 1.484 0.924 0 O-C-N 123.252 1.132 . . . . 0.0 110.204 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 47.4 t -82.41 132.85 35.21 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.505 -0.747 . . . . 0.0 110.24 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.0 t -135.98 48.87 2.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.655 -0.653 . . . . 0.0 109.797 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.4 p -144.92 0.17 0.94 Allowed 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 120.114 -0.634 . . . . 0.0 112.384 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 52.26 89.27 0.01 OUTLIER Glycine 0 N--CA 1.5 2.924 0 O-C-N 120.811 -1.181 . . . . 0.0 110.553 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.0 m -129.67 128.85 43.42 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.418 -1.048 . . . . 0.0 110.251 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.2 m -69.01 -40.02 78.94 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.577 -0.702 . . . . 0.0 110.122 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.69 142.13 58.24 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.557 -0.714 . . . . 0.0 109.965 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.534 ' CD2' HG21 ' A' ' 151' ' ' VAL . 57.2 mt -143.61 158.27 43.79 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.575 -0.703 . . . . 0.0 110.314 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -126.35 109.86 12.72 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.518 -0.739 . . . . 0.0 109.91 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.554 ' C ' HD23 ' A' ' 106' ' ' LEU . 8.4 tt -93.42 133.58 36.55 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.528 -0.733 . . . . 0.0 110.462 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.496 ' N ' HD23 ' A' ' 106' ' ' LEU . 61.1 t -98.28 130.03 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.668 -0.645 . . . . 0.0 109.762 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 68.1 p -99.04 169.91 9.08 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.527 -0.733 . . . . 0.0 110.456 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.535 ' HA ' HD11 ' A' ' 44' ' ' LEU . 8.5 ptm180 -63.34 -18.96 64.2 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.691 -0.631 . . . . 0.0 110.877 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -94.16 25.95 3.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.31 -0.869 . . . . 0.0 110.661 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 53.42 39.93 30.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.346 -0.846 . . . . 0.0 110.887 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -104.68 167.06 9.97 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.531 -0.731 . . . . 0.0 110.078 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.403 ' O ' HG13 ' A' ' 113' ' ' VAL . 8.5 p -133.65 131.53 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.589 -0.694 . . . . 0.0 110.435 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.681 HG21 HD11 ' A' ' 126' ' ' LEU . 87.0 mt -133.08 127.99 20.34 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.587 -0.696 . . . . 0.0 109.872 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -74.94 125.05 9.1 Favored 'Trans proline' 0 N--CA 1.485 0.982 0 O-C-N 123.096 1.051 . . . . 0.0 110.392 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.666 HG13 ' O ' ' A' ' 125' ' ' SER . 58.9 t -120.25 129.53 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.567 -0.708 . . . . 0.0 109.771 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -87.53 136.8 32.8 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.506 -0.746 . . . . 0.0 110.197 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -74.39 140.11 44.52 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.657 -0.652 . . . . 0.0 110.293 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.35 9.5 3.45 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.589 -0.694 . . . . 0.0 111.0 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -169.34 -172.44 36.01 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -70.28 -39.97 74.6 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.615 -0.932 . . . . 0.0 110.68 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 96.1 p -130.77 9.81 5.02 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.462 -0.774 . . . . 0.0 111.393 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -123.66 148.72 46.23 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.1 -1.0 . . . . 0.0 110.17 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.15 167.82 24.8 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.666 ' O ' HG13 ' A' ' 116' ' ' VAL . 19.2 p -107.76 158.9 16.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.52 -0.988 . . . . 0.0 110.21 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.681 HD11 HG21 ' A' ' 114' ' ' ILE . 40.1 tp -117.59 133.21 56.2 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.577 -0.702 . . . . 0.0 110.272 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.454 HD12 ' N ' ' A' ' 127' ' ' LEU . 6.3 mp -69.28 -43.15 74.44 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.588 -0.695 . . . . 0.0 110.401 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 58.4 p -97.42 111.97 59.84 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.474 -0.766 . . . . 0.0 110.168 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -80.91 106.87 1.85 Allowed 'Trans proline' 0 C--N 1.319 -1.006 0 O-C-N 123.197 1.104 . . . . 0.0 110.607 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.72 157.89 38.12 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.554 -0.716 . . . . 0.0 109.851 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.12 150.25 65.75 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.421 1.221 . . . . 0.0 110.867 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.415 HG21 ' SG ' ' A' ' 159' ' ' CYS . 55.3 t -54.13 -30.47 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.422 -0.799 . . . . 0.0 109.723 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 46.0 t -59.91 -41.94 92.79 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.559 -0.713 . . . . 0.0 110.869 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -67.97 -39.97 83.26 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.482 -0.761 . . . . 0.0 109.719 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 135' ' ' LEU . 33.0 tp -92.18 15.49 13.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.803 -0.56 . . . . 0.0 110.286 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -79.65 114.65 18.74 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 122.537 1.161 . . . . 0.0 112.128 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.93 37.18 3.72 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 61.3 m -119.26 19.13 12.89 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.705 -0.88 . . . . 0.0 110.454 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.754 ' HB3' HG21 ' A' ' 55' ' ' VAL . 66.3 m -70.54 136.28 49.2 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.25 -0.906 . . . . 0.0 109.169 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 109.77 -25.35 17.2 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.181 -1.567 . . . . 0.0 109.181 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.0 112.63 3.69 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.489 ' HD2' HG21 ' A' ' 33' ' ' VAL . 47.6 Cg_endo -73.24 148.8 44.5 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 123.25 1.131 . . . . 0.0 111.105 -179.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.497 HD21 HD12 ' A' ' 106' ' ' LEU . 67.7 mt -98.22 116.3 30.15 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.725 HD21 ' OE2' ' A' ' 32' ' ' GLU . 5.6 mp -103.37 127.71 50.66 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.509 -0.744 . . . . 0.0 111.015 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.407 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 27.8 p -67.92 164.85 37.09 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.755 -0.59 . . . . 0.0 109.505 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 39.4 Cg_endo -65.09 -14.22 44.05 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 O-C-N 123.148 1.078 . . . . 0.0 111.104 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.9 t -69.61 -40.02 76.88 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.147 -0.97 . . . . 0.0 109.768 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 122.17 37.82 0.63 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 28.2 m170 -133.6 -173.28 3.18 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.388 -1.066 . . . . 0.0 110.276 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.701 ' HB2' HD21 ' A' ' 94' ' ' LEU . . . -104.55 145.39 30.37 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.552 -0.718 . . . . 0.0 110.158 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.534 HG21 ' CD2' ' A' ' 104' ' ' LEU . 50.7 t -115.75 -62.42 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.518 -0.739 . . . . 0.0 110.454 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -157.08 -158.59 8.99 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.2 mt -133.48 146.68 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.565 -0.962 . . . . 0.0 110.003 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -61.97 140.01 58.36 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.369 -0.832 . . . . 0.0 110.479 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.428 ' NE ' ' HB3' ' A' ' 81' ' ' ASP . 0.6 OUTLIER -117.23 -76.13 0.57 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.57 0.7 . . . . 0.0 110.496 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -125.3 147.18 49.22 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 121.377 -0.827 . . . . 0.0 111.234 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.06 124.83 37.31 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.3 t -95.75 119.03 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.585 -0.697 . . . . 0.0 111.026 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.415 ' SG ' HG21 ' A' ' 132' ' ' VAL . 27.4 p -139.89 146.09 38.84 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.593 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 59.6 m -78.87 -49.92 12.09 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.6 -0.687 . . . . 0.0 109.855 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 5.9 ptt180 -129.11 36.17 4.21 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.614 -0.679 . . . . 0.0 109.915 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 102.7 -11.93 56.39 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 62.9 t -92.33 121.2 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.249 -1.148 . . . . 0.0 109.009 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.17 116.92 25.58 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.5 -0.75 . . . . 0.0 111.218 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -110.98 -29.93 7.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.833 -0.542 . . . . 0.0 109.729 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.403 ' C ' HG13 ' A' ' 167' ' ' VAL . . . -120.05 168.27 11.35 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.638 -0.664 . . . . 0.0 109.958 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.413 HG21 HG11 ' A' ' 116' ' ' VAL . 35.1 m -146.05 137.2 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.581 -0.699 . . . . 0.0 110.64 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -113.05 143.63 43.99 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.598 -0.689 . . . . 0.0 110.404 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -149.49 162.2 40.61 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.631 -0.668 . . . . 0.0 110.879 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.406 HG21 ' NH2' ' A' ' 155' ' ' ARG . 5.6 m -101.62 143.73 27.19 Favored Pre-proline 0 N--CA 1.505 2.317 0 O-C-N 121.448 -0.783 . . . . 0.0 110.135 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -79.69 168.18 19.8 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 O-C-N 123.339 1.179 . . . . 0.0 110.171 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 151' ' ' VAL . 64.9 t -66.29 -24.0 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.521 -0.737 . . . . 0.0 110.118 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -54.32 -38.89 66.5 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.429 -0.795 . . . . 0.0 111.449 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 82.2 p -61.66 -24.55 66.81 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.671 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 65.5 mtt -70.11 -28.72 65.62 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.431 -0.793 . . . . 0.0 110.898 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -59.28 -50.85 72.41 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.409 -0.807 . . . . 0.0 110.596 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 22.1 m -72.03 -29.03 63.76 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.49 -0.756 . . . . 0.0 110.334 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 32.5 m -68.0 -32.29 72.58 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.561 -0.712 . . . . 0.0 110.507 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 34.5 mmm -59.45 -52.04 67.31 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.484 -0.76 . . . . 0.0 110.485 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 56.4 mtp85 -63.87 -40.02 95.57 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.528 -0.732 . . . . 0.0 110.115 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.804 0 O-C-N 121.564 -0.71 . . . . 0.0 110.261 -179.891 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.531 ' CG ' HD13 ' A' ' 94' ' ' LEU . 1.3 tp10 . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 121.142 0.496 . . . . 0.0 110.286 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.878 HG22 HG22 ' A' ' 46' ' ' THR . 92.4 t -109.83 143.96 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.569 -0.707 . . . . 0.0 109.808 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -116.63 148.25 41.15 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.63 -0.669 . . . . 0.0 110.308 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.493 ' HA ' HD22 ' A' ' 44' ' ' LEU . 59.8 t -78.43 124.62 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.701 -0.624 . . . . 0.0 109.699 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.6 m -134.12 138.65 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.428 -0.795 . . . . 0.0 110.545 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 74.7 m -119.38 154.56 33.44 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.593 -0.692 . . . . 0.0 110.294 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.526 HG22 ' H ' ' A' ' 39' ' ' ALA . 1.5 m -110.99 179.6 4.0 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.63 -0.669 . . . . 0.0 110.121 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.526 ' H ' HG22 ' A' ' 38' ' ' THR . . . -62.43 -40.03 95.25 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.807 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.408 HG23 ' HG3' ' A' ' 41' ' ' GLN . 7.7 t -119.78 -28.3 5.26 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.401 -0.812 . . . . 0.0 111.204 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.408 ' HG3' HG23 ' A' ' 40' ' ' THR . 50.0 mt-30 -118.2 178.08 4.56 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.405 -0.81 . . . . 0.0 110.213 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 83.0 p -153.71 117.03 4.59 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.541 -0.724 . . . . 0.0 110.565 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 6.7 p90 -130.4 -176.91 4.11 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.635 -0.665 . . . . 0.0 110.007 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.493 HD22 ' HA ' ' A' ' 35' ' ' VAL . 57.9 mt -117.3 162.93 17.11 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.433 -0.792 . . . . 0.0 110.545 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.863 ' O ' HG13 ' A' ' 33' ' ' VAL . . . -129.53 150.23 50.95 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.668 -0.645 . . . . 0.0 110.504 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.878 HG22 HG22 ' A' ' 33' ' ' VAL . 78.9 p -125.69 144.17 50.72 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.602 -0.687 . . . . 0.0 110.077 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 25.9 p -100.51 106.71 18.27 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.741 0.781 . . . . 0.0 110.575 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.504 ' O ' HG12 ' A' ' 51' ' ' VAL . 60.8 t -130.64 139.58 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.285 -0.884 . . . . 0.0 110.341 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.419 ' OD1' HG12 ' A' ' 48' ' ' VAL . 10.8 m120 55.02 40.48 32.02 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.57 -0.706 . . . . 0.0 111.529 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 87' ' ' ALA . . . 63.78 14.46 55.33 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 48' ' ' VAL . 7.2 p -138.43 138.55 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.148 -1.207 . . . . 0.0 109.354 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.582 ' SG ' ' HB1' ' A' ' 45' ' ' ALA . 43.6 t -87.67 126.28 34.87 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.56 -0.713 . . . . 0.0 110.464 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.661 ' CE3' HD23 ' A' ' 82' ' ' LEU . 75.1 m95 -111.08 136.78 49.6 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.649 -0.657 . . . . 0.0 110.13 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.56 HG21 ' CH2' ' A' ' 85' ' ' TRP . 6.9 t -137.37 -179.81 5.95 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.658 -0.651 . . . . 0.0 110.005 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.612 HG21 ' HB3' ' A' ' 139' ' ' SER . 63.6 t -84.13 141.47 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.491 -0.756 . . . . 0.0 109.124 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.893 ' CE2' HG22 ' A' ' 78' ' ' VAL . 14.4 t80 -85.73 -43.7 13.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.514 -0.741 . . . . 0.0 111.405 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.546 ' CE1' HG11 ' A' ' 55' ' ' VAL . 2.6 p-80 -60.53 -22.28 63.44 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.219 -0.926 . . . . 0.0 110.821 -178.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -93.57 -32.64 7.56 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.03 -63.43 1.35 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.55 -0.97 . . . . 0.0 110.274 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.472 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.836 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 58.6 m . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -86.04 143.53 28.05 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.49 -0.756 . . . . 0.0 110.783 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.9 tpp -119.13 -48.07 2.45 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.549 -0.719 . . . . 0.0 110.742 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.641 ' O ' HG13 ' A' ' 83' ' ' VAL . 29.2 m-85 -109.62 128.46 55.24 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.355 -0.84 . . . . 0.0 110.32 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 54.7 m -152.19 123.38 7.64 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.527 -0.733 . . . . 0.0 110.147 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -166.09 124.24 1.49 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.405 -0.81 . . . . 0.0 111.32 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.893 HG22 ' CE2' ' A' ' 56' ' ' TYR . 94.3 t -72.59 -30.83 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.528 -0.732 . . . . 0.0 109.797 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -57.83 -40.05 79.12 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.47 -0.768 . . . . 0.0 110.433 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -97.63 -7.75 30.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.57 -0.706 . . . . 0.0 111.009 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.5 ' O ' HD12 ' A' ' 82' ' ' LEU . 37.8 t0 53.35 39.66 30.17 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.958 -1.088 . . . . 0.0 110.569 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.661 HD23 ' CE3' ' A' ' 53' ' ' TRP . 0.4 OUTLIER -140.14 155.54 46.93 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.574 -0.851 . . . . 0.0 111.314 -179.071 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.641 HG13 ' O ' ' A' ' 75' ' ' TYR . 3.1 t -145.55 156.74 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -155.46 172.59 33.63 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 119.292 -1.432 . . . . 0.0 111.064 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.56 ' CH2' HG21 ' A' ' 54' ' ' THR . 10.6 m-90 -147.0 159.65 43.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.89 -0.77 . . . . 0.0 109.602 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -70.83 115.64 10.21 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.517 -0.739 . . . . 0.0 110.31 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 50' ' ' GLY . . . -86.57 157.93 54.87 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.623 -0.673 . . . . 0.0 110.056 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.43 155.91 59.21 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.422 1.222 . . . . 0.0 110.396 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -75.22 155.12 41.91 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.466 1.245 . . . . 0.0 110.341 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 97.26 -25.93 25.0 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.5 154.31 24.92 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.396 -1.061 . . . . 0.0 110.063 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.94 135.15 44.99 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.599 -0.688 . . . . 0.0 110.025 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 58.4 m -105.39 130.02 53.58 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.526 -0.734 . . . . 0.0 110.098 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.833 HD23 ' HB2' ' A' ' 150' ' ' ALA . 6.0 tp -83.81 148.94 26.72 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.552 -0.717 . . . . 0.0 110.435 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.577 HG23 ' ND1' ' A' ' 149' ' ' HIS . 6.5 t -113.22 150.98 43.87 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.606 -0.684 . . . . 0.0 110.196 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.72 154.96 63.63 Favored 'Trans proline' 0 N--CA 1.486 1.071 0 O-C-N 123.319 1.168 . . . . 0.0 110.702 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.408 ' HB3' HG12 ' A' ' 151' ' ' VAL . 7.1 t -87.17 144.64 26.75 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.567 -0.708 . . . . 0.0 110.572 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.4 p -136.52 67.97 1.44 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.61 -0.681 . . . . 0.0 110.441 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 28.0 p -145.15 7.16 1.17 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.385 -0.822 . . . . 0.0 111.97 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 52.02 47.84 53.48 Favored Glycine 0 N--CA 1.499 2.881 0 O-C-N 120.863 -1.148 . . . . 0.0 110.384 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.3 t -100.02 120.49 39.9 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.502 -0.999 . . . . 0.0 110.512 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.8 p -69.94 -39.78 75.89 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.629 -0.669 . . . . 0.0 109.918 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -61.58 134.92 57.39 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.561 -0.712 . . . . 0.0 109.881 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 49.9 mt -142.68 160.15 40.86 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.564 -0.71 . . . . 0.0 110.707 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -120.02 134.04 55.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.674 -0.641 . . . . 0.0 109.347 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.457 HD12 ' HG ' ' A' ' 143' ' ' LEU . 3.6 tt -127.33 112.58 15.21 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.489 -0.757 . . . . 0.0 110.711 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.429 ' O ' HD23 ' A' ' 106' ' ' LEU . 55.9 t -69.14 147.52 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.49 -0.756 . . . . 0.0 108.993 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.8 p -108.29 -168.25 1.34 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.51 -0.744 . . . . 0.0 110.614 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.4 ' NH2' HD12 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -88.73 -22.97 23.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.585 -0.697 . . . . 0.0 110.348 -179.662 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -102.56 29.23 5.4 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.452 -0.78 . . . . 0.0 110.167 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 56.89 55.65 6.01 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.471 -0.768 . . . . 0.0 111.019 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.95 144.06 49.09 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.476 -0.765 . . . . 0.0 109.297 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.5 t -115.28 128.29 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.364 -0.835 . . . . 0.0 110.461 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.545 HD11 ' HB3' ' A' ' 128' ' ' SER . 14.8 tt -137.96 134.91 18.24 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.62 -0.675 . . . . 0.0 109.864 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -74.82 145.52 32.29 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 O-C-N 123.208 1.109 . . . . 0.0 110.569 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.4 t -129.95 129.94 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.576 -0.702 . . . . 0.0 109.684 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -85.26 155.84 21.21 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.587 -0.696 . . . . 0.0 110.171 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 71.6 ttt-85 -99.1 134.55 41.79 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.596 -0.69 . . . . 0.0 110.146 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -118.75 -12.58 9.65 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.598 -0.689 . . . . 0.0 110.936 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -169.05 -160.57 17.48 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -70.04 -37.46 75.58 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.549 -0.971 . . . . 0.0 110.874 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.426 ' HA ' ' CE1' ' A' ' 169' ' ' PHE . 50.0 m -134.27 28.02 3.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.356 -0.84 . . . . 0.0 111.07 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.7 ' CZ ' ' HB1' ' A' ' 166' ' ' ALA . 17.4 tpt85 -141.93 139.87 32.64 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.298 -0.876 . . . . 0.0 110.242 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -147.89 161.71 28.61 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 71.4 p -98.78 163.89 12.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.43 -1.041 . . . . 0.0 110.147 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.512 HD11 HD13 ' A' ' 114' ' ' ILE . 22.9 tp -112.63 127.62 56.15 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.649 -0.657 . . . . 0.0 110.151 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.4 mp -64.19 -39.8 94.74 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.587 -0.696 . . . . 0.0 110.408 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.545 ' HB3' HD11 ' A' ' 114' ' ' ILE . 14.0 t -100.36 106.65 43.71 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.528 -0.732 . . . . 0.0 110.298 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -76.1 113.22 3.66 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 O-C-N 123.275 1.145 . . . . 0.0 110.515 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -119.33 155.19 54.04 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.585 -0.697 . . . . 0.0 109.917 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -70.0 150.42 66.76 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 O-C-N 123.432 1.227 . . . . 0.0 110.013 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 90.8 t -53.39 -34.39 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.252 -0.905 . . . . 0.0 110.002 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 34.5 t -57.87 -49.11 77.83 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.587 -0.695 . . . . 0.0 110.632 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -66.55 -38.37 86.98 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.501 -0.749 . . . . 0.0 109.548 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.429 ' O ' ' HG ' ' A' ' 135' ' ' LEU . 40.7 tp -90.23 16.85 7.86 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.826 -0.547 . . . . 0.0 110.335 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -83.28 121.09 26.66 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.757 -1.214 . . . . 0.0 112.126 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.49 33.26 4.87 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.6 m -106.05 13.02 29.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.653 -0.91 . . . . 0.0 110.525 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.612 ' HB3' HG21 ' A' ' 55' ' ' VAL . 18.1 m -62.36 143.58 56.81 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.272 -0.893 . . . . 0.0 109.849 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 83.0 7.06 87.7 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.409 ' O ' HD12 ' A' ' 143' ' ' LEU . . . -59.82 133.54 51.27 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.584 ' HG3' HG21 ' A' ' 33' ' ' VAL . 56.9 Cg_endo -80.17 117.15 3.46 Favored 'Trans proline' 0 N--CA 1.485 0.999 0 O-C-N 123.24 1.126 . . . . 0.0 110.934 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.688 ' C ' HD12 ' A' ' 144' ' ' LEU . 7.8 mp -98.75 104.04 16.04 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.407 -0.808 . . . . 0.0 109.018 178.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.688 HD12 ' C ' ' A' ' 143' ' ' LEU . 9.8 mp -117.74 147.43 42.97 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.498 -0.751 . . . . 0.0 111.065 -179.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.404 ' CB ' ' HD2' ' A' ' 146' ' ' PRO . 0.1 OUTLIER -75.27 178.68 1.69 Allowed Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.746 -0.596 . . . . 0.0 109.455 179.418 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.404 ' HD2' ' CB ' ' A' ' 145' ' ' CYS . 43.1 Cg_endo -70.01 -24.96 27.92 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.215 1.113 . . . . 0.0 110.416 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 36.4 t -69.9 -40.1 75.81 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.48 -0.762 . . . . 0.0 110.035 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 124.15 45.86 0.27 Allowed Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.577 ' ND1' HG23 ' A' ' 95' ' ' THR . 62.5 m-70 -135.96 134.79 39.01 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.574 -0.956 . . . . 0.0 110.318 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.833 ' HB2' HD23 ' A' ' 94' ' ' LEU . . . -77.86 140.87 39.38 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.495 -0.753 . . . . 0.0 110.353 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.615 ' O ' HG23 ' A' ' 172' ' ' VAL . 34.7 m -117.37 -25.82 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.629 -0.67 . . . . 0.0 110.66 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -174.37 -173.77 40.63 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 64.4 mt -129.33 158.17 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.659 -0.907 . . . . 0.0 109.672 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -69.81 148.01 49.66 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.385 -0.822 . . . . 0.0 110.167 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.41 ' NH1' HG22 ' A' ' 170' ' ' VAL . 0.0 OUTLIER -132.41 -80.35 0.5 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.781 -0.575 . . . . 0.0 110.354 -179.49 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -120.66 143.58 48.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.178 -0.951 . . . . 0.0 111.269 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.85 129.82 40.12 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.3 t -100.32 121.27 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.491 -0.756 . . . . 0.0 111.33 -177.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.8 p -140.66 149.54 42.39 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.535 -0.728 . . . . 0.0 110.517 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 37.7 m -88.79 -49.62 6.72 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.553 -0.717 . . . . 0.0 109.804 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -119.71 32.03 6.26 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.52 0.676 . . . . 0.0 109.229 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 97.65 -11.56 64.7 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.244 -1.543 . . . . 0.0 109.244 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 62.4 t -88.11 122.42 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.279 -1.13 . . . . 0.0 109.061 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.55 113.14 22.97 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.528 -0.733 . . . . 0.0 110.784 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -109.14 -30.21 8.15 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.651 -0.656 . . . . 0.0 109.687 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.7 ' HB1' ' CZ ' ' A' ' 123' ' ' ARG . . . -116.52 168.32 10.27 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.664 -0.648 . . . . 0.0 109.681 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.447 HG13 ' C ' ' A' ' 166' ' ' ALA . 35.9 m -148.74 135.82 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.541 -0.724 . . . . 0.0 111.085 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.65 134.46 51.93 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.664 -0.647 . . . . 0.0 109.883 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.426 ' CE1' ' HA ' ' A' ' 122' ' ' SER . 52.2 p90 -131.56 159.94 36.74 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.42 -0.8 . . . . 0.0 110.389 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.41 HG22 ' NH1' ' A' ' 155' ' ' ARG . 60.4 t -92.54 140.53 24.02 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.57 -0.707 . . . . 0.0 110.212 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -75.15 162.51 36.64 Favored 'Trans proline' 0 C--N 1.32 -0.966 0 O-C-N 123.131 1.069 . . . . 0.0 110.337 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 151' ' ' VAL . 87.6 t -79.75 -30.59 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.554 -0.716 . . . . 0.0 110.257 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -60.02 -39.24 85.19 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.493 -0.754 . . . . 0.0 110.605 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 58.4 p -61.7 -25.7 67.58 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.516 -0.74 . . . . 0.0 110.871 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.428 ' CE ' HG13 ' A' ' 172' ' ' VAL . 53.9 mtm -66.99 -36.98 83.38 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.422 -0.799 . . . . 0.0 110.542 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -60.05 -40.01 87.92 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.472 -0.767 . . . . 0.0 110.404 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 31.3 m -61.05 -31.69 71.34 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.536 -0.727 . . . . 0.0 110.511 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 93.2 m -59.95 -40.04 87.64 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.515 -0.74 . . . . 0.0 110.465 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 1.4 ttp -58.82 -36.29 74.26 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.44 -0.787 . . . . 0.0 110.437 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 5.5 ttp180 -59.91 -39.98 87.26 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.433 -0.792 . . . . 0.0 110.212 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.833 0 O-C-N 121.603 -0.686 . . . . 0.0 110.301 179.944 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.435 ' HG2' HD13 ' A' ' 94' ' ' LEU . 8.1 pt-20 . . . . . 0 N--CA 1.498 1.947 0 CA-C-O 121.302 0.572 . . . . 0.0 110.458 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 63.3 t -114.63 125.5 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.54 -0.725 . . . . 0.0 109.78 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -103.01 138.98 39.17 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.576 -0.702 . . . . 0.0 110.065 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.583 ' HA ' HD22 ' A' ' 44' ' ' LEU . 33.5 m -88.38 132.14 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.554 -0.716 . . . . 0.0 110.476 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.1 m -130.6 159.97 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.467 -0.77 . . . . 0.0 110.346 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 64.7 m -135.9 153.49 51.44 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.566 -0.709 . . . . 0.0 110.383 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.529 HG22 ' H ' ' A' ' 39' ' ' ALA . 1.6 m -117.8 179.82 3.96 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.618 -0.677 . . . . 0.0 109.982 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.529 ' H ' HG22 ' A' ' 38' ' ' THR . . . -71.14 -23.73 62.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.671 -0.643 . . . . 0.0 111.288 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.6 p -119.8 -28.29 5.25 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.32 -0.863 . . . . 0.0 111.418 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -142.34 164.72 29.37 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.371 -0.831 . . . . 0.0 110.639 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.4 t -130.94 124.62 31.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.497 -0.752 . . . . 0.0 110.14 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.411 ' CE1' ' OG1' ' A' ' 38' ' ' THR . 4.5 p90 -133.9 178.32 7.04 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.604 -0.685 . . . . 0.0 110.121 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.583 HD22 ' HA ' ' A' ' 35' ' ' VAL . 25.0 mt -121.16 167.55 12.54 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.574 -0.704 . . . . 0.0 110.026 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.79 152.14 46.33 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.592 -0.692 . . . . 0.0 110.06 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.6 m -119.98 135.42 54.92 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.477 -0.765 . . . . 0.0 110.286 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 45.8 t -93.27 103.82 16.04 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.562 -0.711 . . . . 0.0 110.482 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 94' ' ' LEU . 12.0 p -130.44 139.64 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.546 -0.721 . . . . 0.0 110.4 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 57.67 36.17 26.39 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.412 -0.805 . . . . 0.0 110.836 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 63.26 15.76 57.1 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.548 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 56.5 t -139.47 119.3 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.266 -1.137 . . . . 0.0 109.657 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 28.5 p -79.98 137.95 36.95 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.587 -0.696 . . . . 0.0 110.41 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.845 ' CE3' HD21 ' A' ' 82' ' ' LEU . 87.0 m95 -125.92 137.43 53.71 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.554 -0.716 . . . . 0.0 110.404 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.9 t -137.16 179.6 6.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.705 -0.622 . . . . 0.0 109.804 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.601 HG11 ' CE1' ' A' ' 57' ' ' HIS . 0.5 OUTLIER -81.32 142.65 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.175 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.908 ' CE2' HG22 ' A' ' 78' ' ' VAL . 27.5 t80 -81.02 -42.54 20.95 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.458 -0.776 . . . . 0.0 111.199 -178.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.601 ' CE1' HG11 ' A' ' 55' ' ' VAL . 2.2 p-80 -53.72 -21.2 6.64 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.444 -0.785 . . . . 0.0 111.956 -177.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -119.62 -23.63 3.06 Favored Glycine 0 N--CA 1.496 2.677 0 C-N-CA 119.984 -1.103 . . . . 0.0 111.064 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 55' ' ' VAL . . . -113.77 -27.14 7.9 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.235 -1.156 . . . . 0.0 111.083 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.453 ' HA3' ' CD1' ' A' ' 56' ' ' TYR . . . . . . . . 0 N--CA 1.494 2.562 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 40.7 p . . . . . 0 N--CA 1.498 1.947 0 CA-C-O 121.273 0.559 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -87.96 130.95 34.78 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.729 -0.607 . . . . 0.0 109.721 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.7 tpt -119.07 -44.54 2.6 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.464 -0.773 . . . . 0.0 110.976 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.52 ' O ' HG13 ' A' ' 83' ' ' VAL . 24.1 m-85 -109.81 124.78 51.89 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.271 -0.893 . . . . 0.0 110.083 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.503 HG23 ' HE1' ' A' ' 56' ' ' TYR . 56.9 m -152.17 135.47 15.91 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.609 -0.682 . . . . 0.0 110.355 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -167.28 111.85 0.71 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.504 -0.748 . . . . 0.0 110.813 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.908 HG22 ' CE2' ' A' ' 56' ' ' TYR . 75.7 t -72.25 -29.21 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.297 -0.877 . . . . 0.0 109.322 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -60.0 -42.89 95.23 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.47 -0.769 . . . . 0.0 110.012 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -99.81 -6.99 26.0 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.514 -0.741 . . . . 0.0 110.652 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.486 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 30.4 t0 56.39 33.98 23.38 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.065 -1.022 . . . . 0.0 110.635 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.845 HD21 ' CE3' ' A' ' 53' ' ' TRP . 7.8 tt -119.83 145.27 46.79 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.249 -0.907 . . . . 0.0 111.751 -178.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 75' ' ' TYR . 3.1 t -143.97 159.25 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -168.96 164.37 38.02 Favored Glycine 0 N--CA 1.496 2.645 0 C-N-CA 119.46 -1.352 . . . . 0.0 110.624 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.517 ' CZ2' HG12 ' A' ' 83' ' ' VAL . 20.3 m-90 -146.75 160.02 42.76 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.793 -0.828 . . . . 0.0 109.47 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -62.21 138.0 58.34 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.575 -0.703 . . . . 0.0 110.08 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.97 148.5 57.06 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.478 -0.764 . . . . 0.0 110.284 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.9 160.0 48.94 Favored 'Trans proline' 0 C--N 1.317 -1.105 0 O-C-N 123.484 1.254 . . . . 0.0 110.359 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -73.31 126.83 11.36 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 123.377 1.199 . . . . 0.0 110.447 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 108.81 30.09 3.86 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -117.42 159.49 22.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.513 -0.993 . . . . 0.0 110.089 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.2 mtp180 -96.29 163.87 12.9 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.53 -0.731 . . . . 0.0 110.378 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 80.7 p -130.89 145.17 51.93 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.678 -0.639 . . . . 0.0 109.901 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.435 HD13 ' HG2' ' A' ' 32' ' ' GLU . 0.7 OUTLIER -105.09 139.92 39.04 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.588 -0.695 . . . . 0.0 110.303 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 60.3 m -78.07 143.8 66.37 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.747 -0.596 . . . . 0.0 109.917 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.64 161.98 43.82 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 O-C-N 123.302 1.159 . . . . 0.0 110.319 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 45.6 t -72.9 128.01 34.24 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.539 -0.725 . . . . 0.0 110.483 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.3 m -135.73 55.79 1.85 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.662 -0.649 . . . . 0.0 109.531 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.4 p -145.01 4.66 1.1 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.58 -0.7 . . . . 0.0 112.175 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 51.25 91.06 0.01 OUTLIER Glycine 0 N--CA 1.502 3.064 0 O-C-N 120.905 -1.122 . . . . 0.0 110.495 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 98.1 p -139.35 148.06 42.38 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.436 -1.038 . . . . 0.0 110.362 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 63.7 m -95.03 -34.54 12.3 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.64 -0.662 . . . . 0.0 110.176 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -66.37 129.67 40.6 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.642 -0.661 . . . . 0.0 109.915 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.845 HD22 HG21 ' A' ' 151' ' ' VAL . 97.3 mt -136.28 156.53 48.53 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.625 -0.672 . . . . 0.0 110.546 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -126.34 108.72 11.5 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.667 -0.646 . . . . 0.0 109.519 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.473 HD11 ' CD1' ' A' ' 154' ' ' PHE . 9.7 tt -89.46 129.39 35.96 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.638 -0.663 . . . . 0.0 110.763 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.5 t -84.91 131.07 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.64 -0.663 . . . . 0.0 109.575 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.7 p -97.82 -175.51 3.19 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.48 -0.762 . . . . 0.0 110.509 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.2 ttt-85 -69.95 -27.01 64.4 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.706 -0.621 . . . . 0.0 110.846 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.44 ' CD2' ' HB2' ' A' ' 112' ' ' ASP . 41.0 p-80 -106.22 29.96 6.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.43 -0.794 . . . . 0.0 110.859 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 55.36 56.84 5.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.532 -0.73 . . . . 0.0 111.884 178.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.44 ' HB2' ' CD2' ' A' ' 110' ' ' HIS . 0.4 OUTLIER -110.8 137.34 48.57 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.401 -0.812 . . . . 0.0 109.88 179.118 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.44 ' O ' HG13 ' A' ' 113' ' ' VAL . 10.4 p -84.46 128.34 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.65 -0.656 . . . . 0.0 110.275 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.54 ' CG2' HD11 ' A' ' 126' ' ' LEU . 48.6 mm -129.98 105.86 16.67 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.523 -0.735 . . . . 0.0 110.11 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -70.66 119.84 6.64 Favored 'Trans proline' 0 N--CA 1.487 1.088 0 O-C-N 123.241 1.127 . . . . 0.0 110.242 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.635 HG13 ' O ' ' A' ' 125' ' ' SER . 57.5 t -120.36 129.39 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.515 -0.741 . . . . 0.0 110.137 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.514 ' CG ' HD11 ' A' ' 127' ' ' LEU . 4.1 mmt180 -83.03 135.86 34.7 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.566 -0.709 . . . . 0.0 109.809 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -82.24 134.23 35.28 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.522 -0.736 . . . . 0.0 110.431 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.7 18.63 3.3 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.587 -0.696 . . . . 0.0 110.581 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -173.33 178.94 45.05 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -69.55 -39.97 77.11 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.572 -0.958 . . . . 0.0 110.331 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.6 m -130.33 25.06 5.17 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.527 -0.733 . . . . 0.0 110.781 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -142.58 141.83 32.06 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.423 -0.798 . . . . 0.0 110.306 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -142.11 157.16 26.37 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.635 ' O ' HG13 ' A' ' 116' ' ' VAL . 50.6 p -91.57 157.63 16.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.664 -0.904 . . . . 0.0 110.125 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.54 HD11 ' CG2' ' A' ' 114' ' ' ILE . 39.9 tp -105.77 127.17 52.92 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.531 -0.731 . . . . 0.0 110.36 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.514 HD11 ' CG ' ' A' ' 117' ' ' ARG . 4.3 mp -68.6 -42.26 78.44 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.581 -0.7 . . . . 0.0 110.092 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.6 p -102.2 99.79 13.58 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.694 -0.629 . . . . 0.0 109.701 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.15 106.94 2.01 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.388 1.204 . . . . 0.0 110.945 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -114.47 161.5 28.25 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.713 -0.617 . . . . 0.0 109.748 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 44.8 Cg_endo -71.18 150.59 59.86 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 O-C-N 123.391 1.206 . . . . 0.0 110.354 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.413 HG21 ' SG ' ' A' ' 159' ' ' CYS . 64.6 t -51.03 -29.93 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 O-C-N 121.399 -0.813 . . . . 0.0 109.828 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.2 t -61.43 -40.04 92.97 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.728 -0.608 . . . . 0.0 110.956 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -66.87 -39.97 87.71 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.326 -0.859 . . . . 0.0 109.538 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.417 HD21 ' CZ ' ' A' ' 154' ' ' PHE . 17.6 tp -95.4 18.9 11.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.922 -0.486 . . . . 0.0 110.135 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -81.14 116.67 21.16 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 122.541 1.162 . . . . 0.0 112.412 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.72 22.12 11.54 Favored Glycine 0 N--CA 1.492 2.401 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.269 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.3 m -103.44 20.85 17.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.47 -1.018 . . . . 0.0 110.53 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.2 m -69.96 136.12 50.17 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.28 -0.888 . . . . 0.0 109.541 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 100.06 -23.29 36.56 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.79 110.02 1.93 Allowed Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -72.43 138.7 30.35 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 O-C-N 123.18 1.095 . . . . 0.0 111.073 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.459 ' C ' HD12 ' A' ' 144' ' ' LEU . 4.1 mp -86.35 146.3 26.53 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.459 HD12 ' C ' ' A' ' 143' ' ' LEU . 4.1 mp -126.9 162.23 26.41 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.403 -0.81 . . . . 0.0 111.23 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.412 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 27.1 p -119.1 165.12 17.93 Favored Pre-proline 0 N--CA 1.494 1.774 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.412 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 39.9 Cg_endo -65.42 -12.23 33.98 Favored 'Trans proline' 0 N--CA 1.489 1.218 0 O-C-N 123.082 1.043 . . . . 0.0 111.853 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.7 p -72.01 -32.66 67.39 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.117 -0.989 . . . . 0.0 109.943 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 116.15 20.74 5.1 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -131.34 152.95 50.11 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.325 -1.103 . . . . 0.0 110.377 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.403 ' HB2' ' CD2' ' A' ' 94' ' ' LEU . . . -78.77 152.36 31.5 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.542 -0.724 . . . . 0.0 109.931 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.845 HG21 HD22 ' A' ' 104' ' ' LEU . 34.0 m -112.55 -28.81 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.5 -0.75 . . . . 0.0 110.989 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 177.7 -161.01 27.96 Favored Glycine 0 N--CA 1.498 2.776 0 C-N-CA 119.753 -1.213 . . . . 0.0 110.339 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.5 mt -134.42 151.76 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.652 -0.911 . . . . 0.0 110.162 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.473 ' CD1' HD11 ' A' ' 106' ' ' LEU . 14.5 t80 -70.13 153.49 43.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.685 -0.634 . . . . 0.0 110.14 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 46.6 ttm-85 -135.95 -76.41 0.43 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.659 -0.651 . . . . 0.0 110.327 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -120.53 143.04 48.79 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.38 -0.825 . . . . 0.0 110.616 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.27 127.71 38.97 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.5 t -96.9 117.77 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.602 -0.686 . . . . 0.0 111.535 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.413 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.9 p -140.06 147.68 40.67 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.414 -0.804 . . . . 0.0 110.565 178.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 17.9 m -79.49 -50.59 10.53 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.488 -0.758 . . . . 0.0 109.77 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -130.26 36.7 3.96 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.633 -0.667 . . . . 0.0 109.904 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 131' ' ' PRO . . . 104.28 -11.76 51.47 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 65.1 t -93.12 121.95 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.259 -1.142 . . . . 0.0 109.158 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.2 121.1 29.2 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.541 -0.725 . . . . 0.0 111.347 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 5.4 mttp -113.29 -30.11 7.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.804 -0.56 . . . . 0.0 109.933 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -123.64 168.4 12.69 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.518 -0.739 . . . . 0.0 109.9 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.492 HG21 HG11 ' A' ' 116' ' ' VAL . 35.1 m -140.23 137.34 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.517 -0.74 . . . . 0.0 110.887 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -104.65 126.57 51.85 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.53 -0.731 . . . . 0.0 110.606 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -147.8 162.14 39.83 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.595 -0.691 . . . . 0.0 110.332 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 27.1 m -110.96 149.59 40.65 Favored Pre-proline 0 N--CA 1.502 2.129 0 O-C-N 121.353 -0.842 . . . . 0.0 110.708 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -78.6 161.28 28.03 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.496 1.261 . . . . 0.0 109.378 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 54.0 t -58.9 -25.93 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.385 -0.822 . . . . 0.0 110.051 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -59.92 -35.53 75.08 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.557 -0.715 . . . . 0.0 110.643 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 2.3 t -61.51 -24.35 66.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.468 -0.77 . . . . 0.0 110.568 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 68.0 mtt -69.96 -39.06 76.23 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.431 -0.793 . . . . 0.0 110.507 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -60.11 -39.98 88.08 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.443 -0.786 . . . . 0.0 110.566 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 85.3 m -60.8 -40.04 91.15 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.474 -0.766 . . . . 0.0 110.124 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.415 HG21 HD22 ' A' ' 82' ' ' LEU . 61.8 m -67.73 -36.34 80.4 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.559 -0.713 . . . . 0.0 110.321 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 7.9 ttt -60.06 -42.23 94.05 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.553 -0.717 . . . . 0.0 110.539 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -60.07 -39.9 87.66 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.539 -0.726 . . . . 0.0 110.342 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.722 0 O-C-N 121.581 -0.699 . . . . 0.0 110.187 179.956 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.415 ' HG2' HD21 ' A' ' 94' ' ' LEU . 21.7 mp0 . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 120.988 0.423 . . . . 0.0 110.485 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.749 HG23 ' O ' ' A' ' 45' ' ' ALA . 9.1 p -119.31 143.66 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.566 -0.709 . . . . 0.0 110.069 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 54.9 tp60 -110.39 141.65 43.16 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.582 -0.699 . . . . 0.0 110.181 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.609 ' HA ' HD22 ' A' ' 44' ' ' LEU . 10.0 p -82.74 130.26 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.643 -0.661 . . . . 0.0 110.212 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.7 m -138.14 144.31 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.509 -0.744 . . . . 0.0 110.48 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.4 m -130.05 144.04 51.12 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.54 -0.725 . . . . 0.0 110.632 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.526 HG22 ' H ' ' A' ' 39' ' ' ALA . 0.3 OUTLIER -99.86 -169.98 1.82 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.602 -0.686 . . . . 0.0 109.768 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.526 ' H ' HG22 ' A' ' 38' ' ' THR . . . -71.83 -40.04 69.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.614 -0.679 . . . . 0.0 111.597 -178.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 77.6 p -114.59 -18.82 11.34 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.226 -0.922 . . . . 0.0 111.608 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -139.75 161.67 36.99 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.244 -0.91 . . . . 0.0 110.134 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 99.1 p -138.4 123.28 18.87 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.458 -0.776 . . . . 0.0 110.857 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 4.4 p90 -128.05 -174.96 3.35 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.632 -0.668 . . . . 0.0 109.503 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.609 HD22 ' HA ' ' A' ' 35' ' ' VAL . 44.0 mt -126.57 166.08 17.96 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.335 -0.853 . . . . 0.0 110.746 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.749 ' O ' HG23 ' A' ' 33' ' ' VAL . . . -141.49 152.48 44.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.711 -0.618 . . . . 0.0 110.261 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 87.8 m -130.03 139.9 50.94 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.511 -0.743 . . . . 0.0 110.291 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 77.8 m -77.63 120.49 22.65 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.562 -0.712 . . . . 0.0 110.431 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.1 t -130.48 120.82 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.467 -0.771 . . . . 0.0 110.628 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 33.4 m120 50.05 34.47 8.3 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.534 -0.729 . . . . 0.0 111.969 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.75 ' O ' ' HB3' ' A' ' 87' ' ' ALA . . . 91.25 -23.61 23.53 Favored Glycine 0 N--CA 1.497 2.736 0 C-N-CA 120.198 -1.001 . . . . 0.0 110.8 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.0 p -108.89 133.58 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.3 -1.118 . . . . 0.0 109.781 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 77.1 m -91.55 125.03 36.15 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.392 -0.818 . . . . 0.0 110.159 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 71.9 m95 -99.33 137.17 38.21 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.567 -0.708 . . . . 0.0 110.422 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.81 HG21 ' CZ2' ' A' ' 85' ' ' TRP . 8.4 t -137.06 173.43 11.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.765 -0.584 . . . . 0.0 109.751 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.706 HG11 ' CE1' ' A' ' 57' ' ' HIS . 96.9 t -81.78 142.09 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.462 -0.774 . . . . 0.0 109.26 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.903 ' CE2' HG22 ' A' ' 78' ' ' VAL . 15.2 t80 -85.0 -43.37 14.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.63 -0.669 . . . . 0.0 110.806 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.706 ' CE1' HG11 ' A' ' 55' ' ' VAL . 2.2 p-80 -59.45 -22.55 61.67 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.167 -0.958 . . . . 0.0 110.476 -178.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -82.28 -65.77 1.61 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.0 -63.28 1.36 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.418 -1.048 . . . . 0.0 110.188 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.47 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 179.316 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.497 1.901 0 CA-C-O 121.037 0.446 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -92.36 150.83 20.59 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.551 -0.718 . . . . 0.0 110.565 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 97.8 mmm -116.98 -32.7 4.98 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.65 -0.656 . . . . 0.0 110.35 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.582 ' O ' HG13 ' A' ' 83' ' ' VAL . 18.5 m-85 -110.11 129.15 55.74 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.374 -0.829 . . . . 0.0 109.436 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 89.3 m -151.44 132.65 14.46 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.399 -0.813 . . . . 0.0 110.456 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -166.73 125.42 1.42 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.372 -0.83 . . . . 0.0 111.141 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.903 HG22 ' CE2' ' A' ' 56' ' ' TYR . 78.5 t -72.32 -39.29 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.459 -0.776 . . . . 0.0 109.607 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -55.81 -44.93 78.32 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.354 -0.842 . . . . 0.0 110.268 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.576 ' O ' HD12 ' A' ' 82' ' ' LEU . 12.0 tp60 -82.9 -14.0 55.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.754 -0.591 . . . . 0.0 110.279 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 40.2 t0 53.09 39.9 30.31 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.117 -0.989 . . . . 0.0 110.67 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.684 HD13 ' CE ' ' A' ' 175' ' ' MET . 0.3 OUTLIER -146.3 156.98 43.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.406 -0.809 . . . . 0.0 111.065 -179.545 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.733 ' O ' HG22 ' A' ' 54' ' ' THR . 3.5 t -145.11 145.14 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -130.5 154.69 20.77 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.626 -1.273 . . . . 0.0 110.912 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.81 ' CZ2' HG21 ' A' ' 54' ' ' THR . 4.4 m-90 -125.07 159.88 30.36 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.904 -0.763 . . . . 0.0 109.431 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -83.15 122.9 28.98 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.474 -0.766 . . . . 0.0 109.877 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.75 ' HB3' ' O ' ' A' ' 50' ' ' GLY . . . -101.28 160.62 26.1 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.457 -0.777 . . . . 0.0 110.538 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.77 160.05 49.06 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 O-C-N 123.484 1.255 . . . . 0.0 110.506 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.52 158.81 47.28 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.448 1.236 . . . . 0.0 110.526 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 74.27 31.12 59.69 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -107.23 151.33 25.58 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.43 -1.041 . . . . 0.0 110.307 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -60.5 152.3 26.22 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.589 -0.694 . . . . 0.0 110.46 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 92.5 p -148.23 155.39 41.3 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.612 -0.68 . . . . 0.0 110.457 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.626 ' HB3' ' HB2' ' A' ' 150' ' ' ALA . 90.9 mt -111.13 131.92 54.7 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.563 -0.711 . . . . 0.0 110.36 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 72.6 p -76.5 159.91 78.54 Favored Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 121.597 -0.689 . . . . 0.0 110.082 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.0 159.22 50.78 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.38 1.2 . . . . 0.0 110.481 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 47.0 t -86.93 128.15 35.06 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.564 -0.71 . . . . 0.0 110.388 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.5 p -133.69 55.09 1.91 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.603 -0.685 . . . . 0.0 109.989 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.5 p -145.18 7.68 1.18 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.481 -0.762 . . . . 0.0 111.864 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 52.26 41.67 54.72 Favored Glycine 0 N--CA 1.499 2.894 0 O-C-N 121.003 -1.06 . . . . 0.0 110.496 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.8 m -78.92 107.96 12.04 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.519 -0.989 . . . . 0.0 110.386 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.4 m -66.24 -40.01 89.92 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.569 -0.707 . . . . 0.0 110.195 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -67.92 129.12 38.94 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.589 -0.694 . . . . 0.0 109.97 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.579 HD22 HG21 ' A' ' 151' ' ' VAL . 90.8 mt -134.99 150.08 50.29 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.609 -0.682 . . . . 0.0 110.356 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -117.5 125.19 50.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.535 -0.728 . . . . 0.0 109.768 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.686 HD11 ' HB2' ' A' ' 154' ' ' PHE . 26.8 tp -102.53 144.22 31.23 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.5 -0.75 . . . . 0.0 110.556 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.6 t -105.92 126.68 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.603 -0.686 . . . . 0.0 109.73 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 69.7 p -93.98 176.49 6.31 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.501 -0.749 . . . . 0.0 110.58 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -60.13 -24.63 64.84 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.598 -0.689 . . . . 0.0 110.722 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -95.32 27.15 3.43 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.474 -0.766 . . . . 0.0 110.555 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 53.21 27.79 6.39 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.296 -0.878 . . . . 0.0 110.916 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -80.68 152.59 28.36 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.546 -0.721 . . . . 0.0 109.913 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 63.2 t -116.05 128.17 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.543 -0.723 . . . . 0.0 109.929 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.548 HD11 HD23 ' A' ' 106' ' ' LEU . 40.1 pt -134.56 139.07 31.5 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.49 -0.756 . . . . 0.0 110.19 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -82.91 146.45 12.98 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 O-C-N 123.177 1.093 . . . . 0.0 110.521 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.1 t -139.36 129.94 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.584 -0.698 . . . . 0.0 109.768 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.7 tpp180 -92.98 130.71 38.47 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.538 -0.726 . . . . 0.0 110.154 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -80.26 121.33 25.5 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.606 -0.684 . . . . 0.0 110.328 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.88 -12.29 9.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.523 -0.736 . . . . 0.0 110.473 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -134.92 -175.55 13.92 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -70.14 -45.09 67.54 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.557 -0.966 . . . . 0.0 110.57 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.6 m -127.67 21.04 6.54 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.45 -0.781 . . . . 0.0 110.819 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.72 142.13 34.86 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.315 -0.866 . . . . 0.0 110.057 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -134.25 166.86 23.99 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 52.9 p -98.72 165.19 11.91 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.541 -0.976 . . . . 0.0 110.222 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.444 HD21 ' NH1' ' A' ' 130' ' ' ARG . 47.7 tp -120.0 124.2 45.33 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.527 -0.733 . . . . 0.0 110.337 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.459 HD12 ' H ' ' A' ' 127' ' ' LEU . 5.4 mp -62.13 -41.67 98.49 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.51 -0.744 . . . . 0.0 110.182 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.4 p -102.58 105.9 46.6 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.548 -0.72 . . . . 0.0 109.945 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.36 106.85 2.15 Favored 'Trans proline' 0 C--N 1.319 -0.999 0 O-C-N 123.32 1.169 . . . . 0.0 110.876 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.657 ' O ' ' HB3' ' A' ' 164' ' ' ALA . 4.4 mtt85 -106.89 153.09 41.05 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.644 -0.66 . . . . 0.0 109.643 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.27 150.38 52.93 Favored 'Trans proline' 0 C--N 1.315 -1.207 0 O-C-N 123.383 1.202 . . . . 0.0 110.884 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.421 HG21 ' SG ' ' A' ' 159' ' ' CYS . 73.6 t -53.6 -31.95 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.473 -0.767 . . . . 0.0 109.565 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 31.2 t -59.85 -39.99 87.07 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.689 -0.632 . . . . 0.0 110.65 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.448 ' CD2' ' HD2' ' A' ' 130' ' ' ARG . 87.3 t80 -70.06 -39.73 75.5 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.444 -0.785 . . . . 0.0 109.604 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 22.1 tp -95.01 13.59 24.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.725 -0.609 . . . . 0.0 110.581 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.71 113.03 13.9 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.601 1.191 . . . . 0.0 111.087 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.53 34.3 4.48 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 31.1 m -115.29 19.15 15.76 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.747 -0.855 . . . . 0.0 110.46 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.539 ' HB3' HG21 ' A' ' 55' ' ' VAL . 4.5 m -68.12 147.47 52.27 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.3 -0.875 . . . . 0.0 109.508 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.405 ' C ' HG23 ' A' ' 153' ' ' ILE . . . 94.56 -19.75 52.02 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -58.29 112.69 4.15 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.49 157.56 52.65 Favored 'Trans proline' 0 C--N 1.319 -1.025 0 O-C-N 123.201 1.106 . . . . 0.0 110.955 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.575 HD11 HD13 ' A' ' 106' ' ' LEU . 5.9 mp -109.4 127.66 54.54 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.543 HD13 ' O ' ' A' ' 149' ' ' HIS . 2.9 mm? -110.41 160.26 16.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.535 -0.728 . . . . 0.0 111.078 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.421 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 27.1 p -119.92 165.64 17.26 Favored Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 38.5 Cg_endo -63.97 -15.21 47.84 Favored 'Trans proline' 0 N--CA 1.488 1.18 0 O-C-N 123.079 1.042 . . . . 0.0 111.454 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.5 t -70.24 -39.95 74.75 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.282 -0.886 . . . . 0.0 110.044 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 114.87 31.61 2.06 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.543 ' O ' HD13 ' A' ' 144' ' ' LEU . 33.8 m170 -132.15 155.76 47.6 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.492 -1.005 . . . . 0.0 110.404 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.626 ' HB2' ' HB3' ' A' ' 94' ' ' LEU . . . -73.41 146.85 44.78 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.556 -0.715 . . . . 0.0 109.985 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.766 ' O ' HG23 ' A' ' 172' ' ' VAL . 58.9 t -112.08 -61.67 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.479 -0.763 . . . . 0.0 110.353 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -163.19 -158.76 10.0 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.405 HG23 ' C ' ' A' ' 140' ' ' GLY . 96.8 mt -133.97 155.42 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.594 -0.945 . . . . 0.0 109.882 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.686 ' HB2' HD11 ' A' ' 106' ' ' LEU . 19.6 t80 -70.04 147.49 49.98 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.45 -0.781 . . . . 0.0 109.861 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.545 ' NH2' HG22 ' A' ' 170' ' ' VAL . 4.6 ttm-85 -128.6 -79.85 0.57 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.602 -0.686 . . . . 0.0 110.829 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -119.5 143.7 47.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.964 . . . . 0.0 111.313 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.56 128.08 39.53 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.4 t -98.86 119.11 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 121.48 -0.762 . . . . 0.0 111.282 -177.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.421 ' SG ' HG21 ' A' ' 132' ' ' VAL . 27.9 p -139.88 143.59 36.77 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.506 -0.746 . . . . 0.0 110.689 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 87.0 m -76.33 -41.98 46.56 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.596 -0.69 . . . . 0.0 109.872 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -143.24 50.28 1.41 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.646 -0.659 . . . . 0.0 109.897 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 90.77 -11.57 71.41 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 64.3 t -96.07 120.13 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.141 -1.211 . . . . 0.0 108.91 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.657 ' HB3' ' O ' ' A' ' 130' ' ' ARG . . . -87.63 120.91 29.42 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.529 -0.732 . . . . 0.0 111.243 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -112.81 -32.28 6.46 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.296 0.57 . . . . 0.0 109.678 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -118.6 168.26 10.87 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.669 -0.644 . . . . 0.0 109.685 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 35.6 m -144.02 135.77 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.36 -0.838 . . . . 0.0 110.823 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -110.34 138.37 46.81 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.655 -0.653 . . . . 0.0 110.242 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -141.84 162.07 36.39 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.507 -0.746 . . . . 0.0 110.544 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.545 HG22 ' NH2' ' A' ' 155' ' ' ARG . 51.6 t -101.89 143.39 26.51 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.466 -0.771 . . . . 0.0 110.24 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -75.69 166.38 28.47 Favored 'Trans proline' 0 N--CA 1.485 1.006 0 O-C-N 123.296 1.156 . . . . 0.0 110.389 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 151' ' ' VAL . 77.3 t -88.46 -25.86 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.536 -0.728 . . . . 0.0 110.536 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -59.33 -32.94 70.54 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.408 -0.808 . . . . 0.0 110.596 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.611 ' O ' HG22 ' A' ' 177' ' ' THR . 5.8 t -69.19 -22.94 63.86 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.469 -0.769 . . . . 0.0 110.49 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.684 ' CE ' HD13 ' A' ' 82' ' ' LEU . 35.1 mmt -63.29 -27.8 69.58 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.334 -0.854 . . . . 0.0 110.411 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -57.37 -49.95 74.53 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.404 -0.81 . . . . 0.0 110.67 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.611 HG22 ' O ' ' A' ' 174' ' ' SER . 6.1 t -70.03 -23.33 63.09 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.525 -0.735 . . . . 0.0 110.503 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 87.6 m -72.06 -32.95 67.57 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.427 -0.796 . . . . 0.0 110.243 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 95.7 mtp -60.02 -37.02 78.54 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.568 -0.707 . . . . 0.0 110.419 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -59.92 -39.87 86.94 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.528 -0.732 . . . . 0.0 110.273 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.837 0 O-C-N 121.56 -0.713 . . . . 0.0 110.111 179.954 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.795 ' HG3' HG23 ' A' ' 33' ' ' VAL . 12.4 pt-20 . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 120.908 0.385 . . . . 0.0 110.746 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.795 HG23 ' HG3' ' A' ' 32' ' ' GLU . 58.8 t -126.5 140.57 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.399 -0.813 . . . . 0.0 110.311 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -106.84 159.73 16.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.572 -0.705 . . . . 0.0 110.05 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.459 ' HA ' HD22 ' A' ' 44' ' ' LEU . 62.2 t -107.57 118.34 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.485 -0.76 . . . . 0.0 110.224 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 68.0 t -120.9 133.85 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.468 -0.77 . . . . 0.0 110.158 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.5 t -130.48 135.74 48.28 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.617 -0.677 . . . . 0.0 109.763 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.24 173.6 6.25 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.525 -0.734 . . . . 0.0 110.245 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.84 -34.88 74.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.746 -0.596 . . . . 0.0 111.203 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 68.9 p -103.49 -28.18 11.93 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.362 -0.836 . . . . 0.0 111.049 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -142.93 178.11 7.9 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.38 -0.825 . . . . 0.0 110.619 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 24.0 m -148.74 120.6 8.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.711 -0.618 . . . . 0.0 110.223 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.454 ' O ' HD23 ' A' ' 44' ' ' LEU . 27.6 p90 -127.53 172.38 10.76 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.664 -0.647 . . . . 0.0 109.674 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.459 HD22 ' HA ' ' A' ' 35' ' ' VAL . 46.8 mt -121.14 153.96 36.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.492 -0.755 . . . . 0.0 109.978 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.589 ' HB1' ' SG ' ' A' ' 52' ' ' CYS . . . -125.76 154.66 42.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.594 -0.691 . . . . 0.0 110.379 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.4 t -129.11 144.18 51.11 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.667 -0.646 . . . . 0.0 109.902 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 27.9 p -94.84 118.8 32.36 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.696 0.76 . . . . 0.0 110.679 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.4 t -130.27 127.64 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.44 -0.787 . . . . 0.0 109.827 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 52.16 39.13 26.15 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.418 -0.801 . . . . 0.0 110.991 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.593 ' O ' ' HB3' ' A' ' 87' ' ' ALA . . . 68.71 24.67 75.41 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.3 t -136.64 115.09 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.382 -1.069 . . . . 0.0 109.836 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.589 ' SG ' ' HB1' ' A' ' 45' ' ' ALA . 47.9 t -77.42 116.35 17.94 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.546 -0.721 . . . . 0.0 109.958 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.455 ' CZ3' ' CE ' ' A' ' 175' ' ' MET . 56.9 m95 -100.09 137.25 38.8 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.446 -0.783 . . . . 0.0 110.578 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.958 HG21 ' CH2' ' A' ' 85' ' ' TRP . 7.5 t -137.11 173.59 11.52 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.646 -0.659 . . . . 0.0 109.47 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.84 HG11 ' CE1' ' A' ' 57' ' ' HIS . 71.5 t -82.52 143.66 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.362 -0.836 . . . . 0.0 109.495 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.887 ' CE2' HG22 ' A' ' 78' ' ' VAL . 21.2 t80 -84.37 -42.21 15.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.754 -0.591 . . . . 0.0 111.027 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.84 ' CE1' HG11 ' A' ' 55' ' ' VAL . 1.4 p-80 -56.86 -20.02 20.67 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.967 -1.083 . . . . 0.0 111.227 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -102.16 -65.82 0.76 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.68 -22.83 49.94 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.473 -1.016 . . . . 0.0 111.027 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.603 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -179.75 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.6 p . . . . . 0 N--CA 1.493 1.718 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.2 mm-40 -96.8 113.94 25.54 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.493 -0.754 . . . . 0.0 111.123 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.415 ' HG3' ' CD2' ' A' ' 75' ' ' TYR . 19.4 ptt? -113.08 -29.73 7.22 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.658 -0.651 . . . . 0.0 109.783 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.469 ' O ' HG13 ' A' ' 83' ' ' VAL . 29.9 m-85 -120.22 116.37 25.47 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.572 -0.705 . . . . 0.0 109.596 179.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.1 m -150.31 130.92 13.96 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.481 -0.762 . . . . 0.0 110.316 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -167.74 123.24 1.04 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.363 -0.836 . . . . 0.0 111.327 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.887 HG22 ' CE2' ' A' ' 56' ' ' TYR . 70.1 t -72.67 -38.18 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.49 -0.756 . . . . 0.0 109.5 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -55.66 -33.3 63.97 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.484 -0.76 . . . . 0.0 110.641 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.805 ' HG2' HD11 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -100.61 -15.28 17.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.579 -0.7 . . . . 0.0 110.642 179.71 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.3 t0 61.1 39.79 15.73 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.111 -0.993 . . . . 0.0 113.631 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.805 HD11 ' HG2' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -148.76 160.32 43.31 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.721 -1.237 . . . . 0.0 111.68 176.578 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 75' ' ' TYR . 2.2 t -137.6 159.47 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -140.29 137.98 8.73 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.602 -1.285 . . . . 0.0 110.513 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.958 ' CH2' HG21 ' A' ' 54' ' ' THR . 5.3 m-90 -111.79 157.92 19.99 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.845 -0.797 . . . . 0.0 109.701 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -68.32 115.08 7.35 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.609 -0.682 . . . . 0.0 109.974 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.593 ' HB3' ' O ' ' A' ' 50' ' ' GLY . . . -99.87 164.84 15.71 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.483 -0.761 . . . . 0.0 110.19 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.419 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 46.7 Cg_endo -72.42 139.55 31.88 Favored 'Trans proline' 0 C--N 1.317 -1.097 0 O-C-N 123.408 1.215 . . . . 0.0 110.299 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -76.77 160.11 34.49 Favored 'Trans proline' 0 C--N 1.319 -1.003 0 O-C-N 123.26 1.137 . . . . 0.0 110.439 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 70.03 29.82 70.39 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -109.03 168.12 9.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.49 -1.006 . . . . 0.0 110.055 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.8 mtm180 -59.98 138.54 57.82 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.583 -0.698 . . . . 0.0 110.248 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 78.9 p -132.95 152.05 51.97 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.545 -0.722 . . . . 0.0 110.372 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.518 HD21 ' HB2' ' A' ' 32' ' ' GLU . 81.2 mt -97.1 131.58 43.73 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.589 -0.695 . . . . 0.0 110.258 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 44.4 p -85.0 155.54 60.91 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.595 -0.691 . . . . 0.0 110.256 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.67 162.98 39.79 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 O-C-N 123.49 1.258 . . . . 0.0 110.428 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.8 t -82.37 131.23 35.23 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.557 -0.714 . . . . 0.0 110.187 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.2 m -135.77 56.3 1.83 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.596 -0.69 . . . . 0.0 110.088 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.7 p -145.25 6.08 1.12 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.456 -0.778 . . . . 0.0 112.029 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 51.44 51.06 39.03 Favored Glycine 0 N--CA 1.502 3.05 0 O-C-N 120.949 -1.095 . . . . 0.0 110.541 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.2 p -99.06 121.74 41.39 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.441 -1.035 . . . . 0.0 110.525 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 68.2 m -73.42 -40.08 64.52 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.627 -0.671 . . . . 0.0 110.247 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -65.5 131.42 46.36 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.618 -0.676 . . . . 0.0 110.22 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.599 HD22 HG21 ' A' ' 151' ' ' VAL . 95.6 mt -135.95 144.95 45.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.543 -0.723 . . . . 0.0 110.379 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -114.11 129.26 56.62 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.502 -0.749 . . . . 0.0 110.203 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.51 HD13 HD11 ' A' ' 143' ' ' LEU . 38.1 tp -105.41 140.08 39.06 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.572 -0.705 . . . . 0.0 110.228 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.9 t -91.83 121.89 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.6 -0.688 . . . . 0.0 109.76 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.415 HG22 ' H ' ' A' ' 109' ' ' ARG . 4.3 m -85.45 172.69 10.82 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.54 -0.725 . . . . 0.0 110.34 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.415 ' H ' HG22 ' A' ' 108' ' ' THR . 0.0 OUTLIER -59.9 -26.53 65.99 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.572 -0.705 . . . . 0.0 110.523 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -96.05 26.32 4.25 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.528 -0.732 . . . . 0.0 110.453 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 52.9 39.99 30.1 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.323 -0.861 . . . . 0.0 110.827 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -94.52 162.51 13.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.539 -0.725 . . . . 0.0 110.127 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 63.9 t -110.27 130.34 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.538 -0.726 . . . . 0.0 109.897 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.553 ' O ' HG23 ' A' ' 114' ' ' ILE . 4.0 tp -137.88 119.57 10.72 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.606 -0.684 . . . . 0.0 109.994 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -73.07 142.91 35.2 Favored 'Trans proline' 0 N--CA 1.486 1.069 0 O-C-N 123.074 1.039 . . . . 0.0 110.699 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.7 t -139.05 129.06 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.713 -0.617 . . . . 0.0 109.693 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -85.51 129.18 34.88 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.529 -0.732 . . . . 0.0 110.075 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -73.88 135.65 43.36 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.612 -0.68 . . . . 0.0 110.278 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -137.44 26.98 2.84 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.662 -0.649 . . . . 0.0 110.24 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.23 -179.54 43.77 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -70.08 -39.59 75.52 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.592 -0.946 . . . . 0.0 110.562 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 98.4 p -131.44 29.19 4.59 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.431 -0.793 . . . . 0.0 110.875 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.591 HH11 ' HB1' ' A' ' 166' ' ' ALA . 0.0 OUTLIER -148.12 160.29 43.05 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.435 -0.791 . . . . 0.0 110.333 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -160.16 -170.14 24.36 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 88.3 p -126.34 164.55 20.82 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.577 -0.955 . . . . 0.0 110.159 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 46.5 tp -119.99 126.37 50.68 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.586 -0.696 . . . . 0.0 110.183 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.415 HD12 ' H ' ' A' ' 127' ' ' LEU . 5.0 mp -59.83 -49.84 76.14 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.556 -0.715 . . . . 0.0 110.272 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.1 m -91.28 113.51 58.62 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.549 -0.72 . . . . 0.0 110.063 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.81 107.09 2.33 Favored 'Trans proline' 0 C--N 1.32 -0.939 0 O-C-N 123.153 1.081 . . . . 0.0 110.596 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.615 ' O ' ' HB3' ' A' ' 164' ' ' ALA . 81.8 mtt-85 -110.98 149.78 40.93 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.599 -0.688 . . . . 0.0 109.929 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.04 150.37 60.31 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.463 1.243 . . . . 0.0 110.89 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.449 HG21 ' SG ' ' A' ' 159' ' ' CYS . 39.3 t -51.92 -30.09 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.461 -0.774 . . . . 0.0 109.79 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.1 t -61.65 -41.03 96.94 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.626 -0.672 . . . . 0.0 111.222 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.441 ' CE2' ' HD3' ' A' ' 130' ' ' ARG . 86.7 t80 -67.69 -39.96 84.41 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.349 -0.844 . . . . 0.0 109.75 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 135' ' ' LEU . 23.9 tp -93.66 18.94 9.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.838 -0.539 . . . . 0.0 110.253 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -81.34 117.2 21.62 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.542 1.163 . . . . 0.0 112.757 -178.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.2 37.88 3.71 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.0 m -119.55 21.23 12.18 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.715 -0.873 . . . . 0.0 110.44 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.556 ' HB3' HG21 ' A' ' 55' ' ' VAL . 2.6 m -71.98 129.69 39.17 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.324 -0.86 . . . . 0.0 109.497 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 109.84 -24.4 19.4 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.82 110.69 2.28 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.34 149.11 56.38 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 O-C-N 123.234 1.123 . . . . 0.0 110.857 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.605 HD12 ' N ' ' A' ' 143' ' ' LEU . 6.6 mp -99.59 119.33 37.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.708 -0.62 . . . . 0.0 109.535 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.685 HD12 ' HA ' ' A' ' 150' ' ' ALA . 2.6 tp -105.82 120.91 42.92 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.582 -0.699 . . . . 0.0 110.775 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 26.9 p -64.36 163.34 26.23 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.72 -0.613 . . . . 0.0 109.697 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.09 -15.22 47.74 Favored 'Trans proline' 0 N--CA 1.487 1.118 0 O-C-N 123.245 1.129 . . . . 0.0 111.158 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.2 m -70.0 -27.09 64.41 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.264 -0.898 . . . . 0.0 110.084 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 107.84 43.14 1.35 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -144.7 158.65 43.69 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.497 -1.002 . . . . 0.0 110.267 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.685 ' HA ' HD12 ' A' ' 144' ' ' LEU . . . -78.04 148.49 34.29 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.578 -0.701 . . . . 0.0 110.318 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.599 HG21 HD22 ' A' ' 104' ' ' LEU . 59.4 t -119.17 -62.44 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.573 -0.704 . . . . 0.0 110.22 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -156.53 -158.03 8.64 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.6 mt -135.86 145.36 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.597 -0.943 . . . . 0.0 109.675 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.509 ' HB2' HD11 ' A' ' 106' ' ' LEU . 12.7 t80 -62.55 155.46 25.83 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.438 -0.789 . . . . 0.0 109.605 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 33.2 ttm-85 -140.38 -66.17 0.44 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.945 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -130.57 143.68 50.92 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.935 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.59 127.64 39.36 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.1 119.95 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.617 -0.677 . . . . 0.0 111.305 -177.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.449 ' SG ' HG21 ' A' ' 132' ' ' VAL . 27.7 p -141.26 158.98 43.16 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.497 -0.752 . . . . 0.0 110.508 178.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 11.0 m -91.18 -56.86 2.99 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.567 -0.708 . . . . 0.0 109.456 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.5 ptp85 -123.85 36.62 4.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.607 -0.683 . . . . 0.0 109.449 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 103.7 -11.46 53.41 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 63.1 t -92.46 124.23 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.219 -1.165 . . . . 0.0 109.132 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 130' ' ' ARG . . . -87.17 119.84 27.81 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.521 -0.737 . . . . 0.0 110.895 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 12.0 mtpp -110.15 -28.74 8.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.709 -0.619 . . . . 0.0 109.907 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.591 ' HB1' HH11 ' A' ' 123' ' ' ARG . . . -130.14 168.14 17.26 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.601 -0.687 . . . . 0.0 110.172 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.3 m -139.5 142.48 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.548 -0.72 . . . . 0.0 110.518 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -117.06 137.0 52.55 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.588 -0.695 . . . . 0.0 110.851 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -147.75 159.89 43.31 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.677 -0.64 . . . . 0.0 110.525 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.406 HG13 ' HD2' ' A' ' 171' ' ' PRO . 22.5 t -107.33 143.62 27.55 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 121.481 -0.762 . . . . 0.0 109.441 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.406 ' HD2' HG13 ' A' ' 170' ' ' VAL . 47.0 Cg_endo -74.35 -179.67 4.99 Favored 'Trans proline' 0 C--N 1.319 -0.985 0 O-C-N 123.336 1.177 . . . . 0.0 110.603 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 57.4 t -94.79 -27.87 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.623 -0.673 . . . . 0.0 110.025 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -59.95 -34.2 72.93 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.581 -0.699 . . . . 0.0 110.552 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 34.7 t -61.7 -31.31 71.45 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.546 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.455 ' CE ' ' CZ3' ' A' ' 53' ' ' TRP . 69.3 mmm -71.6 -27.37 63.07 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.443 -0.786 . . . . 0.0 110.564 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -56.8 -42.99 80.51 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.361 -0.837 . . . . 0.0 110.496 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 86.3 m -69.59 -40.11 76.88 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.471 -0.768 . . . . 0.0 109.684 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 91.0 m -71.68 -34.47 69.69 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.622 -0.674 . . . . 0.0 110.24 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 4.9 tmm? -60.06 -39.93 87.72 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.511 -0.743 . . . . 0.0 110.278 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -60.08 -39.9 87.71 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.527 -0.733 . . . . 0.0 110.132 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.911 0 O-C-N 121.619 -0.676 . . . . 0.0 110.169 179.841 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 . . . . . 0 N--CA 1.498 1.965 0 CA-C-O 121.062 0.458 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 97.8 t -139.3 140.03 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.569 -0.707 . . . . 0.0 109.808 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -133.62 151.49 51.7 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.535 -0.728 . . . . 0.0 110.201 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.434 ' HA ' HD22 ' A' ' 44' ' ' LEU . 91.0 t -93.79 119.45 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.616 -0.677 . . . . 0.0 110.087 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.1 p -134.07 130.07 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.488 -0.757 . . . . 0.0 109.824 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 66.8 m -116.89 155.15 29.56 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.646 -0.659 . . . . 0.0 110.312 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.514 HG22 ' H ' ' A' ' 39' ' ' ALA . 0.9 OUTLIER -116.38 -178.65 3.46 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.709 -0.619 . . . . 0.0 110.121 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.514 ' H ' HG22 ' A' ' 38' ' ' THR . . . -73.29 -25.47 60.68 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.308 -178.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.3 p -119.11 -28.27 5.51 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.312 -0.868 . . . . 0.0 111.19 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.1 pm0 -140.43 171.9 13.48 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.366 -0.834 . . . . 0.0 110.321 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.0 t -142.99 119.06 10.7 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.503 -0.748 . . . . 0.0 110.658 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 3.4 p90 -128.31 177.69 6.78 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.574 -0.704 . . . . 0.0 109.692 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.434 HD22 ' HA ' ' A' ' 35' ' ' VAL . 54.7 mt -115.83 160.48 20.1 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.504 -0.747 . . . . 0.0 110.052 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -129.64 153.96 47.59 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.39 -0.819 . . . . 0.0 110.504 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.5 p -130.98 144.08 51.21 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.636 -0.665 . . . . 0.0 110.099 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 28.4 p -93.99 121.41 35.43 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.509 -0.744 . . . . 0.0 110.564 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.4 t -130.34 136.66 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.388 -0.82 . . . . 0.0 110.412 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 43.59 34.32 0.79 Allowed 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.573 ' O ' ' HB3' ' A' ' 87' ' ' ALA . . . 89.66 -24.23 15.81 Favored Glycine 0 N--CA 1.497 2.74 0 C-N-CA 120.279 -0.962 . . . . 0.0 111.264 178.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 62.8 t -107.5 129.56 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.179 -1.189 . . . . 0.0 110.073 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -82.45 131.49 35.22 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.653 -0.654 . . . . 0.0 109.955 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.681 ' CE3' HD23 ' A' ' 82' ' ' LEU . 90.5 m95 -117.15 137.83 52.06 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.528 -0.733 . . . . 0.0 110.738 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.751 HG23 HG23 ' A' ' 83' ' ' VAL . 10.0 t -136.6 -179.1 5.48 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.722 -0.611 . . . . 0.0 109.752 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.63 HG11 ' CE1' ' A' ' 57' ' ' HIS . 18.0 t -80.32 142.29 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.542 -0.724 . . . . 0.0 109.465 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.894 ' CE2' HG22 ' A' ' 78' ' ' VAL . 7.8 t80 -84.86 -42.61 14.91 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.633 -0.667 . . . . 0.0 110.875 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.63 ' CE1' HG11 ' A' ' 55' ' ' VAL . 1.1 p-80 -55.77 -20.55 15.29 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.256 -0.903 . . . . 0.0 111.161 -177.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -73.65 -63.92 2.61 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 108.354 -1.899 . . . . 0.0 108.354 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.83 -63.51 1.29 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.563 -0.963 . . . . 0.0 109.568 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.548 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 178.919 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.9 m . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 120.948 0.404 . . . . 0.0 109.953 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -96.31 146.21 24.92 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.502 -0.749 . . . . 0.0 110.312 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.408 ' HG3' ' CD2' ' A' ' 75' ' ' TYR . 19.4 ptp -119.22 -38.53 3.02 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.575 -0.703 . . . . 0.0 110.625 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.5 ' O ' HG12 ' A' ' 83' ' ' VAL . 31.6 m-85 -112.4 120.46 41.74 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.301 -0.874 . . . . 0.0 109.752 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.529 ' HA ' HG12 ' A' ' 83' ' ' VAL . 85.6 m -148.53 130.13 14.96 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.471 -0.768 . . . . 0.0 110.331 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -167.28 117.99 0.87 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.411 -0.806 . . . . 0.0 111.532 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.894 HG22 ' CE2' ' A' ' 56' ' ' TYR . 73.7 t -72.59 -35.09 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.37 -0.831 . . . . 0.0 109.523 178.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -55.71 -35.48 66.14 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.425 -0.797 . . . . 0.0 110.225 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -106.82 -8.02 16.93 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.624 -0.673 . . . . 0.0 110.659 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.462 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 30.9 t0 53.0 43.28 31.93 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.085 -1.009 . . . . 0.0 110.431 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.681 HD23 ' CE3' ' A' ' 53' ' ' TRP . 0.6 OUTLIER -133.15 140.88 47.84 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.928 0.871 . . . . 0.0 111.836 -178.783 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.751 HG23 HG23 ' A' ' 54' ' ' THR . 1.0 OUTLIER -145.65 154.13 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -162.97 170.6 38.52 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.783 -1.199 . . . . 0.0 110.344 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -136.58 167.78 20.74 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.884 -0.774 . . . . 0.0 109.062 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -78.53 122.29 25.69 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.618 -0.677 . . . . 0.0 110.27 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.677 ' HB1' ' HD2' ' A' ' 88' ' ' PRO . . . -88.58 173.76 5.84 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.523 -0.735 . . . . 0.0 110.101 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.677 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 45.7 Cg_endo -72.31 142.6 37.65 Favored 'Trans proline' 0 C--N 1.317 -1.124 0 O-C-N 123.396 1.208 . . . . 0.0 110.362 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -76.12 154.38 37.26 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.378 1.199 . . . . 0.0 110.413 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.42 -28.73 14.08 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.74 143.74 45.98 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.522 -0.987 . . . . 0.0 110.223 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.8 ptt-85 -79.28 159.99 27.01 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.579 -0.701 . . . . 0.0 110.288 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.0 m -125.3 159.21 32.27 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.596 -0.69 . . . . 0.0 110.268 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.99 147.12 39.05 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.518 -0.739 . . . . 0.0 110.152 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.414 HG23 ' HD2' ' A' ' 96' ' ' PRO . 86.0 m -91.4 144.0 29.04 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.626 -0.671 . . . . 0.0 110.103 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.414 ' HD2' HG23 ' A' ' 95' ' ' THR . 45.0 Cg_endo -71.54 166.1 30.45 Favored 'Trans proline' 0 C--N 1.318 -1.056 0 O-C-N 123.259 1.137 . . . . 0.0 110.398 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.464 ' HB2' HG22 ' A' ' 151' ' ' VAL . 46.7 t -65.84 140.02 58.35 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.503 -0.748 . . . . 0.0 110.353 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.8 m -134.38 38.52 3.11 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.654 -0.654 . . . . 0.0 110.029 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.8 p -144.78 -8.31 0.64 Allowed 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 119.981 -0.688 . . . . 0.0 112.368 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 55.65 34.62 60.76 Favored Glycine 0 N--CA 1.5 2.91 0 O-C-N 120.769 -1.207 . . . . 0.0 110.322 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 52.4 p -74.6 159.9 31.54 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.366 -1.079 . . . . 0.0 110.339 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.7 m -95.8 -33.51 12.23 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.635 -0.665 . . . . 0.0 110.302 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -70.29 120.83 16.54 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.503 -0.748 . . . . 0.0 110.112 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.475 HD22 HG21 ' A' ' 151' ' ' VAL . 58.5 mt -130.86 149.95 52.25 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.578 -0.702 . . . . 0.0 110.4 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -115.16 131.01 57.07 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.62 -0.675 . . . . 0.0 109.587 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.421 HD13 ' HG ' ' A' ' 143' ' ' LEU . 36.8 tp -111.83 143.48 42.7 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.48 -0.763 . . . . 0.0 110.58 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 63.3 t -104.61 129.07 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.679 -0.638 . . . . 0.0 109.392 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 70.1 p -104.35 169.38 8.51 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.475 -0.766 . . . . 0.0 110.852 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.409 ' NH1' ' CG1' ' A' ' 35' ' ' VAL . 16.2 tpt180 -59.99 -21.96 61.95 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.64 -0.662 . . . . 0.0 110.264 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -90.85 20.03 5.1 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.336 -0.852 . . . . 0.0 111.019 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 52.21 36.58 19.69 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.208 -0.932 . . . . 0.0 110.878 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -101.14 149.63 23.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.63 -0.669 . . . . 0.0 110.055 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 62.0 t -109.96 128.73 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.644 -0.66 . . . . 0.0 110.044 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 35.7 pt -138.55 138.91 23.06 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.634 -0.666 . . . . 0.0 110.139 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -79.61 151.6 22.38 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 O-C-N 123.289 1.152 . . . . 0.0 110.495 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.7 t -137.55 134.9 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.605 -0.684 . . . . 0.0 109.92 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 8.4 tpp180 -92.2 135.41 34.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.576 -0.703 . . . . 0.0 110.068 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 54.3 ttt180 -81.34 128.58 33.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.574 -0.703 . . . . 0.0 110.193 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.53 20.63 6.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.651 -0.656 . . . . 0.0 109.811 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 168.28 170.82 33.47 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -60.27 -50.05 75.19 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.499 -1.0 . . . . 0.0 110.032 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 53.1 m -114.75 -15.16 11.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.563 -0.71 . . . . 0.0 110.71 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.576 ' NH2' HG21 ' A' ' 158' ' ' VAL . 0.2 OUTLIER -95.61 136.99 35.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.435 -0.791 . . . . 0.0 110.016 -179.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -140.72 178.92 19.68 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 88.6 p -132.26 165.02 25.11 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.586 -0.95 . . . . 0.0 110.198 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 38.5 tp -121.18 138.23 54.31 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.503 -0.748 . . . . 0.0 110.218 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.556 HD12 ' N ' ' A' ' 127' ' ' LEU . 8.5 mp -68.77 -54.85 13.57 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.516 -0.74 . . . . 0.0 110.03 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.1 p -92.41 109.32 37.4 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.581 -0.699 . . . . 0.0 109.809 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -75.11 120.57 6.08 Favored 'Trans proline' 0 C--N 1.319 -0.978 0 O-C-N 123.223 1.118 . . . . 0.0 111.168 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.605 ' O ' ' HB3' ' A' ' 164' ' ' ALA . 94.1 mtm-85 -121.06 154.97 58.36 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.649 -0.657 . . . . 0.0 109.603 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -68.09 150.3 77.27 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 O-C-N 123.282 1.148 . . . . 0.0 111.141 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.447 HG21 ' SG ' ' A' ' 159' ' ' CYS . 40.6 t -53.43 -29.91 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 121.511 -0.743 . . . . 0.0 109.773 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.4 t -59.9 -41.57 91.94 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.659 -0.651 . . . . 0.0 111.23 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.42 ' CD2' ' HD2' ' A' ' 130' ' ' ARG . 83.6 t80 -68.16 -40.0 82.44 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.347 -0.845 . . . . 0.0 109.779 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.416 ' O ' ' HG ' ' A' ' 135' ' ' LEU . 31.5 tp -92.71 18.2 9.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.787 -0.571 . . . . 0.0 110.122 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -81.92 115.01 20.9 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 122.567 1.175 . . . . 0.0 112.078 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.78 28.92 6.76 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 58.1 m -110.66 20.04 18.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.57 -0.959 . . . . 0.0 110.546 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.8 m -65.64 145.18 56.36 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.268 -0.895 . . . . 0.0 109.487 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 95.9 -21.66 43.74 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.04 109.76 1.64 Allowed Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -75.69 150.63 35.52 Favored 'Trans proline' 0 C--N 1.32 -0.927 0 O-C-N 123.203 1.107 . . . . 0.0 111.036 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.421 ' HG ' HD13 ' A' ' 106' ' ' LEU . 5.0 mp -100.72 111.5 23.74 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 150' ' ' ALA . 2.2 tp -97.04 140.1 32.07 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.528 -0.732 . . . . 0.0 110.758 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -76.12 174.57 5.4 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.657 -0.652 . . . . 0.0 109.785 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.05 -28.63 28.42 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 O-C-N 123.368 1.193 . . . . 0.0 110.235 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 83.8 p -70.36 -35.35 73.5 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.573 -0.704 . . . . 0.0 110.108 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 118.88 38.95 0.73 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 58.3 m170 -124.53 137.37 54.42 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.541 -0.976 . . . . 0.0 110.403 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.434 ' HA ' HD12 ' A' ' 144' ' ' LEU . . . -65.4 140.04 58.6 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.523 -0.736 . . . . 0.0 110.148 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.475 HG21 HD22 ' A' ' 104' ' ' LEU . 62.1 t -111.29 -55.99 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.614 -0.679 . . . . 0.0 110.146 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -161.83 -165.25 18.39 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 83.3 mt -131.31 143.71 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.664 -0.903 . . . . 0.0 109.778 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -61.57 147.34 45.91 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.429 -0.795 . . . . 0.0 110.07 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.94 -71.21 0.64 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.597 0.713 . . . . 0.0 110.104 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -126.27 144.57 50.74 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 121.794 0.807 . . . . 0.0 111.269 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.49 128.52 39.63 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.576 HG21 ' NH2' ' A' ' 123' ' ' ARG . 2.4 t -99.02 120.47 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.531 -0.731 . . . . 0.0 111.671 -177.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.447 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.2 p -141.29 136.9 32.06 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.507 -0.746 . . . . 0.0 110.622 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 87.1 m -71.28 -42.52 68.64 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.546 -0.721 . . . . 0.0 109.92 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -140.86 49.54 1.68 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.575 -0.703 . . . . 0.0 110.075 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 89.99 -11.64 70.07 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 61.7 t -94.66 120.44 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.245 -1.15 . . . . 0.0 108.925 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 130' ' ' ARG . . . -87.45 117.49 26.28 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.632 -0.668 . . . . 0.0 111.074 -178.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -113.19 -26.23 8.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.751 -0.593 . . . . 0.0 110.008 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -125.98 168.45 13.91 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.485 -0.759 . . . . 0.0 110.394 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 35.3 m -144.73 135.81 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.542 -0.724 . . . . 0.0 110.48 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -112.94 133.87 54.71 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.411 -0.806 . . . . 0.0 110.954 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -147.04 162.32 39.04 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.67 -0.644 . . . . 0.0 110.366 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 4.1 m -104.23 145.21 30.23 Favored Pre-proline 0 N--CA 1.505 2.291 0 O-C-N 121.449 -0.782 . . . . 0.0 110.456 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -75.33 -171.82 1.12 Allowed 'Trans proline' 0 C--N 1.319 -1.019 0 O-C-N 123.436 1.23 . . . . 0.0 109.83 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 57.3 t -87.39 -23.26 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.595 -0.69 . . . . 0.0 110.417 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -61.69 -30.31 70.66 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.412 -0.805 . . . . 0.0 111.28 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 9.5 t -62.67 -24.46 67.64 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.161 -0.962 . . . . 0.0 110.687 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.427 ' HG2' ' CD2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -80.73 -28.25 36.62 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.487 -0.758 . . . . 0.0 111.15 -179.457 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -59.94 -44.62 94.26 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.433 -0.792 . . . . 0.0 110.551 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 90.0 m -69.9 -39.94 75.93 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.433 -0.792 . . . . 0.0 110.492 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 58.9 m -67.77 -31.85 72.03 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.543 -0.723 . . . . 0.0 110.679 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.8 -38.27 81.45 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.377 -0.827 . . . . 0.0 110.556 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -59.92 -39.96 87.22 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.443 -0.785 . . . . 0.0 110.374 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.803 0 O-C-N 121.499 -0.751 . . . . 0.0 110.148 179.871 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.467 ' CB ' HD11 ' A' ' 94' ' ' LEU . 2.8 pp20? . . . . . 0 N--CA 1.497 1.921 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.794 HG22 HD23 ' A' ' 44' ' ' LEU . 11.3 p -135.0 128.52 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.089 -1.007 . . . . 0.0 109.895 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -107.52 134.56 50.36 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.671 -0.643 . . . . 0.0 110.413 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.2 m -72.54 147.74 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.615 -0.678 . . . . 0.0 110.096 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.5 t -124.9 145.92 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.562 -0.712 . . . . 0.0 109.74 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.6 t -115.85 126.67 54.27 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.656 -0.652 . . . . 0.0 110.36 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.482 HG22 ' H ' ' A' ' 39' ' ' ALA . 2.3 m -113.92 175.57 5.41 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.578 -0.701 . . . . 0.0 110.012 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.482 ' H ' HG22 ' A' ' 38' ' ' THR . . . -77.01 -13.96 59.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.668 -0.645 . . . . 0.0 111.326 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 77.5 p -121.25 -28.21 4.73 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.173 -0.954 . . . . 0.0 111.424 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -154.42 175.86 13.05 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.278 -0.888 . . . . 0.0 110.95 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.5 t -135.91 122.82 21.3 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.71 -0.619 . . . . 0.0 109.935 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -127.78 -169.61 2.09 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.504 -0.748 . . . . 0.0 110.368 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.794 HD23 HG22 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -116.41 167.83 10.69 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.574 -0.704 . . . . 0.0 110.491 -179.455 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.661 ' O ' HG23 ' A' ' 33' ' ' VAL . . . -140.61 140.71 35.12 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.604 -0.685 . . . . 0.0 110.151 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.408 HG21 ' HB3' ' A' ' 142' ' ' PRO . 67.7 p -119.26 138.62 52.88 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.428 -0.795 . . . . 0.0 110.057 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.1 t -101.14 115.09 29.68 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.541 -0.725 . . . . 0.0 110.596 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.0 t -129.98 127.1 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.457 -0.777 . . . . 0.0 110.159 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 64.8 t30 53.16 40.21 30.88 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.455 -0.778 . . . . 0.0 111.045 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.01 21.5 71.67 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.507 HG12 ' NE1' ' A' ' 53' ' ' TRP . 62.9 t -130.21 113.75 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.399 -1.059 . . . . 0.0 109.463 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.2 t -82.98 133.02 35.12 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.593 -0.692 . . . . 0.0 109.906 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.507 ' NE1' HG12 ' A' ' 51' ' ' VAL . 92.9 m95 -119.95 136.39 54.55 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.492 -0.755 . . . . 0.0 111.094 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.665 HG22 ' O ' ' A' ' 83' ' ' VAL . 6.5 t -137.71 -179.92 6.04 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.918 HG11 ' CE1' ' A' ' 57' ' ' HIS . 47.2 t -92.39 147.56 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.294 -0.879 . . . . 0.0 109.979 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.89 ' CE2' HG22 ' A' ' 78' ' ' VAL . 21.6 t80 -84.15 -43.45 14.98 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.539 -0.726 . . . . 0.0 111.407 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.918 ' CE1' HG11 ' A' ' 55' ' ' VAL . 1.5 p-80 -52.38 -25.91 11.08 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.116 -0.99 . . . . 0.0 111.114 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.431 ' N ' ' CD2' ' A' ' 57' ' ' HIS . . . -89.59 -55.99 1.95 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.24 -63.38 1.41 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.527 -0.984 . . . . 0.0 110.334 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.433 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.961 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 64.6 p . . . . . 0 N--CA 1.498 1.938 0 CA-C-O 121.221 0.534 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -82.66 119.95 24.94 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.578 -0.701 . . . . 0.0 110.086 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.2 mtp -83.97 -51.15 7.37 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.526 -0.734 . . . . 0.0 110.473 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.467 ' CD2' ' N ' ' A' ' 75' ' ' TYR . 1.2 p90 -122.54 130.09 52.66 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.672 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.939 ' HA ' HG12 ' A' ' 83' ' ' VAL . 57.0 m -135.28 141.1 45.63 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.659 -0.651 . . . . 0.0 110.501 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -161.34 120.92 2.57 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.234 -0.916 . . . . 0.0 112.133 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.89 HG22 ' CE2' ' A' ' 56' ' ' TYR . 54.2 t -72.88 -39.11 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.295 -0.878 . . . . 0.0 109.34 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -55.54 -43.04 75.45 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.389 -0.82 . . . . 0.0 110.369 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.708 ' HB3' HD22 ' A' ' 82' ' ' LEU . 3.3 tp60 -90.92 -9.68 45.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.608 -0.683 . . . . 0.0 110.485 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.416 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 37.5 t0 52.47 42.0 31.09 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.088 -1.007 . . . . 0.0 111.54 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 1.062 HD21 HG21 ' A' ' 178' ' ' THR . 0.3 OUTLIER -148.58 143.1 26.37 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.173 -0.954 . . . . 0.0 111.123 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.939 HG12 ' HA ' ' A' ' 76' ' ' THR . 28.4 m -145.18 144.08 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.448 ' N ' ' CE1' ' A' ' 75' ' ' TYR . . . -142.61 156.83 26.46 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.571 -1.3 . . . . 0.0 110.347 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.49 ' CH2' HG21 ' A' ' 54' ' ' THR . 3.6 m-90 -113.63 168.11 10.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.901 -0.764 . . . . 0.0 109.331 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -87.29 100.62 12.84 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.494 -0.754 . . . . 0.0 109.299 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.08 158.88 82.6 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.636 -0.665 . . . . 0.0 110.461 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.43 160.13 49.49 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.523 1.275 . . . . 0.0 110.299 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.49 151.01 52.69 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 O-C-N 123.402 1.212 . . . . 0.0 110.283 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.34 -23.72 34.28 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.13 152.76 23.55 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.336 -1.096 . . . . 0.0 110.291 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -70.25 148.01 49.08 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.561 -0.712 . . . . 0.0 110.244 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 80.0 p -126.7 149.71 49.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.58 -0.7 . . . . 0.0 110.093 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.467 HD11 ' CB ' ' A' ' 32' ' ' GLU . 6.6 mt -109.79 157.4 19.2 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.541 -0.725 . . . . 0.0 110.548 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.43 HG23 ' HD2' ' A' ' 96' ' ' PRO . 89.7 m -98.16 144.4 27.99 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.701 -0.625 . . . . 0.0 109.727 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.43 ' HD2' HG23 ' A' ' 95' ' ' THR . 43.5 Cg_endo -69.48 160.47 49.67 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.256 1.135 . . . . 0.0 110.407 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 45.2 t -60.02 134.64 57.23 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.587 -0.695 . . . . 0.0 110.445 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 21.6 m -136.1 48.29 2.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.673 -0.642 . . . . 0.0 109.977 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.9 p -144.89 -8.31 0.63 Allowed 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 119.949 -0.701 . . . . 0.0 112.383 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.68 72.01 0.61 Allowed Glycine 0 N--CA 1.5 2.928 0 O-C-N 120.766 -1.209 . . . . 0.0 110.288 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.0 m -125.09 129.98 51.31 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.522 -0.987 . . . . 0.0 110.471 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.7 m -67.19 -39.95 86.47 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.492 -0.755 . . . . 0.0 110.138 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -60.17 131.75 51.79 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.589 -0.694 . . . . 0.0 110.356 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.708 HD22 HG11 ' A' ' 151' ' ' VAL . 88.3 mt -136.36 160.21 39.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.646 -0.658 . . . . 0.0 110.153 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -122.98 109.45 14.13 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.477 -0.764 . . . . 0.0 110.246 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.653 ' O ' HG11 ' A' ' 113' ' ' VAL . 21.1 tp -74.17 148.14 41.96 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.708 -0.62 . . . . 0.0 109.837 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.454 HG21 HD23 ' A' ' 144' ' ' LEU . 61.0 t -126.28 119.99 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.289 -0.882 . . . . 0.0 110.244 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.887 HG23 HG13 ' A' ' 113' ' ' VAL . 53.0 p -91.36 -164.93 1.25 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.264 -0.898 . . . . 0.0 110.076 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.26 -18.99 24.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.522 -0.736 . . . . 0.0 111.229 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.428 ' O ' ' CG ' ' A' ' 110' ' ' HIS . 4.5 t60 -109.65 29.4 7.62 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.259 -0.9 . . . . 0.0 110.666 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 57.47 33.62 23.52 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.301 -0.874 . . . . 0.0 112.063 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.784 ' O ' HG13 ' A' ' 113' ' ' VAL . 7.0 p-10 -119.39 134.01 55.43 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.285 -0.884 . . . . 0.0 109.727 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.887 HG13 HG23 ' A' ' 108' ' ' THR . 0.0 OUTLIER -176.37 -173.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.425 0 CA-C-O 121.853 0.835 . . . . 0.0 111.143 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.407 ' CG1' ' HD2' ' A' ' 115' ' ' PRO . 0.0 OUTLIER -152.19 168.8 10.58 Favored Pre-proline 0 N--CA 1.49 1.568 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.445 ' O ' HD13 ' A' ' 127' ' ' LEU . 43.0 Cg_endo -70.36 145.12 52.77 Favored 'Trans proline' 0 C--N 1.317 -1.106 0 O-C-N 123.217 1.114 . . . . 0.0 110.066 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.615 HG13 ' O ' ' A' ' 125' ' ' SER . 57.3 t -126.91 130.0 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.569 -0.707 . . . . 0.0 110.116 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.9 mmm180 -83.28 132.39 35.03 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.487 -0.758 . . . . 0.0 110.053 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 49.6 ttm-85 -65.96 133.27 50.49 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.535 -0.728 . . . . 0.0 110.242 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -116.49 -22.44 8.72 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.622 -0.674 . . . . 0.0 110.478 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -155.93 -167.33 17.21 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -70.09 -39.95 75.27 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.598 -0.942 . . . . 0.0 110.565 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 36.9 p -129.9 26.46 5.24 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.396 -0.815 . . . . 0.0 110.801 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.48 152.61 41.7 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.511 -0.743 . . . . 0.0 110.181 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -149.19 -179.98 25.51 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.615 ' O ' HG13 ' A' ' 116' ' ' VAL . 78.0 p -120.0 151.5 38.88 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.703 -0.881 . . . . 0.0 110.217 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.0 tp -100.0 129.88 46.11 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.653 -0.655 . . . . 0.0 110.195 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.445 HD13 ' O ' ' A' ' 115' ' ' PRO . 4.3 mp -61.91 -53.91 49.17 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.581 -0.699 . . . . 0.0 110.404 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.6 t -95.28 129.91 33.87 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.561 -0.712 . . . . 0.0 110.124 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -79.27 106.85 2.1 Favored 'Trans proline' 0 C--N 1.32 -0.97 0 O-C-N 123.175 1.092 . . . . 0.0 110.673 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.418 ' HD2' ' CD2' ' A' ' 134' ' ' TYR . 4.6 mtm180 -114.21 149.91 42.81 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.599 -0.688 . . . . 0.0 109.636 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.36 150.31 70.52 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 123.317 1.167 . . . . 0.0 111.153 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.775 HG12 ' CE ' ' A' ' 136' ' ' LYS . 66.0 t -52.85 -29.26 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.501 -0.749 . . . . 0.0 109.81 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.93 -43.26 95.05 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.605 -0.685 . . . . 0.0 111.279 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.418 ' CD2' ' HD2' ' A' ' 130' ' ' ARG . 88.9 t80 -65.89 -40.01 91.18 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.358 -0.838 . . . . 0.0 109.619 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.42 ' HA ' HD12 ' A' ' 135' ' ' LEU . 21.8 tp -93.26 18.87 8.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.926 -0.484 . . . . 0.0 110.278 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.775 ' CE ' HG12 ' A' ' 132' ' ' VAL . 8.4 ttmt -82.47 116.64 22.01 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 122.523 1.154 . . . . 0.0 112.514 -178.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.97 30.14 6.18 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.0 m -110.57 20.26 17.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.687 -0.89 . . . . 0.0 110.353 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.7 m -76.44 141.81 41.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.311 -0.868 . . . . 0.0 109.557 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.467 ' C ' HG23 ' A' ' 153' ' ' ILE . . . 95.91 -26.62 19.74 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.84 128.35 44.83 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 108.911 -1.675 . . . . 0.0 108.911 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.408 ' HB3' HG21 ' A' ' 46' ' ' THR . 48.4 Cg_endo -75.05 172.54 16.16 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 O-C-N 123.201 1.106 . . . . 0.0 111.142 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.916 ' O ' HG12 ' A' ' 151' ' ' VAL . 3.3 mp -117.68 115.61 25.41 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.455 HD22 ' N ' ' A' ' 144' ' ' LEU . 4.5 mm? -90.09 152.37 21.17 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.701 -0.624 . . . . 0.0 111.017 -178.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.407 ' CB ' ' HD2' ' A' ' 146' ' ' PRO . 0.1 OUTLIER -93.95 179.28 1.28 Allowed Pre-proline 0 N--CA 1.494 1.733 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.375 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.407 ' HD2' ' CB ' ' A' ' 145' ' ' CYS . 43.0 Cg_endo -69.63 -26.62 27.99 Favored 'Trans proline' 0 C--N 1.318 -1.069 0 O-C-N 123.202 1.106 . . . . 0.0 110.319 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 66.2 m -79.41 -29.06 41.8 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.519 -0.738 . . . . 0.0 110.043 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 113.43 50.26 0.54 Allowed Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -135.77 148.06 48.63 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.517 -0.99 . . . . 0.0 110.288 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -76.1 136.94 39.86 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.537 -0.727 . . . . 0.0 110.051 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.916 HG12 ' O ' ' A' ' 143' ' ' LEU . 13.0 p -119.06 -24.45 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.559 -0.713 . . . . 0.0 110.878 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 176.6 -167.74 39.38 Favored Glycine 0 N--CA 1.498 2.784 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.29 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.556 HD12 ' CE ' ' A' ' 175' ' ' MET . 71.8 mt -130.38 158.88 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.598 -0.942 . . . . 0.0 109.833 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -75.84 151.64 37.42 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.454 -0.779 . . . . 0.0 109.918 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.646 ' CZ ' HG21 ' A' ' 170' ' ' VAL . 30.7 ttm180 -131.83 -76.41 0.51 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.572 -0.705 . . . . 0.0 110.797 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -122.46 143.68 49.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.086 -1.009 . . . . 0.0 111.406 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.65 127.87 39.55 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.5 t -97.67 117.98 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 O-C-N 121.506 -0.746 . . . . 0.0 111.673 -177.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.429 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.9 p -141.07 148.72 40.63 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.371 -0.831 . . . . 0.0 110.672 178.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 63.7 m -85.56 -50.14 7.47 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.448 -0.782 . . . . 0.0 109.72 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.75 32.79 5.61 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.74 -0.6 . . . . 0.0 109.608 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 101.44 -11.69 58.23 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 63.4 t -89.51 120.92 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.223 -1.163 . . . . 0.0 108.991 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -86.97 113.25 22.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.644 -0.66 . . . . 0.0 110.975 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -108.52 -26.23 10.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.787 -0.571 . . . . 0.0 109.862 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -121.27 164.02 17.65 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.47 -0.769 . . . . 0.0 109.952 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 167' ' ' VAL . 35.0 m -141.81 131.1 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.534 -0.729 . . . . 0.0 110.659 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -103.83 129.67 51.32 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.477 -0.765 . . . . 0.0 110.709 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -142.65 162.17 36.18 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.568 -0.708 . . . . 0.0 110.188 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.646 HG21 ' CZ ' ' A' ' 155' ' ' ARG . 86.1 t -111.93 144.93 31.7 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.427 -0.796 . . . . 0.0 110.089 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.474 ' HD2' HG13 ' A' ' 170' ' ' VAL . 45.9 Cg_endo -71.95 175.2 10.09 Favored 'Trans proline' 0 N--CA 1.486 1.061 0 O-C-N 123.319 1.168 . . . . 0.0 110.984 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 151' ' ' VAL . 59.4 t -79.42 -41.41 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.657 -0.652 . . . . 0.0 110.153 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -54.41 -36.32 63.84 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.835 -0.541 . . . . 0.0 111.045 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.435 ' O ' HG22 ' A' ' 177' ' ' THR . 45.2 t -61.84 -33.71 74.66 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.485 -0.76 . . . . 0.0 109.906 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.556 ' CE ' HD12 ' A' ' 153' ' ' ILE . 67.2 mtt -70.05 -27.94 65.05 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.595 -0.69 . . . . 0.0 110.446 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -59.5 -50.09 75.28 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.495 -0.753 . . . . 0.0 110.64 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.435 HG22 ' O ' ' A' ' 174' ' ' SER . 7.1 t -69.98 -22.54 63.14 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.516 -0.74 . . . . 0.0 110.825 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 1.062 HG21 HD21 ' A' ' 82' ' ' LEU . 68.4 m -68.68 -29.08 67.46 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.439 -0.788 . . . . 0.0 110.53 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 91.1 mtp -59.98 -48.49 81.48 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.476 -0.765 . . . . 0.0 110.257 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -59.91 -40.07 87.55 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.606 -0.684 . . . . 0.0 110.315 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.792 0 O-C-N 121.65 -0.656 . . . . 0.0 110.188 -179.961 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.729 ' HG2' HD21 ' A' ' 94' ' ' LEU . 26.1 mp0 . . . . . 0 N--CA 1.501 2.124 0 CA-C-O 120.79 0.328 . . . . 0.0 111.221 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.472 HG11 ' CD ' ' A' ' 142' ' ' PRO . 27.4 m -132.77 160.06 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.483 -0.76 . . . . 0.0 109.83 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.547 ' O ' HD23 ' A' ' 44' ' ' LEU . 9.9 pt20 -143.42 126.53 16.46 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.615 -0.678 . . . . 0.0 110.24 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.0 m -74.39 145.54 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.506 -0.746 . . . . 0.0 109.934 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.72 HG22 ' O ' ' A' ' 43' ' ' PHE . 33.6 m -136.0 148.07 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.444 -0.785 . . . . 0.0 110.19 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.8 m -116.41 126.09 52.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.613 -0.68 . . . . 0.0 110.412 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.502 HG22 ' H ' ' A' ' 39' ' ' ALA . 0.3 OUTLIER -101.52 -171.01 1.91 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.624 -0.672 . . . . 0.0 109.455 179.682 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.502 ' H ' HG22 ' A' ' 38' ' ' THR . . . -60.08 -51.74 68.32 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.77 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.1 t -128.02 10.78 6.47 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.468 -0.77 . . . . 0.0 111.529 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -148.29 161.24 41.92 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.135 -0.978 . . . . 0.0 110.603 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 81.2 p -143.3 125.71 15.7 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.547 -0.72 . . . . 0.0 110.144 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.72 ' O ' HG22 ' A' ' 36' ' ' VAL . 27.5 p90 -129.45 -169.69 2.15 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.638 -0.664 . . . . 0.0 110.252 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.547 HD23 ' O ' ' A' ' 34' ' ' GLN . 3.1 mt -126.13 164.49 20.79 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.617 -0.677 . . . . 0.0 110.43 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -138.65 140.33 38.83 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.588 -0.695 . . . . 0.0 110.16 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.7 m -115.01 127.86 55.92 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.528 -0.732 . . . . 0.0 110.096 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.554 ' O ' HD12 ' A' ' 94' ' ' LEU . 26.7 p -75.62 117.02 16.94 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.569 -0.707 . . . . 0.0 110.773 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.7 t -130.29 123.95 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.33 -0.856 . . . . 0.0 110.436 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 50.74 34.06 9.4 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.568 -0.708 . . . . 0.0 111.764 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 87' ' ' ALA . . . 88.76 -24.23 13.49 Favored Glycine 0 N--CA 1.498 2.778 0 C-N-CA 120.365 -0.921 . . . . 0.0 111.216 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.7 t -106.53 113.94 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.155 -1.203 . . . . 0.0 109.781 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 27.5 p -71.12 154.49 41.69 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.438 -0.789 . . . . 0.0 110.259 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.567 ' CE3' HD23 ' A' ' 82' ' ' LEU . 79.0 m95 -124.36 137.06 54.51 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.606 -0.684 . . . . 0.0 110.779 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.951 HG21 ' CH2' ' A' ' 85' ' ' TRP . 7.5 t -136.99 -179.97 6.02 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.738 -0.601 . . . . 0.0 109.888 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.911 HG21 ' HB3' ' A' ' 139' ' ' SER . 62.4 t -85.41 142.01 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.608 -0.682 . . . . 0.0 109.547 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.903 ' CE2' HG22 ' A' ' 78' ' ' VAL . 25.3 t80 -85.2 -44.04 13.27 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.495 -0.753 . . . . 0.0 111.031 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.625 ' CE1' HG11 ' A' ' 55' ' ' VAL . 2.3 p-80 -60.68 -20.15 60.25 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.025 -177.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -92.71 -54.49 1.78 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.15 -47.64 19.82 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.49 -1.006 . . . . 0.0 110.58 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.412 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.801 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 t . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 121.154 0.502 . . . . 0.0 110.541 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.461 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -77.44 124.96 28.58 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.588 -0.695 . . . . 0.0 110.502 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 8.2 ttt -82.78 -52.77 6.44 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.368 -0.832 . . . . 0.0 109.795 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.606 ' O ' HG13 ' A' ' 83' ' ' VAL . 12.1 p90 -147.08 139.91 25.05 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.294 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.493 HG22 HG13 ' A' ' 83' ' ' VAL . 81.7 p -130.52 140.41 50.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.724 -0.61 . . . . 0.0 109.711 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -159.67 120.74 3.17 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.253 -0.904 . . . . 0.0 111.033 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.903 HG22 ' CE2' ' A' ' 56' ' ' TYR . 99.0 t -72.22 -35.6 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.411 -0.806 . . . . 0.0 109.769 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -55.87 -35.71 66.8 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.46 -0.775 . . . . 0.0 110.275 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 31.9 tp60 -102.55 -13.79 17.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.736 -0.603 . . . . 0.0 110.469 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.828 ' O ' HD12 ' A' ' 82' ' ' LEU . 44.9 t0 55.25 38.02 29.77 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.167 -0.958 . . . . 0.0 110.621 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.828 HD12 ' O ' ' A' ' 81' ' ' ASP . 2.2 mp -136.18 148.93 48.38 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.611 -0.681 . . . . 0.0 110.361 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.787 ' O ' HG22 ' A' ' 54' ' ' THR . 4.8 t -146.52 129.87 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.534 ' HA3' ' CZ ' ' A' ' 75' ' ' TYR . . . -118.68 163.7 13.1 Favored Glycine 0 N--CA 1.502 3.071 0 C-N-CA 118.817 -1.658 . . . . 0.0 111.307 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.951 ' CH2' HG21 ' A' ' 54' ' ' THR . 5.7 m-90 -132.51 158.42 42.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.958 -0.731 . . . . 0.0 109.469 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -74.32 103.98 4.91 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.534 -0.729 . . . . 0.0 110.013 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 50' ' ' GLY . . . -70.4 158.51 87.49 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.645 -0.659 . . . . 0.0 110.274 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.45 160.03 47.77 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 O-C-N 123.453 1.238 . . . . 0.0 110.367 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -74.98 160.05 40.68 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 O-C-N 123.404 1.213 . . . . 0.0 110.391 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 87.64 28.18 24.94 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -123.84 139.45 53.96 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.492 -1.005 . . . . 0.0 110.153 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.39 139.02 38.8 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.514 -0.741 . . . . 0.0 110.209 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.9 p -92.39 145.09 24.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.578 -0.701 . . . . 0.0 110.185 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.729 HD21 ' HG2' ' A' ' 32' ' ' GLU . 40.2 mt -79.08 157.35 28.01 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.594 -0.691 . . . . 0.0 110.175 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.2 t -110.99 150.09 41.39 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.623 -0.673 . . . . 0.0 110.209 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.22 161.38 44.69 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 O-C-N 123.388 1.204 . . . . 0.0 110.708 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 37.3 t -70.56 135.55 48.59 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.626 -0.671 . . . . 0.0 110.267 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.2 t -136.19 50.35 2.07 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.61 -0.681 . . . . 0.0 110.337 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.7 p -145.12 4.12 1.07 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.492 -0.755 . . . . 0.0 112.107 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 50.79 70.29 0.89 Allowed Glycine 0 N--CA 1.5 2.928 0 O-C-N 120.897 -1.127 . . . . 0.0 110.693 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 92.7 p -120.89 133.47 55.3 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.467 -1.02 . . . . 0.0 110.474 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 63.8 m -83.01 -28.81 29.4 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.643 -0.66 . . . . 0.0 110.198 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -66.56 133.58 50.62 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.629 -0.669 . . . . 0.0 110.181 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.772 HD22 HG11 ' A' ' 151' ' ' VAL . 91.2 mt -134.9 162.19 33.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.586 -0.696 . . . . 0.0 110.143 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -130.26 108.9 10.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.521 -0.737 . . . . 0.0 110.072 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.612 ' O ' HG11 ' A' ' 113' ' ' VAL . 21.9 tp -74.11 147.19 42.95 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.668 -0.645 . . . . 0.0 109.524 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.5 t -118.62 127.08 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.385 -0.822 . . . . 0.0 110.054 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.688 ' OG1' HG13 ' A' ' 113' ' ' VAL . 37.5 m -103.19 168.12 9.38 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.348 -0.845 . . . . 0.0 110.344 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.48 ' HA ' HD11 ' A' ' 44' ' ' LEU . 5.1 ptm180 -63.22 -27.63 69.49 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.625 -0.672 . . . . 0.0 110.965 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -96.44 26.97 4.03 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.428 -0.795 . . . . 0.0 110.812 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 52.63 24.18 3.01 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.361 -0.837 . . . . 0.0 111.092 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.761 ' O ' HG13 ' A' ' 113' ' ' VAL . 78.3 m-20 -115.03 139.33 49.95 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.426 -0.796 . . . . 0.0 109.547 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.761 HG13 ' O ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -175.7 -172.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 CA-C-O 121.803 0.811 . . . . 0.0 111.05 -179.343 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.412 ' CG1' ' HD2' ' A' ' 115' ' ' PRO . 0.2 OUTLIER -145.01 170.35 8.28 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.412 ' HD2' ' CG1' ' A' ' 114' ' ' ILE . 47.7 Cg_endo -76.13 138.21 20.15 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 O-C-N 123.288 1.152 . . . . 0.0 110.439 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.77 HG13 ' O ' ' A' ' 125' ' ' SER . 62.4 t -120.27 130.01 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.619 -0.676 . . . . 0.0 109.889 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -85.44 135.41 33.87 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.525 -0.734 . . . . 0.0 109.965 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -66.8 135.29 53.71 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.582 -0.699 . . . . 0.0 110.489 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -140.27 27.38 2.13 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.633 -0.667 . . . . 0.0 110.144 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 163.6 169.35 26.96 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -62.53 -45.16 94.25 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.592 -0.946 . . . . 0.0 110.272 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.8 m -123.51 27.08 7.57 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.615 -0.678 . . . . 0.0 110.394 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.53 155.84 45.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.505 -0.747 . . . . 0.0 110.114 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -151.52 -177.09 24.96 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.77 ' O ' HG13 ' A' ' 116' ' ' VAL . 78.9 p -119.67 152.3 37.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.638 -0.919 . . . . 0.0 110.211 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.697 HD21 ' HA ' ' A' ' 129' ' ' PRO . 0.3 OUTLIER -108.51 145.44 34.74 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.667 -0.645 . . . . 0.0 109.898 -179.719 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.5 mp -89.98 -73.79 0.51 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.658 -0.651 . . . . 0.0 109.796 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 43.0 t -72.29 112.63 15.46 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.59 -0.694 . . . . 0.0 109.334 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.697 ' HA ' HD21 ' A' ' 126' ' ' LEU . 46.0 Cg_endo -72.68 124.19 9.57 Favored 'Trans proline' 0 C--N 1.319 -0.984 0 O-C-N 123.161 1.085 . . . . 0.0 111.266 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.521 ' O ' ' HB3' ' A' ' 164' ' ' ALA . 62.6 mtm180 -127.63 153.54 77.66 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.61 150.32 56.77 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 O-C-N 123.338 1.178 . . . . 0.0 110.671 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.475 HG21 ' SG ' ' A' ' 159' ' ' CYS . 19.6 t -52.38 -29.51 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.387 -0.821 . . . . 0.0 109.577 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 46.8 t -61.24 -46.06 91.96 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.745 -0.597 . . . . 0.0 111.382 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -63.87 -39.42 94.15 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.254 -0.904 . . . . 0.0 109.618 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.41 ' O ' ' HG ' ' A' ' 135' ' ' LEU . 35.4 tp -92.2 18.62 7.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.855 -0.528 . . . . 0.0 110.025 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 19.6 tttm -83.47 119.23 24.42 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.491 1.139 . . . . 0.0 112.837 -178.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 98.79 23.51 11.8 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.5 m -105.09 20.79 18.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.496 -1.002 . . . . 0.0 110.584 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.911 ' HB3' HG21 ' A' ' 55' ' ' VAL . 2.6 m -73.61 144.41 45.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.316 -0.865 . . . . 0.0 109.243 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.656 ' HA2' HD11 ' A' ' 153' ' ' ILE . . . 97.31 -25.44 27.09 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -58.5 119.41 17.28 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.472 ' CD ' HG11 ' A' ' 33' ' ' VAL . 48.2 Cg_endo -73.65 173.87 13.19 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 O-C-N 123.214 1.112 . . . . 0.0 111.058 -178.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.427 ' C ' HD22 ' A' ' 144' ' ' LEU . 4.2 mp -121.18 130.55 53.76 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.583 HD13 ' C ' ' A' ' 149' ' ' HIS . 3.8 mm? -115.02 126.15 54.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.597 -0.689 . . . . 0.0 111.093 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.433 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 29.2 p -72.24 165.75 47.79 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.438 -0.789 . . . . 0.0 108.878 178.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.433 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 38.1 Cg_endo -63.54 -14.9 45.3 Favored 'Trans proline' 0 N--CA 1.488 1.188 0 O-C-N 123.022 1.011 . . . . 0.0 111.36 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 8.8 t -75.32 -34.14 61.21 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.227 -0.921 . . . . 0.0 110.02 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 114.31 47.47 0.59 Allowed Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.583 ' C ' HD13 ' A' ' 144' ' ' LEU . 67.6 m-70 -146.29 147.79 31.75 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.645 -0.915 . . . . 0.0 110.136 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -76.98 137.99 39.36 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.485 -0.759 . . . . 0.0 109.89 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.772 HG11 HD22 ' A' ' 104' ' ' LEU . 10.3 p -119.14 -30.87 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.512 -0.742 . . . . 0.0 111.102 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.52 -169.51 32.04 Favored Glycine 0 N--CA 1.498 2.785 0 C-N-CA 119.678 -1.249 . . . . 0.0 110.602 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.656 HD11 ' HA2' ' A' ' 140' ' ' GLY . 12.4 tt -139.96 148.89 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.701 -0.882 . . . . 0.0 109.588 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -66.42 154.95 38.83 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.156 -0.965 . . . . 0.0 111.654 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -137.82 -70.62 0.44 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.06 0.457 . . . . 0.0 109.998 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.489 ' HB3' ' OD1' ' A' ' 168' ' ' ASP . . . -123.29 145.59 48.57 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.26 -0.9 . . . . 0.0 111.743 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.52 129.65 41.23 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.3 t -100.43 122.02 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 121.404 -0.81 . . . . 0.0 111.476 -177.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.475 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.2 p -141.28 139.48 33.68 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.411 -0.805 . . . . 0.0 110.647 178.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 86.9 m -71.28 -44.16 65.74 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.579 -0.7 . . . . 0.0 109.693 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -145.23 52.38 1.2 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.606 -0.684 . . . . 0.0 109.872 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 90.78 -11.59 71.37 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 64.3 t -99.41 129.53 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.19 -1.182 . . . . 0.0 108.779 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 130' ' ' ARG . . . -87.15 123.91 32.7 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.464 -0.772 . . . . 0.0 111.536 -178.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -113.32 -28.84 7.45 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.205 0.526 . . . . 0.0 109.775 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -138.52 168.36 19.94 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.581 -0.7 . . . . 0.0 109.452 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.7 m -138.73 148.83 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.338 -0.851 . . . . 0.0 111.297 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.489 ' OD1' ' HB3' ' A' ' 156' ' ' ALA . 1.4 p30 -120.11 137.92 53.86 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.67 -0.644 . . . . 0.0 110.146 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -139.0 161.9 36.24 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.589 -0.694 . . . . 0.0 110.853 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 59.0 t -93.37 137.84 23.31 Favored Pre-proline 0 N--CA 1.497 1.905 0 O-C-N 121.504 -0.748 . . . . 0.0 110.017 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -77.53 156.28 32.14 Favored 'Trans proline' 0 C--N 1.32 -0.971 0 O-C-N 123.18 1.095 . . . . 0.0 110.293 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 96.0 t -79.94 -26.99 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.352 -0.842 . . . . 0.0 110.213 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 174' ' ' SER . 2.4 pt-20 -59.95 -28.71 67.87 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.367 -0.833 . . . . 0.0 110.375 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.41 ' N ' ' HG3' ' A' ' 173' ' ' GLU . 72.2 m -76.51 -28.83 56.54 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.472 -0.767 . . . . 0.0 110.195 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.575 ' CE ' HD21 ' A' ' 82' ' ' LEU . 64.9 mtt -59.86 -32.82 71.06 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.631 -0.668 . . . . 0.0 110.647 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -59.87 -50.08 75.17 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.433 -0.792 . . . . 0.0 110.168 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 88.1 m -72.05 -39.96 68.69 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.626 -0.671 . . . . 0.0 109.838 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 89.9 m -61.27 -38.06 85.4 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.628 -0.67 . . . . 0.0 110.236 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 5.0 tmm? -59.78 -33.94 72.35 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.509 -0.744 . . . . 0.0 110.372 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 25.9 ttm180 -59.97 -40.07 87.82 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.504 -0.747 . . . . 0.0 110.253 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.734 0 O-C-N 121.579 -0.701 . . . . 0.0 110.229 179.995 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.763 ' OE2' HD21 ' A' ' 144' ' ' LEU . 96.7 mt-10 . . . . . 0 N--CA 1.498 1.926 0 CA-C-O 121.029 0.442 . . . . 0.0 110.244 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.3 p -127.14 140.07 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.563 -0.711 . . . . 0.0 110.055 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -102.88 141.61 35.39 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.602 -0.686 . . . . 0.0 110.246 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.553 ' O ' HG23 ' A' ' 35' ' ' VAL . 33.7 m -87.05 116.28 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.589 -0.695 . . . . 0.0 110.387 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.2 p -138.57 136.14 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.468 -0.77 . . . . 0.0 109.984 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 75.7 m -131.83 143.26 50.06 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.425 -0.797 . . . . 0.0 110.745 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 70.3 p -96.58 -179.98 4.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.629 -0.669 . . . . 0.0 109.737 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.63 -14.25 61.14 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.302 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 75.2 p -119.27 -25.4 6.13 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.136 -0.977 . . . . 0.0 111.432 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -141.83 168.17 20.4 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.253 -0.905 . . . . 0.0 110.96 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.8 t -138.62 118.94 13.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.582 -0.699 . . . . 0.0 110.342 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -140.26 175.83 9.27 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.532 -0.73 . . . . 0.0 109.995 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.477 HD11 ' HA ' ' A' ' 109' ' ' ARG . 81.5 mt -115.6 152.7 32.6 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.251 -0.906 . . . . 0.0 110.545 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -117.17 141.02 48.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.604 -0.685 . . . . 0.0 110.24 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 86.2 m -117.27 143.06 46.31 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.537 -0.727 . . . . 0.0 110.228 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 93.3 m -94.13 113.75 25.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.576 -0.703 . . . . 0.0 110.654 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.2 t -127.49 129.95 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.599 -0.688 . . . . 0.0 109.905 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 53.84 39.84 30.84 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.522 -0.736 . . . . 0.0 111.175 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.639 ' O ' ' HB3' ' A' ' 87' ' ' ALA . . . 66.61 17.8 67.27 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 62.3 t -129.95 130.04 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.25 -1.147 . . . . 0.0 109.755 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 97.9 m -82.02 112.72 19.36 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.529 -0.732 . . . . 0.0 110.002 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -101.76 137.48 40.01 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.606 -0.684 . . . . 0.0 110.52 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.71 HG21 ' CZ3' ' A' ' 85' ' ' TRP . 7.4 t -136.55 -179.87 5.94 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.643 -0.661 . . . . 0.0 109.738 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.601 HG21 ' HB3' ' A' ' 139' ' ' SER . 91.0 t -83.23 142.1 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.516 -0.74 . . . . 0.0 109.872 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.839 ' CE2' HG22 ' A' ' 78' ' ' VAL . 43.0 t80 -84.55 -42.52 15.39 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.609 -0.682 . . . . 0.0 111.223 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.598 ' CE1' HG11 ' A' ' 55' ' ' VAL . 1.9 p-80 -62.01 -20.83 64.32 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.399 -0.921 . . . . 0.0 110.588 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -83.94 -75.28 1.2 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.77 -48.18 77.99 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.581 -0.952 . . . . 0.0 110.082 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.379 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.923 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.6 t . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 120.996 0.427 . . . . 0.0 110.105 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -98.16 126.57 43.68 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.513 -0.742 . . . . 0.0 110.381 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 49.3 tpp -97.22 -47.26 5.81 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.51 -0.744 . . . . 0.0 110.713 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -119.72 134.95 55.03 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.526 -0.734 . . . . 0.0 110.252 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.4 m -151.55 128.09 10.75 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.512 -0.742 . . . . 0.0 110.348 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -158.88 116.31 2.81 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.372 -0.83 . . . . 0.0 111.242 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.839 HG22 ' CE2' ' A' ' 56' ' ' TYR . 54.5 t -69.98 -40.02 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.523 -0.736 . . . . 0.0 109.531 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -59.96 -44.55 94.37 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.414 -0.804 . . . . 0.0 110.294 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.557 ' HG2' HD12 ' A' ' 82' ' ' LEU . 49.4 tt0 -80.88 -13.45 58.91 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.706 -0.621 . . . . 0.0 110.177 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.403 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 39.5 t0 53.44 36.89 24.28 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.269 -0.894 . . . . 0.0 110.866 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.557 HD12 ' HG2' ' A' ' 80' ' ' GLN . 80.5 mt -140.13 156.16 46.67 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.492 -0.755 . . . . 0.0 110.677 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.0 t -138.42 155.73 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -137.0 147.49 19.26 Favored Glycine 0 N--CA 1.494 2.561 0 C-N-CA 119.552 -1.308 . . . . 0.0 111.142 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.71 ' CZ3' HG21 ' A' ' 54' ' ' THR . 3.7 m-90 -127.09 139.35 53.05 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.77 -0.841 . . . . 0.0 109.388 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -60.39 137.37 58.15 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.396 -0.815 . . . . 0.0 110.46 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 50' ' ' GLY . . . -108.87 162.63 19.3 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.532 -0.73 . . . . 0.0 110.195 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.91 148.83 52.39 Favored 'Trans proline' 0 C--N 1.317 -1.1 0 O-C-N 123.397 1.209 . . . . 0.0 110.613 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -76.15 160.35 36.43 Favored 'Trans proline' 0 C--N 1.319 -1.01 0 O-C-N 123.354 1.186 . . . . 0.0 110.54 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 93.82 -10.67 72.08 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.38 -176.82 5.48 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.108 -1.231 . . . . 0.0 110.328 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.88 157.98 43.72 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.656 -0.653 . . . . 0.0 109.977 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.9 m -137.61 175.19 9.82 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.469 -0.769 . . . . 0.0 110.834 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.446 HD11 ' HB3' ' A' ' 32' ' ' GLU . 52.6 mt -84.43 170.21 13.77 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.741 -0.599 . . . . 0.0 110.271 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 60.5 p -115.97 158.93 41.15 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.596 -0.69 . . . . 0.0 110.112 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.37 123.41 8.68 Favored 'Trans proline' 0 C--N 1.317 -1.095 0 O-C-N 123.466 1.245 . . . . 0.0 110.675 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 10.7 t -70.86 142.13 51.23 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.546 -0.722 . . . . 0.0 110.043 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.575 HG23 ' O ' ' A' ' 98' ' ' THR . 7.4 t -135.39 72.21 1.44 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.506 -0.746 . . . . 0.0 110.464 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 27.3 p -144.86 -0.46 0.91 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.515 -0.741 . . . . 0.0 112.285 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 55.29 39.94 73.91 Favored Glycine 0 N--CA 1.498 2.784 0 O-C-N 120.825 -1.172 . . . . 0.0 110.283 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.3 t -69.97 122.75 19.95 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.434 -1.039 . . . . 0.0 110.246 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 58.4 m -70.34 -39.96 74.39 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.561 -0.712 . . . . 0.0 110.283 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -81.62 119.59 24.0 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.566 -0.709 . . . . 0.0 110.183 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 91.0 mt -129.88 150.73 51.05 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.59 -0.694 . . . . 0.0 110.472 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -115.31 133.31 56.15 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.596 -0.69 . . . . 0.0 109.728 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.789 HD12 HD11 ' A' ' 143' ' ' LEU . 9.6 tt -113.49 138.28 50.35 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.435 -0.791 . . . . 0.0 110.351 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.3 t -97.85 129.15 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.602 -0.686 . . . . 0.0 109.839 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 75.0 p -100.9 169.97 8.62 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.623 -0.673 . . . . 0.0 110.391 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.477 ' HA ' HD11 ' A' ' 44' ' ' LEU . 78.8 ttt-85 -62.5 -23.49 66.97 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.635 -0.666 . . . . 0.0 110.342 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.406 ' O ' ' CG ' ' A' ' 110' ' ' HIS . 81.1 t60 -92.86 25.7 3.06 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.409 -0.807 . . . . 0.0 110.75 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.82 44.8 27.86 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.128 -0.983 . . . . 0.0 110.83 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -113.86 155.5 25.61 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.554 -0.716 . . . . 0.0 109.975 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.2 137.2 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.561 -0.712 . . . . 0.0 110.437 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 42.2 pt -136.46 141.72 36.77 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.613 -0.679 . . . . 0.0 109.957 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -76.67 139.45 20.13 Favored 'Trans proline' 0 C--N 1.319 -1.021 0 O-C-N 123.25 1.131 . . . . 0.0 110.447 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.5 t -126.66 130.06 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.608 -0.682 . . . . 0.0 109.86 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -89.7 137.33 32.42 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.495 -0.753 . . . . 0.0 110.078 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 79.1 ttt-85 -82.08 124.33 29.73 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.514 -0.741 . . . . 0.0 110.216 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -128.85 25.19 5.64 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.612 -0.68 . . . . 0.0 110.302 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 168.88 179.56 41.07 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -61.23 -41.33 96.68 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.565 -0.962 . . . . 0.0 110.172 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.3 p -137.15 24.17 3.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.518 -0.739 . . . . 0.0 110.572 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -131.0 139.91 50.06 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.409 -0.807 . . . . 0.0 110.479 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.576 ' O ' ' HB1' ' A' ' 166' ' ' ALA . . . -146.56 179.74 23.3 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 46.9 t -129.63 144.98 51.52 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.506 -0.997 . . . . 0.0 110.26 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.419 HD23 ' O ' ' A' ' 128' ' ' SER . 19.2 tp -99.86 136.8 39.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.605 -0.684 . . . . 0.0 110.145 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.4 mp -69.67 -39.99 76.67 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.531 -0.731 . . . . 0.0 110.452 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.419 ' O ' HD23 ' A' ' 126' ' ' LEU . 47.6 t -98.63 109.48 53.28 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.424 -0.798 . . . . 0.0 110.099 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -76.82 135.3 15.71 Favored 'Trans proline' 0 C--N 1.32 -0.956 0 O-C-N 123.213 1.112 . . . . 0.0 110.751 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -135.96 162.37 57.17 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.62 -0.675 . . . . 0.0 109.769 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.5 150.29 57.4 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 O-C-N 123.385 1.202 . . . . 0.0 110.263 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 162' ' ' GLY . 83.9 t -59.09 -34.29 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.431 -0.793 . . . . 0.0 109.796 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 46.7 t -59.91 -40.04 87.47 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.578 -0.701 . . . . 0.0 110.323 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -61.05 -41.47 96.66 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.491 -0.755 . . . . 0.0 109.68 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.553 HD21 ' CZ ' ' A' ' 154' ' ' PHE . 43.9 tp -89.97 -10.1 46.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.784 -0.573 . . . . 0.0 111.332 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -62.53 138.31 58.45 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.158 -0.964 . . . . 0.0 110.657 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 87.0 20.71 52.63 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 21.8 m -120.59 13.58 11.71 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.317 -1.107 . . . . 0.0 111.052 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.601 ' HB3' HG21 ' A' ' 55' ' ' VAL . 19.8 m -59.79 151.99 24.07 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.155 -0.966 . . . . 0.0 110.287 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 92.52 -17.68 56.9 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -58.08 110.62 2.54 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -76.19 143.4 25.38 Favored 'Trans proline' 0 C--N 1.32 -0.943 0 O-C-N 123.134 1.071 . . . . 0.0 110.963 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.789 HD11 HD12 ' A' ' 106' ' ' LEU . 5.5 mp -95.78 131.82 41.66 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.763 HD21 ' OE2' ' A' ' 32' ' ' GLU . 8.8 mp -110.04 156.36 20.62 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.631 -0.668 . . . . 0.0 110.973 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.0 176.16 1.85 Allowed Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.718 -0.614 . . . . 0.0 109.642 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.59 -26.96 19.24 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 O-C-N 123.324 1.17 . . . . 0.0 110.252 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.53 -30.77 69.65 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.508 -0.745 . . . . 0.0 110.06 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 114.91 27.58 3.18 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -127.73 147.44 50.4 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.38 -1.071 . . . . 0.0 110.218 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -83.38 134.3 34.9 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.465 -0.772 . . . . 0.0 110.276 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 151' ' ' VAL . 34.4 m -90.98 -22.89 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.594 -0.691 . . . . 0.0 110.868 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 167.74 -163.58 37.25 Favored Glycine 0 N--CA 1.498 2.769 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.43 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 77.0 mt -130.05 156.16 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.641 -0.917 . . . . 0.0 109.97 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.553 ' CZ ' HD21 ' A' ' 135' ' ' LEU . 13.5 t80 -68.23 134.78 50.97 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.496 -0.753 . . . . 0.0 109.914 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.443 ' HD3' HG23 ' A' ' 170' ' ' VAL . 59.2 ttp180 -114.26 -64.86 1.25 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.569 -0.707 . . . . 0.0 111.02 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -136.09 149.81 48.87 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.431 -0.793 . . . . 0.0 110.991 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -95.99 126.46 41.25 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.662 -0.648 . . . . 0.0 109.855 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 45.1 t -95.75 118.15 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.595 -0.69 . . . . 0.0 110.453 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 26.7 p -140.05 144.87 37.08 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.464 -0.772 . . . . 0.0 110.632 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 91.8 m -73.95 -49.98 22.1 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.566 -0.709 . . . . 0.0 110.051 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -139.35 50.1 1.8 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.602 -0.686 . . . . 0.0 110.117 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.417 ' O ' HG23 ' A' ' 132' ' ' VAL . . . 96.46 -11.25 66.97 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 62.0 t -102.04 121.78 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.237 -1.155 . . . . 0.0 109.151 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.36 118.78 27.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.55 -0.719 . . . . 0.0 111.078 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -103.37 -25.83 13.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.704 -0.622 . . . . 0.0 109.641 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.576 ' HB1' ' O ' ' A' ' 124' ' ' GLY . . . -135.45 167.62 20.72 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.596 -0.69 . . . . 0.0 109.802 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.8 m -133.58 140.0 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.497 -0.752 . . . . 0.0 110.721 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -110.83 131.01 55.41 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.625 -0.672 . . . . 0.0 109.853 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -139.84 158.07 44.68 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.532 -0.73 . . . . 0.0 110.613 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.443 HG23 ' HD3' ' A' ' 155' ' ' ARG . 62.8 t -95.27 134.94 23.74 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.576 -0.703 . . . . 0.0 109.715 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.02 154.05 57.71 Favored 'Trans proline' 0 C--N 1.318 -1.045 0 O-C-N 123.175 1.092 . . . . 0.0 110.77 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 61.8 t -60.03 -38.82 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.645 -0.659 . . . . 0.0 110.062 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -57.22 -34.07 68.18 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.687 -0.633 . . . . 0.0 110.749 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 47.4 t -61.52 -40.05 93.24 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.504 -0.748 . . . . 0.0 109.964 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 61.3 mtt -59.95 -38.64 83.03 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.637 -0.665 . . . . 0.0 110.333 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -59.97 -33.14 71.53 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.667 -0.646 . . . . 0.0 110.578 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 93.9 m -59.88 -40.06 87.41 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.455 -0.778 . . . . 0.0 110.377 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 92.9 m -62.92 -49.78 73.42 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.495 -0.753 . . . . 0.0 110.094 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 76.6 mtm -65.04 -35.84 82.47 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.528 -0.732 . . . . 0.0 110.244 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -60.0 -40.01 87.74 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.524 -0.735 . . . . 0.0 110.148 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.837 0 O-C-N 121.617 -0.677 . . . . 0.0 110.148 179.87 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.645 ' OE2' HD21 ' A' ' 94' ' ' LEU . 49.5 mm-40 . . . . . 0 N--CA 1.498 1.941 0 CA-C-O 121.304 0.573 . . . . 0.0 110.006 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 45' ' ' ALA . 9.4 p -142.39 139.98 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.8 -0.563 . . . . 0.0 109.901 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -103.08 139.98 37.9 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.564 -0.71 . . . . 0.0 110.101 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.418 ' HA ' HD22 ' A' ' 44' ' ' LEU . 10.0 p -83.48 134.5 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.513 -0.742 . . . . 0.0 110.223 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.8 t -127.93 129.99 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.572 -0.705 . . . . 0.0 110.029 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.9 m -121.96 134.28 54.83 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.608 -0.683 . . . . 0.0 110.026 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.482 HG22 ' H ' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -109.74 -175.11 2.66 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.464 -0.773 . . . . 0.0 110.123 -179.865 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.482 ' H ' HG22 ' A' ' 38' ' ' THR . . . -70.04 -38.46 75.85 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.646 -0.659 . . . . 0.0 111.333 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.468 HG23 ' HG3' ' A' ' 41' ' ' GLN . 6.6 t -118.56 -20.02 8.54 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.305 -0.872 . . . . 0.0 111.738 -178.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.468 ' HG3' HG23 ' A' ' 40' ' ' THR . 79.0 mt-30 -132.38 154.32 49.9 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.21 -0.931 . . . . 0.0 110.743 -179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 73.6 m -132.34 124.07 28.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.539 -0.726 . . . . 0.0 109.923 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -136.11 170.37 16.12 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.587 -0.696 . . . . 0.0 110.532 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.418 HD22 ' HA ' ' A' ' 35' ' ' VAL . 55.6 mt -115.63 149.6 38.04 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.693 -0.629 . . . . 0.0 109.836 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.672 ' O ' HG23 ' A' ' 33' ' ' VAL . . . -115.91 148.32 40.15 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.496 -0.752 . . . . 0.0 110.189 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.629 HG21 ' HB3' ' A' ' 142' ' ' PRO . 87.3 m -119.9 136.55 54.46 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.557 -0.715 . . . . 0.0 109.873 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.415 ' O ' HD12 ' A' ' 94' ' ' LEU . 28.3 p -94.57 121.07 35.75 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.337 -0.852 . . . . 0.0 111.073 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.6 t -130.08 129.99 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.512 -0.743 . . . . 0.0 109.751 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 53.44 39.95 30.66 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.46 -0.775 . . . . 0.0 111.099 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.94 16.19 70.19 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 62.5 t -126.07 123.39 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.181 -1.188 . . . . 0.0 109.722 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 36.2 t -79.67 115.87 19.53 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.535 -0.728 . . . . 0.0 110.166 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 71.6 m95 -104.65 137.57 42.28 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.648 -0.658 . . . . 0.0 110.139 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.573 ' OG1' HG23 ' A' ' 83' ' ' VAL . 34.9 p -136.38 179.32 6.43 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.58 -0.7 . . . . 0.0 109.733 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.582 HG11 ' CE1' ' A' ' 57' ' ' HIS . 59.4 t -85.63 142.28 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.525 -0.734 . . . . 0.0 109.528 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.864 ' CE2' HG22 ' A' ' 78' ' ' VAL . 39.4 t80 -79.82 -42.9 23.39 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.424 -0.798 . . . . 0.0 111.598 -178.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.582 ' CE1' HG11 ' A' ' 55' ' ' VAL . 2.2 p-80 -67.02 -20.0 65.79 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.111 -0.993 . . . . 0.0 110.722 -178.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.74 -50.5 1.51 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -102.56 -38.34 7.57 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.498 -1.001 . . . . 0.0 110.399 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.583 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.853 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 56.3 m . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 121.012 0.434 . . . . 0.0 109.951 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -58.86 124.0 18.38 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.517 -0.739 . . . . 0.0 110.38 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.4 tpt -70.0 -40.03 75.53 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.578 -0.701 . . . . 0.0 110.294 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.536 ' O ' HG12 ' A' ' 83' ' ' VAL . 51.1 m-85 -126.01 129.99 50.28 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.497 -0.752 . . . . 0.0 110.338 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.607 ' HA ' HG12 ' A' ' 83' ' ' VAL . 60.4 m -137.97 118.8 14.16 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.711 -0.618 . . . . 0.0 110.309 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -157.02 113.01 2.93 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.358 -0.838 . . . . 0.0 111.136 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.864 HG22 ' CE2' ' A' ' 56' ' ' TYR . 56.1 t -70.02 -39.99 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.445 -0.785 . . . . 0.0 109.441 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -58.35 -46.03 87.05 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.442 -0.787 . . . . 0.0 110.033 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.9 -14.25 48.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.681 -0.637 . . . . 0.0 110.076 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.419 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 43.8 t0 53.88 39.99 31.04 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.245 -0.909 . . . . 0.0 110.575 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.831 HD11 HG21 ' A' ' 170' ' ' VAL . 68.6 mt -137.63 147.83 45.28 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.565 -0.71 . . . . 0.0 111.325 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.607 HG12 ' HA ' ' A' ' 76' ' ' THR . 11.8 m -149.96 178.85 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -179.76 171.99 43.63 Favored Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.607 -1.283 . . . . 0.0 110.774 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 7.7 m-90 -130.06 159.53 36.46 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.828 -0.807 . . . . 0.0 109.627 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -81.62 124.14 29.29 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.456 -0.777 . . . . 0.0 110.194 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -97.19 163.85 19.03 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.575 -0.703 . . . . 0.0 110.256 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -70.65 151.52 64.04 Favored 'Trans proline' 0 C--N 1.318 -1.078 0 O-C-N 123.391 1.206 . . . . 0.0 110.476 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.28 157.2 54.05 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.379 1.199 . . . . 0.0 110.404 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.04 30.58 12.44 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -123.66 154.36 39.48 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.529 -0.983 . . . . 0.0 110.244 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -70.52 150.05 46.53 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.572 -0.705 . . . . 0.0 110.161 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 94.8 p -134.07 158.96 42.25 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.596 -0.69 . . . . 0.0 110.202 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.645 HD21 ' OE2' ' A' ' 32' ' ' GLU . 59.8 mt -104.16 141.14 36.78 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.52 -0.738 . . . . 0.0 110.381 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 31.5 p -105.77 160.99 24.2 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.647 -0.658 . . . . 0.0 110.229 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.72 152.48 58.86 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.345 1.182 . . . . 0.0 110.328 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 5.5 t -85.69 139.31 31.48 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.476 -0.765 . . . . 0.0 110.271 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.6 m -125.94 72.63 1.3 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.672 -0.643 . . . . 0.0 110.179 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 27.1 p -144.48 -8.29 0.67 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.455 -0.778 . . . . 0.0 112.426 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 55.4 33.2 58.33 Favored Glycine 0 N--CA 1.499 2.841 0 O-C-N 120.773 -1.204 . . . . 0.0 110.318 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.7 t -80.67 118.58 22.35 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.558 -0.966 . . . . 0.0 110.478 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 57.9 m -60.02 -39.97 87.68 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.516 -0.74 . . . . 0.0 110.088 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -64.23 125.59 25.03 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.579 -0.701 . . . . 0.0 109.84 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.6 mt -130.14 155.38 46.3 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.636 -0.665 . . . . 0.0 110.305 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -117.85 135.78 53.87 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.678 -0.639 . . . . 0.0 109.684 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.553 ' HA ' HD23 ' A' ' 143' ' ' LEU . 9.9 tt -114.31 132.0 56.33 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.581 -0.7 . . . . 0.0 110.488 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.0 t -92.32 119.88 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.615 -0.678 . . . . 0.0 109.643 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.0 m -99.21 161.47 13.6 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.558 -0.714 . . . . 0.0 110.391 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.7 ttp180 -60.47 -24.64 65.42 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.567 -0.708 . . . . 0.0 110.359 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 18.3 m80 -92.59 26.84 2.5 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.314 -0.866 . . . . 0.0 110.942 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.61 31.9 16.04 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.151 -0.968 . . . . 0.0 110.545 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -104.89 129.41 53.26 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.66 -0.65 . . . . 0.0 109.847 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 61.9 t -109.9 125.29 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.592 -0.692 . . . . 0.0 110.238 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 38.3 mt -119.73 135.51 24.23 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.678 -0.639 . . . . 0.0 109.648 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -75.72 135.5 17.87 Favored 'Trans proline' 0 C--N 1.319 -1.026 0 O-C-N 123.213 1.112 . . . . 0.0 110.594 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.644 HG13 ' O ' ' A' ' 125' ' ' SER . 60.1 t -129.82 129.98 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.557 -0.714 . . . . 0.0 109.572 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -80.16 156.04 27.15 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.515 -0.741 . . . . 0.0 110.151 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -99.28 121.45 41.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.63 -0.669 . . . . 0.0 110.249 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 31.0 mtp85 -119.63 24.24 10.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.576 -0.703 . . . . 0.0 110.621 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -177.1 -176.9 45.6 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -64.78 -39.97 94.49 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.544 -0.974 . . . . 0.0 110.435 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 46.6 m -136.54 24.48 3.16 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.516 -0.74 . . . . 0.0 110.522 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -125.21 150.56 46.87 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.436 -0.79 . . . . 0.0 110.4 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -144.02 168.92 26.38 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.644 ' O ' HG13 ' A' ' 116' ' ' VAL . 82.9 p -112.02 152.43 28.17 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.555 -0.968 . . . . 0.0 110.23 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 35.2 tp -100.13 120.34 39.71 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.553 -0.717 . . . . 0.0 110.179 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.8 mt -59.95 -47.1 87.19 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.49 -0.756 . . . . 0.0 110.683 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 36.2 t -97.93 111.68 59.79 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.632 -0.667 . . . . 0.0 110.168 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.64 113.21 3.72 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 O-C-N 123.173 1.091 . . . . 0.0 110.479 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.431 ' HD3' ' CD2' ' A' ' 134' ' ' TYR . 37.6 mtt180 -120.25 162.78 32.05 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.577 -0.702 . . . . 0.0 110.126 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.04 150.49 66.56 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 123.384 1.202 . . . . 0.0 110.429 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 162' ' ' GLY . 86.4 t -55.92 -33.25 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.479 -0.763 . . . . 0.0 110.114 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.3 m -58.66 -46.59 86.82 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.62 -0.675 . . . . 0.0 110.763 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.431 ' CD2' ' HD3' ' A' ' 130' ' ' ARG . 64.0 t80 -59.99 -41.61 92.43 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.549 -0.719 . . . . 0.0 110.201 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 58.8 tp -84.87 -9.8 57.76 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.773 -0.579 . . . . 0.0 111.461 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -68.83 143.97 54.41 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.098 -1.002 . . . . 0.0 110.748 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.17 -2.52 65.83 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 89.2 p -102.39 10.49 39.03 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.136 -1.214 . . . . 0.0 110.807 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.97 140.69 56.57 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.252 -0.905 . . . . 0.0 110.188 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 90.51 -10.56 74.15 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.52 129.29 33.62 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.629 ' HB3' HG21 ' A' ' 46' ' ' THR . 50.5 Cg_endo -76.86 148.92 28.8 Favored 'Trans proline' 0 C--N 1.318 -1.037 0 O-C-N 123.217 1.114 . . . . 0.0 110.886 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.553 HD23 ' HA ' ' A' ' 106' ' ' LEU . 21.1 mt -99.14 118.16 35.25 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.448 HD12 ' N ' ' A' ' 144' ' ' LEU . 9.3 mp -92.0 163.14 14.1 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.586 -0.697 . . . . 0.0 111.157 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.2 177.4 1.36 Allowed Pre-proline 0 N--CA 1.493 1.7 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.06 -26.7 21.25 Favored 'Trans proline' 0 C--N 1.317 -1.106 0 O-C-N 123.264 1.139 . . . . 0.0 110.434 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 90.6 p -69.97 -33.04 71.57 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.544 -0.722 . . . . 0.0 110.236 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 106.21 45.22 1.28 Allowed Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -137.17 160.19 39.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.535 -0.979 . . . . 0.0 110.293 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.413 ' HB2' ' HB3' ' A' ' 94' ' ' LEU . . . -78.48 125.3 29.17 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.588 -0.695 . . . . 0.0 110.34 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 63.3 t -91.55 -53.43 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.565 -0.71 . . . . 0.0 110.133 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -171.08 -161.9 22.51 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.471 HD12 ' HE2' ' A' ' 175' ' ' MET . 96.7 mt -130.22 140.06 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.593 -0.945 . . . . 0.0 110.153 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -61.83 128.64 37.19 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.593 -0.692 . . . . 0.0 109.814 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -103.59 -69.6 0.79 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.595 -0.691 . . . . 0.0 110.851 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -133.88 152.41 51.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.528 -0.733 . . . . 0.0 110.692 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.01 149.81 20.9 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 57.9 t -117.79 119.32 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.542 -0.724 . . . . 0.0 110.517 -179.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.2 p -141.5 142.23 33.59 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.565 -0.709 . . . . 0.0 110.55 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 44.4 m -75.38 -40.84 57.58 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.523 -0.735 . . . . 0.0 110.03 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -145.49 51.58 1.19 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.586 -0.697 . . . . 0.0 110.402 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.476 ' O ' HG23 ' A' ' 132' ' ' VAL . . . 91.35 -10.36 75.04 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.381 -1.087 . . . . 0.0 110.381 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 96.9 t -101.77 122.31 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.165 -1.197 . . . . 0.0 109.132 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.33 118.49 26.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.586 -0.696 . . . . 0.0 110.899 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -106.21 -27.75 10.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.777 -0.577 . . . . 0.0 109.645 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -132.62 162.41 31.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.534 -0.728 . . . . 0.0 110.017 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.565 HG21 HG11 ' A' ' 116' ' ' VAL . 34.9 m -129.99 139.59 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.583 -0.698 . . . . 0.0 110.232 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -117.76 123.41 45.92 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.534 -0.729 . . . . 0.0 110.485 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -132.49 159.97 37.85 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.575 -0.703 . . . . 0.0 109.796 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.831 HG21 HD11 ' A' ' 82' ' ' LEU . 27.1 m -97.54 142.45 24.58 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.516 -0.74 . . . . 0.0 110.414 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -77.65 171.08 18.06 Favored 'Trans proline' 0 C--N 1.318 -1.045 0 O-C-N 123.265 1.139 . . . . 0.0 110.255 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 61.4 t -59.98 -36.14 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.532 -0.73 . . . . 0.0 110.167 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -59.65 -33.22 71.26 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.729 -0.607 . . . . 0.0 110.996 -178.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 64.8 p -61.5 -33.32 73.59 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.387 -0.821 . . . . 0.0 109.984 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.471 ' HE2' HD12 ' A' ' 153' ' ' ILE . 44.8 mtt -69.08 -40.07 78.68 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.643 -0.661 . . . . 0.0 110.134 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -60.0 -38.89 83.94 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.651 -0.656 . . . . 0.0 110.468 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 94.2 m -60.07 -39.97 87.88 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.6 -0.688 . . . . 0.0 110.144 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 87.2 m -60.63 -40.48 92.11 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.469 -0.77 . . . . 0.0 109.985 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 40.8 ttp -61.06 -42.03 97.72 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.658 -0.652 . . . . 0.0 110.218 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -62.25 -40.07 94.95 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.495 -0.753 . . . . 0.0 110.292 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.829 0 O-C-N 121.594 -0.691 . . . . 0.0 110.182 179.942 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.563 ' OE1' HD13 ' A' ' 94' ' ' LEU . 44.3 tp10 . . . . . 0 N--CA 1.496 1.854 0 CA-C-O 121.074 0.464 . . . . 0.0 110.232 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.466 HG21 HG11 ' A' ' 107' ' ' VAL . 61.2 t -99.05 126.37 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.638 -0.664 . . . . 0.0 110.068 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -108.2 142.24 38.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.622 -0.674 . . . . 0.0 110.123 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.474 ' HA ' HD22 ' A' ' 44' ' ' LEU . 65.4 t -87.18 114.16 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.55 -0.719 . . . . 0.0 109.589 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 62.0 t -118.45 131.33 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.448 -0.782 . . . . 0.0 109.98 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.8 m -123.12 135.37 54.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.642 -0.661 . . . . 0.0 110.086 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.472 HG22 ' H ' ' A' ' 39' ' ' ALA . 0.3 OUTLIER -101.22 -179.39 4.02 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.658 -0.651 . . . . 0.0 110.284 -179.739 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.472 ' H ' HG22 ' A' ' 38' ' ' THR . . . -67.91 -40.07 83.48 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.898 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 76.6 p -113.79 -28.22 7.51 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.381 -0.824 . . . . 0.0 110.92 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 -126.26 -179.03 4.54 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.473 -0.767 . . . . 0.0 110.452 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 81.2 p -153.47 125.9 8.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.621 -0.674 . . . . 0.0 110.317 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.458 ' O ' HD23 ' A' ' 44' ' ' LEU . 29.1 p90 -131.89 -175.98 3.91 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.644 -0.66 . . . . 0.0 109.803 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.474 HD22 ' HA ' ' A' ' 35' ' ' VAL . 78.4 mt -126.74 150.44 49.07 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.437 -0.789 . . . . 0.0 110.475 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -112.71 162.03 16.2 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.595 -0.69 . . . . 0.0 110.295 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.5 p -131.25 129.03 41.06 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.495 -0.753 . . . . 0.0 110.349 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 98.8 m -78.42 109.5 12.64 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.514 -0.741 . . . . 0.0 110.379 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.526 HG12 HD22 ' A' ' 49' ' ' ASN . 61.6 t -130.07 133.52 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.553 -0.717 . . . . 0.0 110.278 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.526 HD22 HG12 ' A' ' 48' ' ' VAL . 12.3 p30 43.91 34.26 0.88 Allowed 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' A' ' 87' ' ' ALA . . . 88.69 -19.11 38.9 Favored Glycine 0 N--CA 1.498 2.818 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.479 178.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 63.2 t -109.45 128.75 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.115 -1.227 . . . . 0.0 110.283 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 92.7 m -76.57 149.42 36.63 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.595 -0.691 . . . . 0.0 109.735 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -134.21 136.76 43.9 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.494 -0.754 . . . . 0.0 111.048 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.657 ' O ' HD23 ' A' ' 82' ' ' LEU . 7.6 t -137.58 178.29 7.22 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.659 HG11 ' CE1' ' A' ' 57' ' ' HIS . 75.9 t -80.54 141.69 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.314 -0.866 . . . . 0.0 108.993 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.875 ' CE2' HG22 ' A' ' 78' ' ' VAL . 6.5 t80 -85.0 -43.28 14.11 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.506 -0.746 . . . . 0.0 111.327 -179.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.659 ' CE1' HG11 ' A' ' 55' ' ' VAL . 1.8 p-80 -58.8 -21.38 56.11 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.291 -0.88 . . . . 0.0 111.366 -177.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -87.87 -53.64 2.66 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.87 -63.08 1.49 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.526 -0.985 . . . . 0.0 110.46 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.448 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.907 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 64.7 m . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 121.062 0.458 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -68.16 128.73 37.61 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.535 -0.728 . . . . 0.0 110.568 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 40.6 mtm -119.2 -49.71 2.38 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.537 -0.727 . . . . 0.0 110.128 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.565 ' O ' HG13 ' A' ' 83' ' ' VAL . 54.1 m-85 -110.33 127.98 55.32 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.48 -0.763 . . . . 0.0 110.149 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 90.4 m -151.21 122.58 7.84 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.572 -0.705 . . . . 0.0 110.008 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -162.9 125.13 2.64 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.368 -0.833 . . . . 0.0 111.257 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.875 HG22 ' CE2' ' A' ' 56' ' ' TYR . 74.3 t -72.36 -38.8 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.548 -0.72 . . . . 0.0 109.647 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -55.69 -39.53 71.11 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.477 -0.764 . . . . 0.0 110.488 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.1 tp60 -91.18 -14.03 31.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.704 -0.622 . . . . 0.0 110.342 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.403 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 46.8 t0 53.18 39.94 30.46 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.104 -0.997 . . . . 0.0 110.324 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.657 HD23 ' O ' ' A' ' 54' ' ' THR . 5.3 mt -142.16 160.69 39.74 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.855 0.836 . . . . 0.0 111.391 -179.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 75' ' ' TYR . 2.0 t -144.56 160.97 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -155.39 160.42 29.84 Favored Glycine 0 N--CA 1.497 2.731 0 C-N-CA 119.04 -1.553 . . . . 0.0 111.612 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 17.6 m-90 -144.79 168.0 21.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.931 -0.746 . . . . 0.0 109.458 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -69.93 143.74 52.61 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.518 -0.739 . . . . 0.0 109.931 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 50' ' ' GLY . . . -92.54 162.58 29.18 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.445 -0.784 . . . . 0.0 110.524 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.87 149.79 48.24 Favored 'Trans proline' 0 C--N 1.317 -1.093 0 O-C-N 123.581 1.306 . . . . 0.0 110.267 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -76.15 160.07 36.66 Favored 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 123.35 1.184 . . . . 0.0 110.428 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.14 29.03 52.31 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -151.68 137.02 17.6 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.516 -0.99 . . . . 0.0 110.248 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.8 mtm180 -110.81 131.89 54.66 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.553 -0.717 . . . . 0.0 110.219 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.7 m -91.79 175.54 6.85 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.546 -0.721 . . . . 0.0 110.311 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.563 HD13 ' OE1' ' A' ' 32' ' ' GLU . 3.8 mp -87.02 170.46 11.54 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.53 -0.731 . . . . 0.0 110.222 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.64 172.19 3.73 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.709 -0.62 . . . . 0.0 110.057 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.66 156.85 62.51 Favored 'Trans proline' 0 C--N 1.318 -1.039 0 O-C-N 123.314 1.165 . . . . 0.0 110.173 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.694 ' CB ' HG12 ' A' ' 151' ' ' VAL . 1.5 t -81.41 154.96 26.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.499 -0.751 . . . . 0.0 110.493 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 98' ' ' THR . 7.5 t -136.05 56.35 1.82 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.695 -0.628 . . . . 0.0 110.312 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 27.3 p -144.81 -8.41 0.63 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.413 -0.804 . . . . 0.0 112.447 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.42 29.2 38.11 Favored Glycine 0 N--CA 1.499 2.869 0 O-C-N 120.753 -1.217 . . . . 0.0 110.532 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.5 p -70.53 150.38 46.19 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.554 -0.968 . . . . 0.0 110.33 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 58.0 m -86.39 -26.63 24.69 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.639 -0.663 . . . . 0.0 110.474 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -71.74 120.46 17.36 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.544 -0.723 . . . . 0.0 110.122 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.658 HD22 HG21 ' A' ' 151' ' ' VAL . 94.9 mt -137.06 149.68 47.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.553 -0.717 . . . . 0.0 110.347 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -120.53 129.2 53.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.564 -0.71 . . . . 0.0 109.833 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.43 HD13 HD21 ' A' ' 143' ' ' LEU . 47.1 tp -108.09 146.15 33.03 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.554 -0.716 . . . . 0.0 110.276 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.466 HG11 HG21 ' A' ' 33' ' ' VAL . 59.1 t -107.36 122.39 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.655 -0.653 . . . . 0.0 109.812 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.8 p -91.67 178.53 5.89 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.58 -0.7 . . . . 0.0 110.404 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.5 ptt85 -70.2 -15.75 62.97 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.62 -0.675 . . . . 0.0 111.112 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -94.28 26.04 3.54 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.142 -0.974 . . . . 0.0 110.816 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 53.22 25.54 4.43 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.298 -0.876 . . . . 0.0 110.884 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -96.19 155.37 16.79 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.546 -0.721 . . . . 0.0 110.046 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 61.4 t -117.88 125.81 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.511 -0.743 . . . . 0.0 110.053 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 42.9 pt -126.51 142.14 42.18 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.605 -0.685 . . . . 0.0 110.093 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -76.32 153.15 35.47 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 O-C-N 123.289 1.152 . . . . 0.0 110.623 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 63.0 t -140.02 139.64 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.649 -0.657 . . . . 0.0 109.743 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 -105.1 135.04 47.2 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.591 -0.693 . . . . 0.0 110.153 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 14.6 ttt-85 -73.28 139.27 46.01 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.577 -0.702 . . . . 0.0 110.26 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.59 22.05 2.92 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.572 -0.705 . . . . 0.0 110.404 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 166.54 -170.77 41.25 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -71.03 -39.69 72.18 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.591 -0.946 . . . . 0.0 110.284 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 10.6 p -134.43 24.87 3.79 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.527 -0.733 . . . . 0.0 110.703 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.422 HH21 HG11 ' A' ' 158' ' ' VAL . 0.6 OUTLIER -141.62 140.45 33.31 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.507 -0.746 . . . . 0.0 110.317 179.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -143.7 178.03 22.07 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 81.7 p -111.07 164.18 13.1 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.597 -0.943 . . . . 0.0 110.178 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 30.4 tp -109.42 131.01 55.47 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.5 -0.75 . . . . 0.0 110.366 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.12 -51.74 68.31 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.552 -0.717 . . . . 0.0 110.447 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 67.9 m -100.14 107.86 49.38 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.532 -0.73 . . . . 0.0 109.954 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.78 108.41 2.56 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 O-C-N 123.197 1.104 . . . . 0.0 110.9 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.457 ' O ' ' HB3' ' A' ' 164' ' ' ALA . 31.9 mtt180 -115.24 161.31 30.3 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.669 -0.644 . . . . 0.0 109.849 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.21 150.39 71.5 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 O-C-N 123.405 1.213 . . . . 0.0 110.996 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.43 HG21 ' SG ' ' A' ' 159' ' ' CYS . 66.2 t -51.84 -30.04 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 121.507 -0.746 . . . . 0.0 109.731 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 36.9 t -60.71 -41.79 95.93 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.682 -0.636 . . . . 0.0 111.056 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.411 ' CD2' ' HD3' ' A' ' 130' ' ' ARG . 88.5 t80 -66.85 -39.97 87.76 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.355 -0.84 . . . . 0.0 109.41 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 23.0 tp -93.61 18.65 9.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.912 -0.493 . . . . 0.0 110.078 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -82.09 117.71 22.48 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.446 1.117 . . . . 0.0 112.066 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.65 26.87 7.83 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 36.7 m -112.7 21.61 15.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.579 -0.954 . . . . 0.0 110.405 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.544 ' CB ' HG21 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -68.33 129.89 41.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.312 -0.867 . . . . 0.0 108.851 179.353 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 106.37 -13.35 43.67 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -55.04 112.12 2.68 Favored Glycine 0 N--CA 1.499 2.839 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.13 153.22 51.63 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 O-C-N 123.142 1.075 . . . . 0.0 111.128 -178.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.43 HD21 HD13 ' A' ' 106' ' ' LEU . 44.9 mt -108.52 123.42 48.87 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.702 -0.624 . . . . 0.0 109.515 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.504 HD23 ' C ' ' A' ' 149' ' ' HIS . 0.6 OUTLIER -121.41 139.5 53.37 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.432 -0.792 . . . . 0.0 110.849 -179.378 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 68.4 m -74.08 163.63 66.94 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.638 -0.664 . . . . 0.0 109.484 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.62 -43.12 5.95 Favored 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.411 1.216 . . . . 0.0 109.561 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.7 m -119.42 27.54 8.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.705 -0.622 . . . . 0.0 109.899 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -139.0 -173.55 13.05 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.504 ' C ' HD23 ' A' ' 144' ' ' LEU . 30.2 m170 -96.82 -168.11 1.66 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.65 -0.912 . . . . 0.0 110.472 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.56 148.28 51.1 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.573 -0.705 . . . . 0.0 110.892 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.694 HG12 ' CB ' ' A' ' 97' ' ' CYS . 34.4 m -119.13 -29.67 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.701 -0.624 . . . . 0.0 110.722 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.41 -163.42 22.34 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.3 tt -142.51 158.69 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.602 -0.94 . . . . 0.0 109.82 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -71.1 159.31 34.93 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.178 -0.951 . . . . 0.0 111.029 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.56 HH21 HG22 ' A' ' 170' ' ' VAL . 10.2 ttm180 -145.75 -75.66 0.21 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.757 -0.59 . . . . 0.0 109.95 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -121.68 142.62 49.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.035 -1.04 . . . . 0.0 111.313 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.79 128.89 40.26 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.422 HG11 HH21 ' A' ' 123' ' ' ARG . 2.2 t -100.02 122.94 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.483 -0.76 . . . . 0.0 111.472 -177.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.43 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.1 p -141.15 142.57 34.04 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.482 -0.761 . . . . 0.0 110.541 178.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 88.7 m -75.93 -41.76 50.77 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.527 -0.733 . . . . 0.0 109.837 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -142.75 50.1 1.46 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.665 -0.647 . . . . 0.0 109.721 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 90.18 -11.68 70.21 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 62.6 t -94.14 120.29 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.142 -1.211 . . . . 0.0 108.997 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 130' ' ' ARG . . . -87.24 113.74 23.23 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.534 -0.729 . . . . 0.0 111.022 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -110.08 -29.68 8.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.747 -0.596 . . . . 0.0 109.661 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -116.6 168.29 10.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.701 -0.624 . . . . 0.0 109.815 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.9 m -145.11 132.9 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.532 -0.73 . . . . 0.0 110.824 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -107.45 132.14 53.52 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.576 -0.703 . . . . 0.0 110.264 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -130.17 161.1 31.88 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.712 -0.618 . . . . 0.0 110.432 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.56 HG22 HH21 ' A' ' 155' ' ' ARG . 21.9 t -96.3 142.05 24.0 Favored Pre-proline 0 N--CA 1.498 1.973 0 O-C-N 121.514 -0.741 . . . . 0.0 109.96 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.418 ' HB2' ' HG2' ' A' ' 173' ' ' GLU . 49.5 Cg_endo -74.96 159.99 40.81 Favored 'Trans proline' 0 N--CA 1.486 1.047 0 O-C-N 123.253 1.133 . . . . 0.0 110.186 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 151' ' ' VAL . 67.7 t -87.55 -28.2 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.453 -0.779 . . . . 0.0 110.748 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.418 ' HG2' ' HB2' ' A' ' 171' ' ' PRO . 9.0 pt-20 -58.8 -28.64 66.17 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.354 -0.841 . . . . 0.0 110.615 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.404 ' N ' ' HG3' ' A' ' 173' ' ' GLU . 58.0 m -68.15 -28.49 67.34 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.487 -0.758 . . . . 0.0 110.319 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 57.8 mtt -60.37 -29.46 68.94 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.51 -0.743 . . . . 0.0 110.504 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -60.07 -41.09 91.67 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.459 -0.776 . . . . 0.0 110.196 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 88.1 m -70.1 -41.19 74.35 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.551 -0.718 . . . . 0.0 110.05 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 88.0 m -70.1 -39.87 75.27 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.618 -0.676 . . . . 0.0 110.102 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 5.5 tmm? -59.97 -39.88 87.17 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.582 -0.699 . . . . 0.0 110.195 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.03 -39.84 87.26 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.618 -0.676 . . . . 0.0 110.245 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.845 0 O-C-N 121.651 -0.656 . . . . 0.0 110.227 -179.902 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 121.191 0.519 . . . . 0.0 110.294 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.1 p -135.2 146.7 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.489 -0.757 . . . . 0.0 110.064 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -104.24 165.53 10.99 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.561 -0.712 . . . . 0.0 110.256 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.8 p -121.69 129.96 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.578 -0.701 . . . . 0.0 110.074 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.8 m -141.11 147.48 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.532 -0.73 . . . . 0.0 110.512 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 54.2 m -120.07 154.72 34.23 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.581 -0.7 . . . . 0.0 110.201 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.481 HG22 ' H ' ' A' ' 39' ' ' ALA . 0.7 OUTLIER -122.78 -178.09 3.84 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.6 -0.687 . . . . 0.0 110.085 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.481 ' H ' HG22 ' A' ' 38' ' ' THR . . . -59.9 -49.84 76.11 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.553 -0.717 . . . . 0.0 110.744 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.4 p -125.8 8.06 7.49 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.479 -0.763 . . . . 0.0 111.541 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -143.41 159.32 42.6 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.06 -1.025 . . . . 0.0 110.83 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 41.0 m -142.82 121.15 12.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.67 -0.644 . . . . 0.0 109.55 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -135.39 174.81 10.19 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.575 -0.703 . . . . 0.0 110.485 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.8 mt -122.74 163.47 20.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.64 -0.662 . . . . 0.0 110.619 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -132.0 144.98 51.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.648 -0.657 . . . . 0.0 110.125 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.452 HG21 ' HB3' ' A' ' 142' ' ' PRO . 88.9 m -121.73 140.7 51.99 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.494 -0.754 . . . . 0.0 110.233 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.5 t -83.3 106.88 15.43 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.535 -0.728 . . . . 0.0 110.114 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.1 t -122.32 128.38 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.501 -0.749 . . . . 0.0 110.14 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.446 ' O ' HG23 ' A' ' 51' ' ' VAL . 13.1 t-20 53.46 39.95 30.68 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.498 -0.751 . . . . 0.0 111.009 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.638 ' O ' ' HB3' ' A' ' 87' ' ' ALA . . . 64.09 21.56 66.05 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 49' ' ' ASN . 96.7 t -130.2 129.62 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.392 -1.064 . . . . 0.0 109.667 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 35.1 t -81.7 104.51 12.15 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.577 -0.702 . . . . 0.0 109.297 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -95.8 136.91 35.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.599 -0.688 . . . . 0.0 110.779 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.606 HG21 ' CZ3' ' A' ' 85' ' ' TRP . 7.5 t -136.97 177.73 7.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.74 -0.6 . . . . 0.0 109.736 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.652 HG21 ' HB3' ' A' ' 139' ' ' SER . 95.2 t -81.47 141.88 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.477 -0.764 . . . . 0.0 109.277 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.867 ' CE2' HG22 ' A' ' 78' ' ' VAL . 43.6 t80 -84.29 -42.28 15.99 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.333 -0.855 . . . . 0.0 111.18 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.489 ' CE1' HG11 ' A' ' 55' ' ' VAL . 2.2 p-80 -65.72 -17.13 64.39 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.338 -0.851 . . . . 0.0 111.014 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -99.57 -57.32 0.94 Allowed Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.93 -36.52 27.95 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.468 -1.019 . . . . 0.0 110.586 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.531 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -179.703 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 72.4 m . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 121.165 0.507 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -68.8 130.29 42.37 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.593 -0.692 . . . . 0.0 110.722 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.6 ttt -72.94 -40.01 65.77 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.621 -0.674 . . . . 0.0 110.632 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -113.18 140.01 48.28 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.451 -0.781 . . . . 0.0 110.414 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.7 m -145.07 127.31 15.75 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.535 -0.728 . . . . 0.0 110.346 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 -155.36 105.81 2.51 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.38 -0.825 . . . . 0.0 111.184 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.867 HG22 ' CE2' ' A' ' 56' ' ' TYR . 54.4 t -69.94 -40.03 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.466 -0.771 . . . . 0.0 109.21 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -57.8 -45.76 85.61 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.464 -0.772 . . . . 0.0 109.958 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.755 ' HG2' HD12 ' A' ' 82' ' ' LEU . 31.5 tt0 -81.69 -12.47 58.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.795 -0.566 . . . . 0.0 110.114 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 39.6 t0 54.39 39.91 31.35 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.163 -0.961 . . . . 0.0 110.756 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.755 HD12 ' HG2' ' A' ' 80' ' ' GLN . 76.5 mt -140.23 151.57 45.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.588 -0.695 . . . . 0.0 110.698 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.465 HG22 ' HD1' ' A' ' 56' ' ' TYR . 9.8 t -131.94 152.57 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -131.19 156.11 21.63 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.544 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.606 ' CZ3' HG21 ' A' ' 54' ' ' THR . 1.7 m0 -136.08 159.79 40.63 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.785 -0.833 . . . . 0.0 109.755 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -83.4 123.34 29.58 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.394 -0.816 . . . . 0.0 109.954 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 50' ' ' GLY . . . -97.1 149.5 35.77 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.558 -0.714 . . . . 0.0 110.33 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.33 154.95 56.27 Favored 'Trans proline' 0 C--N 1.316 -1.158 0 O-C-N 123.507 1.267 . . . . 0.0 110.272 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.39 160.14 49.55 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 O-C-N 123.377 1.199 . . . . 0.0 110.345 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.21 30.18 13.08 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -129.85 159.14 37.48 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.469 -1.019 . . . . 0.0 110.103 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -87.77 148.44 24.71 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.557 -0.715 . . . . 0.0 110.213 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 71.3 p -120.26 140.22 51.52 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.595 -0.69 . . . . 0.0 110.204 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 70.4 mt -80.01 160.01 26.02 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.601 -0.687 . . . . 0.0 110.17 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 63.8 p -117.26 155.82 49.42 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.655 -0.653 . . . . 0.0 110.131 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.68 164.45 35.39 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 O-C-N 123.374 1.197 . . . . 0.0 110.295 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.639 ' HB2' HG22 ' A' ' 151' ' ' VAL . 7.8 t -68.03 128.45 36.58 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.504 -0.748 . . . . 0.0 110.333 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.0 p -131.93 48.75 2.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.637 -0.664 . . . . 0.0 109.745 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.8 p -144.42 -8.32 0.67 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.63 -0.669 . . . . 0.0 112.428 -179.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.76 32.32 74.06 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.1 t -80.55 113.69 18.92 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.443 -1.034 . . . . 0.0 110.281 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 66.5 m -60.01 -39.96 87.61 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.549 -0.719 . . . . 0.0 110.467 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -68.44 136.21 52.9 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.554 -0.716 . . . . 0.0 110.067 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.432 HD23 ' SG ' ' A' ' 145' ' ' CYS . 48.9 mt -137.44 159.55 41.62 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.563 -0.711 . . . . 0.0 110.61 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -119.98 139.75 52.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.661 -0.649 . . . . 0.0 109.378 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.529 HD13 HD21 ' A' ' 143' ' ' LEU . 51.7 tp -115.15 126.74 54.98 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.515 -0.74 . . . . 0.0 110.223 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 89.5 t -90.61 111.73 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.677 -0.639 . . . . 0.0 109.58 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.5 m -90.02 154.29 19.92 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.607 -0.683 . . . . 0.0 110.321 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 72.6 ttt-85 -60.01 -19.27 51.67 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.652 -0.655 . . . . 0.0 110.619 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -94.82 26.97 3.29 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.341 -0.849 . . . . 0.0 110.544 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 55.69 45.79 23.88 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.262 -0.899 . . . . 0.0 110.648 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -119.72 146.05 45.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.62 -0.675 . . . . 0.0 109.975 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 113' ' ' VAL . 13.9 p -124.21 129.98 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.44 -0.788 . . . . 0.0 110.743 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 61.5 mt -127.77 137.9 31.74 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.63 -0.669 . . . . 0.0 109.727 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -75.97 140.32 22.78 Favored 'Trans proline' 0 N--CA 1.485 1.018 0 O-C-N 123.197 1.104 . . . . 0.0 110.819 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.5 t -129.94 130.86 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.535 -0.728 . . . . 0.0 110.049 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.8 mmm180 -90.51 135.86 33.43 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.53 -0.732 . . . . 0.0 110.229 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 45.5 ttt85 -67.6 122.57 18.31 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.513 -0.742 . . . . 0.0 110.095 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -127.19 22.17 6.64 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.531 -0.731 . . . . 0.0 110.526 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 167.88 -175.92 42.62 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -70.58 -41.29 72.57 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.588 -0.949 . . . . 0.0 110.672 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.7 p -131.18 13.07 5.14 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.525 -0.734 . . . . 0.0 111.275 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 -130.27 138.58 50.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.187 -0.945 . . . . 0.0 110.269 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -137.29 156.15 23.28 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.3 p -86.3 159.48 19.41 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.509 -0.995 . . . . 0.0 110.16 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 49.4 tp -108.05 128.54 54.76 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.652 -0.655 . . . . 0.0 110.012 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.94 -40.05 91.79 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.618 -0.676 . . . . 0.0 110.338 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 62.3 m -116.15 102.61 53.7 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.447 -0.783 . . . . 0.0 110.35 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.3 123.3 8.13 Favored 'Trans proline' 0 C--N 1.319 -1.003 0 O-C-N 123.319 1.168 . . . . 0.0 110.508 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.465 ' CB ' ' CD1' ' A' ' 134' ' ' TYR . 12.7 mtt-85 -131.91 170.94 10.04 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.588 -0.695 . . . . 0.0 110.161 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 41.5 Cg_endo -65.86 150.22 85.99 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 O-C-N 123.385 1.203 . . . . 0.0 111.322 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 162' ' ' GLY . 79.2 t -54.26 -28.44 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.216 -0.927 . . . . 0.0 110.075 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 29.3 t -63.48 -31.04 72.09 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.619 -0.676 . . . . 0.0 109.637 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.465 ' CD1' ' CB ' ' A' ' 130' ' ' ARG . 0.0 OUTLIER -64.76 -40.74 95.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.675 -0.64 . . . . 0.0 109.52 179.784 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.431 ' HA ' HD12 ' A' ' 135' ' ' LEU . 13.9 tp -101.93 17.84 22.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.805 -0.559 . . . . 0.0 110.974 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -84.86 136.02 33.83 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.428 -0.795 . . . . 0.0 110.555 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.71 23.89 57.04 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 19.8 m -120.07 11.15 11.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.444 -1.033 . . . . 0.0 110.967 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.652 ' HB3' HG21 ' A' ' 55' ' ' VAL . 12.6 m -59.18 156.49 12.13 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.184 -0.947 . . . . 0.0 110.352 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 89.97 -13.05 65.66 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.574 -1.011 . . . . 0.0 110.574 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -64.62 120.26 18.39 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.452 ' HB3' HG21 ' A' ' 46' ' ' THR . 51.0 Cg_endo -78.09 145.03 21.65 Favored 'Trans proline' 0 C--N 1.32 -0.949 0 O-C-N 123.039 1.02 . . . . 0.0 111.12 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.529 HD21 HD13 ' A' ' 106' ' ' LEU . 1.0 OUTLIER -100.01 121.02 40.72 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.265 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.5 mp -118.53 154.48 32.49 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.535 -0.728 . . . . 0.0 111.267 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.432 ' SG ' HD23 ' A' ' 104' ' ' LEU . 0.9 OUTLIER -96.22 175.3 2.78 Favored Pre-proline 0 N--CA 1.491 1.603 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.358 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.97 -24.93 38.91 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.233 1.122 . . . . 0.0 110.415 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 28.8 m -65.59 -39.94 92.14 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.442 -0.786 . . . . 0.0 110.172 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 117.03 39.17 0.83 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -127.54 144.56 51.05 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.532 -0.981 . . . . 0.0 110.334 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -74.66 145.2 43.4 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.574 -0.704 . . . . 0.0 110.492 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.639 HG22 ' HB2' ' A' ' 97' ' ' CYS . 66.4 t -113.47 -51.47 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.612 -0.68 . . . . 0.0 109.93 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -174.64 -164.27 29.22 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 95.2 mt -131.72 144.04 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.522 -0.987 . . . . 0.0 109.981 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -59.95 126.56 28.02 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.55 -0.719 . . . . 0.0 109.825 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 44.5 ttt180 -105.8 -69.2 0.83 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.664 -0.647 . . . . 0.0 110.71 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -132.39 151.07 52.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.525 -0.734 . . . . 0.0 110.749 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -95.15 133.93 38.44 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.726 -0.609 . . . . 0.0 110.162 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 51.8 t -100.7 114.88 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.602 -0.686 . . . . 0.0 110.351 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.3 p -140.26 140.55 35.77 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.491 -0.755 . . . . 0.0 110.709 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 36.0 m -81.23 -47.9 12.77 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.611 -0.681 . . . . 0.0 110.045 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -127.31 42.58 3.29 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.674 -0.641 . . . . 0.0 110.031 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.525 ' O ' HG23 ' A' ' 132' ' ' VAL . . . 91.38 -11.33 72.44 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 77.4 t -97.52 122.43 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.141 -1.211 . . . . 0.0 109.198 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -88.84 115.8 26.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.59 -0.694 . . . . 0.0 110.594 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -104.03 -30.1 10.48 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -124.43 155.76 38.3 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.54 139.99 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.539 -0.726 . . . . 0.0 110.384 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -115.3 131.33 56.96 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.657 -0.652 . . . . 0.0 110.408 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -137.14 158.79 43.66 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.652 -0.655 . . . . 0.0 110.015 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 60.2 t -96.52 130.35 30.85 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.555 -0.716 . . . . 0.0 110.361 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.26 167.27 27.76 Favored 'Trans proline' 0 N--CA 1.485 0.989 0 O-C-N 123.157 1.083 . . . . 0.0 110.314 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 67.8 t -70.17 -30.5 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.532 -0.73 . . . . 0.0 110.237 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -59.94 -40.06 87.68 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.546 -0.721 . . . . 0.0 110.586 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 19.8 t -61.74 -38.77 89.19 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.57 -0.706 . . . . 0.0 110.37 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 68.6 mtt -59.93 -29.1 68.16 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.573 -0.704 . . . . 0.0 110.499 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -59.98 -38.11 81.61 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.603 -0.686 . . . . 0.0 110.665 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 91.4 m -60.02 -40.02 87.87 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.409 -0.807 . . . . 0.0 110.615 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 88.0 m -60.01 -36.4 77.14 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.442 -0.786 . . . . 0.0 110.48 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.8 mtt -60.0 -38.96 84.15 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.454 -0.779 . . . . 0.0 110.722 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 53.3 mtt180 -60.05 -39.96 87.79 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.39 -0.819 . . . . 0.0 110.364 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.791 0 O-C-N 121.608 -0.683 . . . . 0.0 110.205 179.894 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.848 ' HG3' HG23 ' A' ' 33' ' ' VAL . 14.6 pt-20 . . . . . 0 N--CA 1.497 1.888 0 CA-C-O 121.106 0.479 . . . . 0.0 110.368 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.848 HG23 ' HG3' ' A' ' 32' ' ' GLU . 71.7 t -118.08 130.01 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.549 -0.719 . . . . 0.0 110.034 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -104.58 140.5 37.91 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.682 -0.636 . . . . 0.0 110.304 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.528 ' O ' HG13 ' A' ' 35' ' ' VAL . 11.1 p -89.62 119.7 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.504 -0.747 . . . . 0.0 110.269 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 62.7 t -124.23 129.9 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.399 -0.813 . . . . 0.0 110.103 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.5 m -119.42 135.67 54.64 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.509 -0.744 . . . . 0.0 110.345 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.43 178.31 4.59 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.469 -0.769 . . . . 0.0 109.892 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.0 -50.18 74.77 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.678 -0.639 . . . . 0.0 110.602 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 74.3 p -117.77 -20.03 9.04 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.575 -0.703 . . . . 0.0 111.041 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -114.81 171.08 7.86 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.313 -0.867 . . . . 0.0 110.394 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 72.1 p -149.84 121.46 8.02 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.642 -0.661 . . . . 0.0 110.034 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 59' ' ' ALA . 41.1 p90 -134.49 171.01 14.91 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.557 -0.715 . . . . 0.0 110.028 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 91.3 mt -119.26 158.37 26.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.568 -0.707 . . . . 0.0 110.529 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -125.64 151.99 45.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.634 -0.666 . . . . 0.0 110.212 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.1 p -125.78 144.12 50.77 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.623 -0.673 . . . . 0.0 110.007 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 35.4 t -94.61 110.08 21.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.448 -0.783 . . . . 0.0 110.434 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.423 HG22 ' HB2' ' A' ' 94' ' ' LEU . 63.3 t -123.05 126.98 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.589 -0.695 . . . . 0.0 110.144 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.9 m120 53.09 39.02 28.88 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.461 -0.774 . . . . 0.0 111.227 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.44 19.59 72.8 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 63.2 t -130.18 129.87 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.296 -1.12 . . . . 0.0 109.623 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 92.4 m -84.47 133.54 34.47 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.522 -0.736 . . . . 0.0 109.684 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -119.91 136.61 54.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.519 -0.738 . . . . 0.0 110.546 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.872 HG23 HG23 ' A' ' 83' ' ' VAL . 9.8 t -137.96 175.02 9.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.708 -0.62 . . . . 0.0 109.72 179.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.643 HG11 ' CE1' ' A' ' 57' ' ' HIS . 85.8 t -80.98 142.45 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.448 -0.783 . . . . 0.0 109.993 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.797 ' CE2' HG22 ' A' ' 78' ' ' VAL . 31.4 t80 -76.54 -42.75 41.92 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.644 -0.66 . . . . 0.0 111.71 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.643 ' CE1' HG11 ' A' ' 55' ' ' VAL . 2.5 p-80 -69.94 -15.22 63.02 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.313 -0.867 . . . . 0.0 111.102 -178.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -104.84 -77.95 1.19 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.417 ' HB2' ' CE2' ' A' ' 43' ' ' PHE . . . -71.16 -39.99 71.58 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.513 -0.993 . . . . 0.0 110.697 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.505 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -179.657 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.3 m . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 121.064 0.459 . . . . 0.0 110.366 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -64.13 131.0 46.17 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.595 -0.691 . . . . 0.0 110.009 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 19.8 mmt -93.21 -35.76 12.96 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.569 -0.707 . . . . 0.0 110.457 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.594 ' O ' HG12 ' A' ' 83' ' ' VAL . 64.3 m-85 -125.57 134.13 52.06 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.509 -0.744 . . . . 0.0 110.432 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.705 ' HA ' HG12 ' A' ' 83' ' ' VAL . 15.0 p -147.11 121.34 9.54 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.51 -0.744 . . . . 0.0 110.146 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -156.91 116.51 3.45 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.451 -0.781 . . . . 0.0 110.93 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.797 HG22 ' CE2' ' A' ' 56' ' ' TYR . 95.7 t -71.74 -37.1 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.484 -0.76 . . . . 0.0 109.616 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -58.62 -48.16 81.94 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.475 -0.766 . . . . 0.0 109.653 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.532 ' HG2' HD12 ' A' ' 82' ' ' LEU . 37.9 tt0 -84.06 -14.25 51.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.579 -0.701 . . . . 0.0 109.922 178.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.492 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 61.4 t0 55.31 40.0 31.41 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.242 -0.911 . . . . 0.0 111.053 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.568 HD11 HG11 ' A' ' 170' ' ' VAL . 74.9 mt -140.96 147.29 38.54 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.424 -0.798 . . . . 0.0 111.595 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.872 HG23 HG23 ' A' ' 54' ' ' THR . 2.4 m -142.26 173.87 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -167.23 169.98 41.28 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -128.98 158.92 37.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.709 -0.877 . . . . 0.0 109.648 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -81.04 121.29 25.88 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.539 -0.726 . . . . 0.0 110.059 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -114.09 155.7 45.11 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.583 -0.698 . . . . 0.0 110.316 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.59 153.68 60.01 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 123.42 1.221 . . . . 0.0 110.543 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.59 155.72 54.41 Favored 'Trans proline' 0 C--N 1.317 -1.094 0 O-C-N 123.405 1.213 . . . . 0.0 110.349 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 109.17 31.0 3.43 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -128.65 160.03 33.74 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.489 -1.006 . . . . 0.0 110.371 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 76.6 mtt85 -65.56 140.96 58.59 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.636 -0.665 . . . . 0.0 110.25 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 58.0 m -121.87 146.46 47.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.575 -0.703 . . . . 0.0 110.219 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.423 ' HB2' HG22 ' A' ' 48' ' ' VAL . 95.4 mt -94.47 144.4 25.6 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.561 -0.712 . . . . 0.0 110.29 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.645 ' O ' ' HB3' ' A' ' 150' ' ' ALA . 7.7 t -104.3 150.73 38.73 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.639 -0.663 . . . . 0.0 110.169 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.76 151.76 69.12 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.384 1.202 . . . . 0.0 110.388 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 18.8 t -80.83 129.97 34.81 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.567 -0.708 . . . . 0.0 110.431 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 98' ' ' THR . 7.7 t -135.44 56.17 1.85 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.632 -0.667 . . . . 0.0 109.859 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.3 p -145.38 11.55 1.31 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.601 -0.687 . . . . 0.0 111.552 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 51.11 51.3 36.05 Favored Glycine 0 N--CA 1.501 2.979 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.33 109.92 15.28 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.463 -1.022 . . . . 0.0 110.506 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 29.6 p -69.92 -34.99 74.21 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.612 -0.68 . . . . 0.0 109.864 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -84.06 110.8 18.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.72 -0.612 . . . . 0.0 109.922 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.515 HD22 HG21 ' A' ' 151' ' ' VAL . 88.0 mt -115.68 136.45 53.05 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.555 -0.716 . . . . 0.0 110.198 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -106.82 139.76 40.73 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.447 -0.783 . . . . 0.0 110.177 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.428 HD12 HD21 ' A' ' 143' ' ' LEU . 7.3 tt -111.3 141.91 44.22 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.558 -0.714 . . . . 0.0 110.322 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.8 t -94.6 130.8 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.675 -0.641 . . . . 0.0 110.113 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.0 m -104.04 162.54 13.06 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.549 -0.719 . . . . 0.0 110.082 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -61.04 -23.84 65.74 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.488 -0.758 . . . . 0.0 110.599 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -95.39 26.53 3.79 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.469 -0.769 . . . . 0.0 110.637 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.14 43.35 30.79 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.336 -0.852 . . . . 0.0 110.991 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -111.34 130.91 55.53 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.477 -0.765 . . . . 0.0 109.821 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.3 m -101.43 148.13 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.558 -0.714 . . . . 0.0 110.578 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.403 ' O ' HG23 ' A' ' 114' ' ' ILE . 7.4 tt -148.55 132.66 8.67 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.561 -0.712 . . . . 0.0 109.997 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.71 142.74 36.32 Favored 'Trans proline' 0 C--N 1.319 -0.994 0 O-C-N 123.14 1.074 . . . . 0.0 110.693 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.0 t -129.97 130.21 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.66 -0.65 . . . . 0.0 110.007 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -78.07 129.97 35.87 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.491 -0.756 . . . . 0.0 110.222 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -64.23 140.03 58.83 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.568 -0.708 . . . . 0.0 110.031 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -147.56 47.19 1.12 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.587 -0.696 . . . . 0.0 110.265 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 138.53 169.05 11.47 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -60.53 -42.04 95.65 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.569 -0.959 . . . . 0.0 110.196 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.8 m -127.94 25.49 5.93 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.59 -0.694 . . . . 0.0 110.143 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.18 136.93 42.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.533 -0.73 . . . . 0.0 110.242 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -134.26 170.4 22.62 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 14.4 m -120.24 139.81 52.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.525 -0.986 . . . . 0.0 110.362 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 57.9 tp -75.86 137.08 40.2 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.625 -0.672 . . . . 0.0 109.941 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.04 -48.69 80.68 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.544 -0.722 . . . . 0.0 110.584 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 78.5 p -117.72 139.66 26.62 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.537 -0.727 . . . . 0.0 110.012 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -75.55 126.35 9.56 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 O-C-N 123.266 1.14 . . . . 0.0 110.788 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 -129.85 163.04 49.89 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.616 -0.678 . . . . 0.0 109.61 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.79 150.18 67.71 Favored 'Trans proline' 0 C--N 1.315 -1.224 0 O-C-N 123.327 1.172 . . . . 0.0 110.739 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 69.9 t -59.95 -33.55 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.601 -0.687 . . . . 0.0 109.664 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 25.6 t -59.37 -40.05 85.24 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.605 -0.684 . . . . 0.0 110.461 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -61.45 -40.76 95.67 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.546 -0.721 . . . . 0.0 109.753 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.545 HD21 ' CZ ' ' A' ' 154' ' ' PHE . 55.6 tp -89.9 -10.3 45.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.783 -0.573 . . . . 0.0 111.282 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.1 tttm -63.7 137.27 58.01 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.271 -0.893 . . . . 0.0 110.622 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 88.65 23.11 37.27 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 70.7 m -120.55 6.34 10.57 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.331 -1.1 . . . . 0.0 111.32 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.592 ' HB3' HG21 ' A' ' 55' ' ' VAL . 50.6 m -58.65 146.17 37.21 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.973 -1.079 . . . . 0.0 110.076 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 96.37 -24.36 30.78 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.16 111.64 3.79 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.24 149.41 45.6 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 O-C-N 123.169 1.089 . . . . 0.0 110.834 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.504 HD12 ' N ' ' A' ' 143' ' ' LEU . 6.3 mp -101.21 127.5 47.76 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.7 mp -118.45 122.35 42.54 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.472 -0.767 . . . . 0.0 110.948 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 27.3 p -68.49 162.93 58.22 Favored Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -64.4 -21.0 66.79 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 O-C-N 123.148 1.078 . . . . 0.0 111.327 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.6 m -62.74 -39.97 95.77 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.341 -0.849 . . . . 0.0 109.997 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.401 ' O ' ' CD2' ' A' ' 149' ' ' HIS . . . 118.59 40.17 0.68 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.401 ' CD2' ' O ' ' A' ' 148' ' ' GLY . 29.3 m170 -133.38 153.36 51.66 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.59 -0.947 . . . . 0.0 110.354 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.645 ' HB3' ' O ' ' A' ' 95' ' ' THR . . . -78.47 134.06 37.38 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.549 -0.719 . . . . 0.0 110.049 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.515 HG21 HD22 ' A' ' 104' ' ' LEU . 59.7 t -99.81 -59.98 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.527 -0.733 . . . . 0.0 110.365 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.528 ' HA2' HG23 ' A' ' 172' ' ' VAL . . . -176.31 -163.54 28.96 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 91.4 mt -128.5 139.99 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.639 -0.918 . . . . 0.0 110.159 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.545 ' CZ ' HD21 ' A' ' 135' ' ' LEU . 15.4 t80 -61.75 130.07 44.04 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.55 -0.719 . . . . 0.0 110.023 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -107.62 -63.83 1.27 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.636 -0.665 . . . . 0.0 110.636 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -136.96 152.65 50.42 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.513 -0.742 . . . . 0.0 110.815 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.64 155.37 16.9 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.694 -0.629 . . . . 0.0 109.632 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 48.0 t -121.05 112.38 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.534 -0.728 . . . . 0.0 110.519 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.4 p -141.58 142.3 33.48 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.485 -0.76 . . . . 0.0 110.429 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 25.0 m -80.2 -41.43 25.24 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.492 -0.755 . . . . 0.0 110.122 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -136.02 46.49 2.3 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.534 -0.729 . . . . 0.0 110.498 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 90.1 -10.68 73.28 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.344 -1.103 . . . . 0.0 110.344 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 63.3 t -98.39 120.75 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.141 -1.211 . . . . 0.0 109.386 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.58 114.61 24.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.587 -0.695 . . . . 0.0 110.752 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -101.65 -29.44 11.92 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 125' ' ' SER . . . -130.34 159.96 35.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.711 -0.618 . . . . 0.0 109.444 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.7 m -133.49 141.41 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.429 -0.794 . . . . 0.0 110.571 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -118.02 133.5 55.86 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.537 -0.727 . . . . 0.0 110.176 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -136.52 160.1 39.79 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.462 -0.773 . . . . 0.0 110.506 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.568 HG11 HD11 ' A' ' 82' ' ' LEU . 58.8 t -96.68 135.43 22.26 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.522 -0.736 . . . . 0.0 110.161 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.08 150.93 43.75 Favored 'Trans proline' 0 N--CA 1.486 1.043 0 O-C-N 123.216 1.114 . . . . 0.0 110.601 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.528 HG23 ' HA2' ' A' ' 152' ' ' GLY . 61.9 t -71.14 -28.4 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.587 -0.695 . . . . 0.0 110.227 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -60.01 -39.93 87.53 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.451 -0.781 . . . . 0.0 110.67 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 62.2 p -61.79 -28.85 69.75 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.516 -0.74 . . . . 0.0 110.589 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 67.6 mtt -61.59 -34.92 76.45 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.535 -0.728 . . . . 0.0 110.475 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -59.98 -40.79 90.31 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.525 -0.734 . . . . 0.0 110.314 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 92.3 m -63.53 -40.04 95.98 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.514 -0.741 . . . . 0.0 109.925 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 63.6 m -62.67 -41.54 99.14 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.59 -0.694 . . . . 0.0 110.154 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 58.8 ttp -60.04 -40.93 91.05 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.613 -0.68 . . . . 0.0 110.315 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 44.5 ttp85 -60.02 -39.99 87.78 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.59 -0.693 . . . . 0.0 110.087 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.852 0 O-C-N 121.577 -0.702 . . . . 0.0 110.162 179.987 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.024 0.44 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 45' ' ' ALA . 11.0 p -137.33 130.46 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.596 -0.69 . . . . 0.0 109.932 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.3 mp0 -104.32 132.48 50.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.568 -0.708 . . . . 0.0 110.273 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.3 m -76.63 135.72 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.659 -0.65 . . . . 0.0 109.934 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.7 p -137.29 138.9 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.56 -0.712 . . . . 0.0 110.148 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.3 t -122.46 136.85 54.98 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.631 -0.668 . . . . 0.0 110.141 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.508 HG22 ' H ' ' A' ' 39' ' ' ALA . 1.1 m -100.16 179.97 4.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.567 -0.708 . . . . 0.0 109.979 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.508 ' H ' HG22 ' A' ' 38' ' ' THR . . . -60.03 -41.23 91.77 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.651 -0.656 . . . . 0.0 111.017 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.4 p -121.59 -25.55 5.1 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.407 -0.808 . . . . 0.0 111.676 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -118.23 159.58 23.08 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.292 -0.88 . . . . 0.0 110.751 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 11.1 m -140.06 120.79 14.35 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.605 -0.684 . . . . 0.0 110.178 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -135.79 176.31 8.8 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.609 -0.682 . . . . 0.0 109.877 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.4 mt -116.86 160.36 20.97 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.451 -0.781 . . . . 0.0 110.398 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.645 ' O ' HG23 ' A' ' 33' ' ' VAL . . . -129.37 143.85 51.0 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.481 -0.762 . . . . 0.0 110.478 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.579 HG21 ' HB3' ' A' ' 142' ' ' PRO . 89.7 m -123.1 136.93 55.0 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.51 -0.743 . . . . 0.0 110.115 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 47.3 t -95.43 111.67 23.52 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.542 -0.724 . . . . 0.0 110.602 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.98 139.35 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.504 -0.748 . . . . 0.0 110.195 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 55.21 37.17 28.49 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.524 -0.735 . . . . 0.0 110.794 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.1 14.15 63.22 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.9 t -131.73 130.0 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.18 -1.188 . . . . 0.0 109.781 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.419 ' SG ' ' HB1' ' A' ' 45' ' ' ALA . 43.1 t -86.02 113.43 22.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.523 -0.736 . . . . 0.0 109.923 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.444 ' CZ3' ' CD2' ' A' ' 82' ' ' LEU . 80.0 m95 -106.51 137.12 45.08 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.558 -0.714 . . . . 0.0 110.82 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.546 HG23 HG13 ' A' ' 83' ' ' VAL . 7.6 t -136.81 -179.31 5.62 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.739 HG11 ' CE1' ' A' ' 57' ' ' HIS . 59.4 t -80.14 142.52 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.398 -0.814 . . . . 0.0 109.194 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.883 ' CE2' HG22 ' A' ' 78' ' ' VAL . 28.7 t80 -83.28 -39.99 20.13 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.352 -0.843 . . . . 0.0 111.861 -178.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.739 ' CE1' HG11 ' A' ' 55' ' ' VAL . 1.6 p-80 -60.19 -18.66 49.73 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.98 -1.075 . . . . 0.0 110.956 -178.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -97.64 -69.37 0.97 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.62 -36.3 70.72 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.582 -0.952 . . . . 0.0 110.588 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.647 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -179.421 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.1 m . . . . . 0 N--CA 1.494 1.732 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.446 ' NE2' HG21 ' A' ' 83' ' ' VAL . 86.0 mt-30 -61.1 124.62 21.05 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.476 -0.765 . . . . 0.0 110.074 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.7 tpt -64.9 -40.04 94.46 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.639 -0.663 . . . . 0.0 110.536 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.408 ' O ' HG23 ' A' ' 83' ' ' VAL . 43.2 m-85 -124.43 134.27 53.13 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.571 -0.706 . . . . 0.0 110.308 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.0 p -146.37 136.21 23.34 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.5 -0.75 . . . . 0.0 110.391 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -162.0 105.46 1.19 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.522 -0.736 . . . . 0.0 110.027 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.883 HG22 ' CE2' ' A' ' 56' ' ' TYR . 72.2 t -68.18 -40.0 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.511 -0.743 . . . . 0.0 110.267 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -57.93 -39.81 78.93 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.546 -0.721 . . . . 0.0 110.762 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -99.06 -7.25 27.05 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.535 -0.728 . . . . 0.0 111.3 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.1 t0 55.81 40.43 30.68 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.881 -1.137 . . . . 0.0 109.616 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.584 HD13 HG11 ' A' ' 170' ' ' VAL . 4.7 tp -119.04 132.01 56.01 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.463 0.649 . . . . 0.0 110.114 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.595 HG11 ' HA ' ' A' ' 56' ' ' TYR . 7.1 p -156.82 160.69 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.721 -0.612 . . . . 0.0 109.427 -179.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -177.33 168.34 40.0 Favored Glycine 0 N--CA 1.495 2.614 0 C-N-CA 119.756 -1.211 . . . . 0.0 110.471 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.406 ' CH2' HG21 ' A' ' 54' ' ' THR . 13.5 m-90 -117.38 155.17 30.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.789 -0.83 . . . . 0.0 109.925 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.8 mm-40 -76.63 148.12 37.12 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.493 -0.754 . . . . 0.0 110.168 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -113.01 158.95 36.42 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.509 -0.745 . . . . 0.0 110.243 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.47 157.38 56.52 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.41 1.216 . . . . 0.0 110.526 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.46 160.24 44.89 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.49 1.258 . . . . 0.0 110.421 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 80.5 27.34 51.83 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -115.15 159.02 21.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.515 -0.991 . . . . 0.0 110.127 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.9 tpt85 -81.41 131.68 35.29 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.569 -0.707 . . . . 0.0 110.125 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 59.4 m -115.59 150.24 36.98 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.574 -0.704 . . . . 0.0 110.229 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 94.2 mt -92.7 136.57 33.11 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.531 -0.73 . . . . 0.0 110.376 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 73.9 p -81.43 156.92 70.84 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.605 -0.684 . . . . 0.0 110.407 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.81 163.68 36.52 Favored 'Trans proline' 0 C--N 1.318 -1.027 0 O-C-N 123.435 1.229 . . . . 0.0 110.372 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 49.5 t -87.23 123.76 32.58 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.538 -0.726 . . . . 0.0 110.379 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 98' ' ' THR . 7.2 t -132.84 61.78 1.67 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.662 -0.649 . . . . 0.0 109.883 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.3 p -145.27 7.4 1.16 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.61 -0.681 . . . . 0.0 111.955 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 51.22 48.06 48.22 Favored Glycine 0 N--CA 1.501 3.029 0 O-C-N 120.919 -1.113 . . . . 0.0 110.416 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.8 p -85.27 109.91 18.69 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.51 -0.994 . . . . 0.0 110.629 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 68.5 p -66.99 -39.66 87.21 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.603 -0.686 . . . . 0.0 109.611 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -79.14 128.15 32.93 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.585 -0.697 . . . . 0.0 109.591 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.549 HD22 HG21 ' A' ' 151' ' ' VAL . 92.9 mt -133.6 150.24 51.61 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.401 -0.812 . . . . 0.0 110.696 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -106.85 128.47 54.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.619 -0.676 . . . . 0.0 109.504 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.747 HD12 HD21 ' A' ' 143' ' ' LEU . 7.9 tt -110.48 142.35 42.35 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.571 -0.705 . . . . 0.0 110.422 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.6 t -107.2 125.26 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.611 -0.681 . . . . 0.0 109.781 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 75.1 p -95.39 168.9 10.43 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.644 -0.66 . . . . 0.0 110.386 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 -66.28 -23.48 66.4 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.71 -0.619 . . . . 0.0 110.161 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -93.16 24.5 3.76 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.425 -0.797 . . . . 0.0 110.79 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.71 50.04 16.69 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.338 -0.851 . . . . 0.0 111.032 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -117.67 127.76 54.25 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.319 -0.863 . . . . 0.0 109.827 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.1 t -93.81 120.0 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.577 -0.702 . . . . 0.0 110.096 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 36.0 mt -123.96 135.06 25.87 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.574 -0.704 . . . . 0.0 109.853 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -77.22 143.77 22.74 Favored 'Trans proline' 0 C--N 1.32 -0.954 0 O-C-N 123.199 1.105 . . . . 0.0 110.277 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.3 t -131.45 139.64 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.568 -0.708 . . . . 0.0 110.158 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.3 tpt85 -96.88 133.59 41.3 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.512 -0.743 . . . . 0.0 110.032 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -70.0 136.85 50.86 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.547 -0.72 . . . . 0.0 110.259 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -136.87 26.2 3.03 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.592 -0.693 . . . . 0.0 110.18 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 151.95 -173.93 31.08 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -70.06 -39.07 75.89 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.593 -0.945 . . . . 0.0 110.429 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.3 m -128.78 23.69 5.75 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.52 -0.737 . . . . 0.0 111.184 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 24.5 ttp180 -141.45 143.66 34.0 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.224 -0.923 . . . . 0.0 110.852 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -139.59 -176.68 15.02 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 1.6 m -116.29 160.8 19.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.568 -0.96 . . . . 0.0 110.042 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.463 HD12 HG13 ' A' ' 167' ' ' VAL . 0.3 OUTLIER -110.96 124.1 51.46 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.555 -0.715 . . . . 0.0 110.087 179.791 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.515 HD12 ' N ' ' A' ' 127' ' ' LEU . 6.5 mp -69.98 -40.04 75.6 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.502 -0.749 . . . . 0.0 110.007 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 67.1 m -103.78 109.92 63.02 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.585 -0.697 . . . . 0.0 109.976 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.92 112.47 3.41 Favored 'Trans proline' 0 C--N 1.319 -1.016 0 O-C-N 123.241 1.127 . . . . 0.0 110.48 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -124.92 162.12 45.16 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.628 -0.67 . . . . 0.0 110.17 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.2 150.56 59.66 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 O-C-N 123.505 1.266 . . . . 0.0 110.503 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 162' ' ' GLY . 85.9 t -56.66 -34.34 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.558 -0.714 . . . . 0.0 110.27 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.2 t -59.98 -39.98 87.56 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.538 -0.726 . . . . 0.0 110.52 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -64.15 -40.04 95.31 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.574 -0.703 . . . . 0.0 110.048 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 45.3 tp -88.99 -4.33 58.46 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.679 -0.638 . . . . 0.0 111.35 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -71.26 140.44 50.36 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.11 -0.994 . . . . 0.0 110.975 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 98.39 -2.56 59.25 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 45.3 p -100.86 9.16 42.66 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.149 -1.206 . . . . 0.0 110.716 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.21 129.9 42.9 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.281 -0.887 . . . . 0.0 109.732 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 107.37 -20.77 32.06 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.57 128.5 38.39 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.579 ' HB3' HG21 ' A' ' 46' ' ' THR . 52.0 Cg_endo -76.94 162.24 32.3 Favored 'Trans proline' 0 C--N 1.319 -0.992 0 O-C-N 123.166 1.087 . . . . 0.0 111.304 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.747 HD21 HD12 ' A' ' 106' ' ' LEU . 2.8 mp -116.56 125.11 51.4 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.63 HD12 ' N ' ' A' ' 144' ' ' LEU . 6.5 mp -116.67 129.99 56.47 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.466 -0.771 . . . . 0.0 111.424 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 29.5 p -80.63 163.75 54.81 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.704 -0.623 . . . . 0.0 109.356 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.41 -14.6 44.81 Favored 'Trans proline' 0 N--CA 1.488 1.154 0 O-C-N 123.162 1.085 . . . . 0.0 111.12 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.6 t -66.89 -40.11 87.67 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.284 -0.885 . . . . 0.0 110.004 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 117.05 32.65 1.49 Allowed Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -132.98 148.24 52.27 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.46 -1.023 . . . . 0.0 110.168 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -72.28 134.78 45.75 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.519 -0.738 . . . . 0.0 110.271 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.549 HG21 HD22 ' A' ' 104' ' ' LEU . 58.0 t -98.52 -59.69 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.513 -0.742 . . . . 0.0 110.145 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -176.16 -170.01 38.35 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 45.4 mt -121.34 143.48 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.614 -0.933 . . . . 0.0 110.323 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -61.12 126.76 28.52 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.577 -0.702 . . . . 0.0 109.668 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -106.74 -64.25 1.2 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.474 -0.767 . . . . 0.0 110.972 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -134.1 150.92 51.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.432 -0.792 . . . . 0.0 110.794 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.49 152.9 18.21 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.584 -0.697 . . . . 0.0 109.439 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 46.6 t -120.0 120.01 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.485 -0.759 . . . . 0.0 110.443 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.2 p -140.98 142.16 34.33 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.473 -0.767 . . . . 0.0 110.536 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 92.6 m -70.03 -44.11 69.92 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.58 -0.7 . . . . 0.0 109.865 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -147.93 49.62 1.06 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.651 -0.656 . . . . 0.0 110.133 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.406 ' O ' HG23 ' A' ' 132' ' ' VAL . . . 97.74 -11.19 64.61 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 58.0 t -101.6 123.64 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.195 -1.179 . . . . 0.0 108.97 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.24 118.21 26.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.443 -0.786 . . . . 0.0 111.136 -178.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -111.42 -15.12 13.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.742 -0.599 . . . . 0.0 110.158 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 125' ' ' SER . . . -144.31 167.99 21.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.354 -0.841 . . . . 0.0 109.356 179.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.463 HG13 HD12 ' A' ' 126' ' ' LEU . 35.0 m -137.81 145.05 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.319 -0.863 . . . . 0.0 111.131 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.47 132.44 54.73 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.71 -0.619 . . . . 0.0 110.082 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -142.11 154.05 44.61 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.493 -0.755 . . . . 0.0 110.502 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.584 HG11 HD13 ' A' ' 82' ' ' LEU . 89.5 t -92.46 130.96 35.55 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.588 -0.695 . . . . 0.0 109.803 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.13 160.08 46.2 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 O-C-N 123.193 1.101 . . . . 0.0 110.366 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 61.8 t -69.4 -33.1 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.602 -0.686 . . . . 0.0 109.932 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -60.03 -39.94 87.63 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.475 -0.766 . . . . 0.0 110.595 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.9 m -64.96 -22.91 67.08 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.526 -0.734 . . . . 0.0 111.28 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.436 ' HG2' HD11 ' A' ' 82' ' ' LEU . 65.6 mtt -59.97 -35.63 75.41 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.26 -0.9 . . . . 0.0 110.526 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -59.97 -32.8 71.16 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.576 -0.702 . . . . 0.0 110.652 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 93.9 m -59.94 -40.03 87.55 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.409 -0.807 . . . . 0.0 110.404 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 24.8 m -68.8 -34.19 75.13 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.429 -0.794 . . . . 0.0 110.561 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 44.8 ttp -59.97 -41.86 92.88 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.574 -0.704 . . . . 0.0 110.662 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 58.8 mtt-85 -61.32 -39.92 92.29 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.518 -0.739 . . . . 0.0 110.364 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.764 0 O-C-N 121.528 -0.732 . . . . 0.0 110.245 179.97 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 N--CA 1.497 1.921 0 CA-C-O 121.292 0.568 . . . . 0.0 109.942 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.4 t -119.57 138.93 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.716 -0.615 . . . . 0.0 109.614 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -119.43 142.63 48.05 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.511 -0.743 . . . . 0.0 110.569 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.524 ' O ' HG23 ' A' ' 35' ' ' VAL . 34.0 m -85.44 120.4 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.724 -0.61 . . . . 0.0 110.425 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.9 p -130.21 140.0 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.448 -0.783 . . . . 0.0 110.199 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 74.8 m -122.02 149.0 44.13 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.673 -0.642 . . . . 0.0 110.279 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.531 HG22 ' H ' ' A' ' 39' ' ' ALA . 1.0 OUTLIER -110.31 -177.38 3.23 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.639 -0.663 . . . . 0.0 110.004 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.531 ' H ' HG22 ' A' ' 38' ' ' THR . . . -64.5 -40.05 94.94 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.668 -0.645 . . . . 0.0 111.263 -179.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.564 HG23 ' HG3' ' A' ' 41' ' ' GLN . 7.2 t -123.72 -11.7 7.7 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.326 -0.859 . . . . 0.0 111.935 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.564 ' HG3' HG23 ' A' ' 40' ' ' THR . 97.0 mt-30 -136.04 162.95 31.46 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.176 -0.952 . . . . 0.0 110.441 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.6 t -140.24 123.47 16.83 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.566 -0.709 . . . . 0.0 110.426 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -136.17 178.03 7.38 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.587 -0.696 . . . . 0.0 110.012 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.402 ' CD2' ' HA ' ' A' ' 35' ' ' VAL . 82.0 mt -117.46 147.19 42.95 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.523 -0.736 . . . . 0.0 110.636 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -109.97 155.3 21.96 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.719 -0.613 . . . . 0.0 110.081 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.7 p -129.95 144.2 51.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.512 -0.742 . . . . 0.0 110.255 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 34.0 t -100.89 115.82 31.3 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.559 -0.713 . . . . 0.0 110.45 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.4 t -129.98 129.97 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.628 -0.67 . . . . 0.0 109.967 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 52.77 40.12 29.93 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.432 -0.793 . . . . 0.0 111.059 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.623 ' O ' ' HB3' ' A' ' 87' ' ' ALA . . . 67.2 20.99 71.68 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 62.1 t -130.87 123.35 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.293 -1.122 . . . . 0.0 109.922 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 42.3 t -80.7 110.07 15.85 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.48 -0.763 . . . . 0.0 109.564 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 46.7 m95 -97.27 137.58 36.06 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.528 -0.732 . . . . 0.0 110.994 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.882 HG23 HG23 ' A' ' 83' ' ' VAL . 10.1 t -136.63 173.1 12.07 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.727 HG11 ' CE1' ' A' ' 57' ' ' HIS . 45.7 t -80.63 142.57 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.376 -0.827 . . . . 0.0 110.372 -179.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.772 ' CE2' HG22 ' A' ' 78' ' ' VAL . 34.7 t80 -74.96 -43.03 56.36 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.606 -0.684 . . . . 0.0 111.976 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.727 ' CE1' HG11 ' A' ' 55' ' ' VAL . 1.8 p-80 -66.35 -13.85 61.2 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.192 -0.942 . . . . 0.0 110.996 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.9 -88.11 1.47 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.33 -39.97 74.41 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.666 -0.902 . . . . 0.0 110.586 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.701 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -179.399 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.0 m . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -77.28 109.29 11.04 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.515 -0.741 . . . . 0.0 110.451 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 48.7 tpp -70.01 -35.77 74.61 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.669 -0.644 . . . . 0.0 110.122 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.581 ' O ' HG12 ' A' ' 83' ' ' VAL . 62.5 m-85 -109.67 128.42 55.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.615 -0.678 . . . . 0.0 109.924 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.637 ' HA ' HG12 ' A' ' 83' ' ' VAL . 11.1 p -144.23 121.21 11.37 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.538 -0.726 . . . . 0.0 110.361 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 59.6 t-20 -151.42 110.85 3.97 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.515 -0.74 . . . . 0.0 110.495 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.772 HG22 ' CE2' ' A' ' 56' ' ' TYR . 99.6 t -70.03 -35.36 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.451 -0.781 . . . . 0.0 109.577 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -60.0 -40.17 88.28 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.392 -0.817 . . . . 0.0 109.391 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.503 ' HG2' HD12 ' A' ' 82' ' ' LEU . 66.7 tt0 -89.93 -14.28 34.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.699 -0.626 . . . . 0.0 110.083 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.47 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 46.5 t0 55.03 40.01 31.81 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.207 -0.933 . . . . 0.0 110.713 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.503 HD12 ' HG2' ' A' ' 80' ' ' GLN . 48.1 mt -144.09 149.6 36.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.512 -0.743 . . . . 0.0 111.165 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.882 HG23 HG23 ' A' ' 54' ' ' THR . 1.9 m -141.24 168.21 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -152.37 156.73 26.87 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 119.747 -1.216 . . . . 0.0 110.318 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -121.71 146.05 47.41 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.705 -0.879 . . . . 0.0 109.919 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -68.44 129.9 41.3 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.594 -0.692 . . . . 0.0 110.028 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.623 ' HB3' ' O ' ' A' ' 50' ' ' GLY . . . -114.14 159.71 35.3 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.526 -0.734 . . . . 0.0 110.131 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.58 154.7 64.34 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 O-C-N 123.413 1.218 . . . . 0.0 110.376 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.51 160.14 44.93 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 O-C-N 123.41 1.216 . . . . 0.0 110.465 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 77.9 28.97 55.69 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -110.3 155.01 22.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.534 -0.98 . . . . 0.0 110.22 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -58.86 146.38 37.61 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.622 -0.673 . . . . 0.0 110.401 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.5 t -143.43 161.56 38.07 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.629 -0.67 . . . . 0.0 110.453 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.452 HD13 ' HA ' ' A' ' 94' ' ' LEU . 2.5 mm? -108.18 144.79 35.12 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.57 -0.706 . . . . 0.0 110.376 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.8 p -95.42 159.42 32.77 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.56 -0.712 . . . . 0.0 110.393 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.84 150.49 49.68 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 O-C-N 123.394 1.207 . . . . 0.0 110.386 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.617 ' CB ' HG12 ' A' ' 151' ' ' VAL . 47.9 t -87.28 128.26 35.17 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.62 -0.675 . . . . 0.0 110.445 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.5 p -136.12 71.79 1.43 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.584 -0.698 . . . . 0.0 109.927 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.6 p -145.4 8.25 1.18 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.473 -0.767 . . . . 0.0 111.916 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 52.59 42.96 58.85 Favored Glycine 0 N--CA 1.499 2.864 0 O-C-N 120.824 -1.172 . . . . 0.0 110.353 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 26.3 t -79.42 116.65 19.78 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.488 -1.007 . . . . 0.0 110.394 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.6 m -70.05 -39.91 75.43 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.603 -0.686 . . . . 0.0 110.275 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -84.27 142.16 30.44 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.609 -0.682 . . . . 0.0 110.402 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 94.9 mt -132.2 152.23 51.41 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.503 -0.748 . . . . 0.0 110.401 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -114.61 136.8 52.65 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.55 -0.719 . . . . 0.0 109.744 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 57.3 tp -110.85 140.13 45.57 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.43 -0.794 . . . . 0.0 110.422 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.3 t -93.69 129.94 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.616 -0.678 . . . . 0.0 109.913 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.4 m -110.01 160.93 16.0 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.47 -0.769 . . . . 0.0 110.519 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 18.0 ptm180 -62.71 -24.58 67.74 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.676 -0.64 . . . . 0.0 110.864 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -95.48 29.19 2.65 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.418 -0.801 . . . . 0.0 110.629 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 55.34 36.28 26.75 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.304 -0.873 . . . . 0.0 110.44 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -109.18 146.43 34.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.644 -0.66 . . . . 0.0 109.849 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.6 p -138.05 135.68 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.511 -0.743 . . . . 0.0 110.526 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.404 HG23 ' HD2' ' A' ' 115' ' ' PRO . 85.4 mt -126.6 143.68 47.16 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.603 -0.685 . . . . 0.0 109.679 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.404 ' HD2' HG23 ' A' ' 114' ' ' ILE . 49.9 Cg_endo -76.79 139.13 19.53 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 O-C-N 123.274 1.144 . . . . 0.0 110.455 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.3 t -124.79 129.94 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.603 -0.686 . . . . 0.0 109.762 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.0 tpp85 -84.24 139.52 32.31 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.531 -0.731 . . . . 0.0 110.022 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -77.2 129.63 36.2 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.543 -0.723 . . . . 0.0 110.152 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -136.59 25.78 3.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.662 -0.649 . . . . 0.0 110.424 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 175.7 179.8 46.42 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -66.78 -40.11 88.06 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.505 -0.997 . . . . 0.0 110.324 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 67.1 m -136.03 25.94 3.28 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.551 -0.718 . . . . 0.0 110.377 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -136.95 159.99 40.24 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.588 -0.695 . . . . 0.0 110.299 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -150.93 -173.71 21.2 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 97.4 p -120.67 153.44 36.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.62 -0.93 . . . . 0.0 110.245 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.7 tp -106.57 123.6 48.34 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.583 -0.698 . . . . 0.0 110.143 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.494 HD12 ' H ' ' A' ' 127' ' ' LEU . 4.7 mp -66.47 -39.99 89.09 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.543 -0.723 . . . . 0.0 110.304 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 30.0 t -100.22 108.47 52.6 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.488 -0.757 . . . . 0.0 110.262 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.33 115.45 4.35 Favored 'Trans proline' 0 C--N 1.319 -0.994 0 O-C-N 123.18 1.094 . . . . 0.0 110.307 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -124.48 160.7 51.93 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.586 -0.696 . . . . 0.0 110.392 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.44 150.52 58.16 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 O-C-N 123.469 1.247 . . . . 0.0 110.567 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 162' ' ' GLY . 95.0 t -57.72 -30.55 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.564 -0.71 . . . . 0.0 110.258 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.5 t -60.07 -40.61 90.1 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.519 -0.738 . . . . 0.0 110.383 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -64.77 -46.02 83.9 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.579 -0.7 . . . . 0.0 109.868 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.474 HD21 ' CZ ' ' A' ' 154' ' ' PHE . 54.1 tp -78.76 -22.59 46.2 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.681 -0.637 . . . . 0.0 110.91 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.468 ' CD ' HG12 ' A' ' 132' ' ' VAL . 22.8 mttt -60.03 136.38 58.0 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.387 -0.821 . . . . 0.0 110.58 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 98.07 -2.35 59.73 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 68.9 m -109.07 16.23 22.72 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.16 -1.2 . . . . 0.0 110.538 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.8 t -62.43 150.15 40.68 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.415 -0.803 . . . . 0.0 109.842 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 90.1 -12.28 68.23 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.37 113.34 5.36 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -70.64 140.9 40.39 Favored 'Trans proline' 0 C--N 1.318 -1.072 0 O-C-N 123.171 1.09 . . . . 0.0 110.981 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.45 ' O ' HG22 ' A' ' 151' ' ' VAL . 21.7 mt -87.51 125.22 34.19 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.468 HD13 ' HA ' ' A' ' 144' ' ' LEU . 4.1 mm? -110.41 160.02 16.96 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.322 0.582 . . . . 0.0 110.856 -178.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -109.6 176.18 1.65 Allowed Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.76 -0.587 . . . . 0.0 109.681 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.77 -35.67 12.18 Favored 'Trans proline' 0 C--N 1.317 -1.081 0 O-C-N 123.292 1.154 . . . . 0.0 110.064 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.8 m -62.43 -40.03 95.24 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.605 -0.684 . . . . 0.0 109.756 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 120.21 36.01 0.84 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 45.5 m170 -126.26 138.14 53.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.523 -0.987 . . . . 0.0 110.146 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.17 140.37 38.97 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.508 -0.745 . . . . 0.0 110.119 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.617 HG12 ' CB ' ' A' ' 97' ' ' CYS . 34.3 m -105.95 -26.51 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.571 -0.705 . . . . 0.0 110.56 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 172.72 -164.49 36.67 Favored Glycine 0 N--CA 1.498 2.77 0 C-N-CA 119.674 -1.25 . . . . 0.0 110.571 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 82.6 mt -130.98 141.83 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.67 -0.9 . . . . 0.0 109.896 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.474 ' CZ ' HD21 ' A' ' 135' ' ' LEU . 20.3 t80 -60.16 130.02 44.61 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.52 -0.737 . . . . 0.0 110.209 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.408 ' HD2' ' CG2' ' A' ' 170' ' ' VAL . 67.8 ttt180 -104.49 -72.96 0.69 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.515 -0.741 . . . . 0.0 110.792 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -132.29 152.96 51.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.306 -0.871 . . . . 0.0 110.867 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.48 156.29 16.53 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.648 -0.658 . . . . 0.0 109.757 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 60.7 t -120.78 115.77 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.601 -0.687 . . . . 0.0 110.248 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.4 p -141.35 146.28 36.46 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.461 -0.774 . . . . 0.0 110.711 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 12.2 m -82.3 -49.16 10.36 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.539 -0.725 . . . . 0.0 110.006 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -129.88 46.44 2.65 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.601 -0.687 . . . . 0.0 110.203 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.516 ' O ' HG23 ' A' ' 132' ' ' VAL . . . 91.78 -10.99 73.33 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 67.2 t -97.61 122.78 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.156 -1.202 . . . . 0.0 109.38 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.55 116.36 25.62 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.542 -0.724 . . . . 0.0 110.9 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 67.5 mttt -104.27 -29.1 11.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.688 -0.633 . . . . 0.0 109.586 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -128.44 157.38 41.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.705 -0.622 . . . . 0.0 109.55 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 31.7 m -133.07 139.99 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.442 -0.786 . . . . 0.0 110.774 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -119.32 133.54 55.68 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.606 -0.683 . . . . 0.0 110.347 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -134.5 156.67 48.21 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.554 -0.716 . . . . 0.0 110.146 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.408 ' CG2' ' HD2' ' A' ' 155' ' ' ARG . 57.5 t -96.2 133.84 24.48 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.507 -0.746 . . . . 0.0 110.254 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.01 159.96 40.68 Favored 'Trans proline' 0 N--CA 1.485 0.988 0 O-C-N 123.253 1.133 . . . . 0.0 110.465 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 59.5 t -72.66 -26.32 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.625 -0.672 . . . . 0.0 110.223 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -59.64 -36.82 77.13 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.458 -0.776 . . . . 0.0 110.46 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 22.9 t -61.17 -38.62 87.15 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.587 -0.696 . . . . 0.0 110.162 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.475 ' HE2' HD13 ' A' ' 82' ' ' LEU . 66.1 mtt -60.04 -34.2 73.07 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.537 -0.727 . . . . 0.0 110.35 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -60.02 -40.34 88.95 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.534 -0.728 . . . . 0.0 110.459 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 94.5 m -65.99 -40.09 90.88 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.523 -0.736 . . . . 0.0 109.67 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 93.9 m -62.89 -40.01 96.23 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.662 -0.649 . . . . 0.0 110.067 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 89.1 mtp -60.08 -40.05 88.22 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.539 -0.726 . . . . 0.0 110.431 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -67.28 -39.97 86.08 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.601 -0.687 . . . . 0.0 110.087 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.798 0 O-C-N 121.593 -0.692 . . . . 0.0 110.251 -179.935 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 120.909 0.385 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.6 t -101.71 124.98 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.42 -0.8 . . . . 0.0 109.978 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -104.62 132.29 51.03 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.521 -0.737 . . . . 0.0 110.362 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.596 HG12 HD22 ' A' ' 44' ' ' LEU . 32.9 m -94.98 129.8 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.644 -0.66 . . . . 0.0 110.116 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.2 m -130.05 159.97 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.353 -0.842 . . . . 0.0 110.772 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 69.0 m -132.76 152.83 51.68 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.544 -0.723 . . . . 0.0 110.152 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.521 HG22 ' H ' ' A' ' 39' ' ' ALA . 0.7 OUTLIER -115.56 -176.53 2.94 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.543 -0.723 . . . . 0.0 110.093 -179.803 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.521 ' H ' HG22 ' A' ' 38' ' ' THR . . . -60.09 -49.6 77.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.74 -0.6 . . . . 0.0 111.049 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.68 HG23 ' HG3' ' A' ' 41' ' ' GLN . 7.6 t -116.99 -22.48 8.43 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.393 -0.817 . . . . 0.0 111.293 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.68 ' HG3' HG23 ' A' ' 40' ' ' THR . 59.9 mt-30 -117.14 164.94 14.0 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.389 -0.819 . . . . 0.0 110.187 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.5 m -147.93 120.19 8.37 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.499 -0.751 . . . . 0.0 110.303 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.412 ' CZ ' ' HB2' ' A' ' 59' ' ' ALA . 27.3 p90 -130.98 -176.66 4.07 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.629 -0.67 . . . . 0.0 110.049 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.596 HD22 HG12 ' A' ' 35' ' ' VAL . 48.9 mt -122.4 173.36 7.7 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.502 -0.748 . . . . 0.0 109.893 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -150.68 160.83 43.57 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.564 -0.71 . . . . 0.0 110.355 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.451 HG21 ' HB3' ' A' ' 142' ' ' PRO . 8.2 t -136.61 144.1 43.91 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.669 -0.644 . . . . 0.0 110.172 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 28.5 p -87.92 123.71 32.95 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.589 -0.695 . . . . 0.0 110.763 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.6 t -130.61 125.26 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.52 -0.737 . . . . 0.0 110.174 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 51.34 40.72 27.05 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.389 -0.819 . . . . 0.0 111.335 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.95 22.77 77.2 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.439 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 60.8 t -142.26 113.62 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.396 -1.061 . . . . 0.0 109.53 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 93.3 m -79.73 125.27 29.44 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.641 -0.662 . . . . 0.0 110.205 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.439 ' CZ2' HG11 ' A' ' 51' ' ' VAL . 98.5 m95 -114.26 136.48 52.92 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.585 -0.697 . . . . 0.0 110.102 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.805 HG23 HG23 ' A' ' 83' ' ' VAL . 7.9 t -137.85 -179.87 6.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.656 -0.653 . . . . 0.0 109.968 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.469 HG11 ' CE1' ' A' ' 57' ' ' HIS . 2.1 t -81.69 141.59 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.503 -0.748 . . . . 0.0 109.415 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.862 ' CE2' HG22 ' A' ' 78' ' ' VAL . 9.6 t80 -85.49 -43.81 13.25 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.392 -0.818 . . . . 0.0 111.85 -179.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.469 ' CE1' HG11 ' A' ' 55' ' ' VAL . 3.1 p-80 -57.76 -17.83 17.89 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.204 -0.935 . . . . 0.0 111.672 -177.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.75 -53.87 2.78 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.412 ' HB2' ' CZ ' ' A' ' 43' ' ' PHE . . . -80.2 -63.39 1.42 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.621 -0.929 . . . . 0.0 109.779 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.428 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.501 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.4 m . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 121.145 0.498 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -74.32 131.07 40.81 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.625 -0.672 . . . . 0.0 110.087 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.426 ' HG3' ' CD2' ' A' ' 75' ' ' TYR . 22.8 ptp -119.69 -42.49 2.63 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.45 -0.781 . . . . 0.0 110.751 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.491 ' O ' HG12 ' A' ' 83' ' ' VAL . 35.0 m-85 -119.98 114.3 21.82 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.265 -0.897 . . . . 0.0 110.088 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.6 m -152.7 131.62 12.52 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.553 -0.717 . . . . 0.0 110.187 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -169.89 125.39 0.81 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.281 -0.887 . . . . 0.0 111.279 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.862 HG22 ' CE2' ' A' ' 56' ' ' TYR . 76.3 t -72.48 -38.17 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.395 -0.816 . . . . 0.0 109.593 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -55.65 -34.22 64.76 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.386 -0.821 . . . . 0.0 110.364 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -98.99 -12.21 20.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.655 -0.653 . . . . 0.0 110.628 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.536 ' O ' HD12 ' A' ' 82' ' ' LEU . 42.8 t0 53.28 40.06 30.71 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.093 -1.004 . . . . 0.0 110.501 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.546 HD22 ' CE ' ' A' ' 175' ' ' MET . 0.2 OUTLIER -141.48 151.03 42.99 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.786 0.803 . . . . 0.0 110.979 -179.608 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.805 HG23 HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -146.32 153.07 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.349 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -153.14 159.25 28.42 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.474 -1.346 . . . . 0.0 110.816 -178.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.473 ' CH2' HG21 ' A' ' 54' ' ' THR . 6.3 m-90 -131.43 168.37 17.72 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.997 -0.707 . . . . 0.0 109.307 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.419 ' H ' ' HE1' ' A' ' 74' ' ' MET . 8.1 mm-40 -68.82 138.51 54.82 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.429 -0.794 . . . . 0.0 110.425 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.38 148.69 45.13 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.577 -0.702 . . . . 0.0 110.109 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.12 144.43 37.6 Favored 'Trans proline' 0 C--N 1.318 -1.065 0 O-C-N 123.29 1.153 . . . . 0.0 110.394 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -77.39 160.26 32.37 Favored 'Trans proline' 0 C--N 1.318 -1.034 0 O-C-N 123.345 1.182 . . . . 0.0 110.548 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 89.61 30.01 14.7 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -151.99 167.84 27.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.55 -0.971 . . . . 0.0 110.301 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -113.76 159.44 19.75 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.515 -0.74 . . . . 0.0 110.123 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.3 m -129.12 171.11 12.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.492 -0.755 . . . . 0.0 110.523 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -81.25 165.08 21.78 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.703 -0.623 . . . . 0.0 110.557 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.453 ' CG2' ' CD2' ' A' ' 149' ' ' HIS . 9.4 t -110.85 151.73 43.11 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.655 -0.653 . . . . 0.0 109.909 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.07 130.29 21.23 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 O-C-N 123.245 1.129 . . . . 0.0 110.232 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.447 ' HB3' HG12 ' A' ' 151' ' ' VAL . 5.0 t -72.31 145.09 48.06 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.64 -0.663 . . . . 0.0 110.538 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 31.3 m -136.28 66.19 1.5 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.573 -0.704 . . . . 0.0 110.477 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 27.7 p -145.01 -8.01 0.62 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.467 -0.771 . . . . 0.0 112.387 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.94 43.71 97.83 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.4 t -71.92 129.87 39.64 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.528 -0.983 . . . . 0.0 110.268 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 73.4 m -71.34 -40.3 70.81 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.563 -0.71 . . . . 0.0 110.267 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -79.75 130.02 34.98 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.518 -0.739 . . . . 0.0 110.328 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 95.9 mt -136.57 151.97 49.96 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.553 -0.717 . . . . 0.0 110.378 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -106.97 123.27 47.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.462 -0.774 . . . . 0.0 109.75 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.482 HD13 HD11 ' A' ' 143' ' ' LEU . 41.0 tp -110.05 140.31 44.24 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.516 -0.74 . . . . 0.0 110.386 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 26.7 m -112.27 141.23 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.584 -0.697 . . . . 0.0 109.954 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.495 HG23 ' OD1' ' A' ' 112' ' ' ASP . 15.5 p -109.85 -162.65 0.81 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.365 -0.834 . . . . 0.0 109.949 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.448 ' HA ' HD11 ' A' ' 44' ' ' LEU . 23.2 ttp180 -70.1 -23.62 63.08 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.653 -0.654 . . . . 0.0 110.353 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -91.68 19.69 6.16 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.37 -0.831 . . . . 0.0 111.01 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.13 24.76 5.08 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.124 -0.985 . . . . 0.0 111.024 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.495 ' OD1' HG23 ' A' ' 108' ' ' THR . 54.7 p-10 -81.0 161.74 24.12 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.477 -0.764 . . . . 0.0 109.914 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.0 p -129.35 133.11 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.626 -0.671 . . . . 0.0 110.062 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.4 tp -143.59 138.38 15.3 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.529 -0.732 . . . . 0.0 109.929 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.464 ' HG2' HD13 ' A' ' 127' ' ' LEU . 47.0 Cg_endo -73.35 139.28 28.71 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 O-C-N 123.201 1.106 . . . . 0.0 110.556 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.578 HG13 ' O ' ' A' ' 125' ' ' SER . 62.3 t -129.93 130.04 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.517 -0.74 . . . . 0.0 109.876 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -81.95 149.02 28.4 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.476 -0.765 . . . . 0.0 110.144 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -83.42 137.18 34.03 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.661 -0.649 . . . . 0.0 110.369 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.6 mmt85 -141.28 26.49 1.99 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.58 -0.7 . . . . 0.0 110.381 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 161.65 171.95 28.39 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -71.66 -45.16 62.81 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.556 -0.967 . . . . 0.0 110.443 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 61.3 p -116.83 20.09 14.09 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.553 -0.717 . . . . 0.0 110.732 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 25.3 ttp180 -147.77 144.21 28.07 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.399 -0.813 . . . . 0.0 110.009 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -139.85 -175.23 14.17 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.578 ' O ' HG13 ' A' ' 116' ' ' VAL . 57.3 p -119.72 147.53 44.48 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.61 -0.936 . . . . 0.0 110.026 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 34.7 tp -95.06 131.23 41.27 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.584 -0.698 . . . . 0.0 110.205 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.464 HD13 ' HG2' ' A' ' 115' ' ' PRO . 1.4 tt -63.03 -54.58 35.95 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.612 -0.68 . . . . 0.0 110.258 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 57.8 m -96.51 130.05 31.62 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.445 -0.784 . . . . 0.0 110.156 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -81.25 116.32 3.02 Favored 'Trans proline' 0 C--N 1.32 -0.939 0 O-C-N 123.132 1.07 . . . . 0.0 110.677 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.422 ' HD2' ' CD2' ' A' ' 134' ' ' TYR . 54.6 mtm-85 -125.09 152.6 70.86 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.518 -0.739 . . . . 0.0 109.779 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.3 150.22 64.62 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 123.369 1.194 . . . . 0.0 110.759 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.421 HG21 ' SG ' ' A' ' 159' ' ' CYS . 51.6 t -54.33 -31.72 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.442 -0.786 . . . . 0.0 109.701 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.6 t -59.9 -40.38 88.59 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.746 -0.596 . . . . 0.0 111.095 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.422 ' CD2' ' HD2' ' A' ' 130' ' ' ARG . 86.3 t80 -68.95 -39.81 79.3 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.342 -0.849 . . . . 0.0 109.685 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 23.2 tp -94.67 18.75 11.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.885 -0.51 . . . . 0.0 110.187 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.64 118.47 23.87 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 122.658 1.218 . . . . 0.0 112.317 -178.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.8 26.35 8.04 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.3 p -109.96 20.94 17.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.529 -0.983 . . . . 0.0 110.621 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.6 m -66.39 144.59 56.44 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.337 -0.852 . . . . 0.0 109.342 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.75 -18.2 57.05 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.63 110.37 2.3 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.451 ' HB3' HG21 ' A' ' 46' ' ' THR . 44.3 Cg_endo -71.05 161.45 45.98 Favored 'Trans proline' 0 C--N 1.318 -1.048 0 O-C-N 123.168 1.088 . . . . 0.0 111.054 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.553 ' O ' HG22 ' A' ' 151' ' ' VAL . 5.1 mp -113.99 119.71 38.15 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.0 tp -96.51 167.34 11.21 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.426 0.631 . . . . 0.0 110.833 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.407 ' CB ' ' HD2' ' A' ' 146' ' ' PRO . 0.1 OUTLIER -108.2 178.49 1.05 Allowed Pre-proline 0 N--CA 1.493 1.701 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.7 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.407 ' HD2' ' CB ' ' A' ' 145' ' ' CYS . 42.9 Cg_endo -69.05 -25.37 31.95 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 O-C-N 123.258 1.136 . . . . 0.0 110.339 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 83.0 p -79.81 -28.58 40.19 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.514 -0.741 . . . . 0.0 110.088 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 115.55 35.01 1.34 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.453 ' CD2' ' CG2' ' A' ' 95' ' ' THR . 22.9 m170 -122.79 153.64 39.27 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.579 -0.953 . . . . 0.0 110.365 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -88.69 144.24 26.4 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.474 -0.766 . . . . 0.0 110.199 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.648 ' O ' HG23 ' A' ' 172' ' ' VAL . 35.1 m -119.14 -24.26 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.476 -0.765 . . . . 0.0 111.067 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -179.73 -173.08 44.48 Favored Glycine 0 N--CA 1.498 2.829 0 C-N-CA 119.672 -1.252 . . . . 0.0 110.385 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 64.0 mt -130.0 159.23 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.562 -0.964 . . . . 0.0 110.033 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -73.77 144.62 45.56 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.55 -0.718 . . . . 0.0 110.248 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 -129.57 -75.97 0.55 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.534 -0.729 . . . . 0.0 110.264 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -120.41 142.35 49.29 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.154 -0.966 . . . . 0.0 110.992 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.52 127.33 39.12 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.4 t -97.83 119.5 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.532 -0.73 . . . . 0.0 111.388 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.421 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.3 p -141.15 151.74 44.13 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.547 -0.721 . . . . 0.0 110.43 178.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 6.8 p -93.7 -48.19 6.44 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.511 -0.743 . . . . 0.0 109.511 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 50.9 mtt85 -119.97 36.7 4.44 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 91.9 -11.57 71.79 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 63.7 t -89.16 123.66 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.178 -1.189 . . . . 0.0 109.284 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.18 114.3 23.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.526 -0.734 . . . . 0.0 110.838 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -107.14 -29.99 9.04 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.809 -0.557 . . . . 0.0 109.64 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -118.47 168.25 10.83 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.668 -0.645 . . . . 0.0 109.863 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.9 m -143.21 131.83 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.498 -0.751 . . . . 0.0 110.702 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.31 127.84 47.74 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.613 -0.679 . . . . 0.0 110.231 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -136.27 162.15 33.79 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.556 -0.715 . . . . 0.0 110.588 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.47 HG13 ' HD2' ' A' ' 171' ' ' PRO . 90.1 t -104.86 144.71 29.28 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.463 -0.773 . . . . 0.0 110.033 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.47 ' HD2' HG13 ' A' ' 170' ' ' VAL . 45.1 Cg_endo -71.41 168.15 24.31 Favored 'Trans proline' 0 N--CA 1.486 1.056 0 O-C-N 123.318 1.168 . . . . 0.0 110.709 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 151' ' ' VAL . 61.4 t -92.44 -45.99 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.606 -0.684 . . . . 0.0 110.467 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -54.61 -28.88 49.67 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.693 -0.629 . . . . 0.0 111.304 -178.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.661 ' O ' HG22 ' A' ' 177' ' ' THR . 4.3 m -61.62 -25.91 67.65 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.378 -0.826 . . . . 0.0 110.279 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.546 ' CE ' HD22 ' A' ' 82' ' ' LEU . 32.8 mmt -70.12 -27.35 64.5 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.498 -0.751 . . . . 0.0 110.641 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -56.83 -41.78 78.46 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.448 -0.783 . . . . 0.0 111.059 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.661 HG22 ' O ' ' A' ' 174' ' ' SER . 7.4 t -73.9 -22.09 59.83 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.405 -0.809 . . . . 0.0 110.556 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 76.7 m -72.0 -39.94 68.87 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.384 -0.823 . . . . 0.0 110.344 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 26.2 ttp -59.98 -44.57 94.41 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.681 -0.637 . . . . 0.0 110.5 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 26.4 mmt85 -60.01 -39.9 87.39 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.531 -0.731 . . . . 0.0 110.389 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.789 0 O-C-N 121.571 -0.706 . . . . 0.0 110.09 179.976 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 . . . . . 0 N--CA 1.501 2.095 0 CA-C-O 120.478 0.18 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.854 HG11 ' HD3' ' A' ' 142' ' ' PRO . 19.3 m -118.92 162.22 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.182 -0.949 . . . . 0.0 110.947 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 22.2 mm100 -136.87 125.2 23.28 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.572 ' O ' HG23 ' A' ' 35' ' ' VAL . 34.5 m -73.76 116.42 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.585 -0.697 . . . . 0.0 109.957 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.587 HG22 ' O ' ' A' ' 43' ' ' PHE . 35.9 m -110.75 152.03 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.431 -0.793 . . . . 0.0 110.157 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.1 m -115.7 125.38 52.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.581 -0.699 . . . . 0.0 110.366 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.05 -169.61 1.89 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.655 -0.653 . . . . 0.0 109.538 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.16 -51.23 70.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.583 -0.698 . . . . 0.0 110.894 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.662 HG23 ' HG3' ' A' ' 41' ' ' GLN . 7.9 t -127.65 0.99 6.15 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.404 -0.81 . . . . 0.0 111.817 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.662 ' HG3' HG23 ' A' ' 40' ' ' THR . 70.1 mt-30 -140.38 171.26 14.4 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.004 -1.06 . . . . 0.0 110.499 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 77.7 p -145.4 131.38 19.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.618 -0.676 . . . . 0.0 110.157 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.587 ' O ' HG22 ' A' ' 36' ' ' VAL . 13.5 p90 -130.21 -175.33 3.6 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.521 -0.737 . . . . 0.0 110.314 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.447 HD23 ' HB ' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -119.44 159.0 25.09 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.455 -0.778 . . . . 0.0 110.633 -179.511 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -126.67 119.56 27.31 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.606 -0.683 . . . . 0.0 110.015 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.772 HG22 HG12 ' A' ' 33' ' ' VAL . 19.0 p -101.8 144.08 30.91 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.496 -0.752 . . . . 0.0 110.504 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 26.3 p -100.68 110.23 22.33 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.683 0.754 . . . . 0.0 110.238 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.3 t -130.25 130.02 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.174 -0.954 . . . . 0.0 110.258 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.427 ' O ' HG23 ' A' ' 51' ' ' VAL . 97.0 m-20 52.73 39.43 28.57 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.4 -0.813 . . . . 0.0 111.116 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.46 24.76 71.06 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 49' ' ' ASN . 60.5 t -135.15 122.73 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.368 -1.077 . . . . 0.0 109.666 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 54.5 m -79.27 111.38 15.46 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.56 -0.712 . . . . 0.0 109.782 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.434 ' CE3' HD23 ' A' ' 82' ' ' LEU . 52.3 m95 -98.6 136.82 38.14 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.528 -0.733 . . . . 0.0 110.82 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.878 HG21 ' CH2' ' A' ' 85' ' ' TRP . 6.4 t -137.36 179.99 6.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.711 -0.618 . . . . 0.0 109.547 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.855 HG21 ' HB3' ' A' ' 139' ' ' SER . 79.0 t -85.47 141.7 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.471 -0.768 . . . . 0.0 109.379 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.886 ' CE2' HG22 ' A' ' 78' ' ' VAL . 15.7 t80 -85.37 -43.68 13.45 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.487 -0.758 . . . . 0.0 111.381 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.59 ' CE1' HG11 ' A' ' 55' ' ' VAL . 2.0 p-80 -60.68 -17.43 47.74 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.308 -0.87 . . . . 0.0 111.419 -178.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -103.1 -62.11 0.7 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -96.1 -23.57 16.71 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.534 -0.98 . . . . 0.0 111.011 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.414 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . . . . . . 0 N--CA 1.496 2.657 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.9 t . . . . . 0 N--CA 1.496 1.865 0 CA-C-O 121.138 0.494 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -94.41 131.15 40.38 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.528 -0.732 . . . . 0.0 110.147 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.453 ' CE ' ' CE2' ' A' ' 75' ' ' TYR . 25.4 ptm -116.54 -37.47 3.7 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.555 -0.716 . . . . 0.0 110.165 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.453 ' CE2' ' CE ' ' A' ' 74' ' ' MET . 28.1 m-85 -111.26 119.6 39.44 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.537 -0.727 . . . . 0.0 109.373 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 88.0 m -148.6 126.06 11.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.48 -0.763 . . . . 0.0 110.277 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -165.43 123.48 1.59 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.384 -0.823 . . . . 0.0 111.307 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.886 HG22 ' CE2' ' A' ' 56' ' ' TYR . 79.7 t -72.36 -34.08 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.478 -0.764 . . . . 0.0 109.376 178.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -55.7 -44.77 77.72 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.567 -0.708 . . . . 0.0 110.536 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -90.76 -10.38 43.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.606 -0.684 . . . . 0.0 110.522 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.82 ' O ' HD12 ' A' ' 82' ' ' LEU . 48.5 t0 53.13 40.36 31.11 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.185 -0.947 . . . . 0.0 110.654 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.82 HD12 ' O ' ' A' ' 81' ' ' ASP . 1.0 OUTLIER -141.62 160.46 40.11 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.884 0.849 . . . . 0.0 111.098 -179.412 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.402 ' HB ' ' CG2' ' A' ' 54' ' ' THR . 1.6 t -138.35 164.43 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.406 ' O ' ' CD1' ' A' ' 85' ' ' TRP . . . -153.68 155.15 25.98 Favored Glycine 0 N--CA 1.496 2.653 0 C-N-CA 119.497 -1.335 . . . . 0.0 110.87 -179.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.878 ' CH2' HG21 ' A' ' 54' ' ' THR . 4.5 m-90 -141.93 163.57 32.52 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.877 -0.778 . . . . 0.0 109.332 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -73.41 122.98 22.97 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.479 -0.763 . . . . 0.0 109.881 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.11 154.88 40.53 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.57 -0.706 . . . . 0.0 110.26 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.98 146.14 41.19 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.467 1.246 . . . . 0.0 110.359 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -76.86 160.08 34.21 Favored 'Trans proline' 0 C--N 1.317 -1.1 0 O-C-N 123.394 1.208 . . . . 0.0 110.43 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.25 28.7 12.6 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -133.34 160.4 37.45 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.519 -0.989 . . . . 0.0 110.165 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -79.57 153.44 29.48 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.551 -0.718 . . . . 0.0 110.229 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.8 m -134.68 158.64 43.56 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.533 -0.729 . . . . 0.0 110.305 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.1 mt -108.24 158.33 17.55 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.584 -0.698 . . . . 0.0 110.408 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.408 ' OG1' ' CE1' ' A' ' 149' ' ' HIS . 71.4 p -137.24 163.21 50.65 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.577 -0.702 . . . . 0.0 110.075 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.79 142.62 43.8 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 O-C-N 123.42 1.221 . . . . 0.0 110.151 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.41 ' CB ' ' HG ' ' A' ' 145' ' ' CYS . 30.5 p -84.77 157.88 20.88 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.563 -0.711 . . . . 0.0 110.828 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 98' ' ' THR . 6.5 t -115.94 65.4 0.7 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.2 p -144.65 -8.71 0.64 Allowed 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 120.044 -0.663 . . . . 0.0 112.582 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 50.5 26.75 10.5 Favored Glycine 0 N--CA 1.502 3.049 0 O-C-N 120.778 -1.201 . . . . 0.0 110.609 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 41.6 m -59.11 127.63 33.14 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.446 -1.031 . . . . 0.0 110.645 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 73.6 m -68.74 -40.14 80.0 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.701 -0.624 . . . . 0.0 109.992 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -61.66 139.4 58.29 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.57 -0.706 . . . . 0.0 110.02 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.5 mt -141.73 169.23 17.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.649 -0.657 . . . . 0.0 110.513 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -138.36 128.89 26.31 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.681 -0.637 . . . . 0.0 109.598 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.4 tt -114.88 123.56 49.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.437 -0.789 . . . . 0.0 110.476 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 63.0 t -94.96 109.9 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.674 -0.641 . . . . 0.0 109.511 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 75.1 p -81.91 174.89 10.86 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.465 -0.772 . . . . 0.0 110.478 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -59.92 -22.78 62.88 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.64 -0.663 . . . . 0.0 110.585 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.81 20.18 5.86 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.359 -0.838 . . . . 0.0 110.675 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 52.76 41.6 31.63 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.198 -0.938 . . . . 0.0 110.881 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.758 ' HB3' HD13 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -100.22 121.2 41.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.567 -0.708 . . . . 0.0 110.091 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.697 HG13 ' H ' ' A' ' 114' ' ' ILE . 1.9 p -57.07 -79.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.598 -0.689 . . . . 0.0 111.018 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.758 HD13 ' HB3' ' A' ' 112' ' ' ASP . 2.4 mp 54.69 99.31 0.04 OUTLIER Pre-proline 0 N--CA 1.504 2.238 0 O-C-N 120.726 -1.234 . . . . 0.0 110.227 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.23 164.37 35.24 Favored 'Trans proline' 0 C--N 1.318 -1.051 0 O-C-N 123.226 1.119 . . . . 0.0 110.6 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.58 HG13 ' O ' ' A' ' 125' ' ' SER . 58.2 t -139.9 139.8 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.556 -0.715 . . . . 0.0 109.719 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -93.5 149.9 20.87 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.584 -0.697 . . . . 0.0 110.102 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -76.76 147.51 37.24 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.59 -0.694 . . . . 0.0 110.615 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -154.63 52.34 0.64 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.616 -0.678 . . . . 0.0 109.785 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 126.13 171.25 13.12 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -60.1 -58.89 6.59 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.454 -1.027 . . . . 0.0 109.974 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 57.8 m -112.85 23.74 13.12 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.558 -0.713 . . . . 0.0 109.871 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.682 ' NH2' HG21 ' A' ' 158' ' ' VAL . 0.3 OUTLIER -126.41 136.71 53.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.548 -0.72 . . . . 0.0 109.832 -179.699 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -142.41 169.44 25.46 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.58 ' O ' HG13 ' A' ' 116' ' ' VAL . 20.2 p -111.06 160.57 16.73 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.571 -0.958 . . . . 0.0 109.989 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.73 HD13 HG11 ' A' ' 167' ' ' VAL . 18.1 tp -106.36 126.35 52.13 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.666 -0.646 . . . . 0.0 110.509 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.32 -56.49 14.13 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.596 -0.69 . . . . 0.0 109.999 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 33.1 t -94.81 112.8 59.44 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.61 -0.681 . . . . 0.0 109.872 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.66 107.25 2.27 Favored 'Trans proline' 0 C--N 1.32 -0.969 0 O-C-N 123.25 1.132 . . . . 0.0 110.799 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.516 ' NH2' HD11 ' A' ' 126' ' ' LEU . 80.2 mtm180 -118.84 158.02 48.75 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.63 -0.668 . . . . 0.0 109.9 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.78 150.41 55.93 Favored 'Trans proline' 0 C--N 1.315 -1.204 0 O-C-N 123.433 1.228 . . . . 0.0 110.678 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.416 HG21 ' SG ' ' A' ' 159' ' ' CYS . 55.6 t -53.65 -29.42 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 O-C-N 121.433 -0.792 . . . . 0.0 109.807 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.1 t -59.83 -44.87 93.84 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.656 -0.653 . . . . 0.0 111.213 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -67.32 -38.7 85.34 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.32 -0.862 . . . . 0.0 109.815 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 135' ' ' LEU . 31.2 tp -92.32 18.43 8.35 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.78 -0.575 . . . . 0.0 110.19 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.7 tttm -82.88 118.28 23.33 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 122.57 1.176 . . . . 0.0 112.145 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.71 26.6 7.95 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 17.0 m -105.35 19.93 19.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.642 -0.916 . . . . 0.0 110.141 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.855 ' HB3' HG21 ' A' ' 55' ' ' VAL . 2.4 m -74.17 130.27 39.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.31 -0.869 . . . . 0.0 109.466 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.412 ' HA2' HD11 ' A' ' 153' ' ' ILE . . . 113.59 -26.51 10.1 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.57 131.01 51.84 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.854 ' HD3' HG11 ' A' ' 33' ' ' VAL . 52.2 Cg_endo -85.7 157.84 10.49 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.117 1.062 . . . . 0.0 111.106 -178.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 143' ' ' LEU . 6.8 mp -107.71 123.5 48.62 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 150' ' ' ALA . 4.1 tp -105.34 162.33 13.53 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.519 -0.738 . . . . 0.0 110.823 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.458 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 28.9 p -115.39 168.45 8.27 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 37.7 Cg_endo -62.47 -15.36 44.98 Favored 'Trans proline' 0 N--CA 1.488 1.18 0 O-C-N 122.935 0.966 . . . . 0.0 111.103 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.2 t -69.94 -35.09 74.25 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.268 -0.895 . . . . 0.0 109.783 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 117.81 15.36 6.31 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.408 ' CE1' ' OG1' ' A' ' 95' ' ' THR . 0.9 OUTLIER -126.89 170.22 12.46 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.199 -1.177 . . . . 0.0 110.095 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.406 ' HA ' HD12 ' A' ' 144' ' ' LEU . . . -94.5 153.26 18.0 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.437 -0.789 . . . . 0.0 110.816 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 143' ' ' LEU . 35.6 m -119.19 -26.02 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.627 -0.671 . . . . 0.0 110.907 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -172.59 -162.07 24.11 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.412 HD11 ' HA2' ' A' ' 140' ' ' GLY . 11.5 tt -140.11 152.87 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.668 -0.901 . . . . 0.0 109.992 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -64.73 144.35 57.3 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.251 -0.906 . . . . 0.0 111.345 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 9.6 ttt180 -129.81 -70.73 0.63 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.272 0.558 . . . . 0.0 109.851 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -128.82 147.9 50.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.288 -0.882 . . . . 0.0 111.047 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.38 158.46 15.72 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.682 HG21 ' NH2' ' A' ' 123' ' ' ARG . 2.5 t -123.29 112.38 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.175 -0.953 . . . . 0.0 111.058 -178.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.416 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.1 p -138.18 144.03 40.52 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.785 179.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 24.2 m -82.81 -43.98 16.04 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.525 -0.734 . . . . 0.0 109.847 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.52 34.99 4.27 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.638 -0.664 . . . . 0.0 109.974 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 99.55 -11.88 61.36 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 63.3 t -92.81 123.47 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.19 -1.183 . . . . 0.0 109.136 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.12 114.22 23.54 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.559 -0.713 . . . . 0.0 111.071 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -104.15 -25.09 13.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.738 -0.601 . . . . 0.0 110.028 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -131.88 168.38 17.96 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.484 -0.76 . . . . 0.0 109.833 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.73 HG11 HD13 ' A' ' 126' ' ' LEU . 36.0 m -141.61 137.36 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.406 -0.809 . . . . 0.0 110.844 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -112.82 140.35 47.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.55 -0.719 . . . . 0.0 110.27 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.4 ' CG ' HD22 ' A' ' 143' ' ' LEU . 50.7 p90 -140.6 159.97 41.05 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.625 -0.672 . . . . 0.0 110.556 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 59.0 t -93.93 135.89 24.35 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.606 -0.684 . . . . 0.0 109.868 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.54 158.45 43.91 Favored 'Trans proline' 0 C--N 1.318 -1.053 0 O-C-N 123.225 1.119 . . . . 0.0 110.515 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.547 HG13 ' CE ' ' A' ' 175' ' ' MET . 79.1 t -77.33 -28.73 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.636 -0.665 . . . . 0.0 110.015 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -59.86 -37.48 79.44 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.435 -0.791 . . . . 0.0 110.429 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 39.0 m -61.65 -35.49 78.07 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.652 -0.655 . . . . 0.0 110.397 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.547 ' CE ' HG13 ' A' ' 172' ' ' VAL . 48.7 mtm -59.99 -30.03 68.85 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.6 -0.688 . . . . 0.0 110.424 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.03 -43.55 95.25 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.502 -0.749 . . . . 0.0 110.302 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 85.1 m -63.55 -40.14 96.21 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.577 -0.702 . . . . 0.0 109.969 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 89.1 m -65.4 -37.21 86.29 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.657 -0.652 . . . . 0.0 110.023 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 19.4 ttt -60.05 -37.96 81.38 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.666 -0.646 . . . . 0.0 110.251 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 39.4 mtp-105 -60.03 -39.74 86.93 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.532 -0.73 . . . . 0.0 110.21 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.749 0 O-C-N 121.509 -0.744 . . . . 0.0 110.18 -179.955 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.4 m . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.034 0.445 . . . . 0.0 110.265 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 135.62 175.01 13.61 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -119.96 132.66 55.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.536 -0.979 . . . . 0.0 110.055 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -159.97 169.99 22.28 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.576 -0.703 . . . . 0.0 110.32 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 45.6 pttt -138.56 165.42 26.91 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.641 -0.662 . . . . 0.0 110.274 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 53.69 49.87 18.34 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.377 -0.827 . . . . 0.0 110.804 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -90.28 6.83 41.27 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.56 -0.713 . . . . 0.0 111.23 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.2 t -59.92 -49.97 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.259 -0.9 . . . . 0.0 110.014 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -139.89 135.63 33.09 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.497 -0.752 . . . . 0.0 110.226 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.44 -15.42 7.03 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.7 mp0 -87.38 2.14 51.26 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.179 -1.189 . . . . 0.0 111.298 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 63.3 t -109.97 126.36 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.072 -1.018 . . . . 0.0 109.922 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -115.29 159.47 20.98 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.638 -0.663 . . . . 0.0 110.074 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.485 ' HA ' HD22 ' A' ' 44' ' ' LEU . 62.7 t -116.63 129.94 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.521 -0.737 . . . . 0.0 110.034 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.5 p -136.99 139.57 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.543 -0.723 . . . . 0.0 110.003 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 72.7 m -125.12 141.2 52.25 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.5 -0.75 . . . . 0.0 110.381 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.527 HG22 ' H ' ' A' ' 39' ' ' ALA . 0.8 OUTLIER -105.68 -177.36 3.34 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.565 -0.709 . . . . 0.0 109.988 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.527 ' H ' HG22 ' A' ' 38' ' ' THR . . . -69.49 -40.01 77.29 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.594 -0.691 . . . . 0.0 111.238 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 67.2 p -114.42 -19.43 11.21 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.341 -0.849 . . . . 0.0 111.569 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -133.58 160.05 38.63 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.205 -0.935 . . . . 0.0 110.725 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.0 t -138.75 119.87 14.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.592 -0.693 . . . . 0.0 110.12 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -135.19 177.11 8.07 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.617 -0.677 . . . . 0.0 109.843 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.486 HD11 ' HA ' ' A' ' 109' ' ' ARG . 65.6 mt -118.68 160.34 22.01 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.486 -0.759 . . . . 0.0 110.36 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -124.99 153.32 42.97 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.544 -0.722 . . . . 0.0 110.043 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.438 HG21 ' HB3' ' A' ' 142' ' ' PRO . 58.8 m -125.87 140.09 52.94 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.522 -0.736 . . . . 0.0 110.402 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.9 t -88.84 108.76 19.7 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.504 -0.747 . . . . 0.0 110.094 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.6 t -123.0 129.99 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.648 -0.657 . . . . 0.0 109.921 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 54.47 38.71 30.18 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.568 -0.707 . . . . 0.0 110.899 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.522 ' O ' ' HB3' ' A' ' 87' ' ' ALA . . . 67.87 17.49 69.5 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 65.6 t -130.22 129.94 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.227 -1.161 . . . . 0.0 109.734 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 69.2 m -79.24 130.15 35.18 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.498 -0.751 . . . . 0.0 109.898 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.496 ' CD2' ' HE3' ' A' ' 175' ' ' MET . 97.0 m95 -120.01 137.16 54.25 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.473 -0.767 . . . . 0.0 110.729 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.686 HG23 HG13 ' A' ' 83' ' ' VAL . 9.7 t -137.35 172.39 13.05 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.841 HG11 ' CE1' ' A' ' 57' ' ' HIS . 59.4 t -80.81 142.3 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.367 -0.833 . . . . 0.0 109.691 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.863 ' CE2' HG22 ' A' ' 78' ' ' VAL . 33.0 t80 -79.28 -39.89 31.85 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.448 -0.783 . . . . 0.0 111.636 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.841 ' CE1' HG11 ' A' ' 55' ' ' VAL . 1.4 p-80 -59.72 -23.27 63.03 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.968 -1.083 . . . . 0.0 110.396 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -74.15 -70.64 1.22 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.831 -1.708 . . . . 0.0 108.831 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.52 -52.9 62.57 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.543 -0.975 . . . . 0.0 109.743 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.6 -170.81 54.44 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 59.2 m -60.03 -39.94 87.61 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.659 -0.906 . . . . 0.0 110.38 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -58.58 139.18 56.22 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.486 -0.759 . . . . 0.0 110.153 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.412 ' H ' HG22 ' A' ' 63' ' ' THR . 8.4 t -81.64 169.07 17.47 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.61 -0.681 . . . . 0.0 110.595 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 pp -140.28 140.68 35.76 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.654 -0.653 . . . . 0.0 110.12 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.35 134.06 36.6 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.509 -0.744 . . . . 0.0 110.554 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -103.62 -157.63 24.63 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -71.21 -41.33 2.62 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 123.415 1.218 . . . . 0.0 110.591 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -69.9 -31.4 69.17 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.527 -0.733 . . . . 0.0 110.208 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 144.12 -151.27 23.28 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.12 136.34 24.44 Favored 'Trans proline' 0 C--N 1.316 -1.154 0 O-C-N 123.353 1.186 . . . . 0.0 110.315 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.512 HD12 ' NE1' ' A' ' 85' ' ' TRP . 8.5 pt -132.53 161.26 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.617 -0.677 . . . . 0.0 110.537 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 35.9 m -112.39 132.29 55.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.624 -0.672 . . . . 0.0 109.708 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -60.24 125.1 22.39 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.509 -0.744 . . . . 0.0 110.509 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 91.0 mmm -92.12 -32.55 15.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.716 -0.615 . . . . 0.0 109.91 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.74 ' O ' HG23 ' A' ' 83' ' ' VAL . 45.5 m-85 -118.95 129.73 55.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.589 -0.694 . . . . 0.0 109.864 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.6 p -141.02 144.95 35.3 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.525 -0.734 . . . . 0.0 110.307 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -168.17 100.93 0.44 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.71 -0.619 . . . . 0.0 109.999 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.863 HG22 ' CE2' ' A' ' 56' ' ' TYR . 53.3 t -70.06 -42.84 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.427 -0.796 . . . . 0.0 109.88 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -60.06 -44.2 94.87 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.507 -0.746 . . . . 0.0 110.162 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -90.04 -8.56 51.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.811 -0.556 . . . . 0.0 110.563 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.4 t0 54.16 39.72 30.98 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.998 -1.064 . . . . 0.0 109.684 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.508 HD21 ' HG2' ' A' ' 175' ' ' MET . 14.5 tp -119.93 129.98 54.58 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.329 0.585 . . . . 0.0 110.472 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 75' ' ' TYR . 14.6 p -153.13 150.29 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.684 -0.635 . . . . 0.0 109.414 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -176.06 -174.31 42.48 Favored Glycine 0 N--CA 1.496 2.65 0 C-N-CA 119.622 -1.275 . . . . 0.0 110.571 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.512 ' NE1' HD12 ' A' ' 71' ' ' ILE . 14.1 m-90 -128.81 160.03 33.86 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.78 -0.836 . . . . 0.0 109.766 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -93.0 131.14 38.26 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.539 -0.726 . . . . 0.0 110.097 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 50' ' ' GLY . . . -111.94 159.6 32.96 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.461 -0.774 . . . . 0.0 110.462 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.2 159.16 50.45 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 O-C-N 123.428 1.225 . . . . 0.0 110.608 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.17 160.2 39.85 Favored 'Trans proline' 0 C--N 1.317 -1.101 0 O-C-N 123.506 1.266 . . . . 0.0 110.412 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 115.35 -4.49 21.74 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -109.93 142.4 41.34 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.092 -1.24 . . . . 0.0 110.172 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -60.34 140.06 57.32 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.507 -0.745 . . . . 0.0 110.124 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 52.6 m -133.1 156.87 46.63 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.593 -0.692 . . . . 0.0 110.402 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.9 mt -91.36 162.84 14.43 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.67 -0.644 . . . . 0.0 110.234 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.2 p -120.89 165.07 19.89 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.63 -0.669 . . . . 0.0 110.075 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.34 164.81 32.69 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 O-C-N 123.369 1.194 . . . . 0.0 110.207 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 7.2 t -75.2 128.1 34.7 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.564 -0.71 . . . . 0.0 110.405 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 46.7 p -129.58 45.48 2.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.743 -0.598 . . . . 0.0 109.682 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.3 p -145.07 12.22 1.39 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.642 -0.661 . . . . 0.0 111.474 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.23 50.97 49.89 Favored Glycine 0 N--CA 1.499 2.866 0 O-C-N 121.062 -1.024 . . . . 0.0 110.546 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.1 m -92.7 107.09 18.95 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.42 -1.047 . . . . 0.0 110.4 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.1 p -70.11 -39.95 75.19 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.487 -0.758 . . . . 0.0 109.931 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -75.11 123.09 24.59 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.653 -0.654 . . . . 0.0 109.857 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.563 HD13 HG11 ' A' ' 151' ' ' VAL . 73.9 mt -129.99 150.61 51.19 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.607 -0.683 . . . . 0.0 110.2 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -106.84 133.5 51.4 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.49 -0.757 . . . . 0.0 109.874 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.1 tt -98.85 130.3 45.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.536 -0.728 . . . . 0.0 110.467 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.1 t -87.79 123.41 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.691 -0.63 . . . . 0.0 109.707 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.2 m -100.77 166.82 10.67 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.56 -0.713 . . . . 0.0 110.386 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.486 ' HA ' HD11 ' A' ' 44' ' ' LEU . 78.3 ttt-85 -61.89 -27.33 68.73 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.59 -0.694 . . . . 0.0 110.332 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -93.41 25.48 3.4 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.527 -0.733 . . . . 0.0 110.781 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.98 40.03 31.85 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.284 -0.885 . . . . 0.0 110.843 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -93.27 156.24 16.94 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.644 -0.66 . . . . 0.0 109.78 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.9 p -129.93 133.44 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.47 -0.769 . . . . 0.0 110.404 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.4 tp -146.13 134.89 11.04 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.702 -0.624 . . . . 0.0 109.892 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.424 ' HG2' HD22 ' A' ' 127' ' ' LEU . 48.5 Cg_endo -76.15 139.2 21.16 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 O-C-N 123.155 1.082 . . . . 0.0 110.291 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.3 t -129.92 130.1 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.646 -0.659 . . . . 0.0 109.713 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.62 146.44 34.13 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.567 -0.708 . . . . 0.0 109.853 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -85.71 118.33 25.14 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.567 -0.708 . . . . 0.0 110.202 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.03 21.22 11.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.759 -0.588 . . . . 0.0 110.34 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 162.64 168.15 24.13 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -70.03 -40.02 75.43 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.566 -0.961 . . . . 0.0 110.693 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 89.8 p -114.68 -7.15 12.73 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.496 -0.753 . . . . 0.0 111.474 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -128.55 143.97 51.06 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.09 -1.006 . . . . 0.0 110.484 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -141.49 -174.64 14.5 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 80.1 p -120.53 144.17 48.2 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.558 -0.966 . . . . 0.0 110.165 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 57.8 tp -91.17 131.3 36.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.636 -0.665 . . . . 0.0 109.899 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.424 HD22 ' HG2' ' A' ' 115' ' ' PRO . 1.7 tp -60.09 -48.66 80.81 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.585 -0.697 . . . . 0.0 110.511 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 45.7 t -106.5 119.54 51.4 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.504 -0.747 . . . . 0.0 110.18 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.87 121.39 7.58 Favored 'Trans proline' 0 N--CA 1.486 1.034 0 O-C-N 123.191 1.101 . . . . 0.0 110.581 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 12.7 mtp85 -132.83 162.81 55.19 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.52 -0.737 . . . . 0.0 110.323 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.6 150.9 63.82 Favored 'Trans proline' 0 N--CA 1.486 1.076 0 O-C-N 123.482 1.254 . . . . 0.0 110.87 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.424 HG21 ' SG ' ' A' ' 159' ' ' CYS . 76.9 t -56.64 -35.29 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.484 -0.76 . . . . 0.0 110.252 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 34.8 t -58.44 -39.97 81.27 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.47 -0.768 . . . . 0.0 110.745 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -63.28 -39.94 95.98 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.489 -0.757 . . . . 0.0 109.592 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 21.3 tp -94.57 16.2 16.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.781 -0.574 . . . . 0.0 110.593 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 44.7 tttt -89.77 141.06 28.98 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.026 -1.046 . . . . 0.0 110.761 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 87.78 20.51 50.39 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 10.5 p -119.58 15.21 12.81 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.37 -1.077 . . . . 0.0 110.933 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.521 ' HB3' HG21 ' A' ' 55' ' ' VAL . 48.9 m -58.75 144.7 42.94 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.183 -0.948 . . . . 0.0 110.043 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 94.72 -16.67 60.72 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -58.5 111.1 2.94 Favored Glycine 0 N--CA 1.498 2.796 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.438 ' HB3' HG21 ' A' ' 46' ' ' THR . 50.1 Cg_endo -73.11 139.63 29.91 Favored 'Trans proline' 0 C--N 1.317 -1.082 0 O-C-N 123.197 1.104 . . . . 0.0 111.099 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.416 ' O ' HG12 ' A' ' 151' ' ' VAL . 4.4 mp -93.37 123.71 36.85 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.3 mp -118.38 127.27 53.53 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.184 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.645 ' SG ' 'ZN ' ' A' ' 202' ' ' ' ZN' . 27.2 p -66.61 163.97 36.9 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.7 -0.625 . . . . 0.0 109.384 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.54 -19.86 68.48 Favored 'Trans proline' 0 C--N 1.315 -1.204 0 O-C-N 123.231 1.121 . . . . 0.0 110.952 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.4 m -69.97 -27.33 64.64 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.295 -0.878 . . . . 0.0 110.031 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 121.64 -21.46 8.01 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.466 -1.053 . . . . 0.0 110.466 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -77.56 162.96 26.7 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.253 -1.145 . . . . 0.0 110.632 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -105.09 145.03 31.08 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.65 -0.656 . . . . 0.0 110.353 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.563 HG11 HD13 ' A' ' 104' ' ' LEU . 12.5 p -101.51 -29.18 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.552 -0.718 . . . . 0.0 110.809 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 169.26 -161.55 35.12 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 55.9 mt -128.87 155.86 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.566 -0.961 . . . . 0.0 110.255 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -66.61 139.94 57.91 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.621 -0.674 . . . . 0.0 110.076 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -122.59 -67.48 0.95 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.564 -0.71 . . . . 0.0 110.803 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.578 ' HB1' ' O32' ' A' ' 201' ' ' 4P2 . . . -135.27 150.3 50.01 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.453 -0.779 . . . . 0.0 110.78 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.41 151.74 19.15 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 48.6 t -120.01 119.97 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.507 -0.745 . . . . 0.0 110.432 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.424 ' SG ' HG21 ' A' ' 132' ' ' VAL . 27.4 p -141.6 157.81 44.63 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.543 -0.723 . . . . 0.0 110.415 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 18.4 p -94.58 -46.07 7.12 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.442 -0.786 . . . . 0.0 109.97 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 55.1 mmm-85 -130.37 35.96 4.01 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.644 -0.66 . . . . 0.0 109.552 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.402 ' O ' HG23 ' A' ' 132' ' ' VAL . . . 101.2 -10.11 58.09 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 57.3 t -96.55 123.47 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.184 -1.186 . . . . 0.0 109.473 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.66 117.3 26.38 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.496 -0.753 . . . . 0.0 110.776 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -109.46 -29.96 8.18 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.654 -0.654 . . . . 0.0 109.674 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -126.5 157.22 39.26 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.633 -0.667 . . . . 0.0 109.618 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 31.0 m -129.42 142.89 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.485 -0.759 . . . . 0.0 110.675 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -117.23 132.51 56.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.653 -0.654 . . . . 0.0 110.421 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -141.31 159.57 41.93 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.595 -0.69 . . . . 0.0 110.135 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 12.9 p -93.15 142.85 25.85 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.505 -0.747 . . . . 0.0 110.446 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -77.34 162.43 31.02 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 O-C-N 123.288 1.151 . . . . 0.0 110.559 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 67.1 t -69.91 -32.38 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.627 -0.671 . . . . 0.0 109.881 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -60.03 -40.01 87.87 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.493 -0.755 . . . . 0.0 110.355 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 48.0 t -62.54 -39.95 95.26 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.633 -0.667 . . . . 0.0 109.924 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.508 ' HG2' HD21 ' A' ' 82' ' ' LEU . 95.0 mtp -60.25 -40.0 88.77 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.674 -0.641 . . . . 0.0 110.177 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.7 -40.02 90.65 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.706 -0.621 . . . . 0.0 110.322 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 94.0 m -60.11 -40.11 88.55 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.645 -0.659 . . . . 0.0 110.156 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 88.2 m -68.17 -44.21 76.47 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.583 -0.698 . . . . 0.0 110.047 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 33.9 ttp -60.63 -40.99 93.97 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.556 -0.715 . . . . 0.0 110.387 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -61.15 -40.02 92.28 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.609 -0.682 . . . . 0.0 110.178 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.767 0 O-C-N 121.608 -0.682 . . . . 0.0 110.268 179.982 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' 4P2 . . . . . 0.578 ' O32' ' HB1' ' A' ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . 0.645 'ZN ' ' SG ' ' A' ' 145' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.567 HG23 ' O ' ' A' ' 22' ' ' THR . 7.4 t . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.158 0.504 . . . . 0.0 110.196 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.37 29.51 11.27 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -118.47 29.21 7.88 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.487 -1.008 . . . . 0.0 110.174 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -96.76 166.04 11.84 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.61 -0.681 . . . . 0.0 110.463 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -136.23 35.45 2.77 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.623 -0.673 . . . . 0.0 110.293 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -92.08 -49.26 6.3 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.546 -0.721 . . . . 0.0 110.519 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -157.6 55.06 0.49 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.506 -0.746 . . . . 0.0 110.456 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.1 m -62.16 132.63 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.483 -0.76 . . . . 0.0 110.349 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 62.31 129.99 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.567 -0.708 . . . . 0.0 110.542 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -126.22 -164.4 11.76 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.725 ' OE2' HD21 ' A' ' 144' ' ' LEU . 52.2 tt0 66.64 -65.12 0.21 Allowed 'General case' 0 N--CA 1.509 2.495 0 O-C-N 121.694 -0.886 . . . . 0.0 110.746 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.489 HG21 ' HD2' ' A' ' 142' ' ' PRO . 60.9 t -103.1 133.33 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.385 -0.822 . . . . 0.0 109.892 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -102.86 162.31 13.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.625 -0.672 . . . . 0.0 109.85 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.511 ' HA ' HD22 ' A' ' 44' ' ' LEU . 34.8 m -117.98 136.59 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.506 -0.746 . . . . 0.0 110.196 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.8 m -144.21 149.27 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.493 -0.755 . . . . 0.0 110.35 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.8 m -119.68 137.8 53.68 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.602 -0.687 . . . . 0.0 110.179 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.518 HG22 ' H ' ' A' ' 39' ' ' ALA . 1.0 OUTLIER -99.57 -178.43 3.89 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.577 -0.702 . . . . 0.0 110.001 179.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.518 ' H ' HG22 ' A' ' 38' ' ' THR . . . -60.0 -45.99 90.93 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.841 -179.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.4 p -118.67 -27.99 5.74 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.403 -0.811 . . . . 0.0 110.995 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -114.27 173.95 6.19 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.324 -0.86 . . . . 0.0 110.526 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 40.3 t -151.87 121.33 6.85 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.55 -0.719 . . . . 0.0 109.975 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 34.7 p90 -132.65 -179.51 5.5 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.625 -0.672 . . . . 0.0 110.064 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.535 HD11 ' HA ' ' A' ' 109' ' ' ARG . 34.7 mt -118.76 178.62 4.41 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.518 -0.739 . . . . 0.0 109.605 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.573 ' CB ' HG22 ' A' ' 54' ' ' THR . . . -143.0 161.37 38.3 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.474 -0.767 . . . . 0.0 110.98 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.8 p -125.34 144.09 50.66 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.721 -0.612 . . . . 0.0 109.689 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.419 ' HB2' ' HA ' ' A' ' 92' ' ' ARG . 27.0 p -91.9 111.79 23.46 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 121.72 0.772 . . . . 0.0 111.403 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.9 t -130.73 123.44 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.213 -0.929 . . . . 0.0 110.683 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 51.4 34.88 12.79 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.53 -0.731 . . . . 0.0 112.412 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.416 ' HA2' ' HB3' ' A' ' 92' ' ' ARG . . . 86.43 -17.04 41.19 Favored Glycine 0 N--CA 1.499 2.872 0 C-N-CA 120.1 -1.047 . . . . 0.0 111.659 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 62.8 t -105.82 128.63 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.091 -1.241 . . . . 0.0 110.477 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.739 ' SG ' ' HB2' ' A' ' 87' ' ' ALA . 78.5 m -84.32 107.78 16.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.634 -0.666 . . . . 0.0 109.532 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.531 ' CE3' HD22 ' A' ' 82' ' ' LEU . 91.1 m95 -91.85 137.48 32.33 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.509 -0.744 . . . . 0.0 110.59 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.573 HG22 ' CB ' ' A' ' 45' ' ' ALA . 77.8 p -136.51 179.74 6.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.773 -0.58 . . . . 0.0 109.611 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.754 HG21 ' HB3' ' A' ' 139' ' ' SER . 94.5 t -80.93 141.93 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.105 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.907 ' CE2' HG22 ' A' ' 78' ' ' VAL . 16.7 t80 -84.98 -43.44 13.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.445 -0.784 . . . . 0.0 111.248 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.688 ' CE1' HG11 ' A' ' 55' ' ' VAL . 2.2 p-80 -58.76 -25.02 62.63 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.24 -0.912 . . . . 0.0 110.941 -177.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -81.47 -48.67 5.82 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.52 -63.09 1.47 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.6 -0.941 . . . . 0.0 110.167 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.81 174.1 30.65 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.2 t -69.63 -18.63 63.61 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.574 -0.956 . . . . 0.0 110.757 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.7 ttmm -57.31 143.17 40.76 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.278 -0.889 . . . . 0.0 110.569 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.4 m -67.08 156.43 36.12 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.585 -0.697 . . . . 0.0 110.282 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.624 HD12 ' CZ2' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -98.0 143.13 28.89 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.592 -0.693 . . . . 0.0 110.276 -179.895 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -108.86 131.84 54.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.618 -0.676 . . . . 0.0 110.069 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -123.06 160.97 17.51 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.22 -46.87 1.91 Allowed 'Trans proline' 0 C--N 1.317 -1.104 0 O-C-N 123.421 1.222 . . . . 0.0 110.675 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -70.09 -31.08 68.48 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.577 -0.702 . . . . 0.0 109.933 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 169.73 153.67 8.72 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.6 172.25 15.53 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 123.36 1.189 . . . . 0.0 110.362 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.402 ' N ' HD12 ' A' ' 71' ' ' ILE . 4.4 mp -126.13 160.34 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.623 -0.673 . . . . 0.0 109.999 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.3 t -101.08 150.24 23.12 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.609 -0.682 . . . . 0.0 110.433 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.5 tm0? -80.08 128.27 33.29 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.611 -0.681 . . . . 0.0 110.163 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.1 tpp -106.36 -51.13 3.01 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.604 -0.685 . . . . 0.0 110.129 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.685 ' O ' HG13 ' A' ' 83' ' ' VAL . 35.5 m-85 -120.73 138.63 53.89 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.48 -0.763 . . . . 0.0 110.184 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.452 HG23 ' HE1' ' A' ' 56' ' ' TYR . 98.8 m -152.23 127.86 10.11 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.602 -0.686 . . . . 0.0 110.175 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -168.45 120.23 0.81 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.416 -0.802 . . . . 0.0 110.833 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.907 HG22 ' CE2' ' A' ' 56' ' ' TYR . 91.8 t -72.25 -39.54 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.35 -0.844 . . . . 0.0 109.735 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.66 -43.01 75.87 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.363 -0.836 . . . . 0.0 109.803 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -92.02 -14.24 29.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.793 -0.567 . . . . 0.0 109.885 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.482 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 49.5 t0 54.27 35.38 22.61 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.064 -1.022 . . . . 0.0 110.099 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.531 HD22 ' CE3' ' A' ' 53' ' ' TRP . 2.5 mt -123.2 149.73 44.29 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.836 0.827 . . . . 0.0 111.934 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.685 HG13 ' O ' ' A' ' 75' ' ' TYR . 2.7 t -146.64 150.95 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 178.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -138.35 148.19 19.74 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 118.992 -1.575 . . . . 0.0 111.636 -178.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.624 ' CZ2' HD12 ' A' ' 64' ' ' LEU . 5.1 m-90 -138.25 124.6 20.54 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.18 135.33 57.69 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.34 -0.85 . . . . 0.0 110.721 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.836 ' HB3' ' HG3' ' A' ' 92' ' ' ARG . . . -101.41 175.44 2.33 Favored Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 121.417 -0.802 . . . . 0.0 109.849 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.756 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 43.8 Cg_endo -70.45 147.96 59.55 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 O-C-N 123.465 1.245 . . . . 0.0 109.548 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.72 134.46 24.01 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 O-C-N 123.369 1.194 . . . . 0.0 110.245 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 131.59 -25.98 3.93 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -150.81 71.64 1.04 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.102 -1.234 . . . . 0.0 111.761 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.836 ' HG3' ' HB3' ' A' ' 87' ' ' ALA . 12.2 mmt180 -154.25 91.78 1.46 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.061 -1.024 . . . . 0.0 110.498 178.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.4 p -177.04 104.98 0.06 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.211 -0.93 . . . . 0.0 111.166 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.701 HD21 ' HB2' ' A' ' 150' ' ' ALA . 25.6 tp -117.34 131.91 56.7 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.583 -0.698 . . . . 0.0 109.406 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.3 t -76.45 137.28 67.66 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.363 -0.836 . . . . 0.0 110.74 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.04 166.21 28.35 Favored 'Trans proline' 0 N--CA 1.484 0.924 0 O-C-N 123.252 1.132 . . . . 0.0 110.204 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 47.4 t -82.41 132.85 35.21 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.505 -0.747 . . . . 0.0 110.24 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.0 t -135.98 48.87 2.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.655 -0.653 . . . . 0.0 109.797 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.4 p -144.92 0.17 0.94 Allowed 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 120.114 -0.634 . . . . 0.0 112.384 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 52.26 89.27 0.01 OUTLIER Glycine 0 N--CA 1.5 2.924 0 O-C-N 120.811 -1.181 . . . . 0.0 110.553 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.0 m -129.67 128.85 43.42 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.418 -1.048 . . . . 0.0 110.251 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.2 m -69.01 -40.02 78.94 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.577 -0.702 . . . . 0.0 110.122 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.69 142.13 58.24 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.557 -0.714 . . . . 0.0 109.965 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.534 ' CD2' HG21 ' A' ' 151' ' ' VAL . 57.2 mt -143.61 158.27 43.79 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.575 -0.703 . . . . 0.0 110.314 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -126.35 109.86 12.72 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.518 -0.739 . . . . 0.0 109.91 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.554 ' C ' HD23 ' A' ' 106' ' ' LEU . 8.4 tt -93.42 133.58 36.55 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.528 -0.733 . . . . 0.0 110.462 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.496 ' N ' HD23 ' A' ' 106' ' ' LEU . 61.1 t -98.28 130.03 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.668 -0.645 . . . . 0.0 109.762 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 68.1 p -99.04 169.91 9.08 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.527 -0.733 . . . . 0.0 110.456 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.535 ' HA ' HD11 ' A' ' 44' ' ' LEU . 8.5 ptm180 -63.34 -18.96 64.2 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.691 -0.631 . . . . 0.0 110.877 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -94.16 25.95 3.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.31 -0.869 . . . . 0.0 110.661 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 53.42 39.93 30.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.346 -0.846 . . . . 0.0 110.887 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -104.68 167.06 9.97 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.531 -0.731 . . . . 0.0 110.078 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.403 ' O ' HG13 ' A' ' 113' ' ' VAL . 8.5 p -133.65 131.53 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.589 -0.694 . . . . 0.0 110.435 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.681 HG21 HD11 ' A' ' 126' ' ' LEU . 87.0 mt -133.08 127.99 20.34 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.587 -0.696 . . . . 0.0 109.872 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -74.94 125.05 9.1 Favored 'Trans proline' 0 N--CA 1.485 0.982 0 O-C-N 123.096 1.051 . . . . 0.0 110.392 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.666 HG13 ' O ' ' A' ' 125' ' ' SER . 58.9 t -120.25 129.53 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.567 -0.708 . . . . 0.0 109.771 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -87.53 136.8 32.8 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.506 -0.746 . . . . 0.0 110.197 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -74.39 140.11 44.52 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.657 -0.652 . . . . 0.0 110.293 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.35 9.5 3.45 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.589 -0.694 . . . . 0.0 111.0 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -169.34 -172.44 36.01 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -70.28 -39.97 74.6 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.615 -0.932 . . . . 0.0 110.68 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 96.1 p -130.77 9.81 5.02 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.462 -0.774 . . . . 0.0 111.393 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -123.66 148.72 46.23 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.1 -1.0 . . . . 0.0 110.17 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.15 167.82 24.8 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.666 ' O ' HG13 ' A' ' 116' ' ' VAL . 19.2 p -107.76 158.9 16.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.52 -0.988 . . . . 0.0 110.21 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.681 HD11 HG21 ' A' ' 114' ' ' ILE . 40.1 tp -117.59 133.21 56.2 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.577 -0.702 . . . . 0.0 110.272 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.454 HD12 ' N ' ' A' ' 127' ' ' LEU . 6.3 mp -69.28 -43.15 74.44 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.588 -0.695 . . . . 0.0 110.401 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 58.4 p -97.42 111.97 59.84 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.474 -0.766 . . . . 0.0 110.168 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -80.91 106.87 1.85 Allowed 'Trans proline' 0 C--N 1.319 -1.006 0 O-C-N 123.197 1.104 . . . . 0.0 110.607 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.72 157.89 38.12 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.554 -0.716 . . . . 0.0 109.851 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.12 150.25 65.75 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.421 1.221 . . . . 0.0 110.867 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.415 HG21 ' SG ' ' A' ' 159' ' ' CYS . 55.3 t -54.13 -30.47 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.422 -0.799 . . . . 0.0 109.723 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 46.0 t -59.91 -41.94 92.79 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.559 -0.713 . . . . 0.0 110.869 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -67.97 -39.97 83.26 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.482 -0.761 . . . . 0.0 109.719 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 135' ' ' LEU . 33.0 tp -92.18 15.49 13.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.803 -0.56 . . . . 0.0 110.286 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -79.65 114.65 18.74 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 122.537 1.161 . . . . 0.0 112.128 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.93 37.18 3.72 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 61.3 m -119.26 19.13 12.89 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.705 -0.88 . . . . 0.0 110.454 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.754 ' HB3' HG21 ' A' ' 55' ' ' VAL . 66.3 m -70.54 136.28 49.2 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.25 -0.906 . . . . 0.0 109.169 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 109.77 -25.35 17.2 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.181 -1.567 . . . . 0.0 109.181 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.0 112.63 3.69 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.489 ' HD2' HG21 ' A' ' 33' ' ' VAL . 47.6 Cg_endo -73.24 148.8 44.5 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 123.25 1.131 . . . . 0.0 111.105 -179.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.497 HD21 HD12 ' A' ' 106' ' ' LEU . 67.7 mt -98.22 116.3 30.15 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.725 HD21 ' OE2' ' A' ' 32' ' ' GLU . 5.6 mp -103.37 127.71 50.66 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.509 -0.744 . . . . 0.0 111.015 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.716 ' SG ' 'ZN ' ' A' ' 202' ' ' ' ZN' . 27.8 p -67.92 164.85 37.09 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.755 -0.59 . . . . 0.0 109.505 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 39.4 Cg_endo -65.09 -14.22 44.05 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 O-C-N 123.148 1.078 . . . . 0.0 111.104 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.9 t -69.61 -40.02 76.88 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.147 -0.97 . . . . 0.0 109.768 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 122.17 37.82 0.63 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 28.2 m170 -133.6 -173.28 3.18 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.388 -1.066 . . . . 0.0 110.276 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.701 ' HB2' HD21 ' A' ' 94' ' ' LEU . . . -104.55 145.39 30.37 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.552 -0.718 . . . . 0.0 110.158 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.534 HG21 ' CD2' ' A' ' 104' ' ' LEU . 50.7 t -115.75 -62.42 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.518 -0.739 . . . . 0.0 110.454 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -157.08 -158.59 8.99 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.2 mt -133.48 146.68 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.565 -0.962 . . . . 0.0 110.003 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -61.97 140.01 58.36 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.369 -0.832 . . . . 0.0 110.479 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.428 ' NE ' ' HB3' ' A' ' 81' ' ' ASP . 0.6 OUTLIER -117.23 -76.13 0.57 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.57 0.7 . . . . 0.0 110.496 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -125.3 147.18 49.22 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 121.377 -0.827 . . . . 0.0 111.234 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.06 124.83 37.31 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.449 HG13 ' C11' ' A' ' 201' ' ' 4P2 . 2.3 t -95.75 119.03 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.585 -0.697 . . . . 0.0 111.026 -177.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.415 ' SG ' HG21 ' A' ' 132' ' ' VAL . 27.4 p -139.89 146.09 38.84 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.593 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 59.6 m -78.87 -49.92 12.09 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.6 -0.687 . . . . 0.0 109.855 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 5.9 ptt180 -129.11 36.17 4.21 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.614 -0.679 . . . . 0.0 109.915 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 102.7 -11.93 56.39 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 62.9 t -92.33 121.2 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.249 -1.148 . . . . 0.0 109.009 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.17 116.92 25.58 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.5 -0.75 . . . . 0.0 111.218 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -110.98 -29.93 7.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.833 -0.542 . . . . 0.0 109.729 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.403 ' C ' HG13 ' A' ' 167' ' ' VAL . . . -120.05 168.27 11.35 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.638 -0.664 . . . . 0.0 109.958 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.413 HG21 HG11 ' A' ' 116' ' ' VAL . 35.1 m -146.05 137.2 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.581 -0.699 . . . . 0.0 110.64 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -113.05 143.63 43.99 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.598 -0.689 . . . . 0.0 110.404 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -149.49 162.2 40.61 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.631 -0.668 . . . . 0.0 110.879 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.406 HG21 ' NH2' ' A' ' 155' ' ' ARG . 5.6 m -101.62 143.73 27.19 Favored Pre-proline 0 N--CA 1.505 2.317 0 O-C-N 121.448 -0.783 . . . . 0.0 110.135 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -79.69 168.18 19.8 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 O-C-N 123.339 1.179 . . . . 0.0 110.171 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 151' ' ' VAL . 64.9 t -66.29 -24.0 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.521 -0.737 . . . . 0.0 110.118 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -54.32 -38.89 66.5 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.429 -0.795 . . . . 0.0 111.449 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 82.2 p -61.66 -24.55 66.81 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.671 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 65.5 mtt -70.11 -28.72 65.62 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.431 -0.793 . . . . 0.0 110.898 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -59.28 -50.85 72.41 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.409 -0.807 . . . . 0.0 110.596 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 22.1 m -72.03 -29.03 63.76 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.49 -0.756 . . . . 0.0 110.334 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 32.5 m -68.0 -32.29 72.58 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.561 -0.712 . . . . 0.0 110.507 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 34.5 mmm -59.45 -52.04 67.31 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.484 -0.76 . . . . 0.0 110.485 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 56.4 mtp85 -63.87 -40.02 95.57 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.528 -0.732 . . . . 0.0 110.115 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.804 0 O-C-N 121.564 -0.71 . . . . 0.0 110.261 -179.891 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' 4P2 . . . . . 0.683 ' C24' HG13 ' A' ' 78' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . 0.716 'ZN ' ' SG ' ' A' ' 145' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.2 m . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.125 0.488 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.47 -154.05 30.45 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 50.7 ttp180 59.35 116.74 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.7 -0.882 . . . . 0.0 110.928 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 53.59 50.1 17.97 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.296 -0.877 . . . . 0.0 110.822 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.7 tttm -114.34 121.87 44.96 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.577 -0.702 . . . . 0.0 110.186 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 51.22 -150.15 0.29 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.396 -0.815 . . . . 0.0 110.796 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 66.28 -73.3 0.07 Allowed 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.155 -0.965 . . . . 0.0 110.749 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.3 t 53.81 69.96 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 O-C-N 121.556 -0.715 . . . . 0.0 110.278 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -65.83 148.91 51.02 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.618 -0.676 . . . . 0.0 110.401 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -147.64 -97.8 0.2 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.531 ' CG ' HD13 ' A' ' 94' ' ' LEU . 1.3 tp10 -169.3 -39.65 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.51 -0.994 . . . . 0.0 110.286 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.878 HG22 HG22 ' A' ' 46' ' ' THR . 92.4 t -109.83 143.96 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.569 -0.707 . . . . 0.0 109.808 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -116.63 148.25 41.15 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.63 -0.669 . . . . 0.0 110.308 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.493 ' HA ' HD22 ' A' ' 44' ' ' LEU . 59.8 t -78.43 124.62 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.701 -0.624 . . . . 0.0 109.699 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.6 m -134.12 138.65 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.428 -0.795 . . . . 0.0 110.545 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 74.7 m -119.38 154.56 33.44 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.593 -0.692 . . . . 0.0 110.294 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.526 HG22 ' H ' ' A' ' 39' ' ' ALA . 1.5 m -110.99 179.6 4.0 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.63 -0.669 . . . . 0.0 110.121 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.526 ' H ' HG22 ' A' ' 38' ' ' THR . . . -62.43 -40.03 95.25 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.807 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.408 HG23 ' HG3' ' A' ' 41' ' ' GLN . 7.7 t -119.78 -28.3 5.26 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.401 -0.812 . . . . 0.0 111.204 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.408 ' HG3' HG23 ' A' ' 40' ' ' THR . 50.0 mt-30 -118.2 178.08 4.56 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.405 -0.81 . . . . 0.0 110.213 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 83.0 p -153.71 117.03 4.59 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.541 -0.724 . . . . 0.0 110.565 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.639 ' HZ ' HD22 ' A' ' 64' ' ' LEU . 6.7 p90 -130.4 -176.91 4.11 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.635 -0.665 . . . . 0.0 110.007 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.493 HD22 ' HA ' ' A' ' 35' ' ' VAL . 57.9 mt -117.3 162.93 17.11 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.433 -0.792 . . . . 0.0 110.545 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.863 ' O ' HG13 ' A' ' 33' ' ' VAL . . . -129.53 150.23 50.95 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.668 -0.645 . . . . 0.0 110.504 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.878 HG22 HG22 ' A' ' 33' ' ' VAL . 78.9 p -125.69 144.17 50.72 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.602 -0.687 . . . . 0.0 110.077 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 25.9 p -100.51 106.71 18.27 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.741 0.781 . . . . 0.0 110.575 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.504 ' O ' HG12 ' A' ' 51' ' ' VAL . 60.8 t -130.64 139.58 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.285 -0.884 . . . . 0.0 110.341 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.419 ' OD1' HG12 ' A' ' 48' ' ' VAL . 10.8 m120 55.02 40.48 32.02 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.57 -0.706 . . . . 0.0 111.529 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 87' ' ' ALA . . . 63.78 14.46 55.33 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 48' ' ' VAL . 7.2 p -138.43 138.55 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.148 -1.207 . . . . 0.0 109.354 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.582 ' SG ' ' HB1' ' A' ' 45' ' ' ALA . 43.6 t -87.67 126.28 34.87 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.56 -0.713 . . . . 0.0 110.464 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.661 ' CE3' HD23 ' A' ' 82' ' ' LEU . 75.1 m95 -111.08 136.78 49.6 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.649 -0.657 . . . . 0.0 110.13 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.56 HG21 ' CH2' ' A' ' 85' ' ' TRP . 6.9 t -137.37 -179.81 5.95 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.658 -0.651 . . . . 0.0 110.005 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.612 HG21 ' HB3' ' A' ' 139' ' ' SER . 63.6 t -84.13 141.47 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.491 -0.756 . . . . 0.0 109.124 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.893 ' CE2' HG22 ' A' ' 78' ' ' VAL . 14.4 t80 -85.73 -43.7 13.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.514 -0.741 . . . . 0.0 111.405 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.546 ' CE1' HG11 ' A' ' 55' ' ' VAL . 2.6 p-80 -60.53 -22.28 63.44 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.219 -0.926 . . . . 0.0 110.821 -178.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -93.57 -32.64 7.56 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.507 ' HB1' ' CD2' ' A' ' 64' ' ' LEU . . . -84.03 -63.43 1.35 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.55 -0.97 . . . . 0.0 110.274 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.61 -176.5 28.75 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.5 t -70.12 -24.03 63.13 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.635 -0.92 . . . . 0.0 110.546 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.67 139.77 56.96 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.435 -0.79 . . . . 0.0 110.382 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.49 HG22 ' HB2' ' A' ' 73' ' ' GLN . 1.8 p -76.94 140.22 40.41 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.62 -0.675 . . . . 0.0 110.251 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.639 HD22 ' HZ ' ' A' ' 43' ' ' PHE . 2.8 pp -143.13 122.42 13.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.498 -0.751 . . . . 0.0 110.588 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.729 ' HB3' HG23 ' A' ' 71' ' ' ILE . . . -147.71 108.15 4.12 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.242 -0.911 . . . . 0.0 110.371 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 57.86 163.04 0.05 OUTLIER Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.43 -8.6 22.91 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 O-C-N 123.024 1.013 . . . . 0.0 110.897 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.35 -31.84 67.82 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.297 -0.877 . . . . 0.0 111.255 -179.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 159.54 161.61 11.41 Favored Glycine 0 N--CA 1.496 2.644 0 C-N-CA 119.802 -1.189 . . . . 0.0 110.486 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -75.84 161.64 36.02 Favored 'Trans proline' 0 N--CA 1.488 1.196 0 O-C-N 123.611 1.322 . . . . 0.0 111.059 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.729 HG23 ' HB3' ' A' ' 65' ' ' ALA . 47.3 pt -128.79 -153.47 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.625 -0.672 . . . . 0.0 109.611 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 58.6 m -94.44 137.31 33.73 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.302 -0.874 . . . . 0.0 109.762 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.49 ' HB2' HG22 ' A' ' 63' ' ' THR . 44.5 tt0 -86.04 143.53 28.05 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.49 -0.756 . . . . 0.0 110.783 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.9 tpp -119.13 -48.07 2.45 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.549 -0.719 . . . . 0.0 110.742 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.641 ' O ' HG13 ' A' ' 83' ' ' VAL . 29.2 m-85 -109.62 128.46 55.24 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.355 -0.84 . . . . 0.0 110.32 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 54.7 m -152.19 123.38 7.64 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.527 -0.733 . . . . 0.0 110.147 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -166.09 124.24 1.49 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.405 -0.81 . . . . 0.0 111.32 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.893 HG22 ' CE2' ' A' ' 56' ' ' TYR . 94.3 t -72.59 -30.83 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.528 -0.732 . . . . 0.0 109.797 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -57.83 -40.05 79.12 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.47 -0.768 . . . . 0.0 110.433 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -97.63 -7.75 30.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.57 -0.706 . . . . 0.0 111.009 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.5 ' O ' HD12 ' A' ' 82' ' ' LEU . 37.8 t0 53.35 39.66 30.17 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.958 -1.088 . . . . 0.0 110.569 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.661 HD23 ' CE3' ' A' ' 53' ' ' TRP . 0.4 OUTLIER -140.14 155.54 46.93 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.574 -0.851 . . . . 0.0 111.314 -179.071 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.641 HG13 ' O ' ' A' ' 75' ' ' TYR . 3.1 t -145.55 156.74 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -155.46 172.59 33.63 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 119.292 -1.432 . . . . 0.0 111.064 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.56 ' CH2' HG21 ' A' ' 54' ' ' THR . 10.6 m-90 -147.0 159.65 43.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.89 -0.77 . . . . 0.0 109.602 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -70.83 115.64 10.21 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.517 -0.739 . . . . 0.0 110.31 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 50' ' ' GLY . . . -86.57 157.93 54.87 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.623 -0.673 . . . . 0.0 110.056 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.43 155.91 59.21 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.422 1.222 . . . . 0.0 110.396 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -75.22 155.12 41.91 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.466 1.245 . . . . 0.0 110.341 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 97.26 -25.93 25.0 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.5 154.31 24.92 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.396 -1.061 . . . . 0.0 110.063 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.94 135.15 44.99 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.599 -0.688 . . . . 0.0 110.025 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 58.4 m -105.39 130.02 53.58 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.526 -0.734 . . . . 0.0 110.098 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.833 HD23 ' HB2' ' A' ' 150' ' ' ALA . 6.0 tp -83.81 148.94 26.72 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.552 -0.717 . . . . 0.0 110.435 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.577 HG23 ' ND1' ' A' ' 149' ' ' HIS . 6.5 t -113.22 150.98 43.87 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.606 -0.684 . . . . 0.0 110.196 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.72 154.96 63.63 Favored 'Trans proline' 0 N--CA 1.486 1.071 0 O-C-N 123.319 1.168 . . . . 0.0 110.702 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 1.056 ' SG ' 'ZN ' ' A' ' 202' ' ' ' ZN' . 7.1 t -87.17 144.64 26.75 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.567 -0.708 . . . . 0.0 110.572 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.4 p -136.52 67.97 1.44 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.61 -0.681 . . . . 0.0 110.441 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 28.0 p -145.15 7.16 1.17 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.385 -0.822 . . . . 0.0 111.97 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 52.02 47.84 53.48 Favored Glycine 0 N--CA 1.499 2.881 0 O-C-N 120.863 -1.148 . . . . 0.0 110.384 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.3 t -100.02 120.49 39.9 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.502 -0.999 . . . . 0.0 110.512 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.8 p -69.94 -39.78 75.89 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.629 -0.669 . . . . 0.0 109.918 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -61.58 134.92 57.39 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.561 -0.712 . . . . 0.0 109.881 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 49.9 mt -142.68 160.15 40.86 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.564 -0.71 . . . . 0.0 110.707 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -120.02 134.04 55.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.674 -0.641 . . . . 0.0 109.347 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.457 HD12 ' HG ' ' A' ' 143' ' ' LEU . 3.6 tt -127.33 112.58 15.21 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.489 -0.757 . . . . 0.0 110.711 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.429 ' O ' HD23 ' A' ' 106' ' ' LEU . 55.9 t -69.14 147.52 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.49 -0.756 . . . . 0.0 108.993 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.8 p -108.29 -168.25 1.34 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.51 -0.744 . . . . 0.0 110.614 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.4 ' NH2' HD12 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -88.73 -22.97 23.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.585 -0.697 . . . . 0.0 110.348 -179.662 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -102.56 29.23 5.4 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.452 -0.78 . . . . 0.0 110.167 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 56.89 55.65 6.01 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.471 -0.768 . . . . 0.0 111.019 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.95 144.06 49.09 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.476 -0.765 . . . . 0.0 109.297 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.5 t -115.28 128.29 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.364 -0.835 . . . . 0.0 110.461 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.545 HD11 ' HB3' ' A' ' 128' ' ' SER . 14.8 tt -137.96 134.91 18.24 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.62 -0.675 . . . . 0.0 109.864 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -74.82 145.52 32.29 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 O-C-N 123.208 1.109 . . . . 0.0 110.569 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.4 t -129.95 129.94 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.576 -0.702 . . . . 0.0 109.684 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -85.26 155.84 21.21 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.587 -0.696 . . . . 0.0 110.171 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 71.6 ttt-85 -99.1 134.55 41.79 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.596 -0.69 . . . . 0.0 110.146 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -118.75 -12.58 9.65 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.598 -0.689 . . . . 0.0 110.936 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -169.05 -160.57 17.48 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -70.04 -37.46 75.58 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.549 -0.971 . . . . 0.0 110.874 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.426 ' HA ' ' CE1' ' A' ' 169' ' ' PHE . 50.0 m -134.27 28.02 3.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.356 -0.84 . . . . 0.0 111.07 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.7 ' CZ ' ' HB1' ' A' ' 166' ' ' ALA . 17.4 tpt85 -141.93 139.87 32.64 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.298 -0.876 . . . . 0.0 110.242 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -147.89 161.71 28.61 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 71.4 p -98.78 163.89 12.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.43 -1.041 . . . . 0.0 110.147 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.512 HD11 HD13 ' A' ' 114' ' ' ILE . 22.9 tp -112.63 127.62 56.15 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.649 -0.657 . . . . 0.0 110.151 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.4 mp -64.19 -39.8 94.74 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.587 -0.696 . . . . 0.0 110.408 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.545 ' HB3' HD11 ' A' ' 114' ' ' ILE . 14.0 t -100.36 106.65 43.71 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.528 -0.732 . . . . 0.0 110.298 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -76.1 113.22 3.66 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 O-C-N 123.275 1.145 . . . . 0.0 110.515 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -119.33 155.19 54.04 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.585 -0.697 . . . . 0.0 109.917 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -70.0 150.42 66.76 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 O-C-N 123.432 1.227 . . . . 0.0 110.013 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 90.8 t -53.39 -34.39 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.252 -0.905 . . . . 0.0 110.002 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 34.5 t -57.87 -49.11 77.83 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.587 -0.695 . . . . 0.0 110.632 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -66.55 -38.37 86.98 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.501 -0.749 . . . . 0.0 109.548 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.429 ' O ' ' HG ' ' A' ' 135' ' ' LEU . 40.7 tp -90.23 16.85 7.86 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.826 -0.547 . . . . 0.0 110.335 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -83.28 121.09 26.66 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.757 -1.214 . . . . 0.0 112.126 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.49 33.26 4.87 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.6 m -106.05 13.02 29.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.653 -0.91 . . . . 0.0 110.525 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.612 ' HB3' HG21 ' A' ' 55' ' ' VAL . 18.1 m -62.36 143.58 56.81 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.272 -0.893 . . . . 0.0 109.849 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 83.0 7.06 87.7 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.409 ' O ' HD12 ' A' ' 143' ' ' LEU . . . -59.82 133.54 51.27 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.584 ' HG3' HG21 ' A' ' 33' ' ' VAL . 56.9 Cg_endo -80.17 117.15 3.46 Favored 'Trans proline' 0 N--CA 1.485 0.999 0 O-C-N 123.24 1.126 . . . . 0.0 110.934 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.688 ' C ' HD12 ' A' ' 144' ' ' LEU . 7.8 mp -98.75 104.04 16.04 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.407 -0.808 . . . . 0.0 109.018 178.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.688 HD12 ' C ' ' A' ' 143' ' ' LEU . 9.8 mp -117.74 147.43 42.97 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.498 -0.751 . . . . 0.0 111.065 -179.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.404 ' CB ' ' HD2' ' A' ' 146' ' ' PRO . 0.1 OUTLIER -75.27 178.68 1.69 Allowed Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.746 -0.596 . . . . 0.0 109.455 179.418 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.404 ' HD2' ' CB ' ' A' ' 145' ' ' CYS . 43.1 Cg_endo -70.01 -24.96 27.92 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.215 1.113 . . . . 0.0 110.416 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 36.4 t -69.9 -40.1 75.81 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.48 -0.762 . . . . 0.0 110.035 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 124.15 45.86 0.27 Allowed Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.577 ' ND1' HG23 ' A' ' 95' ' ' THR . 62.5 m-70 -135.96 134.79 39.01 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.574 -0.956 . . . . 0.0 110.318 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.833 ' HB2' HD23 ' A' ' 94' ' ' LEU . . . -77.86 140.87 39.38 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.495 -0.753 . . . . 0.0 110.353 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.615 ' O ' HG23 ' A' ' 172' ' ' VAL . 34.7 m -117.37 -25.82 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.629 -0.67 . . . . 0.0 110.66 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -174.37 -173.77 40.63 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 64.4 mt -129.33 158.17 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.659 -0.907 . . . . 0.0 109.672 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -69.81 148.01 49.66 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.385 -0.822 . . . . 0.0 110.167 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.41 ' NH1' HG22 ' A' ' 170' ' ' VAL . 0.0 OUTLIER -132.41 -80.35 0.5 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.781 -0.575 . . . . 0.0 110.354 -179.49 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -120.66 143.58 48.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.178 -0.951 . . . . 0.0 111.269 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.85 129.82 40.12 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.449 HG13 ' C11' ' A' ' 201' ' ' 4P2 . 2.3 t -100.32 121.27 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.491 -0.756 . . . . 0.0 111.33 -177.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.8 p -140.66 149.54 42.39 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.535 -0.728 . . . . 0.0 110.517 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 37.7 m -88.79 -49.62 6.72 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.553 -0.717 . . . . 0.0 109.804 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -119.71 32.03 6.26 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.52 0.676 . . . . 0.0 109.229 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 97.65 -11.56 64.7 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.244 -1.543 . . . . 0.0 109.244 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 62.4 t -88.11 122.42 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.279 -1.13 . . . . 0.0 109.061 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.55 113.14 22.97 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.528 -0.733 . . . . 0.0 110.784 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -109.14 -30.21 8.15 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.651 -0.656 . . . . 0.0 109.687 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.7 ' HB1' ' CZ ' ' A' ' 123' ' ' ARG . . . -116.52 168.32 10.27 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.664 -0.648 . . . . 0.0 109.681 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.447 HG13 ' C ' ' A' ' 166' ' ' ALA . 35.9 m -148.74 135.82 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.541 -0.724 . . . . 0.0 111.085 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.65 134.46 51.93 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.664 -0.647 . . . . 0.0 109.883 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.426 ' CE1' ' HA ' ' A' ' 122' ' ' SER . 52.2 p90 -131.56 159.94 36.74 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.42 -0.8 . . . . 0.0 110.389 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.41 HG22 ' NH1' ' A' ' 155' ' ' ARG . 60.4 t -92.54 140.53 24.02 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.57 -0.707 . . . . 0.0 110.212 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -75.15 162.51 36.64 Favored 'Trans proline' 0 C--N 1.32 -0.966 0 O-C-N 123.131 1.069 . . . . 0.0 110.337 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 151' ' ' VAL . 87.6 t -79.75 -30.59 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.554 -0.716 . . . . 0.0 110.257 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -60.02 -39.24 85.19 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.493 -0.754 . . . . 0.0 110.605 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 58.4 p -61.7 -25.7 67.58 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.516 -0.74 . . . . 0.0 110.871 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.428 ' CE ' HG13 ' A' ' 172' ' ' VAL . 53.9 mtm -66.99 -36.98 83.38 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.422 -0.799 . . . . 0.0 110.542 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -60.05 -40.01 87.92 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.472 -0.767 . . . . 0.0 110.404 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 31.3 m -61.05 -31.69 71.34 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.536 -0.727 . . . . 0.0 110.511 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 93.2 m -59.95 -40.04 87.64 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.515 -0.74 . . . . 0.0 110.465 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 1.4 ttp -58.82 -36.29 74.26 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.44 -0.787 . . . . 0.0 110.437 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 5.5 ttp180 -59.91 -39.98 87.26 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.433 -0.792 . . . . 0.0 110.212 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.833 0 O-C-N 121.603 -0.686 . . . . 0.0 110.301 179.944 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' 4P2 . . . . . 0.734 ' C24' HG13 ' A' ' 78' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . 1.056 'ZN ' ' SG ' ' A' ' 97' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.2 p . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.193 0.521 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.37 143.23 3.64 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -124.42 178.4 5.41 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.563 -0.963 . . . . 0.0 110.053 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -59.99 139.94 57.09 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.55 -0.719 . . . . 0.0 110.279 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -139.01 34.44 2.14 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.562 -0.711 . . . . 0.0 110.317 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -83.17 126.69 32.89 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.49 -0.756 . . . . 0.0 110.288 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -81.33 159.98 24.27 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.616 -0.678 . . . . 0.0 110.438 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.7 t -111.37 130.03 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.513 -0.742 . . . . 0.0 109.982 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -147.84 162.21 39.72 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.559 -0.713 . . . . 0.0 110.384 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -136.16 170.32 23.29 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.435 ' HG2' HD13 ' A' ' 94' ' ' LEU . 8.1 pt-20 -113.1 63.27 0.64 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.611 -0.934 . . . . 0.0 110.458 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 63.3 t -114.63 125.5 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.54 -0.725 . . . . 0.0 109.78 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -103.01 138.98 39.17 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.576 -0.702 . . . . 0.0 110.065 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.583 ' HA ' HD22 ' A' ' 44' ' ' LEU . 33.5 m -88.38 132.14 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.554 -0.716 . . . . 0.0 110.476 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.1 m -130.6 159.97 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.467 -0.77 . . . . 0.0 110.346 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 64.7 m -135.9 153.49 51.44 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.566 -0.709 . . . . 0.0 110.383 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.529 HG22 ' H ' ' A' ' 39' ' ' ALA . 1.6 m -117.8 179.82 3.96 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.618 -0.677 . . . . 0.0 109.982 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.529 ' H ' HG22 ' A' ' 38' ' ' THR . . . -71.14 -23.73 62.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.671 -0.643 . . . . 0.0 111.288 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.6 p -119.8 -28.29 5.25 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.32 -0.863 . . . . 0.0 111.418 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -142.34 164.72 29.37 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.371 -0.831 . . . . 0.0 110.639 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.4 t -130.94 124.62 31.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.497 -0.752 . . . . 0.0 110.14 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.411 ' CE1' ' OG1' ' A' ' 38' ' ' THR . 4.5 p90 -133.9 178.32 7.04 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.604 -0.685 . . . . 0.0 110.121 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.583 HD22 ' HA ' ' A' ' 35' ' ' VAL . 25.0 mt -121.16 167.55 12.54 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.574 -0.704 . . . . 0.0 110.026 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.79 152.14 46.33 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.592 -0.692 . . . . 0.0 110.06 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.6 m -119.98 135.42 54.92 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.477 -0.765 . . . . 0.0 110.286 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 45.8 t -93.27 103.82 16.04 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.562 -0.711 . . . . 0.0 110.482 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 94' ' ' LEU . 12.0 p -130.44 139.64 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.546 -0.721 . . . . 0.0 110.4 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 57.67 36.17 26.39 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.412 -0.805 . . . . 0.0 110.836 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 63.26 15.76 57.1 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.548 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 56.5 t -139.47 119.3 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.266 -1.137 . . . . 0.0 109.657 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 28.5 p -79.98 137.95 36.95 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.587 -0.696 . . . . 0.0 110.41 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.845 ' CE3' HD21 ' A' ' 82' ' ' LEU . 87.0 m95 -125.92 137.43 53.71 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.554 -0.716 . . . . 0.0 110.404 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.9 t -137.16 179.6 6.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.705 -0.622 . . . . 0.0 109.804 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.601 HG11 ' CE1' ' A' ' 57' ' ' HIS . 0.5 OUTLIER -81.32 142.65 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.175 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.908 ' CE2' HG22 ' A' ' 78' ' ' VAL . 27.5 t80 -81.02 -42.54 20.95 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.458 -0.776 . . . . 0.0 111.199 -178.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.601 ' CE1' HG11 ' A' ' 55' ' ' VAL . 2.2 p-80 -53.72 -21.2 6.64 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.444 -0.785 . . . . 0.0 111.956 -177.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -119.62 -23.63 3.06 Favored Glycine 0 N--CA 1.496 2.677 0 C-N-CA 119.984 -1.103 . . . . 0.0 111.064 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 55' ' ' VAL . . . -113.77 -27.14 7.9 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.235 -1.156 . . . . 0.0 111.083 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.453 ' HA3' ' CD1' ' A' ' 56' ' ' TYR . . . -60.0 -18.91 49.29 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 79.8 p -57.62 -22.71 46.99 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.276 -1.132 . . . . 0.0 111.02 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.1 tttm -152.2 161.48 42.55 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.368 -0.832 . . . . 0.0 110.702 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.822 HG22 ' HB2' ' A' ' 73' ' ' GLN . 76.0 p -66.0 149.15 50.69 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.569 -0.707 . . . . 0.0 109.624 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.451 ' HB2' ' CH2' ' A' ' 85' ' ' TRP . 19.4 mt -142.38 144.71 33.27 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.446 -0.784 . . . . 0.0 111.736 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.854 ' HB3' ' O ' ' A' ' 69' ' ' GLY . . . -147.58 164.02 34.76 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.33 -131.91 0.01 OUTLIER Glycine 0 N--CA 1.497 2.74 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.46 -9.45 25.36 Favored 'Trans proline' 0 N--CA 1.491 1.352 0 O-C-N 122.708 0.846 . . . . 0.0 111.988 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.493 ' HB3' HD11 ' A' ' 71' ' ' ILE . 24.4 tptt -69.79 -31.06 68.77 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.175 -0.953 . . . . 0.0 110.722 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.854 ' O ' ' HB3' ' A' ' 65' ' ' ALA . . . 104.58 -172.03 19.84 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.65 127.78 15.17 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 123.203 1.107 . . . . 0.0 110.377 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.493 HD11 ' HB3' ' A' ' 68' ' ' LYS . 68.9 mt -129.7 -109.72 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.518 -0.739 . . . . 0.0 110.215 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.452 ' N ' HG22 ' A' ' 71' ' ' ILE . 40.7 p -120.27 150.57 40.49 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.583 -1.323 . . . . 0.0 111.082 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.822 ' HB2' HG22 ' A' ' 63' ' ' THR . 0.4 OUTLIER -87.96 130.95 34.78 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.729 -0.607 . . . . 0.0 109.721 179.275 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.7 tpt -119.07 -44.54 2.6 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.464 -0.773 . . . . 0.0 110.976 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.52 ' O ' HG13 ' A' ' 83' ' ' VAL . 24.1 m-85 -109.81 124.78 51.89 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.271 -0.893 . . . . 0.0 110.083 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.503 HG23 ' HE1' ' A' ' 56' ' ' TYR . 56.9 m -152.17 135.47 15.91 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.609 -0.682 . . . . 0.0 110.355 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -167.28 111.85 0.71 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.504 -0.748 . . . . 0.0 110.813 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.908 HG22 ' CE2' ' A' ' 56' ' ' TYR . 75.7 t -72.25 -29.21 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.297 -0.877 . . . . 0.0 109.322 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -60.0 -42.89 95.23 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.47 -0.769 . . . . 0.0 110.012 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -99.81 -6.99 26.0 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.514 -0.741 . . . . 0.0 110.652 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.486 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 30.4 t0 56.39 33.98 23.38 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.065 -1.022 . . . . 0.0 110.635 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.845 HD21 ' CE3' ' A' ' 53' ' ' TRP . 7.8 tt -119.83 145.27 46.79 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.249 -0.907 . . . . 0.0 111.751 -178.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 75' ' ' TYR . 3.1 t -143.97 159.25 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -168.96 164.37 38.02 Favored Glycine 0 N--CA 1.496 2.645 0 C-N-CA 119.46 -1.352 . . . . 0.0 110.624 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.517 ' CZ2' HG12 ' A' ' 83' ' ' VAL . 20.3 m-90 -146.75 160.02 42.76 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.793 -0.828 . . . . 0.0 109.47 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -62.21 138.0 58.34 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.575 -0.703 . . . . 0.0 110.08 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.97 148.5 57.06 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.478 -0.764 . . . . 0.0 110.284 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.9 160.0 48.94 Favored 'Trans proline' 0 C--N 1.317 -1.105 0 O-C-N 123.484 1.254 . . . . 0.0 110.359 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -73.31 126.83 11.36 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 123.377 1.199 . . . . 0.0 110.447 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 108.81 30.09 3.86 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -117.42 159.49 22.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.513 -0.993 . . . . 0.0 110.089 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.2 mtp180 -96.29 163.87 12.9 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.53 -0.731 . . . . 0.0 110.378 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 80.7 p -130.89 145.17 51.93 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.678 -0.639 . . . . 0.0 109.901 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.435 HD13 ' HG2' ' A' ' 32' ' ' GLU . 0.7 OUTLIER -105.09 139.92 39.04 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.588 -0.695 . . . . 0.0 110.303 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 60.3 m -78.07 143.8 66.37 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.747 -0.596 . . . . 0.0 109.917 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.64 161.98 43.82 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 O-C-N 123.302 1.159 . . . . 0.0 110.319 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 45.6 t -72.9 128.01 34.24 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.539 -0.725 . . . . 0.0 110.483 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.3 m -135.73 55.79 1.85 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.662 -0.649 . . . . 0.0 109.531 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.4 p -145.01 4.66 1.1 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.58 -0.7 . . . . 0.0 112.175 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 51.25 91.06 0.01 OUTLIER Glycine 0 N--CA 1.502 3.064 0 O-C-N 120.905 -1.122 . . . . 0.0 110.495 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 98.1 p -139.35 148.06 42.38 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.436 -1.038 . . . . 0.0 110.362 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 63.7 m -95.03 -34.54 12.3 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.64 -0.662 . . . . 0.0 110.176 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -66.37 129.67 40.6 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.642 -0.661 . . . . 0.0 109.915 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.845 HD22 HG21 ' A' ' 151' ' ' VAL . 97.3 mt -136.28 156.53 48.53 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.625 -0.672 . . . . 0.0 110.546 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -126.34 108.72 11.5 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.667 -0.646 . . . . 0.0 109.519 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.473 HD11 ' CD1' ' A' ' 154' ' ' PHE . 9.7 tt -89.46 129.39 35.96 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.638 -0.663 . . . . 0.0 110.763 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.5 t -84.91 131.07 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.64 -0.663 . . . . 0.0 109.575 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.7 p -97.82 -175.51 3.19 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.48 -0.762 . . . . 0.0 110.509 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.2 ttt-85 -69.95 -27.01 64.4 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.706 -0.621 . . . . 0.0 110.846 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.44 ' CD2' ' HB2' ' A' ' 112' ' ' ASP . 41.0 p-80 -106.22 29.96 6.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.43 -0.794 . . . . 0.0 110.859 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 55.36 56.84 5.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.532 -0.73 . . . . 0.0 111.884 178.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.44 ' HB2' ' CD2' ' A' ' 110' ' ' HIS . 0.4 OUTLIER -110.8 137.34 48.57 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.401 -0.812 . . . . 0.0 109.88 179.118 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.44 ' O ' HG13 ' A' ' 113' ' ' VAL . 10.4 p -84.46 128.34 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.65 -0.656 . . . . 0.0 110.275 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.54 ' CG2' HD11 ' A' ' 126' ' ' LEU . 48.6 mm -129.98 105.86 16.67 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.523 -0.735 . . . . 0.0 110.11 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -70.66 119.84 6.64 Favored 'Trans proline' 0 N--CA 1.487 1.088 0 O-C-N 123.241 1.127 . . . . 0.0 110.242 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.635 HG13 ' O ' ' A' ' 125' ' ' SER . 57.5 t -120.36 129.39 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.515 -0.741 . . . . 0.0 110.137 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.514 ' CG ' HD11 ' A' ' 127' ' ' LEU . 4.1 mmt180 -83.03 135.86 34.7 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.566 -0.709 . . . . 0.0 109.809 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -82.24 134.23 35.28 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.522 -0.736 . . . . 0.0 110.431 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.7 18.63 3.3 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.587 -0.696 . . . . 0.0 110.581 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -173.33 178.94 45.05 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -69.55 -39.97 77.11 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.572 -0.958 . . . . 0.0 110.331 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.6 m -130.33 25.06 5.17 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.527 -0.733 . . . . 0.0 110.781 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -142.58 141.83 32.06 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.423 -0.798 . . . . 0.0 110.306 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -142.11 157.16 26.37 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.635 ' O ' HG13 ' A' ' 116' ' ' VAL . 50.6 p -91.57 157.63 16.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.664 -0.904 . . . . 0.0 110.125 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.54 HD11 ' CG2' ' A' ' 114' ' ' ILE . 39.9 tp -105.77 127.17 52.92 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.531 -0.731 . . . . 0.0 110.36 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.514 HD11 ' CG ' ' A' ' 117' ' ' ARG . 4.3 mp -68.6 -42.26 78.44 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.581 -0.7 . . . . 0.0 110.092 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.6 p -102.2 99.79 13.58 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.694 -0.629 . . . . 0.0 109.701 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.15 106.94 2.01 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.388 1.204 . . . . 0.0 110.945 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -114.47 161.5 28.25 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.713 -0.617 . . . . 0.0 109.748 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 44.8 Cg_endo -71.18 150.59 59.86 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 O-C-N 123.391 1.206 . . . . 0.0 110.354 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.413 HG21 ' SG ' ' A' ' 159' ' ' CYS . 64.6 t -51.03 -29.93 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 O-C-N 121.399 -0.813 . . . . 0.0 109.828 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.2 t -61.43 -40.04 92.97 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.728 -0.608 . . . . 0.0 110.956 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -66.87 -39.97 87.71 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.326 -0.859 . . . . 0.0 109.538 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.417 HD21 ' CZ ' ' A' ' 154' ' ' PHE . 17.6 tp -95.4 18.9 11.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.922 -0.486 . . . . 0.0 110.135 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -81.14 116.67 21.16 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 122.541 1.162 . . . . 0.0 112.412 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.72 22.12 11.54 Favored Glycine 0 N--CA 1.492 2.401 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.269 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.3 m -103.44 20.85 17.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.47 -1.018 . . . . 0.0 110.53 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.2 m -69.96 136.12 50.17 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.28 -0.888 . . . . 0.0 109.541 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 100.06 -23.29 36.56 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.79 110.02 1.93 Allowed Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -72.43 138.7 30.35 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 O-C-N 123.18 1.095 . . . . 0.0 111.073 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.459 ' C ' HD12 ' A' ' 144' ' ' LEU . 4.1 mp -86.35 146.3 26.53 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.459 HD12 ' C ' ' A' ' 143' ' ' LEU . 4.1 mp -126.9 162.23 26.41 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.403 -0.81 . . . . 0.0 111.23 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.412 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 27.1 p -119.1 165.12 17.93 Favored Pre-proline 0 N--CA 1.494 1.774 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.412 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 39.9 Cg_endo -65.42 -12.23 33.98 Favored 'Trans proline' 0 N--CA 1.489 1.218 0 O-C-N 123.082 1.043 . . . . 0.0 111.853 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.7 p -72.01 -32.66 67.39 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.117 -0.989 . . . . 0.0 109.943 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 116.15 20.74 5.1 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -131.34 152.95 50.11 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.325 -1.103 . . . . 0.0 110.377 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.403 ' HB2' ' CD2' ' A' ' 94' ' ' LEU . . . -78.77 152.36 31.5 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.542 -0.724 . . . . 0.0 109.931 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.845 HG21 HD22 ' A' ' 104' ' ' LEU . 34.0 m -112.55 -28.81 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.5 -0.75 . . . . 0.0 110.989 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 177.7 -161.01 27.96 Favored Glycine 0 N--CA 1.498 2.776 0 C-N-CA 119.753 -1.213 . . . . 0.0 110.339 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.5 mt -134.42 151.76 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.652 -0.911 . . . . 0.0 110.162 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.473 ' CD1' HD11 ' A' ' 106' ' ' LEU . 14.5 t80 -70.13 153.49 43.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.685 -0.634 . . . . 0.0 110.14 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 46.6 ttm-85 -135.95 -76.41 0.43 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.659 -0.651 . . . . 0.0 110.327 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -120.53 143.04 48.79 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.38 -0.825 . . . . 0.0 110.616 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.27 127.71 38.97 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.491 HG13 ' C11' ' A' ' 201' ' ' 4P2 . 2.5 t -96.9 117.77 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.602 -0.686 . . . . 0.0 111.535 -177.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.413 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.9 p -140.06 147.68 40.67 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.414 -0.804 . . . . 0.0 110.565 178.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 17.9 m -79.49 -50.59 10.53 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.488 -0.758 . . . . 0.0 109.77 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -130.26 36.7 3.96 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.633 -0.667 . . . . 0.0 109.904 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 131' ' ' PRO . . . 104.28 -11.76 51.47 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 65.1 t -93.12 121.95 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.259 -1.142 . . . . 0.0 109.158 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.2 121.1 29.2 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.541 -0.725 . . . . 0.0 111.347 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 5.4 mttp -113.29 -30.11 7.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.804 -0.56 . . . . 0.0 109.933 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -123.64 168.4 12.69 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.518 -0.739 . . . . 0.0 109.9 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.492 HG21 HG11 ' A' ' 116' ' ' VAL . 35.1 m -140.23 137.34 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.517 -0.74 . . . . 0.0 110.887 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -104.65 126.57 51.85 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.53 -0.731 . . . . 0.0 110.606 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -147.8 162.14 39.83 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.595 -0.691 . . . . 0.0 110.332 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 27.1 m -110.96 149.59 40.65 Favored Pre-proline 0 N--CA 1.502 2.129 0 O-C-N 121.353 -0.842 . . . . 0.0 110.708 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -78.6 161.28 28.03 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.496 1.261 . . . . 0.0 109.378 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 54.0 t -58.9 -25.93 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.385 -0.822 . . . . 0.0 110.051 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -59.92 -35.53 75.08 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.557 -0.715 . . . . 0.0 110.643 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 2.3 t -61.51 -24.35 66.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.468 -0.77 . . . . 0.0 110.568 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 68.0 mtt -69.96 -39.06 76.23 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.431 -0.793 . . . . 0.0 110.507 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -60.11 -39.98 88.08 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.443 -0.786 . . . . 0.0 110.566 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 85.3 m -60.8 -40.04 91.15 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.474 -0.766 . . . . 0.0 110.124 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.415 HG21 HD22 ' A' ' 82' ' ' LEU . 61.8 m -67.73 -36.34 80.4 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.559 -0.713 . . . . 0.0 110.321 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 7.9 ttt -60.06 -42.23 94.05 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.553 -0.717 . . . . 0.0 110.539 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -60.07 -39.9 87.66 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.539 -0.726 . . . . 0.0 110.342 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.722 0 O-C-N 121.581 -0.699 . . . . 0.0 110.187 179.956 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' 4P2 . . . . . 0.765 ' C24' HG13 ' A' ' 78' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.6 t . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.087 0.47 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.94 28.54 71.7 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 53.79 176.27 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.47 -1.018 . . . . 0.0 110.935 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -147.15 35.51 0.9 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.518 -0.739 . . . . 0.0 110.384 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.8 mmtm 53.14 39.96 30.46 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.465 -0.772 . . . . 0.0 110.858 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 52.23 42.9 31.01 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.468 -0.77 . . . . 0.0 110.886 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -79.11 130.3 35.36 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.56 -0.712 . . . . 0.0 110.157 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.5 p -133.27 131.27 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.547 -0.72 . . . . 0.0 110.248 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -89.43 -38.99 13.68 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.642 -0.662 . . . . 0.0 110.308 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.42 174.0 44.94 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.415 ' HG2' HD21 ' A' ' 94' ' ' LEU . 21.7 mp0 -90.17 -24.63 20.98 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.556 -0.967 . . . . 0.0 110.485 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.749 HG23 ' O ' ' A' ' 45' ' ' ALA . 9.1 p -119.31 143.66 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.566 -0.709 . . . . 0.0 110.069 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 54.9 tp60 -110.39 141.65 43.16 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.582 -0.699 . . . . 0.0 110.181 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.609 ' HA ' HD22 ' A' ' 44' ' ' LEU . 10.0 p -82.74 130.26 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.643 -0.661 . . . . 0.0 110.212 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.7 m -138.14 144.31 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.509 -0.744 . . . . 0.0 110.48 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.4 m -130.05 144.04 51.12 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.54 -0.725 . . . . 0.0 110.632 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.575 HG23 ' CD2' ' A' ' 64' ' ' LEU . 0.3 OUTLIER -99.86 -169.98 1.82 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.602 -0.686 . . . . 0.0 109.768 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.526 ' H ' HG22 ' A' ' 38' ' ' THR . . . -71.83 -40.04 69.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.614 -0.679 . . . . 0.0 111.597 -178.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 77.6 p -114.59 -18.82 11.34 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.226 -0.922 . . . . 0.0 111.608 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -139.75 161.67 36.99 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.244 -0.91 . . . . 0.0 110.134 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 99.1 p -138.4 123.28 18.87 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.458 -0.776 . . . . 0.0 110.857 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.618 ' CZ ' HD21 ' A' ' 64' ' ' LEU . 4.4 p90 -128.05 -174.96 3.35 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.632 -0.668 . . . . 0.0 109.503 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.609 HD22 ' HA ' ' A' ' 35' ' ' VAL . 44.0 mt -126.57 166.08 17.96 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.335 -0.853 . . . . 0.0 110.746 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.749 ' O ' HG23 ' A' ' 33' ' ' VAL . . . -141.49 152.48 44.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.711 -0.618 . . . . 0.0 110.261 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 87.8 m -130.03 139.9 50.94 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.511 -0.743 . . . . 0.0 110.291 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 77.8 m -77.63 120.49 22.65 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.562 -0.712 . . . . 0.0 110.431 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.1 t -130.48 120.82 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.467 -0.771 . . . . 0.0 110.628 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 33.4 m120 50.05 34.47 8.3 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.534 -0.729 . . . . 0.0 111.969 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.75 ' O ' ' HB3' ' A' ' 87' ' ' ALA . . . 91.25 -23.61 23.53 Favored Glycine 0 N--CA 1.497 2.736 0 C-N-CA 120.198 -1.001 . . . . 0.0 110.8 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.0 p -108.89 133.58 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.3 -1.118 . . . . 0.0 109.781 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 77.1 m -91.55 125.03 36.15 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.392 -0.818 . . . . 0.0 110.159 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 71.9 m95 -99.33 137.17 38.21 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.567 -0.708 . . . . 0.0 110.422 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.81 HG21 ' CZ2' ' A' ' 85' ' ' TRP . 8.4 t -137.06 173.43 11.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.765 -0.584 . . . . 0.0 109.751 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.706 HG11 ' CE1' ' A' ' 57' ' ' HIS . 96.9 t -81.78 142.09 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.462 -0.774 . . . . 0.0 109.26 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.903 ' CE2' HG22 ' A' ' 78' ' ' VAL . 15.2 t80 -85.0 -43.37 14.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.63 -0.669 . . . . 0.0 110.806 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.706 ' CE1' HG11 ' A' ' 55' ' ' VAL . 2.2 p-80 -59.45 -22.55 61.67 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.167 -0.958 . . . . 0.0 110.476 -178.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -82.28 -65.77 1.61 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.0 -63.28 1.36 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.418 -1.048 . . . . 0.0 110.188 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.02 -153.63 21.22 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 72.8 m -59.78 -52.22 66.4 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.591 -0.946 . . . . 0.0 110.766 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -62.5 137.26 58.22 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.368 -0.832 . . . . 0.0 109.946 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 71' ' ' ILE . 8.5 t -114.24 140.94 48.17 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.563 -0.711 . . . . 0.0 110.318 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.742 ' O ' HD12 ' A' ' 64' ' ' LEU . 4.4 pp -142.27 140.26 32.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.471 -0.768 . . . . 0.0 110.235 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.608 ' HB3' HG12 ' A' ' 71' ' ' ILE . . . -147.19 119.53 8.38 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.671 -0.643 . . . . 0.0 109.931 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.57 128.35 0.03 OUTLIER Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.46 -9.19 25.57 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 O-C-N 123.169 1.089 . . . . 0.0 111.454 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -89.0 12.52 15.24 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.243 -0.91 . . . . 0.0 111.27 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 150.6 128.94 1.58 Allowed Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -87.2 168.86 7.54 Favored 'Trans proline' 0 C--N 1.32 -0.926 0 O-C-N 123.156 1.082 . . . . 0.0 110.464 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.608 HG12 ' HB3' ' A' ' 65' ' ' ALA . 45.1 pt -145.42 161.43 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.585 -0.697 . . . . 0.0 110.29 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.9 m -73.18 149.96 42.51 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.525 -0.735 . . . . 0.0 110.272 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -92.36 150.83 20.59 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.551 -0.718 . . . . 0.0 110.565 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 97.8 mmm -116.98 -32.7 4.98 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.65 -0.656 . . . . 0.0 110.35 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.582 ' O ' HG13 ' A' ' 83' ' ' VAL . 18.5 m-85 -110.11 129.15 55.74 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.374 -0.829 . . . . 0.0 109.436 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 89.3 m -151.44 132.65 14.46 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.399 -0.813 . . . . 0.0 110.456 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -166.73 125.42 1.42 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.372 -0.83 . . . . 0.0 111.141 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.903 HG22 ' CE2' ' A' ' 56' ' ' TYR . 78.5 t -72.32 -39.29 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.459 -0.776 . . . . 0.0 109.607 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -55.81 -44.93 78.32 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.354 -0.842 . . . . 0.0 110.268 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.576 ' O ' HD12 ' A' ' 82' ' ' LEU . 12.0 tp60 -82.9 -14.0 55.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.754 -0.591 . . . . 0.0 110.279 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 40.2 t0 53.09 39.9 30.31 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.117 -0.989 . . . . 0.0 110.67 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.684 HD13 ' CE ' ' A' ' 175' ' ' MET . 0.3 OUTLIER -146.3 156.98 43.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.406 -0.809 . . . . 0.0 111.065 -179.545 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.733 ' O ' HG22 ' A' ' 54' ' ' THR . 3.5 t -145.11 145.14 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -130.5 154.69 20.77 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.626 -1.273 . . . . 0.0 110.912 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.81 ' CZ2' HG21 ' A' ' 54' ' ' THR . 4.4 m-90 -125.07 159.88 30.36 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.904 -0.763 . . . . 0.0 109.431 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -83.15 122.9 28.98 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.474 -0.766 . . . . 0.0 109.877 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.75 ' HB3' ' O ' ' A' ' 50' ' ' GLY . . . -101.28 160.62 26.1 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.457 -0.777 . . . . 0.0 110.538 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.77 160.05 49.06 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 O-C-N 123.484 1.255 . . . . 0.0 110.506 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.52 158.81 47.28 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.448 1.236 . . . . 0.0 110.526 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 74.27 31.12 59.69 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -107.23 151.33 25.58 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.43 -1.041 . . . . 0.0 110.307 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -60.5 152.3 26.22 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.589 -0.694 . . . . 0.0 110.46 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 92.5 p -148.23 155.39 41.3 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.612 -0.68 . . . . 0.0 110.457 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.626 ' HB3' ' HB2' ' A' ' 150' ' ' ALA . 90.9 mt -111.13 131.92 54.7 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.563 -0.711 . . . . 0.0 110.36 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 72.6 p -76.5 159.91 78.54 Favored Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 121.597 -0.689 . . . . 0.0 110.082 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.0 159.22 50.78 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.38 1.2 . . . . 0.0 110.481 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 47.0 t -86.93 128.15 35.06 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.564 -0.71 . . . . 0.0 110.388 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.5 p -133.69 55.09 1.91 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.603 -0.685 . . . . 0.0 109.989 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.5 p -145.18 7.68 1.18 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.481 -0.762 . . . . 0.0 111.864 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 52.26 41.67 54.72 Favored Glycine 0 N--CA 1.499 2.894 0 O-C-N 121.003 -1.06 . . . . 0.0 110.496 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.8 m -78.92 107.96 12.04 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.519 -0.989 . . . . 0.0 110.386 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.4 m -66.24 -40.01 89.92 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.569 -0.707 . . . . 0.0 110.195 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -67.92 129.12 38.94 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.589 -0.694 . . . . 0.0 109.97 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.579 HD22 HG21 ' A' ' 151' ' ' VAL . 90.8 mt -134.99 150.08 50.29 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.609 -0.682 . . . . 0.0 110.356 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -117.5 125.19 50.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.535 -0.728 . . . . 0.0 109.768 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.686 HD11 ' HB2' ' A' ' 154' ' ' PHE . 26.8 tp -102.53 144.22 31.23 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.5 -0.75 . . . . 0.0 110.556 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.6 t -105.92 126.68 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.603 -0.686 . . . . 0.0 109.73 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 69.7 p -93.98 176.49 6.31 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.501 -0.749 . . . . 0.0 110.58 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -60.13 -24.63 64.84 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.598 -0.689 . . . . 0.0 110.722 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -95.32 27.15 3.43 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.474 -0.766 . . . . 0.0 110.555 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 53.21 27.79 6.39 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.296 -0.878 . . . . 0.0 110.916 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -80.68 152.59 28.36 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.546 -0.721 . . . . 0.0 109.913 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 63.2 t -116.05 128.17 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.543 -0.723 . . . . 0.0 109.929 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.548 HD11 HD23 ' A' ' 106' ' ' LEU . 40.1 pt -134.56 139.07 31.5 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.49 -0.756 . . . . 0.0 110.19 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -82.91 146.45 12.98 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 O-C-N 123.177 1.093 . . . . 0.0 110.521 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.1 t -139.36 129.94 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.584 -0.698 . . . . 0.0 109.768 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.7 tpp180 -92.98 130.71 38.47 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.538 -0.726 . . . . 0.0 110.154 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -80.26 121.33 25.5 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.606 -0.684 . . . . 0.0 110.328 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.88 -12.29 9.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.523 -0.736 . . . . 0.0 110.473 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -134.92 -175.55 13.92 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -70.14 -45.09 67.54 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.557 -0.966 . . . . 0.0 110.57 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.6 m -127.67 21.04 6.54 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.45 -0.781 . . . . 0.0 110.819 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.72 142.13 34.86 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.315 -0.866 . . . . 0.0 110.057 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -134.25 166.86 23.99 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 52.9 p -98.72 165.19 11.91 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.541 -0.976 . . . . 0.0 110.222 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.444 HD21 ' NH1' ' A' ' 130' ' ' ARG . 47.7 tp -120.0 124.2 45.33 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.527 -0.733 . . . . 0.0 110.337 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.459 HD12 ' H ' ' A' ' 127' ' ' LEU . 5.4 mp -62.13 -41.67 98.49 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.51 -0.744 . . . . 0.0 110.182 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.4 p -102.58 105.9 46.6 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.548 -0.72 . . . . 0.0 109.945 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.36 106.85 2.15 Favored 'Trans proline' 0 C--N 1.319 -0.999 0 O-C-N 123.32 1.169 . . . . 0.0 110.876 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.657 ' O ' ' HB3' ' A' ' 164' ' ' ALA . 4.4 mtt85 -106.89 153.09 41.05 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.644 -0.66 . . . . 0.0 109.643 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.27 150.38 52.93 Favored 'Trans proline' 0 C--N 1.315 -1.207 0 O-C-N 123.383 1.202 . . . . 0.0 110.884 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.421 HG21 ' SG ' ' A' ' 159' ' ' CYS . 73.6 t -53.6 -31.95 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.473 -0.767 . . . . 0.0 109.565 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 31.2 t -59.85 -39.99 87.07 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.689 -0.632 . . . . 0.0 110.65 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.448 ' CD2' ' HD2' ' A' ' 130' ' ' ARG . 87.3 t80 -70.06 -39.73 75.5 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.444 -0.785 . . . . 0.0 109.604 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 22.1 tp -95.01 13.59 24.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.725 -0.609 . . . . 0.0 110.581 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.71 113.03 13.9 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.601 1.191 . . . . 0.0 111.087 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.53 34.3 4.48 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 31.1 m -115.29 19.15 15.76 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.747 -0.855 . . . . 0.0 110.46 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.539 ' HB3' HG21 ' A' ' 55' ' ' VAL . 4.5 m -68.12 147.47 52.27 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.3 -0.875 . . . . 0.0 109.508 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.405 ' C ' HG23 ' A' ' 153' ' ' ILE . . . 94.56 -19.75 52.02 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -58.29 112.69 4.15 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.49 157.56 52.65 Favored 'Trans proline' 0 C--N 1.319 -1.025 0 O-C-N 123.201 1.106 . . . . 0.0 110.955 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.575 HD11 HD13 ' A' ' 106' ' ' LEU . 5.9 mp -109.4 127.66 54.54 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.543 HD13 ' O ' ' A' ' 149' ' ' HIS . 2.9 mm? -110.41 160.26 16.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.535 -0.728 . . . . 0.0 111.078 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.933 ' SG ' 'ZN ' ' A' ' 202' ' ' ' ZN' . 27.1 p -119.92 165.64 17.26 Favored Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 38.5 Cg_endo -63.97 -15.21 47.84 Favored 'Trans proline' 0 N--CA 1.488 1.18 0 O-C-N 123.079 1.042 . . . . 0.0 111.454 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.5 t -70.24 -39.95 74.75 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.282 -0.886 . . . . 0.0 110.044 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 114.87 31.61 2.06 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.543 ' O ' HD13 ' A' ' 144' ' ' LEU . 33.8 m170 -132.15 155.76 47.6 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.492 -1.005 . . . . 0.0 110.404 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.626 ' HB2' ' HB3' ' A' ' 94' ' ' LEU . . . -73.41 146.85 44.78 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.556 -0.715 . . . . 0.0 109.985 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.766 ' O ' HG23 ' A' ' 172' ' ' VAL . 58.9 t -112.08 -61.67 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.479 -0.763 . . . . 0.0 110.353 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -163.19 -158.76 10.0 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.405 HG23 ' C ' ' A' ' 140' ' ' GLY . 96.8 mt -133.97 155.42 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.594 -0.945 . . . . 0.0 109.882 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.686 ' HB2' HD11 ' A' ' 106' ' ' LEU . 19.6 t80 -70.04 147.49 49.98 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.45 -0.781 . . . . 0.0 109.861 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.545 ' NH2' HG22 ' A' ' 170' ' ' VAL . 4.6 ttm-85 -128.6 -79.85 0.57 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.602 -0.686 . . . . 0.0 110.829 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -119.5 143.7 47.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.964 . . . . 0.0 111.313 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.56 128.08 39.53 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.458 HG13 ' C11' ' A' ' 201' ' ' 4P2 . 2.4 t -98.86 119.11 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 121.48 -0.762 . . . . 0.0 111.282 -177.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.421 ' SG ' HG21 ' A' ' 132' ' ' VAL . 27.9 p -139.88 143.59 36.77 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.506 -0.746 . . . . 0.0 110.689 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 87.0 m -76.33 -41.98 46.56 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.596 -0.69 . . . . 0.0 109.872 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -143.24 50.28 1.41 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.646 -0.659 . . . . 0.0 109.897 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 90.77 -11.57 71.41 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 64.3 t -96.07 120.13 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.141 -1.211 . . . . 0.0 108.91 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.657 ' HB3' ' O ' ' A' ' 130' ' ' ARG . . . -87.63 120.91 29.42 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.529 -0.732 . . . . 0.0 111.243 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -112.81 -32.28 6.46 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.296 0.57 . . . . 0.0 109.678 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -118.6 168.26 10.87 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.669 -0.644 . . . . 0.0 109.685 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 35.6 m -144.02 135.77 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.36 -0.838 . . . . 0.0 110.823 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -110.34 138.37 46.81 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.655 -0.653 . . . . 0.0 110.242 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -141.84 162.07 36.39 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.507 -0.746 . . . . 0.0 110.544 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.545 HG22 ' NH2' ' A' ' 155' ' ' ARG . 51.6 t -101.89 143.39 26.51 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.466 -0.771 . . . . 0.0 110.24 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -75.69 166.38 28.47 Favored 'Trans proline' 0 N--CA 1.485 1.006 0 O-C-N 123.296 1.156 . . . . 0.0 110.389 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 151' ' ' VAL . 77.3 t -88.46 -25.86 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.536 -0.728 . . . . 0.0 110.536 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -59.33 -32.94 70.54 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.408 -0.808 . . . . 0.0 110.596 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.611 ' O ' HG22 ' A' ' 177' ' ' THR . 5.8 t -69.19 -22.94 63.86 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.469 -0.769 . . . . 0.0 110.49 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.684 ' CE ' HD13 ' A' ' 82' ' ' LEU . 35.1 mmt -63.29 -27.8 69.58 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.334 -0.854 . . . . 0.0 110.411 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -57.37 -49.95 74.53 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.404 -0.81 . . . . 0.0 110.67 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.611 HG22 ' O ' ' A' ' 174' ' ' SER . 6.1 t -70.03 -23.33 63.09 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.525 -0.735 . . . . 0.0 110.503 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 87.6 m -72.06 -32.95 67.57 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.427 -0.796 . . . . 0.0 110.243 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 95.7 mtp -60.02 -37.02 78.54 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.568 -0.707 . . . . 0.0 110.419 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -59.92 -39.87 86.94 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.528 -0.732 . . . . 0.0 110.273 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.837 0 O-C-N 121.56 -0.713 . . . . 0.0 110.111 179.954 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' 4P2 . . . . . 0.709 ' C24' HG13 ' A' ' 78' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . 0.933 'ZN ' ' SG ' ' A' ' 145' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.3 t . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.164 0.507 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -132.43 -153.56 7.35 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.37 160.59 42.37 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.498 -1.001 . . . . 0.0 110.326 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -101.47 102.63 13.43 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.537 -0.727 . . . . 0.0 110.187 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.8 tptp -141.47 128.34 20.56 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.551 -0.718 . . . . 0.0 110.187 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -83.42 133.02 34.94 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.527 -0.733 . . . . 0.0 110.026 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 36.1 tp60 -116.67 137.68 52.01 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.446 -0.784 . . . . 0.0 110.407 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.6 p -137.62 141.7 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.542 -0.724 . . . . 0.0 109.959 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -121.58 158.31 28.85 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.479 -0.763 . . . . 0.0 110.512 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.7 28.03 27.76 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.795 ' HG3' HG23 ' A' ' 33' ' ' VAL . 12.4 pt-20 -117.04 -27.84 6.42 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.484 -1.01 . . . . 0.0 110.746 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.795 HG23 ' HG3' ' A' ' 32' ' ' GLU . 58.8 t -126.5 140.57 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.399 -0.813 . . . . 0.0 110.311 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -106.84 159.73 16.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.572 -0.705 . . . . 0.0 110.05 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.459 ' HA ' HD22 ' A' ' 44' ' ' LEU . 62.2 t -107.57 118.34 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.485 -0.76 . . . . 0.0 110.224 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 68.0 t -120.9 133.85 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.468 -0.77 . . . . 0.0 110.158 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.5 t -130.48 135.74 48.28 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.617 -0.677 . . . . 0.0 109.763 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.24 173.6 6.25 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.525 -0.734 . . . . 0.0 110.245 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.84 -34.88 74.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.746 -0.596 . . . . 0.0 111.203 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 68.9 p -103.49 -28.18 11.93 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.362 -0.836 . . . . 0.0 111.049 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -142.93 178.11 7.9 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.38 -0.825 . . . . 0.0 110.619 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 24.0 m -148.74 120.6 8.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.711 -0.618 . . . . 0.0 110.223 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.463 ' HZ ' HD11 ' A' ' 64' ' ' LEU . 27.6 p90 -127.53 172.38 10.76 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.664 -0.647 . . . . 0.0 109.674 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.459 HD22 ' HA ' ' A' ' 35' ' ' VAL . 46.8 mt -121.14 153.96 36.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.492 -0.755 . . . . 0.0 109.978 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.589 ' HB1' ' SG ' ' A' ' 52' ' ' CYS . . . -125.76 154.66 42.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.594 -0.691 . . . . 0.0 110.379 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.4 t -129.11 144.18 51.11 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.667 -0.646 . . . . 0.0 109.902 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 27.9 p -94.84 118.8 32.36 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.696 0.76 . . . . 0.0 110.679 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.4 t -130.27 127.64 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.44 -0.787 . . . . 0.0 109.827 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 52.16 39.13 26.15 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.418 -0.801 . . . . 0.0 110.991 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.593 ' O ' ' HB3' ' A' ' 87' ' ' ALA . . . 68.71 24.67 75.41 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.3 t -136.64 115.09 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.382 -1.069 . . . . 0.0 109.836 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.589 ' SG ' ' HB1' ' A' ' 45' ' ' ALA . 47.9 t -77.42 116.35 17.94 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.546 -0.721 . . . . 0.0 109.958 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.455 ' CZ3' ' CE ' ' A' ' 175' ' ' MET . 56.9 m95 -100.09 137.25 38.8 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.446 -0.783 . . . . 0.0 110.578 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.958 HG21 ' CH2' ' A' ' 85' ' ' TRP . 7.5 t -137.11 173.59 11.52 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.646 -0.659 . . . . 0.0 109.47 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.84 HG11 ' CE1' ' A' ' 57' ' ' HIS . 71.5 t -82.52 143.66 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.362 -0.836 . . . . 0.0 109.495 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.887 ' CE2' HG22 ' A' ' 78' ' ' VAL . 21.2 t80 -84.37 -42.21 15.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.754 -0.591 . . . . 0.0 111.027 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.84 ' CE1' HG11 ' A' ' 55' ' ' VAL . 1.4 p-80 -56.86 -20.02 20.67 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.967 -1.083 . . . . 0.0 111.227 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -102.16 -65.82 0.76 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.68 -22.83 49.94 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.473 -1.016 . . . . 0.0 111.027 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.95 -30.85 70.76 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 79.2 p -62.51 -50.99 69.21 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.483 -1.01 . . . . 0.0 110.6 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.12 138.85 51.99 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.475 -0.766 . . . . 0.0 110.171 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.614 ' CG2' HD13 ' A' ' 71' ' ' ILE . 5.1 t -65.86 142.33 57.96 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.512 -0.742 . . . . 0.0 110.27 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.463 HD11 ' HZ ' ' A' ' 43' ' ' PHE . 4.2 mm? -97.45 119.43 35.97 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.455 -0.778 . . . . 0.0 109.957 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.899 ' HB2' HD11 ' A' ' 71' ' ' ILE . . . -124.7 161.48 26.25 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.508 -0.745 . . . . 0.0 110.933 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.9 -156.73 21.54 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.91 -50.21 0.47 Allowed 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 123.341 1.179 . . . . 0.0 111.336 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -130.76 37.3 3.82 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.372 -0.83 . . . . 0.0 111.083 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -134.19 147.41 19.08 Favored Glycine 0 N--CA 1.496 2.699 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.347 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -76.32 174.68 12.43 Favored 'Trans proline' 0 C--N 1.321 -0.903 0 O-C-N 123.545 1.287 . . . . 0.0 110.252 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.899 HD11 ' HB2' ' A' ' 65' ' ' ALA . 4.8 mp -102.18 140.22 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.54 -0.725 . . . . 0.0 110.969 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.6 p -115.45 109.86 18.47 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.2 mm-40 -96.8 113.94 25.54 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.493 -0.754 . . . . 0.0 111.123 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.415 ' HG3' ' CD2' ' A' ' 75' ' ' TYR . 19.4 ptt? -113.08 -29.73 7.22 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.658 -0.651 . . . . 0.0 109.783 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.469 ' O ' HG13 ' A' ' 83' ' ' VAL . 29.9 m-85 -120.22 116.37 25.47 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.572 -0.705 . . . . 0.0 109.596 179.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.1 m -150.31 130.92 13.96 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.481 -0.762 . . . . 0.0 110.316 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -167.74 123.24 1.04 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.363 -0.836 . . . . 0.0 111.327 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.887 HG22 ' CE2' ' A' ' 56' ' ' TYR . 70.1 t -72.67 -38.18 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.49 -0.756 . . . . 0.0 109.5 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -55.66 -33.3 63.97 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.484 -0.76 . . . . 0.0 110.641 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.805 ' HG2' HD11 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -100.61 -15.28 17.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.579 -0.7 . . . . 0.0 110.642 179.71 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.3 t0 61.1 39.79 15.73 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.111 -0.993 . . . . 0.0 113.631 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.805 HD11 ' HG2' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -148.76 160.32 43.31 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.721 -1.237 . . . . 0.0 111.68 176.578 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 75' ' ' TYR . 2.2 t -137.6 159.47 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -140.29 137.98 8.73 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.602 -1.285 . . . . 0.0 110.513 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.958 ' CH2' HG21 ' A' ' 54' ' ' THR . 5.3 m-90 -111.79 157.92 19.99 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.845 -0.797 . . . . 0.0 109.701 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -68.32 115.08 7.35 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.609 -0.682 . . . . 0.0 109.974 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.593 ' HB3' ' O ' ' A' ' 50' ' ' GLY . . . -99.87 164.84 15.71 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.483 -0.761 . . . . 0.0 110.19 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.419 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 46.7 Cg_endo -72.42 139.55 31.88 Favored 'Trans proline' 0 C--N 1.317 -1.097 0 O-C-N 123.408 1.215 . . . . 0.0 110.299 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -76.77 160.11 34.49 Favored 'Trans proline' 0 C--N 1.319 -1.003 0 O-C-N 123.26 1.137 . . . . 0.0 110.439 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 70.03 29.82 70.39 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -109.03 168.12 9.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.49 -1.006 . . . . 0.0 110.055 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.8 mtm180 -59.98 138.54 57.82 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.583 -0.698 . . . . 0.0 110.248 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 78.9 p -132.95 152.05 51.97 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.545 -0.722 . . . . 0.0 110.372 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.518 HD21 ' HB2' ' A' ' 32' ' ' GLU . 81.2 mt -97.1 131.58 43.73 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.589 -0.695 . . . . 0.0 110.258 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 44.4 p -85.0 155.54 60.91 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.595 -0.691 . . . . 0.0 110.256 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.67 162.98 39.79 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 O-C-N 123.49 1.258 . . . . 0.0 110.428 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.8 t -82.37 131.23 35.23 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.557 -0.714 . . . . 0.0 110.187 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.2 m -135.77 56.3 1.83 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.596 -0.69 . . . . 0.0 110.088 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.7 p -145.25 6.08 1.12 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.456 -0.778 . . . . 0.0 112.029 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 51.44 51.06 39.03 Favored Glycine 0 N--CA 1.502 3.05 0 O-C-N 120.949 -1.095 . . . . 0.0 110.541 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.2 p -99.06 121.74 41.39 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.441 -1.035 . . . . 0.0 110.525 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 68.2 m -73.42 -40.08 64.52 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.627 -0.671 . . . . 0.0 110.247 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -65.5 131.42 46.36 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.618 -0.676 . . . . 0.0 110.22 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.599 HD22 HG21 ' A' ' 151' ' ' VAL . 95.6 mt -135.95 144.95 45.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.543 -0.723 . . . . 0.0 110.379 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -114.11 129.26 56.62 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.502 -0.749 . . . . 0.0 110.203 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.51 HD13 HD11 ' A' ' 143' ' ' LEU . 38.1 tp -105.41 140.08 39.06 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.572 -0.705 . . . . 0.0 110.228 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.9 t -91.83 121.89 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.6 -0.688 . . . . 0.0 109.76 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.415 HG22 ' H ' ' A' ' 109' ' ' ARG . 4.3 m -85.45 172.69 10.82 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.54 -0.725 . . . . 0.0 110.34 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.415 ' H ' HG22 ' A' ' 108' ' ' THR . 0.0 OUTLIER -59.9 -26.53 65.99 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.572 -0.705 . . . . 0.0 110.523 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -96.05 26.32 4.25 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.528 -0.732 . . . . 0.0 110.453 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 52.9 39.99 30.1 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.323 -0.861 . . . . 0.0 110.827 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -94.52 162.51 13.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.539 -0.725 . . . . 0.0 110.127 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 63.9 t -110.27 130.34 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.538 -0.726 . . . . 0.0 109.897 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.553 ' O ' HG23 ' A' ' 114' ' ' ILE . 4.0 tp -137.88 119.57 10.72 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.606 -0.684 . . . . 0.0 109.994 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -73.07 142.91 35.2 Favored 'Trans proline' 0 N--CA 1.486 1.069 0 O-C-N 123.074 1.039 . . . . 0.0 110.699 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.7 t -139.05 129.06 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.713 -0.617 . . . . 0.0 109.693 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -85.51 129.18 34.88 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.529 -0.732 . . . . 0.0 110.075 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -73.88 135.65 43.36 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.612 -0.68 . . . . 0.0 110.278 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -137.44 26.98 2.84 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.662 -0.649 . . . . 0.0 110.24 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.23 -179.54 43.77 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -70.08 -39.59 75.52 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.592 -0.946 . . . . 0.0 110.562 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 98.4 p -131.44 29.19 4.59 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.431 -0.793 . . . . 0.0 110.875 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.591 HH11 ' HB1' ' A' ' 166' ' ' ALA . 0.0 OUTLIER -148.12 160.29 43.05 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.435 -0.791 . . . . 0.0 110.333 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -160.16 -170.14 24.36 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 88.3 p -126.34 164.55 20.82 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.577 -0.955 . . . . 0.0 110.159 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 46.5 tp -119.99 126.37 50.68 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.586 -0.696 . . . . 0.0 110.183 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.415 HD12 ' H ' ' A' ' 127' ' ' LEU . 5.0 mp -59.83 -49.84 76.14 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.556 -0.715 . . . . 0.0 110.272 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.1 m -91.28 113.51 58.62 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.549 -0.72 . . . . 0.0 110.063 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.81 107.09 2.33 Favored 'Trans proline' 0 C--N 1.32 -0.939 0 O-C-N 123.153 1.081 . . . . 0.0 110.596 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.615 ' O ' ' HB3' ' A' ' 164' ' ' ALA . 81.8 mtt-85 -110.98 149.78 40.93 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.599 -0.688 . . . . 0.0 109.929 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.04 150.37 60.31 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.463 1.243 . . . . 0.0 110.89 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.449 HG21 ' SG ' ' A' ' 159' ' ' CYS . 39.3 t -51.92 -30.09 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.461 -0.774 . . . . 0.0 109.79 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.1 t -61.65 -41.03 96.94 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.626 -0.672 . . . . 0.0 111.222 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.441 ' CE2' ' HD3' ' A' ' 130' ' ' ARG . 86.7 t80 -67.69 -39.96 84.41 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.349 -0.844 . . . . 0.0 109.75 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 135' ' ' LEU . 23.9 tp -93.66 18.94 9.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.838 -0.539 . . . . 0.0 110.253 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.405 ' HA ' ' C48' ' A' ' 201' ' ' 4P2 . 15.2 tttm -81.34 117.2 21.62 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.542 1.163 . . . . 0.0 112.757 -178.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.2 37.88 3.71 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.0 m -119.55 21.23 12.18 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.715 -0.873 . . . . 0.0 110.44 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.556 ' HB3' HG21 ' A' ' 55' ' ' VAL . 2.6 m -71.98 129.69 39.17 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.324 -0.86 . . . . 0.0 109.497 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 109.84 -24.4 19.4 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.82 110.69 2.28 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.34 149.11 56.38 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 O-C-N 123.234 1.123 . . . . 0.0 110.857 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.605 HD12 ' N ' ' A' ' 143' ' ' LEU . 6.6 mp -99.59 119.33 37.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.708 -0.62 . . . . 0.0 109.535 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.685 HD12 ' HA ' ' A' ' 150' ' ' ALA . 2.6 tp -105.82 120.91 42.92 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.582 -0.699 . . . . 0.0 110.775 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.692 ' SG ' 'ZN ' ' A' ' 202' ' ' ' ZN' . 26.9 p -64.36 163.34 26.23 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.72 -0.613 . . . . 0.0 109.697 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.09 -15.22 47.74 Favored 'Trans proline' 0 N--CA 1.487 1.118 0 O-C-N 123.245 1.129 . . . . 0.0 111.158 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.2 m -70.0 -27.09 64.41 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.264 -0.898 . . . . 0.0 110.084 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 107.84 43.14 1.35 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -144.7 158.65 43.69 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.497 -1.002 . . . . 0.0 110.267 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.685 ' HA ' HD12 ' A' ' 144' ' ' LEU . . . -78.04 148.49 34.29 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.578 -0.701 . . . . 0.0 110.318 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.599 HG21 HD22 ' A' ' 104' ' ' LEU . 59.4 t -119.17 -62.44 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.573 -0.704 . . . . 0.0 110.22 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -156.53 -158.03 8.64 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.6 mt -135.86 145.36 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.597 -0.943 . . . . 0.0 109.675 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.509 ' HB2' HD11 ' A' ' 106' ' ' LEU . 12.7 t80 -62.55 155.46 25.83 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.438 -0.789 . . . . 0.0 109.605 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 33.2 ttm-85 -140.38 -66.17 0.44 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.945 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -130.57 143.68 50.92 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.935 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.59 127.64 39.36 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.456 HG13 ' C11' ' A' ' 201' ' ' 4P2 . 2.1 t -98.1 119.95 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.617 -0.677 . . . . 0.0 111.305 -177.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.449 ' SG ' HG21 ' A' ' 132' ' ' VAL . 27.7 p -141.26 158.98 43.16 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.497 -0.752 . . . . 0.0 110.508 178.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 11.0 m -91.18 -56.86 2.99 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.567 -0.708 . . . . 0.0 109.456 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.5 ptp85 -123.85 36.62 4.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.607 -0.683 . . . . 0.0 109.449 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 103.7 -11.46 53.41 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 63.1 t -92.46 124.23 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.219 -1.165 . . . . 0.0 109.132 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 130' ' ' ARG . . . -87.17 119.84 27.81 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.521 -0.737 . . . . 0.0 110.895 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 12.0 mtpp -110.15 -28.74 8.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.709 -0.619 . . . . 0.0 109.907 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.591 ' HB1' HH11 ' A' ' 123' ' ' ARG . . . -130.14 168.14 17.26 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.601 -0.687 . . . . 0.0 110.172 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.3 m -139.5 142.48 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.548 -0.72 . . . . 0.0 110.518 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -117.06 137.0 52.55 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.588 -0.695 . . . . 0.0 110.851 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -147.75 159.89 43.31 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.677 -0.64 . . . . 0.0 110.525 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.406 HG13 ' HD2' ' A' ' 171' ' ' PRO . 22.5 t -107.33 143.62 27.55 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 121.481 -0.762 . . . . 0.0 109.441 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.406 ' HD2' HG13 ' A' ' 170' ' ' VAL . 47.0 Cg_endo -74.35 -179.67 4.99 Favored 'Trans proline' 0 C--N 1.319 -0.985 0 O-C-N 123.336 1.177 . . . . 0.0 110.603 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 57.4 t -94.79 -27.87 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.623 -0.673 . . . . 0.0 110.025 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -59.95 -34.2 72.93 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.581 -0.699 . . . . 0.0 110.552 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 34.7 t -61.7 -31.31 71.45 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.546 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.455 ' CE ' ' CZ3' ' A' ' 53' ' ' TRP . 69.3 mmm -71.6 -27.37 63.07 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.443 -0.786 . . . . 0.0 110.564 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -56.8 -42.99 80.51 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.361 -0.837 . . . . 0.0 110.496 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 86.3 m -69.59 -40.11 76.88 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.471 -0.768 . . . . 0.0 109.684 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 91.0 m -71.68 -34.47 69.69 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.622 -0.674 . . . . 0.0 110.24 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 4.9 tmm? -60.06 -39.93 87.72 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.511 -0.743 . . . . 0.0 110.278 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -60.08 -39.9 87.71 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.527 -0.733 . . . . 0.0 110.132 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.911 0 O-C-N 121.619 -0.676 . . . . 0.0 110.169 179.841 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' 4P2 . . . . . 0.755 ' C24' HG13 ' A' ' 78' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . 0.692 'ZN ' ' SG ' ' A' ' 145' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.4 p . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.045 0.45 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -130.34 26.93 4.07 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 33.4 ptt-85 -143.15 49.12 1.46 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.447 -1.031 . . . . 0.0 110.101 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -69.97 -19.95 63.33 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.579 -0.7 . . . . 0.0 110.808 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.5 ttmt 55.01 33.37 20.12 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.252 -0.905 . . . . 0.0 110.129 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.8 t30 55.22 20.64 3.54 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.652 -0.655 . . . . 0.0 111.178 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 48.12 85.01 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.341 -0.849 . . . . 0.0 111.356 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.9 m -118.3 151.12 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.525 -0.734 . . . . 0.0 110.521 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -139.76 159.96 40.97 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.614 -0.679 . . . . 0.0 110.179 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -137.52 -170.85 12.0 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -58.95 -39.9 83.06 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.573 -0.957 . . . . 0.0 110.425 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 97.8 t -139.3 140.03 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.569 -0.707 . . . . 0.0 109.808 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -133.62 151.49 51.7 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.535 -0.728 . . . . 0.0 110.201 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.434 ' HA ' HD22 ' A' ' 44' ' ' LEU . 91.0 t -93.79 119.45 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.616 -0.677 . . . . 0.0 110.087 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.554 HG21 HD21 ' A' ' 64' ' ' LEU . 8.1 p -134.07 130.07 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.488 -0.757 . . . . 0.0 109.824 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 66.8 m -116.89 155.15 29.56 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.646 -0.659 . . . . 0.0 110.312 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.784 HG21 ' NZ ' ' A' ' 62' ' ' LYS . 0.9 OUTLIER -116.38 -178.65 3.46 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.709 -0.619 . . . . 0.0 110.121 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.514 ' H ' HG22 ' A' ' 38' ' ' THR . . . -73.29 -25.47 60.68 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.308 -178.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.3 p -119.11 -28.27 5.51 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.312 -0.868 . . . . 0.0 111.19 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.1 pm0 -140.43 171.9 13.48 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.366 -0.834 . . . . 0.0 110.321 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.0 t -142.99 119.06 10.7 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.503 -0.748 . . . . 0.0 110.658 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.777 ' CE2' HD22 ' A' ' 64' ' ' LEU . 3.4 p90 -128.31 177.69 6.78 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.574 -0.704 . . . . 0.0 109.692 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.434 HD22 ' HA ' ' A' ' 35' ' ' VAL . 54.7 mt -115.83 160.48 20.1 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.504 -0.747 . . . . 0.0 110.052 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -129.64 153.96 47.59 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.39 -0.819 . . . . 0.0 110.504 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.5 p -130.98 144.08 51.21 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.636 -0.665 . . . . 0.0 110.099 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 28.4 p -93.99 121.41 35.43 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.509 -0.744 . . . . 0.0 110.564 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.4 t -130.34 136.66 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.388 -0.82 . . . . 0.0 110.412 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 43.59 34.32 0.79 Allowed 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.573 ' O ' ' HB3' ' A' ' 87' ' ' ALA . . . 89.66 -24.23 15.81 Favored Glycine 0 N--CA 1.497 2.74 0 C-N-CA 120.279 -0.962 . . . . 0.0 111.264 178.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 62.8 t -107.5 129.56 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.179 -1.189 . . . . 0.0 110.073 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -82.45 131.49 35.22 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.653 -0.654 . . . . 0.0 109.955 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.681 ' CE3' HD23 ' A' ' 82' ' ' LEU . 90.5 m95 -117.15 137.83 52.06 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.528 -0.733 . . . . 0.0 110.738 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.751 HG23 HG23 ' A' ' 83' ' ' VAL . 10.0 t -136.6 -179.1 5.48 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.722 -0.611 . . . . 0.0 109.752 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.63 HG11 ' CE1' ' A' ' 57' ' ' HIS . 18.0 t -80.32 142.29 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.542 -0.724 . . . . 0.0 109.465 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.894 ' CE2' HG22 ' A' ' 78' ' ' VAL . 7.8 t80 -84.86 -42.61 14.91 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.633 -0.667 . . . . 0.0 110.875 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.63 ' CE1' HG11 ' A' ' 55' ' ' VAL . 1.1 p-80 -55.77 -20.55 15.29 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.256 -0.903 . . . . 0.0 111.161 -177.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -73.65 -63.92 2.61 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 108.354 -1.899 . . . . 0.0 108.354 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.83 -63.51 1.29 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.563 -0.963 . . . . 0.0 109.568 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.2 -97.8 0.1 OUTLIER Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.3 p -49.12 -76.89 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.467 -1.019 . . . . 0.0 111.675 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.784 ' NZ ' HG21 ' A' ' 38' ' ' THR . 10.5 pttp -67.98 171.76 6.39 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.466 -0.771 . . . . 0.0 110.4 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.547 HG22 ' CG ' ' A' ' 73' ' ' GLN . 69.8 p -113.83 165.87 12.14 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.642 -0.662 . . . . 0.0 110.226 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.777 HD22 ' CE2' ' A' ' 43' ' ' PHE . 2.4 tp -142.39 126.72 17.64 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.468 -0.77 . . . . 0.0 110.4 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.41 ' CB ' ' CD1' ' A' ' 71' ' ' ILE . . . -146.9 109.35 4.54 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.361 -0.837 . . . . 0.0 110.308 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 57.19 171.15 0.17 Allowed Glycine 0 N--CA 1.494 2.555 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.57 -4.23 14.92 Favored 'Trans proline' 0 N--CA 1.487 1.135 0 O-C-N 123.3 1.158 . . . . 0.0 111.572 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.2 mmtt -69.66 -31.85 70.15 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.088 -1.007 . . . . 0.0 111.123 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 142.92 -176.57 22.43 Favored Glycine 0 N--CA 1.496 2.661 0 C-N-CA 119.862 -1.161 . . . . 0.0 110.267 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.445 ' C ' HG23 ' A' ' 71' ' ' ILE . 53.5 Cg_endo -77.16 161.99 31.9 Favored 'Trans proline' 0 N--CA 1.486 1.056 0 O-C-N 123.556 1.293 . . . . 0.0 111.123 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.445 HG23 ' C ' ' A' ' 70' ' ' PRO . 45.4 pt -149.27 -157.64 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.588 -0.695 . . . . 0.0 109.648 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.9 m -79.36 140.02 37.6 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.266 -0.896 . . . . 0.0 109.953 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.547 ' CG ' HG22 ' A' ' 63' ' ' THR . 1.0 OUTLIER -96.31 146.21 24.92 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.502 -0.749 . . . . 0.0 110.312 -179.759 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.408 ' HG3' ' CD2' ' A' ' 75' ' ' TYR . 19.4 ptp -119.22 -38.53 3.02 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.575 -0.703 . . . . 0.0 110.625 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.5 ' O ' HG12 ' A' ' 83' ' ' VAL . 31.6 m-85 -112.4 120.46 41.74 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.301 -0.874 . . . . 0.0 109.752 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.529 ' HA ' HG12 ' A' ' 83' ' ' VAL . 85.6 m -148.53 130.13 14.96 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.471 -0.768 . . . . 0.0 110.331 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -167.28 117.99 0.87 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.411 -0.806 . . . . 0.0 111.532 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.894 HG22 ' CE2' ' A' ' 56' ' ' TYR . 73.7 t -72.59 -35.09 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.37 -0.831 . . . . 0.0 109.523 178.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -55.71 -35.48 66.14 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.425 -0.797 . . . . 0.0 110.225 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -106.82 -8.02 16.93 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.624 -0.673 . . . . 0.0 110.659 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.462 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 30.9 t0 53.0 43.28 31.93 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.085 -1.009 . . . . 0.0 110.431 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.681 HD23 ' CE3' ' A' ' 53' ' ' TRP . 0.6 OUTLIER -133.15 140.88 47.84 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.928 0.871 . . . . 0.0 111.836 -178.783 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.751 HG23 HG23 ' A' ' 54' ' ' THR . 1.0 OUTLIER -145.65 154.13 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -162.97 170.6 38.52 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.783 -1.199 . . . . 0.0 110.344 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.437 ' CE2' ' O ' ' A' ' 64' ' ' LEU . 0.3 OUTLIER -136.58 167.78 20.74 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.884 -0.774 . . . . 0.0 109.062 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -78.53 122.29 25.69 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.618 -0.677 . . . . 0.0 110.27 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.677 ' HB1' ' HD2' ' A' ' 88' ' ' PRO . . . -88.58 173.76 5.84 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.523 -0.735 . . . . 0.0 110.101 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.677 ' HD2' ' HB1' ' A' ' 87' ' ' ALA . 45.7 Cg_endo -72.31 142.6 37.65 Favored 'Trans proline' 0 C--N 1.317 -1.124 0 O-C-N 123.396 1.208 . . . . 0.0 110.362 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -76.12 154.38 37.26 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.378 1.199 . . . . 0.0 110.413 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.42 -28.73 14.08 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.74 143.74 45.98 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.522 -0.987 . . . . 0.0 110.223 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.8 ptt-85 -79.28 159.99 27.01 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.579 -0.701 . . . . 0.0 110.288 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.0 m -125.3 159.21 32.27 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.596 -0.69 . . . . 0.0 110.268 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.99 147.12 39.05 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.518 -0.739 . . . . 0.0 110.152 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.414 HG23 ' HD2' ' A' ' 96' ' ' PRO . 86.0 m -91.4 144.0 29.04 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.626 -0.671 . . . . 0.0 110.103 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.414 ' HD2' HG23 ' A' ' 95' ' ' THR . 45.0 Cg_endo -71.54 166.1 30.45 Favored 'Trans proline' 0 C--N 1.318 -1.056 0 O-C-N 123.259 1.137 . . . . 0.0 110.398 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.464 ' HB2' HG22 ' A' ' 151' ' ' VAL . 46.7 t -65.84 140.02 58.35 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.503 -0.748 . . . . 0.0 110.353 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.8 m -134.38 38.52 3.11 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.654 -0.654 . . . . 0.0 110.029 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.8 p -144.78 -8.31 0.64 Allowed 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 119.981 -0.688 . . . . 0.0 112.368 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 55.65 34.62 60.76 Favored Glycine 0 N--CA 1.5 2.91 0 O-C-N 120.769 -1.207 . . . . 0.0 110.322 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 52.4 p -74.6 159.9 31.54 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.366 -1.079 . . . . 0.0 110.339 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.7 m -95.8 -33.51 12.23 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.635 -0.665 . . . . 0.0 110.302 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -70.29 120.83 16.54 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.503 -0.748 . . . . 0.0 110.112 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.475 HD22 HG21 ' A' ' 151' ' ' VAL . 58.5 mt -130.86 149.95 52.25 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.578 -0.702 . . . . 0.0 110.4 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -115.16 131.01 57.07 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.62 -0.675 . . . . 0.0 109.587 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.421 HD13 ' HG ' ' A' ' 143' ' ' LEU . 36.8 tp -111.83 143.48 42.7 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.48 -0.763 . . . . 0.0 110.58 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 63.3 t -104.61 129.07 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.679 -0.638 . . . . 0.0 109.392 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 70.1 p -104.35 169.38 8.51 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.475 -0.766 . . . . 0.0 110.852 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.409 ' NH1' ' CG1' ' A' ' 35' ' ' VAL . 16.2 tpt180 -59.99 -21.96 61.95 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.64 -0.662 . . . . 0.0 110.264 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -90.85 20.03 5.1 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.336 -0.852 . . . . 0.0 111.019 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 52.21 36.58 19.69 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.208 -0.932 . . . . 0.0 110.878 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -101.14 149.63 23.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.63 -0.669 . . . . 0.0 110.055 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 62.0 t -109.96 128.73 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.644 -0.66 . . . . 0.0 110.044 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 35.7 pt -138.55 138.91 23.06 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.634 -0.666 . . . . 0.0 110.139 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -79.61 151.6 22.38 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 O-C-N 123.289 1.152 . . . . 0.0 110.495 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.7 t -137.55 134.9 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.605 -0.684 . . . . 0.0 109.92 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 8.4 tpp180 -92.2 135.41 34.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.576 -0.703 . . . . 0.0 110.068 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 54.3 ttt180 -81.34 128.58 33.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.574 -0.703 . . . . 0.0 110.193 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.53 20.63 6.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.651 -0.656 . . . . 0.0 109.811 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 168.28 170.82 33.47 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -60.27 -50.05 75.19 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.499 -1.0 . . . . 0.0 110.032 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 53.1 m -114.75 -15.16 11.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.563 -0.71 . . . . 0.0 110.71 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.576 ' NH2' HG21 ' A' ' 158' ' ' VAL . 0.2 OUTLIER -95.61 136.99 35.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.435 -0.791 . . . . 0.0 110.016 -179.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -140.72 178.92 19.68 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 88.6 p -132.26 165.02 25.11 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.586 -0.95 . . . . 0.0 110.198 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 38.5 tp -121.18 138.23 54.31 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.503 -0.748 . . . . 0.0 110.218 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.556 HD12 ' N ' ' A' ' 127' ' ' LEU . 8.5 mp -68.77 -54.85 13.57 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.516 -0.74 . . . . 0.0 110.03 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.1 p -92.41 109.32 37.4 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.581 -0.699 . . . . 0.0 109.809 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -75.11 120.57 6.08 Favored 'Trans proline' 0 C--N 1.319 -0.978 0 O-C-N 123.223 1.118 . . . . 0.0 111.168 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.605 ' O ' ' HB3' ' A' ' 164' ' ' ALA . 94.1 mtm-85 -121.06 154.97 58.36 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.649 -0.657 . . . . 0.0 109.603 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -68.09 150.3 77.27 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 O-C-N 123.282 1.148 . . . . 0.0 111.141 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.447 HG21 ' SG ' ' A' ' 159' ' ' CYS . 40.6 t -53.43 -29.91 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 121.511 -0.743 . . . . 0.0 109.773 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.4 t -59.9 -41.57 91.94 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.659 -0.651 . . . . 0.0 111.23 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.42 ' CD2' ' HD2' ' A' ' 130' ' ' ARG . 83.6 t80 -68.16 -40.0 82.44 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.347 -0.845 . . . . 0.0 109.779 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.416 ' O ' ' HG ' ' A' ' 135' ' ' LEU . 31.5 tp -92.71 18.2 9.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.787 -0.571 . . . . 0.0 110.122 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -81.92 115.01 20.9 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 122.567 1.175 . . . . 0.0 112.078 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.78 28.92 6.76 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 58.1 m -110.66 20.04 18.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.57 -0.959 . . . . 0.0 110.546 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.404 ' OG ' ' C55' ' A' ' 201' ' ' 4P2 . 1.8 m -65.64 145.18 56.36 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.268 -0.895 . . . . 0.0 109.487 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 95.9 -21.66 43.74 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.04 109.76 1.64 Allowed Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -75.69 150.63 35.52 Favored 'Trans proline' 0 C--N 1.32 -0.927 0 O-C-N 123.203 1.107 . . . . 0.0 111.036 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.421 ' HG ' HD13 ' A' ' 106' ' ' LEU . 5.0 mp -100.72 111.5 23.74 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 150' ' ' ALA . 2.2 tp -97.04 140.1 32.07 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.528 -0.732 . . . . 0.0 110.758 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -76.12 174.57 5.4 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.657 -0.652 . . . . 0.0 109.785 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.05 -28.63 28.42 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 O-C-N 123.368 1.193 . . . . 0.0 110.235 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 83.8 p -70.36 -35.35 73.5 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.573 -0.704 . . . . 0.0 110.108 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 118.88 38.95 0.73 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 58.3 m170 -124.53 137.37 54.42 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.541 -0.976 . . . . 0.0 110.403 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.434 ' HA ' HD12 ' A' ' 144' ' ' LEU . . . -65.4 140.04 58.6 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.523 -0.736 . . . . 0.0 110.148 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.475 HG21 HD22 ' A' ' 104' ' ' LEU . 62.1 t -111.29 -55.99 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.614 -0.679 . . . . 0.0 110.146 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -161.83 -165.25 18.39 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 83.3 mt -131.31 143.71 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.664 -0.903 . . . . 0.0 109.778 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -61.57 147.34 45.91 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.429 -0.795 . . . . 0.0 110.07 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.94 -71.21 0.64 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.597 0.713 . . . . 0.0 110.104 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -126.27 144.57 50.74 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 121.794 0.807 . . . . 0.0 111.269 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.49 128.52 39.63 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.576 HG21 ' NH2' ' A' ' 123' ' ' ARG . 2.4 t -99.02 120.47 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.531 -0.731 . . . . 0.0 111.671 -177.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.447 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.2 p -141.29 136.9 32.06 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.507 -0.746 . . . . 0.0 110.622 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 87.1 m -71.28 -42.52 68.64 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.546 -0.721 . . . . 0.0 109.92 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -140.86 49.54 1.68 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.575 -0.703 . . . . 0.0 110.075 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 89.99 -11.64 70.07 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 61.7 t -94.66 120.44 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.245 -1.15 . . . . 0.0 108.925 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 130' ' ' ARG . . . -87.45 117.49 26.28 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.632 -0.668 . . . . 0.0 111.074 -178.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -113.19 -26.23 8.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.751 -0.593 . . . . 0.0 110.008 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -125.98 168.45 13.91 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.485 -0.759 . . . . 0.0 110.394 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 35.3 m -144.73 135.81 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.542 -0.724 . . . . 0.0 110.48 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -112.94 133.87 54.71 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.411 -0.806 . . . . 0.0 110.954 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -147.04 162.32 39.04 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.67 -0.644 . . . . 0.0 110.366 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 4.1 m -104.23 145.21 30.23 Favored Pre-proline 0 N--CA 1.505 2.291 0 O-C-N 121.449 -0.782 . . . . 0.0 110.456 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -75.33 -171.82 1.12 Allowed 'Trans proline' 0 C--N 1.319 -1.019 0 O-C-N 123.436 1.23 . . . . 0.0 109.83 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 57.3 t -87.39 -23.26 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.595 -0.69 . . . . 0.0 110.417 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -61.69 -30.31 70.66 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.412 -0.805 . . . . 0.0 111.28 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 9.5 t -62.67 -24.46 67.64 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.161 -0.962 . . . . 0.0 110.687 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.427 ' HG2' ' CD2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -80.73 -28.25 36.62 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.487 -0.758 . . . . 0.0 111.15 -179.457 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -59.94 -44.62 94.26 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.433 -0.792 . . . . 0.0 110.551 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 90.0 m -69.9 -39.94 75.93 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.433 -0.792 . . . . 0.0 110.492 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 58.9 m -67.77 -31.85 72.03 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.543 -0.723 . . . . 0.0 110.679 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.8 -38.27 81.45 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.377 -0.827 . . . . 0.0 110.556 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -59.92 -39.96 87.22 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.443 -0.785 . . . . 0.0 110.374 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.803 0 O-C-N 121.499 -0.751 . . . . 0.0 110.148 179.871 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' 4P2 . . . . . 0.775 ' C24' HG13 ' A' ' 78' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 56.4 p . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.027 0.441 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.77 27.04 6.15 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 51.68 59.49 4.53 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.278 -1.131 . . . . 0.0 110.869 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.428 ' HA ' ' CE1' ' A' ' 110' ' ' HIS . 41.0 t0 -75.02 116.54 15.87 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.48 -0.763 . . . . 0.0 110.227 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.7 pttt -119.98 -7.02 9.99 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.599 -0.688 . . . . 0.0 111.18 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 53.34 94.26 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.051 -1.03 . . . . 0.0 110.706 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -71.4 162.17 29.86 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.542 -0.724 . . . . 0.0 110.203 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.2 t -60.1 141.48 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.565 -0.709 . . . . 0.0 110.064 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -60.0 134.94 57.52 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.547 -0.72 . . . . 0.0 110.147 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.86 -80.37 0.84 Allowed Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.467 ' CB ' HD11 ' A' ' 94' ' ' LEU . 2.8 pp20? -133.92 -0.46 3.1 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.546 -0.973 . . . . 0.0 111.848 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.794 HG22 HD23 ' A' ' 44' ' ' LEU . 11.3 p -135.0 128.52 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.089 -1.007 . . . . 0.0 109.895 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -107.52 134.56 50.36 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.671 -0.643 . . . . 0.0 110.413 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.2 m -72.54 147.74 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.615 -0.678 . . . . 0.0 110.096 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.5 t -124.9 145.92 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.562 -0.712 . . . . 0.0 109.74 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.6 t -115.85 126.67 54.27 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.656 -0.652 . . . . 0.0 110.36 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.482 HG22 ' H ' ' A' ' 39' ' ' ALA . 2.3 m -113.92 175.57 5.41 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.578 -0.701 . . . . 0.0 110.012 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.482 ' H ' HG22 ' A' ' 38' ' ' THR . . . -77.01 -13.96 59.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.668 -0.645 . . . . 0.0 111.326 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 77.5 p -121.25 -28.21 4.73 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.173 -0.954 . . . . 0.0 111.424 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -154.42 175.86 13.05 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.278 -0.888 . . . . 0.0 110.95 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.5 t -135.91 122.82 21.3 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.71 -0.619 . . . . 0.0 109.935 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -127.78 -169.61 2.09 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.504 -0.748 . . . . 0.0 110.368 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.794 HD23 HG22 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -116.41 167.83 10.69 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.574 -0.704 . . . . 0.0 110.491 -179.455 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.661 ' O ' HG23 ' A' ' 33' ' ' VAL . . . -140.61 140.71 35.12 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.604 -0.685 . . . . 0.0 110.151 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.408 HG21 ' HB3' ' A' ' 142' ' ' PRO . 67.7 p -119.26 138.62 52.88 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.428 -0.795 . . . . 0.0 110.057 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.1 t -101.14 115.09 29.68 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.541 -0.725 . . . . 0.0 110.596 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.0 t -129.98 127.1 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.457 -0.777 . . . . 0.0 110.159 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 64.8 t30 53.16 40.21 30.88 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.455 -0.778 . . . . 0.0 111.045 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.01 21.5 71.67 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.507 HG12 ' NE1' ' A' ' 53' ' ' TRP . 62.9 t -130.21 113.75 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.399 -1.059 . . . . 0.0 109.463 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.2 t -82.98 133.02 35.12 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.593 -0.692 . . . . 0.0 109.906 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.507 ' NE1' HG12 ' A' ' 51' ' ' VAL . 92.9 m95 -119.95 136.39 54.55 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.492 -0.755 . . . . 0.0 111.094 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.665 HG22 ' O ' ' A' ' 83' ' ' VAL . 6.5 t -137.71 -179.92 6.04 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.918 HG11 ' CE1' ' A' ' 57' ' ' HIS . 47.2 t -92.39 147.56 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.294 -0.879 . . . . 0.0 109.979 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.89 ' CE2' HG22 ' A' ' 78' ' ' VAL . 21.6 t80 -84.15 -43.45 14.98 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.539 -0.726 . . . . 0.0 111.407 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.918 ' CE1' HG11 ' A' ' 55' ' ' VAL . 1.5 p-80 -52.38 -25.91 11.08 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.116 -0.99 . . . . 0.0 111.114 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.431 ' N ' ' CD2' ' A' ' 57' ' ' HIS . . . -89.59 -55.99 1.95 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.24 -63.38 1.41 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.527 -0.984 . . . . 0.0 110.334 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.12 -144.71 17.28 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 89.1 p -104.94 21.76 16.46 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.591 -0.947 . . . . 0.0 110.654 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.67 160.49 19.55 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.365 -0.834 . . . . 0.0 109.959 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.9 m -77.82 147.92 34.97 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.567 -0.708 . . . . 0.0 110.298 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.471 HD13 ' HA ' ' A' ' 64' ' ' LEU . 3.6 mm? -97.94 143.01 28.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.523 -0.736 . . . . 0.0 110.113 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.55 127.08 44.35 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.629 -0.669 . . . . 0.0 110.268 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -129.96 158.93 22.5 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.48 -47.0 1.64 Allowed 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.377 1.198 . . . . 0.0 110.731 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -71.55 -31.1 66.63 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.544 -0.722 . . . . 0.0 110.161 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 162.92 156.97 8.8 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.04 164.64 34.95 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 O-C-N 123.384 1.202 . . . . 0.0 110.445 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 85.7 mt -129.42 137.24 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.533 -0.729 . . . . 0.0 109.891 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 64.6 p -83.49 150.3 26.09 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.585 -0.697 . . . . 0.0 110.538 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -82.66 119.95 24.94 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.578 -0.701 . . . . 0.0 110.086 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.2 mtp -83.97 -51.15 7.37 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.526 -0.734 . . . . 0.0 110.473 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.467 ' CD2' ' N ' ' A' ' 75' ' ' TYR . 1.2 p90 -122.54 130.09 52.66 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.672 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.939 ' HA ' HG12 ' A' ' 83' ' ' VAL . 57.0 m -135.28 141.1 45.63 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.659 -0.651 . . . . 0.0 110.501 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -161.34 120.92 2.57 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.234 -0.916 . . . . 0.0 112.133 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.89 HG22 ' CE2' ' A' ' 56' ' ' TYR . 54.2 t -72.88 -39.11 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.295 -0.878 . . . . 0.0 109.34 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -55.54 -43.04 75.45 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.389 -0.82 . . . . 0.0 110.369 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.708 ' HB3' HD22 ' A' ' 82' ' ' LEU . 3.3 tp60 -90.92 -9.68 45.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.608 -0.683 . . . . 0.0 110.485 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.416 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 37.5 t0 52.47 42.0 31.09 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.088 -1.007 . . . . 0.0 111.54 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 1.062 HD21 HG21 ' A' ' 178' ' ' THR . 0.3 OUTLIER -148.58 143.1 26.37 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.173 -0.954 . . . . 0.0 111.123 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.939 HG12 ' HA ' ' A' ' 76' ' ' THR . 28.4 m -145.18 144.08 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.448 ' N ' ' CE1' ' A' ' 75' ' ' TYR . . . -142.61 156.83 26.46 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.571 -1.3 . . . . 0.0 110.347 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.49 ' CH2' HG21 ' A' ' 54' ' ' THR . 3.6 m-90 -113.63 168.11 10.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.901 -0.764 . . . . 0.0 109.331 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -87.29 100.62 12.84 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.494 -0.754 . . . . 0.0 109.299 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.08 158.88 82.6 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.636 -0.665 . . . . 0.0 110.461 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.43 160.13 49.49 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.523 1.275 . . . . 0.0 110.299 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.49 151.01 52.69 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 O-C-N 123.402 1.212 . . . . 0.0 110.283 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.34 -23.72 34.28 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.13 152.76 23.55 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.336 -1.096 . . . . 0.0 110.291 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -70.25 148.01 49.08 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.561 -0.712 . . . . 0.0 110.244 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 80.0 p -126.7 149.71 49.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.58 -0.7 . . . . 0.0 110.093 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.467 HD11 ' CB ' ' A' ' 32' ' ' GLU . 6.6 mt -109.79 157.4 19.2 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.541 -0.725 . . . . 0.0 110.548 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.43 HG23 ' HD2' ' A' ' 96' ' ' PRO . 89.7 m -98.16 144.4 27.99 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.701 -0.625 . . . . 0.0 109.727 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.43 ' HD2' HG23 ' A' ' 95' ' ' THR . 43.5 Cg_endo -69.48 160.47 49.67 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.256 1.135 . . . . 0.0 110.407 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 45.2 t -60.02 134.64 57.23 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.587 -0.695 . . . . 0.0 110.445 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 21.6 m -136.1 48.29 2.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.673 -0.642 . . . . 0.0 109.977 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.9 p -144.89 -8.31 0.63 Allowed 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 119.949 -0.701 . . . . 0.0 112.383 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.68 72.01 0.61 Allowed Glycine 0 N--CA 1.5 2.928 0 O-C-N 120.766 -1.209 . . . . 0.0 110.288 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.0 m -125.09 129.98 51.31 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.522 -0.987 . . . . 0.0 110.471 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.7 m -67.19 -39.95 86.47 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.492 -0.755 . . . . 0.0 110.138 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -60.17 131.75 51.79 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.589 -0.694 . . . . 0.0 110.356 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.708 HD22 HG11 ' A' ' 151' ' ' VAL . 88.3 mt -136.36 160.21 39.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.646 -0.658 . . . . 0.0 110.153 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -122.98 109.45 14.13 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.477 -0.764 . . . . 0.0 110.246 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.653 ' O ' HG11 ' A' ' 113' ' ' VAL . 21.1 tp -74.17 148.14 41.96 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.708 -0.62 . . . . 0.0 109.837 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.454 HG21 HD23 ' A' ' 144' ' ' LEU . 61.0 t -126.28 119.99 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.289 -0.882 . . . . 0.0 110.244 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.887 HG23 HG13 ' A' ' 113' ' ' VAL . 53.0 p -91.36 -164.93 1.25 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.264 -0.898 . . . . 0.0 110.076 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.26 -18.99 24.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.522 -0.736 . . . . 0.0 111.229 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.428 ' CE1' ' HA ' ' A' ' 25' ' ' ASP . 4.5 t60 -109.65 29.4 7.62 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.259 -0.9 . . . . 0.0 110.666 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 57.47 33.62 23.52 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.301 -0.874 . . . . 0.0 112.063 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.784 ' O ' HG13 ' A' ' 113' ' ' VAL . 7.0 p-10 -119.39 134.01 55.43 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.285 -0.884 . . . . 0.0 109.727 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.887 HG13 HG23 ' A' ' 108' ' ' THR . 0.0 OUTLIER -176.37 -173.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.425 0 CA-C-O 121.853 0.835 . . . . 0.0 111.143 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.407 ' CG1' ' HD2' ' A' ' 115' ' ' PRO . 0.0 OUTLIER -152.19 168.8 10.58 Favored Pre-proline 0 N--CA 1.49 1.568 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.445 ' O ' HD13 ' A' ' 127' ' ' LEU . 43.0 Cg_endo -70.36 145.12 52.77 Favored 'Trans proline' 0 C--N 1.317 -1.106 0 O-C-N 123.217 1.114 . . . . 0.0 110.066 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.615 HG13 ' O ' ' A' ' 125' ' ' SER . 57.3 t -126.91 130.0 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.569 -0.707 . . . . 0.0 110.116 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.9 mmm180 -83.28 132.39 35.03 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.487 -0.758 . . . . 0.0 110.053 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 49.6 ttm-85 -65.96 133.27 50.49 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.535 -0.728 . . . . 0.0 110.242 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -116.49 -22.44 8.72 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.622 -0.674 . . . . 0.0 110.478 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -155.93 -167.33 17.21 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -70.09 -39.95 75.27 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.598 -0.942 . . . . 0.0 110.565 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 36.9 p -129.9 26.46 5.24 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.396 -0.815 . . . . 0.0 110.801 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.48 152.61 41.7 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.511 -0.743 . . . . 0.0 110.181 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -149.19 -179.98 25.51 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.615 ' O ' HG13 ' A' ' 116' ' ' VAL . 78.0 p -120.0 151.5 38.88 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.703 -0.881 . . . . 0.0 110.217 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.0 tp -100.0 129.88 46.11 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.653 -0.655 . . . . 0.0 110.195 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.445 HD13 ' O ' ' A' ' 115' ' ' PRO . 4.3 mp -61.91 -53.91 49.17 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.581 -0.699 . . . . 0.0 110.404 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.6 t -95.28 129.91 33.87 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.561 -0.712 . . . . 0.0 110.124 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -79.27 106.85 2.1 Favored 'Trans proline' 0 C--N 1.32 -0.97 0 O-C-N 123.175 1.092 . . . . 0.0 110.673 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.418 ' HD2' ' CD2' ' A' ' 134' ' ' TYR . 4.6 mtm180 -114.21 149.91 42.81 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.599 -0.688 . . . . 0.0 109.636 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.36 150.31 70.52 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 123.317 1.167 . . . . 0.0 111.153 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.775 HG12 ' CE ' ' A' ' 136' ' ' LYS . 66.0 t -52.85 -29.26 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.501 -0.749 . . . . 0.0 109.81 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.93 -43.26 95.05 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.605 -0.685 . . . . 0.0 111.279 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.418 ' CD2' ' HD2' ' A' ' 130' ' ' ARG . 88.9 t80 -65.89 -40.01 91.18 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.358 -0.838 . . . . 0.0 109.619 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.42 ' HA ' HD12 ' A' ' 135' ' ' LEU . 21.8 tp -93.26 18.87 8.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.926 -0.484 . . . . 0.0 110.278 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.775 ' CE ' HG12 ' A' ' 132' ' ' VAL . 8.4 ttmt -82.47 116.64 22.01 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 122.523 1.154 . . . . 0.0 112.514 -178.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.97 30.14 6.18 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.0 m -110.57 20.26 17.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.687 -0.89 . . . . 0.0 110.353 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.7 m -76.44 141.81 41.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.311 -0.868 . . . . 0.0 109.557 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.467 ' C ' HG23 ' A' ' 153' ' ' ILE . . . 95.91 -26.62 19.74 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.84 128.35 44.83 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 108.911 -1.675 . . . . 0.0 108.911 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.408 ' HB3' HG21 ' A' ' 46' ' ' THR . 48.4 Cg_endo -75.05 172.54 16.16 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 O-C-N 123.201 1.106 . . . . 0.0 111.142 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.916 ' O ' HG12 ' A' ' 151' ' ' VAL . 3.3 mp -117.68 115.61 25.41 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.455 HD22 ' N ' ' A' ' 144' ' ' LEU . 4.5 mm? -90.09 152.37 21.17 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.701 -0.624 . . . . 0.0 111.017 -178.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.407 ' CB ' ' HD2' ' A' ' 146' ' ' PRO . 0.1 OUTLIER -93.95 179.28 1.28 Allowed Pre-proline 0 N--CA 1.494 1.733 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.375 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.407 ' HD2' ' CB ' ' A' ' 145' ' ' CYS . 43.0 Cg_endo -69.63 -26.62 27.99 Favored 'Trans proline' 0 C--N 1.318 -1.069 0 O-C-N 123.202 1.106 . . . . 0.0 110.319 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 66.2 m -79.41 -29.06 41.8 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.519 -0.738 . . . . 0.0 110.043 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 113.43 50.26 0.54 Allowed Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -135.77 148.06 48.63 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.517 -0.99 . . . . 0.0 110.288 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -76.1 136.94 39.86 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.537 -0.727 . . . . 0.0 110.051 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.916 HG12 ' O ' ' A' ' 143' ' ' LEU . 13.0 p -119.06 -24.45 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.559 -0.713 . . . . 0.0 110.878 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 176.6 -167.74 39.38 Favored Glycine 0 N--CA 1.498 2.784 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.29 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.556 HD12 ' CE ' ' A' ' 175' ' ' MET . 71.8 mt -130.38 158.88 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.598 -0.942 . . . . 0.0 109.833 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -75.84 151.64 37.42 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.454 -0.779 . . . . 0.0 109.918 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.646 ' CZ ' HG21 ' A' ' 170' ' ' VAL . 30.7 ttm180 -131.83 -76.41 0.51 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.572 -0.705 . . . . 0.0 110.797 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -122.46 143.68 49.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.086 -1.009 . . . . 0.0 111.406 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.65 127.87 39.55 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.489 HG13 ' C11' ' A' ' 201' ' ' 4P2 . 2.5 t -97.67 117.98 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 O-C-N 121.506 -0.746 . . . . 0.0 111.673 -177.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.429 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.9 p -141.07 148.72 40.63 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.371 -0.831 . . . . 0.0 110.672 178.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 63.7 m -85.56 -50.14 7.47 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.448 -0.782 . . . . 0.0 109.72 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.75 32.79 5.61 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.74 -0.6 . . . . 0.0 109.608 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 101.44 -11.69 58.23 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 63.4 t -89.51 120.92 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.223 -1.163 . . . . 0.0 108.991 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -86.97 113.25 22.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.644 -0.66 . . . . 0.0 110.975 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -108.52 -26.23 10.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.787 -0.571 . . . . 0.0 109.862 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -121.27 164.02 17.65 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.47 -0.769 . . . . 0.0 109.952 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 167' ' ' VAL . 35.0 m -141.81 131.1 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.534 -0.729 . . . . 0.0 110.659 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -103.83 129.67 51.32 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.477 -0.765 . . . . 0.0 110.709 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -142.65 162.17 36.18 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.568 -0.708 . . . . 0.0 110.188 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.646 HG21 ' CZ ' ' A' ' 155' ' ' ARG . 86.1 t -111.93 144.93 31.7 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.427 -0.796 . . . . 0.0 110.089 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.474 ' HD2' HG13 ' A' ' 170' ' ' VAL . 45.9 Cg_endo -71.95 175.2 10.09 Favored 'Trans proline' 0 N--CA 1.486 1.061 0 O-C-N 123.319 1.168 . . . . 0.0 110.984 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 151' ' ' VAL . 59.4 t -79.42 -41.41 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.657 -0.652 . . . . 0.0 110.153 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -54.41 -36.32 63.84 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.835 -0.541 . . . . 0.0 111.045 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.435 ' O ' HG22 ' A' ' 177' ' ' THR . 45.2 t -61.84 -33.71 74.66 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.485 -0.76 . . . . 0.0 109.906 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.556 ' CE ' HD12 ' A' ' 153' ' ' ILE . 67.2 mtt -70.05 -27.94 65.05 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.595 -0.69 . . . . 0.0 110.446 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -59.5 -50.09 75.28 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.495 -0.753 . . . . 0.0 110.64 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.435 HG22 ' O ' ' A' ' 174' ' ' SER . 7.1 t -69.98 -22.54 63.14 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.516 -0.74 . . . . 0.0 110.825 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 1.062 HG21 HD21 ' A' ' 82' ' ' LEU . 68.4 m -68.68 -29.08 67.46 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.439 -0.788 . . . . 0.0 110.53 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 91.1 mtp -59.98 -48.49 81.48 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.476 -0.765 . . . . 0.0 110.257 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -59.91 -40.07 87.55 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.606 -0.684 . . . . 0.0 110.315 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.792 0 O-C-N 121.65 -0.656 . . . . 0.0 110.188 -179.961 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' 4P2 . . . . . 0.731 ' C24' HG13 ' A' ' 78' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.2 m . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.022 0.439 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -138.19 -74.84 0.06 OUTLIER Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 53.37 51.28 15.72 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.433 -1.04 . . . . 0.0 110.574 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -84.62 169.97 13.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.688 -0.632 . . . . 0.0 110.367 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.0 mmmt -80.96 -176.72 6.06 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.673 -0.642 . . . . 0.0 110.213 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -60.63 144.64 51.41 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.558 -0.714 . . . . 0.0 110.28 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 64.1 mm-40 -128.02 162.95 25.62 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.527 -0.733 . . . . 0.0 110.329 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.2 t -71.47 140.01 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.608 -0.683 . . . . 0.0 110.093 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -72.35 157.98 36.65 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.526 -0.734 . . . . 0.0 110.46 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.497 ' O ' HG13 ' A' ' 33' ' ' VAL . . . -120.31 88.05 0.42 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.729 ' HG2' HD21 ' A' ' 94' ' ' LEU . 26.1 mp0 54.13 22.02 3.32 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.531 -0.982 . . . . 0.0 111.221 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 31' ' ' GLY . 27.4 m -132.77 160.06 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.483 -0.76 . . . . 0.0 109.83 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.547 ' O ' HD23 ' A' ' 44' ' ' LEU . 9.9 pt20 -143.42 126.53 16.46 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.615 -0.678 . . . . 0.0 110.24 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.0 m -74.39 145.54 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.506 -0.746 . . . . 0.0 109.934 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.72 HG22 ' O ' ' A' ' 43' ' ' PHE . 33.6 m -136.0 148.07 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.444 -0.785 . . . . 0.0 110.19 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.501 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 45.8 m -116.41 126.09 52.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.613 -0.68 . . . . 0.0 110.412 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.502 HG22 ' H ' ' A' ' 39' ' ' ALA . 0.3 OUTLIER -101.52 -171.01 1.91 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.624 -0.672 . . . . 0.0 109.455 179.682 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.502 ' H ' HG22 ' A' ' 38' ' ' THR . . . -60.08 -51.74 68.32 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.77 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.1 t -128.02 10.78 6.47 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.468 -0.77 . . . . 0.0 111.529 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -148.29 161.24 41.92 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.135 -0.978 . . . . 0.0 110.603 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 81.2 p -143.3 125.71 15.7 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.547 -0.72 . . . . 0.0 110.144 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.72 ' O ' HG22 ' A' ' 36' ' ' VAL . 27.5 p90 -129.45 -169.69 2.15 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.638 -0.664 . . . . 0.0 110.252 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.547 HD23 ' O ' ' A' ' 34' ' ' GLN . 3.1 mt -126.13 164.49 20.79 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.617 -0.677 . . . . 0.0 110.43 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -138.65 140.33 38.83 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.588 -0.695 . . . . 0.0 110.16 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.7 m -115.01 127.86 55.92 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.528 -0.732 . . . . 0.0 110.096 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.554 ' O ' HD12 ' A' ' 94' ' ' LEU . 26.7 p -75.62 117.02 16.94 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.569 -0.707 . . . . 0.0 110.773 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.7 t -130.29 123.95 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.33 -0.856 . . . . 0.0 110.436 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 50.74 34.06 9.4 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.568 -0.708 . . . . 0.0 111.764 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 87' ' ' ALA . . . 88.76 -24.23 13.49 Favored Glycine 0 N--CA 1.498 2.778 0 C-N-CA 120.365 -0.921 . . . . 0.0 111.216 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.7 t -106.53 113.94 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.155 -1.203 . . . . 0.0 109.781 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 27.5 p -71.12 154.49 41.69 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.438 -0.789 . . . . 0.0 110.259 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.567 ' CE3' HD23 ' A' ' 82' ' ' LEU . 79.0 m95 -124.36 137.06 54.51 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.606 -0.684 . . . . 0.0 110.779 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.951 HG21 ' CH2' ' A' ' 85' ' ' TRP . 7.5 t -136.99 -179.97 6.02 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.738 -0.601 . . . . 0.0 109.888 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.911 HG21 ' HB3' ' A' ' 139' ' ' SER . 62.4 t -85.41 142.01 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.608 -0.682 . . . . 0.0 109.547 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.903 ' CE2' HG22 ' A' ' 78' ' ' VAL . 25.3 t80 -85.2 -44.04 13.27 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.495 -0.753 . . . . 0.0 111.031 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.625 ' CE1' HG11 ' A' ' 55' ' ' VAL . 2.3 p-80 -60.68 -20.15 60.25 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.025 -177.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -92.71 -54.49 1.78 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.15 -47.64 19.82 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.49 -1.006 . . . . 0.0 110.58 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.25 -146.15 28.83 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 61.9 m -123.22 43.91 2.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.547 -0.973 . . . . 0.0 110.354 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -115.2 177.31 4.7 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.559 -0.713 . . . . 0.0 110.215 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.6 p -65.97 153.78 41.18 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.639 -0.663 . . . . 0.0 110.08 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.431 HD21 ' CZ ' ' A' ' 43' ' ' PHE . 0.8 OUTLIER -110.01 150.61 28.27 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.615 -0.678 . . . . 0.0 110.419 -179.797 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 37' ' ' SER . . . -99.84 110.98 23.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.647 -0.658 . . . . 0.0 109.977 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -129.29 170.02 20.42 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.0 -45.84 2.75 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 O-C-N 123.405 1.213 . . . . 0.0 110.484 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.2 tptp -70.47 -31.28 68.35 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.579 -0.701 . . . . 0.0 110.079 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 145.81 -176.15 24.94 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.83 169.32 22.34 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 O-C-N 123.43 1.226 . . . . 0.0 110.509 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 44.3 pt -133.76 -175.4 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.491 -0.756 . . . . 0.0 110.246 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 t -113.8 142.66 45.8 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.524 -0.735 . . . . 0.0 110.541 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.461 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -77.44 124.96 28.58 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.588 -0.695 . . . . 0.0 110.502 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 8.2 ttt -82.78 -52.77 6.44 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.368 -0.832 . . . . 0.0 109.795 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.606 ' O ' HG13 ' A' ' 83' ' ' VAL . 12.1 p90 -147.08 139.91 25.05 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.294 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.493 HG22 HG13 ' A' ' 83' ' ' VAL . 81.7 p -130.52 140.41 50.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.724 -0.61 . . . . 0.0 109.711 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -159.67 120.74 3.17 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.253 -0.904 . . . . 0.0 111.033 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.903 HG22 ' CE2' ' A' ' 56' ' ' TYR . 99.0 t -72.22 -35.6 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.411 -0.806 . . . . 0.0 109.769 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -55.87 -35.71 66.8 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.46 -0.775 . . . . 0.0 110.275 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 31.9 tp60 -102.55 -13.79 17.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.736 -0.603 . . . . 0.0 110.469 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.828 ' O ' HD12 ' A' ' 82' ' ' LEU . 44.9 t0 55.25 38.02 29.77 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.167 -0.958 . . . . 0.0 110.621 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.828 HD12 ' O ' ' A' ' 81' ' ' ASP . 2.2 mp -136.18 148.93 48.38 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.611 -0.681 . . . . 0.0 110.361 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.787 ' O ' HG22 ' A' ' 54' ' ' THR . 4.8 t -146.52 129.87 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.534 ' HA3' ' CZ ' ' A' ' 75' ' ' TYR . . . -118.68 163.7 13.1 Favored Glycine 0 N--CA 1.502 3.071 0 C-N-CA 118.817 -1.658 . . . . 0.0 111.307 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.951 ' CH2' HG21 ' A' ' 54' ' ' THR . 5.7 m-90 -132.51 158.42 42.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.958 -0.731 . . . . 0.0 109.469 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -74.32 103.98 4.91 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.534 -0.729 . . . . 0.0 110.013 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 50' ' ' GLY . . . -70.4 158.51 87.49 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.645 -0.659 . . . . 0.0 110.274 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.45 160.03 47.77 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 O-C-N 123.453 1.238 . . . . 0.0 110.367 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -74.98 160.05 40.68 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 O-C-N 123.404 1.213 . . . . 0.0 110.391 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 87.64 28.18 24.94 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -123.84 139.45 53.96 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.492 -1.005 . . . . 0.0 110.153 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.39 139.02 38.8 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.514 -0.741 . . . . 0.0 110.209 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.9 p -92.39 145.09 24.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.578 -0.701 . . . . 0.0 110.185 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.729 HD21 ' HG2' ' A' ' 32' ' ' GLU . 40.2 mt -79.08 157.35 28.01 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.594 -0.691 . . . . 0.0 110.175 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.2 t -110.99 150.09 41.39 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.623 -0.673 . . . . 0.0 110.209 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.22 161.38 44.69 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 O-C-N 123.388 1.204 . . . . 0.0 110.708 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 37.3 t -70.56 135.55 48.59 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.626 -0.671 . . . . 0.0 110.267 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.2 t -136.19 50.35 2.07 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.61 -0.681 . . . . 0.0 110.337 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.7 p -145.12 4.12 1.07 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.492 -0.755 . . . . 0.0 112.107 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 50.79 70.29 0.89 Allowed Glycine 0 N--CA 1.5 2.928 0 O-C-N 120.897 -1.127 . . . . 0.0 110.693 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 92.7 p -120.89 133.47 55.3 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.467 -1.02 . . . . 0.0 110.474 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 63.8 m -83.01 -28.81 29.4 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.643 -0.66 . . . . 0.0 110.198 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -66.56 133.58 50.62 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.629 -0.669 . . . . 0.0 110.181 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.772 HD22 HG11 ' A' ' 151' ' ' VAL . 91.2 mt -134.9 162.19 33.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.586 -0.696 . . . . 0.0 110.143 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -130.26 108.9 10.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.521 -0.737 . . . . 0.0 110.072 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.612 ' O ' HG11 ' A' ' 113' ' ' VAL . 21.9 tp -74.11 147.19 42.95 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.668 -0.645 . . . . 0.0 109.524 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.5 t -118.62 127.08 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.385 -0.822 . . . . 0.0 110.054 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.688 ' OG1' HG13 ' A' ' 113' ' ' VAL . 37.5 m -103.19 168.12 9.38 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.348 -0.845 . . . . 0.0 110.344 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.48 ' HA ' HD11 ' A' ' 44' ' ' LEU . 5.1 ptm180 -63.22 -27.63 69.49 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.625 -0.672 . . . . 0.0 110.965 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -96.44 26.97 4.03 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.428 -0.795 . . . . 0.0 110.812 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 52.63 24.18 3.01 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.361 -0.837 . . . . 0.0 111.092 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.761 ' O ' HG13 ' A' ' 113' ' ' VAL . 78.3 m-20 -115.03 139.33 49.95 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.426 -0.796 . . . . 0.0 109.547 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.761 HG13 ' O ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -175.7 -172.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 CA-C-O 121.803 0.811 . . . . 0.0 111.05 -179.343 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.412 ' CG1' ' HD2' ' A' ' 115' ' ' PRO . 0.2 OUTLIER -145.01 170.35 8.28 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.412 ' HD2' ' CG1' ' A' ' 114' ' ' ILE . 47.7 Cg_endo -76.13 138.21 20.15 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 O-C-N 123.288 1.152 . . . . 0.0 110.439 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.77 HG13 ' O ' ' A' ' 125' ' ' SER . 62.4 t -120.27 130.01 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.619 -0.676 . . . . 0.0 109.889 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -85.44 135.41 33.87 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.525 -0.734 . . . . 0.0 109.965 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -66.8 135.29 53.71 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.582 -0.699 . . . . 0.0 110.489 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -140.27 27.38 2.13 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.633 -0.667 . . . . 0.0 110.144 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 163.6 169.35 26.96 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -62.53 -45.16 94.25 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.592 -0.946 . . . . 0.0 110.272 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.8 m -123.51 27.08 7.57 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.615 -0.678 . . . . 0.0 110.394 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.53 155.84 45.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.505 -0.747 . . . . 0.0 110.114 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -151.52 -177.09 24.96 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.77 ' O ' HG13 ' A' ' 116' ' ' VAL . 78.9 p -119.67 152.3 37.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.638 -0.919 . . . . 0.0 110.211 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.697 HD21 ' HA ' ' A' ' 129' ' ' PRO . 0.3 OUTLIER -108.51 145.44 34.74 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.667 -0.645 . . . . 0.0 109.898 -179.719 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.5 mp -89.98 -73.79 0.51 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.658 -0.651 . . . . 0.0 109.796 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 43.0 t -72.29 112.63 15.46 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.59 -0.694 . . . . 0.0 109.334 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.697 ' HA ' HD21 ' A' ' 126' ' ' LEU . 46.0 Cg_endo -72.68 124.19 9.57 Favored 'Trans proline' 0 C--N 1.319 -0.984 0 O-C-N 123.161 1.085 . . . . 0.0 111.266 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.521 ' O ' ' HB3' ' A' ' 164' ' ' ALA . 62.6 mtm180 -127.63 153.54 77.66 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.61 150.32 56.77 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 O-C-N 123.338 1.178 . . . . 0.0 110.671 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.475 HG21 ' SG ' ' A' ' 159' ' ' CYS . 19.6 t -52.38 -29.51 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.387 -0.821 . . . . 0.0 109.577 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 46.8 t -61.24 -46.06 91.96 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.745 -0.597 . . . . 0.0 111.382 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -63.87 -39.42 94.15 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.254 -0.904 . . . . 0.0 109.618 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.41 ' O ' ' HG ' ' A' ' 135' ' ' LEU . 35.4 tp -92.2 18.62 7.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.855 -0.528 . . . . 0.0 110.025 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.415 ' HA ' ' C48' ' A' ' 201' ' ' 4P2 . 19.6 tttm -83.47 119.23 24.42 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.491 1.139 . . . . 0.0 112.837 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 98.79 23.51 11.8 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.5 m -105.09 20.79 18.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.496 -1.002 . . . . 0.0 110.584 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.911 ' HB3' HG21 ' A' ' 55' ' ' VAL . 2.6 m -73.61 144.41 45.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.316 -0.865 . . . . 0.0 109.243 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.656 ' HA2' HD11 ' A' ' 153' ' ' ILE . . . 97.31 -25.44 27.09 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -58.5 119.41 17.28 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.472 ' CD ' HG11 ' A' ' 33' ' ' VAL . 48.2 Cg_endo -73.65 173.87 13.19 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 O-C-N 123.214 1.112 . . . . 0.0 111.058 -178.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.427 ' C ' HD22 ' A' ' 144' ' ' LEU . 4.2 mp -121.18 130.55 53.76 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.583 HD13 ' C ' ' A' ' 149' ' ' HIS . 3.8 mm? -115.02 126.15 54.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.597 -0.689 . . . . 0.0 111.093 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.655 ' SG ' 'ZN ' ' A' ' 202' ' ' ' ZN' . 29.2 p -72.24 165.75 47.79 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.438 -0.789 . . . . 0.0 108.878 178.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.433 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 38.1 Cg_endo -63.54 -14.9 45.3 Favored 'Trans proline' 0 N--CA 1.488 1.188 0 O-C-N 123.022 1.011 . . . . 0.0 111.36 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 8.8 t -75.32 -34.14 61.21 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.227 -0.921 . . . . 0.0 110.02 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 114.31 47.47 0.59 Allowed Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.583 ' C ' HD13 ' A' ' 144' ' ' LEU . 67.6 m-70 -146.29 147.79 31.75 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.645 -0.915 . . . . 0.0 110.136 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -76.98 137.99 39.36 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.485 -0.759 . . . . 0.0 109.89 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.772 HG11 HD22 ' A' ' 104' ' ' LEU . 10.3 p -119.14 -30.87 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.512 -0.742 . . . . 0.0 111.102 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.52 -169.51 32.04 Favored Glycine 0 N--CA 1.498 2.785 0 C-N-CA 119.678 -1.249 . . . . 0.0 110.602 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.656 HD11 ' HA2' ' A' ' 140' ' ' GLY . 12.4 tt -139.96 148.89 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.701 -0.882 . . . . 0.0 109.588 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -66.42 154.95 38.83 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.156 -0.965 . . . . 0.0 111.654 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -137.82 -70.62 0.44 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.06 0.457 . . . . 0.0 109.998 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.489 ' HB3' ' OD1' ' A' ' 168' ' ' ASP . . . -123.29 145.59 48.57 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.26 -0.9 . . . . 0.0 111.743 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.52 129.65 41.23 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.463 HG13 ' C11' ' A' ' 201' ' ' 4P2 . 2.3 t -100.43 122.02 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 121.404 -0.81 . . . . 0.0 111.476 -177.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.475 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.2 p -141.28 139.48 33.68 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.411 -0.805 . . . . 0.0 110.647 178.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 86.9 m -71.28 -44.16 65.74 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.579 -0.7 . . . . 0.0 109.693 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -145.23 52.38 1.2 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.606 -0.684 . . . . 0.0 109.872 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 90.78 -11.59 71.37 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 64.3 t -99.41 129.53 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.19 -1.182 . . . . 0.0 108.779 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 130' ' ' ARG . . . -87.15 123.91 32.7 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.464 -0.772 . . . . 0.0 111.536 -178.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -113.32 -28.84 7.45 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.205 0.526 . . . . 0.0 109.775 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -138.52 168.36 19.94 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.581 -0.7 . . . . 0.0 109.452 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.7 m -138.73 148.83 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.338 -0.851 . . . . 0.0 111.297 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.489 ' OD1' ' HB3' ' A' ' 156' ' ' ALA . 1.4 p30 -120.11 137.92 53.86 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.67 -0.644 . . . . 0.0 110.146 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -139.0 161.9 36.24 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.589 -0.694 . . . . 0.0 110.853 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 59.0 t -93.37 137.84 23.31 Favored Pre-proline 0 N--CA 1.497 1.905 0 O-C-N 121.504 -0.748 . . . . 0.0 110.017 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -77.53 156.28 32.14 Favored 'Trans proline' 0 C--N 1.32 -0.971 0 O-C-N 123.18 1.095 . . . . 0.0 110.293 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 96.0 t -79.94 -26.99 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.352 -0.842 . . . . 0.0 110.213 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 174' ' ' SER . 2.4 pt-20 -59.95 -28.71 67.87 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.367 -0.833 . . . . 0.0 110.375 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.41 ' N ' ' HG3' ' A' ' 173' ' ' GLU . 72.2 m -76.51 -28.83 56.54 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.472 -0.767 . . . . 0.0 110.195 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.575 ' CE ' HD21 ' A' ' 82' ' ' LEU . 64.9 mtt -59.86 -32.82 71.06 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.631 -0.668 . . . . 0.0 110.647 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -59.87 -50.08 75.17 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.433 -0.792 . . . . 0.0 110.168 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 88.1 m -72.05 -39.96 68.69 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.626 -0.671 . . . . 0.0 109.838 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 89.9 m -61.27 -38.06 85.4 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.628 -0.67 . . . . 0.0 110.236 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 5.0 tmm? -59.78 -33.94 72.35 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.509 -0.744 . . . . 0.0 110.372 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 25.9 ttm180 -59.97 -40.07 87.82 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.504 -0.747 . . . . 0.0 110.253 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.734 0 O-C-N 121.579 -0.701 . . . . 0.0 110.229 179.995 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' 4P2 . . . . . 0.749 ' C24' HG13 ' A' ' 78' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . 0.655 'ZN ' ' SG ' ' A' ' 145' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.4 p . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.097 0.475 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.72 170.43 36.12 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -88.11 131.03 34.85 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.574 -0.957 . . . . 0.0 110.259 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -124.15 14.38 9.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.522 -0.736 . . . . 0.0 111.028 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -124.35 139.02 54.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.37 -0.831 . . . . 0.0 110.094 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -121.45 113.39 19.78 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.57 -0.706 . . . . 0.0 110.349 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -64.43 -39.88 94.68 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.612 -0.68 . . . . 0.0 109.979 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.6 m -125.67 157.01 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.74 -0.6 . . . . 0.0 110.158 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -120.29 139.42 52.76 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.594 -0.691 . . . . 0.0 110.053 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.63 41.44 0.03 OUTLIER Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.763 ' OE2' HD21 ' A' ' 144' ' ' LEU . 96.7 mt-10 -69.82 -29.03 66.21 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.571 -0.958 . . . . 0.0 110.244 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.3 p -127.14 140.07 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.563 -0.711 . . . . 0.0 110.055 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -102.88 141.61 35.39 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.602 -0.686 . . . . 0.0 110.246 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.553 ' O ' HG23 ' A' ' 35' ' ' VAL . 33.7 m -87.05 116.28 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.589 -0.695 . . . . 0.0 110.387 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.2 p -138.57 136.14 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.468 -0.77 . . . . 0.0 109.984 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 75.7 m -131.83 143.26 50.06 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.425 -0.797 . . . . 0.0 110.745 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 70.3 p -96.58 -179.98 4.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.629 -0.669 . . . . 0.0 109.737 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.63 -14.25 61.14 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.302 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 75.2 p -119.27 -25.4 6.13 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.136 -0.977 . . . . 0.0 111.432 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -141.83 168.17 20.4 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.253 -0.905 . . . . 0.0 110.96 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.8 t -138.62 118.94 13.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.582 -0.699 . . . . 0.0 110.342 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -140.26 175.83 9.27 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.532 -0.73 . . . . 0.0 109.995 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.477 HD11 ' HA ' ' A' ' 109' ' ' ARG . 81.5 mt -115.6 152.7 32.6 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.251 -0.906 . . . . 0.0 110.545 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -117.17 141.02 48.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.604 -0.685 . . . . 0.0 110.24 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 86.2 m -117.27 143.06 46.31 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.537 -0.727 . . . . 0.0 110.228 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 93.3 m -94.13 113.75 25.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.576 -0.703 . . . . 0.0 110.654 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.2 t -127.49 129.95 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.599 -0.688 . . . . 0.0 109.905 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 53.84 39.84 30.84 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.522 -0.736 . . . . 0.0 111.175 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.639 ' O ' ' HB3' ' A' ' 87' ' ' ALA . . . 66.61 17.8 67.27 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 62.3 t -129.95 130.04 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.25 -1.147 . . . . 0.0 109.755 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 97.9 m -82.02 112.72 19.36 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.529 -0.732 . . . . 0.0 110.002 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -101.76 137.48 40.01 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.606 -0.684 . . . . 0.0 110.52 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.71 HG21 ' CZ3' ' A' ' 85' ' ' TRP . 7.4 t -136.55 -179.87 5.94 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.643 -0.661 . . . . 0.0 109.738 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.601 HG21 ' HB3' ' A' ' 139' ' ' SER . 91.0 t -83.23 142.1 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.516 -0.74 . . . . 0.0 109.872 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.839 ' CE2' HG22 ' A' ' 78' ' ' VAL . 43.0 t80 -84.55 -42.52 15.39 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.609 -0.682 . . . . 0.0 111.223 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.598 ' CE1' HG11 ' A' ' 55' ' ' VAL . 1.9 p-80 -62.01 -20.83 64.32 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.399 -0.921 . . . . 0.0 110.588 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -83.94 -75.28 1.2 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.77 -48.18 77.99 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.581 -0.952 . . . . 0.0 110.082 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.89 -175.95 35.78 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.2 t -60.04 -39.86 87.37 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.628 -0.925 . . . . 0.0 110.242 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -60.08 134.86 57.45 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.568 -0.708 . . . . 0.0 110.096 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.1 t -92.84 179.18 5.54 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.521 -0.737 . . . . 0.0 110.391 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 93.6 mt -111.9 143.08 43.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.639 -0.663 . . . . 0.0 110.275 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -117.13 130.53 56.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.643 -0.661 . . . . 0.0 110.2 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.97 -149.7 5.68 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -71.1 -42.25 2.17 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.41 1.216 . . . . 0.0 110.466 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -119.99 20.09 12.21 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.592 -0.692 . . . . 0.0 110.646 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -106.11 137.12 13.66 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -81.46 165.1 18.68 Favored 'Trans proline' 0 C--N 1.319 -1.004 0 O-C-N 123.198 1.104 . . . . 0.0 110.642 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 31.3 pt -106.3 2.77 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.701 -0.624 . . . . 0.0 111.016 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.6 t -119.24 150.04 40.75 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.136 -0.978 . . . . 0.0 110.105 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -98.16 126.57 43.68 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.513 -0.742 . . . . 0.0 110.381 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 49.3 tpp -97.22 -47.26 5.81 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.51 -0.744 . . . . 0.0 110.713 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -119.72 134.95 55.03 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.526 -0.734 . . . . 0.0 110.252 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.4 m -151.55 128.09 10.75 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.512 -0.742 . . . . 0.0 110.348 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -158.88 116.31 2.81 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.372 -0.83 . . . . 0.0 111.242 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.839 HG22 ' CE2' ' A' ' 56' ' ' TYR . 54.5 t -69.98 -40.02 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.523 -0.736 . . . . 0.0 109.531 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -59.96 -44.55 94.37 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.414 -0.804 . . . . 0.0 110.294 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.557 ' HG2' HD12 ' A' ' 82' ' ' LEU . 49.4 tt0 -80.88 -13.45 58.91 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.706 -0.621 . . . . 0.0 110.177 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.403 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 39.5 t0 53.44 36.89 24.28 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.269 -0.894 . . . . 0.0 110.866 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.557 HD12 ' HG2' ' A' ' 80' ' ' GLN . 80.5 mt -140.13 156.16 46.67 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.492 -0.755 . . . . 0.0 110.677 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.0 t -138.42 155.73 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -137.0 147.49 19.26 Favored Glycine 0 N--CA 1.494 2.561 0 C-N-CA 119.552 -1.308 . . . . 0.0 111.142 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.71 ' CZ3' HG21 ' A' ' 54' ' ' THR . 3.7 m-90 -127.09 139.35 53.05 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.77 -0.841 . . . . 0.0 109.388 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -60.39 137.37 58.15 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.396 -0.815 . . . . 0.0 110.46 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 50' ' ' GLY . . . -108.87 162.63 19.3 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.532 -0.73 . . . . 0.0 110.195 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.91 148.83 52.39 Favored 'Trans proline' 0 C--N 1.317 -1.1 0 O-C-N 123.397 1.209 . . . . 0.0 110.613 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -76.15 160.35 36.43 Favored 'Trans proline' 0 C--N 1.319 -1.01 0 O-C-N 123.354 1.186 . . . . 0.0 110.54 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 93.82 -10.67 72.08 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.38 -176.82 5.48 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.108 -1.231 . . . . 0.0 110.328 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.88 157.98 43.72 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.656 -0.653 . . . . 0.0 109.977 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.9 m -137.61 175.19 9.82 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.469 -0.769 . . . . 0.0 110.834 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.446 HD11 ' HB3' ' A' ' 32' ' ' GLU . 52.6 mt -84.43 170.21 13.77 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.741 -0.599 . . . . 0.0 110.271 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 60.5 p -115.97 158.93 41.15 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.596 -0.69 . . . . 0.0 110.112 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.37 123.41 8.68 Favored 'Trans proline' 0 C--N 1.317 -1.095 0 O-C-N 123.466 1.245 . . . . 0.0 110.675 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 1.272 ' SG ' 'ZN ' ' A' ' 202' ' ' ' ZN' . 10.7 t -70.86 142.13 51.23 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.546 -0.722 . . . . 0.0 110.043 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.575 HG23 ' O ' ' A' ' 98' ' ' THR . 7.4 t -135.39 72.21 1.44 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.506 -0.746 . . . . 0.0 110.464 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 27.3 p -144.86 -0.46 0.91 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.515 -0.741 . . . . 0.0 112.285 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 55.29 39.94 73.91 Favored Glycine 0 N--CA 1.498 2.784 0 O-C-N 120.825 -1.172 . . . . 0.0 110.283 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.3 t -69.97 122.75 19.95 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.434 -1.039 . . . . 0.0 110.246 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 58.4 m -70.34 -39.96 74.39 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.561 -0.712 . . . . 0.0 110.283 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -81.62 119.59 24.0 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.566 -0.709 . . . . 0.0 110.183 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 91.0 mt -129.88 150.73 51.05 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.59 -0.694 . . . . 0.0 110.472 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -115.31 133.31 56.15 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.596 -0.69 . . . . 0.0 109.728 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.789 HD12 HD11 ' A' ' 143' ' ' LEU . 9.6 tt -113.49 138.28 50.35 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.435 -0.791 . . . . 0.0 110.351 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.3 t -97.85 129.15 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.602 -0.686 . . . . 0.0 109.839 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 75.0 p -100.9 169.97 8.62 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.623 -0.673 . . . . 0.0 110.391 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.477 ' HA ' HD11 ' A' ' 44' ' ' LEU . 78.8 ttt-85 -62.5 -23.49 66.97 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.635 -0.666 . . . . 0.0 110.342 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.406 ' O ' ' CG ' ' A' ' 110' ' ' HIS . 81.1 t60 -92.86 25.7 3.06 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.409 -0.807 . . . . 0.0 110.75 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.82 44.8 27.86 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.128 -0.983 . . . . 0.0 110.83 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -113.86 155.5 25.61 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.554 -0.716 . . . . 0.0 109.975 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.2 137.2 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.561 -0.712 . . . . 0.0 110.437 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 42.2 pt -136.46 141.72 36.77 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.613 -0.679 . . . . 0.0 109.957 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -76.67 139.45 20.13 Favored 'Trans proline' 0 C--N 1.319 -1.021 0 O-C-N 123.25 1.131 . . . . 0.0 110.447 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.5 t -126.66 130.06 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.608 -0.682 . . . . 0.0 109.86 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -89.7 137.33 32.42 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.495 -0.753 . . . . 0.0 110.078 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 79.1 ttt-85 -82.08 124.33 29.73 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.514 -0.741 . . . . 0.0 110.216 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -128.85 25.19 5.64 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.612 -0.68 . . . . 0.0 110.302 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 168.88 179.56 41.07 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -61.23 -41.33 96.68 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.565 -0.962 . . . . 0.0 110.172 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.3 p -137.15 24.17 3.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.518 -0.739 . . . . 0.0 110.572 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -131.0 139.91 50.06 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.409 -0.807 . . . . 0.0 110.479 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.576 ' O ' ' HB1' ' A' ' 166' ' ' ALA . . . -146.56 179.74 23.3 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 46.9 t -129.63 144.98 51.52 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.506 -0.997 . . . . 0.0 110.26 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.419 HD23 ' O ' ' A' ' 128' ' ' SER . 19.2 tp -99.86 136.8 39.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.605 -0.684 . . . . 0.0 110.145 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.4 mp -69.67 -39.99 76.67 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.531 -0.731 . . . . 0.0 110.452 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.419 ' O ' HD23 ' A' ' 126' ' ' LEU . 47.6 t -98.63 109.48 53.28 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.424 -0.798 . . . . 0.0 110.099 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -76.82 135.3 15.71 Favored 'Trans proline' 0 C--N 1.32 -0.956 0 O-C-N 123.213 1.112 . . . . 0.0 110.751 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -135.96 162.37 57.17 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.62 -0.675 . . . . 0.0 109.769 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.5 150.29 57.4 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 O-C-N 123.385 1.202 . . . . 0.0 110.263 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 162' ' ' GLY . 83.9 t -59.09 -34.29 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.431 -0.793 . . . . 0.0 109.796 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 46.7 t -59.91 -40.04 87.47 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.578 -0.701 . . . . 0.0 110.323 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -61.05 -41.47 96.66 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.491 -0.755 . . . . 0.0 109.68 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.553 HD21 ' CZ ' ' A' ' 154' ' ' PHE . 43.9 tp -89.97 -10.1 46.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.784 -0.573 . . . . 0.0 111.332 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -62.53 138.31 58.45 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.158 -0.964 . . . . 0.0 110.657 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 87.0 20.71 52.63 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 21.8 m -120.59 13.58 11.71 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.317 -1.107 . . . . 0.0 111.052 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.601 ' HB3' HG21 ' A' ' 55' ' ' VAL . 19.8 m -59.79 151.99 24.07 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.155 -0.966 . . . . 0.0 110.287 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 92.52 -17.68 56.9 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -58.08 110.62 2.54 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -76.19 143.4 25.38 Favored 'Trans proline' 0 C--N 1.32 -0.943 0 O-C-N 123.134 1.071 . . . . 0.0 110.963 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.789 HD11 HD12 ' A' ' 106' ' ' LEU . 5.5 mp -95.78 131.82 41.66 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.763 HD21 ' OE2' ' A' ' 32' ' ' GLU . 8.8 mp -110.04 156.36 20.62 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.631 -0.668 . . . . 0.0 110.973 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.0 176.16 1.85 Allowed Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.718 -0.614 . . . . 0.0 109.642 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.59 -26.96 19.24 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 O-C-N 123.324 1.17 . . . . 0.0 110.252 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.53 -30.77 69.65 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.508 -0.745 . . . . 0.0 110.06 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 114.91 27.58 3.18 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -127.73 147.44 50.4 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.38 -1.071 . . . . 0.0 110.218 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -83.38 134.3 34.9 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.465 -0.772 . . . . 0.0 110.276 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 151' ' ' VAL . 34.4 m -90.98 -22.89 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.594 -0.691 . . . . 0.0 110.868 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 167.74 -163.58 37.25 Favored Glycine 0 N--CA 1.498 2.769 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.43 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 77.0 mt -130.05 156.16 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.641 -0.917 . . . . 0.0 109.97 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.553 ' CZ ' HD21 ' A' ' 135' ' ' LEU . 13.5 t80 -68.23 134.78 50.97 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.496 -0.753 . . . . 0.0 109.914 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.443 ' HD3' HG23 ' A' ' 170' ' ' VAL . 59.2 ttp180 -114.26 -64.86 1.25 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.569 -0.707 . . . . 0.0 111.02 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.733 ' HB1' ' O32' ' A' ' 201' ' ' 4P2 . . . -136.09 149.81 48.87 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.431 -0.793 . . . . 0.0 110.991 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -95.99 126.46 41.25 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.662 -0.648 . . . . 0.0 109.855 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 45.1 t -95.75 118.15 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.595 -0.69 . . . . 0.0 110.453 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 26.7 p -140.05 144.87 37.08 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.464 -0.772 . . . . 0.0 110.632 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 91.8 m -73.95 -49.98 22.1 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.566 -0.709 . . . . 0.0 110.051 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -139.35 50.1 1.8 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.602 -0.686 . . . . 0.0 110.117 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.417 ' O ' HG23 ' A' ' 132' ' ' VAL . . . 96.46 -11.25 66.97 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 62.0 t -102.04 121.78 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.237 -1.155 . . . . 0.0 109.151 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.36 118.78 27.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.55 -0.719 . . . . 0.0 111.078 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -103.37 -25.83 13.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.704 -0.622 . . . . 0.0 109.641 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.576 ' HB1' ' O ' ' A' ' 124' ' ' GLY . . . -135.45 167.62 20.72 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.596 -0.69 . . . . 0.0 109.802 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.8 m -133.58 140.0 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.497 -0.752 . . . . 0.0 110.721 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -110.83 131.01 55.41 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.625 -0.672 . . . . 0.0 109.853 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -139.84 158.07 44.68 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.532 -0.73 . . . . 0.0 110.613 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.443 HG23 ' HD3' ' A' ' 155' ' ' ARG . 62.8 t -95.27 134.94 23.74 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.576 -0.703 . . . . 0.0 109.715 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.02 154.05 57.71 Favored 'Trans proline' 0 C--N 1.318 -1.045 0 O-C-N 123.175 1.092 . . . . 0.0 110.77 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 61.8 t -60.03 -38.82 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.645 -0.659 . . . . 0.0 110.062 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -57.22 -34.07 68.18 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.687 -0.633 . . . . 0.0 110.749 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 47.4 t -61.52 -40.05 93.24 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.504 -0.748 . . . . 0.0 109.964 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 61.3 mtt -59.95 -38.64 83.03 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.637 -0.665 . . . . 0.0 110.333 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -59.97 -33.14 71.53 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.667 -0.646 . . . . 0.0 110.578 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 93.9 m -59.88 -40.06 87.41 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.455 -0.778 . . . . 0.0 110.377 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 92.9 m -62.92 -49.78 73.42 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.495 -0.753 . . . . 0.0 110.094 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 76.6 mtm -65.04 -35.84 82.47 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.528 -0.732 . . . . 0.0 110.244 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -60.0 -40.01 87.74 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.524 -0.735 . . . . 0.0 110.148 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.837 0 O-C-N 121.617 -0.677 . . . . 0.0 110.148 179.87 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' 4P2 . . . . . 0.733 ' O32' ' HB1' ' A' ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . 1.272 'ZN ' ' SG ' ' A' ' 97' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 45.9 p . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.069 0.461 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.45 -110.43 3.07 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -77.76 154.28 32.13 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.581 -0.952 . . . . 0.0 110.265 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -137.33 83.71 2.01 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.547 -0.72 . . . . 0.0 110.172 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -66.49 -34.76 78.65 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.556 -0.715 . . . . 0.0 110.384 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -60.01 -40.03 87.87 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.492 -0.755 . . . . 0.0 110.398 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -99.45 109.96 22.48 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.491 -0.756 . . . . 0.0 110.038 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.494 HG12 ' HG3' ' A' ' 30' ' ' GLU . 58.4 t -76.25 -50.06 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.627 -0.67 . . . . 0.0 110.266 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.494 ' HG3' HG12 ' A' ' 29' ' ' VAL . 49.2 mt-10 -128.45 157.88 39.89 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.518 -0.739 . . . . 0.0 110.328 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -106.32 38.32 3.37 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.645 ' OE2' HD21 ' A' ' 94' ' ' LEU . 49.5 mm-40 -60.2 -40.65 90.8 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.562 -0.964 . . . . 0.0 110.006 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 45' ' ' ALA . 9.4 p -142.39 139.98 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.8 -0.563 . . . . 0.0 109.901 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -103.08 139.98 37.9 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.564 -0.71 . . . . 0.0 110.101 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.418 ' HA ' HD22 ' A' ' 44' ' ' LEU . 10.0 p -83.48 134.5 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.513 -0.742 . . . . 0.0 110.223 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.8 t -127.93 129.99 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.572 -0.705 . . . . 0.0 110.029 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.9 m -121.96 134.28 54.83 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.608 -0.683 . . . . 0.0 110.026 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.482 HG22 ' H ' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -109.74 -175.11 2.66 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.464 -0.773 . . . . 0.0 110.123 -179.865 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.482 ' H ' HG22 ' A' ' 38' ' ' THR . . . -70.04 -38.46 75.85 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.646 -0.659 . . . . 0.0 111.333 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.468 HG23 ' HG3' ' A' ' 41' ' ' GLN . 6.6 t -118.56 -20.02 8.54 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.305 -0.872 . . . . 0.0 111.738 -178.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.468 ' HG3' HG23 ' A' ' 40' ' ' THR . 79.0 mt-30 -132.38 154.32 49.9 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.21 -0.931 . . . . 0.0 110.743 -179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 73.6 m -132.34 124.07 28.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.539 -0.726 . . . . 0.0 109.923 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -136.11 170.37 16.12 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.587 -0.696 . . . . 0.0 110.532 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.418 HD22 ' HA ' ' A' ' 35' ' ' VAL . 55.6 mt -115.63 149.6 38.04 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.693 -0.629 . . . . 0.0 109.836 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.672 ' O ' HG23 ' A' ' 33' ' ' VAL . . . -115.91 148.32 40.15 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.496 -0.752 . . . . 0.0 110.189 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.629 HG21 ' HB3' ' A' ' 142' ' ' PRO . 87.3 m -119.9 136.55 54.46 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.557 -0.715 . . . . 0.0 109.873 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.415 ' O ' HD12 ' A' ' 94' ' ' LEU . 28.3 p -94.57 121.07 35.75 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.337 -0.852 . . . . 0.0 111.073 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.6 t -130.08 129.99 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.512 -0.743 . . . . 0.0 109.751 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 53.44 39.95 30.66 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.46 -0.775 . . . . 0.0 111.099 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.94 16.19 70.19 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 62.5 t -126.07 123.39 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.181 -1.188 . . . . 0.0 109.722 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 36.2 t -79.67 115.87 19.53 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.535 -0.728 . . . . 0.0 110.166 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 71.6 m95 -104.65 137.57 42.28 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.648 -0.658 . . . . 0.0 110.139 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.573 ' OG1' HG23 ' A' ' 83' ' ' VAL . 34.9 p -136.38 179.32 6.43 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.58 -0.7 . . . . 0.0 109.733 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.582 HG11 ' CE1' ' A' ' 57' ' ' HIS . 59.4 t -85.63 142.28 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.525 -0.734 . . . . 0.0 109.528 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.864 ' CE2' HG22 ' A' ' 78' ' ' VAL . 39.4 t80 -79.82 -42.9 23.39 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.424 -0.798 . . . . 0.0 111.598 -178.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.582 ' CE1' HG11 ' A' ' 55' ' ' VAL . 2.2 p-80 -67.02 -20.0 65.79 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.111 -0.993 . . . . 0.0 110.722 -178.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.74 -50.5 1.51 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -102.56 -38.34 7.57 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.498 -1.001 . . . . 0.0 110.399 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.38 -21.61 54.36 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 75.1 m -59.78 -34.04 72.49 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.388 -1.066 . . . . 0.0 110.294 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.1 ptmt -135.08 169.32 17.62 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.506 -0.746 . . . . 0.0 110.493 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 20.8 m -101.38 140.67 35.35 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.71 -0.619 . . . . 0.0 110.237 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.0 mt -103.85 147.84 26.84 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.564 -0.71 . . . . 0.0 110.258 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.77 122.91 42.61 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.525 -0.735 . . . . 0.0 110.44 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.1 159.32 47.09 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -72.43 -41.29 1.79 Allowed 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.433 1.228 . . . . 0.0 110.523 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.6 tptm -69.84 -31.27 69.04 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.613 -0.679 . . . . 0.0 109.982 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 168.89 164.3 24.37 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.4 126.41 11.59 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 123.318 1.167 . . . . 0.0 110.23 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 85.3 mt -119.57 129.98 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.642 -0.661 . . . . 0.0 110.129 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 56.3 m -69.61 150.07 47.45 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.64 -0.663 . . . . 0.0 109.951 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -58.86 124.0 18.38 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.517 -0.739 . . . . 0.0 110.38 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.4 tpt -70.0 -40.03 75.53 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.578 -0.701 . . . . 0.0 110.294 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.536 ' O ' HG12 ' A' ' 83' ' ' VAL . 51.1 m-85 -126.01 129.99 50.28 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.497 -0.752 . . . . 0.0 110.338 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.607 ' HA ' HG12 ' A' ' 83' ' ' VAL . 60.4 m -137.97 118.8 14.16 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.711 -0.618 . . . . 0.0 110.309 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -157.02 113.01 2.93 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.358 -0.838 . . . . 0.0 111.136 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.864 HG22 ' CE2' ' A' ' 56' ' ' TYR . 56.1 t -70.02 -39.99 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.445 -0.785 . . . . 0.0 109.441 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -58.35 -46.03 87.05 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.442 -0.787 . . . . 0.0 110.033 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.9 -14.25 48.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.681 -0.637 . . . . 0.0 110.076 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.419 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 43.8 t0 53.88 39.99 31.04 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.245 -0.909 . . . . 0.0 110.575 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.831 HD11 HG21 ' A' ' 170' ' ' VAL . 68.6 mt -137.63 147.83 45.28 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.565 -0.71 . . . . 0.0 111.325 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.607 HG12 ' HA ' ' A' ' 76' ' ' THR . 11.8 m -149.96 178.85 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -179.76 171.99 43.63 Favored Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.607 -1.283 . . . . 0.0 110.774 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 7.7 m-90 -130.06 159.53 36.46 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.828 -0.807 . . . . 0.0 109.627 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -81.62 124.14 29.29 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.456 -0.777 . . . . 0.0 110.194 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -97.19 163.85 19.03 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.575 -0.703 . . . . 0.0 110.256 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -70.65 151.52 64.04 Favored 'Trans proline' 0 C--N 1.318 -1.078 0 O-C-N 123.391 1.206 . . . . 0.0 110.476 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.28 157.2 54.05 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.379 1.199 . . . . 0.0 110.404 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.04 30.58 12.44 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -123.66 154.36 39.48 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.529 -0.983 . . . . 0.0 110.244 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -70.52 150.05 46.53 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.572 -0.705 . . . . 0.0 110.161 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 94.8 p -134.07 158.96 42.25 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.596 -0.69 . . . . 0.0 110.202 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.645 HD21 ' OE2' ' A' ' 32' ' ' GLU . 59.8 mt -104.16 141.14 36.78 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.52 -0.738 . . . . 0.0 110.381 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 31.5 p -105.77 160.99 24.2 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.647 -0.658 . . . . 0.0 110.229 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.72 152.48 58.86 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.345 1.182 . . . . 0.0 110.328 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 1.376 ' SG ' 'ZN ' ' A' ' 202' ' ' ' ZN' . 5.5 t -85.69 139.31 31.48 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.476 -0.765 . . . . 0.0 110.271 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.6 m -125.94 72.63 1.3 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.672 -0.643 . . . . 0.0 110.179 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 27.1 p -144.48 -8.29 0.67 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.455 -0.778 . . . . 0.0 112.426 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 55.4 33.2 58.33 Favored Glycine 0 N--CA 1.499 2.841 0 O-C-N 120.773 -1.204 . . . . 0.0 110.318 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.7 t -80.67 118.58 22.35 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.558 -0.966 . . . . 0.0 110.478 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 57.9 m -60.02 -39.97 87.68 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.516 -0.74 . . . . 0.0 110.088 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -64.23 125.59 25.03 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.579 -0.701 . . . . 0.0 109.84 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.6 mt -130.14 155.38 46.3 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.636 -0.665 . . . . 0.0 110.305 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -117.85 135.78 53.87 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.678 -0.639 . . . . 0.0 109.684 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.553 ' HA ' HD23 ' A' ' 143' ' ' LEU . 9.9 tt -114.31 132.0 56.33 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.581 -0.7 . . . . 0.0 110.488 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.0 t -92.32 119.88 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.615 -0.678 . . . . 0.0 109.643 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.0 m -99.21 161.47 13.6 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.558 -0.714 . . . . 0.0 110.391 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.7 ttp180 -60.47 -24.64 65.42 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.567 -0.708 . . . . 0.0 110.359 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 18.3 m80 -92.59 26.84 2.5 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.314 -0.866 . . . . 0.0 110.942 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.61 31.9 16.04 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.151 -0.968 . . . . 0.0 110.545 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -104.89 129.41 53.26 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.66 -0.65 . . . . 0.0 109.847 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 61.9 t -109.9 125.29 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.592 -0.692 . . . . 0.0 110.238 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 38.3 mt -119.73 135.51 24.23 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.678 -0.639 . . . . 0.0 109.648 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -75.72 135.5 17.87 Favored 'Trans proline' 0 C--N 1.319 -1.026 0 O-C-N 123.213 1.112 . . . . 0.0 110.594 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.644 HG13 ' O ' ' A' ' 125' ' ' SER . 60.1 t -129.82 129.98 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.557 -0.714 . . . . 0.0 109.572 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -80.16 156.04 27.15 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.515 -0.741 . . . . 0.0 110.151 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -99.28 121.45 41.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.63 -0.669 . . . . 0.0 110.249 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 31.0 mtp85 -119.63 24.24 10.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.576 -0.703 . . . . 0.0 110.621 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -177.1 -176.9 45.6 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -64.78 -39.97 94.49 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.544 -0.974 . . . . 0.0 110.435 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 46.6 m -136.54 24.48 3.16 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.516 -0.74 . . . . 0.0 110.522 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -125.21 150.56 46.87 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.436 -0.79 . . . . 0.0 110.4 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -144.02 168.92 26.38 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.644 ' O ' HG13 ' A' ' 116' ' ' VAL . 82.9 p -112.02 152.43 28.17 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.555 -0.968 . . . . 0.0 110.23 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 35.2 tp -100.13 120.34 39.71 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.553 -0.717 . . . . 0.0 110.179 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.8 mt -59.95 -47.1 87.19 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.49 -0.756 . . . . 0.0 110.683 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 36.2 t -97.93 111.68 59.79 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.632 -0.667 . . . . 0.0 110.168 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.64 113.21 3.72 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 O-C-N 123.173 1.091 . . . . 0.0 110.479 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.431 ' HD3' ' CD2' ' A' ' 134' ' ' TYR . 37.6 mtt180 -120.25 162.78 32.05 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.577 -0.702 . . . . 0.0 110.126 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.04 150.49 66.56 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 123.384 1.202 . . . . 0.0 110.429 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 162' ' ' GLY . 86.4 t -55.92 -33.25 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.479 -0.763 . . . . 0.0 110.114 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.3 m -58.66 -46.59 86.82 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.62 -0.675 . . . . 0.0 110.763 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.431 ' CD2' ' HD3' ' A' ' 130' ' ' ARG . 64.0 t80 -59.99 -41.61 92.43 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.549 -0.719 . . . . 0.0 110.201 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 58.8 tp -84.87 -9.8 57.76 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.773 -0.579 . . . . 0.0 111.461 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -68.83 143.97 54.41 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.098 -1.002 . . . . 0.0 110.748 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 95.17 -2.52 65.83 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 89.2 p -102.39 10.49 39.03 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.136 -1.214 . . . . 0.0 110.807 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.97 140.69 56.57 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.252 -0.905 . . . . 0.0 110.188 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 90.51 -10.56 74.15 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.52 129.29 33.62 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.629 ' HB3' HG21 ' A' ' 46' ' ' THR . 50.5 Cg_endo -76.86 148.92 28.8 Favored 'Trans proline' 0 C--N 1.318 -1.037 0 O-C-N 123.217 1.114 . . . . 0.0 110.886 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.553 HD23 ' HA ' ' A' ' 106' ' ' LEU . 21.1 mt -99.14 118.16 35.25 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.448 HD12 ' N ' ' A' ' 144' ' ' LEU . 9.3 mp -92.0 163.14 14.1 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.586 -0.697 . . . . 0.0 111.157 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.2 177.4 1.36 Allowed Pre-proline 0 N--CA 1.493 1.7 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.06 -26.7 21.25 Favored 'Trans proline' 0 C--N 1.317 -1.106 0 O-C-N 123.264 1.139 . . . . 0.0 110.434 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 90.6 p -69.97 -33.04 71.57 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.544 -0.722 . . . . 0.0 110.236 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 106.21 45.22 1.28 Allowed Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -137.17 160.19 39.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.535 -0.979 . . . . 0.0 110.293 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.413 ' HB2' ' HB3' ' A' ' 94' ' ' LEU . . . -78.48 125.3 29.17 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.588 -0.695 . . . . 0.0 110.34 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 63.3 t -91.55 -53.43 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.565 -0.71 . . . . 0.0 110.133 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -171.08 -161.9 22.51 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.471 HD12 ' HE2' ' A' ' 175' ' ' MET . 96.7 mt -130.22 140.06 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.593 -0.945 . . . . 0.0 110.153 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -61.83 128.64 37.19 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.593 -0.692 . . . . 0.0 109.814 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -103.59 -69.6 0.79 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.595 -0.691 . . . . 0.0 110.851 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.683 ' HB1' ' O32' ' A' ' 201' ' ' 4P2 . . . -133.88 152.41 51.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.528 -0.733 . . . . 0.0 110.692 -179.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.01 149.81 20.9 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 57.9 t -117.79 119.32 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.542 -0.724 . . . . 0.0 110.517 -179.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.2 p -141.5 142.23 33.59 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.565 -0.709 . . . . 0.0 110.55 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 44.4 m -75.38 -40.84 57.58 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.523 -0.735 . . . . 0.0 110.03 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -145.49 51.58 1.19 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.586 -0.697 . . . . 0.0 110.402 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.476 ' O ' HG23 ' A' ' 132' ' ' VAL . . . 91.35 -10.36 75.04 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.381 -1.087 . . . . 0.0 110.381 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 96.9 t -101.77 122.31 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.165 -1.197 . . . . 0.0 109.132 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.33 118.49 26.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.586 -0.696 . . . . 0.0 110.899 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -106.21 -27.75 10.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.777 -0.577 . . . . 0.0 109.645 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -132.62 162.41 31.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.534 -0.728 . . . . 0.0 110.017 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.565 HG21 HG11 ' A' ' 116' ' ' VAL . 34.9 m -129.99 139.59 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.583 -0.698 . . . . 0.0 110.232 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -117.76 123.41 45.92 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.534 -0.729 . . . . 0.0 110.485 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -132.49 159.97 37.85 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.575 -0.703 . . . . 0.0 109.796 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.831 HG21 HD11 ' A' ' 82' ' ' LEU . 27.1 m -97.54 142.45 24.58 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.516 -0.74 . . . . 0.0 110.414 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -77.65 171.08 18.06 Favored 'Trans proline' 0 C--N 1.318 -1.045 0 O-C-N 123.265 1.139 . . . . 0.0 110.255 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 61.4 t -59.98 -36.14 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.532 -0.73 . . . . 0.0 110.167 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -59.65 -33.22 71.26 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.729 -0.607 . . . . 0.0 110.996 -178.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 64.8 p -61.5 -33.32 73.59 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.387 -0.821 . . . . 0.0 109.984 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.471 ' HE2' HD12 ' A' ' 153' ' ' ILE . 44.8 mtt -69.08 -40.07 78.68 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.643 -0.661 . . . . 0.0 110.134 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -60.0 -38.89 83.94 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.651 -0.656 . . . . 0.0 110.468 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 94.2 m -60.07 -39.97 87.88 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.6 -0.688 . . . . 0.0 110.144 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 87.2 m -60.63 -40.48 92.11 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.469 -0.77 . . . . 0.0 109.985 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 40.8 ttp -61.06 -42.03 97.72 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.658 -0.652 . . . . 0.0 110.218 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -62.25 -40.07 94.95 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.495 -0.753 . . . . 0.0 110.292 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.829 0 O-C-N 121.594 -0.691 . . . . 0.0 110.182 179.942 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' 4P2 . . . . . 0.683 ' O32' ' HB1' ' A' ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . 1.376 'ZN ' ' SG ' ' A' ' 97' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.07 0.462 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -133.53 147.36 18.99 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -115.0 128.79 56.49 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.559 -0.965 . . . . 0.0 109.948 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 53.58 37.51 26.07 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.425 -0.797 . . . . 0.0 110.585 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 49.5 mttm -111.3 35.2 3.68 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.558 -0.714 . . . . 0.0 110.176 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -62.71 -39.02 92.73 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.565 -0.709 . . . . 0.0 109.936 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -88.29 99.85 12.55 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.646 -0.659 . . . . 0.0 110.215 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.7 p -107.32 -26.48 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.553 -0.717 . . . . 0.0 110.355 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -146.15 159.57 43.12 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.463 -0.773 . . . . 0.0 109.835 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -154.3 -124.4 0.94 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.563 ' OE1' HD13 ' A' ' 94' ' ' LEU . 44.3 tp10 -60.02 -39.94 87.55 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.582 -0.951 . . . . 0.0 110.232 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.466 HG21 HG11 ' A' ' 107' ' ' VAL . 61.2 t -99.05 126.37 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.638 -0.664 . . . . 0.0 110.068 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -108.2 142.24 38.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.622 -0.674 . . . . 0.0 110.123 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.474 ' HA ' HD22 ' A' ' 44' ' ' LEU . 65.4 t -87.18 114.16 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.55 -0.719 . . . . 0.0 109.589 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 62.0 t -118.45 131.33 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.448 -0.782 . . . . 0.0 109.98 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.8 m -123.12 135.37 54.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.642 -0.661 . . . . 0.0 110.086 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.472 HG22 ' H ' ' A' ' 39' ' ' ALA . 0.3 OUTLIER -101.22 -179.39 4.02 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.658 -0.651 . . . . 0.0 110.284 -179.739 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.472 ' H ' HG22 ' A' ' 38' ' ' THR . . . -67.91 -40.07 83.48 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.898 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 76.6 p -113.79 -28.22 7.51 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.381 -0.824 . . . . 0.0 110.92 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 -126.26 -179.03 4.54 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.473 -0.767 . . . . 0.0 110.452 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 81.2 p -153.47 125.9 8.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.621 -0.674 . . . . 0.0 110.317 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.458 ' O ' HD23 ' A' ' 44' ' ' LEU . 29.1 p90 -131.89 -175.98 3.91 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.644 -0.66 . . . . 0.0 109.803 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.474 HD22 ' HA ' ' A' ' 35' ' ' VAL . 78.4 mt -126.74 150.44 49.07 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.437 -0.789 . . . . 0.0 110.475 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -112.71 162.03 16.2 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.595 -0.69 . . . . 0.0 110.295 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.5 p -131.25 129.03 41.06 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.495 -0.753 . . . . 0.0 110.349 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 98.8 m -78.42 109.5 12.64 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.514 -0.741 . . . . 0.0 110.379 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.526 HG12 HD22 ' A' ' 49' ' ' ASN . 61.6 t -130.07 133.52 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.553 -0.717 . . . . 0.0 110.278 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.526 HD22 HG12 ' A' ' 48' ' ' VAL . 12.3 p30 43.91 34.26 0.88 Allowed 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' A' ' 87' ' ' ALA . . . 88.69 -19.11 38.9 Favored Glycine 0 N--CA 1.498 2.818 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.479 178.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 63.2 t -109.45 128.75 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.115 -1.227 . . . . 0.0 110.283 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 92.7 m -76.57 149.42 36.63 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.595 -0.691 . . . . 0.0 109.735 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -134.21 136.76 43.9 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.494 -0.754 . . . . 0.0 111.048 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.657 ' O ' HD23 ' A' ' 82' ' ' LEU . 7.6 t -137.58 178.29 7.22 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.659 HG11 ' CE1' ' A' ' 57' ' ' HIS . 75.9 t -80.54 141.69 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.314 -0.866 . . . . 0.0 108.993 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.875 ' CE2' HG22 ' A' ' 78' ' ' VAL . 6.5 t80 -85.0 -43.28 14.11 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.506 -0.746 . . . . 0.0 111.327 -179.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.659 ' CE1' HG11 ' A' ' 55' ' ' VAL . 1.8 p-80 -58.8 -21.38 56.11 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.291 -0.88 . . . . 0.0 111.366 -177.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -87.87 -53.64 2.66 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.87 -63.08 1.49 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.526 -0.985 . . . . 0.0 110.46 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.61 -142.66 16.1 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 85.3 p -109.86 25.48 11.74 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.521 -0.988 . . . . 0.0 110.564 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? -90.91 163.99 14.18 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.422 -0.799 . . . . 0.0 110.4 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.456 ' O ' HD23 ' A' ' 64' ' ' LEU . 70.3 p -69.95 156.43 39.11 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.691 -0.63 . . . . 0.0 109.997 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 63' ' ' THR . 25.4 mt -118.49 144.42 46.03 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.593 -0.692 . . . . 0.0 110.691 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -95.12 118.68 32.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.635 -0.666 . . . . 0.0 110.004 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -135.21 -162.29 9.67 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.08 -39.8 10.04 Favored 'Trans proline' 0 C--N 1.315 -1.204 0 O-C-N 123.478 1.252 . . . . 0.0 110.606 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -86.8 -31.29 20.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.512 -0.742 . . . . 0.0 110.309 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.78 -148.32 18.99 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.69 163.7 37.72 Favored 'Trans proline' 0 N--CA 1.485 0.99 0 O-C-N 123.389 1.205 . . . . 0.0 110.596 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 86.0 mt -131.96 159.56 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.549 -0.72 . . . . 0.0 109.957 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 64.7 m -81.83 130.59 35.11 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.608 -0.682 . . . . 0.0 110.129 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -68.16 128.73 37.61 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.535 -0.728 . . . . 0.0 110.568 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 40.6 mtm -119.2 -49.71 2.38 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.537 -0.727 . . . . 0.0 110.128 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.565 ' O ' HG13 ' A' ' 83' ' ' VAL . 54.1 m-85 -110.33 127.98 55.32 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.48 -0.763 . . . . 0.0 110.149 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 90.4 m -151.21 122.58 7.84 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.572 -0.705 . . . . 0.0 110.008 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -162.9 125.13 2.64 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.368 -0.833 . . . . 0.0 111.257 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.875 HG22 ' CE2' ' A' ' 56' ' ' TYR . 74.3 t -72.36 -38.8 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.548 -0.72 . . . . 0.0 109.647 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -55.69 -39.53 71.11 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.477 -0.764 . . . . 0.0 110.488 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.1 tp60 -91.18 -14.03 31.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.704 -0.622 . . . . 0.0 110.342 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.403 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 46.8 t0 53.18 39.94 30.46 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.104 -0.997 . . . . 0.0 110.324 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.657 HD23 ' O ' ' A' ' 54' ' ' THR . 5.3 mt -142.16 160.69 39.74 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.855 0.836 . . . . 0.0 111.391 -179.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 75' ' ' TYR . 2.0 t -144.56 160.97 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -155.39 160.42 29.84 Favored Glycine 0 N--CA 1.497 2.731 0 C-N-CA 119.04 -1.553 . . . . 0.0 111.612 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 17.6 m-90 -144.79 168.0 21.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.931 -0.746 . . . . 0.0 109.458 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -69.93 143.74 52.61 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.518 -0.739 . . . . 0.0 109.931 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 50' ' ' GLY . . . -92.54 162.58 29.18 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.445 -0.784 . . . . 0.0 110.524 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.87 149.79 48.24 Favored 'Trans proline' 0 C--N 1.317 -1.093 0 O-C-N 123.581 1.306 . . . . 0.0 110.267 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -76.15 160.07 36.66 Favored 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 123.35 1.184 . . . . 0.0 110.428 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.14 29.03 52.31 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -151.68 137.02 17.6 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.516 -0.99 . . . . 0.0 110.248 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.8 mtm180 -110.81 131.89 54.66 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.553 -0.717 . . . . 0.0 110.219 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.7 m -91.79 175.54 6.85 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.546 -0.721 . . . . 0.0 110.311 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.563 HD13 ' OE1' ' A' ' 32' ' ' GLU . 3.8 mp -87.02 170.46 11.54 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.53 -0.731 . . . . 0.0 110.222 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.64 172.19 3.73 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.709 -0.62 . . . . 0.0 110.057 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.66 156.85 62.51 Favored 'Trans proline' 0 C--N 1.318 -1.039 0 O-C-N 123.314 1.165 . . . . 0.0 110.173 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.694 ' CB ' HG12 ' A' ' 151' ' ' VAL . 1.5 t -81.41 154.96 26.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.499 -0.751 . . . . 0.0 110.493 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 98' ' ' THR . 7.5 t -136.05 56.35 1.82 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.695 -0.628 . . . . 0.0 110.312 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 27.3 p -144.81 -8.41 0.63 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.413 -0.804 . . . . 0.0 112.447 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.42 29.2 38.11 Favored Glycine 0 N--CA 1.499 2.869 0 O-C-N 120.753 -1.217 . . . . 0.0 110.532 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.5 p -70.53 150.38 46.19 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.554 -0.968 . . . . 0.0 110.33 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 58.0 m -86.39 -26.63 24.69 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.639 -0.663 . . . . 0.0 110.474 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -71.74 120.46 17.36 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.544 -0.723 . . . . 0.0 110.122 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.658 HD22 HG21 ' A' ' 151' ' ' VAL . 94.9 mt -137.06 149.68 47.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.553 -0.717 . . . . 0.0 110.347 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -120.53 129.2 53.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.564 -0.71 . . . . 0.0 109.833 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.43 HD13 HD21 ' A' ' 143' ' ' LEU . 47.1 tp -108.09 146.15 33.03 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.554 -0.716 . . . . 0.0 110.276 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.466 HG11 HG21 ' A' ' 33' ' ' VAL . 59.1 t -107.36 122.39 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.655 -0.653 . . . . 0.0 109.812 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.8 p -91.67 178.53 5.89 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.58 -0.7 . . . . 0.0 110.404 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.5 ptt85 -70.2 -15.75 62.97 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.62 -0.675 . . . . 0.0 111.112 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -94.28 26.04 3.54 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.142 -0.974 . . . . 0.0 110.816 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 53.22 25.54 4.43 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.298 -0.876 . . . . 0.0 110.884 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -96.19 155.37 16.79 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.546 -0.721 . . . . 0.0 110.046 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 61.4 t -117.88 125.81 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.511 -0.743 . . . . 0.0 110.053 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 42.9 pt -126.51 142.14 42.18 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.605 -0.685 . . . . 0.0 110.093 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -76.32 153.15 35.47 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 O-C-N 123.289 1.152 . . . . 0.0 110.623 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 63.0 t -140.02 139.64 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.649 -0.657 . . . . 0.0 109.743 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 -105.1 135.04 47.2 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.591 -0.693 . . . . 0.0 110.153 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 14.6 ttt-85 -73.28 139.27 46.01 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.577 -0.702 . . . . 0.0 110.26 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.59 22.05 2.92 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.572 -0.705 . . . . 0.0 110.404 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 166.54 -170.77 41.25 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -71.03 -39.69 72.18 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.591 -0.946 . . . . 0.0 110.284 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 10.6 p -134.43 24.87 3.79 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.527 -0.733 . . . . 0.0 110.703 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.422 HH21 HG11 ' A' ' 158' ' ' VAL . 0.6 OUTLIER -141.62 140.45 33.31 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.507 -0.746 . . . . 0.0 110.317 179.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -143.7 178.03 22.07 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 81.7 p -111.07 164.18 13.1 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.597 -0.943 . . . . 0.0 110.178 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 30.4 tp -109.42 131.01 55.47 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.5 -0.75 . . . . 0.0 110.366 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.12 -51.74 68.31 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.552 -0.717 . . . . 0.0 110.447 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 67.9 m -100.14 107.86 49.38 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.532 -0.73 . . . . 0.0 109.954 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.78 108.41 2.56 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 O-C-N 123.197 1.104 . . . . 0.0 110.9 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.457 ' O ' ' HB3' ' A' ' 164' ' ' ALA . 31.9 mtt180 -115.24 161.31 30.3 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.669 -0.644 . . . . 0.0 109.849 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.21 150.39 71.5 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 O-C-N 123.405 1.213 . . . . 0.0 110.996 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.43 HG21 ' SG ' ' A' ' 159' ' ' CYS . 66.2 t -51.84 -30.04 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 121.507 -0.746 . . . . 0.0 109.731 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 36.9 t -60.71 -41.79 95.93 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.682 -0.636 . . . . 0.0 111.056 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.411 ' CD2' ' HD3' ' A' ' 130' ' ' ARG . 88.5 t80 -66.85 -39.97 87.76 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.355 -0.84 . . . . 0.0 109.41 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 23.0 tp -93.61 18.65 9.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.912 -0.493 . . . . 0.0 110.078 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -82.09 117.71 22.48 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.446 1.117 . . . . 0.0 112.066 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.65 26.87 7.83 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 36.7 m -112.7 21.61 15.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.579 -0.954 . . . . 0.0 110.405 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.544 ' CB ' HG21 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -68.33 129.89 41.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.312 -0.867 . . . . 0.0 108.851 179.353 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 106.37 -13.35 43.67 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -55.04 112.12 2.68 Favored Glycine 0 N--CA 1.499 2.839 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.13 153.22 51.63 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 O-C-N 123.142 1.075 . . . . 0.0 111.128 -178.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.43 HD21 HD13 ' A' ' 106' ' ' LEU . 44.9 mt -108.52 123.42 48.87 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.702 -0.624 . . . . 0.0 109.515 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.504 HD23 ' C ' ' A' ' 149' ' ' HIS . 0.6 OUTLIER -121.41 139.5 53.37 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.432 -0.792 . . . . 0.0 110.849 -179.378 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 68.4 m -74.08 163.63 66.94 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.638 -0.664 . . . . 0.0 109.484 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.62 -43.12 5.95 Favored 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.411 1.216 . . . . 0.0 109.561 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.7 m -119.42 27.54 8.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.705 -0.622 . . . . 0.0 109.899 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -139.0 -173.55 13.05 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.504 ' C ' HD23 ' A' ' 144' ' ' LEU . 30.2 m170 -96.82 -168.11 1.66 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.65 -0.912 . . . . 0.0 110.472 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.56 148.28 51.1 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.573 -0.705 . . . . 0.0 110.892 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.694 HG12 ' CB ' ' A' ' 97' ' ' CYS . 34.4 m -119.13 -29.67 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.701 -0.624 . . . . 0.0 110.722 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.41 -163.42 22.34 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.3 tt -142.51 158.69 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.602 -0.94 . . . . 0.0 109.82 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -71.1 159.31 34.93 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.178 -0.951 . . . . 0.0 111.029 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.56 HH21 HG22 ' A' ' 170' ' ' VAL . 10.2 ttm180 -145.75 -75.66 0.21 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.757 -0.59 . . . . 0.0 109.95 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -121.68 142.62 49.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.035 -1.04 . . . . 0.0 111.313 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.79 128.89 40.26 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.453 HG13 ' C11' ' A' ' 201' ' ' 4P2 . 2.2 t -100.02 122.94 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.483 -0.76 . . . . 0.0 111.472 -177.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.43 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.1 p -141.15 142.57 34.04 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.482 -0.761 . . . . 0.0 110.541 178.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 88.7 m -75.93 -41.76 50.77 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.527 -0.733 . . . . 0.0 109.837 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -142.75 50.1 1.46 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.665 -0.647 . . . . 0.0 109.721 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 90.18 -11.68 70.21 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 62.6 t -94.14 120.29 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.142 -1.211 . . . . 0.0 108.997 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 130' ' ' ARG . . . -87.24 113.74 23.23 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.534 -0.729 . . . . 0.0 111.022 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -110.08 -29.68 8.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.747 -0.596 . . . . 0.0 109.661 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -116.6 168.29 10.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.701 -0.624 . . . . 0.0 109.815 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.9 m -145.11 132.9 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.532 -0.73 . . . . 0.0 110.824 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -107.45 132.14 53.52 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.576 -0.703 . . . . 0.0 110.264 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -130.17 161.1 31.88 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.712 -0.618 . . . . 0.0 110.432 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.56 HG22 HH21 ' A' ' 155' ' ' ARG . 21.9 t -96.3 142.05 24.0 Favored Pre-proline 0 N--CA 1.498 1.973 0 O-C-N 121.514 -0.741 . . . . 0.0 109.96 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.418 ' HB2' ' HG2' ' A' ' 173' ' ' GLU . 49.5 Cg_endo -74.96 159.99 40.81 Favored 'Trans proline' 0 N--CA 1.486 1.047 0 O-C-N 123.253 1.133 . . . . 0.0 110.186 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 151' ' ' VAL . 67.7 t -87.55 -28.2 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.453 -0.779 . . . . 0.0 110.748 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.418 ' HG2' ' HB2' ' A' ' 171' ' ' PRO . 9.0 pt-20 -58.8 -28.64 66.17 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.354 -0.841 . . . . 0.0 110.615 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.404 ' N ' ' HG3' ' A' ' 173' ' ' GLU . 58.0 m -68.15 -28.49 67.34 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.487 -0.758 . . . . 0.0 110.319 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 57.8 mtt -60.37 -29.46 68.94 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.51 -0.743 . . . . 0.0 110.504 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -60.07 -41.09 91.67 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.459 -0.776 . . . . 0.0 110.196 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 88.1 m -70.1 -41.19 74.35 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.551 -0.718 . . . . 0.0 110.05 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 88.0 m -70.1 -39.87 75.27 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.618 -0.676 . . . . 0.0 110.102 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 5.5 tmm? -59.97 -39.88 87.17 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.582 -0.699 . . . . 0.0 110.195 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.03 -39.84 87.26 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.618 -0.676 . . . . 0.0 110.245 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.845 0 O-C-N 121.651 -0.656 . . . . 0.0 110.227 -179.902 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' 4P2 . . . . . 0.701 ' C24' HG13 ' A' ' 78' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.8 p . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.044 0.45 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.14 -7.17 69.39 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.4 ' NH1' ' HA ' ' A' ' 26' ' ' LYS . 74.2 ttt-85 -60.05 -43.53 95.3 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.044 -1.268 . . . . 0.0 110.165 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 50.28 37.55 15.35 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.436 -0.79 . . . . 0.0 111.194 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.4 ' HA ' ' NH1' ' A' ' 24' ' ' ARG . 32.8 mttm 55.1 170.74 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.632 -0.668 . . . . 0.0 110.97 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -115.56 -9.09 12.08 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.517 -0.739 . . . . 0.0 110.894 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -60.03 -42.85 95.28 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.16 -0.963 . . . . 0.0 110.452 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.0 m -67.74 -32.31 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.633 -0.667 . . . . 0.0 110.393 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -68.26 -39.97 82.04 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.563 -0.71 . . . . 0.0 110.364 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.84 -169.4 53.64 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -112.89 77.32 1.04 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.529 -0.983 . . . . 0.0 110.294 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.1 p -135.2 146.7 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.489 -0.757 . . . . 0.0 110.064 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -104.24 165.53 10.99 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.561 -0.712 . . . . 0.0 110.256 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.8 p -121.69 129.96 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.578 -0.701 . . . . 0.0 110.074 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.8 m -141.11 147.48 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.532 -0.73 . . . . 0.0 110.512 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 54.2 m -120.07 154.72 34.23 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.581 -0.7 . . . . 0.0 110.201 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.481 HG22 ' H ' ' A' ' 39' ' ' ALA . 0.7 OUTLIER -122.78 -178.09 3.84 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.6 -0.687 . . . . 0.0 110.085 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.481 ' H ' HG22 ' A' ' 38' ' ' THR . . . -59.9 -49.84 76.11 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.553 -0.717 . . . . 0.0 110.744 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.4 p -125.8 8.06 7.49 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.479 -0.763 . . . . 0.0 111.541 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -143.41 159.32 42.6 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.06 -1.025 . . . . 0.0 110.83 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 41.0 m -142.82 121.15 12.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.67 -0.644 . . . . 0.0 109.55 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -135.39 174.81 10.19 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.575 -0.703 . . . . 0.0 110.485 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.8 mt -122.74 163.47 20.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.64 -0.662 . . . . 0.0 110.619 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -132.0 144.98 51.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.648 -0.657 . . . . 0.0 110.125 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.452 HG21 ' HB3' ' A' ' 142' ' ' PRO . 88.9 m -121.73 140.7 51.99 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.494 -0.754 . . . . 0.0 110.233 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.5 t -83.3 106.88 15.43 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.535 -0.728 . . . . 0.0 110.114 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.1 t -122.32 128.38 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.501 -0.749 . . . . 0.0 110.14 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.446 ' O ' HG23 ' A' ' 51' ' ' VAL . 13.1 t-20 53.46 39.95 30.68 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.498 -0.751 . . . . 0.0 111.009 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.638 ' O ' ' HB3' ' A' ' 87' ' ' ALA . . . 64.09 21.56 66.05 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 49' ' ' ASN . 96.7 t -130.2 129.62 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.392 -1.064 . . . . 0.0 109.667 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 35.1 t -81.7 104.51 12.15 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.577 -0.702 . . . . 0.0 109.297 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -95.8 136.91 35.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.599 -0.688 . . . . 0.0 110.779 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.606 HG21 ' CZ3' ' A' ' 85' ' ' TRP . 7.5 t -136.97 177.73 7.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.74 -0.6 . . . . 0.0 109.736 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.652 HG21 ' HB3' ' A' ' 139' ' ' SER . 95.2 t -81.47 141.88 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.477 -0.764 . . . . 0.0 109.277 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.867 ' CE2' HG22 ' A' ' 78' ' ' VAL . 43.6 t80 -84.29 -42.28 15.99 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.333 -0.855 . . . . 0.0 111.18 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.489 ' CE1' HG11 ' A' ' 55' ' ' VAL . 2.2 p-80 -65.72 -17.13 64.39 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.338 -0.851 . . . . 0.0 111.014 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -99.57 -57.32 0.94 Allowed Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.93 -36.52 27.95 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.468 -1.019 . . . . 0.0 110.586 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.98 -25.22 61.56 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 82.8 p -60.0 -39.95 87.53 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.411 -1.052 . . . . 0.0 110.702 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.1 mtpt -130.18 160.22 34.46 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.482 -0.761 . . . . 0.0 110.639 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.7 p -70.0 164.82 23.13 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.549 -0.719 . . . . 0.0 110.048 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.433 HD13 ' HA ' ' A' ' 64' ' ' LEU . 4.2 mm? -97.7 134.68 40.56 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.589 -0.694 . . . . 0.0 110.173 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.39 136.15 41.7 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.532 -0.73 . . . . 0.0 110.261 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -143.39 -165.31 10.69 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -71.05 -47.84 0.51 Allowed 'Trans proline' 0 C--N 1.317 -1.13 0 O-C-N 123.417 1.219 . . . . 0.0 110.483 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -69.93 -31.63 69.49 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.548 -0.72 . . . . 0.0 110.407 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 135.44 -143.07 14.54 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.3 161.35 35.04 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 O-C-N 123.343 1.18 . . . . 0.0 110.624 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 44.7 pt -138.97 156.63 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.636 -0.665 . . . . 0.0 110.271 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 72.4 m -100.57 124.63 46.4 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.503 -0.748 . . . . 0.0 110.275 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -68.8 130.29 42.37 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.593 -0.692 . . . . 0.0 110.722 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.6 ttt -72.94 -40.01 65.77 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.621 -0.674 . . . . 0.0 110.632 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -113.18 140.01 48.28 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.451 -0.781 . . . . 0.0 110.414 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.7 m -145.07 127.31 15.75 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.535 -0.728 . . . . 0.0 110.346 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 -155.36 105.81 2.51 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.38 -0.825 . . . . 0.0 111.184 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.867 HG22 ' CE2' ' A' ' 56' ' ' TYR . 54.4 t -69.94 -40.03 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.466 -0.771 . . . . 0.0 109.21 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -57.8 -45.76 85.61 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.464 -0.772 . . . . 0.0 109.958 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.755 ' HG2' HD12 ' A' ' 82' ' ' LEU . 31.5 tt0 -81.69 -12.47 58.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.795 -0.566 . . . . 0.0 110.114 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 39.6 t0 54.39 39.91 31.35 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.163 -0.961 . . . . 0.0 110.756 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.755 HD12 ' HG2' ' A' ' 80' ' ' GLN . 76.5 mt -140.23 151.57 45.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.588 -0.695 . . . . 0.0 110.698 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.465 HG22 ' HD1' ' A' ' 56' ' ' TYR . 9.8 t -131.94 152.57 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -131.19 156.11 21.63 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.544 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.606 ' CZ3' HG21 ' A' ' 54' ' ' THR . 1.7 m0 -136.08 159.79 40.63 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.785 -0.833 . . . . 0.0 109.755 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -83.4 123.34 29.58 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.394 -0.816 . . . . 0.0 109.954 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 50' ' ' GLY . . . -97.1 149.5 35.77 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.558 -0.714 . . . . 0.0 110.33 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.33 154.95 56.27 Favored 'Trans proline' 0 C--N 1.316 -1.158 0 O-C-N 123.507 1.267 . . . . 0.0 110.272 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.39 160.14 49.55 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 O-C-N 123.377 1.199 . . . . 0.0 110.345 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.21 30.18 13.08 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -129.85 159.14 37.48 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.469 -1.019 . . . . 0.0 110.103 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -87.77 148.44 24.71 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.557 -0.715 . . . . 0.0 110.213 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 71.3 p -120.26 140.22 51.52 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.595 -0.69 . . . . 0.0 110.204 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 70.4 mt -80.01 160.01 26.02 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.601 -0.687 . . . . 0.0 110.17 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 63.8 p -117.26 155.82 49.42 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.655 -0.653 . . . . 0.0 110.131 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.68 164.45 35.39 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 O-C-N 123.374 1.197 . . . . 0.0 110.295 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.639 ' HB2' HG22 ' A' ' 151' ' ' VAL . 7.8 t -68.03 128.45 36.58 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.504 -0.748 . . . . 0.0 110.333 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.0 p -131.93 48.75 2.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.637 -0.664 . . . . 0.0 109.745 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.8 p -144.42 -8.32 0.67 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.63 -0.669 . . . . 0.0 112.428 -179.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.76 32.32 74.06 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.1 t -80.55 113.69 18.92 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.443 -1.034 . . . . 0.0 110.281 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 66.5 m -60.01 -39.96 87.61 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.549 -0.719 . . . . 0.0 110.467 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -68.44 136.21 52.9 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.554 -0.716 . . . . 0.0 110.067 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.432 HD23 ' SG ' ' A' ' 145' ' ' CYS . 48.9 mt -137.44 159.55 41.62 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.563 -0.711 . . . . 0.0 110.61 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -119.98 139.75 52.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.661 -0.649 . . . . 0.0 109.378 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.529 HD13 HD21 ' A' ' 143' ' ' LEU . 51.7 tp -115.15 126.74 54.98 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.515 -0.74 . . . . 0.0 110.223 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 89.5 t -90.61 111.73 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.677 -0.639 . . . . 0.0 109.58 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.5 m -90.02 154.29 19.92 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.607 -0.683 . . . . 0.0 110.321 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 72.6 ttt-85 -60.01 -19.27 51.67 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.652 -0.655 . . . . 0.0 110.619 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -94.82 26.97 3.29 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.341 -0.849 . . . . 0.0 110.544 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 55.69 45.79 23.88 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.262 -0.899 . . . . 0.0 110.648 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -119.72 146.05 45.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.62 -0.675 . . . . 0.0 109.975 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 113' ' ' VAL . 13.9 p -124.21 129.98 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.44 -0.788 . . . . 0.0 110.743 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 61.5 mt -127.77 137.9 31.74 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.63 -0.669 . . . . 0.0 109.727 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -75.97 140.32 22.78 Favored 'Trans proline' 0 N--CA 1.485 1.018 0 O-C-N 123.197 1.104 . . . . 0.0 110.819 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.5 t -129.94 130.86 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.535 -0.728 . . . . 0.0 110.049 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.8 mmm180 -90.51 135.86 33.43 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.53 -0.732 . . . . 0.0 110.229 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 45.5 ttt85 -67.6 122.57 18.31 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.513 -0.742 . . . . 0.0 110.095 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -127.19 22.17 6.64 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.531 -0.731 . . . . 0.0 110.526 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 167.88 -175.92 42.62 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -70.58 -41.29 72.57 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.588 -0.949 . . . . 0.0 110.672 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.7 p -131.18 13.07 5.14 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.525 -0.734 . . . . 0.0 111.275 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 -130.27 138.58 50.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.187 -0.945 . . . . 0.0 110.269 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -137.29 156.15 23.28 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.3 p -86.3 159.48 19.41 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.509 -0.995 . . . . 0.0 110.16 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 49.4 tp -108.05 128.54 54.76 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.652 -0.655 . . . . 0.0 110.012 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.94 -40.05 91.79 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.618 -0.676 . . . . 0.0 110.338 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 62.3 m -116.15 102.61 53.7 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.447 -0.783 . . . . 0.0 110.35 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.3 123.3 8.13 Favored 'Trans proline' 0 C--N 1.319 -1.003 0 O-C-N 123.319 1.168 . . . . 0.0 110.508 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.465 ' CB ' ' CD1' ' A' ' 134' ' ' TYR . 12.7 mtt-85 -131.91 170.94 10.04 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.588 -0.695 . . . . 0.0 110.161 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 41.5 Cg_endo -65.86 150.22 85.99 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 O-C-N 123.385 1.203 . . . . 0.0 111.322 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 162' ' ' GLY . 79.2 t -54.26 -28.44 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.216 -0.927 . . . . 0.0 110.075 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 29.3 t -63.48 -31.04 72.09 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.619 -0.676 . . . . 0.0 109.637 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.465 ' CD1' ' CB ' ' A' ' 130' ' ' ARG . 0.0 OUTLIER -64.76 -40.74 95.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.675 -0.64 . . . . 0.0 109.52 179.784 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.431 ' HA ' HD12 ' A' ' 135' ' ' LEU . 13.9 tp -101.93 17.84 22.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.805 -0.559 . . . . 0.0 110.974 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -84.86 136.02 33.83 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.428 -0.795 . . . . 0.0 110.555 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.71 23.89 57.04 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 19.8 m -120.07 11.15 11.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.444 -1.033 . . . . 0.0 110.967 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.652 ' HB3' HG21 ' A' ' 55' ' ' VAL . 12.6 m -59.18 156.49 12.13 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.184 -0.947 . . . . 0.0 110.352 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 89.97 -13.05 65.66 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.574 -1.011 . . . . 0.0 110.574 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -64.62 120.26 18.39 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.452 ' HB3' HG21 ' A' ' 46' ' ' THR . 51.0 Cg_endo -78.09 145.03 21.65 Favored 'Trans proline' 0 C--N 1.32 -0.949 0 O-C-N 123.039 1.02 . . . . 0.0 111.12 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.529 HD21 HD13 ' A' ' 106' ' ' LEU . 1.0 OUTLIER -100.01 121.02 40.72 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.265 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.5 mp -118.53 154.48 32.49 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.535 -0.728 . . . . 0.0 111.267 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.432 ' SG ' HD23 ' A' ' 104' ' ' LEU . 0.9 OUTLIER -96.22 175.3 2.78 Favored Pre-proline 0 N--CA 1.491 1.603 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.358 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.97 -24.93 38.91 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.233 1.122 . . . . 0.0 110.415 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 28.8 m -65.59 -39.94 92.14 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.442 -0.786 . . . . 0.0 110.172 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 117.03 39.17 0.83 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -127.54 144.56 51.05 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.532 -0.981 . . . . 0.0 110.334 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -74.66 145.2 43.4 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.574 -0.704 . . . . 0.0 110.492 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.639 HG22 ' HB2' ' A' ' 97' ' ' CYS . 66.4 t -113.47 -51.47 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.612 -0.68 . . . . 0.0 109.93 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -174.64 -164.27 29.22 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 95.2 mt -131.72 144.04 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.522 -0.987 . . . . 0.0 109.981 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -59.95 126.56 28.02 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.55 -0.719 . . . . 0.0 109.825 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 44.5 ttt180 -105.8 -69.2 0.83 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.664 -0.647 . . . . 0.0 110.71 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.731 ' HB1' ' O32' ' A' ' 201' ' ' 4P2 . . . -132.39 151.07 52.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.525 -0.734 . . . . 0.0 110.749 -179.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -95.15 133.93 38.44 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.726 -0.609 . . . . 0.0 110.162 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 51.8 t -100.7 114.88 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.602 -0.686 . . . . 0.0 110.351 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.3 p -140.26 140.55 35.77 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.491 -0.755 . . . . 0.0 110.709 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 36.0 m -81.23 -47.9 12.77 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.611 -0.681 . . . . 0.0 110.045 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -127.31 42.58 3.29 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.674 -0.641 . . . . 0.0 110.031 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.525 ' O ' HG23 ' A' ' 132' ' ' VAL . . . 91.38 -11.33 72.44 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 77.4 t -97.52 122.43 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.141 -1.211 . . . . 0.0 109.198 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -88.84 115.8 26.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.59 -0.694 . . . . 0.0 110.594 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -104.03 -30.1 10.48 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -124.43 155.76 38.3 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.54 139.99 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.539 -0.726 . . . . 0.0 110.384 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -115.3 131.33 56.96 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.657 -0.652 . . . . 0.0 110.408 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -137.14 158.79 43.66 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.652 -0.655 . . . . 0.0 110.015 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 60.2 t -96.52 130.35 30.85 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.555 -0.716 . . . . 0.0 110.361 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.26 167.27 27.76 Favored 'Trans proline' 0 N--CA 1.485 0.989 0 O-C-N 123.157 1.083 . . . . 0.0 110.314 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 67.8 t -70.17 -30.5 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.532 -0.73 . . . . 0.0 110.237 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -59.94 -40.06 87.68 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.546 -0.721 . . . . 0.0 110.586 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 19.8 t -61.74 -38.77 89.19 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.57 -0.706 . . . . 0.0 110.37 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 68.6 mtt -59.93 -29.1 68.16 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.573 -0.704 . . . . 0.0 110.499 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -59.98 -38.11 81.61 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.603 -0.686 . . . . 0.0 110.665 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 91.4 m -60.02 -40.02 87.87 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.409 -0.807 . . . . 0.0 110.615 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 88.0 m -60.01 -36.4 77.14 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.442 -0.786 . . . . 0.0 110.48 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 66.8 mtt -60.0 -38.96 84.15 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.454 -0.779 . . . . 0.0 110.722 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 53.3 mtt180 -60.05 -39.96 87.79 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.39 -0.819 . . . . 0.0 110.364 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.791 0 O-C-N 121.608 -0.683 . . . . 0.0 110.205 179.894 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' 4P2 . . . . . 0.731 ' O32' ' HB1' ' A' ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.0 t . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 121.127 0.489 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -157.91 163.68 32.85 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -127.07 27.76 5.88 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.542 -0.975 . . . . 0.0 110.34 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -115.78 130.03 56.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.559 -0.713 . . . . 0.0 110.045 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -112.59 135.31 53.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.656 -0.652 . . . . 0.0 110.165 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -128.88 138.75 52.2 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.584 -0.698 . . . . 0.0 110.084 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -66.44 123.25 19.49 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.58 -0.7 . . . . 0.0 110.169 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 91.7 t -69.94 -40.07 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.624 -0.673 . . . . 0.0 109.831 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -71.91 149.97 44.62 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.583 -0.698 . . . . 0.0 110.281 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 177.98 -158.14 22.88 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.848 ' HG3' HG23 ' A' ' 33' ' ' VAL . 14.6 pt-20 -59.97 -30.29 69.01 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.465 -1.021 . . . . 0.0 110.368 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.848 HG23 ' HG3' ' A' ' 32' ' ' GLU . 71.7 t -118.08 130.01 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.549 -0.719 . . . . 0.0 110.034 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -104.58 140.5 37.91 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.682 -0.636 . . . . 0.0 110.304 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.528 ' O ' HG13 ' A' ' 35' ' ' VAL . 11.1 p -89.62 119.7 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.504 -0.747 . . . . 0.0 110.269 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 62.7 t -124.23 129.9 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.399 -0.813 . . . . 0.0 110.103 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.5 m -119.42 135.67 54.64 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.509 -0.744 . . . . 0.0 110.345 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.43 178.31 4.59 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.469 -0.769 . . . . 0.0 109.892 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.0 -50.18 74.77 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.678 -0.639 . . . . 0.0 110.602 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 74.3 p -117.77 -20.03 9.04 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.575 -0.703 . . . . 0.0 111.041 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -114.81 171.08 7.86 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.313 -0.867 . . . . 0.0 110.394 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 72.1 p -149.84 121.46 8.02 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.642 -0.661 . . . . 0.0 110.034 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 59' ' ' ALA . 41.1 p90 -134.49 171.01 14.91 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.557 -0.715 . . . . 0.0 110.028 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 91.3 mt -119.26 158.37 26.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.568 -0.707 . . . . 0.0 110.529 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -125.64 151.99 45.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.634 -0.666 . . . . 0.0 110.212 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.1 p -125.78 144.12 50.77 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.623 -0.673 . . . . 0.0 110.007 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 35.4 t -94.61 110.08 21.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.448 -0.783 . . . . 0.0 110.434 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.423 HG22 ' HB2' ' A' ' 94' ' ' LEU . 63.3 t -123.05 126.98 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.589 -0.695 . . . . 0.0 110.144 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.9 m120 53.09 39.02 28.88 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.461 -0.774 . . . . 0.0 111.227 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.44 19.59 72.8 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 63.2 t -130.18 129.87 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.296 -1.12 . . . . 0.0 109.623 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 92.4 m -84.47 133.54 34.47 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.522 -0.736 . . . . 0.0 109.684 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -119.91 136.61 54.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.519 -0.738 . . . . 0.0 110.546 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.872 HG23 HG23 ' A' ' 83' ' ' VAL . 9.8 t -137.96 175.02 9.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.708 -0.62 . . . . 0.0 109.72 179.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.643 HG11 ' CE1' ' A' ' 57' ' ' HIS . 85.8 t -80.98 142.45 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.448 -0.783 . . . . 0.0 109.993 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.797 ' CE2' HG22 ' A' ' 78' ' ' VAL . 31.4 t80 -76.54 -42.75 41.92 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.644 -0.66 . . . . 0.0 111.71 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.643 ' CE1' HG11 ' A' ' 55' ' ' VAL . 2.5 p-80 -69.94 -15.22 63.02 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.313 -0.867 . . . . 0.0 111.102 -178.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -104.84 -77.95 1.19 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.417 ' HB2' ' CE2' ' A' ' 43' ' ' PHE . . . -71.16 -39.99 71.58 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.513 -0.993 . . . . 0.0 110.697 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.98 -21.38 58.94 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 57.4 m -60.0 -40.55 89.58 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.252 -1.146 . . . . 0.0 110.786 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.1 mttp -137.28 150.36 47.75 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.348 -0.845 . . . . 0.0 110.614 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 70.9 m -74.14 147.21 42.86 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.593 -0.692 . . . . 0.0 109.907 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.424 HD12 ' CH2' ' A' ' 85' ' ' TRP . 88.4 mt -99.21 140.55 33.21 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.576 -0.702 . . . . 0.0 110.551 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.43 134.97 51.83 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.62 -0.675 . . . . 0.0 110.177 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -132.22 170.2 21.91 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -69.25 -23.29 33.28 Favored 'Trans proline' 0 C--N 1.316 -1.142 0 O-C-N 123.395 1.208 . . . . 0.0 110.593 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -69.92 -31.47 69.26 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.47 -0.769 . . . . 0.0 110.215 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.47 174.12 13.21 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.12 145.56 44.56 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.38 1.2 . . . . 0.0 110.436 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.9 mt -119.93 123.37 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.609 -0.682 . . . . 0.0 109.886 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.3 m -74.29 133.43 42.6 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.554 -0.716 . . . . 0.0 110.366 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -64.13 131.0 46.17 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.595 -0.691 . . . . 0.0 110.009 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 19.8 mmt -93.21 -35.76 12.96 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.569 -0.707 . . . . 0.0 110.457 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.594 ' O ' HG12 ' A' ' 83' ' ' VAL . 64.3 m-85 -125.57 134.13 52.06 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.509 -0.744 . . . . 0.0 110.432 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.705 ' HA ' HG12 ' A' ' 83' ' ' VAL . 15.0 p -147.11 121.34 9.54 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.51 -0.744 . . . . 0.0 110.146 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -156.91 116.51 3.45 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.451 -0.781 . . . . 0.0 110.93 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.797 HG22 ' CE2' ' A' ' 56' ' ' TYR . 95.7 t -71.74 -37.1 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.484 -0.76 . . . . 0.0 109.616 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -58.62 -48.16 81.94 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.475 -0.766 . . . . 0.0 109.653 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.532 ' HG2' HD12 ' A' ' 82' ' ' LEU . 37.9 tt0 -84.06 -14.25 51.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.579 -0.701 . . . . 0.0 109.922 178.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.492 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 61.4 t0 55.31 40.0 31.41 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.242 -0.911 . . . . 0.0 111.053 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.568 HD11 HG11 ' A' ' 170' ' ' VAL . 74.9 mt -140.96 147.29 38.54 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.424 -0.798 . . . . 0.0 111.595 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.872 HG23 HG23 ' A' ' 54' ' ' THR . 2.4 m -142.26 173.87 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -167.23 169.98 41.28 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.424 ' CH2' HD12 ' A' ' 64' ' ' LEU . 5.3 m-90 -128.98 158.92 37.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.709 -0.877 . . . . 0.0 109.648 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -81.04 121.29 25.88 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.539 -0.726 . . . . 0.0 110.059 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -114.09 155.7 45.11 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.583 -0.698 . . . . 0.0 110.316 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.59 153.68 60.01 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 123.42 1.221 . . . . 0.0 110.543 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.59 155.72 54.41 Favored 'Trans proline' 0 C--N 1.317 -1.094 0 O-C-N 123.405 1.213 . . . . 0.0 110.349 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 109.17 31.0 3.43 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -128.65 160.03 33.74 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.489 -1.006 . . . . 0.0 110.371 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 76.6 mtt85 -65.56 140.96 58.59 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.636 -0.665 . . . . 0.0 110.25 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 58.0 m -121.87 146.46 47.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.575 -0.703 . . . . 0.0 110.219 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.423 ' HB2' HG22 ' A' ' 48' ' ' VAL . 95.4 mt -94.47 144.4 25.6 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.561 -0.712 . . . . 0.0 110.29 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.645 ' O ' ' HB3' ' A' ' 150' ' ' ALA . 7.7 t -104.3 150.73 38.73 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.639 -0.663 . . . . 0.0 110.169 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.76 151.76 69.12 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.384 1.202 . . . . 0.0 110.388 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 18.8 t -80.83 129.97 34.81 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.567 -0.708 . . . . 0.0 110.431 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 98' ' ' THR . 7.7 t -135.44 56.17 1.85 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.632 -0.667 . . . . 0.0 109.859 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.3 p -145.38 11.55 1.31 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.601 -0.687 . . . . 0.0 111.552 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 51.11 51.3 36.05 Favored Glycine 0 N--CA 1.501 2.979 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.33 109.92 15.28 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.463 -1.022 . . . . 0.0 110.506 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 29.6 p -69.92 -34.99 74.21 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.612 -0.68 . . . . 0.0 109.864 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -84.06 110.8 18.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.72 -0.612 . . . . 0.0 109.922 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.515 HD22 HG21 ' A' ' 151' ' ' VAL . 88.0 mt -115.68 136.45 53.05 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.555 -0.716 . . . . 0.0 110.198 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -106.82 139.76 40.73 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.447 -0.783 . . . . 0.0 110.177 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.428 HD12 HD21 ' A' ' 143' ' ' LEU . 7.3 tt -111.3 141.91 44.22 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.558 -0.714 . . . . 0.0 110.322 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.8 t -94.6 130.8 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.675 -0.641 . . . . 0.0 110.113 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.0 m -104.04 162.54 13.06 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.549 -0.719 . . . . 0.0 110.082 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -61.04 -23.84 65.74 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.488 -0.758 . . . . 0.0 110.599 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -95.39 26.53 3.79 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.469 -0.769 . . . . 0.0 110.637 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.14 43.35 30.79 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.336 -0.852 . . . . 0.0 110.991 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -111.34 130.91 55.53 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.477 -0.765 . . . . 0.0 109.821 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.3 m -101.43 148.13 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.558 -0.714 . . . . 0.0 110.578 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.403 ' O ' HG23 ' A' ' 114' ' ' ILE . 7.4 tt -148.55 132.66 8.67 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.561 -0.712 . . . . 0.0 109.997 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.71 142.74 36.32 Favored 'Trans proline' 0 C--N 1.319 -0.994 0 O-C-N 123.14 1.074 . . . . 0.0 110.693 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.0 t -129.97 130.21 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.66 -0.65 . . . . 0.0 110.007 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -78.07 129.97 35.87 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.491 -0.756 . . . . 0.0 110.222 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -64.23 140.03 58.83 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.568 -0.708 . . . . 0.0 110.031 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -147.56 47.19 1.12 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.587 -0.696 . . . . 0.0 110.265 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 138.53 169.05 11.47 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -60.53 -42.04 95.65 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.569 -0.959 . . . . 0.0 110.196 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.8 m -127.94 25.49 5.93 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.59 -0.694 . . . . 0.0 110.143 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.18 136.93 42.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.533 -0.73 . . . . 0.0 110.242 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -134.26 170.4 22.62 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 14.4 m -120.24 139.81 52.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.525 -0.986 . . . . 0.0 110.362 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 57.9 tp -75.86 137.08 40.2 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.625 -0.672 . . . . 0.0 109.941 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.04 -48.69 80.68 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.544 -0.722 . . . . 0.0 110.584 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 78.5 p -117.72 139.66 26.62 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.537 -0.727 . . . . 0.0 110.012 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -75.55 126.35 9.56 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 O-C-N 123.266 1.14 . . . . 0.0 110.788 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 -129.85 163.04 49.89 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.616 -0.678 . . . . 0.0 109.61 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.79 150.18 67.71 Favored 'Trans proline' 0 C--N 1.315 -1.224 0 O-C-N 123.327 1.172 . . . . 0.0 110.739 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 69.9 t -59.95 -33.55 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.601 -0.687 . . . . 0.0 109.664 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 25.6 t -59.37 -40.05 85.24 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.605 -0.684 . . . . 0.0 110.461 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -61.45 -40.76 95.67 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.546 -0.721 . . . . 0.0 109.753 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.545 HD21 ' CZ ' ' A' ' 154' ' ' PHE . 55.6 tp -89.9 -10.3 45.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.783 -0.573 . . . . 0.0 111.282 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.1 tttm -63.7 137.27 58.01 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.271 -0.893 . . . . 0.0 110.622 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 88.65 23.11 37.27 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 70.7 m -120.55 6.34 10.57 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.331 -1.1 . . . . 0.0 111.32 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.592 ' HB3' HG21 ' A' ' 55' ' ' VAL . 50.6 m -58.65 146.17 37.21 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.973 -1.079 . . . . 0.0 110.076 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 96.37 -24.36 30.78 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.16 111.64 3.79 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.24 149.41 45.6 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 O-C-N 123.169 1.089 . . . . 0.0 110.834 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.504 HD12 ' N ' ' A' ' 143' ' ' LEU . 6.3 mp -101.21 127.5 47.76 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.7 mp -118.45 122.35 42.54 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.472 -0.767 . . . . 0.0 110.948 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 27.3 p -68.49 162.93 58.22 Favored Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -64.4 -21.0 66.79 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 O-C-N 123.148 1.078 . . . . 0.0 111.327 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.6 m -62.74 -39.97 95.77 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.341 -0.849 . . . . 0.0 109.997 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.401 ' O ' ' CD2' ' A' ' 149' ' ' HIS . . . 118.59 40.17 0.68 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.401 ' CD2' ' O ' ' A' ' 148' ' ' GLY . 29.3 m170 -133.38 153.36 51.66 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.59 -0.947 . . . . 0.0 110.354 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.645 ' HB3' ' O ' ' A' ' 95' ' ' THR . . . -78.47 134.06 37.38 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.549 -0.719 . . . . 0.0 110.049 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.515 HG21 HD22 ' A' ' 104' ' ' LEU . 59.7 t -99.81 -59.98 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.527 -0.733 . . . . 0.0 110.365 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.528 ' HA2' HG23 ' A' ' 172' ' ' VAL . . . -176.31 -163.54 28.96 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 91.4 mt -128.5 139.99 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.639 -0.918 . . . . 0.0 110.159 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.545 ' CZ ' HD21 ' A' ' 135' ' ' LEU . 15.4 t80 -61.75 130.07 44.04 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.55 -0.719 . . . . 0.0 110.023 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -107.62 -63.83 1.27 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.636 -0.665 . . . . 0.0 110.636 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.575 ' HB1' ' O32' ' A' ' 201' ' ' 4P2 . . . -136.96 152.65 50.42 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.513 -0.742 . . . . 0.0 110.815 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.64 155.37 16.9 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.694 -0.629 . . . . 0.0 109.632 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 48.0 t -121.05 112.38 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.534 -0.728 . . . . 0.0 110.519 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.4 p -141.58 142.3 33.48 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.485 -0.76 . . . . 0.0 110.429 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 25.0 m -80.2 -41.43 25.24 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.492 -0.755 . . . . 0.0 110.122 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -136.02 46.49 2.3 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.534 -0.729 . . . . 0.0 110.498 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 90.1 -10.68 73.28 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.344 -1.103 . . . . 0.0 110.344 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 63.3 t -98.39 120.75 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.141 -1.211 . . . . 0.0 109.386 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.58 114.61 24.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.587 -0.695 . . . . 0.0 110.752 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -101.65 -29.44 11.92 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 125' ' ' SER . . . -130.34 159.96 35.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.711 -0.618 . . . . 0.0 109.444 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.7 m -133.49 141.41 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.429 -0.794 . . . . 0.0 110.571 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -118.02 133.5 55.86 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.537 -0.727 . . . . 0.0 110.176 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -136.52 160.1 39.79 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.462 -0.773 . . . . 0.0 110.506 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.568 HG11 HD11 ' A' ' 82' ' ' LEU . 58.8 t -96.68 135.43 22.26 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.522 -0.736 . . . . 0.0 110.161 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.08 150.93 43.75 Favored 'Trans proline' 0 N--CA 1.486 1.043 0 O-C-N 123.216 1.114 . . . . 0.0 110.601 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.528 HG23 ' HA2' ' A' ' 152' ' ' GLY . 61.9 t -71.14 -28.4 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.587 -0.695 . . . . 0.0 110.227 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -60.01 -39.93 87.53 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.451 -0.781 . . . . 0.0 110.67 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 62.2 p -61.79 -28.85 69.75 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.516 -0.74 . . . . 0.0 110.589 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 67.6 mtt -61.59 -34.92 76.45 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.535 -0.728 . . . . 0.0 110.475 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -59.98 -40.79 90.31 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.525 -0.734 . . . . 0.0 110.314 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 92.3 m -63.53 -40.04 95.98 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.514 -0.741 . . . . 0.0 109.925 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 63.6 m -62.67 -41.54 99.14 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.59 -0.694 . . . . 0.0 110.154 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 58.8 ttp -60.04 -40.93 91.05 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.613 -0.68 . . . . 0.0 110.315 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 44.5 ttp85 -60.02 -39.99 87.78 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.59 -0.693 . . . . 0.0 110.087 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.852 0 O-C-N 121.577 -0.702 . . . . 0.0 110.162 179.987 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' 4P2 . . . . . 0.649 ' C24' HG13 ' A' ' 78' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.1 m . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.079 0.466 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -79.05 -59.96 2.65 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 52.7 ttt85 -128.01 133.65 49.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.506 -0.997 . . . . 0.0 110.238 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -127.22 137.84 52.98 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.652 -0.655 . . . . 0.0 110.177 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.7 mttm -104.07 123.35 47.09 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.634 -0.666 . . . . 0.0 110.2 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -109.09 117.36 33.96 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.483 -0.761 . . . . 0.0 110.142 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -113.91 141.79 46.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.572 -0.705 . . . . 0.0 109.949 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.5 t -106.3 122.89 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.509 -0.744 . . . . 0.0 109.866 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -140.56 157.59 45.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.619 -0.675 . . . . 0.0 110.363 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.48 136.86 8.11 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -120.9 104.79 10.11 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.588 -0.948 . . . . 0.0 110.41 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 45' ' ' ALA . 11.0 p -137.33 130.46 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.596 -0.69 . . . . 0.0 109.932 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.3 mp0 -104.32 132.48 50.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.568 -0.708 . . . . 0.0 110.273 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.3 m -76.63 135.72 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.659 -0.65 . . . . 0.0 109.934 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.7 p -137.29 138.9 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.56 -0.712 . . . . 0.0 110.148 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.3 t -122.46 136.85 54.98 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.631 -0.668 . . . . 0.0 110.141 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.508 HG22 ' H ' ' A' ' 39' ' ' ALA . 1.1 m -100.16 179.97 4.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.567 -0.708 . . . . 0.0 109.979 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.508 ' H ' HG22 ' A' ' 38' ' ' THR . . . -60.03 -41.23 91.77 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.651 -0.656 . . . . 0.0 111.017 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.4 p -121.59 -25.55 5.1 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.407 -0.808 . . . . 0.0 111.676 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -118.23 159.58 23.08 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.292 -0.88 . . . . 0.0 110.751 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 11.1 m -140.06 120.79 14.35 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.605 -0.684 . . . . 0.0 110.178 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -135.79 176.31 8.8 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.609 -0.682 . . . . 0.0 109.877 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.4 mt -116.86 160.36 20.97 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.451 -0.781 . . . . 0.0 110.398 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.645 ' O ' HG23 ' A' ' 33' ' ' VAL . . . -129.37 143.85 51.0 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.481 -0.762 . . . . 0.0 110.478 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.579 HG21 ' HB3' ' A' ' 142' ' ' PRO . 89.7 m -123.1 136.93 55.0 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.51 -0.743 . . . . 0.0 110.115 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 47.3 t -95.43 111.67 23.52 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.542 -0.724 . . . . 0.0 110.602 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.98 139.35 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.504 -0.748 . . . . 0.0 110.195 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 55.21 37.17 28.49 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.524 -0.735 . . . . 0.0 110.794 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.1 14.15 63.22 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.9 t -131.73 130.0 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.18 -1.188 . . . . 0.0 109.781 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.419 ' SG ' ' HB1' ' A' ' 45' ' ' ALA . 43.1 t -86.02 113.43 22.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.523 -0.736 . . . . 0.0 109.923 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.444 ' CZ3' ' CD2' ' A' ' 82' ' ' LEU . 80.0 m95 -106.51 137.12 45.08 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.558 -0.714 . . . . 0.0 110.82 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.546 HG23 HG13 ' A' ' 83' ' ' VAL . 7.6 t -136.81 -179.31 5.62 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.739 HG11 ' CE1' ' A' ' 57' ' ' HIS . 59.4 t -80.14 142.52 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.398 -0.814 . . . . 0.0 109.194 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.883 ' CE2' HG22 ' A' ' 78' ' ' VAL . 28.7 t80 -83.28 -39.99 20.13 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.352 -0.843 . . . . 0.0 111.861 -178.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.739 ' CE1' HG11 ' A' ' 55' ' ' VAL . 1.6 p-80 -60.19 -18.66 49.73 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.98 -1.075 . . . . 0.0 110.956 -178.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -97.64 -69.37 0.97 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.62 -36.3 70.72 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.582 -0.952 . . . . 0.0 110.588 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.69 -29.16 66.6 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.8 t -61.08 -39.94 91.79 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.548 -0.972 . . . . 0.0 110.943 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -127.93 143.29 51.1 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.459 -0.776 . . . . 0.0 110.549 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.3 t -65.92 151.39 46.86 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.534 -0.729 . . . . 0.0 110.539 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 13.6 tp -100.03 133.56 44.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.624 -0.672 . . . . 0.0 109.868 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.05 130.59 36.94 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.497 -0.752 . . . . 0.0 110.499 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -97.44 -179.22 33.89 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.8 -36.1 8.58 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 O-C-N 123.391 1.206 . . . . 0.0 110.445 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -85.29 -12.12 53.13 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.574 -0.704 . . . . 0.0 111.061 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 146.95 -164.99 28.55 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.15 151.44 55.22 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 O-C-N 123.397 1.209 . . . . 0.0 110.173 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 44.5 pt -130.0 156.58 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.595 -0.69 . . . . 0.0 110.483 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.1 m -100.65 133.19 45.48 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.643 -0.661 . . . . 0.0 109.743 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.446 ' NE2' HG21 ' A' ' 83' ' ' VAL . 86.0 mt-30 -61.1 124.62 21.05 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.476 -0.765 . . . . 0.0 110.074 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.7 tpt -64.9 -40.04 94.46 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.639 -0.663 . . . . 0.0 110.536 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.408 ' O ' HG23 ' A' ' 83' ' ' VAL . 43.2 m-85 -124.43 134.27 53.13 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.571 -0.706 . . . . 0.0 110.308 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.0 p -146.37 136.21 23.34 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.5 -0.75 . . . . 0.0 110.391 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -162.0 105.46 1.19 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.522 -0.736 . . . . 0.0 110.027 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.883 HG22 ' CE2' ' A' ' 56' ' ' TYR . 72.2 t -68.18 -40.0 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.511 -0.743 . . . . 0.0 110.267 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -57.93 -39.81 78.93 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.546 -0.721 . . . . 0.0 110.762 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -99.06 -7.25 27.05 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.535 -0.728 . . . . 0.0 111.3 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.1 t0 55.81 40.43 30.68 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.881 -1.137 . . . . 0.0 109.616 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.584 HD13 HG11 ' A' ' 170' ' ' VAL . 4.7 tp -119.04 132.01 56.01 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.463 0.649 . . . . 0.0 110.114 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.595 HG11 ' HA ' ' A' ' 56' ' ' TYR . 7.1 p -156.82 160.69 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.721 -0.612 . . . . 0.0 109.427 -179.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -177.33 168.34 40.0 Favored Glycine 0 N--CA 1.495 2.614 0 C-N-CA 119.756 -1.211 . . . . 0.0 110.471 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.406 ' CH2' HG21 ' A' ' 54' ' ' THR . 13.5 m-90 -117.38 155.17 30.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.789 -0.83 . . . . 0.0 109.925 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.8 mm-40 -76.63 148.12 37.12 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.493 -0.754 . . . . 0.0 110.168 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -113.01 158.95 36.42 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.509 -0.745 . . . . 0.0 110.243 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.47 157.38 56.52 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.41 1.216 . . . . 0.0 110.526 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.46 160.24 44.89 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.49 1.258 . . . . 0.0 110.421 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 80.5 27.34 51.83 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -115.15 159.02 21.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.515 -0.991 . . . . 0.0 110.127 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.9 tpt85 -81.41 131.68 35.29 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.569 -0.707 . . . . 0.0 110.125 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 59.4 m -115.59 150.24 36.98 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.574 -0.704 . . . . 0.0 110.229 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 94.2 mt -92.7 136.57 33.11 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.531 -0.73 . . . . 0.0 110.376 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 73.9 p -81.43 156.92 70.84 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.605 -0.684 . . . . 0.0 110.407 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.81 163.68 36.52 Favored 'Trans proline' 0 C--N 1.318 -1.027 0 O-C-N 123.435 1.229 . . . . 0.0 110.372 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 49.5 t -87.23 123.76 32.58 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.538 -0.726 . . . . 0.0 110.379 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 98' ' ' THR . 7.2 t -132.84 61.78 1.67 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.662 -0.649 . . . . 0.0 109.883 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.3 p -145.27 7.4 1.16 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.61 -0.681 . . . . 0.0 111.955 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 51.22 48.06 48.22 Favored Glycine 0 N--CA 1.501 3.029 0 O-C-N 120.919 -1.113 . . . . 0.0 110.416 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.8 p -85.27 109.91 18.69 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.51 -0.994 . . . . 0.0 110.629 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 68.5 p -66.99 -39.66 87.21 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.603 -0.686 . . . . 0.0 109.611 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -79.14 128.15 32.93 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.585 -0.697 . . . . 0.0 109.591 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.549 HD22 HG21 ' A' ' 151' ' ' VAL . 92.9 mt -133.6 150.24 51.61 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.401 -0.812 . . . . 0.0 110.696 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -106.85 128.47 54.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.619 -0.676 . . . . 0.0 109.504 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.747 HD12 HD21 ' A' ' 143' ' ' LEU . 7.9 tt -110.48 142.35 42.35 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.571 -0.705 . . . . 0.0 110.422 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.6 t -107.2 125.26 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.611 -0.681 . . . . 0.0 109.781 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 75.1 p -95.39 168.9 10.43 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.644 -0.66 . . . . 0.0 110.386 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 -66.28 -23.48 66.4 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.71 -0.619 . . . . 0.0 110.161 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -93.16 24.5 3.76 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.425 -0.797 . . . . 0.0 110.79 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.71 50.04 16.69 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.338 -0.851 . . . . 0.0 111.032 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -117.67 127.76 54.25 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.319 -0.863 . . . . 0.0 109.827 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.1 t -93.81 120.0 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.577 -0.702 . . . . 0.0 110.096 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 36.0 mt -123.96 135.06 25.87 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.574 -0.704 . . . . 0.0 109.853 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -77.22 143.77 22.74 Favored 'Trans proline' 0 C--N 1.32 -0.954 0 O-C-N 123.199 1.105 . . . . 0.0 110.277 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.3 t -131.45 139.64 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.568 -0.708 . . . . 0.0 110.158 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.3 tpt85 -96.88 133.59 41.3 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.512 -0.743 . . . . 0.0 110.032 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -70.0 136.85 50.86 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.547 -0.72 . . . . 0.0 110.259 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -136.87 26.2 3.03 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.592 -0.693 . . . . 0.0 110.18 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 151.95 -173.93 31.08 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -70.06 -39.07 75.89 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.593 -0.945 . . . . 0.0 110.429 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.3 m -128.78 23.69 5.75 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.52 -0.737 . . . . 0.0 111.184 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 24.5 ttp180 -141.45 143.66 34.0 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.224 -0.923 . . . . 0.0 110.852 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -139.59 -176.68 15.02 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 166' ' ' ALA . 1.6 m -116.29 160.8 19.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.568 -0.96 . . . . 0.0 110.042 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.463 HD12 HG13 ' A' ' 167' ' ' VAL . 0.3 OUTLIER -110.96 124.1 51.46 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.555 -0.715 . . . . 0.0 110.087 179.791 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.515 HD12 ' N ' ' A' ' 127' ' ' LEU . 6.5 mp -69.98 -40.04 75.6 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.502 -0.749 . . . . 0.0 110.007 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 67.1 m -103.78 109.92 63.02 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.585 -0.697 . . . . 0.0 109.976 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.92 112.47 3.41 Favored 'Trans proline' 0 C--N 1.319 -1.016 0 O-C-N 123.241 1.127 . . . . 0.0 110.48 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -124.92 162.12 45.16 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.628 -0.67 . . . . 0.0 110.17 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.2 150.56 59.66 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 O-C-N 123.505 1.266 . . . . 0.0 110.503 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 162' ' ' GLY . 85.9 t -56.66 -34.34 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.558 -0.714 . . . . 0.0 110.27 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.2 t -59.98 -39.98 87.56 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.538 -0.726 . . . . 0.0 110.52 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -64.15 -40.04 95.31 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.574 -0.703 . . . . 0.0 110.048 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 45.3 tp -88.99 -4.33 58.46 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.679 -0.638 . . . . 0.0 111.35 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -71.26 140.44 50.36 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.11 -0.994 . . . . 0.0 110.975 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 98.39 -2.56 59.25 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 45.3 p -100.86 9.16 42.66 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.149 -1.206 . . . . 0.0 110.716 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.21 129.9 42.9 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.281 -0.887 . . . . 0.0 109.732 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 107.37 -20.77 32.06 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.57 128.5 38.39 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.579 ' HB3' HG21 ' A' ' 46' ' ' THR . 52.0 Cg_endo -76.94 162.24 32.3 Favored 'Trans proline' 0 C--N 1.319 -0.992 0 O-C-N 123.166 1.087 . . . . 0.0 111.304 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.747 HD21 HD12 ' A' ' 106' ' ' LEU . 2.8 mp -116.56 125.11 51.4 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.63 HD12 ' N ' ' A' ' 144' ' ' LEU . 6.5 mp -116.67 129.99 56.47 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.466 -0.771 . . . . 0.0 111.424 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 29.5 p -80.63 163.75 54.81 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.704 -0.623 . . . . 0.0 109.356 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.41 -14.6 44.81 Favored 'Trans proline' 0 N--CA 1.488 1.154 0 O-C-N 123.162 1.085 . . . . 0.0 111.12 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.6 t -66.89 -40.11 87.67 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.284 -0.885 . . . . 0.0 110.004 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 117.05 32.65 1.49 Allowed Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -132.98 148.24 52.27 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.46 -1.023 . . . . 0.0 110.168 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -72.28 134.78 45.75 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.519 -0.738 . . . . 0.0 110.271 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.549 HG21 HD22 ' A' ' 104' ' ' LEU . 58.0 t -98.52 -59.69 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.513 -0.742 . . . . 0.0 110.145 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -176.16 -170.01 38.35 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 45.4 mt -121.34 143.48 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.614 -0.933 . . . . 0.0 110.323 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -61.12 126.76 28.52 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.577 -0.702 . . . . 0.0 109.668 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -106.74 -64.25 1.2 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.474 -0.767 . . . . 0.0 110.972 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.584 ' HB1' ' O32' ' A' ' 201' ' ' 4P2 . . . -134.1 150.92 51.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.432 -0.792 . . . . 0.0 110.794 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.49 152.9 18.21 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.584 -0.697 . . . . 0.0 109.439 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 46.6 t -120.0 120.01 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.485 -0.759 . . . . 0.0 110.443 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.2 p -140.98 142.16 34.33 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.473 -0.767 . . . . 0.0 110.536 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 92.6 m -70.03 -44.11 69.92 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.58 -0.7 . . . . 0.0 109.865 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -147.93 49.62 1.06 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.651 -0.656 . . . . 0.0 110.133 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.406 ' O ' HG23 ' A' ' 132' ' ' VAL . . . 97.74 -11.19 64.61 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 58.0 t -101.6 123.64 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.195 -1.179 . . . . 0.0 108.97 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.24 118.21 26.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.443 -0.786 . . . . 0.0 111.136 -178.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -111.42 -15.12 13.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.742 -0.599 . . . . 0.0 110.158 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 125' ' ' SER . . . -144.31 167.99 21.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.354 -0.841 . . . . 0.0 109.356 179.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.463 HG13 HD12 ' A' ' 126' ' ' LEU . 35.0 m -137.81 145.05 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.319 -0.863 . . . . 0.0 111.131 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.47 132.44 54.73 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.71 -0.619 . . . . 0.0 110.082 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -142.11 154.05 44.61 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.493 -0.755 . . . . 0.0 110.502 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.584 HG11 HD13 ' A' ' 82' ' ' LEU . 89.5 t -92.46 130.96 35.55 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.588 -0.695 . . . . 0.0 109.803 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.13 160.08 46.2 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 O-C-N 123.193 1.101 . . . . 0.0 110.366 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 61.8 t -69.4 -33.1 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.602 -0.686 . . . . 0.0 109.932 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -60.03 -39.94 87.63 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.475 -0.766 . . . . 0.0 110.595 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.9 m -64.96 -22.91 67.08 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.526 -0.734 . . . . 0.0 111.28 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.436 ' HG2' HD11 ' A' ' 82' ' ' LEU . 65.6 mtt -59.97 -35.63 75.41 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.26 -0.9 . . . . 0.0 110.526 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -59.97 -32.8 71.16 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.576 -0.702 . . . . 0.0 110.652 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 93.9 m -59.94 -40.03 87.55 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.409 -0.807 . . . . 0.0 110.404 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 24.8 m -68.8 -34.19 75.13 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.429 -0.794 . . . . 0.0 110.561 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 44.8 ttp -59.97 -41.86 92.88 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.574 -0.704 . . . . 0.0 110.662 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 58.8 mtt-85 -61.32 -39.92 92.29 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.518 -0.739 . . . . 0.0 110.364 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.764 0 O-C-N 121.528 -0.732 . . . . 0.0 110.245 179.97 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' 4P2 . . . . . 0.584 ' O32' ' HB1' ' A' ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.7 p . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.055 0.455 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 145.12 44.82 0.04 OUTLIER Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -61.3 -40.34 93.79 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.449 -1.03 . . . . 0.0 110.304 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -70.03 -41.04 74.79 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.603 -0.685 . . . . 0.0 110.134 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 72.8 tttt 50.2 40.17 21.44 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.39 -0.819 . . . . 0.0 110.943 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -88.77 62.08 6.27 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.471 -0.768 . . . . 0.0 110.202 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -60.1 -40.04 88.26 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.51 -0.744 . . . . 0.0 110.077 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.421 ' O ' HG12 ' A' ' 29' ' ' VAL . 58.9 t 50.28 70.01 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.504 -0.747 . . . . 0.0 110.997 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -68.91 140.06 55.12 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.46 -0.775 . . . . 0.0 109.693 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -136.58 44.67 1.13 Allowed Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.3 -40.03 89.05 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.438 -1.037 . . . . 0.0 109.942 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.4 t -119.57 138.93 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.716 -0.615 . . . . 0.0 109.614 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -119.43 142.63 48.05 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.511 -0.743 . . . . 0.0 110.569 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.524 ' O ' HG23 ' A' ' 35' ' ' VAL . 34.0 m -85.44 120.4 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.724 -0.61 . . . . 0.0 110.425 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.9 p -130.21 140.0 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.448 -0.783 . . . . 0.0 110.199 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 74.8 m -122.02 149.0 44.13 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.673 -0.642 . . . . 0.0 110.279 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.531 HG22 ' H ' ' A' ' 39' ' ' ALA . 1.0 OUTLIER -110.31 -177.38 3.23 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.639 -0.663 . . . . 0.0 110.004 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.531 ' H ' HG22 ' A' ' 38' ' ' THR . . . -64.5 -40.05 94.94 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.668 -0.645 . . . . 0.0 111.263 -179.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.564 HG23 ' HG3' ' A' ' 41' ' ' GLN . 7.2 t -123.72 -11.7 7.7 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.326 -0.859 . . . . 0.0 111.935 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.564 ' HG3' HG23 ' A' ' 40' ' ' THR . 97.0 mt-30 -136.04 162.95 31.46 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.176 -0.952 . . . . 0.0 110.441 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.6 t -140.24 123.47 16.83 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.566 -0.709 . . . . 0.0 110.426 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -136.17 178.03 7.38 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.587 -0.696 . . . . 0.0 110.012 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.402 ' CD2' ' HA ' ' A' ' 35' ' ' VAL . 82.0 mt -117.46 147.19 42.95 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.523 -0.736 . . . . 0.0 110.636 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -109.97 155.3 21.96 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.719 -0.613 . . . . 0.0 110.081 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.7 p -129.95 144.2 51.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.512 -0.742 . . . . 0.0 110.255 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 34.0 t -100.89 115.82 31.3 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.559 -0.713 . . . . 0.0 110.45 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.4 t -129.98 129.97 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.628 -0.67 . . . . 0.0 109.967 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 52.77 40.12 29.93 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.432 -0.793 . . . . 0.0 111.059 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.623 ' O ' ' HB3' ' A' ' 87' ' ' ALA . . . 67.2 20.99 71.68 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 62.1 t -130.87 123.35 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.293 -1.122 . . . . 0.0 109.922 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 42.3 t -80.7 110.07 15.85 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.48 -0.763 . . . . 0.0 109.564 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 46.7 m95 -97.27 137.58 36.06 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.528 -0.732 . . . . 0.0 110.994 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.882 HG23 HG23 ' A' ' 83' ' ' VAL . 10.1 t -136.63 173.1 12.07 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.727 HG11 ' CE1' ' A' ' 57' ' ' HIS . 45.7 t -80.63 142.57 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.376 -0.827 . . . . 0.0 110.372 -179.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.772 ' CE2' HG22 ' A' ' 78' ' ' VAL . 34.7 t80 -74.96 -43.03 56.36 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.606 -0.684 . . . . 0.0 111.976 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.727 ' CE1' HG11 ' A' ' 55' ' ' VAL . 1.8 p-80 -66.35 -13.85 61.2 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.192 -0.942 . . . . 0.0 110.996 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.9 -88.11 1.47 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.736 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -70.33 -39.97 74.41 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.666 -0.902 . . . . 0.0 110.586 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.93 -27.56 56.83 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.7 m -59.97 -40.42 89.05 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.412 -1.052 . . . . 0.0 110.593 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.7 ttpt -138.26 145.05 40.85 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.485 -0.76 . . . . 0.0 110.468 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 74.9 m -65.9 140.99 58.39 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.609 -0.682 . . . . 0.0 109.903 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.736 HD21 ' HB1' ' A' ' 59' ' ' ALA . 2.5 pp -140.26 147.66 40.3 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.519 -0.738 . . . . 0.0 110.356 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -119.97 136.5 54.51 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.665 -0.647 . . . . 0.0 110.282 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -88.33 -164.44 40.27 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -70.54 -25.9 24.5 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 O-C-N 123.35 1.184 . . . . 0.0 110.454 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -70.03 -31.32 68.91 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.609 -0.682 . . . . 0.0 110.227 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 144.77 -156.27 26.8 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.83 145.41 45.7 Favored 'Trans proline' 0 N--CA 1.486 1.044 0 O-C-N 123.418 1.22 . . . . 0.0 110.613 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 85.5 mt -125.46 131.15 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.597 -0.69 . . . . 0.0 110.127 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.0 m -104.96 131.0 53.03 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.545 -0.722 . . . . 0.0 109.844 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -77.28 109.29 11.04 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.515 -0.741 . . . . 0.0 110.451 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 48.7 tpp -70.01 -35.77 74.61 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.669 -0.644 . . . . 0.0 110.122 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.581 ' O ' HG12 ' A' ' 83' ' ' VAL . 62.5 m-85 -109.67 128.42 55.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.615 -0.678 . . . . 0.0 109.924 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.637 ' HA ' HG12 ' A' ' 83' ' ' VAL . 11.1 p -144.23 121.21 11.37 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.538 -0.726 . . . . 0.0 110.361 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 59.6 t-20 -151.42 110.85 3.97 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.515 -0.74 . . . . 0.0 110.495 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.772 HG22 ' CE2' ' A' ' 56' ' ' TYR . 99.6 t -70.03 -35.36 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.451 -0.781 . . . . 0.0 109.577 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -60.0 -40.17 88.28 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.392 -0.817 . . . . 0.0 109.391 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.503 ' HG2' HD12 ' A' ' 82' ' ' LEU . 66.7 tt0 -89.93 -14.28 34.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.699 -0.626 . . . . 0.0 110.083 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.47 ' HA ' ' HB3' ' A' ' 56' ' ' TYR . 46.5 t0 55.03 40.01 31.81 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.207 -0.933 . . . . 0.0 110.713 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.503 HD12 ' HG2' ' A' ' 80' ' ' GLN . 48.1 mt -144.09 149.6 36.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.512 -0.743 . . . . 0.0 111.165 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.882 HG23 HG23 ' A' ' 54' ' ' THR . 1.9 m -141.24 168.21 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -152.37 156.73 26.87 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 119.747 -1.216 . . . . 0.0 110.318 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -121.71 146.05 47.41 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.705 -0.879 . . . . 0.0 109.919 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -68.44 129.9 41.3 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.594 -0.692 . . . . 0.0 110.028 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.623 ' HB3' ' O ' ' A' ' 50' ' ' GLY . . . -114.14 159.71 35.3 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.526 -0.734 . . . . 0.0 110.131 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.58 154.7 64.34 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 O-C-N 123.413 1.218 . . . . 0.0 110.376 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.51 160.14 44.93 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 O-C-N 123.41 1.216 . . . . 0.0 110.465 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 77.9 28.97 55.69 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -110.3 155.01 22.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.534 -0.98 . . . . 0.0 110.22 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -58.86 146.38 37.61 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.622 -0.673 . . . . 0.0 110.401 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.5 t -143.43 161.56 38.07 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.629 -0.67 . . . . 0.0 110.453 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.452 HD13 ' HA ' ' A' ' 94' ' ' LEU . 2.5 mm? -108.18 144.79 35.12 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.57 -0.706 . . . . 0.0 110.376 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.8 p -95.42 159.42 32.77 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.56 -0.712 . . . . 0.0 110.393 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.84 150.49 49.68 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 O-C-N 123.394 1.207 . . . . 0.0 110.386 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.617 ' CB ' HG12 ' A' ' 151' ' ' VAL . 47.9 t -87.28 128.26 35.17 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.62 -0.675 . . . . 0.0 110.445 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.5 p -136.12 71.79 1.43 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.584 -0.698 . . . . 0.0 109.927 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.6 p -145.4 8.25 1.18 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.473 -0.767 . . . . 0.0 111.916 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 52.59 42.96 58.85 Favored Glycine 0 N--CA 1.499 2.864 0 O-C-N 120.824 -1.172 . . . . 0.0 110.353 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 26.3 t -79.42 116.65 19.78 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.488 -1.007 . . . . 0.0 110.394 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.6 m -70.05 -39.91 75.43 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.603 -0.686 . . . . 0.0 110.275 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -84.27 142.16 30.44 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.609 -0.682 . . . . 0.0 110.402 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 94.9 mt -132.2 152.23 51.41 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.503 -0.748 . . . . 0.0 110.401 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -114.61 136.8 52.65 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.55 -0.719 . . . . 0.0 109.744 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 57.3 tp -110.85 140.13 45.57 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.43 -0.794 . . . . 0.0 110.422 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.3 t -93.69 129.94 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.616 -0.678 . . . . 0.0 109.913 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.4 m -110.01 160.93 16.0 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.47 -0.769 . . . . 0.0 110.519 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 18.0 ptm180 -62.71 -24.58 67.74 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.676 -0.64 . . . . 0.0 110.864 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -95.48 29.19 2.65 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.418 -0.801 . . . . 0.0 110.629 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 55.34 36.28 26.75 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.304 -0.873 . . . . 0.0 110.44 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -109.18 146.43 34.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.644 -0.66 . . . . 0.0 109.849 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.6 p -138.05 135.68 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.511 -0.743 . . . . 0.0 110.526 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.404 HG23 ' HD2' ' A' ' 115' ' ' PRO . 85.4 mt -126.6 143.68 47.16 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.603 -0.685 . . . . 0.0 109.679 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.404 ' HD2' HG23 ' A' ' 114' ' ' ILE . 49.9 Cg_endo -76.79 139.13 19.53 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 O-C-N 123.274 1.144 . . . . 0.0 110.455 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.3 t -124.79 129.94 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.603 -0.686 . . . . 0.0 109.762 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.0 tpp85 -84.24 139.52 32.31 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.531 -0.731 . . . . 0.0 110.022 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -77.2 129.63 36.2 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.543 -0.723 . . . . 0.0 110.152 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -136.59 25.78 3.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.662 -0.649 . . . . 0.0 110.424 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 175.7 179.8 46.42 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -66.78 -40.11 88.06 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.505 -0.997 . . . . 0.0 110.324 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 67.1 m -136.03 25.94 3.28 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.551 -0.718 . . . . 0.0 110.377 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -136.95 159.99 40.24 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.588 -0.695 . . . . 0.0 110.299 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -150.93 -173.71 21.2 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 97.4 p -120.67 153.44 36.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.62 -0.93 . . . . 0.0 110.245 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.7 tp -106.57 123.6 48.34 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.583 -0.698 . . . . 0.0 110.143 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.494 HD12 ' H ' ' A' ' 127' ' ' LEU . 4.7 mp -66.47 -39.99 89.09 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.543 -0.723 . . . . 0.0 110.304 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 30.0 t -100.22 108.47 52.6 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.488 -0.757 . . . . 0.0 110.262 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.33 115.45 4.35 Favored 'Trans proline' 0 C--N 1.319 -0.994 0 O-C-N 123.18 1.094 . . . . 0.0 110.307 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -124.48 160.7 51.93 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.586 -0.696 . . . . 0.0 110.392 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.44 150.52 58.16 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 O-C-N 123.469 1.247 . . . . 0.0 110.567 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 162' ' ' GLY . 95.0 t -57.72 -30.55 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.564 -0.71 . . . . 0.0 110.258 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.5 t -60.07 -40.61 90.1 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.519 -0.738 . . . . 0.0 110.383 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -64.77 -46.02 83.9 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.579 -0.7 . . . . 0.0 109.868 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.474 HD21 ' CZ ' ' A' ' 154' ' ' PHE . 54.1 tp -78.76 -22.59 46.2 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.681 -0.637 . . . . 0.0 110.91 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.468 ' CD ' HG12 ' A' ' 132' ' ' VAL . 22.8 mttt -60.03 136.38 58.0 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.387 -0.821 . . . . 0.0 110.58 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 98.07 -2.35 59.73 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 68.9 m -109.07 16.23 22.72 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.16 -1.2 . . . . 0.0 110.538 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.8 t -62.43 150.15 40.68 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.415 -0.803 . . . . 0.0 109.842 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 90.1 -12.28 68.23 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.37 113.34 5.36 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -70.64 140.9 40.39 Favored 'Trans proline' 0 C--N 1.318 -1.072 0 O-C-N 123.171 1.09 . . . . 0.0 110.981 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.45 ' O ' HG22 ' A' ' 151' ' ' VAL . 21.7 mt -87.51 125.22 34.19 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.468 HD13 ' HA ' ' A' ' 144' ' ' LEU . 4.1 mm? -110.41 160.02 16.96 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.322 0.582 . . . . 0.0 110.856 -178.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -109.6 176.18 1.65 Allowed Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.76 -0.587 . . . . 0.0 109.681 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.77 -35.67 12.18 Favored 'Trans proline' 0 C--N 1.317 -1.081 0 O-C-N 123.292 1.154 . . . . 0.0 110.064 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.8 m -62.43 -40.03 95.24 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.605 -0.684 . . . . 0.0 109.756 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 120.21 36.01 0.84 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 45.5 m170 -126.26 138.14 53.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.523 -0.987 . . . . 0.0 110.146 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.17 140.37 38.97 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.508 -0.745 . . . . 0.0 110.119 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.617 HG12 ' CB ' ' A' ' 97' ' ' CYS . 34.3 m -105.95 -26.51 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.571 -0.705 . . . . 0.0 110.56 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 172.72 -164.49 36.67 Favored Glycine 0 N--CA 1.498 2.77 0 C-N-CA 119.674 -1.25 . . . . 0.0 110.571 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 82.6 mt -130.98 141.83 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.67 -0.9 . . . . 0.0 109.896 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.474 ' CZ ' HD21 ' A' ' 135' ' ' LEU . 20.3 t80 -60.16 130.02 44.61 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.52 -0.737 . . . . 0.0 110.209 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.408 ' HD2' ' CG2' ' A' ' 170' ' ' VAL . 67.8 ttt180 -104.49 -72.96 0.69 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.515 -0.741 . . . . 0.0 110.792 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.683 ' HB1' ' O32' ' A' ' 201' ' ' 4P2 . . . -132.29 152.96 51.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.306 -0.871 . . . . 0.0 110.867 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.48 156.29 16.53 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.648 -0.658 . . . . 0.0 109.757 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 60.7 t -120.78 115.77 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.601 -0.687 . . . . 0.0 110.248 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 27.4 p -141.35 146.28 36.46 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.461 -0.774 . . . . 0.0 110.711 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 12.2 m -82.3 -49.16 10.36 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.539 -0.725 . . . . 0.0 110.006 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -129.88 46.44 2.65 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.601 -0.687 . . . . 0.0 110.203 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.516 ' O ' HG23 ' A' ' 132' ' ' VAL . . . 91.78 -10.99 73.33 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 67.2 t -97.61 122.78 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.156 -1.202 . . . . 0.0 109.38 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.55 116.36 25.62 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.542 -0.724 . . . . 0.0 110.9 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 67.5 mttt -104.27 -29.1 11.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.688 -0.633 . . . . 0.0 109.586 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -128.44 157.38 41.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.705 -0.622 . . . . 0.0 109.55 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 31.7 m -133.07 139.99 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.442 -0.786 . . . . 0.0 110.774 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -119.32 133.54 55.68 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.606 -0.683 . . . . 0.0 110.347 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -134.5 156.67 48.21 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.554 -0.716 . . . . 0.0 110.146 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.408 ' CG2' ' HD2' ' A' ' 155' ' ' ARG . 57.5 t -96.2 133.84 24.48 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.507 -0.746 . . . . 0.0 110.254 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.01 159.96 40.68 Favored 'Trans proline' 0 N--CA 1.485 0.988 0 O-C-N 123.253 1.133 . . . . 0.0 110.465 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 59.5 t -72.66 -26.32 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.625 -0.672 . . . . 0.0 110.223 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -59.64 -36.82 77.13 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.458 -0.776 . . . . 0.0 110.46 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 22.9 t -61.17 -38.62 87.15 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.587 -0.696 . . . . 0.0 110.162 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.475 ' HE2' HD13 ' A' ' 82' ' ' LEU . 66.1 mtt -60.04 -34.2 73.07 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.537 -0.727 . . . . 0.0 110.35 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -60.02 -40.34 88.95 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.534 -0.728 . . . . 0.0 110.459 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 94.5 m -65.99 -40.09 90.88 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.523 -0.736 . . . . 0.0 109.67 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 93.9 m -62.89 -40.01 96.23 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.662 -0.649 . . . . 0.0 110.067 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 89.1 mtp -60.08 -40.05 88.22 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.539 -0.726 . . . . 0.0 110.431 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -67.28 -39.97 86.08 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.601 -0.687 . . . . 0.0 110.087 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.798 0 O-C-N 121.593 -0.692 . . . . 0.0 110.251 -179.935 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' 4P2 . . . . . 0.689 ' C24' HG13 ' A' ' 78' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.8 p . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.049 0.452 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.01 85.5 1.0 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.92 139.92 50.16 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.568 -0.96 . . . . 0.0 110.712 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -117.76 25.31 10.48 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.506 -0.746 . . . . 0.0 110.362 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.719 ' O ' HG23 ' A' ' 29' ' ' VAL . 57.9 mttt -102.67 -55.78 2.37 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.404 -0.81 . . . . 0.0 110.328 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 35.96 -90.9 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.901 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -112.41 -70.89 0.78 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.048 -1.033 . . . . 0.0 110.636 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 26' ' ' LYS . 57.6 t 57.53 162.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 CA-C-O 121.569 0.7 . . . . 0.0 110.578 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.416 ' N ' HG12 ' A' ' 29' ' ' VAL . 20.5 mt-10 50.03 -170.5 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.329 -0.857 . . . . 0.0 111.185 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.63 -88.05 0.43 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -76.87 -23.05 52.63 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.552 -0.969 . . . . 0.0 110.604 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.6 t -101.71 124.98 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.42 -0.8 . . . . 0.0 109.978 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -104.62 132.29 51.03 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.521 -0.737 . . . . 0.0 110.362 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.596 HG12 HD22 ' A' ' 44' ' ' LEU . 32.9 m -94.98 129.8 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.644 -0.66 . . . . 0.0 110.116 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.2 m -130.05 159.97 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.353 -0.842 . . . . 0.0 110.772 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 69.0 m -132.76 152.83 51.68 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.544 -0.723 . . . . 0.0 110.152 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.521 HG22 ' H ' ' A' ' 39' ' ' ALA . 0.7 OUTLIER -115.56 -176.53 2.94 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.543 -0.723 . . . . 0.0 110.093 -179.803 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.521 ' H ' HG22 ' A' ' 38' ' ' THR . . . -60.09 -49.6 77.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.74 -0.6 . . . . 0.0 111.049 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.68 HG23 ' HG3' ' A' ' 41' ' ' GLN . 7.6 t -116.99 -22.48 8.43 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.393 -0.817 . . . . 0.0 111.293 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.68 ' HG3' HG23 ' A' ' 40' ' ' THR . 59.9 mt-30 -117.14 164.94 14.0 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.389 -0.819 . . . . 0.0 110.187 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.5 m -147.93 120.19 8.37 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.499 -0.751 . . . . 0.0 110.303 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.454 ' HZ ' HD11 ' A' ' 64' ' ' LEU . 27.3 p90 -130.98 -176.66 4.07 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.629 -0.67 . . . . 0.0 110.049 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.596 HD22 HG12 ' A' ' 35' ' ' VAL . 48.9 mt -122.4 173.36 7.7 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.502 -0.748 . . . . 0.0 109.893 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -150.68 160.83 43.57 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.564 -0.71 . . . . 0.0 110.355 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.451 HG21 ' HB3' ' A' ' 142' ' ' PRO . 8.2 t -136.61 144.1 43.91 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.669 -0.644 . . . . 0.0 110.172 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 28.5 p -87.92 123.71 32.95 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.589 -0.695 . . . . 0.0 110.763 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.6 t -130.61 125.26 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.52 -0.737 . . . . 0.0 110.174 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 51.34 40.72 27.05 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.389 -0.819 . . . . 0.0 111.335 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.95 22.77 77.2 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.439 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 60.8 t -142.26 113.62 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.396 -1.061 . . . . 0.0 109.53 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 93.3 m -79.73 125.27 29.44 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.641 -0.662 . . . . 0.0 110.205 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.439 ' CZ2' HG11 ' A' ' 51' ' ' VAL . 98.5 m95 -114.26 136.48 52.92 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.585 -0.697 . . . . 0.0 110.102 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.805 HG23 HG23 ' A' ' 83' ' ' VAL . 7.9 t -137.85 -179.87 6.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.656 -0.653 . . . . 0.0 109.968 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.469 HG11 ' CE1' ' A' ' 57' ' ' HIS . 2.1 t -81.69 141.59 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.503 -0.748 . . . . 0.0 109.415 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.862 ' CE2' HG22 ' A' ' 78' ' ' VAL . 9.6 t80 -85.49 -43.81 13.25 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.392 -0.818 . . . . 0.0 111.85 -179.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.469 ' CE1' HG11 ' A' ' 55' ' ' VAL . 3.1 p-80 -57.76 -17.83 17.89 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.204 -0.935 . . . . 0.0 111.672 -177.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.75 -53.87 2.78 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.412 ' HB2' ' CZ ' ' A' ' 43' ' ' PHE . . . -80.2 -63.39 1.42 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.621 -0.929 . . . . 0.0 109.779 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.89 -169.05 14.19 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 95.8 p -66.13 -35.07 79.53 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.603 -0.939 . . . . 0.0 110.286 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -60.04 136.78 58.12 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.513 -0.742 . . . . 0.0 110.261 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.1 t -80.83 175.55 10.59 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.573 -0.704 . . . . 0.0 110.094 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.454 HD11 ' HZ ' ' A' ' 43' ' ' PHE . 61.7 mt -97.9 137.21 37.08 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.571 -0.706 . . . . 0.0 110.622 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -100.54 109.8 21.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.62 -0.675 . . . . 0.0 110.075 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -86.02 -158.48 30.95 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.14 -36.66 16.31 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 O-C-N 123.381 1.201 . . . . 0.0 110.347 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.9 mmmt -76.85 -31.31 56.76 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.556 -0.715 . . . . 0.0 110.377 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 138.26 176.84 14.78 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.34 172.9 14.7 Favored 'Trans proline' 0 N--CA 1.486 1.041 0 O-C-N 123.425 1.224 . . . . 0.0 110.468 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.449 HD11 ' CD1' ' A' ' 85' ' ' TRP . 44.2 pt -131.88 169.99 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.565 -0.71 . . . . 0.0 110.335 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.4 m -72.41 139.21 47.66 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.503 -0.748 . . . . 0.0 110.267 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -74.32 131.07 40.81 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.625 -0.672 . . . . 0.0 110.087 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.426 ' HG3' ' CD2' ' A' ' 75' ' ' TYR . 22.8 ptp -119.69 -42.49 2.63 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.45 -0.781 . . . . 0.0 110.751 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.491 ' O ' HG12 ' A' ' 83' ' ' VAL . 35.0 m-85 -119.98 114.3 21.82 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.265 -0.897 . . . . 0.0 110.088 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.6 m -152.7 131.62 12.52 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.553 -0.717 . . . . 0.0 110.187 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -169.89 125.39 0.81 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.281 -0.887 . . . . 0.0 111.279 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.862 HG22 ' CE2' ' A' ' 56' ' ' TYR . 76.3 t -72.48 -38.17 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.395 -0.816 . . . . 0.0 109.593 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -55.65 -34.22 64.76 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.386 -0.821 . . . . 0.0 110.364 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -98.99 -12.21 20.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.655 -0.653 . . . . 0.0 110.628 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.536 ' O ' HD12 ' A' ' 82' ' ' LEU . 42.8 t0 53.28 40.06 30.71 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.093 -1.004 . . . . 0.0 110.501 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.546 HD22 ' CE ' ' A' ' 175' ' ' MET . 0.2 OUTLIER -141.48 151.03 42.99 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.786 0.803 . . . . 0.0 110.979 -179.608 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.805 HG23 HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -146.32 153.07 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.349 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -153.14 159.25 28.42 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.474 -1.346 . . . . 0.0 110.816 -178.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.473 ' CH2' HG21 ' A' ' 54' ' ' THR . 6.3 m-90 -131.43 168.37 17.72 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.997 -0.707 . . . . 0.0 109.307 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.419 ' H ' ' HE1' ' A' ' 74' ' ' MET . 8.1 mm-40 -68.82 138.51 54.82 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.429 -0.794 . . . . 0.0 110.425 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.38 148.69 45.13 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.577 -0.702 . . . . 0.0 110.109 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.12 144.43 37.6 Favored 'Trans proline' 0 C--N 1.318 -1.065 0 O-C-N 123.29 1.153 . . . . 0.0 110.394 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -77.39 160.26 32.37 Favored 'Trans proline' 0 C--N 1.318 -1.034 0 O-C-N 123.345 1.182 . . . . 0.0 110.548 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 89.61 30.01 14.7 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -151.99 167.84 27.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.55 -0.971 . . . . 0.0 110.301 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -113.76 159.44 19.75 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.515 -0.74 . . . . 0.0 110.123 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.3 m -129.12 171.11 12.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.492 -0.755 . . . . 0.0 110.523 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -81.25 165.08 21.78 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.703 -0.623 . . . . 0.0 110.557 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.453 ' CG2' ' CD2' ' A' ' 149' ' ' HIS . 9.4 t -110.85 151.73 43.11 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.655 -0.653 . . . . 0.0 109.909 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.07 130.29 21.23 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 O-C-N 123.245 1.129 . . . . 0.0 110.232 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.864 ' SG ' 'ZN ' ' A' ' 202' ' ' ' ZN' . 5.0 t -72.31 145.09 48.06 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.64 -0.663 . . . . 0.0 110.538 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 31.3 m -136.28 66.19 1.5 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.573 -0.704 . . . . 0.0 110.477 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 27.7 p -145.01 -8.01 0.62 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.467 -0.771 . . . . 0.0 112.387 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.94 43.71 97.83 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.4 t -71.92 129.87 39.64 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.528 -0.983 . . . . 0.0 110.268 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 73.4 m -71.34 -40.3 70.81 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.563 -0.71 . . . . 0.0 110.267 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -79.75 130.02 34.98 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.518 -0.739 . . . . 0.0 110.328 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 95.9 mt -136.57 151.97 49.96 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.553 -0.717 . . . . 0.0 110.378 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -106.97 123.27 47.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.462 -0.774 . . . . 0.0 109.75 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.482 HD13 HD11 ' A' ' 143' ' ' LEU . 41.0 tp -110.05 140.31 44.24 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.516 -0.74 . . . . 0.0 110.386 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 26.7 m -112.27 141.23 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.584 -0.697 . . . . 0.0 109.954 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.495 HG23 ' OD1' ' A' ' 112' ' ' ASP . 15.5 p -109.85 -162.65 0.81 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.365 -0.834 . . . . 0.0 109.949 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.448 ' HA ' HD11 ' A' ' 44' ' ' LEU . 23.2 ttp180 -70.1 -23.62 63.08 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.653 -0.654 . . . . 0.0 110.353 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -91.68 19.69 6.16 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.37 -0.831 . . . . 0.0 111.01 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 54.13 24.76 5.08 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.124 -0.985 . . . . 0.0 111.024 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.495 ' OD1' HG23 ' A' ' 108' ' ' THR . 54.7 p-10 -81.0 161.74 24.12 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.477 -0.764 . . . . 0.0 109.914 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.0 p -129.35 133.11 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.626 -0.671 . . . . 0.0 110.062 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.4 tp -143.59 138.38 15.3 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.529 -0.732 . . . . 0.0 109.929 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.464 ' HG2' HD13 ' A' ' 127' ' ' LEU . 47.0 Cg_endo -73.35 139.28 28.71 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 O-C-N 123.201 1.106 . . . . 0.0 110.556 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.578 HG13 ' O ' ' A' ' 125' ' ' SER . 62.3 t -129.93 130.04 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.517 -0.74 . . . . 0.0 109.876 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -81.95 149.02 28.4 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.476 -0.765 . . . . 0.0 110.144 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -83.42 137.18 34.03 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.661 -0.649 . . . . 0.0 110.369 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.6 mmt85 -141.28 26.49 1.99 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.58 -0.7 . . . . 0.0 110.381 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 161.65 171.95 28.39 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -71.66 -45.16 62.81 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.556 -0.967 . . . . 0.0 110.443 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 61.3 p -116.83 20.09 14.09 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.553 -0.717 . . . . 0.0 110.732 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 25.3 ttp180 -147.77 144.21 28.07 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.399 -0.813 . . . . 0.0 110.009 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -139.85 -175.23 14.17 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.578 ' O ' HG13 ' A' ' 116' ' ' VAL . 57.3 p -119.72 147.53 44.48 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.61 -0.936 . . . . 0.0 110.026 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 34.7 tp -95.06 131.23 41.27 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.584 -0.698 . . . . 0.0 110.205 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.464 HD13 ' HG2' ' A' ' 115' ' ' PRO . 1.4 tt -63.03 -54.58 35.95 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.612 -0.68 . . . . 0.0 110.258 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 57.8 m -96.51 130.05 31.62 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.445 -0.784 . . . . 0.0 110.156 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -81.25 116.32 3.02 Favored 'Trans proline' 0 C--N 1.32 -0.939 0 O-C-N 123.132 1.07 . . . . 0.0 110.677 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.422 ' HD2' ' CD2' ' A' ' 134' ' ' TYR . 54.6 mtm-85 -125.09 152.6 70.86 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.518 -0.739 . . . . 0.0 109.779 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.3 150.22 64.62 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 123.369 1.194 . . . . 0.0 110.759 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.421 HG21 ' SG ' ' A' ' 159' ' ' CYS . 51.6 t -54.33 -31.72 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.442 -0.786 . . . . 0.0 109.701 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.6 t -59.9 -40.38 88.59 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.746 -0.596 . . . . 0.0 111.095 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.422 ' CD2' ' HD2' ' A' ' 130' ' ' ARG . 86.3 t80 -68.95 -39.81 79.3 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.342 -0.849 . . . . 0.0 109.685 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 23.2 tp -94.67 18.75 11.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.885 -0.51 . . . . 0.0 110.187 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.408 ' HA ' ' C48' ' A' ' 201' ' ' 4P2 . 0.2 OUTLIER -83.64 118.47 23.87 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 122.658 1.218 . . . . 0.0 112.317 -178.879 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.8 26.35 8.04 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.3 p -109.96 20.94 17.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.529 -0.983 . . . . 0.0 110.621 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.6 m -66.39 144.59 56.44 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.337 -0.852 . . . . 0.0 109.342 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.75 -18.2 57.05 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.63 110.37 2.3 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.451 ' HB3' HG21 ' A' ' 46' ' ' THR . 44.3 Cg_endo -71.05 161.45 45.98 Favored 'Trans proline' 0 C--N 1.318 -1.048 0 O-C-N 123.168 1.088 . . . . 0.0 111.054 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.553 ' O ' HG22 ' A' ' 151' ' ' VAL . 5.1 mp -113.99 119.71 38.15 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.0 tp -96.51 167.34 11.21 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.426 0.631 . . . . 0.0 110.833 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.407 ' CB ' ' HD2' ' A' ' 146' ' ' PRO . 0.1 OUTLIER -108.2 178.49 1.05 Allowed Pre-proline 0 N--CA 1.493 1.701 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.7 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.407 ' HD2' ' CB ' ' A' ' 145' ' ' CYS . 42.9 Cg_endo -69.05 -25.37 31.95 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 O-C-N 123.258 1.136 . . . . 0.0 110.339 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 83.0 p -79.81 -28.58 40.19 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.514 -0.741 . . . . 0.0 110.088 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 115.55 35.01 1.34 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.453 ' CD2' ' CG2' ' A' ' 95' ' ' THR . 22.9 m170 -122.79 153.64 39.27 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.579 -0.953 . . . . 0.0 110.365 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -88.69 144.24 26.4 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.474 -0.766 . . . . 0.0 110.199 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.648 ' O ' HG23 ' A' ' 172' ' ' VAL . 35.1 m -119.14 -24.26 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.476 -0.765 . . . . 0.0 111.067 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -179.73 -173.08 44.48 Favored Glycine 0 N--CA 1.498 2.829 0 C-N-CA 119.672 -1.252 . . . . 0.0 110.385 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 64.0 mt -130.0 159.23 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.562 -0.964 . . . . 0.0 110.033 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -73.77 144.62 45.56 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.55 -0.718 . . . . 0.0 110.248 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 -129.57 -75.97 0.55 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.534 -0.729 . . . . 0.0 110.264 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -120.41 142.35 49.29 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.154 -0.966 . . . . 0.0 110.992 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.52 127.33 39.12 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.471 HG13 ' C11' ' A' ' 201' ' ' 4P2 . 2.4 t -97.83 119.5 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.532 -0.73 . . . . 0.0 111.388 -177.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.421 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.3 p -141.15 151.74 44.13 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.547 -0.721 . . . . 0.0 110.43 178.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 6.8 p -93.7 -48.19 6.44 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.511 -0.743 . . . . 0.0 109.511 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 50.9 mtt85 -119.97 36.7 4.44 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 91.9 -11.57 71.79 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 63.7 t -89.16 123.66 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.178 -1.189 . . . . 0.0 109.284 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.18 114.3 23.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.526 -0.734 . . . . 0.0 110.838 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -107.14 -29.99 9.04 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.809 -0.557 . . . . 0.0 109.64 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -118.47 168.25 10.83 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.668 -0.645 . . . . 0.0 109.863 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.9 m -143.21 131.83 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.498 -0.751 . . . . 0.0 110.702 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.31 127.84 47.74 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.613 -0.679 . . . . 0.0 110.231 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -136.27 162.15 33.79 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.556 -0.715 . . . . 0.0 110.588 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.47 HG13 ' HD2' ' A' ' 171' ' ' PRO . 90.1 t -104.86 144.71 29.28 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.463 -0.773 . . . . 0.0 110.033 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.47 ' HD2' HG13 ' A' ' 170' ' ' VAL . 45.1 Cg_endo -71.41 168.15 24.31 Favored 'Trans proline' 0 N--CA 1.486 1.056 0 O-C-N 123.318 1.168 . . . . 0.0 110.709 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 151' ' ' VAL . 61.4 t -92.44 -45.99 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.606 -0.684 . . . . 0.0 110.467 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -54.61 -28.88 49.67 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.693 -0.629 . . . . 0.0 111.304 -178.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.661 ' O ' HG22 ' A' ' 177' ' ' THR . 4.3 m -61.62 -25.91 67.65 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.378 -0.826 . . . . 0.0 110.279 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.546 ' CE ' HD22 ' A' ' 82' ' ' LEU . 32.8 mmt -70.12 -27.35 64.5 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.498 -0.751 . . . . 0.0 110.641 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -56.83 -41.78 78.46 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.448 -0.783 . . . . 0.0 111.059 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.661 HG22 ' O ' ' A' ' 174' ' ' SER . 7.4 t -73.9 -22.09 59.83 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.405 -0.809 . . . . 0.0 110.556 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 76.7 m -72.0 -39.94 68.87 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.384 -0.823 . . . . 0.0 110.344 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 26.2 ttp -59.98 -44.57 94.41 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.681 -0.637 . . . . 0.0 110.5 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 26.4 mmt85 -60.01 -39.9 87.39 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.531 -0.731 . . . . 0.0 110.389 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.789 0 O-C-N 121.571 -0.706 . . . . 0.0 110.09 179.976 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' 4P2 . . . . . 0.759 ' C24' HG13 ' A' ' 78' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . 0.864 'ZN ' ' SG ' ' A' ' 97' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.5 m . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.088 0.47 . . . . 0.0 110.15 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.7 -71.41 0.08 OUTLIER Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -39.98 89.07 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.536 -0.979 . . . . 0.0 110.206 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -60.45 131.52 51.02 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.506 -0.746 . . . . 0.0 110.505 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -147.11 27.55 1.04 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.547 -0.72 . . . . 0.0 110.277 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -94.19 152.55 18.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.504 -0.748 . . . . 0.0 110.349 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 32.2 tp60 -99.56 123.1 43.51 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.544 -0.722 . . . . 0.0 110.06 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.7 t -129.98 136.4 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.635 -0.665 . . . . 0.0 110.096 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -60.02 146.0 44.35 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.468 -0.77 . . . . 0.0 110.342 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.53 68.11 0.01 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 56.23 -84.59 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.771 -0.841 . . . . 0.0 111.008 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.854 HG11 ' HD3' ' A' ' 142' ' ' PRO . 19.3 m -118.92 162.22 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.182 -0.949 . . . . 0.0 110.947 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 22.2 mm100 -136.87 125.2 23.28 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.572 ' O ' HG23 ' A' ' 35' ' ' VAL . 34.5 m -73.76 116.42 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.585 -0.697 . . . . 0.0 109.957 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.587 HG22 ' O ' ' A' ' 43' ' ' PHE . 35.9 m -110.75 152.03 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.431 -0.793 . . . . 0.0 110.157 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.1 m -115.7 125.38 52.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.581 -0.699 . . . . 0.0 110.366 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.05 -169.61 1.89 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.655 -0.653 . . . . 0.0 109.538 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.16 -51.23 70.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.583 -0.698 . . . . 0.0 110.894 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.662 HG23 ' HG3' ' A' ' 41' ' ' GLN . 7.9 t -127.65 0.99 6.15 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.404 -0.81 . . . . 0.0 111.817 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.662 ' HG3' HG23 ' A' ' 40' ' ' THR . 70.1 mt-30 -140.38 171.26 14.4 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.004 -1.06 . . . . 0.0 110.499 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 77.7 p -145.4 131.38 19.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.618 -0.676 . . . . 0.0 110.157 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.587 ' O ' HG22 ' A' ' 36' ' ' VAL . 13.5 p90 -130.21 -175.33 3.6 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.521 -0.737 . . . . 0.0 110.314 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.447 HD23 ' HB ' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -119.44 159.0 25.09 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.455 -0.778 . . . . 0.0 110.633 -179.511 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -126.67 119.56 27.31 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.606 -0.683 . . . . 0.0 110.015 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.772 HG22 HG12 ' A' ' 33' ' ' VAL . 19.0 p -101.8 144.08 30.91 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.496 -0.752 . . . . 0.0 110.504 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 26.3 p -100.68 110.23 22.33 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.683 0.754 . . . . 0.0 110.238 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.3 t -130.25 130.02 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.174 -0.954 . . . . 0.0 110.258 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.427 ' O ' HG23 ' A' ' 51' ' ' VAL . 97.0 m-20 52.73 39.43 28.57 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.4 -0.813 . . . . 0.0 111.116 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.46 24.76 71.06 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 49' ' ' ASN . 60.5 t -135.15 122.73 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.368 -1.077 . . . . 0.0 109.666 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 54.5 m -79.27 111.38 15.46 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.56 -0.712 . . . . 0.0 109.782 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.434 ' CE3' HD23 ' A' ' 82' ' ' LEU . 52.3 m95 -98.6 136.82 38.14 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.528 -0.733 . . . . 0.0 110.82 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.878 HG21 ' CH2' ' A' ' 85' ' ' TRP . 6.4 t -137.36 179.99 6.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.711 -0.618 . . . . 0.0 109.547 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.855 HG21 ' HB3' ' A' ' 139' ' ' SER . 79.0 t -85.47 141.7 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.471 -0.768 . . . . 0.0 109.379 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.886 ' CE2' HG22 ' A' ' 78' ' ' VAL . 15.7 t80 -85.37 -43.68 13.45 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.487 -0.758 . . . . 0.0 111.381 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.59 ' CE1' HG11 ' A' ' 55' ' ' VAL . 2.0 p-80 -60.68 -17.43 47.74 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.308 -0.87 . . . . 0.0 111.419 -178.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -103.1 -62.11 0.7 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -96.1 -23.57 16.71 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.534 -0.98 . . . . 0.0 111.011 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.414 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -59.99 -40.05 96.46 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.1 t -70.14 -39.78 75.17 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.523 -0.986 . . . . 0.0 110.864 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.496 ' NZ ' HG22 ' A' ' 40' ' ' THR . 47.3 mtpt -99.61 178.9 4.72 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.416 -0.803 . . . . 0.0 110.828 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.417 HG22 ' N ' ' A' ' 64' ' ' LEU . 15.4 m -81.19 169.94 16.74 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.695 -0.628 . . . . 0.0 110.23 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.438 ' CD2' ' CZ2' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -100.85 147.38 26.17 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.492 -0.755 . . . . 0.0 110.589 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.03 123.81 44.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.643 -0.661 . . . . 0.0 110.005 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -142.66 -174.27 14.98 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.4 -45.15 2.78 Favored 'Trans proline' 0 C--N 1.318 -1.072 0 O-C-N 123.402 1.212 . . . . 0.0 110.619 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 38.6 tptt -70.05 -31.2 68.7 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.511 -0.743 . . . . 0.0 110.133 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.56 -159.89 22.1 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.72 153.09 53.84 Favored 'Trans proline' 0 C--N 1.318 -1.053 0 O-C-N 123.345 1.181 . . . . 0.0 110.344 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 41.6 pt -129.99 160.16 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.577 -0.702 . . . . 0.0 110.345 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.9 t -71.32 150.3 45.26 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.602 -0.687 . . . . 0.0 110.177 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -94.41 131.15 40.38 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.528 -0.732 . . . . 0.0 110.147 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.453 ' CE ' ' CE2' ' A' ' 75' ' ' TYR . 25.4 ptm -116.54 -37.47 3.7 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.555 -0.716 . . . . 0.0 110.165 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.453 ' CE2' ' CE ' ' A' ' 74' ' ' MET . 28.1 m-85 -111.26 119.6 39.44 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.537 -0.727 . . . . 0.0 109.373 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 88.0 m -148.6 126.06 11.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.48 -0.763 . . . . 0.0 110.277 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -165.43 123.48 1.59 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.384 -0.823 . . . . 0.0 111.307 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.886 HG22 ' CE2' ' A' ' 56' ' ' TYR . 79.7 t -72.36 -34.08 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.478 -0.764 . . . . 0.0 109.376 178.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -55.7 -44.77 77.72 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.567 -0.708 . . . . 0.0 110.536 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -90.76 -10.38 43.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.606 -0.684 . . . . 0.0 110.522 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.82 ' O ' HD12 ' A' ' 82' ' ' LEU . 48.5 t0 53.13 40.36 31.11 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.185 -0.947 . . . . 0.0 110.654 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.82 HD12 ' O ' ' A' ' 81' ' ' ASP . 1.0 OUTLIER -141.62 160.46 40.11 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.884 0.849 . . . . 0.0 111.098 -179.412 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.402 ' HB ' ' CG2' ' A' ' 54' ' ' THR . 1.6 t -138.35 164.43 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.406 ' O ' ' CD1' ' A' ' 85' ' ' TRP . . . -153.68 155.15 25.98 Favored Glycine 0 N--CA 1.496 2.653 0 C-N-CA 119.497 -1.335 . . . . 0.0 110.87 -179.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.878 ' CH2' HG21 ' A' ' 54' ' ' THR . 4.5 m-90 -141.93 163.57 32.52 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.877 -0.778 . . . . 0.0 109.332 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -73.41 122.98 22.97 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.479 -0.763 . . . . 0.0 109.881 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.11 154.88 40.53 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.57 -0.706 . . . . 0.0 110.26 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.98 146.14 41.19 Favored 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.467 1.246 . . . . 0.0 110.359 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -76.86 160.08 34.21 Favored 'Trans proline' 0 C--N 1.317 -1.1 0 O-C-N 123.394 1.208 . . . . 0.0 110.43 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.25 28.7 12.6 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -133.34 160.4 37.45 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.519 -0.989 . . . . 0.0 110.165 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -79.57 153.44 29.48 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.551 -0.718 . . . . 0.0 110.229 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.8 m -134.68 158.64 43.56 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.533 -0.729 . . . . 0.0 110.305 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.1 mt -108.24 158.33 17.55 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.584 -0.698 . . . . 0.0 110.408 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.408 ' OG1' ' CE1' ' A' ' 149' ' ' HIS . 71.4 p -137.24 163.21 50.65 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.577 -0.702 . . . . 0.0 110.075 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.79 142.62 43.8 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 O-C-N 123.42 1.221 . . . . 0.0 110.151 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.408 ' HB3' ' HB2' ' A' ' 149' ' ' HIS . 30.5 p -84.77 157.88 20.88 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.563 -0.711 . . . . 0.0 110.828 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 98' ' ' THR . 6.5 t -115.94 65.4 0.7 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.2 p -144.65 -8.71 0.64 Allowed 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 120.044 -0.663 . . . . 0.0 112.582 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 50.5 26.75 10.5 Favored Glycine 0 N--CA 1.502 3.049 0 O-C-N 120.778 -1.201 . . . . 0.0 110.609 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 41.6 m -59.11 127.63 33.14 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.446 -1.031 . . . . 0.0 110.645 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 73.6 m -68.74 -40.14 80.0 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.701 -0.624 . . . . 0.0 109.992 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -61.66 139.4 58.29 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.57 -0.706 . . . . 0.0 110.02 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.5 mt -141.73 169.23 17.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.649 -0.657 . . . . 0.0 110.513 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -138.36 128.89 26.31 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.681 -0.637 . . . . 0.0 109.598 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.4 tt -114.88 123.56 49.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.437 -0.789 . . . . 0.0 110.476 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 63.0 t -94.96 109.9 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.674 -0.641 . . . . 0.0 109.511 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 75.1 p -81.91 174.89 10.86 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.465 -0.772 . . . . 0.0 110.478 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -59.92 -22.78 62.88 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.64 -0.663 . . . . 0.0 110.585 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.81 20.18 5.86 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.359 -0.838 . . . . 0.0 110.675 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 52.76 41.6 31.63 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.198 -0.938 . . . . 0.0 110.881 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.758 ' HB3' HD13 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -100.22 121.2 41.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.567 -0.708 . . . . 0.0 110.091 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.697 HG13 ' H ' ' A' ' 114' ' ' ILE . 1.9 p -57.07 -79.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.598 -0.689 . . . . 0.0 111.018 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.758 HD13 ' HB3' ' A' ' 112' ' ' ASP . 2.4 mp 54.69 99.31 0.04 OUTLIER Pre-proline 0 N--CA 1.504 2.238 0 O-C-N 120.726 -1.234 . . . . 0.0 110.227 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.23 164.37 35.24 Favored 'Trans proline' 0 C--N 1.318 -1.051 0 O-C-N 123.226 1.119 . . . . 0.0 110.6 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.58 HG13 ' O ' ' A' ' 125' ' ' SER . 58.2 t -139.9 139.8 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.556 -0.715 . . . . 0.0 109.719 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -93.5 149.9 20.87 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.584 -0.697 . . . . 0.0 110.102 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -76.76 147.51 37.24 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.59 -0.694 . . . . 0.0 110.615 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -154.63 52.34 0.64 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.616 -0.678 . . . . 0.0 109.785 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 126.13 171.25 13.12 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -60.1 -58.89 6.59 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.454 -1.027 . . . . 0.0 109.974 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 57.8 m -112.85 23.74 13.12 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.558 -0.713 . . . . 0.0 109.871 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.682 ' NH2' HG21 ' A' ' 158' ' ' VAL . 0.3 OUTLIER -126.41 136.71 53.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.548 -0.72 . . . . 0.0 109.832 -179.699 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -142.41 169.44 25.46 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.58 ' O ' HG13 ' A' ' 116' ' ' VAL . 20.2 p -111.06 160.57 16.73 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.571 -0.958 . . . . 0.0 109.989 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.73 HD13 HG11 ' A' ' 167' ' ' VAL . 18.1 tp -106.36 126.35 52.13 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.666 -0.646 . . . . 0.0 110.509 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.32 -56.49 14.13 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.596 -0.69 . . . . 0.0 109.999 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 33.1 t -94.81 112.8 59.44 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.61 -0.681 . . . . 0.0 109.872 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.66 107.25 2.27 Favored 'Trans proline' 0 C--N 1.32 -0.969 0 O-C-N 123.25 1.132 . . . . 0.0 110.799 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.516 ' NH2' HD11 ' A' ' 126' ' ' LEU . 80.2 mtm180 -118.84 158.02 48.75 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.63 -0.668 . . . . 0.0 109.9 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.78 150.41 55.93 Favored 'Trans proline' 0 C--N 1.315 -1.204 0 O-C-N 123.433 1.228 . . . . 0.0 110.678 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.416 HG21 ' SG ' ' A' ' 159' ' ' CYS . 55.6 t -53.65 -29.42 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 O-C-N 121.433 -0.792 . . . . 0.0 109.807 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.1 t -59.83 -44.87 93.84 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.656 -0.653 . . . . 0.0 111.213 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -67.32 -38.7 85.34 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.32 -0.862 . . . . 0.0 109.815 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 135' ' ' LEU . 31.2 tp -92.32 18.43 8.35 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.78 -0.575 . . . . 0.0 110.19 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.7 tttm -82.88 118.28 23.33 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 122.57 1.176 . . . . 0.0 112.145 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.71 26.6 7.95 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 17.0 m -105.35 19.93 19.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.642 -0.916 . . . . 0.0 110.141 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.855 ' HB3' HG21 ' A' ' 55' ' ' VAL . 2.4 m -74.17 130.27 39.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.31 -0.869 . . . . 0.0 109.466 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.412 ' HA2' HD11 ' A' ' 153' ' ' ILE . . . 113.59 -26.51 10.1 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.57 131.01 51.84 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.854 ' HD3' HG11 ' A' ' 33' ' ' VAL . 52.2 Cg_endo -85.7 157.84 10.49 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.117 1.062 . . . . 0.0 111.106 -178.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 143' ' ' LEU . 6.8 mp -107.71 123.5 48.62 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 150' ' ' ALA . 4.1 tp -105.34 162.33 13.53 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.519 -0.738 . . . . 0.0 110.823 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.707 ' SG ' 'ZN ' ' A' ' 202' ' ' ' ZN' . 28.9 p -115.39 168.45 8.27 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 37.7 Cg_endo -62.47 -15.36 44.98 Favored 'Trans proline' 0 N--CA 1.488 1.18 0 O-C-N 122.935 0.966 . . . . 0.0 111.103 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.2 t -69.94 -35.09 74.25 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.268 -0.895 . . . . 0.0 109.783 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 117.81 15.36 6.31 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.408 ' CE1' ' OG1' ' A' ' 95' ' ' THR . 0.9 OUTLIER -126.89 170.22 12.46 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.199 -1.177 . . . . 0.0 110.095 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.406 ' HA ' HD12 ' A' ' 144' ' ' LEU . . . -94.5 153.26 18.0 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.437 -0.789 . . . . 0.0 110.816 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 143' ' ' LEU . 35.6 m -119.19 -26.02 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.627 -0.671 . . . . 0.0 110.907 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -172.59 -162.07 24.11 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.412 HD11 ' HA2' ' A' ' 140' ' ' GLY . 11.5 tt -140.11 152.87 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.668 -0.901 . . . . 0.0 109.992 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -64.73 144.35 57.3 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.251 -0.906 . . . . 0.0 111.345 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 9.6 ttt180 -129.81 -70.73 0.63 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.272 0.558 . . . . 0.0 109.851 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -128.82 147.9 50.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.288 -0.882 . . . . 0.0 111.047 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -93.38 158.46 15.72 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.682 HG21 ' NH2' ' A' ' 123' ' ' ARG . 2.5 t -123.29 112.38 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.175 -0.953 . . . . 0.0 111.058 -178.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.416 ' SG ' HG21 ' A' ' 132' ' ' VAL . 28.1 p -138.18 144.03 40.52 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.785 179.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 24.2 m -82.81 -43.98 16.04 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.525 -0.734 . . . . 0.0 109.847 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.52 34.99 4.27 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.638 -0.664 . . . . 0.0 109.974 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 99.55 -11.88 61.36 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 63.3 t -92.81 123.47 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.19 -1.183 . . . . 0.0 109.136 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -87.12 114.22 23.54 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.559 -0.713 . . . . 0.0 111.071 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -104.15 -25.09 13.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.738 -0.601 . . . . 0.0 110.028 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -131.88 168.38 17.96 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.484 -0.76 . . . . 0.0 109.833 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.73 HG11 HD13 ' A' ' 126' ' ' LEU . 36.0 m -141.61 137.36 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.406 -0.809 . . . . 0.0 110.844 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -112.82 140.35 47.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.55 -0.719 . . . . 0.0 110.27 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.4 ' CG ' HD22 ' A' ' 143' ' ' LEU . 50.7 p90 -140.6 159.97 41.05 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.625 -0.672 . . . . 0.0 110.556 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 59.0 t -93.93 135.89 24.35 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.606 -0.684 . . . . 0.0 109.868 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.54 158.45 43.91 Favored 'Trans proline' 0 C--N 1.318 -1.053 0 O-C-N 123.225 1.119 . . . . 0.0 110.515 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.547 HG13 ' CE ' ' A' ' 175' ' ' MET . 79.1 t -77.33 -28.73 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.636 -0.665 . . . . 0.0 110.015 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -59.86 -37.48 79.44 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.435 -0.791 . . . . 0.0 110.429 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 39.0 m -61.65 -35.49 78.07 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.652 -0.655 . . . . 0.0 110.397 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.547 ' CE ' HG13 ' A' ' 172' ' ' VAL . 48.7 mtm -59.99 -30.03 68.85 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.6 -0.688 . . . . 0.0 110.424 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.03 -43.55 95.25 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.502 -0.749 . . . . 0.0 110.302 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 85.1 m -63.55 -40.14 96.21 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.577 -0.702 . . . . 0.0 109.969 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 89.1 m -65.4 -37.21 86.29 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.657 -0.652 . . . . 0.0 110.023 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 19.4 ttt -60.05 -37.96 81.38 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.666 -0.646 . . . . 0.0 110.251 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 39.4 mtp-105 -60.03 -39.74 86.93 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.532 -0.73 . . . . 0.0 110.21 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.749 0 O-C-N 121.509 -0.744 . . . . 0.0 110.18 -179.955 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' 4P2 . . . . . 0.753 ' C24' HG13 ' A' ' 78' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ' ZN' . . . . . 0.707 'ZN ' ' SG ' ' A' ' 145' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_